Citrus Sinensis ID: 005944
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 668 | 2.2.26 [Sep-21-2011] | |||||||
| O22042 | 651 | Mitogen-activated protein | yes | no | 0.953 | 0.978 | 0.671 | 0.0 | |
| O22040 | 666 | Mitogen-activated protein | no | no | 0.947 | 0.950 | 0.561 | 0.0 | |
| Q9FZ36 | 651 | Mitogen-activated protein | no | no | 0.917 | 0.941 | 0.544 | 0.0 | |
| Q54R82 | 942 | Mitogen-activated protein | yes | no | 0.390 | 0.277 | 0.533 | 5e-83 | |
| P28829 | 659 | Protein kinase byr2 OS=Sc | yes | no | 0.404 | 0.409 | 0.510 | 5e-72 | |
| Q56UN5 | 1328 | Mitogen-activated protein | yes | no | 0.390 | 0.196 | 0.492 | 7e-72 | |
| E9Q3S4 | 1311 | Mitogen-activated protein | yes | no | 0.389 | 0.198 | 0.498 | 2e-70 | |
| Q99759 | 626 | Mitogen-activated protein | no | no | 0.404 | 0.431 | 0.467 | 3e-69 | |
| Q9Y2U5 | 619 | Mitogen-activated protein | no | no | 0.402 | 0.434 | 0.487 | 7e-69 | |
| Q61084 | 626 | Mitogen-activated protein | no | no | 0.404 | 0.431 | 0.467 | 1e-68 |
| >sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 829 bits (2142), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 445/663 (67%), Positives = 511/663 (77%), Gaps = 26/663 (3%)
Query: 1 MQDILGSVRRSLVFRST-SGDDG--GGGISGLVEKIGSSIRKSRIGLFSKPAVPALPPIE 57
MQDILGSVRRSLVFRS+ +GDDG GGG+SG V KI SSIR SRIGLFSKP P LP
Sbjct: 1 MQDILGSVRRSLVFRSSLAGDDGTSGGGLSGFVGKINSSIRSSRIGLFSKPP-PGLPAPR 59
Query: 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE 117
K +AP IRWRKGEL+GCGAFGRVYMGMNLDSGELLA+KQVLIA +SASKEKTQ HIRELE
Sbjct: 60 KEEAPSIRWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELE 119
Query: 118 EEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ 177
EEV+LLKNL+HPNIVRYLGT RE DSLNIL+EFVPGGSISSLL KFGSFPE VI MYTKQ
Sbjct: 120 EEVQLLKNLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQ 179
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 237
LLLGLEYLH NGIMHRDIKGANILVDNKGCI+LADFGASKKVVELAT+NGAKSMKGTPYW
Sbjct: 180 LLLGLEYLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYW 239
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297
MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWS+Q+Q+ AA+ HIG TK+HPPIPE L
Sbjct: 240 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDL 299
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATPGMNL 357
S EAKDFL+KCL KEP LR +A+ELLQHPFVTGK Q+P+P +RNS+ E GN I T GMN+
Sbjct: 300 SPEAKDFLMKCLHKEPSLRLSATELLQHPFVTGKRQEPYPAYRNSLTECGNPITTQGMNV 359
Query: 358 RNSMNSLVRRST--GLKDVCEMGSVRCSTVYPE-NLSSGSYWKAGNCDDDMCLIDDKDDF 414
R+S+NSL+RRST GLKDVCE+GS+R S +YP+ + +SG W+ G+ DD+C D DD
Sbjct: 360 RSSINSLIRRSTCSGLKDVCELGSLRSSIIYPQKSNNSGFGWRDGD-SDDLCQT-DMDDL 417
Query: 415 GISESVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQAINEAAGS 474
ESV+ N S DL+KSFNPMC+ TD+W CKFDESP+V +++ N+ S QA G
Sbjct: 418 CNIESVRNNVLSQSTDLNKSFNPMCDSTDNWSCKFDESPKVMKSKSNLLSYQASQLQTGV 477
Query: 475 IGVSKAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEEFYNTLNATG 534
E TF GSS AEDD + TE KIK+FLDEKA DLK+L+TPL EEF+N +N G
Sbjct: 478 --PCDEETSLTFAGGSSVAEDDYKGTELKIKSFLDEKAQDLKRLQTPLLEEFHNAMNP-G 534
Query: 535 HPRG-VGITNGENLMNLPPKSRSPKRLPSRRLSAAVLGAANSASPGHQKDRVSNVNSIQD 593
P+G +G TN NL NLP S++PKRLPSRRLSA + SP R N + +
Sbjct: 535 IPQGALGDTNIYNLPNLPSISKTPKRLPSRRLSAI---SDAMPSPLKSSKRTLNTSRVMQ 591
Query: 594 QALQEIQPPQLNEWKELLLSAQKETISPRMSISERLRKWEEELDEEIERKREMRRQAGVG 653
+P Q+NE + K+ ++ SE RKWEEEL EE+ER RE R AG G
Sbjct: 592 SG---TEPTQVNE-------STKKGVNNSRCFSEIRRKWEEELYEELERHRENLRHAGAG 641
Query: 654 GKA 656
GK
Sbjct: 642 GKT 644
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 680 bits (1755), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/691 (56%), Positives = 478/691 (69%), Gaps = 58/691 (8%)
Query: 1 MQDILGSVRRSLVFRSTSGDDGGG------GISGLVEKIGSSIRKSRIGLFSKPAVPALP 54
MQD GSVRRSLVFR +S DD G+ L +KI S IRKS+I F KP+ P
Sbjct: 1 MQDFFGSVRRSLVFRPSSDDDNQENQPPFPGV--LADKITSCIRKSKI--FIKPSFSPPP 56
Query: 55 PIEKTD-APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHI 113
P D APPI WRKG+L+G GAFG VYMGMNLDSGELLAVKQVLIAAN ASKEKTQAHI
Sbjct: 57 PANTVDMAPPISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHI 116
Query: 114 RELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRM 173
+ELEEEVKLLKNL+HPNIVRYLGT REDD+LNILLEFVPGGSISSLL KFG FPESV+R
Sbjct: 117 QELEEEVKLLKNLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRT 176
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
YT+QLLLGLEYLH + IMHRDIKGANILVDNKGCIKLADFGASK+V ELAT+ GAKSMKG
Sbjct: 177 YTRQLLLGLEYLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKG 236
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI 293
TPYWMAPEVILQTGHSFSADIWSVGCTVIEM TGK PWSQQ++EVAA+F IGTTKSHPPI
Sbjct: 237 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPI 296
Query: 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATP 353
P+ LS +AKDFLLKCLQ+ P LR TASELL+HPFV GK+++ SV+ N ++TP
Sbjct: 297 PDTLSSDAKDFLLKCLQEVPNLRPTASELLKHPFVMGKHKESASTDLGSVL---NNLSTP 353
Query: 354 -GMNLRNSMNSLVRRSTGLKDVCEMGSVRCSTVYP-ENLSSGSYWKA---GNCDDDMCLI 408
+ + N+ ++ + D+C GS+ S V P +++ + + W+ G +DDMCLI
Sbjct: 354 LPLQINNTKSTPDSTCDDVGDMCNFGSLNYSLVDPVKSIQNKNLWQQNDNGGDEDDMCLI 413
Query: 409 DDKDDFGISESVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQAI 468
DD ++F + ++ L KS + + + + KFDESP
Sbjct: 414 DD-ENFLTFDGEMSSTLEKDCHLKKSCDDISDMSIALKSKFDESP--------------- 457
Query: 469 NEAAGSIGVSKAENEFTFPCGS-SAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEEFY 527
G + E+ + C S +EDDDE+TESKIKAFLDEKA DLKKL+TPLYEEFY
Sbjct: 458 -------GNGEKESTMSMECDQPSYSEDDDELTESKIKAFLDEKAADLKKLQTPLYEEFY 510
Query: 528 NTLNATGHPRGV--GITNGE------NLMNLPPKSRSPKRLP-SRRLSAAVLGAANSASP 578
N+L T P + ++N + + LPPKSRSP R P S A + S SP
Sbjct: 511 NSL-ITFSPSCMESNLSNSKREDTARGFLKLPPKSRSPSRGPLGGSPSRATDATSCSKSP 569
Query: 579 GHQKDRVSNVNSIQDQALQEIQPPQLNEWKELLLSAQKETISPRMSISERLRKWEEELDE 638
G R N+N+ D+A Q+ ++ +W+ L++ ++E +S +++SE +KW+EELD+
Sbjct: 570 GSGGSRELNINNGGDEASQDGVSARVTDWRGLVVDTKQE-LSQCVALSEIEKKWKEELDQ 628
Query: 639 EIERKR-EMRRQAGVGGKASSPKYQILVRPR 668
E+ERKR E+ RQAG+G SSP+ + + R R
Sbjct: 629 ELERKRQEIMRQAGLG---SSPRDRGMSRQR 656
|
May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 647 bits (1669), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 379/696 (54%), Positives = 458/696 (65%), Gaps = 83/696 (11%)
Query: 1 MQDILGSVRRSLVFRSTSGDDGGGGI-----SGLVEKIGSSIRKSRIGLFSKPAVPALPP 55
MQD+ GSVRRSLVFRST+ D+ S L +KI S IRKS + F+K P P
Sbjct: 1 MQDLFGSVRRSLVFRSTTDDENQENHPPPFPSLLADKITSCIRKSMV--FAKSQSP---P 55
Query: 56 IEKTDA--PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHI 113
T PPIRWRKG+L+G GAFG VYMGMNLDSGELLAVKQVLI +N ASKEKTQAHI
Sbjct: 56 NNSTVQIKPPIRWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLITSNCASKEKTQAHI 115
Query: 114 RELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRM 173
+ELEEEVKLLKNL+HPNIVRYLGT RED++LNILLEFVPGGSISSLL KFG+FPESV+R
Sbjct: 116 QELEEEVKLLKNLSHPNIVRYLGTVREDETLNILLEFVPGGSISSLLEKFGAFPESVVRT 175
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
YT QLLLGLEYLH + IMHRDIKGANILVDN+GCIKLADFGASK+V ELATI+GAKSMKG
Sbjct: 176 YTNQLLLGLEYLHNHAIMHRDIKGANILVDNQGCIKLADFGASKQVAELATISGAKSMKG 235
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI 293
TPYWMAPEVILQTGHSFSADIWSVGCTVIEM TGK PWSQQ++E+AA+FHIGTTKSHPPI
Sbjct: 236 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEIAAIFHIGTTKSHPPI 295
Query: 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATP 353
P+++S +A DFLLKCLQ+EP LR TASELL+HPFVTGK ++ S M+ N +
Sbjct: 296 PDNISSDANDFLLKCLQQEPNLRPTASELLKHPFVTGKQKESASKDLTSFMD--NSCSPL 353
Query: 354 GMNLRNSMNSLVRRSTGLKDVCEMGSVRCSTVYPE-NLSSGSYWKAGN------CDDDMC 406
L N + S + D+C +GS+ C+ +PE ++ + S N D+DMC
Sbjct: 354 PSELTNITSYQTSTSDDVGDICNLGSLTCTLAFPEKSIQNNSLCLKSNNGYDDDDDNDMC 413
Query: 407 LIDDKDDFGISESVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQ 466
LIDD ++F S + D KS + M E +D CKFDE
Sbjct: 414 LIDD-ENFLTYNGETGPSLDNNTDAKKSCDTMSEISDILKCKFDE--------------- 457
Query: 467 AINEAAGSIGVSKAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEEF 526
N G +K E P S +ED++E+TESKIKAFLD+KA +LKKL+TPLYEEF
Sbjct: 458 --NSGNGETE-TKVSMEVDHP---SYSEDENELTESKIKAFLDDKAAELKKLQTPLYEEF 511
Query: 527 YNTLNATGHPRGV--GITNGEN------LMNLPPKSRSPK-----RLPSRRLSAAVLGAA 573
YN + T P + I N + + LPPKSRSP R PSR AA +
Sbjct: 512 YNGM-ITCSPICMESNINNNKREEAPRGFLKLPPKSRSPSQGHIGRSPSRATDAACCSKS 570
Query: 574 NSASPGHQKDRVSNVNSIQDQALQEIQPPQLNEWKELLLSAQKETISPRMSISERLRKWE 633
+ + SN ++ A++E+ S +++SE RKW+
Sbjct: 571 PESGNSSGAPKNSNASA----------------------GAEQESNSQSVALSEIERKWK 608
Query: 634 EELDEEIERK-REMRRQAGVGGKASSPKYQILVRPR 668
EELD+E+ERK RE+ RQAG+G SSP+ + L R R
Sbjct: 609 EELDQELERKRREITRQAGMG---SSPRDRSLSRHR 641
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function description |
|---|
Score = 309 bits (791), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 142/266 (53%), Positives = 198/266 (74%), Gaps = 5/266 (1%)
Query: 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQV-LIAANSASKEKTQAHIRELEEEVKL 122
I+W+KG+++G G +G VY+G+N D+GEL AVKQ+ ++ NS K K I +E+++
Sbjct: 168 IKWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNM--ILSFSKEIEV 225
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
+++L H NIVRYLGT+ + L++ LE++PGGSISSLLGKFG+F E+VI++YTKQ+L GL
Sbjct: 226 MRSLRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGL 285
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
+LH N I+HRDIKGANIL+D KG +KL+DFG SK ++ KSM+GTPYWMAPEV
Sbjct: 286 SFLHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFS--GIVSQFKSMQGTPYWMAPEV 343
Query: 243 ILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
I QTGH S+DIWS+GC ++EMAT +PPWS + A ++HI ++ S P IP H+S EA
Sbjct: 344 IKQTGHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAF 403
Query: 303 DFLLKCLQKEPYLRSTASELLQHPFV 328
DFL C +++P R A++LL+HPF+
Sbjct: 404 DFLNLCFKRDPKERPDANQLLKHPFI 429
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 273 bits (697), Expect = 5e-72, Method: Compositional matrix adjust.
Identities = 142/278 (51%), Positives = 191/278 (68%), Gaps = 8/278 (2%)
Query: 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIREL 116
E TD I+W +G L+G G+FG+VY+GMN SGEL+AVKQV++ + S SK++ + L
Sbjct: 385 EDTDDQSIKWIRGALIGSGSFGQVYLGMNASSGELMAVKQVILDSVSESKDRHAKLLDAL 444
Query: 117 EEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTK 176
E+ LL+ L+H +IV+YLG+ D LNI LE+VPGGS++ LL +GSF E++++ + K
Sbjct: 445 AGEIALLQELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGSFEETLVKNFIK 504
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN----GAK-SM 231
Q L GLEYLH GI+HRDIKGANILVDNKG IK++DFG SKK +EL + + GA+ S
Sbjct: 505 QTLKGLEYLHSRGIVHRDIKGANILVDNKGKIKISDFGISKK-LELNSTSTKTGGARPSF 563
Query: 232 KGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP 291
+G+ +WMAPEV+ QT H+ DIWS+GC VIEM T K P+ ++ A+F IG P
Sbjct: 564 QGSSFWMAPEVVKQTMHTEKTDIWSLGCLVIEMLTSKHPYP-NCDQMQAIFRIGEN-ILP 621
Query: 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
P ++S A DFL K + LR TASELL HPFV+
Sbjct: 622 EFPSNISSSAIDFLEKTFAIDCNLRPTASELLSHPFVS 659
|
Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q56UN5|M3K19_HUMAN Mitogen-activated protein kinase kinase kinase 19 OS=Homo sapiens GN=MAP3K19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 272 bits (695), Expect = 7e-72, Method: Compositional matrix adjust.
Identities = 134/272 (49%), Positives = 190/272 (69%), Gaps = 11/272 (4%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
PI W KGE++G GA+G VY G+ G+L+AVKQV A ++++K + R+L+EEV L
Sbjct: 1058 PILWTKGEILGKGAYGTVYCGLT-SQGQLIAVKQV--ALDTSNKLAAEKEYRKLQEEVDL 1114
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
LK L H NIV YLGT ++++++I +EFVPGGSISS++ +FG PE V YTKQ+L G+
Sbjct: 1115 LKALKHVNIVAYLGTCLQENTVSIFMEFVPGGSISSIINRFGPLPEMVFCKYTKQILQGV 1174
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA-----KSMKGTPYW 237
YLH+N ++HRDIKG N+++ G IKL DFG ++++ A +NG KSM GTPYW
Sbjct: 1175 AYLHENCVVHRDIKGNNVMLMPTGIIKLIDFGCARRLA-WAGLNGTHSDMLKSMHGTPYW 1233
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS-HPPIPEH 296
MAPEVI ++G+ +DIWS+GCTV EMATGKPP + +AA+F+IG + PP+P+H
Sbjct: 1234 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA-SMDRMAAMFYIGAHRGLMPPLPDH 1292
Query: 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
S A DF+ CL ++ + R +A +LL+H F+
Sbjct: 1293 FSENAADFVRMCLTRDQHERPSALQLLKHSFL 1324
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 267 bits (682), Expect = 2e-70, Method: Compositional matrix adjust.
Identities = 135/271 (49%), Positives = 187/271 (69%), Gaps = 11/271 (4%)
Query: 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLL 123
I W KGE++G GA+G VY G+ G+L+AVKQV A +++ K T+ R+L+EEV LL
Sbjct: 1042 IFWTKGEILGRGAYGTVYCGLT-SLGQLIAVKQV--ALDTSDKLATEKEYRKLQEEVDLL 1098
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLE 183
K L H NIV YLGT E+++L+I +EFVPGGSISS++ +FG PE V YT+Q+L G+
Sbjct: 1099 KALKHVNIVAYLGTCLEENTLSIFMEFVPGGSISSIINRFGPLPEMVFCKYTRQILQGVA 1158
Query: 184 YLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA-----KSMKGTPYWM 238
YLH N ++HRDIKG N+++ G IKL DFG +K++ A +NG KSM+GTPYWM
Sbjct: 1159 YLHDNCVVHRDIKGNNVMLMPTGIIKLIDFGCAKRLA-WAGLNGTHSDMLKSMRGTPYWM 1217
Query: 239 APEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS-HPPIPEHL 297
APEVI ++G+ +DIWS+GCTV EMATGKPP + +AA+F+IG + PP+P
Sbjct: 1218 APEVINESGYGRKSDIWSIGCTVFEMATGKPPLA-SMDRMAAMFYIGAHRGLMPPLPARF 1276
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
S A DF+ CL ++ + R +A +LL+H F+
Sbjct: 1277 SEPAADFVRLCLTRDQHERPSALQLLKHSFL 1307
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q99759|M3K3_HUMAN Mitogen-activated protein kinase kinase kinase 3 OS=Homo sapiens GN=MAP3K3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 263 bits (672), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 130/278 (46%), Positives = 184/278 (66%), Gaps = 8/278 (2%)
Query: 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE 117
K+ + PI WR+G+L+G GAFGRVY+ ++D+G LA KQV +S +T + LE
Sbjct: 354 KSPSAPINWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSP---ETSKEVSALE 410
Query: 118 EEVKLLKNLTHPNIVRYLGTARE--DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYT 175
E++LLKNL H IV+Y G R+ + +L I +E++PGGS+ L +G+ ESV R YT
Sbjct: 411 CEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT 470
Query: 176 KQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA-TINGAKSMKGT 234
+Q+L G+ YLH N I+HRDIKGANIL D+ G +KL DFGASK++ + + G +S+ GT
Sbjct: 471 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGMRSVTGT 530
Query: 235 PYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP 294
PYWM+PEVI G+ AD+WS+GCTV+EM T KPPW+ +++ +AA+F I T ++P +P
Sbjct: 531 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA-EYEAMAAIFKIATQPTNPQLP 589
Query: 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332
H+S +DFL + E R +A ELL H F Y
Sbjct: 590 SHISEHGRDFLRRIF-VEARQRPSAEELLTHHFAQLMY 626
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q9Y2U5|M3K2_HUMAN Mitogen-activated protein kinase kinase kinase 2 OS=Homo sapiens GN=MAP3K2 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 262 bits (669), Expect = 7e-69, Method: Compositional matrix adjust.
Identities = 135/277 (48%), Positives = 186/277 (67%), Gaps = 8/277 (2%)
Query: 55 PIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIR 114
P ++ P WR G+L+G GAFGRVY+ ++D+G LAVKQV +S +T +
Sbjct: 345 PPSRSPRAPTNWRLGKLLGQGAFGRVYLCYDVDTGRELAVKQVQFDPDSP---ETSKEVN 401
Query: 115 ELEEEVKLLKNLTHPNIVRYLGTAR--EDDSLNILLEFVPGGSISSLLGKFGSFPESVIR 172
LE E++LLKNL H IV+Y G R ++ +L+I +E++PGGSI L +G+ E+V R
Sbjct: 402 ALECEIQLLKNLLHERIVQYYGCLRDPQEKTLSIFMEYMPGGSIKDQLKAYGALTENVTR 461
Query: 173 MYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA-TINGAKSM 231
YT+Q+L G+ YLH N I+HRDIKGANIL D+ G +KL DFGASK++ + + G KS+
Sbjct: 462 KYTRQILEGVHYLHSNMIVHRDIKGANILRDSTGNVKLGDFGASKRLQTICLSGTGMKSV 521
Query: 232 KGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP 291
GTPYWM+PEVI G+ ADIWSV CTV+EM T KPPW+ +F+ +AA+F I T ++P
Sbjct: 522 TGTPYWMSPEVISGEGYGRKADIWSVACTVVEMLTEKPPWA-EFEAMAAIFKIATQPTNP 580
Query: 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
+P H+S +DF LK + E LR +A ELL+H FV
Sbjct: 581 KLPPHVSDYTRDF-LKRIFVEAKLRPSADELLRHMFV 616
|
Component of a protein kinase signal transduction cascade. Regulates the JNK and ERK5 pathways by phosphorylating and activating MAP2K5 and MAP2K7 (By similarity). Plays a role in caveolae kiss-and-run dynamics. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q61084|M3K3_MOUSE Mitogen-activated protein kinase kinase kinase 3 OS=Mus musculus GN=Map3k3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 1e-68, Method: Compositional matrix adjust.
Identities = 130/278 (46%), Positives = 183/278 (65%), Gaps = 8/278 (2%)
Query: 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE 117
K+ + PI WR+G+L+G GAFGRVY+ ++D+G LA KQV +S +T + LE
Sbjct: 354 KSPSAPINWRRGKLLGQGAFGRVYLCYDVDTGRELASKQVQFDPDSP---ETSKEVSALE 410
Query: 118 EEVKLLKNLTHPNIVRYLGTARE--DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYT 175
E++LLKNL H IV+Y G R+ + L I +E++PGGS+ L +G+ ESV R YT
Sbjct: 411 CEIQLLKNLQHERIVQYYGCLRDRAEKILTIFMEYMPGGSVKDQLKAYGALTESVTRKYT 470
Query: 176 KQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA-TINGAKSMKGT 234
+Q+L G+ YLH N I+HRDIKGANIL D+ G +KL DFGASK++ + + G +S+ GT
Sbjct: 471 RQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGT 530
Query: 235 PYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP 294
PYWM+PEVI G+ AD+WS+GCTV+EM T KPPW+ +++ +AA+F I T ++P +P
Sbjct: 531 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA-EYEAMAAIFKIATQPTNPQLP 589
Query: 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332
H+S +DFL + E R +A ELL H F Y
Sbjct: 590 SHISEHGRDFLRRIF-VEARQRPSAEELLTHHFAQLVY 626
|
Component of a protein kinase signal transduction cascade. Mediates activation of the NF-kappa-B, AP1 and DDIT3 transcriptional regulators. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 668 | ||||||
| 225432572 | 686 | PREDICTED: mitogen-activated protein kin | 0.998 | 0.972 | 0.760 | 0.0 | |
| 42540755 | 686 | mitogen-activated protein kinase kinase | 0.998 | 0.972 | 0.754 | 0.0 | |
| 255552309 | 653 | mitogen activated protein kinase kinase | 0.952 | 0.973 | 0.783 | 0.0 | |
| 224111246 | 680 | predicted protein [Populus trichocarpa] | 0.962 | 0.945 | 0.744 | 0.0 | |
| 224099755 | 653 | predicted protein [Populus trichocarpa] | 0.952 | 0.973 | 0.770 | 0.0 | |
| 456309 | 690 | protein kinase [Nicotiana tabacum] | 0.988 | 0.956 | 0.672 | 0.0 | |
| 449444789 | 636 | PREDICTED: mitogen-activated protein kin | 0.941 | 0.988 | 0.699 | 0.0 | |
| 449481062 | 636 | PREDICTED: mitogen-activated protein kin | 0.941 | 0.988 | 0.699 | 0.0 | |
| 296088323 | 663 | unnamed protein product [Vitis vinifera] | 0.970 | 0.977 | 0.656 | 0.0 | |
| 359487737 | 686 | PREDICTED: LOW QUALITY PROTEIN: mitogen- | 0.985 | 0.959 | 0.645 | 0.0 |
| >gi|225432572|ref|XP_002281142.1| PREDICTED: mitogen-activated protein kinase kinase kinase 3 [Vitis vinifera] gi|297737007|emb|CBI26208.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1010 bits (2612), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 515/677 (76%), Positives = 571/677 (84%), Gaps = 10/677 (1%)
Query: 1 MQDILGSVRRSLVFRSTSGDDGGGGISGL-VEKIGSSIRKSRIGLFSKPAVPALPPIEKT 59
MQDI GSVRRSLVFR SG+DG G G VEKI SSIRKS IGLFS+ +V ALPPI K
Sbjct: 1 MQDIFGSVRRSLVFRPASGEDGEYGGYGGPVEKIWSSIRKSGIGLFSRQSVRALPPIPKD 60
Query: 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEE 119
+AP IRWRKGEL+GCGAFGRVYMGMNLDSGELLA+KQV IAANSASKEKTQAHIRELEEE
Sbjct: 61 EAPSIRWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVSIAANSASKEKTQAHIRELEEE 120
Query: 120 VKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL 179
VKLLKNL+HPNIVRYLGTARED+SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL
Sbjct: 121 VKLLKNLSHPNIVRYLGTAREDESLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL 180
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMA 239
LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT+ GAKSMKGTPYWMA
Sbjct: 181 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATMTGAKSMKGTPYWMA 240
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ+QEVAALFHIGTTKSHPPIPEHL+
Sbjct: 241 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEHLTA 300
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVME-SGNQIATPGMNLR 358
EAKDFLLKCLQKEP LR ASELLQHPFV+G+YQ+PHPVF+ SVME SGN +AT +L+
Sbjct: 301 EAKDFLLKCLQKEPNLRPAASELLQHPFVSGEYQEPHPVFQTSVMENSGNMMATSETDLK 360
Query: 359 NSMNSLVRRS--TGLKDVCEMGSVRCSTVYPENLS-SGSYWKAGNCDDDMCLIDDKDDFG 415
+ N ++RRS T +VC MGSVRCSTVYPE S +G W A +CDDDMC IDDKDDF
Sbjct: 361 SFPNPVIRRSNCTSSNNVCNMGSVRCSTVYPEKFSGTGPLWGANSCDDDMCQIDDKDDFI 420
Query: 416 ISESVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQAINEAAGSI 475
+ +SVKF S+ S L+KSFNPMCEPTDDWPCKFDESPE+ ++ N+SS Q I++ AGS
Sbjct: 421 VHQSVKFGSAILSDHLNKSFNPMCEPTDDWPCKFDESPELTKSGANLSSHQTISKPAGSP 480
Query: 476 GVS-KAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEEFYN-TLNAT 533
S + EN+FTFPCG +DDDEVTESKI+AFLDEKALDLKKL+TPLYEEFYN TLNA
Sbjct: 481 RASNERENDFTFPCGPLVGDDDDEVTESKIRAFLDEKALDLKKLQTPLYEEFYNSTLNAA 540
Query: 534 GHPRGVGIT--NGENLMNLPPKSRSPKRLPSRRLSAAVLGAANSASPGHQKDRVSNVNSI 591
G P VG + N N +NLPPKSRSP + P+RRLSAAV A S S H K R NV +I
Sbjct: 541 GPPSAVGKSHDNVTNFLNLPPKSRSPNQTPTRRLSAAVDAACISNSANHTK-RGLNVGTI 599
Query: 592 QDQALQEIQPPQLNEWKELLLSAQKETISPRMSISERLRKWEEELDEEIERKREMRRQAG 651
D+ L+EIQ PQL+EWKELLL AQ+E +S + SER RKW+EELD+E+E+KRE+ RQAG
Sbjct: 600 SDRTLKEIQSPQLSEWKELLLDAQQEPVSLSTNFSERRRKWKEELDQELEKKRELLRQAG 659
Query: 652 VGGKASSPKYQILVRPR 668
VGGK +SPK QIL RPR
Sbjct: 660 VGGKTASPKDQILNRPR 676
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|42540755|gb|AAS19278.1| mitogen-activated protein kinase kinase kinase [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1001 bits (2589), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 511/677 (75%), Positives = 567/677 (83%), Gaps = 10/677 (1%)
Query: 1 MQDILGSVRRSLVFRSTSGDDGGGGISGL-VEKIGSSIRKSRIGLFSKPAVPALPPIEKT 59
MQDI GSVRRSLVFR SG+DG G G EKI SIRKS IGLFS+ +V ALPPI K
Sbjct: 1 MQDIFGSVRRSLVFRPASGEDGEYGGYGGPAEKIWFSIRKSGIGLFSRQSVRALPPIPKD 60
Query: 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEE 119
+AP RWRKGEL+GCGAFGRVYMGMNLDSGELLA++QV IAANSASKEKTQAHIRELEEE
Sbjct: 61 EAPSTRWRKGELIGCGAFGRVYMGMNLDSGELLAIRQVSIAANSASKEKTQAHIRELEEE 120
Query: 120 VKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL 179
VKLLKNL+HPNIVRYLGTARED+SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL
Sbjct: 121 VKLLKNLSHPNIVRYLGTAREDESLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL 180
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMA 239
LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT+ GAKSMKGTPY MA
Sbjct: 181 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATMTGAKSMKGTPYRMA 240
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ+QEVAALFHIGTTKSHPPIPEHL+
Sbjct: 241 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEHLTA 300
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVME-SGNQIATPGMNLR 358
EAKDFLLKCLQKEP LR ASELLQHPFV+G+YQ+PHPVF+ SVME SGN +AT +L+
Sbjct: 301 EAKDFLLKCLQKEPNLRPAASELLQHPFVSGEYQEPHPVFQTSVMENSGNMMATSETDLK 360
Query: 359 NSMNSLVRRS--TGLKDVCEMGSVRCSTVYPENLS-SGSYWKAGNCDDDMCLIDDKDDFG 415
+ N ++RRS T +VC MGSVRCSTVYPE S +G W A +CDDDMC IDDKDDF
Sbjct: 361 SFPNPVIRRSNCTSSNNVCNMGSVRCSTVYPEKFSGTGPLWGANSCDDDMCQIDDKDDFI 420
Query: 416 ISESVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQAINEAAGSI 475
+ +SVKF S+ S L+KSFNPMCEPTDDWPCKFDESPE+ ++ N+SS Q I++ AGS
Sbjct: 421 VHQSVKFGSAILSDHLNKSFNPMCEPTDDWPCKFDESPELTKSGANLSSHQTISKPAGSP 480
Query: 476 GVS-KAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEEFYN-TLNAT 533
S + EN+FTFPCG +DDDEVTESKI+AFLDEKALDLKKL+TPLYEEFYN TLNA
Sbjct: 481 RASNERENDFTFPCGPLVGDDDDEVTESKIRAFLDEKALDLKKLQTPLYEEFYNSTLNAA 540
Query: 534 GHPRGVGIT--NGENLMNLPPKSRSPKRLPSRRLSAAVLGAANSASPGHQKDRVSNVNSI 591
G P VG + N N +NLPPKSRSP R P+RRLSAAV A S S H K R NV +I
Sbjct: 541 GPPSAVGKSHDNVTNFLNLPPKSRSPNRTPTRRLSAAVDAACTSNSANHTK-RGLNVGTI 599
Query: 592 QDQALQEIQPPQLNEWKELLLSAQKETISPRMSISERLRKWEEELDEEIERKREMRRQAG 651
D+ L+EIQ PQL+EWKELLL AQ+E +S + SER RKW+EELD+E+E+KRE+ RQAG
Sbjct: 600 SDRTLKEIQSPQLSEWKELLLDAQQEPVSLSTNFSERRRKWKEELDQELEKKRELLRQAG 659
Query: 652 VGGKASSPKYQILVRPR 668
VGGK +SPK QIL RPR
Sbjct: 660 VGGKTASPKDQILNRPR 676
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255552309|ref|XP_002517199.1| mitogen activated protein kinase kinase kinase 3, mapkkk3, mekk3, putative [Ricinus communis] gi|223543834|gb|EEF45362.1| mitogen activated protein kinase kinase kinase 3, mapkkk3, mekk3, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 999 bits (2582), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/650 (78%), Positives = 558/650 (85%), Gaps = 14/650 (2%)
Query: 1 MQDILGSVRRSLVFRSTSGDDGGGGISGLVEKIGSSIRKSRIGLFSKPAVPALPPIEKTD 60
MQD+ GSVRRSLVF+STSGDDGG +G VEKIGSSIRKSRIGLFSKP PALPP +K D
Sbjct: 1 MQDLFGSVRRSLVFKSTSGDDGG--FTGFVEKIGSSIRKSRIGLFSKP--PALPPCKKDD 56
Query: 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV 120
PPIRWRKGEL+GCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQA I ELEEEV
Sbjct: 57 TPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQASILELEEEV 116
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL
Sbjct: 117 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 176
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP
Sbjct: 177 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 236
Query: 241 EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300
EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ+QEVAALFHIGTTKSHPPIPEHLS+E
Sbjct: 237 EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEHLSIE 296
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATPGMNLRNS 360
AKDFLLKCLQKEP LR TA +LLQHPFVTG+Y +PH VFR+SV ESGN +AT G+N++NS
Sbjct: 297 AKDFLLKCLQKEPNLRPTAFDLLQHPFVTGEYHEPHLVFRSSVRESGNLMATTGLNIKNS 356
Query: 361 MNSLVRRS-TGLKDVCEMGSVRCSTVYPENLS-SGSYWKAGNCDDDMCLIDDKDDFGISE 418
+N ++ + GLKDVC M S R S YP N++ SG W N DDDMC IDDKDDF +S
Sbjct: 357 VNPVIMSACAGLKDVCGMSSSRSSIRYPNNITRSGFTWGETNIDDDMCQIDDKDDFVVSP 416
Query: 419 SVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQAINEAAGSIGVS 478
S +F S+FASADL+KSFNPMCEP D+W CKFDESP +R +N+SSSQ++++ A S
Sbjct: 417 SARFKSAFASADLNKSFNPMCEPIDEWTCKFDESP--KRGGINLSSSQSLHDIADIPAES 474
Query: 479 -KAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEEFYNTLNATGHPR 537
K EN+FTFPCG A EDDDEVTESKI+AFLDEKALDLKKL+TPLYEEFYNTLNA G
Sbjct: 475 GKEENDFTFPCGPVATEDDDEVTESKIRAFLDEKALDLKKLQTPLYEEFYNTLNAAGLAS 534
Query: 538 GVGITNGENLMN---LPPKSRSPKRLPSRRLSAAVLGAANSASPGHQKDRVSNVNSIQDQ 594
VG TN EN+ N LPPKSRSPKRLPSRR S ++ AAN+AS ++ N +SI D+
Sbjct: 535 AVGSTNTENITNLPTLPPKSRSPKRLPSRRFS--IIEAANTASTRSSNKQILNDSSIHDR 592
Query: 595 ALQEIQPPQLNEWKELLLSAQKETISPRMSISERLRKWEEELDEEIERKR 644
ALQEIQPPQ+NEWK +LL AQKE I+P S SER RKW+EELDEE+ERKR
Sbjct: 593 ALQEIQPPQVNEWKGMLLDAQKEAITPSASFSERQRKWKEELDEELERKR 642
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224111246|ref|XP_002315791.1| predicted protein [Populus trichocarpa] gi|222864831|gb|EEF01962.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 973 bits (2515), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 505/678 (74%), Positives = 559/678 (82%), Gaps = 35/678 (5%)
Query: 1 MQDILGSVRRSLVFRSTSGDDG--GGGISGLVEKIGSSIRKSRIGLFSKPAVPALPPIEK 58
MQDI GSVRRSLVF+STSG G G SG VE+IGSSIRKSRIGLFSKP++P LPP K
Sbjct: 1 MQDIFGSVRRSLVFKSTSGGGGGEDGAFSGFVERIGSSIRKSRIGLFSKPSIPPLPPPSK 60
Query: 59 TD-APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE 117
D APPIR RKGEL+GCGAFGRVYMGMNLDSGELLAVKQVLIAA+SASKEKTQAHIRELE
Sbjct: 61 KDDAPPIRCRKGELIGCGAFGRVYMGMNLDSGELLAVKQVLIAASSASKEKTQAHIRELE 120
Query: 118 EEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ 177
EEVKLLKNL+HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ
Sbjct: 121 EEVKLLKNLSHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ 180
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 237
LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW
Sbjct: 181 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 240
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297
MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ+QEVAALFHIGTTKSHPPIPEHL
Sbjct: 241 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEHL 300
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATPGMNL 357
S+EAKDFLL+CLQ+ P LR ASELLQHPFVTG+YQ+PH VFRNSV ESGN IA GMNL
Sbjct: 301 SIEAKDFLLECLQEVPNLRPAASELLQHPFVTGEYQEPHSVFRNSVRESGNLIAATGMNL 360
Query: 358 RNSMNSLVRRST--GLKDVCEMGSVRCSTVYPENLS-SGSYWKAGNCDDDMCLIDDKDDF 414
++SMNS++RRS+ GLKDVCEMGSV+ S +YP+ LS S SYW A N DDDMCLIDDKDDF
Sbjct: 361 KSSMNSVIRRSSCAGLKDVCEMGSVKSSIIYPDKLSISRSYWGAANFDDDMCLIDDKDDF 420
Query: 415 GISESVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQAINEAAGS 474
+ S +F S+ AS+DL+KSFNPMCEP +DWPCKFDE P R+ +N+ SQ+I+E S
Sbjct: 421 VVGASTRFKSTVASSDLNKSFNPMCEPMEDWPCKFDEDPLFRRSGINLYCSQSIHEVIDS 480
Query: 475 IGVS-KAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEEFY-NTLNA 532
S K +++FTFP G EDDDEVTESKI+AFLDEKA+DL KL+TPLYEEFY +TLN
Sbjct: 481 HEASGKGQHDFTFPRGPVMPEDDDEVTESKIRAFLDEKAIDLTKLQTPLYEEFYSSTLNT 540
Query: 533 TGHPRGVGITNGEN---LMNLPPKSRSPKRLPSRRLSAAVLGAANSASPGHQKDRVSNVN 589
G P VG N EN L++LPPKSRSPK PSRRLS AV+ AAN SPG V+N +
Sbjct: 541 MGAPTAVGTENSENPTHLLSLPPKSRSPKCFPSRRLS-AVVDAANIVSPGRHTKHVANES 599
Query: 590 SIQDQALQEIQPPQLNEWKELLLSAQKETISPRM-----------------------SIS 626
SI ++ALQEI PPQL+EWKE L + Q+ET++ + S S
Sbjct: 600 SIHNRALQEIHPPQLSEWKEFLHNGQRETLTSSLILLMRITPDIMLPENDISLTCSASFS 659
Query: 627 ERLRKWEEELDEEIERKR 644
ER RKWEEEL +E+ERKR
Sbjct: 660 ERQRKWEEELYQELERKR 677
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224099755|ref|XP_002311605.1| predicted protein [Populus trichocarpa] gi|222851425|gb|EEE88972.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 961 bits (2483), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 509/661 (77%), Positives = 556/661 (84%), Gaps = 25/661 (3%)
Query: 1 MQDILGSVRRSLVFRSTSGDDGGGGISGL--VEKIGSSIRKSRIGLFSKPAVPALPPI-E 57
MQDI GSVRRSLVF+STSG GG VEKIGSSIR SRIGLF+KP++P+LPP +
Sbjct: 1 MQDIFGSVRRSLVFKSTSGGGGGEDGGFSGFVEKIGSSIRTSRIGLFAKPSIPSLPPPSK 60
Query: 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE 117
K DAPPIRWRKGEL+GCGAFGRVYMGMNLDSGELLAVKQV IAA+SASKEKTQAHIRELE
Sbjct: 61 KEDAPPIRWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVSIAASSASKEKTQAHIRELE 120
Query: 118 EEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ 177
EEVKLLKNL+HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ
Sbjct: 121 EEVKLLKNLSHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ 180
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 237
LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW
Sbjct: 181 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 240
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297
MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ+QEVAALFHIGTTKSHPPIPEHL
Sbjct: 241 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGTTKSHPPIPEHL 300
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIA-TPGMN 356
S+EAKDFLLKCLQ+ P LR ASELLQHPFVTG+YQ+ H VFRNSV S + A M
Sbjct: 301 SIEAKDFLLKCLQEVPNLRPAASELLQHPFVTGEYQETHSVFRNSVRVSVVRCAGLITMY 360
Query: 357 LRNSMNSLVRRST--GLKDVCEMGSVRCSTVYPENLS-SGSYWKAGNCDDDMCLIDDKDD 413
SMNS++RRST GLKDVCEMGSV+ STVY +NLS S SYW A N DDDMCLIDDKDD
Sbjct: 361 RWRSMNSVIRRSTCAGLKDVCEMGSVKSSTVYRDNLSRSRSYWGAANFDDDMCLIDDKDD 420
Query: 414 FGISESVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQA------ 467
F +S S +F S+ ASADL+KS NPMCEP DDWPCKFDE P +R+ N+S SQ+
Sbjct: 421 FAVSASTRFKSTLASADLNKSVNPMCEPLDDWPCKFDEDPLFKRSGYNLSCSQSNHEAID 480
Query: 468 INEAAGSIGVSKAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEEFY 527
I+EA+G K +N+FTFPCG EDDDEVTESKI+AFLDEKALDLKKL+TPLYEEFY
Sbjct: 481 IHEASG-----KGQNDFTFPCGPVVPEDDDEVTESKIRAFLDEKALDLKKLQTPLYEEFY 535
Query: 528 N-TLNATGHPRGVGITNGEN---LMNLPPKSRSPKRLPSRRLSAAVLGAANSASPGHQKD 583
N TLN G P VG N EN L +LPPKSRSPKRLPSRRLS AV+ A + ASPG Q +
Sbjct: 536 NSTLNTMGAPTAVGTENSENPTHLPSLPPKSRSPKRLPSRRLS-AVVDAPSIASPGRQTN 594
Query: 584 RVSNVNSIQDQALQEIQPPQLNEWKELLLSAQKETISPRMSISERLRKWEEELDEEIERK 643
V+N +SI ++ALQEIQPPQL+EWKE L Q+ET++ S SER RKWEEEL +E+ERK
Sbjct: 595 HVANESSIHNRALQEIQPPQLSEWKEFLHDGQQETLT--TSFSERQRKWEEELYQELERK 652
Query: 644 R 644
R
Sbjct: 653 R 653
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|456309|dbj|BAA05648.1| protein kinase [Nicotiana tabacum] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2299), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 463/688 (67%), Positives = 532/688 (77%), Gaps = 28/688 (4%)
Query: 1 MQDILGSVRRSLVFRSTSGDD-----GGGGISGLVEKIGSSIRKSRIGLFSKPAVPALPP 55
MQD +GSVRRSLVF+ + D G G G VEK+GSSIRKS IG+FSK VPALP
Sbjct: 1 MQDFIGSVRRSLVFKQSGDFDTGAAGVGSGFGGFVEKLGSSIRKSSIGIFSKAHVPALPS 60
Query: 56 IEKT---------DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASK 106
I K D PPIRWRKGE++GCGAFGRVYMGMN+DSGELLA+K+V IA N AS+
Sbjct: 61 ISKAELPAKARKDDTPPIRWRKGEMIGCGAFGRVYMGMNVDSGELLAIKEVSIAMNGASR 120
Query: 107 EKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSF 166
E+ QAH+RELEEEV LLKNL+HPNIVRYLGTARE SLNILLEFVPGGSISSLLGKFGSF
Sbjct: 121 ERAQAHVRELEEEVNLLKNLSHPNIVRYLGTAREAGSLNILLEFVPGGSISSLLGKFGSF 180
Query: 167 PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226
PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT+
Sbjct: 181 PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATMT 240
Query: 227 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT 286
GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCT+IEMATGKPPWSQQ+QEVAALFHIGT
Sbjct: 241 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTIIEMATGKPPWSQQYQEVAALFHIGT 300
Query: 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMES 346
TKSHPPIPEHLS E+KDFLLKCLQKEP+LR +AS LLQHPFVT ++Q+ P R+S M +
Sbjct: 301 TKSHPPIPEHLSAESKDFLLKCLQKEPHLRHSASNLLQHPFVTAEHQEARPFLRSSFMGN 360
Query: 347 GNQIATPGMNLRNSMNSLVRRS-TGLKDVCEMGSVRCSTVYPEN-LSSGSYWKAGNCDDD 404
+A M++R S+ +R S GLKDVC + +VRCSTVYPEN L S WK GN DDD
Sbjct: 361 PENMAAQRMDVRTSIIPDMRASCNGLKDVCGVSAVRCSTVYPENSLGKESLWKLGNSDDD 420
Query: 405 MCLIDDKDDFGISESVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISS 464
MC +D+ DDF SVK +S S KSFNPMCEP +DWPCKFDESPE+ +++ N+
Sbjct: 421 MCQMDN-DDFMFGASVKCSSDLHSPANYKSFNPMCEPDNDWPCKFDESPELTKSQANLHY 479
Query: 465 SQA-INEAAGSIGVSKAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLY 523
QA I I K + FTFP G SAAEDDDE+TESKI+AFLDEKA+DLKKL+TPLY
Sbjct: 480 DQATIKPTNNPIMSYKEDLAFTFPSGQSAAEDDDELTESKIRAFLDEKAMDLKKLQTPLY 539
Query: 524 EEFYNTLNATGHPRGVGITNGENL---MNLPPKSRSPKRLPSRRLSAAVLGAANSASPGH 580
E FYN+LN + P VG N EN+ +NLPPKSRSPKR+ SRRLS A+ GA + SP
Sbjct: 540 EGFYNSLNVSSTPSPVGTGNKENVPSNINLPPKSRSPKRMLSRRLSTAIEGAC-APSPVT 598
Query: 581 QKDRVSNVNSIQDQALQEIQPPQLNEWKELLLSAQKETISPRMSISERLRKWEEELDEEI 640
R+SN+ + +A+QE Q P+ NEWK+ LL +Q+E ++ S SER R+W+EELDEE+
Sbjct: 599 HSKRISNIGGLNGEAIQEAQLPRHNEWKD-LLGSQREAVNS--SFSERQRRWKEELDEEL 655
Query: 641 ERKREMRRQAGVGGKASSPKYQILVRPR 668
+RKRE+ RQA S PK IL R R
Sbjct: 656 QRKREIMRQA---VNLSPPKDPILNRCR 680
|
Source: Nicotiana tabacum Species: Nicotiana tabacum Genus: Nicotiana Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449444789|ref|XP_004140156.1| PREDICTED: mitogen-activated protein kinase kinase kinase 3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2223), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/659 (69%), Positives = 521/659 (79%), Gaps = 30/659 (4%)
Query: 1 MQDILGSVRRSLVFRSTSGDDGGGGISGLVEKIGSSIRKSRIGLFSKPAVPALPPIEKTD 60
MQD GSVRRSLVF + GDDGG LVEKIGSSIRKSR GLFSK ++ ALPP+ K D
Sbjct: 1 MQDFFGSVRRSLVFLAPDGDDGGRFGG-LVEKIGSSIRKSRNGLFSKQSLRALPPVAKED 59
Query: 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV 120
APPI WRKGEL+GCGAFGRVYMGMNLDSGELLAVKQV IAANSAS+EK QAHIRELEEEV
Sbjct: 60 APPIWWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVSIAANSASREKAQAHIRELEEEV 119
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
+LLKNL+HPNIVRYLGTARE+DSLNILLEFVPGGSISSLLGKFGSFPESVI+ YTKQLLL
Sbjct: 120 RLLKNLSHPNIVRYLGTAREEDSLNILLEFVPGGSISSLLGKFGSFPESVIKTYTKQLLL 179
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP
Sbjct: 180 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 239
Query: 241 EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300
EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ+QEVAALFHIG TKSHPPIPEHLS E
Sbjct: 240 EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGNTKSHPPIPEHLSAE 299
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATPGMNLRNS 360
AKDFLLKCLQ+EP R TAS+LLQHPFV+ +YQ+P R S MESG Q+A +N +
Sbjct: 300 AKDFLLKCLQEEPNSRPTASDLLQHPFVSCEYQEPIAAVRASSMESGKQMADSRLNSNDL 359
Query: 361 MNSLVRRST--GLKDVCEMGSVRCSTVYPENLSSGSYWKAGNCDDDMCLIDDKDDFGISE 418
S + RST GLKD+CEMGS+RCS+V+ N S S W + N +DDMC IDDKD F S
Sbjct: 360 KKSTILRSTCEGLKDICEMGSLRCSSVFSGNYGSRSNWGSSNFEDDMCQIDDKDLFATS- 418
Query: 419 SVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQAINEAAGSIGVS 478
S+K+NS +S DL+KSFNPMCEPTDD DES E+ N M +SS Q +
Sbjct: 419 SMKYNSIISSNDLNKSFNPMCEPTDD----LDESSELGGNLMELSSVQTVK--------- 465
Query: 479 KAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEEFYNTLNATGHPRG 538
N+ TFPCG SAAEDD+EVTESKIKAFLDEKAL+LKKL+TPLYEEF +T+NA
Sbjct: 466 --GNDSTFPCGQSAAEDDEEVTESKIKAFLDEKALELKKLQTPLYEEFRSTVNAANAIGT 523
Query: 539 VGITNGE---NLMNLPPKSRSPKRLPSRRLSAAVLGAANSASPGHQKDRVSNVNSIQDQA 595
VGI N + N + LPPK SP +L +RLS+ +G +S ++ R+ + +QD+A
Sbjct: 524 VGIENIKSVSNFLKLPPKCGSPSKLRGKRLSSVDVGNYSS-----RQSRIKQASILQDRA 578
Query: 596 LQEIQPPQLNEWKELLLSAQKETISPRMSISERLRKWEEELDEEIERKREMRRQAGVGG 654
LQEIQ PQL EW +LL Q + S +S SER RKW+EEL+EE++RKREM R+ VG
Sbjct: 579 LQEIQSPQLGEWNKLL---QNQPDSSTLSFSERQRKWKEELEEELKRKREMMRRGIVGA 634
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449481062|ref|XP_004156070.1| PREDICTED: mitogen-activated protein kinase kinase kinase 3-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 860 bits (2221), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 461/659 (69%), Positives = 521/659 (79%), Gaps = 30/659 (4%)
Query: 1 MQDILGSVRRSLVFRSTSGDDGGGGISGLVEKIGSSIRKSRIGLFSKPAVPALPPIEKTD 60
MQD GSVRRSLVF + GDDGG LVEKIGSSIRKSR GLFSK ++ ALPP+ K D
Sbjct: 1 MQDFFGSVRRSLVFLAPDGDDGGRFGG-LVEKIGSSIRKSRNGLFSKQSLRALPPVAKED 59
Query: 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV 120
APPI WRKGEL+GCGAFGRVYMGMNLDSGELLAVKQV IAANSAS+EK QAHIRELEEEV
Sbjct: 60 APPIWWRKGELIGCGAFGRVYMGMNLDSGELLAVKQVSIAANSASREKAQAHIRELEEEV 119
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
+LLKNL+HPNIVRYLGTARE+DSLNILLEFVPGGSISSLLGKFGSFPESVI+ YTKQLLL
Sbjct: 120 RLLKNLSHPNIVRYLGTAREEDSLNILLEFVPGGSISSLLGKFGSFPESVIKTYTKQLLL 179
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP
Sbjct: 180 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 239
Query: 241 EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300
EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ+QEVAALFHIG TKSHPPIPEHLS E
Sbjct: 240 EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQYQEVAALFHIGNTKSHPPIPEHLSAE 299
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATPGMNLRNS 360
AKDFLLKCLQ+EP R TAS+LLQHPFV+ +YQ+P R S MESG Q+A +N +
Sbjct: 300 AKDFLLKCLQEEPNSRPTASDLLQHPFVSCEYQEPIAAVRASSMESGKQMADSRLNSNDL 359
Query: 361 MNSLVRRST--GLKDVCEMGSVRCSTVYPENLSSGSYWKAGNCDDDMCLIDDKDDFGISE 418
S + RST GLKD+CEMGS+RCS+V+ N S S W + N +DDMC IDDKD F S
Sbjct: 360 KKSTILRSTCEGLKDICEMGSLRCSSVFSGNYGSRSNWGSSNFEDDMCQIDDKDLFSTS- 418
Query: 419 SVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQAINEAAGSIGVS 478
S+K+NS +S DL+KSFNPMCEPTDD DES E+ N M +SS Q +
Sbjct: 419 SMKYNSIISSNDLNKSFNPMCEPTDD----LDESSELGGNLMELSSVQTVK--------- 465
Query: 479 KAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEEFYNTLNATGHPRG 538
N+ TFPCG SAAEDD+EVTESKIKAFLDEKAL+LKKL+TPLYEEF +T+NA
Sbjct: 466 --GNDSTFPCGQSAAEDDEEVTESKIKAFLDEKALELKKLQTPLYEEFRSTVNAANAIGT 523
Query: 539 VGITNGE---NLMNLPPKSRSPKRLPSRRLSAAVLGAANSASPGHQKDRVSNVNSIQDQA 595
VGI N + N + LPPK SP +L +RLS+ +G +S ++ R+ + +QD+A
Sbjct: 524 VGIENIKSVSNFLKLPPKCGSPSKLRGKRLSSVDVGNYSS-----RQSRIKQASILQDRA 578
Query: 596 LQEIQPPQLNEWKELLLSAQKETISPRMSISERLRKWEEELDEEIERKREMRRQAGVGG 654
LQEIQ PQL EW +LL Q + S +S SER RKW+EEL+EE++RKREM R+ VG
Sbjct: 579 LQEIQSPQLGEWNKLL---QNQPDSSTLSFSERQRKWKEELEEELKRKREMMRRGIVGA 634
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296088323|emb|CBI36768.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 843 bits (2177), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/673 (65%), Positives = 512/673 (76%), Gaps = 25/673 (3%)
Query: 1 MQDILGSVRRSLVFRSTSGDDGGGGISGLVEKIGSSIRKSRIGLFSKPAVPALPPIEKTD 60
MQDI GSVRRSLV RS GDD G LV+KI S IRKSR+ FS+ + P L P + T
Sbjct: 1 MQDIFGSVRRSLVLRSPDGDDTSPGT--LVDKINSCIRKSRV--FSRASPPPLIPKDAT- 55
Query: 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV 120
AP IR RKGEL+GCGAFGRVYMGMNLDSGEL+AVKQVLI ++A+KEK QAHIRELEEEV
Sbjct: 56 APSIRCRKGELIGCGAFGRVYMGMNLDSGELIAVKQVLITTSNATKEKAQAHIRELEEEV 115
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
KLLKNL+HPNIVRYLG RE+++LNILLEFVPGGSISSLLGKFGSFPE+VIRMYTKQLLL
Sbjct: 116 KLLKNLSHPNIVRYLGIVREEETLNILLEFVPGGSISSLLGKFGSFPEAVIRMYTKQLLL 175
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
GL+YLH NGIMHRDIKGANILVDNKGCIKLADFGASK+VVELATI+GAKSMKGTPYWMAP
Sbjct: 176 GLDYLHNNGIMHRDIKGANILVDNKGCIKLADFGASKQVVELATISGAKSMKGTPYWMAP 235
Query: 241 EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300
EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQ++QEVAALF+IGTTKSHPPIP HLS E
Sbjct: 236 EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQKYQEVAALFYIGTTKSHPPIPAHLSAE 295
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVME-SGNQIATPGMNLRN 359
AKDFLLKCLQKEP LR A ELL+HPFVTG+Y + + SVME S ++T NL N
Sbjct: 296 AKDFLLKCLQKEPDLRPAAYELLKHPFVTGEYNEAQLALQTSVMENSETPVSTSEENLPN 355
Query: 360 SMNSLVRRSTGLKDVCEMGSVRCSTVYPENLSSGSYWKAGNCDDDMCLIDDKDDFGISES 419
L DVCEMG++ CST YPEN S W + DMC IDDKDD +
Sbjct: 356 P----------LLDVCEMGNLSCSTGYPENSESKPNWGTSS-SIDMCQIDDKDDVMMVGE 404
Query: 420 VKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQAINEAAGSIGVS- 478
VKFNS + +KSFNP+ EP+ DW C+ D + E + M++ ++ +++ AGS G+S
Sbjct: 405 VKFNSILLPDNFNKSFNPISEPSHDWSCEIDGNLRPEHSGMDMDTNPSLDMPAGSSGISN 464
Query: 479 KAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEEFYNTLNATGHPRG 538
K N+F+FPCG S +EDDDEVTESKI+ FLDEKA++LKKL+TPLYEEFYNTLNA P
Sbjct: 465 KGGNDFSFPCGPSVSEDDDEVTESKIRDFLDEKAIELKKLQTPLYEEFYNTLNAACSPSV 524
Query: 539 VGITNGENLMN---LPPKSRSPKRLPSRRLSAAVLGAANSASPGHQKDRVSNVNSIQDQA 595
T EN++N LPPKSRSP R P SAAV + ++ASPG R+SNV + DQ
Sbjct: 525 AERTQDENVINYLKLPPKSRSPSRAPIGTPSAAV-DSTSTASPGSCGRRMSNVGNAGDQT 583
Query: 596 LQEIQPPQLNEWKELLLSAQKETISPRMSISERLRKWEEELDEEIERKREMRRQAGVGGK 655
Q+ P N+WK LL+ +Q+E SP +S E RKW+EELD+E+ERKREM RQA GK
Sbjct: 584 AQDTPSPPHNDWKGLLVDSQQEPNSPSVSFYEIQRKWKEELDQELERKREMMRQA---GK 640
Query: 656 ASSPKYQILVRPR 668
SSPK + L RPR
Sbjct: 641 TSSPKDRALNRPR 653
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359487737|ref|XP_003633640.1| PREDICTED: LOW QUALITY PROTEIN: mitogen-activated protein kinase kinase kinase ANP1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 842 bits (2176), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/686 (64%), Positives = 517/686 (75%), Gaps = 28/686 (4%)
Query: 1 MQDILGSVRRSLVFRSTSGDDGGGGISGLVEKIGSSIRKSRIGLFSKPAVPALPPIEKTD 60
MQDI GSVRRSLV RS GDD G LV+KI S IRKSR+ FS+ + P L P + T
Sbjct: 1 MQDIFGSVRRSLVLRSPDGDDTSPGT--LVDKINSCIRKSRV--FSRASPPPLIPKDAT- 55
Query: 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV 120
AP IR RKGEL+GCGAFGRVYMGMNLDSGEL+AVKQVLI ++A+KEK QAHIRELEEEV
Sbjct: 56 APSIRCRKGELIGCGAFGRVYMGMNLDSGELIAVKQVLITTSNATKEKAQAHIRELEEEV 115
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
KLLKNL+HPNIVRYLG RE+++LNILLEFVPGGSISSLLGKFGSFPE+VIRMYTKQLLL
Sbjct: 116 KLLKNLSHPNIVRYLGIVREEETLNILLEFVPGGSISSLLGKFGSFPEAVIRMYTKQLLL 175
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
GL+YLH NGIMHRDIKGANILVDNKGCIKLADFGASK+VVELATI+GAKSMKGTPYWMAP
Sbjct: 176 GLDYLHNNGIMHRDIKGANILVDNKGCIKLADFGASKQVVELATISGAKSMKGTPYWMAP 235
Query: 241 EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300
EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQ++QEVAALF+IGTTKSHPPIP HLS E
Sbjct: 236 EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQKYQEVAALFYIGTTKSHPPIPAHLSAE 295
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVME-SGNQIATPGMNLRN 359
AKDFLLKCLQKEP LR A ELL+HPFVTG+Y + + SVME S ++T NL N
Sbjct: 296 AKDFLLKCLQKEPDLRPAAYELLKHPFVTGEYNEAQLALQTSVMENSETPVSTSEENLPN 355
Query: 360 SM-------------NSLVRRSTGLKDVCEMGSVRCSTVYPENLSSGSYWKAGNCDDDMC 406
+ +S + + L DVCEMG++ CST YPEN S W + DMC
Sbjct: 356 PLIIKAFWXCCINCVSSQMTNDSSLLDVCEMGNLSCSTGYPENSESKPNWGTSS-SIDMC 414
Query: 407 LIDDKDDFGISESVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQ 466
IDDKDD + VKFNS + +KSFNP+ EP+ DW C+ D + E + M++ ++
Sbjct: 415 QIDDKDDVMMVGEVKFNSILLPDNFNKSFNPISEPSHDWSCEIDGNLRPEHSGMDMDTNP 474
Query: 467 AINEAAGSIGVS-KAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEE 525
+++ AGS G+S K N+F+FPCG S +EDDDEVTESKI+ FLDEKA++LKKL+TPLYEE
Sbjct: 475 SLDMPAGSSGISNKGGNDFSFPCGPSVSEDDDEVTESKIRDFLDEKAIELKKLQTPLYEE 534
Query: 526 FYNTLNATGHPRGVGITNGENLMN---LPPKSRSPKRLPSRRLSAAVLGAANSASPGHQK 582
FYNTLNA P T EN++N LPPKSRSP R P SAAV + ++ASPG
Sbjct: 535 FYNTLNAACSPSVAERTQDENVINYLKLPPKSRSPSRAPIGTPSAAV-DSTSTASPGSCG 593
Query: 583 DRVSNVNSIQDQALQEIQPPQLNEWKELLLSAQKETISPRMSISERLRKWEEELDEEIER 642
R+SNV + DQ Q+ P N+WK LL+ +Q+E SP +S E RKW+EELD+E+ER
Sbjct: 594 RRMSNVGNAGDQTAQDTPSPPHNDWKGLLVDSQQEPNSPSVSFYEIQRKWKEELDQELER 653
Query: 643 KREMRRQAGVGGKASSPKYQILVRPR 668
KREM RQA GK SSPK + L RPR
Sbjct: 654 KREMMRQA---GKTSSPKDRALNRPR 676
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 668 | ||||||
| UNIPROTKB|Q40541 | 690 | Q40541 "Protein kinase" [Nicot | 0.929 | 0.9 | 0.604 | 3.1e-193 | |
| TAIR|locus:2080394 | 651 | NP3 "NPK1-related protein kina | 0.887 | 0.910 | 0.614 | 9.7e-183 | |
| TAIR|locus:2035989 | 666 | NP1 "NPK1-related protein kina | 0.666 | 0.668 | 0.589 | 5.5e-143 | |
| DICTYBASE|DDB_G0283265 | 1267 | mkkA "octicosapeptide/Phox/Bem | 0.390 | 0.205 | 0.526 | 2.1e-74 | |
| TAIR|locus:2026674 | 883 | YDA "YODA" [Arabidopsis thalia | 0.452 | 0.342 | 0.464 | 1.3e-68 | |
| TAIR|locus:2024832 | 609 | MAP3KA "mitogen-activated prot | 0.381 | 0.418 | 0.505 | 4.4e-68 | |
| POMBASE|SPBC1D7.05 | 659 | byr2 "MAP kinase kinase kinase | 0.405 | 0.411 | 0.490 | 4.7e-64 | |
| SGD|S000004354 | 717 | STE11 "Signal transducing MEK | 0.297 | 0.277 | 0.509 | 3.7e-62 | |
| ZFIN|ZDB-GENE-070910-1 | 620 | map3k3 "mitogen-activated prot | 0.431 | 0.464 | 0.435 | 1.6e-61 | |
| UNIPROTKB|F1S0D3 | 1325 | YSK4 "Uncharacterized protein" | 0.390 | 0.196 | 0.474 | 5.3e-61 |
| UNIPROTKB|Q40541 Q40541 "Protein kinase" [Nicotiana tabacum (taxid:4097)] | Back alignment and assigned GO terms |
|---|
Score = 1872 (664.0 bits), Expect = 3.1e-193, P = 3.1e-193
Identities = 389/644 (60%), Positives = 446/644 (69%)
Query: 1 MQDILGSVRRSLVFRS-----TXXXXXXXXXXXLVEKIGSSIRKSRIGLFSKPAVPALPP 55
MQD +GSVRRSLVF+ T VEK+GSSIRKS IG+FSK VPALP
Sbjct: 1 MQDFIGSVRRSLVFKQSGDFDTGAAGVGSGFGGFVEKLGSSIRKSSIGIFSKAHVPALPS 60
Query: 56 IEKT---------DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASK 106
I K D PPIRWRKGE++GCGAFGRVYMGMN+DSGELLA+K+V IA N AS+
Sbjct: 61 ISKAELPAKARKDDTPPIRWRKGEMIGCGAFGRVYMGMNVDSGELLAIKEVSIAMNGASR 120
Query: 107 EKTQAHIRXXXXXXXXXXXXTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSF 166
E+ QAH+R +HPNIVRYLGTARE SLNILLEFVPGGSISSLLGKFGSF
Sbjct: 121 ERAQAHVRELEEEVNLLKNLSHPNIVRYLGTAREAGSLNILLEFVPGGSISSLLGKFGSF 180
Query: 167 PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226
PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT+
Sbjct: 181 PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATMT 240
Query: 227 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT 286
GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCT+IEMATGKPPWSQQ+QEVAALFHIGT
Sbjct: 241 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTIIEMATGKPPWSQQYQEVAALFHIGT 300
Query: 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMES 346
TKSHPPIPEHLS E+KDFLLKCLQKEP+LR +AS LLQHPFVT ++Q+ P R+S M +
Sbjct: 301 TKSHPPIPEHLSAESKDFLLKCLQKEPHLRHSASNLLQHPFVTAEHQEARPFLRSSFMGN 360
Query: 347 GNQIATPGMNLRNSMNSLVRRS-TGLKDVCEMGSVRCSTVYPEN-LSSGSYWKAGNCXXX 404
+A M++R S+ +R S GLKDVC + +VRCSTVYPEN L S WK GN
Sbjct: 361 PENMAAQRMDVRTSIIPDMRASCNGLKDVCGVSAVRCSTVYPENSLGKESLWKLGN-SDD 419
Query: 405 XXXXXXXXXFGISESVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISS 464
F SVK +S S KSFNPMCEP +DWPCKFDESPE+ +++ N+
Sbjct: 420 DMCQMDNDDFMFGASVKCSSDLHSPANYKSFNPMCEPDNDWPCKFDESPELTKSQANLHY 479
Query: 465 SQA-INEAAGSIGVSKAENEFTFPCGSSAAEDDDEVTESKIXXXXXXXXXXXXXXXTPLY 523
QA I I K + FTFP G SAAEDDDE+TESKI TPLY
Sbjct: 480 DQATIKPTNNPIMSYKEDLAFTFPSGQSAAEDDDELTESKIRAFLDEKAMDLKKLQTPLY 539
Query: 524 EEFYNTLNATGHPRGVGITNGENL---MNXXXXXXXXXXXXXXXXXAAVLGAANSASPGH 580
E FYN+LN + P VG N EN+ +N A+ GA + H
Sbjct: 540 EGFYNSLNVSSTPSPVGTGNKENVPSNINLPPKSRSPKRMLSRRLSTAIEGACAPSPVTH 599
Query: 581 QKDRVSNVNSIQDQALQEIQPPQLNEWKELLLSAQKETISPRMS 624
K R+SN+ + +A+QE Q P+ NEWK+LL +Q+E ++ S
Sbjct: 600 SK-RISNIGGLNGEAIQEAQLPRHNEWKDLL-GSQREAVNSSFS 641
|
|
| TAIR|locus:2080394 NP3 "NPK1-related protein kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1773 (629.2 bits), Expect = 9.7e-183, P = 9.7e-183
Identities = 377/614 (61%), Positives = 432/614 (70%)
Query: 1 MQDILGSVRRSLVFRSTXXXXXXXXXXXL---VEKIGSSIRKSRIGLFSKPAVPALPPIE 57
MQDILGSVRRSLVFRS+ L V KI SSIR SRIGLFSKP P LP
Sbjct: 1 MQDILGSVRRSLVFRSSLAGDDGTSGGGLSGFVGKINSSIRSSRIGLFSKPP-PGLPAPR 59
Query: 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRXXX 117
K +AP IRWRKGEL+GCGAFGRVYMGMNLDSGELLA+KQVLIA +SASKEKTQ HIR
Sbjct: 60 KEEAPSIRWRKGELIGCGAFGRVYMGMNLDSGELLAIKQVLIAPSSASKEKTQGHIRELE 119
Query: 118 XXXXXXXXXTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ 177
+HPNIVRYLGT RE DSLNIL+EFVPGGSISSLL KFGSFPE VI MYTKQ
Sbjct: 120 EEVQLLKNLSHPNIVRYLGTVRESDSLNILMEFVPGGSISSLLEKFGSFPEPVIIMYTKQ 179
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 237
LLLGLEYLH NGIMHRDIKGANILVDNKGCI+LADFGASKKVVELAT+NGAKSMKGTPYW
Sbjct: 180 LLLGLEYLHNNGIMHRDIKGANILVDNKGCIRLADFGASKKVVELATVNGAKSMKGTPYW 239
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297
MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWS+Q+Q+ AA+ HIG TK+HPPIPE L
Sbjct: 240 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSEQYQQFAAVLHIGRTKAHPPIPEDL 299
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATPGMNL 357
S EAKDFL+KCL KEP LR +A+ELLQHPFVTGK Q+P+P +RNS+ E GN I T GMN+
Sbjct: 300 SPEAKDFLMKCLHKEPSLRLSATELLQHPFVTGKRQEPYPAYRNSLTECGNPITTQGMNV 359
Query: 358 RNSMNSLVRRST--GLKDVCEMGSVRCSTVYPENLS-SGSYWKAGNCXXXXXXXXXXXXF 414
R+S+NSL+RRST GLKDVCE+GS+R S +YP+ + SG W+ G+
Sbjct: 360 RSSINSLIRRSTCSGLKDVCELGSLRSSIIYPQKSNNSGFGWRDGD-SDDLCQTDMDDLC 418
Query: 415 GISESVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEVERNRMNISSSQAINEAAGS 474
I ESV+ N S DL+KSFNPMC+ TD+W CKFDESP+V +++ N+ S QA G
Sbjct: 419 NI-ESVRNNVLSQSTDLNKSFNPMCDSTDNWSCKFDESPKVMKSKSNLLSYQASQLQTG- 476
Query: 475 IGVSKAENEFTFPCGSSAAEDDDEVTESKIXXXXXXXXXXXXXXXTPLYEEFYNTLNATG 534
+ + E TF GSS AEDD + TE KI TPL EEF+N +N G
Sbjct: 477 VPCDE-ETSLTFAGGSSVAEDDYKGTELKIKSFLDEKAQDLKRLQTPLLEEFHNAMNP-G 534
Query: 535 HPRG-VGITNGENLMNXXXXXXXXXXXXXXXXXAAVLGAANSASPGHQKDRVSNVNSIQD 593
P+G +G TN NL N L A + A P K +N+
Sbjct: 535 IPQGALGDTNIYNLPNLPSISKTPKRLPSRR-----LSAISDAMPSPLKSSKRTLNT--S 587
Query: 594 QALQE-IQPPQLNE 606
+ +Q +P Q+NE
Sbjct: 588 RVMQSGTEPTQVNE 601
|
|
| TAIR|locus:2035989 NP1 "NPK1-related protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1283 (456.7 bits), Expect = 5.5e-143, Sum P(2) = 5.5e-143
Identities = 274/465 (58%), Positives = 321/465 (69%)
Query: 1 MQDILGSVRRSLVFRSTXXXXXXXXX----XXLVEKIGSSIRKSRIGLFSKPAVPALPPI 56
MQD GSVRRSLVFR + L +KI S IRKS+I F KP+ PP
Sbjct: 1 MQDFFGSVRRSLVFRPSSDDDNQENQPPFPGVLADKITSCIRKSKI--FIKPSFSPPPPA 58
Query: 57 EKTD-APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRX 115
D APPI WRKG+L+G GAFG VYMGMNLDSGELLAVKQVLIAAN ASKEKTQAHI+
Sbjct: 59 NTVDMAPPISWRKGQLIGRGAFGTVYMGMNLDSGELLAVKQVLIAANFASKEKTQAHIQE 118
Query: 116 XXXXXXXXXXXTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYT 175
+HPNIVRYLGT REDD+LNILLEFVPGGSISSLL KFG FPESV+R YT
Sbjct: 119 LEEEVKLLKNLSHPNIVRYLGTVREDDTLNILLEFVPGGSISSLLEKFGPFPESVVRTYT 178
Query: 176 KQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP 235
+QLLLGLEYLH + IMHRDIKGANILVDNKGCIKLADFGASK+V ELAT+ GAKSMKGTP
Sbjct: 179 RQLLLGLEYLHNHAIMHRDIKGANILVDNKGCIKLADFGASKQVAELATMTGAKSMKGTP 238
Query: 236 YWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295
YWMAPEVILQTGHSFSADIWSVGCTVIEM TGK PWSQQ++EVAA+F IGTTKSHPPIP+
Sbjct: 239 YWMAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPWSQQYKEVAAIFFIGTTKSHPPIPD 298
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATP-G 354
LS +AKDFLLKCLQ+ P LR TASELL+HPFV GK+++ SV+ N ++TP
Sbjct: 299 TLSSDAKDFLLKCLQEVPNLRPTASELLKHPFVMGKHKESASTDLGSVL---NNLSTPLP 355
Query: 355 MNLRNSMNSLVRRSTGLKDVCEMGSVRCSTVYP-ENLSSGSYWKAGNCXXXXXXXXXXXX 413
+ + N+ ++ + D+C GS+ S V P +++ + + W+ +
Sbjct: 356 LQINNTKSTPDSTCDDVGDMCNFGSLNYSLVDPVKSIQNKNLWQQND---NGGDEDDMCL 412
Query: 414 FGISESVKFNSSFASA-DLDKSFNPMCEPTDDWPC----KFDESP 453
+ F+ +S + D C+ D KFDESP
Sbjct: 413 IDDENFLTFDGEMSSTLEKDCHLKKSCDDISDMSIALKSKFDESP 457
|
|
| DICTYBASE|DDB_G0283265 mkkA "octicosapeptide/Phox/Bem1p domain-containing protein" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 2.1e-74, Sum P(2) = 2.1e-74
Identities = 140/266 (52%), Positives = 190/266 (71%)
Query: 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQV-LIAANSASKEKTQAHIRXXXXXXXX 122
I+W+KG+++G G +G VY+G+N D+GEL AVKQ+ ++ NS K K I
Sbjct: 493 IKWQKGQILGRGGYGSVYLGLNKDTGELFAVKQLEIVDINSDPKLKNM--ILSFSKEIEV 550
Query: 123 XXXXTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
H NIVRYLGT+ + L++ LE++PGGSISSLLGKFG+F E+VI++YTKQ+L GL
Sbjct: 551 MRSLRHDNIVRYLGTSLDQSFLSVFLEYIPGGSISSLLGKFGAFSENVIKVYTKQILQGL 610
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
+LH N I+HRDIKGANIL+D KG +KL+DFG SK + ++ KSM+GTPYWMAPEV
Sbjct: 611 SFLHANSIIHRDIKGANILIDTKGIVKLSDFGCSKSFSGI--VSQFKSMQGTPYWMAPEV 668
Query: 243 ILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
I QTGH S+DIWS+GC ++EMAT +PPWS + A ++HI ++ S P IP H+S EA
Sbjct: 669 IKQTGHGRSSDIWSLGCVIVEMATAQPPWSNITELAAVMYHIASSNSIPNIPSHMSQEAF 728
Query: 303 DFLLKCLQKEPYLRSTASELLQHPFV 328
DFL C +++P R A++LL+HPF+
Sbjct: 729 DFLNLCFKRDPKERPDANQLLKHPFI 754
|
|
| TAIR|locus:2026674 YDA "YODA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 696 (250.1 bits), Expect = 1.3e-68, P = 1.3e-68
Identities = 145/312 (46%), Positives = 195/312 (62%)
Query: 46 SKPAVPALPP-IEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSA 104
+ P+VP P E T +P RW+KG L+G G+FG VY+G N +SGE+ A+K+V + ++
Sbjct: 379 TSPSVPRSPARAEATVSPGSRWKKGRLLGMGSFGHVYLGFNSESGEMCAMKEVTLCSDDP 438
Query: 105 SKEKTQAHIRXXXXXXXXXXXXTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG 164
K++ + H NIV+Y G+ DD L I LE+V GGSI LL ++G
Sbjct: 439 ---KSRESAQQLGQEISVLSRLRHQNIVQYYGSETVDDKLYIYLEYVSGGSIYKLLQEYG 495
Query: 165 SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224
F E+ IR YT+Q+L GL YLH +HRDIKGANILVD G +K+ADFG +K + +
Sbjct: 496 QFGENAIRNYTQQILSGLAYLHAKNTVHRDIKGANILVDPHGRVKVADFGMAKHITAQS- 554
Query: 225 INGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH 283
G S KG+PYWMAPEVI + G + + DIWS+GCTV+EMAT KPPWSQ ++ V A+F
Sbjct: 555 --GPLSFKGSPYWMAPEVIKNSNGSNLAVDIWSLGCTVLEMATTKPPWSQ-YEGVPAMFK 611
Query: 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSV 343
IG +K P IP+HLS E KDF+ KCLQ+ P R TA++LL H FV P+
Sbjct: 612 IGNSKELPDIPDHLSEEGKDFVRKCLQRNPANRPTAAQLLDHAFVRNVMPMERPIVSGEP 671
Query: 344 MESGNQIATPGM 355
E+ N +A+ M
Sbjct: 672 AEAMN-VASSTM 682
|
|
| TAIR|locus:2024832 MAP3KA "mitogen-activated protein kinase kinase kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 691 (248.3 bits), Expect = 4.4e-68, P = 4.4e-68
Identities = 134/265 (50%), Positives = 186/265 (70%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQV-LIAANSASKEKTQAHIRXXXXXXXXXX 124
W+KG+ +G G FG+VY+G N + G++ A+K+V +I+ + SKE ++
Sbjct: 214 WKKGKFLGSGTFGQVYLGFNSEKGKMCAIKEVKVISDDQTSKEC----LKQLNQEINLLN 269
Query: 125 XXTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
HPNIV+Y G+ +++L++ LE+V GGSI LL +GSF E VI+ YT+Q+L GL Y
Sbjct: 270 QLCHPNIVQYYGSELSEETLSVYLEYVSGGSIHKLLKDYGSFTEPVIQNYTRQILAGLAY 329
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
LH +HRDIKGANILVD G IKLADFG +K V +T+ S KG+PYWMAPEV++
Sbjct: 330 LHGRNTVHRDIKGANILVDPNGEIKLADFGMAKHVTAFSTM---LSFKGSPYWMAPEVVM 386
Query: 245 -QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
Q G++ + DIWS+GCT++EMAT KPPWSQ F+ VAA+F IG +K P IP+HLS +AK+
Sbjct: 387 SQNGYTHAVDIWSLGCTILEMATSKPPWSQ-FEGVAAIFKIGNSKDTPEIPDHLSNDAKN 445
Query: 304 FLLKCLQKEPYLRSTASELLQHPFV 328
F+ CLQ+ P +R TAS+LL+HPF+
Sbjct: 446 FIRLCLQRNPTVRPTASQLLEHPFL 470
|
|
| POMBASE|SPBC1D7.05 byr2 "MAP kinase kinase kinase Byr2" [Schizosaccharomyces pombe (taxid:4896)] | Back alignment and assigned GO terms |
|---|
Score = 653 (234.9 bits), Expect = 4.7e-64, P = 4.7e-64
Identities = 136/277 (49%), Positives = 182/277 (65%)
Query: 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRXX 116
E TD I+W +G L+G G+FG+VY+GMN SGEL+AVKQV++ + S SK++ +
Sbjct: 385 EDTDDQSIKWIRGALIGSGSFGQVYLGMNASSGELMAVKQVILDSVSESKDRHAKLLDAL 444
Query: 117 XXXXXXXXXXTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTK 176
+H +IV+YLG+ D LNI LE+VPGGS++ LL +GSF E++++ + K
Sbjct: 445 AGEIALLQELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGSFEETLVKNFIK 504
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT---INGAK-SMK 232
Q L GLEYLH GI+HRDIKGANILVDNKG IK++DFG SKK+ +T GA+ S +
Sbjct: 505 QTLKGLEYLHSRGIVHRDIKGANILVDNKGKIKISDFGISKKLELNSTSTKTGGARPSFQ 564
Query: 233 GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP 292
G+ +WMAPEV+ QT H+ DIWS+GC VIEM T K P+ ++ A+F IG P
Sbjct: 565 GSSFWMAPEVVKQTMHTEKTDIWSLGCLVIEMLTSKHPYPN-CDQMQAIFRIGENIL-PE 622
Query: 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
P ++S A DFL K + LR TASELL HPFV+
Sbjct: 623 FPSNISSSAIDFLEKTFAIDCNLRPTASELLSHPFVS 659
|
|
| SGD|S000004354 STE11 "Signal transducing MEK kinase" [Saccharomyces cerevisiae (taxid:4932)] | Back alignment and assigned GO terms |
|---|
Score = 529 (191.3 bits), Expect = 3.7e-62, Sum P(2) = 3.7e-62
Identities = 103/202 (50%), Positives = 140/202 (69%)
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
H NIV Y G ++E +LNI LE+VPGGS+SS+L +G F ES+I +T+Q+L+G+ YLHK
Sbjct: 513 HENIVTYYGASQEGGNLNIFLEYVPGGSVSSMLNNYGPFEESLITNFTRQILIGVAYLHK 572
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL-ATINGAKSMKGTPYWMAPEVILQT 246
I+HRDIKGANIL+D KGC+K+ DFG SKK+ L N S++G+ +WM+PEV+ QT
Sbjct: 573 KNIIHRDIKGANILIDIKGCVKITDFGISKKLSPLNKKQNKRASLQGSVFWMSPEVVKQT 632
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLL 306
+ ADIWS GC VIEM TGK P+ F ++ A+F IGT + P IP + E K+FL
Sbjct: 633 ATTAKADIWSTGCVVIEMFTGKHPFPD-FSQMQAIFKIGTNTT-PEIPSWATSEGKNFLR 690
Query: 307 KCLQKEPYLRSTASELLQHPFV 328
K + + R +A ELLQHP++
Sbjct: 691 KAFELDYQYRPSALELLQHPWL 712
|
|
| ZFIN|ZDB-GENE-070910-1 map3k3 "mitogen-activated protein kinase kinase kinase 3" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 629 (226.5 bits), Expect = 1.6e-61, P = 1.6e-61
Identities = 131/301 (43%), Positives = 190/301 (63%)
Query: 31 EKIGS-SIRKSRIGLFSKPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSG 89
E +GS + ++ L +P A+P K+ P+ WR+G+L+G GAFGRVY+ ++D+G
Sbjct: 324 ESLGSWQLENTQSRL--RPQDRAVP--HKSPTAPVTWRRGKLLGQGAFGRVYLCYDVDTG 379
Query: 90 ELLAVKQVLIAANSASKEKTQAHIRXXXXXXXXXXXXTHPNIVRYLGTARE--DDSLNIL 147
LA KQV + AS E T + H IV+Y G R+ + +L I
Sbjct: 380 RELAAKQVHF--DPASPE-TSKEVSALECEIQLLKNLHHERIVQYYGCLRDHNEKTLTIF 436
Query: 148 LEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC 207
+E++PGGS+ L +G+ E+V R YT+Q+L G+ YLH N I+HRDIKGANIL D+ G
Sbjct: 437 MEYMPGGSVKDQLKAYGALTENVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN 496
Query: 208 IKLADFGASKKVVELA-TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT 266
+KL DFGASK++ + + G +S+ GTPYWM+PEVI G+ AD+WS+GCTV+EM T
Sbjct: 497 VKLGDFGASKRLQTICMSSTGVRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT 556
Query: 267 GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHP 326
KPPW++ F+ +AA+F I T ++P +P H+S +DFL +C+ E R +A ELL+HP
Sbjct: 557 EKPPWAE-FEAMAAIFKIATQPTNPQLPSHISEHTRDFL-RCIFVEAKYRPSAEELLRHP 614
Query: 327 F 327
F
Sbjct: 615 F 615
|
|
| UNIPROTKB|F1S0D3 YSK4 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 635 (228.6 bits), Expect = 5.3e-61, P = 5.3e-61
Identities = 129/272 (47%), Positives = 178/272 (65%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRXXXXXXXX 122
P+ W KGE++G GA+G VY G+ GEL+AVKQV A +++ K T+ R
Sbjct: 1055 PVLWTKGEILGKGAYGTVYCGLT-SHGELIAVKQV--ALDTSDKSATEKEYRKLQEEVDL 1111
Query: 123 XXXXTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
H NIV YLGT E++ ++I +EFVPGGSISS++ +FG PE+V YTKQ+L G+
Sbjct: 1112 LKALKHINIVAYLGTCLEENIVSIFMEFVPGGSISSIINRFGPLPETVFCKYTKQILQGV 1171
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA-----KSMKGTPYW 237
YLH+N ++HRDIKG N+++ G IKL DFG +K++ A +NG KSM GTPYW
Sbjct: 1172 AYLHENCVVHRDIKGNNVMLMPTGIIKLIDFGCAKRLA-WAGLNGTHSDMLKSMHGTPYW 1230
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS-HPPIPEH 296
MAPEVI ++G+ +DIWS+GCTV EMATGKPP + +AA+F+IG + P +PEH
Sbjct: 1231 MAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASM-DRMAAMFYIGAHRGLMPALPEH 1289
Query: 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
S A DF+ CL ++ R +A +LL+H F+
Sbjct: 1290 FSENAADFVRVCLTRDQRERPSAIQLLKHSFL 1321
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O22042 | M3K3_ARATH | 2, ., 7, ., 1, 1, ., 2, 5 | 0.6711 | 0.9535 | 0.9784 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.25 | 0.991 |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | MAP3K | SubName- Full=Chromosome chr5 scaffold_2, whole genome shotgun sequence; (696 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
 | AP3 | SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (226 aa) | • | 0.483 | |||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 668 | |||
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-166 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-150 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-109 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-102 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-102 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-102 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-100 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-98 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-95 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-92 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-89 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 7e-87 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 7e-84 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-83 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-81 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-80 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-79 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-76 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-72 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-70 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-66 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-64 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-64 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-63 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-62 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-60 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-59 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-59 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-58 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-57 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-54 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-54 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-53 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-53 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-52 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-52 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-52 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-51 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-49 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-49 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 7e-49 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-49 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-48 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-48 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-48 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-47 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-46 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-45 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-45 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-45 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-44 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-44 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-44 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-44 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-44 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-44 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-43 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-43 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-43 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-43 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-43 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-42 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-42 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-42 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-42 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-42 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-42 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-42 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-41 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-41 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-41 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-41 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-41 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-40 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-40 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-40 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-40 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-39 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-39 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-38 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-38 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-38 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 8e-38 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 8e-38 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-37 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-37 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-37 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-36 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-36 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-36 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-36 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-36 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-35 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-35 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-35 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 9e-35 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-34 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-34 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-34 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-34 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-34 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-34 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-34 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 8e-34 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-33 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-33 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-33 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-33 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-33 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-32 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-32 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-32 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-32 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-32 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-32 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-32 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-31 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-31 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-31 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-31 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-31 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-31 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-31 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-31 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-30 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-30 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-30 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 9e-30 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-30 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-29 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-29 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-29 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-29 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-29 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 5e-29 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 6e-29 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 7e-29 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 8e-29 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-28 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-28 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-28 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-27 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-27 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-27 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-27 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-27 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-27 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-26 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-26 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-26 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-26 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-26 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 8e-26 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-25 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-25 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-25 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-25 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-25 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-25 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-25 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-25 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 8e-25 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-24 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-24 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-24 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-24 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-24 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-24 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-24 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-24 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 5e-24 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-24 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 9e-24 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-23 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-23 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-23 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-23 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-23 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-23 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-23 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-23 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-23 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-23 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-23 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-23 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-22 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-22 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-22 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-22 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-22 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-21 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-21 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-21 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-21 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-21 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-21 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-21 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-20 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-20 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-20 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-20 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 5e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 9e-20 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 9e-20 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-19 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-19 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-19 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 9e-19 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 9e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-18 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-18 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-18 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-18 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-18 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 9e-18 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-17 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-17 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-17 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-17 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-17 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-17 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-16 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-16 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-16 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-15 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-15 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-15 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-15 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-15 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 6e-15 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 6e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-14 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-14 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-13 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-12 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 6e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-11 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 2e-11 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-11 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-11 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-10 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 7e-07 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-06 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 8e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.004 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 476 bits (1227), Expect = e-166
Identities = 168/265 (63%), Positives = 207/265 (78%), Gaps = 8/265 (3%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
RWRKGEL+G G+FG VY G+NLD G+ AVK+V +A + Q +++LE+E+ LL
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQ---TGQEAVKQLEQEIALLS 57
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
L HPNIV+YLGT RE+D+L I LE VPGGS++ LL K+GSFPE VIR+YT+Q+LLGLEY
Sbjct: 58 KLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEY 117
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
LH +HRDIKGANILVD G +KLADFG +K+VVE + AKS KG+PYWMAPEVI
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF---AKSFKGSPYWMAPEVIA 174
Query: 245 QTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
Q G + +ADIWS+GCTV+EMATGKPPWSQ VAA+F IG +K PPIP+HLS EAKD
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG-VAAVFKIGRSKELPPIPDHLSDEAKD 233
Query: 304 FLLKCLQKEPYLRSTASELLQHPFV 328
F+LKCLQ++P LR TA+ELL+HPFV
Sbjct: 234 FILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 434 bits (1119), Expect = e-150
Identities = 151/266 (56%), Positives = 196/266 (73%), Gaps = 8/266 (3%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
W +GEL+G G+FG VY+ ++ D+GEL+AVK V + ++ + LE E+++L
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVEL------SGDSEEELEALEREIRILS 54
Query: 125 NLTHPNIVRYLGT--AREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
+L HPNIVRY G+ E ++LNI LE+V GGS+SSLL KFG PE VIR YT+Q+L GL
Sbjct: 55 SLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGL 114
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
YLH NGI+HRDIKGANILVD+ G +KLADFG +K++ ++ T G S++GTPYWMAPEV
Sbjct: 115 AYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEV 174
Query: 243 ILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
I + +ADIWS+GCTVIEMATGKPPWS+ +AAL+ IG++ P IPEHLS EAK
Sbjct: 175 IRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234
Query: 303 DFLLKCLQKEPYLRSTASELLQHPFV 328
DFL KCL+++P R TA ELLQHPF+
Sbjct: 235 DFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 329 bits (845), Expect = e-109
Identities = 130/260 (50%), Positives = 183/260 (70%), Gaps = 10/260 (3%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
G+L+G GAFG VY G+NL++G+ +A+KQ+ S K K +A ++ + +E+ LLKNL H
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFVAIKQI-----SLEKIKEEA-LKSIMQEIDLLKNLKH 58
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
PNIV+Y+G+ DSL I+LE+ GS+ ++ KFG FPES++ +Y Q+L GL YLH+
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGH 248
G++HRDIK ANIL G +KLADFG + K+ +++ S+ GTPYWMAPEVI +G
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDASVVGTPYWMAPEVIEMSGA 176
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308
S ++DIWS+GCTVIE+ TG PP+ +AALF I HPP+PE +S E KDFL++C
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYY-DLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQC 234
Query: 309 LQKEPYLRSTASELLQHPFV 328
QK+P LR TA +LL+HP++
Sbjct: 235 FQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 312 bits (801), Expect = e-102
Identities = 136/270 (50%), Positives = 191/270 (70%), Gaps = 9/270 (3%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRE-LEEEVKLL 123
+W KG L+G G+FG VY+GMN SGEL+AVKQV + + SAS + + + + L E+ LL
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLE 183
K L H NIV+YLG++ + D LNI LE+VPGGS+++LL +G+F E+++R + +Q+L GL
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLN 120
Query: 184 YLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAK-----SMKGTPYWM 238
YLH GI+HRDIKGANILVDNKG IK++DFG SKK +E +++ S++G+ +WM
Sbjct: 121 YLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPSLQGSVFWM 179
Query: 239 APEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLS 298
APEV+ QT ++ ADIWS+GC V+EM TGK P+ Q + A+F IG + P IP ++S
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ-LQAIFKIG-ENASPEIPSNIS 237
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
EA DFL K + + R TA+ELL+HPF+
Sbjct: 238 SEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 311 bits (800), Expect = e-102
Identities = 107/264 (40%), Positives = 152/264 (57%), Gaps = 11/264 (4%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+ E +G G+FG+VY+ + +G+L+A+K + K+K + + E+K+LK
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVI-------KKKKIKKDRERILREIKILKK 53
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
L HPNIVR ++D L +++E+ GG + LL K G E R Y +Q+L LEYL
Sbjct: 54 LKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYL 113
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
H GI+HRD+K NIL+D G +KLADFG ++ +L + GTP +MAPEV+L
Sbjct: 114 HSKGIVHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLG 170
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE-HLSMEAKDF 304
G+ + DIWS+G + E+ TGKPP+ Q + IG K P PE +S EAKD
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDL 230
Query: 305 LLKCLQKEPYLRSTASELLQHPFV 328
+ K L K+P R TA E LQHPF
Sbjct: 231 IRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 311 bits (799), Expect = e-102
Identities = 131/271 (48%), Positives = 176/271 (64%), Gaps = 14/271 (5%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
RW++G +G G FG+VY +NLD+GEL+AVK++ I ++ I+E+ +E+K+L+
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRI------QDNDPKTIKEIADEMKVLE 54
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
L HPN+V+Y G + + I +E+ GG++ LL E VIR+YT QLL GL Y
Sbjct: 55 LLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAY 114
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA--KSMKGTPYWMAPEV 242
LH +GI+HRDIK ANI +D+ G IKL DFG + K+ T G +S+ GTP +MAPEV
Sbjct: 115 LHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 243 ILQT---GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEH--L 297
I GH +ADIWS+GC V+EMATGK PWS+ E +FH+G PPIP+ L
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVG-AGHKPPIPDSLQL 233
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
S E KDFL +CL+ +P R TASELLQHPFV
Sbjct: 234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 306 bits (785), Expect = e-100
Identities = 135/270 (50%), Positives = 187/270 (69%), Gaps = 11/270 (4%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P WR+G+L+G GAFGRVY+ ++D+G LAVKQV +S T+ + LE E++L
Sbjct: 1 PTNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPE---TKKEVNALECEIQL 57
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
LKNL H IV+Y G R+D++L+I +E++PGGS+ L +G+ E+V R YT+Q+L G+
Sbjct: 58 LKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGV 117
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI----NGAKSMKGTPYWM 238
EYLH N I+HRDIKGANIL D+ G +KL DFGASK+ L TI G KS+ GTPYWM
Sbjct: 118 EYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR---LQTICSSGTGMKSVTGTPYWM 174
Query: 239 APEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLS 298
+PEVI G+ AD+WSVGCTV+EM T KPPW+ +F+ +AA+F I T ++P +P H+S
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA-EFEAMAAIFKIATQPTNPQLPSHVS 233
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
+A++FL + + R +A ELL+H FV
Sbjct: 234 PDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 301 bits (771), Expect = 7e-98
Identities = 127/269 (47%), Positives = 184/269 (68%), Gaps = 11/269 (4%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
W KGE++G GA+G VY G+ + G+L+AVKQV ++++ + +L+EEV LLK+
Sbjct: 2 WTKGEVLGKGAYGTVYCGL-TNQGQLIAVKQV--ELDTSNVLAAEKEYEKLQEEVDLLKS 58
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
L H NIV+YLGT +D++++I +EFVPGGSISS+L +FG PE V YTKQ+L G+ YL
Sbjct: 59 LKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYL 118
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA-----KSMKGTPYWMAP 240
H N ++HRDIKG N+++ G IKL DFG ++++ ++G KSM GTPYWMAP
Sbjct: 119 HNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA-WVGLHGTHSNMLKSMHGTPYWMAP 177
Query: 241 EVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS-HPPIPEHLSM 299
EVI ++G+ +DIWS+GCTV EMATGKPP + +AA+F+IG + P +P+ S
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLA-SMDRLAAMFYIGAHRGLMPRLPDSFSA 236
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFV 328
A DF+ CL ++ + R +A +LL+H F+
Sbjct: 237 AAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 294 bits (753), Expect = 4e-95
Identities = 127/272 (46%), Positives = 177/272 (65%), Gaps = 9/272 (3%)
Query: 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSAS--KEKTQAHIRELEEEVK 121
+W KGEL+G G +GRVY+ +N+ +GE++AVKQV + A A + + ++ L E++
Sbjct: 1 FKWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIE 60
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181
LK+L H NIV+YLG ++ L+I LE+VPGGSI S L +G F E ++R +T+Q+L G
Sbjct: 61 TLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG 120
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
L YLH GI+HRD+K N+LVD G K++DFG SKK ++ + SM+G+ +WMAPE
Sbjct: 121 LAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 242 VILQTGHSFSA--DIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
VI +SA DIWS+GC V+EM G+ PWS + + +AA+F +G +S PPIP +SM
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE-EAIAAMFKLGNKRSAPPIPPDVSM 239
Query: 300 ----EAKDFLLKCLQKEPYLRSTASELLQHPF 327
A DFL C P R TA ELLQHPF
Sbjct: 240 NLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 285 bits (732), Expect = 4e-92
Identities = 119/266 (44%), Positives = 160/266 (60%), Gaps = 18/266 (6%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+ E +G G FG VY + +G+ +A+K + K +++ ++ E+++LK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVI--------KLESKEKKEKIINEIQILKK 53
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLEY 184
HPNIV+Y G+ + D L I++EF GGS+ LL + ES I K+LL GLEY
Sbjct: 54 CKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEY 113
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
LH NGI+HRDIK ANIL+ + G +KL DFG S + L+ +M GTPYWMAPEVI
Sbjct: 114 LHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQ---LSDTKARNTMVGTPYWMAPEVIN 170
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP---IPEHLSMEA 301
+ + ADIWS+G T IE+A GKPP+S + + ALF I T + PP PE S E
Sbjct: 171 GKPYDYKADIWSLGITAIELAEGKPPYS-ELPPMKALFKIAT--NGPPGLRNPEKWSDEF 227
Query: 302 KDFLLKCLQKEPYLRSTASELLQHPF 327
KDFL KCLQK P R TA +LL+HPF
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 277 bits (712), Expect = 4e-89
Identities = 99/268 (36%), Positives = 154/268 (57%), Gaps = 13/268 (4%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+ +G G+FG VY + +G+++AVK + S +K Q RE+ ++L+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKR--SEKSKKDQTARREI----RILRR 54
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
L+HPNIVR + + D L +++E+ GG + L + G E + Q+L GLEYL
Sbjct: 55 LSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYL 114
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL- 244
H NGI+HRD+K NIL+D G +K+ADFG +KK+++ ++ + GTP++MAPEV+L
Sbjct: 115 HSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLG 172
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTKSHPPIPEHLSM--E 300
G+ D+WS+G + E+ TGKPP+S + ++ + I P+ S E
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEE 232
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFV 328
AKD + KCL K+P R TA E+LQHP+
Sbjct: 233 AKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 272 bits (697), Expect = 7e-87
Identities = 117/271 (43%), Positives = 174/271 (64%), Gaps = 11/271 (4%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
W KG+ +G GAF Y ++ +G L+AVKQV N++S+++ + L +E++L+
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEV--VEALRKEIRLMAR 59
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
L HP+I+R LG ED N+ +E++ GGS+S LL K+G+F E+VI YT+QLL GL YL
Sbjct: 60 LNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYL 119
Query: 186 HKNGIMHRDIKGANILVDNKG-CIKLADFGASKKVVELATINGAKSMK----GTPYWMAP 240
H+N I+HRD+KGAN+L+D+ G +++ADFGA+ ++ A GA + GT +MAP
Sbjct: 120 HENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA--AKGTGAGEFQGQLLGTIAFMAP 177
Query: 241 EVILQTGHSFSADIWSVGCTVIEMATGKPPWS--QQFQEVAALFHIGTTKSHPPIPEHLS 298
EV+ + S D+WSVGC +IEMAT KPPW+ + +A +F I + + P IPEHLS
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS 237
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
+D L+CL+ +P R + ELL+HP
Sbjct: 238 PGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 264 bits (676), Expect = 7e-84
Identities = 131/268 (48%), Positives = 183/268 (68%), Gaps = 8/268 (2%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
PI WR+G+L+G GAFGRVY+ ++D+G LA KQV S +T + LE E++L
Sbjct: 1 PINWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESP---ETSKEVSALECEIQL 57
Query: 123 LKNLTHPNIVRYLGTARE--DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
LKNL H IV+Y G R+ + +L I +E++PGGS+ L +G+ ESV R YT+Q+L
Sbjct: 58 LKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILE 117
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA-TINGAKSMKGTPYWMA 239
G+ YLH N I+HRDIKGANIL D+ G +KL DFGASK++ + + G +S+ GTPYWM+
Sbjct: 118 GMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMS 177
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
PEVI G+ AD+WS+GCTV+EM T KPPW+ +++ +AA+F I T ++P +P H+S
Sbjct: 178 PEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA-EYEAMAAIFKIATQPTNPQLPSHISE 236
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPF 327
A+DF L C+ E R +A ELL+HPF
Sbjct: 237 HARDF-LGCIFVEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 261 bits (669), Expect = 8e-83
Identities = 138/272 (50%), Positives = 181/272 (66%), Gaps = 14/272 (5%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P WR G+L+G GAFGRVY+ + D+G LAVKQV S +T + LE E++L
Sbjct: 1 PTNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESP---ETSKEVNALECEIQL 57
Query: 123 LKNLTHPNIVRYLGTARE--DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
LKNL H IV+Y G R+ + +L+I +E +PGGSI L +G+ E+V R YT+Q+L
Sbjct: 58 LKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILE 117
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI----NGAKSMKGTPY 236
G+ YLH N I+HRDIKGANIL D+ G +KL DFGASK+ L TI G KS+ GTPY
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKR---LQTICLSGTGMKSVTGTPY 174
Query: 237 WMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEH 296
WM+PEVI G+ ADIWSVGCTV+EM T KPPW+ +F+ +AA+F I T ++P +P H
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWA-EFEAMAAIFKIATQPTNPVLPPH 233
Query: 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
+S +DF LK + E LR +A ELL+H FV
Sbjct: 234 VSDHCRDF-LKRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 257 bits (658), Expect = 3e-81
Identities = 131/269 (48%), Positives = 180/269 (66%), Gaps = 8/269 (2%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P+ WR G+L+G GAFG VY+ + D+G LAVKQV +S ++T + LE E++L
Sbjct: 1 PVNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDS---QETSKEVNALECEIQL 57
Query: 123 LKNLTHPNIVRYLGTAR--EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
LKNL H IV+Y G R E+ L+I +E++PGGSI L +G+ E+V R YT+Q+L
Sbjct: 58 LKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQ 117
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA-TINGAKSMKGTPYWMA 239
G+ YLH N I+HRDIKGANIL D+ G +KL DFGASK++ + + G KS+ GTPYWM+
Sbjct: 118 GVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMS 177
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
PEVI G+ AD+WSV CTV+EM T KPPW+ +++ +AA+F I T + P +P+ +S
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPPWA-EYEAMAAIFKIATQPTKPMLPDGVSD 236
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFV 328
+DF LK + E R TA LL+HPFV
Sbjct: 237 ACRDF-LKQIFVEEKRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 254 bits (652), Expect = 6e-80
Identities = 103/267 (38%), Positives = 159/267 (59%), Gaps = 15/267 (5%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ E +G G+FG VY ++ + +++A+K + + E+ + I ++++E++ L
Sbjct: 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDL-------EEAEDEIEDIQQEIQFLS 54
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
P I +Y G+ + L I++E+ GGS LL K G E+ I +++LLGLEY
Sbjct: 55 QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEY 113
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
LH+ G +HRDIK ANIL+ +G +KLADFG S ++ T++ + GTP+WMAPEVI
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS--TMSKRNTFVGTPFWMAPEVIK 171
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP-IPEHL-SMEAK 302
Q+G+ ADIWS+G T IE+A G+PP S + LF I K++PP + + S K
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLS-DLHPMRVLFLI--PKNNPPSLEGNKFSKPFK 228
Query: 303 DFLLKCLQKEPYLRSTASELLQHPFVT 329
DF+ CL K+P R +A ELL+H F+
Sbjct: 229 DFVSLCLNKDPKERPSAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 6e-79
Identities = 105/266 (39%), Positives = 158/266 (59%), Gaps = 25/266 (9%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
E +G G++G VY ++ ++G+++A+K V + + ++E+ +E+ +LK P
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----------LQEIIKEISILKQCDSP 58
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLL---GKFGSFPESVIRMYTKQLLLGLEYLH 186
IV+Y G+ ++ L I++E+ GS+S ++ K + E I Q L GLEYLH
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLH 116
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
N +HRDIK NIL++ +G KLADFG S ++ + T+ ++ GTP+WMAPEVI +
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPFWMAPEVIQEI 174
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP----IPEHLSMEAK 302
G++ ADIWS+G T IEMA GKPP+S + A+F I PP PE S E
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYS-DIHPMRAIFMIPN---KPPPTLSDPEKWSPEFN 230
Query: 303 DFLLKCLQKEPYLRSTASELLQHPFV 328
DF+ KCL K+P R +A +LLQHPF+
Sbjct: 231 DFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 245 bits (627), Expect = 1e-76
Identities = 119/265 (44%), Positives = 171/265 (64%), Gaps = 18/265 (6%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
++G G +G VY +L + +A+K++ E+ +++ L EE+ L L H N
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEI--------PERDSRYVQPLHEEIALHSYLKHRN 66
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFP--ESVIRMYTKQLLLGLEYLHK 187
IV+YLG+ E+ I +E VPGGS+S+LL K+G E I YTKQ+L GL+YLH
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126
Query: 188 NGIMHRDIKGANILVDN-KGCIKLADFGASKKVVELATIN-GAKSMKGTPYWMAPEVILQ 245
N I+HRDIKG N+LV+ G +K++DFG SK+ LA IN ++ GT +MAPEVI +
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKR---LAGINPCTETFTGTLQYMAPEVIDK 183
Query: 246 --TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
G+ ADIWS+GCT++EMATGKPP+ + + AA+F +G K HP IPE LS EAK+
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN 243
Query: 304 FLLKCLQKEPYLRSTASELLQHPFV 328
F+L+C + +P R++A +LLQ PF+
Sbjct: 244 FILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 233 bits (596), Expect = 5e-72
Identities = 94/265 (35%), Positives = 149/265 (56%), Gaps = 18/265 (6%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+ +G G+FG+VY+ G+L +K++ ++ N + KE+ A EVK+LK L HP
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLS-NMSEKEREDAL-----NEVKILKKLNHP 59
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGS----ISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
NI++Y + E L I++E+ GG I + FPE I + QL L L+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
H I+HRDIK NI + + G +KL DFG SK + T++ AK++ GTPY+++PE+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLSPELCQN 177
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTKSHPPIPEHLSMEAKD 303
+++ +DIWS+GC + E+ T K P F+ + L +PPIP S E ++
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHP----FEGENLLELALKILKGQYPPIPSQYSSELRN 233
Query: 304 FLLKCLQKEPYLRSTASELLQHPFV 328
+ LQK+P R + +++LQ PF+
Sbjct: 234 LVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 4e-70
Identities = 105/263 (39%), Positives = 145/263 (55%), Gaps = 18/263 (6%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G +G VY ++ +GEL+A+K + + +++E+ +LK HPNI
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEP--------GDDFEIIQQEISMLKECRHPNI 62
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGI 190
V Y G+ D L I++E+ GGS+ + G E I ++ L GL YLH+ G
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK 122
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVI---LQTG 247
+HRDIKGANIL+ G +KLADFG S ++ ATI KS GTPYWMAPEV + G
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLT--ATIAKRKSFIGTPYWMAPEVAAVERKGG 180
Query: 248 HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI---PEHLSMEAKDF 304
+ DIW++G T IE+A +PP + ALF I + PP E S DF
Sbjct: 181 YDGKCDIWALGITAIELAELQPPMF-DLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDF 239
Query: 305 LLKCLQKEPYLRSTASELLQHPF 327
+ KCL K+P R TA++LLQHPF
Sbjct: 240 IKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 3e-66
Identities = 105/264 (39%), Positives = 152/264 (57%), Gaps = 18/264 (6%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
E +G GA G VY + +G+ +A+K++ + + + + E+ ++K+ HP
Sbjct: 25 EKIGEGASGEVYKATDRATGKEVAIKKMRL---------RKQNKELIINEILIMKDCKHP 75
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLEYLHKN 188
NIV Y + D L +++E++ GGS++ ++ F E I +++L GLEYLH
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA-KSMKGTPYWMAPEVILQTG 247
++HRDIK NIL+ G +KLADFG + +L S+ GTPYWMAPEVI +
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFA---AQLTKEKSKRNSVVGTPYWMAPEVIKRKD 192
Query: 248 HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI--PEHLSMEAKDFL 305
+ DIWS+G IEMA G+PP+ + + ALF I TTK PP+ PE S E KDFL
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPPY-LREPPLRALFLI-TTKGIPPLKNPEKWSPEFKDFL 250
Query: 306 LKCLQKEPYLRSTASELLQHPFVT 329
KCL K+P R +A ELLQHPF+
Sbjct: 251 NKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 214 bits (546), Expect = 1e-64
Identities = 103/272 (37%), Positives = 149/272 (54%), Gaps = 26/272 (9%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
E++G GA VY + L + E +A+K++ + EK Q + EL +EV+ + HP
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDL-------EKCQTSVDELRKEVQAMSQCNHP 59
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLG---KFGSFPESVIRMYTKQLLLGLEYLH 186
N+V+Y + D L +++ ++ GGS+ ++ G E++I K++L GLEYLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK---GTPYWMAPEVI 243
NG +HRDIK NIL+ G +K+ADFG S + + K K GTP WMAPEV+
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD-GGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 244 LQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQF-QEVAALFHIGTTKSHPPIPEH----- 296
Q G+ F ADIWS G T IE+ATG P+S+ +V L T ++ PP E
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLML----TLQNDPPSLETGADYK 234
Query: 297 -LSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
S + + CLQK+P R TA ELL+H F
Sbjct: 235 KYSKSFRKMISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 213 bits (544), Expect = 2e-64
Identities = 94/259 (36%), Positives = 140/259 (54%), Gaps = 13/259 (5%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G+FG+V + D+G+L A+K + K K H E +L + HP I
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKV--LKKKKIIKRKEVEHTLT---ERNILSRINHPFI 55
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
V+ + ++ L ++LE+ PGG + S L K G F E R Y +++L LEYLH GI+
Sbjct: 56 VKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFS 251
+RD+K NIL+D G IKL DFG +K++ + + GTP ++APEV+L G+ +
Sbjct: 116 YRDLKPENILLDADGHIKLTDFGLAKELSS--EGSRTNTFCGTPEYLAPEVLLGKGYGKA 173
Query: 252 ADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQK 311
D WS+G + EM TGKPP+ ++ ++ K PE LS EA+D + LQK
Sbjct: 174 VDWWSLGVLLYEMLTGKPPFYA--EDRKEIYEK-ILKDPLRFPEFLSPEARDLISGLLQK 230
Query: 312 EPYLR---STASELLQHPF 327
+P R A E+ HPF
Sbjct: 231 DPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 210 bits (538), Expect = 2e-63
Identities = 97/261 (37%), Positives = 152/261 (58%), Gaps = 12/261 (4%)
Query: 73 GCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV 132
G G+ G VY + +G++ A+K I + ++L E+K L++ P +V
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALK--KIHVDGDE-----EFRKQLLRELKTLRSCESPYVV 62
Query: 133 RYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH-KNGIM 191
+ G ++ ++I+LE++ GGS++ LL K G PE V+ +Q+L GL+YLH K I+
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFS 251
HRDIK +N+L+++KG +K+ADFG S KV+E T++ + GT +M+PE I +S++
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGIS-KVLE-NTLDQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 252 ADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTTKSHPPIPEHLSMEAKDFLLKCL 309
ADIWS+G T++E A GK P+ Q + I E S E +DF+ CL
Sbjct: 181 ADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACL 240
Query: 310 QKEPYLRSTASELLQHPFVTG 330
QK+P R +A+ELLQHPF+
Sbjct: 241 QKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 206 bits (527), Expect = 2e-62
Identities = 92/258 (35%), Positives = 139/258 (53%), Gaps = 46/258 (17%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG VY+ + +G+ +A+K + KE + + + EL E+++LK L HPNI
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-------KKEDSSSLLEELLREIEILKKLNHPNI 53
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGI 190
V+ G +++ L +++E+ GGS+ LL + G E I Q+L GLEYLH NGI
Sbjct: 54 VKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGI 113
Query: 191 MHRDIKGANILVDNK-GCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGH- 248
+HRD+K NIL+D+ G +KLADFG SK + ++ K++ GTP +MAPEV+L G+
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL--KTIVGTPAYMAPEVLLGKGYY 171
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308
S +DIWS+G + E+ E KD + K
Sbjct: 172 SEKSDIWSLGVILYELP----------------------------------ELKDLIRKM 197
Query: 309 LQKEPYLRSTASELLQHP 326
LQK+P R +A E+L+H
Sbjct: 198 LQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (513), Expect = 9e-60
Identities = 104/273 (38%), Positives = 146/273 (53%), Gaps = 29/273 (10%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEE---EVKLLKN 125
GEL G GAFG+VY + ++G A K + I + ELE+ E+ +L
Sbjct: 11 GEL-GDGAFGKVYKAQHKETGLFAAAKIIQIESEE-----------ELEDFMVEIDILSE 58
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS-FPESVIRMYTKQLLLGLEY 184
HPNIV ++ L IL+EF GG++ S++ + E IR +Q+L L +
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
LH + ++HRD+K NIL+ G +KLADFG S K +T+ + GTPYWMAPEV+
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAK--NKSTLQKRDTFIGTPYWMAPEVVA 176
Query: 245 -----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI---PEH 296
+ + ADIWS+G T+IE+A +PP + + L I KS PP P
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPHH-ELNPMRVLLKI--LKSEPPTLDQPSK 233
Query: 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
S DFL CL K+P R TA+ELL+HPFV+
Sbjct: 234 WSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 201 bits (512), Expect = 1e-59
Identities = 105/272 (38%), Positives = 161/272 (59%), Gaps = 25/272 (9%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+++ EL+G GA+G VY G ++ +G ++A+K +I ++ + + +++ EV LL
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALK--IINLDTPDDD-----VSDIQREVALLSQ 55
Query: 126 LTH---PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
L PNI +Y G+ + L I++E+ GGS+ +L+ K G E I + +++L+ L
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLVAL 114
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAK--SMKGTPYWMAP 240
+Y+HK G++HRDIK ANILV N G +KL DFG V L N +K + GTPYWMAP
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFG----VAALLNQNSSKRSTFVGTPYWMAP 170
Query: 241 EVILQTGHSFS--ADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP-IPE-H 296
EVI + G + ADIWS+G T+ EMATG PP+S A+ I KS PP + +
Sbjct: 171 EVITE-GKYYDTKADIWSLGITIYEMATGNPPYSDV-DAFRAMMLIP--KSKPPRLEDNG 226
Query: 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
S ++F+ CL +EP R +A ELL+ ++
Sbjct: 227 YSKLLREFVAACLDEEPKERLSAEELLKSKWI 258
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 200 bits (510), Expect = 3e-59
Identities = 101/287 (35%), Positives = 149/287 (51%), Gaps = 35/287 (12%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P + E++G G +G+VY + +G+L+A+K I +E+ E++EE
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK---IMDIIEDEEE------EIKEEYN 54
Query: 122 LLKNLT-HPNIVRYLGTAR------EDDSLNILLEFVPGGSIS----SLLGKFGSFPESV 170
+L+ + HPNI + G DD L +++E GGS++ L K E
Sbjct: 55 ILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW 114
Query: 171 IRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAK- 229
I ++ L GL YLH+N ++HRDIKG NIL+ +KL DFG S +L + G +
Sbjct: 115 IAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDSTLGRRN 171
Query: 230 SMKGTPYWMAPEVI-----LQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI 284
+ GTPYWMAPEVI + +D+WS+G T IE+A GKPP + ALF I
Sbjct: 172 TFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-HPMRALFKI 230
Query: 285 GTTKSHPPI---PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
++ PP PE+ S + DF+ +CL K R ELL+HPF+
Sbjct: 231 --PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 5e-58
Identities = 93/268 (34%), Positives = 141/268 (52%), Gaps = 21/268 (7%)
Query: 75 GAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134
GA+GRV++ +G++ A+K + + + + ++ E +L P +V+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVI-----KKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58
Query: 135 LGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRD 194
+ + +L +++E++PGG ++SLL GS E V R+Y +++L LEYLH NGI+HRD
Sbjct: 59 YYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118
Query: 195 IKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK------GTPYWMAPEVILQTGH 248
+K NIL+D+ G +KL DFG SK + IN K GTP ++APEVIL GH
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALF-HIGTTKSHPPIPEHLSMEAKDFL 305
S + D WS+GC + E G PP F +F +I K P +S EA D +
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPP----FHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLI 234
Query: 306 LKCLQKEPYLR---STASELLQHPFVTG 330
K L +P R + E+ HPF G
Sbjct: 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 194 bits (496), Expect = 4e-57
Identities = 89/273 (32%), Positives = 149/273 (54%), Gaps = 38/273 (13%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEE---EVKLLKNL 126
+ +G G+FGRV + + SG+ A+K +L SK K ++++E E ++L+++
Sbjct: 7 KTLGTGSFGRVMLVRHKGSGKYYALK-IL------SKAKI-VKLKQVEHVLNEKRILQSI 58
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
HP +V G+ ++D +L +++E+VPGG + S L K G FPE V R Y Q++L LEYLH
Sbjct: 59 RHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLH 118
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
I++RD+K N+L+D+ G IK+ DFG +K+V ++ GTP ++APE+IL
Sbjct: 119 SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG-----RTYTLCGTPEYLAPEIILSK 173
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI-------PEHLSM 299
G+ + D W++G + EM G PP+ F + + I P S
Sbjct: 174 GYGKAVDWWALGILIYEMLAGYPPF----------FDDNPIQIYEKILEGKVRFPSFFSP 223
Query: 300 EAKDFLLKCLQKEP-----YLRSTASELLQHPF 327
+AKD + LQ + L++ +++ HP+
Sbjct: 224 DAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 6e-54
Identities = 86/290 (29%), Positives = 144/290 (49%), Gaps = 47/290 (16%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQV----LIAANSASKEKTQAHIRELEEEVKLLK 124
G+++G G+F V + ++ + A+K + LI KEK +++ +E+EV L +
Sbjct: 6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLI------KEKKVKYVK-IEKEV-LTR 57
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
HP I++ T +++++L +LE+ P G + + K+GS E R Y ++LL LEY
Sbjct: 58 LNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEY 117
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASK-----------KVVELATINGAKSMK- 232
LH GI+HRD+K NIL+D IK+ DFG +K K + + +
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177
Query: 233 ------GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ-----FQEVAAL 281
GT +++PE++ + S+D+W++GC + +M TGKPP+ FQ++
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI--- 234
Query: 282 FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTAS----ELLQHPF 327
K P + +AKD + K L +P R + EL HPF
Sbjct: 235 -----LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 8e-54
Identities = 89/271 (32%), Positives = 133/271 (49%), Gaps = 23/271 (8%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
E +G G+FG V G++L K+ + N KEK Q L EV +L+ L HP
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKE-IDYGNMTEKEKQQ-----LVSEVNILRELKHP 59
Query: 130 NIVRYLG--TAREDDSLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLE 183
NIVRY R + +L I++E+ GG ++ L+ K E I QLLL L
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 184 YLH-----KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWM 238
H N ++HRD+K ANI +D +KL DFG +K + + AK+ GTPY+M
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYM 177
Query: 239 APEVILQTGHSFSADIWSVGCTVIEMATGKPPWS-QQFQEVAALFHIGTTKSHPPIPEHL 297
+PE + + +DIWS+GC + E+ PP++ + ++A+ G IP
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG---KFRRIPYRY 234
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
S E + + L +P R + ELLQ P +
Sbjct: 235 SSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 1e-53
Identities = 91/258 (35%), Positives = 141/258 (54%), Gaps = 12/258 (4%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G F VY + L G ++A+K+V I +K + ++ +E+ LLK L HPN+
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR-----QDCLKEIDLLKQLDHPNV 64
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS----FPESVIRMYTKQLLLGLEYLHK 187
++YL + E++ LNI+LE G +S ++ F PE I Y QL LE++H
Sbjct: 65 IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
IMHRDIK AN+ + G +KL D G + T A S+ GTPY+M+PE I + G
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG 182
Query: 248 HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP-EHLSMEAKDFLL 306
++F +DIWS+GC + EMA + P+ + +L +PP+P +H S E +D +
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVS 242
Query: 307 KCLQKEPYLRSTASELLQ 324
+C+ +P R S +LQ
Sbjct: 243 RCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 184 bits (468), Expect = 3e-53
Identities = 110/270 (40%), Positives = 157/270 (58%), Gaps = 23/270 (8%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
GEL G GAFG+VY N ++G L A K + + S+E+ + ++ E+E +L H
Sbjct: 18 GEL-GDGAFGKVYKAKNKETGALAAAKVI----ETKSEEELEDYMVEIE----ILATCNH 68
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHK 187
P IV+ LG D L I++EF PGG++ +++ + E I++ +Q+L L+YLH
Sbjct: 69 PYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL--- 244
I+HRD+K N+L+ G IKLADFG S K V+ T+ S GTPYWMAPEV++
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TLQRRDSFIGTPYWMAPEVVMCET 186
Query: 245 --QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI---PEHLSM 299
T + + ADIWS+G T+IEMA +PP + + L I KS PP P SM
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPP-HHELNPMRVLLKIA--KSEPPTLSQPSKWSM 243
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
E +DFL L K P R +A++LL+HPFV+
Sbjct: 244 EFRDFLKTALDKHPETRPSAAQLLEHPFVS 273
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 1e-52
Identities = 105/269 (39%), Positives = 158/269 (58%), Gaps = 14/269 (5%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P + K E +G G+FG VY G++ + E++A+K + + E+ + I ++++E+
Sbjct: 2 PEELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDL-------EEAEDEIEDIQQEIT 54
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181
+L P I RY G+ + L I++E++ GGS LL K G E+ I +++L G
Sbjct: 55 VLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKG 113
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
L+YLH +HRDIK AN+L+ +G +KLADFG + ++ + T + GTP+WMAPE
Sbjct: 114 LDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE-HLSME 300
VI Q+ + F ADIWS+G T IE+A G+PP S + LF I K+ PP E S
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPPNS-DLHPMRVLFLI--PKNSPPTLEGQYSKP 228
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFVT 329
K+F+ CL K+P R TA ELL+H F+T
Sbjct: 229 FKEFVEACLNKDPRFRPTAKELLKHKFIT 257
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 1e-52
Identities = 82/267 (30%), Positives = 133/267 (49%), Gaps = 18/267 (6%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FGRV + A+K + + Q HI E ++L+ HP I
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKC--VKKRHIVETGQQEHIFS---EKEILEECNHPFI 55
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
V+ T ++ + +L+E+ GG + ++L G F E R Y ++L EYLH GI+
Sbjct: 56 VKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGII 115
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFS 251
+RD+K N+L+D+ G +KL DFG +KK L + + GTP ++APE+IL G+ FS
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKK---LKSGQKTWTFCGTPEYVAPEIILNKGYDFS 172
Query: 252 ADIWSVGCTVIEMATGKPPWSQ---QFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308
D WS+G + E+ TG+PP+ + E+ G K P ++ AKD + +
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE--FPNYIDKAAKDLIKQL 230
Query: 309 LQKEPYLR-----STASELLQHPFVTG 330
L++ P R ++ +H + G
Sbjct: 231 LRRNPEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 8e-52
Identities = 95/298 (31%), Positives = 135/298 (45%), Gaps = 55/298 (18%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK---TQAHIRELEEEVKLL 123
K E +G G +G VY + +GE++A+K++ + E+ +RE + LL
Sbjct: 2 EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL-----DNEEEGIPSTALRE----ISLL 52
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGL 182
K L HPNIV+ L + L ++ E+ + L K G ++I+ QLL GL
Sbjct: 53 KELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGL 111
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG--TPYWMAP 240
Y H + I+HRD+K NIL++ G +KLADFG ++ I T ++ AP
Sbjct: 112 AYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAF----GIPLRTYTHEVVTLWYRAP 167
Query: 241 EVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ---EVAALFHI----GT------ 286
E++L +S + DIWSVGC EM TGKP F E+ LF I GT
Sbjct: 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPL----FPGDSEIDQLFKIFQILGTPTEESW 223
Query: 287 ------------TKSHPPIPEH-----LSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
PP L E D L K LQ P R +A E L+HP+
Sbjct: 224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 113/276 (40%), Positives = 152/276 (55%), Gaps = 23/276 (8%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
GEL G GAFG+VY N ++G L A K + K++ + + E+ +L + H
Sbjct: 11 GEL-GDGAFGKVYKAQNKETGVLAAAKVI--------DTKSEEELEDYMVEIDILASCDH 61
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHK 187
PNIV+ L +++L IL+EF GG++ +++ + E IR+ KQ L L YLH+
Sbjct: 62 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL--- 244
N I+HRD+K NIL G IKLADFG S K TI S GTPYWMAPEV++
Sbjct: 122 NKIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 245 --QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI---PEHLSM 299
+ + AD+WS+G T+IEMA +PP + + L I KS PP P S
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPP-HHELNPMRVLLKIA--KSEPPTLAQPSRWSS 236
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
E KDFL KCL+K R T ++LLQHPFVT P
Sbjct: 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKP 272
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 173 bits (441), Expect = 1e-49
Identities = 95/268 (35%), Positives = 149/268 (55%), Gaps = 18/268 (6%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
GEL G G G V ++ +G+++AVK + + N A + Q +REL +L
Sbjct: 7 GEL-GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEA--IQKQI-LREL----DILHKCNS 58
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLH- 186
P IV + G + ++I +E++ GGS+ +L + G PE ++ +L GL YLH
Sbjct: 59 PYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
K+ I+HRD+K +NILV+++G IKL DFG S ++V AK+ GT +MAPE I
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL----AKTFVGTSSYMAPERIQGN 174
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT--TKSHPP-IPEH-LSMEAK 302
+S +DIWS+G ++IE+ATG+ P+ + +F + PP +P S + +
Sbjct: 175 DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQ 234
Query: 303 DFLLKCLQKEPYLRSTASELLQHPFVTG 330
DF+ CL K+P R + ELL+HPF+
Sbjct: 235 DFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 96/262 (36%), Positives = 139/262 (53%), Gaps = 17/262 (6%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G+FG VY ++ + E++A+K++ + S EK Q I+E V+ L+ L HPN
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQ-SNEKWQDIIKE----VRFLQQLRHPNT 77
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS-FPESVIRMYTKQLLLGLEYLHKNGI 190
+ Y G + + +++E+ G S S +L E I L GL YLH +
Sbjct: 78 IEYKGCYLREHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHER 136
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL--QTGH 248
+HRDIK NIL+ G +KLADFG++ + ++ A S GTPYWMAPEVIL G
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSA------SLVSPANSFVGTPYWMAPEVILAMDEGQ 190
Query: 249 -SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307
D+WS+G T IE+A KPP ++AL+HI S S ++F+
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDS 249
Query: 308 CLQKEPYLRSTASELLQHPFVT 329
CLQK P R ++ ELL+H FV
Sbjct: 250 CLQKIPQDRPSSEELLKHRFVL 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 7e-49
Identities = 104/262 (39%), Positives = 143/262 (54%), Gaps = 17/262 (6%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G +G VY N+++GEL A+K + K + +++E+ ++K+ H NI
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI--------KLEPGEDFAVVQQEIIMMKDCKHSNI 68
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
V Y G+ D L I +EF GGS+ + G ES I +++ L GL YLH G M
Sbjct: 69 VAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM 128
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL---QTGH 248
HRDIKGANIL+ + G +KLADFG S ++ ATI KS GTPYWMAPEV + G+
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQIT--ATIAKRKSFIGTPYWMAPEVAAVERKGGY 186
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE---HLSMEAKDFL 305
+ DIW+VG T IE+A +PP + ALF + + PP + S F+
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMF-DLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFV 245
Query: 306 LKCLQKEPYLRSTASELLQHPF 327
L K P R TA +LLQHPF
Sbjct: 246 KMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 7e-49
Identities = 98/268 (36%), Positives = 157/268 (58%), Gaps = 14/268 (5%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P + K E +G G+FG V+ G++ + +++A+K + + E+ + I ++++E+
Sbjct: 2 PEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDL-------EEAEDEIEDIQQEIT 54
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181
+L P + +Y G+ + L I++E++ GGS LL + G F E I K++L G
Sbjct: 55 VLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKG 113
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
L+YLH +HRDIK AN+L+ +G +KLADFG + ++ + T + GTP+WMAPE
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP-IPEHLSME 300
VI Q+ + ADIWS+G T IE+A G+PP + + LF I K++PP + S
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPP-NSDMHPMRVLFLI--PKNNPPTLTGEFSKP 228
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFV 328
K+F+ CL K+P R TA ELL+H F+
Sbjct: 229 FKEFIDACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 174 bits (441), Expect = 2e-48
Identities = 104/330 (31%), Positives = 155/330 (46%), Gaps = 36/330 (10%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+R +G G+FG VY+ + +L+A+K + S SKE + E+++L +
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVER-----FLREIQILAS 53
Query: 126 LTHP-NIVRYLGTAREDDSLNILLEFVPGGSISSLL---GKFGSFPESVIRMYTKQLLLG 181
L HP NIV+ +++ SL +++E+V GGS+ LL G+ G ES Q+L
Sbjct: 54 LNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSA 113
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGC-IKLADFGASKKV----VELATINGAKSMKGTPY 236
LEYLH GI+HRDIK NIL+D G +KL DFG +K + + + GTP
Sbjct: 114 LEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 237 WMAPEVILQTGH---SFSADIWSVGCTVIEMATGKPPW-----SQQFQEVAALFHIGTTK 288
+MAPEV+L S S+DIWS+G T+ E+ TG PP+ S + + T
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233
Query: 289 SHPP-----IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSV 343
S PE +S A D L K L K+P R ++S L H + H + S
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA------HLKLKESD 287
Query: 344 MESGNQIATPGMNLRNSMNSLVRRSTGLKD 373
+ + + SL + L
Sbjct: 288 LSDLLKPDDSAPLRLSLPPSLEALISSLNS 317
|
Length = 384 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-48
Identities = 100/268 (37%), Positives = 159/268 (59%), Gaps = 14/268 (5%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P + K E +G G+FG V+ G++ + +++A+K + + E+ + I ++++E+
Sbjct: 2 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL-------EEAEDEIEDIQQEIT 54
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181
+L P + +Y G+ +D L I++E++ GGS LL + G E+ I +++L G
Sbjct: 55 VLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKG 113
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
L+YLH +HRDIK AN+L+ G +KLADFG + ++ + T + GTP+WMAPE
Sbjct: 114 LDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPE 171
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE-HLSME 300
VI Q+ + ADIWS+G T IE+A G+PP S + + LF I K++PP E + S
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHS-ELHPMKVLFLI--PKNNPPTLEGNYSKP 228
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFV 328
K+F+ CL KEP R TA ELL+H F+
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-48
Identities = 95/268 (35%), Positives = 150/268 (55%), Gaps = 13/268 (4%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P ++ + E +G GA G VY +++ +G+ +A+KQ+ N + K + I E+
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM----NLQQQPKKELII----NEIL 68
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181
+++ HPNIV YL + D L +++E++ GGS++ ++ + E I ++ L
Sbjct: 69 VMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
LE+LH N ++HRDIK NIL+ G +KL DFG ++ + +M GTPYWMAPE
Sbjct: 128 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT--PEQSKRSTMVGTPYWMAPE 185
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT-KSHPPIPEHLSME 300
V+ + + DIWS+G IEM G+PP+ + + AL+ I T PE LS
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGTPELQNPEKLSAI 244
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFV 328
+DFL +CL+ + R +A ELLQHPF+
Sbjct: 245 FRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 1e-47
Identities = 100/299 (33%), Positives = 138/299 (46%), Gaps = 62/299 (20%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKT---QAHIRELEEEVKLLKNLTH 128
+G G +G+VY N +GEL+A+K++ + EK IRE +KLL+ L H
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIRM-----ENEKEGFPITAIRE----IKLLQKLRH 57
Query: 129 PNIVRYLGTAREDDSLNILL--EFVP---GGSISSLLGKFGSFPESVIRMYTKQLLLGLE 183
PNIVR +I + E++ G + S KF ES I+ Y KQLL GL+
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFT---ESQIKCYMKQLLEGLQ 114
Query: 184 YLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA-TINGAKSMKGTP-----YW 237
YLH NGI+HRDIKG+NIL++N G +KLADFG LA S T ++
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGVLKLADFG-------LARPYTKRNSADYTNRVITLWY 167
Query: 238 MAPEVIL-QTGHSFSADIWSVGCTVIEMATGKP--------------------PWSQQFQ 276
PE++L T + D+WSVGC + E+ GKP P + +
Sbjct: 168 RPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227
Query: 277 EVAALFHIGTTKSHPPIPEHL--------SMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
V+ L K P L A D L K L +P R +A + LQH +
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 2e-47
Identities = 80/266 (30%), Positives = 122/266 (45%), Gaps = 17/266 (6%)
Query: 67 RKGELVGCGAFGRVYMGM----NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
G+ +G GAFG VY G + +AVK + A ++ E EE +
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA-------SEEEREEFLEEASI 54
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLG 181
+K L+HPNIVR LG + + L I+ E++PGG + L + Q+ G
Sbjct: 55 MKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKG 114
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
+EYL +HRD+ N LV +K++DFG S+ + E K WMAPE
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPE 174
Query: 242 VILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQ-FQEVAALFHIGTTKSHPPIPEHLSM 299
+ + +D+WS G + E+ T G+ P+ +EV L G P PE+
Sbjct: 175 SLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGY---RLPRPENCPD 231
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQH 325
E + +L+C +P R T SEL++
Sbjct: 232 ELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 3e-47
Identities = 89/262 (33%), Positives = 141/262 (53%), Gaps = 16/262 (6%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
+G G++G VY L + A+K+V + + + KE+ A E+++L ++ HPN
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLG-SMSQKEREDA-----VNEIRILASVNHPN 60
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS----FPESVIRMYTKQLLLGLEYLH 186
I+ Y + + L I++E+ P G +S + K PE I QLL GL+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
+ I+HRD+K ANIL+ +K+ D G SK + N AK+ GTP++MAPEV
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISK----VLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLL 306
+S+ +DIWS+GC + EMAT PP+ + + + L + +PPIP S + ++F+
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPF--EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234
Query: 307 KCLQKEPYLRSTASELLQHPFV 328
LQ +P LR ++L P V
Sbjct: 235 SMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 7e-46
Identities = 76/269 (28%), Positives = 128/269 (47%), Gaps = 26/269 (9%)
Query: 67 RKGELVGCGAFGRVYMGM----NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
G+ +G GAFG VY G +AVK + ++ ++ I E E ++
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVK-------TLKEDASEQQIEEFLREARI 54
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRM-----YTKQ 177
++ L HPN+V+ LG E++ L I++E++ GG + S L K + + + Q
Sbjct: 55 MRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK----NRPKLSLSDLLSFALQ 110
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 237
+ G+EYL +HRD+ N LV +K++DFG S+ + + + K W
Sbjct: 111 IARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYRKRGGKLPIRW 169
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFHIGTTKSHPPIPE 295
MAPE + + + +D+WS G + E+ T G+ P+ +EV G P P
Sbjct: 170 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYR---LPQPP 226
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+ E D +L+C ++P R T SEL++
Sbjct: 227 NCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 1e-45
Identities = 94/302 (31%), Positives = 145/302 (48%), Gaps = 72/302 (23%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEE-----EVKLLKNL 126
+G G FG VY+ N ++GEL+A+K++ K+K + EE EVK L+ L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM--------KKKFYS----WEECMNLREVKSLRKL 54
Query: 127 T-HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLG-----KFGSFPESVIRMYTKQLLL 180
HPNIV+ RE+D L + E++ G +L K F ESVIR Q+L
Sbjct: 55 NEHPNIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK------GT 234
GL ++HK+G HRD+K N+LV +K+ADFG ++++ +S T
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREI---------RSRPPYTDYVST 161
Query: 235 PYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKP------------------------ 269
++ APE++L+ T +S DIW++GC + E+ T +P
Sbjct: 162 RWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQ 221
Query: 270 PWSQQFQEVAAL-FHIGTTKSHPP---IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
W + ++ + L F IP + S EA D + L+ +P R TAS+ LQH
Sbjct: 222 DWPEGYKLASKLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH 280
Query: 326 PF 327
P+
Sbjct: 281 PY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 163 bits (413), Expect = 1e-45
Identities = 102/262 (38%), Positives = 137/262 (52%), Gaps = 17/262 (6%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
VG G +G VY NL +GEL AVK + K + +++E+ ++K H NI
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII--------KLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
V Y G+ + L I +E+ GGS+ + G E I ++ L GL YLH G M
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM 128
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL---QTGH 248
HRDIKGANIL+ + G +KLADFG + K+ ATI KS GTPYWMAPEV G+
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKIT--ATIAKRKSFIGTPYWMAPEVAAVEKNGGY 186
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP-IPEHL--SMEAKDFL 305
+ DIW+VG T IE+A +PP + ALF + + PP + + S +F+
Sbjct: 187 NQLCDIWAVGITAIELAELQPPMF-DLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFV 245
Query: 306 LKCLQKEPYLRSTASELLQHPF 327
L K P R TA LL H F
Sbjct: 246 KISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 8e-45
Identities = 80/273 (29%), Positives = 127/273 (46%), Gaps = 30/273 (10%)
Query: 70 ELVGCGAFGRVYMGM--NLDSGELL-AVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+ +G GAFG VY G D AVK + A+ ++ +E +++K L
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-------ERKDFLKEARVMKKL 53
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRM-----YTKQ 177
HPN+VR LG E++ L ++LE++ GG + L F S +S + + + Q
Sbjct: 54 GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQ 113
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP-- 235
+ G+EYL +HRD+ N LV +K++DFG S+ V + + + G
Sbjct: 114 IAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD---DDYYRKKTGGKLP 170
Query: 236 -YWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFHIGTTKSHPP 292
WMAPE + + +D+WS G + E+ T G P+ +EV G P
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG---YRLP 227
Query: 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
PE+ E + +L C Q +P R T SEL++
Sbjct: 228 KPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-44
Identities = 83/268 (30%), Positives = 128/268 (47%), Gaps = 36/268 (13%)
Query: 75 GAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134
GAFG VY+ +G+ A+K VL ++ +K + E ++ P + +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIK-VLKKSDMIAKNQV---TNVKAERAIMMIQGESPYVAKL 62
Query: 135 LGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRD 194
+ + D L +++E++ GG +SL+ G PE + Y +++LG+E LH+ GI+HRD
Sbjct: 63 YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122
Query: 195 IKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADI 254
IK N+L+D G +KL DFG S+ +E K GTP ++APE IL G +D
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDW 176
Query: 255 WSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS------------HPPIPEHLSMEAK 302
WS+GC + E G PP FH T + + E S EA
Sbjct: 177 WSLGCVIFEFLFGYPP-----------FHAETPDAVFDNILSRRINWPEEVKEFCSPEAV 225
Query: 303 DFLLKCLQKEPYLRSTAS---ELLQHPF 327
D + + L +P R A+ E+ HPF
Sbjct: 226 DLINRLLCMDPAKRLGANGYQEIKSHPF 253
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 160 bits (405), Expect = 2e-44
Identities = 102/285 (35%), Positives = 151/285 (52%), Gaps = 32/285 (11%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P W E +G G +G+V+ +N +G AVK +L + +E +E E
Sbjct: 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEE--------IEAEYN 66
Query: 122 LLKNLT-HPNIVRYLGT-----AREDDSLNILLEFVPGGSISSLLGKF----GSFPESVI 171
+LK L+ HPN+V++ G + D L ++LE GGS++ L+ F E +I
Sbjct: 67 ILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII 126
Query: 172 RMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSM 231
+ L+GL++LH N +HRD+KG NIL+ +G +KL DFG S ++ +T +
Sbjct: 127 AYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTS 184
Query: 232 KGTPYWMAPEVI-----LQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT 286
GTP+WMAPEVI L + + D+WS+G T IE+ G PP + + ALF I
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA-DLHPMRALFKI-- 241
Query: 287 TKSHPPI---PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
++ PP PE S E DF+ KCL K+ R T S+LLQH F+
Sbjct: 242 PRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 2e-44
Identities = 79/262 (30%), Positives = 130/262 (49%), Gaps = 11/262 (4%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
G+ +G GAFG VY G G+ K+V +A + ++ ++ I E E ++++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGD---GKEVEVAVKTLKEDASEQQIEEFLREARIMRKL 58
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRM--YTKQLLLGLEY 184
HPNIV+ LG E++ L I++E++PGG + L K S+ + + Q+ G+EY
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
L +HRD+ N LV +K++DFG S+ + + K K WMAPE +
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD-DDYYKVKGGKLPIRWMAPESLK 177
Query: 245 QTGHSFSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
+ + +D+WS G + E+ T G+ P+ EV G P P + E
Sbjct: 178 EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR---LPKPPNCPPELY 234
Query: 303 DFLLKCLQKEPYLRSTASELLQ 324
+L+C ++P R T SEL++
Sbjct: 235 KLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 2e-44
Identities = 85/291 (29%), Positives = 132/291 (45%), Gaps = 43/291 (14%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIA-ANSASKEKTQAHIRELEEEVKLLKNLTH 128
+VG GA+G V N +GE++A+K+ + + K+ EVK+L+ L H
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL-------REVKVLRQLRH 59
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHK 187
NIV R L ++ E+V ++ LL G P +R Y QLL + Y H
Sbjct: 60 ENIVNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL-QT 246
+ I+HRDIK NILV G +KL DFG ++ + T ++ APE+++ T
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP-LTDYVATRWYRAPELLVGDT 177
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI-----GTTKSH----------- 290
+ D+W++GC + E+ G+P + ++ L+ I SH
Sbjct: 178 NYGKPVDVWAIGCIMAELLDGEPLFPGD-SDIDQLYLIQKCLGPLPPSHQELFSSNPRFA 236
Query: 291 ----PPIPEHLSMEAK----------DFLLKCLQKEPYLRSTASELLQHPF 327
P + S+E + DFL CL+ +P R T ELLQHP+
Sbjct: 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 2e-44
Identities = 85/258 (32%), Positives = 136/258 (52%), Gaps = 12/258 (4%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G F VY L + +A+K+V I +K + ++ +E+ LLK L HPN+
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKAR-----QDCVKEIDLLKQLNHPNV 64
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS----FPESVIRMYTKQLLLGLEYLHK 187
++YL + ED+ LNI+LE G +S ++ F PE + Y QL +E++H
Sbjct: 65 IKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS 124
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
+MHRDIK AN+ + G +KL D G + T A S+ GTPY+M+PE I + G
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG 182
Query: 248 HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP-EHLSMEAKDFLL 306
++F +DIWS+GC + EMA + P+ + +L +PP+P EH S + ++ +
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVS 242
Query: 307 KCLQKEPYLRSTASELLQ 324
C+ +P R + Q
Sbjct: 243 MCIYPDPDQRPDIGYVHQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 3e-44
Identities = 91/261 (34%), Positives = 144/261 (55%), Gaps = 19/261 (7%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE-EEVKLLKNLTHPN 130
+G G+ G V + + +G +AVK++ + K Q REL EV ++++ HPN
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDL-------RKQQR--RELLFNEVVIMRDYQHPN 77
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGI 190
IV + D L +++EF+ GG+++ ++ E I +L L +LH G+
Sbjct: 78 IVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGV 136
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSF 250
+HRDIK +IL+ + G +KL+DFG +V + + KS+ GTPYWMAPEVI + +
Sbjct: 137 IHRDIKSDSILLTSDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPEVISRLPYGT 194
Query: 251 SADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL---SMEAKDFLLK 307
DIWS+G VIEM G+PP+ + + A+ I PP ++L S + FL +
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNE-PPLQAMKRIRDNL--PPKLKNLHKVSPRLRSFLDR 251
Query: 308 CLQKEPYLRSTASELLQHPFV 328
L ++P R+TA+ELL HPF+
Sbjct: 252 MLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 9e-44
Identities = 90/290 (31%), Positives = 140/290 (48%), Gaps = 48/290 (16%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G +G VY + +GE++A+K++ + +++ + E+KLLK L HPNI
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI------KLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
++ L R L ++ EF+ + + PES+I+ Y QLL GL + H +GI+
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY----WM-APEVIL-Q 245
HRD+K N+L++ +G +KLADFG LA G+ T Y W APE++L
Sbjct: 121 HRDLKPENLLINTEGVLKLADFG-------LARSFGSPVRPYTHYVVTRWYRAPELLLGD 173
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI----GTT-------------- 287
G+S DIWSVGC E+ + +P + + E+ LF I GT
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGK-SEIDQLFKIFRTLGTPDPEVWPKFTSLARN 232
Query: 288 -----KSHPPIPEH-----LSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
+P S +A D L + L +P+ R TA + L HP+
Sbjct: 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY 282
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 1e-43
Identities = 95/260 (36%), Positives = 140/260 (53%), Gaps = 15/260 (5%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G+FG VY N + E++AVK++ S S ++T +++ +EVK L+ L HPN
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKM-----SYSGKQTNEKWQDIIKEVKFLQQLKHPNT 83
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
+ Y G ++ + +++E+ G + L E I T L GL YLH + ++
Sbjct: 84 IEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL---QTGH 248
HRDIK NIL+ G +KLADFG++ K + A S GTPYWMAPEVIL + +
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASKS------SPANSFVGTPYWMAPEVILAMDEGQY 197
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308
D+WS+G T IE+A KPP ++AL+HI S + + F+ C
Sbjct: 198 DGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYC 256
Query: 309 LQKEPYLRSTASELLQHPFV 328
LQK P R ++ELL+H FV
Sbjct: 257 LQKIPQERPASAELLRHDFV 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 158 bits (400), Expect = 1e-43
Identities = 94/269 (34%), Positives = 153/269 (56%), Gaps = 15/269 (5%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P ++ + E +G GA G VY +++ +G+ +A+KQ+ N + K + I E+
Sbjct: 17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQM----NLQQQPKKELII----NEIL 68
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181
+++ +PNIV YL + D L +++E++ GGS++ ++ + E I ++ L
Sbjct: 69 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 127
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
L++LH N ++HRDIK NIL+ G +KL DFG ++ + +M GTPYWMAPE
Sbjct: 128 LDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPE 185
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI--PEHLSM 299
V+ + + DIWS+G IEM G+PP+ + + AL+ I T + P + PE LS
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGT-PELQNPERLSA 243
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFV 328
+DFL +CL+ + R +A ELLQHPF+
Sbjct: 244 VFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 1e-43
Identities = 74/260 (28%), Positives = 128/260 (49%), Gaps = 14/260 (5%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQV-LIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+G G+FG V+ + + A+KQ+ L N +E E +E ++L L
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE-------EAIDEARVLAKLDS 58
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLLLGLEYLH 186
I+RY + + LNI++E+ G + LL PE + + Q+LLGL +LH
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
I+HRDIK N+ +D +K+ D G +K + N A ++ GTPY+++PE+
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELCEDK 176
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLL 306
++ +D+W++G + E TGK P+ + A + I PP+ + S + +
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHPFDAN-NQGALILKIIRGV-FPPVSQMYSQQLAQLID 234
Query: 307 KCLQKEPYLRSTASELLQHP 326
+CL K+ R +LL++P
Sbjct: 235 QCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-43
Identities = 94/269 (34%), Positives = 155/269 (57%), Gaps = 15/269 (5%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P ++ + E +G GA G V+ +++ +G+ +A+KQ+ N + K + I E+
Sbjct: 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI----NLQKQPKKELII----NEIL 68
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181
++K L +PNIV +L + D L +++E++ GGS++ ++ + E+ I ++ L
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQA 127
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
LE+LH N ++HRDIK N+L+ G +KL DFG ++ + +M GTPYWMAPE
Sbjct: 128 LEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPE 185
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI--PEHLSM 299
V+ + + DIWS+G IEM G+PP+ + + AL+ I T + P + PE LS
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYLIATNGT-PELQNPEKLSP 243
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFV 328
+DFL +CL+ + R +A ELLQHPF+
Sbjct: 244 IFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 26/271 (9%)
Query: 73 GCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV 132
G GA G V ++G + A+K + N +++ +RELE + K+ P IV
Sbjct: 10 GEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQI---LRELE----INKSCKSPYIV 62
Query: 133 RYLGT--AREDDSLNILLEFVPGGSISSLLGKF----GSFPESVIRMYTKQLLLGLEYLH 186
+Y G S+ I +E+ GGS+ S+ K G E V+ + +L GL YLH
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
I+HRDIK +NIL+ KG +KL DFG S ++V + A + GT ++MAPE I
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN----SLAGTFTGTSFYMAPERIQGK 178
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE---------HL 297
+S ++D+WS+G T++E+A + P+ + + + + + P PE
Sbjct: 179 PYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW 238
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
S E KDF+ +CL+K+P R T ++L+HP++
Sbjct: 239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-42
Identities = 80/266 (30%), Positives = 139/266 (52%), Gaps = 26/266 (9%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK--TQAHIRELEEEVKLLKNLTHP 129
+G GAFG+V + D+ ++ A+K + +K+K + +R + E ++L+ L HP
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYM-------NKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
+V + ++++++ ++++ + GG + L + F E ++ + +++L LEYLH G
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG 120
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVV--ELATINGAKSMKGTPYWMAPEVILQTG 247
I+HRDIK NIL+D +G + + DF + KV L T S GTP +MAPEV+ + G
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTT-----STSGTPGYMAPEVLCRQG 175
Query: 248 HSFSADIWSVGCTVIEMATGKPPW----SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
+S + D WS+G T E GK P+ ++ A + P S EA D
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQE----TADVLYPATWSTEAID 231
Query: 304 FLLKCLQKEPYLR--STASELLQHPF 327
+ K L+++P R +L HP+
Sbjct: 232 AINKLLERDPQKRLGDNLKDLKNHPY 257
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 2e-42
Identities = 107/304 (35%), Positives = 156/304 (51%), Gaps = 34/304 (11%)
Query: 43 GLFSKPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAAN 102
GLF P ++ +E P W E +G G +G+VY N G L AVK +L +
Sbjct: 3 GLF--PYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPIS 59
Query: 103 SASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDD-----SLNILLEFVPGGSI 156
+E +E E +L++L HPN+V++ G + D L ++LE GGS+
Sbjct: 60 DVDEE--------IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV 111
Query: 157 SSL---LGKFGS-FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLAD 212
+ L L G E++I LLGL++LH N I+HRD+KG NIL+ +G +KL D
Sbjct: 112 TELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVD 171
Query: 213 FGASKKVVELATINGAKSMKGTPYWMAPEVIL---QTGHSFSA--DIWSVGCTVIEMATG 267
FG S ++ +T + GTP+WMAPEVI Q +S+ A D+WS+G T IE+ G
Sbjct: 172 FGVSAQLT--STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
Query: 268 KPPWSQQFQEVAALFHIGTTKSHPPI---PEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
PP V LF I ++ PP PE F+ +CL K+ R + + LL+
Sbjct: 230 DPPLF-DMHPVKTLFKI--PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286
Query: 325 HPFV 328
HPF+
Sbjct: 287 HPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 2e-42
Identities = 91/288 (31%), Positives = 142/288 (49%), Gaps = 27/288 (9%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
GE +G G+FGRV + + +GE A+K + K K H+ +E +L L+H
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYAIK--CLKKREILKMKQVQHV---AQEKSILMELSH 77
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
P IV + + ++++ + LLEFV GG + + L K G FP V + Y +L+L EYLH
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSK 137
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGH 248
I++RD+K N+L+DNKG +K+ DFG +KKV + ++ GTP ++APEVI GH
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF-----TLCGTPEYLAPEVIQSKGH 192
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308
+ D W++G + E G PP+ F + + P A+D +
Sbjct: 193 GKAVDWWTMGVLLYEFIAGYPPF---FDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGL 249
Query: 309 LQKEPY-----LRSTASELLQHPFVTG---------KYQDPHPVFRNS 342
LQ + L+ +++ HP+ G Y P PV S
Sbjct: 250 LQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKS 297
|
Length = 329 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-42
Identities = 86/270 (31%), Positives = 139/270 (51%), Gaps = 23/270 (8%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
PIR ++G GAFG + + L+ K+V + S KE+ R+ E+ +
Sbjct: 4 PIR-----VLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKER-----RDALNEIVI 52
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLG--KFGSFPESVIRMYTKQLLL 180
L L HPNI+ Y +D++L I +E+ GG++ + K F E ++ Y Q++
Sbjct: 53 LSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVS 112
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT-INGAKSMKGTPYWMA 239
+ Y+HK GI+HRDIK NI + G IKL DFG SK L + + A+++ GTPY+M+
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKI---LGSEYSMAETVVGTPYYMS 169
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPW--SQQFQEVAALFHIGTTKSHPPIPEHL 297
PE+ ++F +DIW++GC + E+ T K + + V + ++ P+
Sbjct: 170 PELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI----VQGNYTPVVSVY 225
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
S E + LQ++P R TA E+L P
Sbjct: 226 SSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 2e-42
Identities = 96/273 (35%), Positives = 149/273 (54%), Gaps = 25/273 (9%)
Query: 73 GCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
G GA+G+V++ + D+G+L A+K VL A K KT H R + ++ ++ P
Sbjct: 9 GTGAYGKVFLVRKVGGHDAGKLYAMK-VLKKATIVQKAKTAEHTRTERQVLEAVRR--CP 65
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
+V + D L+++L++V GG + + L + F ES +R+Y +++L L++LH+ G
Sbjct: 66 FLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATING--AKSMKGTPYWMAPEVIL--Q 245
I++RDIK NIL+D++G + L DFG SK E A S GT +MAPEVI
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSK---EFLAEEEERAYSFCGTIEYMAPEVIRGGS 182
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWS-----QQFQEVAALFHIGTTKSHPPIPEHLSME 300
GH + D WS+G E+ TG P++ E++ KS PP P+ +S E
Sbjct: 183 GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI----LKSKPPFPKTMSAE 238
Query: 301 AKDFLLKCLQKEPYLR---STASELLQHPFVTG 330
A+DF+ K L+K+P R + A E+ HPF G
Sbjct: 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 84/265 (31%), Positives = 131/265 (49%), Gaps = 23/265 (8%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
VG G +G+V++ D+GE++A+K +L N +R + E +L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLN---------EVRHVLTERDILTTTK 59
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
+V+ L ++D+ L + +E+VPGG +LL G E R Y ++ ++ LH+
Sbjct: 60 SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE 119
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
G +HRD+K N L+D G IKL DFG SK +V A S+ G+P +MAPEV+ G
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY-----ANSVVGSPDYMAPEVLRGKG 174
Query: 248 HSFSADIWSVGCTVIEMATGKPPWS-QQFQEV-AALFHIGTTKSHPPIPE---HLSMEAK 302
+ F+ D WS+GC + E G PP+S E L + T P + +LS EA
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234
Query: 303 DFLLKCLQKEPYLRSTASELLQHPF 327
D + K + + ++ HPF
Sbjct: 235 DLITKLINDPSRRFGSLEDIKNHPF 259
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 6e-42
Identities = 94/269 (34%), Positives = 151/269 (56%), Gaps = 15/269 (5%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P ++ + E +G GA G VY M++ +G+ +A++Q+ N + K + I E+
Sbjct: 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM----NLQQQPKKELII----NEIL 69
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181
+++ +PNIV YL + D L +++E++ GGS++ ++ + E I ++ L
Sbjct: 70 VMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQA 128
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
LE+LH N ++HRDIK NIL+ G +KL DFG ++ + +M GTPYWMAPE
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPE 186
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI--PEHLSM 299
V+ + + DIWS+G IEM G+PP+ + + AL+ I T + P + PE LS
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE-NPLRALYLIATNGT-PELQNPEKLSA 244
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFV 328
+DFL +CL + R +A ELLQH F+
Sbjct: 245 IFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 92/295 (31%), Positives = 144/295 (48%), Gaps = 41/295 (13%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKT--QAHIRELEEEVKLLKN 125
+++G GAFG V++ + D+G++ A+K + K + I + E +L +
Sbjct: 5 VIKVIGRGAFGEVWLVRDKDTGQVYAMKVL-------RKSDMIKRNQIAHVRAERDILAD 57
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
P IV+ + ++++ L +++E++PGG + +LL + FPE R Y +L+L L+ +
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKK--------VVELATING---------- 227
HK G +HRDIK NIL+D G IKLADFG KK + N
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 228 ---------AKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW-SQQFQE 277
A S GTP ++APEV+ T + D WS+G + EM G PP+ S QE
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
Query: 278 VAA-LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLR-STASELLQHPFVTG 330
+ + + PP P +S EA D + + L +P R + E+ HPF G
Sbjct: 238 TYNKIINWKESLRFPPDP-PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (385), Expect = 2e-41
Identities = 91/300 (30%), Positives = 138/300 (46%), Gaps = 58/300 (19%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKT-QAHIRELEEEVKLLKNLT 127
+G GA+G VY +L++G +A+K+V + S+E + +RE + LLK L
Sbjct: 4 LAEIGEGAYGTVYKARDLNTGRFVALKKVRV---PLSEEGIPLSTLRE----IALLKQLE 56
Query: 128 ---HPNIVRYLG------TAREDDSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTK 176
HPNIVR L T RE L ++ E V +++ L K P I+ +
Sbjct: 57 SFEHPNIVRLLDVCHGPRTDRELK-LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMR 114
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP- 235
QLL G+++LH + I+HRD+K NILV + G +K+ADFG ++ M T
Sbjct: 115 QLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF--------EMALTSV 166
Query: 236 ----YWMAPEVILQTGHSFSADIWSVGCTVIEMA---------------------TGKPP 270
++ APEV+LQ+ ++ D+WSVGC E+ G P
Sbjct: 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPS 226
Query: 271 WSQQFQEVAAL---FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
+ + V+ F T +S + E D L K L P+ R +A E LQHP+
Sbjct: 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 3e-41
Identities = 81/267 (30%), Positives = 146/267 (54%), Gaps = 14/267 (5%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ K +VG GAFG V++ +L+ +KQ I +K++ A + E ++LK
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQ--IPVEQMTKDERLA----AQNECQVLK 54
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLLLGL 182
L+HPNI+ Y ED +L I++E+ PGG+++ + K + E I + Q+LL L
Sbjct: 55 LLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLAL 114
Query: 183 EYLHKNGIMHRDIKGANILVD-NKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
++H I+HRD+K NIL+D +K +K+ DFG SK L++ + A ++ GTP +++PE
Sbjct: 115 HHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK---ILSSKSKAYTVVGTPCYISPE 171
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301
+ ++ +DIW++GC + E+A+ K + + + AL + + PI + S +
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAF--EAANLPALVLKIMSGTFAPISDRYSPDL 229
Query: 302 KDFLLKCLQKEPYLRSTASELLQHPFV 328
+ +L L +P R S+++ P
Sbjct: 230 RQLILSMLNLDPSKRPQLSQIMAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 5e-41
Identities = 85/250 (34%), Positives = 131/250 (52%), Gaps = 12/250 (4%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G F VY L G +A+K+V I +K + + +E+ LLK L HPN+
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKAR-----ADCIKEIDLLKQLNHPNV 64
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS----FPESVIRMYTKQLLLGLEYLHK 187
++Y + ED+ LNI+LE G +S ++ F PE + Y QL LE++H
Sbjct: 65 IKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS 124
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
+MHRDIK AN+ + G +KL D G + T A S+ GTPY+M+PE I + G
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENG 182
Query: 248 HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP-EHLSMEAKDFLL 306
++F +DIWS+GC + EMA + P+ + +L +PP+P +H S E + +
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN 242
Query: 307 KCLQKEPYLR 316
C+ +P R
Sbjct: 243 MCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 6e-41
Identities = 89/260 (34%), Positives = 141/260 (54%), Gaps = 15/260 (5%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G+FG VY ++ + E++A+K++ S S +++ +++ +EV+ L+ L HPN
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKM-----SYSGKQSNEKWQDIIKEVRFLQKLRHPNT 77
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
++Y G + + +++E+ G + L E I T L GL YLH + ++
Sbjct: 78 IQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMI 137
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL---QTGH 248
HRD+K NIL+ G +KL DFG++ + + A GTPYWMAPEVIL + +
Sbjct: 138 HRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANXFVGTPYWMAPEVILAMDEGQY 191
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308
D+WS+G T IE+A KPP ++AL+HI +S H S ++F+ C
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSC 250
Query: 309 LQKEPYLRSTASELLQHPFV 328
LQK P R T+ LL+H FV
Sbjct: 251 LQKIPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 1e-40
Identities = 95/275 (34%), Positives = 145/275 (52%), Gaps = 30/275 (10%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH- 128
E+VG G +G+VY G ++ +G+L A+K + + T+ E++ E+ +LK +H
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDV---------TEDEEEEIKLEINMLKKYSHH 72
Query: 129 PNIVRYLGT------AREDDSLNILLEFVPGGSISSLLG--KFGSFPESVIRMYTKQLLL 180
NI Y G DD L +++EF GS++ L+ K + E I +++L
Sbjct: 73 RNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
GL +LH + ++HRDIKG N+L+ +KL DFG S ++ T+ + GTPYWMAP
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAP 190
Query: 241 EVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295
EVI + + +DIWS+G T IEMA G PP + ALF I ++ PP +
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC-DMHPMRALFLI--PRNPPPKLK 247
Query: 296 HLSMEAK--DFLLKCLQKEPYLRSTASELLQHPFV 328
K DF+ CL K R + +LL+HPF+
Sbjct: 248 SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 84/245 (34%), Positives = 129/245 (52%), Gaps = 23/245 (9%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
VG G FGRV++ + S A+K + I K++ H E ++LK ++HP
Sbjct: 8 TVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH-----NEKRVLKEVSHPF 62
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGI 190
I+R T + L +L+E+VPGG + S L G F S Y +++ LEYLH I
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSF 250
++RD+K NIL+D +G IKL DFG +KK+ + ++ GTP ++APEVI GH+
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW-----TLCGTPEYLAPEVIQSKGHNK 177
Query: 251 SADIWSVGCTVIEMATGKPPW-----SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFL 305
+ D W++G + EM G PP+ ++++ A G + P HL + AKD +
Sbjct: 178 AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA----GKLE----FPRHLDLYAKDLI 229
Query: 306 LKCLQ 310
K L
Sbjct: 230 KKLLV 234
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 92/260 (35%), Positives = 142/260 (54%), Gaps = 15/260 (5%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G+FG VY ++ + E++A+K++ S S +++ +++ +EVK L+ + HPN
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKM-----SYSGKQSNEKWQDIIKEVKFLQRIKHPNS 87
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
+ Y G + + +++E+ G + L E I T L GL YLH + ++
Sbjct: 88 IEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMI 147
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL---QTGH 248
HRDIK NIL+ G +KLADFG++ + + A S GTPYWMAPEVIL + +
Sbjct: 148 HRDIKAGNILLTEPGQVKLADFGSA------SIASPANSFVGTPYWMAPEVILAMDEGQY 201
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308
D+WS+G T IE+A KPP ++AL+HI +S S ++F+ C
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSC 260
Query: 309 LQKEPYLRSTASELLQHPFV 328
LQK P R T+ ELL+H FV
Sbjct: 261 LQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 87/296 (29%), Positives = 138/296 (46%), Gaps = 45/296 (15%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK-TQAHIRELEEEVKLL 123
R+ KG+ +G G + VY + ++G ++A+K++ + +K+ +RE +KLL
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALRE----IKLL 56
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGL 182
+ L HPNI+ L ++N++ EF+ + ++ K + I+ Y L GL
Sbjct: 57 QELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGL 115
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP-----YW 237
EYLH N I+HRD+K N+L+ + G +KLADFG LA G+ + K T ++
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFG-------LARSFGSPNRKMTHQVVTRWY 168
Query: 238 MAPEVILQTGH-SFSADIWSVGCTVIEMATGKP--PWSQQFQEVAALFHI-GTT------ 287
APE++ H D+WSVGC E+ P P ++ +F GT
Sbjct: 169 RAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228
Query: 288 -----------KSHPPIP-----EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
K PP P S +A D L + L P R TA + L+HP+
Sbjct: 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-40
Identities = 92/273 (33%), Positives = 145/273 (53%), Gaps = 26/273 (9%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH- 128
ELVG G +G+VY G ++ +G+L A+K + + + E+++E+ +LK +H
Sbjct: 12 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE---------EEIKQEINMLKKYSHH 62
Query: 129 PNIVRYLGTARE------DDSLNILLEFVPGGSISSLLG--KFGSFPESVIRMYTKQLLL 180
NI Y G + DD L +++EF GS++ L+ K + E I +++L
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
GL +LH++ ++HRDIKG N+L+ +KL DFG S ++ T+ + GTPYWMAP
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAP 180
Query: 241 EVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295
EVI + F +D+WS+G T IEMA G PP + ALF I + +
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-DMHPMRALFLIPRNPAPRLKSK 239
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
S + + F+ CL K R T +L++HPF+
Sbjct: 240 KWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 85/308 (27%), Positives = 138/308 (44%), Gaps = 65/308 (21%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEE------ 118
R++ +G GA G V+ + ++GE +A+K+V +R LE
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKV--------------ALRRLEGGIPNQA 46
Query: 119 --EVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYT 175
E+K L+ HP +V+ L +++E++P +S +L PE+ ++ Y
Sbjct: 47 LREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYM 105
Query: 176 KQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK--- 232
+ LL G+ Y+H NGIMHRD+K AN+L+ G +K+ADFG LA + + +
Sbjct: 106 RMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFG-------LARLFSEEEPRLYS 158
Query: 233 ---GTPYWMAPEVIL-QTGHSFSADIWSVGCTVIEMATGKP------------------- 269
T ++ APE++ + D+W+VGC E+ G P
Sbjct: 159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLG 218
Query: 270 -PWSQQFQEVAALFHIG--TTKSHPPIP--EHL---SMEAKDFLLKCLQKEPYLRSTASE 321
P + + + +L T PIP E S EA D L L +P R +A+E
Sbjct: 219 TPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE 278
Query: 322 LLQHPFVT 329
L+HP+ T
Sbjct: 279 ALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 5e-39
Identities = 96/310 (30%), Positives = 135/310 (43%), Gaps = 55/310 (17%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ +G G FG VY + +G ++A+K++L+ EK I L E +K+LK
Sbjct: 9 DYEILGKLGEGTFGEVYKARQIKTGRVVALKKILM-----HNEKDGFPITALRE-IKILK 62
Query: 125 NLTHPNIVRYLGTA--REDDSLNILLEF--VPGGSISSLLGKFGS----FPESVIRMYTK 176
L HPN+V + A R D S V L G + ES I+ Y
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYML 122
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG-------ASKKVVELATINGAK 229
QLL G+ YLH+N I+HRDIK ANIL+DN+G +K+ADFG K
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 230 --SMKGTPYWMAPEVILQTGHSFSA-DIWSVGCTVIEMATGKPPW-----SQQFQEVAAL 281
++ T ++ PE++L +A DIW +GC EM T +P Q + L
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL 242
Query: 282 FHIGT--------------------TKSHPPIPE----HLSMEAKDFLLKCLQKEPYLRS 317
GT ++P E L E D L K L +PY R
Sbjct: 243 --CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300
Query: 318 TASELLQHPF 327
TAS+ L+HP+
Sbjct: 301 TASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 3e-38
Identities = 87/282 (30%), Positives = 154/282 (54%), Gaps = 32/282 (11%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
EL G G +G VY ++ +G +A+K++ + E ++ ++ E+ +L
Sbjct: 7 DEL-GKGNYGSVYKVLHRPTGVTMAMKEIRL-------ELDESKFNQIIMELDILHKAVS 58
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLG---KFGSFPESVIRMYTKQLLLGLEYL 185
P IV + G + ++ + +E++ GS+ L PE V+R T ++ GL++L
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 186 -HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
++ I+HRD+K N+LV+ G +KL DFG S +V A++ AK+ G +MAPE I
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV--ASL--AKTNIGCQSYMAPERIK 174
Query: 245 QTG------HSFSADIWSVGCTVIEMATGK---PP--WSQQFQEVAALFHIGTTKSHPPI 293
G ++ +D+WS+G +++EMA G+ PP ++ F +++A+ G P +
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD-GDP---PTL 230
Query: 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
P S +A+DF+ KCL K P R T ++LL+HP++ KY++
Sbjct: 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV-KYKNA 271
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-38
Identities = 94/307 (30%), Positives = 142/307 (46%), Gaps = 57/307 (18%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQV----LIAANSASKEKTQAHIRELEEEVKLLKNLT 127
+G GAFG V + +D+ L A+K + ++ N A AH++ E +L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQA------AHVKA---ERDILAEAD 59
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
+ +V+ + ++ D+L +++++PGG + SLL + G F E + R Y +L +E +HK
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHK 119
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFG--------------------------------- 214
G +HRDIK NIL+D G IKL DFG
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179
Query: 215 ---ASKKVVELATING-----AKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT 266
K +E A S+ GTP ++APEV+L+TG++ D WSVG + EM
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239
Query: 267 GKPPWSQQFQEVAALFHIGTTKS-HPPIPEHLSMEAKDFLLK-CLQKEPYL-RSTASELL 323
G+PP+ L I + H P LS EA D +L+ C E L ++ A E+
Sbjct: 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIK 299
Query: 324 QHPFVTG 330
HPF G
Sbjct: 300 AHPFFKG 306
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 6e-38
Identities = 93/270 (34%), Positives = 153/270 (56%), Gaps = 17/270 (6%)
Query: 70 ELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+++G GA+G+V++ + DSG+L A+K VL A K KT H R E ++L+++
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMK-VLKKATIVQKAKTTEHTRT---ERQVLEHI 61
Query: 127 TH-PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
P +V + D L+++L+++ GG + + L + F E +++Y+ +++L LE+L
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL- 244
HK GI++RDIK NIL+D+ G + L DFG SK+ E A S GT +MAP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRG 180
Query: 245 -QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVA-ALFHIGTTKSHPPIPEHLSMEAK 302
GH + D WS+G + E+ TG P++ ++ + A KS PP P+ +S AK
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 240
Query: 303 DFLLKCLQKEPYLR-----STASELLQHPF 327
D + + L K+P R S A E+ +HPF
Sbjct: 241 DIIQRLLMKDPKKRLGCGPSDADEIKKHPF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 8e-38
Identities = 80/275 (29%), Positives = 148/275 (53%), Gaps = 30/275 (10%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ K + +G G+FG+ + + + G+ +K++ I+ S KE+ ++ +EV +L
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREES-----RKEVAVLS 54
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGS-FPESVIRMYTKQLLLGL 182
N+ HPNIV+Y + E+ +L I++++ GG + + + G FPE I + Q+ L L
Sbjct: 55 NMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL 114
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
+++H I+HRDIK NI + G IKL DFG ++ V +T+ A++ GTPY+++PE+
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIAR--VLNSTVELARTCIGTPYYLSPEI 172
Query: 243 ILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTK---------SHPPI 293
++ +DIW++GC + EM T K F G K S+PP+
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHA-----------FEAGNMKNLVLKIIRGSYPPV 221
Query: 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
H S + ++ + + ++ P R + + +L+ F+
Sbjct: 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 8e-38
Identities = 88/260 (33%), Positives = 138/260 (53%), Gaps = 17/260 (6%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G+ G V + SG +AVK + + + Q L EV ++++ H N+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDL--------RKQQRRELLFNEVVIMRDYQHQNV 80
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
V + + L +L+EF+ GG+++ ++ + E I + +L L YLH G++
Sbjct: 81 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQGVI 139
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFS 251
HRDIK +IL+ G +KL+DFG ++ + + KS+ GTPYWMAPEVI +T +
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRTPYGTE 197
Query: 252 ADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA---KDFLLKC 308
DIWS+G VIEM G+PP+ F + S PP ++ + +DFL +
Sbjct: 198 VDIWSLGIMVIEMVDGEPPY---FSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254
Query: 309 LQKEPYLRSTASELLQHPFV 328
L +EP R+TA ELL HPF+
Sbjct: 255 LTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 3e-37
Identities = 91/271 (33%), Positives = 150/271 (55%), Gaps = 14/271 (5%)
Query: 70 ELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+++G GA+G+V++ + D+G+L A+K VL A K KT H R ++ ++
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQ- 63
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
P +V + + L+++L++V GG + + L + +F E +R Y+ +++L LE+LH
Sbjct: 64 -SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLH 122
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL-Q 245
K GI++RDIK NIL+D++G + L DFG SK+ + S GT +MAPE+I +
Sbjct: 123 KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGK 181
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDF 304
GH + D WS+G + E+ TG P++ + + + K PP P + EA+D
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDL 241
Query: 305 LLKCLQKEPYLR-----STASELLQHPFVTG 330
L K L+K+P R ASE+ +HPF G
Sbjct: 242 LHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 3e-37
Identities = 86/265 (32%), Positives = 147/265 (55%), Gaps = 17/265 (6%)
Query: 71 LVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
++G G +G+V+ + D+G++ A+K VL A +K AH + E +L+ +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKA---ERNILEAVK 58
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
HP IV + + L ++LE++ GG + L + G F E Y ++ L LE+LH+
Sbjct: 59 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQ 118
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
GI++RD+K NIL+D +G +KL DFG K+ + T+ + GT +MAPE+++++G
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV--THTFCGTIEYMAPEILMRSG 176
Query: 248 HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307
H + D WS+G + +M TG PP++ + ++ + I K +P +L+ EA+D L K
Sbjct: 177 HGKAVDWWSLGALMYDMLTGAPPFTAENRK-KTIDKI--LKGKLNLPPYLTPEARDLLKK 233
Query: 308 CLQKEPYLR-----STASELLQHPF 327
L++ P R A+E+ HPF
Sbjct: 234 LLKRNPSSRLGAGPGDAAEVQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 92/302 (30%), Positives = 145/302 (48%), Gaps = 48/302 (15%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+++G GAFG V + D+G + A+K L + KE+ AH+R E +L +P
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMK-KLRKSEMLEKEQV-AHVRA---ERDILAEADNP 61
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
+V+ + ++++ L +++E++PGG + +LL K +F E R Y + +L ++ +HK G
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG 121
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASK---------------------KVVELAT---- 224
+HRDIK N+L+D KG IKL+DFG + ++
Sbjct: 122 YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSS 181
Query: 225 -----------INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW-S 272
A S GTP ++APEV LQTG++ D WS+G + EM G PP+ S
Sbjct: 182 KRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 273 QQFQEVAALFHIGTTKSHPPIPE--HLSMEAKDFLLK--CLQKEPYLRSTASELLQHPFV 328
QE I K P+ LS EAKD + + C + + +E+ HPF
Sbjct: 242 DNPQETYR--KIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFF 299
Query: 329 TG 330
G
Sbjct: 300 KG 301
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 89/265 (33%), Positives = 142/265 (53%), Gaps = 19/265 (7%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G GA G VY ++ +G L A+K +I N R++ E+++L+++ HPN+
Sbjct: 82 IGSGAGGTVYKVIHRPTGRLYALK--VIYGN-----HEDTVRRQICREIEILRDVNHPNV 134
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
V+ + + +LLEF+ GGS+ F V R Q+L G+ YLH+ I+
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHRRHIV 190
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVI---LQTG- 247
HRDIK +N+L+++ +K+ADFG S+ + + T++ S GT +M+PE I L G
Sbjct: 191 HRDIKPSNLLINSAKNVKIADFGVSRILAQ--TMDPCNSSVGTIAYMSPERINTDLNHGA 248
Query: 248 -HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP-IPEHLSMEAKDFL 305
++ DIWS+G +++E G+ P+ Q A S PP P S E + F+
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFI 308
Query: 306 LKCLQKEPYLRSTASELLQHPFVTG 330
CLQ+EP R +A +LLQHPF+
Sbjct: 309 SCCLQREPAKRWSAMQLLQHPFILR 333
|
Length = 353 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 3e-36
Identities = 98/300 (32%), Positives = 153/300 (51%), Gaps = 52/300 (17%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+ GEL G G G V ++ SG ++A K + + A + + IREL K+L
Sbjct: 5 KLGEL-GAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQI---IREL----KVLHEC 56
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
P IV + G D ++I +E + GGS+ +L K G PE+++ + +L GL YL
Sbjct: 57 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLR 116
Query: 187 -KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
K+ IMHRD+K +NILV+++G IKL DFG S ++++ + A S GT +M+PE +
Sbjct: 117 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQG 172
Query: 246 TGHSFSADIWSVGCTVIEMATGK---PPWSQQFQEVAALFH-----IGTTKSHPPIPEH- 296
T ++ +DIWS+G +++EMA G+ PP +E+ A+F +SH P+ H
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPIPPPDA--KELEAMFGRPVSEGEAKESHRPVSGHP 230
Query: 297 ----------------------------LSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
S E +DF+ KCL+K P R+ EL +HPF+
Sbjct: 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 82/296 (27%), Positives = 141/296 (47%), Gaps = 55/296 (18%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE-EEVKLLKNLTH 128
LVG G++G V + ++G+++A+K+ L + + ++++ E+++LK L H
Sbjct: 7 GLVGEGSYGMVMKCKHKETGQIVAIKKFL-------ESEDDKMVKKIAMREIRMLKQLRH 59
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFP----ESVIRMYTKQLLLGLEY 184
N+V + R L ++ EFV ++L +P ES +R Y Q+L G+E+
Sbjct: 60 ENLVNLIEVFRRKKRLYLVFEFVD----HTVLDDLEKYPNGLDESRVRKYLFQILRGIEF 115
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK----GTPYWMAP 240
H + I+HRDIK NILV G +KL DFG ++ T+ + T ++ AP
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR------TLAAPGEVYTDYVATRWYRAP 169
Query: 241 EVIL-QTGHSFSADIWSVGCTVIEMATGKPPW-------------------SQQFQEVAA 280
E+++ T + + DIW+VGC V EM TG+P + + QE+
Sbjct: 170 ELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQ 229
Query: 281 LFHIGTTKSHPPIPEHLSMEAK---------DFLLKCLQKEPYLRSTASELLQHPF 327
+ P + E +E + D +CL+ +P R ++S+LL H F
Sbjct: 230 KNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 6e-36
Identities = 78/265 (29%), Positives = 136/265 (51%), Gaps = 21/265 (7%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
E++G G G VY +L + +LAVK + + + T +++ E+++L P
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPL-------DITVELQKQIMSELEILYKCDSP 59
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
I+ + G ++ ++I EF+ GGS L + PE V+ ++ GL YL
Sbjct: 60 YIIGFYGAFFVENRISICTEFMDGGS----LDVYRKIPEHVLGRIAVAVVKGLTYLWSLK 115
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHS 249
I+HRD+K +N+LV+ +G +KL DFG S ++V + AK+ GT +MAPE I +
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAKTYVGTNAYMAPERISGEQYG 171
Query: 250 FSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIG-----TTKSHPPIPEHLSMEA-KD 303
+D+WS+G + +E+A G+ P+ Q + +L + + P +P E
Sbjct: 172 IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVH 231
Query: 304 FLLKCLQKEPYLRSTASELLQHPFV 328
F+ +C++K+P R L+ HPF+
Sbjct: 232 FITQCMRKQPKERPAPENLMDHPFI 256
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 7e-36
Identities = 89/308 (28%), Positives = 136/308 (44%), Gaps = 72/308 (23%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
++K E +G G +G VY + +GE++A+K++ + T IRE + LLK
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTA--IRE----ISLLKE 54
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF------GSFPESVIRMYTKQLL 179
L HPNIVR L ++ L ++ EF+ L K+ +I+ Y QLL
Sbjct: 55 LNHPNIVRLLDVVHSENKLYLVFEFL-----DLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK-----------KVVELATINGA 228
G+ Y H + ++HRD+K N+L+D +G +KLADFG ++ +VV L
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL------ 163
Query: 229 KSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI--- 284
++ APE++L + S DIWS+GC EM +P + E+ LF I
Sbjct: 164 -------WYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGD-SEIDQLFRIFRT 215
Query: 285 -GTTKS------------------------HPPIPEHLSMEAKDFLLKCLQKEPYLRSTA 319
GT +P L + D L K L +P R +A
Sbjct: 216 LGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPN-LDEDGLDLLSKMLVYDPAKRISA 274
Query: 320 SELLQHPF 327
LQHP+
Sbjct: 275 KAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-35
Identities = 77/269 (28%), Positives = 132/269 (49%), Gaps = 28/269 (10%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++G G+FG+V + + EL AVK V++ + T+ + L +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK------- 54
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
HP + + + D L ++E+V GG + + + G F E R Y +++LGL++LH
Sbjct: 55 -HPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK--GTPYWMAPEVIL 244
+ GI++RD+K N+L+D++G IK+ADFG K+ + + G + GTP ++APE++
Sbjct: 114 ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI----LGGVTTSTFCGTPDYIAPEILS 169
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP-IPEHLSMEAKD 303
+ + D W++G + EM G+ P+ ++ LF + P LS EAK
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQ--SILEDEVRYPRWLSKEAKS 225
Query: 304 FLLKCLQKEPYLRSTAS-----ELLQHPF 327
L L K P R ++ HPF
Sbjct: 226 ILKSFLTKNPEKRLGCLPTGEQDIKGHPF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 89/267 (33%), Positives = 146/267 (54%), Gaps = 21/267 (7%)
Query: 70 ELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+++G G+FG+V++ + D+G+L A+K VL A +++ + + E +L +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMK-VLKKATLKVRDRVRTKM-----ERDILAEV 55
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
HP IV+ + + L ++L+F+ GG + + L K F E ++ Y +L L L++LH
Sbjct: 56 NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLH 115
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
GI++RD+K NIL+D +G IKL DFG SK+ ++ A S GT +MAPEV+ +
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRR 173
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWS-QQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFL 305
GH+ SAD WS G + EM TG P+ + +E + K+ +P+ LS EA+ L
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI----LKAKLGMPQFLSPEAQSLL 229
Query: 306 LKCLQKEPYLRSTAS-----ELLQHPF 327
++ P R A E+ +HPF
Sbjct: 230 RALFKRNPANRLGAGPDGVEEIKRHPF 256
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 90/288 (31%), Positives = 139/288 (48%), Gaps = 36/288 (12%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+G GAFG V ++ SG ++AVK++ S EK Q + ++ +V ++++ P
Sbjct: 10 GEIGRGAFGTVNKMLHKPSGTIMAVKRI----RSTVDEKEQKRLL-MDLDV-VMRSSDCP 63
Query: 130 NIVRYLG-TAREDDSLNILLEFVPGGSISSLLGKF---------GSFPESVIRMYTKQLL 179
IV++ G RE D I +E + IS L KF PE ++ +
Sbjct: 64 YIVKFYGALFREGDCW-ICMELM---DIS--LDKFYKYVYEVLKSVIPEEILGKIAVATV 117
Query: 180 LGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG--TPY 236
L YL + I+HRD+K +NIL+D G IKL DFG S ++V+ +I AK+ PY
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD--SI--AKTRDAGCRPY 173
Query: 237 WMAPEVIL---QTGHSFSADIWSVGCTVIEMATGK---PPWSQQFQEVAALFHIGTTKSH 290
MAPE I + G+ +D+WS+G T+ E+ATGK P W+ F ++ +
Sbjct: 174 -MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232
Query: 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPV 338
S +F+ CL K+ R ELL+HPF+ + V
Sbjct: 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDV 280
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 9e-35
Identities = 80/298 (26%), Positives = 141/298 (47%), Gaps = 49/298 (16%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE-EEVKLL 123
++ K +G G++G V+ N ++G+++A+K+ + S++ I+++ E+++L
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFV-----ESED--DPVIKKIALREIRML 54
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLE 183
K L HPN+V + R L+++ E+ ++ L PE +I+ Q L +
Sbjct: 55 KQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 184 YLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK----GTPYWMA 239
+ HK+ +HRD+K NIL+ +G IKL DFG ++ + G T ++ A
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFAR------ILTGPGDDYTDYVATRWYRA 168
Query: 240 PEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS--------- 289
PE+++ T + D+W++GC E+ TG+P W + +V L+ I T
Sbjct: 169 PELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK-SDVDQLYLIRKTLGDLIPRHQQI 227
Query: 290 ----------HPPIPEH----------LSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
P PE +S A FL CLQ +P R + ELL+HP+
Sbjct: 228 FSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 80/269 (29%), Positives = 137/269 (50%), Gaps = 24/269 (8%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G G V ++ +G ++A K V I A S+ +++ +REL+ ++ P I
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI---LRELQ----IMHECRSPYI 65
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH-KNGI 190
V + G ++++ + +EF+ GS+ + K G P ++ ++ GL YL+ + I
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRI 125
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVVELATING-AKSMKGTPYWMAPEVILQTGHS 249
MHRDIK +NILV+++G IKL DFG S ++ IN A + GT +M+PE I ++
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGEL-----INSIADTFVGTSTYMSPERIQGGKYT 180
Query: 250 FSADIWSVGCTVIEMATGKPPWSQQFQEVAA---------LFHIGTTKSHPPIP-EHLSM 299
+D+WS+G ++IE+A GK P++ + L + P +P
Sbjct: 181 VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPE 240
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFV 328
+ +DF+ CL K+P R T +L P
Sbjct: 241 DLRDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 84/287 (29%), Positives = 136/287 (47%), Gaps = 38/287 (13%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
E +G G + VY G N +GE++A+K++ + A + IRE + L+K L H
Sbjct: 6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTA---IRE----ISLMKELKHE 58
Query: 130 NIVRYLGTAREDDSLNILLEFVPGG--SISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
NIVR ++ L ++ E++ G G+ + ++ +T QLL G+ + H+
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE 118
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT- 246
N ++HRD+K N+L++ +G +KLADFG ++ +N + T ++ AP+V+L +
Sbjct: 119 NRVLHRDLKPQNLLINKRGELKLADFGLARAFG--IPVNTFSNEVVTLWYRAPDVLLGSR 176
Query: 247 GHSFSADIWSVGCTVIEMATGKP--------------------------PWSQQFQEVAA 280
+S S DIWSVGC + EM TG+P P Q E
Sbjct: 177 TYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP 236
Query: 281 LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
F + + H D L + LQ P LR +A + LQHP+
Sbjct: 237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 83/264 (31%), Positives = 136/264 (51%), Gaps = 18/264 (6%)
Query: 72 VGCGAFGRVYMGMN--LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+G G+FG VY+ + + E L V + + E QA+ E +LL L HP
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-----EAQLLSKLDHP 62
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG----SFPESVIRMYTKQLLLGLEYL 185
IV++ + E D+ I+ E+ G + L + + E+ + + QLLLG+ Y+
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
H+ I+HRD+K NI + N +K+ DFG S+ + + + + A + GTPY+M+PE +
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL--MGSCDLATTFTGTPYYMSPEALKH 179
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPW-SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
G+ +DIWS+GC + EM + Q F V G T P +PE S +
Sbjct: 180 QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPT---PSLPETYSRQLNSI 236
Query: 305 LLKCLQKEPYLRSTASELLQHPFV 328
+ L K+P LR +A+E+L++PF+
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 89/260 (34%), Positives = 136/260 (52%), Gaps = 17/260 (6%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G+ G V + +G+ +AVK++ + + Q L EV ++++ H N+
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDL--------RKQQRRELLFNEVVIMRDYHHENV 81
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
V + D L +++EF+ GG+++ ++ E I +L L YLH G++
Sbjct: 82 VDMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVI 140
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFS 251
HRDIK +IL+ + G IKL+DFG +V + + KS+ GTPYWMAPEVI + +
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 252 ADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL---SMEAKDFLLKC 308
DIWS+G VIEM G+PP+ F E + PP + S + FL
Sbjct: 199 VDIWSLGIMVIEMIDGEPPY---FNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLM 255
Query: 309 LQKEPYLRSTASELLQHPFV 328
L +EP R+TA ELLQHPF+
Sbjct: 256 LVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 86/270 (31%), Positives = 138/270 (51%), Gaps = 23/270 (8%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+G G G+VY +G ++AVKQ+ + +KE+ + + +L+ +LK+ P
Sbjct: 21 GEIGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLD---VVLKSHDCP 74
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYL-HK 187
IV+ G D + I +E + + LL + G PE ++ T ++ L YL K
Sbjct: 75 YIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS-MKGTPYWMAPEVI-LQ 245
+G++HRD+K +NIL+D G +KL DFG S ++V+ + AK+ G +MAPE I
Sbjct: 134 HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD----SKAKTRSAGCAAYMAPERIDPP 189
Query: 246 TGHS---FSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP---EHLSM 299
+ AD+WS+G +++E+ATG+ P+ E L I + PP E S
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKI--LQEEPPSLPPNEGFSP 247
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
+ F+ CL K+ R ELLQHPF+
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 88/261 (33%), Positives = 140/261 (53%), Gaps = 17/261 (6%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G+ G V + SG+L+AVK++ + + Q L EV ++++ H N+
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDL--------RKQQRRELLFNEVVIMRDYQHENV 79
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
V + D L +++EF+ GG+++ ++ E I +L L LH G++
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVI 138
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFS 251
HRDIK +IL+ + G +KL+DFG +V + + KS+ GTPYWMAPE+I + +
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 252 ADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL---SMEAKDFLLKC 308
DIWS+G VIEM G+PP+ F E + PP ++L S K FL +
Sbjct: 197 VDIWSLGIMVIEMVDGEPPY---FNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRL 253
Query: 309 LQKEPYLRSTASELLQHPFVT 329
L ++P R+TA+ELL+HPF+
Sbjct: 254 LVRDPAQRATAAELLKHPFLA 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 5e-34
Identities = 90/301 (29%), Positives = 136/301 (45%), Gaps = 61/301 (20%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
K E +G G +G VY G N +G+++A+K++ + + T IRE + LLK L
Sbjct: 4 KIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTA--IRE----ISLLKELQ 57
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSL--LGKFGSFPESVIRMYTKQLLLGLEYL 185
HPNIV ++ L ++ EF+ L L K +++ Y Q+L G+ +
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASK-----------KVVELATINGAKSMKGT 234
H ++HRD+K N+L+DNKG IKLADFG ++ +VV L
Sbjct: 118 HSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL------------ 165
Query: 235 PYWMAPEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP-- 291
++ APEV+L +S DIWS+G EMAT KP + E+ LF I P
Sbjct: 166 -WYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLF-HGDSEIDQLFRIFRILGTPTE 223
Query: 292 -------PIPEH------------------LSMEAKDFLLKCLQKEPYLRSTASELLQHP 326
+P++ L + D L K L +P R +A + L HP
Sbjct: 224 DVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHP 283
Query: 327 F 327
+
Sbjct: 284 Y 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 90/297 (30%), Positives = 141/297 (47%), Gaps = 50/297 (16%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
++K E +G G +G VY N +GE++A+K++ + + T IRE + LLK
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA--IRE----ISLLKE 55
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF------GSFPESVIRMYTKQLL 179
L HPNIV+ L ++ L ++ EF + L KF P +I+ Y QLL
Sbjct: 56 LNHPNIVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQLL 110
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV-VELATINGAKSMKGTPYWM 238
GL + H + ++HRD+K N+L++ +G IKLADFG ++ V + T T ++
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYR 167
Query: 239 APEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP------ 291
APE++L +S + DIWS+GC EM T + + E+ LF I T P
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD-SEIDQLFRIFRTLGTPDEVVWP 226
Query: 292 ---PIPEH------------------LSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
+P++ L + +D L + L +P R +A L HPF
Sbjct: 227 GVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 87/299 (29%), Positives = 136/299 (45%), Gaps = 43/299 (14%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+K +L+G G GRV++ +G+L A+K ++ K + E+E+ L L
Sbjct: 4 KKIKLLGKGDVGRVFLVRLKGTGKLFALK--VLDKKEMIKRNKVKRVL-TEQEI--LATL 58
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGK--FGSFPESVIRMYTKQLLLGLEY 184
HP + + + + L +++++ PGG + LL + E V R Y ++LL LEY
Sbjct: 59 DHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASK------KVVELATINGAKSMK------ 232
LH GI++RD+K NIL+ G I L+DF SK V A G++
Sbjct: 119 LHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPS 178
Query: 233 ---------------GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE 277
GT ++APEVI GH + D W++G + EM G P+ ++
Sbjct: 179 ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238
Query: 278 VAALFHIGTTKSHPPIPEH--LSMEAKDFLLKCLQKEPYLR----STASELLQHPFVTG 330
+I K P +S A+D + K L K+P R A+E+ QHPF G
Sbjct: 239 -ETFSNI--LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-33
Identities = 95/312 (30%), Positives = 146/312 (46%), Gaps = 59/312 (18%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQ-AHIRELEEEVKLLKNLTH 128
+++G GAFG V + D+G++ A+K +L S +K Q AH++ E +L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLL---KSEMFKKDQLAHVKA---ERDVLAESDS 60
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
P +V + ++ L +++EF+PGG + ++L K+ +F E V R Y + +L +E +HK
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGAS---------------------------KKVVE 221
G +HRDIK NIL+D G IKL+DFG S + V
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 222 LATINGAKSMK------------------GTPYWMAPEVILQTGHSFSADIWSVGCTVIE 263
+ +IN S K GTP ++APE+ LQ G+ D WS+G + E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 264 MATGKPPW-SQQFQEVAALFHIGTTKSHPPIPE--HLSMEAKDFL--LKCLQKEPYLRST 318
G PP+ S+ E I + P+ HLS+EA+D + L + R
Sbjct: 241 CLIGWPPFCSENSHETYR--KIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGG 298
Query: 319 ASELLQHPFVTG 330
A E+ HPF G
Sbjct: 299 AHEIKSHPFFRG 310
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 2e-33
Identities = 77/278 (27%), Positives = 132/278 (47%), Gaps = 40/278 (14%)
Query: 72 VGCGAFGRVYMG----MNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
+G G FG+V + + ++GE +AVK + + + H + E E+++L+ L
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSL-------NHSGEEQHRSDFEREIEILRTLD 64
Query: 128 HPNIVRYLGTARED--DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL----- 180
H NIV+Y G + SL +++E++P GS+ L ++ K+LLL
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL------QRHRDQINLKRLLLFSSQI 118
Query: 181 --GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP-YW 237
G++YL +HRD+ NILV+++ +K++DFG +K + E K +P +W
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWS--QQF-------QEVAALFH-IGT 286
APE + + S ++D+WS G T+ E+ T G P S +F Q + +
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL 238
Query: 287 TKSHP--PIPEHLSMEAKDFLLKCLQKEPYLRSTASEL 322
K P P E D + C + EP R + ++L
Sbjct: 239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 5e-33
Identities = 81/262 (30%), Positives = 142/262 (54%), Gaps = 17/262 (6%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
VG G++G V + + G+ +K+ L N++ +E+ A E+E +LL L HPNI
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKK-LNLRNASRRERKAA-----EQEAQLLSQLKHPNI 61
Query: 132 VRYLGTAR-EDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLEYLH 186
V Y + ED L I++ F GG + L GK PE+ + + Q+ + L+YLH
Sbjct: 62 VAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKL--LPENQVVEWFVQIAMALQYLH 119
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
+ I+HRD+K N+ + IK+ D G ++ V+E + A ++ GTPY+M+PE+
Sbjct: 120 EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLE-NQCDMASTLIGTPYYMSPELFSNK 177
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLL 306
+++ +D+W++GC V EMAT K ++ +++ +L + PP+P+ S E + +
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNA--KDMNSLVYRIIEGKLPPMPKDYSPELGELIA 235
Query: 307 KCLQKEPYLRSTASELLQHPFV 328
L K P R + +L+ P++
Sbjct: 236 TMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 90/318 (28%), Positives = 138/318 (43%), Gaps = 79/318 (24%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
+G GA+G V ++ +G +A+K++ ++ + A R L E +KLL++L H N
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI----SNVFDDLIDAK-RILRE-IKLLRHLRHEN 60
Query: 131 IVRYLGTAREDDSLN-----ILLEFVPGGSISSLLGKFGSFPESVIR------------- 172
I+ L R + I+ E + + L VI+
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELME----TDL--------HKVIKSPQPLTDDHIQYF 108
Query: 173 MYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC-IKLADFGASKKVVELATINGAKSM 231
+Y Q+L GL+YLH ++HRD+K +NILV N C +K+ DFG ++ V G
Sbjct: 109 LY--QILRGLKYLHSANVIHRDLKPSNILV-NSNCDLKICDFGLARGVDPDEDEKGFL-- 163
Query: 232 KGTPY----WM-APEVILQTGH-SFSADIWSVGCTVIEMATGKP---------------- 269
T Y W APE++L + + + DIWSVGC E+ T KP
Sbjct: 164 --TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVE 221
Query: 270 ----PWSQQFQEVA---ALFHIGTTKSHPPIP-EHL----SMEAKDFLLKCLQKEPYLRS 317
P + + + A ++ + P P L S EA D L K L +P R
Sbjct: 222 VLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI 281
Query: 318 TASELLQHPFVTGKYQDP 335
TA E L HP++ + DP
Sbjct: 282 TADEALAHPYLA-QLHDP 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 8e-33
Identities = 89/282 (31%), Positives = 136/282 (48%), Gaps = 33/282 (11%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
L+ GA+G VY+ + ++ + A+K Q LI N I+++ E +L
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRN---------QIQQVFVERDILTFA 58
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
+P +V + L +++E+V GG ++LL G+ P + RMY + +L LEYLH
Sbjct: 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA-------------KSMKG 233
GI+HRD+K N+L+ + G IKL DFG SK + T N K + G
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCG 178
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH--IGTTKSHP 291
TP ++APEVIL+ G+ D W++G + E G P+ E LF I P
Sbjct: 179 TPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--ELFGQVISDDIEWP 236
Query: 292 PIPEHLSMEAKDFLLKCLQKEPYLR---STASELLQHPFVTG 330
E L +A+D + + L++ P R A E+ QH F G
Sbjct: 237 EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 78/257 (30%), Positives = 137/257 (53%), Gaps = 17/257 (6%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
+VG G+FGR + +++S + A+K++ + +S++ E ++ +E LL + HPN
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR-------KEAVLLAKMKHPN 59
Query: 131 IVRYLGTAREDDSLNILLEFVPGG----SISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
IV + + D L I++E+ GG I GK FPE I + Q+ LG++++H
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL--FPEDTILQWFVQMCLGVQHIH 117
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
+ ++HRDIK NI + G +KL DFG+++ + A + GTPY++ PE+
Sbjct: 118 EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVPPEIWENM 175
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLL 306
++ +DIWS+GC + E+ T K P+ Q L S+ P+P H S E + +
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPF--QANSWKNLILKVCQGSYKPLPSHYSYELRSLIK 233
Query: 307 KCLQKEPYLRSTASELL 323
+ ++ P R +A+ +L
Sbjct: 234 QMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 88/276 (31%), Positives = 142/276 (51%), Gaps = 39/276 (14%)
Query: 73 GCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV 132
G GA+G V ++ +G ++AVK++ NS ++ R L + ++++ P V
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK------RLLMDLDISMRSVDCPYTV 63
Query: 133 RYLGTA-REDDSLNILLEFVPGGSISSLLGKF--------GSFPESVIRMYTKQLLLGLE 183
+ G RE D + I +E + + L KF + PE ++ ++ LE
Sbjct: 64 TFYGALFREGD-VWICMEV-----MDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALE 117
Query: 184 YLHKN-GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK-GTPYWMAPE 241
YLH ++HRD+K +N+L++ G +KL DFG S +V+ + AK++ G +MAPE
Sbjct: 118 YLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD----SVAKTIDAGCKPYMAPE 173
Query: 242 VI----LQTGHSFSADIWSVGCTVIEMATGKPP---WSQQFQEVAALFHIGTTKSHPPIP 294
I Q G+ +D+WS+G T+IE+ATG+ P W FQ++ + + P +P
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE----EPSPQLP 229
Query: 295 -EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
E S E +DF+ KCL+K R ELLQHPF
Sbjct: 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 89/312 (28%), Positives = 139/312 (44%), Gaps = 71/312 (22%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+ K E +G G +G+VY + ++G+L+A+K+ + + T E+ LL+
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTAL------REISLLQM 56
Query: 126 LTH-PNIVRYLGTAREDD-----SLNILLEFVPGGSISSLLGKF---------GSFPESV 170
L+ IVR L ++ SL ++ E+ + S L KF P
Sbjct: 57 LSESIYIVRLLDVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKT 111
Query: 171 IRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD-NKGCIKLADFGASKKVV--------E 221
I+ + QLL G+ + HK+G+MHRD+K N+LVD KG +K+AD G + E
Sbjct: 112 IKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHE 171
Query: 222 LATINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKP--PWSQQFQEV 278
+ T+ ++ APEV+L + H S DIWSVGC EM+ +P P + Q++
Sbjct: 172 IVTL----------WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL 221
Query: 279 AALFH-IGTTKSH-----------------PPIP-----EHLSMEAKDFLLKCLQKEPYL 315
+F +GT P LS E D L K L+ +P
Sbjct: 222 LHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAK 281
Query: 316 RSTASELLQHPF 327
R +A L HP+
Sbjct: 282 RISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-32
Identities = 95/295 (32%), Positives = 131/295 (44%), Gaps = 54/295 (18%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT---H 128
+G GA+G VY + SG +A+K V + N + EV LLK L H
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV------REVALLKRLEAFDH 61
Query: 129 PNIVRYL---GTAREDDSLNILLEFVP-GGSISSLLGKFGS--FPESVIRMYTKQLLLGL 182
PNIVR + T+R D + L F + + L K P I+ +Q L GL
Sbjct: 62 PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP-----YW 237
++LH N I+HRD+K NILV + G +KLADFG LA I + M TP ++
Sbjct: 122 DFLHANCIVHRDLKPENILVTSGGQVKLADFG-------LARIYSCQ-MALTPVVVTLWY 173
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEM---------------------ATGKPPWSQQFQ 276
APEV+LQ+ ++ D+WSVGC EM G PP +
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233
Query: 277 EVAALFHIGTTKSHPPI----PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
+V + + P+ PE A LL+ L P+ R +A LQHPF
Sbjct: 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGA-QLLLEMLTFNPHKRISAFRALQHPF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-32
Identities = 80/264 (30%), Positives = 133/264 (50%), Gaps = 16/264 (6%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V +G++ A K++ + +K + L E+ K+L+ ++ I
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL----DKKRLKKRKGEQMALNEK-KILEKVSSRFI 55
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLLLGLEYLHKNG 189
V D L +++ + GG + + G FPE+ Y Q++ GLE+LH+
Sbjct: 56 VSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHS 249
I++RD+K N+L+D+ G ++++D G + VEL K GTP +MAPEV+ +
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA---VELKGGKKIKGRAGTPGYMAPEVLQGEVYD 172
Query: 250 FSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP-PIPEHLSMEAKDFLLKC 308
FS D +++GCT+ EM G+ P+ Q+ ++V T P+ S EAKD
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232
Query: 309 LQKEPYLR-----STASELLQHPF 327
LQK+P R +A E+ +HP
Sbjct: 233 LQKDPEKRLGCRGGSADEVREHPL 256
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 6e-32
Identities = 75/268 (27%), Positives = 133/268 (49%), Gaps = 25/268 (9%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+L+G G FG+V + +G+ A+K +V+IA + + T++ + L+N
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRV---------LQN 51
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
HP + + + D L ++E+ GG + L + F E R Y +++ L YL
Sbjct: 52 TRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYL 111
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
H +++RD+K N+++D G IK+ DFG K+ ++ K+ GTP ++APEV+
Sbjct: 112 HSCDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEVLED 169
Query: 246 TGHSFSADIWSVGCTVIEMATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
+ + D W +G + EM G+ P ++Q +++ L + + P LS EAK
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR----FPRTLSPEAKSL 225
Query: 305 LLKCLQKEPYLR-----STASELLQHPF 327
L L+K+P R A E+++H F
Sbjct: 226 LAGLLKKDPKQRLGGGPEDAKEIMEHRF 253
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 83/272 (30%), Positives = 133/272 (48%), Gaps = 23/272 (8%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
LVG G FG V + +G++ A+K + S Q + EEE +L P
Sbjct: 8 LVGRGHFGEVQVVREKATGDIYAMKVM-----KKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNG 189
I + ++ D+L +++E+ PGG + SLL ++ F E + + Y +L+L + +H+ G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVI--LQTG 247
+HRDIK N+L+D G IKLADFG++ ++ +N +K GTP ++APEV+ +
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN-SKLPVGTPDYIAPEVLTTMNGD 181
Query: 248 ----HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALF-HIGTTKSHPPIPEHL--SME 300
+ D WS+G EM G+ P+ + A + +I + PE S +
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIYGRSPFHE--GTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 301 AKDFL--LKCLQKEPYLRSTASELLQHPFVTG 330
D + L C QKE R L HPF +
Sbjct: 240 FLDLIQSLLCGQKE---RLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 77/262 (29%), Positives = 131/262 (50%), Gaps = 18/262 (6%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++G G+FG+V + + E A+K V++ + + + L E
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE------- 54
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
HP + T + + L ++E++ GG + + G F E+ R Y +++ GL++LH
Sbjct: 55 -HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLH 113
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
K GI++RD+K N+L+D G IK+ADFG K+ + A + GTP ++APE++
Sbjct: 114 KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE--NMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLL 306
++ S D WS G + EM G+ P+ + ++ LF P P +S EAKD L
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFD-SILNDRPHFPRWISKEAKDCLS 228
Query: 307 KCLQKEPYLR-STASELLQHPF 327
K +++P R ++ QHPF
Sbjct: 229 KLFERDPTKRLGVDGDIRQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 81/263 (30%), Positives = 132/263 (50%), Gaps = 27/263 (10%)
Query: 70 ELVGCGAFGRVYMGMNLDSGE-LLAVKQVLI--AANSASKEKTQAHIRELEEEVKLLK-N 125
E +G GAFG VY ++G+ LLA+K++ + A K + I ++ EV ++K
Sbjct: 6 EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSI----SSLLGKFGSFPESVIRMYTKQLLLG 181
L HPNIVRY T E+D L I+++ + G + +SL K F E I Q++L
Sbjct: 66 LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125
Query: 182 LEYLHKNG-IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
L YLHK I+HRD+ NI++ + + DFG +K+ + + S+ GT + P
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSCP 182
Query: 241 EVILQTGHSFSADIWSVGCTVIEMATGKPPW------SQQFQEVAALFHIGTTKSHPPIP 294
E++ + AD+W+ GC + +M T +PP+ S + V A++ P+P
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE--------PLP 234
Query: 295 EHL-SMEAKDFLLKCLQKEPYLR 316
E + S + D + CL + R
Sbjct: 235 EGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 1e-31
Identities = 73/264 (27%), Positives = 136/264 (51%), Gaps = 17/264 (6%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQV-LIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+ +G G+FG++Y+ E +K++ L KE ++ +EV LL + H
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASK-------KEVILLAKMKH 58
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLLLGLEYLH 186
PNIV + + +E+ L I++E+ GG + + + F E I + Q+ LGL+++H
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 187 KNGIMHRDIKGANILVDNKGCI-KLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
I+HRDIK NI + G + KL DFG ++++ + ++ A + GTPY+++PE+
Sbjct: 119 DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPYYLSPEICQN 176
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPW-SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
++ DIWS+GC + E+ T K P+ ++ + I P P + S + +
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL--VLKICQGYFAPISP-NFSRDLRSL 233
Query: 305 LLKCLQKEPYLRSTASELLQHPFV 328
+ + + P R + + +L+ PF+
Sbjct: 234 ISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 83/263 (31%), Positives = 136/263 (51%), Gaps = 19/263 (7%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G+FG+V + + G+ AVK ++ + K+K Q HI + E LLKN+ HP +
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVK--VLQKKAILKKKEQKHI--MAERNVLLKNVKHPFL 58
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
V + + D L +L++V GG + L + SFPE R Y ++ L YLH I+
Sbjct: 59 VGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS-MKGTPYWMAPEVILQTGHSF 250
+RD+K NIL+D++G + L DFG K+ +E + S GTP ++APEV+ + +
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLCKEGIE---HSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 251 SADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP--IPEHLSMEAKDFLLKC 308
+ D W +G + EM G PP+ ++ A ++ + P + ++S+ A+ L
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYS--RDTAEMYD---NILNKPLRLKPNISVSARHLLEGL 230
Query: 309 LQKEPYLRSTAS----ELLQHPF 327
LQK+ R A E+ H F
Sbjct: 231 LQKDRTKRLGAKDDFLEIKNHVF 253
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 75/304 (24%), Positives = 126/304 (41%), Gaps = 62/304 (20%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
V++ + + L+AVK++ + +S SKE + L++E+ + L HPNI
Sbjct: 8 KCFEDLMIVHLAKHKPTNTLVAVKKINL--DSCSKEDLK----LLQQEIITSRQLQHPNI 61
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGK-FGS-FPESVIRMYTKQLLLGLEYLHKNG 189
+ Y+ + D L ++ + GS LL F PE I K +L L+Y+H G
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG 121
Query: 190 IMHRDIKGANILVDNKGCIKLADF---------GASKKVVELATINGAKSMKGTPYWMAP 240
+HR +K ++IL+ G + L+ G ++VV + K++ W++P
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL----PWLSP 177
Query: 241 EVILQTGHSFSA--DIWSVGCTVIEMATGKPPWSQQFQEVAALF---------------- 282
EV+ Q ++ DI+SVG T E+A G P F+++ A
Sbjct: 178 EVLQQNLQGYNEKSDIYSVGITACELANGHVP----FKDMPATQMLLEKVRGTVPCLLDK 233
Query: 283 -----------------HIGTTKSHPPIPEH--LSMEAKDFLLKCLQKEPYLRSTASELL 323
+ P S F+ CLQ++P R +AS+LL
Sbjct: 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293
Query: 324 QHPF 327
H F
Sbjct: 294 NHSF 297
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 90/302 (29%), Positives = 138/302 (45%), Gaps = 59/302 (19%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G +G+VY + D+GEL+A+K+V + EK I + E +K+L+ L H NI
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRL-----DNEKEGFPITAIRE-IKILRQLNHRNI 68
Query: 132 VRY----------LGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181
V L ++ + ++ E++ + L F E I+ + KQLL G
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG 128
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG------TP 235
L Y HK +HRDIK +NIL++NKG IKLADFG LA + ++ + T
Sbjct: 129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG-------LARLYNSEESRPYTNKVITL 181
Query: 236 YWMAPEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP--- 291
++ PE++L + + + D+WS GC + E+ T KP + Q QE+A L I P
Sbjct: 182 WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIF-QANQELAQLELISRLCGSPCPA 240
Query: 292 ------PIP-------------------EHLSMEAKDFLLKCLQKEPYLRSTASELLQHP 326
+P + A D L L +P R TA E L P
Sbjct: 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSP 300
Query: 327 FV 328
++
Sbjct: 301 WL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-31
Identities = 95/308 (30%), Positives = 141/308 (45%), Gaps = 53/308 (17%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
K + +G GAFG V + +D+ L A+K + AH++ E +L
Sbjct: 5 KIKTLGIGAFGEVCLARKVDTKALYAMKT--LRKKDVLLRNQVAHVKA---ERDILAEAD 59
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
+ +VR + ++ D+L +++++PGG + SLL + G FPE + R Y +L +E +HK
Sbjct: 60 NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHK 119
Query: 188 NGIMHRDIKGANILVDNKGCIKLA----------------------------DF------ 213
G +HRDIK NIL+D G IKL DF
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGD 179
Query: 214 ------GASKKVVELATING-----AKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVI 262
G K +E A S+ GTP ++APEV+L+TG++ D WSVG +
Sbjct: 180 PANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 239
Query: 263 EMATGKPPW-SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLK-CLQKEPYL-RSTA 319
EM G+PP+ +Q E T H P LS EA D ++K C E L ++ A
Sbjct: 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGA 299
Query: 320 SELLQHPF 327
E+ HPF
Sbjct: 300 DEIKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 75/207 (36%), Positives = 119/207 (57%), Gaps = 23/207 (11%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G +G VY + SGE++A+K+V + E+ I L E + LL NL HPNI
Sbjct: 15 IGEGTYGIVYRARDTTSGEIVALKKVRM-----DNERDGIPISSLRE-ITLLLNLRHPNI 68
Query: 132 VRYLG--TAREDDSLNILLEFVPGGSISSLLGKFGS-FPESVIRMYTKQLLLGLEYLHKN 188
V + DS+ +++E+ ++SLL + F ES ++ QLL GL+YLH+N
Sbjct: 69 VELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN 127
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP-----YWMAPEVI 243
I+HRD+K +N+L+ +KGC+K+ADFG ++ AK M TP ++ APE++
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLAR-----TYGLPAKPM--TPKVVTLWYRAPELL 180
Query: 244 L-QTGHSFSADIWSVGCTVIEMATGKP 269
L T ++ + D+W+VGC + E+ KP
Sbjct: 181 LGCTTYTTAIDMWAVGCILAELLAHKP 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 77/265 (29%), Positives = 132/265 (49%), Gaps = 22/265 (8%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+++G G+FG+V++ + + A+K V++ + + + L E
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE------ 54
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
HP + T + ++L ++E++ GG + + F Y +++ GL++L
Sbjct: 55 --HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFL 112
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK--GTPYWMAPEVI 243
H GI++RD+K NIL+D G IK+ADFG K+ + + AK+ GTP ++APE++
Sbjct: 113 HSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENM----LGDAKTCTFCGTPDYIAPEIL 168
Query: 244 LQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
L ++ S D WS G + EM G+ P+ +E LF +P P L+ EAKD
Sbjct: 169 LGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQ-SIRMDNPCYPRWLTREAKD 225
Query: 304 FLLKCLQKEPYLR-STASELLQHPF 327
L+K +EP R ++ QHPF
Sbjct: 226 ILVKLFVREPERRLGVKGDIRQHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 95/299 (31%), Positives = 150/299 (50%), Gaps = 45/299 (15%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+++G GAFG V + D+G + A+K +L A+ KE+ AHIR E +L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKEQV-AHIRA---ERDILVEADGA 61
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
+V+ + ++ +L +++EF+PGG + +LL K + E + Y + +L ++ +H+ G
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 190 IMHRDIKGANILVDNKGCIKLADFGA------------------------------SKKV 219
+HRDIK N+L+D KG +KL+DFG SK+
Sbjct: 122 FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRK 181
Query: 220 VELATING---AKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW-SQQF 275
E N A S GTP ++APEV +QTG++ D WS+G + EM G PP+ S+
Sbjct: 182 AETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 276 QEV-AALFHIGTTKSHPP-IPEHLSMEAKDFLLK-CLQKEPYLRSTA-SELLQHPFVTG 330
QE + + T PP +P +S +AKD +L+ C E + S E+ HPF G
Sbjct: 242 QETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEG 298
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 6e-30
Identities = 79/279 (28%), Positives = 133/279 (47%), Gaps = 32/279 (11%)
Query: 67 RKGELVGCGAFGRV----YMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
+K ++G G FG+V Y N +GE++AVK + +E Q + ++E+ +
Sbjct: 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVK-------TLKRECGQQNTSGWKKEINI 59
Query: 123 LKNLTHPNIVRYLGTARE--DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
LK L H NIV+Y G E L +++E+VP GS+ L K + + ++ +Q+
Sbjct: 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICE 118
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP-YWMA 239
G+ YLH +HRD+ N+L+DN +K+ DFG +K V E + +P +W A
Sbjct: 119 GMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA 178
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATG-----KPPWSQQFQE----------VAALFHI 284
E + + S+++D+WS G T+ E+ T PP ++F+E V L +
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPP--KKFEEMIGPKQGQMTVVRLIEL 236
Query: 285 GTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELL 323
P P++ E + C + E R T L+
Sbjct: 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 9e-30
Identities = 89/309 (28%), Positives = 143/309 (46%), Gaps = 77/309 (24%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIA-ANSASKEKTQAHIRELEEEVKLLKNLT-HP 129
+G GA+G V+ ++ + E++A+K++ A N+ ++T RE + L+ L HP
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRT---FRE----IMFLQELGDHP 67
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPES----VIR------------M 173
NIV+ L + ++ +I L F + E+ VIR M
Sbjct: 68 NIVKLLNVIKAENDKDIYLVF--------------EYMETDLHAVIRANILEDVHKRYIM 113
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
Y QLL L+Y+H ++HRD+K +NIL+++ +KLADFG ++ + EL +
Sbjct: 114 Y--QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL-- 169
Query: 234 TPY----WM-APEVIL-QTGHSFSADIWSVGCTVIEMATGKP------------------ 269
T Y W APE++L T ++ D+WSVGC + EM GKP
Sbjct: 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVI 229
Query: 270 --PWSQQFQEV-----AALFHIGTTKSHPPIPEHLSM---EAKDFLLKCLQKEPYLRSTA 319
P ++ + + A + ++ P+ E L +A D L K L P R TA
Sbjct: 230 GPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTA 289
Query: 320 SELLQHPFV 328
E L+HP+V
Sbjct: 290 EEALEHPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 69/200 (34%), Positives = 107/200 (53%), Gaps = 9/200 (4%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G+FGRV + + V I SK Q + + E K+L + HP
Sbjct: 38 LGTGSFGRVILATYKNED----FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFC 93
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
V G+ +++ L ++LEFV GG + L + FP V Y Q++L EYL I+
Sbjct: 94 VNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIV 153
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFS 251
+RD+K N+L+D G IK+ DFG + KVV+ T ++ GTP ++APE++L GH +
Sbjct: 154 YRDLKPENLLLDKDGFIKMTDFGFA-KVVDTRTY----TLCGTPEYIAPEILLNVGHGKA 208
Query: 252 ADIWSVGCTVIEMATGKPPW 271
AD W++G + E+ G PP+
Sbjct: 209 ADWWTLGIFIYEILVGCPPF 228
|
Length = 340 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 87/276 (31%), Positives = 139/276 (50%), Gaps = 26/276 (9%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+L+G G FG+V + SG+ A+K +V+IA + + T E ++LKN
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLT---------ESRVLKN 51
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
HP + + + D L ++E+V GG + L + F E R Y +++ L+YL
Sbjct: 52 TRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYL 111
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKK-VVELATINGAKSMKGTPYWMAPEVIL 244
H I++RD+K N+++D G IK+ DFG K+ + + AT+ K+ GTP ++APEV+
Sbjct: 112 HSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATM---KTFCGTPEYLAPEVLE 168
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
+ + D W +G + EM G+ P+ Q E LF + P LS +AK
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFEL-ILMEDIKFPRTLSADAKSL 225
Query: 305 LLKCLQKEPYLR-----STASELLQHPFVTG-KYQD 334
L L K+P R A E+++H F TG +QD
Sbjct: 226 LSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQD 261
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 85/302 (28%), Positives = 138/302 (45%), Gaps = 74/302 (24%)
Query: 75 GAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134
G +G VY + +GE++A+K++ + KEK I L E + +L L HPNIV
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKM-----EKEKEGFPITSLRE-INILLKLQHPNIV-- 67
Query: 135 LGTARE------DDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHK 187
T +E D + +++E+V + SL+ F +S ++ QLL G+ +LH
Sbjct: 68 --TVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHD 124
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKK-----------VVELATINGAKSMKGTPY 236
N I+HRD+K +N+L++N+G +K+ DFG +++ VV L +
Sbjct: 125 NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTL-------------W 171
Query: 237 WMAPEVILQTGHSFSA-DIWSVGCTVIEMATGKPPWSQQFQEVAALFHI----GT----- 286
+ APE++L +A D+WSVGC E+ T KP + + E+ L I GT
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK-SEIDQLNKIFKLLGTPTEKI 230
Query: 287 ----------TKSHPPIPEH-----------LSMEAKDFLLKCLQKEPYLRSTASELLQH 325
K + LS D L + L +P R +A + L+H
Sbjct: 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290
Query: 326 PF 327
P+
Sbjct: 291 PY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 85/295 (28%), Positives = 140/295 (47%), Gaps = 34/295 (11%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEE------EVKLLKN 125
+G G+FG+V D+ + A+K + +AHI E E +L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTI-----------RKAHIVSRSEVTHTLAERTVLAQ 49
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
+ P IV + + + L ++L F+ GG + L + G F S R YT +LL LE L
Sbjct: 50 VNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENL 109
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
HK +++RD+K NIL+D +G I L DFG K + + + + GTP ++APE++L
Sbjct: 110 HKFNVIYRDLKPENILLDYQGHIALCDFGLCK--LNMKDDDKTNTFCGTPEYLAPELLLG 167
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFL 305
G++ + D W++G + EM TG PP+ + E + + P+ +AKD L
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTGLPPF---YDENVNEMYRKILQEPLRFPDGFDRDAKDLL 224
Query: 306 LKCLQKEPYLR---STASELLQHPFVT---------GKYQDPHPVFRNSVMESGN 348
+ L ++P R + A E+ HPF + Q P +S +++ N
Sbjct: 225 IGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSN 279
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 85/265 (32%), Positives = 133/265 (50%), Gaps = 19/265 (7%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH--P 129
+G G FG+VY D+ + A+K +++ +K AH + E L++ L P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMK--VLSKKEIVAKKEVAHT--IGERNILVRTLLDESP 56
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
IV + + D L ++ +++ GG + L K G F E + Y +L+L LE+LHK
Sbjct: 57 FIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD 116
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL-QTGH 248
I++RD+K NIL+D G I L DFG SK L + GT ++APEV+L + G+
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY 174
Query: 249 SFSADIWSVGCTVIEMATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEH-LSMEAKDFLL 306
+ D WS+G V EM G P +++ Q++ G + P++ LS E + F+
Sbjct: 175 TKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVR----FPKNVLSDEGRQFVK 230
Query: 307 KCLQKEPYLR----STASELLQHPF 327
L + P R A EL +HPF
Sbjct: 231 GLLNRNPQHRLGAHRDAVELKEHPF 255
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-29
Identities = 80/307 (26%), Positives = 131/307 (42%), Gaps = 68/307 (22%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ K E +G G +G V+ N ++ E++A+K+V + + + + +RE + LLK
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL--DDDDEGVPSSALRE----ICLLK 54
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-----GSFPESVIRMYTKQLL 179
L H NIVR D L ++ E+ L K+ G +++ + QLL
Sbjct: 55 ELKHKNIVRLYDVLHSDKKLTLVFEYC-----DQDLKKYFDSCNGDIDPEIVKSFMFQLL 109
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA-----------SKKVVELATINGA 228
GL + H + ++HRD+K N+L++ G +KLADFG S +VV L
Sbjct: 110 KGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTL------ 163
Query: 229 KSMKGTPYWMAPEVIL-QTGHSFSADIWSVGCTVIEMATGKPPW------SQQFQEVAAL 281
++ P+V+ +S S D+WS GC E+A P Q + + L
Sbjct: 164 -------WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 216
Query: 282 FHIGTTKSHPPIPE---------------------HLSMEAKDFLLKCLQKEPYLRSTAS 320
T +S P + + L+ +D L L P R +A
Sbjct: 217 LGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAE 276
Query: 321 ELLQHPF 327
E LQHP+
Sbjct: 277 EALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 88/308 (28%), Positives = 137/308 (44%), Gaps = 53/308 (17%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
K + +G GAFG V + +D+ L A+K + AH++ E +L
Sbjct: 5 KIKTLGIGAFGEVCLACKVDTHALYAMKT--LRKKDVLNRNQVAHVKA---ERDILAEAD 59
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
+ +V+ + ++ D+L +++++PGG + SLL + FPE + R Y +L L +E +HK
Sbjct: 60 NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHK 119
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGA--------SKKVVELATINGAKSMKGTPYW-- 237
G +HRDIK NIL+D G IKL DFG + K + + SM+ + W
Sbjct: 120 MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 238 -----------------------------------MAPEVILQTGHSFSADIWSVGCTVI 262
+APEV+L+ G++ D WSVG +
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 263 EMATGKPPWSQQFQEVAALFHIGTTKS-HPPIPEHLSMEAKDFLLK--CLQKEPYLRSTA 319
EM G+PP+ L I + H P LS EA D + K C +E R+ A
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299
Query: 320 SELLQHPF 327
++ HPF
Sbjct: 300 DDIKAHPF 307
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 88/301 (29%), Positives = 147/301 (48%), Gaps = 55/301 (18%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G G V+ + SG ++A K + + A + + IREL+ +L P I
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQI---IRELQ----VLHECNSPYI 65
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL-HKNGI 190
V + G D ++I +E + GGS+ +L K G PE ++ + ++ GL YL K+ I
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 125
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSF 250
MHRD+K +NILV+++G IKL DFG S ++++ + A S GT +M+PE + T +S
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSV 181
Query: 251 SADIWSVGCTVIEMATGK----PPWSQQFQEV---------------------------- 278
+DIWS+G +++EMA G+ PP +++ + +
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSY 241
Query: 279 -------AALFHIGTTKSHPPIPE----HLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
A+F + + P P+ E +DF+ KCL K P R+ +L+ H F
Sbjct: 242 GPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301
Query: 328 V 328
+
Sbjct: 302 I 302
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 85/276 (30%), Positives = 136/276 (49%), Gaps = 26/276 (9%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+L+G G FG+V + +G A+K +V+IA + + T E ++L+N
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT---------ESRVLQN 51
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
HP + + D L ++E+ GG + L + F E R Y +++ LEYL
Sbjct: 52 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 111
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKK-VVELATINGAKSMKGTPYWMAPEVIL 244
H +++RDIK N+++D G IK+ DFG K+ + + AT+ K+ GTP ++APEV+
Sbjct: 112 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPEVLE 168
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
+ + D W +G + EM G+ P+ Q E LF + P LS EAK
Sbjct: 169 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RLFEL-ILMEEIRFPRTLSPEAKSL 225
Query: 305 LLKCLQKEPYLR-----STASELLQHPFVTG-KYQD 334
L L+K+P R S A E+++H F +QD
Sbjct: 226 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 261
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 85/306 (27%), Positives = 133/306 (43%), Gaps = 75/306 (24%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEE-----EVK 121
+ GE G F V + +G+ A+K + H + LE+ E++
Sbjct: 6 KIGE----GTFSEVLKAQSRKTGKYYAIK------------CMKKHFKSLEQVNNLREIQ 49
Query: 122 LLKNLT-HPNIVRYLGTA--REDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQ 177
L+ L+ HPNI+R + R+ L ++ E + ++ L+ G+ PE ++ Y Q
Sbjct: 50 ALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQ 108
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY- 236
LL L+++H+NGI HRDIK NIL+ + +KLADFG+ + I PY
Sbjct: 109 LLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCR------GIYSKP-----PYT 156
Query: 237 ------WM-APEVILQTG-HSFSADIWSVGCTVIEMATGKP--PWSQQF----------- 275
W APE +L G + DIW+VGC E+ + P P + +
Sbjct: 157 EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLG 216
Query: 276 ---QEVAALFHIGTTKSH--PP---------IPEHLSMEAKDFLLKCLQKEPYLRSTASE 321
EV F ++ P +P + S E D L K L +P R TA +
Sbjct: 217 TPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLP-NASAEGLDLLKKLLAYDPDERITAKQ 275
Query: 322 LLQHPF 327
L+HP+
Sbjct: 276 ALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 81/314 (25%), Positives = 142/314 (45%), Gaps = 48/314 (15%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRE------LEEEVK 121
KG +G G +G+V + +G+++A+K+V I S K + + E+K
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181
++ + H NI+ + E D +N++++ + + ++ + ES ++ Q+L G
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNG 131
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE-------LATINGAKSMKGT 234
L LHK MHRD+ ANI +++KG K+ADFG +++ + + T
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191
Query: 235 P-----YWMAPEVIL-QTGHSFSADIWSVGCTVIEMATGKP--PWSQQFQEVAALFHI-G 285
++ APE+++ + F+ D+WSVGC E+ TGKP P + ++ +F + G
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLG 251
Query: 286 T------------------TKSHPP----IPEHLSMEAKDFLLKCLQKEPYLRSTASELL 323
T T P I + S +A D L L+ P R +A E L
Sbjct: 252 TPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311
Query: 324 QHPFVTGKYQDPHP 337
+H + DP P
Sbjct: 312 KHEYFK---SDPLP 322
|
Length = 335 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-28
Identities = 78/280 (27%), Positives = 132/280 (47%), Gaps = 40/280 (14%)
Query: 72 VGCGAFGRV----YMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
+G G FG+V Y ++GE +AVK S E HI +L++E+++L+NL
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVK-------SLKPESGGNHIADLKKEIEILRNLY 64
Query: 128 HPNIVRYLGTARED--DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL------ 179
H NIV+Y G ED + + +++EF+P GS+ L P + ++ KQ L
Sbjct: 65 HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL------PRNKNKINLKQQLKYAVQI 118
Query: 180 -LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP-YW 237
G++YL +HRD+ N+LV+++ +K+ DFG +K + K +P +W
Sbjct: 119 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMAT----GKPPWS---------QQFQEVAALFHI 284
APE ++Q+ ++D+WS G T+ E+ T P + V L +
Sbjct: 179 YAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238
Query: 285 GTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
P P + E + KC + +P R+T L++
Sbjct: 239 LEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-28
Identities = 83/301 (27%), Positives = 134/301 (44%), Gaps = 60/301 (19%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
K + +G G++ VY G + +G+L+A+K++ + + IRE LLK+L
Sbjct: 9 KLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA---IRE----ASLLKDLK 61
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSF--PESVIRMYTKQLLLGLEYL 185
H NIV +L ++ E++ + + G +V R++ QLL GL Y
Sbjct: 62 HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNV-RLFLFQLLRGLAYC 119
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-------WM 238
H+ ++HRD+K N+L+ +G +KLADFG ++ AKS+ Y W
Sbjct: 120 HQRRVLHRDLKPQNLLISERGELKLADFGLAR----------AKSVPSKTYSNEVVTLWY 169
Query: 239 -APEVIL-QTGHSFSADIWSVGCTVIEMATGKP---------------------PWSQQF 275
P+V+L T +S S D+W VGC EMATG+P P + +
Sbjct: 170 RPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 276 QEVAALFHIGTTKSHPPIPEHL---------SMEAKDFLLKCLQKEPYLRSTASELLQHP 326
V++ P L ++ LK LQ EP R +A+E ++HP
Sbjct: 230 PGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHP 289
Query: 327 F 327
+
Sbjct: 290 Y 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 68/202 (33%), Positives = 109/202 (53%), Gaps = 6/202 (2%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+++G G+FG+V + G+ AVK ++ K Q HI + E LLKN+ HP
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVK--VLQKKIVLNRKEQKHI--MAERNVLLKNVKHP 56
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
+V + + + L +L+FV GG + L + SFPE R Y ++ L YLH
Sbjct: 57 FLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN 116
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHS 249
I++RD+K NIL+D++G + L DFG K+ + + + + GTP ++APEVI + +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYD 174
Query: 250 FSADIWSVGCTVIEMATGKPPW 271
+ D W +G + EM G PP+
Sbjct: 175 NTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 89/289 (30%), Positives = 146/289 (50%), Gaps = 44/289 (15%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+++G GAFG V + D+G + A+K +L A+ KE+ HIR E +L
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMK-ILRKADMLEKEQV-GHIRA---ERDILVEADSL 61
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
+V+ + ++ +L +++EF+PGG + +LL K + E + Y + +L ++ +H+ G
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 190 IMHRDIKGANILVDNKGCIKLADFGA------------------------------SKKV 219
+HRDIK N+L+D+KG +KL+DFG SK+
Sbjct: 122 FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRK 181
Query: 220 VELATING---AKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW-SQQF 275
E N A S GTP ++APEV +QTG++ D WS+G + EM G PP+ S+
Sbjct: 182 AETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 276 QEV-AALFHIGTTKSHPP-IPEHLSMEAKDFLLK-CLQKEPYLRSTASE 321
QE + + T PP +P +S +AKD +L+ C + E + + E
Sbjct: 242 QETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFCCEWEHRIGAPGVE 288
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 91/329 (27%), Positives = 141/329 (42%), Gaps = 87/329 (26%)
Query: 70 ELVGC---GAFGRVY--MGMNLDSGELLAVKQVLIAANSASKEKT----QAHIRELEEEV 120
E+ GC G +GRVY N G+ A+K+ KE+ Q+ RE +
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACRE----I 53
Query: 121 KLLKNLTHPNIVRYLGT--AREDDSLNILLEFVPGGSISSLLG--------KFGSFPESV 170
LL+ L H N+V + D S+ +L ++ + L K S P S+
Sbjct: 54 ALLRELKHENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSM 109
Query: 171 IRMYTKQLLLGLEYLHKNGIMHRDIKGANILV----DNKGCIKLADFGASKKVVE----L 222
++ Q+L G+ YLH N ++HRD+K ANILV +G +K+ D G ++ L
Sbjct: 110 VKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSA-DIWSVGCTVIEMATGKPPW---------S 272
A ++ T ++ APE++L H A DIW++GC E+ T +P + S
Sbjct: 170 ADLDPVVV---TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKS 226
Query: 273 QQFQ--EVAALFHI-G--TTKSHPPI---PEH--------------------------LS 298
FQ ++ +F + G T K P I PE+
Sbjct: 227 NPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPD 286
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQHPF 327
+ D L K L+ +P R TA E L+HP+
Sbjct: 287 SQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 73/264 (27%), Positives = 126/264 (47%), Gaps = 21/264 (7%)
Query: 73 GCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
G G FG+V + +GEL A+K +IA + + I E + H
Sbjct: 8 GRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER------H 61
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
P +V + +D + ++E+ GG + + F E Y ++LGL+YLH+N
Sbjct: 62 PFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHEN 120
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGH 248
I++RD+K N+L+D +G +K+ADFG K+ + + + GTP ++APEV+ +T +
Sbjct: 121 KIVYRDLKLDNLLLDTEGFVKIADFGLCKE--GMGFGDRTSTFCGTPEFLAPEVLTETSY 178
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308
+ + D W +G + EM G+ P+ +E +F P LS EA + +
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFD-SIVNDEVRYPRFLSREAISIMRRL 235
Query: 309 LQKEPYLR-----STASELLQHPF 327
L++ P R A ++ + PF
Sbjct: 236 LRRNPERRLGSGEKDAEDVKKQPF 259
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 75/263 (28%), Positives = 127/263 (48%), Gaps = 18/263 (6%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+++G G+FG+V + GE AVK V++ + + + L E
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWE------ 54
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
+P + T + + L ++EF+ GG + + G F Y +++ GL++L
Sbjct: 55 --NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFL 112
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
H GI++RD+K N+++D G IK+ADFG K+ V N A + GTP ++APE++
Sbjct: 113 HSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENV--FGDNRASTFCGTPDYIAPEILQG 170
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFL 305
++FS D WS G + EM G+ P+ ++ LF P P ++ E+KD L
Sbjct: 171 LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFE-SIRVDTPHYPRWITKESKDIL 227
Query: 306 LKCLQKEPYLR-STASELLQHPF 327
K +++P R + HPF
Sbjct: 228 EKLFERDPTRRLGVVGNIRGHPF 250
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 76/269 (28%), Positives = 128/269 (47%), Gaps = 28/269 (10%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++G G+FG+V + + EL A+K V+I + + + L + L L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
H + D L ++E+V GG + + + G F E Y ++ +GL +LH
Sbjct: 67 -H-------SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK---GTPYWMAPEVI 243
GI++RD+K N+++D +G IK+ADFG K+ I G K+ + GTP ++APE+I
Sbjct: 119 SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-----NIFGGKTTRTFCGTPDYIAPEII 173
Query: 244 LQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
+ S D W+ G + EM G+PP+ + ++ LF + + P+ LS EA
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQ-SIMEHNVSYPKSLSKEAVS 230
Query: 304 FLLKCLQKEPYLR-----STASELLQHPF 327
L K P R + ++ +H F
Sbjct: 231 ICKGLLTKHPAKRLGCGPTGERDIREHAF 259
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 79/264 (29%), Positives = 132/264 (50%), Gaps = 13/264 (4%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+++G G+FG+V + G AVK ++ + K+K Q HI + E LLKNL HP
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVK--VLQKKTILKKKEQNHI--MAERNVLLKNLKHP 56
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
+V + + + L +L++V GG + L + F E R Y ++ + YLH
Sbjct: 57 FLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN 116
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHS 249
I++RD+K NIL+D++G + L DFG K+ VE + GTP ++APEV+ + +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 250 FSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCL 309
+ D W +G + EM G PP+ ++V+ ++ +P ++ A D L+ L
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYS--RDVSQMYD-NILHKPLQLPGGKTVAACDLLVGLL 231
Query: 310 QKEPYLRSTAS----ELLQHPFVT 329
K+ R A E+ H F +
Sbjct: 232 HKDQRRRLGAKADFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 86/305 (28%), Positives = 142/305 (46%), Gaps = 59/305 (19%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P R+ + VG GA+G V ++ +GE +A+K++ + +++ + E+ L
Sbjct: 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL------SRPFQSEIFAKRAYRELTL 67
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEF---VP--GGSISSLLGKFGSFPESVIRMYTKQ 177
LK++ H N++ L S + +F +P + ++G E ++ Q
Sbjct: 68 LKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH--PLSEDKVQYLVYQ 125
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG---T 234
+L GL+Y+H GI+HRD+K N+ V+ +K+ DFG ++ + M G T
Sbjct: 126 MLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--------HADAEMTGYVVT 177
Query: 235 PYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGK-----------------------PP 270
++ APEVIL H + + DIWSVGC + EM TGK P
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237
Query: 271 WSQQFQEVAALFHIGTTKSHPPIPE--------HLSMEAKDFLLKCLQKEPYLRSTASEL 322
+ Q+ ++ AA +I KS P P S +A D L K L+ + R TA+E
Sbjct: 238 FVQKLEDKAAKSYI---KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA 294
Query: 323 LQHPF 327
L+HP+
Sbjct: 295 LEHPY 299
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 81/304 (26%), Positives = 135/304 (44%), Gaps = 49/304 (16%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
E +G GA+G V ++ SG+ +A+K++ A T A R L E +K+L++ H
Sbjct: 11 ENIGSGAYGVVCSAIDTRSGKKVAIKKI----PHAFDVPTLAK-RTLRE-LKILRHFKHD 64
Query: 130 NIV--RYLGTAREDDSLNILLEF-VPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
NI+ R + D ++ + + + ++ E IR + QLL GL+Y+H
Sbjct: 65 NIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-----WMAPE 241
++HRD+K +N+LV+ +++ DFG ++ L++ T Y + APE
Sbjct: 125 SANVIHRDLKPSNLLVNEDCELRIGDFGMAR---GLSSSPTEHKYFMTEYVATRWYRAPE 181
Query: 242 VILQTG-HSFSADIWSVGCTVIEM---------------------ATGKPPWSQQFQEVA 279
++L ++ + D+WSVGC EM G P + +
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPS-EEVLNRIG 240
Query: 280 ALF---HIGTTKSHPPIPEH-----LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331
+ +I P+P S EA D L + LQ +P R T + LQHPF+
Sbjct: 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ- 299
Query: 332 YQDP 335
Y DP
Sbjct: 300 YHDP 303
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 89/312 (28%), Positives = 150/312 (48%), Gaps = 57/312 (18%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P R++ VG GA+G+V + +G +A+K++ SA H + E++L
Sbjct: 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAI------HAKRTYRELRL 67
Query: 123 LKNLTHPNIVRYLGTAREDDSLN------ILLEFVPGGSISSLLGKFGSFPESVIRMYTK 176
LK++ H N++ L SL ++ + G +++++ K + I+
Sbjct: 68 LKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV-KCQKLSDDHIQFLVY 125
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGC-IKLADFGASKKVVELATINGAKSMKG-- 233
Q+L GL+Y+H GI+HRD+K +NI V N+ C +K+ DFG ++ M G
Sbjct: 126 QILRGLKYIHSAGIIHRDLKPSNIAV-NEDCELKILDFGLARHT--------DDEMTGYV 176
Query: 234 -TPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKP--PWSQQFQEVAALFHI-GT-- 286
T ++ APE++L H + + DIWSVGC + E+ TGK P S ++ + ++ GT
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPD 236
Query: 287 ---------------TKSHPPIPE----HL----SMEAKDFLLKCLQKEPYLRSTASELL 323
+S P +P+ + + A D L K L +P R TA+E L
Sbjct: 237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEAL 296
Query: 324 QHPFVTGKYQDP 335
HP++ +Y DP
Sbjct: 297 AHPYLA-EYHDP 307
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 75/275 (27%), Positives = 134/275 (48%), Gaps = 30/275 (10%)
Query: 70 ELVGCGAFGRV----YMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+ +G G FG V Y + ++GE++AVK++ + T H+R+ E E+++LK+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKL--------QHSTAEHLRDFEREIEILKS 61
Query: 126 LTHPNIVRYLGT--AREDDSLNILLEFVPGGSISSLLGKFGS-FPESVIRMYTKQLLLGL 182
L H NIV+Y G + +L +++E++P GS+ L K + +Y Q+ G+
Sbjct: 62 LQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGM 121
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP-YWMAPE 241
EYL +HRD+ NILV+++ +K+ DFG +K + + + +P +W APE
Sbjct: 122 EYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPE 181
Query: 242 VILQTGHSFSADIWSVGCTVIEMAT-----GKPP--WSQQF----QEVAALFH---IGTT 287
+ ++ S ++D+WS G + E+ T PP + + Q ++H +
Sbjct: 182 SLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN 241
Query: 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASEL 322
P P E + +C +P R + SEL
Sbjct: 242 NGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 89/305 (29%), Positives = 137/305 (44%), Gaps = 66/305 (21%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
VG GAFG V + +G+ +A+K+++ T + E+KLLK+L H NI
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIM------KPFSTPVLAKRTYRELKLLKHLRHENI 71
Query: 132 VR------------YLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL 179
+ Y T L+ LL P L +F I+ + Q+L
Sbjct: 72 ISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP------LEKQF-------IQYFLYQIL 118
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMA 239
GL+Y+H G++HRD+K +NIL++ +K+ DFG ++ ++ + G S T Y+ A
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR--IQDPQMTGYVS---TRYYRA 173
Query: 240 PEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWS-----QQFQEVAALF---------HI 284
PE++L + DIWS GC EM GKP + QF + L I
Sbjct: 174 PEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233
Query: 285 GTT------KSHP---PIP-----EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330
+ +S P P+P ++ A D L K L +P R +A+E L HP++
Sbjct: 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL-A 292
Query: 331 KYQDP 335
Y DP
Sbjct: 293 PYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 83/278 (29%), Positives = 138/278 (49%), Gaps = 29/278 (10%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+L+G G FG+V + +G A+K +V++A + + T E ++L+N
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT---------ENRVLQN 51
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
HP + + + D L ++E+ GG + L + F E R Y +++ L+YL
Sbjct: 52 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYL 111
Query: 186 H-KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA--KSMKGTPYWMAPEV 242
H + +++RD+K N+++D G IK+ DFG K+ ++ +GA K+ GTP ++APEV
Sbjct: 112 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK----DGATMKTFCGTPEYLAPEV 167
Query: 243 ILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
+ + + D W +G + EM G+ P+ Q E LF + P LS EAK
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFEL-ILMEEIRFPRTLSPEAK 224
Query: 303 DFLLKCLQKEPYLR-----STASELLQHPFVTG-KYQD 334
L L+K+P R A E++QH F G +QD
Sbjct: 225 SLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQD 262
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 79/274 (28%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE----EEVK 121
+R ++G G FG V +G++ A K++ EK + R+ E E +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---------EKKRIKKRKGEAMALNEKQ 52
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLL 179
+L+ + +V D+L ++L + GG + + G+ F E Y ++
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEIT 112
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMA 239
GLE LH+ I++RD+K NIL+D+ G I+++D G + ++ E TI G GT +MA
Sbjct: 113 CGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG---RVGTVGYMA 169
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI-PEHLS 298
PEV+ ++FS D W +GC + EM GK P+ Q+ ++V K E S
Sbjct: 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFS 229
Query: 299 MEAKDFLLKCLQKEPYLR-----STASELLQHPF 327
A+ + L K+P R A E+ HPF
Sbjct: 230 EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 1e-25
Identities = 77/273 (28%), Positives = 130/273 (47%), Gaps = 32/273 (11%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+++G G+FG+V + + E+ A+K V++ + T+ I L +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK------ 54
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
HP + + D L ++E+V GG + + + F E R Y ++ L L +L
Sbjct: 55 --HPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFL 112
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK--GTPYWMAPEVI 243
H++G+++RD+K NIL+D +G KLADFG K+ +NG + GTP ++APE++
Sbjct: 113 HRHGVIYRDLKLDNILLDAEGHCKLADFGMCKE----GILNGVTTTTFCGTPDYIAPEIL 168
Query: 244 LQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI--PEHLSMEA 301
+ + S D W++G + EM G+PP+ ++ LF + H + P LS EA
Sbjct: 169 QELEYGPSVDWWALGVLMYEMMAGQPPFEADNED--DLFE---SILHDDVLYPVWLSKEA 223
Query: 302 KDFLLKCLQKEPYLR-------STASELLQHPF 327
L + K P R + QHPF
Sbjct: 224 VSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 79/246 (32%), Positives = 122/246 (49%), Gaps = 17/246 (6%)
Query: 105 SKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGG----SISSLL 160
+ E+ A+ R E+ L H IV++ + DD L +++E+ GG I L
Sbjct: 104 NDERQAAYARS---ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRL 160
Query: 161 GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220
+ F E + + Q++L L+ +H +MHRD+K ANI + G IKL DFG SK+
Sbjct: 161 KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220
Query: 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVA 279
+ +++ A S GTPY++APE+ + +S AD+WS+G + E+ T P+ Q E+
Sbjct: 221 DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM 280
Query: 280 ALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF---VTGKYQDPH 336
G + P P +S K L L K P LR T +LL F V +QD
Sbjct: 281 QQVLYG---KYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVANLFQD-- 335
Query: 337 PVFRNS 342
+ R+S
Sbjct: 336 -IVRHS 340
|
Length = 478 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 79/273 (28%), Positives = 129/273 (47%), Gaps = 26/273 (9%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV--KLLKNLTH 128
++G G FG VY D+G++ A+K + + Q L E + L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK----CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
P IV D L+ +L+ + GG + L + G F E+ +R Y +++LGLE++H
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGA----SKKVVELATINGAKSMKGTPYWMAPEVIL 244
+++RD+K ANIL+D G ++++D G SKK + GT +MAPEV L
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--------GTHGYMAPEV-L 167
Query: 245 QTGHSF--SADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
Q G ++ SAD +S+GC + ++ G P+ Q + T +P+ S E +
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 227
Query: 303 DFLLKCLQKEPYLR-----STASELLQHPFVTG 330
L LQ++ R A E+ +HPF
Sbjct: 228 SLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRS 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 68/203 (33%), Positives = 111/203 (54%), Gaps = 8/203 (3%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+++G G+FG+V + + + AVK ++ + K+K + HI + E LLKN+ HP
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVK--VLQKKAILKKKEEKHI--MSERNVLLKNVKHP 56
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
+V + + D L +L+++ GG + L + F E R Y ++ L YLH
Sbjct: 57 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 116
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS-MKGTPYWMAPEVILQTGH 248
I++RD+K NIL+D++G I L DFG K+ +E NG S GTP ++APEV+ + +
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH---NGTTSTFCGTPEYLAPEVLHKQPY 173
Query: 249 SFSADIWSVGCTVIEMATGKPPW 271
+ D W +G + EM G PP+
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 81/266 (30%), Positives = 135/266 (50%), Gaps = 16/266 (6%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+++G GAFG V + + S ++ A+K L++ K A E E ++ N P
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMK--LLSKFEMIKRSDSAFFWE-ERDIMAFAN--SP 103
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
+V+ ++D L +++E++PGG + +L+ + PE + YT +++L L+ +H G
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG-- 247
++HRD+K N+L+D G +KLADFG K+ E + + GTP +++PEV+ G
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVR-CDTAVGTPDYISPEVLKSQGGD 221
Query: 248 --HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE--HLSMEAKD 303
+ D WSVG + EM G P+ V I K+ PE +S AK+
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYAD-SLVGTYSKIMDHKNSLNFPEDVEISKHAKN 280
Query: 304 FLLKCL-QKEPYL-RSTASELLQHPF 327
+ L +E L R+ E+ QHPF
Sbjct: 281 LICAFLTDREVRLGRNGVEEIKQHPF 306
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 5e-25
Identities = 69/200 (34%), Positives = 113/200 (56%), Gaps = 12/200 (6%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G G V + SG ++A K + + A + + IREL+ +L P I
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQI---IRELQ----VLHECNSPYI 65
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL-HKNGI 190
V + G D ++I +E + GGS+ +L + PE ++ + +L GL YL K+ I
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQI 125
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSF 250
MHRD+K +NILV+++G IKL DFG S ++++ + A S GT +M+PE + T +S
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSV 181
Query: 251 SADIWSVGCTVIEMATGKPP 270
+DIWS+G +++E+A G+ P
Sbjct: 182 QSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-25
Identities = 78/267 (29%), Positives = 129/267 (48%), Gaps = 18/267 (6%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+++G GAFG V + + S ++ A+K L++ K A EE ++ +
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMK--LLSKFEMIKRSDSAF---FWEERDIMAHANSE 103
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
IV+ ++D L +++E++PGG + +L+ + PE R YT +++L L+ +H G
Sbjct: 104 WIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMG 162
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHS 249
+HRD+K N+L+D G +KLADFG K+ + ++ GTP +++PEV+ G
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGD 221
Query: 250 ----FSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTK---SHPPIPEHLSMEAK 302
D WSVG + EM G P+ V I K + P E +S +AK
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYAD-SLVGTYSKIMDHKNSLTFPDDIE-ISKQAK 279
Query: 303 DFLLKCLQKEPYL--RSTASELLQHPF 327
D + L R+ E+ HPF
Sbjct: 280 DLICAFLTDREVRLGRNGVDEIKSHPF 306
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 76/258 (29%), Positives = 119/258 (46%), Gaps = 14/258 (5%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
EL G G FG V G+ L K+V +A + +E A +E E ++ L H
Sbjct: 1 KEL-GHGNFGSVVKGVYLMKSG----KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDH 55
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
P IVR +G + + L +++E P G + L K P S ++ Q+ +G+ YL
Sbjct: 56 PCIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAPEVILQTG 247
+HRD+ N+L+ N+ K++DFG S+ + + A + P W APE I
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174
Query: 248 HSFSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFHIGTTKSHPP-IPEHLSMEAKDF 304
S +D+WS G T+ E + G P+ + + EV A+ G P P+ +
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIY----SI 230
Query: 305 LLKCLQKEPYLRSTASEL 322
+L C + P R T SEL
Sbjct: 231 MLSCWKYRPEDRPTFSEL 248
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 78/308 (25%), Positives = 144/308 (46%), Gaps = 56/308 (18%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAH-IRELEEEVKLL 123
R+ +GCG+ G V+ ++ D + +AVK++++ T ++ E+K++
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL---------TDPQSVKHALREIKII 56
Query: 124 KNLTHPNIVR--------------YLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPES 169
+ L H NIV+ +G+ E +S+ I+ E++ ++++L + G E
Sbjct: 57 RRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEE 114
Query: 170 VIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCI-KLADFGASKKVVELATINGA 228
R++ QLL GL+Y+H ++HRD+K AN+ ++ + + K+ DFG ++ V + G
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 229 KSMKGTPYWM-APEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWS-----QQFQEV--- 278
S W +P ++L ++ + D+W+ GC EM TGKP ++ +Q Q +
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234
Query: 279 ----------------AALFHIGTTKSHPPIPEHL---SMEAKDFLLKCLQKEPYLRSTA 319
+ + P+ + L + EA DFL + L P R TA
Sbjct: 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294
Query: 320 SELLQHPF 327
E L HP+
Sbjct: 295 EEALMHPY 302
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 80/273 (29%), Positives = 129/273 (47%), Gaps = 27/273 (9%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKN 125
++G G+FG+V + +SG L AVK V++ + T+ I L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARN------ 54
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
HP + + + D L ++EFV GG + + K F E+ R Y ++ L +L
Sbjct: 55 --HPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFL 112
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATING--AKSMKGTPYWMAPEVI 243
H GI++RD+K N+L+D++G KLADFG K+ + NG + GTP ++APE++
Sbjct: 113 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF----NGKTTSTFCGTPDYIAPEIL 168
Query: 244 LQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
+ + S D W++G + EM G P+ + ++ LF P LS +A D
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFE-AILNDEVVYPTWLSQDAVD 225
Query: 304 FLLKCLQKEPYLR--STA----SELLQHPFVTG 330
L + K P +R S +L+HPF
Sbjct: 226 ILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 80/270 (29%), Positives = 122/270 (45%), Gaps = 38/270 (14%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
E +G G FG VY G+ L +AVK + R+ +E ++LK HP
Sbjct: 1 EKIGKGNFGDVYKGV-LKGNTEVAVK-------TCRSTLPPDLKRKFLQEAEILKQYDHP 52
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL-------LGL 182
NIV+ +G + + I++E VPGGS+ + L K + R+ K+LL G+
Sbjct: 53 NIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN------RLTVKKLLQMSLDAAAGM 106
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS-MKGTPY-WMAP 240
EYL +HRD+ N LV +K++DFG S++ E I +K P W AP
Sbjct: 107 EYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRE--EEGGIYTVSDGLKQIPIKWTAP 164
Query: 241 EVILQTG-HSFSADIWSVGCTVIEMATGK----PPWS-QQFQEVAALFHIGTTKSHPPIP 294
E L G ++ +D+WS G + E + P S QQ +E I + P P
Sbjct: 165 EA-LNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE-----RIESGYRMPA-P 217
Query: 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+ E +L+C +P R + SE+
Sbjct: 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 74/258 (28%), Positives = 117/258 (45%), Gaps = 14/258 (5%)
Query: 69 GELVGCGAFGRVYMGMNLD-SGELLAVKQVLIAANSASKEKTQAHIREL-EEEVKLLKNL 126
G +G G FG VY G+ + E +AV A K T +RE +E +++
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAV------AVKTCKNCTSPSVREKFLQEAYIMRQF 64
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYL 185
HP+IV+ +G ++ + I++E P G + S L S + + +Y+ QL L YL
Sbjct: 65 DHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
+HRDI N+LV + C+KL DFG S + +E + A K WMAPE I
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLS-RYLEDESYYKASKGKLPIKWMAPESINF 182
Query: 246 TGHSFSADIWSVGCTVIE-MATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
+ ++D+W G + E + G P+ Q + + I P+P +
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPF-QGVKNNDVIGRI-ENGERLPMPPNCPPTLYSL 240
Query: 305 LLKCLQKEPYLRSTASEL 322
+ KC +P R +EL
Sbjct: 241 MTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-24
Identities = 87/309 (28%), Positives = 151/309 (48%), Gaps = 60/309 (19%)
Query: 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV 120
+P ++ G ++G G+FG VY + +D+ E +A+K+VL + Q REL
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVL--------QDPQYKNREL---- 110
Query: 121 KLLKNLTHPNIV-----RYLGTAREDDS---LNILLEFVPGGSISSLLGKFG----SFPE 168
++KNL H NI+ Y ++++ LN+++EF+P ++ + + + P
Sbjct: 111 LIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPL 169
Query: 169 SVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD-NKGCIKLADFGASKKVVELATING 227
++++Y+ QL L Y+H I HRD+K N+L+D N +KL DFG++K + + G
Sbjct: 170 FLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL-----LAG 224
Query: 228 AKSMK--GTPYWMAPEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQF---QEVAAL 281
+S+ + ++ APE++L T ++ D+WS+GC + EM G P +S Q Q V +
Sbjct: 225 QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284
Query: 282 FHIGT-----TKSHPP------------------IPEHLSMEAKDFLLKCLQKEPYLRST 318
+GT K P P+ +A +F+ + L+ EP R
Sbjct: 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN 344
Query: 319 ASELLQHPF 327
E L PF
Sbjct: 345 PIEALADPF 353
|
Length = 440 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-24
Identities = 81/249 (32%), Positives = 122/249 (48%), Gaps = 19/249 (7%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G + V+ G + + L+A+K++ + + IRE V LLKNL H NI
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA---IRE----VSLLKNLKHANI 65
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSL--LGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
V + L ++ E++ L G S I M+ QLL GL Y HK
Sbjct: 66 VTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMF--QLLRGLSYCHKRK 123
Query: 190 IMHRDIKGANILVDNKGCIKLADFG-ASKKVVELATINGAKSMKGTPYWMAPEVIL-QTG 247
I+HRD+K N+L++ KG +KLADFG A K V T + T ++ P+V+L T
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV---TLWYRPPDVLLGSTE 180
Query: 248 HSFSADIWSVGCTVIEMATGKP--PWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA-KDF 304
+S D+W VGC + EMATG+P P S +E+ +F + T + P S E + +
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240
Query: 305 LLKCLQKEP 313
L + +P
Sbjct: 241 LFPQYRAQP 249
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 70/268 (26%), Positives = 128/268 (47%), Gaps = 37/268 (13%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+ +G G FG V++G ++ A+K +I + S++ + EE K++ L+H
Sbjct: 9 LKELGSGQFGVVHLGKWRGKIDV-AIK--MIREGAMSED-------DFIEEAKVMMKLSH 58
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLEY 184
PN+V+ G + + I+ E++ G + + L GK G+ E ++ M + +EY
Sbjct: 59 PNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGT--EWLLDM-CSDVCEAMEY 115
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY---WMAPE 241
L NG +HRD+ N LV +K++DFG ++ V++ + S +GT + W PE
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD----DQYTSSQGTKFPVKWAPPE 171
Query: 242 VILQTGHSFSADIWSVGCTVIEMAT-GKPPW-----SQQFQEVAALFHIGTTKSHPPIPE 295
V + S +D+WS G + E+ + GK P+ S+ + V+A + + P+
Sbjct: 172 VFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL-------YRPK 224
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELL 323
E + C ++P R +LL
Sbjct: 225 LAPTEVYTIMYSCWHEKPEDRPAFKKLL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 67/217 (30%), Positives = 103/217 (47%), Gaps = 19/217 (8%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ K +G G FG V+ + + +++A+K+VL+ EK I L E +K+L+
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLM-----ENEKEGFPITALRE-IKILQ 66
Query: 125 NLTHPNIVRYL--------GTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTK 176
L H N+V + R S ++ EF L K F S I+ K
Sbjct: 67 LLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG--- 233
LL GL Y+H+N I+HRD+K ANIL+ G +KLADFG ++ L+ +
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS-LSKNSKPNRYTNRVV 185
Query: 234 TPYWMAPEVILQTGHSFSA-DIWSVGCTVIEMATGKP 269
T ++ PE++L D+W GC + EM T P
Sbjct: 186 TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 3e-24
Identities = 84/292 (28%), Positives = 134/292 (45%), Gaps = 53/292 (18%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G + VY G + + L+A+K++ + + IRE V LLK+L H NI
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTA---IRE----VSLLKDLKHANI 66
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
V + SL ++ E++ L S ++++ QLL GL Y H+ ++
Sbjct: 67 VTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126
Query: 192 HRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-------WMAPEVIL 244
HRD+K N+L++ +G +KLADFG ++ AKS+ Y W P IL
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR----------AKSIPTKTYSNEVVTLWYRPPDIL 176
Query: 245 --QTGHSFSADIWSVGCTVIEMATGKP--PWSQQFQEVAALFHI-GT------------- 286
T +S D+W VGC EM+TG+P P S +++ +F I GT
Sbjct: 177 LGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236
Query: 287 ---TKSHP-----PIPEH---LSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
+ ++P + H L + + L K LQ E R +A E ++HP+
Sbjct: 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-24
Identities = 85/297 (28%), Positives = 134/297 (45%), Gaps = 57/297 (19%)
Query: 72 VGCGAFGRVYMGMNL-DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
+G GA+G+V+ +L + G +A+K+V + + + + IRE+ ++ L+ HPN
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAV-LRHLETFEHPN 65
Query: 131 IVRYLG------TARE----------DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMY 174
+VR T RE D L L+ VP + P I+
Sbjct: 66 VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGV----------PTETIKDM 115
Query: 175 TKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGT 234
QLL GL++LH + ++HRD+K NILV + G IKLADFG ++ + S+ T
Sbjct: 116 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT---SVVVT 172
Query: 235 PYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW--SQQFQEVAALFHIGTTKSHPP 292
++ APEV+LQ+ ++ D+WSVGC EM KP + S ++ + +
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 232
Query: 293 IPEHLSME----------------------AKDFLLKCLQKEPYLRSTASELLQHPF 327
P +++ KD LLKCL P R +A L HP+
Sbjct: 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 80/273 (29%), Positives = 128/273 (46%), Gaps = 26/273 (9%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV--KLLKNLTH 128
++G G FG VY D+G++ A+K + + Q L E + L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMK----CLDKKRIKMKQGETLALNERIMLSLVSTGDC 56
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
P IV D L +L+ + GG + L + G F E +R Y +++LGLE++H
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGA----SKKVVELATINGAKSMKGTPYWMAPEVIL 244
+++RD+K ANIL+D G ++++D G SKK + GT +MAPEV L
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--------GTHGYMAPEV-L 167
Query: 245 QTGHSF--SADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
Q G ++ SAD +S+GC + ++ G P+ Q + T + +P+ S E K
Sbjct: 168 QKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELK 227
Query: 303 DFLLKCLQKEPYLR-----STASELLQHPFVTG 330
L LQ++ R A E+ +H F G
Sbjct: 228 SLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 9e-24
Identities = 87/310 (28%), Positives = 146/310 (47%), Gaps = 53/310 (17%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P R+R + VG GA+G V ++ +G +A+K++ S + + E++L
Sbjct: 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS------ELFAKRAYRELRL 67
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEF---VP--GGSISSLLGKFGSFPESVIRMYTKQ 177
LK++ H N++ L D SL+ +F +P G + L+ K E I+ Q
Sbjct: 68 LKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLM-KHEKLSEDRIQFLVYQ 126
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG---T 234
+L GL+Y+H GI+HRD+K N+ V+ +K+ DFG +++ M G T
Sbjct: 127 MLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT--------DSEMTGYVVT 178
Query: 235 PYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPW--SQQFQEVAALFHIGTTKSHP 291
++ APEVIL H + + DIWSVGC + EM TGKP + ++ + + T S
Sbjct: 179 RWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKE 238
Query: 292 PIPEHLSMEAKDFL----------------------LKCLQK----EPYLRSTASELLQH 325
+ + S +AK+++ + L+K + R TA+E L H
Sbjct: 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298
Query: 326 PFVTGKYQDP 335
P+ ++ DP
Sbjct: 299 PYFE-EFHDP 307
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 71/251 (28%), Positives = 126/251 (50%), Gaps = 19/251 (7%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++G G+FG+V + + EL A+K V+I + + + L+++ L L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
+ D L ++E+V GG + + + G F E Y ++ +GL +LH
Sbjct: 67 H--------SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKK-VVELATINGAKSMKGTPYWMAPEVILQ 245
+ GI++RD+K N+++D++G IK+ADFG K+ +V+ T ++ GTP ++APE+I
Sbjct: 119 RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT---TRTFCGTPDYIAPEIIAY 175
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFL 305
+ S D W+ G + EM G+PP+ + ++ LF + + P+ LS EA
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQ-SIMEHNVSYPKSLSKEAVSIC 232
Query: 306 LKCLQKEPYLR 316
+ K P R
Sbjct: 233 KGLMTKHPSKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 77/280 (27%), Positives = 121/280 (43%), Gaps = 28/280 (10%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G GAFG+V++ + L K ++ A A K+ T A ++ + E +LL NL H +I
Sbjct: 13 LGEGAFGKVFLA---ECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRM------------------ 173
V++ G + D L ++ E++ G ++ L G P+++I +
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHG--PDAMILVDGQPRQAKGELGLSQMLH 127
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
Q+ G+ YL +HRD+ N LV +K+ DFG S+ V
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFHIGTTKSHP 291
WM PE I+ + +D+WS G + E+ T GK PW Q EV G P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 247
Query: 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331
+ E D +L C Q+EP R E+ + GK
Sbjct: 248 RV---CPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 75/280 (26%), Positives = 116/280 (41%), Gaps = 39/280 (13%)
Query: 70 ELVGCGAFGRVYMG-----MNLDSGELLAVKQVLIAANSASKEKTQAHIRE-LEEEVKLL 123
+G GAFG+V++G + EL+AVK KE R+ E E +LL
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVK--------TLKETASNDARKDFEREAELL 62
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL--------------GKFGSFPES 169
N H NIV++ G E D ++ E++ G ++ L G S
Sbjct: 63 TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122
Query: 170 VIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV--VELATING 227
+ Q+ G+ YL +HRD+ N LV +K+ DFG S+ V + + G
Sbjct: 123 QLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG 182
Query: 228 AKSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFHI 284
+ P WM PE I+ + +D+WS G + E+ T GK PW +EV
Sbjct: 183 HTML---PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ 239
Query: 285 GTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
G P E D +L C +++P R ++ +
Sbjct: 240 GRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 81/278 (29%), Positives = 139/278 (50%), Gaps = 30/278 (10%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVK-----QVLIAANSASKEKTQAHIRELEEEVKLLK 124
+++G GAFG V + ++G++ A+K ++L A +A EE +L
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETAC----------FREERDVLV 56
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS-FPESVIRMYTKQLLLGLE 183
N I +++++L +++++ GG + +LL KF PE + R Y +++L ++
Sbjct: 57 NGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAID 116
Query: 184 YLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVI 243
+H+ G +HRDIK N+L+D G I+LADFG+ +++ T+ ++ GTP +++PE I
Sbjct: 117 SVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTPDYISPE-I 174
Query: 244 LQ-----TGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSH---PPIP 294
LQ G D WS+G + EM G+ P+ + V I K H PP
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHKEHFQFPPDV 233
Query: 295 EHLSMEAKDFLLK--CLQKEPYLRSTASELLQHPFVTG 330
+S EAKD + + C + R+ + HPF G
Sbjct: 234 TDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 88/308 (28%), Positives = 135/308 (43%), Gaps = 69/308 (22%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ K E +G G +G VY + + E +A+K++ + T IRE + LLK
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTA--IRE----ISLLK 56
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPE-----SVIRMYTKQLL 179
+ H NIVR + L ++ E++ L S P+ +I+ Y Q+L
Sbjct: 57 EMQHGNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDSSPDFAKNPRLIKTYLYQIL 112
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNK-GCIKLADFGASK-----------KVVELATING 227
G+ Y H + ++HRD+K N+L+D + +KLADFG ++ +VV L
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTL----- 167
Query: 228 AKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKP--PWSQQFQEVAALFHI 284
++ APE++L + H S DIWSVGC EM KP P + E+ +F I
Sbjct: 168 --------WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRI 219
Query: 285 -GTT--------------KSHPP----------IPEHLSMEAKDFLLKCLQKEPYLRSTA 319
GT KS P +P L D L K L+ +P R TA
Sbjct: 220 LGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITA 278
Query: 320 SELLQHPF 327
L+H +
Sbjct: 279 RAALEHEY 286
|
Length = 294 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 76/274 (27%), Positives = 129/274 (47%), Gaps = 24/274 (8%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEE----EVK 121
+R+ ++G G FG V +G++ A K++ EK + R+ E E +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRL---------EKKRIKKRKGESMALNEKQ 52
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLL 179
+L+ + +V D+L ++L + GG + + G+ F E Y ++L
Sbjct: 53 ILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEIL 112
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMA 239
GLE LH+ ++RD+K NIL+D+ G I+++D G + K+ E +I G GT +MA
Sbjct: 113 CGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG---RVGTVGYMA 169
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVA-ALFHIGTTKSHPPIPEHLS 298
PEV+ ++ S D W +GC + EM G+ P+ + ++V ++ S
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFS 229
Query: 299 MEAKDFLLKCLQKEPYLR-----STASELLQHPF 327
EAK L K+P R A E+ +HPF
Sbjct: 230 EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPF 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 4e-23
Identities = 67/224 (29%), Positives = 118/224 (52%), Gaps = 10/224 (4%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
+VG GA+G V + ++ E++A+K+ + ++E + +REL K+L+ L N
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKK--FKDSEENEEVKETTLREL----KMLRTLKQEN 61
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGI 190
IV R L ++ E+V + L P +R Y QL+ + + HKN I
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSF 250
+HRDIK N+L+ + +KL DFG ++ + E + N + + T ++ +PE++L +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAPYGK 180
Query: 251 SADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP 294
+ D+WSVGC + E++ G+P + + E+ LF I K P+P
Sbjct: 181 AVDMWSVGCILGELSDGQPLFPGE-SEIDQLFTI--QKVLGPLP 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 99.8 bits (248), Expect = 4e-23
Identities = 76/265 (28%), Positives = 118/265 (44%), Gaps = 31/265 (11%)
Query: 72 VGCGAFGRVYMG--MNLDSGE---LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+G GAFG+V++ NL + L+AVK + A+++A K+ E +LL NL
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKD--------FHREAELLTNL 64
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-------------SFPESVIRM 173
H +IV++ G E D L ++ E++ G ++ L G +S +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
+Q+ G+ YL +HRD+ N LV +K+ DFG S+ V
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML 184
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFHIGTTKSHP 291
WM PE I+ + +D+WS+G + E+ T GK PW Q EV G
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR- 243
Query: 292 PIPEHLSMEAKDFLLKCLQKEPYLR 316
P E D +L C Q+EP++R
Sbjct: 244 --PRTCPKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 79/278 (28%), Positives = 130/278 (46%), Gaps = 32/278 (11%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE----EEVK 121
+R+ ++G G FG V +G++ A K++ EK + R+ E E +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKL---------EKKRIKKRKGESMALNEKQ 52
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLL 179
+L+ + +V D+L ++L + GG + + G F E Y ++
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEIC 112
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMA 239
GLE LH+ I++RD+K NIL+D+ G I+++D G + V E TI G GT +MA
Sbjct: 113 CGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG---RVGTVGYMA 169
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQ-----QFQEVAALFHIGTTKSHPPIP 294
PEV+ ++FS D W++GC + EM G+ P+ Q + +EV L +
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEE----YS 225
Query: 295 EHLSMEAKDFLLKCLQKEPYLR-----STASELLQHPF 327
E S +A+ L K+P R A E+ +HP
Sbjct: 226 EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 5e-23
Identities = 82/290 (28%), Positives = 135/290 (46%), Gaps = 42/290 (14%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
E +G G++ VY G++ +G+L+A+K +I+ + A IRE LLK L H
Sbjct: 11 EKLGEGSYATVYKGISRINGQLVALK--VISMKTEEGVPFTA-IRE----ASLLKGLKHA 63
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
NIV ++L + E++ ++ G +R++ QLL GL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH 123
Query: 190 IMHRDIKGANILVDNKGCIKLADFG-ASKKVVELATINGAKSMKGTPYWMAPEVIL-QTG 247
I+HRD+K N+L+ G +KLADFG A K + T + S T ++ P+V+L T
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS---SEVVTLWYRPPDVLLGATD 180
Query: 248 HSFSADIWSVGCTVIEMATGKPPWS------QQFQEVAALFHIGTTKSHP---------- 291
+S + DIW GC IEM G+P + +Q +++ + + T + P
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240
Query: 292 -----PIPEHLSM---------EAKDFLLKCLQKEPYLRSTASELLQHPF 327
P+ L + +A+D + L P R +A + L HP+
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 5e-23
Identities = 78/266 (29%), Positives = 134/266 (50%), Gaps = 16/266 (6%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+++G GAFG V + + + ++ A+K L++ K A E E ++ N P
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMK--LLSKFEMIKRSDSAFFWE-ERDIMAFAN--SP 103
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
+V+ ++D L +++E++PGG + +L+ + PE R YT +++L L+ +H G
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG 162
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG-- 247
+HRD+K N+L+D G +KLADFG K+ + + + GTP +++PEV+ G
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGD 221
Query: 248 --HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE--HLSMEAKD 303
+ D WSVG + EM G P+ V I K+ P+ +S EAK+
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYAD-SLVGTYSKIMNHKNSLTFPDDNDISKEAKN 280
Query: 304 FLLKCL-QKEPYL-RSTASELLQHPF 327
+ L +E L R+ E+ +H F
Sbjct: 281 LICAFLTDREVRLGRNGVEEIKRHLF 306
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-23
Identities = 87/319 (27%), Positives = 142/319 (44%), Gaps = 61/319 (19%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R++ +G GA+G V + +G +A+K++ + E R L E +K+L+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKI------SPFEHQTFCQRTLRE-IKILR 58
Query: 125 NLTHPNIVRYLGTARED--DSLN---ILLEFVPGGSISSL--LGKFGSFPESVIRMYTKQ 177
H NI+ L R +S N I+ E + + L L K I+ + Q
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELME----TDLYKLIKTQHLSNDHIQYFLYQ 114
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGC-IKLADFGASKKVVELATINGAKSMKGTPY 236
+L GL+Y+H ++HRD+K +N+L+ N C +K+ DFG ++ +A + T Y
Sbjct: 115 ILRGLKYIHSANVLHRDLKPSNLLL-NTNCDLKICDFGLAR----IADPEHDHTGFLTEY 169
Query: 237 ----WM-APEVIL-QTGHSFSADIWSVGCTVIEMATGKP--------------------P 270
W APE++L G++ + DIWSVGC + EM + +P P
Sbjct: 170 VATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTP 229
Query: 271 WSQQFQEVA---ALFHIGTTKSHPPIP-----EHLSMEAKDFLLKCLQKEPYLRSTASEL 322
+ + A +I + P +P + +A D L K L P+ R T E
Sbjct: 230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEA 289
Query: 323 LQHPFVTGKYQDPH--PVF 339
L HP++ +Y DP PV
Sbjct: 290 LAHPYLE-QYHDPSDEPVA 307
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 8e-23
Identities = 76/273 (27%), Positives = 128/273 (46%), Gaps = 24/273 (8%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE----EEVK 121
+R ++G G FG V +G++ A K++ EK + R+ E E +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---------EKKRIKKRKGEAMALNEKR 52
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLL 179
+L+ + +V D+L ++L + GG + + G+ F E Y +L
Sbjct: 53 ILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELC 112
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMA 239
GLE L + I++RD+K NIL+D++G I+++D G + ++ E T+ G GT +MA
Sbjct: 113 CGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG---RVGTVGYMA 169
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVA-ALFHIGTTKSHPPIPEHLS 298
PEVI ++FS D W +GC + EM G+ P+ ++ + V + E S
Sbjct: 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFS 229
Query: 299 MEAKDFLLKCLQKEPYLR-----STASELLQHP 326
+AK L K P R + A+ + QHP
Sbjct: 230 EDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 9e-23
Identities = 80/307 (26%), Positives = 146/307 (47%), Gaps = 47/307 (15%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P R++ VG GA+G V + + +AVK++ + ++ H R E++L
Sbjct: 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKL------SRPFQSLIHARRTYRELRL 67
Query: 123 LKNLTHPNIVRYL-----GTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ 177
LK++ H N++ L T+ E+ + L+ + G +++++ K + ++ Q
Sbjct: 68 LKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIV-KCQKLSDEHVQFLIYQ 126
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 237
LL GL+Y+H GI+HRD+K +N+ V+ +++ DFG +++ + T T ++
Sbjct: 127 LLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT-----GYVATRWY 181
Query: 238 MAPEVILQTGH-SFSADIWSVGCTVIEMATGKP--PWSQQFQEVAALFHIGTT------- 287
APE++L H + + DIWSVGC + E+ GK P + ++ + + T
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK 241
Query: 288 -----------KSHPPIPEHLSME--------AKDFLLKCLQKEPYLRSTASELLQHPFV 328
+S P +P+ + A D L K L + R +ASE L HP+
Sbjct: 242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
Query: 329 TGKYQDP 335
+ +Y DP
Sbjct: 302 S-QYHDP 307
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 1e-22
Identities = 84/298 (28%), Positives = 136/298 (45%), Gaps = 57/298 (19%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
K E +G G + V+ G + + L+A+K++ + + IRE V LLK+L
Sbjct: 10 KLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTA---IRE----VSLLKDLK 62
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPG---------GSISSLLGKFGSFPESVIRMYTKQL 178
H NIV D SL ++ E++ G+I S+ ++++ Q+
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHN---------VKIFLYQI 113
Query: 179 LLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG-ASKKVVELATINGAKSMKGTPYW 237
L GL Y H+ ++HRD+K N+L++ +G +KLADFG A K V T + T ++
Sbjct: 114 LRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV---TLWY 170
Query: 238 MAPEVILQTG-HSFSADIWSVGCTVIEMATGKP--PWSQQFQEVAALFHIGTTKSHP--- 291
P+V+L + +S D+W VGC EMA+G+P P S E+ +F + T +
Sbjct: 171 RPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWP 230
Query: 292 -------------------PIPEH---LSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
P+ H L E + L K LQ E R +A E ++H +
Sbjct: 231 GISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 1e-22
Identities = 70/262 (26%), Positives = 112/262 (42%), Gaps = 20/262 (7%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+ +G G+FG V G SG K + +A +K + + +E ++ +L H
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGG----KVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHE 56
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGK--FGSFPESVIRMYTKQLLLGLEYLHK 187
N++R G L ++ E P GS+ L K G F S + Y Q+ G+ YL
Sbjct: 57 NLIRLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES 115
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAPEVILQT 246
+HRD+ NIL+ + +K+ DFG + + + + P+ W APE +
Sbjct: 116 KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 247 GHSFSADIWSVGCTVIEMAT-GKPPW-----SQQFQEVAALFHIGTTKSHPPIPEHLSME 300
S ++D+W G T+ EM T G+ PW SQ L I PE +
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILKKIDKEGERLERPEACPQD 229
Query: 301 AKDFLLKCLQKEPYLRSTASEL 322
+ +L+C P R T + L
Sbjct: 230 IYNVMLQCWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 72/238 (30%), Positives = 115/238 (48%), Gaps = 23/238 (9%)
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
HP +V + + L ++E+V GG + + + PE R Y+ ++ L L YLH+
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
GI++RD+K N+L+D++G IKL D+G K+ L + + GTP ++APE++
Sbjct: 115 RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 248 HSFSADIWSVGCTVIEMATGKPPW---------SQQFQEVAALFHIGTTKSHPPIPEHLS 298
+ FS D W++G + EM G+ P+ Q ++ LF + K IP LS
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY--LFQVILEK-QIRIPRSLS 229
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRN---SVMESGNQIATP 353
++A L L K+P R + G HP FRN +ME Q+ P
Sbjct: 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQG-----HPFFRNVDWDLMEQ-KQVVPP 281
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 74/272 (27%), Positives = 128/272 (47%), Gaps = 23/272 (8%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V +G+L A K++ N +K + + + E+ L K H
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKL----NKKRLKKRKGYEGAMVEKRILAK--VHSRF 54
Query: 132 VRYLGTAREDDS-LNILLEFVPGGS----ISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
+ L A + + L +++ + GG I ++ + FPE YT Q++ GLE+LH
Sbjct: 55 IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT-INGAKSMKGTPYWMAPEVILQ 245
+ I++RD+K N+L+DN G ++++D G + VEL + K GTP +MAPE++
Sbjct: 115 QRRIIYRDLKPENVLLDNDGNVRISDLGLA---VELKDGQSKTKGYAGTPGFMAPELLQG 171
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI--PEHLSMEAKD 303
+ FS D +++G T+ EM + P+ + ++V + + + P+ S +K
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK-ELKQRILNDSVTYPDKFSPASKS 230
Query: 304 FLLKCLQKEPYLR-----STASELLQHPFVTG 330
F L K+P R L HP
Sbjct: 231 FCEALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 3e-22
Identities = 85/315 (26%), Positives = 134/315 (42%), Gaps = 66/315 (20%)
Query: 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVK------QVLIAANSASKEKTQAHI 113
D P R +G GAFG V+ + G+ +A+K Q L++
Sbjct: 1 DVEPDR-----PIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRV--------F 47
Query: 114 RELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLE-FVPGGSISSLLGKFGSFPESV-- 170
REL K+L H N++ L + ++ E +V + S L K P+ +
Sbjct: 48 REL----KMLCFFKHDNVLSALDILQPPH-IDPFEEIYVVTELMQSDLHKIIVSPQPLSS 102
Query: 171 --IRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228
++++ Q+L GL+YLH GI+HRDIK N+LV++ +K+ DFG + +V E +
Sbjct: 103 DHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA-RVEEPDE---S 158
Query: 229 KSMKG---TPYWMAPEVILQTGHSFSA-DIWSVGCTVIEMATGK---------------- 268
K M T Y+ APE+++ + H SA DIWSVGC E+ +
Sbjct: 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLIT 218
Query: 269 -----PPWSQQFQEV-AALFHIGTTKSHPP-------IPEHLSMEAKDFLLKCLQKEPYL 315
P A HI PP + + EA L + L +P
Sbjct: 219 DLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDK 278
Query: 316 RSTASELLQHPFVTG 330
R +A++ L HP++
Sbjct: 279 RISAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 5e-22
Identities = 73/261 (27%), Positives = 132/261 (50%), Gaps = 27/261 (10%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V++G + +A+K I + S+E + EE K++ L+HP +
Sbjct: 12 LGSGQFGVVHLG-KWRAQIKVAIKA--INEGAMSEE-------DFIEEAKVMMKLSHPKL 61
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLEYLHKNGI 190
V+ G + L I+ EF+ G + + L + G + ++ + + G+EYL +N
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVV--ELATINGAK-SMKGTPYWMAPEVILQTG 247
+HRD+ N LV + G +K++DFG ++ V+ E + +GAK +K W PEV +
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVK----WSPPEVFNFSK 177
Query: 248 HSFSADIWSVGCTVIEMAT-GKPPWSQQ--FQEVAALFHIGTTKSHPPIPEHL-SMEAKD 303
+S +D+WS G + E+ T GK P+ ++ ++ V + ++ L SM +
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI-----SRGFRLYRPKLASMTVYE 232
Query: 304 FLLKCLQKEPYLRSTASELLQ 324
+ C ++P R T +ELL+
Sbjct: 233 VMYSCWHEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 8e-22
Identities = 77/279 (27%), Positives = 123/279 (44%), Gaps = 33/279 (11%)
Query: 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLL 123
++W GE GAFG+V++ + LL + ++ A A KE +++ ++ + E +LL
Sbjct: 9 LKWELGE----GAFGKVFLA---ECHNLLPEQDKMLVAVKALKEASESARQDFQREAELL 61
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTK------- 176
L H +IVR+ G E L ++ E++ G ++ L G P++ I +
Sbjct: 62 TVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHG--PDAKILAGGEDVAPGQL 119
Query: 177 ----------QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226
Q+ G+ YL +HRD+ N LV +K+ DFG S+ +
Sbjct: 120 TLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179
Query: 227 -GAKSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFH 283
G ++M P WM PE IL + +DIWS G + E+ T GK PW Q A+
Sbjct: 180 VGGRTM--LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPW-YQLSNTEAIEC 236
Query: 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASEL 322
I T P E + C Q+EP R ++
Sbjct: 237 I-TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 9e-22
Identities = 65/214 (30%), Positives = 106/214 (49%), Gaps = 18/214 (8%)
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
HP +V + + L ++EFV GG + + + PE R Y+ ++ L L +LH+
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE 114
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
GI++RD+K N+L+D +G IKL D+G K+ + + + GTP ++APE++
Sbjct: 115 RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE--GIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 248 HSFSADIWSVGCTVIEMATGKPPW--------SQQFQEVAALFHIGTTKSHPPIPEHLSM 299
+ FS D W++G + EM G+ P+ Q E LF + K IP LS+
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTE-DYLFQVILEKQ-IRIPRSLSV 230
Query: 300 EAKDFLLKCLQKEPYLR------STASELLQHPF 327
+A L L K+P R + ++ HPF
Sbjct: 231 KASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPF 264
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 73/271 (26%), Positives = 142/271 (52%), Gaps = 16/271 (5%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+++G GAFG V + ++ ++ A+K +L + +T EE +L N +
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMK-ILNKWEMLKRAETAC----FREERDVLVNGDNQ 61
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKN 188
I +++++L +++++ GG + +LL KF PE + R Y ++++ ++ +H+
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVI--LQT 246
+HRDIK NIL+D G I+LADFG+ K++E T+ + ++ GTP +++PE++ ++
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMED 180
Query: 247 G---HSFSADIWSVGCTVIEMATGKPPWSQQ--FQEVAALFHIGTTKSHPPIPEHLSMEA 301
G + D WS+G + EM G+ P+ + + + + P +S +A
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240
Query: 302 KDFL--LKCLQKEPYLRSTASELLQHPFVTG 330
KD + L C ++ ++ + QHPF TG
Sbjct: 241 KDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 74/270 (27%), Positives = 116/270 (42%), Gaps = 34/270 (12%)
Query: 71 LVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+G GAFG VY G D SG + +A + K T +E +E L+ N
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGP------IRVAVKTLRKGATDQEKKEFLKEAHLMSN 55
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL--GKFGSFPESVIRMYTKQLLL--- 180
HPNIV+ LG ++ I++E + GG + S L + F ++ + K+LL
Sbjct: 56 FNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL--KELLDICL 113
Query: 181 ----GLEYLHKNGIMHRDIKGANILVDNKG-----CIKLADFGASKKVVELATINGAKSM 231
G YL + +HRD+ N LV KG +K+ DFG ++ + +
Sbjct: 114 DVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 232 KGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPW-SQQFQEVAALFHIGTTKS 289
WMAPE +L + +D+WS G + E+ T G+ P+ + QEV G
Sbjct: 174 LLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ 233
Query: 290 HPP-IPEHLSMEAKDFLLKCLQKEPYLRST 318
P P+ + + C ++P R T
Sbjct: 234 KPENCPDKI----YQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 1e-21
Identities = 70/258 (27%), Positives = 111/258 (43%), Gaps = 19/258 (7%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G +G VY G+ +AVK + KE T + E +E ++K + HPN+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL--------KEDTME-VEEFLKEAAVMKEIKHPNL 64
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNG 189
V+ LG + I+ EF+ G++ L + V+ Q+ +EYL K
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN 124
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHS 249
+HRD+ N LV +K+ADFG S+ + T K W APE + S
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNKFS 183
Query: 250 FSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFHIGTTKSHPP-IPEHLSMEAKDFLL 306
+D+W+ G + E+AT G P+ +V L G P P + + +
Sbjct: 184 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPP----KVYELMR 239
Query: 307 KCLQKEPYLRSTASELLQ 324
C Q P R + +E+ Q
Sbjct: 240 ACWQWNPSDRPSFAEIHQ 257
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-21
Identities = 68/246 (27%), Positives = 119/246 (48%), Gaps = 9/246 (3%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
++G G+FG+V + + EL A+K I + +E+ V L P
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIK---ILKKDVVIQDDDVECTMVEKRVLALSG-KPPF 62
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGI 190
+ + + D L ++E+V GG + + + G F E Y ++ +GL +LH GI
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSF 250
++RD+K N+++D++G IK+ADFG K+ + K+ GTP ++APE+I +
Sbjct: 123 IYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTPDYIAPEIIAYQPYGK 180
Query: 251 SADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQ 310
S D W+ G + EM G+ P+ + ++ LF + + P+ +S EA +
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQ-SIMEHNVAYPKSMSKEAVAICKGLMT 237
Query: 311 KEPYLR 316
K P R
Sbjct: 238 KHPGKR 243
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-21
Identities = 76/307 (24%), Positives = 143/307 (46%), Gaps = 47/307 (15%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P R++ VG GA+G V + +G +AVK++ + ++ H + E++L
Sbjct: 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRL 69
Query: 123 LKNLTHPNIVRYLGT---AREDDSLN--ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ 177
LK++ H N++ L AR + N L+ + G +++++ K + ++ Q
Sbjct: 70 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQ 128
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 237
+L GL+Y+H I+HRD+K +N+ V+ +K+ DFG ++ + T T ++
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT-----GYVATRWY 183
Query: 238 MAPEVILQTGH-SFSADIWSVGCTVIEMATGK--------------------PPWSQQFQ 276
APE++L H + + DIWSVGC + E+ TG+ P ++ +
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 243
Query: 277 EVAALFHIGTTKSHPPIPEH--------LSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
++++ +S +P+ + A D L K L + R TA++ L H +
Sbjct: 244 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 303
Query: 329 TGKYQDP 335
+Y DP
Sbjct: 304 -AQYHDP 309
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
PN+V +DS+ ++L+ GG + S + KF + PE ++ + ++++ L+ LH+
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGH 248
GI+ RD+ NIL+D++G I+L F +V + ++M + APEV +
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAPEVGGISEE 159
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP---------IPEHLSM 299
+ + D WS+G + E+ TGK + HP IPE +S
Sbjct: 160 TEACDWWSLGAILFELLTGK----------------TLVECHPSGINTHTTLNIPEWVSE 203
Query: 300 EAKDFLLKCLQKEPYLRSTA-----SELLQHPF 327
EA+ L + LQ P R A ++ HPF
Sbjct: 204 EARSLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 70/265 (26%), Positives = 120/265 (45%), Gaps = 22/265 (8%)
Query: 70 ELVGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+++G G FG V G G+ +A+K + + S +K + + E ++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL----KAGSSDKQR---LDFLTEASIMGQF 62
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGL 182
HPNI+R G + + I+ E++ GS+ L GKF ++ M + + G+
Sbjct: 63 DHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFT--VGQLVGM-LRGIASGM 119
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
+YL + +HRD+ NILV++ K++DFG S+++ + K K W APE
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179
Query: 243 ILQTGHSFSADIWSVGCTVIE-MATG-KPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300
I + ++D+WS G + E M+ G +P W Q+V G P P
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY---RLPPPMDCPSA 236
Query: 301 AKDFLLKCLQKEPYLRSTASELLQH 325
+L C QK+ R T S+++
Sbjct: 237 LYQLMLDCWQKDRNERPTFSQIVST 261
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-21
Identities = 83/332 (25%), Positives = 136/332 (40%), Gaps = 86/332 (25%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
R++ + +G GA G V + +G+ +A+K++ + + H + E+ L
Sbjct: 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKL------SRPFQNVTHAKRAYRELVL 68
Query: 123 LKNLTHPNIVRYLGTAREDDSLN------ILLEFVPGGSISSLLGKFGSFPESVIRM--- 173
+K + H NI+ L SL +++E + ++L VI+M
Sbjct: 69 MKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD----ANLC--------QVIQMDLD 116
Query: 174 ------YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATING 227
Q+L G+++LH GI+HRD+K +NI+V + +K+ DFG LA G
Sbjct: 117 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-------LARTAG 169
Query: 228 AKSMKGTP-----YWMAPEVILQTGHSFSADIWSVGCTVIEMATGK-------------- 268
M TP Y+ APEVIL G+ + DIWSVGC + EM G
Sbjct: 170 TSFMM-TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK 228
Query: 269 ---------PPWSQQFQEVAALF------HIGTTKSH-------PPIPEHLS----MEAK 302
+ + Q + + G + PP E + +A+
Sbjct: 229 IIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR 288
Query: 303 DFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334
D L K L +P R + + LQHP++ Y
Sbjct: 289 DLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.4 bits (230), Expect = 8e-21
Identities = 74/266 (27%), Positives = 119/266 (44%), Gaps = 37/266 (13%)
Query: 73 GCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV 132
G G FG V+MG + ++ AVK + + S E +E +++K L H +V
Sbjct: 15 GAGQFGEVWMGTWNGTTKV-AVKT--LKPGTMSPE-------AFLQEAQIMKKLRHDKLV 64
Query: 133 RYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLEYLHKN 188
+ E++ + I+ E++ GS+ L GK P+ V Q+ G+ YL
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLV--DMAAQIAEGMAYLESR 122
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVV--ELATINGAK-SMKGTPYWMAPEVILQ 245
+HRD+ NILV K+ADFG ++ + E GAK +K W APE
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIK----WTAPEAANY 178
Query: 246 TGHSFSADIWSVGCTVIEMAT-GKPPW-----SQQFQEVAALFHIGTTKSHPPIPEHLSM 299
+ +D+WS G + E+ T G+ P+ + ++V + + P P +
Sbjct: 179 GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM-------PRPPNCPE 231
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQH 325
E D +L+C K+P R T E LQ
Sbjct: 232 ELYDLMLQCWDKDPEERPTF-EYLQS 256
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 9e-21
Identities = 72/272 (26%), Positives = 135/272 (49%), Gaps = 18/272 (6%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+++G GAFG V + + + E + ++L + +T EE +L N
Sbjct: 7 KVIGRGAFGEVAV-VKMKHTERIYAMKILNKWEMLKRAETAC----FREERNVLVNGDCQ 61
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKN 188
I ++++ L +++++ GG + +LL KF PE + R Y +++L + +H+
Sbjct: 62 WITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVI--LQT 246
+HRDIK N+L+D G I+LADFG+ K+ + T+ + ++ GTP +++PE++ ++
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTPDYISPEILQAMED 180
Query: 247 G---HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL---SME 300
G + D WS+G + EM G+ P+ + V I + P H+ S E
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAE-SLVETYGKIMNHEERFQFPSHITDVSEE 239
Query: 301 AKDFL--LKCLQKEPYLRSTASELLQHPFVTG 330
AKD + L C ++ ++ + +H F G
Sbjct: 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 1e-20
Identities = 58/195 (29%), Positives = 98/195 (50%), Gaps = 8/195 (4%)
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
++P +V + L +++E+V GG + + + PE R Y ++ + L +LH
Sbjct: 54 SNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLH 113
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
+ GI++RD+K N+L+D G IKL D+G K+ L + + GTP ++APE++
Sbjct: 114 ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKE--GLGPGDTTSTFCGTPNYIAPEILRGE 171
Query: 247 GHSFSADIWSVGCTVIEMATGKPPW-----SQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301
+ FS D W++G + EM G+ P+ + LF + K IP LS++A
Sbjct: 172 EYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP-IRIPRFLSVKA 230
Query: 302 KDFLLKCLQKEPYLR 316
L L K+P R
Sbjct: 231 SHVLKGFLNKDPKER 245
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 71/262 (27%), Positives = 124/262 (47%), Gaps = 16/262 (6%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
K +++G GAFG VY G+ + GE + ++ +A +E + +E+ +E ++ ++
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKV---KIPVAIKVLREETSPKANKEILDEAYVMASV 66
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGL 182
HP++VR LG + ++ + +P G + + GS + + Q+ G+
Sbjct: 67 DHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQ---YLLNWCVQIAKGM 122
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
YL + ++HRD+ N+LV +K+ DFG +K + A+ K WMA E
Sbjct: 123 SYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 243 ILQTGHSFSADIWSVGCTVIEMAT-GKPPW-SQQFQEVAALFHIGTTKSHPPIPEHLSME 300
IL ++ +D+WS G TV E+ T G P+ E+ L G PPI +++
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPI---CTID 239
Query: 301 AKDFLLKCLQKEPYLRSTASEL 322
L+KC + R T EL
Sbjct: 240 VYMVLVKCWMIDAESRPTFKEL 261
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 10/225 (4%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V G+ + KQ+ +A E ++ E+ E +++ L +P I
Sbjct: 3 LGSGNFGCVKKGV-----YKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYI 57
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLEYLHKNGI 190
VR +G E ++L +++E GG ++ L GK S + Q+ +G++YL
Sbjct: 58 VRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAPEVILQTGHS 249
+HRD+ N+L+ N+ K++DFG SK + + A+S P W APE I S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 250 FSADIWSVGCTVIEMAT--GKPPWSQQFQEVAALFHIGTTKSHPP 292
+D+WS G T+ E + KP + EV + G P
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPA 221
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 75/268 (27%), Positives = 114/268 (42%), Gaps = 33/268 (12%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
E +G G FG V+ G +AVK K K +E ++LK +HP
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAK-------FLQEARILKQYSHP 53
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL-------LGL 182
NIVR +G + + I++E V GG + L G R+ K+L+ G+
Sbjct: 54 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGP------RLKVKELIQMVENAAAGM 107
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAPE 241
EYL +HRD+ N LV K +K++DFG S++ E MK P W APE
Sbjct: 108 EYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPE 166
Query: 242 VILQTGHSFSADIWSVGCTVIE-MATGKPPW----SQQFQEVAALFHIGTTKSHPPIPEH 296
+ +S +D+WS G + E + G P+ +QQ +E P PE
Sbjct: 167 ALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAI------EQGVRLPCPEL 220
Query: 297 LSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+ +C + +P R + S + Q
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQ 248
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-20
Identities = 80/270 (29%), Positives = 130/270 (48%), Gaps = 24/270 (8%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQV-LIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
++G GA G V + GE AVK V + + A K + QA EV L N
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQA-------EVCCLLNCDFF 91
Query: 130 NIVRY---LGTAREDDSLNIL-----LEFVPGG----SISSLLGKFGSFPESVIRMYTKQ 177
+IV+ + N+L L++ G I S +F E + Q
Sbjct: 92 SIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQ 151
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 237
+LL + ++H ++HRDIK ANIL+ + G +KL DFG SK + + ++ GTPY+
Sbjct: 152 VLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWS-QQFQEVAALFHIGTTKSHPPIPEH 296
+APE+ + +S AD++S+G + E+ T K P+ + +EV H + P+P
Sbjct: 212 VAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV---MHKTLAGRYDPLPPS 268
Query: 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHP 326
+S E ++ + L +P R ++S+LL P
Sbjct: 269 ISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 74/292 (25%), Positives = 126/292 (43%), Gaps = 49/292 (16%)
Query: 69 GELVGCGAFGRVYM----------------GMNLDSGELLAVKQVLIAANSASKEKTQAH 112
E +G G FG V++ N D+ L+AVK + A+ ++E
Sbjct: 10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE----- 64
Query: 113 IRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESV-- 170
+ +EVK+L L+ PNI R LG D L +++E++ G ++ L K + +
Sbjct: 65 --DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122
Query: 171 -IRMYTKQLLL--------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221
+ + LL G+ YL +HRD+ N LV IK+ADFG S+
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRN--- 179
Query: 222 LATINGAKSMKGTP----YWMAPEVILQTGHSFSADIWSVGCTVIEMAT--GKPPWS--- 272
+ ++G WMA E +L + +D+W+ G T+ E+ T + P+
Sbjct: 180 -LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238
Query: 273 -QQFQEVAALFHIGTT-KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASEL 322
QQ E A F + + P P + + + +L+C +++ R T E+
Sbjct: 239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 4e-20
Identities = 65/204 (31%), Positives = 103/204 (50%), Gaps = 12/204 (5%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+ K E +G G++ VY G + +G+L+A+K + + + IRE LLK
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA---IRE----ASLLKG 59
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
L H NIV ++L ++ E+V + G ++++ QLL GL Y+
Sbjct: 60 LKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYI 119
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFG-ASKKVVELATINGAKSMKGTPYWMAPEVIL 244
H+ I+HRD+K N+L+ + G +KLADFG A K V T + T ++ P+V+L
Sbjct: 120 HQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV---TLWYRPPDVLL 176
Query: 245 -QTGHSFSADIWSVGCTVIEMATG 267
T +S D+W VGC +EM G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-20
Identities = 80/309 (25%), Positives = 136/309 (44%), Gaps = 57/309 (18%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R++ E++G G++G V ++ +GE +A+K++ N + + A R L E +KLL+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI----NDVFEHVSDAT-RILRE-IKLLR 54
Query: 125 NLTHPNIVRYLG-----TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL 179
L HP+IV + RE + ++ E + + ++ + + QLL
Sbjct: 55 LLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLL 113
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY--- 236
L+Y+H + HRD+K NIL + +K+ DFG ++ +A + ++ T Y
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLAR----VAFNDTPTAIFWTDYVAT 169
Query: 237 --WMAPEVILQTGHSFSA-----DIWSVGCTVIEMATGKP-------------------- 269
+ APE+ G FS DIWS+GC E+ TGKP
Sbjct: 170 RWYRAPEL---CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGT 226
Query: 270 PWSQQFQEV---AALFHIGTTKSHPPIPEHLSMEAKDFL-LKCLQK----EPYLRSTASE 321
P + V A ++ + + P+P D L L+ L++ +P R TA E
Sbjct: 227 PSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEE 286
Query: 322 LLQHPFVTG 330
L P+ G
Sbjct: 287 ALADPYFKG 295
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 5e-20
Identities = 53/143 (37%), Positives = 87/143 (60%), Gaps = 5/143 (3%)
Query: 75 GAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134
GAFG+VY+G ++ +L AVK V+ A+ +K E + + L K+ P IV
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVK-VVKKADMINKNMVHQVQAE-RDALALSKS---PFIVHL 69
Query: 135 LGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRD 194
+ + +++ +++E++ GG + SLL +G F E + Y ++ L L+YLH++GI+HRD
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRD 129
Query: 195 IKGANILVDNKGCIKLADFGASK 217
+K N+L+ N+G IKL DFG SK
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 5e-20
Identities = 74/274 (27%), Positives = 124/274 (45%), Gaps = 26/274 (9%)
Query: 69 GELVGCGAFGRVYMG-MNLDSGELL--AVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
G+++G G FG V G ++ D G L AVK + E I E E +K+
Sbjct: 4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVK-TMKLDIHTYSE-----IEEFLSEAACMKD 57
Query: 126 LTHPNIVRYLGTAREDDSLN------ILLEFVPGGSISSLL--GKFGSFPESV-IRMYTK 176
HPN+++ +G E SL ++L F+ G + S L + G PE + ++ K
Sbjct: 58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117
Query: 177 QLL---LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
++ LG+EYL +HRD+ N ++ + +ADFG SKK+ + K
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM 177
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFHIGTTKSHP 291
W+A E + ++ +D+W+ G T+ E+AT G+ P+ + E+ G
Sbjct: 178 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ- 236
Query: 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
PE E D + C + +P R T ++L +
Sbjct: 237 --PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 69/266 (25%), Positives = 115/266 (43%), Gaps = 33/266 (12%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
G +G G FG V +G G+ +AVK + + + E ++ L
Sbjct: 10 LGATIGKGEFGDVMLGDYR--GQKVAVKCL---------KDDSTAAQAFLAEASVMTTLR 58
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL------- 180
HPN+V+ LG + + L I+ E++ GS+ L G +VI Q L
Sbjct: 59 HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG---RAVIT--LAQQLGFALDVCE 113
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
G+EYL + +HRD+ N+LV K++DFG +K+ +G +K W AP
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE-ASQGQDSGKLPVK----WTAP 168
Query: 241 EVILQTGHSFSADIWSVGCTVIEM-ATGKPPWSQQ-FQEVAALFHIGTTKSHPPIPEHLS 298
E + + S +D+WS G + E+ + G+ P+ + ++V G PE
Sbjct: 169 EALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME---APEGCP 225
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQ 324
E + C + +P R T +L +
Sbjct: 226 PEVYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 9e-20
Identities = 77/268 (28%), Positives = 119/268 (44%), Gaps = 39/268 (14%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIR-ELEEEVKLLKNLTH 128
EL+G G FG V+ G L +AVK KE ++ + E ++LK H
Sbjct: 1 ELLGKGNFGEVFKG-TLKDKTPVAVK--------TCKEDLPQELKIKFLSEARILKQYDH 51
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL-------LG 181
PNIV+ +G + + I++E VPGG S L K + TKQL+ G
Sbjct: 52 PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD------ELKTKQLVKFALDAAAG 105
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAP 240
+ YL +HRD+ N LV +K++DFG S++ E I + +K P W AP
Sbjct: 106 MAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIKWTAP 163
Query: 241 EVILQTGHSFSADIWSVGCTVIE-MATGKPPW----SQQFQE-VAALFHIGTTKSHPPIP 294
E + +S +D+WS G + E + G P+ +QQ +E V + + P
Sbjct: 164 EALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC-------P 216
Query: 295 EHLSMEAKDFLLKCLQKEPYLRSTASEL 322
+ + + +C +P R SEL
Sbjct: 217 QKCPDDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 9e-20
Identities = 75/277 (27%), Positives = 133/277 (48%), Gaps = 20/277 (7%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
RK +L+G G FG V+ G+ + G+ + ++ +A + + +E+ + + + +L
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSI---KIPVAIKTIQDRSGRQTFQEITDHMLAMGSL 66
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYL 185
H IVR LG SL ++ + P GS+ + + S + + Q+ G+ YL
Sbjct: 67 DHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYL 125
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAK---SMKGTPY-WMAPE 241
++ ++HR++ NIL+ + +++ADFG V +L + K S TP WMA E
Sbjct: 126 EEHRMVHRNLAARNILLKSDSIVQIADFG----VADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 242 VILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFHIGTTKSHPPIPEHLSM 299
IL ++ +D+WS G TV EM + G P++ + EV L G + P I ++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQI---CTI 238
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPH 336
+ ++KC + +R T EL T +DP
Sbjct: 239 DVYMVMVKCWMIDENVRPTFKELANE--FTRMARDPP 273
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 9e-20
Identities = 69/264 (26%), Positives = 116/264 (43%), Gaps = 38/264 (14%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+G G FG V+ G+ + + A+K + K ++ ++EV+ LK L H
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRV-AIKIL--------KSDDLLKQQDFQKEVQALKRLRH 61
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPE-------SVIRMYTKQLLLG 181
+++ + + I+ E + GS+ + L PE S+I M Q+ G
Sbjct: 62 KHLISLFAVCSVGEPVYIITELMEKGSLLAFLRS----PEGQVLPVASLIDMAC-QVAEG 116
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAP 240
+ YL + +HRD+ NILV K+ADFG ++ + E ++ S K PY W AP
Sbjct: 117 MAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS---SDKKIPYKWTAP 173
Query: 241 EVILQTGHSFSADIWSVGCTVIEMAT-GKPPW-----SQQFQEVAALFHIGTTKSHPPIP 294
E S +D+WS G + EM T G+ P+ + + ++ A + + P P
Sbjct: 174 EAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM-------PCP 226
Query: 295 EHLSMEAKDFLLKCLQKEPYLRST 318
E +L+C EP R +
Sbjct: 227 AKCPQEIYKIMLECWAAEPEDRPS 250
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 56/205 (27%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V++G L+ ++ A+K + A S + EE +++ L+HP +
Sbjct: 12 IGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSE---------EDFIEEAQVMMKLSHPKL 61
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLEYLHKNGI 190
V+ G E + ++ EF+ G +S L + G F + + + G+ YL + +
Sbjct: 62 VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV 121
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY---WMAPEVILQTG 247
+HRD+ N LV +K++DFG ++ V++ + S GT + W +PEV +
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLD----DQYTSSTGTKFPVKWSSPEVFSFSK 177
Query: 248 HSFSADIWSVGCTVIEM-ATGKPPW 271
+S +D+WS G + E+ + GK P+
Sbjct: 178 YSSKSDVWSFGVLMWEVFSEGKTPY 202
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 1e-19
Identities = 74/263 (28%), Positives = 119/263 (45%), Gaps = 35/263 (13%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
GE++G G FG V G G+ +AVK + K + EE ++ L H
Sbjct: 11 GEIIGEGEFGAVLQGEYT--GQKVAVKNI----------KCDVTAQAFLEETAVMTKLHH 58
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRM--YTKQLLLGLEYLH 186
N+VR LG + L I++E + G++ + L G SVI++ ++ + G+EYL
Sbjct: 59 KNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN--GAKSMKGTPYWMAPEVIL 244
++HRD+ NILV G K++DFG LA + G + K W APE +
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFG-------LARVGSMGVDNSKLPVKWTAPEALK 170
Query: 245 QTGHSFSADIWSVGCTVIEM-ATGKPPWSQ-QFQEVAALFHIGTTKSHP---PIPEHLSM 299
S +D+WS G + E+ + G+ P+ + +EV G P P ++ M
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230
Query: 300 EAKDFLLKCLQKEPYLRSTASEL 322
+ C + EP R + +L
Sbjct: 231 TS------CWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 68/253 (26%), Positives = 116/253 (45%), Gaps = 22/253 (8%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V+MG +S ++ AVK + S ++ EE L+K L H +
Sbjct: 14 LGAGQFGEVWMGYYNNSTKV-AVKTLKPGTMS---------VQAFLEEANLMKTLQHDKL 63
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLEYLHK 187
VR +++ + I+ E++ GS+ L G P+ + ++ Q+ G+ Y+ +
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLI--DFSAQIAEGMAYIER 121
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
+HRD++ AN+LV K+ADFG + +V+E + K W APE I
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGS 180
Query: 248 HSFSADIWSVGCTVIEMAT-GKPPW-SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFL 305
+ +D+WS G + E+ T GK P+ +V + G P E+ E D +
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM---PRMENCPDELYDIM 237
Query: 306 LKCLQKEPYLRST 318
C +++ R T
Sbjct: 238 KTCWKEKAEERPT 250
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 67/264 (25%), Positives = 126/264 (47%), Gaps = 16/264 (6%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
++K +++G GAFG VY G+ + GE + + + A+ K +E+ +E ++ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN---KEILDEAYVMAS 65
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMY----TKQLLLG 181
+ +P++ R LG ++ ++ + +P G LL +++ Y Q+ G
Sbjct: 66 VDNPHVCRLLGICLTS-TVQLITQLMPFGC---LLDYVREHKDNIGSQYLLNWCVQIAKG 121
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
+ YL + ++HRD+ N+LV +K+ DFG +K + A+ K WMA E
Sbjct: 122 MNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 242 VILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFHIGTTKSHPPIPEHLSM 299
IL ++ +D+WS G TV E+ T G P+ E++++ G PPI ++
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPI---CTI 238
Query: 300 EAKDFLLKCLQKEPYLRSTASELL 323
+ ++KC + R EL+
Sbjct: 239 DVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-19
Identities = 70/279 (25%), Positives = 124/279 (44%), Gaps = 29/279 (10%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
G+ +G G FG+V V A + + + +R+L E LLK + H
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTV--AVKMLKENASSSELRDLLSEFNLLKQVNH 62
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLL-----------GKFGSFPESV------- 170
P++++ G +D L +++E+ GS+ S L G G+ S
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 171 ------IRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224
+ + Q+ G++YL + ++HRD+ N+LV +K++DFG S+ V E +
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDS 182
Query: 225 INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFH 283
+ WMA E + ++ +D+WS G + E+ T G P+ E LF+
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE--RLFN 240
Query: 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASEL 322
+ T PE+ S E + +L C ++EP R T +++
Sbjct: 241 LLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 68/259 (26%), Positives = 124/259 (47%), Gaps = 25/259 (9%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V G +A+K +I S S++ E EE K++ L+H +
Sbjct: 12 LGTGQFGVVKYG-KWRGQYDVAIK--MIKEGSMSED-------EFIEEAKVMMKLSHEKL 61
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESV--IRMYTKQLLLGLEYLHKNG 189
V+ G + + I+ E++ G + + L + G + + M K + G+ YL
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEM-CKDVCEGMAYLESKQ 120
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY---WMAPEVILQT 246
+HRD+ N LVD++GC+K++DFG S+ V++ + S G+ + W PEV+L +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD----DEYTSSVGSKFPVRWSPPEVLLYS 176
Query: 247 GHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME-AKDF 304
S +D+W+ G + E+ + GK P+ ++F + + ++ HL+ E
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPY-ERFNNSETVEKV--SQGLRLYRPHLASEKVYAI 233
Query: 305 LLKCLQKEPYLRSTASELL 323
+ C ++ R T +LL
Sbjct: 234 MYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 9e-19
Identities = 75/307 (24%), Positives = 130/307 (42%), Gaps = 71/307 (23%)
Query: 80 VYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139
VY+ + +G L+ V+ + + ++E H++ L+ EV L HPNI+
Sbjct: 16 VYLARHTPTGTLVTVR--ITDLENCTEE----HLKALQNEVVLSHFFRHPNIMTSWTVFT 69
Query: 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG----LEYLHKNGIMHRDI 195
L ++ F+ GS +SLL + FPE + +L G L YLH+NG +HR+I
Sbjct: 70 TGSWLWVISPFMAYGSANSLLKTY--FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNI 127
Query: 196 KGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY---------WMAPEVILQ- 245
K ++IL+ G + L+ +V NG K+ + W++PE++ Q
Sbjct: 128 KASHILISGDGLVSLSGLSHLYSLVR----NGQKAKVVYDFPQFSTSVLPWLSPELLRQD 183
Query: 246 -TGHSFSADIWSVGCTVIEMATGKPPWSQQ------FQEVAALFH--------------- 283
G++ +DI+SVG T E+ATG+ P+ Q++ +
Sbjct: 184 LYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRM 243
Query: 284 -----------------------IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTAS 320
+ + + P + S ++ + CLQ++P R +AS
Sbjct: 244 KNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSAS 303
Query: 321 ELLQHPF 327
LL H F
Sbjct: 304 SLLSHAF 310
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.6 bits (224), Expect = 9e-19
Identities = 80/281 (28%), Positives = 131/281 (46%), Gaps = 53/281 (18%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V++ + + E K + +EK+Q I EV +++ L H NI
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRG-LKEREKSQLVI-----EVNVMRELKHKNI 74
Query: 132 VRYLGT--AREDDSLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYL 185
VRY+ + + L IL+EF G +S + K FG E I T+QLL L Y
Sbjct: 75 VRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 186 H--KNG-----IMHRDIKGANILV-----------------DNKGCIKLADFGASKKVVE 221
H K+G ++HRD+K NI + + + K+ DFG SK +
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNI-- 192
Query: 222 LATINGAKSMKGTPYWMAPEVILQTGHSF--SADIWSVGCTVIEMATGKPPW--SQQFQE 277
+ A S GTPY+ +PE++L S+ +D+W++GC + E+ +GK P+ + F +
Sbjct: 193 -GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251
Query: 278 VAALFHIGTTKSHPPIP-----EHLSMEAKDFLLKCLQKEP 313
+ I K P +P + L++ K+ L ++ P
Sbjct: 252 L-----ISELKRGPDLPIKGKSKELNILIKNLLNLSAKERP 287
|
Length = 1021 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 1e-18
Identities = 64/263 (24%), Positives = 122/263 (46%), Gaps = 14/263 (5%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++ +++G GAFG VY G+ + GE + + + N + K E +E ++ ++
Sbjct: 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANV---EFMDEALIMASM 66
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYL 185
HP++VR LG ++ ++ + +P G + + + + ++ + Q+ G+ YL
Sbjct: 67 DHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL 125
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
+ ++HRD+ N+LV + +K+ DFG ++ + A K WMA E I
Sbjct: 126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 246 TGHSFSADIWSVGCTVIEMAT--GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
+ +D+WS G T+ E+ T GKP +E+ L G PPI +++
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPI---CTIDVYM 242
Query: 304 FLLKC----LQKEPYLRSTASEL 322
++KC P + A+E
Sbjct: 243 VMVKCWMIDADSRPKFKELAAEF 265
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 2e-18
Identities = 66/263 (25%), Positives = 120/263 (45%), Gaps = 16/263 (6%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+K +++G GAFG VY G+ + GE + + + + K +E+ +E ++ +
Sbjct: 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN---KEILDEAYVMAGV 66
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGL 182
P + R LG ++ ++ + +P G + + + GS + + Q+ G+
Sbjct: 67 GSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGS---QDLLNWCVQIAKGM 122
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
YL + ++HRD+ N+LV + +K+ DFG ++ + T A K WMA E
Sbjct: 123 SYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALES 182
Query: 243 ILQTGHSFSADIWSVGCTVIEMAT--GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300
IL + +D+WS G TV E+ T KP +E+ L G PPI +++
Sbjct: 183 ILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPI---CTID 239
Query: 301 AKDFLLKCLQKEPYLRSTASELL 323
++KC + R EL+
Sbjct: 240 VYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-18
Identities = 81/316 (25%), Positives = 135/316 (42%), Gaps = 80/316 (25%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G GA+G V N ++ E +A+K++ +A + A R L E +KLL++L H N+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKI----ANAFDNRIDAK-RTLRE-IKLLRHLDHENV 66
Query: 132 VR----------------YLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYT 175
+ Y+ D L+ ++ S +L + + +
Sbjct: 67 IAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIR-----SSQTL-------SDDHCQYFL 114
Query: 176 KQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP 235
QLL GL+Y+H ++HRD+K +N+L++ +K+ DFG LA K T
Sbjct: 115 YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-------LARTTSEKGDFMTE 167
Query: 236 Y-----WMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKP-----PWSQQFQEVAALFHI 284
Y + APE++L + ++ + D+WSVGC E+ KP + Q + + L +
Sbjct: 168 YVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL--L 225
Query: 285 GT-----------------TKSHPPIPE--------HLSMEAKDFLLKCLQKEPYLRSTA 319
G+ +S P P H + A D L K L +P R T
Sbjct: 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV 285
Query: 320 SELLQHPFVTGKYQDP 335
E L HP++ + DP
Sbjct: 286 EEALAHPYLASLH-DP 300
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 68/282 (24%), Positives = 116/282 (41%), Gaps = 34/282 (12%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIR-ELEEEVKLLKNLTHPN 130
+G GAFGRV+ LL + + A KE+ A ++ + + E L+ HPN
Sbjct: 13 IGQGAFGRVFQARAPG---LLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-------SFPESVIRMYT-------- 175
IV+ LG + +L E++ G ++ L S S R
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 176 -------KQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228
KQ+ G+ YL + +HRD+ N LV +K+ADFG S+ + +
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATG--KPPWSQQFQEVAALFHIGT 286
++ WM PE I ++ +D+W+ G + E+ + +P + +EV G
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN 249
Query: 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASEL---LQH 325
S P++ +E + + C K P R + + + LQ
Sbjct: 250 VLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 67/260 (25%), Positives = 116/260 (44%), Gaps = 13/260 (5%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
E++G G FG V G G+ +++ +A + T+ R+ E ++ HP
Sbjct: 10 EVIGAGEFGEVCRGRLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 65
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGLEYLHKN 188
NI+ G + + I+ EF+ G++ S L G F + + + G++YL +
Sbjct: 66 NIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELA---TINGAKSMKGTPYWMAPEVILQ 245
+HRD+ NILV++ K++DFG S+ + + T + K W APE I
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 246 TGHSFSADIWSVGCTVIE-MATG-KPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
+ ++D+WS G + E M+ G +P W Q+V + I PP P
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--INAIEQDYRLPP-PMDCPTALHQ 242
Query: 304 FLLKCLQKEPYLRSTASELL 323
+L C QK+ R +++
Sbjct: 243 LMLDCWQKDRNARPKFGQIV 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-18
Identities = 80/321 (24%), Positives = 137/321 (42%), Gaps = 68/321 (21%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R+++ + +G GA G V + G +AVK++ + + Q H + E+ LLK
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKL------SRPFQNQTHAKRAYRELVLLK 75
Query: 125 NLTHPNIVRYLG------TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQL 178
+ H NI+ L + E + +++E + + + S + +Y Q+
Sbjct: 76 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL-LY--QM 132
Query: 179 LLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP--- 235
L G+++LH GI+HRD+K +NI+V + +K+ DFG ++ + TP
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------TACTNFMMTPYVV 184
Query: 236 --YWMAPEVILQTGHSFSADIWSVGCTVIEMATGK---------PPWSQ----------- 273
Y+ APEVIL G+ + DIWSVGC + E+ G W++
Sbjct: 185 TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAE 244
Query: 274 ---QFQEVAALFHIGTTKSH-------------PPIPEHLSM---EAKDFLLKCLQKEPY 314
+ Q + + P E + +A+D L K L +P
Sbjct: 245 FMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPD 304
Query: 315 LRSTASELLQHPFVTGKYQDP 335
R + E L+HP++T Y DP
Sbjct: 305 KRISVDEALRHPYITVWY-DP 324
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 79/295 (26%), Positives = 127/295 (43%), Gaps = 30/295 (10%)
Query: 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAH 112
LP K + R G+ +G G FG+V M + + K V +A + T
Sbjct: 1 LPADPKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKD 60
Query: 113 IRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL------GKFGS 165
+ +L E++++K + H NI+ LG +D L +L+E+ G++ L G S
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120
Query: 166 F-----PESVIRMY-----TKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215
F PE + Q+ G+EYL +HRD+ N+LV +K+ADFG
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGL 180
Query: 216 SKKVVEL----ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT--GKP 269
++ V + T NG +K WMAPE + ++ +D+WS G + E+ T G P
Sbjct: 181 ARDVHNIDYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
Query: 270 PWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+E+ L G P H E + +C P R T +L++
Sbjct: 237 YPGIPVEELFKLLKEGHRMDKPANCTH---ELYMIMRECWHAVPSQRPTFKQLVE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 76/296 (25%), Positives = 129/296 (43%), Gaps = 32/296 (10%)
Query: 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAH 112
LP + + + G+ +G G FG+V M L + + V +A + T+
Sbjct: 4 LPEDPRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKD 63
Query: 113 IRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL------GKFGS 165
+ +L E++++K + H NI+ LG +D L +++E+ G++ L G S
Sbjct: 64 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 123
Query: 166 F-----PESVIRMY-----TKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215
+ P+ + T Q+ G+EYL +HRD+ N+LV +K+ADFG
Sbjct: 124 YDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 183
Query: 216 SKKVVEL----ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT--GKP 269
++ V + T NG +K WMAPE + ++ +D+WS G + E+ T G P
Sbjct: 184 ARDVNNIDYYKKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
Query: 270 PWSQQFQEVAALFHIGTTKSHPP-IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+E+ L G P L M +D C P R T +L++
Sbjct: 240 YPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRD----CWHAIPSHRPTFKQLVE 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 8e-18
Identities = 59/211 (27%), Positives = 112/211 (53%), Gaps = 12/211 (5%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V ++G++ A K++ K+K+ + LE+E+ L+ + P I
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKL---DKKRLKKKSGEKMALLEKEI--LEKVNSPFI 55
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLL---GKFGSFPESVIRMYTKQLLLGLEYLHKN 188
V L +++ + GG + + G+ G E VI Y+ Q+ G+ +LH
Sbjct: 56 VNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVI-HYSAQITCGILHLHSM 114
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGH 248
I++RD+K N+L+D++G +L+D G + ++ + TI GT +MAPE++ + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTIT---QRAGTNGYMAPEILKEEPY 171
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQEVA 279
S+ D +++GC++ EM G+ P+ ++VA
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 9e-18
Identities = 68/255 (26%), Positives = 117/255 (45%), Gaps = 23/255 (9%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+ +G G FG V+MG + +A+K + K+ + + E L+K L HP
Sbjct: 12 KKLGAGQFGEVWMGY-YNGHTKVAIKSL--------KQGSMS-PEAFLAEANLMKQLQHP 61
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLEYL 185
+VR L + + I+ E++ GS+ L G + + +I M Q+ G+ ++
Sbjct: 62 RLVR-LYAVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINK-LIDM-AAQIAEGMAFI 118
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
+ +HRD++ ANILV C K+ADFG + +++E + K W APE I
Sbjct: 119 ERKNYIHRDLRAANILVSETLCCKIADFGLA-RLIEDNEYTAREGAKFPIKWTAPEAINY 177
Query: 246 TGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKD 303
+ +D+WS G + E+ T G+ P+ EV G P P++ E +
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM---PRPDNCPEELYE 234
Query: 304 FLLKCLQKEPYLRST 318
+ C +++P R T
Sbjct: 235 LMRLCWKEKPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 71/254 (27%), Positives = 114/254 (44%), Gaps = 25/254 (9%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V+MG +V I +A + +E +++K L H +
Sbjct: 14 LGQGCFGEVWMGT------WNGTTRVAIKTLKPGTMSPEAFL----QEAQVMKKLRHEKL 63
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLEYLHK 187
V+ E+ + I+ E++ GS+ L GK+ P+ V Q+ G+ Y+ +
Sbjct: 64 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DMAAQIASGMAYVER 120
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
+HRD++ ANILV K+ADFG + +++E + K W APE L
Sbjct: 121 MNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 248 HSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVAALFHIGTTKSHPP-IPEHLSMEAKDF 304
+ +D+WS G + E+ T G+ P+ +EV G PP PE L D
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESL----HDL 235
Query: 305 LLKCLQKEPYLRST 318
+ +C +KEP R T
Sbjct: 236 MCQCWRKEPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 1e-17
Identities = 75/264 (28%), Positives = 121/264 (45%), Gaps = 27/264 (10%)
Query: 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEE 119
DA I+ K ++G G FG V G +L +++ +A + T+ R+ E
Sbjct: 2 DASCIKIEK--VIGAGEFGEVCSG----RLKLPGKREIPVAIKTLKAGYTEKQRRDFLSE 55
Query: 120 VKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRM--YTK 176
++ HPNI+ G + + I+ E++ GS+ + L K G F +VI++ +
Sbjct: 56 ASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQF--TVIQLVGMLR 113
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE-----LATINGAKSM 231
+ G++YL G +HRD+ NILV++ K++DFG S +V+E T G K
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLS-RVLEDDPEAAYTTRGGK-- 170
Query: 232 KGTPY-WMAPEVILQTGHSFSADIWSVGCTVIE-MATG-KPPWSQQFQEVAALFHIGTTK 288
P W APE I + ++D+WS G + E M+ G +P W Q+V G
Sbjct: 171 --IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY-- 226
Query: 289 SHPPIPEHLSMEAKDFLLKCLQKE 312
P P +L C QK+
Sbjct: 227 -RLPAPMDCPAALHQLMLDCWQKD 249
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 83/279 (29%), Positives = 120/279 (43%), Gaps = 43/279 (15%)
Query: 72 VGCGAFGRVYMG----MNLDSGEL-LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+G GAFG VY G + D+ EL +AVK + E+ ++ + E ++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVK----TLPESCSEQDES---DFLMEALIMSKF 66
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPE--SVIRMYTKQLL----- 179
H NIVR +G + E ILLE + GG + S L + PE S + M K LL
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTM--KDLLFCARD 124
Query: 180 --LGLEYLHKNGIMHRDIKGANILVDNKG---CIKLADFGASKKV--VELATINGAKSMK 232
G +YL +N +HRDI N L+ KG K+ADFG ++ + G ++M
Sbjct: 125 VAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGG-RAM- 182
Query: 233 GTPY-WMAPEVILQTGHSFSADIWSVGCTVIE-MATGKPPW-SQQFQEVAALFHIGTTKS 289
P WM PE L + D+WS G + E + G P+ + QEV G
Sbjct: 183 -LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241
Query: 290 HP---PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
P P P + M C Q P R + +L+
Sbjct: 242 PPKGCPGPVYRIMT------DCWQHTPEDRPNFATILER 274
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 79/300 (26%), Positives = 132/300 (44%), Gaps = 40/300 (13%)
Query: 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVYMG--MNLDSGELLAVKQVLIAANSASKEKTQ 110
LP + + P R G+ +G G FG+V M + LD + V +V A + T+
Sbjct: 7 LPEDPRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKV--AVKMLKSDATE 64
Query: 111 AHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL--------- 160
+ +L E++++K + H NI+ LG +D L +++E+ G++ L
Sbjct: 65 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGME 124
Query: 161 ---------GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211
+ SF + V Y Q+ G+EYL +HRD+ N+LV +K+A
Sbjct: 125 YCYNPTQVPEEQLSFKDLVSCAY--QVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 182
Query: 212 DFGASKKVVEL----ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT- 266
DFG ++ + + T NG +K WMAPE + ++ +D+WS G + E+ T
Sbjct: 183 DFGLARDIHHIDYYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTL 238
Query: 267 -GKPPWSQQFQEVAALFHIGTTKSHPPIPEH-LSMEAKDFLLKCLQKEPYLRSTASELLQ 324
G P +E+ L G P + L M +D C P R T +L++
Sbjct: 239 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRD----CWHAVPSQRPTFKQLVE 294
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 25/227 (11%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAV-------KQVLIAANSASKEKTQAHIR 114
P + R E +G G FG V++ E L + VL+A + T+
Sbjct: 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARN 62
Query: 115 ELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGG---------SISSLLGKFGS 165
+ +E+K++ L +PNI+R LG DD L ++ E++ G I S +
Sbjct: 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANN 122
Query: 166 FP----ESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV- 220
P +++ M Q+ G++YL +HRD+ N LV N IK+ADFG S+ +
Sbjct: 123 IPSVSIANLLYMAV-QIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181
Query: 221 -ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT 266
+ I G + WMA E IL + ++D+W+ G T+ EM T
Sbjct: 182 GDYYRIQGRAVLP--IRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 69/270 (25%), Positives = 111/270 (41%), Gaps = 29/270 (10%)
Query: 72 VGCGAFGRVYMGM--NLDSGEL---LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+G G+FG VY G+ + GE +A+K V A+ E E ++K
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRE-------RIEFLNEASVMKEF 66
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL----------GKFGSFPESVIRMYTK 176
++VR LG +++E + G + S L G
Sbjct: 67 NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAA 126
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGT-P 235
++ G+ YL +HRD+ N +V +K+ DFG ++ + E T K KG P
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE--TDYYRKGGKGLLP 184
Query: 236 Y-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPI 293
WMAPE + + +D+WS G + EMAT + P+ E F I H +
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GGHLDL 242
Query: 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELL 323
PE+ + + + C Q P +R T E++
Sbjct: 243 PENCPDKLLELMRMCWQYNPKMRPTFLEIV 272
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 79/310 (25%), Positives = 138/310 (44%), Gaps = 48/310 (15%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDS--GELLAVKQVLIAANSASKE-KTQAHIRELEEEVK 121
R+ + +G GA+G V N ++ E +A+K++ N SK+ + +REL K
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKI---TNVFSKKILAKRALREL----K 53
Query: 122 LLKNL-THPNIVRYLGT-AREDDSLN--ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ 177
LL++ H NI + N L E + + ++ ++ + + Q
Sbjct: 54 LLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQ 113
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG---T 234
+L GL+Y+H ++HRD+K N+LV+ +K+ DFG ++ E N M T
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF-MTEYVAT 172
Query: 235 PYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKP-----PWSQQFQEV---------A 279
++ APE++L ++ + D+WSVGC + E+ KP + Q ++
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232
Query: 280 ALFHIGTTKSH---------PPIP-----EHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
L IG+ K+ P P + + A D L K L +P R + E L+H
Sbjct: 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292
Query: 326 PFVTGKYQDP 335
P++ + DP
Sbjct: 293 PYLA-IWHDP 301
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 84.0 bits (207), Expect = 2e-17
Identities = 83/323 (25%), Positives = 138/323 (42%), Gaps = 66/323 (20%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R++ + +G GA G V + +A+K++ + + Q H + E+ L+K
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL------SRPFQNQTHAKRAYRELVLMK 71
Query: 125 NLTHPNIVRYLG------TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQL 178
+ H NI+ L + E + +++E + + + S + +Y Q+
Sbjct: 72 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL-LY--QM 128
Query: 179 LLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG----T 234
L G+++LH GI+HRD+K +NI+V + +K+ DFG LA G M T
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-------LARTAGTSFMMTPYVVT 181
Query: 235 PYWMAPEVILQTGHSFSADIWSVGCTVIEMATGK---------PPWSQQFQEVAALFHIG 285
Y+ APEVIL G+ + DIWSVGC + EM K W++ +++
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 286 TTKSHPPI-------------------PEHL-----------SMEAKDFLLKCLQKEPYL 315
K P + P+ L + +A+D L K L +P
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 316 RSTASELLQHPFVTGKYQDPHPV 338
R + E LQHP++ Y DP V
Sbjct: 302 RISVDEALQHPYINVWY-DPAEV 323
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 3e-17
Identities = 70/245 (28%), Positives = 109/245 (44%), Gaps = 16/245 (6%)
Query: 69 GELVGCGAFGRVYMGM--NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
GEL G G FG V GM S + +AVK I N + + EL E +++ L
Sbjct: 1 GEL-GSGNFGTVKKGMYKMKKSEKTVAVK---ILKNDNNDPALK---DELLREANVMQQL 53
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
+P IVR +G E +S +++E G ++ L K E I Q+ +G++YL
Sbjct: 54 DNPYIVRMIGIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAPEVILQ 245
+ +HRD+ N+L+ + K++DFG SK + AK+ P W APE +
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172
Query: 246 TGHSFSADIWSVGCTVIE-MATGKPPW-SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
S +D+WS G + E + G+ P+ + EV + G P E D
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQ---RCPPEMYD 229
Query: 304 FLLKC 308
+ C
Sbjct: 230 LMKLC 234
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 72/259 (27%), Positives = 119/259 (45%), Gaps = 24/259 (9%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V+MG + +AVK + + S E EE +++K L H +
Sbjct: 14 LGNGQFGEVWMGT-WNGNTKVAVKT--LKPGTMSPES-------FLEEAQIMKKLRHDKL 63
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLEYLHK 187
V+ E+ + I+ E++ GS+ L G+ P V Q+ G+ Y+ +
Sbjct: 64 VQLYAVVSEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DMAAQVAAGMAYIER 120
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
+HRD++ ANILV + K+ADFG + +++E + K W APE L
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 248 HSFSADIWSVGCTVIEMAT-GKPPW-SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFL 305
+ +D+WS G + E+ T G+ P+ +EV G P P+ + + +
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---PCPQDCPISLHELM 236
Query: 306 LKCLQKEPYLRSTASELLQ 324
L+C +K+P R T E LQ
Sbjct: 237 LQCWKKDPEERPTF-EYLQ 254
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 69/267 (25%), Positives = 114/267 (42%), Gaps = 20/267 (7%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
+G G FG V++ G + L+ + K K + E E+ + + L+H N
Sbjct: 12 TLGRGEFGEVFLAKA--KGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKN 69
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLL--GKFGSFPESVIRMYTKQLL-------LG 181
+VR LG RE + ++LE+ G + L K + TKQ + LG
Sbjct: 70 VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV--ELATINGAKSMKGTPY-WM 238
+++L +HRD+ N LV ++ +K++ SK V E + A P W+
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNAL----IPLRWL 185
Query: 239 APEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297
APE + + S +D+WS G + E+ T G+ P+ E L + K P+PE
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-EVLNRLQAGKLELPVPEGC 244
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQ 324
+ +C P R + SEL+
Sbjct: 245 PSRLYKLMTRCWAVNPKDRPSFSELVS 271
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 65/252 (25%), Positives = 115/252 (45%), Gaps = 17/252 (6%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
K +++G G FG V+ G+ G K+V +A + T+ ++ E ++ +
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGR----KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS 64
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLE 183
H NI+R G + I+ E++ G++ L G+F S+ ++ M + + G++
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY--QLVGML-RGIAAGMK 121
Query: 184 YLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAPEV 242
YL +HRD+ NILV++ K++DFG S+ + + S P W APE
Sbjct: 122 YLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 243 ILQTGHSFSADIWSVGCTVIE-MATG-KPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300
I + ++D+WS G + E M+ G +P W EV + G P P
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDCPSA 238
Query: 301 AKDFLLKCLQKE 312
+L+C Q++
Sbjct: 239 VYQLMLQCWQQD 250
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 5e-17
Identities = 77/302 (25%), Positives = 129/302 (42%), Gaps = 44/302 (14%)
Query: 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVY----MGMNLDSGELLAVKQVLIAANSASKEK 108
LP K + P R G+ +G G FG+V G++ + + V +A
Sbjct: 1 LPLDPKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPD----QTVTVAVKMLKDNA 56
Query: 109 TQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL------- 160
T + +L E++L+K + H NI+ LG ++ L +++E+ G++ L
Sbjct: 57 TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPG 116
Query: 161 -----------GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIK 209
+ SF + V Y Q+ G+EYL +HRD+ N+LV +K
Sbjct: 117 PDYTFDITKVPEEQLSFKDLVSCAY--QVARGMEYLESRRCIHRDLAARNVLVTEDNVMK 174
Query: 210 LADFGASKKVVEL----ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMA 265
+ADFG ++ V ++ T NG +K WMAPE + ++ +D+WS G + E+
Sbjct: 175 IADFGLARGVHDIDYYKKTSNGRLPVK----WMAPEALFDRVYTHQSDVWSFGILMWEIF 230
Query: 266 T--GKPPWSQQFQEVAALFHIGTTKSHPP-IPEHLSMEAKDFLLKCLQKEPYLRSTASEL 322
T G P +E+ L G P L M ++ C P R T +L
Sbjct: 231 TLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRE----CWHAVPTQRPTFKQL 286
Query: 323 LQ 324
++
Sbjct: 287 VE 288
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 8e-17
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 22/213 (10%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIR-ELEEEVKLLKNLTH 128
E +G GAFG+VY G E L+ V I KE + ++ E +E +L+ +L H
Sbjct: 11 EELGEGAFGKVYKGELTGPNERLSATSVAI---KTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLL--------GKFGSFPESVIRMYTK---- 176
PNIV LG ++ +L E++ G + L S E+V
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 177 ----QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK 232
Q+ G+EYL + +HRD+ N LV +K++DFG S+ + A +S
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS-ADYYRVQSKS 186
Query: 233 GTPY-WMAPEVILQTGHSFSADIWSVGCTVIEM 264
P WM PE IL + +DIWS G + E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 68/266 (25%), Positives = 121/266 (45%), Gaps = 37/266 (13%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V+ G+ ++ + AVK + + + + E +++K L HP +
Sbjct: 14 LGAGQFGEVWEGLWNNTTPV-AVKT--LKPGTMDPK-------DFLAEAQIMKKLRHPKL 63
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLEYLHK 187
++ ++ + I+ E + GS+ L G+ P+ +I M Q+ G+ YL
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQ-LIDM-AAQVASGMAYLEA 121
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY---WMAPEVIL 244
+HRD+ N+LV K+ADFG ++ + E + ++ +G + W APE L
Sbjct: 122 QNYIHRDLAARNVLVGENNICKVADFGLARVIKE----DIYEAREGAKFPIKWTAPEAAL 177
Query: 245 QTGHSFSADIWSVGCTVIEMAT-GKPPWS-----QQFQEVAALFHIGTTKSHPPIPEHLS 298
S +D+WS G + E+ T G+ P+ + Q+V + + P P
Sbjct: 178 YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRM-------PCPPGCP 230
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQ 324
E D +L C +++P R T E LQ
Sbjct: 231 KELYDIMLDCWKEDPDDRPTF-ETLQ 255
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-16
Identities = 51/172 (29%), Positives = 80/172 (46%), Gaps = 12/172 (6%)
Query: 109 TQAHIR-ELEEEVKLLKNLTHPNIVRYLGTAR-EDDSLNILLEFVPGGSISSLLGKFGSF 166
+ H R E L L HPNIV L + L + E+VPG ++ +L G+
Sbjct: 17 EEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGAL 76
Query: 167 P-ESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG---CIKLADFGASK----- 217
P R+ Q+L L H GI+HRD+K NI+V G K+ DFG
Sbjct: 77 PAGETGRLML-QVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGV 135
Query: 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKP 269
+ ++AT+ + GTP + APE + + ++D+++ G +E TG+
Sbjct: 136 RDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 83/320 (25%), Positives = 134/320 (41%), Gaps = 66/320 (20%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R++ + +G GA G V + +A+K++ + + Q H + E+ L+K
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL------SRPFQNQTHAKRAYRELVLMK 78
Query: 125 NLTHPNIVRYLGTAREDDSLN------ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQL 178
+ H NI+ L SL I++E + + + S + +Y Q+
Sbjct: 79 CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL-LY--QM 135
Query: 179 LLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG----T 234
L G+++LH GI+HRD+K +NI+V + +K+ DFG LA G M T
Sbjct: 136 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-------LARTAGTSFMMTPYVVT 188
Query: 235 PYWMAPEVILQTGHSFSADIWSVGCTVIEMATGK---------PPWSQQFQEVAALFHIG 285
Y+ APEVIL G+ + DIWSVGC + EM G W++ +++
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248
Query: 286 TTKSHPPI---------------------------PEHLSM---EAKDFLLKCLQKEPYL 315
K P + EH + +A+D L K L +
Sbjct: 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 308
Query: 316 RSTASELLQHPFVTGKYQDP 335
R + E LQHP++ Y DP
Sbjct: 309 RISVDEALQHPYINVWY-DP 327
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-16
Identities = 51/174 (29%), Positives = 82/174 (47%), Gaps = 11/174 (6%)
Query: 95 KQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGG 154
+ V+I A T+AHI L+ + HP+I++ GT + L+
Sbjct: 118 EHVVIKAGQRGGTATEAHI---------LRAINHPSIIQLKGTFTYN-KFTCLILPRYKT 167
Query: 155 SISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214
+ L + I + +L ++YLH+N I+HRDIK NI +++ G + L DFG
Sbjct: 168 DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG 227
Query: 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGK 268
A+ V++ N GT APE++ + + + DIWS G + EMAT
Sbjct: 228 AACFPVDI-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 68/271 (25%), Positives = 116/271 (42%), Gaps = 35/271 (12%)
Query: 70 ELVGCGAFGRVYMGM----NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
E +G AFG++Y G +D +L+A+K L N+ E ++E L+
Sbjct: 11 EELGECAFGKIYKGHLYLPGMDHAQLVAIK-TLKDINNPQ------QWGEFQQEASLMAE 63
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-------------GKFGSFPESV-- 170
L HPNIV LG ++ + +L E++ G + L + G+ S+
Sbjct: 64 LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123
Query: 171 --IRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228
Q+ G+EYL + +H+D+ NIL+ + +K++D G S+++ A
Sbjct: 124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS-ADYYRV 182
Query: 229 KSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMATG--KPPWSQQFQEVAALFHIG 285
+ P WM PE I+ S +DIWS G + E+ + +P + QEV +
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR-- 240
Query: 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLR 316
+ P E + +C Q+ P R
Sbjct: 241 -KRQLLPCSEDCPPRMYSLMTECWQEGPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-16
Identities = 64/254 (25%), Positives = 111/254 (43%), Gaps = 25/254 (9%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V+M + +AVK + + S E ++K L H +
Sbjct: 14 LGAGQFGEVWMA-TYNKHTKVAVKTMKPGSMSVEA---------FLAEANVMKTLQHDKL 63
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLEYLHK 187
V+ L + + I+ EF+ GS+ L G P+ + ++ Q+ G+ ++ +
Sbjct: 64 VK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQ 120
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
+HRD++ ANILV K+ADFG + +V+E + K W APE I
Sbjct: 121 RNYIHRDLRAANILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGS 179
Query: 248 HSFSADIWSVGCTVIEMAT-GKPPWS--QQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
+ +D+WS G ++E+ T G+ P+ + + AL PE L +
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELY----NI 235
Query: 305 LLKCLQKEPYLRST 318
+++C + P R T
Sbjct: 236 MMRCWKNRPEERPT 249
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 66/274 (24%), Positives = 119/274 (43%), Gaps = 28/274 (10%)
Query: 69 GELVGCGAFGRV---YMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
G ++G G FG V + S + +AVK + S+S I E E +K
Sbjct: 4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD------IEEFLREAACMKE 57
Query: 126 LTHPNIVRYLGTA---REDDSLNI---LLEFVPGGSISS--LLGKFGSFPESVIRMYTKQ 177
HPN+++ +G + R L I +L F+ G + + L+ + G P ++ +
Sbjct: 58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVR 117
Query: 178 LLL----GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
++ G+EYL +HRD+ N +++ + +ADFG SKK+ + K
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFHIGTTKSHP 291
W+A E + ++ +D+W+ G T+ E+ T G+ P++ + E+ G P
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP 237
Query: 292 P-IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
P E + + + +C EP R + L
Sbjct: 238 PDCLE----DVYELMCQCWSPEPKCRPSFQHLRD 267
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 58/224 (25%), Positives = 108/224 (48%), Gaps = 27/224 (12%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLI--AANSASKEKTQAHIRELEEEVKL 122
R +L+ G FGR++ G+ L + ++V + + AS + + L +E L
Sbjct: 7 RVTLSDLLQEGTFGRIFYGI-LIDEKPGKEEEVFVKTVKDHAS----EIQVTLLLQESCL 61
Query: 123 LKNLTHPNIVRYLGTARED-DSLNILLEFVPGGSISSLLGKFGSFPESVIR-MYTKQLLL 180
L L+H NI+ L ED + +L ++ G++ L + + + + T+QL+
Sbjct: 62 LYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVH 121
Query: 181 -------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE-----LATINGA 228
G+ YLHK G++H+DI N ++D + +K+ D S+ + L N
Sbjct: 122 MAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD-NEN 180
Query: 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPW 271
+ +K WMA E ++ +S ++D+WS G + E+ T G+ P+
Sbjct: 181 RPVK----WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 67/253 (26%), Positives = 113/253 (44%), Gaps = 23/253 (9%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G FG V+MG + +A+K + + E +E +++K L H +
Sbjct: 14 LGQGCFGEVWMG-TWNGTTKVAIKT--LKPGTMMPEA-------FLQEAQIMKKLRHDKL 63
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLEYLHK 187
V E+ + I+ EF+ GS+ L GK+ P+ V Q+ G+ Y+ +
Sbjct: 64 VPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DMAAQIADGMAYIER 120
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
+HRD++ ANILV + K+ADFG + +++E + K W APE L
Sbjct: 121 MNYIHRDLRAANILVGDNLVCKIADFGLA-RLIEDNEYTARQGAKFPIKWTAPEAALYGR 179
Query: 248 HSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVAALFHIGTTKSHPPIPEHLSMEAKDFL 305
+ +D+WS G + E+ T G+ P+ +EV G P P+ + +
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRM---PCPQGCPESLHELM 236
Query: 306 LKCLQKEPYLRST 318
C +K+P R T
Sbjct: 237 KLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 3e-15
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 28/220 (12%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGEL--LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+G VG G +G VY D + A+KQ+ S S + E+ LL+
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR----------EIALLRE 54
Query: 126 LTHPNIV--RYLGTAREDDSLNILLEF--------VPGGSISSLLGKFGSFPESVIRMYT 175
L HPN++ + + + D + +L ++ + S K P S+++
Sbjct: 55 LKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL 114
Query: 176 KQLLLGLEYLHKNGIMHRDIKGANILV----DNKGCIKLADFGASKKV-VELATINGAKS 230
Q+L G+ YLH N ++HRD+K ANILV +G +K+AD G ++ L +
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 231 MKGTPYWMAPEVILQTGHSFSA-DIWSVGCTVIEMATGKP 269
+ T ++ APE++L H A DIW++GC E+ T +P
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 77/312 (24%), Positives = 132/312 (42%), Gaps = 51/312 (16%)
Query: 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAV---------KQVLIAANSASKEKTQ 110
P E +G G FG V++ ++ +L + + +L+A + +
Sbjct: 1 KFPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK 60
Query: 111 AHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL---------- 160
+ +EVK+L L PNI+R LG ++D L ++ E++ G ++ L
Sbjct: 61 NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 161 -GKFGSFPESVIRMYTKQLLL--------GLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211
G P + + LL G++YL +HRD+ N LV IK+A
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIA 180
Query: 212 DFGASKKVV--ELATINGAKSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIE--MAT 266
DFG S+ + + I G + P WMA E IL + ++D+W+ G T+ E M
Sbjct: 181 DFGMSRNLYAGDYYRIQGRAVL---PIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237
Query: 267 GKPPWSQ----QFQEVAALFHIGTTKS-----HPPIPEHLSMEAKDFLLKCLQKEPYLRS 317
+ P+ + Q E A F + PP P+ L + +L+C ++ R
Sbjct: 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLY----ELMLQCWSRDCRERP 293
Query: 318 TASELLQHPFVT 329
+ S++ H F+T
Sbjct: 294 SFSDI--HAFLT 303
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 45/290 (15%)
Query: 62 PPIRWRK---GELVGCGAFGRVYM------GMNLDSGELLAVKQVLIAANSASKEKTQAH 112
P + W +++G G FG+V G+ +D+ A+K++ ASK+ +
Sbjct: 2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDA----AIKRM---KEYASKDDHRDF 54
Query: 113 IRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGK---------F 163
ELE KL HPNI+ LG L + +E+ P G++ L K F
Sbjct: 55 AGELEVLCKLGH---HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 111
Query: 164 GSFPESVIRMYTKQLLL-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216
+ + ++QLL G++YL + +HRD+ NILV K+ADFG S
Sbjct: 112 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 217 KKVVELATINGAKSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT--GKPPWSQ 273
+ + K+M P WMA E + + ++ ++D+WS G + E+ + G P
Sbjct: 172 RG----QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227
Query: 274 QFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELL 323
E+ G P + E D + +C +++PY R + +++L
Sbjct: 228 TCAELYEKLPQGYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 21/218 (9%)
Query: 69 GELVGCGAFGRVYMG-MNLDSGEL-LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
G+ +G G FG V G +N D L +AVK + IA T++ + + E +K
Sbjct: 4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC------TRSEMEDFLSEAVCMKEF 57
Query: 127 THPNIVRYLG-----TARED-DSLNILLEFVPGGSISSLL--GKFGS----FPESVIRMY 174
HPN++R +G E S ++L F+ G + S L + G P ++ +
Sbjct: 58 DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 175 TKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGT 234
+ G+EYL +HRD+ N +++ + +ADFG SKK+ + K
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177
Query: 235 PYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPW 271
W+A E + ++ +D+WS G T+ E+AT G+ P+
Sbjct: 178 VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 5e-15
Identities = 68/263 (25%), Positives = 121/263 (46%), Gaps = 21/263 (7%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
++G G FG VY G +DS +++ A S ++ + + +E ++K+ +HP
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDG----QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHP 56
Query: 130 NIVRYLGTAREDDSLN-ILLEFVPGGSISSLLGKFGSFPESVIRM--YTKQLLLGLEYLH 186
N++ LG + ++L ++ G + + + P +V + + Q+ G+EYL
Sbjct: 57 NVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP-TVKDLIGFGLQVAKGMEYLA 115
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVV--ELATINGAKSMKGTPYWMAPEVIL 244
+HRD+ N ++D +K+ADFG ++ + E +++ K WMA E L
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES-L 174
Query: 245 QTGHSFS--ADIWSVGCTVIEMAT-GKPPWS--QQFQEVAALFHIGTTKSHPPIPEHLSM 299
QT F+ +D+WS G + E+ T G PP+ F L PE+
Sbjct: 175 QT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ----GRRLLQPEYCPD 229
Query: 300 EAKDFLLKCLQKEPYLRSTASEL 322
+ +L C +P +R T SEL
Sbjct: 230 PLYEVMLSCWHPKPEMRPTFSEL 252
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 5e-15
Identities = 70/263 (26%), Positives = 121/263 (46%), Gaps = 33/263 (12%)
Query: 74 CGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV-KLLKNLTHPNIV 132
G FG+V + + + +L K + K K + +E V +L+K+ +PN +
Sbjct: 26 DGKFGKVSVLKHKPTQKLFVQKII--------KAK---NFNAIEPMVHQLMKD--NPNFI 72
Query: 133 R-YLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIM 191
+ Y + ++++++ G + LL K G E+ ++ +QL+ L LHK+ I+
Sbjct: 73 KLYYSVTTLKGHV-LIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNII 131
Query: 192 HRDIKGANILVD-NKGCIKLADFGASKKVVELATINGAKSM-KGTPYWMAPEVILQTGHS 249
H DIK N+L D K I L D+G K + G S GT + +PE I +
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCKII-------GTPSCYDGTLDYFSPEKIKGHNYD 184
Query: 250 FSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTK----SHPPIPEHLSMEAKDFL 305
S D W+VG E+ TGK P+ + E + + P +++S A DF+
Sbjct: 185 VSFDWWAVGVLTYELLTGKHPFKEDEDEE---LDLESLLKRQQKKLPFIKNVSKNANDFV 241
Query: 306 LKCLQKEPYLR-STASELLQHPF 327
L+ R + +E+++HPF
Sbjct: 242 QSMLKYNINYRLTNYNEIIKHPF 264
|
Length = 267 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 6e-15
Identities = 45/146 (30%), Positives = 71/146 (48%), Gaps = 3/146 (2%)
Query: 119 EVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQL 178
E LL+N+ HP+++R T ++L + L + P + KQ+
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQI 166
Query: 179 LLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWM 238
L GL YLH I+HRD+K NI +++ + + D GA++ V G + GT
Sbjct: 167 LEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG---LAGTVETN 223
Query: 239 APEVILQTGHSFSADIWSVGCTVIEM 264
APEV+ + ++ ADIWS G + EM
Sbjct: 224 APEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 6e-15
Identities = 70/258 (27%), Positives = 109/258 (42%), Gaps = 17/258 (6%)
Query: 71 LVGCGAFGRVYMG-MNLDSG-ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
++G G FG + G + L S EL L A S + R E L H
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR------RGFLAEALTLGQFDH 65
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHK 187
NIVR G +++ I+ E++ G++ S L K G + L G++YL +
Sbjct: 66 SNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
G +H+ + +LV++ K++ F ++ + I S K W APE I Q
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQE-DKSEAIYTTMSGKSPVLWAAPEAI-QYH 183
Query: 248 H-SFSADIWSVGCTVIE-MATG-KPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
H S ++D+WS G + E M+ G +P W Q+V G P P +
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGF---RLPAPRNCPNLLHQL 240
Query: 305 LLKCLQKEPYLRSTASEL 322
+L C QKE R S++
Sbjct: 241 MLDCWQKERGERPRFSQI 258
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 6e-15
Identities = 38/161 (23%), Positives = 63/161 (39%), Gaps = 24/161 (14%)
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY 236
Q L L LH+ + + L+ G + + PY
Sbjct: 25 QCLGALRELHRQAKSGNILLTWDGLLKLDG---------------SVAFKTPEQSRPDPY 69
Query: 237 WMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI---GTTKSHPP- 292
+MAPEVI ++ ADI+S+G T+ E + P++++ E++A+ I G P
Sbjct: 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER-ELSAILEILLNGMPADDPRD 128
Query: 293 --IPEHLS--MEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
E +S +DF+ C + P R A+ L H
Sbjct: 129 RSNLEGVSAARSFEDFMRLCASRLPQRREAANHYLAHCRAL 169
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 1e-14
Identities = 72/293 (24%), Positives = 132/293 (45%), Gaps = 41/293 (13%)
Query: 53 LPPIEKTDAPPIRWRKGELVGCGAFGRV-----YMGMNLDSGELLAVKQVLIAANSASKE 107
LP K + P G+ +G GAFG+V Y D+ +AVK + A+S+ +E
Sbjct: 24 LPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSERE 83
Query: 108 KTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGK---- 162
L E+K++ +L H NIV LG + ++ E+ G + + L +
Sbjct: 84 A-------LMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES 136
Query: 163 FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222
F + + + ++ Q+ G+ +L +HRD+ N+L+ + +K+ DFG ++ ++
Sbjct: 137 FLTLED--LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN- 193
Query: 223 ATINGAKSMKGTPY----WMAPEVILQTGHSFSADIWSVGCTVIEMAT-------GKPPW 271
+ +KG WMAPE I ++F +D+WS G + E+ + G P
Sbjct: 194 ---DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD 250
Query: 272 SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
S+ ++ + + + PEH E D + C +P R T +++Q
Sbjct: 251 SKFYKLIKEGYRMAQ-------PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 62/220 (28%), Positives = 103/220 (46%), Gaps = 28/220 (12%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGEL--LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+G VG G +G VY D + A+KQ+ S S + E+ LL+
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR----------EIALLRE 54
Query: 126 LTHPNIV--RYLGTAREDDSLNILLEF--------VPGGSISSLLGKFGSFPESVIRMYT 175
L HPN++ + + + D + +L ++ + S K P +++
Sbjct: 55 LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLL 114
Query: 176 KQLLLGLEYLHKNGIMHRDIKGANILV----DNKGCIKLADFGASKKV-VELATINGAKS 230
Q+L G+ YLH N ++HRD+K ANILV +G +K+AD G ++ L +
Sbjct: 115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 174
Query: 231 MKGTPYWMAPEVILQTGHSFSA-DIWSVGCTVIEMATGKP 269
+ T ++ APE++L H A DIW++GC E+ T +P
Sbjct: 175 VVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 214
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 74/300 (24%), Positives = 136/300 (45%), Gaps = 42/300 (14%)
Query: 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVYM----GMNLDSGEL-LAVKQVLIAANSASKE 107
LP + + P R G+ +G GAFG+V G++ + +AVK ++ ++ K+
Sbjct: 1 LPLDPEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK--MLKDDATEKD 58
Query: 108 KTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL------ 160
+ +L E++++K + H NI+ LG ++ L +++E+ G++ L
Sbjct: 59 -----LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPP 113
Query: 161 GKFGSF-----PESVIRMY-----TKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKL 210
G++ S PE + Q+ G+E+L +HRD+ N+LV +K+
Sbjct: 114 GEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKI 173
Query: 211 ADFGASKKVVEL----ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT 266
ADFG ++ + + T NG +K WMAPE + ++ +D+WS G + E+ T
Sbjct: 174 ADFGLARDIHHIDYYRKTTNGRLPVK----WMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
Query: 267 --GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
G P +E+ L G P + + E + C + P R T +L++
Sbjct: 230 LGGSPYPGIPVEELFKLLKEGYRMEKPQ---NCTQELYHLMRDCWHEVPSQRPTFKQLVE 286
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 76/296 (25%), Positives = 118/296 (39%), Gaps = 66/296 (22%)
Query: 88 SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNIL 147
+GE + V+++ + A T + L+ E+ + K HPNIV Y T D+ L ++
Sbjct: 24 TGEYVTVRRINLEAC------TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 77
Query: 148 LEFVPGGSISSLLGKFGS--FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANIL--VD 203
F+ GS L+ E I + +L L+Y+H G +HR +K ++IL VD
Sbjct: 78 TSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137
Query: 204 NKGCI-------KLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT--GHSFSADI 254
K + + + G +VV K + W++PEV+ Q G+ +DI
Sbjct: 138 GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLP----WLSPEVLQQNLQGYDAKSDI 193
Query: 255 WSVGCTVIEMATGKPPW-----SQQFQE-----VAALFHIGT------------------ 286
+SVG T E+A G P+ +Q E V L T
Sbjct: 194 YSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSG 253
Query: 287 ----------TKSHPPIPEH-----LSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
S+ H S F+ +CLQ+ P R +AS LL H F
Sbjct: 254 LGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 62/230 (26%), Positives = 107/230 (46%), Gaps = 30/230 (13%)
Query: 70 ELVGCGAFGRVYM----GMN--LD---SGELLAVKQVLIAANSASKEKTQAHIRELEEEV 120
E +G G FG V++ GM +D S ++ + VL+A ++ + + +E+
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPE------------ 168
K++ L PNI+R L D L ++ E++ G ++ L + E
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQEAAEKADVVTISY 129
Query: 169 SVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV--ELATIN 226
S + Q+ G++YL +HRD+ N LV IK+ADFG S+ + + I
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 227 GAKSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT--GKPPWSQ 273
G + P WM+ E IL + ++D+W+ G T+ E+ T + P+SQ
Sbjct: 190 GRAVL---PIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQ 236
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 7e-14
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 32/218 (14%)
Query: 70 ELVGCGAFGRVYMG--MNLDSGELLAVKQVLIAANSASKEKTQAHIRE-LEEEVKLLKNL 126
E +G FG+VY G GE Q A K+K + +RE + E + L
Sbjct: 11 EELGEDRFGKVYKGHLFGTAPGE-----QTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL 65
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL------GKFGSF-----------PES 169
HPNIV LG ++ L+++ + + L GS P
Sbjct: 66 QHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPAD 125
Query: 170 VIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAK 229
+ + T Q+ G+E+L + ++H+D+ N+LV +K +K++D G + E+ + K
Sbjct: 126 FVHIVT-QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR---EVYAADYYK 181
Query: 230 SMKGTPY---WMAPEVILQTGHSFSADIWSVGCTVIEM 264
M + WM+PE I+ S +DIWS G + E+
Sbjct: 182 LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 67/276 (24%), Positives = 123/276 (44%), Gaps = 38/276 (13%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKE----KTQAHIRELEEEVKLLKN 125
+++G G FG+V +K+ + ++A K ++ R+ E+++L
Sbjct: 1 DVIGEGNFGQVLKAR---------IKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK 51
Query: 126 LTH-PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGK---------FGSFPESVIRMYT 175
L H PNI+ LG L + +E+ P G++ L K F + + +
Sbjct: 52 LGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 111
Query: 176 KQLLL-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228
+QLL G++YL + +HRD+ NILV K+ADFG S+ +
Sbjct: 112 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVK 167
Query: 229 KSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGT 286
K+M P WMA E + + ++ ++D+WS G + E+ + G P+ A L+
Sbjct: 168 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAELYEKLP 225
Query: 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASEL 322
P + E D + +C +++PY R + +++
Sbjct: 226 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 70/272 (25%), Positives = 118/272 (43%), Gaps = 30/272 (11%)
Query: 70 ELVGCGAFGRVYMGM-NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+++G G FG+V M D ++ A ++L AS+ + ELE KL H
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKML--KEFASENDHRDFAGELEVLCKLGH---H 62
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGK---------FGSFPESVIRMYTKQLL 179
PNI+ LG L I +E+ P G++ L K F + + ++QLL
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 180 -------LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK 232
G++YL + +HRD+ N+LV K+ADFG S+ + K+M
Sbjct: 123 QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRG----EEVYVKKTMG 178
Query: 233 GTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSH 290
P WMA E + + ++ +D+WS G + E+ + G P+ A L+
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCG--MTCAELYEKLPQGYR 236
Query: 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASEL 322
P + E + + +C + PY R +++
Sbjct: 237 MEKPRNCDDEVYELMRQCWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+ +G G FG V +G G +AVK + K A + E ++ L H
Sbjct: 12 QTIGKGEFGDVMLGDY--RGNKVAVKCI----------KNDATAQAFLAEASVMTQLRHS 59
Query: 130 NIVRYLGTAREDD-SLNILLEFVPGGSISSLLGKFGSFPESVIR-----MYTKQLLLGLE 183
N+V+ LG E+ L I+ E++ GS+ L G SV+ ++ + +E
Sbjct: 60 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAME 116
Query: 184 YLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAPEV 242
YL N +HRD+ N+LV K++DFG +K+ +T + K P W APE
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS--STQDTGK----LPVKWTAPEA 170
Query: 243 ILQTGHSFSADIWSVGCTVIEMAT-GKPPW 271
+ + S +D+WS G + E+ + G+ P+
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 80/328 (24%), Positives = 126/328 (38%), Gaps = 68/328 (20%)
Query: 62 PPIRWRKGELVGCGAFGRVY----MGMNL-DSGELLAVKQVLIAANSA------SKEKTQ 110
P R R G+++G GAFG+V G++ S +AVK + A ++ S+ K
Sbjct: 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKIL 64
Query: 111 AHIRELEEEVKLLKNLTHP--------------NIVRYLGTARE------DDSLNILLEF 150
HI V LL T P N+ +L RE + S F
Sbjct: 65 IHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRF 124
Query: 151 ------------VPGGSISSLLGKF------GSFPESVIR-------------MYTKQLL 179
+ G S L +F + P Y+ Q+
Sbjct: 125 RAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVA 184
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMA 239
G+E+L +HRD+ NIL+ +K+ DFG ++ + + S + WMA
Sbjct: 185 RGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244
Query: 240 PEVILQTGHSFSADIWSVGCTVIEM-ATGKPPWS--QQFQEVAALFHIGTTKSHPPIPEH 296
PE I ++ +D+WS G + E+ + G P+ Q +E GT PE+
Sbjct: 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR---APEN 301
Query: 297 LSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+ E +L C Q +P R T S L++
Sbjct: 302 ATPEIYRIMLACWQGDPKERPTFSALVE 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 77/289 (26%), Positives = 123/289 (42%), Gaps = 38/289 (13%)
Query: 72 VGCGAFGRVYMGMNLD--SGEL---LAVKQVLIAANSAS-KEKTQAHIRELEEEVKLLKN 125
+G G+FG VY G D GE +AVK V SAS +E+ E E ++K
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTV---NESASLRERI-----EFLNEASVMKG 65
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF--------GSFPESVIRM--YT 175
T ++VR LG + +++E + G + S L G P ++ M
Sbjct: 66 FTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMA 125
Query: 176 KQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG-T 234
++ G+ YL+ +HRD+ N +V + +K+ DFG ++ + E T K KG
Sbjct: 126 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE--TDYYRKGGKGLL 183
Query: 235 PY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT--GKPPWSQQFQEVAALFHIGTTKSHP 291
P WMAPE + + S+D+WS G + E+ + +P ++V G
Sbjct: 184 PVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ- 242
Query: 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFR 340
P++ D + C Q P +R T E++ D HP F
Sbjct: 243 --PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNL-----LKDDLHPSFP 284
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 43/155 (27%), Positives = 73/155 (47%), Gaps = 6/155 (3%)
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
Y+ Q+ G+E+L +HRD+ NIL+ +K+ DFG ++ + + +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEM-ATGKPPWS--QQFQEVAALFHIGTTKSH 290
WMAPE I ++ +D+WS G + E+ + G P+ + +E GT
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR- 302
Query: 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
P++ + E +L C EP R T SEL++H
Sbjct: 303 --APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 4e-12
Identities = 52/207 (25%), Positives = 93/207 (44%), Gaps = 16/207 (7%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131
+G G+FG VY G + G + + +A + ++ + E E ++K ++
Sbjct: 14 LGQGSFGMVYEG--IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 71
Query: 132 VRYLGTAREDDSLNILLEFVPGGSISSLL--------GKFGSFPESVIRM--YTKQLLLG 181
VR LG + +++E + G + S L P S+ +M ++ G
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG--TPYWMA 239
+ YL+ N +HRD+ N +V +K+ DFG ++ + E T K KG WM+
Sbjct: 132 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVRWMS 189
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMAT 266
PE + + +D+WS G + E+AT
Sbjct: 190 PESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 6e-12
Identities = 54/221 (24%), Positives = 102/221 (46%), Gaps = 30/221 (13%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIA---ANSASKEKTQAHIRELEEEVKLLKNLTH 128
+G G FG+V +G ++ ++ +V++ A++ E+ +EV+ + L H
Sbjct: 3 IGNGWFGKVLLG---EAHRGMSKARVVVKELRASATPDEQLL-----FLQEVQPYRELNH 54
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGK------FGSFPESVIRMYTKQLLLGL 182
PN+++ LG E ++LEF P G + + L + + + RM ++ GL
Sbjct: 55 PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM-ACEVASGL 113
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFG-ASKKVVELATINGAKSMKGTPY-WMAP 240
+LH+ +H D+ N + +K+ D+G A ++ E I K P W+AP
Sbjct: 114 LWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI--TKDCHAVPLRWLAP 171
Query: 241 EV-------ILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ 273
E+ +L + ++IWS+G T+ E+ T P+
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 8e-12
Identities = 79/300 (26%), Positives = 126/300 (42%), Gaps = 69/300 (23%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN----- 125
L+G G G VY+ + +A+K+ IRE E LLK
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKK----------------IREDLSENPLLKKRFLRE 52
Query: 126 ------LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF---GSFP------ESV 170
L HP IV + D + + ++ G ++ SLL S SV
Sbjct: 53 AKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV 112
Query: 171 ---IRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK-----KVVEL 222
+ ++ K + +EY+H G++HRD+K NIL+ G + + D+GA+ + L
Sbjct: 113 GAFLSIFHK-ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLL 171
Query: 223 A-------------TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKP 269
TI G + GTP +MAPE +L S S DI+++G + +M T
Sbjct: 172 DIDVDERNICYSSMTIPG--KIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229
Query: 270 PW-SQQFQEVAALFHIGTTKSHPP---IPEHLSMEAKDFLLKCLQKEPYLR-STASELLQ 324
P+ ++ ++++ I + P IP LS A +K L +P R S+ EL Q
Sbjct: 230 PYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIA----MKALAVDPAERYSSVQELKQ 285
|
Length = 932 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-11
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 1/157 (0%)
Query: 114 RELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRM 173
+ E+ +LK ++H I+ + R ++ +++ + + + + G P
Sbjct: 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP-KYKCDLFTYVDRSGPLPLEQAIT 189
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
++LL L YLH GI+HRD+K NI +D L DFGA+ K+ G
Sbjct: 190 IQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPP 270
T +PE++ + DIWS G + EM+
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 64/258 (24%), Positives = 109/258 (42%), Gaps = 27/258 (10%)
Query: 73 GCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE--EEVKLLKNLTHPN 130
G G F +Y G+ +L V + K H L E L+ L+H +
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVL-KVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYT-KQLLLGLEYLHKNG 189
+V+ G D+++ ++ E+V G + L + + ++ KQL L YL
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 190 IMHRDIKGANILV----DNKGC---IKLADFGASKKVVELATINGAKSMKGTPY-WMAPE 241
++H ++ G NILV N+G IKL+D G V ++ + W+APE
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV-------LSREERVERIPWIAPE 174
Query: 242 VI--LQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLS 298
I Q + +AD WS G T++E+ + G+ P S F+ + P+P+
Sbjct: 175 CIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY--QDQHRLPMPD--C 230
Query: 299 MEAKDFLLKCLQKEPYLR 316
E + + +C +P R
Sbjct: 231 AELANLINQCWTYDPTKR 248
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-11
Identities = 62/249 (24%), Positives = 98/249 (39%), Gaps = 45/249 (18%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV---- 120
W+ +L+GCG FG VY + A++ + A I LE E
Sbjct: 13 EWKIDKLIGCGGFGCVY--------------ETQCASDHCINNQAVAKIENLENETIVME 58
Query: 121 ----------------KLLKNLTHPNIVRYLGTAREDDSLN----ILLEFVPGGSISSLL 160
K + N+ H I +Y G ILLE + + +
Sbjct: 59 TLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIF 117
Query: 161 GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG-ASKKV 219
+ + +I+ K +L LEY+H++GI H DIK NI+VD + D+G AS +
Sbjct: 118 KRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFI 177
Query: 220 VELATINGAKSMK----GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF 275
+ I +K K GT Y+ + + D+ S+G +++ A K PW + F
Sbjct: 178 IHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPW-KGF 236
Query: 276 QEVAALFHI 284
L H
Sbjct: 237 GHNGNLIHA 245
|
Length = 294 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 50/166 (30%), Positives = 75/166 (45%), Gaps = 38/166 (22%)
Query: 119 EVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSL-LGKFGS------------ 165
E +LL+ L+HP ++ LL+ G ++ L L K+ S
Sbjct: 210 EARLLRRLSHPAVLA-------------LLDVRVVGGLTCLVLPKYRSDLYTYLGARLRP 256
Query: 166 FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI 225
+ + +QLL ++Y+H GI+HRDIK N+LV+ I L DFGA+
Sbjct: 257 LGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA------CFA 310
Query: 226 NGAKS------MKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMA 265
G+ S + GT APEV+ ++ S DIWS G + E A
Sbjct: 311 RGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356
|
Length = 461 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 8e-11
Identities = 43/155 (27%), Positives = 70/155 (45%), Gaps = 6/155 (3%)
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
Y+ Q+ G+E+L +HRD+ NIL+ +K+ DFG ++ + + +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 237
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT--GKP-PWSQQFQEVAALFHIGTTKSH 290
WMAPE I ++ +D+WS G + E+ + P P Q +E GT
Sbjct: 238 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRA 297
Query: 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
PE+ + E +L C P R T SEL++
Sbjct: 298 ---PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 41/170 (24%), Positives = 79/170 (46%), Gaps = 4/170 (2%)
Query: 152 PGGSISSLLGKFGSFPESVIRM--YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIK 209
+ +LL GS + + + +T Q+ G+E+L +HRD+ N+L+ +K
Sbjct: 218 NDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVK 277
Query: 210 LADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEM-ATGK 268
+ DFG ++ ++ + S WMAPE I ++ +D+WS G + E+ + G
Sbjct: 278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGG 337
Query: 269 PPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRST 318
P+ + + ++ + P+H + E D ++KC EP R +
Sbjct: 338 TPYPGMIVD-STFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 67/273 (24%), Positives = 123/273 (45%), Gaps = 34/273 (12%)
Query: 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIA---ANSASKEKTQAHIRELEEEVKLLKNLTH 128
+G G FG+V +G ++SG QV++ +++ +E+ + EE + ++L H
Sbjct: 3 IGNGWFGKVILG-EVNSG--YTPAQVVVKELRVSASVQEQ-----MKFLEEAQPYRSLQH 54
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGK------FGSFPESVIRMYTKQLLLGL 182
N+++ LG E +++EF P G + L P ++ RM ++ LGL
Sbjct: 55 SNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM-ACEIALGL 113
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK-KVVELATINGAKSMKGTPY-WMAP 240
+LHKN +H D+ N L+ +K+ D+G S K E + + P W+AP
Sbjct: 114 LHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQ--LWVPLRWIAP 171
Query: 241 EVI-------LQTGHSFSADIWSVGCTVIEM-ATGKPPWSQQFQEVAALFHIGTTKSHPP 292
E++ L + +++WS+G T+ E+ G P+ E + + + P
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLP 231
Query: 293 IPEHLSMEAKDFLLKCLQK---EPYLRSTASEL 322
P L + D + +Q +P R +A E+
Sbjct: 232 KPR-LKLPLSDRWYEVMQFCWLQPEQRPSAEEV 263
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 6e-09
Identities = 66/254 (25%), Positives = 106/254 (41%), Gaps = 47/254 (18%)
Query: 115 ELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVI--- 171
+LE E+ L L H NI++ R + + ++ + S + + + + +
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQ 268
Query: 172 -RMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS 230
R KQLL +EY+H ++HRDIK NI ++ G I L DFG + E
Sbjct: 269 TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMP-FEKEREAFDYG 327
Query: 231 MKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEM----------ATGKPPWSQQFQEV-- 278
GT +PE++ G+ DIWS G +++M GKP +Q ++
Sbjct: 328 WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP--GKQLLKIID 385
Query: 279 ----------------------AALFHIGTTKSHPPIPEHLSMEAKDF---LLKCLQKEP 313
A + H G + PP+ +L + A DF L+K L +
Sbjct: 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSV--PPLIRNLGLPA-DFEYPLVKMLTFDW 442
Query: 314 YLRSTASELLQHPF 327
+LR A+ELL P
Sbjct: 443 HLRPGAAELLALPL 456
|
Length = 501 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 1e-08
Identities = 73/357 (20%), Positives = 134/357 (37%), Gaps = 96/357 (26%)
Query: 53 LPPIEKTDAPPIRWRKGELVGCGAFGRV-----YMGMNLDSGELLAVKQVLIAANSASKE 107
LP K + P R G+ +G GAFG+V Y D+ +AVK + +A+ +E
Sbjct: 24 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTERE 83
Query: 108 KTQAHIRELE------EEVKLL-------------KNLTHPNIVRYLGTARED------- 141
+ ++ L V LL + + +++ +L R+
Sbjct: 84 ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHE 143
Query: 142 -------------------DSLNILLEFVPGGSIS-------SLLGKFGSFPESVIRM-- 173
DSLN ++ PG S + GS+ + +
Sbjct: 144 DHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEI 203
Query: 174 ---------------YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218
++ Q+ G+ +L +HRD+ NIL+ + K+ DFG ++
Sbjct: 204 LEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 263
Query: 219 VVELATINGAKSMKGTPY----WMAPEVILQTGHSFSADIWSVGCTVIEM-ATGKPPW-- 271
+ + +KG WMAPE I ++F +D+WS G + E+ + G P+
Sbjct: 264 I----RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319
Query: 272 ----SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
S+ ++ + + + + PE E D + C +P R T +++Q
Sbjct: 320 MPVDSKFYKMIKEGYRMLS-------PECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 41/156 (26%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
++ Q+ G+E+L +HRD+ N+L+ +K+ DFG ++ ++ + S
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFL 303
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT--GKP----PWSQQFQEVAALFHIGTT 287
WMAPE I ++ +D+WS G + E+ T G P P ++QF G
Sbjct: 304 PLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNA---IKRGYR 360
Query: 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELL 323
+ P H S E + + KC +++ +R S+L+
Sbjct: 361 MAK---PAHASDEIYEIMQKCWEEKFEIRPDFSQLV 393
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 23/211 (10%)
Query: 70 ELVGCGAFGRVYMGMN---LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
E +G G F +++ G+ D GEL + +L + + + +++ E ++ L
Sbjct: 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFF----EAASMMSQL 56
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRM-YTKQLLLGLEYL 185
+H ++V G D ++ E+V GS+ + L K + ++ KQL L +L
Sbjct: 57 SHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFL 116
Query: 186 HKNGIMHRDIKGANILVDNKG--------CIKLADFGASKKVVELATINGAKSMKGTPYW 237
G+ H ++ N+L+ + IKL+D G S V+ + ++ P W
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEIL-----LERIP-W 170
Query: 238 MAPEVILQTGH-SFSADIWSVGCTVIEMATG 267
+ PE I + S +AD WS G T+ E+ +G
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 67/294 (22%), Positives = 116/294 (39%), Gaps = 80/294 (27%)
Query: 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVY----MGM-NLDSGELLAVKQVLIAANSASKE 107
LP EK + P + G+ +G GAFG+V G+ D+ +AVK + +A++ +E
Sbjct: 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDERE 86
Query: 108 ------KTQAHIRELEEEVKLLKNLTHP---------------------------NIVRY 134
K +H+ + + V LL TH N V
Sbjct: 87 ALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMA 146
Query: 135 LGTAREDDS----------------------LNILLEFVPGGSISS-------LLGKFGS 165
L E S + +E P S SS S
Sbjct: 147 LPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDS 206
Query: 166 FP---ESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222
+P + ++R ++ Q+ G+++L +HRD+ N+L+ + K+ DFG ++ ++
Sbjct: 207 WPLDLDDLLR-FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN- 264
Query: 223 ATINGAKSMKGTPY----WMAPEVILQTGHSFSADIWSVGCTVIEM-ATGKPPW 271
+ +KG WMAPE I ++ +D+WS G + E+ + GK P+
Sbjct: 265 ---DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY 315
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 34/106 (32%), Positives = 50/106 (47%), Gaps = 16/106 (15%)
Query: 233 GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW-----SQQFQEVAALFHIGTT 287
GTP ++APE++L H + D W++G + E TG PP+ Q FQ +
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNI--------L 593
Query: 288 KSHPPIP---EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330
P P E LS+ A++ + L +P R+ EL QHP G
Sbjct: 594 NRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHG 639
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 24/48 (50%), Positives = 34/48 (70%)
Query: 169 SVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216
+VI+ +Q+L GL LH+ GI+HRDIK N+LV G +K+ DFGA+
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 1e-06
Identities = 57/273 (20%), Positives = 113/273 (41%), Gaps = 35/273 (12%)
Query: 72 VGCGAFGRVYMG-MNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN----- 125
+G G FG+V + + D+G V + L AN++SKE+ + L+
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKEL-KANASSKEQNE-----------FLQQGDPYR 50
Query: 126 -LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLG----KFGSFPESVIRMYTKQLLL 180
L HPNI++ LG E ++ E+ G + S L + +++ ++
Sbjct: 51 ILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA 110
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
G+ ++HK+ +H D+ N + + +K+ D+G + I W+AP
Sbjct: 111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170
Query: 241 EVI-------LQTGHSFSADIWSVGCTVIEM-ATGKPPWSQQFQEVAALFHIGTTKSHPP 292
E++ + + +++W++G T+ E+ P+S + L H+ +
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYS-HLSDREVLNHVIKDQQVKL 229
Query: 293 IPEHLSMEAKDFLLKCLQ---KEPYLRSTASEL 322
L + + + LQ P R+TA E+
Sbjct: 230 FKPQLELPYSERWYEVLQFCWLSPEKRATAEEV 262
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 5e-06
Identities = 55/231 (23%), Positives = 93/231 (40%), Gaps = 29/231 (12%)
Query: 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIREL 116
E D R++ L+G G FG+V + E AVK V K + E
Sbjct: 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEK 181
Query: 117 EEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVP--GGSISSLLGKFGSFPESVIRMY 174
+ I RY ++++ ++ + +P G + + K G F +
Sbjct: 182 VRQADPADRFPLMKIQRYF----QNETGHMCI-VMPKYGPCLLDWIMKHGPFSHRHLAQI 236
Query: 175 TKQLLLGLEYLHKN-GIMHRDIKGANILVDNKG---------------C-IKLADFGASK 217
Q + L+Y H +MH D+K NIL++ C +++ D G
Sbjct: 237 IFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCC 296
Query: 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGK 268
T ++ T ++ +PEV+L G +S D+WS+GC + E+ TGK
Sbjct: 297 DERHSRT-----AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 61/227 (26%), Positives = 96/227 (42%), Gaps = 40/227 (17%)
Query: 118 EEVKLLKNLTHPNIVRYLGT-AREDDSLNILL-EFVPGGSISSLLGK-FGSFPESVIRMY 174
E L+ ++H ++ G R S NI++ EFV G + L K G P +
Sbjct: 65 ETASLMSQVSHIHLAFVHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV 122
Query: 175 TKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC-------IKLADFGASKKVVELATING 227
+QL L YL ++H ++ NIL+ G IKL+D G V ++
Sbjct: 123 AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPG-----VSFTALSR 177
Query: 228 AKSMKGTPYWMAPEVILQTGHSFS--ADIWSVGCTVIE--------MATGKPPWSQQFQE 277
+ ++ P W+APE + G+S S AD WS G T++E + P ++F E
Sbjct: 178 EERVERIP-WIAPECV-PGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE 235
Query: 278 VAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
K H +PE E + +CL EP R + +L+
Sbjct: 236 ----------KKH-RLPEPSCKELATLISQCLTYEPTQRPSFRTILR 271
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 3e-05
Identities = 53/193 (27%), Positives = 76/193 (39%), Gaps = 36/193 (18%)
Query: 53 LPPIEKTDAPPIRWRKGELV-----GCGAFGRVYMGM----NLDSGELLAVKQ------V 97
L P+E P ++K + V G GAFG VY +K+ V
Sbjct: 118 LAPLEGLFRP--SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV 175
Query: 98 LIAANS----ASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILL---EF 150
I N A + E V K + + RY G + +L L+ EF
Sbjct: 176 EIWMNERVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEG----ESTLADLMQSKEF 231
Query: 151 VPGGSISSLLGKFGSFPES------VIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN 204
P LLGK P+ +I+ +Q+L L+ LH GI+HRD+K NI+
Sbjct: 232 -PYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSE 290
Query: 205 -KGCIKLADFGAS 216
G K+ D GA+
Sbjct: 291 GSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 49/209 (23%), Positives = 91/209 (43%), Gaps = 20/209 (9%)
Query: 118 EEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRM-YTK 176
E +++ ++H +IV G D ++ EFV G + + + + + K
Sbjct: 53 ETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAK 112
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGC-------IKLADFGASKKVVELATINGAK 229
QL L YL ++H ++ NIL+ +G IKL+D G + + ++ +
Sbjct: 113 QLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG-----IPITVLSRQE 167
Query: 230 SMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMA-TGKPPWSQQFQEVAALFHIGTT 287
++ P W+APE + + + S +AD WS G T+ E+ G+ P + F+ G
Sbjct: 168 CVERIP-WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC 226
Query: 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLR 316
P + L+ D + C+ +P R
Sbjct: 227 MLVTPSCKELA----DLMTHCMNYDPNQR 251
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.004
Identities = 23/82 (28%), Positives = 41/82 (50%), Gaps = 8/82 (9%)
Query: 146 ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK 205
I++E++ G + L+ G + R + + G LH GI+H D+ +N+++ +
Sbjct: 76 IVMEYIEGEPLKDLINSNGMEELELSREIGRLV--GK--LHSAGIIHGDLTTSNMIL-SG 130
Query: 206 GCIKLADFG---ASKKVVELAT 224
G I L DFG SK + + A
Sbjct: 131 GKIYLIDFGLAEFSKDLEDRAV 152
|
Length = 211 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 668 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.92 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.86 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.81 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.41 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.35 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.23 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.17 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.15 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.96 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.94 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.88 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.81 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.71 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.66 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.52 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.49 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.46 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.43 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.37 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.36 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.35 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.05 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.01 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.97 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.96 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.93 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.91 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.79 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.78 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.57 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.54 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.54 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.44 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.41 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.34 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.29 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.28 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.09 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.72 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.32 | |
| PLN02236 | 344 | choline kinase | 96.2 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.12 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.83 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.83 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.79 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.76 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.58 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.12 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 94.8 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.65 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.17 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.06 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.53 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.17 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 92.97 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 92.41 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 92.22 | |
| PTZ00296 | 442 | choline kinase; Provisional | 92.21 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=465.83 Aligned_cols=268 Identities=32% Similarity=0.504 Sum_probs=234.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.....|.+.+.||+|+||.|-+|..+.||+.||||++.......... .......+.+|+++|++|+|||||+++++|..
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~-~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~ 247 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSR-AIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV 247 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccc-cccchhhhHHHHHHHHhcCCCCEEEEeeeeec
Confidence 45677999999999999999999999999999999995443322111 11223346799999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC---CceEEecCCchh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK---GCIKLADFGASK 217 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~---g~vKL~DFGlA~ 217 (668)
.+..||||||+.||+|.+.+-.++.+.+...+.+++||+.||.|||++||+||||||+|||+..+ ..+||+|||+|+
T Consensus 248 ~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 248 PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999876 789999999999
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCC---CcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccCCCCCC
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGH---SFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTTKSHPP 292 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~---s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~~~~~~ 292 (668)
...+ ..-..+.||||.|.|||++.+..+ ..++|||||||+||-+|+|.+||.+.... ....+..+.....++
T Consensus 328 ~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~ 404 (475)
T KOG0615|consen 328 VSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPL 404 (475)
T ss_pred cccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccCh
Confidence 7653 344678999999999999987653 44889999999999999999999876543 456666677777888
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.|..++.++.+||.+||..||++|||+.|+|+||||+...
T Consensus 405 ~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 405 QWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 8999999999999999999999999999999999998543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-53 Score=466.61 Aligned_cols=260 Identities=34% Similarity=0.645 Sum_probs=231.2
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|..+++||+|||++||.+++..+|..||+|+|.... -......+.+.+||+|.+.|+|||||+++++|++.+
T Consensus 17 ~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~-----l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~ 91 (592)
T KOG0575|consen 17 SKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKL-----LKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN 91 (592)
T ss_pred cceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHH-----hcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence 388999999999999999999999999999999994322 223344567889999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.+|||+|+|..++|..++++.+.++|.+++.+++||+.||.|||+++|+|||||..||||+.+.+|||+|||||..+...
T Consensus 92 nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 92 NVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred ceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987532
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchh-HHHHHHHHhhccCCCCCCCCcccCHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ-FQEVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~-~~~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
.....+.||||.|+|||++....++..+||||+|||||.||+|++||... ..+....+.. ....+|..++.++
T Consensus 172 --~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~----~~Y~~P~~ls~~A 245 (592)
T KOG0575|consen 172 --GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKL----NEYSMPSHLSAEA 245 (592)
T ss_pred --ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHh----cCcccccccCHHH
Confidence 23356799999999999999999999999999999999999999999765 3444333333 3445778999999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
++||.+||+.+|.+|||+++||.|+||+..+.
T Consensus 246 ~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~ 277 (592)
T KOG0575|consen 246 KDLIRKLLRPNPSERPSLDEVLDHPFFKSGFT 277 (592)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCHhhhCCCc
Confidence 99999999999999999999999999955443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-52 Score=433.63 Aligned_cols=262 Identities=34% Similarity=0.585 Sum_probs=229.1
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|+++++||+|+||+||+++.+++++.+|+|++.+.... .....+...+|..||..++||+||+++..|+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv-----~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQ 95 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIV-----EKKEVRHTKAERNILSKIKHPFIVKLIYSFQ 95 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhh-----hhhhHHHHHHHHHHHHhCCCCcEeeeEEecc
Confidence 35678899999999999999999999999999999999543322 2234567889999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
+.+.+|||+||+.||+|+.+|++.+.|+|..++.++.+|+.||.|||++|||||||||+|||||.+|+++|+||||++..
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999854
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-HHHHHHHhhccCCCCCCCCcccC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-QEVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-~~~~~~~~~~~~~~~~~~p~~ls 298 (668)
... .....++|||+.|||||++.+.+|+.++|+|||||++|+|++|.+||.... ......+.... ....+..++
T Consensus 176 ~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k---~~~~p~~ls 250 (357)
T KOG0598|consen 176 LKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK---LPLPPGYLS 250 (357)
T ss_pred ccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc---CCCCCccCC
Confidence 322 234556899999999999999999999999999999999999999998654 33333322222 234556699
Q ss_pred HHHHHHHHHhhhhCCCCCC----CHHHHHcCccccCC
Q 005944 299 MEAKDFLLKCLQKEPYLRS----TASELLQHPFVTGK 331 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RP----Sa~EIL~Hpwf~~~ 331 (668)
.++++||+++|+.||.+|. ++.+|.+||||.+.
T Consensus 251 ~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 251 EEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 9999999999999999995 79999999999864
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-52 Score=434.93 Aligned_cols=260 Identities=33% Similarity=0.597 Sum_probs=230.6
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
+...+.+.++.||+|..|+||+|+|+.|++.+|+|+|.. ..++...+++.+|+++++..+|||||.+||.|..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~-------~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL-------NIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc-------cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 334578889999999999999999999999999999832 2334566788999999999999999999999999
Q ss_pred CCc-ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 DDS-LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 ~~~-~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
+.. ++|+||||++|+|..++...++++|..+..|+.+|++||.|||. ++||||||||+||||+..|.|||||||.++.
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 985 99999999999999999998999999999999999999999995 8999999999999999999999999999987
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchh---HHHHHHHHhhccCCCCCCCCc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ---FQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~---~~~~~~~~~~~~~~~~~~~p~ 295 (668)
+... .+.+++||..|||||.+.+..|+.++||||||++|+||++|+.||... ......++...-....+.+|.
T Consensus 229 lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~ 304 (364)
T KOG0581|consen 229 LVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPE 304 (364)
T ss_pred hhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCc
Confidence 7532 567899999999999999999999999999999999999999999753 223344444333445667777
Q ss_pred c-cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 296 H-LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 296 ~-ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
. +|+++++||..||++||.+||++.|+++|||+++.
T Consensus 305 ~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 305 GEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF 341 (364)
T ss_pred ccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence 6 99999999999999999999999999999999854
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-51 Score=429.24 Aligned_cols=262 Identities=32% Similarity=0.575 Sum_probs=230.5
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|.+.+.||.|+||+||+|+++.++..||||.|.... ......+.+..|+.+|+.++|||||.|++++..+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~------l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~ 81 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKK------LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD 81 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhc------cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC
Confidence 4467999999999999999999999999999999984321 1344566788999999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC------CceEEecCCc
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK------GCIKLADFGA 215 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~------g~vKL~DFGl 215 (668)
+.+|||||||.||+|..+|++.+.++|..++.++.||+.||++||+++||||||||+||||+.. -.+||+|||+
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999999999999999999999999999999999999999999999999999999765 4689999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCc
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~ 295 (668)
|+.+.+ .....+.||+|.|||||+++...|+.|+|+||+|+|||+|++|++||...................+.++.
T Consensus 162 AR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~ 238 (429)
T KOG0595|consen 162 ARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPA 238 (429)
T ss_pred hhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhh
Confidence 998754 33356789999999999999999999999999999999999999999866544333333334455566777
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.++..+.+|+...|+.+|.+|.+..+-+.|+++....
T Consensus 239 ~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 239 ELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 8888899999999999999999999999999987544
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=436.97 Aligned_cols=265 Identities=31% Similarity=0.572 Sum_probs=228.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~ 138 (668)
.....+|..++.||.|+|++|++|+++.+++.||||++.+. .-..+...+.+..|-.+|.+| .||.||+|+..|
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~-----~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF 143 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKR-----YIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF 143 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHH-----HHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence 34567899999999999999999999999999999998321 122233345567788889999 899999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
+++..+|+|+||+++|+|.++|.+.+.|++..++.++.||+.||+|||++|||||||||+|||||.+|++||+|||.|+.
T Consensus 144 QD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 144 QDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred ecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999998
Q ss_pred hHhhhhh-----------cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccC
Q 005944 219 VVELATI-----------NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT 287 (668)
Q Consensus 219 ~~~~~~~-----------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~ 287 (668)
+.+.... ....+++||..|++||+|.....++.+|||+||||||+|+.|.+||....+-..- ..+ .
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliF-qkI--~ 300 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIF-QKI--Q 300 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHH-HHH--H
Confidence 7554322 1125689999999999999999999999999999999999999999765332211 111 1
Q ss_pred CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 288 ~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.....++..+++.+++||+++|..||.+|+|+.+|.+||||.+..
T Consensus 301 ~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 301 ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 223467888999999999999999999999999999999998743
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=411.56 Aligned_cols=258 Identities=33% Similarity=0.569 Sum_probs=228.1
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
..-.+|+..+.||.|+||+|.+++++.+|..+|+|++.+. .-......+...+|..+|+.+.||+++++++.+.+
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~-----~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d 115 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQ-----KVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD 115 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHH-----HHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc
Confidence 4556899999999999999999999999999999998432 22333455678899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...+||||||++||.|+.++++.++|++..++.++.||+.||+|||+++|++|||||+|||||.+|.+||+|||+|+.+.
T Consensus 116 ~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 116 NSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred CCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999764
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
. ..-+.||||.|+|||++...+|+.++|+|||||++|||+.|.+||..... +....++ ......+|..++.+
T Consensus 196 ~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI--~~~~v~fP~~fs~~ 267 (355)
T KOG0616|consen 196 G-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKI--LEGKVKFPSYFSSD 267 (355)
T ss_pred C-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHH--HhCcccCCcccCHH
Confidence 3 24578999999999999999999999999999999999999999976543 2222222 22334578899999
Q ss_pred HHHHHHHhhhhCCCCC-----CCHHHHHcCccccCC
Q 005944 301 AKDFLLKCLQKEPYLR-----STASELLQHPFVTGK 331 (668)
Q Consensus 301 l~dLI~kcL~~dP~~R-----PSa~EIL~Hpwf~~~ 331 (668)
+++||.++|++|-.+| ....+|..||||.+.
T Consensus 268 ~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v 303 (355)
T KOG0616|consen 268 AKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV 303 (355)
T ss_pred HHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence 9999999999999999 578899999999853
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=430.65 Aligned_cols=262 Identities=31% Similarity=0.517 Sum_probs=226.1
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~ 139 (668)
....+|.+++.||+|+||+|++|.+..++..||||++....... .. ......+.+|+.+++.++ ||||+++++++.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~--~~-~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSS--KS-QKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccc--cc-cccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 56778999999999999999999999999999999764321110 11 133455668999999999 999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-CceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK-GCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~-g~vKL~DFGlA~~ 218 (668)
....+|+|||||.||+|++++.+.+++.|.+++.+|+||+.||+|||++||+||||||+|||++.+ +++||+|||++..
T Consensus 91 t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 91 TPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred cCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999 9999999999986
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcC-C-CcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTG-H-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ 296 (668)
.. .......+.|||+.|+|||++.+.. | +.++||||+||+||.|++|+.||.+.... .++.. .......+|..
T Consensus 171 ~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--~l~~k-i~~~~~~~p~~ 245 (370)
T KOG0583|consen 171 SP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--NLYRK-IRKGEFKIPSY 245 (370)
T ss_pred cC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--HHHHH-HhcCCccCCCC
Confidence 53 2234567899999999999999977 7 57899999999999999999999863221 11111 23344556777
Q ss_pred c-CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 297 L-SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 297 l-s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+ +.++++||.+||..||.+|+++.+|+.||||+.
T Consensus 246 ~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 246 LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 7 999999999999999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-49 Score=428.08 Aligned_cols=266 Identities=32% Similarity=0.513 Sum_probs=227.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|+++.+||+|+||.||+|+.+.||..+|+|++.+. .-.....+..+..|-.+|....+|+||+||..|++
T Consensus 138 ~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS-----~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD 212 (550)
T KOG0605|consen 138 LSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKS-----EMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD 212 (550)
T ss_pred CCcccchhheeeccccceeEEEEEEccCCcEEeeecccHH-----HHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC
Confidence 4667899999999999999999999999999999999532 22334556778899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.+++||||||++||++..+|.+.+.|++..++.++.+++.||..||++|||||||||+|+|||..|++||+||||+..+.
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999986442
Q ss_pred hhh--------------h-------hc------------------------CCccCCCCCCCCChHHHhhcCCCcchhHH
Q 005944 221 ELA--------------T-------IN------------------------GAKSMKGTPYWMAPEVILQTGHSFSADIW 255 (668)
Q Consensus 221 ~~~--------------~-------~~------------------------~~~~~~GT~~Y~APEvl~~~~~s~ksDIW 255 (668)
... . .. ...+.+|||.|||||+|.+.+|+..+|+|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 200 0 00 01246799999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCchhH-HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCC---CHHHHHcCccccCC
Q 005944 256 SVGCTVIEMATGKPPWSQQF-QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRS---TASELLQHPFVTGK 331 (668)
Q Consensus 256 SLGvILyeLLTG~~PF~~~~-~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RP---Sa~EIL~Hpwf~~~ 331 (668)
|||||+||||.|.+||.... .+....+..+......+....++.+++|||.+||. ||++|. +++||..||||.+.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v 451 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV 451 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence 99999999999999997553 33333333333333344455788999999999999 999996 59999999999875
Q ss_pred C
Q 005944 332 Y 332 (668)
Q Consensus 332 ~ 332 (668)
.
T Consensus 452 ~ 452 (550)
T KOG0605|consen 452 D 452 (550)
T ss_pred C
Confidence 3
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=418.72 Aligned_cols=262 Identities=49% Similarity=0.881 Sum_probs=226.7
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|..++.||+|+||+||++.+.++|..+|||.+.... . ...+.+.+|+.+|.+++|||||+++|......
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~-------~-~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~ 87 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED-------S-PTSESLEREIRILSRLNHPNIVQYYGSSSSRE 87 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc-------c-hhHHHHHHHHHHHHhCCCCCEEeeCCcccccc
Confidence 567999999999999999999999999999999985431 1 11567889999999999999999999755554
Q ss_pred --cceEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-CCceEEecCCchhh
Q 005944 143 --SLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN-KGCIKLADFGASKK 218 (668)
Q Consensus 143 --~~~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~-~g~vKL~DFGlA~~ 218 (668)
.++|+|||+++|+|.+++.+.+ .+++..++.+++||++||+|||++|||||||||+||||+. ++.+||+|||+++.
T Consensus 88 ~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 88 NDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred CeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 6999999999999999999887 7999999999999999999999999999999999999999 79999999999987
Q ss_pred hHh-hhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcc
Q 005944 219 VVE-LATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 219 ~~~-~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ 296 (668)
... ...........||+.|||||++.++. ...++|||||||++.||+||++||.........++.++.....+.+|..
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ 247 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDS 247 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcc
Confidence 653 11223344688999999999998632 3459999999999999999999998754444556666666667789999
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
++.++++||.+||..+|.+||||.++|+|||.+...
T Consensus 248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 999999999999999999999999999999997543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=438.44 Aligned_cols=260 Identities=31% Similarity=0.546 Sum_probs=227.6
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.-|++++.||.|+-|.|.+|+|..||+.+|||+|.+.. ...+.....+.+|+-||+.+.||||+++|++|.+...
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~-----~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRS-----ELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH 86 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeecccc-----ccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence 34999999999999999999999999999999995432 2223334567899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|+|+||++||.|++++.+.+++++.++.++++||+.|+.|||..+|+||||||+|+||+..+++||+|||+|..-.+
T Consensus 87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~-- 164 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVP-- 164 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccC--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999986433
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
.....+.||+|.|.|||+++|..| +.++||||+|||||.||||+.||.+..-.. .+.++. .....+|..++.+++
T Consensus 165 -gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~-LLlKV~--~G~f~MPs~Is~eaQ 240 (786)
T KOG0588|consen 165 -GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV-LLLKVQ--RGVFEMPSNISSEAQ 240 (786)
T ss_pred -CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH-HHHHHH--cCcccCCCcCCHHHH
Confidence 233567899999999999999998 789999999999999999999998543221 122222 233457799999999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHcCccccCCCCC
Q 005944 303 DFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334 (668)
Q Consensus 303 dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~ 334 (668)
+||.+||.+||.+|+|.+||++|||+.+....
T Consensus 241 dLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~ 272 (786)
T KOG0588|consen 241 DLLRRMLDVDPSTRITTEEILKHPFLSGYTSL 272 (786)
T ss_pred HHHHHHhccCccccccHHHHhhCchhhcCCCC
Confidence 99999999999999999999999999875543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=406.14 Aligned_cols=259 Identities=30% Similarity=0.543 Sum_probs=217.7
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|+.+.++|+|+||+||+|++++||+.||||++. ..+.++...+-..+|+++|++|+|+|+|.|+++|.....
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~------Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrk 75 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFV------ESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRK 75 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeec------cCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcce
Confidence 46888999999999999999999999999999983 334445566677899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
++||+|||+..-|.++-+....++...++.+++|++.|+.|||++++|||||||+||||+.+|.+||||||+|+.+..
T Consensus 76 lhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 76 LHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred eEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 999999999877776666667899999999999999999999999999999999999999999999999999998753
Q ss_pred hhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhcc---------------C
Q 005944 224 TINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT---------------T 287 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~---------------~ 287 (668)
....++.++.|.+|+|||++.+ ..|+..+||||+||++.||++|.+.|.+..+ +..++.+.. .
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD-iDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD-IDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch-HHHHHHHHHHHcccCHHHHHHhccC
Confidence 3344667899999999999998 6799999999999999999999999975422 111111100 0
Q ss_pred CC----CCCCC----------cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 288 KS----HPPIP----------EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 288 ~~----~~~~p----------~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.. ..+.+ ..++.-+.+|+++||+.||.+|++.+++|.|+||.+.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 00 00111 2356678899999999999999999999999999653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-48 Score=395.17 Aligned_cols=248 Identities=33% Similarity=0.592 Sum_probs=212.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc-ccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG-TAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g-~~~ 139 (668)
....+|++.+.||.|.||+||++.+..+|..||.|.+.. ...+.........|+.+|++|+|||||++++ .+.
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f------~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~ 89 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF------GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI 89 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch------hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh
Confidence 445679999999999999999999999999999998842 2223344556788999999999999999998 454
Q ss_pred cCCc-ceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccccCCcccEEeCCCCceEE
Q 005944 140 EDDS-LNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHK--NG--IMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 140 ~~~~-~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs--~g--IvHrDLKPeNILld~~g~vKL 210 (668)
.+.. ++||||||.+|+|..+|+. .+.++|..+|+++.|++.||.+||. .. |+||||||.||+|+.+|.+||
T Consensus 90 ~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL 169 (375)
T KOG0591|consen 90 EDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL 169 (375)
T ss_pred ccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee
Confidence 4444 9999999999999999854 3569999999999999999999999 45 999999999999999999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchh-HHHHHHHHhhccCCC
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ-FQEVAALFHIGTTKS 289 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~-~~~~~~~~~~~~~~~ 289 (668)
+||||++.+.... ..+.+.+|||+||+||.+.+.+|+.++||||+||++|||+.-++||.+. ..++...+..+ .
T Consensus 170 GDfGL~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qg---d 244 (375)
T KOG0591|consen 170 GDFGLGRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQG---D 244 (375)
T ss_pred ccchhHhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcC---C
Confidence 9999999875433 3456799999999999999999999999999999999999999999865 23333333332 4
Q ss_pred CCCCC-cccCHHHHHHHHHhhhhCCCCCCCH
Q 005944 290 HPPIP-EHLSMEAKDFLLKCLQKEPYLRSTA 319 (668)
Q Consensus 290 ~~~~p-~~ls~el~dLI~kcL~~dP~~RPSa 319 (668)
.+++| .++|.++..||..|+.+||+.||+.
T Consensus 245 ~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 245 YPPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred CCCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 45567 7899999999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=414.35 Aligned_cols=257 Identities=33% Similarity=0.591 Sum_probs=225.6
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|.+.+.||+|+||+||+|+.+.+.+.||+|.+.+. .+.+..++.+.+|++|++.|+|||||.++++|++...
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~------gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKS------GRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhc------CCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence 4788999999999999999999999999999998432 3344566778999999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+++|+|||.| +|+.+|...+.++|+.++.|+.|++.||.|||+++|+|||+||.|||+...|.+|+||||+|+.+...
T Consensus 76 ~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred EEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 9999999987 99999999999999999999999999999999999999999999999999999999999999976542
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~d 303 (668)
....+...|||.|||||++.+..|+..+|+||||||+|||++|++||.... +..+... ........|...+..+.+
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--i~~Lv~~-I~~d~v~~p~~~S~~f~n 229 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--ITQLVKS-ILKDPVKPPSTASSSFVN 229 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--HHHHHHH-HhcCCCCCcccccHHHHH
Confidence 223456789999999999999999999999999999999999999997532 1111111 122334456689999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 304 FLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 304 LI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
|+..+|.+||.+|.+..+++.|||+++..
T Consensus 230 fl~gLL~kdP~~RltW~~Ll~HpF~k~~~ 258 (808)
T KOG0597|consen 230 FLQGLLIKDPAQRLTWTDLLGHPFWKGKI 258 (808)
T ss_pred HHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence 99999999999999999999999998754
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=389.15 Aligned_cols=262 Identities=29% Similarity=0.447 Sum_probs=234.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.+...|.+.+.||+|.|+.||++.+..+|+.+|+|++....-. ....+.+.+|++|-+.|+|||||+|.+.+..
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~------~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~ 81 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS------ARDFQKLEREARICRKLQHPNIVRLHDSIQE 81 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhc------cccHHHHHHHHHHHHhcCCCcEeehhhhhcc
Confidence 4567899999999999999999999999999999998543222 2245678899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC---CceEEecCCchh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK---GCIKLADFGASK 217 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~---g~vKL~DFGlA~ 217 (668)
....|||+|++.|++|..-|-...-++|..+..+++||+.||.|||.+||||||+||+|+|+... .-+||+|||+|.
T Consensus 82 ~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 82 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred cceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999999999998777666778999999999999999999999999999999999999543 469999999998
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCch-hHHHHHHHHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQ-QFQEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~-~~~~~~~~~~~~~~~~~~~~p~~ 296 (668)
.+. .........|||.|||||++....|+..+|||+.|||||-||.|.+||.+ ....+.+.+..+......+.+.+
T Consensus 162 ~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~ 238 (355)
T KOG0033|consen 162 EVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDT 238 (355)
T ss_pred EeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCc
Confidence 765 23345568899999999999999999999999999999999999999998 56777777888888888889999
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
+++++++||++||..||.+|+|+.|+|+|||+.+.
T Consensus 239 is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 239 VTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred CCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 99999999999999999999999999999999753
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=407.70 Aligned_cols=262 Identities=32% Similarity=0.498 Sum_probs=218.1
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~ 139 (668)
..-.||.+.+.||.|+||.||+|+.+.+|..||||.++..... .++. .-.+|++.|++|+ |||||+|.+++.
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-----~ee~--~nLREvksL~kln~hpniikL~Evi~ 79 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-----WEEC--MNLREVKSLRKLNPHPNIIKLKEVIR 79 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-----HHHH--HHHHHHHHHHhcCCCCcchhhHHHhh
Confidence 4557899999999999999999999999999999998532211 1222 2357999999998 999999999999
Q ss_pred cCC-cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 EDD-SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~-~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
+.+ .+|+||||++. +|+++++.. ..|++..++.|++||++||+|+|.+|+.|||||||||||.....|||+|||+|+
T Consensus 80 d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 80 DNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred ccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccc
Confidence 988 89999999976 999998654 569999999999999999999999999999999999999999999999999999
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCCCC----
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTKSH---- 290 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~~~---- 290 (668)
.+. ...+++.++.|.+|+|||+|+... |+.++||||+|||++|+.+-++.|.+.. +++..+..+......
T Consensus 159 ev~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 159 EVR---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred ccc---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 764 456677899999999999997654 8999999999999999999999997542 333333322111110
Q ss_pred -------------C--------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 291 -------------P--------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 291 -------------~--------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
+ .+-...+.++.+||.+||.+||.+||||.++|+||||+....
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 0 111247889999999999999999999999999999986543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-46 Score=390.04 Aligned_cols=253 Identities=33% Similarity=0.527 Sum_probs=218.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|.+..+++.||||++... ..........+.+|+.+|+.++||||+++++++.+...
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 75 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIP-----EVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRF 75 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHH-----HHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCe
Confidence 3689999999999999999999999999999998432 11122334567889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+..
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-- 153 (291)
T cd05612 76 LYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-- 153 (291)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC--
Confidence 999999999999999998888999999999999999999999999999999999999999999999999999876532
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....++..++..++
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~ 226 (291)
T cd05612 154 ---RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA----GKLEFPRHLDLYAK 226 (291)
T ss_pred ---CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCcCCCccCCHHHH
Confidence 223467999999999999988999999999999999999999999754322 1111111 12345667899999
Q ss_pred HHHHHhhhhCCCCCCC-----HHHHHcCccccC
Q 005944 303 DFLLKCLQKEPYLRST-----ASELLQHPFVTG 330 (668)
Q Consensus 303 dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~ 330 (668)
+||.+||+.||.+|++ ++++++||||..
T Consensus 227 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 227 DLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 9999999999999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=409.58 Aligned_cols=262 Identities=33% Similarity=0.552 Sum_probs=220.4
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC-
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED- 141 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~- 141 (668)
...|+..+.||+|.||.||+|++..+|+.||+|++.+.. ..+.......+||.||++|+||||++|.+.....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~------~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN------EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc------CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 446999999999999999999999999999999985432 2334556678999999999999999999988776
Q ss_pred -CcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 142 -DSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 142 -~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
..+|||+|||+. +|.-++... -.|++.+++.|++||+.||+|||.+||+|||||..|||||++|.+||+|||||+.+
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred CceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 689999999986 888888763 57999999999999999999999999999999999999999999999999999976
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCCC---CC--
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTKS---HP-- 291 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~~---~~-- 291 (668)
... ....++..+.|++|+|||+|+|.. |+.++|+||+||||.||++|++.|.+.. ..+..++++..... +.
T Consensus 269 ~~~-~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPS-GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCC-CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 543 333467788999999999999865 9999999999999999999999997643 33344444332211 11
Q ss_pred CC-------------------CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 292 PI-------------------PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 292 ~~-------------------p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.+ -..++..+.+|+..||..||.+|.||.++|+|+||....
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 11 135678899999999999999999999999999995433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=414.35 Aligned_cols=258 Identities=36% Similarity=0.622 Sum_probs=224.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.+...|.....||+|+.|.||.|....++..||||.+.+.. +...+.+.+|+.+|+..+|+|||.+++.|..
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--------Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv 341 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--------QPKKELLLNEILVMRDLHHPNIVNFLDSYLV 341 (550)
T ss_pred ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--------CCchhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence 34567899999999999999999999999999999995432 2334567899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.+.+++||||++||+|.+++... .++|.++..|++++++||+|||.+||+|||||.+|||++.+|.+||+|||++..+.
T Consensus 342 ~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 342 GDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred cceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999999999999998764 59999999999999999999999999999999999999999999999999998876
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
+... ...+.+|||+|||||++....|++++||||||++++||+-|.+||.....-....+...........++.+|++
T Consensus 421 ~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~ 498 (550)
T KOG0578|consen 421 EEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPE 498 (550)
T ss_pred cccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHH
Confidence 5443 34678999999999999999999999999999999999999999964322111122222233344567889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
+++|+.+||+.|+.+|+++.|+|+||||+
T Consensus 499 ~kdFL~~cL~~dv~~RasA~eLL~HpFl~ 527 (550)
T KOG0578|consen 499 LKDFLDRCLVVDVEQRASAKELLEHPFLK 527 (550)
T ss_pred HHHHHHHHhhcchhcCCCHHHHhcChhhh
Confidence 99999999999999999999999999995
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=396.73 Aligned_cols=256 Identities=32% Similarity=0.573 Sum_probs=221.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+++.||||++... ..........+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 89 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR-----EILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD 89 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH-----HHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence 4457899999999999999999999999999999998421 11122344668899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
++.+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 90 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 90 ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999987653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...... .....++..++.
T Consensus 170 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~----~~~~~~p~~~~~ 240 (329)
T PTZ00263 170 D-----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL----AGRLKFPNWFDG 240 (329)
T ss_pred C-----CcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh----cCCcCCCCCCCH
Confidence 2 223468999999999999999999999999999999999999999754321 111111 123345667899
Q ss_pred HHHHHHHHhhhhCCCCCCC-----HHHHHcCccccC
Q 005944 300 EAKDFLLKCLQKEPYLRST-----ASELLQHPFVTG 330 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~ 330 (668)
.+++||.+||+.||.+|++ +.+|+.||||.+
T Consensus 241 ~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 241 RARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 9999999999999999987 799999999975
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=396.25 Aligned_cols=251 Identities=29% Similarity=0.473 Sum_probs=214.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEee
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLE 149 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmE 149 (668)
++||+|+||.||+|.+..+|+.||||++.... .........+.+|+.+|+.++||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 75 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEV-----IIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEe
Confidence 47999999999999999999999999984321 1122334567789999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCc
Q 005944 150 FVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAK 229 (668)
Q Consensus 150 y~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~ 229 (668)
|+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.... ......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~ 153 (323)
T cd05571 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMK 153 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCccc
Confidence 999999999998888999999999999999999999999999999999999999999999999999874321 112234
Q ss_pred cCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH-HHHHhhccCCCCCCCCcccCHHHHHHHHHh
Q 005944 230 SMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV-AALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308 (668)
Q Consensus 230 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~-~~~~~~~~~~~~~~~p~~ls~el~dLI~kc 308 (668)
..+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..... .....++..++.++.+||.+|
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~p~~~~~~~~~li~~~ 229 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL----MEEIRFPRTLSPEAKSLLAGL 229 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH----cCCCCCCCCCCHHHHHHHHHH
Confidence 5679999999999999999999999999999999999999997543322 22211 123356678999999999999
Q ss_pred hhhCCCCCC-----CHHHHHcCccccCC
Q 005944 309 LQKEPYLRS-----TASELLQHPFVTGK 331 (668)
Q Consensus 309 L~~dP~~RP-----Sa~EIL~Hpwf~~~ 331 (668)
|+.||.+|| ++.++++||||...
T Consensus 230 L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 230 LKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred ccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999 89999999999763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=412.23 Aligned_cols=260 Identities=28% Similarity=0.479 Sum_probs=224.3
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeecccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~ 138 (668)
.....+|++.++||+|.||+|++|..+.+++.+|||++++.... ..+.++....|.+|+.... ||.++.|+..|
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il-----~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f 438 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDIL-----QRDEVESLMCEKRIFELANRHPFLVNLFSCF 438 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeecccee-----ccccHHHHHHHHHHHHHhccCCeEeeccccc
Confidence 35567899999999999999999999999999999999654432 2344566778888888875 99999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
++.+++|+||||+.||++. ++.+.+.|++..++.|+..|+.||.|||++||||||||.+|||||.+|++||+|||+++.
T Consensus 439 QT~~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 439 QTKEHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred ccCCeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999999999944 445558999999999999999999999999999999999999999999999999999985
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~l 297 (668)
.. ...+...++||||.|||||++.+..|+.++|+|||||+|||||.|..||.+..+ ++...+. .....+|..+
T Consensus 518 ~m--~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~----~d~~~yP~~l 591 (694)
T KOG0694|consen 518 GM--GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV----NDEVRYPRFL 591 (694)
T ss_pred cC--CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----cCCCCCCCcc
Confidence 32 133456789999999999999999999999999999999999999999986543 3333222 2345678899
Q ss_pred CHHHHHHHHHhhhhCCCCCCC-----HHHHHcCccccCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRST-----ASELLQHPFVTGK 331 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~~ 331 (668)
+.++.++|+++|.++|++|.. +++|..||||...
T Consensus 592 s~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 592 SKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred cHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccC
Confidence 999999999999999999976 5899999999854
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=391.61 Aligned_cols=272 Identities=28% Similarity=0.485 Sum_probs=214.7
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchh------hHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSAS------KEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~------~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
-+.|++.+.||+|.||.|.+|++..+++.||||++........ .......++.+.+||.||++|+|||||+|++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 3579999999999999999999999999999999943322111 0111123457899999999999999999999
Q ss_pred cccc--CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 137 TARE--DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 137 ~~~~--~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
+..+ .+.+|||+|||..|.+...=.....+++.++++|+++++.||+|||.+|||||||||.|+||+.+|++||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 9865 46799999999998887554443349999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhh---hhhcCCccCCCCCCCCChHHHhhcC----CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccC
Q 005944 215 ASKKVVEL---ATINGAKSMKGTPYWMAPEVILQTG----HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT 287 (668)
Q Consensus 215 lA~~~~~~---~~~~~~~~~~GT~~Y~APEvl~~~~----~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~ 287 (668)
.+..+... .........+|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||.+...-.. .-++...
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l-~~KIvn~ 334 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL-FDKIVND 334 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH-HHHHhcC
Confidence 98755211 0011122368999999999998733 36789999999999999999999976543211 1122222
Q ss_pred CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCCC
Q 005944 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335 (668)
Q Consensus 288 ~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~~ 335 (668)
....+....+..++++||++||.+||++|.++.+|..|||.......+
T Consensus 335 pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~ 382 (576)
T KOG0585|consen 335 PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSP 382 (576)
T ss_pred cccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCC
Confidence 222222335789999999999999999999999999999998765544
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=397.07 Aligned_cols=262 Identities=29% Similarity=0.442 Sum_probs=213.5
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|.+..+++.||||++... ..........+.+|+.++..++|+||+++++.+.+...
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~ 75 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKA-----DMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLN 75 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHH-----HHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCe
Confidence 3699999999999999999999999999999998421 11223345667889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|||||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 76 LYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999987543211
Q ss_pred h---------------------------------hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCC
Q 005944 224 T---------------------------------INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPP 270 (668)
Q Consensus 224 ~---------------------------------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~P 270 (668)
. .......+||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 0001246899999999999999999999999999999999999999
Q ss_pred CchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCC---CCCCHHHHHcCccccCC
Q 005944 271 WSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPY---LRSTASELLQHPFVTGK 331 (668)
Q Consensus 271 F~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~---~RPSa~EIL~Hpwf~~~ 331 (668)
|...... ....+.........+....++.++++||.+|+. +|. .||+++||++||||++.
T Consensus 236 f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 236 FCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 9754322 211111111111111123478999999999775 444 56899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-46 Score=393.25 Aligned_cols=269 Identities=32% Similarity=0.477 Sum_probs=228.0
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
.......|++++.||+|.-|+||+|....++..+|+|++.... -.....+.+++.|-.||..++||.++.||..|
T Consensus 72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~-----l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f 146 (459)
T KOG0610|consen 72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKES-----LASRKKLKRAQTEREILSLLDHPFLPTLYASF 146 (459)
T ss_pred CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHH-----HhhhhHHHHHHHHHHHHHhcCCCccchhhhee
Confidence 3455667999999999999999999999999999999994322 22244566788899999999999999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+.+...|+|||||+||+|..+++++ +.|++..++.++.+++.||+|||-.|||+|||||+||||.++|+|-|.||.|+
T Consensus 147 et~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS 226 (459)
T KOG0610|consen 147 ETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLS 226 (459)
T ss_pred eccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeecccc
Confidence 9999999999999999999998775 56999999999999999999999999999999999999999999999999986
Q ss_pred hhhHh---------------------------------hhh---------------------hcCCccCCCCCCCCChHH
Q 005944 217 KKVVE---------------------------------LAT---------------------INGAKSMKGTPYWMAPEV 242 (668)
Q Consensus 217 ~~~~~---------------------------------~~~---------------------~~~~~~~~GT~~Y~APEv 242 (668)
..+.- ... .....+++||-.|+|||+
T Consensus 227 ~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEv 306 (459)
T KOG0610|consen 227 LRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEV 306 (459)
T ss_pred ccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccccccccccee
Confidence 53310 000 011235689999999999
Q ss_pred HhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCC----
Q 005944 243 ILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRST---- 318 (668)
Q Consensus 243 l~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPS---- 318 (668)
|.+.+++.++|||+|||+|||||.|..||.+...+..-...+......+..+ .++..++|||+++|.+||.+|..
T Consensus 307 I~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rG 385 (459)
T KOG0610|consen 307 IRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRG 385 (459)
T ss_pred eecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccc
Confidence 9999999999999999999999999999987765544444444333333333 78899999999999999999998
Q ss_pred HHHHHcCccccCCCC
Q 005944 319 ASELLQHPFVTGKYQ 333 (668)
Q Consensus 319 a~EIL~Hpwf~~~~~ 333 (668)
|.||.+||||++..-
T Consensus 386 A~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 386 AAEIKRHPFFEGVNW 400 (459)
T ss_pred hHHhhcCccccCCCh
Confidence 999999999998653
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=381.81 Aligned_cols=258 Identities=25% Similarity=0.398 Sum_probs=211.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|++..++..||||++..... .......+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE------NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK 74 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc------cccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence 379999999999999999999999999999999853211 12234557789999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|+||||++++.+..+......+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+....
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 75 LYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99999999998887666656679999999999999999999999999999999999999999999999999998653221
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhcc------------C--
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGT------------T-- 287 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~------------~-- 287 (668)
........||+.|+|||++.+..++.++|||||||++|+|++|++||..... ....+..... .
T Consensus 155 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 155 -NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred -cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 1122346799999999999988899999999999999999999999974321 1111111000 0
Q ss_pred ---CCC----------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 288 ---KSH----------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 288 ---~~~----------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
... ......++.++.+||.+||++||.+|||++++|+||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 01122478889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=391.82 Aligned_cols=257 Identities=31% Similarity=0.533 Sum_probs=217.7
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||.||+|++..+++.||||++.... .........+.+|+.+|..++||||+++++++.....
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~ 75 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSL-----LFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEY 75 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHH-----HhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCE
Confidence 36999999999999999999999999999999984221 1122345667889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.||||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 76 LYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred EEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 999999999999999998888899999999999999999999999999999999999999999999999999975432
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCC-CCCCC---cccC
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKS-HPPIP---EHLS 298 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~-~~~~p---~~ls 298 (668)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... +....+....... .+... ..++
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s 230 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLS 230 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccC
Confidence 23456899999999999998999999999999999999999999975432 2212121111111 11111 2568
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.++.+||.+||..+|.+||++.++++||||..
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence 99999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=381.77 Aligned_cols=267 Identities=28% Similarity=0.447 Sum_probs=239.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
.....|.-.+.||.|..++|.++.++.+|..+|+|++.........+......+.-..|+.||+++ .||+|+.+.++|+
T Consensus 14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye 93 (411)
T KOG0599|consen 14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE 93 (411)
T ss_pred hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence 455678888999999999999999999999999999987776666666566667778899999998 5999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.+..+++|+|.|+.|.|+++|...-.++|...+.|++||+.|+.|||.++||||||||+|||++++.++||+|||+|+.+
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l 173 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL 173 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc
Confidence 99999999999999999999999899999999999999999999999999999999999999999999999999999987
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHh------hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVIL------QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPP 292 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~------~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~ 292 (668)
..+.. ....||||+|+|||.+. ..+|+..+|+|++|||+|.||.|.+||....+- +...+..+......+
T Consensus 174 ~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~sp 250 (411)
T KOG0599|consen 174 EPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSP 250 (411)
T ss_pred CCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCc
Confidence 65433 45689999999999995 345888999999999999999999999866543 344556677777888
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
-|.+++.++++||.+||++||.+|.|+.|+|.||||..
T Consensus 251 eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 251 EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 89999999999999999999999999999999999954
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=396.67 Aligned_cols=262 Identities=31% Similarity=0.493 Sum_probs=215.9
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.++||+|+||+||+|++..+++.||||++.... .........+.+|+.+|..++|+||+++++++.....
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE-----MLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENY 75 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCe
Confidence 36999999999999999999999999999999984221 1122344567889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|||||||++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.+....
T Consensus 76 ~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 76 LYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred EEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987542211
Q ss_pred hh------------------------------------cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhC
Q 005944 224 TI------------------------------------NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATG 267 (668)
Q Consensus 224 ~~------------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG 267 (668)
.. ......+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 011235799999999999999999999999999999999999
Q ss_pred CCCCchhHHHH-HHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCC---HHHHHcCccccCC
Q 005944 268 KPPWSQQFQEV-AALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRST---ASELLQHPFVTGK 331 (668)
Q Consensus 268 ~~PF~~~~~~~-~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPS---a~EIL~Hpwf~~~ 331 (668)
.+||....... .............+....+++++++||.+||. +|.+|++ +.+++.||||.+.
T Consensus 236 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 236 YPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 99997543221 11111111111112223578999999999996 9999998 9999999999753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=374.12 Aligned_cols=259 Identities=28% Similarity=0.477 Sum_probs=216.1
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|...+.||+|.||.||+|++..+|+.||||+|+... ..........+||++|+.++|+||+.|+++|...+.
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~------~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~ 75 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGN------AKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN 75 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccc------cccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence 47889999999999999999999999999999996542 222333557789999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
+.||+||++. +|..+|+.. ..++..+++.|+.++++||+|||.+.|+||||||.|+||+.+|.+||+|||+|+.+...
T Consensus 76 l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 76 LSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9999999975 999988664 56899999999999999999999999999999999999999999999999999987543
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCCCCCC-------
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTKSHPP------- 292 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~~~~~------- 292 (668)
... ....+-|.+|+|||++.|.. |+..+||||.|||+.||+-|.+-|.+.. +.+..++..........
T Consensus 155 ~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l 232 (318)
T KOG0659|consen 155 NRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL 232 (318)
T ss_pred Ccc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence 322 23347899999999999865 9999999999999999999998886543 33334443322111111
Q ss_pred ----------------CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 293 ----------------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 293 ----------------~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
+-...+.++.||+.+||..||.+|+++.|+|+|+||+..
T Consensus 233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 112357788999999999999999999999999999863
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=398.91 Aligned_cols=262 Identities=32% Similarity=0.514 Sum_probs=214.7
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
.|++.+.||+|+||+||+|++..++..||||++... ..........+.+|+.+|+.++|+|||++++++.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~-----~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~ 76 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKK-----DVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNL 76 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHH-----HhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEE
Confidence 689999999999999999999999999999998421 112233456788999999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
|+|||||++|+|.+++.+.+.+++..++.++.||+.||.|||..||+||||||+||||+.++.+||+|||+++.+.....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 77 YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999753310000
Q ss_pred ---------------------------------------------hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHH
Q 005944 225 ---------------------------------------------INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGC 259 (668)
Q Consensus 225 ---------------------------------------------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGv 259 (668)
.......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 00112467999999999999888999999999999
Q ss_pred HHHHHHhCCCCCchhHHHHHHH-HhhccCCCCCCCCcccCHHHHHHHHHhh--hhCCCCCCCHHHHHcCccccCC
Q 005944 260 TVIEMATGKPPWSQQFQEVAAL-FHIGTTKSHPPIPEHLSMEAKDFLLKCL--QKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 260 ILyeLLTG~~PF~~~~~~~~~~-~~~~~~~~~~~~p~~ls~el~dLI~kcL--~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++|+|+||..||.......... ..........+....+++++.+||.+|| ..+|..|+++.+++.||||+..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 9999999999997543322111 1111112222333468999999999955 4555669999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=400.59 Aligned_cols=266 Identities=29% Similarity=0.463 Sum_probs=232.0
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeecccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~ 138 (668)
......|.+.+.||.|.||+||+|+++.+|+.+|+|++....... ......+.+|+.+|+++. |||||.++++|
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~-----~~~~~~v~~Ev~il~~l~~hpniv~l~~~~ 105 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRG-----KEDREDVRREVAILQQLSGHPNIVQLKDAF 105 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccc-----cccHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 466778999999999999999999999999999999995433221 124457889999999998 99999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC----CceEEecCC
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK----GCIKLADFG 214 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~----g~vKL~DFG 214 (668)
++...+++|||+|.||.|++.|.+. .++|..+..+++||+.+++|||+.||+||||||+|||+... +.+|++|||
T Consensus 106 e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 106 EDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999999999998776 59999999999999999999999999999999999999643 579999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCC
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPI 293 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~ 293 (668)
++..... .......+||+.|+|||++.+..|+..+||||+||++|.|++|.+||...... ....+..+......+.
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~ 261 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEP 261 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCC
Confidence 9987654 33456789999999999999999999999999999999999999999876533 2333444555566778
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~ 334 (668)
+..++..+++||.+||..||.+|+|+.++|+|||++.....
T Consensus 262 w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~ 302 (382)
T KOG0032|consen 262 WDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEA 302 (382)
T ss_pred ccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccc
Confidence 88999999999999999999999999999999999875433
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=381.55 Aligned_cols=259 Identities=27% Similarity=0.414 Sum_probs=214.3
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
.|++.+.||+|+||+||+|.+..+++.||||++.... .........+.+|+.+|..++|+||+++++++...+.+
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~ 75 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-----IKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhh-----hhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeE
Confidence 3788999999999999999999999999999884221 11122234567899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
++||||+++|+|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 76 CLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 9999999999998877543 46899999999999999999999999999999999999999999999999998764321
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...............++..++.++
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 232 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDA 232 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHH
Confidence 1 123467999999999999999999999999999999999999999753211 001111111122334566789999
Q ss_pred HHHHHHhhhhCCCCCCC-----HHHHHcCccccCC
Q 005944 302 KDFLLKCLQKEPYLRST-----ASELLQHPFVTGK 331 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~~ 331 (668)
.+||.+||+.||.+||+ ++++++||||.+.
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 233 KSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 99999999999999997 9999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=397.47 Aligned_cols=260 Identities=34% Similarity=0.537 Sum_probs=214.7
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.++||+|+||+||+|++..+++.||||++... ..........+.+|+.+|+.++|+|||++++.+.+.+.+
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~-----~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~ 76 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKK-----DVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 76 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHH-----HhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEE
Confidence 689999999999999999999999999999998421 112234456788999999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh-
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA- 223 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~- 223 (668)
|+|||||++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 77 YFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999975321000
Q ss_pred --------------------------------------------hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHH
Q 005944 224 --------------------------------------------TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGC 259 (668)
Q Consensus 224 --------------------------------------------~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGv 259 (668)
........+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 000112357999999999999999999999999999
Q ss_pred HHHHHHhCCCCCchhHHHHHHH-HhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCC---HHHHHcCccccC
Q 005944 260 TVIEMATGKPPWSQQFQEVAAL-FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRST---ASELLQHPFVTG 330 (668)
Q Consensus 260 ILyeLLTG~~PF~~~~~~~~~~-~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPS---a~EIL~Hpwf~~ 330 (668)
+||+|++|++||.......... ..........+....+++++.+||.+|+ .+|.+|++ +.++++||||..
T Consensus 237 il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 9999999999997543221111 1111112222334568999999999986 59999987 999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=396.95 Aligned_cols=262 Identities=32% Similarity=0.515 Sum_probs=213.5
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||.|+||+||+|.+..+++.||||++... ..........+.+|+++|+.++|||||++++++.+...
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~ 75 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQY 75 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHH-----HHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCe
Confidence 3699999999999999999999999999999998421 11123345678899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+||||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+....
T Consensus 76 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 76 LYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999986332100
Q ss_pred hh---------------------------------------------cCCccCCCCCCCCChHHHhhcCCCcchhHHHHH
Q 005944 224 TI---------------------------------------------NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVG 258 (668)
Q Consensus 224 ~~---------------------------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLG 258 (668)
.. ......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 000135799999999999998999999999999
Q ss_pred HHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCC---CCHHHHHcCccccCC
Q 005944 259 CTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLR---STASELLQHPFVTGK 331 (668)
Q Consensus 259 vILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~R---PSa~EIL~Hpwf~~~ 331 (668)
|+||+|++|.+||..... .....+.........+-...++.++++||.+||. +|.+| +++.+++.||||.+.
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 236 AIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred hhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 999999999999965432 1111111111111112223578999999999997 67665 699999999999753
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=397.05 Aligned_cols=261 Identities=33% Similarity=0.509 Sum_probs=215.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|.+..+++.||||++... ..........+.+|+.+|+.++|+||+++++.+..++.
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~-----~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~ 75 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA-----DVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN 75 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHH-----HHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence 3699999999999999999999999999999988321 11122334567889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh-
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL- 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~- 222 (668)
+|+|||||++|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|..+...
T Consensus 76 ~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999997532100
Q ss_pred ----------------------------------------hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHH
Q 005944 223 ----------------------------------------ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVI 262 (668)
Q Consensus 223 ----------------------------------------~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILy 262 (668)
.........+||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 0000112457999999999999999999999999999999
Q ss_pred HHHhCCCCCchhHHHH-HHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCC---CHHHHHcCccccC
Q 005944 263 EMATGKPPWSQQFQEV-AALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRS---TASELLQHPFVTG 330 (668)
Q Consensus 263 eLLTG~~PF~~~~~~~-~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RP---Sa~EIL~Hpwf~~ 330 (668)
+|++|+.||....... .............+....++.++.+||.+|+ .+|.+|+ ++.++++||||..
T Consensus 236 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 236 EMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred ehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 9999999997543221 1111111112222333468999999999977 5999999 9999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=391.99 Aligned_cols=258 Identities=29% Similarity=0.474 Sum_probs=219.8
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCC-cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSG-ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg-~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
.....+|.+.+.||+|+||.||+|.+..++ ..||||++.... .........+.+|+.+|+.++|||||++++++
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~ 100 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK-----IIKQKQVDHVFSERKILNYINHPFCVNLYGSF 100 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHH-----hhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE
Confidence 455678999999999999999999876654 789999884221 11223445678899999999999999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.....+|+||||+.+|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus 101 ~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~ 180 (340)
T PTZ00426 101 KDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180 (340)
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999999975
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccC
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls 298 (668)
+.. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+. .....++..++
T Consensus 181 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~-~i~--~~~~~~p~~~~ 252 (340)
T PTZ00426 181 VDT-----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ-KIL--EGIIYFPKFLD 252 (340)
T ss_pred cCC-----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH-HHh--cCCCCCCCCCC
Confidence 422 2235689999999999999889999999999999999999999997654322111 111 12234567789
Q ss_pred HHHHHHHHHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 299 MEAKDFLLKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
..+.+||++||+.||.+|+ +++++++||||.+
T Consensus 253 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 253 NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999999995 8999999999975
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=384.86 Aligned_cols=262 Identities=25% Similarity=0.402 Sum_probs=208.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC---
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED--- 141 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~--- 141 (668)
+|++.++||+|+||.||+|++..++..||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 74 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF------EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR 74 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh------ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence 6999999999999999999999999999999884211 1112234577899999999999999999987543
Q ss_pred --CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 142 --DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 142 --~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
..+|+|||||. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 75 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 75 EFKDIYVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred CCceEEEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 24799999995 689999988888999999999999999999999999999999999999999999999999999754
Q ss_pred Hhhhh-hcCCccCCCCCCCCChHHHhh--cCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHH-------------
Q 005944 220 VELAT-INGAKSMKGTPYWMAPEVILQ--TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAAL------------- 281 (668)
Q Consensus 220 ~~~~~-~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~------------- 281 (668)
..... .......+||+.|+|||++.+ ..++.++|||||||++|+|+||++||...... ...+
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 112234679999999999876 56899999999999999999999999643210 0000
Q ss_pred ----------HhhccCCCCCC---CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 282 ----------FHIGTTKSHPP---IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 282 ----------~~~~~~~~~~~---~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
..........+ ....++.++.+||.+||+.||.+||++.++++||||+....
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 00000000000 11246788999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=396.07 Aligned_cols=255 Identities=34% Similarity=0.545 Sum_probs=218.9
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcE-EEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGEL-LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~-VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
..+......+.+.||.|+||+||+|.+. |.. ||||++..... .....+.|.+|+.+|.+++|||||+++|+
T Consensus 36 ~~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~------~~~~~~~f~~E~~il~~l~HpNIV~f~G~ 107 (362)
T KOG0192|consen 36 EEIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDF------DDESRKAFRREASLLSRLRHPNIVQFYGA 107 (362)
T ss_pred eecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhc------ChHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence 3455566677778999999999999884 455 99999843221 11226789999999999999999999999
Q ss_pred cccCC-cceEEeeccCCCChhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-cccccCCcccEEeCCCC-ceEEec
Q 005944 138 AREDD-SLNILLEFVPGGSISSLLGK--FGSFPESVIRMYTKQLLLGLEYLHKNG-IMHRDIKGANILVDNKG-CIKLAD 212 (668)
Q Consensus 138 ~~~~~-~~~LVmEy~~gGsL~~~L~~--~~~l~e~~~~~i~~QIl~aL~yLHs~g-IvHrDLKPeNILld~~g-~vKL~D 212 (668)
+.... .++|||||+++|+|..++.+ .+.++...+..|+.||++||.|||+++ ||||||||+||||+.++ ++||+|
T Consensus 108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~D 187 (362)
T KOG0192|consen 108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIAD 187 (362)
T ss_pred EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECC
Confidence 99887 79999999999999999987 688999999999999999999999999 99999999999999998 999999
Q ss_pred CCchhhhHhhhhhcCCccCCCCCCCCChHHHh--hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCC
Q 005944 213 FGASKKVVELATINGAKSMKGTPYWMAPEVIL--QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSH 290 (668)
Q Consensus 213 FGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~--~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~ 290 (668)
||+++...... ...+...||+.|||||++. ...|+.++|||||||+||||+||+.||..... .............
T Consensus 188 FGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v~~~~~R 264 (362)
T KOG0192|consen 188 FGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAVVVGGLR 264 (362)
T ss_pred Cccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHhcCCC
Confidence 99998653311 3334478999999999999 56899999999999999999999999987665 4445555556667
Q ss_pred CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 291 ~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+.++..+++.+..||.+||..||.+||++.+|+.
T Consensus 265 p~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 265 PPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 7788889999999999999999999999999985
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=385.82 Aligned_cols=248 Identities=31% Similarity=0.505 Sum_probs=211.8
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeecc
Q 005944 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFV 151 (668)
Q Consensus 72 LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~ 151 (668)
||+|+||+||+|.+..++..||||++... ..........+.+|+.+|..++|||||++++++...+..|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~-----~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 75 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKA-----HIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFI 75 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHH-----HhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCC
Confidence 69999999999999999999999998421 1122334556788999999999999999999999999999999999
Q ss_pred CCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccC
Q 005944 152 PGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSM 231 (668)
Q Consensus 152 ~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 231 (668)
++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... .......
T Consensus 76 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~ 153 (312)
T cd05585 76 NGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD--DDKTNTF 153 (312)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC--CCccccc
Confidence 99999999988889999999999999999999999999999999999999999999999999998753221 1223456
Q ss_pred CCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHHhhh
Q 005944 232 KGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQ 310 (668)
Q Consensus 232 ~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~ 310 (668)
+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ..... ......++..++.++++||.+||.
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~L~ 229 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI----LQEPLRFPDGFDRDAKDLLIGLLS 229 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH----HcCCCCCCCcCCHHHHHHHHHHcC
Confidence 7999999999999999999999999999999999999999754322 11111 122345667889999999999999
Q ss_pred hCCCCCC---CHHHHHcCccccC
Q 005944 311 KEPYLRS---TASELLQHPFVTG 330 (668)
Q Consensus 311 ~dP~~RP---Sa~EIL~Hpwf~~ 330 (668)
.||.+|| ++.+++.||||..
T Consensus 230 ~dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 230 RDPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred CCHHHcCCCCCHHHHHcCCCcCC
Confidence 9999997 5899999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=390.60 Aligned_cols=261 Identities=33% Similarity=0.513 Sum_probs=217.7
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|++..+++.||||++.... .........+.+|+.+|..++|+||+++++++.+.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD-----MIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEH 75 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHH-----HhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCe
Confidence 37999999999999999999999999999999984321 1122345568889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|+||||+++++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 76 LYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999987654322
Q ss_pred ---------------------------hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH
Q 005944 224 ---------------------------TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ 276 (668)
Q Consensus 224 ---------------------------~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~ 276 (668)
.........||+.|+|||++.+..++.++|||||||+||+|++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00123346799999999999999999999999999999999999999975432
Q ss_pred HH-HHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCC-HHHHHcCccccC
Q 005944 277 EV-AALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRST-ASELLQHPFVTG 330 (668)
Q Consensus 277 ~~-~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPS-a~EIL~Hpwf~~ 330 (668)
.. ...+.........+....+++++.+||.+||. +|.+|++ +.++++||||.+
T Consensus 236 ~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 236 QETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred HHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 21 11111111111222223469999999999997 9999999 999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=387.35 Aligned_cols=266 Identities=27% Similarity=0.456 Sum_probs=219.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|...+.||.|+||.|..|+++.+|+.||||++. .........+...+|+++|+.++|+||+.+++++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~------~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p 92 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL------NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP 92 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhh------hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc
Confidence 44556777899999999999999999999999999983 223445667778899999999999999999998866
Q ss_pred -----CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 141 -----DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 141 -----~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
-..+|+|+|++ +.+|..+|+....+++..++.+++||+.||+|+|+.||+||||||.|+|++.++.+||||||+
T Consensus 93 ~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 93 PSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccc
Confidence 35699999999 569999999888899999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhh--------
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHI-------- 284 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~-------- 284 (668)
|+...........+.++.|.+|+|||++.. ..|+.++||||+|||+.||++|++.|.+.. +.+..+...
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 998754322333467889999999999875 459999999999999999999999996421 111111111
Q ss_pred -------------ccCCCCCC-----CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 285 -------------GTTKSHPP-----IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 285 -------------~~~~~~~~-----~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
......+. +-.+.++.+.+|+.+||..||.+|+|++|+|+||||.....
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hd 318 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHD 318 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcC
Confidence 01111111 12478899999999999999999999999999999986544
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-45 Score=388.75 Aligned_cols=250 Identities=31% Similarity=0.506 Sum_probs=213.4
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEee
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLE 149 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmE 149 (668)
++||+|+||.||+|.+..++..||||++.... .........+.+|+.+|+.++||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~E 75 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEV-----IIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVME 75 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999984321 1122344567889999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCc
Q 005944 150 FVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAK 229 (668)
Q Consensus 150 y~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~ 229 (668)
|+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... .....
T Consensus 76 y~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~--~~~~~ 153 (328)
T cd05593 76 YVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD--AATMK 153 (328)
T ss_pred CCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc--ccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999998753211 12233
Q ss_pred cCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHHh
Q 005944 230 SMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308 (668)
Q Consensus 230 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~kc 308 (668)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..... ......++..++.++.+||.+|
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~----~~~~~~~p~~~~~~~~~li~~~ 229 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----LMEDIKFPRTLSADAKSLLSGL 229 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh----ccCCccCCCCCCHHHHHHHHHH
Confidence 567999999999999888999999999999999999999999654322 21111 1223456778999999999999
Q ss_pred hhhCCCCCC-----CHHHHHcCccccC
Q 005944 309 LQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 309 L~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
|+.||.+|+ ++.+|++||||.+
T Consensus 230 L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 230 LIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred cCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=386.94 Aligned_cols=250 Identities=30% Similarity=0.487 Sum_probs=212.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEee
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLE 149 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmE 149 (668)
++||+|+||.||+|.+..+|..||+|++.... .........+.+|+.+|+.++||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E 75 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEV-----IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 75 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEe
Confidence 47999999999999999999999999984321 1122344567789999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCc
Q 005944 150 FVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAK 229 (668)
Q Consensus 150 y~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~ 229 (668)
|+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..... ......
T Consensus 76 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~ 153 (323)
T cd05595 76 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMK 153 (323)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccc
Confidence 999999999998888899999999999999999999999999999999999999999999999999864321 112233
Q ss_pred cCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHHh
Q 005944 230 SMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308 (668)
Q Consensus 230 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~kc 308 (668)
..+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...... .....++..+++++.+||.+|
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~----~~~~~~p~~~~~~~~~li~~~ 229 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL----MEEIRFPRTLSPEAKSLLAGL 229 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh----cCCCCCCCCCCHHHHHHHHHH
Confidence 467999999999999889999999999999999999999999754322 211111 112345678899999999999
Q ss_pred hhhCCCCCC-----CHHHHHcCccccC
Q 005944 309 LQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 309 L~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
|+.||.+|+ ++.++++||||.+
T Consensus 230 L~~dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 230 LKKDPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred ccCCHHHhCCCCCCCHHHHHcCCCcCC
Confidence 999999998 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=386.56 Aligned_cols=266 Identities=33% Similarity=0.597 Sum_probs=221.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
......|++...||.|.-++||+|+.+.+++.||||++.. ++-...+..+.+|+..|+.++|||||+++..|.
T Consensus 22 p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inL-------Ekc~~~ld~l~kE~~~msl~~HPNIv~~~~sFv 94 (516)
T KOG0582|consen 22 PLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINL-------EKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFV 94 (516)
T ss_pred CCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeeh-------hhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence 4667889999999999999999999999999999999843 333444788999999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.+..+|+||.|+.+|++.+++... ..|.|..+..|+++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+.
T Consensus 95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeee
Confidence 999999999999999999999764 459999999999999999999999999999999999999999999999999876
Q ss_pred hhHhhhhh--cCCccCCCCCCCCChHHHhhc--CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCC----
Q 005944 218 KVVELATI--NGAKSMKGTPYWMAPEVILQT--GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS---- 289 (668)
Q Consensus 218 ~~~~~~~~--~~~~~~~GT~~Y~APEvl~~~--~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~---- 289 (668)
.+...... ....+++||++|||||++++. +|+.|+|||||||+..||.+|..||.....--..+..+.....
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t 254 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLT 254 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCccc
Confidence 55432211 112567899999999997654 5899999999999999999999999754322222222221111
Q ss_pred ---CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 290 ---HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 290 ---~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
........+..++.+|..||++||.+|||+.++|+|+||+...
T Consensus 255 ~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 255 SGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 1111234677899999999999999999999999999998654
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=378.84 Aligned_cols=259 Identities=28% Similarity=0.444 Sum_probs=206.2
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||.|+||+||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-------EGTPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-------cccchhHHHHHHHHhhCCCCCcCeEEEEEecCC
Confidence 4679999999999999999999999999999999843211 111234567999999999999999999999999
Q ss_pred cceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
..++||||+. ++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 155 (303)
T cd07869 77 TLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV 155 (303)
T ss_pred eEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence 9999999996 567666654 46799999999999999999999999999999999999999999999999999864321
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH---HHHHHHhhccCCCC-------
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ---EVAALFHIGTTKSH------- 290 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~---~~~~~~~~~~~~~~------- 290 (668)
.........||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ....+.........
T Consensus 156 --~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 156 --PSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred --CCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence 11223446789999999998764 578999999999999999999999975321 11111111100000
Q ss_pred -----------CCCC---------cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 291 -----------PPIP---------EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 291 -----------~~~p---------~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
...+ ...+..+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 0000 1245678999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=377.44 Aligned_cols=255 Identities=29% Similarity=0.470 Sum_probs=206.0
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||.|+||+||+|.+..++..||+|++...... .....+.+|+.+++.++||||+++++++.....
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 77 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-------GAPCTAIREVSLLKNLKHANIVTLHDIIHTERC 77 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-------CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 4699999999999999999999999999999998432111 112345689999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.++||||+++ +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 78 ~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~- 155 (288)
T cd07871 78 LTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV- 155 (288)
T ss_pred EEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC-
Confidence 9999999975 8888876543 579999999999999999999999999999999999999999999999999875422
Q ss_pred hhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCC-----------
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTK----------- 288 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~----------- 288 (668)
.........||+.|+|||++.+ ..++.++|||||||++|+|+||++||..... ....+.......
T Consensus 156 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07871 156 -PTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234 (288)
T ss_pred -CCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccc
Confidence 1112234578999999999876 4589999999999999999999999964321 111111110000
Q ss_pred ------CC--------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 289 ------SH--------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 289 ------~~--------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.. ......++.++++||.+||+.||.+|||+.|+|+||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00 00123468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=378.70 Aligned_cols=271 Identities=28% Similarity=0.438 Sum_probs=221.7
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc--
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE-- 140 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~-- 140 (668)
-..|+.+..|++|+||.||+|+++.|++.||+|+++... .....--...+||.+|.+++|||||.+-.+...
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek------ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~ 148 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK------EKEGFPITSLREINILLKARHPNIVEVKEVVVGSN 148 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc------ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc
Confidence 346999999999999999999999999999999985432 111222345789999999999999999887654
Q ss_pred CCcceEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
-+.+|||||||+. +|..++...+ +|...+++.++.|++.||+|||.+.|+||||||+|+|+++.|.+||+|||+|+.+
T Consensus 149 ~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y 227 (419)
T KOG0663|consen 149 MDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREY 227 (419)
T ss_pred cceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhh
Confidence 3679999999976 9999998765 8999999999999999999999999999999999999999999999999999987
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCC---CCCC-
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTK---SHPP- 292 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~---~~~~- 292 (668)
.. .....+..+.|.+|+|||++.+.. |++++||||+|||+.||+++++.|.+.. +.+..++...... .++.
T Consensus 228 gs--p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~ 305 (419)
T KOG0663|consen 228 GS--PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY 305 (419)
T ss_pred cC--CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence 54 345567788999999999999865 9999999999999999999999997542 3344444332211 1110
Q ss_pred ----------------------CCc-ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCCCCcccccc
Q 005944 293 ----------------------IPE-HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNS 342 (668)
Q Consensus 293 ----------------------~p~-~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~~~~~~~~~ 342 (668)
++. .++....+|+..+|..||.+|.||.|+|+|.||.....+..|.+...
T Consensus 306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt 378 (419)
T KOG0663|consen 306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPT 378 (419)
T ss_pred cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCC
Confidence 111 25688899999999999999999999999999998655544444333
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-45 Score=385.31 Aligned_cols=261 Identities=33% Similarity=0.563 Sum_probs=214.1
Q ss_pred CeeeeeEEcccCceEEEEEEEc---CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccccc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTARE 140 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~ 140 (668)
+|++.+.||+|+||+||+|.+. .++..||+|++..... .........+..|+.+|..+ +|+||+++++++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAAL----VQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT 76 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHH----hhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec
Confidence 5899999999999999999864 4789999999843211 11223345677899999999 59999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.+.+++||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 77 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 77 EAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999987643
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccC
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls 298 (668)
... .......+||+.|+|||++.+.. ++.++|||||||++|+|+||..||..... .....+..........++..++
T Consensus 157 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd05614 157 SEE-KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIG 235 (332)
T ss_pred ccC-CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Confidence 221 11223467999999999998654 78899999999999999999999953210 0000111111123345667889
Q ss_pred HHHHHHHHHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 299 MEAKDFLLKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
..+.+||.+||+.||.+|| +++++++||||++
T Consensus 236 ~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 272 (332)
T cd05614 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKG 272 (332)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 9999999999999999999 8999999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=389.59 Aligned_cols=261 Identities=29% Similarity=0.479 Sum_probs=214.5
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||+|+||+||+|.+..+++.||||++... ..........+.+|+.++..++|+||+++++.+...+.+
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 76 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKA-----DMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNL 76 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH-----HHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 689999999999999999999999999999998421 112233456788899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 77 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 77 YLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999875422110
Q ss_pred ---------------------------------hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCC
Q 005944 225 ---------------------------------INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW 271 (668)
Q Consensus 225 ---------------------------------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF 271 (668)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 00112457999999999999999999999999999999999999999
Q ss_pred chhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCC---CHHHHHcCccccCC
Q 005944 272 SQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRS---TASELLQHPFVTGK 331 (668)
Q Consensus 272 ~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RP---Sa~EIL~Hpwf~~~ 331 (668)
...... ....+.........+....++.++++||.+|+ .+|.+|+ ++.++++||||++.
T Consensus 237 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 237 CSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 754322 11111111111111112247899999999987 4999998 58999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=384.99 Aligned_cols=254 Identities=27% Similarity=0.484 Sum_probs=211.0
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~~~~~LVm 148 (668)
++||+|+||.||+|.+..++..||||++... ..........+..|+.++..+ +||||+++++++.....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~-----~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKE-----LVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHH-----HhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEE
Confidence 4799999999999999999999999998422 112233455678899999998 7999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
|||++|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus 76 e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~--~~~~~ 153 (329)
T cd05588 76 EFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR--PGDTT 153 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc--CCCcc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999864211 11223
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH------HHHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF------QEVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~------~~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .................+|..++.++.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 233 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAS 233 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 45689999999999999999999999999999999999999995210 000001100111223346678899999
Q ss_pred HHHHHhhhhCCCCCCC------HHHHHcCccccC
Q 005944 303 DFLLKCLQKEPYLRST------ASELLQHPFVTG 330 (668)
Q Consensus 303 dLI~kcL~~dP~~RPS------a~EIL~Hpwf~~ 330 (668)
+||.+||+.||.+|++ +.++++||||..
T Consensus 234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 234 SVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999999987 799999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=396.11 Aligned_cols=259 Identities=37% Similarity=0.666 Sum_probs=228.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.....|+..+.||+|+||.||+|.+..+++.||+|++.+ +.....+..+++|+.+|.+++++||.++|+.|..
T Consensus 10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~L-------e~~~deIediqqei~~Ls~~~~~~it~yygsyl~ 82 (467)
T KOG0201|consen 10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDL-------EEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK 82 (467)
T ss_pred CcccccccchhccccccceeeeeeeccccceEEEEEech-------hhcchhhHHHHHHHHHHHhcCcchHHhhhhheee
Confidence 445668888999999999999999999999999999943 3344566788999999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
+..++++||||.||++.+++.....+.|..+..++++++.||.|||.++.+|||||+.||||...|.+||+|||.+..+.
T Consensus 83 g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~ 162 (467)
T KOG0201|consen 83 GTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT 162 (467)
T ss_pred cccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee
Confidence 99999999999999999999887777999999999999999999999999999999999999999999999999998765
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
.... ...+++|||+|||||++.+..|+.++||||||++.|||++|.+||..... ...+........+.+....++.
T Consensus 163 ~~~~--rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP--mrvlflIpk~~PP~L~~~~S~~ 238 (467)
T KOG0201|consen 163 NTVK--RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP--MRVLFLIPKSAPPRLDGDFSPP 238 (467)
T ss_pred chhh--ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc--ceEEEeccCCCCCccccccCHH
Confidence 4333 23789999999999999998999999999999999999999999976543 2222222334455566789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+++||..||.+||+.||+|.++|+|+|++.
T Consensus 239 ~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 239 FKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred HHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 999999999999999999999999999975
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=366.13 Aligned_cols=259 Identities=30% Similarity=0.493 Sum_probs=227.0
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.+...+|++++.||.|.||.||+|+.+.++-.||+|++.+.. -.......++.+|++|-..|+||||+++|++|.
T Consensus 18 ~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsq-----i~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh 92 (281)
T KOG0580|consen 18 TWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQ-----ILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH 92 (281)
T ss_pred ccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHH-----HHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence 466788999999999999999999999999999999984322 222334456889999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLG--KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~--~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
+...+||++||...|+|+..|. ....|++..+..+++|++.||.|||..+|+||||||+|+|++..|.+||+|||.+.
T Consensus 93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV 172 (281)
T KOG0580|consen 93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV 172 (281)
T ss_pred ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence 9999999999999999999998 66789999999999999999999999999999999999999999999999999986
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCccc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~l 297 (668)
.- ..+.-.+.|||..|.+||+..+..++..+|+|++|++.||++.|.+||....... ....+ ......+|..+
T Consensus 173 ~~----p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-tYkrI--~k~~~~~p~~i 245 (281)
T KOG0580|consen 173 HA----PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-TYKRI--RKVDLKFPSTI 245 (281)
T ss_pred ec----CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-HHHHH--HHccccCCccc
Confidence 42 2445678999999999999999999999999999999999999999998665221 11111 12234466899
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+.+++|||.+||.++|.+|....|++.|||+..
T Consensus 246 s~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 246 SGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred ChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 999999999999999999999999999999864
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=385.15 Aligned_cols=250 Identities=30% Similarity=0.493 Sum_probs=212.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEee
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLE 149 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmE 149 (668)
++||+|+||+||+|.+..+|..||+|++.... .........+..|++++..++||||+++++++...+.+|+|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~-----~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E 75 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEV-----IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVME 75 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEe
Confidence 46999999999999999999999999984321 1122334566789999999999999999999999999999999
Q ss_pred ccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 150 FVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 150 y~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
|+++|+|..++...+.+++..++.++.||+.||.|||+ .||+||||||+||||+.++.+||+|||+++..... ....
T Consensus 76 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--~~~~ 153 (325)
T cd05594 76 YANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GATM 153 (325)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC--Cccc
Confidence 99999999999888889999999999999999999997 79999999999999999999999999998743211 1223
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
...+||+.|+|||++.+..++.++|||||||+||+|+||..||...... ...... .....++..+++++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~----~~~~~~p~~~~~~~~~li~~ 229 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL----MEEIRFPRTLSPEAKSLLSG 229 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh----cCCCCCCCCCCHHHHHHHHH
Confidence 3467999999999999989999999999999999999999999654332 222211 12334567789999999999
Q ss_pred hhhhCCCCCC-----CHHHHHcCccccC
Q 005944 308 CLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 308 cL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
||+.||.+|+ ++.++++||||.+
T Consensus 230 ~L~~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 230 LLKKDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred HhhcCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 9999999997 9999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=380.76 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=215.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCC-CeeeeccccccCCc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP-NIVRYLGTAREDDS 143 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-NIV~l~g~~~~~~~ 143 (668)
+|++.+.||+|+||.||+|.+..+++.||||++.... .........+..|+.++..+.|+ +|+.+++++...+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV-----IIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 75 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCE
Confidence 5899999999999999999999999999999984321 11223445677899999999765 58889999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|+||||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~-- 153 (324)
T cd05587 76 LYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF-- 153 (324)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--
Confidence 999999999999999998888899999999999999999999999999999999999999999999999999864211
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~d 303 (668)
........+||+.|+|||++.+..++.++|||||||++|+|+||+.||.......... .+ ......++..++.++.+
T Consensus 154 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~-~i--~~~~~~~~~~~~~~~~~ 230 (324)
T cd05587 154 GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ-SI--MEHNVSYPKSLSKEAVS 230 (324)
T ss_pred CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH-HH--HcCCCCCCCCCCHHHHH
Confidence 1122335679999999999999899999999999999999999999997543321111 11 12234566788999999
Q ss_pred HHHHhhhhCCCCCCCH-----HHHHcCccccC
Q 005944 304 FLLKCLQKEPYLRSTA-----SELLQHPFVTG 330 (668)
Q Consensus 304 LI~kcL~~dP~~RPSa-----~EIL~Hpwf~~ 330 (668)
||.+||..||.+|++. .++++||||..
T Consensus 231 li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 231 ICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred HHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999976 89999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=381.98 Aligned_cols=250 Identities=29% Similarity=0.471 Sum_probs=210.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~~~~~LVm 148 (668)
++||+|+||+||+|.+..+++.||||++.... .........+..|+.++..+ +||||+++++++...+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~ 75 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDV-----ILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVM 75 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHH-----HhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEE
Confidence 47999999999999999999999999984221 11223345567788888876 6999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 76 Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--~~~~ 153 (320)
T cd05590 76 EFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--GKTT 153 (320)
T ss_pred cCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC--CCcc
Confidence 99999999999988889999999999999999999999999999999999999999999999999998743211 1123
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH-HHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV-AALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~-~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...+. .....++..++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~~~li~~ 229 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL----NDEVVYPTWLSQDAVDILKA 229 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh----cCCCCCCCCCCHHHHHHHHH
Confidence 34679999999999998889999999999999999999999997543322 11111 12234566789999999999
Q ss_pred hhhhCCCCCCCH------HHHHcCccccC
Q 005944 308 CLQKEPYLRSTA------SELLQHPFVTG 330 (668)
Q Consensus 308 cL~~dP~~RPSa------~EIL~Hpwf~~ 330 (668)
||+.||.+||++ +++++||||..
T Consensus 230 ~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 230 FMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred HcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 999999999998 99999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=384.53 Aligned_cols=259 Identities=29% Similarity=0.467 Sum_probs=214.7
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|.+.+.||+|+||+||+|.+..+++.||||++... ..........+.+|+.+++.++|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~ 75 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKS-----VLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDN 75 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHH-----HhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCe
Confidence 3699999999999999999999999999999998432 11223345668889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
+|+||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 76 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 76 LYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred EEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999999999776 68999999999999999999999999999999999999999999999999999765322
Q ss_pred hhhcCCccCCCCCCCCChHHHh------hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccCCCCCCCC
Q 005944 223 ATINGAKSMKGTPYWMAPEVIL------QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTTKSHPPIP 294 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~------~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~~~~~~~p 294 (668)
... ......||+.|+|||++. ...++.++|||||||++|+|++|..||...... ...+.... .....+..
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~ 233 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ-RFLKFPED 233 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC-CccCCCCC
Confidence 111 123457999999999997 455789999999999999999999999754321 11221111 11111222
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
..++.++.+||.+||+ +|.+||++.+++.||||..
T Consensus 234 ~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 234 PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred CCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 3578999999999998 9999999999999999975
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=379.95 Aligned_cols=259 Identities=31% Similarity=0.503 Sum_probs=216.3
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||.||+|++..++..||+|++.... .......+.+|+++|+.++||||+++++++..+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 75 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 75 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC
Confidence 4578999999999999999999999999999999884321 223345688999999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
+.+++||||+++|+|.+++.....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+.
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 76 GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999999999999998888899999999999999999999986 69999999999999999999999999987553
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhc--------------
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIG-------------- 285 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~-------------- 285 (668)
.. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... +....+...
T Consensus 156 ~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 156 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred cc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence 21 22346799999999999988899999999999999999999999964322 111111100
Q ss_pred -----------------------------cCCCCCCC-CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 286 -----------------------------TTKSHPPI-PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 286 -----------------------------~~~~~~~~-p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.....+.. ...++.++++||.+||+.||++|||+.+|++||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 00000111 12467899999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=378.73 Aligned_cols=254 Identities=28% Similarity=0.496 Sum_probs=210.6
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHH---HhCCCCCeeeeccccccCC
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLL---KNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL---~~L~HpNIV~l~g~~~~~~ 142 (668)
|++.+.||+|+||.||+|.+..+++.||||++.... .........+..|++++ +.++||||+++++++....
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~ 75 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGD-----IIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTED 75 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCC
Confidence 788999999999999999999999999999984321 11122334455565554 5678999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.+|+||||+++|+|..++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 76 ~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~- 153 (324)
T cd05589 76 HVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG- 153 (324)
T ss_pred EEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC-
Confidence 99999999999999988865 5799999999999999999999999999999999999999999999999999864321
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....+.. .....+..++.++
T Consensus 154 -~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~----~~~~~p~~~~~~~ 228 (324)
T cd05589 154 -FGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVN----DEVRYPRFLSREA 228 (324)
T ss_pred -CCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCCCCCHHH
Confidence 112234567999999999999989999999999999999999999999754322 2211111 1234566789999
Q ss_pred HHHHHHhhhhCCCCCC-----CHHHHHcCccccCC
Q 005944 302 KDFLLKCLQKEPYLRS-----TASELLQHPFVTGK 331 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~~ 331 (668)
.+||.+||+.||.+|| ++.++++||||.+.
T Consensus 229 ~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 229 ISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred HHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999999999999 79999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=379.96 Aligned_cols=251 Identities=28% Similarity=0.449 Sum_probs=210.6
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~~~~~LVm 148 (668)
++||+|+||.||+|++..+++.||||++.... .........+..|..++..+ +||||+++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDV-----ILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVM 75 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEE
Confidence 46999999999999999999999999984321 11223345566788888866 7999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 76 E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 153 (321)
T cd05591 76 EYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTT 153 (321)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999875321 11223
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHh
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kc 308 (668)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+. ......+..++.++.+||.+|
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~-~i~--~~~~~~p~~~~~~~~~ll~~~ 230 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE-SIL--HDDVLYPVWLSKEAVSILKAF 230 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH-HHH--cCCCCCCCCCCHHHHHHHHHH
Confidence 45679999999999998899999999999999999999999997543322111 111 122335567899999999999
Q ss_pred hhhCCCCCC-------CHHHHHcCccccC
Q 005944 309 LQKEPYLRS-------TASELLQHPFVTG 330 (668)
Q Consensus 309 L~~dP~~RP-------Sa~EIL~Hpwf~~ 330 (668)
|+.||.+|+ ++.++++||||..
T Consensus 231 L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 231 MTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred hccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 999999999 9999999999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=383.05 Aligned_cols=254 Identities=27% Similarity=0.488 Sum_probs=210.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~~~~~LVm 148 (668)
++||+|+||+||+|.+..+++.||+|++.... .........+..|+.++..+ +||||+++++++.....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKEL-----VNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhH-----hcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEE
Confidence 47999999999999999999999999985321 11223445677888888877 7999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... .....
T Consensus 76 E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (329)
T cd05618 76 EYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTT 153 (329)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCcc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999874321 11223
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchh------HHHHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ------FQEVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~------~~~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||... ..................+|..++.++.
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 233 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAA 233 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 3567999999999999999999999999999999999999999421 0000011111111223456778899999
Q ss_pred HHHHHhhhhCCCCCCC------HHHHHcCccccC
Q 005944 303 DFLLKCLQKEPYLRST------ASELLQHPFVTG 330 (668)
Q Consensus 303 dLI~kcL~~dP~~RPS------a~EIL~Hpwf~~ 330 (668)
+||.+||+.||.+||+ +.++++||||..
T Consensus 234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 234 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999999998 589999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=387.86 Aligned_cols=263 Identities=27% Similarity=0.435 Sum_probs=215.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||+||+|.+..++..||||++... ..........+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~ 113 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF-----EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQ 113 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHH-----HhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 35567899999999999999999999999999999998421 1111223345778999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
+...+|+|||||++|+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 114 DDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 99999999999999999998865 46899999999999999999999999999999999999999999999999998764
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhc----CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCC-
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQT----GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP- 294 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~----~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p- 294 (668)
.... .......+||+.|+|||++.+. .++.++|||||||+||+|++|+.||........ ...+........++
T Consensus 193 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~ 270 (370)
T cd05596 193 DANG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-YSKIMDHKNSLTFPD 270 (370)
T ss_pred cCCC-cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH-HHHHHcCCCcCCCCC
Confidence 3211 1123356799999999999754 378899999999999999999999975432211 11111111112223
Q ss_pred -cccCHHHHHHHHHhhhhCCCC--CCCHHHHHcCccccC
Q 005944 295 -EHLSMEAKDFLLKCLQKEPYL--RSTASELLQHPFVTG 330 (668)
Q Consensus 295 -~~ls~el~dLI~kcL~~dP~~--RPSa~EIL~Hpwf~~ 330 (668)
..++.++++||.+||+.+|.+ |+++.++++||||+.
T Consensus 271 ~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 271 DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 357999999999999999987 999999999999975
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=369.46 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=208.1
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeecc
Q 005944 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFV 151 (668)
Q Consensus 72 LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~ 151 (668)
||+|+||+||+|.+..+++.||||++.... .........+..|+.+|+.++|+||+++.+++.....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKR-----LKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIM 75 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHH-----HhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCC
Confidence 699999999999999999999999884211 112223456778999999999999999999999999999999999
Q ss_pred CCCChhcccc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcC
Q 005944 152 PGGSISSLLG----KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATING 227 (668)
Q Consensus 152 ~gGsL~~~L~----~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~ 227 (668)
++|+|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ..
T Consensus 76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--~~ 153 (280)
T cd05608 76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SK 153 (280)
T ss_pred CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC--cc
Confidence 9999987763 33569999999999999999999999999999999999999999999999999987553321 12
Q ss_pred CccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccCCCCCCCCcccCHHHHHHH
Q 005944 228 AKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTTKSHPPIPEHLSMEAKDFL 305 (668)
Q Consensus 228 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~~~~~~~p~~ls~el~dLI 305 (668)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...... ........++..++.++.+|+
T Consensus 154 ~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li 232 (280)
T cd05608 154 TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ-RILNDSVTYPDKFSPASKSFC 232 (280)
T ss_pred ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHH-hhcccCCCCcccCCHHHHHHH
Confidence 23467999999999999999999999999999999999999999643211 111111 111223345667899999999
Q ss_pred HHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 306 LKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 306 ~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
.+||+.||.+|| +++++++||||+.
T Consensus 233 ~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 233 EALLAKDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHhcCCHHHhcCCCCCCHHHHhcChhhhc
Confidence 999999999999 8899999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=377.54 Aligned_cols=255 Identities=26% Similarity=0.412 Sum_probs=214.3
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccCCc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDS 143 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~~~ 143 (668)
+|++.+.||+|+||.||+|.+..++..||||++.... .........+..|..++..+ +|++|+.+++++...+.
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDV-----VIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDR 75 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCE
Confidence 5889999999999999999999999999999984321 11222334566678888777 58999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|+||||+++|+|..++...+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 76 ~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~- 154 (323)
T cd05616 76 LYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD- 154 (323)
T ss_pred EEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence 9999999999999999988888999999999999999999999999999999999999999999999999998743211
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
.......+||+.|+|||++.+..++.++|||||||++|+|+||+.||...... ....+. .....++..++.++.
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~ 229 (323)
T cd05616 155 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM----EHNVAYPKSMSKEAV 229 (323)
T ss_pred -CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCCCCCcCCHHHH
Confidence 11233567999999999999999999999999999999999999999754332 211111 122345677899999
Q ss_pred HHHHHhhhhCCCCCCC-----HHHHHcCccccC
Q 005944 303 DFLLKCLQKEPYLRST-----ASELLQHPFVTG 330 (668)
Q Consensus 303 dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~ 330 (668)
+||.+||+.+|.+|++ ..++++||||..
T Consensus 230 ~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 230 AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred HHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999999998 489999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=360.89 Aligned_cols=261 Identities=50% Similarity=0.890 Sum_probs=220.8
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
..|.+.++||.|+||.||.|.+..++..||||.+...... .........+.+|+.++++++||||+++++++.....
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDS---PETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccc---hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCe
Confidence 4699999999999999999999999999999988533211 1122345678899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.++|+||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||+|+|||++.++.++|+|||+++......
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987653322
Q ss_pred hhc-CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 224 TIN-GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 224 ~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
... ......|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ..............++..++.++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 237 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM-AAIFKIATQPTNPQLPSHVSPDAR 237 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH-HHHHHHhccCCCCCCCccCCHHHH
Confidence 111 113456889999999999888999999999999999999999999754222 222222333344556778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 303 DFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 303 dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
+||.+||..+|.+||++.++++||||
T Consensus 238 ~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 238 NFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=387.53 Aligned_cols=264 Identities=27% Similarity=0.448 Sum_probs=214.0
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||.||+|.+..+++.||+|++.... .........+.+|+.+++.++||||+++++++.
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE-----MIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQ 113 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHH-----hhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 355678999999999999999999999999999999984211 111223345778999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.+..+|+|||||++|+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 114 DDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999999999999865 46899999999999999999999999999999999999999999999999999765
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcC----CCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTG----HSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIP 294 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~----~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p 294 (668)
.... .......+||+.|+|||++.+.. ++.++|||||||+||+|++|..||...... ....+.........+..
T Consensus 193 ~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~ 271 (370)
T cd05621 193 DETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPED 271 (370)
T ss_pred ccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCc
Confidence 3211 11234568999999999997643 788999999999999999999999754321 11111111111112222
Q ss_pred cccCHHHHHHHHHhhhhCCCC--CCCHHHHHcCccccC
Q 005944 295 EHLSMEAKDFLLKCLQKEPYL--RSTASELLQHPFVTG 330 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~--RPSa~EIL~Hpwf~~ 330 (668)
..++..+++||.+||..++.+ |+++.++++||||+.
T Consensus 272 ~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 272 VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCC
Confidence 357999999999999865543 899999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-44 Score=378.39 Aligned_cols=252 Identities=32% Similarity=0.564 Sum_probs=211.1
Q ss_pred eEEcccCceEEEEEEEc---CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceE
Q 005944 70 ELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNI 146 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~---~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~L 146 (668)
++||+|+||.||+|.+. .+++.||||++.... ..........+.+|+.+|+.++||||+++++++..++.+|+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~----~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~l 77 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKAT----IVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYL 77 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHH----HHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEE
Confidence 67999999999999864 478999999984321 11122334557789999999999999999999999999999
Q ss_pred EeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhc
Q 005944 147 LLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226 (668)
Q Consensus 147 VmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~ 226 (668)
||||+++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ..
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 155 (323)
T cd05584 78 ILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GT 155 (323)
T ss_pred EEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC--CC
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998643221 11
Q ss_pred CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHH
Q 005944 227 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLL 306 (668)
Q Consensus 227 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~ 306 (668)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ...+. .....++..++.++.+||.
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-~~~~~--~~~~~~~~~~~~~~~~li~ 232 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-IDKIL--KGKLNLPPYLTPEARDLLK 232 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-HHHHH--cCCCCCCCCCCHHHHHHHH
Confidence 23346799999999999988899999999999999999999999975432211 11111 1233566778999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 307 KCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 307 kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
+||+.+|.+|| ++++++.||||..
T Consensus 233 ~~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 233 KLLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HHcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999 8999999999975
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=377.39 Aligned_cols=251 Identities=29% Similarity=0.490 Sum_probs=209.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~~~~~LVm 148 (668)
++||+|+||.||+|.+..+|..||||++..... ........+..|..++..+ +||||+++++++...+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVV-----LIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEE
Confidence 479999999999999999999999999843211 1112334456677777754 8999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+.+|+|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus 76 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (316)
T cd05620 76 EFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRA 153 (316)
T ss_pred CCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCce
Confidence 9999999999998888899999999999999999999999999999999999999999999999999864211 11223
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...... ...+.++..++.++++||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~li~~ 229 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR----VDTPHYPRWITKESKDILEK 229 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH----hCCCCCCCCCCHHHHHHHHH
Confidence 4578999999999999999999999999999999999999999754322 222221 12344566789999999999
Q ss_pred hhhhCCCCCCCH-HHHHcCccccCC
Q 005944 308 CLQKEPYLRSTA-SELLQHPFVTGK 331 (668)
Q Consensus 308 cL~~dP~~RPSa-~EIL~Hpwf~~~ 331 (668)
||+.||.+|+++ +++++||||...
T Consensus 230 ~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 230 LFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HccCCHHHcCCChHHHHcCCCcCCC
Confidence 999999999998 589999999753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=377.01 Aligned_cols=251 Identities=30% Similarity=0.527 Sum_probs=207.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHh-CCCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN-LTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
++||+|+||+||+|.+..+++.||||++..... ........+..|..++.. .+||||+++++++.....+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~ 75 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVV-----LEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVM 75 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 479999999999999999999999999853211 112223344556666665 48999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 76 e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 76 EYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999987532211 223
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHh
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kc 308 (668)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+ ....+.++..++.++.+||.+|
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~-~i--~~~~~~~~~~~~~~~~~ll~~~ 230 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD-SI--LNDRPHFPRWISKEAKDCLSKL 230 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH-HH--HcCCCCCCCCCCHHHHHHHHHH
Confidence 45679999999999998889999999999999999999999997543221111 11 1223456677899999999999
Q ss_pred hhhCCCCCCCH-HHHHcCccccC
Q 005944 309 LQKEPYLRSTA-SELLQHPFVTG 330 (668)
Q Consensus 309 L~~dP~~RPSa-~EIL~Hpwf~~ 330 (668)
|+.+|.+||++ .++++||||..
T Consensus 231 l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 231 FERDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred ccCCHHHcCCChHHHHcCcccCC
Confidence 99999999986 58999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=380.39 Aligned_cols=260 Identities=26% Similarity=0.471 Sum_probs=225.9
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....||++.+.||+|.||.|-+|+....|+.||||.|.. ..-++++.+-.+.+||+||..|+||||+.+|++|+
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrK-----dkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE 123 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRK-----DKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE 123 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhh-----hhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence 3566799999999999999999999999999999998843 23345566778899999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
+.+.+.|||||..+|.|++++.+.+.++|.+++.||+||+.|+.|||.+++||||||.+|||+|.++++||+||||+-.+
T Consensus 124 NkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 124 NKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred CCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999876
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHHHH-HHHHhhccCCCCCCCCccc
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEV-AALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~~-~~~~~~~~~~~~~~~p~~l 297 (668)
... ....++||+|.|.+||++.+..| ++.+|-|||||+||.|+.|.+||.+..... ...+..+.+. . | .-
T Consensus 204 ~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr-E---P-~~ 275 (668)
T KOG0611|consen 204 ADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR-E---P-ET 275 (668)
T ss_pred ccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc-C---C-CC
Confidence 543 33568999999999999999998 788999999999999999999998765432 2222222221 1 2 23
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+..+.-||+.||.++|++|.|+++|-.|=|+.=.+
T Consensus 276 PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwgy 310 (668)
T KOG0611|consen 276 PSDASGLIRWMLMVNPERRATIEDIASHWWVNWGY 310 (668)
T ss_pred CchHHHHHHHHHhcCcccchhHHHHhhhheeeccc
Confidence 45678899999999999999999999998876433
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=367.60 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=214.5
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
.|++.++||+|+||+||++.+..+++.||||++.... .........+.+|+.+++.++|+||+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 75 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-----IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhh-----hhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeE
Confidence 4889999999999999999999999999999884211 11122334567899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 76 CLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred EEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 9999999999999887543 46999999999999999999999999999999999999999999999999998764321
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH-HHHHhhccCCCCCCCCcccCHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV-AALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~-~~~~~~~~~~~~~~~p~~ls~el 301 (668)
......+|++.|+|||++.+..++.++|||||||++|+|++|..||....... ..............++..++..+
T Consensus 156 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05605 156 ---ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAA 232 (285)
T ss_pred ---CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHH
Confidence 12234579999999999998889999999999999999999999997543211 11111111222334566789999
Q ss_pred HHHHHHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 302 KDFLLKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
.+||.+||..||.+|| ++.++++||||..
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 233 RSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 9999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=382.29 Aligned_cols=256 Identities=31% Similarity=0.542 Sum_probs=209.5
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|+..+.||+|+||+||+|++..+++.||||++... ........+.+|+.+|+.++|+||+++++++...+
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 145 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-------HEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNG 145 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecC-------CcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCC
Confidence 45688999999999999999999999999999998422 12233456789999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.+|+||||+++|+|... ....+..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 146 ~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~ 221 (353)
T PLN00034 146 EIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT 221 (353)
T ss_pred eEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence 99999999999998654 24567888999999999999999999999999999999999999999999998765321
Q ss_pred hhhcCCccCCCCCCCCChHHHhh-----cCCCcchhHHHHHHHHHHHHhCCCCCchhH-HHHHHHHhhccCCCCCCCCcc
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQ-----TGHSFSADIWSVGCTVIEMATGKPPWSQQF-QEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-~~~~~~~~~~~~~~~~~~p~~ 296 (668)
........||..|+|||++.. ...+.++|||||||++|+|++|+.||.... ..................+..
T Consensus 222 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (353)
T PLN00034 222 --MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPAT 299 (353)
T ss_pred --cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCc
Confidence 122345679999999999843 224568999999999999999999996321 111111111112233445667
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++.++++||.+||+.||.+||++.||++||||.+.
T Consensus 300 ~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 300 ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 89999999999999999999999999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=386.96 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=208.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||.||+|.+..+++.||||+.. ...+.+|+++|+.++|||||++++++..
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------------~~~~~~E~~il~~l~HpnIv~~~~~~~~ 154 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------------RGGTATEAHILRAINHPSIIQLKGTFTY 154 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------------hhhhHHHHHHHHhCCCCCCCCEeEEEEE
Confidence 34568999999999999999999999999999999641 1235689999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
....++|||++. ++|..++.....+++..++.++.||+.||.|||++|||||||||+||||+.++.+||+|||+|+...
T Consensus 155 ~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 155 NKFTCLILPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred CCeeEEEEecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 999999999995 6888888777889999999999999999999999999999999999999999999999999997532
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH---------HHHHHHHhhc------
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF---------QEVAALFHIG------ 285 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~---------~~~~~~~~~~------ 285 (668)
.. ........+||+.|+|||++.+..++.++|||||||+||+|++|..||.... ..+..++...
T Consensus 234 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~ 312 (391)
T PHA03212 234 DI-NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNE 312 (391)
T ss_pred cc-cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhh
Confidence 21 1122335689999999999999899999999999999999999998764210 0111111000
Q ss_pred -----------------c--CCC--CCCCC---cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 286 -----------------T--TKS--HPPIP---EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 286 -----------------~--~~~--~~~~p---~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
. ... ..+.+ ..++.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~ 382 (391)
T PHA03212 313 FPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382 (391)
T ss_pred cCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence 0 000 00001 1346688999999999999999999999999999864
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=376.96 Aligned_cols=250 Identities=31% Similarity=0.485 Sum_probs=206.6
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHH-HHHHhCCCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV-KLLKNLTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei-~iL~~L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
++||+|+||+||+|++..+|+.||||++.... .........+..|. .+++.++||||+++++++...+.+|+||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~ 75 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKA-----ILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVL 75 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-----HhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEE
Confidence 47999999999999999999999999984321 11112223334444 4668899999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.... .....
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (323)
T cd05575 76 DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTT 153 (323)
T ss_pred cCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCcc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999874321 11223
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||..... +....... ....++..++.++.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~li~~ 229 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN----KPLRLKPNISVSARHLLEG 229 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc----CCCCCCCCCCHHHHHHHHH
Confidence 456799999999999998999999999999999999999999975432 22111111 1233455679999999999
Q ss_pred hhhhCCCCCCCH----HHHHcCccccC
Q 005944 308 CLQKEPYLRSTA----SELLQHPFVTG 330 (668)
Q Consensus 308 cL~~dP~~RPSa----~EIL~Hpwf~~ 330 (668)
||+.||.+||++ .++++||||..
T Consensus 230 ~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 230 LLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred HhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 999999999987 69999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=374.49 Aligned_cols=251 Identities=29% Similarity=0.480 Sum_probs=211.1
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~~~~~LVm 148 (668)
++||+|+||+||+|.+..++..||||++.... .........+..|+.++..+ +||||+++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~ 75 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDV-----ILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVM 75 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHH-----HhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEE
Confidence 47999999999999999999999999984221 11223345567888888888 6999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++|+|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (318)
T cd05570 76 EYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTT 153 (318)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999864211 11123
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHh
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kc 308 (668)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||........... +. .....++..++.++.+||.+|
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~-i~--~~~~~~~~~~~~~~~~li~~~ 230 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS-IL--EDEVRYPRWLSKEAKSILKSF 230 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH-HH--cCCCCCCCcCCHHHHHHHHHH
Confidence 346799999999999999999999999999999999999999975432221111 11 122345667899999999999
Q ss_pred hhhCCCCCCCH-----HHHHcCccccC
Q 005944 309 LQKEPYLRSTA-----SELLQHPFVTG 330 (668)
Q Consensus 309 L~~dP~~RPSa-----~EIL~Hpwf~~ 330 (668)
|+.||.+||++ .+++.||||..
T Consensus 231 l~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 231 LTKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred ccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99999999999 99999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=375.49 Aligned_cols=261 Identities=32% Similarity=0.518 Sum_probs=216.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||.|+||.||+|.+..++..+|+|++.... .......+.+|+++|+.++|+|||++++++..
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 74 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFYS 74 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHHCCCCcccceeEEEEE
Confidence 34578999999999999999999999999999999874321 12334567899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.+.+++||||+++|+|.+++...+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~ 154 (333)
T cd06650 75 DGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 154 (333)
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence 999999999999999999998888899999999999999999999975 7999999999999999999999999998765
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHH-HHHh---------------
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVA-ALFH--------------- 283 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~-~~~~--------------- 283 (668)
... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ....
T Consensus 155 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 155 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred hhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 321 22345799999999999988899999999999999999999999964332111 1110
Q ss_pred --------------------------hccCCCCCCCC-cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 284 --------------------------IGTTKSHPPIP-EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 284 --------------------------~~~~~~~~~~p-~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.......+..+ ..++.++++||.+||+.||.+|||+.|++.||||+...
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 00000001111 13578899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=373.35 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=214.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCCc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDDS 143 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~~ 143 (668)
+|+..++||+|+||+||+|.++.+|+.||||++... ..........+..|+.++..+. |++|+++++++...+.
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~ 75 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKD-----VVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDR 75 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH-----HhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCE
Confidence 478899999999999999999999999999998421 1112233455677888888885 5778889999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|+||||+++|+|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 76 ~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~- 154 (323)
T cd05615 76 LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD- 154 (323)
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999998743211
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~d 303 (668)
.......+||+.|+|||++.+..++.++|||||||++|+|++|..||............. .....++..++.++.+
T Consensus 155 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~---~~~~~~p~~~~~~~~~ 230 (323)
T cd05615 155 -GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIM---EHNVSYPKSLSKEAVS 230 (323)
T ss_pred -CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH---hCCCCCCccCCHHHHH
Confidence 112334679999999999998889999999999999999999999997653321111111 1223456778999999
Q ss_pred HHHHhhhhCCCCCCC-----HHHHHcCccccCC
Q 005944 304 FLLKCLQKEPYLRST-----ASELLQHPFVTGK 331 (668)
Q Consensus 304 LI~kcL~~dP~~RPS-----a~EIL~Hpwf~~~ 331 (668)
|+.+||+.+|.+|++ ..++++||||...
T Consensus 231 li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 231 ICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 999999999999997 5899999999753
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=377.07 Aligned_cols=253 Identities=26% Similarity=0.480 Sum_probs=211.0
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~~~~~LVm 148 (668)
++||+|+||+||+|.+..+++.||||++... ..........+..|+.++..+ +|+||+.+++++.....+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 75 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKE-----LVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVI 75 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHH-----HhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEE
Confidence 4799999999999999999999999998432 112234456678899999888 6999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus 76 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (327)
T cd05617 76 EYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTT 153 (327)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCce
Confidence 9999999999998888899999999999999999999999999999999999999999999999999874321 11223
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-----HHHHHHHhhccCCCCCCCCcccCHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-----QEVAALFHIGTTKSHPPIPEHLSMEAKD 303 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-----~~~~~~~~~~~~~~~~~~p~~ls~el~d 303 (668)
...+||+.|+|||++.+..++.++|||||||+||+|++|..||.... ......... .......+|..++..+.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~p~~~~~~~~~ 232 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV-ILEKPIRIPRFLSVKASH 232 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHH-HHhCCCCCCCCCCHHHHH
Confidence 45689999999999999999999999999999999999999995210 000111111 112233467788999999
Q ss_pred HHHHhhhhCCCCCCC------HHHHHcCccccC
Q 005944 304 FLLKCLQKEPYLRST------ASELLQHPFVTG 330 (668)
Q Consensus 304 LI~kcL~~dP~~RPS------a~EIL~Hpwf~~ 330 (668)
||.+||+.||.+|++ +.+++.||||..
T Consensus 233 li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 233 VLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred HHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 999999999999997 579999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=365.47 Aligned_cols=255 Identities=31% Similarity=0.529 Sum_probs=199.5
Q ss_pred CCeeeeeEEcccCceEEEEEEEcC-CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC---CCCCeeeeccccc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLD-SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL---THPNIVRYLGTAR 139 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~-tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIV~l~g~~~ 139 (668)
.+|++.+.||+|+||+||+|.+.. ++..||||++........ ....+.+|+.+++.+ .||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~ 74 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG------MPLSTIREVAVLRHLETFEHPNVVRLFDVCT 74 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC------chHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence 379999999999999999999864 478999998854322111 112234566666555 7999999999874
Q ss_pred -----cCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEec
Q 005944 140 -----EDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLAD 212 (668)
Q Consensus 140 -----~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~D 212 (668)
....+++||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 3456899999996 5888888653 4589999999999999999999999999999999999999999999999
Q ss_pred CCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCCCC
Q 005944 213 FGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTKSH 290 (668)
Q Consensus 213 FGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~~~ 290 (668)
||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ....+.........
T Consensus 154 fg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~ 230 (290)
T cd07862 154 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 230 (290)
T ss_pred ccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCCh
Confidence 9998764321 223456799999999999988899999999999999999999999975422 12222111100000
Q ss_pred ----------------------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 291 ----------------------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 291 ----------------------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
..+...++..+++||.+||+.||++|||+.++|+||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 00113467888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=385.64 Aligned_cols=259 Identities=25% Similarity=0.420 Sum_probs=223.3
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..-|.+.+.||+|.|+.|-+|+|.-+|..||||+|.... .+....-.+.+|+++|+.++|||||+||++..+..
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTK------lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT 90 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTK------LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT 90 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccc------cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence 445889999999999999999999999999999995332 22233345778999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC-CCCceEEecCCchhhhH
Q 005944 143 SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD-NKGCIKLADFGASKKVV 220 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld-~~g~vKL~DFGlA~~~~ 220 (668)
.+|||+|+-++|+|+++|.++ ..+.|+.+++||+||+.||.|||+.++|||||||+||.+- .-|-|||+|||++-.+.
T Consensus 91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999999999776 5799999999999999999999999999999999998775 56899999999998765
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCC-cchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHS-FSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s-~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
+.. ...+.||++.|-|||++++..|+ +++||||||||||-|++|++||....+....... ......+|.+++.
T Consensus 171 PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI---mDCKYtvPshvS~ 244 (864)
T KOG4717|consen 171 PGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI---MDCKYTVPSHVSK 244 (864)
T ss_pred Ccc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh---hcccccCchhhhH
Confidence 433 35678999999999999999985 6789999999999999999999765433221111 2234567899999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
++++||..||..||.+|.+.++|..|+|++..-.
T Consensus 245 eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 245 ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 9999999999999999999999999999997543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=376.27 Aligned_cols=255 Identities=28% Similarity=0.465 Sum_probs=205.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVR 133 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~ 133 (668)
.+...+|++.++||+|+||.||+|.+. .++..||||++... ........+.+|+.+|..+ +|||||+
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~niv~ 75 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-------ATASEHKALMSELKILIHIGNHLNVVN 75 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-------cchHHHHHHHHHHHHHHHhccCcceee
Confidence 466789999999999999999999752 34678999988421 1122345678899999999 8999999
Q ss_pred eccccccC-CcceEEeeccCCCChhcccccC-------------------------------------------------
Q 005944 134 YLGTARED-DSLNILLEFVPGGSISSLLGKF------------------------------------------------- 163 (668)
Q Consensus 134 l~g~~~~~-~~~~LVmEy~~gGsL~~~L~~~------------------------------------------------- 163 (668)
+++++... ..+++||||+++|+|.+++...
T Consensus 76 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (338)
T cd05102 76 LLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSG 155 (338)
T ss_pred EEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCc
Confidence 99987654 4689999999999999888642
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCcc
Q 005944 164 -------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS 230 (668)
Q Consensus 164 -------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~ 230 (668)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...........
T Consensus 156 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~ 235 (338)
T cd05102 156 STNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGS 235 (338)
T ss_pred ccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccC
Confidence 2377888999999999999999999999999999999999999999999999986533222222233
Q ss_pred CCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH--HHHHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 231 MKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ--EVAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 231 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~--~~~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
..+++.|+|||++.+..++.++|||||||+||||++ |..||..... ....... .......+..++.++.+||.+
T Consensus 236 ~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~ 312 (338)
T cd05102 236 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK---DGTRMRAPENATPEIYRIMLA 312 (338)
T ss_pred CCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHh---cCCCCCCCCCCCHHHHHHHHH
Confidence 456788999999999899999999999999999997 9999975321 2222221 122234566788999999999
Q ss_pred hhhhCCCCCCCHHHHHc
Q 005944 308 CLQKEPYLRSTASELLQ 324 (668)
Q Consensus 308 cL~~dP~~RPSa~EIL~ 324 (668)
||+.||.+|||+.+|++
T Consensus 313 cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 313 CWQGDPKERPTFSALVE 329 (338)
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999985
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=373.55 Aligned_cols=250 Identities=29% Similarity=0.503 Sum_probs=208.0
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHh-CCCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN-LTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
+.||+|+||+||+|.+..++..||||++..... ........+..|..++.. ++||||+++++++.+.+.+|+||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVM 75 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHh-----hhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEE
Confidence 469999999999999999999999999843211 111223445567777775 48999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++|+|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.... .....
T Consensus 76 ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (316)
T cd05619 76 EYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKT 153 (316)
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCce
Confidence 9999999999998878899999999999999999999999999999999999999999999999999864321 11123
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||..... ........ ..+.++..++.++++||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~li~~ 229 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRM----DNPCYPRWLTREAKDILVK 229 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCccCCHHHHHHHHH
Confidence 346799999999999988899999999999999999999999975432 22222211 1233556789999999999
Q ss_pred hhhhCCCCCCCHH-HHHcCccccC
Q 005944 308 CLQKEPYLRSTAS-ELLQHPFVTG 330 (668)
Q Consensus 308 cL~~dP~~RPSa~-EIL~Hpwf~~ 330 (668)
||+.+|.+||++. ++++||||..
T Consensus 230 ~l~~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 230 LFVREPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred HhccCHhhcCCChHHHHcCcccCC
Confidence 9999999999996 9999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=359.42 Aligned_cols=255 Identities=37% Similarity=0.580 Sum_probs=209.7
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcce
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN 145 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~ 145 (668)
|++++.||+|+||+||+|.+..++..||+|++.... ...........|+.+++.++|+||+++++++......+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 74 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSE------IEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLY 74 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTT------HHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccc------ccccccchhhhhhhcccccccccccccccccccccccc
Confidence 889999999999999999999999999999985322 11222223345999999999999999999999999999
Q ss_pred EEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhh
Q 005944 146 ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI 225 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 225 (668)
+||||+.+++|.+++.....+++..++.++.||+.||.+||+.||+|+||||+|||++.++.++|+|||++.... ...
T Consensus 75 ~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~~ 152 (260)
T PF00069_consen 75 IVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLS--ENN 152 (260)
T ss_dssp EEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEEST--STT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccc
Confidence 999999999999999877899999999999999999999999999999999999999999999999999987531 112
Q ss_pred cCCccCCCCCCCCChHHHh-hcCCCcchhHHHHHHHHHHHHhCCCCCchh--HHHHHHHHhhcc--CCCCCCCCcccCHH
Q 005944 226 NGAKSMKGTPYWMAPEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQ--FQEVAALFHIGT--TKSHPPIPEHLSME 300 (668)
Q Consensus 226 ~~~~~~~GT~~Y~APEvl~-~~~~s~ksDIWSLGvILyeLLTG~~PF~~~--~~~~~~~~~~~~--~~~~~~~p~~ls~e 300 (668)
.......+|..|+|||++. +..++.++||||||+++|+|++|..||... ............ ...........+.+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEE 232 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHH
Confidence 2334567899999999998 778999999999999999999999999865 111111111110 00001111122489
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
+.+||.+||+.||.+||++.++++||||
T Consensus 233 l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 233 LRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=382.81 Aligned_cols=265 Identities=26% Similarity=0.427 Sum_probs=214.6
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
......+|++.+.||+|+||.||+|.+..+++.||+|++... ..........+.+|+.+++.++||||+++++++
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~-----~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~ 112 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF-----EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF 112 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHH-----HhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 345668999999999999999999999999999999998421 111222344577899999999999999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.....+|+|||||++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 113 ~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~ 191 (371)
T cd05622 113 QDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK 191 (371)
T ss_pred EcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeE
Confidence 999999999999999999999865 4689999999999999999999999999999999999999999999999999976
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcC----CCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCC
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTG----HSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPI 293 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~----~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~ 293 (668)
+.... .......+||+.|+|||++.+.. ++.++|||||||+||+|++|..||...... ....+.........+.
T Consensus 192 ~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 270 (371)
T cd05622 192 MNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 270 (371)
T ss_pred cCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCC
Confidence 53211 11233567999999999997543 788999999999999999999999754321 1111111111112223
Q ss_pred CcccCHHHHHHHHHhhhhCCCC--CCCHHHHHcCccccC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYL--RSTASELLQHPFVTG 330 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~--RPSa~EIL~Hpwf~~ 330 (668)
...++.++++||.+||..++.+ |+++++|++||||++
T Consensus 271 ~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 271 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence 3468999999999999844433 789999999999975
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=375.72 Aligned_cols=250 Identities=34% Similarity=0.545 Sum_probs=210.3
Q ss_pred eEEcccCceEEEEEEEc---CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceE
Q 005944 70 ELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNI 146 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~---~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~L 146 (668)
+.||+|+||.||++.+. .+|+.||+|++.... ........+..|+.+|++++||||+++++++.....+|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 75 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT------LKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYL 75 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHH------hhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEE
Confidence 57999999999999863 578999999984321 111223456789999999999999999999999999999
Q ss_pred EeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhc
Q 005944 147 LLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226 (668)
Q Consensus 147 VmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~ 226 (668)
||||+++|+|.+++.+...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...... ..
T Consensus 76 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~--~~ 153 (318)
T cd05582 76 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EK 153 (318)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC--CC
Confidence 9999999999999988888999999999999999999999999999999999999999999999999998754321 12
Q ss_pred CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHH
Q 005944 227 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLL 306 (668)
Q Consensus 227 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~ 306 (668)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+. .....++..++.++.+||.
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~-~i~--~~~~~~p~~~~~~~~~li~ 230 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT-MIL--KAKLGMPQFLSPEAQSLLR 230 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH-HHH--cCCCCCCCCCCHHHHHHHH
Confidence 2335679999999999998889999999999999999999999997543221111 111 1223456778999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHcCccccC
Q 005944 307 KCLQKEPYLRST-----ASELLQHPFVTG 330 (668)
Q Consensus 307 kcL~~dP~~RPS-----a~EIL~Hpwf~~ 330 (668)
+||+.||.+||+ +.+++.||||..
T Consensus 231 ~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 231 ALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred HHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 999999999999 788999999975
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=373.07 Aligned_cols=261 Identities=27% Similarity=0.450 Sum_probs=210.8
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|++..+++.||||++... ..........+.+|+.++..++|+||+++++++..+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKW-----EMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENN 75 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHH-----HHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCe
Confidence 3799999999999999999999999999999998421 11223344567889999999999999999999999999
Q ss_pred ceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
+|+||||+++|+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 76 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred EEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999999999976 457999999999999999999999999999999999999999999999999998654321
Q ss_pred hhhcCCccCCCCCCCCChHHHhh-----cCCCcchhHHHHHHHHHHHHhCCCCCchhHH-H-HHHHHhhccCCCCCCCCc
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQ-----TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-E-VAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~-~~~~~~~~~~~~~~~~p~ 295 (668)
.. ......+||+.|+|||++.. ..++.++|||||||++|+|++|+.||..... + ...+.........+....
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 234 (331)
T cd05597 156 GT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVT 234 (331)
T ss_pred CC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccC
Confidence 11 11223569999999999973 3478899999999999999999999965321 1 112221111112222334
Q ss_pred ccCHHHHHHHHHhhhhCCCC--CCCHHHHHcCccccC
Q 005944 296 HLSMEAKDFLLKCLQKEPYL--RSTASELLQHPFVTG 330 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~--RPSa~EIL~Hpwf~~ 330 (668)
.++.++++||.+||..++.+ |+++.++++||||.+
T Consensus 235 ~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 235 DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 57899999999999764443 789999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=390.15 Aligned_cols=255 Identities=29% Similarity=0.529 Sum_probs=202.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|+++++||+|+||+||+|.+..+++.||||++.... ....+|+.+|+.++|+|||++++++..
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------------~~~~~Ei~il~~l~h~niv~l~~~~~~ 130 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------------QYKNRELLIMKNLNHINIIFLKDYYYT 130 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------------chHHHHHHHHHhcCCCCCcceeeeEee
Confidence 34568999999999999999999999999999999873211 123469999999999999999887633
Q ss_pred C--------CcceEEeeccCCCChhcccc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC-c
Q 005944 141 D--------DSLNILLEFVPGGSISSLLG----KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-C 207 (668)
Q Consensus 141 ~--------~~~~LVmEy~~gGsL~~~L~----~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-~ 207 (668)
. ..+++||||+++ +|.+++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++ .
T Consensus 131 ~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~ 209 (440)
T PTZ00036 131 ECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHT 209 (440)
T ss_pred cccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCc
Confidence 2 246799999975 6665553 346799999999999999999999999999999999999998665 7
Q ss_pred eEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhh
Q 005944 208 IKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHI 284 (668)
Q Consensus 208 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~ 284 (668)
+||+|||+|+.+... ......+||+.|+|||++.+. .|+.++|||||||+||+|++|.+||.... .....+...
T Consensus 210 vkL~DFGla~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 210 LKLCDFGSAKNLLAG---QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred eeeeccccchhccCC---CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999999865322 223456789999999998764 58999999999999999999999997532 122222111
Q ss_pred ccC------------------------CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 285 GTT------------------------KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 285 ~~~------------------------~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
... .....++...+.++.+||.+||++||.+|||+.|+|+||||...
T Consensus 287 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 287 LGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred hCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 000 00011344578899999999999999999999999999999754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=375.88 Aligned_cols=261 Identities=27% Similarity=0.408 Sum_probs=206.8
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||.||+|.+..+|..||||++.... ........+.+|+.+++.++||||+++++++..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 91 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF------QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP 91 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc------cchhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence 34578999999999999999999999999999999984321 122334557789999999999999999998865
Q ss_pred CC------cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 141 DD------SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 141 ~~------~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
.. .+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 92 ~~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 92 QKSLEEFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred CCCccccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCC
Confidence 43 47999999976 5555553 358899999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHh---------
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFH--------- 283 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~--------- 283 (668)
+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ......
T Consensus 169 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACT---NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred Ccccccc---CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 9875422 12234467899999999999999999999999999999999999999643210 000000
Q ss_pred ------------hccCCC----------------CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 284 ------------IGTTKS----------------HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 284 ------------~~~~~~----------------~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
...... ........+.++++||.+||+.||.+|||+.|+|+||||+..+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 000000 00111234678999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=372.17 Aligned_cols=251 Identities=29% Similarity=0.456 Sum_probs=206.4
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHH-HHHHhCCCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV-KLLKNLTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei-~iL~~L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
++||+|+||+||+|++..++..||||++.... .........+..|. .+++.++|||||++++++...+..|+||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 75 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKT-----ILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVL 75 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----HHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEE
Confidence 47999999999999999999999999984221 11112223344444 4688899999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++|+|...+.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... .....
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~ 153 (321)
T cd05603 76 DYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETT 153 (321)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCcc
Confidence 9999999999988878899999999999999999999999999999999999999999999999999874321 11223
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHh
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kc 308 (668)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+ ......++...+.++.++|.+|
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~i--~~~~~~~~~~~~~~~~~li~~~ 230 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD-NI--LHKPLQLPGGKTVAACDLLVGL 230 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH-HH--hcCCCCCCCCCCHHHHHHHHHH
Confidence 45679999999999998889999999999999999999999997543221111 11 1123345667889999999999
Q ss_pred hhhCCCCCCCH----HHHHcCccccC
Q 005944 309 LQKEPYLRSTA----SELLQHPFVTG 330 (668)
Q Consensus 309 L~~dP~~RPSa----~EIL~Hpwf~~ 330 (668)
|+.+|.+|+++ .++++|+||..
T Consensus 231 l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 231 LHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred ccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 99999999875 59999999974
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=371.95 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=211.5
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||++.+..+++.||+|++... ..........+.+|+.++..++|+||+++++++.....
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 75 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKW-----EMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENN 75 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHH-----HHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCE
Confidence 3699999999999999999999999999999998321 11222334557889999999999999999999999999
Q ss_pred ceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
+|+||||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred EEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999999999976 467999999999999999999999999999999999999999999999999998754322
Q ss_pred hhhcCCccCCCCCCCCChHHHhh-----cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCCCCCCCCc
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQ-----TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~~~~~~p~ 295 (668)
.. ......+||+.|+|||++.. ..++.++|||||||+||+|++|+.||..... ....+.........+....
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVT 234 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccc
Confidence 11 11234679999999999863 4578899999999999999999999975432 1111111111111222334
Q ss_pred ccCHHHHHHHHHhhhhCCCC--CCCHHHHHcCccccCC
Q 005944 296 HLSMEAKDFLLKCLQKEPYL--RSTASELLQHPFVTGK 331 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~--RPSa~EIL~Hpwf~~~ 331 (668)
.++.++++||.+||..++.+ |+++.++++||||++.
T Consensus 235 ~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 235 DVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred cCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 67999999999999765544 6899999999999753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=372.81 Aligned_cols=250 Identities=29% Similarity=0.445 Sum_probs=205.7
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHH-HHHHHhCCCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEE-VKLLKNLTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~E-i~iL~~L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
+.||+|+||+||+|.+..++..||+|++..... ........+..| ..+++.++|+||+++++++...+.+|+||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAI-----LKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVL 75 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHH-----HhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEE
Confidence 479999999999999999999999999843211 111122233333 44678899999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++|+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..... ....
T Consensus 76 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~~~ 153 (325)
T cd05602 76 DYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NGTT 153 (325)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC--CCCc
Confidence 99999999999988888999999999999999999999999999999999999999999999999998753221 1223
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....++..++..+.+||.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~li~~ 229 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN----KPLQLKPNITNSARHLLEG 229 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh----CCcCCCCCCCHHHHHHHHH
Confidence 4567999999999999989999999999999999999999999754322 1111111 1223455789999999999
Q ss_pred hhhhCCCCCCCHH----HHHcCccccC
Q 005944 308 CLQKEPYLRSTAS----ELLQHPFVTG 330 (668)
Q Consensus 308 cL~~dP~~RPSa~----EIL~Hpwf~~ 330 (668)
||+.+|.+|+++. ++++|+||..
T Consensus 230 ~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 230 LLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred HcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 9999999999865 8999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=354.30 Aligned_cols=262 Identities=52% Similarity=0.906 Sum_probs=219.9
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchh-hHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSAS-KEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
+|.++..||.|+||.||+|.+..++..||+|.+........ ..........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 57889999999999999999998999999998854332221 22233455778899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||+|+|||++.++.+||+|||+++.+....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999988664211
Q ss_pred hh----cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 224 TI----NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 224 ~~----~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.. .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+..... ...+..+..++.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~ 238 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL-QAIFKIGE-NASPEIPSNISS 238 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH-HHHHHHhc-cCCCcCCcccCH
Confidence 11 1112346889999999999888999999999999999999999999754321 12222221 233456677899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
++.++|.+||+.+|.+||++.+|++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=387.47 Aligned_cols=256 Identities=33% Similarity=0.546 Sum_probs=224.7
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|.+++++|+|+||.+++++++.++..|++|+|....... ...+...+|+.+++++.|||||.+.+.|..++.
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~------~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~ 77 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE------PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ 77 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc------hhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence 57999999999999999999999999999999996543322 223367889999999999999999999999988
Q ss_pred -ceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 144 -LNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 144 -~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
++|||+||+||+|.+.|.+. ..|+|+.++.|+.||+.||.|||+++|+|||||+.|||++.++.|||+|||+|+.+.
T Consensus 78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999999999665 459999999999999999999999999999999999999999999999999999875
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-HHHHHHHhhccCCCCCCCCcccCH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-QEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
... ....+++|||.||.||++.+.+|+.++|||||||++|||++-+++|.... ..+... +. .....+++...+.
T Consensus 158 ~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k--i~-~~~~~Plp~~ys~ 232 (426)
T KOG0589|consen 158 PED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK--IN-RGLYSPLPSMYSS 232 (426)
T ss_pred Cch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH--Hh-hccCCCCCccccH
Confidence 433 24567899999999999999999999999999999999999999997543 222221 11 2225788999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+++.||+.||..+|..||++.++|.+|.+..
T Consensus 233 el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 233 ELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred HHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999999999999999998764
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=378.15 Aligned_cols=259 Identities=24% Similarity=0.412 Sum_probs=208.8
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC--
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD-- 142 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~-- 142 (668)
+|++.+.||+|+||+||+|.+..+++.||||++.... ......+.+.+|+.+|+.++|+||+++++++....
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 74 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF------QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID 74 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc------cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence 4788999999999999999999999999999873211 11223456788999999999999999999988776
Q ss_pred ---cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 143 ---SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 143 ---~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
..|+||||+. ++|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++..
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 75 PFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred ccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 7899999996 588888877788999999999999999999999999999999999999999999999999998754
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhh------------
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHI------------ 284 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~------------ 284 (668)
.... ........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||..... ....+...
T Consensus 154 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 3221 1122345689999999999875 478999999999999999999999964321 11111000
Q ss_pred ---------ccCCCC------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 285 ---------GTTKSH------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 285 ---------~~~~~~------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
...... ..+....+.++.+||.+||+.||.+|||+.++|+||||.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 000000 02234568899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-43 Score=393.75 Aligned_cols=263 Identities=28% Similarity=0.423 Sum_probs=218.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.++||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+|..++|+||+++++.+.
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~------~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~ 101 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEG------MSEADKNRAQAEVCCLLNCDFFSIVKCHEDFA 101 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEeccc------CCHHHHHHHHHHHHHHhcCCCCcEEEeeccee
Confidence 355679999999999999999999999999999999984321 12234456788999999999999999887764
Q ss_pred cCC--------cceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc
Q 005944 140 EDD--------SLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC 207 (668)
Q Consensus 140 ~~~--------~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~ 207 (668)
..+ .+++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+||||+.++.
T Consensus 102 ~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 102 KKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL 181 (496)
T ss_pred cccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC
Confidence 332 36899999999999998854 246899999999999999999999999999999999999999999
Q ss_pred eEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccC
Q 005944 208 IKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT 287 (668)
Q Consensus 208 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~ 287 (668)
+||+|||+++.+............+||+.|+|||++.+..++.++|||||||+||+|++|+.||....... .+.....
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~--~~~~~~~ 259 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE--VMHKTLA 259 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHhc
Confidence 99999999986543222233445789999999999999889999999999999999999999997543221 1111112
Q ss_pred CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 288 ~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
....+++..+++++.+||.+||+.+|.+||++.++++|||++.
T Consensus 260 ~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~ 302 (496)
T PTZ00283 260 GRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL 302 (496)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence 2334567789999999999999999999999999999999875
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=373.75 Aligned_cols=250 Identities=30% Similarity=0.464 Sum_probs=206.0
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHH-HHHhCCCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK-LLKNLTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
++||+|+||+||+|.+..+|+.||||++..... ........+..|.. +++.++||||+++++++...+.+|+||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~ 75 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIV-----LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVL 75 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHh-----hhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEE
Confidence 469999999999999999999999999843211 11122233444544 577899999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.... .....
T Consensus 76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~ 153 (325)
T cd05604 76 DFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTT 153 (325)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999874321 12223
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
...+||+.|+|||++.+..++.++|||||||++|+|++|..||..... +....... ....++..++..+.++|.+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~ll~~ 229 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILH----KPLVLRPGASLTAWSILEE 229 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHc----CCccCCCCCCHHHHHHHHH
Confidence 456799999999999999999999999999999999999999975432 22111111 1223344688999999999
Q ss_pred hhhhCCCCCCCH----HHHHcCccccC
Q 005944 308 CLQKEPYLRSTA----SELLQHPFVTG 330 (668)
Q Consensus 308 cL~~dP~~RPSa----~EIL~Hpwf~~ 330 (668)
||+.+|.+||++ .++++||||..
T Consensus 230 ll~~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 230 LLEKDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred HhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence 999999999876 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=395.28 Aligned_cols=252 Identities=46% Similarity=0.831 Sum_probs=228.3
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeec
Q 005944 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEF 150 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy 150 (668)
+||+|.||+||.|++..+...+|||.| .++......-+.+||.+.++|+|.|||+++|.+.+++.+-|.||-
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEI--------pekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEq 653 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEI--------PEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQ 653 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeec--------ccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeec
Confidence 699999999999999999999999988 234444556688999999999999999999999999999999999
Q ss_pred cCCCChhccccc-CCCC--CHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-CCceEEecCCchhhhHhhhhhc
Q 005944 151 VPGGSISSLLGK-FGSF--PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN-KGCIKLADFGASKKVVELATIN 226 (668)
Q Consensus 151 ~~gGsL~~~L~~-~~~l--~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~-~g~vKL~DFGlA~~~~~~~~~~ 226 (668)
++||+|.++|+. .+++ +|..+-.+.+||++||+|||++.|||||||-+||||+. .|.+||.|||.++.+.....
T Consensus 654 VPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-- 731 (1226)
T KOG4279|consen 654 VPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-- 731 (1226)
T ss_pred CCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc--
Confidence 999999999976 4777 89999999999999999999999999999999999975 58999999999987643222
Q ss_pred CCccCCCCCCCCChHHHhhcC--CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHH
Q 005944 227 GAKSMKGTPYWMAPEVILQTG--HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304 (668)
Q Consensus 227 ~~~~~~GT~~Y~APEvl~~~~--~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dL 304 (668)
-..++.||..|||||+|..+. |+.++|||||||++.||.||++||.........+++.+....++++|..++.+++.|
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~F 811 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNF 811 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHH
Confidence 234688999999999997654 899999999999999999999999877777788999999999999999999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 305 LLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 305 I~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
|.+|+.+||.+||++.++|..||++...
T Consensus 812 ilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 812 ILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred HHHHcCCCcccCccHHHhccCcccccCC
Confidence 9999999999999999999999998763
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=392.17 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=216.3
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCC-CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDS-GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~t-g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...|.+.+.||+|+||.||+|.+..+ +..||+|.+... .......+.+|+.+|+.++|||||++++++...
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--------~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~ 137 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--------DERQAAYARSELHCLAACDHFGIVKHFDDFKSD 137 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence 44599999999999999999998887 788999976321 122334567899999999999999999999999
Q ss_pred CcceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 142 DSLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
+.+||||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 138 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~ 217 (478)
T PTZ00267 138 DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK 217 (478)
T ss_pred CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCce
Confidence 999999999999999887643 3568999999999999999999999999999999999999999999999999998
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ 296 (668)
.+............+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +...... ....+.+..
T Consensus 218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~---~~~~~~~~~ 294 (478)
T PTZ00267 218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY---GKYDPFPCP 294 (478)
T ss_pred ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCcc
Confidence 654322222344567999999999999989999999999999999999999999754322 1111111 223345667
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
++.++.+||.+||..+|.+||++.+++.|+|++.
T Consensus 295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 295 VSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 8999999999999999999999999999999864
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=360.16 Aligned_cols=254 Identities=32% Similarity=0.527 Sum_probs=199.4
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHh---CCCCCeeeecccccc-
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN---LTHPNIVRYLGTARE- 140 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~---L~HpNIV~l~g~~~~- 140 (668)
+|++.+.||+|+||+||+|.+..+++.||+|++........ ....+.+|+.+++. ++||||+++++++..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~------~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~ 74 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG------LPLSTVREVALLKRLEAFDHPNIVRLMDVCATS 74 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC------CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence 58999999999999999999999999999998854321111 11123345555554 479999999998754
Q ss_pred ----CCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 141 ----DDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 141 ----~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
...+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 75 RTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred cCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccC
Confidence 3457999999975 888887653 358999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCC---C
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTK---S 289 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~---~ 289 (668)
++...... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||..... ....+....... .
T Consensus 154 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07863 154 LARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 230 (288)
T ss_pred ccccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhh
Confidence 98765321 122345789999999999988899999999999999999999999964321 111111110000 0
Q ss_pred -------------------CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 290 -------------------HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 290 -------------------~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.......++.++.+||.+||+.||.+|||+.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 001123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=352.81 Aligned_cols=261 Identities=47% Similarity=0.837 Sum_probs=217.3
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++++.||.|+||+||+|.. .++..+|||++...... ..........+.+|+.+|+.++|+||+++++++.....+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 77 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSN--VLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTI 77 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccc--hhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeE
Confidence 588999999999999999986 57889999988543221 122234456788999999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
++||||+++++|.+++.+...+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++........
T Consensus 78 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 78 SIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876532111
Q ss_pred ----hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 225 ----INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 225 ----~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
........|+..|+|||++.+..++.++|||||||++|+|++|..||...................+..+..++.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06631 158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAA 237 (265)
T ss_pred cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHH
Confidence 1122345689999999999988899999999999999999999999975322211111111112334566778999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
+.+||.+||+.+|.+||++.+++.||||
T Consensus 238 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 238 AIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=389.65 Aligned_cols=257 Identities=22% Similarity=0.356 Sum_probs=199.9
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC------CCeeeec
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH------PNIVRYL 135 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H------pNIV~l~ 135 (668)
...+|++.++||+|+||+||+|.+..++..||||++... ......+..|+.++..+.| .+|+.++
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---------~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~ 197 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---------PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQ 197 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---------hhhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence 457899999999999999999999999999999998421 1122334556666666644 4588888
Q ss_pred cccccC-CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCC-------
Q 005944 136 GTARED-DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKG------- 206 (668)
Q Consensus 136 g~~~~~-~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g------- 206 (668)
+++... ..+|||||++ |++|.+++.+.+.+++..++.|+.||+.||.|||. .|||||||||+||||+.++
T Consensus 198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 198 RYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred EEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence 888654 5688999988 77899988888899999999999999999999998 5999999999999998765
Q ss_pred ---------ceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH
Q 005944 207 ---------CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE 277 (668)
Q Consensus 207 ---------~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~ 277 (668)
.+||+|||++... .......+||+.|+|||++.+..|+.++|||||||+||||++|++||......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 4999999987532 12234578999999999999999999999999999999999999999643211
Q ss_pred --HHHHHhhcc----------------------CCCCCC--------------CC-cccCHHHHHHHHHhhhhCCCCCCC
Q 005944 278 --VAALFHIGT----------------------TKSHPP--------------IP-EHLSMEAKDFLLKCLQKEPYLRST 318 (668)
Q Consensus 278 --~~~~~~~~~----------------------~~~~~~--------------~p-~~ls~el~dLI~kcL~~dP~~RPS 318 (668)
...+..... ....+. .. ...+..+.+||.+||++||.+|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 111100000 000000 00 012456789999999999999999
Q ss_pred HHHHHcCccccCCCC
Q 005944 319 ASELLQHPFVTGKYQ 333 (668)
Q Consensus 319 a~EIL~Hpwf~~~~~ 333 (668)
+.|+|+||||...+.
T Consensus 432 a~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 432 ARQMTTHPYVLKYYP 446 (467)
T ss_pred HHHHhcCccccccCC
Confidence 999999999987544
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=370.49 Aligned_cols=261 Identities=25% Similarity=0.384 Sum_probs=211.4
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|++..+++.||||++... ..........+.+|+.++..++|+||+.+++++...+.
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~ 75 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKW-----EMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENY 75 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHH-----HHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3799999999999999999999999999999988421 11222334557889999999999999999999999999
Q ss_pred ceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.|+||||++||+|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 76 ~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 76 LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred EEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999999976 467999999999999999999999999999999999999999999999999998765322
Q ss_pred hhhcCCccCCCCCCCCChHHHhh-----cCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccC-CCCCCCCc
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQ-----TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTT-KSHPPIPE 295 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~-~~~~~~p~ 295 (668)
.. ......+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||..... +....+..... ...+....
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~ 234 (331)
T cd05624 156 GT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHIT 234 (331)
T ss_pred Cc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccc
Confidence 11 11224579999999999976 4578899999999999999999999975332 11111111111 11122234
Q ss_pred ccCHHHHHHHHHhhhhCCCC--CCCHHHHHcCccccC
Q 005944 296 HLSMEAKDFLLKCLQKEPYL--RSTASELLQHPFVTG 330 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~--RPSa~EIL~Hpwf~~ 330 (668)
.++.++++||.+||..++.+ |++++++++||||+.
T Consensus 235 ~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 235 DVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred cCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 57899999999999876654 579999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=365.28 Aligned_cols=259 Identities=27% Similarity=0.448 Sum_probs=207.3
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|.+.+.||+|+||+||+|++..++..||||++...... .....+.+|+.+++.++|+||+++++++..++.
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 78 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKS 78 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-------CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCe
Confidence 5799999999999999999999999999999988532211 112245679999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.++||||+++ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 79 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 157 (309)
T cd07872 79 LTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP 157 (309)
T ss_pred EEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence 9999999975 777776554 45899999999999999999999999999999999999999999999999998754221
Q ss_pred hhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhcc-------------
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGT------------- 286 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~------------- 286 (668)
........+|+.|+|||++.+ ..++.++|||||||++|+|+||++||..... ....+.....
T Consensus 158 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07872 158 --TKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235 (309)
T ss_pred --ccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence 112234568999999999875 4578999999999999999999999964321 1111111000
Q ss_pred -----CCCC-------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 287 -----TKSH-------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 287 -----~~~~-------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.... ......++.++++||.+||+.||.+|||+.|+++||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0000 011134788999999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=373.40 Aligned_cols=248 Identities=32% Similarity=0.497 Sum_probs=203.2
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC---CCCCeeeeccccccCCcceEEe
Q 005944 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL---THPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 72 LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIV~l~g~~~~~~~~~LVm 148 (668)
||+|+||+||+|++..++..||||++.... .........+..|..++..+ .||||+.+++++.....+|+||
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~ 75 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE-----IVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVT 75 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHH-----HhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEE
Confidence 699999999999999999999999984211 11122233445566666655 6999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++|+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..... .....
T Consensus 76 e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~ 153 (330)
T cd05586 76 DYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTT 153 (330)
T ss_pred cCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999875321 11223
Q ss_pred ccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCC-cccCHHHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIP-EHLSMEAKDFL 305 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p-~~ls~el~dLI 305 (668)
...+||+.|+|||++.+. .++.++|||||||++|+|++|..||..... .....+.... ..++ ..++.++.+||
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~~li 229 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK----VRFPKNVLSDEGRQFV 229 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC----CCCCCccCCHHHHHHH
Confidence 456899999999999765 489999999999999999999999975432 2222222221 1122 35789999999
Q ss_pred HHhhhhCCCCCC----CHHHHHcCccccC
Q 005944 306 LKCLQKEPYLRS----TASELLQHPFVTG 330 (668)
Q Consensus 306 ~kcL~~dP~~RP----Sa~EIL~Hpwf~~ 330 (668)
.+||+.||.+|| ++.++++||||..
T Consensus 230 ~~~L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 230 KGLLNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred HHHcCCCHHHCCCCCCCHHHHhcCccccC
Confidence 999999999998 7999999999975
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=375.90 Aligned_cols=299 Identities=27% Similarity=0.434 Sum_probs=252.9
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
......|+.-++||+||||.||-++.+.||+.+|+|.+.. .+-+.........+|-.||..++.+.||.+-..|+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~K-----KRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe 255 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDK-----KRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE 255 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHH-----HHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence 3455678999999999999999999999999999998732 22333344456778999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
+.+.+++||..|.||+|.-+|.+.+ .|++..++.++.+|+.||++||..+||+|||||+|||+|+.|+++|.|+|||.
T Consensus 256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEE
Confidence 9999999999999999999998877 79999999999999999999999999999999999999999999999999998
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHH-HHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAA-LFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~-~~~~~~~~~~~~~p~~ 296 (668)
.+.+... ....+||.+|||||++.+..|+...|+|||||+||+|+.|+.||......+.. .+..........+++.
T Consensus 336 ei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~k 412 (591)
T KOG0986|consen 336 EIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDK 412 (591)
T ss_pred ecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccc
Confidence 7755433 44569999999999999999999999999999999999999999876554433 2333334445567889
Q ss_pred cCHHHHHHHHHhhhhCCCCCC-----CHHHHHcCccccCCC--------------CCCCccccccccccCccccCCCCCc
Q 005944 297 LSMEAKDFLLKCLQKEPYLRS-----TASELLQHPFVTGKY--------------QDPHPVFRNSVMESGNQIATPGMNL 357 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~~~--------------~~~~~~~~~~v~~~~~~~~~~~~~~ 357 (668)
.|+++++|...+|++||.+|. +++++.+||||+... .+++.++...+.+..+...+.++.+
T Consensus 413 FS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~VKGV~l 492 (591)
T KOG0986|consen 413 FSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFSTVKGVKL 492 (591)
T ss_pred cCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccchhhhhhhhhcccccceec
Confidence 999999999999999999995 467999999998632 3445666677777777777777777
Q ss_pred cchhhhhhh
Q 005944 358 RNSMNSLVR 366 (668)
Q Consensus 358 ~~s~~s~~~ 366 (668)
......+..
T Consensus 493 d~~D~~fy~ 501 (591)
T KOG0986|consen 493 DDTDTDFYK 501 (591)
T ss_pred ccccHHHHH
Confidence 777666554
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=361.43 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=212.3
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
.|++.++||+|+||+||+|.+..+++.||||.+..... ........+.+|+.+++.++|+||+.+++.+...+.+
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~-----~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI-----KKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDAL 75 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhc-----cchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEE
Confidence 47888999999999999999999999999998742211 1122334567899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 76 ~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 76 CLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred EEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 9999999999999888543 35899999999999999999999999999999999999999999999999998654321
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH--HHHHhhccCCCCCCCCcccCHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV--AALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~--~~~~~~~~~~~~~~~p~~ls~e 300 (668)
. ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....... .......+..++.+
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 231 (285)
T cd05630 156 Q---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV-KEVQEEYSEKFSPD 231 (285)
T ss_pred c---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh-hhhhhhcCccCCHH
Confidence 1 1234579999999999998889999999999999999999999997532111 0111110 11122345678899
Q ss_pred HHHHHHHhhhhCCCCCCC-----HHHHHcCccccC
Q 005944 301 AKDFLLKCLQKEPYLRST-----ASELLQHPFVTG 330 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~ 330 (668)
+.+||.+||+.||.+||| +.++++||||..
T Consensus 232 ~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 232 ARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=375.27 Aligned_cols=258 Identities=22% Similarity=0.341 Sum_probs=209.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEc--CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNL--DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~--~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
....+|++.+.||.|+||.||+|... .++..||||.+... ....+|+.+|+.++|||||++++++
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------------~~~~~E~~il~~l~h~~iv~~~~~~ 155 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------------KTPGREIDILKTISHRAIINLIHAY 155 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------------ccHHHHHHHHHhcCCCCccceeeeE
Confidence 44568999999999999999999764 35688999987311 1245799999999999999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.....+|+|||++. ++|.+++...+.+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus 156 ~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~ 234 (392)
T PHA03207 156 RWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACK 234 (392)
T ss_pred eeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccc
Confidence 99999999999996 58888887778899999999999999999999999999999999999999999999999999976
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-----HHHHHHHhhc--------
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-----QEVAALFHIG-------- 285 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-----~~~~~~~~~~-------- 285 (668)
+.............||+.|+|||++.+..++.++|||||||+||+|++|+.||.... ..+..+....
T Consensus 235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 544332223345679999999999999899999999999999999999999995321 1111111100
Q ss_pred --------------cCCCCC--CCC-----cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 286 --------------TTKSHP--PIP-----EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 286 --------------~~~~~~--~~p-----~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
...... ..+ ..++.++.+||.+||..||.+||++.++|.||||....
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~ 382 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEP 382 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccc
Confidence 000000 011 23467889999999999999999999999999997643
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=358.33 Aligned_cols=251 Identities=23% Similarity=0.367 Sum_probs=203.0
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeecc
Q 005944 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFV 151 (668)
Q Consensus 72 LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~ 151 (668)
||+|+||+||++.+..+|+.||+|++..... ........+..|+++|+.++||||+++++++.....+|+||||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRL-----KKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLM 75 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHh-----hcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecC
Confidence 6999999999999999999999998842111 11112234456999999999999999999999999999999999
Q ss_pred CCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCc
Q 005944 152 PGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAK 229 (668)
Q Consensus 152 ~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~ 229 (668)
+|++|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++...... ....
T Consensus 76 ~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~---~~~~ 152 (277)
T cd05607 76 NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG---KTIT 152 (277)
T ss_pred CCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCC---ceee
Confidence 999998887543 35889999999999999999999999999999999999999999999999998765321 1223
Q ss_pred cCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH--HHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 230 SMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV--AALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 230 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~--~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
...||+.|+|||++.+..++.++|||||||++|+|++|..||....... ..................++.++++||.+
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 232 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRL 232 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHH
Confidence 4578999999999998889999999999999999999999996432211 11111111111111224678999999999
Q ss_pred hhhhCCCCCCCH----HHHHcCccccC
Q 005944 308 CLQKEPYLRSTA----SELLQHPFVTG 330 (668)
Q Consensus 308 cL~~dP~~RPSa----~EIL~Hpwf~~ 330 (668)
||+.||.+||++ ++++.||||+.
T Consensus 233 ~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 233 FLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred HhccCHhhCCCCccchhhhhcChhhcC
Confidence 999999999999 77889999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=352.26 Aligned_cols=261 Identities=50% Similarity=0.898 Sum_probs=215.7
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc--C
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE--D 141 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~--~ 141 (668)
.+|++.++||+|+||.||+|.+..++..||+|++...... .........+.+|+.+++.++|+||+++++++.. .
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~---~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPES---PETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAE 78 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCC---chhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCC
Confidence 5799999999999999999999999999999987433211 1122345668899999999999999999998765 3
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
..++++|||+++++|.+++.....+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++..+..
T Consensus 79 ~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 79 KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 56889999999999999998877899999999999999999999999999999999999999999999999999875432
Q ss_pred hhh-hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 222 LAT-INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 222 ~~~-~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
... ........++..|+|||++.+..++.++|||||||++|+|++|+.||...... ............+.++..++..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-AAIFKIATQPTNPQLPSHISEH 237 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-HHHHHHhcCCCCCCCchhcCHH
Confidence 111 11123356899999999999888999999999999999999999999754322 2222222233345566778899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
+++|| +||..+|.+||++.||++||||+
T Consensus 238 ~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 238 ARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 99999 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=370.33 Aligned_cols=261 Identities=26% Similarity=0.399 Sum_probs=206.6
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++||||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 87 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP 87 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc------cChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence 34578999999999999999999999999999999884221 122334567789999999999999999998754
Q ss_pred C------CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 141 D------DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 141 ~------~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
. ...|+||||+++ +|...+.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 88 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 88 QKSLEEFQDVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cccccccceeEEEhhhhcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCc
Confidence 3 347999999976 56665543 58899999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhc-------
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIG------- 285 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~------- 285 (668)
+++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .........
T Consensus 165 ~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (355)
T cd07874 165 LARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_pred ccccCCC---ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9975422 1223346799999999999998899999999999999999999999964321 111100000
Q ss_pred -------------c-CC----------------CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 286 -------------T-TK----------------SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 286 -------------~-~~----------------~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
. .. .....+...+.++++||.+||+.||.+|||+.|+|+||||...+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0 00 000112234678899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=369.92 Aligned_cols=259 Identities=26% Similarity=0.389 Sum_probs=205.5
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~ 95 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 95 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc------cCchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence 4578999999999999999999999999999999884221 1223345567899999999999999999987543
Q ss_pred ------CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 142 ------DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 142 ------~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
..+|+||||+++ +|..++.. .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 96 ~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 96 KSLEEFQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred ccccccCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 66666643 588999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhcc-------
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGT------- 286 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~------- 286 (668)
++.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+.....
T Consensus 173 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 249 (364)
T cd07875 173 ARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 249 (364)
T ss_pred ccccCC---CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 975422 1123346789999999999999999999999999999999999999964321 1111110000
Q ss_pred -------------CC-----------------CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 287 -------------TK-----------------SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 287 -------------~~-----------------~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.. .........+.++++||.+||+.||.+|||+.++|+||||...+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~ 325 (364)
T cd07875 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325 (364)
T ss_pred HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccccccc
Confidence 00 00011122356789999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=365.54 Aligned_cols=261 Identities=31% Similarity=0.554 Sum_probs=213.3
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC-eeeeccccccC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN-IVRYLGTARED 141 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IV~l~g~~~~~ 141 (668)
...|...+.||+|+||+||+|+.+.+|+.||+|++...... +.......+|+.+|+.|+|+| ||.|++++...
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~------EG~P~taiREisllk~L~~~~~iv~L~dv~~~~ 83 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE------EGVPSTAIREISLLKRLSHANHIVRLHDVIHTS 83 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc------cCCCchhhHHHHHHHHhCCCcceEEEEeeeeec
Confidence 44588888899999999999999999999999998543321 112234578999999999999 99999999887
Q ss_pred C------cceEEeeccCCCChhcccccCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 142 D------SLNILLEFVPGGSISSLLGKFG----SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 142 ~------~~~LVmEy~~gGsL~~~L~~~~----~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
+ .+++|+||++. +|..++.... .++...++.+++||+.||+|||+++|+||||||+||||+..|.+||+
T Consensus 84 ~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 84 NNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred ccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeee
Confidence 7 89999999965 9999987755 57888999999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCC
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTK 288 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~ 288 (668)
|||+|+.+.- .....+..++|.+|+|||++.+. .|+...||||+|||++||+++++.|.+.. +....++......
T Consensus 163 DFGlAra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 163 DFGLARAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred ccchHHHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 9999985531 22235567899999999999988 58999999999999999999999997543 3333333332221
Q ss_pred C---CC----------CC-----C-------cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 289 S---HP----------PI-----P-------EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 289 ~---~~----------~~-----p-------~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
. ++ .+ + ...+....+|+.+||+.+|.+|.|+..+|.||||....
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 1 11 00 0 12335789999999999999999999999999998643
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=350.86 Aligned_cols=263 Identities=47% Similarity=0.850 Sum_probs=215.1
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhh--HhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASK--EKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~--~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
+|.+.+.||.|+||.||+|.+..+|..||||.+......... .......+.+..|+.+++.++|+||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 689999999999999999999989999999988543221111 122334567888999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
..++||||+++++|.+++.+.+.+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998754322
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcC--CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCC----CCCcc
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTG--HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP----PIPEH 296 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~--~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~----~~p~~ 296 (668)
..........|+..|+|||++.... ++.++||||||+++|+|++|..||...... ............. .....
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 240 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-AAMFKLGNKRSAPPIPPDVSMN 240 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-HHHHHhhccccCCcCCcccccc
Confidence 1111223456899999999997655 788999999999999999999999643221 1122211111112 22235
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
++.++.+||.+||..+|.+||++.++++||||
T Consensus 241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 241 LSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 68899999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=368.06 Aligned_cols=258 Identities=27% Similarity=0.468 Sum_probs=206.6
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|.+.+.||.|+||+||+|.+..++..||||++... .........+.+|+.+|+.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRP------FQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPA 86 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCch------hhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccc
Confidence 457899999999999999999999999999999988421 11223345577899999999999999999987543
Q ss_pred ------CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 142 ------DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 142 ------~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
...|++++++ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 87 TSIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred ccccccCcEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3478999998 7788887754 5799999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccC-----
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTT----- 287 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~----- 287 (668)
++.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .....+......
T Consensus 165 ~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 165 ARQADD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred ceecCC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 976432 2345679999999999987 468999999999999999999999996432 111111110000
Q ss_pred -------------CCCC--------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 288 -------------KSHP--------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 288 -------------~~~~--------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.... ......++.+.+||.+||..||.+|||+.++|.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 240 LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred HHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 0000 01123567789999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=345.83 Aligned_cols=257 Identities=65% Similarity=1.143 Sum_probs=218.5
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|+..+.||+|+||+||+|+...++..||+|.+...... ...+...+.+.+|+.+++.++|+||+++++++.....+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDG---QTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEcccc---ccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeE
Confidence 588889999999999999999889999999988542211 11234456788999999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
++||||+++++|.+++.+...+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~- 156 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS- 156 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999987653222
Q ss_pred hcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHH
Q 005944 225 INGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~d 303 (668)
......|++.|+|||.+.... ++.++|||||||++|+|++|..||.... ................++..++..+.+
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRSKELPPIPDHLSDEAKD 233 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhcccCCCcCCCcCHHHHH
Confidence 233567899999999998776 8999999999999999999999996543 222222333323344566778999999
Q ss_pred HHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 304 FLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 304 LI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
||.+||+.+|.+||++.+++.|||+
T Consensus 234 li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 234 FILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=345.45 Aligned_cols=254 Identities=28% Similarity=0.526 Sum_probs=211.5
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc-CCc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE-DDS 143 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~-~~~ 143 (668)
+|++.+.||.|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++|+||+++++.+.. +..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRN------ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL 74 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhh------cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence 5899999999999999999999999999999984221 122334567889999999999999999988764 446
Q ss_pred ceEEeeccCCCChhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 144 LNILLEFVPGGSISSLLGK--FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
+|+||||+++++|.+++.. ...+++.+++.++.||+.||.+||+.||+||||||+|||++.++.++|+|||++.....
T Consensus 75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 8999999999999998865 34589999999999999999999999999999999999999999999999999876532
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
. ........|++.|+|||++.+..++.++|||||||++|+|++|+.||............. ....+..+..++.++
T Consensus 155 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 230 (257)
T cd08223 155 Q--CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII--EGKLPPMPKDYSPEL 230 (257)
T ss_pred c--CCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH--hcCCCCCccccCHHH
Confidence 1 122345678999999999998889999999999999999999999997543221111111 112234566788999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.+||.+||+.+|.+||++.++++||||
T Consensus 231 ~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 231 GELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=355.21 Aligned_cols=254 Identities=33% Similarity=0.572 Sum_probs=218.4
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||.||+|.+..+++.||+|++... ..........+.+|+++|++++||||+++++++.....
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKA-----KIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSN 75 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHH-----HhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCe
Confidence 3699999999999999999999999999999988421 11122345668899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|+||||+++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|.||||+.++.+||+|||++......
T Consensus 76 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 76 LYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999999988889999999999999999999999999999999999999999999999999998765322
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~d 303 (668)
....+|++.|+|||.+.+..++.++||||||+++|+|++|..||............. .....++..++..+++
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~ 227 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL---EGKVRFPSFFSPDAKD 227 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh---cCCccCCccCCHHHHH
Confidence 334578999999999988888999999999999999999999997543221111111 2234566778999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 304 FLLKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 304 LI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
+|.+||..+|.+|+ +++++++||||..
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~ 259 (290)
T cd05580 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG 259 (290)
T ss_pred HHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence 99999999999999 9999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=345.35 Aligned_cols=254 Identities=28% Similarity=0.504 Sum_probs=215.1
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|.+.+.||+|+||.||+|++..++..|++|.+.... ........+.+|+.+++.++||||+++++++......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSK------MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL 74 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhh------CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence 4888999999999999999999999999999884321 1123445678899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||+++.+...
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 9999999999999998764 56899999999999999999999999999999999999999999999999998765432
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
. .......|++.|+|||++.+..++.++|||||||++|+|++|+.||......... ... .......++..++.++.
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~ 230 (256)
T cd08529 155 T--NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI-LKI-IRGVFPPVSQMYSQQLA 230 (256)
T ss_pred c--chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHH-HcCCCCCCccccCHHHH
Confidence 2 1223457899999999999888999999999999999999999999755432211 111 12233445557889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 303 DFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 303 dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
++|.+||+.+|++||++.++++|||+
T Consensus 231 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 231 QLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=352.85 Aligned_cols=255 Identities=38% Similarity=0.628 Sum_probs=210.1
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+|+.+++.++||||+++++.+...+
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~ 79 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--------GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRD 79 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--------hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCC
Confidence 457999999999999999999999999999999884321 112345678999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.+|+||||+++++|.+++...+.+++.+++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+...
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 80 KLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998755321
Q ss_pred hhhcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCC--Cccc
Q 005944 223 ATINGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI--PEHL 297 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~--p~~l 297 (668)
........|++.|+|||++. ...++.++|||||||++|+|++|..||...................... ...+
T Consensus 160 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd06645 160 --IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237 (267)
T ss_pred --ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCC
Confidence 12233467999999999985 4457889999999999999999999986432211111111111111111 1246
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCcc
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPF 327 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpw 327 (668)
+..+.+||.+||+.+|++||++.++++|||
T Consensus 238 ~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 238 SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=354.85 Aligned_cols=259 Identities=27% Similarity=0.428 Sum_probs=214.4
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
.|+..++||.|+||+||+|.+..+++.||+|++.... .........+.+|+.+|+.++|+||+.+++.+..++..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~ 75 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKR-----IKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDAL 75 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhh-----hhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEE
Confidence 3788899999999999999999999999999884211 11222334567899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
++||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 76 CLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred EEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 9999999999999887543 46999999999999999999999999999999999999999999999999998654221
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHH-HHHhhccCCCCCCCCcccCHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVA-ALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~-~~~~~~~~~~~~~~p~~ls~el 301 (668)
.......|++.|+|||++.+..++.++|||||||++|+|++|..||........ .............++..++.++
T Consensus 156 ---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (285)
T cd05632 156 ---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEA 232 (285)
T ss_pred ---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHH
Confidence 122346799999999999988899999999999999999999999975432211 1111111222234556788999
Q ss_pred HHHHHHhhhhCCCCCCC-----HHHHHcCccccCC
Q 005944 302 KDFLLKCLQKEPYLRST-----ASELLQHPFVTGK 331 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~~ 331 (668)
.+|+.+||+.+|.+||+ +.+++.|+||...
T Consensus 233 ~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 233 KSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 99999999999999999 8999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=355.77 Aligned_cols=263 Identities=39% Similarity=0.635 Sum_probs=215.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.....|++.+.||.|+||.||+|.+..++..||+|++.. ........+.+|+.+++.++|+||+++++.+..
T Consensus 9 ~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 80 (292)
T cd06644 9 DPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIET--------KSEEELEDYMVEIEILATCNHPYIVKLLGAFYW 80 (292)
T ss_pred CcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEecc--------CCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence 455779999999999999999999999999999999832 123345667889999999999999999999999
Q ss_pred CCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
+..+|+||||+++++|..++.+ ...+++..++.++.||+.+|.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999887754 456899999999999999999999999999999999999999999999999988653
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHh-----hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP 294 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p 294 (668)
.. .........+++.|+|||++. ...++.++|||||||++|+|++|.+||......................+
T Consensus 161 ~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (292)
T cd06644 161 VK--TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQP 238 (292)
T ss_pred cc--cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCC
Confidence 22 112223456899999999985 34467899999999999999999999965432111111111111122335
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
..++.++.+||.+||..+|++||++.++++||||.....
T Consensus 239 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 277 (292)
T cd06644 239 SKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTS 277 (292)
T ss_pred cccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 567889999999999999999999999999999975443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=368.26 Aligned_cols=258 Identities=34% Similarity=0.554 Sum_probs=210.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.....|+..+++|.|+||.||+|....++..||||++..... .-.+|+.+|+.++|||||+|..+|..
T Consensus 21 ~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------------~knrEl~im~~l~HpNIV~L~~~f~~ 88 (364)
T KOG0658|consen 21 KVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------------YKNRELQIMRKLDHPNIVRLLYFFSS 88 (364)
T ss_pred ceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------------cCcHHHHHHHhcCCcCeeeEEEEEEe
Confidence 445679999999999999999999999999999999843221 12358999999999999999887743
Q ss_pred C-----CcceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-CceEE
Q 005944 141 D-----DSLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK-GCIKL 210 (668)
Q Consensus 141 ~-----~~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~-g~vKL 210 (668)
. -...+||||++. +|..+++. +..++...++-+++||++||.|||..||+||||||.|||||.+ |.+||
T Consensus 89 ~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKi 167 (364)
T KOG0658|consen 89 STESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKI 167 (364)
T ss_pred cCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEe
Confidence 2 245689999986 88888874 4789999999999999999999999999999999999999976 99999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccC
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTT 287 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~ 287 (668)
||||.|+.+.... +..++..|..|+|||++.+.. |+.+.||||.||++.||+-|++.|.+.. +.+..++.+...
T Consensus 168 cDFGSAK~L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~ 244 (364)
T KOG0658|consen 168 CDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT 244 (364)
T ss_pred ccCCcceeeccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence 9999999875433 345778899999999999865 8999999999999999999999997542 222222221111
Q ss_pred CC------------------------CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCC
Q 005944 288 KS------------------------HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334 (668)
Q Consensus 288 ~~------------------------~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~ 334 (668)
.. ..-+...+++++.+|+.++|+.+|.+|.++.|++.||||......
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 00 001334678999999999999999999999999999999865443
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=348.50 Aligned_cols=263 Identities=43% Similarity=0.794 Sum_probs=218.9
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|+.+++||+|+||.||+|.+..++..||+|++...... ..........+.+|+++|+.++|+||+++++++...+.+
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNT--SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHF 78 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCC--chhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeE
Confidence 488899999999999999999999999999988533211 112233457788999999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC-ceEEecCCchhhhHhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-CIKLADFGASKKVVELA 223 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-~vKL~DFGlA~~~~~~~ 223 (668)
++||||+++++|.+++.+.+.+++..+..++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++..+....
T Consensus 79 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 79 NLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999999998888899999999999999999999999999999999999998776 69999999987654321
Q ss_pred hh--cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCCCCCCCCcccCH
Q 005944 224 TI--NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 224 ~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.. .......|+..|+|||++.+..++.++|||||||++|+|++|..||.... ..................+..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06630 159 TGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSP 238 (268)
T ss_pred ccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCH
Confidence 11 11123468899999999988889999999999999999999999996322 112222222223344566778899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
++.++|.+||..+|.+||++.++++||||+
T Consensus 239 ~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 239 GLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=362.85 Aligned_cols=249 Identities=26% Similarity=0.428 Sum_probs=190.2
Q ss_pred eeEEcccCceEEEEEEEc--CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc--CCcc
Q 005944 69 GELVGCGAFGRVYMGMNL--DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE--DDSL 144 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~--~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~--~~~~ 144 (668)
+..||+|+||+||+|+++ .++..||+|++.... ....+.+|+.+|+.++||||+++++++.. ...+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG----------ISMSACREIALLRELKHPNVISLQKVFLSHADRKV 75 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC----------CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEE
Confidence 468999999999999975 467899999883211 11235679999999999999999998853 4568
Q ss_pred eEEeeccCCCChhccccc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe----CCCCceEEe
Q 005944 145 NILLEFVPGGSISSLLGK---------FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV----DNKGCIKLA 211 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~---------~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl----d~~g~vKL~ 211 (668)
|+||||+.+ +|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 76 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 899999964 77766532 1358999999999999999999999999999999999999 456799999
Q ss_pred cCCchhhhHhhhh-hcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH-----------HH
Q 005944 212 DFGASKKVVELAT-INGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ-----------EV 278 (668)
Q Consensus 212 DFGlA~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-----------~~ 278 (668)
|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|+|++|++||..... ..
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 234 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHH
Confidence 9999976532211 1123356789999999999874 589999999999999999999999953211 11
Q ss_pred HHHHhhccCCC------------------------C---------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 279 AALFHIGTTKS------------------------H---------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 279 ~~~~~~~~~~~------------------------~---------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
..++....... . .......+.++.+||.+||+.||.+|||++|+|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h 314 (317)
T cd07868 235 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 314 (317)
T ss_pred HHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11111100000 0 00011235678999999999999999999999999
Q ss_pred ccc
Q 005944 326 PFV 328 (668)
Q Consensus 326 pwf 328 (668)
|||
T Consensus 315 p~f 317 (317)
T cd07868 315 PYF 317 (317)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=353.33 Aligned_cols=256 Identities=40% Similarity=0.625 Sum_probs=211.2
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcce
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN 145 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~ 145 (668)
|++.+.||.|+||.||+|.+..++..+|+|.+... .......+.+|+.+++.++|+||+++++++......|
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 78 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--------SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW 78 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--------CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEE
Confidence 78889999999999999999999999999987321 1233456788999999999999999999999999999
Q ss_pred EEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 146 ILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
+||||+++++|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus 79 ~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-- 156 (282)
T cd06643 79 ILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-- 156 (282)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc--
Confidence 99999999999888754 467999999999999999999999999999999999999999999999999998754321
Q ss_pred hcCCccCCCCCCCCChHHHh-----hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 225 INGAKSMKGTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
........|++.|+|||++. +..++.++|||||||++|+|++|.+||......................+..++.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd06643 157 IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSS 236 (282)
T ss_pred ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCH
Confidence 11223457899999999984 3446789999999999999999999997543221111111111122234556889
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++.+||.+||+.+|.+||++.++++||||...
T Consensus 237 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 237 EFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 99999999999999999999999999999754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=354.74 Aligned_cols=255 Identities=28% Similarity=0.495 Sum_probs=203.8
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||.|+||.||+|++..+|..||+|++..... .......+.+|+.+++.++|+||+++++++.....+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~------~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL 74 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc------cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence 58999999999999999999999999999999853221 111223466799999999999999999999999999
Q ss_pred eEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 145 NILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
++|+||+.+ +|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...
T Consensus 75 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~- 152 (284)
T cd07839 75 TLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP- 152 (284)
T ss_pred EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC-
Confidence 999999975 77776654 567999999999999999999999999999999999999999999999999998754321
Q ss_pred hhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhH---HHHHHHHhh---------------
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQF---QEVAALFHI--------------- 284 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~---~~~~~~~~~--------------- 284 (668)
........+++.|+|||++.+.. ++.++|||||||++|+|+||..||.... .....+...
T Consensus 153 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 153 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhc
Confidence 11223456789999999987754 7899999999999999999988863211 111111100
Q ss_pred ccCCCC---------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 285 GTTKSH---------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 285 ~~~~~~---------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
...... ......++.++++||.+||+.||.+|||+.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000000 11123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=353.39 Aligned_cols=259 Identities=37% Similarity=0.617 Sum_probs=214.1
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
+..+|++.+.||.|+||+||+|.+..++..||+|++... .......+..|+.+++.++|+||+++++++...
T Consensus 3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 74 (280)
T cd06611 3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--------SEEELEDFMVEIDILSECKHPNIVGLYEAYFYE 74 (280)
T ss_pred chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--------CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC
Confidence 346799999999999999999999889999999998432 222345677899999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 142 DSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...|+||||+++++|..++.+. ..+++..++.++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++....
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999999999999998764 569999999999999999999999999999999999999999999999999987543
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhh-----cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhcc-CCCCCCCC
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQ-----TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT-TKSHPPIP 294 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~-~~~~~~~p 294 (668)
.. ........|++.|+|||++.. ..++.++|||||||++|+|++|+.||....... ....... .......+
T Consensus 155 ~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 231 (280)
T cd06611 155 ST--LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILKSEPPTLDQP 231 (280)
T ss_pred cc--ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhcCCCCCcCCc
Confidence 21 112234568999999999863 346779999999999999999999997543211 1111111 11122335
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
..++.++.+||.+||+.+|.+||++.++++||||...
T Consensus 232 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 232 SKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 5688999999999999999999999999999999753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=352.86 Aligned_cols=255 Identities=31% Similarity=0.513 Sum_probs=204.8
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||.|+||.||+|++..++..||||++..... .......+.+|+.+++.++||||+++++++..+..+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE------EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL 74 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc------cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence 58899999999999999999999999999998843211 112234567899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 145 NILLEFVPGGSISSLLGKF---GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~---~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
|+||||+. ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 153 (285)
T cd07861 75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI 153 (285)
T ss_pred EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC
Confidence 99999997 5787777542 5689999999999999999999999999999999999999999999999999875422
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhc-------------
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIG------------- 285 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~------------- 285 (668)
. ........+++.|+|||++.+. .++.++|||||||++|+|+||++||..... .........
T Consensus 154 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 154 P--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred C--cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchh
Confidence 1 1122334678999999998754 478899999999999999999999964322 111111100
Q ss_pred -----------cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 286 -----------TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 286 -----------~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
...........++.++.+||.+||+.||.+|||+.+|+.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000011123578899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=346.75 Aligned_cols=260 Identities=51% Similarity=0.861 Sum_probs=215.1
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC--
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED-- 141 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~-- 141 (668)
.+|++.++||+|+||.||.|.+..++..||||++....... ........+.+|+.+++.++|+||+++++++.+.
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 78 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESP---ETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPME 78 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCc---ccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCC
Confidence 57999999999999999999999999999999874322111 1223456788899999999999999999987663
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
..+++||||+++++|.+++.+...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++.....
T Consensus 79 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~ 158 (265)
T cd06652 79 RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQT 158 (265)
T ss_pred ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence 46889999999999999998877899999999999999999999999999999999999999999999999999875432
Q ss_pred hhh-hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 222 LAT-INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 222 ~~~-~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ............+..+..++..
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 237 (265)
T cd06652 159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM-AAIFKIATQPTNPVLPPHVSDH 237 (265)
T ss_pred ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH-HHHHHHhcCCCCCCCchhhCHH
Confidence 111 11233456899999999998888999999999999999999999999754222 2222222223344566778889
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
+.++|.+||. +|.+||+++++++|||+
T Consensus 238 ~~~~i~~~l~-~p~~Rp~~~~il~~~~~ 264 (265)
T cd06652 238 CRDFLKRIFV-EAKLRPSADELLRHTFV 264 (265)
T ss_pred HHHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence 9999999994 99999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=343.88 Aligned_cols=254 Identities=39% Similarity=0.645 Sum_probs=214.0
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||.|+||.||+|.+..++..||+|.+.... ....+.+|+++++.++|+||+++++++....
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----------DLQEIIKEISILKQCDSPYIVKYYGSYFKNT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----------HHHHHHHHHHHHHhCCCCcEeeeeeeeecCC
Confidence 467999999999999999999999889999999883211 1456889999999999999999999999999
Q ss_pred cceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
.+|+++||+.+++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|.||+++.++.+||+|||++..+..
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999999999999865 45689999999999999999999999999999999999999999999999999886543
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
.. .......|+..|+|||++.+..++.++|||||||++|+|++|+.||......................+..++.++
T Consensus 152 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (256)
T cd06612 152 TM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEF 229 (256)
T ss_pred Cc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHH
Confidence 21 1223456889999999999888999999999999999999999999754332211111111112222345678899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.+||.+||+.+|.+|||+.++|.||||
T Consensus 230 ~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=376.77 Aligned_cols=260 Identities=29% Similarity=0.486 Sum_probs=217.4
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeecccccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTARE 140 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~ 140 (668)
-...|+++++||+||.+.||++..- +...||+|++. ....+...+.-+.+|+.+|.+|+ |.+||+|++|-..
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~------~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~ 431 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVV------LLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT 431 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecC-CCcchhhhHHH------HhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc
Confidence 3456999999999999999999854 34566666552 23455667788999999999995 9999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCC-CHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSF-PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l-~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
++.+||||||-+ .+|..+|.+.... +...++.|..||++|++++|.+||||.||||.|+|+- .|.+||+|||+|..+
T Consensus 432 d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI 509 (677)
T KOG0596|consen 432 DGYLYMVMECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAI 509 (677)
T ss_pred CceEEEEeeccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhccc
Confidence 999999999864 4999999876554 4468889999999999999999999999999999995 589999999999988
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcC-----------CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTG-----------HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTK 288 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~-----------~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~ 288 (668)
....+..-..+.+||+.||+||.+.... .+.++||||||||||+|+.|++||......+..+..+....
T Consensus 510 ~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 510 QPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN 589 (677)
T ss_pred CccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC
Confidence 8777777677889999999999997443 35689999999999999999999976655555555555544
Q ss_pred CCCCCCcccCHH-HHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 289 SHPPIPEHLSME-AKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 289 ~~~~~p~~ls~e-l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
...++|..-+.. +.++++.||+.||.+||++.++|+|||++.
T Consensus 590 ~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 590 HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 444555554444 999999999999999999999999999985
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=355.73 Aligned_cols=259 Identities=34% Similarity=0.587 Sum_probs=215.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.+.|+||+++++.+..
T Consensus 17 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--------~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~ 88 (296)
T cd06654 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--------PKKELIINEILVMRENKNPNIVNYLDSYLV 88 (296)
T ss_pred CcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--------chHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence 344689999999999999999999999999999998843211 123457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
....|+||||+++++|.+++.. ..+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~ 167 (296)
T cd06654 89 GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (296)
T ss_pred CCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence 9999999999999999999864 468999999999999999999999999999999999999999999999999987543
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
... .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||......................+..++..
T Consensus 168 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06654 168 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (296)
T ss_pred ccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHH
Confidence 221 112345789999999999988899999999999999999999999975433211111111112222345668889
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+.+||.+||..+|.+||++.++++||||..
T Consensus 246 l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 246 FRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 999999999999999999999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=357.20 Aligned_cols=256 Identities=34% Similarity=0.562 Sum_probs=212.8
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|++++..++||||+++++++..++.+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-------KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI 74 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence 6899999999999999999999999999999874211 123345678899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
++||||+++++|.+++.+.+.+++..+..++.||+.||.|||+ .+|+||||||+|||++.++.+||+|||++......
T Consensus 75 ~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 75 SICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred EEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999999999999888889999999999999999999997 59999999999999999999999999998754221
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH-HHHHhhcc----------------
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV-AALFHIGT---------------- 286 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~-~~~~~~~~---------------- 286 (668)
.....+|++.|+|||++.+..++.++|||||||++|+|++|..||....... ...+....
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHP 230 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCC
Confidence 2235678999999999988889999999999999999999999996432111 11111000
Q ss_pred -----------------CCCCCCCC-cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 287 -----------------TKSHPPIP-EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 287 -----------------~~~~~~~p-~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
....+..+ ..++.++++||.+||..+|++||++.++++||||.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 231 PDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00011111 1367889999999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=344.67 Aligned_cols=255 Identities=38% Similarity=0.640 Sum_probs=213.2
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||.|+||.||+|.+..++..+|+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 73 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--------GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD 73 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--------hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCC
Confidence 467999999999999999999999999999999985321 123466788999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
.+|++|||+.+++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.+||+|||++..+..
T Consensus 74 ~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 74 KLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred EEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 999999999999999998776 7899999999999999999999999999999999999999999999999999886543
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhc---CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHH-HHhhcc-CCCCCCCCcc
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQT---GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAA-LFHIGT-TKSHPPIPEH 296 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~---~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~-~~~~~~-~~~~~~~p~~ 296 (668)
.. .......++..|+|||++.+. .++.++|||||||++|+|+||.+||......... ...... .......+..
T Consensus 154 ~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (262)
T cd06613 154 TI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEK 231 (262)
T ss_pred hh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhh
Confidence 22 122346789999999999776 7889999999999999999999999754321111 111110 1111122345
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCcc
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpw 327 (668)
++.++.+||.+||..+|..||++.+|+.|+|
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 232 WSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 6788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=360.72 Aligned_cols=260 Identities=28% Similarity=0.463 Sum_probs=226.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
..-.+|..+++||+|.||.|.+|+.+.+++.+|||+++..... ....+..-..|-++|+..+||.+..|-..|+.
T Consensus 165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKevii-----akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt 239 (516)
T KOG0690|consen 165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVII-----AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT 239 (516)
T ss_pred eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhhee-----ehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc
Confidence 4456799999999999999999999999999999998543322 22344556779999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.+.+|+||||+.||.|+.+|.+.+.|++..++.+-..|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++.-
T Consensus 240 ~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~- 318 (516)
T KOG0690|consen 240 QDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE- 318 (516)
T ss_pred CceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999998742
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
........++||||.|+|||++....|+.++|+|.+||++|||++|+.||+.... .+..++... ...+|..+++
T Consensus 319 -I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e----d~kFPr~ls~ 393 (516)
T KOG0690|consen 319 -IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME----DLKFPRTLSP 393 (516)
T ss_pred -ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh----hccCCccCCH
Confidence 2333456789999999999999999999999999999999999999999986543 333333332 3356889999
Q ss_pred HHHHHHHHhhhhCCCCCC-----CHHHHHcCccccCC
Q 005944 300 EAKDFLLKCLQKEPYLRS-----TASELLQHPFVTGK 331 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~~ 331 (668)
+++.|+..+|.+||.+|. .+.||.+|+||...
T Consensus 394 eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 394 EAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 999999999999999995 48899999999864
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=349.69 Aligned_cols=256 Identities=39% Similarity=0.613 Sum_probs=210.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||.||+|++..++..||+|++.... ......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--------~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~ 77 (267)
T cd06646 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--------GDDFSLIQQEIFMVKECKHCNIVAYFGSYLS 77 (267)
T ss_pred CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--------cchHHHHHHHHHHHHhcCCCCeeeeeEEEEe
Confidence 45568999999999999999999999999999999884321 1122457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...+++||||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+.
T Consensus 78 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 78 REKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999999999999999877889999999999999999999999999999999999999999999999999987653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCC---CCC
Q 005944 221 ELATINGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP---PIP 294 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~---~~p 294 (668)
.. ........|++.|+|||.+. ...++.++|||||||++|+|++|..||....... ............ ...
T Consensus 158 ~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 234 (267)
T cd06646 158 AT--IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-ALFLMSKSNFQPPKLKDK 234 (267)
T ss_pred cc--ccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh-hheeeecCCCCCCCCccc
Confidence 21 11223457899999999985 3447889999999999999999999996432211 111111111111 112
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcc
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpw 327 (668)
..++..+.+||.+||+.+|++||++++|++|+|
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 356889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=347.82 Aligned_cols=256 Identities=29% Similarity=0.523 Sum_probs=217.8
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+.+|++++++++||||+++++.+......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 75 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQK-----CVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENM 75 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhh-----hcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeE
Confidence 5899999999999999999999999999999984221 11223456788999999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
++|+||+.+++|..++.....+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 76 YLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred EEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 9999999999999999887789999999999999999999999999999999999999999999999999987653321
Q ss_pred hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHH
Q 005944 225 INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dL 304 (668)
......|+..|+|||++.+..++.++||||||+++|+|++|..||..........+...........+..++..+.++
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDA 232 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHH
Confidence 223456889999999998888999999999999999999999999754321111111111114455667788999999
Q ss_pred HHHhhhhCCCCCCCH--HHHHcCccc
Q 005944 305 LLKCLQKEPYLRSTA--SELLQHPFV 328 (668)
Q Consensus 305 I~kcL~~dP~~RPSa--~EIL~Hpwf 328 (668)
|.+||..+|.+||++ .|+++||||
T Consensus 233 i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 233 INKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHccCChhHcCCccHHHHhcCCCC
Confidence 999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=351.02 Aligned_cols=252 Identities=30% Similarity=0.520 Sum_probs=208.4
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.++||+|+||.||+|.+..++..||||++.... .......+.+|+.+|.+++||||+++++++...+..
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 74 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-------TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRI 74 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-------ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEE
Confidence 5788999999999999999999999999999884321 122335678899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
++||||+++++|..+ ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++..+...
T Consensus 75 ~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 75 SICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred EEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 999999999998654 35789999999999999999999999999999999999999999999999998754321
Q ss_pred hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-----HHHHHhhccCCCCCC-CCcccC
Q 005944 225 INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-----VAALFHIGTTKSHPP-IPEHLS 298 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-----~~~~~~~~~~~~~~~-~p~~ls 298 (668)
.....+||..|+|||++.+..++.++|||||||++|+|++|..||...... ............... .....+
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFS 226 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCC
Confidence 233467999999999999888999999999999999999999999642211 001111111111111 233578
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.++.+||.+||+.+|.+||+++++++||||...
T Consensus 227 ~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 227 EKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 899999999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=355.74 Aligned_cols=260 Identities=28% Similarity=0.461 Sum_probs=207.9
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||.|+||.||+|.+..++..||+|.+...... .....+.+|+.+++.++|+||+++++++....
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~ 77 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-------GAPCTAIREVSLLKDLKHANIVTLHDIIHTEK 77 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-------CchhHHHHHHHHHHhcCCCCcceEEEEEecCC
Confidence 45799999999999999999999999999999988432211 11224567999999999999999999999999
Q ss_pred cceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
..++||||+. ++|..++.. ...+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||++.....
T Consensus 78 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 78 SLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred eEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 9999999997 588877755 35689999999999999999999999999999999999999999999999999875422
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccC-----------
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTT----------- 287 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~----------- 287 (668)
.. .......+++.|+|||++.+. .++.++|||||||++|+|+||++||...... ...+......
T Consensus 157 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 157 PT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred CC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence 11 112234678999999998764 4788999999999999999999999754321 1111110000
Q ss_pred ------CCCC--------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 288 ------KSHP--------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 288 ------~~~~--------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
...+ .....+++++++||.+||+.||.+|||+.|+++||||+...
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 0000 11235788999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=349.45 Aligned_cols=256 Identities=35% Similarity=0.632 Sum_probs=208.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|++.+.||+|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +|+||+++++++.
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---------DEEEEIKQEINMLKKYSHHRNIATYYGAFI 73 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---------ccHHHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence 45677999999999999999999999999999999984321 1123467789999998 6999999999886
Q ss_pred cC------CcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 140 ED------DSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 140 ~~------~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
.. ..+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+++|+|+||||+||+++.++.+||+
T Consensus 74 ~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred ecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEc
Confidence 43 4589999999999999998763 468999999999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHh-----hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhcc
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT 286 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~ 286 (668)
|||++...... ........|++.|+|||++. +..++.++|||||||++|+|++|..||......... .....
T Consensus 154 Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~-~~~~~ 230 (272)
T cd06637 154 DFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL-FLIPR 230 (272)
T ss_pred cCCCceecccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH-HHHhc
Confidence 99998754321 12234567999999999986 335788999999999999999999999654322211 11122
Q ss_pred CCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 287 ~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.......+..++.++.+||.+||..+|.+|||+.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 231 NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 222222344678899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=344.26 Aligned_cols=257 Identities=37% Similarity=0.611 Sum_probs=212.0
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||.|+||+||+|....++..+|+|++.... .......+.+|+.+|+.++|+||+++++.+.....
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 73 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-------CQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDE 73 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCC-------cchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCE
Confidence 36999999999999999999998899999999873211 11145668899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 144 LNILLEFVPGGSISSLLGKF---GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~---~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.++||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.++|+|||++..+.
T Consensus 74 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~ 153 (267)
T cd06610 74 LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA 153 (267)
T ss_pred EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhc
Confidence 99999999999999999764 458999999999999999999999999999999999999999999999999987664
Q ss_pred hhhhhc--CCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccCCCCCCC--
Q 005944 221 ELATIN--GAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTTKSHPPI-- 293 (668)
Q Consensus 221 ~~~~~~--~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~~~~~~~-- 293 (668)
...... ......|+..|+|||++... .++.++|||||||++|+|++|+.||...... ........ .......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (267)
T cd06610 154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQND-PPSLETGAD 232 (267)
T ss_pred cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCC-CCCcCCccc
Confidence 432221 22345689999999999877 6899999999999999999999999653221 11111111 1111111
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
...++.++.+||.+||..+|.+||++.+|++||||
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 13678899999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=382.21 Aligned_cols=256 Identities=30% Similarity=0.502 Sum_probs=209.1
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-C-----CCeeee
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-H-----PNIVRY 134 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H-----pNIV~l 134 (668)
....+|.+.++||+|+||+|.+|.+..|++.||||+++. .....++...|++||..|+ | -|||++
T Consensus 183 ~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN---------~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm 253 (586)
T KOG0667|consen 183 HIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN---------KKRFLRQAQIEIRILELLNKHDPDDKYNIVRM 253 (586)
T ss_pred eeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeecc---------ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence 344589999999999999999999999999999999942 2345566778999999997 4 389999
Q ss_pred ccccccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC--ceEE
Q 005944 135 LGTAREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG--CIKL 210 (668)
Q Consensus 135 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g--~vKL 210 (668)
+++|...+++|||+|+.. -+|+++|+.+ ..|+...++.|+.||+.||.+||+.||||+|||||||||...+ .|||
T Consensus 254 ~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 254 LDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred eeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeE
Confidence 999999999999999995 5999999765 5689999999999999999999999999999999999997654 7999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhcc--
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGT-- 286 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~-- 286 (668)
+|||.|+.... ...+++.+..|+|||+|.|..|+.+.||||||||++||++|.+.|.+.. +.+..+..+..
T Consensus 333 IDFGSSc~~~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 333 IDFGSSCFESQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred EecccccccCC-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 99999986532 1237889999999999999999999999999999999999999885432 11111111000
Q ss_pred ----------------C-C----------------------------CCCCCC-----------cccCHHHHHHHHHhhh
Q 005944 287 ----------------T-K----------------------------SHPPIP-----------EHLSMEAKDFLLKCLQ 310 (668)
Q Consensus 287 ----------------~-~----------------------------~~~~~p-----------~~ls~el~dLI~kcL~ 310 (668)
. . .....| ..-...+.+||++||.
T Consensus 408 p~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~ 487 (586)
T KOG0667|consen 408 PPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLE 487 (586)
T ss_pred CHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhc
Confidence 0 0 000011 0123456899999999
Q ss_pred hCCCCCCCHHHHHcCccccCC
Q 005944 311 KEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 311 ~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
+||.+|+|+.++|+||||+..
T Consensus 488 ~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 488 WDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred cCchhcCCHHHHhcCcccccc
Confidence 999999999999999999854
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=346.87 Aligned_cols=255 Identities=33% Similarity=0.591 Sum_probs=214.9
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||.|+||.||+|.+..+++.||+|.+.... .......+.+|+.+++.+.||||+++++.+.....+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI-------NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDI 74 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc-------ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEE
Confidence 5788899999999999999999999999999884321 113345678899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
++|+||+++++|.+++... ..+++..+..++.||+.||.|||+ .||+|+||||+||+++.++.++|+|||++......
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 75 SICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999999999999776 789999999999999999999999 99999999999999999999999999998766432
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH---HHHHHHHhhccCCCCCCCCcc-cC
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF---QEVAALFHIGTTKSHPPIPEH-LS 298 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~---~~~~~~~~~~~~~~~~~~p~~-ls 298 (668)
... ...++..|+|||.+.+..++.++|||||||++|+|++|..||.... ...............+..+.. ++
T Consensus 155 ~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (265)
T cd06605 155 LAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFS 230 (265)
T ss_pred Hhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 221 2678999999999998899999999999999999999999996431 111111211112222333333 88
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.++.+||.+||..+|.+||++.+++.||||+.
T Consensus 231 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~ 262 (265)
T cd06605 231 PDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262 (265)
T ss_pred HHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence 99999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=354.70 Aligned_cols=260 Identities=34% Similarity=0.602 Sum_probs=217.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||.|+||+||+|.+..+++.||||.+.... ......+.+|+.+++.++|+||+++++++..
T Consensus 16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 87 (296)
T cd06655 16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--------QPKKELIINEILVMKELKNPNIVNFLDSFLV 87 (296)
T ss_pred CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--------CchHHHHHHHHHHHHhcCCCceeeeeeeEec
Confidence 34567999999999999999999999999999999884321 1123457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...+|+|+||+++++|..++.. ..+++.++..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~ 166 (296)
T cd06655 88 GDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT 166 (296)
T ss_pred CceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence 9999999999999999998865 468999999999999999999999999999999999999999999999999987653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
.... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||......................+..++..
T Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (296)
T cd06655 167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244 (296)
T ss_pred cccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHH
Confidence 3211 12345789999999999988899999999999999999999999975432211111111112223345678899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
+.+||.+||..+|.+||++.+++.||||...
T Consensus 245 ~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred HHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 9999999999999999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=349.77 Aligned_cols=257 Identities=28% Similarity=0.513 Sum_probs=209.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++|+||+++++++.....
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 74 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED------DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK 74 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc------CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence 379999999999999999999999999999998843211 11122446789999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+++||||++++.|..++.....+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||++..+....
T Consensus 75 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 75 LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred EEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999999999999888777789999999999999999999999999999999999999999999999999987653321
Q ss_pred hhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhh-ccC------------
Q 005944 224 TINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHI-GTT------------ 287 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~-~~~------------ 287 (668)
. ......++..|+|||++.+ ..++.++|||||||++|+|++|.+||..... ....+... ...
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1224567899999999876 4578999999999999999999999974322 11111110 000
Q ss_pred -----CCCC--------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 288 -----KSHP--------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 288 -----~~~~--------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.... .....++..+.+||.+||+.+|++||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 0000 0012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=380.20 Aligned_cols=254 Identities=24% Similarity=0.321 Sum_probs=204.8
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+++|++|+|+|||++++++...
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------------~~~~~E~~iL~~L~HpnIv~l~~~~~~~ 232 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------------ASSVHEARLLRRLSHPAVLALLDVRVVG 232 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------------cCHHHHHHHHHHCCCCCCCcEEEEEEEC
Confidence 45689999999999999999999999999999996411 1245799999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 142 DSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...++|||++. ++|..++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+.
T Consensus 233 ~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 233 GLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred CEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 99999999995 6888777553 569999999999999999999999999999999999999999999999999997653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchh---------HHHHHHHHhhccCCC--
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ---------FQEVAALFHIGTTKS-- 289 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~---------~~~~~~~~~~~~~~~-- 289 (668)
...........+||+.|+|||++.+..++.++||||||||||||++|..|+... ...+..++.......
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 322211223467999999999999999999999999999999999987654211 112222222111100
Q ss_pred CC-------------------------CCC---cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 290 HP-------------------------PIP---EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 290 ~~-------------------------~~p---~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.. ..+ ..++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 000 134568899999999999999999999999999974
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.40 Aligned_cols=257 Identities=28% Similarity=0.437 Sum_probs=203.5
Q ss_pred eeeEEccc--CceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcce
Q 005944 68 KGELVGCG--AFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN 145 (668)
Q Consensus 68 i~~~LG~G--~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~ 145 (668)
+.++||+| +|++||++.+..+|+.||||++.... ........+.+|+.+++.++|||||++++++..++..+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~ 75 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEA------CTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 75 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhh------ccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence 46789999 78999999999999999999984321 12234456788999999999999999999999999999
Q ss_pred EEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 146 ILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+||+.+.......
T Consensus 76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 999999999999998653 458999999999999999999999999999999999999999999999998654332111
Q ss_pred h-----hcCCccCCCCCCCCChHHHhh--cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccC-C-------
Q 005944 224 T-----INGAKSMKGTPYWMAPEVILQ--TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT-K------- 288 (668)
Q Consensus 224 ~-----~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~-~------- 288 (668)
. ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||................ .
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccc
Confidence 0 001122356788999999976 458999999999999999999999996432211111110000 0
Q ss_pred -----------------------------------CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 289 -----------------------------------SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 289 -----------------------------------~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
...+....+++++.+||.+||+.||.+|||+.++++||||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000112245778999999999999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=337.87 Aligned_cols=258 Identities=59% Similarity=1.048 Sum_probs=222.8
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC--C
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED--D 142 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~--~ 142 (668)
+|++.+.||+|++|.||+|.+..++..|++|++...... ......+.+|+.++++++|+||+++++.+... .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS------EEELEALEREIRILSSLQHPNIVRYYGSERDEEKN 74 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc------hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence 588899999999999999999999999999998533211 34456788999999999999999999999888 8
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.+++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 75 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 75 TLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred eEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 89999999999999999988779999999999999999999999999999999999999999999999999998866443
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
..........++..|+|||.+.+..++.++||||||+++|+|++|..||.....................++..++.++.
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 234 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAK 234 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHH
Confidence 22111344678999999999988889999999999999999999999997654333333444433455667778899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 303 DFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 303 dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
+||.+||+.+|.+||++.+++.||||
T Consensus 235 ~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 235 DFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=352.70 Aligned_cols=260 Identities=31% Similarity=0.488 Sum_probs=213.8
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||+|+||.||+|.+..+++.||||.+.... .........+.+|+.+++.++||||+++++.+.....+
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~-----~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 76 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQN-----LILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHL 76 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhh-----hhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEE
Confidence 6899999999999999999999999999999874221 11223445678899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh--
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL-- 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~-- 222 (668)
++||||++|++|.+++...+.+++..+..++.|++.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 77 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 77 CMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999999999988888999999999999999999999999999999999999999999999999988631100
Q ss_pred -----------hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCC
Q 005944 223 -----------ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSH 290 (668)
Q Consensus 223 -----------~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~ 290 (668)
..........|+..|+|||.+.+..++.++|||||||++|+|++|..||...... ........ ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~-~~~~ 235 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD-DIEW 235 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-ccCC
Confidence 0000112346788999999998888999999999999999999999999754322 22221111 1112
Q ss_pred CCCCcccCHHHHHHHHHhhhhCCCCCCC---HHHHHcCccccC
Q 005944 291 PPIPEHLSMEAKDFLLKCLQKEPYLRST---ASELLQHPFVTG 330 (668)
Q Consensus 291 ~~~p~~ls~el~dLI~kcL~~dP~~RPS---a~EIL~Hpwf~~ 330 (668)
+.....++.++.+||.+||+.+|.+||+ +.++|+||||..
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 236 PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence 2223367899999999999999999998 799999999965
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=357.20 Aligned_cols=258 Identities=29% Similarity=0.419 Sum_probs=221.1
Q ss_pred CCCCeeee-eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 62 PPIRWRKG-ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 62 ~~~ry~i~-~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
.+.+|.+. ++||-|-.|.|..|.++.||+.+|+|++. ......+|+++.-.. .|||||.++++|.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-------------Ds~KARrEVeLHw~~s~h~~iV~IidVye 125 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-------------DSPKARREVELHWMASGHPHIVSIIDVYE 125 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-------------cCHHHHhHhhhhhhhcCCCceEEeehhhh
Confidence 45566664 57999999999999999999999999872 112345677765555 5999999999886
Q ss_pred cC----CcceEEeeccCCCChhcccccCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC---CCceEE
Q 005944 140 ED----DSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---KGCIKL 210 (668)
Q Consensus 140 ~~----~~~~LVmEy~~gGsL~~~L~~~~~--l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---~g~vKL 210 (668)
+. ..+.+|||.++||.|+..++.++. |+|.++..|++||..||.|||+.+|.||||||+|+|... +..+||
T Consensus 126 Ns~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKL 205 (400)
T KOG0604|consen 126 NSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKL 205 (400)
T ss_pred hhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEe
Confidence 53 567899999999999999988765 999999999999999999999999999999999999975 457999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-----HHHHHHHhhc
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-----QEVAALFHIG 285 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-----~~~~~~~~~~ 285 (668)
+|||+|+.-. ......+.|-||+|.|||++-...|+..+|+||+||++|.||+|.+||+... ......+..+
T Consensus 206 tDfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 206 TDFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred cccccccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 9999998643 2345678899999999999998899999999999999999999999997542 4555666677
Q ss_pred cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCCC
Q 005944 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335 (668)
Q Consensus 286 ~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~~ 335 (668)
......+.|..+|.+++++|+++|..+|.+|.|+++++.|||+......+
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp 332 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVP 332 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCC
Confidence 77777888899999999999999999999999999999999998654433
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=348.64 Aligned_cols=257 Identities=38% Similarity=0.662 Sum_probs=216.1
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++|+||+++++++..+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-------AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK 73 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-------cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCe
Confidence 36889999999999999999999999999999884321 12234557789999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|+|+||+++++|.+++... .+++..++.++.||+.||.|||+.+|+|+||+|+||+++.++.++|+|||+++.+....
T Consensus 74 ~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 74 LWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred EEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 99999999999999999765 89999999999999999999999999999999999999999999999999987664321
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcc-cCHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEH-LSMEAK 302 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~-ls~el~ 302 (668)
.......|++.|+|||++.+..++.++|||||||++|+|+||..||....... ....+. ....+..+.. ++.++.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~ 228 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR-VLFLIP-KNNPPSLEGNKFSKPFK 228 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH-HHHHhh-hcCCCCCcccccCHHHH
Confidence 22334678999999999998889999999999999999999999996533211 111111 1122333334 788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 303 DFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 303 dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
++|.+||..+|++||++.++++||||+...
T Consensus 229 ~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 229 DFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred HHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 999999999999999999999999998644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=354.93 Aligned_cols=261 Identities=35% Similarity=0.615 Sum_probs=216.6
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||.|+||.||+|.+..++..||||.+.... ......+.+|+.+++.++|+||+++++++..
T Consensus 16 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~ 87 (297)
T cd06656 16 DPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--------QPKKELIINEILVMRENKNPNIVNYLDSYLV 87 (297)
T ss_pred ChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--------cchHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 44578999999999999999999999999999999884321 1122457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
....|+||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++....
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 88 GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred CCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 9999999999999999999865 568999999999999999999999999999999999999999999999999987543
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhcc-CCCCCCCCcccCH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT-TKSHPPIPEHLSM 299 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~-~~~~~~~p~~ls~ 299 (668)
... .......+++.|+|||.+.+..++.++|||||||++|+|++|..||....... ....... .......+..++.
T Consensus 167 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T cd06656 167 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPERLSA 243 (297)
T ss_pred CCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-heeeeccCCCCCCCCccccCH
Confidence 221 11234578999999999998889999999999999999999999996543211 1111111 1112224566788
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.+++||.+||..+|.+||++.++++||||.....
T Consensus 244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 244 VFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 9999999999999999999999999999975443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=345.65 Aligned_cols=254 Identities=44% Similarity=0.762 Sum_probs=209.6
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
......+||+|+||.||+|++..++..||+|.+... .......+.+|+.+++.++|+||+++++++...+..
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER--------DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFF 80 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC--------CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence 344446899999999999999999999999987321 122345678999999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC-CCC--CHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-CCceEEecCCchhhhH
Q 005944 145 NILLEFVPGGSISSLLGKF-GSF--PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN-KGCIKLADFGASKKVV 220 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~-~~l--~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~-~g~vKL~DFGlA~~~~ 220 (668)
++|+||+++++|.+++... ..+ ++..+..++.||+.||.|||+.||+||||||+|||++. .+.++|+|||++..+.
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 160 (268)
T cd06624 81 KIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA 160 (268)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence 9999999999999998754 455 88889999999999999999999999999999999976 6799999999987543
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcC--CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccC
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTG--HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~--~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls 298 (668)
... .......|++.|+|||++.+.. ++.++|||||||++|+|++|..||...................+.++..++
T Consensus 161 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd06624 161 GIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLS 238 (268)
T ss_pred cCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccC
Confidence 211 1122346899999999987644 788999999999999999999999754322222233333334455677889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.++++|+.+||+.+|.+|||+.+++.||||
T Consensus 239 ~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 239 AEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=353.13 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=202.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcC----------------CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHH
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLD----------------SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~----------------tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~ 124 (668)
....+|++.+.||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+|.
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~ 74 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-------NKNARNDFLKEVKILS 74 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-------CHHHHHHHHHHHHHHh
Confidence 345789999999999999999997532 34579999874221 1223456889999999
Q ss_pred hCCCCCeeeeccccccCCcceEEeeccCCCChhcccccC-------------------CCCCHHHHHHHHHHHHHHHHHH
Q 005944 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-------------------GSFPESVIRMYTKQLLLGLEYL 185 (668)
Q Consensus 125 ~L~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~-------------------~~l~e~~~~~i~~QIl~aL~yL 185 (668)
.++||||+++++++...+..++||||+.+|+|.+++... ..+++..+..++.||+.||.||
T Consensus 75 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~l 154 (304)
T cd05096 75 RLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL 154 (304)
T ss_pred hcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999999999999887542 2367788999999999999999
Q ss_pred HhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHH
Q 005944 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMA 265 (668)
Q Consensus 186 Hs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLL 265 (668)
|+.||+||||||+||||+.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|+|+
T Consensus 155 H~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~ 234 (304)
T cd05096 155 SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234 (304)
T ss_pred HHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999999999999999999987653322222223345688999999999888999999999999999998
Q ss_pred h--CCCCCchhHH-HHHH----HHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 266 T--GKPPWSQQFQ-EVAA----LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 266 T--G~~PF~~~~~-~~~~----~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+ +..||..... .... .............+..++..+.+||.+||+.+|.+|||+.+|.+
T Consensus 235 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 235 MLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 6 6678864321 1111 11111111222334567889999999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=370.96 Aligned_cols=264 Identities=25% Similarity=0.404 Sum_probs=210.8
Q ss_pred CCCCCCCCCCCCCeeeeeEEcccCceEEEEEEEcCC-----CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-
Q 005944 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL- 126 (668)
Q Consensus 53 ~pp~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L- 126 (668)
+|-...+.....+|++++.||+|+||.||+|++... +..||||++.... .......+.+|+.+|+.+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~il~~l~ 99 (374)
T cd05106 27 LPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-------HTDEREALMSELKILSHLG 99 (374)
T ss_pred ccccccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-------CHHHHHHHHHHHHHHHhhc
Confidence 344445567778899999999999999999986544 3579999884321 122345678899999999
Q ss_pred CCCCeeeeccccccCCcceEEeeccCCCChhcccccC-------------------------------------------
Q 005944 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF------------------------------------------- 163 (668)
Q Consensus 127 ~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~------------------------------------------- 163 (668)
+|+|||++++++.....+++|||||++|+|.+++...
T Consensus 100 ~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (374)
T cd05106 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSD 179 (374)
T ss_pred cCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccc
Confidence 8999999999999999999999999999999887432
Q ss_pred ---------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 164 ---------------------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 164 ---------------------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla 259 (374)
T cd05106 180 TYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259 (374)
T ss_pred cccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceee
Confidence 24788899999999999999999999999999999999999999999999998
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~ 295 (668)
+.+.............+++.|+|||++.+..++.++|||||||++|+|++ |+.||....... ..............+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~~~~~~~ 338 (374)
T cd05106 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGYQMSRPD 338 (374)
T ss_pred eeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHcccCccCCC
Confidence 76533221111222345678999999998889999999999999999997 999997543221 1111112223334556
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.++.++.+||.+||+.||.+||++.++++
T Consensus 339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 339 FAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 67899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=350.33 Aligned_cols=257 Identities=30% Similarity=0.549 Sum_probs=213.6
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++.+.....+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-------DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAV 74 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-------CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeE
Confidence 6889999999999999999999999999999884321 222345678899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC---CCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 145 NILLEFVPGGSISSLLGKF---GSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~---~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
|+||||+++++|..++... ..+++..+..++.||+.||.|||. .||+||||||+|||++.++.+||+|||++..+.
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 75 YMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred EEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999999999999888763 379999999999999999999996 599999999999999999999999999987542
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcC------CCcchhHHHHHHHHHHHHhCCCCCchhH-HHHHHHHhhccCCCCCCC
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTG------HSFSADIWSVGCTVIEMATGKPPWSQQF-QEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~------~s~ksDIWSLGvILyeLLTG~~PF~~~~-~~~~~~~~~~~~~~~~~~ 293 (668)
. .......|++.|+|||++.+.. ++.++|||||||++|+|++|..||.... .................+
T Consensus 155 ~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd06622 155 A----SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL 230 (286)
T ss_pred C----CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC
Confidence 2 1223456889999999985443 4789999999999999999999996432 222222222222233456
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+..++.++.+||.+||+.+|.+||++.+++.||||....
T Consensus 231 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 231 PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred CcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 667899999999999999999999999999999997644
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=374.66 Aligned_cols=254 Identities=25% Similarity=0.428 Sum_probs=213.6
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
..+++....+++.+.||+|-||.||+|.+. ....||+|.++.. ......|.+|+++|++|+|+|||+|++
T Consensus 199 d~wei~r~~l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~---------~m~~~~f~~Ea~iMk~L~H~~lV~l~g 268 (468)
T KOG0197|consen 199 DPWEIPREELKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG---------SMSPEAFLREAQIMKKLRHEKLVKLYG 268 (468)
T ss_pred CCeeecHHHHHHHHHhcCCccceEEEEEEc-CCCcccceEEecc---------ccChhHHHHHHHHHHhCcccCeEEEEE
Confidence 334455666788899999999999999974 3458999998432 112245779999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGK--FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
++..++.+||||||++.|+|.++|+. ...+...+...++.||+.|++||+++++|||||.+.||||++++.+||+|||
T Consensus 269 V~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFG 348 (468)
T KOG0197|consen 269 VCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFG 348 (468)
T ss_pred EEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccc
Confidence 99998899999999999999999987 4679999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCC
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~ 293 (668)
||+.+.+ ..+.......-...|.|||.+....++.++|||||||+||||+| |+.||...... ..+.........+.
T Consensus 349 LAr~~~d-~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~--ev~~~le~GyRlp~ 425 (468)
T KOG0197|consen 349 LARLIGD-DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE--EVLELLERGYRLPR 425 (468)
T ss_pred cccccCC-CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHH--HHHHHHhccCcCCC
Confidence 9994432 33333333344678999999999999999999999999999999 99998765432 22233334566778
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELL 323 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL 323 (668)
|..++.++.++|..||+.+|++|||++.+.
T Consensus 426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 426 PEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 899999999999999999999999999765
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=347.75 Aligned_cols=256 Identities=36% Similarity=0.631 Sum_probs=208.6
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
.....|++.+.||.|+||.||+|.+..++..||+|++... ......+..|+.++..+ +|+||+++++++.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---------~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 83 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---------EDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---------hHHHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence 4567899999999999999999999999999999987321 11234567889999998 6999999999885
Q ss_pred c------CCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 140 E------DDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 140 ~------~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
. ...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+
T Consensus 84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~ 163 (282)
T cd06636 84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLV 163 (282)
T ss_pred cccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEe
Confidence 3 45789999999999999988653 458899999999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHh-----hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhcc
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT 286 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~ 286 (668)
|||++...... ........|++.|+|||++. +..++.++|||||||++|+|++|..||...... ........
T Consensus 164 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~-~~~~~~~~ 240 (282)
T cd06636 164 DFGVSAQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPM-RALFLIPR 240 (282)
T ss_pred eCcchhhhhcc--ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHH-hhhhhHhh
Confidence 99998765321 12234567899999999986 345788999999999999999999999654321 11111211
Q ss_pred CCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 287 ~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
..........++.++.+||.+||..||.+||++.+|++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 241 NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 112222234578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=352.19 Aligned_cols=262 Identities=31% Similarity=0.499 Sum_probs=215.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|.+..++..||||.+..... ........+.+|+.+|+.++|+||+++++.+.....
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 75 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEM-----IKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETY 75 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEecccc-----chHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCE
Confidence 369999999999999999999999999999999853211 112345668889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 144 LNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
.|+||||+.+++|.+++... ..+++..++.++.||+.||.|||+.||+|+||||+||||+.++.++|+|||++.....
T Consensus 76 ~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 76 LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 99999999999999998754 5689999999999999999999999999999999999999999999999999875422
Q ss_pred hhhh---------------------------cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchh
Q 005944 222 LATI---------------------------NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ 274 (668)
Q Consensus 222 ~~~~---------------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~ 274 (668)
.... .......||..|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1100 0112346899999999999888999999999999999999999999654
Q ss_pred HHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCC----HHHHHcCccccCC
Q 005944 275 FQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRST----ASELLQHPFVTGK 331 (668)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPS----a~EIL~Hpwf~~~ 331 (668)
..... ...........+....++.++.+||.+||..+|.+||+ ++++|.||||++.
T Consensus 236 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 236 NRDET-FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred chHHH-HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 32211 11111111122222337899999999999999999999 9999999999863
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=340.08 Aligned_cols=257 Identities=51% Similarity=0.903 Sum_probs=215.3
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|.+.+.||+|+||.||+|.+..++..||+|++..... .+...+.+.+|+.+++.++|+||+++++.+...+.+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN------DPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV 74 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc------chHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence 68999999999999999999998999999999854321 134567789999999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
++|+||+++++|.+++.....+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 75 YIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred EEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999999999998877799999999999999999999999999999999999999999999999999876543222
Q ss_pred hcC--CccCCCCCCCCChHHHhhcC---CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcc--c
Q 005944 225 ING--AKSMKGTPYWMAPEVILQTG---HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEH--L 297 (668)
Q Consensus 225 ~~~--~~~~~GT~~Y~APEvl~~~~---~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~--l 297 (668)
... .....+++.|+|||++.+.. ++.++||||||+++|+|++|..||............... .....++.. +
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 233 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKPPIPDSLQL 233 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCCCCCccccc
Confidence 111 12356889999999998766 889999999999999999999999643222222222222 223333333 4
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
+..+.+||.+||+.+|.+||++.+++.|||+
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 234 SPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 8899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=349.05 Aligned_cols=253 Identities=27% Similarity=0.431 Sum_probs=209.6
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCC-----cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSG-----ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg-----~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
..+|++.+.||+|+||.||+|.+...+ ..||+|.+... ........+.+|+.++..++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-------~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~ 76 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-------AEPKVQQEFRQEAELMSDLQHPNIVCLLGV 76 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-------CCHHHHHHHHHHHHHHHhcCCcccceEEEE
Confidence 347899999999999999999876655 68999987421 112334568899999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEE
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF----------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANIL 201 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNIL 201 (668)
+......+++|||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 77 ~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil 156 (283)
T cd05048 77 CTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCL 156 (283)
T ss_pred EcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEE
Confidence 99999999999999999999988654 45788999999999999999999999999999999999
Q ss_pred eCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH-HHHH
Q 005944 202 VDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVA 279 (668)
Q Consensus 202 ld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~-~~~~ 279 (668)
++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|+|++ |..||.... .++.
T Consensus 157 ~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05048 157 VGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI 236 (283)
T ss_pred EcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999875533222222334567889999999998889999999999999999998 999997543 2322
Q ss_pred HHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 280 ALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 280 ~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
..+. .......+..++.++.+|+.+||+.+|.+||++.+|+++
T Consensus 237 ~~i~---~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 237 EMIR---SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHH---cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 2222 223344567889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=368.14 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=210.0
Q ss_pred CCCCCCCCCCCCCeeeeeEEcccCceEEEEEEE-----cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-
Q 005944 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMN-----LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL- 126 (668)
Q Consensus 53 ~pp~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L- 126 (668)
+|....+.....+|+++++||+|+||+||+|++ ..++..||||++.... .......+.+|+.+|..+
T Consensus 24 ~~~~~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~Ei~il~~l~ 96 (375)
T cd05104 24 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-------HLTEREALMSELKVLSYLG 96 (375)
T ss_pred CCCccccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-------CcHHHHHHHHHHHHHHHhc
Confidence 344444566777999999999999999999974 3457799999884221 112234677899999999
Q ss_pred CCCCeeeeccccccCCcceEEeeccCCCChhcccccCC------------------------------------------
Q 005944 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG------------------------------------------ 164 (668)
Q Consensus 127 ~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~------------------------------------------ 164 (668)
+|||||++++++......++|||||++|+|.+++....
T Consensus 97 ~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (375)
T cd05104 97 NHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVS 176 (375)
T ss_pred CCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcc
Confidence 89999999999999999999999999999998885421
Q ss_pred ---------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 165 ---------------------------------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 165 ---------------------------------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~ 256 (375)
T cd05104 177 YVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKIC 256 (375)
T ss_pred cccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEe
Confidence 46788899999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH--HHHHHHhhccCC
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ--EVAALFHIGTTK 288 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~--~~~~~~~~~~~~ 288 (668)
|||+++.+.............++..|+|||++.+..++.++|||||||++|+|++ |..||..... .....+. ..
T Consensus 257 DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~---~~ 333 (375)
T cd05104 257 DFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK---EG 333 (375)
T ss_pred cCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH---hC
Confidence 9999976533222111222345678999999999999999999999999999998 8999965322 2222222 12
Q ss_pred CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 289 SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 289 ~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.....+...+.++++||.+||+.||.+||++.+|++.
T Consensus 334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 2233455678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=342.93 Aligned_cols=256 Identities=36% Similarity=0.626 Sum_probs=207.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|++.+.||+|+||+||+|.+..++..||+|++.... .....+.+|+.+++.+ .|+||+++++++.
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~ 73 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---------DEEEEIKEEYNILRKYSNHPNIATFYGAFI 73 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---------hhHHHHHHHHHHHHHhcCCCChheEEEEEE
Confidence 45688999999999999999999999899999999884321 1234578899999999 7999999999986
Q ss_pred cCC------cceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceE
Q 005944 140 EDD------SLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIK 209 (668)
Q Consensus 140 ~~~------~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vK 209 (668)
... .+++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.+|
T Consensus 74 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~ 153 (275)
T cd06608 74 KKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVK 153 (275)
T ss_pred ecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEE
Confidence 544 48999999999999998765 35789999999999999999999999999999999999999999999
Q ss_pred EecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhh-----cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhh
Q 005944 210 LADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ-----TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI 284 (668)
Q Consensus 210 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~ 284 (668)
|+|||++....... .......|++.|+|||++.. ..++.++|||||||+||+|++|..||...... ......
T Consensus 154 l~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~ 230 (275)
T cd06608 154 LVDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKI 230 (275)
T ss_pred ECCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHh
Confidence 99999987543211 12234568999999999854 34678899999999999999999999743221 111111
Q ss_pred cc-CCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 285 GT-TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 285 ~~-~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.. .......+..++.++++||.+||..||.+|||+.++++|||+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 231 PRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 11 111122233477899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=349.79 Aligned_cols=252 Identities=29% Similarity=0.441 Sum_probs=202.5
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHH---HHHHhCCCCCeeeeccccccCCcceEE
Q 005944 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV---KLLKNLTHPNIVRYLGTAREDDSLNIL 147 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei---~iL~~L~HpNIV~l~g~~~~~~~~~LV 147 (668)
+||+|+||.||+|.+..+++.||||.+........ . ....+.+|. .++...+|+||+.+++++...+..++|
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~--~---~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv 75 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--Q---GETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFI 75 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccc--h---HHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEE
Confidence 48999999999999999999999998843221111 1 111122333 344445799999999999999999999
Q ss_pred eeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcC
Q 005944 148 LEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATING 227 (668)
Q Consensus 148 mEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~ 227 (668)
|||+++|+|..++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++...... .
T Consensus 76 ~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~----~ 151 (279)
T cd05633 76 LDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----K 151 (279)
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc----C
Confidence 999999999999988888999999999999999999999999999999999999999999999999998654321 1
Q ss_pred CccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHH
Q 005944 228 AKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLL 306 (668)
Q Consensus 228 ~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~ 306 (668)
.....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||.....................++..++.++.+||.
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 231 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLE 231 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHH
Confidence 234579999999999864 5588999999999999999999999964321111111111222334566778999999999
Q ss_pred HhhhhCCCCCC-----CHHHHHcCccccCC
Q 005944 307 KCLQKEPYLRS-----TASELLQHPFVTGK 331 (668)
Q Consensus 307 kcL~~dP~~RP-----Sa~EIL~Hpwf~~~ 331 (668)
+||..||.+|+ ++.++++||||++.
T Consensus 232 ~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 232 GLLQRDVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred HHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence 99999999999 69999999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=343.37 Aligned_cols=251 Identities=31% Similarity=0.535 Sum_probs=212.3
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeecc
Q 005944 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFV 151 (668)
Q Consensus 72 LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~ 151 (668)
||.|+||.||+|++..++..||+|++.... .........+.+|+.+++.++|+||+++++.+..+..+|+||||+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRH-----IVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYC 75 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhc-----chhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecC
Confidence 699999999999999999999999984321 112233456889999999999999999999999999999999999
Q ss_pred CCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccC
Q 005944 152 PGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSM 231 (668)
Q Consensus 152 ~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 231 (668)
++++|.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 76 LGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred CCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 999999999888889999999999999999999999999999999999999999999999999987654321 22345
Q ss_pred CCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHH-HHhhccCCCCCCCCcccCHHHHHHHHHhhh
Q 005944 232 KGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAA-LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQ 310 (668)
Q Consensus 232 ~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~-~~~~~~~~~~~~~p~~ls~el~dLI~kcL~ 310 (668)
.|++.|+|||.+.+..++.++||||||+++|+|++|..||.....+... .............+...+.++.++|.+||+
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 232 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR 232 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHcc
Confidence 7899999999998888999999999999999999999999754311111 111221233445566678999999999999
Q ss_pred hCCCCCCC-----HHHHHcCccccC
Q 005944 311 KEPYLRST-----ASELLQHPFVTG 330 (668)
Q Consensus 311 ~dP~~RPS-----a~EIL~Hpwf~~ 330 (668)
.+|.+||+ +.|+++||||.+
T Consensus 233 ~~p~~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 233 RNPEERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred CChhhCcCCcccCHHHHhcChhhhC
Confidence 99999999 999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=365.47 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=199.9
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||.||+|++..++..||+|+.... ....|+.+|+.++|+|||++++++...
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------------~~~~E~~~l~~l~h~~iv~~~~~~~~~ 129 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------------TTLIEAMLLQNVNHPSVIRMKDTLVSG 129 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------------ccHHHHHHHHhCCCCCCcChhheEEeC
Confidence 345799999999999999999999999999999975211 124589999999999999999999999
Q ss_pred CcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 142 DSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...++||||+. ++|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 130 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 208 (357)
T PHA03209 130 AITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208 (357)
T ss_pred CeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccc
Confidence 99999999996 577777654 4679999999999999999999999999999999999999999999999999987432
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCC-chhH-----------HHHHHHHhhccC-
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW-SQQF-----------QEVAALFHIGTT- 287 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF-~~~~-----------~~~~~~~~~~~~- 287 (668)
. ........||+.|+|||++.+..++.++|||||||++|+|+++..|+ .... ..+..+......
T Consensus 209 ~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 285 (357)
T PHA03209 209 V---APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285 (357)
T ss_pred c---CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence 1 11223467999999999999989999999999999999999854443 3110 011111110000
Q ss_pred --CCC-------------------CC-------CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 288 --KSH-------------------PP-------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 288 --~~~-------------------~~-------~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
... .+ ....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 000 00 01145667788999999999999999999999999974
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=345.77 Aligned_cols=256 Identities=38% Similarity=0.618 Sum_probs=206.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|++.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+ +|+||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~---------~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI---------HDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc---------cchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 5678899999999999999999999999999999987321 11123467899999999 6999999999873
Q ss_pred -----cCCcceEEeeccCCCChhcccc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEE
Q 005944 140 -----EDDSLNILLEFVPGGSISSLLG----KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 140 -----~~~~~~LVmEy~~gGsL~~~L~----~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL 210 (668)
....+++||||+++++|.+++. ....+++..++.++.||+.||.|||+.+|+||||||+||+++.++.+||
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEE
Confidence 4467899999999999998764 3356899999999999999999999999999999999999999999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhh-----cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhc
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ-----TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIG 285 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~ 285 (668)
+|||++..+... ........|++.|+|||++.. ..++.++|||||||++|+|++|+.||...... .......
T Consensus 166 ~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-~~~~~~~ 242 (286)
T cd06638 166 VDFGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-RALFKIP 242 (286)
T ss_pred ccCCceeecccC--CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-HHHhhcc
Confidence 999998765321 112234569999999999853 44788999999999999999999999754321 1111111
Q ss_pred cCC-CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 286 TTK-SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 286 ~~~-~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
... .....+..++.++.+||.+||+.+|.+||++.+|++|+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred ccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 111 1112344567899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=378.86 Aligned_cols=259 Identities=37% Similarity=0.620 Sum_probs=219.7
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..-|.|..-||.|+||.||+|.++.++...|.|+|. .+..+.+..+.-||.||..+.||+||+|++.|..++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe--------tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en 102 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE--------TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN 102 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc--------ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC
Confidence 345888889999999999999999999999999883 234566778888999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
.++|+.|||.||-...++-.. ..+.+.++..+++|++.||.|||+++|||||||..|||++-+|.++|+|||.+...
T Consensus 103 kLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn-- 180 (1187)
T KOG0579|consen 103 KLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKN-- 180 (1187)
T ss_pred ceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccc--
Confidence 999999999999998877554 56999999999999999999999999999999999999999999999999987543
Q ss_pred hhhhcCCccCCCCCCCCChHHHh-----hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCC-CCCCCc
Q 005944 222 LATINGAKSMKGTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS-HPPIPE 295 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~-~~~~p~ 295 (668)
..+.....+++|||+|||||+.+ ..+|++++|||||||+|.||.-+.+|.... ..+..++.+..... -..-|.
T Consensus 181 ~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhel-npMRVllKiaKSePPTLlqPS 259 (1187)
T KOG0579|consen 181 KSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHEL-NPMRVLLKIAKSEPPTLLQPS 259 (1187)
T ss_pred hhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCcccc-chHHHHHHHhhcCCCcccCcc
Confidence 23344456799999999999986 456999999999999999999999997543 22222333322211 122366
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+.+..+.||+++||.+||..||++.+||+||||++..
T Consensus 260 ~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 260 HWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred hhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 7888999999999999999999999999999999654
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=338.82 Aligned_cols=254 Identities=33% Similarity=0.523 Sum_probs=212.8
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc--CC
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE--DD 142 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~--~~ 142 (668)
+|++.+.||.|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++|+||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN------MTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ 74 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEeccc------CCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence 5889999999999999999999999999999884321 122334567889999999999999999997653 45
Q ss_pred cceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccccCCcccEEeCCCCceEEecC
Q 005944 143 SLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLH-----KNGIMHRDIKGANILVDNKGCIKLADF 213 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLH-----s~gIvHrDLKPeNILld~~g~vKL~DF 213 (668)
..+++|||+++++|.+++.. ...+++..++.++.||+.||.||| +.+|+|+||||+||+++.++.+||+||
T Consensus 75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence 68999999999999999865 367899999999999999999999 889999999999999999999999999
Q ss_pred CchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCC
Q 005944 214 GASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 214 GlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~ 293 (668)
|++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||....... ............+
T Consensus 155 g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~ 230 (265)
T cd08217 155 GLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ--LASKIKEGKFRRI 230 (265)
T ss_pred cccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH--HHHHHhcCCCCCC
Confidence 99886543221 1234578999999999998889999999999999999999999997543221 1122222334456
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
+..++.++.+|+.+||+.+|.+||++.+|++|||+
T Consensus 231 ~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 231 PYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 77889999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=338.83 Aligned_cols=254 Identities=29% Similarity=0.532 Sum_probs=213.3
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||+|+||.||++.+..+|+.||||.+..... .......+.+|+.+++.++|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM------SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL 74 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC------ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence 58999999999999999999999999999998843211 122335678899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
++||||+.+++|.+++... ..+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++..+...
T Consensus 75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999999999988654 35889999999999999999999999999999999999999999999999998755332
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
.. ......|++.|+|||++.+..++.++|||||||++|+|++|..||............ ........+..++.++.
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (256)
T cd08218 155 VE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKI--IRGSYPPVSSHYSYDLR 230 (256)
T ss_pred hh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHH--hcCCCCCCcccCCHHHH
Confidence 11 122356889999999998888999999999999999999999999643322111111 12233445667899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 303 DFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 303 dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
++|.+||+.+|.+||++.++++||||
T Consensus 231 ~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=338.12 Aligned_cols=253 Identities=30% Similarity=0.514 Sum_probs=214.4
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.++||.|+||.||.+.+..++..+++|.+.... ........+.+|+.+|++++|+||+++++++.....+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~------~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR------LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL 74 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecc------cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence 6899999999999999999999999999999884322 1123345678899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
++||||+++++|.+++.+. ..+++..+..++.|++.+|.|||+.||+|+||+|+||+++.++.+||+|||++......
T Consensus 75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999999999764 46899999999999999999999999999999999999999999999999998765332
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
.. ......|++.|+|||++.+..++.++|||||||++|+|++|..||..... +....... ....+.+..++.++
T Consensus 155 ~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 229 (256)
T cd08221 155 YS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ---GNYTPVVSVYSSEL 229 (256)
T ss_pred cc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc---CCCCCCccccCHHH
Confidence 21 23346789999999999888889999999999999999999999975432 21111111 22233446778999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.++|.+||..+|.+||++.++++|||+
T Consensus 230 ~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 230 ISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=396.68 Aligned_cols=264 Identities=29% Similarity=0.447 Sum_probs=221.1
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|+++++||+|+||.|.+++++.+++.||+|++.. -.-..+.....|..|-.+|..-+.+-||.|+..|+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK-----~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ 145 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNK-----WEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ 145 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhH-----HHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence 4567789999999999999999999999999999998821 01112344567888999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
++.++|+||||++||+|..++.+.+.+|+.-++.|+..|+.||.-||+.|+|||||||+|||||..|++||+|||.+-.+
T Consensus 146 D~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 146 DERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred CccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998777
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHh----h-cCCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCCCCCC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVIL----Q-TGHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTKSHPP 292 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~----~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~~~~~ 292 (668)
....+ ....+.+|||.|++||+|. + +.|+..+|+||+||++|||+.|..||+... .....+.........+
T Consensus 226 ~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP- 303 (1317)
T KOG0612|consen 226 DADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP- 303 (1317)
T ss_pred CCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC-
Confidence 54333 3355678999999999996 2 458999999999999999999999998542 1222222221122222
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCC---HHHHHcCccccCC
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRST---ASELLQHPFVTGK 331 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPS---a~EIL~Hpwf~~~ 331 (668)
-...+|.++++||.++| -+|+.|.. +++|..||||.+.
T Consensus 304 ~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~ 344 (1317)
T KOG0612|consen 304 DETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGI 344 (1317)
T ss_pred cccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCC
Confidence 12459999999999988 46778877 9999999999864
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=347.03 Aligned_cols=260 Identities=29% Similarity=0.482 Sum_probs=216.5
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|.+..++..||+|++.... .......+.+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 75 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-------KSSVRKQILRELQIMHECRSPYIVSFYGAFLNE 75 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-------cchHHHHHHHHHHHHHHcCCCCcceEeeeEecC
Confidence 3467999999999999999999999999999999874321 123345678999999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
..+++||||+++++|..++.+.+.+++..++.++.|++.+|.|||+ .+|+||||||+||+++.++.++|+|||++....
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~ 155 (284)
T cd06620 76 NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155 (284)
T ss_pred CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchh
Confidence 9999999999999999999888889999999999999999999997 699999999999999999999999999986542
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH---------HHHHHHhhccCCCCC
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ---------EVAALFHIGTTKSHP 291 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~---------~~~~~~~~~~~~~~~ 291 (668)
.. .....+|+..|+|||++.+..++.++|||||||++|+|+||..||..... ...............
T Consensus 156 ~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd06620 156 NS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP 231 (284)
T ss_pred hh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC
Confidence 21 12346799999999999888899999999999999999999999974322 111111111111122
Q ss_pred CCCc-ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 292 PIPE-HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 292 ~~p~-~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.++. .++.++.+||.+||+.||.+||++.|+++|+||....
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 2222 3778999999999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=346.06 Aligned_cols=258 Identities=30% Similarity=0.512 Sum_probs=211.7
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||.||+|.+..+++.||||++.... ........+.+|+++++.++|+||+++++++...+.
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 74 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESE------DDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR 74 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhc------ccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence 37999999999999999999999999999999873211 122334567889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.++||||++++.|..++.+...+++..++.++.||+.||.|||..||+|+||+|+||+++.++.+||+|||++..+....
T Consensus 75 ~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 75 LYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99999999998888777776779999999999999999999999999999999999999999999999999988654322
Q ss_pred hhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhc-c------------C
Q 005944 224 TINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIG-T------------T 287 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~-~------------~ 287 (668)
. .......++..|+|||++.+. .++.++||||||+++|+|++|.+||..... ......... . .
T Consensus 155 ~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07833 155 A-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233 (288)
T ss_pred c-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence 1 123346789999999999888 789999999999999999999999964321 111110000 0 0
Q ss_pred --C--CC----------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 288 --K--SH----------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 288 --~--~~----------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
. .. ...+..++.++.+||++||..+|++||++.++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 0 00 01233458899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=345.25 Aligned_cols=251 Identities=30% Similarity=0.474 Sum_probs=208.5
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeecc
Q 005944 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFV 151 (668)
Q Consensus 72 LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~ 151 (668)
||+|+||+||+|.+..+|+.||+|++.... .........+.+|+.+|+.++||||+++++++...+..|+||||+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 75 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKR-----LKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLM 75 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhh-----hhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecC
Confidence 699999999999999999999999884211 112223445678999999999999999999999999999999999
Q ss_pred CCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCc
Q 005944 152 PGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAK 229 (668)
Q Consensus 152 ~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~ 229 (668)
++++|.+++.+.. .+++..++.++.||+.||.|||+.||+||||+|+|||++.++.+||+|||++..... .....
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~ 152 (277)
T cd05577 76 NGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIK 152 (277)
T ss_pred CCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccc
Confidence 9999999987655 799999999999999999999999999999999999999999999999999876532 12223
Q ss_pred cCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHHh
Q 005944 230 SMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308 (668)
Q Consensus 230 ~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~kc 308 (668)
...++..|+|||++.+..++.++|||||||++|+|++|+.||...... ....+...........+..+++++.++|.+|
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 232 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEAL 232 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHH
Confidence 456888999999998888999999999999999999999999653221 1111111122233445667899999999999
Q ss_pred hhhCCCCCC-----CHHHHHcCccccC
Q 005944 309 LQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 309 L~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
|+.+|.+|| ++.+++.||||..
T Consensus 233 l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 233 LQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred ccCChhHccCCCcccHHHHHhChhhhc
Confidence 999999999 8999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=343.22 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=207.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEc---CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
+...+|++.++||+|+||.||+|.+. ..+..||+|.+.... .......+.+|+.+|+.++||||++++++
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 74 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-------SDKQRRGFLAEALTLGQFDHSNIVRLEGV 74 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 34567999999999999999999865 356799999884321 12233568889999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+......++||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||.+
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~ 154 (266)
T cd05064 75 ITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRL 154 (266)
T ss_pred EecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccc
Confidence 99999999999999999999998764 57899999999999999999999999999999999999999999999999987
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCCC
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPIP 294 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~p 294 (668)
........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||...... ...... .....+.+
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~---~~~~~~~~ 230 (266)
T cd05064 155 QEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVE---DGFRLPAP 230 (266)
T ss_pred ccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHH---CCCCCCCC
Confidence 64322111 11123345678999999999999999999999999999775 99999754322 222211 12234556
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..++..+.+++.+||+.+|.+||++.+|++
T Consensus 231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 231 RNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 788999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=345.35 Aligned_cols=257 Identities=30% Similarity=0.494 Sum_probs=208.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||.|+||.||+|.+..+|..||||++..... .......+.+|+.+++.++|+||+++++++.....+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL------EGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF 74 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc------cchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence 58999999999999999999999999999999853221 122335678899999999999999999999999999
Q ss_pred eEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 145 NILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
++||||+ +++|.+++.. ...+++.+++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 75 ~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 75 VLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred EEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9999999 9999998854 3569999999999999999999999999999999999999999999999999987653321
Q ss_pred hhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccC-------------
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTT------------- 287 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~------------- 287 (668)
. .......|+..|+|||++.+.. ++.++|||||||++|+|++|.+||...... ..........
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcc
Confidence 1 1233457899999999986544 689999999999999999998888643221 1111110000
Q ss_pred -----CC-------CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 288 -----KS-------HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 288 -----~~-------~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
.. ........+.++.+||.+||..+|.+||+++++++||||.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00 0011134578999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=350.48 Aligned_cols=262 Identities=33% Similarity=0.500 Sum_probs=214.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.....|.....||+|+||.||++.+..++..||||.+... .......+.+|+.+++.++|+||+++++.+..
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~ 90 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--------KQQRRELLFNEVVIMRDYHHENVVDMYNSYLV 90 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--------hHHHHHHHHHHHHHHHhCCCCcHHHHHHheec
Confidence 3344566678899999999999999999999999987321 12234557889999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.+..|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 91 GDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred CCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 9999999999999999998854 578999999999999999999999999999999999999999999999999987543
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.. ........|++.|+|||++.+..++.++|||||||++|+|++|+.||...... ....... ...........++.
T Consensus 170 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 246 (292)
T cd06658 170 KE--VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHKVSS 246 (292)
T ss_pred cc--cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCccccccccCH
Confidence 21 12223457899999999998888999999999999999999999999643221 1111111 11111222335788
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~ 334 (668)
.+.+||.+||..+|.+|||++++++||||......
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 99999999999999999999999999999865443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=344.04 Aligned_cols=257 Identities=35% Similarity=0.602 Sum_probs=207.1
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|.+.+.||+|+||.||+|.+..+++.+|+|++... ......+.+|+.+++.+ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~---------~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI---------SDVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc---------ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 4568899999999999999999999999999999987321 11123466789999998 7999999999886
Q ss_pred cC-----CcceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEE
Q 005944 140 ED-----DSLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 140 ~~-----~~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL 210 (668)
.. ...++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl 169 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKL 169 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEE
Confidence 43 358999999999999988753 357899999999999999999999999999999999999999999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-----CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhc
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT-----GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIG 285 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-----~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~ 285 (668)
+|||++..+..... ......|+..|+|||++... .++.++|||||||++|+|++|+.||...... .....+.
T Consensus 170 ~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~ 246 (291)
T cd06639 170 VDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIP 246 (291)
T ss_pred eecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHh
Confidence 99999876532211 12235689999999998643 3678999999999999999999999754321 1111211
Q ss_pred cC-CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 286 TT-KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 286 ~~-~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
.. ......+..++..+.+||.+||+.+|++||++.+|++||||+
T Consensus 247 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 247 RNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 11 111122445678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.79 Aligned_cols=241 Identities=18% Similarity=0.240 Sum_probs=201.7
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc----CCcce
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE----DDSLN 145 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~----~~~~~ 145 (668)
..||+|++|.||+|.. +|+.||||++.... .......+.+.+|+.+|++++|||||++++++.+ ...++
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~ 98 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFH-----KGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLS 98 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccc-----cccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceE
Confidence 6799999999999987 78999999884321 1222335678899999999999999999998866 35689
Q ss_pred EEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 146 ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
+||||+++|+|.+++.+...+++.....++.|++.||.|||.. +++||||||+|||++.++.+||+|||+++.+..
T Consensus 99 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~--- 175 (283)
T PHA02988 99 LILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS--- 175 (283)
T ss_pred EEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc---
Confidence 9999999999999998888899999999999999999999984 999999999999999999999999999876432
Q ss_pred hcCCccCCCCCCCCChHHHhh--cCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHH
Q 005944 225 INGAKSMKGTPYWMAPEVILQ--TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... +..... .........+..++.++
T Consensus 176 --~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~l 251 (283)
T PHA02988 176 --PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI--INKNNSLKLPLDCPLEI 251 (283)
T ss_pred --ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhcCCCCCCCCcCcHHH
Confidence 1234578999999999976 6789999999999999999999999976432 222221 11223344555789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHc
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
++||.+||+.||.+|||+.++++
T Consensus 252 ~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 252 KCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHhcCCcccCcCHHHHHH
Confidence 99999999999999999999985
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=354.32 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=189.6
Q ss_pred eeEEcccCceEEEEEEEcC--CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc--cCCcc
Q 005944 69 GELVGCGAFGRVYMGMNLD--SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR--EDDSL 144 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~--tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~--~~~~~ 144 (668)
+..||+|+||+||+|++.. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++. ....+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 75 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG----------ISMSACREIALLRELKHPNVIALQKVFLSHSDRKV 75 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC----------CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeE
Confidence 4689999999999999654 56899999873211 1124568999999999999999999874 45678
Q ss_pred eEEeeccCCCChhccccc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe----CCCCceEEe
Q 005944 145 NILLEFVPGGSISSLLGK---------FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV----DNKGCIKLA 211 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~---------~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl----d~~g~vKL~ 211 (668)
++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+
T Consensus 76 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 76 WLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred EEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 999999975 66666531 2358899999999999999999999999999999999999 456799999
Q ss_pred cCCchhhhHhhhh-hcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHH-----------H
Q 005944 212 DFGASKKVVELAT-INGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQE-----------V 278 (668)
Q Consensus 212 DFGlA~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-----------~ 278 (668)
|||+++.+..... ........||+.|+|||++.+. .++.++|||||||++|+|+||.+||.....+ .
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~ 234 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQL 234 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHH
Confidence 9999986532211 1122345789999999999764 4789999999999999999999999532111 1
Q ss_pred HHHHhhccCC---------------------------------CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 279 AALFHIGTTK---------------------------------SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 279 ~~~~~~~~~~---------------------------------~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.......... .........+..+.+||.+||+.||.+|||+.|+|+|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 235 DRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred HHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 1111100000 0000111235678899999999999999999999999
Q ss_pred ccc
Q 005944 326 PFV 328 (668)
Q Consensus 326 pwf 328 (668)
|||
T Consensus 315 p~f 317 (317)
T cd07867 315 PYF 317 (317)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=373.09 Aligned_cols=246 Identities=33% Similarity=0.559 Sum_probs=219.8
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
++++.....-++-||.|+.|.||+|+. .++.||||++. + .-..+|+-|++|+|+||+.|.|+|
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~--------e-------lkETdIKHLRkLkH~NII~FkGVC 181 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVR--------E-------LKETDIKHLRKLKHPNIITFKGVC 181 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeec--cCceehhHHHh--------h-------hhhhhHHHHHhccCcceeeEeeee
Confidence 444555555577899999999999976 56899999871 1 123578899999999999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.....+|||||||..|-|..+|+....+.......|..+|+.|+.|||.+.|||||||.-||||..+..|||+|||.++.
T Consensus 182 tqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e 261 (904)
T KOG4721|consen 182 TQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKE 261 (904)
T ss_pred cCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999987
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccC
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls 298 (668)
..+..+ .-+++||..|||||+|.+...+.|+|||||||+|||||||..||.+- +....++-++....+.++|..++
T Consensus 262 ~~~~ST---kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV-dssAIIwGVGsNsL~LpvPstcP 337 (904)
T KOG4721|consen 262 LSDKST---KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV-DSSAIIWGVGSNSLHLPVPSTCP 337 (904)
T ss_pred hhhhhh---hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc-chheeEEeccCCcccccCcccCc
Confidence 765533 34689999999999999999999999999999999999999999754 34456667777888889999999
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
..++-||++||+-.|..||++.+||.|
T Consensus 338 ~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 338 DGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred hHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 999999999999999999999999998
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=358.46 Aligned_cols=257 Identities=35% Similarity=0.603 Sum_probs=221.5
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..-|.++..||+|+||.||+|.|+.+|..||||.+.+. ..+.++..|+.||++++.++||++||.|....
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----------sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s 101 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----------TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS 101 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----------chHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence 34588899999999999999999999999999988432 34566788999999999999999999999999
Q ss_pred cceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
.++||||||..|++.++++. +..+++.++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|..+.+
T Consensus 102 DLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD 181 (502)
T KOG0574|consen 102 DLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD 181 (502)
T ss_pred ceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh
Confidence 99999999999999999864 46799999999999999999999999999999999999999999999999999987754
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCC-CCCCCcccCHH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS-HPPIPEHLSME 300 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~-~~~~p~~ls~e 300 (668)
. .-...++.|||.|||||++....|+.++||||||++..||..|++||.+-. ....++.+.+... ...-|+..+.+
T Consensus 182 T--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH-PMRAIFMIPT~PPPTF~KPE~WS~~ 258 (502)
T KOG0574|consen 182 T--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH-PMRAIFMIPTKPPPTFKKPEEWSSE 258 (502)
T ss_pred h--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc-ccceeEeccCCCCCCCCChHhhhhH
Confidence 2 223457899999999999999999999999999999999999999997532 2223333322211 11235667889
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+.+||++||.+.|++|-|+.++++|||+++..
T Consensus 259 F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 259 FNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 99999999999999999999999999998643
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=344.97 Aligned_cols=257 Identities=30% Similarity=0.496 Sum_probs=208.7
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 74 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESED------DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR 74 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccC------cchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence 368999999999999999999998999999998743211 11223457789999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.|+||||++++.|..+......+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+....
T Consensus 75 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 75 LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred EEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999999999999888776779999999999999999999999999999999999999999999999999987653221
Q ss_pred hhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccC-------------
Q 005944 224 TINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTT------------- 287 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~------------- 287 (668)
.......++..|+|||++.+. .++.++|||||||++|+|++|.+||..... ....+......
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 223345689999999998764 478899999999999999999999963321 11111100000
Q ss_pred ----CCCC---------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 288 ----KSHP---------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 288 ----~~~~---------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
...+ .....++..+.+|+.+||..+|.+||++.++++||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0000 0123567889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=343.62 Aligned_cols=257 Identities=22% Similarity=0.365 Sum_probs=207.0
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcC-----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l 134 (668)
+....+|++.+.||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+++.++|+||+++
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~iv~~ 74 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-------SMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-------CHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 4567789999999999999999998642 45789999873211 11223457889999999999999999
Q ss_pred ccccccCCcceEEeeccCCCChhcccccCC----------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC
Q 005944 135 LGTAREDDSLNILLEFVPGGSISSLLGKFG----------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN 204 (668)
Q Consensus 135 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~----------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~ 204 (668)
++++......++||||+++|+|.+++.+.. .++...+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~ 154 (277)
T cd05062 75 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 154 (277)
T ss_pred EEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcC
Confidence 999999999999999999999999886532 3567888999999999999999999999999999999999
Q ss_pred CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHh
Q 005944 205 KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFH 283 (668)
Q Consensus 205 ~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~ 283 (668)
++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||............
T Consensus 155 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (277)
T cd05062 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234 (277)
T ss_pred CCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999875533222222223456788999999998889999999999999999999 78899754332211111
Q ss_pred hccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 284 ~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
........+..++..+.+||.+||+.+|.+||++.+++++
T Consensus 235 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 235 --MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred --HcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1222334566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=346.28 Aligned_cols=264 Identities=28% Similarity=0.481 Sum_probs=211.1
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|.+.+.||.|+||.||+|.+..+++.||||++....... ........+..|+.+++.++|+||+++++++......
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKE---AKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEecccccc---ccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEE
Confidence 5889999999999999999999999999999985432211 1112334567899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 145 NILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
++||||+ +|+|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++.......
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999999 899999997765 79999999999999999999999999999999999999999999999999987653321
Q ss_pred hhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccC-------------
Q 005944 224 TINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTT------------- 287 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~------------- 287 (668)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||..... ...........
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 157 --RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred --ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 12233456888999999865 3578899999999999999999888854321 11111110000
Q ss_pred -----CC-----CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCC
Q 005944 288 -----KS-----HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334 (668)
Q Consensus 288 -----~~-----~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~ 334 (668)
.. ........+.++.+||.+||+++|.+|||+.+++.||||++....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 235 DYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred ccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 00 001123457889999999999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.48 Aligned_cols=253 Identities=30% Similarity=0.517 Sum_probs=212.5
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||+|+||.||+|.+..++..+|||.+..... .......+.+|+.+|+.++|+||+++++.+......
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM------TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL 74 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc------ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence 58999999999999999999999999999999843211 122345688999999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-CceEEecCCchhhhHh
Q 005944 145 NILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK-GCIKLADFGASKKVVE 221 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~-g~vKL~DFGlA~~~~~ 221 (668)
++||||+++++|.+++... ..+++..+..++.|++.+|+|||++||+|+||||+||+++.+ +.+||+|||++.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999999999764 358999999999999999999999999999999999999855 4689999999876533
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
. .......|+..|+|||.+.+..++.++|||||||++|+|++|..||............ ......+++..++.++
T Consensus 155 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l 229 (256)
T cd08220 155 K---SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKI--MSGTFAPISDRYSPDL 229 (256)
T ss_pred C---ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHH--HhcCCCCCCCCcCHHH
Confidence 2 1223456899999999999888899999999999999999999999754322211111 1222334566789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.++|.+||..+|.+|||+.++++||||
T Consensus 230 ~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 230 RQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=350.55 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=219.1
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCCcceEE
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDDSLNIL 147 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~~~~LV 147 (668)
.++||+|+|+.|--|+...+|..||||+|.+.. -.....+.+|++++.+.+ |+||+.|+++|+++..+|||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--------gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLV 154 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--------GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLV 154 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCC--------chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEE
Confidence 467999999999999999999999999984321 122345778999999995 99999999999999999999
Q ss_pred eeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC---ceEEecCCchhhhHhhhh
Q 005944 148 LEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELAT 224 (668)
Q Consensus 148 mEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g---~vKL~DFGlA~~~~~~~~ 224 (668)
||.+.||.|..+|.++..|+|.++.+++++|+.||.|||.+||.||||||+|||-...+ -||||||.|...+.....
T Consensus 155 fEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 155 FEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred EecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999999999999999999999999999999999999999999999999999997654 589999998765433222
Q ss_pred -----hcCCccCCCCCCCCChHHHh-----hcCCCcchhHHHHHHHHHHHHhCCCCCchh----------------HHHH
Q 005944 225 -----INGAKSMKGTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQ----------------FQEV 278 (668)
Q Consensus 225 -----~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGvILyeLLTG~~PF~~~----------------~~~~ 278 (668)
.....+.+|+..|||||+.. ...|+.++|.||||||||.||+|.+||.+. .+.+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~L 314 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKL 314 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHH
Confidence 22234678999999999874 234899999999999999999999999532 2345
Q ss_pred HHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 279 AALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 279 ~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
..-++.+.......-|.++|.++++||..+|..|+.+|.++.++++|||++....
T Consensus 315 FesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 315 FESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred HHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 5555666666666778899999999999999999999999999999999986543
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=344.04 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=204.1
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeec
Q 005944 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEF 150 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy 150 (668)
+||+|+||.||+|.+..+++.||||++........ ............+.+++...||||+.+++++...+.+++||||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK--QGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccc--hhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEec
Confidence 48999999999999999999999998843221111 1111111122234456667899999999999999999999999
Q ss_pred cCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCcc
Q 005944 151 VPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS 230 (668)
Q Consensus 151 ~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~ 230 (668)
+.||+|..++...+.+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+... ....
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~----~~~~ 154 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK----KPHA 154 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc----CCcC
Confidence 999999999988888999999999999999999999999999999999999999999999999998754321 2234
Q ss_pred CCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhh
Q 005944 231 MKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCL 309 (668)
Q Consensus 231 ~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL 309 (668)
.+|+..|+|||++.+. .++.++||||+||++|+|++|+.||.....................++..++.++.++|.+||
T Consensus 155 ~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l 234 (278)
T cd05606 155 SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 234 (278)
T ss_pred cCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHh
Confidence 5799999999999754 589999999999999999999999975421111111111122334566678999999999999
Q ss_pred hhCCCCCC-----CHHHHHcCccccCC
Q 005944 310 QKEPYLRS-----TASELLQHPFVTGK 331 (668)
Q Consensus 310 ~~dP~~RP-----Sa~EIL~Hpwf~~~ 331 (668)
..+|.+|| ++.++++||||...
T Consensus 235 ~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 235 QRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred hcCHHhccCCCCCCHHHHHhCccccCC
Confidence 99999999 99999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=344.00 Aligned_cols=262 Identities=24% Similarity=0.377 Sum_probs=209.4
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcC-----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l 134 (668)
+....+|++.+.||+|+||.||+|.++. .+..||+|.+.... .......+.+|+.+++.++|+||+++
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~ 74 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-------SLRERIEFLNEASVMKGFTCHHVVRL 74 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-------CHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 4567889999999999999999997653 35689999873211 11122346789999999999999999
Q ss_pred ccccccCCcceEEeeccCCCChhcccccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC
Q 005944 135 LGTAREDDSLNILLEFVPGGSISSLLGKF----------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN 204 (668)
Q Consensus 135 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~----------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~ 204 (668)
++++......|+||||+++|+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.
T Consensus 75 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~ 154 (288)
T cd05061 75 LGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAH 154 (288)
T ss_pred EEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcC
Confidence 99999999999999999999999998653 22456788899999999999999999999999999999999
Q ss_pred CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHh
Q 005944 205 KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFH 283 (668)
Q Consensus 205 ~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~ 283 (668)
++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|+|++ |..||............
T Consensus 155 ~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~ 234 (288)
T cd05061 155 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234 (288)
T ss_pred CCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999999875533222222223346778999999998889999999999999999998 78899654322211111
Q ss_pred hccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc------CccccC
Q 005944 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ------HPFVTG 330 (668)
Q Consensus 284 ~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~------Hpwf~~ 330 (668)
. .......+..++..+.++|.+||+.+|.+|||+.++++ ||||.+
T Consensus 235 ~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 235 M--DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred H--cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 1 12223445667899999999999999999999999987 888865
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=337.39 Aligned_cols=260 Identities=49% Similarity=0.846 Sum_probs=215.8
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC--
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED-- 141 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~-- 141 (668)
.+|++.++||+|+||.||+|.+..++..||+|++..... ..........+.+|+.+++.++|+||+++++.+...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 78 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD---SQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEE 78 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcc---cchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCC
Confidence 579999999999999999999999999999998743211 111233456788999999999999999999988654
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
..+++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+|+||||+||+++.++.++|+|||+++....
T Consensus 79 ~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 158 (264)
T cd06653 79 KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQT 158 (264)
T ss_pred CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence 45889999999999999998777899999999999999999999999999999999999999999999999999876532
Q ss_pred hhh-hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 222 LAT-INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 222 ~~~-~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ............+.++..++.+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~ 237 (264)
T cd06653 159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM-AAIFKIATQPTKPMLPDGVSDA 237 (264)
T ss_pred ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH-HHHHHHHcCCCCCCCCcccCHH
Confidence 111 11123456899999999999888999999999999999999999999754322 2222333333345577889999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
+.++|.+||. +|..||++.+++.|||+
T Consensus 238 ~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 238 CRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=372.60 Aligned_cols=262 Identities=28% Similarity=0.456 Sum_probs=221.6
Q ss_pred CCCCCCCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCe
Q 005944 52 ALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI 131 (668)
Q Consensus 52 ~~pp~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI 131 (668)
+..+...+++......++..||+|.||+||+|.+-. .||||++.+.. ..++.++.|++|+..|++-+|.||
T Consensus 380 ~s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~------pt~~qlqaFKnEVa~lkkTRH~NI 450 (678)
T KOG0193|consen 380 ASDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDD------PTPEQLQAFKNEVAVLKKTRHENI 450 (678)
T ss_pred CCccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCC------CCHHHHHHHHHHHHHHhhcchhhh
Confidence 334457788889999999999999999999999854 69999995533 344578899999999999999999
Q ss_pred eeeccccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEE
Q 005944 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 132 V~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL 210 (668)
+-+.|++..... .||+.+|+|-+|+.+|+-. ..|.......|++||++|+.|||.++|||||||..|||+.+++.|||
T Consensus 451 lLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkI 529 (678)
T KOG0193|consen 451 LLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKI 529 (678)
T ss_pred eeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEE
Confidence 999999988776 9999999999999999654 56899999999999999999999999999999999999999999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhh---cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccC
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ---TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT 287 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~ 287 (668)
+||||+..-.............|...|||||++.. .+|++.+|||||||++|||+||..||... .....++.++..
T Consensus 530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~-~~dqIifmVGrG 608 (678)
T KOG0193|consen 530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQ-NRDQIIFMVGRG 608 (678)
T ss_pred ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCC-ChhheEEEeccc
Confidence 99999875443344455566778999999999974 45899999999999999999999999843 333445555555
Q ss_pred CCCCC---CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 288 KSHPP---IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 288 ~~~~~---~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
...+. ....++.++++|+..||.+++++||.+.+||.
T Consensus 609 ~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 609 YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 33333 23467789999999999999999999999986
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=342.48 Aligned_cols=257 Identities=31% Similarity=0.489 Sum_probs=202.4
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHH-HHHhCCCCCeeeeccccccCC
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK-LLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIV~l~g~~~~~~ 142 (668)
.+|++.+.||+|+||.||+|.+..+|..||||++...... .... .+..|+. .++.++||||+++++++..+.
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~ 73 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS------QEQK-RLLMDLDISMRSVDCPYTVTFYGALFREG 73 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc------HHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCC
Confidence 3689999999999999999999999999999988532211 1112 2333444 467779999999999999999
Q ss_pred cceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEecCCchh
Q 005944 143 SLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
..|+||||++ |+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.
T Consensus 74 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~ 152 (283)
T cd06617 74 DVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISG 152 (283)
T ss_pred cEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 9999999997 577666543 35689999999999999999999997 99999999999999999999999999987
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhh----cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCC
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQ----TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~----~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~ 293 (668)
.+... .......|+..|+|||++.+ ..++.++|||||||++|+|++|..||............... .....+
T Consensus 153 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~ 228 (283)
T cd06617 153 YLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQL 228 (283)
T ss_pred ccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHh-cCCCCC
Confidence 65321 11223568899999999864 44688999999999999999999999642211111111111 111222
Q ss_pred -CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 294 -PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 294 -p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
...++.++.+||.+||..+|.+||++.+++.||||....
T Consensus 229 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 229 PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 235789999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=338.76 Aligned_cols=255 Identities=24% Similarity=0.389 Sum_probs=210.0
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCC-----CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l 134 (668)
++...+|++.+.||+|+||.||+|.+... +..||+|.+.... .......+.+|+.+|..++|+||+++
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~~~~~~i~~~ 74 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-------SMRERIEFLNEASVMKEFNCHHVVRL 74 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-------CHHHHHHHHHHHHHHHhCCCCceeEE
Confidence 35667899999999999999999988654 4899999873211 11223457789999999999999999
Q ss_pred ccccccCCcceEEeeccCCCChhcccccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC
Q 005944 135 LGTAREDDSLNILLEFVPGGSISSLLGKF----------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN 204 (668)
Q Consensus 135 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~----------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~ 204 (668)
++++......++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus 75 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~ 154 (277)
T cd05032 75 LGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAE 154 (277)
T ss_pred EEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcC
Confidence 99999999999999999999999988543 23678899999999999999999999999999999999999
Q ss_pred CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHH
Q 005944 205 KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALF 282 (668)
Q Consensus 205 ~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~ 282 (668)
++.+||+|||+++.+.............++..|+|||.+.+..++.++|||||||++|+|+| |..||..... ......
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 234 (277)
T cd05032 155 DLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV 234 (277)
T ss_pred CCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH
Confidence 99999999999986543322222334567889999999988889999999999999999998 9999965432 222222
Q ss_pred hhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 283 HIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 283 ~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
. .......+..++.++.+||.+||+.+|.+|||+.+++.
T Consensus 235 ~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 235 I---DGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred h---cCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 2 23344566778999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=338.68 Aligned_cols=257 Identities=31% Similarity=0.558 Sum_probs=216.7
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCC
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDD 142 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~ 142 (668)
.+|.+.+.||+|+||.||+|++..++..||+|++..... ........+.+|+.+++.+. |+||+++++++...+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQL-----IKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhc-----cchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCc
Confidence 379999999999999999999999999999998843211 12223356788999999998 999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
..++||||+.+++|.+++.+.+.+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998765432
Q ss_pred hhh------------------cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhh
Q 005944 223 ATI------------------NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI 284 (668)
Q Consensus 223 ~~~------------------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~ 284 (668)
... .......|+..|+|||++.+..++.++||||||+++|+|++|..||........ ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~ 234 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT-FQKI 234 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH-HHHH
Confidence 211 112235678999999999888899999999999999999999999975432111 1111
Q ss_pred ccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCH----HHHHcCccc
Q 005944 285 GTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTA----SELLQHPFV 328 (668)
Q Consensus 285 ~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa----~EIL~Hpwf 328 (668)
. .....++..++..+.+||.+||+.+|.+||++ .++++||||
T Consensus 235 ~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 235 L--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred H--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 1 22334566779999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=336.22 Aligned_cols=257 Identities=36% Similarity=0.635 Sum_probs=217.4
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||.|++|.||+|++..++..||||++..... ......+.+|+.++..++|+||+++++++......
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD-------EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEI 74 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc-------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeE
Confidence 68899999999999999999999999999998843221 13345688999999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
++||||+++++|.+++.....+++..++.++.||+.||.|||+ .|++||||+|+||+++.++.++|+|||++..+....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 75 SIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999999999887889999999999999999999999 999999999999999999999999999987653322
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcc-cCHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEH-LSMEA 301 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~-ls~el 301 (668)
. ......++..|+|||.+.+..++.++||||||+++|+|+||..||..... .................+.. ++..+
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 232 (264)
T cd06623 155 D--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEF 232 (264)
T ss_pred C--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence 1 12245688999999999888899999999999999999999999965431 11111111112233344555 88999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.++|.+||..+|.+||++.++++||||+.
T Consensus 233 ~~li~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 233 RDFISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=337.55 Aligned_cols=255 Identities=32% Similarity=0.537 Sum_probs=209.4
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||.|+||.||+|++..++..||||.+..... ........+.+|+.+++.++||||+++++++...+.
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEM-----MDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNE 76 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeecccc-----CCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCe
Confidence 479999999999999999999999999999998743211 122334567889999999999999999999999999
Q ss_pred ceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 144 LNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.++||||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~ 156 (267)
T cd08228 77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceec
Confidence 9999999999999988743 345899999999999999999999999999999999999999999999999998765
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCC-CCcccC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP-IPEHLS 298 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~-~p~~ls 298 (668)
..... ......|++.|+|||.+.+..++.++||||||+++|+|++|..||...................++ ....++
T Consensus 157 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08228 157 SSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYS 234 (267)
T ss_pred cchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcC
Confidence 43221 122456899999999999888999999999999999999999999654322222222211112222 234678
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
..+.+||.+||+.+|.+||++.++++.
T Consensus 235 ~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 235 EKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 899999999999999999999999963
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=343.03 Aligned_cols=255 Identities=31% Similarity=0.547 Sum_probs=204.6
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||.|+||.||+|++..++..||||++..... .......+.+|++++++++||||+++++++...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 74 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE------TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL 74 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc------ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence 48899999999999999999999999999998743221 111224577899999999999999999999999999
Q ss_pred eEEeeccCCCChhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGGSISSLLGK--FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
++||||+. ++|..++.. ...+++..++.++.||+.||+|||+.||+|+||+|+||+++.++.+||+|||++..+...
T Consensus 75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999996 578887754 356899999999999999999999999999999999999999999999999998754321
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccC------------
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTT------------ 287 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~------------ 287 (668)
........+++.|+|||++.+.. ++.++|||||||++|+|+||+.||..... ...........
T Consensus 154 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 154 --VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred --ccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence 11223345788999999887644 68899999999999999999999964321 11111110000
Q ss_pred ------------CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 288 ------------KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 288 ------------~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.....+...++.++++||.+||+.||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 232 PDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred HHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00001123467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=390.72 Aligned_cols=261 Identities=27% Similarity=0.440 Sum_probs=211.2
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
++....+|++.+.||.|+||+||+|.+..++..||+|++.... ........+..|+.+|..|+|||||+++++|
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~------l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f 81 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG------LKEREKSQLVIEVNVMRELKHKNIVRYIDRF 81 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccc------cCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE
Confidence 4566779999999999999999999999999999999985322 1223345678899999999999999999987
Q ss_pred cc--CCcceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccccCCcccEEeCC-
Q 005944 139 RE--DDSLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKN-------GIMHRDIKGANILVDN- 204 (668)
Q Consensus 139 ~~--~~~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~-------gIvHrDLKPeNILld~- 204 (668)
.. ...+|||||||++|+|..+|.. .+.+++..++.|+.||+.||.|||.. +||||||||+||||+.
T Consensus 82 ~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 82 LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred EecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 54 4568999999999999998865 35799999999999999999999985 4999999999999964
Q ss_pred ----------------CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhh--cCCCcchhHHHHHHHHHHHHh
Q 005944 205 ----------------KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ--TGHSFSADIWSVGCTVIEMAT 266 (668)
Q Consensus 205 ----------------~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGvILyeLLT 266 (668)
.+.+||+|||++..+... ......+||+.|+|||++.+ ..++.++||||||||||+|+|
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 345999999999765321 12335679999999999965 348899999999999999999
Q ss_pred CCCCCchhH--HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 267 GKPPWSQQF--QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 267 G~~PF~~~~--~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
|..||.... ..+...+.. .. .......+.++.+||.+||..+|.+||++.++|.||||....
T Consensus 239 Gk~PF~~~~~~~qli~~lk~---~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 239 GKTPFHKANNFSQLISELKR---GP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCCCCCcCCcHHHHHHHHhc---CC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 999996432 222221111 11 111235688999999999999999999999999999997543
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.04 Aligned_cols=252 Identities=27% Similarity=0.458 Sum_probs=206.6
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcC-----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
..+|.+.+.||+|+||.||+|.+.. ++..||||++... ........+.+|+++|+.+.|+||++++++
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~ 76 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET-------ASNDARKDFEREAELLTNFQHENIVKFYGV 76 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc-------CCHHHHHHHHHHHHHHHhcCCCCchheeeE
Confidence 4568899999999999999998753 3688999987421 112234568899999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF--------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD 203 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~--------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld 203 (668)
+......++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~ 156 (280)
T cd05049 77 CTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG 156 (280)
T ss_pred EecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEc
Confidence 99999999999999999999998654 3478899999999999999999999999999999999999
Q ss_pred CCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHH
Q 005944 204 NKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAAL 281 (668)
Q Consensus 204 ~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~ 281 (668)
.++.+||+|||++..+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||..... +....
T Consensus 157 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~ 236 (280)
T cd05049 157 YDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236 (280)
T ss_pred CCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 999999999999875432211111223446788999999999999999999999999999998 9999865432 22222
Q ss_pred HhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 282 FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 282 ~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.. .......+..++.++.+||.+||+.+|.+||++.|+++
T Consensus 237 ~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 237 IT---QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HH---cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 22 22233445678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=332.88 Aligned_cols=254 Identities=35% Similarity=0.620 Sum_probs=216.5
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||.|+||.||+|.+..++..||+|++.... ........+.+|+++++.++|+|++++++.+......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~ 74 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN------MSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL 74 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeeccc------CChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence 5899999999999999999999999999999984322 1123445678899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 145 NILLEFVPGGSISSLLGKF----GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~----~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
++|+||+++++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+|||++.++.++|+|||++....
T Consensus 75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 154 (258)
T cd08215 75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS 154 (258)
T ss_pred EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecc
Confidence 9999999999999998763 679999999999999999999999999999999999999999999999999987654
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||...... .............++..++.+
T Consensus 155 ~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (258)
T cd08215 155 STV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--ELALKILKGQYPPIPSQYSSE 230 (258)
T ss_pred cCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--HHHHHHhcCCCCCCCCCCCHH
Confidence 322 1233457899999999998888999999999999999999999999654321 111111223345566788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
+.++|.+||..+|.+||++.++|+||||
T Consensus 231 ~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 231 LRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=342.03 Aligned_cols=257 Identities=35% Similarity=0.642 Sum_probs=215.9
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
..|+..+.||.|+||.||+|.+..++..||||++.... .......+.+|+.+++.+.|+||+++++++.....
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTK 76 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-------cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCE
Confidence 45788899999999999999999999999999884321 12334678889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+....
T Consensus 77 ~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 77 LWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred EEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 9999999999999999865 578999999999999999999999999999999999999999999999999987653221
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~d 303 (668)
.......++..|+|||++.+..++.++|||||||++|+|+||..||........... ......+.++..++..+.+
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL--IPKNNPPTLTGEFSKPFKE 231 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh--hhcCCCCCCchhhhHHHHH
Confidence 112335688899999999888899999999999999999999999975432211111 1122234455667889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 304 FLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 304 LI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
||.+||+.+|.+||++.+++.|+||....
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 232 FIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred HHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 99999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=344.55 Aligned_cols=256 Identities=38% Similarity=0.666 Sum_probs=214.0
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
..|...+.||+|+||.||+|.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++.+.....
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 76 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-------AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTK 76 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-------chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCc
Confidence 34778889999999999999999999999999874221 12334578899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++..+....
T Consensus 77 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06642 77 LWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred eEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence 9999999999999998865 578999999999999999999999999999999999999999999999999987653221
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~d 303 (668)
.......|+..|+|||++.+..++.++|||||||++|+|++|..||........... ........+...++.++.+
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 231 (277)
T cd06642 156 --IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL--IPKNSPPTLEGQYSKPFKE 231 (277)
T ss_pred --hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh--hhcCCCCCCCcccCHHHHH
Confidence 112235688999999999988899999999999999999999999965432211111 1112233345567889999
Q ss_pred HHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 304 FLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 304 LI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
||.+||+.+|.+||++.++++||||...
T Consensus 232 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 232 FVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred HHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 9999999999999999999999999753
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=342.65 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=207.7
Q ss_pred CCCeeeeeEEcccCceEEEEEEEc----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNL----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
-.+|++.+.||+|+||+||+|... .++..||+|.+... ........+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 76 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-------NNPQQWGEFQQEASLMAELHHPNIVCLLGVV 76 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-------CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEE
Confidence 356899999999999999999853 35678999987421 1123345678899999999999999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEE
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKF-----------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANIL 201 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~-----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNIL 201 (668)
......|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 77 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil 156 (283)
T cd05090 77 TQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL 156 (283)
T ss_pred ecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence 9999999999999999999988422 24788899999999999999999999999999999999
Q ss_pred eCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHH
Q 005944 202 VDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVA 279 (668)
Q Consensus 202 ld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~ 279 (668)
++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|+|++ |..||..... .+.
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05090 157 IGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI 236 (283)
T ss_pred EcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999976533222222334456778999999988889999999999999999998 9999965432 222
Q ss_pred HHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 280 ALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 280 ~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.... .....+.+..++.++.++|.+||+.+|.+||++.+|+++
T Consensus 237 ~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 237 EMVR---KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHH---cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 2222 223345667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=335.57 Aligned_cols=245 Identities=25% Similarity=0.410 Sum_probs=200.1
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEee
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLE 149 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmE 149 (668)
+.||+|+||+||+|++..+++.||+|.+... ........+.+|+++|+.++|+||+++++++......++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 73 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET-------LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 73 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc-------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEe
Confidence 3689999999999999999999999987321 122334567889999999999999999999999999999999
Q ss_pred ccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 150 FVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 150 y~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
|+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||.|||++.++.+||+|||++............
T Consensus 74 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 153 (252)
T cd05084 74 LVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153 (252)
T ss_pred eccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence 99999999998654 46899999999999999999999999999999999999999999999999998754321111001
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLL 306 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~ 306 (668)
....++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ...... .......+..++..+.+|+.
T Consensus 154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~ 230 (252)
T cd05084 154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE---QGVRLPCPELCPDAVYRLME 230 (252)
T ss_pred CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH---cCCCCCCcccCCHHHHHHHH
Confidence 11123456999999998889999999999999999998 99998643322 222221 12233456678899999999
Q ss_pred HhhhhCCCCCCCHHHHHc
Q 005944 307 KCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 307 kcL~~dP~~RPSa~EIL~ 324 (668)
+||+.+|.+||++.++++
T Consensus 231 ~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 231 RCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=335.64 Aligned_cols=251 Identities=31% Similarity=0.555 Sum_probs=203.9
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHH-HHHhCCCCCeeeeccccccCCcceEEe
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK-LLKNLTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
+.||.|+||.||+|.+..+++.||||++.... .........+..|.. +....+|+||+++++++...+.+|+||
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~ 76 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSD-----MIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVM 76 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchh-----hhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEE
Confidence 56899999999999999999999999874221 111112223334444 345568999999999999999999999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
||+++++|.+++...+.+++..+..++.||+.||.|||+.||+||||+|.|||++.++.+||+|||++..... .
T Consensus 77 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 77 EYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred eccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 9999999999998888899999999999999999999999999999999999999999999999999875322 2
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ...................++.++.++|.+
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 230 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINR 230 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHH
Confidence 3456899999999998888899999999999999999999999754322 222222222222333445688999999999
Q ss_pred hhhhCCCCCC---CHHHHHcCccccCC
Q 005944 308 CLQKEPYLRS---TASELLQHPFVTGK 331 (668)
Q Consensus 308 cL~~dP~~RP---Sa~EIL~Hpwf~~~ 331 (668)
||+.+|++|| ++.|++.||||...
T Consensus 231 ~l~~~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 231 LLCMDPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred HccCCHHHccCCCcHHHHHcChHhhcC
Confidence 9999999999 55899999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=349.81 Aligned_cols=254 Identities=25% Similarity=0.451 Sum_probs=207.8
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcE----EEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGEL----LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~----VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
....+|++.+.||+|+||+||+|++..++.. ||||++... ........+.+|+.+++.++||||+++++
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~niv~~~g 76 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPKANKEILDEAYVMASVDNPHVCRLLG 76 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-------CCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3456799999999999999999998766654 899987321 11233456788999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++... ..++|+||+++|+|.+++... ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~ 155 (316)
T cd05108 77 ICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGL 155 (316)
T ss_pred EEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccc
Confidence 88764 578999999999999998764 4688999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~ 293 (668)
++.+.............++..|+|||++.+..++.++|||||||++|+|++ |..||..... ....... .....+.
T Consensus 156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~ 232 (316)
T cd05108 156 AKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGERLPQ 232 (316)
T ss_pred cccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---CCCCCCC
Confidence 987643322222223345678999999999999999999999999999998 9999975432 2222222 2223344
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+..++.++.++|.+||..+|.+||++.+++.+
T Consensus 233 ~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 233 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 56778899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=341.23 Aligned_cols=255 Identities=26% Similarity=0.404 Sum_probs=207.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcC-----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
....+|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+..|+.+++.++|+||++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~ 75 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-------SEQDESDFLMEALIMSKFNHQNIVRLI 75 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 455779999999999999999999987 77899999873211 112234578899999999999999999
Q ss_pred cccccCCcceEEeeccCCCChhcccccCC-------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC--
Q 005944 136 GTAREDDSLNILLEFVPGGSISSLLGKFG-------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-- 206 (668)
Q Consensus 136 g~~~~~~~~~LVmEy~~gGsL~~~L~~~~-------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-- 206 (668)
+++......++||||+++++|.+++...+ .+++..+..++.||+.||.|||+++|+||||||+|||++.++
T Consensus 76 ~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~ 155 (277)
T cd05036 76 GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPG 155 (277)
T ss_pred EEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCC
Confidence 99999999999999999999999986543 488999999999999999999999999999999999998765
Q ss_pred -ceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHh
Q 005944 207 -CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFH 283 (668)
Q Consensus 207 -~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~ 283 (668)
.+||+|||+++.+..............++.|+|||++.+..++.++|||||||++|+|++ |..||..... .......
T Consensus 156 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~ 235 (277)
T cd05036 156 RVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT 235 (277)
T ss_pred cceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 699999999986532211111112234568999999998889999999999999999997 9999975432 2222222
Q ss_pred hccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 284 ~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.......+..++..+.+|+.+||+.+|.+||++.++++|
T Consensus 236 ---~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 236 ---GGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred ---cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 122334566788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=346.99 Aligned_cols=258 Identities=33% Similarity=0.512 Sum_probs=211.5
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
-|.....||.|+||.||+|.+..++..||||++.... ......+.+|+.+++.+.||||+++++.+...+..
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--------~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 93 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--------QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEEL 93 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--------cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeE
Confidence 3555668999999999999999999999999884321 11234577899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
|+||||+++++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+....
T Consensus 94 ~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~- 171 (297)
T cd06659 94 WVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV- 171 (297)
T ss_pred EEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-
Confidence 999999999999987754 578999999999999999999999999999999999999999999999999987543221
Q ss_pred hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHH
Q 005944 225 INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dL 304 (668)
.......|++.|+|||++.+..++.++|||||||++|+|++|+.||......................+..++.++.++
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 250 (297)
T cd06659 172 -PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDF 250 (297)
T ss_pred -ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHH
Confidence 1223467899999999999888999999999999999999999999643321111111111111222344678899999
Q ss_pred HHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 305 LLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 305 I~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
|.+||+.+|.+||++.++++||||.....
T Consensus 251 i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 251 LERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred HHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 99999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=327.60 Aligned_cols=251 Identities=44% Similarity=0.711 Sum_probs=210.9
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|.+.+.||+|++|.||+|.+..++..|++|++..... .....+.+|+.+++.++|+||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 72 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--------EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDEL 72 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--------hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 48889999999999999999998999999999843211 2445678899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 145 NILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
++++||+++++|.+++... ..+++..+..++.|++.||.|||.+|++||||+|+||+++.++.++|+|||++.......
T Consensus 73 ~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 152 (253)
T cd05122 73 WIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK 152 (253)
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence 9999999999999998776 689999999999999999999999999999999999999999999999999987654322
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
. .....++..|+|||++.+..++.++||||||+++|+|++|..||..... ........ ...........++.++.
T Consensus 153 ~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 228 (253)
T cd05122 153 A---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFK 228 (253)
T ss_pred c---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-cCCCCcCcccccCHHHH
Confidence 1 2356789999999999888889999999999999999999999975421 11111111 11111112223488999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHcCcc
Q 005944 303 DFLLKCLQKEPYLRSTASELLQHPF 327 (668)
Q Consensus 303 dLI~kcL~~dP~~RPSa~EIL~Hpw 327 (668)
++|.+||+.||.+|||+.++++|||
T Consensus 229 ~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 229 DFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHccCChhhCCCHHHHhcCCC
Confidence 9999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=332.72 Aligned_cols=254 Identities=28% Similarity=0.534 Sum_probs=210.7
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|.+.+.||.|+||.||+|.+..+|..||+|.+.... ........+.+|+.+++.++|+||+++++.+......
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~ 74 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTK------MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL 74 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhh------ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence 5899999999999999999999999999999884321 1112234577899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC-ceEEecCCchhhhHh
Q 005944 145 NILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-CIKLADFGASKKVVE 221 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-~vKL~DFGlA~~~~~ 221 (668)
++|+||+++++|.+++.... .+++..+..++.||+.||.|||+.+|+|+||||+||+++.++ .+||+|||.+.....
T Consensus 75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 99999999999999886543 478999999999999999999999999999999999999886 469999999876532
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
.. .......|++.|+|||++.+..++.++|||||||++|+|++|..||.......... ... ..........++.++
T Consensus 155 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~ 230 (257)
T cd08225 155 SM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVL-KIC-QGYFAPISPNFSRDL 230 (257)
T ss_pred Cc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH-HHh-cccCCCCCCCCCHHH
Confidence 21 12233568999999999988889999999999999999999999997543221111 111 122233445678899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.++|.+||..+|.+|||+.++++||||
T Consensus 231 ~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 231 RSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=340.73 Aligned_cols=257 Identities=32% Similarity=0.524 Sum_probs=212.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|...++||.|++|.||++.+..++..||+|++... .......+.+|+.+++.++|+||+++++++...+.
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--------~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~ 90 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--------KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE 90 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--------chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCe
Confidence 4566678999999999999999999999999987321 11223457789999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.++|+||+.+++|.+++.. +.+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 91 ~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 91 LWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred EEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 9999999999999999877 679999999999999999999999999999999999999999999999999887543221
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||..... ......... .......+..++..+.
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~ 246 (285)
T cd06648 170 --PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLR 246 (285)
T ss_pred --cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHH
Confidence 122345689999999999888899999999999999999999999964322 111111111 1111122334788999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 303 DFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 303 dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+||.+||+.+|.+||++.++++||||....
T Consensus 247 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 247 SFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=334.91 Aligned_cols=250 Identities=28% Similarity=0.541 Sum_probs=209.7
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||.|+||.||++.+..++..||+|.+.... .......+.+|+.+++.++|+||+++++.+.....+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-------SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHL 73 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-------chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEE
Confidence 5889999999999999999999999999999884321 112335577899999999999999999999999999
Q ss_pred eEEeeccCCCChhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGGSISSLLGK--FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
|+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 74 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 74 YIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred EEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 999999999999988754 345899999999999999999999999999999999999999999999999998755322
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
. .......|++.|+|||++.+..++.++||||||+++|+|++|..||......... ... ......+++..++..+.
T Consensus 154 ~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~ 229 (255)
T cd08219 154 G--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI-LKV-CQGSYKPLPSHYSYELR 229 (255)
T ss_pred c--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH-HHH-hcCCCCCCCcccCHHHH
Confidence 1 1123457899999999998888999999999999999999999999754322111 111 12233446677889999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHcC
Q 005944 303 DFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 303 dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+||.+||+.+|.+||++.+|+.-
T Consensus 230 ~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 230 SLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHhCCcccCCCHHHHhhc
Confidence 99999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=342.28 Aligned_cols=256 Identities=28% Similarity=0.425 Sum_probs=201.2
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||+|+||.||+|.+..++..||||++..... ......+.+|+.+|+.++|+||+++++++....
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 76 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-------EGVPFTAIREASLLKGLKHANIVLLHDIIHTKE 76 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-------CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCC
Confidence 3679999999999999999999999999999999843211 111224567999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~-~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
..|+||||+. ++|.+++. ....+++..++.++.||+.||.|||+.||+|+||||+|||++.++.+||+|||+++....
T Consensus 77 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 77 TLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9999999996 56665554 345688999999999999999999999999999999999999999999999999875422
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhc---c-----------
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIG---T----------- 286 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~---~----------- 286 (668)
. ........+++.|+|||++.+. .++.++|||||||++|+|++|..||.........+.... .
T Consensus 156 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 P--SQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred C--CCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 1 1112334579999999998764 478899999999999999999999964332111111100 0
Q ss_pred ----C--C-CCC-------CCC--cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 287 ----T--K-SHP-------PIP--EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 287 ----~--~-~~~-------~~p--~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
. . ... ..+ ...+.++.+||.+||..||.+|||+.+++.||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 0 000 000 0125688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=332.28 Aligned_cols=247 Identities=30% Similarity=0.486 Sum_probs=208.1
Q ss_pred eEEcccCceEEEEEEEcCC---CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceE
Q 005944 70 ELVGCGAFGRVYMGMNLDS---GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNI 146 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~t---g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~L 146 (668)
++||+|+||.||+|.+... +..||+|++..... ......+.+|+.+++.++|+||+++++++.....+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~l 73 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS-------EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYL 73 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc-------hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEE
Confidence 4699999999999999866 89999999843211 1135678899999999999999999999999999999
Q ss_pred EeeccCCCChhcccccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 147 LLEFVPGGSISSLLGKF---------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 147 VmEy~~gGsL~~~L~~~---------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||.+.
T Consensus 74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~ 153 (262)
T cd00192 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153 (262)
T ss_pred EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccc
Confidence 99999999999999875 779999999999999999999999999999999999999999999999999998
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ 296 (668)
...............+++.|+|||.+....++.++|||||||++|+|++ |..||........ ............+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 231 (262)
T cd00192 154 DVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV--LEYLRKGYRLPKPEY 231 (262)
T ss_pred ccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH--HHHHHcCCCCCCCcc
Confidence 7654322222344568899999999988889999999999999999999 6999976532211 111112334456677
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
++.++.+++.+||+.+|.+||++.+++++
T Consensus 232 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 232 CPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 89999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=342.09 Aligned_cols=259 Identities=24% Similarity=0.439 Sum_probs=211.2
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEcCC-----CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCC
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPN 130 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpN 130 (668)
........+|++.+.||+|+||.||++.+... ...||+|.+... ........+.+|+.++..+ +|+|
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~ 77 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-------ATEKDLSDLVSEMEMMKMIGKHKN 77 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC-------CCHHHHHHHHHHHHHHHhhcCCCC
Confidence 34457778999999999999999999987643 378999987421 1122334578899999999 7999
Q ss_pred eeeeccccccCCcceEEeeccCCCChhccccc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGK----------------FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRD 194 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~----------------~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrD 194 (668)
|+++++++.....+++||||+++|+|..++.. ...+++..+..++.||+.||.|||++||+|||
T Consensus 78 i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~d 157 (293)
T cd05053 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRD 157 (293)
T ss_pred eeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 99999999999999999999999999998853 24588999999999999999999999999999
Q ss_pred CCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCch
Q 005944 195 IKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ 273 (668)
Q Consensus 195 LKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~ 273 (668)
|||+|||++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 158 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 237 (293)
T cd05053 158 LAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237 (293)
T ss_pred cceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCC
Confidence 999999999999999999999986543322222223345678999999988889999999999999999997 9999965
Q ss_pred hHH-HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 274 QFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 274 ~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
... +...... .......+..++.++.+|+.+||..+|.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 238 IPVEELFKLLK---EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred CCHHHHHHHHH---cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 432 2222222 222334556778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=340.45 Aligned_cols=260 Identities=37% Similarity=0.674 Sum_probs=213.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC---CCCeeeeccccccC
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT---HPNIVRYLGTARED 141 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIV~l~g~~~~~ 141 (668)
.|++.+.||.|+||.||+|.+..++..||||.+.... .......+.+|+.+++.+. ||||+++++++...
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~ 74 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-------PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG 74 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-------CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC
Confidence 4788899999999999999999999999999874321 1123345778999999986 99999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
...++||||+++++|.+++.. +.+++..++.++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++..+..
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 75 PRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred CEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 999999999999999999866 4799999999999999999999999999999999999999999999999999876543
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCc-ccCH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE-HLSM 299 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~-~ls~ 299 (668)
.. .......|+..|+|||.+.+. .++.++|||||||++|+|++|..||........ ..... ....+.++. .++.
T Consensus 154 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~ 229 (277)
T cd06917 154 NS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-MMLIP-KSKPPRLEDNGYSK 229 (277)
T ss_pred Cc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-hhccc-cCCCCCCCcccCCH
Confidence 22 122345689999999998754 468899999999999999999999965432211 11111 112222333 3788
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCCCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPH 336 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~~~ 336 (668)
++.++|.+||+.+|.+||++.+++.|+||+.....+.
T Consensus 230 ~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~~~ 266 (277)
T cd06917 230 LLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTPV 266 (277)
T ss_pred HHHHHHHHHcCCCcccCcCHHHHhhChHhhccccCch
Confidence 9999999999999999999999999999987554433
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=344.88 Aligned_cols=261 Identities=34% Similarity=0.600 Sum_probs=214.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|.+.+.||+|+||.||++.+..++..||+|.+... .......+.+|+.+++.++||||+++++++..
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~ 87 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ--------QQPKKELIINEILVMRENKHPNIVNYLDSYLV 87 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc--------cchHHHHHHHHHHHHhhcCCCCeeehhheeee
Confidence 4457899999999999999999999889999999987321 11223457889999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.+..|+|+||+++++|.+++.+ ..+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||++....
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~ 166 (293)
T cd06647 88 GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (293)
T ss_pred CCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence 9999999999999999999865 468899999999999999999999999999999999999999999999999887543
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
.... ......|++.|+|||.+.+..++.++|||||||++|+|++|..||......................+..++..
T Consensus 167 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (293)
T cd06647 167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 244 (293)
T ss_pred cccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHH
Confidence 3221 12335689999999999888899999999999999999999999975432211111111111112234557889
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+++||.+||..+|.+||++.+++.|+||+...
T Consensus 245 l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 245 FRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 99999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=333.25 Aligned_cols=253 Identities=36% Similarity=0.615 Sum_probs=208.3
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeecc
Q 005944 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFV 151 (668)
Q Consensus 72 LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~ 151 (668)
||.|+||.||+|.+..+|+.||+|++.... .........+.+|+++++.++|+||+++++.+......|+||||+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 75 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKAD-----MIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYL 75 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchh-----hhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecC
Confidence 689999999999999999999999884221 112345567888999999999999999999999999999999999
Q ss_pred CCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh------h
Q 005944 152 PGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT------I 225 (668)
Q Consensus 152 ~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~------~ 225 (668)
++++|.+++.+.+.+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.++|+|||++........ .
T Consensus 76 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 76 PGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 9999999998878899999999999999999999999999999999999999999999999999875432211 0
Q ss_pred cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHH
Q 005944 226 NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFL 305 (668)
Q Consensus 226 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI 305 (668)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||.............. .....+....++..+.+||
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i 234 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-GKIEWPEDVEVSDEAIDLI 234 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCcCCCccccCCHHHHHHH
Confidence 122345688999999999888899999999999999999999999975433221111111 1111111122489999999
Q ss_pred HHhhhhCCCCCCCH---HHHHcCccccC
Q 005944 306 LKCLQKEPYLRSTA---SELLQHPFVTG 330 (668)
Q Consensus 306 ~kcL~~dP~~RPSa---~EIL~Hpwf~~ 330 (668)
.+||+.+|.+|||+ .++|+||||.+
T Consensus 235 ~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 235 SKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 99999999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=330.15 Aligned_cols=254 Identities=50% Similarity=0.944 Sum_probs=218.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||+|++|.||+|++..++..||+|.+.... ........+.+|++++..++|+||+++++++......
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK------IKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL 74 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccc------cCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence 5889999999999999999999999999999984322 1123456788999999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
++||||+++++|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 75 YIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred EEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999986543221
Q ss_pred hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHH
Q 005944 225 INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dL 304 (668)
......++..|+|||.+.+..++.++|||+||+++|+|++|..||...... ....... ......++..++.++.++
T Consensus 155 --~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-~~~~~~~-~~~~~~~~~~~~~~~~~~ 230 (254)
T cd06627 155 --DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-AALFRIV-QDDHPPLPEGISPELKDF 230 (254)
T ss_pred --cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHh-ccCCCCCCCCCCHHHHHH
Confidence 123456899999999998888899999999999999999999999654321 1122221 233455677889999999
Q ss_pred HHHhhhhCCCCCCCHHHHHcCccc
Q 005944 305 LLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 305 I~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
|.+||..+|++||++.+++.||||
T Consensus 231 i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 231 LMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHhCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=342.26 Aligned_cols=252 Identities=28% Similarity=0.468 Sum_probs=206.2
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
...+|.+.+.||+|+||+||++... .++..+|+|.+.. ........+.+|+.+|++++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--------ASDNARKDFHREAELLTNLQHEHIVKFYG 74 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCC--------cCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4567999999999999999999853 3456799998732 12233456888999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKFG-------------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD 203 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~-------------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld 203 (668)
++.....+++||||+++++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~ 154 (288)
T cd05093 75 VCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG 154 (288)
T ss_pred EEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEc
Confidence 9999999999999999999999986443 489999999999999999999999999999999999999
Q ss_pred CCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHH
Q 005944 204 NKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAAL 281 (668)
Q Consensus 204 ~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~ 281 (668)
.++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|+|++ |.+||..... .....
T Consensus 155 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~ 234 (288)
T cd05093 155 ENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC 234 (288)
T ss_pred cCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999876533222122223446788999999998889999999999999999998 9999965432 22222
Q ss_pred HhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 282 FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 282 ~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
... ......+..++.++.+|+.+||+.+|.+|||+.+++.
T Consensus 235 i~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 235 ITQ---GRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHc---CCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 221 2223345678899999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=368.35 Aligned_cols=257 Identities=37% Similarity=0.615 Sum_probs=220.1
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.+...|.-++-||.|+||.||.|++..+...||||++..... ...+....+..||++|+++.|||+|.+-|+|..
T Consensus 23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGK-----Qs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr 97 (948)
T KOG0577|consen 23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR 97 (948)
T ss_pred CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeecccccc-----ccHHHHHHHHHHHHHHHhccCCCcccccceeec
Confidence 444568888899999999999999999999999999854322 233445668889999999999999999999999
Q ss_pred CCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
+...+||||||-| +-.+++.- ..++.+.++..|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.|...
T Consensus 98 e~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~ 176 (948)
T KOG0577|consen 98 EHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM 176 (948)
T ss_pred cchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc
Confidence 9999999999964 66666643 357999999999999999999999999999999999999999999999999999765
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcc
Q 005944 220 VELATINGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ 296 (668)
. +..+++|||+|||||+|. .+.|+-++|||||||+..||.-.++|+... ..+..++++.......--...
T Consensus 177 ~------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM-NAMSALYHIAQNesPtLqs~e 249 (948)
T KOG0577|consen 177 A------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESPTLQSNE 249 (948)
T ss_pred C------chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc-hHHHHHHHHHhcCCCCCCCch
Confidence 3 355789999999999996 466999999999999999999999997543 444556666655544444556
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.+..++.|+..||++-|.+|||.+++|.|+|+..
T Consensus 250 WS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R 283 (948)
T KOG0577|consen 250 WSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR 283 (948)
T ss_pred hHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence 7889999999999999999999999999999874
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=341.59 Aligned_cols=255 Identities=29% Similarity=0.509 Sum_probs=202.1
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||.|+||.||+|.+..+++.||||.+...... .....+.+|+.+++.++|+||+++++++.....
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 77 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-------GAPFTAIREASLLKDLKHANIVTLHDIIHTKKT 77 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-------CCchhHHHHHHHHhhCCCcceeeEEEEEecCCe
Confidence 5799999999999999999999999999999998432211 111235679999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 156 (291)
T cd07844 78 LTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156 (291)
T ss_pred EEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence 9999999975 898887654 46899999999999999999999999999999999999999999999999998643211
Q ss_pred hhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhH---HHHHHHHhhccC---C-------
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQF---QEVAALFHIGTT---K------- 288 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~---~~~~~~~~~~~~---~------- 288 (668)
........++..|+|||++.+ ..++.++|||||||++|+|++|..||.... .....+...... .
T Consensus 157 --~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 157 --SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred --CccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhh
Confidence 111223356889999999876 457899999999999999999999996432 111111110000 0
Q ss_pred ----------CC--C---CCCcccC--HHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 289 ----------SH--P---PIPEHLS--MEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 289 ----------~~--~---~~p~~ls--~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.. . .....++ .++.++|.+||+.+|.+||++.+++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0 0001233 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=356.34 Aligned_cols=257 Identities=27% Similarity=0.442 Sum_probs=206.1
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcC-----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIV 132 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV 132 (668)
+..+..+|++.++||.|+||.||+|.+.. +++.||+|++.... .......+..|+.++..+ +|+||+
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~E~~~~~~l~~h~niv 74 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-------TASEYKALMTELKILIHIGHHLNVV 74 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-------CHHHHHHHHHHHHHHHhhccCcchh
Confidence 45667799999999999999999997543 45789999874211 122335567899999999 899999
Q ss_pred eecccccc-CCcceEEeeccCCCChhcccccC------------------------------------------------
Q 005944 133 RYLGTARE-DDSLNILLEFVPGGSISSLLGKF------------------------------------------------ 163 (668)
Q Consensus 133 ~l~g~~~~-~~~~~LVmEy~~gGsL~~~L~~~------------------------------------------------ 163 (668)
++++++.. +..+++||||+++++|.+++...
T Consensus 75 ~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (337)
T cd05054 75 NLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLS 154 (337)
T ss_pred heeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchh
Confidence 99998754 46788999999999999887432
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCcc
Q 005944 164 -------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS 230 (668)
Q Consensus 164 -------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~ 230 (668)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+...........
T Consensus 155 ~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~ 234 (337)
T cd05054 155 DVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234 (337)
T ss_pred hcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccC
Confidence 2578899999999999999999999999999999999999999999999999986543222222234
Q ss_pred CCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH--HHHHHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 231 MKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF--QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 231 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~--~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
..++..|+|||++.+..++.++|||||||+||+|++ |..||.... ........ .......+...+.++.+++.+
T Consensus 235 ~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLK---EGTRMRAPEYATPEIYSIMLD 311 (337)
T ss_pred CCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHh---ccCCCCCCccCCHHHHHHHHH
Confidence 456788999999999999999999999999999998 999996432 11112221 112233456778899999999
Q ss_pred hhhhCCCCCCCHHHHHcC
Q 005944 308 CLQKEPYLRSTASELLQH 325 (668)
Q Consensus 308 cL~~dP~~RPSa~EIL~H 325 (668)
||+.+|++||++.++++|
T Consensus 312 cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 312 CWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HccCChhhCcCHHHHHHH
Confidence 999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=335.75 Aligned_cols=252 Identities=26% Similarity=0.407 Sum_probs=209.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
+....|.+.+.||.|+||.||+|.+..++..||+|++... ......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 73 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---------TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---------chHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence 4556799999999999999999999999999999987321 1123457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
+..+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 74 EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999999999999999998653 3589999999999999999999999999999999999999999999999999876
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ 296 (668)
...... .......+++.|+|||++.+..++.++|||||||++|+|++ |..||..... +...... .......+..
T Consensus 154 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~ 229 (263)
T cd05052 154 MTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KGYRMERPEG 229 (263)
T ss_pred ccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---CCCCCCCCCC
Confidence 543211 11112334678999999998889999999999999999998 9999965332 2222222 2223455677
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
++.++.+||.+||+.+|.+||++.++++.
T Consensus 230 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 230 CPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 89999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=341.30 Aligned_cols=257 Identities=31% Similarity=0.515 Sum_probs=201.7
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCC
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDD 142 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~ 142 (668)
.+|++.+.||.|+||.||+|.+..+++.||||++..... .......+.+|+.+++.+. |+||+++++++....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~ 74 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD------EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE 74 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc------ccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence 369999999999999999999999999999998743211 1112245678999999995 699999999887766
Q ss_pred c-----ceEEeeccCCCChhcccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-CCceEEe
Q 005944 143 S-----LNILLEFVPGGSISSLLGKF-----GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN-KGCIKLA 211 (668)
Q Consensus 143 ~-----~~LVmEy~~gGsL~~~L~~~-----~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~-~g~vKL~ 211 (668)
. .|+||||+++ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~ 153 (295)
T cd07837 75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIA 153 (295)
T ss_pred CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEe
Confidence 5 8999999986 787776432 35899999999999999999999999999999999999998 8899999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhcc--
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGT-- 286 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~-- 286 (668)
|||++..+... ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.... .....+.....
T Consensus 154 dfg~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 231 (295)
T cd07837 154 DLGLGRAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTP 231 (295)
T ss_pred ecccceecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99998754221 112223457889999999875 457899999999999999999999996432 11111111100
Q ss_pred -CCC------------CC--------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 287 -TKS------------HP--------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 287 -~~~------------~~--------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
... .+ .....++.++.+||.+||..+|.+||++.+++.||||+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 232 TEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred ChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 00 01134788999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=378.68 Aligned_cols=255 Identities=24% Similarity=0.395 Sum_probs=208.2
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeecc-c
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLG-T 137 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g-~ 137 (668)
.+...+++|.++|.+|||+.||+|.+...|..||+|++.+. ++..++.+.+||.+|+.|+ |+|||.|++ .
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--------de~~L~~v~~EI~~MK~L~gh~nIV~yidss 104 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--------DEEALNAVKREIDIMKLLSGHKNIVSYIDSS 104 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--------CHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence 46778899999999999999999999988899999998532 4566788999999999997 999999999 3
Q ss_pred cccC------CcceEEeeccCCCChhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCcccEEeCCCCc
Q 005944 138 ARED------DSLNILLEFVPGGSISSLLGK--FGSFPESVIRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVDNKGC 207 (668)
Q Consensus 138 ~~~~------~~~~LVmEy~~gGsL~~~L~~--~~~l~e~~~~~i~~QIl~aL~yLHs~g--IvHrDLKPeNILld~~g~ 207 (668)
.... -.++|+||||.||.|-+++.. ...|+|.++++|++|+++||.+||... |||||||-|||||..+|.
T Consensus 105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~ 184 (738)
T KOG1989|consen 105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN 184 (738)
T ss_pred cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC
Confidence 3221 247799999999999999974 356999999999999999999999997 999999999999999999
Q ss_pred eEEecCCchhhhHhhhh-------hcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH
Q 005944 208 IKLADFGASKKVVELAT-------INGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE 277 (668)
Q Consensus 208 vKL~DFGlA~~~~~~~~-------~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~ 277 (668)
.||||||.|+....... ........-|+.|+|||+|. +...++|+|||+|||+||-|+....||.....
T Consensus 185 ~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~- 263 (738)
T KOG1989|consen 185 YKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK- 263 (738)
T ss_pred EEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-
Confidence 99999999864321110 00011233699999999984 56689999999999999999999999975421
Q ss_pred HHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcc
Q 005944 278 VAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327 (668)
Q Consensus 278 ~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpw 327 (668)
+.+....+..+....++..+++||+.||+.||.+||++.+++.+-+
T Consensus 264 ----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~ 309 (738)
T KOG1989|consen 264 ----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF 309 (738)
T ss_pred ----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence 1222233333333578999999999999999999999999987543
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=352.78 Aligned_cols=261 Identities=26% Similarity=0.396 Sum_probs=206.8
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF------QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQ 87 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc------cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccC
Confidence 4678999999999999999999999999999999873211 1122334567899999999999999999987644
Q ss_pred ------CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 142 ------DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 142 ------~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
...|+||||+.+ +|.+.+... +++..+..++.||+.||+|||.+||+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 88 KSLEEFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CCccccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCcc
Confidence 347999999964 787777543 89999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhh---------
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHI--------- 284 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~--------- 284 (668)
++..... .......+++.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+...
T Consensus 165 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (353)
T cd07850 165 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFM 241 (353)
T ss_pred ceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9764321 112345689999999999999999999999999999999999999963211 11111000
Q ss_pred -------------ccCCCCC----------------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCC
Q 005944 285 -------------GTTKSHP----------------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334 (668)
Q Consensus 285 -------------~~~~~~~----------------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~ 334 (668)
....... ..+...+.++++||.+||+.||.+|||+.|+|.||||..++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 0000000 0012346678999999999999999999999999999866553
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=335.55 Aligned_cols=252 Identities=26% Similarity=0.424 Sum_probs=202.6
Q ss_pred eeeeeEEcccCceEEEEEEEcCC---CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDS---GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
|.++++||+|+||.||+|....+ +..||||++.... ........+.+|+.+|+.++|+||+++++++....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 74 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI------HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEAS 74 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc------CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCC
Confidence 57889999999999999987653 4789999884321 12233456889999999999999999999876554
Q ss_pred c------ceEEeeccCCCChhcccccC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEE
Q 005944 143 S------LNILLEFVPGGSISSLLGKF------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 143 ~------~~LVmEy~~gGsL~~~L~~~------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL 210 (668)
. .++||||+++|+|..++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl 154 (273)
T cd05035 75 SLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCV 154 (273)
T ss_pred ccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEE
Confidence 4 79999999999999887332 36899999999999999999999999999999999999999999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCC
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKS 289 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~ 289 (668)
+|||+++.+.............++..|+|||++.+..++.++|||||||++|||++ |..||........ ........
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~--~~~~~~~~ 232 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI--YDYLRHGN 232 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH--HHHHHcCC
Confidence 99999986543322222222345678999999988889999999999999999999 8999965432211 11111223
Q ss_pred CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 290 ~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
....+..++.++.++|.+||+.||.+||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 344567789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=344.93 Aligned_cols=263 Identities=32% Similarity=0.480 Sum_probs=206.1
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||.|+||.||+|.+..+|..||+|++...... ......+.+|+.++++++|+||+++++++...
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER------DGIPISSLREITLLLNLRHPNIVELKEVVVGK 78 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC------CCCcchhhHHHHHHHhCCCCCCcceEEEEecC
Confidence 456899999999999999999999999999999988533211 11112345799999999999999999988654
Q ss_pred --CcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 142 --DSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 142 --~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
+.+++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 79 HLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred CCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 568999999975 78777765 36789999999999999999999999999999999999999999999999999876
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccC---CC---
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTT---KS--- 289 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~---~~--- 289 (668)
+.... .......+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...... ...+...... ..
T Consensus 158 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (309)
T cd07845 158 YGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPG 235 (309)
T ss_pred cCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchh
Confidence 53221 11223346888999999876 45789999999999999999999999643221 1111111000 00
Q ss_pred --------C---C--C------CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 290 --------H---P--P------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 290 --------~---~--~------~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
. . . .....++++.+||.+||+.||.+|||+.+++.||||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 236 FSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred hhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 0 0 0 01235888999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=344.34 Aligned_cols=258 Identities=25% Similarity=0.433 Sum_probs=209.0
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcC-------CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCC
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THP 129 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~Hp 129 (668)
..++...+|.+++.||+|+||.||+|.+.. +...||+|.+... ........+.+|+.+++.+ +|+
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~e~~~l~~l~~h~ 84 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-------ATEKDLSDLISEMEMMKMIGKHK 84 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-------CChHHHHHHHHHHHHHHHhcCCC
Confidence 345667899999999999999999998643 2357999987421 1122345677899999999 799
Q ss_pred CeeeeccccccCCcceEEeeccCCCChhcccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 005944 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF----------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHR 193 (668)
Q Consensus 130 NIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHr 193 (668)
||+++++++...+..|+||||+++|+|.+++... ..++..+++.++.||+.||+|||++||+||
T Consensus 85 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred CEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 9999999999999999999999999999998653 247889999999999999999999999999
Q ss_pred cCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCc
Q 005944 194 DIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWS 272 (668)
Q Consensus 194 DLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~ 272 (668)
||||+|||++.++.+||+|||++..+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred cccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999876543222111222335578999999998889999999999999999998 889986
Q ss_pred hhHH-HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 273 QQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 273 ~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.... +...... .......+..++.++.+||.+||..+|.+||++.+++++
T Consensus 245 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 245 GVPVEELFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cCCHHHHHHHHH---cCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 5432 2222222 222334566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=335.03 Aligned_cols=253 Identities=25% Similarity=0.411 Sum_probs=207.6
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCC---CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDS---GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
..+|++.+.||+|+||+||+|.+..+ ...||||++.... .......+.+|+.+++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-------SDKQRLDFLTEASIMGQFDHPNIIRLEGVVT 75 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-------ChHHHHHHHHHHHHHHhCCCCCcceEeEEEe
Confidence 46799999999999999999998654 4689999874221 1223445778999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.....++||||+++++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 76 ~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 76 KSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred cCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 999999999999999999998664 5789999999999999999999999999999999999999999999999999987
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCCCcc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ 296 (668)
+.............+++.|+|||.+.+..++.++|||||||++|+|++ |..||...... ...... .....+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~ 232 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE---DGYRLPPPMD 232 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH---cCCCCCCCCC
Confidence 642111111222345678999999998889999999999999999998 99999654322 222221 1223344567
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
++..+.+|+.+||+.+|.+||++.+++++
T Consensus 233 ~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 233 CPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 88999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=340.98 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=207.2
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCC-----CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
..+|++.+.||.|+||.||+|.+..+ +..||||++.... .......+.+|+.++..++||||++++++
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~~~~l~h~~iv~~~~~ 76 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-------EGPLREEFKHEAMMRSRLQHPNIVCLLGV 76 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-------CHHHHHHHHHHHHHHhcCCCCCcCeEEEE
Confidence 34688899999999999999987543 5789999884211 12234567889999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhccccc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEE
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGK----------------FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANIL 201 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~----------------~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNIL 201 (668)
+......++++||+.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||.|||
T Consensus 77 ~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil 156 (283)
T cd05091 77 VTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVL 156 (283)
T ss_pred EcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheE
Confidence 9999999999999999999988742 134788899999999999999999999999999999999
Q ss_pred eCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HH
Q 005944 202 VDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VA 279 (668)
Q Consensus 202 ld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~ 279 (668)
++.++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|||++ |..||...... ..
T Consensus 157 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 236 (283)
T cd05091 157 VFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI 236 (283)
T ss_pred ecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999876543322222334456789999999988889999999999999999998 88898654332 22
Q ss_pred HHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 280 ALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 280 ~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.... .....+.+..++.++.+|+.+||+.+|.+||++.+|+..
T Consensus 237 ~~i~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 237 EMIR---NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHH---cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 2221 222345667889999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=337.62 Aligned_cols=256 Identities=36% Similarity=0.660 Sum_probs=214.4
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
-|++.+.||.|+||.||+|.+..++..||||++... ........+.+|+.++..++|+||+++++.+..+...
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 77 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE-------EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 77 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccc-------cchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE
Confidence 377888999999999999999889999999987321 1123345688999999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
|+||||+++++|..++.. ..+++..+..++.||+.+|.|||+.||+|+||||.||+++.++.++|+|||++..+.....
T Consensus 78 ~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 78 WIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred EEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 999999999999998865 5789999999999999999999999999999999999999999999999999875532211
Q ss_pred hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHH
Q 005944 225 INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dL 304 (668)
......|+..|+|||.+.+..++.++|||||||++|+|++|..||.......... .+ .....+.++..++.++.++
T Consensus 157 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~ 232 (277)
T cd06641 157 --KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF-LI-PKNNPPTLEGNYSKPLKEF 232 (277)
T ss_pred --hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH-HH-hcCCCCCCCcccCHHHHHH
Confidence 1233568999999999988888999999999999999999999997543221111 11 1222334556788999999
Q ss_pred HHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 305 LLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 305 I~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
|.+||+.+|.+||++.++++||||....
T Consensus 233 i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 233 VEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred HHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 9999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=368.92 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=228.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
......|.+...||+|.|+.|.+|++..++..||||++.... ........+.+|+++|..|+|||||+++.+..
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~------ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~ 125 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQ------LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE 125 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcc------cChHHHHHHHHHHHHHHhcCCcceeeeeeeee
Confidence 455678999999999999999999999999999999985432 22233445789999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
....+|+||||+.+|.+++++.+++.+.+..++.++.|++.|++|||+++|||||||++||||+.+.++||+|||++..+
T Consensus 126 t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 126 TEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred ecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999877
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCccc
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~l 297 (668)
.. .....++||++.|.|||++.+..| ++.+|+||+|++||.|+.|..||.+..-. ..... ......++..+
T Consensus 206 ~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv----l~gk~rIp~~m 278 (596)
T KOG0586|consen 206 DY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV----LRGKYRIPFYM 278 (596)
T ss_pred cc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh----eeeeeccccee
Confidence 53 344668999999999999999887 78999999999999999999999865322 21111 22234567778
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~ 334 (668)
+.++.+||+++|..+|.+|++.++|+.|.|....+..
T Consensus 279 s~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 279 SCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred echhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 9999999999999999999999999999998755443
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=341.15 Aligned_cols=259 Identities=29% Similarity=0.447 Sum_probs=199.9
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
-.+|++.+.||+|+||.||+|.+..++..||||++...... ......+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 84 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK------EGFPITALREIKILQLLKHENVVNLIEICRTKA 84 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc------CCchhHHHHHHHHHHhCCCCCccceEEEEeccc
Confidence 45799999999999999999999999999999988432111 111233567999999999999999999876543
Q ss_pred --------cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecC
Q 005944 143 --------SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADF 213 (668)
Q Consensus 143 --------~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DF 213 (668)
..++||||+.+ +|.+++... ..+++.+++.++.||+.||.|||++||+|+||||+|||++.++.+||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 85 TPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcC
Confidence 35999999965 777776544 47899999999999999999999999999999999999999999999999
Q ss_pred CchhhhHhhhhh--cCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccCC
Q 005944 214 GASKKVVELATI--NGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTTK 288 (668)
Q Consensus 214 GlA~~~~~~~~~--~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~~ 288 (668)
|++..+...... .......++..|+|||++.+.. ++.++||||||+++|+|++|.+||...... ...+.......
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 998765322111 1122346788999999987654 688999999999999999999999643221 11111110000
Q ss_pred CC--------------CCC-------------CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 289 SH--------------PPI-------------PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 289 ~~--------------~~~-------------p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.. ... +...+..+.+||.+||..||.+|||++++|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00 000 11235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=331.14 Aligned_cols=254 Identities=35% Similarity=0.591 Sum_probs=209.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||.||+|.+..+|..||+|.+..... ........+.+|+.++++++|+||+++++++...+.
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-----~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~ 76 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEM-----MDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNE 76 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccc-----cchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence 579999999999999999999999999999998853221 112234567889999999999999999999999999
Q ss_pred ceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 144 LNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.++||||+++|+|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~ 156 (267)
T cd08224 77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeec
Confidence 9999999999999988853 345899999999999999999999999999999999999999999999999998754
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCc-ccC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE-HLS 298 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~-~ls 298 (668)
.... .......|++.|+|||.+.+..++.++|||||||++|+|++|..||....................+.+. .++
T Consensus 157 ~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08224 157 SSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYS 234 (267)
T ss_pred cCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcC
Confidence 3211 1123456899999999999888999999999999999999999999644322222222111222333444 678
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.++.++|.+||..+|.+||++.+|++
T Consensus 235 ~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 235 EELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 89999999999999999999999885
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=343.96 Aligned_cols=258 Identities=27% Similarity=0.462 Sum_probs=202.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcC--CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC-
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLD--SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED- 141 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~--tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~- 141 (668)
+|++.+.||+|+||.||+|.+.. ++..||||++..... ........+.+|+.++..++||||+++++++...
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 75 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-----QYTGISQSACREIALLRELKHENVVSLVEVFLEHA 75 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccc-----cccCccHHHHHHHHHHHhcCCCCccceEEEEeCCC
Confidence 58899999999999999999988 899999999853211 1112234467799999999999999999999888
Q ss_pred -CcceEEeeccCCCChhcccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC----CCceEEe
Q 005944 142 -DSLNILLEFVPGGSISSLLGKF-----GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN----KGCIKLA 211 (668)
Q Consensus 142 -~~~~LVmEy~~gGsL~~~L~~~-----~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~----~g~vKL~ 211 (668)
..+++||||+++ +|.+++... ..+++..++.++.||+.||.|||+.+|+||||||+|||++. ++.+||+
T Consensus 76 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~ 154 (316)
T cd07842 76 DKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIG 154 (316)
T ss_pred CceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEEC
Confidence 789999999975 566555321 36899999999999999999999999999999999999999 8999999
Q ss_pred cCCchhhhHhhhh-hcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHHH-----------
Q 005944 212 DFGASKKVVELAT-INGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQEV----------- 278 (668)
Q Consensus 212 DFGlA~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~----------- 278 (668)
|||++..+..... ........+++.|+|||++.+. .++.++|||||||++|+|++|++||.......
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (316)
T cd07842 155 DLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234 (316)
T ss_pred CCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHH
Confidence 9999886533221 1122345789999999998764 47899999999999999999999996332111
Q ss_pred HHHHhhcc---------------------CCCCCCCC-----------cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCc
Q 005944 279 AALFHIGT---------------------TKSHPPIP-----------EHLSMEAKDFLLKCLQKEPYLRSTASELLQHP 326 (668)
Q Consensus 279 ~~~~~~~~---------------------~~~~~~~p-----------~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hp 326 (668)
..+..... .......+ ...+.++.++|.+||+.||.+|||+.+++.||
T Consensus 235 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~ 314 (316)
T cd07842 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHP 314 (316)
T ss_pred HHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCC
Confidence 11100000 00001111 15677899999999999999999999999999
Q ss_pred cc
Q 005944 327 FV 328 (668)
Q Consensus 327 wf 328 (668)
||
T Consensus 315 ~f 316 (316)
T cd07842 315 YF 316 (316)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=339.14 Aligned_cols=256 Identities=27% Similarity=0.390 Sum_probs=206.8
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCC----------------cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHh
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSG----------------ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg----------------~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 125 (668)
...+|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+++|+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~e~~~l~~ 75 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-------SDNAREDFLKEVKILSR 75 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHh
Confidence 3568999999999999999999876543 568999874221 12345668899999999
Q ss_pred CCCCCeeeeccccccCCcceEEeeccCCCChhcccccCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 005944 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-----------SFPESVIRMYTKQLLLGLEYLHKNGIMHRD 194 (668)
Q Consensus 126 L~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~-----------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrD 194 (668)
++||||+++++++..+...++||||+++++|..++.... .+++..++.++.||+.||.|||++||+|||
T Consensus 76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~d 155 (296)
T cd05051 76 LSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRD 155 (296)
T ss_pred cCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccc
Confidence 999999999999999999999999999999999987655 689999999999999999999999999999
Q ss_pred CCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh--CCCCCc
Q 005944 195 IKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT--GKPPWS 272 (668)
Q Consensus 195 LKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT--G~~PF~ 272 (668)
|||+|||++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 235 (296)
T cd05051 156 LATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYE 235 (296)
T ss_pred cchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999875533222222234556789999999998889999999999999999998 778886
Q ss_pred hhHH-HHHHHHh-h---ccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 273 QQFQ-EVAALFH-I---GTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 273 ~~~~-~~~~~~~-~---~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.... ....... . .......+.+..++.++.+||.+||+.+|.+|||+.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 236 HLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 4321 1111111 1 1112222334567889999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=334.00 Aligned_cols=254 Identities=32% Similarity=0.535 Sum_probs=208.5
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||.|+||.||+|.+..++..||||.+.... .........+.+|+.+++.+.|+||+++++++...+.
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~ 76 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFD-----LMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNE 76 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehh-----hhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCe
Confidence 46889999999999999999999999999999874321 1122334567889999999999999999999999999
Q ss_pred ceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 144 LNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++..+
T Consensus 77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd08229 77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF 156 (267)
T ss_pred EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhcc
Confidence 9999999999999998753 356899999999999999999999999999999999999999999999999998765
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCC-CCCcccC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP-PIPEHLS 298 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~-~~p~~ls 298 (668)
.... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||...................+ ..+..++
T Consensus 157 ~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (267)
T cd08229 157 SSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 234 (267)
T ss_pred ccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCccccc
Confidence 3221 122345789999999999888899999999999999999999999964432222222211111122 2234678
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.++++||.+||+.+|.+|||+.+|++
T Consensus 235 ~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 235 EELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 89999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=400.31 Aligned_cols=262 Identities=49% Similarity=0.844 Sum_probs=231.8
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....||..+..||.|.||.||-|.+..+|...|+|-+++.... ......+.+|..+|..|+|||+|++||+-.+
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~------~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvH 1305 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD------HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVH 1305 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc------cccCcchHHHHHHHHhccCccccccCceeec
Confidence 3456888999999999999999999999999999999766543 3345567889999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.+.++|.||||.+|+|.+++...+..+|...+.+..|++.|+.|||++|||||||||+|||++.+|.+|++|||.|..+.
T Consensus 1306 Rekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1306 REKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEec
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999998775
Q ss_pred hhhhh--cCCccCCCCCCCCChHHHhhc---CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCc
Q 005944 221 ELATI--NGAKSMKGTPYWMAPEVILQT---GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 221 ~~~~~--~~~~~~~GT~~Y~APEvl~~~---~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~ 295 (668)
..... .......||+-|||||+|.+. ++.-++|||||||++.||+||+.||.....+...+++++ ....+++|.
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~-~gh~Pq~P~ 1464 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVA-AGHKPQIPE 1464 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHh-ccCCCCCch
Confidence 43211 123357899999999999764 467899999999999999999999988777777777765 455678899
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
.++.+.++||.+||..||.+|+++.|||+|-|-+
T Consensus 1465 ~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1465 RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence 9999999999999999999999999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=347.84 Aligned_cols=262 Identities=26% Similarity=0.434 Sum_probs=205.2
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC-
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED- 141 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~- 141 (668)
..+|++.+.||+|+||.||+|++..+|..||||++... ........+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 76 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF-------EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPS 76 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc-------ccchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence 46899999999999999999999999999999987321 1112344567899999999999999999876543
Q ss_pred ----CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 142 ----DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 142 ----~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
...|+|+||+.+ +|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.
T Consensus 77 ~~~~~~~~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 77 FESFNDVYIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred ccccceEEEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence 357999999964 78777754 579999999999999999999999999999999999999999999999999987
Q ss_pred hhHhhhhhc-CCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhcc-------
Q 005944 218 KVVELATIN-GAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGT------- 286 (668)
Q Consensus 218 ~~~~~~~~~-~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~------- 286 (668)
......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ....+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 234 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDL 234 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 653221111 1234578999999998765 4588999999999999999999999954211 0000000000
Q ss_pred --------------CCCCCC-----CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 287 --------------TKSHPP-----IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 287 --------------~~~~~~-----~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
...... ....++.++.+||.+||+.+|.+|||+.++++||||.....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 000000 11245788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=337.22 Aligned_cols=259 Identities=37% Similarity=0.619 Sum_probs=216.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.....|++.+.||+|+||.||+|.+..++..||+|++..... ....+.+|+.+++.++|+||+++++.+..
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 86 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---------NKELIINEILIMKDCKHPNIVDYYDSYLV 86 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---------hHHHHHHHHHHHHHCCCCCeeEEEEEEEE
Confidence 566779999999999999999999998899999999843211 34557789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
....|+|+||+++++|.+++.... .+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.++|+|||++...
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 87 GDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 999999999999999999998876 8999999999999999999999999999999999999999999999999988654
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
..... ......+++.|+|||++.+..++.++|||||||++|+|++|..||......................+..++.
T Consensus 167 ~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (286)
T cd06614 167 TKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSP 244 (286)
T ss_pred ccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCH
Confidence 32211 1234568899999999988889999999999999999999999997543221111111111111122334788
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
++.+||.+||+.+|.+||++.++++|+||..
T Consensus 245 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 245 EFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred HHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 9999999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=337.68 Aligned_cols=256 Identities=29% Similarity=0.441 Sum_probs=204.5
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCC
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDD 142 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~ 142 (668)
.+|...+.||+|+||.||++.+..++..||||++..... ......+.+|+.++.++. |+||+++++++..+.
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~ 76 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD-------EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREG 76 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC-------hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCC
Confidence 356677899999999999999999999999998843211 123456788999999996 999999999999889
Q ss_pred cceEEeeccCCCChhccc-----ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEecCCch
Q 005944 143 SLNILLEFVPGGSISSLL-----GKFGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L-----~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
..+++|||+.. +|.++. .....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 155 (288)
T cd06616 77 DCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155 (288)
T ss_pred cEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchh
Confidence 99999999864 544432 2236799999999999999999999975 9999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhc---CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccC---CCC
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQT---GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT---KSH 290 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~---~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~---~~~ 290 (668)
..+... .......|++.|+|||++.+. .++.++|||||||++|+|++|+.||................ ...
T Consensus 156 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd06616 156 GQLVDS---IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILS 232 (288)
T ss_pred HHhccC---CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCC
Confidence 765321 122334689999999999876 68999999999999999999999996543221222221111 111
Q ss_pred CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 291 ~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
...+..++.++.+||.+||+.+|.+|||+++|+.||||..
T Consensus 233 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 233 NSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 1223457899999999999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=348.49 Aligned_cols=261 Identities=25% Similarity=0.421 Sum_probs=208.4
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|.+.+.||.|+||+||+|.+..++..||||.+..... .......+.+|+.+++.++|+||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~ 76 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD------NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP 76 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc------ccchhHHHHHHHHHHHhcCCCCccchHHheecc
Confidence 34689999999999999999999999999999998743211 111233456799999999999999999987644
Q ss_pred -----CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 142 -----DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 142 -----~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
...|+||||+. ++|.+++...+.+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 77 HREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred cccccCcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 34799999996 689999888888999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhh---------
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHI--------- 284 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~--------- 284 (668)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||..... ....+...
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 7653221 22234568999999999875 4588999999999999999999999964311 00000000
Q ss_pred --------------ccCCC---CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 285 --------------GTTKS---HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 285 --------------~~~~~---~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
..... .......++.++.+||.+||+.+|.+|||+.++++||||...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000 011223578899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=359.58 Aligned_cols=258 Identities=26% Similarity=0.401 Sum_probs=207.5
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCC-----CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIV 132 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV 132 (668)
......+|+++++||+|+||.||+|++... +..||||++.... .......+.+|+.+|..+. |||||
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~Ei~~l~~l~~HpnIv 104 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-------RSSEKQALMSELKIMTHLGPHLNIV 104 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhcCCCCCee
Confidence 346677899999999999999999987433 4579999884221 1122356788999999996 99999
Q ss_pred eeccccccCCcceEEeeccCCCChhcccccC-------------------------------------------------
Q 005944 133 RYLGTAREDDSLNILLEFVPGGSISSLLGKF------------------------------------------------- 163 (668)
Q Consensus 133 ~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~------------------------------------------------- 163 (668)
++++++.....+|||||||++|+|.++|...
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 184 (400)
T cd05105 105 NLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQAD 184 (400)
T ss_pred eEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccc
Confidence 9999999999999999999999998887432
Q ss_pred -----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC
Q 005944 164 -----------------------------------------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIK 196 (668)
Q Consensus 164 -----------------------------------------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLK 196 (668)
..+++..+..++.||+.||+|||+.+|+|||||
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dik 264 (400)
T cd05105 185 TTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264 (400)
T ss_pred ccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCC
Confidence 237788889999999999999999999999999
Q ss_pred cccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH
Q 005944 197 GANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF 275 (668)
Q Consensus 197 PeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~ 275 (668)
|+|||++.++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 265 p~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred hHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 9999999999999999999876533222222333457788999999998889999999999999999997 999997543
Q ss_pred HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 276 QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
...... ...........+..++.++.+||.+||+.+|++||++.++.+
T Consensus 345 ~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 345 VDSTFY-NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred hhHHHH-HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 211111 111122233456678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=331.89 Aligned_cols=251 Identities=25% Similarity=0.426 Sum_probs=206.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.+...+|++.+.||+|+||.||+|.+. ++..||+|.+... ......+.+|+.+++.++|+||+++++.+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~---------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPG---------TMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCC---------chhHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 456778999999999999999999864 5678999987321 112356788999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.....++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~ 151 (261)
T cd05072 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLAR 151 (261)
T ss_pred CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccce
Confidence 999999999999999999998653 568899999999999999999999999999999999999999999999999997
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCCCc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~p~ 295 (668)
....... .......++..|+|||++.+..++.++|||||||++|+|+| |..||...... ....+.. ....+...
T Consensus 152 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~ 227 (261)
T cd05072 152 VIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQR---GYRMPRME 227 (261)
T ss_pred ecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHc---CCCCCCCC
Confidence 6533211 11223346778999999988889999999999999999998 99999654322 2221111 12233445
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.++.++.+||.+||..+|++||+++++++
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 68899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=350.30 Aligned_cols=263 Identities=27% Similarity=0.452 Sum_probs=209.1
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc--
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE-- 140 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~-- 140 (668)
..+|++.+.||.|+||.||+|.+..+|..||+|++..... .......+.+|+.+|+.++|+||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 77 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD------VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG 77 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc------cccchHHHHHHHHHHHhcCCCCccCHHHhccccC
Confidence 3689999999999999999999999999999998843211 11234456789999999999999999998753
Q ss_pred --CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 --DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 --~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
...+|+||||+. ++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 78 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 78 ADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred CCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 346899999995 58999998778899999999999999999999999999999999999999999999999999876
Q ss_pred hHhhhhh--cCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhh---------
Q 005944 219 VVELATI--NGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHI--------- 284 (668)
Q Consensus 219 ~~~~~~~--~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~--------- 284 (668)
....... .......|+..|+|||++.+ ..++.++|||||||++|+|++|++||..... ....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5322111 11224578999999999866 4588999999999999999999999964321 10000000
Q ss_pred ------------ccCCCCCC-----CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 285 ------------GTTKSHPP-----IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 285 ------------~~~~~~~~-----~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
........ +...++.++.++|.+||+.+|.+||++.+++.||||....
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 00000111 1234688999999999999999999999999999998544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.73 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=199.4
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCc--EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC--
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGE--LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED-- 141 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~--~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~-- 141 (668)
|.++++||+|+||.||+|.+..++. .||+|.+.... ........+..|+.+|+.++|+||+++++++...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI------CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVE 74 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCc
Confidence 3567899999999999999877765 69999874321 1223456778899999999999999999876322
Q ss_pred ----CcceEEeeccCCCChhcccc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 142 ----DSLNILLEFVPGGSISSLLG------KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 142 ----~~~~LVmEy~~gGsL~~~L~------~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
...++||||+.+|+|..++. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 75 ~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 154 (272)
T cd05075 75 SEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVA 154 (272)
T ss_pred ccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEEC
Confidence 24689999999999988763 22348899999999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCC
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKS 289 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~ 289 (668)
|||+++.+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ........ ..
T Consensus 155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---~~ 231 (272)
T cd05075 155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ---GN 231 (272)
T ss_pred CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc---CC
Confidence 9999986543222112223456778999999998889999999999999999999 8999965332 22222221 12
Q ss_pred CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 290 ~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
....+..++..+.++|.+||+.+|.+|||+.+|+++
T Consensus 232 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 232 RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 223455788899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=339.49 Aligned_cols=252 Identities=29% Similarity=0.456 Sum_probs=205.6
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcC-----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
...+|.+.+.||+|+||.||+|.+.. ++..+++|.+.. ........+.+|+.+++.++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD--------PTLAARKDFQREAELLTNLQHEHIVKFYG 74 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCC--------ccHHHHHHHHHHHHHHhcCCCCCcceEEE
Confidence 34578999999999999999998543 456789998731 11223356788999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccE
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKF----------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANI 200 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNI 200 (668)
++......++||||+++++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 154 (291)
T cd05094 75 VCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNC 154 (291)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceE
Confidence 999999999999999999999998653 2388999999999999999999999999999999999
Q ss_pred EeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HH
Q 005944 201 LVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EV 278 (668)
Q Consensus 201 Lld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~ 278 (668)
|++.++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|+| |..||..... ..
T Consensus 155 l~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 234 (291)
T cd05094 155 LVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV 234 (291)
T ss_pred EEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999875433221122233456889999999999889999999999999999999 9999865332 22
Q ss_pred HHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 279 AALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 279 ~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.... ........+..++..+.+|+.+||+.+|.+||++.++++
T Consensus 235 ~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 235 IECI---TQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHH---hCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 2222 122233345567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=336.63 Aligned_cols=257 Identities=32% Similarity=0.512 Sum_probs=207.0
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC--
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED-- 141 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~-- 141 (668)
.+|+..+.||.|++|.||+|.+..+++.||+|.+.... .......+.+|+++++.++||||+++++++...
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 73 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-------NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESS 73 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-------chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCC
Confidence 36899999999999999999999999999999884321 113345678899999999999999999987543
Q ss_pred CcceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 142 DSLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
..+|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|.||+++.++.++|+|||++.
T Consensus 74 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 153 (287)
T cd06621 74 SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSG 153 (287)
T ss_pred CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccc
Confidence 468999999999999887643 3568999999999999999999999999999999999999999999999999986
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH------HHHHHHHhhccCCCCC
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF------QEVAALFHIGTTKSHP 291 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~------~~~~~~~~~~~~~~~~ 291 (668)
..... ......++..|+|||.+.+..++.++|||||||++|+|++|..||.... .+..............
T Consensus 154 ~~~~~----~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 154 ELVNS----LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred ccccc----ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 54321 1123567889999999998889999999999999999999999997541 1111111110110101
Q ss_pred -CCC--cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 292 -PIP--EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 292 -~~p--~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
... ...++++.+||.+||..+|.+|||+.|+++||||+..
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 230 DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 111 2346789999999999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=338.57 Aligned_cols=254 Identities=30% Similarity=0.536 Sum_probs=204.6
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcce
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN 145 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~ 145 (668)
|++.+.||.|++|.||+|.+..+|..||||++..... .......+.+|+.+++.++|+||+++++++......|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~------~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~ 74 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE------DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY 74 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc------cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence 6788999999999999999999999999998843211 1122244678999999999999999999999999999
Q ss_pred EEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 146 ILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+++++||||+|+|||++.++.++|+|||++..+...
T Consensus 75 iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~- 152 (283)
T cd07835 75 LVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP- 152 (283)
T ss_pred EEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC-
Confidence 9999995 68999887665 7899999999999999999999999999999999999999999999999998754221
Q ss_pred hhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhc---------------
Q 005944 224 TINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIG--------------- 285 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~--------------- 285 (668)
........+++.|+|||++.+. .++.++|||||||++|+|++|++||..... .........
T Consensus 153 -~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 153 -VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred -ccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence 1112234568899999988764 478899999999999999999999964321 111111100
Q ss_pred ---------cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 286 ---------TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 286 ---------~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
...........++.++.+||.+||+.+|.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0000111234577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=335.57 Aligned_cols=254 Identities=31% Similarity=0.564 Sum_probs=203.9
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||.|++|.||+|++..+|..||||++...... .....+.+|+.+++.++|+||+++++++...+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 73 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-------GTPSTAIREISLMKELKHENIVRLHDVIHTENKL 73 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-------cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcE
Confidence 589999999999999999999999999999998543211 1123456799999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 145 NILLEFVPGGSISSLLGKF---GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~---~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
++||||+++ +|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 74 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~ 152 (284)
T cd07836 74 MLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152 (284)
T ss_pred EEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcC
Confidence 999999985 788877543 3589999999999999999999999999999999999999999999999999875432
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhcc------------
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGT------------ 286 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~------------ 286 (668)
. ........+++.|++||++.+. .++.++|||||||++|+|++|..||..... ....+.....
T Consensus 153 ~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 153 P--VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred C--ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 1 1122335678999999998764 478899999999999999999999964321 1111111100
Q ss_pred -CCCCCC-----------CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 287 -TKSHPP-----------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 287 -~~~~~~-----------~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
...... +...++.++.++|.+||+.+|.+||++.++++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000000 112457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=335.48 Aligned_cols=253 Identities=25% Similarity=0.428 Sum_probs=205.8
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCc----EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGE----LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~----~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
....+|++.++||+|+||+||+|++..++. .||+|++... ........+.+|+.++..++|+||+++++
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~-------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~ 76 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN-------TSPKANKEILDEAYVMAGVGSPYVCRLLG 76 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCC-------CCHHHHHHHHHHHHHHHhcCCCCCceEEE
Confidence 345689999999999999999999877776 4899987421 11223456788999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++.. ...++++||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~ 155 (279)
T cd05109 77 ICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGL 155 (279)
T ss_pred EEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCc
Confidence 8875 4578999999999999998764 5699999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~ 293 (668)
++.+.............+++.|+|||.+.+..++.++|||||||++|||++ |..||..... .....+.. ....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~ 232 (279)
T cd05109 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK---GERLPQ 232 (279)
T ss_pred eeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---CCcCCC
Confidence 986543222111222345678999999998889999999999999999998 9999975432 22222222 222344
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+..++.++.++|.+||..||++||++.+++.
T Consensus 233 ~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 233 PPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5678899999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=336.98 Aligned_cols=244 Identities=26% Similarity=0.396 Sum_probs=200.4
Q ss_pred CeeeeeEE--cccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccC
Q 005944 65 RWRKGELV--GCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTARED 141 (668)
Q Consensus 65 ry~i~~~L--G~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~ 141 (668)
+|++.+.+ |.|+||.||++.+..++..+|+|++..... . . .|+.....+ +|+||+++++.+...
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~------~-----~--~e~~~~~~~~~h~~iv~~~~~~~~~ 81 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF------N-----A--IEPMVHQLMKDNPNFIKLYYSVTTL 81 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc------c-----h--hhHHHHHHhhcCCCEEEEEEEEecC
Confidence 45555555 999999999999999999999998842110 0 0 122222222 799999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC-ceEEecCCchhhhH
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-CIKLADFGASKKVV 220 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-~vKL~DFGlA~~~~ 220 (668)
+.+|+||||+++++|.+++.....+++.+++.++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++....
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~ 161 (267)
T PHA03390 82 KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161 (267)
T ss_pred CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence 99999999999999999998877999999999999999999999999999999999999999998 99999999987542
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH---HHHHhhccCCCCCCCCccc
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV---AALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~---~~~~~~~~~~~~~~~p~~l 297 (668)
. .....|+..|+|||++.+..++.++|||||||++|+|++|..||....... ....... ......+..+
T Consensus 162 ~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 233 (267)
T PHA03390 162 T------PSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNV 233 (267)
T ss_pred C------CccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCccccc
Confidence 1 223568999999999998889999999999999999999999997443221 1111111 2233455678
Q ss_pred CHHHHHHHHHhhhhCCCCCCC-HHHHHcCcccc
Q 005944 298 SMEAKDFLLKCLQKEPYLRST-ASELLQHPFVT 329 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPS-a~EIL~Hpwf~ 329 (668)
+..+.+||.+||+.+|.+||+ +++||+||||.
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK 266 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence 999999999999999999996 69999999996
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=367.10 Aligned_cols=261 Identities=31% Similarity=0.515 Sum_probs=219.1
Q ss_pred CCCCCe-eeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 61 APPIRW-RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry-~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.+..|| +...+||+|+|-+||+|.+..+|..||.-.+++. ...+.+..+..|..|+.+|+.|+|+|||++|++|.
T Consensus 36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~----d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~ 111 (632)
T KOG0584|consen 36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIR----DVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWV 111 (632)
T ss_pred CCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHH----HhhcChHHHHHHHHHHHHHccCCCCceeeeeehee
Confidence 344454 5667899999999999999999999997766332 23345566788999999999999999999999998
Q ss_pred cCCc--ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCcccEEeCCC-CceEEecCC
Q 005944 140 EDDS--LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVDNK-GCIKLADFG 214 (668)
Q Consensus 140 ~~~~--~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~g--IvHrDLKPeNILld~~-g~vKL~DFG 214 (668)
+... +.+|+|++..|+|..|+++++.++...++.|++||+.||.|||++. |||||||.+||||+.+ |.|||+|+|
T Consensus 112 d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG 191 (632)
T KOG0584|consen 112 DTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG 191 (632)
T ss_pred cCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence 7765 7889999999999999999999999999999999999999999984 9999999999999865 899999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCC
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP 294 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p 294 (668)
||+.... ..++.++|||.|||||++. ..|+..+||||||+++.||+|+.+||...........++....-...+.
T Consensus 192 LAtl~r~----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~ 266 (632)
T KOG0584|consen 192 LATLLRK----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS 266 (632)
T ss_pred HHHHhhc----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh
Confidence 9987532 2355689999999999986 7799999999999999999999999987654433333332222222333
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
..-.+++++||.+||.. ...|+|+.|+|.||||...
T Consensus 267 kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 267 KVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 44578999999999999 9999999999999999864
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=334.57 Aligned_cols=251 Identities=28% Similarity=0.454 Sum_probs=198.0
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccC--C
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTARED--D 142 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~--~ 142 (668)
|++.+.||+|+||.||+|.+..++..||+|++..... .... ....+|+.++.++. |+||+++++++.+. +
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~------~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK------SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC------Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCC
Confidence 6788999999999999999999999999998743211 1111 12346888888885 99999999999887 8
Q ss_pred cceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
.+++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+||+++. +.+||+|||++..+..
T Consensus 74 ~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 74 RLALVFELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cEEEEEecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 89999999975 77776654 457899999999999999999999999999999999999999 9999999999876532
Q ss_pred hhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhcc------------
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGT------------ 286 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~------------ 286 (668)
. .......+++.|+|||++.. ..++.++|||||||++|+|++|.+||..... ..........
T Consensus 152 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07831 152 K---PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRK 228 (282)
T ss_pred C---CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcc
Confidence 2 22234568999999998754 4468899999999999999999999964321 1111110000
Q ss_pred -CCCCC-----------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 287 -TKSHP-----------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 287 -~~~~~-----------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
..... .....++.++.+||.+||.++|.+||++.++++||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 229 SRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred cccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00000 0113568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=326.28 Aligned_cols=252 Identities=34% Similarity=0.540 Sum_probs=214.4
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|++.+.||.|+||.||++.+..++..+|+|.+.... ........+.+|+.+++.++|+||+++++++......
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGS------MSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL 74 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhh------ccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence 5899999999999999999999999999999884322 1123345567899999999999999999999999999
Q ss_pred eEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 145 NILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
|+||||+++++|..++.+ ...+++..++.++.||+.||.|||+.|++|+||+|.||+++.++.+||+|||++....
T Consensus 75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~ 154 (256)
T cd08530 75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK 154 (256)
T ss_pred EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhc
Confidence 999999999999998865 3568999999999999999999999999999999999999999999999999998664
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
.. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.......... ..........+..++.+
T Consensus 155 ~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 228 (256)
T cd08530 155 KN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY--KVQRGKYPPIPPIYSQD 228 (256)
T ss_pred cC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHhcCCCCCCchhhCHH
Confidence 32 2234568999999999998889999999999999999999999997544322111 11223344556678899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
++++|.+||..+|.+||++.++++||++
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 229 LQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=341.22 Aligned_cols=260 Identities=36% Similarity=0.596 Sum_probs=210.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|.+.+.||+|+||+||+|++..+++.||+|++.... .........+.+|+.+++.++||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~ 85 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-----KQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccc-----cCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEE
Confidence 345567999999999999999999999999999999884221 112233456788999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~-~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
..+..|+||||+.+ +|.+++. ....+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~ 164 (307)
T cd06607 86 REHTAWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASL 164 (307)
T ss_pred eCCeEEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCccee
Confidence 99999999999975 6666554 345789999999999999999999999999999999999999999999999999865
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~ 295 (668)
... .....|++.|+|||++. ...++.++||||||+++|+|+||.+||........ .............+.
T Consensus 165 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 237 (307)
T cd06607 165 VSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQNDSPTLSSN 237 (307)
T ss_pred cCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH-HHHHhcCCCCCCCch
Confidence 422 23457889999999884 34578899999999999999999999965432211 112211111112233
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.++.++.+||.+||..+|.+||++.+|+.||||....
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 238 DWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred hhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 5678899999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=341.64 Aligned_cols=258 Identities=25% Similarity=0.416 Sum_probs=208.5
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEcC-------CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CC
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-TH 128 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~H 128 (668)
..++....+|.+.+.||+|+||.||+|.+.. ....||+|++... ........+..|+.+++.+ .|
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h 77 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-------ATDKDLADLISEMELMKLIGKH 77 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-------CChHHHHHHHHHHHHHHhccCC
Confidence 3456777899999999999999999998642 3457999987321 1123345678899999999 69
Q ss_pred CCeeeeccccccCCcceEEeeccCCCChhcccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 005944 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF----------------GSFPESVIRMYTKQLLLGLEYLHKNGIMH 192 (668)
Q Consensus 129 pNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvH 192 (668)
|||+++++++.....+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+|
T Consensus 78 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H 157 (314)
T cd05099 78 KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIH 157 (314)
T ss_pred CCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeee
Confidence 99999999999989999999999999999998543 34788999999999999999999999999
Q ss_pred ccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCC
Q 005944 193 RDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPW 271 (668)
Q Consensus 193 rDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF 271 (668)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~ 237 (314)
T cd05099 158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPY 237 (314)
T ss_pred ccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999986543222221222334568999999998889999999999999999999 89999
Q ss_pred chhHH-HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 272 SQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 272 ~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..... ........ ......+..++.++.+||.+||..+|.+||++.++++
T Consensus 238 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 238 PGIPVEELFKLLRE---GHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCCHHHHHHHHHc---CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 65432 22222221 2223455678889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.03 Aligned_cols=259 Identities=29% Similarity=0.468 Sum_probs=204.5
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||.|++|+||+|.+..+|+.||||++..... .......+.+|+++++.++|+||+++++++.....
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 75 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE------DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR 75 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc------cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence 479999999999999999999999999999998743211 11223456789999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-CCceEEecCCchhhhH
Q 005944 144 LNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN-KGCIKLADFGASKKVV 220 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~-~g~vKL~DFGlA~~~~ 220 (668)
.|+||||++ ++|.+++.... .+++..++.++.||+.||+|||++||+||||+|+|||++. ++.+||+|||++....
T Consensus 76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 999999996 47777765443 3578889999999999999999999999999999999985 5679999999987543
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCC---C-----
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTK---S----- 289 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~---~----- 289 (668)
.. ........+++.|+|||++.+. .++.++|||||||++|+|+||.+||.... ......+...... .
T Consensus 155 ~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (294)
T PLN00009 155 IP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232 (294)
T ss_pred CC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccc
Confidence 21 1222345678999999998764 47889999999999999999999996432 1222211110000 0
Q ss_pred --------CC--------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 290 --------HP--------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 290 --------~~--------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.. .....++.++.++|.+||+.+|.+||++.++++||||.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 0123467889999999999999999999999999999754
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=340.29 Aligned_cols=257 Identities=25% Similarity=0.429 Sum_probs=209.3
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEc-------CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCC
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNL-------DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPN 130 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~-------~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpN 130 (668)
..+...+|.+.+.||+|+||.||+|++. .++..||+|.+... ........+.+|+.+++.+ +|||
T Consensus 10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h~~ 82 (304)
T cd05101 10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-------ATEKDLSDLVSEMEMMKMIGKHKN 82 (304)
T ss_pred ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-------cchHHHHHHHHHHHHHHhhccCCC
Confidence 4577889999999999999999999753 23457999987311 1123345688899999999 8999
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKF----------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRD 194 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrD 194 (668)
|+++++++......|+||||+++|+|.+++.+. ..++...+..++.||+.||.|||++||+|||
T Consensus 83 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~d 162 (304)
T cd05101 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRD 162 (304)
T ss_pred chheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 999999999999999999999999999998653 2467888999999999999999999999999
Q ss_pred CCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCch
Q 005944 195 IKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ 273 (668)
Q Consensus 195 LKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~ 273 (668)
|||+|||++.++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 163 lkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 242 (304)
T cd05101 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242 (304)
T ss_pred cccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999986643322222333456788999999988889999999999999999998 8888865
Q ss_pred hH-HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 274 QF-QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 274 ~~-~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.. .+...... .......+..++.++.+||.+||..+|.+||++.++++.
T Consensus 243 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 243 IPVEELFKLLK---EGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred CCHHHHHHHHH---cCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 42 22222222 222334456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=339.32 Aligned_cols=256 Identities=29% Similarity=0.494 Sum_probs=205.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC--
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED-- 141 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~-- 141 (668)
.+|++.+.||.|+||.||+|.+..+++.||||.+...... ......+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~------~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 78 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK------EGFPITSLREINILLKLQHPNIVTVKEVVVGSNL 78 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc------ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence 4689999999999999999999999999999998543221 12223466799999999999999999988777
Q ss_pred CcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 142 DSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...|+||||+.+ +|.+++... ..+++..++.++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++..+.
T Consensus 79 ~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 79 DKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred CcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 889999999975 888888654 458999999999999999999999999999999999999999999999999987654
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhcc-----------
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGT----------- 286 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~----------- 286 (668)
... .......+++.|+|||++.+.. ++.++|||||||++|+|++|.+||..... ....+.....
T Consensus 158 ~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 321 2223456789999999987654 68899999999999999999999964321 1111110000
Q ss_pred ---------------CCCCCCCCcc-cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 287 ---------------TKSHPPIPEH-LSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 287 ---------------~~~~~~~p~~-ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
......++.. ++..+.+||.+||+.+|++|||+.|++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0001112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=360.86 Aligned_cols=253 Identities=30% Similarity=0.489 Sum_probs=220.3
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEe
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
.++||+|-||+||-|+++++|+.||||+|.+-.-....+ ..+.+|+.||.+++||.||.|--.|++.+.+++||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe------sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM 642 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE------SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM 642 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchH------HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence 478999999999999999999999999995443322222 45789999999999999999999999999999999
Q ss_pred eccCCCChhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC---CceEEecCCchhhhHhhhh
Q 005944 149 EFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK---GCIKLADFGASKKVVELAT 224 (668)
Q Consensus 149 Ey~~gGsL~~~L-~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~---g~vKL~DFGlA~~~~~~~~ 224 (668)
|.+.|.-|.-+| ...+++++...+.++.||+.||.|||.+||||+||||+|||+... -++||||||+|+.+.+..-
T Consensus 643 EKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF 722 (888)
T KOG4236|consen 643 EKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF 722 (888)
T ss_pred hhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh
Confidence 999765554444 345889999999999999999999999999999999999999654 4799999999998876433
Q ss_pred hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHH
Q 005944 225 INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dL 304 (668)
..+++|||.|+|||++.+..|....|+||+|||+|.-|+|..||... +++...++.....+.+..|..++.++.+|
T Consensus 723 ---RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd-EdIndQIQNAaFMyPp~PW~eis~~Aidl 798 (888)
T KOG4236|consen 723 ---RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED-EDINDQIQNAAFMYPPNPWSEISPEAIDL 798 (888)
T ss_pred ---hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc-cchhHHhhccccccCCCchhhcCHHHHHH
Confidence 45789999999999999999999999999999999999999999764 44555555555666777788999999999
Q ss_pred HHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 305 LLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 305 I~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
|..+|++.-.+|.+.+..|.|||+++.
T Consensus 799 In~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 799 INNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred HHHHHHHHHHHhcchHhhccchhhhcc
Confidence 999999999999999999999999864
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=332.08 Aligned_cols=250 Identities=26% Similarity=0.396 Sum_probs=208.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||.|+||.||+|.+.. +..+|+|++... .......+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~--------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 73 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSD--------DLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEecccc--------chhhHHHHHHHHHHHhcCCCcchhheeeeEec
Confidence 445679999999999999999999877 899999987421 11223457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
....++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARL 153 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhh
Confidence 99999999999999999999753 4689999999999999999999999999999999999999999999999999876
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ 296 (668)
...... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||..... +...... .....+.+..
T Consensus 154 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~ 228 (261)
T cd05148 154 IKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---AGYRMPCPAK 228 (261)
T ss_pred cCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---hCCcCCCCCC
Confidence 532211 1223446778999999988889999999999999999998 8999965432 2222222 2233455668
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
++..+.++|.+||+.+|.+|||+.+|++
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 229 CPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 8999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=336.57 Aligned_cols=250 Identities=26% Similarity=0.450 Sum_probs=204.3
Q ss_pred CeeeeeEEcccCceEEEEEEEcC-----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
+|++.+.||+|+||.||+|++.. ....+|+|.+... ........+.+|+.+++.++||||+++++.+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 73 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-------ASSSELRDLLSEFNLLKQVNHPHVIKLYGACS 73 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-------CCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe
Confidence 47889999999999999998753 2357888877321 11223456888999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF------------------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDI 195 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~------------------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDL 195 (668)
..+..++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~di 153 (290)
T cd05045 74 QDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDL 153 (290)
T ss_pred cCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 999999999999999999887532 34788899999999999999999999999999
Q ss_pred CcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchh
Q 005944 196 KGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQ 274 (668)
Q Consensus 196 KPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~ 274 (668)
||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||...
T Consensus 154 kp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 154 AARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred hhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999999876533222222233456788999999988889999999999999999998 99999754
Q ss_pred H-HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 275 F-QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 275 ~-~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
. ..+..... .......+..++.++.+||.+||+.+|.+||++.++++
T Consensus 234 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 234 APERLFNLLK---TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CHHHHHHHHh---CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 3 22222222 22334456778899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=330.15 Aligned_cols=247 Identities=28% Similarity=0.458 Sum_probs=202.1
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||.||+|... ++..+|+|.+.... .....+.+|+.+|+.++||||+++++++.....
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA---------MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKP 73 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC---------ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCC
Confidence 56899999999999999999865 45689999873211 112357789999999999999999999999999
Q ss_pred ceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.++||||+++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 74 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 74 LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred EEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 9999999999999999865 356899999999999999999999999999999999999999999999999998754321
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
.. .......++..|+|||++.+..++.++||||||+++|+|++ |+.||..... +....... ......+...+.+
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~ 229 (256)
T cd05114 154 EY-TSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISR---GFRLYRPKLASMT 229 (256)
T ss_pred ce-eccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHC---CCCCCCCCCCCHH
Confidence 11 11122345678999999988889999999999999999999 9999965432 22222221 1223345567889
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+.+|+.+||+.+|.+||++.++++
T Consensus 230 ~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 230 VYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred HHHHHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=330.40 Aligned_cols=244 Identities=26% Similarity=0.383 Sum_probs=200.0
Q ss_pred EEcccCceEEEEEEE--cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEe
Q 005944 71 LVGCGAFGRVYMGMN--LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~--~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
.||+|+||.||+|.+ ..++..||+|++.... ........+.+|+.+++.+.|+||+++++++. .+..++||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~ 74 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN------NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVM 74 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC------CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEE
Confidence 589999999999965 4578899999874221 12234566888999999999999999999875 45678999
Q ss_pred eccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhh-cC
Q 005944 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI-NG 227 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~-~~ 227 (668)
||+++|+|.+++.....+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+|||++..+...... ..
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 75 ELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999999999988788999999999999999999999999999999999999999999999999998765322211 11
Q ss_pred CccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHHHHH
Q 005944 228 AKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDFL 305 (668)
Q Consensus 228 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dLI 305 (668)
.....+++.|+|||.+....++.++|||||||++|+|++ |..||..... .....+. .....+.+..++.++.+||
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~---~~~~~~~~~~~~~~l~~li 231 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE---SGERMECPQRCPPEMYDLM 231 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---CCCCCCCCCCCCHHHHHHH
Confidence 122344678999999988889999999999999999998 9999975432 2222222 2223456778899999999
Q ss_pred HHhhhhCCCCCCCHHHHHc
Q 005944 306 LKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 306 ~kcL~~dP~~RPSa~EIL~ 324 (668)
.+||+.||.+||++.+|..
T Consensus 232 ~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 232 KLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHhccCchhCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=337.16 Aligned_cols=248 Identities=29% Similarity=0.501 Sum_probs=199.3
Q ss_pred eeeeEEcccCceEEEEEEEc----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 67 RKGELVGCGAFGRVYMGMNL----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 67 ~i~~~LG~G~fG~Vy~a~~~----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
.+.+.||.|.||.||+|.+. ..+..|+||++.. .........+.+|+++|++++||||+++++++....
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-------~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~ 74 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-------SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENE 74 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-------TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSS
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-------ccccccceeeeecccccccccccccccccccccccc
Confidence 46789999999999999987 4578999998832 122233567888999999999999999999999888
Q ss_pred cceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 143 SLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
..++|||||++|+|.++|... ..+++..+..|+.||+.||.|||+++|+|+||+++|||++.++.+||+|||++....
T Consensus 75 ~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~ 154 (259)
T PF07714_consen 75 PLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPIS 154 (259)
T ss_dssp SEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999999999999999876 779999999999999999999999999999999999999999999999999987652
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCCCcccC
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls 298 (668)
............+...|+|||.+.+..++.++||||||+++|||++ |+.||...... ....+ ........+..++
T Consensus 155 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~ 231 (259)
T PF07714_consen 155 EKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL---KQGQRLPIPDNCP 231 (259)
T ss_dssp TSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH---HTTEETTSBTTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccceeccchh
Confidence 2222222233456788999999999989999999999999999999 78999764322 22222 2223344567789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..+.++|.+||..+|.+||++.+|++
T Consensus 232 ~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 232 KDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred HHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99999999999999999999999985
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=336.38 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=204.8
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
...+|.+.+.||+|+||.||+|... .++..+|+|.+.. ........+.+|+++++.++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~--------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 74 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--------ASESARQDFQREAELLTVLQHQHIVRFYG 74 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCc--------CCHHHHHHHHHHHHHHhcCCCCCCceEEE
Confidence 3457888999999999999999643 3567899998732 12233456889999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEE
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKFG---------------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANIL 201 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~---------------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNIL 201 (668)
++......++||||+++++|.+++...+ .+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil 154 (280)
T cd05092 75 VCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCL 154 (280)
T ss_pred EEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEE
Confidence 9999999999999999999999986543 4789999999999999999999999999999999999
Q ss_pred eCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HH
Q 005944 202 VDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VA 279 (668)
Q Consensus 202 ld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~ 279 (668)
++.++.+||+|||++..+.............+++.|+|||.+.+..++.++|||||||++|+|++ |.+||...... ..
T Consensus 155 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 234 (280)
T cd05092 155 VGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI 234 (280)
T ss_pred EcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH
Confidence 99999999999999875432211111223345788999999998889999999999999999998 99999654322 11
Q ss_pred HHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 280 ALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 280 ~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.... .......+..++..+.+||.+||+.||.+||++.+|++
T Consensus 235 ~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 235 ECIT---QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHH---cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1111 12223445678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=339.69 Aligned_cols=258 Identities=25% Similarity=0.414 Sum_probs=209.3
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCC
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPN 130 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpN 130 (668)
..+.....+|.+.+.||+|+||.||+|.+. .++..||||++.... .......+.+|+.+++++ +|+|
T Consensus 28 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 100 (302)
T cd05055 28 LKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-------HSSEREALMSELKIMSHLGNHEN 100 (302)
T ss_pred ccccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-------ChHHHHHHHHHHHHHHhccCCCC
Confidence 345677788999999999999999999753 345689999873211 122345678999999999 7999
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCce
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCI 208 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~v 208 (668)
|+++++++...+..|+||||+.+|+|.+++.... .+++.++..++.||+.||.|||+++|+|+||||+|||++.++.+
T Consensus 101 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~ 180 (302)
T cd05055 101 IVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIV 180 (302)
T ss_pred cceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeE
Confidence 9999999999999999999999999999986543 38999999999999999999999999999999999999999999
Q ss_pred EEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH--HHHHHhhc
Q 005944 209 KLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE--VAALFHIG 285 (668)
Q Consensus 209 KL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~--~~~~~~~~ 285 (668)
||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .......
T Consensus 181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~- 259 (302)
T cd05055 181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE- 259 (302)
T ss_pred EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHc-
Confidence 9999999876533221111223346788999999998889999999999999999998 99999654321 1122211
Q ss_pred cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 286 ~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
......+...+.++.+|+.+||..+|++||++.++++
T Consensus 260 --~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 260 --GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred --CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1223345567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=335.97 Aligned_cols=261 Identities=33% Similarity=0.543 Sum_probs=212.3
Q ss_pred CeeeeeEEcccCceEEEEEEEc---CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccccc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTARE 140 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~ 140 (668)
.|++.+.||.|+||.||+|.+. .+|..||+|++.... ........+.+.+|+++|..+ +|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~----~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKAT----IVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhh----hhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 4889999999999999999875 478999999984211 111122345577899999999 59999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
+..+|+||||+++++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 156 (290)
T cd05613 77 DTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH 156 (290)
T ss_pred CCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999987653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhc--CCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCCCCCCCCcc
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQT--GHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~--~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~~~~~~p~~ 296 (668)
... ........|+..|+|||.+.+. .++.++|||||||++|+|++|..||.... .....+... ......+++..
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (290)
T cd05613 157 EDE-VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRR-ILKSEPPYPQE 234 (290)
T ss_pred ccc-ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHH-hhccCCCCCcc
Confidence 321 1122346789999999998753 46789999999999999999999995321 111111111 11123445667
Q ss_pred cCHHHHHHHHHhhhhCCCCCC-----CHHHHHcCccccCC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRS-----TASELLQHPFVTGK 331 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~~ 331 (668)
++..+.+|+.+||+.+|.+|| ++++++.||||+..
T Consensus 235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 274 (290)
T cd05613 235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274 (290)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence 899999999999999999997 89999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=337.73 Aligned_cols=259 Identities=33% Similarity=0.536 Sum_probs=200.4
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC-
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED- 141 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~- 141 (668)
..+|++.+.||.|+||.||+|.+..++..||||++....... .....+.+|+++++.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD------GFPITALREIKILKKLKHPNVVPLIDMAVERP 80 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC------CcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence 578999999999999999999999999999999885432111 1112356799999999999999999887443
Q ss_pred -------CcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecC
Q 005944 142 -------DSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADF 213 (668)
Q Consensus 142 -------~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DF 213 (668)
..+++||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 81 DKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred ccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcC
Confidence 346999999975 56555543 457999999999999999999999999999999999999999999999999
Q ss_pred CchhhhHhhhhh---------cCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHH
Q 005944 214 GASKKVVELATI---------NGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAAL 281 (668)
Q Consensus 214 GlA~~~~~~~~~---------~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~ 281 (668)
|++......... .......|++.|+|||++.+. .++.++|||||||++|+|++|++||...... ...+
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999765332111 112234678899999998764 4789999999999999999999999643221 1111
Q ss_pred HhhccC------------------CCCCCC-------CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 282 FHIGTT------------------KSHPPI-------PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 282 ~~~~~~------------------~~~~~~-------p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
...... ...... ...++..+.+||.+||+.+|.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 111000 000000 12345678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=344.82 Aligned_cols=263 Identities=28% Similarity=0.431 Sum_probs=212.5
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC--
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD-- 142 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~-- 142 (668)
+|++.+.||.|+||.||+|++..++..||||++.... ......+.+.+|+.+++.++|+||+++++++....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 74 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF------DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE 74 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc------ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence 6899999999999999999999999999999884321 11233456788999999999999999999988775
Q ss_pred ---cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 143 ---SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 143 ---~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.+|+||||+. ++|..++.+...+++..++.++.||+.||+|||++||+||||||.|||++.++.++|+|||++...
T Consensus 75 ~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 75 DFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred cccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 7899999997 489999888789999999999999999999999999999999999999999999999999999865
Q ss_pred Hhhhhh-cCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccC--------
Q 005944 220 VELATI-NGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTT-------- 287 (668)
Q Consensus 220 ~~~~~~-~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~-------- 287 (668)
...... .......+++.|+|||++.+. .++.++|||||||++|+|++|.+||...... ...+......
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 432210 112345689999999999887 7899999999999999999999999643211 1111110000
Q ss_pred -------------CC-----CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCC
Q 005944 288 -------------KS-----HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334 (668)
Q Consensus 288 -------------~~-----~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~ 334 (668)
.. .......++.++.+||.+||+++|.+||++.+++.||||+.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 00 001123467889999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=339.89 Aligned_cols=252 Identities=23% Similarity=0.394 Sum_probs=203.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcE--EEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGEL--LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~--VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~ 137 (668)
+...+|++.+.||+|+||.||+|.+..++.. +|+|.+.. .........+.+|+.++.++ +|+||++++++
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~-------~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~ 76 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-------YASKDDHRDFAGELEVLCKLGHHPNIINLLGA 76 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecc-------cCCHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence 4456899999999999999999998887765 46665521 11223345678899999999 89999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEE
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKFG----------------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANIL 201 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNIL 201 (668)
+...+.+|+||||+++|+|.+++.+.+ .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nil 156 (303)
T cd05088 77 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 156 (303)
T ss_pred ECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEE
Confidence 999999999999999999999886432 5789999999999999999999999999999999999
Q ss_pred eCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HH
Q 005944 202 VDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VA 279 (668)
Q Consensus 202 ld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~ 279 (668)
++.++.+||+|||++...... .......++..|+|||++.+..++.++|||||||++|+|+| |..||...... ..
T Consensus 157 i~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~ 233 (303)
T cd05088 157 VGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233 (303)
T ss_pred ecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH
Confidence 999999999999998643211 11112234677999999988889999999999999999998 99999643322 11
Q ss_pred HHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 280 ALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 280 ~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
... ........+..++.++.+||.+||+.+|.+||++.+++.+
T Consensus 234 ~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 234 EKL---PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred HHH---hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 111 1122233455678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.83 Aligned_cols=257 Identities=28% Similarity=0.445 Sum_probs=204.3
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEE-----cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMN-----LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIV 132 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV 132 (668)
++....+|++.++||+|+||+||+|.+ ..+++.||||++.... .......+.+|+.+|..+ +|+||+
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~niv 74 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-------THSEHRALMSELKILIHIGHHLNVV 74 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-------ChHHHHHHHHHHHHHHhccCCccHh
Confidence 345667999999999999999999984 3467899999884221 122345677899999999 689999
Q ss_pred eecccccc-CCcceEEeeccCCCChhcccccC------------------------------------------------
Q 005944 133 RYLGTARE-DDSLNILLEFVPGGSISSLLGKF------------------------------------------------ 163 (668)
Q Consensus 133 ~l~g~~~~-~~~~~LVmEy~~gGsL~~~L~~~------------------------------------------------ 163 (668)
++++++.. +..+++|||||++|+|.+++...
T Consensus 75 ~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (343)
T cd05103 75 NLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVE 154 (343)
T ss_pred hhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccC
Confidence 99998754 45688999999999999887542
Q ss_pred -------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 164 -------------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 164 -------------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 234 (343)
T cd05103 155 EKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD 234 (343)
T ss_pred CCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcc
Confidence 1367788889999999999999999999999999999999999999999999876532222
Q ss_pred hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH--HHHHHHhhccCCCCCCCCcccCHHH
Q 005944 225 INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ--EVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~--~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
........+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ....... .......+..+++++
T Consensus 235 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 311 (343)
T cd05103 235 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK---EGTRMRAPDYTTPEM 311 (343)
T ss_pred hhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHh---ccCCCCCCCCCCHHH
Confidence 122223445678999999998889999999999999999997 9999965321 1111111 122234455678899
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.+++.+||+.+|.+||++.+|++|
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=334.00 Aligned_cols=252 Identities=26% Similarity=0.425 Sum_probs=204.3
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcE----EEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGEL----LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~----VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
...+|++.+.||+|+||+||+|.+..++.. |++|.+.. .........+..|+.++..+.||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~-------~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~ 77 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQD-------RSGRQTFQEITDHMLAMGSLDHAYIVRLLGI 77 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccc-------ccchHHHHHHHHHHHHHhcCCCCCcceEEEE
Confidence 345789999999999999999999887774 56665521 1112334567788889999999999999998
Q ss_pred cccCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+. ....++++||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 78 ~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~ 156 (279)
T cd05111 78 CP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156 (279)
T ss_pred EC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccc
Confidence 75 4567899999999999999965 357899999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCC
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIP 294 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p 294 (668)
+.+.............++..|+|||.+.+..++.++|||||||++|||++ |..||..... ....... .......+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~~~ 233 (279)
T cd05111 157 DLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---KGERLAQP 233 (279)
T ss_pred eeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---CCCcCCCC
Confidence 86543222222334567788999999998889999999999999999998 9999976432 2222222 22233345
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..++.++.+++.+||..+|.+||++.++++
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 234 QICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 567788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=344.24 Aligned_cols=259 Identities=25% Similarity=0.431 Sum_probs=209.7
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEcCC-------CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CC
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDS-------GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-TH 128 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t-------g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~H 128 (668)
+.++....+|++++.||+|+||.||+|.+... +..||+|++... ........+.+|+.+++++ +|
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h 77 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-------ATDKDLSDLVSEMEMMKMIGKH 77 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-------cCHHHHHHHHHHHHHHHhhcCC
Confidence 44567778899999999999999999986432 347899987321 1223345678899999999 79
Q ss_pred CCeeeeccccccCCcceEEeeccCCCChhcccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 005944 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF----------------GSFPESVIRMYTKQLLLGLEYLHKNGIMH 192 (668)
Q Consensus 129 pNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvH 192 (668)
+||+++++++......++||||+++|+|.+++.+. ..++...+..++.||+.||.|||++||+|
T Consensus 78 ~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH 157 (334)
T cd05100 78 KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIH 157 (334)
T ss_pred CCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 99999999999999999999999999999998653 23677888999999999999999999999
Q ss_pred ccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCC
Q 005944 193 RDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPW 271 (668)
Q Consensus 193 rDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF 271 (668)
|||||+|||++.++.+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 237 (334)
T cd05100 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237 (334)
T ss_pred cccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence 99999999999999999999999876543222222223345678999999999889999999999999999998 88999
Q ss_pred chhH-HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 272 SQQF-QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 272 ~~~~-~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.... .+....+. .......+..++.++.+||.+||+.+|.+||++.+++++
T Consensus 238 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 238 PGIPVEELFKLLK---EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCCHHHHHHHHH---cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 6543 22222221 222334556778899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=338.07 Aligned_cols=256 Identities=32% Similarity=0.515 Sum_probs=210.7
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcce
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN 145 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~ 145 (668)
|....+||+|+||.||++....++..||||++... .......+.+|+.+++.++|+||+++++.+...+..+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 93 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--------KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW 93 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--------chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEE
Confidence 44456799999999999999999999999987321 1123455788999999999999999999999999999
Q ss_pred EEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhh
Q 005944 146 ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI 225 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 225 (668)
+||||+++++|.+++.. +.+++..++.++.||+.||+|||+.||+||||+|+||+++.++.++|+|||++..+....
T Consensus 94 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-- 170 (292)
T cd06657 94 VVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-- 170 (292)
T ss_pred EEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--
Confidence 99999999999998754 578999999999999999999999999999999999999999999999999886543211
Q ss_pred cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHHHH
Q 005944 226 NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDF 304 (668)
Q Consensus 226 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dL 304 (668)
.......|++.|+|||.+.+..++.++|||||||++|+|++|..||..... ......... ..........++..+.++
T Consensus 171 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l 249 (292)
T cd06657 171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPKLKNLHKVSPSLKGF 249 (292)
T ss_pred ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CCcccCCcccCCHHHHHH
Confidence 122345689999999999888889999999999999999999999965322 111222111 111112234578899999
Q ss_pred HHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 305 LLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 305 I~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
|.+||+.+|.+||++.+++.||||.....
T Consensus 250 i~~~l~~~P~~R~~~~~ll~~~~~~~~~~ 278 (292)
T cd06657 250 LDRLLVRDPAQRATAAELLKHPFLAKAGP 278 (292)
T ss_pred HHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence 99999999999999999999999987664
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=328.74 Aligned_cols=252 Identities=24% Similarity=0.395 Sum_probs=205.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
+....+|++.+.||.|+||.||+|.+. ++..||||.+.... .....+.+|+.++++++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT---------MDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc---------ccHHHHHHHHHHHHHCCCCCccceeEEEe
Confidence 355678999999999999999999864 45789999874211 11245778999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
..+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 72 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~ 151 (261)
T cd05068 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLAR 151 (261)
T ss_pred cCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEE
Confidence 9999999999999999999987644 68999999999999999999999999999999999999999999999999988
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ 296 (668)
.+.... .........+..|+|||++.+..++.++|||||||++|+|++ |+.||.......... .+. .....+.+..
T Consensus 152 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~-~~~~~~~~~~ 228 (261)
T cd05068 152 VIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ-QVD-QGYRMPCPPG 228 (261)
T ss_pred EccCCc-ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-HHH-cCCCCCCCCc
Confidence 654211 111111223457999999988889999999999999999999 999997643321111 111 1222345567
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
++..+.+++.+||+.+|.+||++.++++
T Consensus 229 ~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 229 CPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 8899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=336.72 Aligned_cols=256 Identities=26% Similarity=0.382 Sum_probs=202.4
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCC--------------CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDS--------------GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~t--------------g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~ 127 (668)
...+|++.+.||+|+||.||+|.+..+ ...||||++... ........+.+|+++|++++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~ei~~l~~l~ 75 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-------VTKTARNDFLKEIKIMSRLK 75 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-------CCHHHHHHHHHHHHHHHhCC
Confidence 456899999999999999999987543 235899987321 11223456889999999999
Q ss_pred CCCeeeeccccccCCcceEEeeccCCCChhcccccCC------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 005944 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG------------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDI 195 (668)
Q Consensus 128 HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~------------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDL 195 (668)
|+||+++++++......++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||
T Consensus 76 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dl 155 (295)
T cd05097 76 NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDL 155 (295)
T ss_pred CCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeecccc
Confidence 9999999999999999999999999999999885431 3678899999999999999999999999999
Q ss_pred CcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh--CCCCCch
Q 005944 196 KGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT--GKPPWSQ 273 (668)
Q Consensus 196 KPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT--G~~PF~~ 273 (668)
||+|||++.++.+||+|||++..+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 156 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 156 ATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred ChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999999999875532221111223345778999999998889999999999999999988 6778864
Q ss_pred hHH-HH-H---HHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 274 QFQ-EV-A---ALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 274 ~~~-~~-~---~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
... .. . ..............+..++..+.+||.+||+.+|.+||++.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 236 LSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred cChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 321 11 1 111111112223344567889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=343.60 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=201.0
Q ss_pred EEccc--CceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEe
Q 005944 71 LVGCG--AFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 71 ~LG~G--~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
.||.| +||+||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~ 78 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLEN------CTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVIS 78 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEecccc------CCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEE
Confidence 46666 99999999999999999999884321 12234567889999999999999999999999999999999
Q ss_pred eccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhc
Q 005944 149 EFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~ 226 (668)
||+.+++|.+++.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||+.+..........
T Consensus 79 e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 79 PFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred ecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 999999999998764 358999999999999999999999999999999999999999999999998654332211100
Q ss_pred -----CCccCCCCCCCCChHHHhhc--CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccC------------
Q 005944 227 -----GAKSMKGTPYWMAPEVILQT--GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT------------ 287 (668)
Q Consensus 227 -----~~~~~~GT~~Y~APEvl~~~--~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~------------ 287 (668)
......++..|+|||++.+. .++.++|||||||++|+|++|..||................
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccch
Confidence 01112356679999999764 47899999999999999999999997543221111111000
Q ss_pred --------------------------------CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 288 --------------------------------KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 288 --------------------------------~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
....+.+..++..+.+||.+||+.||.+|||+.++|+||||....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~ 315 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHH
Confidence 001112234677899999999999999999999999999997544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=329.57 Aligned_cols=249 Identities=25% Similarity=0.410 Sum_probs=202.5
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||+|+||.||+|.+. ++..+|+|++.... . ....+.+|+.+++.++|+||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~------~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGA------M---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQR 72 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCC------C---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence 356889999999999999999875 56789999873211 1 1134677999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 73 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~ 152 (256)
T cd05059 73 PIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD 152 (256)
T ss_pred ceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccc
Confidence 999999999999999998653 4689999999999999999999999999999999999999999999999999875532
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcccCH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
... .......++..|+|||++.+..++.++|||||||++|+|++ |..||..... +...... .......+..++.
T Consensus 153 ~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 228 (256)
T cd05059 153 DQY-TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS---AGYRLYRPKLAPT 228 (256)
T ss_pred ccc-cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH---cCCcCCCCCCCCH
Confidence 111 11111223457999999998889999999999999999999 8999964332 2211111 1223344566899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
++.+|+.+||..+|.+||++.++++.
T Consensus 229 ~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 229 EVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 99999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=335.58 Aligned_cols=249 Identities=23% Similarity=0.401 Sum_probs=202.0
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCc--EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccccc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGE--LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTARE 140 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~--~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~ 140 (668)
.+|++.++||+|+||.||+|....++. .+++|.+... ......+.+.+|+.++.++ +||||+++++++..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-------ASENDHRDFAGELEVLCKLGHHPNIINLLGACEN 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-------CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc
Confidence 579999999999999999999877765 4688876321 1122345678899999999 79999999999999
Q ss_pred CCcceEEeeccCCCChhcccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF----------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN 204 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~ 204 (668)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 154 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE 154 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC
Confidence 99999999999999999998653 24888999999999999999999999999999999999999
Q ss_pred CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHH
Q 005944 205 KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALF 282 (668)
Q Consensus 205 ~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~ 282 (668)
++.+||+|||++..... .........+..|+|||++.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 155 ~~~~kl~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 155 NLASKIADFGLSRGEEV---YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred CCeEEECCcCCCccccc---eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999999999863211 111112233567999999988889999999999999999997 99999654322 22211
Q ss_pred hhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 283 HIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 283 ~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
........+..++.++.+||.+||+.+|.+||+++++++.
T Consensus 232 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 232 ---PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred ---hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1122334566789999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=327.98 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=203.1
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||+|+||+||+|.+.. +..||||.+.... . ....+.+|+.+++.++||||+++++++....
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~------~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 72 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGS------M---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQR 72 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCc------c---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4579999999999999999997643 4569999873211 1 1235778999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
..++||||+.+|+|.+++... ..+++..++.++.||+.||.|||+.||+|+||||.|||++.++.+||+|||+++.+..
T Consensus 73 ~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 73 PIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 999999999999999998764 4689999999999999999999999999999999999999999999999999875432
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcccCH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
... .......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ........ ......+...+.
T Consensus 153 ~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 228 (256)
T cd05113 153 DEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ---GLRLYRPHLASE 228 (256)
T ss_pred Cce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhc---CCCCCCCCCCCH
Confidence 211 11122345678999999988889999999999999999999 9999965432 22222221 122234556789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.+++++.+||+.+|.+||++.+|+.+
T Consensus 229 ~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 229 KVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=335.46 Aligned_cols=260 Identities=30% Similarity=0.467 Sum_probs=204.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||.|+||+||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~ 77 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK------EGFPITAIREIKILRQLNHRNIVNLKEIVTD 77 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc------cCchHHHHHHHHHHHhCCCCCeeeeeheecC
Confidence 4456899999999999999999999999999999998543211 1122346679999999999999999998876
Q ss_pred CC----------cceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceE
Q 005944 141 DD----------SLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIK 209 (668)
Q Consensus 141 ~~----------~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vK 209 (668)
.. .+++|+||+++ +|..++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++.++.+|
T Consensus 78 ~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 78 KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred cchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEE
Confidence 54 78999999986 56565554 35799999999999999999999999999999999999999999999
Q ss_pred EecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhcc
Q 005944 210 LADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGT 286 (668)
Q Consensus 210 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~ 286 (668)
|+|||++..+..... .......++..|+|||++.+. .++.++|||||||++|+|++|++||.... .....+.....
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~ 235 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCG 235 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 999999876533221 122234568889999998654 47889999999999999999999996432 11111111110
Q ss_pred CCC---C----------------------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 287 TKS---H----------------------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 287 ~~~---~----------------------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
... . ......++..+.+||.+||+.+|.+||++.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 000 0 01123468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=323.70 Aligned_cols=247 Identities=37% Similarity=0.602 Sum_probs=210.3
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeecc
Q 005944 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFV 151 (668)
Q Consensus 72 LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~ 151 (668)
||.|+||.||++.+..++..||+|++.... .........+..|+.+++.++|+||+++++.+..+...|+||||+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 75 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKK-----IIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYA 75 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhh-----hcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecC
Confidence 699999999999998899999999884321 122234556888999999999999999999999999999999999
Q ss_pred CCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccC
Q 005944 152 PGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSM 231 (668)
Q Consensus 152 ~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~ 231 (668)
++++|.+++.....+++..+..++.||+.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 76 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 76 PGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 999999999888789999999999999999999999999999999999999999999999999987653221 123446
Q ss_pred CCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhh
Q 005944 232 KGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQK 311 (668)
Q Consensus 232 ~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~ 311 (668)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..... .....++..++..+.++|.+||..
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~ 230 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-YEKIL--KDPLRFPEFLSPEARDLISGLLQK 230 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHh--cCCCCCCCCCCHHHHHHHHHHhcC
Confidence 789999999999888889999999999999999999999965432111 11111 134456777899999999999999
Q ss_pred CCCCCCCH---HHHHcCccc
Q 005944 312 EPYLRSTA---SELLQHPFV 328 (668)
Q Consensus 312 dP~~RPSa---~EIL~Hpwf 328 (668)
||++||++ .+++.||||
T Consensus 231 ~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 231 DPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CHhhCCCcccHHHHHhCCCC
Confidence 99999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=341.33 Aligned_cols=259 Identities=29% Similarity=0.499 Sum_probs=208.6
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+.+|+.++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 86 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF------QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPD 86 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCCccceeeeecCC
Confidence 5678999999999999999999999999999999874211 1122334577899999999999999999988765
Q ss_pred C------cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 142 D------SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 142 ~------~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
. .+++||||+ +++|..++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 87 LSLDRFHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred ccccccceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 4 358999999 7789888764 5799999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccC-----
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTT----- 287 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~----- 287 (668)
+..... ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+......
T Consensus 165 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07880 165 ARQTDS-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEF 239 (343)
T ss_pred cccccc-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 875422 2234567999999999876 3578999999999999999999999964321 11111110000
Q ss_pred ---------------------CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 288 ---------------------KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 288 ---------------------~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.........++.++.++|.+||+.||.+|||+.+++.||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred HHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0001122457888999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=334.00 Aligned_cols=256 Identities=25% Similarity=0.395 Sum_probs=202.5
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcC----------------CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHh
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLD----------------SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~----------------tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~ 125 (668)
+..+|++.+.||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~-------~~~~~~~~~~~E~~~l~~ 75 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED-------ANKNARNDFLKEIKIMSR 75 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc-------CCHHHHHHHHHHHHHHHh
Confidence 45679999999999999999986432 3457999987321 122334567889999999
Q ss_pred CCCCCeeeeccccccCCcceEEeeccCCCChhcccccCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 005944 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-----------SFPESVIRMYTKQLLLGLEYLHKNGIMHRD 194 (668)
Q Consensus 126 L~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~-----------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrD 194 (668)
++|+||+++++++...+..++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.||+|||
T Consensus 76 l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~d 155 (296)
T cd05095 76 LKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRD 155 (296)
T ss_pred CCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 999999999999999999999999999999999886532 366788999999999999999999999999
Q ss_pred CCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh--CCCCCc
Q 005944 195 IKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT--GKPPWS 272 (668)
Q Consensus 195 LKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT--G~~PF~ 272 (668)
|||+|||++.++.++|+|||+++.+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 156 lkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~ 235 (296)
T cd05095 156 LATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS 235 (296)
T ss_pred CChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcc
Confidence 999999999999999999999876532221111222344678999999988889999999999999999998 778986
Q ss_pred hhHH-HHH----HHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 273 QQFQ-EVA----ALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 273 ~~~~-~~~----~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.... +.. ..+.........+.+..++..+.+||.+||+.||.+||++.+|++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 236 QLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred ccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 4321 111 111111112223345567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=340.77 Aligned_cols=269 Identities=28% Similarity=0.452 Sum_probs=209.0
Q ss_pred CCCee-eeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHH------HHHHHHHHHHHHHhCCCCCeeeec
Q 005944 63 PIRWR-KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQA------HIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 63 ~~ry~-i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~------~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
..+|. +.+.||.|+||+||+|.+..+++.||||++.............. ....+.+|+.+++.++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 45665 46789999999999999999999999999854322111100000 112467899999999999999999
Q ss_pred cccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 136 GTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 136 g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
+++...+..++||||+. |+|.+++.....+++..+..++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||+
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~ 165 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGL 165 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccc
Confidence 99999999999999997 58999998878899999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhh------------hhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHH
Q 005944 216 SKKVVELA------------TINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAA 280 (668)
Q Consensus 216 A~~~~~~~------------~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~ 280 (668)
+....... .........+++.|+|||++.+.. ++.++|||||||++|+|++|.+||..... ....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~ 245 (335)
T PTZ00024 166 ARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245 (335)
T ss_pred eeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 87653100 011122345788999999987654 68999999999999999999999964422 1111
Q ss_pred HHhhccCCCC-----------------------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 281 LFHIGTTKSH-----------------------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 281 ~~~~~~~~~~-----------------------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+......... .......+.++.+||.+||+.+|.+||+++++|.||||+...
T Consensus 246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~ 320 (335)
T PTZ00024 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDP 320 (335)
T ss_pred HHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCC
Confidence 1111000000 001124578899999999999999999999999999998653
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=332.37 Aligned_cols=253 Identities=24% Similarity=0.397 Sum_probs=204.8
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcC-----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
...+|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.+.||||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-------~~~~~~~~~~ei~~l~~l~h~~iv~~~~ 75 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-------SADMQADFQREAALMAEFDHPNIVKLLG 75 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-------CHHHHHHHHHHHHHHHhcCCCchheEEE
Confidence 45679999999999999999998743 67899999874211 1223356788999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKF----------------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRD 194 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~----------------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrD 194 (668)
++......++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~d 155 (288)
T cd05050 76 VCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRD 155 (288)
T ss_pred EEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 999999999999999999999998642 2467888999999999999999999999999
Q ss_pred CCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCch
Q 005944 195 IKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ 273 (668)
Q Consensus 195 LKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~ 273 (668)
|||.|||++.++.+||+|||++..+.............++..|+|||.+.+..++.++|||||||++|+|++ |..||..
T Consensus 156 l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 156 LATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred ccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999875432221111223345677999999998889999999999999999997 8888864
Q ss_pred hH-HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 274 QF-QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 274 ~~-~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.. .+....+.. ......+..++.++.+||.+||+.+|.+||++.|+++
T Consensus 236 ~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 236 MAHEEVIYYVRD---GNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCHHHHHHHHhc---CCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 32 222222221 1223345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=343.38 Aligned_cols=259 Identities=27% Similarity=0.494 Sum_probs=203.0
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||.|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--------~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~ 74 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--------QSVKHALREIKIIRRLDHDNIVKVYEVLGPS 74 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--------chHHHHHHHHHHHHhcCCCcchhhHhhhccc
Confidence 35789999999999999999999999999999998843221 2345677899999999999999999876554
Q ss_pred --------------CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-CC
Q 005944 142 --------------DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN-KG 206 (668)
Q Consensus 142 --------------~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~-~g 206 (668)
...|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++. ++
T Consensus 75 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~ 152 (342)
T cd07854 75 GSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152 (342)
T ss_pred ccccccccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCc
Confidence 35789999997 588887754 57999999999999999999999999999999999999974 55
Q ss_pred ceEEecCCchhhhHhhhhhc-CCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHH
Q 005944 207 CIKLADFGASKKVVELATIN-GAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALF 282 (668)
Q Consensus 207 ~vKL~DFGlA~~~~~~~~~~-~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~ 282 (668)
.+||+|||++..+....... ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ......
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 78999999987543211111 1122467889999998765 4578899999999999999999999964321 111110
Q ss_pred hh----------------------ccCCCCC---CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 283 HI----------------------GTTKSHP---PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 283 ~~----------------------~~~~~~~---~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.. ....... .....++.++.+||.+||+.||.+|||+.+++.||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 00 0000000 112357789999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=330.05 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=206.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcC----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLD----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
+...+|.+.++||+|+||.||+|.+.. ++..||+|++... ........+.+|+.+|+.++|+||+++++
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~ 75 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-------ASEIQVTLLLQESCLLYGLSHQNILPILH 75 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-------CCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 556789999999999999999999876 3688999987311 12233466788999999999999999999
Q ss_pred cccc-CCcceEEeeccCCCChhcccccC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc
Q 005944 137 TARE-DDSLNILLEFVPGGSISSLLGKF--------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC 207 (668)
Q Consensus 137 ~~~~-~~~~~LVmEy~~gGsL~~~L~~~--------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~ 207 (668)
++.. ....+++++|+++|+|.+++... ..+++..++.++.||+.||.|||+++|+||||||+|||++.++.
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~ 155 (280)
T cd05043 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ 155 (280)
T ss_pred EEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc
Confidence 8665 57789999999999999988553 45889999999999999999999999999999999999999999
Q ss_pred eEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhc
Q 005944 208 IKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIG 285 (668)
Q Consensus 208 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~ 285 (668)
+||+|||+++.+.............++..|+|||++.+..++.++|||||||++|+|++ |+.||..... +......
T Consensus 156 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-- 233 (280)
T cd05043 156 VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK-- 233 (280)
T ss_pred EEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHH--
Confidence 99999999986543222222233456778999999998889999999999999999999 9999975432 2222211
Q ss_pred cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 286 ~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.......+..++.++.+++.+||..+|++|||+.++++
T Consensus 234 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 234 -DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -cCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 12223344567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.16 Aligned_cols=298 Identities=32% Similarity=0.468 Sum_probs=236.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....-|...+.||-|+||.|.++...+|...||+|.+.+ ........+..++.|-.||...+.+-||+||..|++
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrK-----aDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD 700 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRK-----ADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD 700 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHH-----HHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc
Confidence 345568889999999999999999999999999998732 222334556678889999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
++.+|+||+|++||++-.+|.+.+-|.|..++.++.++..||++.|..|+|||||||+|||||.+|++||+||||++-+.
T Consensus 701 kdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 701 KDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred CCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999975320
Q ss_pred ---------hhh-------------------------------hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHH
Q 005944 221 ---------ELA-------------------------------TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCT 260 (668)
Q Consensus 221 ---------~~~-------------------------------~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvI 260 (668)
+.+ ........+||+.|+|||+|...+|+..+|+||.|||
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 000 0001124679999999999999999999999999999
Q ss_pred HHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCC---CHHHHHcCccccCCCCCCC
Q 005944 261 VIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRS---TASELLQHPFVTGKYQDPH 336 (668)
Q Consensus 261 LyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RP---Sa~EIL~Hpwf~~~~~~~~ 336 (668)
||||+.|++||-..... ....+..+....+.+...+++.++.+||.++. .+++.|. .++++..||||+++-..
T Consensus 861 l~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDfs-- 937 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDFS-- 937 (1034)
T ss_pred HHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccchH--
Confidence 99999999999654321 11111222333445566789999999998865 5677774 57789999999874321
Q ss_pred ccccccccccCccccCCCCCccchhhhhhhhccCCcccccCCccccCCCCCCCc
Q 005944 337 PVFRNSVMESGNQIATPGMNLRNSMNSLVRRSTGLKDVCEMGSVRCSTVYPENL 390 (668)
Q Consensus 337 ~~~~~~v~~~~~~~~~~~~~~~~s~~s~~~~s~~~~~~~~~~s~r~s~~~~~~~ 390 (668)
+++.--..++++.+...|+.+++. +.++++
T Consensus 938 -------------------slRkq~ApYIP~ItHptDTSNFdp-----vdpekl 967 (1034)
T KOG0608|consen 938 -------------------SLRKQRAPYIPRITHPTDTSNFDP-----VDPEKL 967 (1034)
T ss_pred -------------------hhhhccCCcCccccCCCccccCCc-----CCcccc
Confidence 112222345666667777777775 555554
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=325.22 Aligned_cols=244 Identities=30% Similarity=0.464 Sum_probs=199.1
Q ss_pred eEEcccCceEEEEEEEcCCC---cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceE
Q 005944 70 ELVGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNI 146 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg---~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~L 146 (668)
+.||+|+||.||+|++..++ ..||+|.+..... ......+.+|+.+++.+.|+|||++++++. ....++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 72 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHI-------AAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLML 72 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccc-------hHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEE
Confidence 46999999999999876655 7899998743211 123456788999999999999999999876 456899
Q ss_pred EeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhc
Q 005944 147 LLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226 (668)
Q Consensus 147 VmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~ 226 (668)
||||+++|+|.+++.....+++..+..++.||+.||.|||..||+|+||||+|||++.++.+||+|||+++.+.......
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 73 VMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred EEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 99999999999999887889999999999999999999999999999999999999999999999999998654322111
Q ss_pred -CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHHH
Q 005944 227 -GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKD 303 (668)
Q Consensus 227 -~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~d 303 (668)
......++..|+|||.+.+..++.++|||||||++|+|++ |.+||..... +....+. .......+..++..+++
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~ 229 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE---SGERLPRPEECPQEIYS 229 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---cCCcCCCCCCCCHHHHH
Confidence 1112223567999999998889999999999999999998 9999965432 2222222 22233556778899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHc
Q 005944 304 FLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 304 LI~kcL~~dP~~RPSa~EIL~ 324 (668)
||.+||..+|.+||++.++++
T Consensus 230 li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 230 IMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=357.43 Aligned_cols=263 Identities=28% Similarity=0.441 Sum_probs=224.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....++++...||-||||.|=++........+|+|+++.... .+....+.+..|-+||..++.|.||+||..|.+
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hI-----VdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd 491 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHI-----VDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD 491 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhc-----cchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc
Confidence 334567788899999999999998776666799998843221 222334567789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
..++|++||-|-||.|...|+..+.|.+..++.++.-+++|++|||++|||+|||||+|.|++.+|.+||.|||+|+.+.
T Consensus 492 ~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 492 SKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred chhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999875
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
.. ...-++||||.|.|||++++..++.++|.|||||++||||+|.+||..... +.....+........+|..++..
T Consensus 572 ~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dp-mktYn~ILkGid~i~~Pr~I~k~ 647 (732)
T KOG0614|consen 572 SG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDP-MKTYNLILKGIDKIEFPRRITKT 647 (732)
T ss_pred cC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCch-HHHHHHHHhhhhhhhcccccchh
Confidence 43 334579999999999999999999999999999999999999999986432 22222222233345677899999
Q ss_pred HHHHHHHhhhhCCCCCCC-----HHHHHcCccccCCC
Q 005944 301 AKDFLLKCLQKEPYLRST-----ASELLQHPFVTGKY 332 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~~~ 332 (668)
+.+||+++...+|.+|.. +.+|.+|.||.+..
T Consensus 648 a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 648 ATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred HHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 999999999999999966 89999999998743
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=362.47 Aligned_cols=271 Identities=23% Similarity=0.263 Sum_probs=197.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCC-CcEEEEEEeeeccc---------chhhHhhHHHHHHHHHHHHHHHhCCCC
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDS-GELLAVKQVLIAAN---------SASKEKTQAHIRELEEEVKLLKNLTHP 129 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t-g~~VAVK~i~~~~~---------~~~~~~~~~~~~~~~~Ei~iL~~L~Hp 129 (668)
+....+|++.+.||+|+||+||+|..+.. +..+++|.+..... .............+.+|+.+|+.++|+
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 34457899999999999999999976543 22223221100000 000111223445678999999999999
Q ss_pred CeeeeccccccCCcceEEeeccCCCChhcccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC
Q 005944 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-----GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN 204 (668)
Q Consensus 130 NIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~-----~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~ 204 (668)
|||++++++...+..|+|++++.+ +|..++... .......++.|+.||+.||.|||++|||||||||+||||+.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 999999999999999999999954 666655321 23456778899999999999999999999999999999999
Q ss_pred CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCC-Cchh----HHHHH
Q 005944 205 KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPP-WSQQ----FQEVA 279 (668)
Q Consensus 205 ~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~P-F~~~----~~~~~ 279 (668)
++.+||+|||+++.+..... ......+||+.|+|||++.+..++.++|||||||+||||++|..+ |... .....
T Consensus 303 ~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 99999999999986543211 122346799999999999999999999999999999999998754 4211 11111
Q ss_pred HHHhhcc---CC---------------CCC----CC-----CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 280 ALFHIGT---TK---------------SHP----PI-----PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 280 ~~~~~~~---~~---------------~~~----~~-----p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.++.... .. ... .+ ...++..+.++|.+||+.||.+|||+.|+|.||||....
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 1111000 00 000 00 013456778899999999999999999999999997643
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=341.99 Aligned_cols=261 Identities=27% Similarity=0.477 Sum_probs=209.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++...||+|+||.||+|.+..++..||||++.... ........+.+|+.+++.+.|+||+++++++..
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 85 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF------QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTP 85 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc------chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence 45778999999999999999999999999999999874221 112234556789999999999999999998876
Q ss_pred CCc------ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 141 DDS------LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 141 ~~~------~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
... .++|+||+ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 86 ASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccc
Confidence 654 89999999 6699988865 579999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccC----
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTT---- 287 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~---- 287 (668)
++..... ......++..|+|||++.+. .++.++|||||||++|+|++|+.||..... ....+......
T Consensus 164 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 164 LARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccccc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence 9875432 23445789999999998753 578999999999999999999999964321 11111111000
Q ss_pred -------------------CCC---CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCC
Q 005944 288 -------------------KSH---PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334 (668)
Q Consensus 288 -------------------~~~---~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~ 334 (668)
... ......++.++.+||.+||+.+|.+|||+.+|+.||||......
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~ 307 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence 000 01112458899999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.91 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=206.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCc---EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~---~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
+...+|+..+.||+|+||.||+|++..++. .+|+|.+.... .......+..|+++++.++|+||++++++
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 74 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-------TEKQRQDFLSEASIMGQFSHHNIIRLEGV 74 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-------CHHHHHHHHHHHHHHhcCCCCCeeEEEEE
Confidence 345678999999999999999999876654 79999873221 12234567889999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+...+..|+||||+++++|.+++... +.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 75 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~ 154 (268)
T cd05063 75 VTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLS 154 (268)
T ss_pred EccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccc
Confidence 99999999999999999999998654 67899999999999999999999999999999999999999999999999998
Q ss_pred hhhHhhhhhcC-CccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCC
Q 005944 217 KKVVELATING-AKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPI 293 (668)
Q Consensus 217 ~~~~~~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~ 293 (668)
........... ......++.|+|||++.+..++.++|||||||++|+|++ |..||..... +....+. .....+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~---~~~~~~~ 231 (268)
T cd05063 155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN---DGFRLPA 231 (268)
T ss_pred eecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh---cCCCCCC
Confidence 75532211111 111223557999999998889999999999999999997 9999964432 2222222 1223344
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+..++.++.+|+.+||+.+|.+||++.+|++
T Consensus 232 ~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 232 PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 5567899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=327.70 Aligned_cols=251 Identities=25% Similarity=0.431 Sum_probs=204.4
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCc---EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~---~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.+|++.+.||+|+||.||+|.+..++. .||||++... ........+..|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~ 76 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-------YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-------CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC
Confidence 468999999999999999999887665 6999987421 122334668899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
+...++||||+++++|.+++... +.+++.+++.++.|++.||.|||++||+|+||||+|||++.++.+||+|||++..+
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~ 156 (269)
T cd05065 77 SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 156 (269)
T ss_pred CCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence 99999999999999999998753 56899999999999999999999999999999999999999999999999998765
Q ss_pred HhhhhhcCCccC---CCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCC
Q 005944 220 VELATINGAKSM---KGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIP 294 (668)
Q Consensus 220 ~~~~~~~~~~~~---~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p 294 (668)
............ ..+..|+|||++.+..++.++|||||||++|||++ |..||..... +...... .....+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~---~~~~~~~~ 233 (269)
T cd05065 157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE---QDYRLPPP 233 (269)
T ss_pred ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH---cCCcCCCc
Confidence 332211111111 12457999999998889999999999999999886 9999965432 2222211 12233445
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..++..+.+++.+||..+|.+||++.+|+.
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 234 MDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 577889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=327.30 Aligned_cols=252 Identities=25% Similarity=0.432 Sum_probs=205.2
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCC---cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg---~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
..+|++.+.||+|+||.||+|.+..++ ..+|+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 75 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-------TEKQRRDFLSEASIMGQFDHPNIIHLEGVVT 75 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence 457999999999999999999886554 379999874211 1223456888999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
..+..|+||||+++++|.+++... +.+++.++..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 76 KSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred cCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 999999999999999999998764 4689999999999999999999999999999999999999999999999999886
Q ss_pred hHhhhhhc-CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCc
Q 005944 219 VVELATIN-GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 219 ~~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~ 295 (668)
+....... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... +....+. .....+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 232 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE---EGYRLPAPM 232 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh---CCCcCCCCC
Confidence 54322111 1112234568999999998889999999999999999886 9999965432 2222111 112234455
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.++..+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 233 DCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 67889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.65 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=206.6
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
+....+|++.+.||.|+||.||+|.+. ++..||||.+.... .....+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~---------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT---------MSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc---------cCHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence 456788999999999999999999865 56789999874211 11245778999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.....++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+||||+.++.+||+|||++.
T Consensus 72 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~ 151 (261)
T cd05034 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLAR 151 (261)
T ss_pred cCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccce
Confidence 889999999999999999999764 368999999999999999999999999999999999999999999999999987
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ 296 (668)
.+.... ........++..|+|||.+.+..++.++|||||||++|+|++ |+.||.......... ........+.+..
T Consensus 152 ~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~ 228 (261)
T cd05034 152 LIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE--QVERGYRMPRPPN 228 (261)
T ss_pred eccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH--HHHcCCCCCCCCC
Confidence 654321 111122335678999999998889999999999999999998 999997543221111 1112223345566
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.+.++.+++.+||+.+|.+||++.++++
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 229 CPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=331.01 Aligned_cols=261 Identities=34% Similarity=0.553 Sum_probs=210.8
Q ss_pred CeeeeeEEcccCceEEEEEEEc---CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccccc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTARE 140 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~ 140 (668)
+|++.+.||+|+||.||+|++. .++..||||++.... ..........+.+|+.++.++ +|+||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~----~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~ 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKAT----IVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHH----HHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec
Confidence 4889999999999999999864 467899999884221 112223445678899999999 59999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...+|+||||+.+|+|.+++.....+++..++.++.|++.+|.|||+.|++||||||.||+++.++.++|+|||++..+.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 156 (288)
T cd05583 77 DTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (288)
T ss_pred CCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence 99999999999999999999877789999999999999999999999999999999999999999999999999987653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcC--CCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCCCCCCCCcc
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTG--HSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~--~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~~~~~~p~~ 296 (668)
.... .......|+..|+|||.+.+.. ++.++||||||+++|+|++|..||..... ....+... ......+.+..
T Consensus 157 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (288)
T cd05583 157 AEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRR-ILKSKPPFPKT 234 (288)
T ss_pred cccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHH-HHccCCCCCcc
Confidence 2211 1122356899999999987655 78899999999999999999999953210 11111111 11223456667
Q ss_pred cCHHHHHHHHHhhhhCCCCCCC---HHHHHcCccccCC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRST---ASELLQHPFVTGK 331 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPS---a~EIL~Hpwf~~~ 331 (668)
++.++.+||.+||+.+|++||| +.++|+||||+..
T Consensus 235 ~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 235 MSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred cCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 8899999999999999999998 5678999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=329.18 Aligned_cols=254 Identities=33% Similarity=0.572 Sum_probs=205.3
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcce
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN 145 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~ 145 (668)
|++.+.||.|++|.||+|.+..++..+|+|.+.... ..+.....+.+|+.+|+.++|+||+++++++......+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF------ESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY 74 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccc------ccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence 667889999999999999999999999999874321 11123456778999999999999999999999999999
Q ss_pred EEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 146 ILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
+||||+++ +|..++.. ...+++..+..++.||+.||.|||+.||+|+||||+||+++.++.+||+|||.+.......
T Consensus 75 ~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 75 LVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred EEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 99999975 77777755 4689999999999999999999999999999999999999999999999999987654322
Q ss_pred hcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCC-------------
Q 005944 225 INGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTK------------- 288 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~------------- 288 (668)
.......++..|+|||.+.+. .++.++|||||||++|+|+||+.||..... ............
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 122335688899999999876 689999999999999999999999964321 111111100000
Q ss_pred ------------CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 289 ------------SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 289 ------------~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
........++.++.+||.+||+.||.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0001123467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=327.55 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=202.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
+...+|++.+.||+|+||.||+|++..+ ..||||++..... ....+.+|+.+++.++|+||+++++.+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~---------~~~~~~~E~~~l~~l~~~~i~~~~~~~~- 71 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAVVS- 71 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc---------CHHHHHHHHHHHHhCCCCCcceEEEEEC-
Confidence 5567899999999999999999987655 4699998842110 1235778999999999999999999875
Q ss_pred CCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
....++||||+++|+|.+++.+. ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++..
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 72 EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceee
Confidence 45689999999999999999753 3578999999999999999999999999999999999999999999999999876
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~~l 297 (668)
+..... .......++..|+|||++.+..++.++|||||||++|+|+| |..||............. .....+.+..+
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~ 228 (262)
T cd05071 152 IEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE--RGYRMPCPPEC 228 (262)
T ss_pred cccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh--cCCCCCCcccc
Confidence 532211 11223446778999999988889999999999999999999 888997543322111111 11223345678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+..+.+||.+||+.+|.+||++.++++
T Consensus 229 ~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 229 PESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=330.98 Aligned_cols=253 Identities=28% Similarity=0.488 Sum_probs=200.7
Q ss_pred CCe-eeeeEEcccCceEEEEEE----EcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 64 IRW-RKGELVGCGAFGRVYMGM----NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 64 ~ry-~i~~~LG~G~fG~Vy~a~----~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
.+| ++.+.||+|+||+||++. ...++..||+|++.... .......+.+|+.+|+.++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 75 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-------GQQNTSGWKKEINILKTLYHENIVKYKGCC 75 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 355 899999999999998865 34568899999884221 112345577899999999999999999987
Q ss_pred ccC--CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 139 RED--DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 139 ~~~--~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
... ..+++||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 76 ~~~~~~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 76 SEQGGKGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred ecCCCceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccc
Confidence 653 458899999999999999876 46999999999999999999999999999999999999999999999999998
Q ss_pred hhhHhhhhhc-CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHh------------
Q 005944 217 KKVVELATIN-GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH------------ 283 (668)
Q Consensus 217 ~~~~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~------------ 283 (668)
+.+....... ......++..|+|||++.+..++.++|||||||++|+|+||..||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLI 234 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhh
Confidence 8654322111 112234667899999998888999999999999999999999998543221111110
Q ss_pred -hccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 284 -IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 284 -~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
........+.+..++.++.+|+.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111223345678899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=328.79 Aligned_cols=254 Identities=28% Similarity=0.485 Sum_probs=200.7
Q ss_pred CCCeeeeeEEcccCceEEEEEEE----cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMN----LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~----~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
..+|++.+.||+|+||+||+|.. ..++..||||++... .....+.+.+|+++|+.++||||+++++++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 74 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--------TAEHLRDFEREIEILKSLQHDNIVKYKGVC 74 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 34789999999999999999973 457889999987321 223345688999999999999999999876
Q ss_pred cc--CCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 139 RE--DDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 139 ~~--~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
.. ...+++||||+++|+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 75 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 75 YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred ccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcc
Confidence 43 35689999999999999998654 4689999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcC-CccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHH--------------
Q 005944 216 SKKVVELATING-AKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAA-------------- 280 (668)
Q Consensus 216 A~~~~~~~~~~~-~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~-------------- 280 (668)
+..+........ .....++..|+|||++.+..++.++|||||||++|+|++|..|+.........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 986533221111 11123445699999999888999999999999999999987776432211110
Q ss_pred HHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 281 LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 281 ~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+..........+.+..++.++.+||.+||..+|++|||+.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 235 LIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 01111112223445678899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=325.86 Aligned_cols=250 Identities=25% Similarity=0.427 Sum_probs=202.9
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||.||+|.+. ++..||+|.+..... ....+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~---------~~~~~~~E~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05070 2 EIPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM---------SPESFLEEAQIMKKLRHDKLVQLYAVVS 71 (260)
T ss_pred CCchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC---------CHHHHHHHHHHHHhcCCCceEEEEeEEC
Confidence 345678999999999999999999765 567799998843211 1134778999999999999999999875
Q ss_pred cCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~ 150 (260)
T cd05070 72 -EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLAR 150 (260)
T ss_pred -CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeee
Confidence 45689999999999999998653 458999999999999999999999999999999999999999999999999987
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCCCc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~p~ 295 (668)
.+..... .......++..|+|||++.+..++.++||||||+++|+|++ |.+||...... ....+ ......+.+.
T Consensus 151 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~ 226 (260)
T cd05070 151 LIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQV---ERGYRMPCPQ 226 (260)
T ss_pred eccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---HcCCCCCCCC
Confidence 6532211 11122345668999999988889999999999999999999 89999654322 22211 1223345567
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..+..+.+|+.+||..+|.+|||+.++++
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 227 DCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 78899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=321.92 Aligned_cols=245 Identities=26% Similarity=0.428 Sum_probs=206.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
+...+|++.+.||.|+||.||+|.. .|+.||||.+.... .....+.+|+.+++.++|+||+++++++..
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~---------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 71 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDS---------TAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccch---------hHHHHHHHHHHHHHhcCCcceeeeEEEEcC
Confidence 3456899999999999999999986 47899999884211 134567889999999999999999999998
Q ss_pred CCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
....++||||+++++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 72 GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccc
Confidence 999999999999999999997655 689999999999999999999999999999999999999999999999999986
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCCCcc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ 296 (668)
.... .....++..|+|||.+....++.++|||||||++|+|++ |..||...... ...... .......+..
T Consensus 152 ~~~~-----~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~ 223 (256)
T cd05039 152 ASQG-----QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVE---KGYRMEAPEG 223 (256)
T ss_pred cccc-----cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh---cCCCCCCccC
Confidence 5321 113345677999999988889999999999999999997 99999654322 222111 1223344567
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
++.++.+||.+||..+|.+||++.++++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 8899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=328.25 Aligned_cols=255 Identities=34% Similarity=0.572 Sum_probs=204.2
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC--Cc
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED--DS 143 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~--~~ 143 (668)
|++.+.||.|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++|+||+++++++... ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~------~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 74 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN------EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS 74 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc------ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence 678899999999999999999999999999985432 1122334577899999999999999999999888 88
Q ss_pred ceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.++||||+++ +|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+|||++.++.+||+|||++......
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 75 IYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred EEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9999999975 888887665 57999999999999999999999999999999999999999999999999998765432
Q ss_pred hhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccC---CCC------
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTT---KSH------ 290 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~---~~~------ 290 (668)
.. .......++..|+|||.+.+. .++.++|||||||++|+|++|..||...... ...+...... ..+
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 21 112334678899999987653 5789999999999999999999999643321 1111111000 000
Q ss_pred ---------C--------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 291 ---------P--------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 291 ---------~--------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
. .+...++.++.++|.+||..+|.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 0111138889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=328.40 Aligned_cols=253 Identities=32% Similarity=0.534 Sum_probs=200.0
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC---CCCCeeeeccccccCC
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL---THPNIVRYLGTAREDD 142 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIV~l~g~~~~~~ 142 (668)
|++.+.||.|+||.||+|.+..++..||||++..... .......+.+|+.+++.+ .|+||+++++++...+
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~------~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 74 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS------EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR 74 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc------cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence 6789999999999999999988999999999853321 111123345677766655 6999999999998877
Q ss_pred c-----ceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 143 S-----LNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 143 ~-----~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
. ++++|||+.+ +|.+++... ..+++..++.++.||+.||.|||+.||+|+||+|+|||++.++.+||+|||+
T Consensus 75 ~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 75 TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred CCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCc
Confidence 6 9999999975 788887654 3589999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccCCC----
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTTKS---- 289 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~~~---- 289 (668)
+..+.... ......+++.|+|||++.+..++.++|||||||++|+|++|.+||...... ...+........
T Consensus 154 ~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 154 ARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEW 230 (287)
T ss_pred ceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhc
Confidence 87653221 122345789999999999888999999999999999999999999754321 111111100000
Q ss_pred ---------------C---CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 290 ---------------H---PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 290 ---------------~---~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
. ......++..+.+||.+||+.||.+||++.+++.||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 00112356788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=322.02 Aligned_cols=248 Identities=31% Similarity=0.519 Sum_probs=205.4
Q ss_pred eeeeeEEcccCceEEEEEEEcCCC----cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSG----ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg----~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
+.+.+.||.|+||.||+|.+...+ ..||+|++.... .......+..|+.++..++|+||+++++++...
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 73 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-------DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE 73 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-------ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 356789999999999999998766 899999884221 111445688899999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~--l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
...+++|||+++++|.+++..... +++..+..++.||+.||.|||+.||+|+||||+||+++.++.++|+|||++...
T Consensus 74 ~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 74 EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999999999999976544 999999999999999999999999999999999999999999999999999766
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCccc
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~l 297 (668)
......... ...+++.|+|||.+.+..++.++|||||||++|+|++ |.+||..... ....... .......+..+
T Consensus 154 ~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~ 229 (258)
T smart00219 154 YDDDYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLK---KGYRLPKPENC 229 (258)
T ss_pred ccccccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---cCCCCCCCCcC
Confidence 443221111 2337789999999988889999999999999999998 8899864322 2222221 22233455668
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+.++.+++.+||..+|.+|||+.++++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 230 PPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 999999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=324.13 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=201.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
+...+|++.+.||.|+||.||+|.+..+ ..+|+|.+.... .....+.+|+++++.++|+||+++++++.
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 71 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT---------MMPEAFLQEAQIMKKLRHDKLVPLYAVVS- 71 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC---------ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-
Confidence 4456799999999999999999987554 469999873211 11245678999999999999999999875
Q ss_pred CCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
....++||||+.+++|.+++... ..+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++..
T Consensus 72 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceE
Confidence 45689999999999999998654 3478999999999999999999999999999999999999999999999999875
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~~l 297 (668)
..... ........++..|+|||.+.+..++.++|||||||++|+|+| |..||.......... .. ......+.+..+
T Consensus 152 ~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~-~~~~~~~~~~~~ 228 (260)
T cd05069 152 IEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE-QV-ERGYRMPCPQGC 228 (260)
T ss_pred ccCCc-ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-HH-HcCCCCCCCccc
Confidence 53211 111223346778999999988889999999999999999999 999997643322111 11 112233456678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+..+.+|+.+||.++|.+||+++++++
T Consensus 229 ~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 229 PESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=324.20 Aligned_cols=250 Identities=25% Similarity=0.451 Sum_probs=203.9
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
++...+|++.++||+|+||.||+|.. .+++.||+|.+.... .....+.+|+.+++.++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~---------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 71 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGS---------MSPEAFLAEANLMKQLQHPRLVRLYAVVT 71 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCC---------CcHHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence 45677899999999999999999985 467889999874211 11235778999999999999999999864
Q ss_pred cCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.+..++||||+.+++|.+++... ..+++.++..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++.
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 150 (260)
T cd05067 72 -QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150 (260)
T ss_pred -cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCccee
Confidence 56789999999999999988653 468999999999999999999999999999999999999999999999999987
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~ 295 (668)
...... ........++..|+|||++....++.++|||||||++|+|++ |++||..... ....... .....+.+.
T Consensus 151 ~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 226 (260)
T cd05067 151 LIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLE---RGYRMPRPD 226 (260)
T ss_pred ecCCCC-cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHH---cCCCCCCCC
Confidence 553211 111123346778999999988889999999999999999999 9999975432 2222221 122334566
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.++.++.+||.+||..+|.+||++++++.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 78899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=370.16 Aligned_cols=150 Identities=34% Similarity=0.578 Sum_probs=136.0
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|.+.+.||+|+||+||+|.+..+++.||||++.... .........+..|+.++..++|+||+++++++....
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 77 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKAD-----MINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN 77 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhh-----ccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence 357999999999999999999999999999999984321 112234456888999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.+||||||+.+++|.+++...+.+++..++.|+.||+.||.|||.+|||||||||+||||+.++.+||+|||+++
T Consensus 78 ~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 78 NVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999999999888889999999999999999999999999999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=323.87 Aligned_cols=256 Identities=30% Similarity=0.537 Sum_probs=207.2
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|.+.+.||+|+||.||+|.+..++..+++|+++....... .......+..|+.+++.++||||+++++++......
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGEL---NPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEecccccccc---CcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCce
Confidence 68999999999999999999988877787877643221111 111223456789999999999999999999999999
Q ss_pred eEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 145 NILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
++||||+++++|.+++.. ...+++..++.++.||+.||.|||+.||+|+||||+||+++. +.+||+|||++..+.
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999988753 356899999999999999999999999999999999999975 679999999987653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
... .......|++.|+|||.+.+..++.++||||||+++|+|++|..||....... ..... .....+..+..++.+
T Consensus 157 ~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~ 232 (260)
T cd08222 157 GSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLS-VVLRI-VEGPTPSLPETYSRQ 232 (260)
T ss_pred CCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHH-HcCCCCCCcchhcHH
Confidence 221 12234568899999999988888999999999999999999999996432211 11111 122334456678899
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
+.++|.+||..+|.+||++.++++||||
T Consensus 233 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 233 LNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=366.49 Aligned_cols=258 Identities=29% Similarity=0.484 Sum_probs=218.5
Q ss_pred CCCCCCCCCCeeeeeEEcccCceEEEEEEEcC-----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC
Q 005944 56 IEKTDAPPIRWRKGELVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130 (668)
Q Consensus 56 ~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN 130 (668)
....++...+.+..+.||+|+||+||+|.-.. ....||||.++ .....+....|++|+.+|..++|||
T Consensus 478 ~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LK-------d~a~~~~~~dF~REaeLla~l~H~n 550 (774)
T KOG1026|consen 478 LKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALK-------DKAENQARQDFRREAELLAELQHPN 550 (774)
T ss_pred cceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhc-------ccccHHHHHHHHHHHHHHHhccCCC
Confidence 33445677788889999999999999997533 35789999883 2223346678999999999999999
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcccccCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCC
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG--------------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIK 196 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~--------------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLK 196 (668)
||+|+|+|.+++.+|+|+|||..|||.++|+... +++..+.+.|+.||+.|+.||-++++|||||-
T Consensus 551 IVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLA 630 (774)
T KOG1026|consen 551 IVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLA 630 (774)
T ss_pred eEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchh
Confidence 9999999999999999999999999999985431 27888999999999999999999999999999
Q ss_pred cccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH
Q 005944 197 GANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF 275 (668)
Q Consensus 197 PeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~ 275 (668)
..|+||..+-.|||+||||++.+...+.+.....-.-..+|||||.|+.+.|+.++||||+||+|||+++ |+.||.+..
T Consensus 631 TRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 631 TRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred hhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 9999999999999999999997755444332222234678999999999999999999999999999998 999998764
Q ss_pred -HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 005944 276 -QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELL 323 (668)
Q Consensus 276 -~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL 323 (668)
+++...+..+.. .+.|++++.++++||..||+.+|.+||++.||-
T Consensus 711 n~EVIe~i~~g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 711 NQEVIECIRAGQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred hHHHHHHHHcCCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 455555554433 677899999999999999999999999999984
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=342.28 Aligned_cols=264 Identities=28% Similarity=0.463 Sum_probs=207.6
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|++.+.||+|+||.||+|.+..++..||||++.... ........+.+|+.+++++ +|+||+++++++.
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~ 77 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF------RNATDAQRTFREIMFLQELGDHPNIVKLLNVIK 77 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc------CcchhhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence 45578999999999999999999999899999999874211 1111234466799999999 9999999999876
Q ss_pred cC--CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 ED--DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~--~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.. ...|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 78 ~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 78 AENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred cCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 54 35899999997 5898888765 78899999999999999999999999999999999999999999999999998
Q ss_pred hhHhhhhh---cCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhh-------
Q 005944 218 KVVELATI---NGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHI------- 284 (668)
Q Consensus 218 ~~~~~~~~---~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~------- 284 (668)
.+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65432211 12234568999999998865 45788999999999999999999999532211 1110000
Q ss_pred -----------------c--cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 285 -----------------G--TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 285 -----------------~--~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
. ...........++.++.+||.+||+.+|.+|||+.++++||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence 0 00000111223688999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=335.45 Aligned_cols=251 Identities=28% Similarity=0.447 Sum_probs=195.5
Q ss_pred CceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeeccCCCC
Q 005944 76 AFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGS 155 (668)
Q Consensus 76 ~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~~gGs 155 (668)
++|.||.+++..+++.||||++... .........+.+|+.+++.++|+||+++++++...+..+++|||+++|+
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~------~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLD------SCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEecc------ccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 4455666666679999999998432 1123345678899999999999999999999999999999999999999
Q ss_pred hhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh-----hcCC
Q 005944 156 ISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT-----INGA 228 (668)
Q Consensus 156 L~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~-----~~~~ 228 (668)
|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+..+..... ....
T Consensus 86 l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~ 165 (314)
T cd08216 86 CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFP 165 (314)
T ss_pred HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccc
Confidence 99998753 4689999999999999999999999999999999999999999999999998865432111 1112
Q ss_pred ccCCCCCCCCChHHHhhc--CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccC-------------------
Q 005944 229 KSMKGTPYWMAPEVILQT--GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT------------------- 287 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~--~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~------------------- 287 (668)
....++..|+|||++.+. .++.++|||||||++|+|++|..||................
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (314)
T cd08216 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQ 245 (314)
T ss_pred ccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCc
Confidence 234578889999999763 58899999999999999999999997432111111000000
Q ss_pred ------------CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 288 ------------KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 288 ------------~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.........++.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 246 SRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 000111223456789999999999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=333.75 Aligned_cols=253 Identities=38% Similarity=0.607 Sum_probs=205.4
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
.|...+.||+|+||+||+|++..++..||+|++..... ........+.+|+.+++.++|+||+++++++......
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK-----QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEecccc-----CchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 36677889999999999999999999999998843211 1223345678899999999999999999999999999
Q ss_pred eEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 145 NILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++||+|+||+|+||+++.++.+||+|||++....
T Consensus 97 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 97 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 999999965 66666643 4578999999999999999999999999999999999999999999999999986421
Q ss_pred hhcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 224 TINGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
......|+..|+|||++. ...++.++|||||||++|+|++|..||....... .................++..
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 248 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNDSPTLQSNEWTDS 248 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCccccCHH
Confidence 223467899999999984 3557889999999999999999999996532211 111111111222223456788
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+++||.+||+.+|.+||++.+++.||||..
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~ 278 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFVRR 278 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=336.93 Aligned_cols=261 Identities=25% Similarity=0.392 Sum_probs=204.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcCC--CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccccc-
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDS--GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTARE- 140 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~t--g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~- 140 (668)
+|++.+.||+|+||.||+|.+..+ +..||||++.... ........+.+|+.+++.+ +|+||+++++....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 74 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF------SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVF 74 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc------ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeec
Confidence 589999999999999999999888 9999999874211 1112234567899999999 59999999986432
Q ss_pred ---CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 141 ---DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 141 ---~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
...+|++++|+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 75 ~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 75 PGNFNELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred cccCCcEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 245788999986 6899998888889999999999999999999999999999999999999999999999999997
Q ss_pred hhHhhhhh--cCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH-H-HHHHHh---------
Q 005944 218 KVVELATI--NGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-E-VAALFH--------- 283 (668)
Q Consensus 218 ~~~~~~~~--~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~-~~~~~~--------- 283 (668)
.+...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||..... . ......
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432111 11234578999999998876 4589999999999999999999999964211 0 000000
Q ss_pred --------------hc-c--CCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 284 --------------IG-T--TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 284 --------------~~-~--~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.. . ..........++.++.+||.+||+.+|.+|||+.+++.||||....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH 299 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence 00 0 0000112234578999999999999999999999999999997553
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=334.02 Aligned_cols=255 Identities=36% Similarity=0.597 Sum_probs=207.9
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
...|...+.||+|+||.||+|++..++..||||++.... .........+.+|+.+++.++|+||+++++++..+.
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 98 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSG-----KQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH 98 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCC-----CCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence 344888999999999999999999999999999874321 112233456788999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~-~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
..++||||+.| +|.+++. ....+++..+..++.||+.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 99 ~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 99 TAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99999999975 6666654 346689999999999999999999999999999999999999999999999998864321
Q ss_pred hhhhcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccC
Q 005944 222 LATINGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls 298 (668)
.....|++.|+|||++. ...++.++|||||||++|+|++|..||....... .................++
T Consensus 178 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 250 (317)
T cd06635 178 ------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPTLQSNEWS 250 (317)
T ss_pred ------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH-HHHHHHhccCCCCCCcccc
Confidence 23457899999999984 3557889999999999999999999986543211 1111111122222344678
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
..+++||.+||+.+|.+||++.++++|+|+..
T Consensus 251 ~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 251 DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 89999999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=325.88 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=207.2
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcC-----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
...+|++.+.||.|+||.||+|+... +...||+|.+.. .........+.+|+++|+.++|+||+++++
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 75 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-------TKDENLQSEFRRELDMFRKLSHKNVVRLLG 75 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCC-------ccchHHHHHHHHHHHHHHhcCCcceeeeEE
Confidence 34679999999999999999999754 346788997632 112234567889999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccCC---------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKFG---------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC 207 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~---------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~ 207 (668)
++......++||||+++|+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+|||++.++.
T Consensus 76 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~ 155 (275)
T cd05046 76 LCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE 155 (275)
T ss_pred EECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc
Confidence 9999999999999999999999987655 6899999999999999999999999999999999999999999
Q ss_pred eEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhcc
Q 005944 208 IKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGT 286 (668)
Q Consensus 208 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~ 286 (668)
++|+|||++...... .........++..|+|||.+.+..++.++|||||||++|+|++ |..||........ ......
T Consensus 156 ~~l~~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~-~~~~~~ 233 (275)
T cd05046 156 VKVSLLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV-LNRLQA 233 (275)
T ss_pred EEEcccccccccCcc-cccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH-HHHHHc
Confidence 999999998643211 1112233456778999999988888999999999999999998 8889965332211 111111
Q ss_pred CCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 287 ~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.......+..++..+.++|.+||+.+|.+||++.+++.+
T Consensus 234 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 234 GKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 222233456788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=330.79 Aligned_cols=255 Identities=27% Similarity=0.480 Sum_probs=203.0
Q ss_pred CCeeeeeEEcccCceEEEEEEE----cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMN----LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~----~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.-|++.+.||+|+||.||+|.. ..++..||+|.+... ........+.+|+.+|+.+.|+||+++++++.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-------SGGNHIADLKKEIEILRNLYHENIVKYKGICT 76 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-------ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence 3478899999999999999974 457889999987321 11233456889999999999999999999887
Q ss_pred cC--CcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 140 ED--DSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 140 ~~--~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
.. ...++||||++|++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 77 ~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~ 156 (284)
T cd05079 77 EDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 156 (284)
T ss_pred cCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccc
Confidence 65 5689999999999999998654 45899999999999999999999999999999999999999999999999998
Q ss_pred hhhHhhhhh-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH-------------HHHH
Q 005944 217 KKVVELATI-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV-------------AALF 282 (668)
Q Consensus 217 ~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~-------------~~~~ 282 (668)
+.+...... .......++..|+|||++.+..++.++|||||||++|+|+|+..|+....... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05079 157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV 236 (284)
T ss_pred cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence 865322211 11224557788999999988889999999999999999999877653221110 0011
Q ss_pred hhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 283 HIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 283 ~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.........+.+..++..+.+||.+||+.+|.+||++.+++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 1111122334556789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=337.49 Aligned_cols=259 Identities=24% Similarity=0.434 Sum_probs=205.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|.+.+.||+|+||.||+|.+..++..||+|++.... ........+.+|+.+++.++|+||+++++++..
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc------hhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 45688999999999999999999999999999999884311 112233457789999999999999999988754
Q ss_pred C------CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 141 D------DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 141 ~------~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
. ...|++++++ +++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg 165 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 165 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccc
Confidence 3 3468888887 7799887765 469999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhcc-----
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGT----- 286 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~----- 286 (668)
++..... ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ....+.....
T Consensus 166 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (345)
T cd07877 166 LARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 240 (345)
T ss_pred ccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9875422 2334578999999999876 4578899999999999999999999963221 1111100000
Q ss_pred ----------------CCC-----CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 287 ----------------TKS-----HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 287 ----------------~~~-----~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
... ........++++.+||.+||+.||.+||++.+++.||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 000 0011124578899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=374.23 Aligned_cols=257 Identities=22% Similarity=0.327 Sum_probs=204.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.++||+|+||.||+|++..+++.||||++..... ......+.+.+|+++++.++|||||++++++...+.
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~-----~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~ 76 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLS-----ENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDP 76 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccc-----cCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCE
Confidence 579999999999999999999999999999999843211 122334568889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEec
Q 005944 144 LNILLEFVPGGSISSLLGKF-----------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLAD 212 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~-----------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~D 212 (668)
.|+||||++||+|.+++... ..++...+..++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiD 156 (932)
T PRK13184 77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILD 156 (932)
T ss_pred EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEe
Confidence 99999999999999988531 2355677889999999999999999999999999999999999999999
Q ss_pred CCchhhhHhhhh----------------hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH
Q 005944 213 FGASKKVVELAT----------------INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ 276 (668)
Q Consensus 213 FGlA~~~~~~~~----------------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~ 276 (668)
||+++....... .......+||+.|+|||++.+..++.++|||||||++|+|+||..||.....
T Consensus 157 FGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 157 WGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred cCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 999976521100 0111235799999999999999999999999999999999999999975322
Q ss_pred HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 277 EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 277 ~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
....................+++.+.+++.+||+.||.+|++..+.+.+
T Consensus 237 ~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 237 RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1111111111111111124678899999999999999999876665544
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=322.65 Aligned_cols=243 Identities=25% Similarity=0.419 Sum_probs=200.5
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc-cc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA-RE 140 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~-~~ 140 (668)
...+|++.+.||+|+||.||++.. .|..||+|.+... .....+.+|+.+++.++|+||+++++++ ..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~----------~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 71 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----------ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE 71 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCC----------chHHHHHHHHHHHHhCCCCCeeeEEEEEEcC
Confidence 345799999999999999999976 4788999987321 1234577899999999999999999875 45
Q ss_pred CCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
....++||||+++++|.+++.+.. .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus 72 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 72 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151 (256)
T ss_pred CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCcccee
Confidence 567899999999999999987543 488999999999999999999999999999999999999999999999999875
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH-HHHHHHHhhccCCCCCCCCcc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~-~~~~~~~~~~~~~~~~~~p~~ 296 (668)
... ......++..|+|||++.+..++.++|||||||++|+|++ |+.||.... ........ .......+..
T Consensus 152 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~ 223 (256)
T cd05082 152 ASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---KGYKMDAPDG 223 (256)
T ss_pred ccc-----cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---cCCCCCCCCC
Confidence 422 1223445678999999988889999999999999999997 999996532 22222222 1223345567
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
++..+.+||.+||+.+|.+|||+.++++
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 224 CPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 8999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.92 Aligned_cols=258 Identities=26% Similarity=0.386 Sum_probs=207.8
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCe
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNI 131 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNI 131 (668)
.+.....+|.++++||+|+||.||+|++. .++..||||++.... .......+.+|+.+|..+. ||||
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-------~~~~~~~~~~E~~~l~~l~~H~ni 103 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-------RSSEKQALMSELKIMSHLGPHLNI 103 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-------ChhHHHHHHHHHHHHHhcCCCCCe
Confidence 35567778999999999999999999864 356789999984321 1122345778999999997 9999
Q ss_pred eeeccccccCCcceEEeeccCCCChhcccccCC-----------------------------------------------
Q 005944 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKFG----------------------------------------------- 164 (668)
Q Consensus 132 V~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~----------------------------------------------- 164 (668)
|++++++......++|||||.+|+|.+++.+.+
T Consensus 104 v~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 183 (401)
T cd05107 104 VNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSK 183 (401)
T ss_pred EEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCC
Confidence 999999999999999999999999999885431
Q ss_pred ---------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 005944 165 ---------------------------------------------------SFPESVIRMYTKQLLLGLEYLHKNGIMHR 193 (668)
Q Consensus 165 ---------------------------------------------------~l~e~~~~~i~~QIl~aL~yLHs~gIvHr 193 (668)
.+++..++.|+.||+.||.|||+.+|+||
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHr 263 (401)
T cd05107 184 DESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHR 263 (401)
T ss_pred ccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcc
Confidence 25667788999999999999999999999
Q ss_pred cCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCc
Q 005944 194 DIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWS 272 (668)
Q Consensus 194 DLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~ 272 (668)
||||+|||++.++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~ 343 (401)
T cd05107 264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP 343 (401)
T ss_pred cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence 9999999999999999999999976432222122223457889999999998889999999999999999998 899996
Q ss_pred hhHH-H-HHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 273 QQFQ-E-VAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 273 ~~~~-~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.... + ...... .......+..++.++.+||.+||..+|.+||++.+|++.
T Consensus 344 ~~~~~~~~~~~~~---~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 344 ELPMNEQFYNAIK---RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCchHHHHHHHH---cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4321 1 111111 122334566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=320.16 Aligned_cols=245 Identities=27% Similarity=0.426 Sum_probs=200.1
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEee
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLE 149 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmE 149 (668)
++||.|+||.||+|.+.. ++.||+|++..... ......+.+|+++++++.|+||+++++++......++|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~-------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 72 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP-------PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVME 72 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC-------HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEE
Confidence 468999999999999877 99999998743211 1234567889999999999999999999999999999999
Q ss_pred ccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 150 FVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 150 y~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
|+.+++|.+++.. ...+++..+..++.|++.+|.|||++||+||||||+|||++.++.+||+|||++............
T Consensus 73 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 73 LVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9999999999865 356899999999999999999999999999999999999999999999999998754321111111
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
....++..|+|||++.+..++.++|||||||++|+|+| |..||............ ........+..++.++.+||.+
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~ 230 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI--ESGYRMPAPQLCPEEIYRLMLQ 230 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHH--hcCCCCCCCccCCHHHHHHHHH
Confidence 12334667999999988889999999999999999999 89998654322211111 1122334566788999999999
Q ss_pred hhhhCCCCCCCHHHHHc
Q 005944 308 CLQKEPYLRSTASELLQ 324 (668)
Q Consensus 308 cL~~dP~~RPSa~EIL~ 324 (668)
||..+|.+||++.++++
T Consensus 231 ~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 231 CWAYDPENRPSFSEIYN 247 (251)
T ss_pred HhccChhhCcCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=326.32 Aligned_cols=253 Identities=26% Similarity=0.446 Sum_probs=206.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCc----EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGE----LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~----~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
....+|++.+.||+|+||+||+|.+..+|. .||+|.+.... .......+.+|+.+|..++|+||+++++
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 76 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-------SPKANKEILDEAYVMASVDHPHVVRLLG 76 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-------CHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 345679999999999999999999877665 58888763221 1334456788999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++.. ...++||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 77 ~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~ 155 (279)
T cd05057 77 ICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGL 155 (279)
T ss_pred EEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcc
Confidence 8877 7899999999999999998764 5689999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH-HHHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~-~~~~~~~~~~~~~~~~~~ 293 (668)
++.+.............++..|+|||.+....++.++|||||||++|+|++ |..||.... .+....+. .....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~ 232 (279)
T cd05057 156 AKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE---KGERLPQ 232 (279)
T ss_pred cccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh---CCCCCCC
Confidence 986643222111222334678999999988889999999999999999998 999997543 22222222 2223344
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+...+..+.+++.+||..+|..||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 233 PPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=321.86 Aligned_cols=245 Identities=26% Similarity=0.417 Sum_probs=200.0
Q ss_pred eEEcccCceEEEEEEEcC-CC--cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceE
Q 005944 70 ELVGCGAFGRVYMGMNLD-SG--ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNI 146 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~-tg--~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~L 146 (668)
++||+|+||.||+|.+.. .+ ..||||.+.... .....+.+.+|+.++++++|+||+++++++.. ...++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~ 72 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK-------LSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMM 72 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcc-------cHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEE
Confidence 468999999999999865 33 369999883221 11455678899999999999999999999888 88999
Q ss_pred EeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 147 LLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 147 VmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
||||+++++|.+++.... .+++..++.++.||+.||.|||++||+|+||||+|||++.++.+||+|||++..+.....
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred EEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 999999999999987654 689999999999999999999999999999999999999999999999999987643221
Q ss_pred h-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHH
Q 005944 225 I-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 225 ~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
. .......++..|+|||.+.+..++.++|||||||++|+|++ |..||..... +...... ........+..++..+
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 230 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID--KEGERLERPEACPQDI 230 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--hcCCcCCCCccCCHHH
Confidence 1 11123457889999999998889999999999999999998 9999964322 2211111 1223334556778999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHc
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.+++.+||+.+|.+||++.++++
T Consensus 231 ~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 231 YNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHCCCCcccCCCHHHHHH
Confidence 99999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=322.97 Aligned_cols=243 Identities=24% Similarity=0.381 Sum_probs=196.2
Q ss_pred EEcccCceEEEEEEEc--CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEe
Q 005944 71 LVGCGAFGRVYMGMNL--DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~--~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
.||+|+||.||+|.+. ..+..||+|++... ........+.+|+.++++++|+||+++++++. ....++||
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~ 73 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNE-------NEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVM 73 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccc-------cChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEE
Confidence 3899999999999765 44667999987321 11233456889999999999999999999875 45789999
Q ss_pred eccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhc-
Q 005944 149 EFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN- 226 (668)
Q Consensus 149 Ey~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~- 226 (668)
||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.......
T Consensus 74 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 153 (257)
T cd05115 74 EMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153 (257)
T ss_pred EeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence 99999999998864 4578999999999999999999999999999999999999999999999999987553322111
Q ss_pred CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHHHH
Q 005944 227 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDF 304 (668)
Q Consensus 227 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dL 304 (668)
......+++.|+|||++.+..++.++|||||||++|+|++ |..||..... ........ ......+...+.++.+|
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~l 230 (257)
T cd05115 154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ---GKRLDCPAECPPEMYAL 230 (257)
T ss_pred ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC---CCCCCCCCCCCHHHHHH
Confidence 1112234678999999988889999999999999999996 9999975432 22222222 22344566789999999
Q ss_pred HHHhhhhCCCCCCCHHHHHc
Q 005944 305 LLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 305 I~kcL~~dP~~RPSa~EIL~ 324 (668)
|.+||..+|++||++.+|++
T Consensus 231 i~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 231 MKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=324.66 Aligned_cols=247 Identities=23% Similarity=0.389 Sum_probs=191.0
Q ss_pred eEEcccCceEEEEEEEcC--CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEE
Q 005944 70 ELVGCGAFGRVYMGMNLD--SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNIL 147 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~--tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LV 147 (668)
+.||+|+||.||+|.... ++..+|+|.+.... .......+.+|+.+++.++||||+++++++......++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 73 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-------SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLV 73 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-------ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEE
Confidence 368999999999998643 45689999874221 112234578899999999999999999999999999999
Q ss_pred eeccCCCChhcccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 148 LEFVPGGSISSLLGKF-----GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 148 mEy~~gGsL~~~L~~~-----~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
|||+++|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 74 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~ 153 (269)
T cd05087 74 MEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKE 153 (269)
T ss_pred EECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCc
Confidence 9999999999998643 24567788899999999999999999999999999999999999999999998754322
Q ss_pred hhhcCCccCCCCCCCCChHHHhhc-------CCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccC---CCCC
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQT-------GHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTT---KSHP 291 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~-------~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~---~~~~ 291 (668)
..........|++.|+|||++.+. .++.++|||||||++|+|++ |..||................ ...+
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 221222335678899999998643 35789999999999999996 999996543222111111111 1112
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
......+..+.+++.+|+ .+|++|||+++|+.
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 223356788999999999 68999999999984
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=333.22 Aligned_cols=267 Identities=26% Similarity=0.464 Sum_probs=209.9
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCc----EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGE----LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~----~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
..|++...||+|.||.||+|..++++. .+|||+++..... ...-....+|+.+++.++|+|||.|..++.
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~------tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl 97 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG------TGISMSACREIALLRELKHPNVISLVKVFL 97 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC------CCcCHHHHHHHHHHHHhcCCcchhHHHHHh
Confidence 468999999999999999997766543 7899988533221 122234678999999999999999999998
Q ss_pred c-CCcceEEeeccCCCChhcccccC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC----CceE
Q 005944 140 E-DDSLNILLEFVPGGSISSLLGKF-----GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK----GCIK 209 (668)
Q Consensus 140 ~-~~~~~LVmEy~~gGsL~~~L~~~-----~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~----g~vK 209 (668)
. +..+++++||++. +|..+|+-+ ..++...++.|+.||+.|+.|||++=|+||||||.||||..+ |.||
T Consensus 98 ~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VK 176 (438)
T KOG0666|consen 98 SHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVK 176 (438)
T ss_pred ccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeE
Confidence 7 7889999999976 888777433 468999999999999999999999999999999999999988 8999
Q ss_pred EecCCchhhhHhhhh-hcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchh-----------HH
Q 005944 210 LADFGASKKVVELAT-INGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQ-----------FQ 276 (668)
Q Consensus 210 L~DFGlA~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~-----------~~ 276 (668)
|+|||+++.+...-. ......++.|.+|+|||++.+.. |+.+.|||++|||+.||+|-.+.|... .+
T Consensus 177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d 256 (438)
T KOG0666|consen 177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD 256 (438)
T ss_pred eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence 999999998754322 22344567899999999999875 899999999999999999998887432 22
Q ss_pred HHHHHHhhccCCCCCC------CC--------------------------cccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 277 EVAALFHIGTTKSHPP------IP--------------------------EHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 277 ~~~~~~~~~~~~~~~~------~p--------------------------~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.+..++++........ +| ..-++.+.+|+.+||+.||.+|.|++++|+
T Consensus 257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 3333443322211111 11 112445789999999999999999999999
Q ss_pred CccccCCCCCCCc
Q 005944 325 HPFVTGKYQDPHP 337 (668)
Q Consensus 325 Hpwf~~~~~~~~~ 337 (668)
|+||.....++.+
T Consensus 337 h~yF~~d~lpp~p 349 (438)
T KOG0666|consen 337 HPYFTEDPLPPLP 349 (438)
T ss_pred ccccccCCCCCCc
Confidence 9999876555443
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=323.49 Aligned_cols=246 Identities=23% Similarity=0.362 Sum_probs=190.2
Q ss_pred EEcccCceEEEEEEEcC--CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEe
Q 005944 71 LVGCGAFGRVYMGMNLD--SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~~--tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
.||+|+||.||+|.... ....+|+|.+... ........+.+|+.+++.++|+||+++++.+.....+|+||
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~ 74 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS-------ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVL 74 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCcc-------CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEE
Confidence 58999999999996533 3457888876321 11223456788999999999999999999999999999999
Q ss_pred eccCCCChhcccccCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 149 EFVPGGSISSLLGKFG-----SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~~-----~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 75 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 154 (269)
T cd05042 75 EFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPED 154 (269)
T ss_pred EeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccch
Confidence 9999999999986542 24678889999999999999999999999999999999999999999999986533222
Q ss_pred hhcCCccCCCCCCCCChHHHhh-------cCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHH--HHHHhhcc-CCCCCC
Q 005944 224 TINGAKSMKGTPYWMAPEVILQ-------TGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEV--AALFHIGT-TKSHPP 292 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~-------~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~--~~~~~~~~-~~~~~~ 292 (668)
.........+++.|+|||++.. ..++.++|||||||++|+|++ |..||....... ........ ....+.
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05042 155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQ 234 (269)
T ss_pred heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCc
Confidence 2122233456778999999853 346789999999999999999 788886543221 11111111 111223
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
++..++..+.+++..|+ .||++||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 235 LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 45578889999999999 59999999999986
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=328.45 Aligned_cols=260 Identities=30% Similarity=0.483 Sum_probs=204.6
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|++.+.||+|+||.||+|.+..++..||||++..... ......+..|+.++..+ .|+||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~ 84 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-------KEENKRILMDLDVVLKSHDCPYIVKCYGYFI 84 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-------hHHHHHHHHHHHHHHhccCCCchHhhheeee
Confidence 455779999999999999999999998899999999843211 11223445566666666 4999999999999
Q ss_pred cCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.....|+||||+. +.|..++.. ...+++..+..++.||+.||.|||+ .||+||||+|+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 85 TDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred cCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccch
Confidence 9999999999985 467766654 3578999999999999999999997 599999999999999999999999999987
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcC----CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhcc-CCCCCC
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTG----HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT-TKSHPP 292 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~----~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~-~~~~~~ 292 (668)
.+.... ......+++.|+|||.+.+.. ++.++|||||||++|+|++|+.||............... .....+
T Consensus 164 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T cd06618 164 RLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP 240 (296)
T ss_pred hccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC
Confidence 653211 122345788999999987553 788999999999999999999999653222111111111 111112
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
....++.++.+||.+||..+|.+||+++++++||||+..
T Consensus 241 ~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 241 PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 223478899999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=318.67 Aligned_cols=244 Identities=26% Similarity=0.411 Sum_probs=197.9
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEee
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLE 149 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmE 149 (668)
++||+|+||.||+|.. .++..||+|++.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 72 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL-------PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVME 72 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEE
Confidence 3689999999999985 468899999873211 12233457889999999999999999999999999999999
Q ss_pred ccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCC
Q 005944 150 FVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228 (668)
Q Consensus 150 y~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~ 228 (668)
|+++++|.+++... ..+++..+..++.||+.+|.|||++|++||||||+||+++.++.+||+|||++........ ...
T Consensus 73 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~ 151 (250)
T cd05085 73 LVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSS 151 (250)
T ss_pred CCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc-ccC
Confidence 99999999988653 4689999999999999999999999999999999999999999999999999875422111 111
Q ss_pred ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 229 ~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
....+++.|+|||++.+..++.++|||||||++|+|++ |..||............. .......+..++..+.+|+.+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~ 229 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVE--KGYRMSCPQKCPDDVYKVMQR 229 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH--cCCCCCCCCCCCHHHHHHHHH
Confidence 12344677999999988889999999999999999998 999997543222111111 122334456788999999999
Q ss_pred hhhhCCCCCCCHHHHHc
Q 005944 308 CLQKEPYLRSTASELLQ 324 (668)
Q Consensus 308 cL~~dP~~RPSa~EIL~ 324 (668)
||..+|++||++.++++
T Consensus 230 ~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 230 CWDYKPENRPKFSELQK 246 (250)
T ss_pred HcccCcccCCCHHHHHH
Confidence 99999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=324.00 Aligned_cols=245 Identities=28% Similarity=0.455 Sum_probs=198.2
Q ss_pred eEEcccCceEEEEEEEcCCC------cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 70 ELVGCGAFGRVYMGMNLDSG------ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg------~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
+.||+|+||.||+|++.... ..||||.+... ........+.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 73 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-------ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP 73 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc-------cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC
Confidence 36899999999999886543 78999987321 112234567889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC-----ceEEe
Q 005944 144 LNILLEFVPGGSISSLLGKF-------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-----CIKLA 211 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~-------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-----~vKL~ 211 (668)
.++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+|+|+||||+|||++.++ .+||+
T Consensus 74 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 74 QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEEC
Confidence 99999999999999998642 3478899999999999999999999999999999999999887 89999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCC
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKS 289 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~ 289 (668)
|||++..+.............++..|+|||++.+..++.++|||||||++|+|++ |..||..... +..... ....
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~---~~~~ 230 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV---TAGG 230 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH---hcCC
Confidence 9999876543222222223456788999999998889999999999999999998 9999964332 111111 1122
Q ss_pred CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 290 ~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
....+..++..+.+||.+||..+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33445678899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=327.18 Aligned_cols=254 Identities=34% Similarity=0.550 Sum_probs=205.2
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcce
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN 145 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~ 145 (668)
|++.+.||.|+||.||+|++..+++.||+|++.... ........+..|+.+++.++|+||+++++++......+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~------~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 74 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN------EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY 74 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc------ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence 667889999999999999999999999999985432 11222345668999999999999999999999999999
Q ss_pred EEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 146 ILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
+||||+. ++|.+++.+. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.+||+|||++.......
T Consensus 75 ~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 152 (282)
T cd07829 75 LVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL- 152 (282)
T ss_pred EEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-
Confidence 9999997 5899999776 579999999999999999999999999999999999999999999999999987653221
Q ss_pred hcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhcc------------C--
Q 005944 225 INGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGT------------T-- 287 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~------------~-- 287 (668)
.......++..|+|||++.+. .++.++|||||||++|+|++|.+||...... ...+..... .
T Consensus 153 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 153 -RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred -cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 122334567889999999876 7899999999999999999999999653211 111111000 0
Q ss_pred --CCCC--------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 288 --KSHP--------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 288 --~~~~--------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.... .....++..+.++|.+||..+|.+||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000 0111347789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=331.94 Aligned_cols=258 Identities=35% Similarity=0.602 Sum_probs=209.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.....|...+.||.|+||.||+|++..++..||||.+.... .........+.+|+.+++.++|+||+++++++..
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 86 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSG-----KQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR 86 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEeccc-----ccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc
Confidence 34556888899999999999999999999999999874221 1122334557789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~-~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
....++||||+. |+|.+++. ....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 165 (308)
T cd06634 87 EHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165 (308)
T ss_pred CCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceee
Confidence 999999999997 57766654 3456899999999999999999999999999999999999999999999999998754
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhh---cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcc
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQ---TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ 296 (668)
.. .....|++.|+|||++.+ ..++.++|||||||++|+|++|..||....... .................
T Consensus 166 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~ 238 (308)
T cd06634 166 AP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPALQSGH 238 (308)
T ss_pred cC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH-HHHHHhhcCCCCcCccc
Confidence 22 234568999999999853 457889999999999999999999986532211 11122212222223446
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++..+.+||.+||..+|.+||++.++++|||+...
T Consensus 239 ~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 78899999999999999999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=338.11 Aligned_cols=256 Identities=28% Similarity=0.483 Sum_probs=202.6
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|.+.+.||+|+||.||+|++..+|..||||++.... ........+.+|+.+++.++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPF------QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcc------ccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 468999999999999999999999999999999874321 11222345678999999999999999999886543
Q ss_pred ------cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 143 ------SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 143 ------~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
.+|+|+||+.. +|..++. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred cCCCCceEEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46899999964 6766553 36899999999999999999999999999999999999999999999999998
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhcc-------
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGT------- 286 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~------- 286 (668)
+.... ......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .....+.....
T Consensus 165 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 165 RHADA-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFV 239 (342)
T ss_pred cCCCC-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 75321 2234568899999999876 458899999999999999999999997432 11111111000
Q ss_pred --------------CCCC--C---CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 287 --------------TKSH--P---PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 287 --------------~~~~--~---~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.... . ......+.++.+||.+||+.||.+||++.+++.||||....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0000 0 01124677899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=324.27 Aligned_cols=242 Identities=25% Similarity=0.431 Sum_probs=195.2
Q ss_pred eEEcccCceEEEEEEEcCCCc--EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccCCcceE
Q 005944 70 ELVGCGAFGRVYMGMNLDSGE--LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNI 146 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~--~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~~~~~L 146 (668)
++||+|+||.||+|.+..++. .+|+|.+.. .........+.+|+.++.++ +||||+++++++......|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~-------~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKE-------YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccc-------cCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceE
Confidence 368999999999999988775 468887631 11123345678899999999 79999999999999999999
Q ss_pred EeeccCCCChhcccccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEE
Q 005944 147 LLEFVPGGSISSLLGKFG----------------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 147 VmEy~~gGsL~~~L~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL 210 (668)
||||+++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEE
Confidence 999999999999986532 4789999999999999999999999999999999999999999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCC
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTK 288 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~ 288 (668)
+|||++...... ........+..|+|||++.+..++.++|||||||++|+|++ |..||..... +..... ...
T Consensus 154 ~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~---~~~ 227 (270)
T cd05047 154 ADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL---PQG 227 (270)
T ss_pred CCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHH---hCC
Confidence 999998632211 11112234667999999988889999999999999999997 9999964322 212111 112
Q ss_pred CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 289 SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 289 ~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.....+..++.++.+|+.+||..+|.+||++.+++.
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 228 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 223345567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-39 Score=326.16 Aligned_cols=238 Identities=24% Similarity=0.379 Sum_probs=192.2
Q ss_pred eEEcccCceEEEEEEEcCCCcE-------EEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 70 ELVGCGAFGRVYMGMNLDSGEL-------LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~-------VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
+.||.|+||.||+|.+...+.. ||+|.+.. ........+.+|+.+++.++|||||++++++....
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~--------~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~ 72 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDK--------SHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGD 72 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcc--------hhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCC
Confidence 3689999999999998665543 88887621 12234456788999999999999999999999989
Q ss_pred cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc--------eEEecC
Q 005944 143 SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC--------IKLADF 213 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~--------vKL~DF 213 (668)
..++||||+++|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+||
T Consensus 73 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~ 152 (258)
T cd05078 73 ESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP 152 (258)
T ss_pred CcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence 999999999999999999764 45899999999999999999999999999999999999987764 699999
Q ss_pred CchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCC-CCCchhHHHHHHHHhhccCCCCC
Q 005944 214 GASKKVVELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGK-PPWSQQFQEVAALFHIGTTKSHP 291 (668)
Q Consensus 214 GlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~-~PF~~~~~~~~~~~~~~~~~~~~ 291 (668)
|++..... .....+++.|+|||++.+. .++.++|||||||++|+|++|. +||............. ...
T Consensus 153 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~----~~~ 222 (258)
T cd05078 153 GISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE----DRH 222 (258)
T ss_pred ccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH----ccc
Confidence 98865422 2235688999999999864 4789999999999999999985 6664332222111111 123
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.++...+.++.+||.+||+.+|++|||+.+|++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 223 QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 4555677889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=322.78 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=204.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCC---CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDS---GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
....+|.+.++||+|+||.||+|.+... ...||||.+.... .....+.+.+|+.+++.+.|+||++++++
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-------~~~~~~~~~~e~~~l~~~~h~~i~~~~~~ 75 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-------SPSVREKFLQEAYIMRQFDHPHIVKLIGV 75 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-------CHHHHHHHHHHHHHHHhCCCCchhceeEE
Confidence 3456799999999999999999987654 3578999873221 12234567889999999999999999998
Q ss_pred cccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+.. ...|+||||+++|+|.+++.+. ..+++..++.++.||+.||+|||+.|++||||||+|||++.++.+||+|||++
T Consensus 76 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~ 154 (270)
T cd05056 76 ITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154 (270)
T ss_pred EcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCcee
Confidence 875 5578999999999999999764 35899999999999999999999999999999999999999999999999998
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~ 295 (668)
+......... .....+++.|+|||.+....++.++|||||||++|+|++ |..||........ ...+. .......+.
T Consensus 155 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-~~~~~-~~~~~~~~~ 231 (270)
T cd05056 155 RYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-IGRIE-NGERLPMPP 231 (270)
T ss_pred eeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHH-cCCcCCCCC
Confidence 7654322111 122334568999999988889999999999999999996 9999965432211 11111 122334566
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.++.++.+||.+||..+|.+|||+.+++..
T Consensus 232 ~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 232 NCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=318.92 Aligned_cols=249 Identities=26% Similarity=0.454 Sum_probs=202.8
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||.|+||.||+|.+. .+..+|+|++..... ....+.+|+++++++.||||+++++++....
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~---------~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 72 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM---------SEEDFIEEAQVMMKLSHPKLVQLYGVCTERS 72 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC---------CHHHHHHHHHHHHhCCCCCeeeEEEEEccCC
Confidence 457899999999999999999875 467899998742111 1134678999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
..++||||+.+++|.+++... +.+++..++.++.|++.+|.|||+.||+|+||||+||+++.++.+||+|||++.....
T Consensus 73 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 73 PICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred ceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 999999999999999998654 5689999999999999999999999999999999999999999999999999875432
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcccCH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
... .......++..|+|||++.+..++.++|||||||++|+|++ |..||..... ........ ......+...+.
T Consensus 153 ~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 228 (256)
T cd05112 153 DQY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA---GFRLYKPRLASQ 228 (256)
T ss_pred Ccc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhC---CCCCCCCCCCCH
Confidence 111 11122335678999999998889999999999999999998 9999964432 22222211 112233455789
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
++.+|+.+||+.+|.+||++.+++++
T Consensus 229 ~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 229 SVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HHHHHHHHHcccChhhCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=329.69 Aligned_cols=253 Identities=24% Similarity=0.440 Sum_probs=204.4
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCc----EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGE----LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~----~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
...+|+..+.||+|+||.||+|.+..+|. .||+|.+... ........+.+|+.+++.++||||++++++
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~~~~l~h~niv~~~~~ 77 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNET-------TGPKANVEFMDEALIMASMDHPHLVRLLGV 77 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEecccc-------CCHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 45678999999999999999999887776 4678876321 112223457889999999999999999998
Q ss_pred cccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+... ..++|+||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 78 ~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~ 156 (303)
T cd05110 78 CLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (303)
T ss_pred EcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccc
Confidence 8654 467999999999999998764 36899999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH-HHHHHHHhhccCCCCCCCC
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVAALFHIGTTKSHPPIP 294 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~-~~~~~~~~~~~~~~~~~~p 294 (668)
+.+.............++..|+|||++.+..++.++|||||||++|+|++ |..||.... ......... ....+.+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~ 233 (303)
T cd05110 157 RLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK---GERLPQP 233 (303)
T ss_pred ccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHC---CCCCCCC
Confidence 86543222222233456788999999998889999999999999999997 999996543 233333222 2223344
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
..++..+.+++.+||..+|++||++.++++.
T Consensus 234 ~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 234 PICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=321.56 Aligned_cols=238 Identities=23% Similarity=0.334 Sum_probs=189.6
Q ss_pred eEEcccCceEEEEEEEcC------------CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 70 ELVGCGAFGRVYMGMNLD------------SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~------------tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
+.||+|+||.||+|+... ....||+|++.. ........+.+|+.+++.++||||++++++
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~--------~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~ 72 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP--------SHRDISLAFFETASMMRQVSHKHIVLLYGV 72 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecCh--------hhhhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 368999999999998532 233588887621 122334567889999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc-------eE
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC-------IK 209 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~-------vK 209 (668)
+......++||||+++|+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +|
T Consensus 73 ~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~ 152 (262)
T cd05077 73 CVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIK 152 (262)
T ss_pred EecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeE
Confidence 99999999999999999999888653 56899999999999999999999999999999999999987664 89
Q ss_pred EecCCchhhhHhhhhhcCCccCCCCCCCCChHHHh-hcCCCcchhHHHHHHHHHHHH-hCCCCCchhHHHHHHHHhhccC
Q 005944 210 LADFGASKKVVELATINGAKSMKGTPYWMAPEVIL-QTGHSFSADIWSVGCTVIEMA-TGKPPWSQQFQEVAALFHIGTT 287 (668)
Q Consensus 210 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDIWSLGvILyeLL-TG~~PF~~~~~~~~~~~~~~~~ 287 (668)
++|||++..+.. .....++..|+|||++. +..++.++|||||||++|+|+ +|..||..........+....
T Consensus 153 l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~- 225 (262)
T cd05077 153 LSDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQ- 225 (262)
T ss_pred eCCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcC-
Confidence 999999865421 22356888999999987 456899999999999999998 588998654322211111111
Q ss_pred CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 288 ~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.......+.++.+||.+||+.||.+||++.+|+++
T Consensus 226 ---~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 ---CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred ---ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 11223345788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=322.80 Aligned_cols=252 Identities=34% Similarity=0.528 Sum_probs=200.9
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCCcc
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDDSL 144 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~~~ 144 (668)
|.+.+.||.|+||+||+|+...+++.||||.+...... .......+|+..++.+. |+||+++++++..++..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-------~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 73 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-------WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDEL 73 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-------hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcE
Confidence 67889999999999999999989999999987422110 11122346889999999 99999999999999999
Q ss_pred eEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
++||||+ +|+|.+++.... .+++..+..++.||+.+|.|||++||+|+||+|.||+++.++.++|+|||++......
T Consensus 74 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 74 YFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred EEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9999999 779988887654 7899999999999999999999999999999999999999999999999998755321
Q ss_pred hhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccC------------
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTT------------ 287 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~------------ 287 (668)
.......++..|+|||++.+ ..++.++||||||+++|+|++|++||..... ...........
T Consensus 153 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07830 153 ---PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL 229 (283)
T ss_pred ---CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh
Confidence 12234568999999998854 4578999999999999999999999954321 11111100000
Q ss_pred ----C--C-------CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 288 ----K--S-------HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 288 ----~--~-------~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
. . ........+..+.+||.+||+.+|.+||++.|++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0 0 000111236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=318.44 Aligned_cols=246 Identities=24% Similarity=0.433 Sum_probs=192.8
Q ss_pred eEEcccCceEEEEEEEcC---CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc-cCCcce
Q 005944 70 ELVGCGAFGRVYMGMNLD---SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR-EDDSLN 145 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~---tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~-~~~~~~ 145 (668)
+.||+|+||.||+|.+.. ....||||.+... ........+.+|+.+++.++||||+++++++. .+...+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 73 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-------TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPL 73 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-------CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcE
Confidence 368999999999998754 3467999986311 11223456778999999999999999999765 456689
Q ss_pred EEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 146 ILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
+||||+.+|+|.+++.+. ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 74 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~ 153 (262)
T cd05058 74 VVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY 153 (262)
T ss_pred EEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence 999999999999998754 4567788899999999999999999999999999999999999999999999875432111
Q ss_pred --hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHH
Q 005944 225 --INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 225 --~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
........+++.|+|||.+.+..++.++|||||||++|+|++ |.+||..... ...... ........+..++..
T Consensus 154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 230 (262)
T cd05058 154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL---LQGRRLLQPEYCPDP 230 (262)
T ss_pred eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---hcCCCCCCCCcCCHH
Confidence 111123456778999999988889999999999999999999 4666754322 111111 112233345567889
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+.+++.+||..+|.+||++.+++..
T Consensus 231 ~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 231 LYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=308.41 Aligned_cols=258 Identities=29% Similarity=0.528 Sum_probs=210.2
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
+|..++.||+|.||+||+|++..+++.||+|.+....+.. .......+|+-+|+.++|.|||+++++...+..+
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddde------gvpssalreicllkelkhknivrl~dvlhsdkkl 76 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDE------GVPSSALREICLLKELKHKNIVRLHDVLHSDKKL 76 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCC------CCcHHHHHHHHHHHHhhhcceeehhhhhccCcee
Confidence 5778899999999999999999999999999986543322 2223467899999999999999999999999999
Q ss_pred eEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 145 NILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.+|+|||.. +|..+... ++.+..+.++.++.|+++||.|||++++.||||||.|+||+.+|.+||+|||+++-+.-.
T Consensus 77 tlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip- 154 (292)
T KOG0662|consen 77 TLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP- 154 (292)
T ss_pred EEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc-
Confidence 999999965 77777654 477999999999999999999999999999999999999999999999999999876421
Q ss_pred hhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHh-CCCCCchh--HHHHHHHHhhccCC---CCCC----
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMAT-GKPPWSQQ--FQEVAALFHIGTTK---SHPP---- 292 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLT-G~~PF~~~--~~~~~~~~~~~~~~---~~~~---- 292 (668)
..-+..-+.|.+|++|.++.+.. |+...|+||.|||+.|+.. |++.|.+. .+....++...... .++.
T Consensus 155 -vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred -eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence 11223345799999999999877 8999999999999999987 77778644 23444444432221 1111
Q ss_pred --------CC---------cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 293 --------IP---------EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 293 --------~p---------~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++ ..++..-++|+.++|.-+|.+|++++++|+||||...
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 11 1344556899999999999999999999999999753
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=333.14 Aligned_cols=260 Identities=28% Similarity=0.453 Sum_probs=206.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||.|+||.||+|.+..++..||||++..... .......+.+|+.+++.++||||+++++++..
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 80 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS------TPVLAKRTYRELKLLKHLRHENIISLSDIFIS 80 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc------ccchhHHHHHHHHHHHhcCCCCeeeEeeeEec
Confidence 457789999999999999999999999999999998743211 11223456789999999999999999998865
Q ss_pred -CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 -DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 -~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
....|+||||+ +++|..++.. ..+++..+..++.||+.||.|||+.||+||||+|.|||++.++.+||+|||++...
T Consensus 81 ~~~~~~lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 81 PLEDIYFVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred CCCcEEEEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 56789999998 5688888764 46889999999999999999999999999999999999999999999999998743
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHH--------------
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALF-------------- 282 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~-------------- 282 (668)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||...... ...+.
T Consensus 159 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 159 DP-----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred CC-----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 21 2234567899999999866 56899999999999999999999999643210 00000
Q ss_pred ---------hhccCCCCCC---CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 283 ---------HIGTTKSHPP---IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 283 ---------~~~~~~~~~~---~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.........+ ....++.++.++|.+||+.+|.+||++.+++.||||.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~ 296 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccC
Confidence 0000000011 11346789999999999999999999999999999975443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=317.94 Aligned_cols=250 Identities=24% Similarity=0.433 Sum_probs=203.1
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
++...+|++.+.||+|+||.||+|.+. .+..+|+|.+... ......+.+|+.+++.++|+||+++++.+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~---------~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 71 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPG---------SMSVEAFLAEANVMKTLQHDKLVKLHAVVT 71 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCC---------hhHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence 456788999999999999999999754 5667999987321 112356788999999999999999999987
Q ss_pred cCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
. ...++||||+++++|.+++.+. ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.+||+|||++.
T Consensus 72 ~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 150 (260)
T cd05073 72 K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 150 (260)
T ss_pred C-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCccee
Confidence 7 7789999999999999998653 457888999999999999999999999999999999999999999999999987
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCCCc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~p~ 295 (668)
.+.... ........++..|+|||++....++.++|||||||++|+|+| |..||...... ...... .....+.+.
T Consensus 151 ~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---~~~~~~~~~ 226 (260)
T cd05073 151 VIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE---RGYRMPRPE 226 (260)
T ss_pred eccCCC-cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHh---CCCCCCCcc
Confidence 543211 111122345677999999988889999999999999999999 99999754322 222111 122234456
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..+.++.+++.+||+.+|.+||++.++++
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 78899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=319.82 Aligned_cols=229 Identities=28% Similarity=0.433 Sum_probs=193.2
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeeccCCC
Q 005944 75 GAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGG 154 (668)
Q Consensus 75 G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~~gG 154 (668)
|.||.||+|.+..+++.||+|++.... .+..|...+....||||+++++++......++||||+++|
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 70 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGG 70 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCC
Confidence 899999999999999999999984211 1223445555667999999999999999999999999999
Q ss_pred ChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCC
Q 005944 155 SISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGT 234 (668)
Q Consensus 155 sL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT 234 (668)
+|.+++.+...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++..+.. ......++
T Consensus 71 ~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~ 145 (237)
T cd05576 71 KLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVE 145 (237)
T ss_pred CHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcC
Confidence 9999998877899999999999999999999999999999999999999999999999998765432 12234567
Q ss_pred CCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCC
Q 005944 235 PYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPY 314 (668)
Q Consensus 235 ~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~ 314 (668)
..|+|||.+.+..++.++||||+||++|+|++|..||........ ......++..++..+++||.+||+.||.
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dp~ 218 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN-------THTTLNIPEWVSEEARSLLQQLLQFNPT 218 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc-------cccccCCcccCCHHHHHHHHHHccCCHH
Confidence 889999999888889999999999999999999998754322110 1112235667899999999999999999
Q ss_pred CCCCH-----HHHHcCccc
Q 005944 315 LRSTA-----SELLQHPFV 328 (668)
Q Consensus 315 ~RPSa-----~EIL~Hpwf 328 (668)
+||++ ++++.||||
T Consensus 219 ~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 219 ERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HhcCCCccchHHHHcCCCC
Confidence 99986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=317.88 Aligned_cols=234 Identities=25% Similarity=0.395 Sum_probs=190.6
Q ss_pred eEEcccCceEEEEEEEcCCC----------cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 70 ELVGCGAFGRVYMGMNLDSG----------ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg----------~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
+.||+|+||.||+|.+..++ ..|++|++... . .....+.+|+.+|+.++|+||+++++++.
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~------~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 71 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSD------H---RDSLAFFETASLMSQLSHKHLVKLYGVCV 71 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccc------h---hhHHHHHHHHHHHHcCCCcchhheeeEEe
Confidence 46899999999999998776 35778876311 1 11456788999999999999999999988
Q ss_pred cCCcceEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC-------ceEEe
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-------CIKLA 211 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-------~vKL~ 211 (668)
. ...++||||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+
T Consensus 72 ~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~ 150 (259)
T cd05037 72 R-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLS 150 (259)
T ss_pred c-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeC
Confidence 7 77899999999999999997765 789999999999999999999999999999999999999887 89999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc--CCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccC
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQT--GHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTT 287 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~--~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~ 287 (668)
|||++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||..... ....... .
T Consensus 151 Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---~ 221 (259)
T cd05037 151 DPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---D 221 (259)
T ss_pred CCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---c
Confidence 9999876432 2234577889999999876 68999999999999999999 6888865422 1111111 1
Q ss_pred CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 288 ~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
. ...+......+.+||.+||..+|.+||++.++++
T Consensus 222 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 222 Q--HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred C--CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 1 1122223378999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=367.80 Aligned_cols=255 Identities=24% Similarity=0.421 Sum_probs=214.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCC-----cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSG-----ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg-----~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l 134 (668)
.+........+.||+|+||.||.|+...-. ..||||.+. +..+.+....|.+|..+|+.++|||||++
T Consensus 688 ~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~-------~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~l 760 (1025)
T KOG1095|consen 688 EVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLK-------RLSSEQEVSDFLKEALLMSKFDHPNIVSL 760 (1025)
T ss_pred cCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecc-------ccCCHHHHHHHHHHHHHHhcCCCcceeeE
Confidence 356677889999999999999999876533 348888873 22345567789999999999999999999
Q ss_pred ccccccCCcceEEeeccCCCChhcccccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc
Q 005944 135 LGTAREDDSLNILLEFVPGGSISSLLGKF-------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC 207 (668)
Q Consensus 135 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~-------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~ 207 (668)
+|++......+|++|||+||+|..+|++. ..++..+...++.||++|++||+++++|||||...|+||+....
T Consensus 761 iGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~ 840 (1025)
T KOG1095|consen 761 IGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRV 840 (1025)
T ss_pred EEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCc
Confidence 99999999999999999999999999876 34889999999999999999999999999999999999999999
Q ss_pred eEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhc
Q 005944 208 IKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIG 285 (668)
Q Consensus 208 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~ 285 (668)
|||+|||+|+.+.....+.....-.-...|||||.+....++.++|||||||+|||++| |..||...... +...+..
T Consensus 841 VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~- 919 (1025)
T KOG1095|consen 841 VKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLE- 919 (1025)
T ss_pred EEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHh-
Confidence 99999999995543333222211123468999999999999999999999999999999 99999765433 2222222
Q ss_pred cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 286 ~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
....+.|..++..+.++|.+||+.+|++||++..|++
T Consensus 920 --ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 920 --GGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred --CCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 2266778899999999999999999999999999998
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=323.06 Aligned_cols=237 Identities=24% Similarity=0.341 Sum_probs=189.1
Q ss_pred EEcccCceEEEEEEEcCC------------------------CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC
Q 005944 71 LVGCGAFGRVYMGMNLDS------------------------GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~~t------------------------g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 126 (668)
.||+|+||.||+|....+ ...||+|++.. ........+.+|+.+++.+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~--------~~~~~~~~~~~~~~~~~~l 73 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDP--------SHRDIALAFFETASLMSQV 73 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecCh--------HHHHHHHHHHHHHHHHhcC
Confidence 589999999999985322 24688887731 1122345677899999999
Q ss_pred CCCCeeeeccccccCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC
Q 005944 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK 205 (668)
Q Consensus 127 ~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~ 205 (668)
+||||+++++++......++||||+++|+|..++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++..
T Consensus 74 ~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~ 153 (274)
T cd05076 74 SHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARL 153 (274)
T ss_pred CCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEecc
Confidence 999999999999999999999999999999998865 4678999999999999999999999999999999999999764
Q ss_pred C-------ceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHH-hCCCCCchhHH
Q 005944 206 G-------CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMA-TGKPPWSQQFQ 276 (668)
Q Consensus 206 g-------~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLL-TG~~PF~~~~~ 276 (668)
+ .+||+|||++..... .....++..|+|||.+.+ ..++.++|||||||++|+|+ +|..||.....
T Consensus 154 ~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 154 GLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred CcccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 4 489999998754321 123457888999999875 45899999999999999995 79999975432
Q ss_pred HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 277 EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 277 ~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
......... ....+.....++.+||.+||+.+|.+||++.+|+++
T Consensus 228 ~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 228 SEKERFYEK----KHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHHHh----ccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 221111111 122344456789999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=342.60 Aligned_cols=253 Identities=29% Similarity=0.454 Sum_probs=198.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
..+.+|....+||+|+||.||+|.. .+|..||||++.... .. . .++|.+|+.+|.+++|||+|+|+|+|.+
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~------~~-~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNS------GQ-G-EREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCC------Cc-c-hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 4457888889999999999999985 455999999773211 11 1 3459999999999999999999999999
Q ss_pred CCc-ceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCCcccEEeCCCCceEEecCC
Q 005944 141 DDS-LNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNG---IMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 141 ~~~-~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~g---IvHrDLKPeNILld~~g~vKL~DFG 214 (668)
.+. .+||+||++.|+|.++|.... .+++....+|+.++++||+|||... ||||||||+|||||.+.++||+|||
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG 222 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG 222 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence 984 999999999999999997764 8999999999999999999999864 9999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccC-CCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH----HHHHH----HHhhc
Q 005944 215 ASKKVVELATINGAKSM-KGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF----QEVAA----LFHIG 285 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~-~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~----~~~~~----~~~~~ 285 (668)
+|+..... .....+. .||.+|+|||++..+..+.++|||||||+|.||+||+.+..... ..... .+...
T Consensus 223 La~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 223 LAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred CcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99654321 1111222 89999999999999889999999999999999999998876321 11111 11111
Q ss_pred cC--CCCCCCC-cccC-----HHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 286 TT--KSHPPIP-EHLS-----MEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 286 ~~--~~~~~~p-~~ls-----~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.. ...+.+. .... ..+..+..+|++.+|..||++.++++
T Consensus 301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 00 0111111 1222 23567788999999999999999754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=319.45 Aligned_cols=257 Identities=27% Similarity=0.417 Sum_probs=205.6
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
+...||++.+.||+|||+-||++.+..++..||+|++.+.. .+.++...+|++..++++||||++++++...
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--------~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~ 89 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--------QEDIEEALREIDNHRKFNSPNVLRLVDHQLR 89 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--------hHHHHHHHHHHHHHHhhCCcchHHHHHHHHH
Confidence 66789999999999999999999999999999999996542 2345667889999999999999999988755
Q ss_pred CC-----cceEEeeccCCCChhcccccC----CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCcccEEeCCCCceE
Q 005944 141 DD-----SLNILLEFVPGGSISSLLGKF----GSFPESVIRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVDNKGCIK 209 (668)
Q Consensus 141 ~~-----~~~LVmEy~~gGsL~~~L~~~----~~l~e~~~~~i~~QIl~aL~yLHs~g--IvHrDLKPeNILld~~g~vK 209 (668)
+. ..||++.|...|+|.+.+... ..++|.++.+|+.+|++||++||+.. ++||||||.|||+.+.+.++
T Consensus 90 ~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~v 169 (302)
T KOG2345|consen 90 EEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPV 169 (302)
T ss_pred hhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceE
Confidence 44 499999999999999988543 36999999999999999999999998 99999999999999999999
Q ss_pred EecCCchhhhHhh-------hhhcCCccCCCCCCCCChHHHhhc---CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHH
Q 005944 210 LADFGASKKVVEL-------ATINGAKSMKGTPYWMAPEVILQT---GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVA 279 (668)
Q Consensus 210 L~DFGlA~~~~~~-------~~~~~~~~~~GT~~Y~APEvl~~~---~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~ 279 (668)
|.|||.++...-. ........-..|..|+|||++.-. ..+.++|||||||+||.|+.|..||....+.-.
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg 249 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG 249 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC
Confidence 9999998754210 001111123468889999999644 458899999999999999999999965433111
Q ss_pred HH-HhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 280 AL-FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 280 ~~-~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.+ +.+.......+-...+|..+.+||+.||++||.+||++.+++.+
T Consensus 250 SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 250 SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00 00111111122223489999999999999999999999999864
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=321.53 Aligned_cols=254 Identities=27% Similarity=0.478 Sum_probs=203.5
Q ss_pred CCeeeeeEEcccCceEEEEEEEcC----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLD----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
..|++.+.||+|+||.||+|.... ++..||||++..... ......+.+|+.+++.+.|+||+++++++.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~-------~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~ 76 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE-------EQHRSDFEREIEILRTLDHENIVKYKGVCE 76 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc-------hHHHHHHHHHHHHHHhCCCCChheEEeeee
Confidence 467888999999999999998643 488999998843211 134467889999999999999999999887
Q ss_pred c--CCcceEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 140 E--DDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 140 ~--~~~~~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
. ....++||||+++++|.+++.... .+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++
T Consensus 77 ~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 77 KPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred cCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 6 567899999999999999997654 6899999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhh-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH-------------HHHH
Q 005944 217 KKVVELATI-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV-------------AALF 282 (668)
Q Consensus 217 ~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~-------------~~~~ 282 (668)
......... .......++..|+|||.+.+..++.++|||||||++|+|+||..||....... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 866422111 11112345667999999988889999999999999999999999986432211 1111
Q ss_pred hhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 283 HIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 283 ~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.........+.+..++.++.+|+.+||+.+|.+||++.+|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111112223345567789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=340.54 Aligned_cols=261 Identities=28% Similarity=0.433 Sum_probs=219.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
+...+|..+.+||+|+||.|.+|..+.+.+.+|||+++...... ...++.-..|-++|... +-|.+++|...|+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQ-----dDDvectm~EKrvLAL~~kppFL~qlHScFQ 420 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQ-----DDDVECTMVEKRVLALPGKPPFLVQLHSCFQ 420 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeee-----cCcccceehhhhheecCCCCchHHHHHHHhh
Confidence 44567999999999999999999999999999999985433221 12223334566777666 4688999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
+-+.+|+|||||.||+|--.|+..+.|-|..+..++.+|+-||-|||++|||+||||..|||++.+|++||+|||+++.-
T Consensus 421 TmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 421 TMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred hhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998742
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
. .......++||||.|+|||++...+|+.++|+||+||+|||||.|++||.+..++..-... ......+|..+|.
T Consensus 501 i--~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI---~ehnvsyPKslSk 575 (683)
T KOG0696|consen 501 I--FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI---MEHNVSYPKSLSK 575 (683)
T ss_pred c--cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---HHccCcCcccccH
Confidence 1 2223356799999999999999999999999999999999999999999875443221111 1233457889999
Q ss_pred HHHHHHHHhhhhCCCCCCCH-----HHHHcCccccCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTA-----SELLQHPFVTGK 331 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa-----~EIL~Hpwf~~~ 331 (668)
++.++++.+|.+.|.+|... .+|..||||...
T Consensus 576 EAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i 612 (683)
T KOG0696|consen 576 EAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI 612 (683)
T ss_pred HHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence 99999999999999999653 589999999753
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=315.98 Aligned_cols=240 Identities=28% Similarity=0.481 Sum_probs=198.3
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||.||++.. ++..||+|++... .....+.+|+.+++.++||||+++++++..+ .
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~----------~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 72 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCD----------VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-G 72 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCc----------chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-C
Confidence 5699999999999999999864 7889999987321 1124577899999999999999999988654 5
Q ss_pred ceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 144 LNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 73 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~ 152 (254)
T cd05083 73 LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM 152 (254)
T ss_pred cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc
Confidence 799999999999999986543 588999999999999999999999999999999999999999999999999875322
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcccCH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.......+..|+|||.+.+..++.++|||||||++|+|++ |..||..... +...... .......+..++.
T Consensus 153 -----~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 224 (254)
T cd05083 153 -----GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE---KGYRMEPPEGCPA 224 (254)
T ss_pred -----cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh---CCCCCCCCCcCCH
Confidence 1122344678999999988889999999999999999997 9999965432 2222221 1222334567889
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
++.+||.+||+.+|..||++.+++.
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=319.74 Aligned_cols=251 Identities=22% Similarity=0.381 Sum_probs=197.8
Q ss_pred eeeeeEEcccCceEEEEEEEcC---CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 66 WRKGELVGCGAFGRVYMGMNLD---SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~---tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
|++.++||+|+||.||+|.... ++..||||++.... ......+.+.+|+++|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 74 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI------FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSR 74 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc------CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 6778899999999999998653 57899999884321 12233456788999999999999999999875432
Q ss_pred ------cceEEeeccCCCChhccccc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEE
Q 005944 143 ------SLNILLEFVPGGSISSLLGK------FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 143 ------~~~LVmEy~~gGsL~~~L~~------~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL 210 (668)
..+++++|+.+|+|..++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl 154 (273)
T cd05074 75 AKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCV 154 (273)
T ss_pred CCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEE
Confidence 24788999999999877632 125789999999999999999999999999999999999999999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCC
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTK 288 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~ 288 (668)
+|||+++...............+++.|++||.+.+..++.++|||||||++|+|++ |.+||...... ....... .
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~---~ 231 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK---G 231 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHc---C
Confidence 99999886533222222223445678999999998889999999999999999999 89998654322 2221111 1
Q ss_pred CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 289 SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 289 ~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.....+...+..+.+++.+||+.+|.+||++.+++.+
T Consensus 232 ~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 232 NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1223345677899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=317.15 Aligned_cols=257 Identities=29% Similarity=0.465 Sum_probs=205.7
Q ss_pred CeeeeeEEcccCceEEEEEEEcC-CCcEEEEEEeeecccchh--hHhhHHHHHHHHHHHHHHHh-CCCCCeeeecccccc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLD-SGELLAVKQVLIAANSAS--KEKTQAHIRELEEEVKLLKN-LTHPNIVRYLGTARE 140 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~-tg~~VAVK~i~~~~~~~~--~~~~~~~~~~~~~Ei~iL~~-L~HpNIV~l~g~~~~ 140 (668)
.|++.+.||+|+||.||+|.+.. ++..+|+|.+........ ..........+..|+.++.. ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999887 688999998854322111 11223445567788888875 799999999999999
Q ss_pred CCcceEEeeccCCCChhcccc----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceEEecCCc
Q 005944 141 DDSLNILLEFVPGGSISSLLG----KFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~----~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++..++||||+++++|.+++. ....+++..++.++.||+.+|.|||. .||+|+||||+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988873 23568999999999999999999996 6899999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCc
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~ 295 (668)
+....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||......... .........+....
T Consensus 161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA-TKIVEAVYEPLPEG 236 (269)
T ss_pred eeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH-HHHhhccCCcCCcc
Confidence 87653321 234567899999999999888999999999999999999999999654322111 11111122222223
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.++.++.+||.+||+.||++||++.|+..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 678899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=353.97 Aligned_cols=245 Identities=27% Similarity=0.416 Sum_probs=209.7
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTARE 140 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~ 140 (668)
....|.+...||.|+|+.|..+.+..+++..++|++.... ....+|+.++... +||||+++.+++.+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------------~~~~~e~~~~~~~~~h~niv~~~~v~~~ 387 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------------DDNQDEIPISLLVRDHPNIVKSHDVYED 387 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------------cccccccchhhhhcCCCcceeecceecC
Confidence 4667888888999999999999999999999999984321 1123466444444 79999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe-CCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV-DNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl-d~~g~vKL~DFGlA~~~ 219 (668)
....|+|||++.|+.|.+.+.....+. .++..|+++|+.|+.|||++|||||||||+|||+ +..|+++|+|||.++..
T Consensus 388 ~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 388 GKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred CceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 999999999999999998887766666 7888999999999999999999999999999999 68999999999999865
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
... ..+.|-|..|.|||++....|+.++||||||++||+||+|+.||......+.....+ ..+.+...+|.
T Consensus 467 ~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i----~~~~~s~~vS~ 537 (612)
T KOG0603|consen 467 ERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRI----QMPKFSECVSD 537 (612)
T ss_pred chh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhh----cCCccccccCH
Confidence 432 445677999999999999999999999999999999999999998665543222222 23344588999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
++++||.+||++||.+|+++.+++.||||
T Consensus 538 ~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 538 EAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHHHHHHHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999999999
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=347.46 Aligned_cols=259 Identities=31% Similarity=0.474 Sum_probs=215.7
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCc---E-EEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCee
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGE---L-LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV 132 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~---~-VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV 132 (668)
..++....+..+.++||+|+||.||+|+.+..+. . ||||..+. ........+..+.+|+++|++++|||||
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~-----~~~~~~~~~~e~m~EArvMr~l~H~NVV 224 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKG-----SSELTKEQIKEFMKEARVMRQLNHPNVV 224 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecc-----cccccHHHHHHHHHHHHHHHhCCCCCEE
Confidence 3355666677778999999999999998766432 3 89998743 1223456678899999999999999999
Q ss_pred eeccccccCCcceEEeeccCCCChhcccccCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 133 RYLGTAREDDSLNILLEFVPGGSISSLLGKFGS-FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 133 ~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~-l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
++||++.....++||||+|.||+|.++|++.+. ++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+
T Consensus 225 r~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 225 RFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeC
Confidence 999999999999999999999999999998874 9999999999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhhhhhcCCc-cCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCC
Q 005944 212 DFGASKKVVELATINGAK-SMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKS 289 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~-~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~ 289 (668)
|||+++.-.. ..... ...-...|+|||.+....|+.++|||||||++||+++ |..||.+........ .+.....
T Consensus 305 DFGLs~~~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~-kI~~~~~ 380 (474)
T KOG0194|consen 305 DFGLSRAGSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA-KIVKNGY 380 (474)
T ss_pred ccccccCCcc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH-HHHhcCc
Confidence 9999875321 11111 1235678999999999999999999999999999999 888997654332222 2223445
Q ss_pred CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 290 ~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..+.+...+.++..++.+|+..+|++||++.++.+
T Consensus 381 r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 381 RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 56677788899999999999999999999999875
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=321.71 Aligned_cols=265 Identities=21% Similarity=0.264 Sum_probs=193.4
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCC---CcEEEEEEeeecccchhhHhh---HHHHHHHHHHHHHHHhCCCCCee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDS---GELLAVKQVLIAANSASKEKT---QAHIRELEEEVKLLKNLTHPNIV 132 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~i~~~~~~~~~~~~---~~~~~~~~~Ei~iL~~L~HpNIV 132 (668)
.++...+|++.++||+|+||+||+|.+..+ +..+|+|+..........+.. .........+...+..+.|+||+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 356778999999999999999999998877 677888864322211100100 00011122344556677899999
Q ss_pred eeccccccCC----cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCce
Q 005944 133 RYLGTAREDD----SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCI 208 (668)
Q Consensus 133 ~l~g~~~~~~----~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~v 208 (668)
++++.+.... ..+++++++. ..+.+++.....+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence 9998765443 3467888874 3666666665567899999999999999999999999999999999999999999
Q ss_pred EEecCCchhhhHhhhhh-----cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHH
Q 005944 209 KLADFGASKKVVELATI-----NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAAL 281 (668)
Q Consensus 209 KL~DFGlA~~~~~~~~~-----~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~ 281 (668)
+|+|||+|+.+...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 99999999865321111 112235799999999999999999999999999999999999999975421 11100
Q ss_pred Hh---hccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 282 FH---IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 282 ~~---~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.. ..............+.++.+++..||..+|++||++.+|++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 00 00000011112356789999999999999999999999975
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=365.90 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=207.3
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc-
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE- 140 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~- 140 (668)
...+|+.+++||+||||.||+|+++-+|+.||||+|.... .......+.+|+++|.+|+|||||+++..|.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-------s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs 549 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-------SDKLYSKILREVKLLARLNHPNVVRYYSAWVES 549 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-------HHHHHHHHHHHHHHHhhcCCcceeeeehhhhcc
Confidence 3456888999999999999999999999999999985432 23445668899999999999999999843311
Q ss_pred --------------------------------------------------------------------------------
Q 005944 141 -------------------------------------------------------------------------------- 140 (668)
Q Consensus 141 -------------------------------------------------------------------------------- 140 (668)
T Consensus 550 ~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~ 629 (1351)
T KOG1035|consen 550 TAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRN 629 (1351)
T ss_pred CCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccc
Confidence
Q ss_pred ------------------------------C--------CcceEEeeccCCCChhcccccCCCC-CHHHHHHHHHHHHHH
Q 005944 141 ------------------------------D--------DSLNILLEFVPGGSISSLLGKFGSF-PESVIRMYTKQLLLG 181 (668)
Q Consensus 141 ------------------------------~--------~~~~LVmEy~~gGsL~~~L~~~~~l-~e~~~~~i~~QIl~a 181 (668)
+ ..+||-||||+..+|.++++++... ....++++|+||+.|
T Consensus 630 ~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 630 LSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEG 709 (1351)
T ss_pred cccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHH
Confidence 0 1267889999998888888776444 478899999999999
Q ss_pred HHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh----hhh------------hcCCccCCCCCCCCChHHHhh
Q 005944 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE----LAT------------INGAKSMKGTPYWMAPEVILQ 245 (668)
Q Consensus 182 L~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~----~~~------------~~~~~~~~GT~~Y~APEvl~~ 245 (668)
|.|+|+.|||||||||.||+++.++.|||+|||+|+.... ... ....+..+||..|+|||++.+
T Consensus 710 LaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~ 789 (1351)
T KOG1035|consen 710 LAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD 789 (1351)
T ss_pred HHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence 9999999999999999999999999999999999987320 000 112345789999999999976
Q ss_pred cC---CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCC--CCcccCHHHHHHHHHhhhhCCCCCCCHH
Q 005944 246 TG---HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP--IPEHLSMEAKDFLLKCLQKEPYLRSTAS 320 (668)
Q Consensus 246 ~~---~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~--~p~~ls~el~dLI~kcL~~dP~~RPSa~ 320 (668)
.. |+.|+|||||||||+||+. ||....+.+..+..+.......+ ++..--+....+|..||+.||.+||||.
T Consensus 790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~ 866 (1351)
T KOG1035|consen 790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTAT 866 (1351)
T ss_pred cccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHH
Confidence 55 9999999999999999986 68877777666655553333222 2223334567899999999999999999
Q ss_pred HHHcCcccc
Q 005944 321 ELLQHPFVT 329 (668)
Q Consensus 321 EIL~Hpwf~ 329 (668)
|+|++.||.
T Consensus 867 eLL~s~llp 875 (1351)
T KOG1035|consen 867 ELLNSELLP 875 (1351)
T ss_pred HHhhccCCC
Confidence 999999997
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=315.12 Aligned_cols=246 Identities=21% Similarity=0.328 Sum_probs=187.7
Q ss_pred EEcccCceEEEEEEEcCC--CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEe
Q 005944 71 LVGCGAFGRVYMGMNLDS--GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~~t--g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVm 148 (668)
.||+|+||.||+|..... ...+++|.+... ........+.+|+.+++.++||||+++++.+......|+||
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~-------~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~ 74 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKAN-------ASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVF 74 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCC-------CChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEE
Confidence 589999999999975433 234566655221 11223456888999999999999999999999999999999
Q ss_pred eccCCCChhcccccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 149 EFVPGGSISSLLGKF----GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 149 Ey~~gGsL~~~L~~~----~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
||+++|+|.+++.+. ..+++..++.++.||+.||+|||+.+|+||||||+|||++.++.+||+|||++........
T Consensus 75 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~ 154 (268)
T cd05086 75 EYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY 154 (268)
T ss_pred ecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchh
Confidence 999999999998653 3467778889999999999999999999999999999999999999999999764322111
Q ss_pred hcCCccCCCCCCCCChHHHhh-------cCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHH-HHhhc-cCCCCCCC
Q 005944 225 INGAKSMKGTPYWMAPEVILQ-------TGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAA-LFHIG-TTKSHPPI 293 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl~~-------~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~-~~~~~-~~~~~~~~ 293 (668)
.......+|+..|+|||++.. ..++.++|||||||++|+|++ |..||..... +... ..... .....+.+
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 122234678899999999853 235778999999999999997 5778854322 1111 11111 11122344
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+..++..+.+++..|| .+|.+||++.+|++
T Consensus 235 ~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 235 ELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 4567889999999999 67999999999975
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=321.71 Aligned_cols=264 Identities=25% Similarity=0.439 Sum_probs=222.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~ 138 (668)
.....+|+++.+||+|+|+.|.+++++.|.+.||+|+++.. -....+.+..++.|-.+..+. +||.+|-|...|
T Consensus 246 ~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkke-----l~nddedidwvqtek~vfe~asn~pflvglhscf 320 (593)
T KOG0695|consen 246 GLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKE-----LVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF 320 (593)
T ss_pred ccccccceeeeeecCcchhhhhheehcccceeeehhhHHHH-----hcCCcccchhHHhhHHHHHhccCCCeEEehhhhh
Confidence 35567899999999999999999999999999999998432 222334566677777777766 699999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
+++..+++|.||++||+|--++++.+.++++.++.+...|+.||.|||++|||+||||..||||+..|++||+|+|+++.
T Consensus 321 qtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke 400 (593)
T KOG0695|consen 321 QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 400 (593)
T ss_pred cccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999874
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCch-----hHHHHHHHHhhccCCCCCCC
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQ-----QFQEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~-----~~~~~~~~~~~~~~~~~~~~ 293 (668)
- ........++||||.|+|||++.+..|++.+|+|+|||+++||+.|+.||.- ........+-.........+
T Consensus 401 ~--l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri 478 (593)
T KOG0695|consen 401 G--LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI 478 (593)
T ss_pred C--CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence 2 2233445679999999999999999999999999999999999999999951 11111111111122233457
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCC------CHHHHHcCccccC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRS------TASELLQHPFVTG 330 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RP------Sa~EIL~Hpwf~~ 330 (668)
|..+|..+..+++..|++||.+|. .+.++..|+||..
T Consensus 479 prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 479 PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 888999999999999999999994 5789999999974
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=332.39 Aligned_cols=272 Identities=28% Similarity=0.384 Sum_probs=224.5
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
.......||-++.+||+|||+.||+|.+....++||||+-.+..++.. ++.....+...+|.+|.+.|.||.||++|++
T Consensus 457 DHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~Wrd-EKKeNYhKHAcREyrIHKeLDHpRIVKlYDy 535 (775)
T KOG1151|consen 457 DHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRD-EKKENYHKHACREYRIHKELDHPRIVKLYDY 535 (775)
T ss_pred cCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhh-HhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence 344567789999999999999999999999999999998766655543 4445667788899999999999999999999
Q ss_pred ccc-CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccccCCcccEEeCC---CCceEEe
Q 005944 138 ARE-DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN--GIMHRDIKGANILVDN---KGCIKLA 211 (668)
Q Consensus 138 ~~~-~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~--gIvHrDLKPeNILld~---~g~vKL~ 211 (668)
|.- .+.+|-|+|||+|.+|.-+|+.+.-++|.+++.|+.||+.||.||... .|||-||||.|||+-. -|.+||+
T Consensus 536 fslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 536 FSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred eeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee
Confidence 864 467899999999999999999999999999999999999999999987 5999999999999953 4789999
Q ss_pred cCCchhhhHhhhhh-----cCCccCCCCCCCCChHHHhhc----CCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHH
Q 005944 212 DFGASKKVVELATI-----NGAKSMKGTPYWMAPEVILQT----GHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAA 280 (668)
Q Consensus 212 DFGlA~~~~~~~~~-----~~~~~~~GT~~Y~APEvl~~~----~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~ 280 (668)
||||++.+...... .......||.+|++||.+.-+ ..+.++||||+|||+|+++.|+.||.... +++..
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq 695 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ 695 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence 99999987543322 112346799999999998643 36889999999999999999999997543 22222
Q ss_pred HHhh-ccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 281 LFHI-GTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 281 ~~~~-~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
...+ .......+....++.++++||++||+..-++|....++..||||..
T Consensus 696 eNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 696 ENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred hhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 2111 1122233344578999999999999999999999999999999964
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=311.87 Aligned_cols=253 Identities=29% Similarity=0.503 Sum_probs=205.2
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCCcc
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDDSL 144 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~~~ 144 (668)
.+.+..||.|+-|+|++++.+.+|...|||.+.... ..+..+.+...+.++...+ .|+||+.+|+|..+..+
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-------Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV 166 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-------NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDV 166 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-------CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchH
Confidence 445677999999999999999999999999984322 2233455666777666654 89999999999999999
Q ss_pred eEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
+|.||.+. ..+..++++ .++++|..+-++...++.||.||..+ ||+|||+||+|||+|..|++||||||++..+.+.
T Consensus 167 ~IcMelMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 167 FICMELMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHHHHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 99999883 356666644 46799999999999999999999865 8999999999999999999999999999876543
Q ss_pred hhhcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCC--ccc
Q 005944 223 ATINGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP--EHL 297 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p--~~l 297 (668)
.. .....|-+.|||||.|. ...|+.++|||||||+|+||+||..||.....+...+.++.. ...+.++ ...
T Consensus 246 kA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gF 321 (391)
T KOG0983|consen 246 KA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGF 321 (391)
T ss_pred cc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCc
Confidence 22 23456889999999985 346899999999999999999999999875444333333332 2223333 347
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
|+.+++|+..||++|+.+||...++|+|||+..
T Consensus 322 Sp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ 354 (391)
T KOG0983|consen 322 SPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKR 354 (391)
T ss_pred CHHHHHHHHHHhhcCcccCcchHHHhcCcceee
Confidence 999999999999999999999999999999874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=316.85 Aligned_cols=264 Identities=28% Similarity=0.460 Sum_probs=210.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.....|+...+||+|.||.||+|+...+|+.||+|++... ......-....+|+++|..|+|+|++.++++|..
T Consensus 14 ~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlme------neKeGfpitalreikiL~~lkHenv~nliEic~t 87 (376)
T KOG0669|consen 14 DEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLME------NEKEGFPITALREIKILQLLKHENVVNLIEICRT 87 (376)
T ss_pred ecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHh------ccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhh
Confidence 4567799999999999999999999999999999987321 1112233445789999999999999999988754
Q ss_pred C--------CcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 141 D--------DSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 141 ~--------~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
. ..+|+||.+|+. +|..+|... .+|+..++++++.+++.||.|+|+..|+|||+||+|+||+.+|.+||+
T Consensus 88 k~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklA 166 (376)
T KOG0669|consen 88 KATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLA 166 (376)
T ss_pred ccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEee
Confidence 3 348999999975 888888665 679999999999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhh--hhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHHHHH--HHHhhcc
Q 005944 212 DFGASKKVVEL--ATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQEVA--ALFHIGT 286 (668)
Q Consensus 212 DFGlA~~~~~~--~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~--~~~~~~~ 286 (668)
|||+++.+... .....++..+.|.+|++||.+.+.. |+.+.|||+.|||+.+|+||.+.|.++.+... .+-....
T Consensus 167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG 246 (376)
T KOG0669|consen 167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG 246 (376)
T ss_pred ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence 99999766322 2233355567799999999999765 89999999999999999999999976643221 1111111
Q ss_pred C---CCC--------------CCCCc-------------ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 287 T---KSH--------------PPIPE-------------HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 287 ~---~~~--------------~~~p~-------------~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
. ..+ ++++. .-.+++.+|+.++|..||.+|+.+.++|.|.||...
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 1 111 11111 124578899999999999999999999999999753
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=341.20 Aligned_cols=260 Identities=19% Similarity=0.256 Sum_probs=182.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCC----CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDS----GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~t----g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
....+|.+.++||+|+||.||+|++..+ +..||||++.... .. +....+ .++...+.+++.++.
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~------~~----e~~~~e--~l~~~~~~~~~~~~~ 196 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG------AV----EIWMNE--RVRRACPNSCADFVY 196 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc------hh----HHHHHH--HHHhhchhhHHHHHH
Confidence 4567899999999999999999999988 9999999873110 00 001111 122222333333222
Q ss_pred c------cccCCcceEEeeccCCCChhcccccCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCc
Q 005944 137 T------AREDDSLNILLEFVPGGSISSLLGKFGS--------------------FPESVIRMYTKQLLLGLEYLHKNGI 190 (668)
Q Consensus 137 ~------~~~~~~~~LVmEy~~gGsL~~~L~~~~~--------------------l~e~~~~~i~~QIl~aL~yLHs~gI 190 (668)
. ......++|||||+.+++|.+++..... ..+..+..++.||+.||.|||++||
T Consensus 197 ~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gI 276 (566)
T PLN03225 197 GFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276 (566)
T ss_pred hhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCE
Confidence 2 2456679999999999999988864321 1234567899999999999999999
Q ss_pred ccccCCcccEEeCC-CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcC----------------------
Q 005944 191 MHRDIKGANILVDN-KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG---------------------- 247 (668)
Q Consensus 191 vHrDLKPeNILld~-~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~---------------------- 247 (668)
+||||||+||||+. ++.+||+|||+|+.+.... .......+||+.|+|||.+....
T Consensus 277 iHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~ 355 (566)
T PLN03225 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLN 355 (566)
T ss_pred EeCcCCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhcccc
Confidence 99999999999986 5799999999997653222 12234578999999999774322
Q ss_pred CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCC-------CCC----------CCCcccCHHHHHHHHHhhh
Q 005944 248 HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTK-------SHP----------PIPEHLSMEAKDFLLKCLQ 310 (668)
Q Consensus 248 ~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~-------~~~----------~~p~~ls~el~dLI~kcL~ 310 (668)
++.++||||||||||||+++..|+..........+...... ... .+.........+||.+||+
T Consensus 356 ~~~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 356 LPDRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred CCCCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 34467999999999999998887754433222222111100 000 0111223345699999999
Q ss_pred hCCCCCCCHHHHHcCccccCCCC
Q 005944 311 KEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 311 ~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
+||.+|||+.++|+||||++...
T Consensus 436 ~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 436 FKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred CCcccCCCHHHHhCCcCcCCCCc
Confidence 99999999999999999987543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.60 Aligned_cols=258 Identities=29% Similarity=0.404 Sum_probs=205.7
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC--CCC----e
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT--HPN----I 131 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpN----I 131 (668)
..+....+|.+..+||+|.||.|..+.+..++..||||+++. .....+...-|+++|.++. .|+ +
T Consensus 83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~---------V~kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKN---------VDKYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred eccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHH---------HHHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 346778999999999999999999999999999999999831 1223344566999999993 233 7
Q ss_pred eeeccccccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-----
Q 005944 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN----- 204 (668)
Q Consensus 132 V~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~----- 204 (668)
|.+.+||...+..+||+|.+ |-+++++|..+ .+|+...++.+++||+.+++|||+.+++|-||||+|||+..
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence 89999999999999999998 66999999775 56999999999999999999999999999999999999832
Q ss_pred ---------------CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCC
Q 005944 205 ---------------KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKP 269 (668)
Q Consensus 205 ---------------~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~ 269 (668)
+..|+|+|||.|+...+. ..+.+.|..|+|||++++-+++..+||||+||||+||.||..
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 235899999999864332 245788999999999999999999999999999999999999
Q ss_pred CCchhH--HHHHHHHhh--------------------ccCCCCC-------------CCC--------cccCHHHHHHHH
Q 005944 270 PWSQQF--QEVAALFHI--------------------GTTKSHP-------------PIP--------EHLSMEAKDFLL 306 (668)
Q Consensus 270 PF~~~~--~~~~~~~~~--------------------~~~~~~~-------------~~p--------~~ls~el~dLI~ 306 (668)
.|+... +.+..+..+ +...+.. ..| +..-.++-|||+
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 997432 111111110 0000000 000 011235679999
Q ss_pred HhhhhCCCCCCCHHHHHcCccccC
Q 005944 307 KCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 307 kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+||..||.+|+|+.|+|.||||..
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpFF~~ 411 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPFFAR 411 (415)
T ss_pred HHHccCccccccHHHHhcCHHhhc
Confidence 999999999999999999999974
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=293.31 Aligned_cols=242 Identities=40% Similarity=0.672 Sum_probs=201.4
Q ss_pred CceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeeccCCCC
Q 005944 76 AFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGS 155 (668)
Q Consensus 76 ~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~~gGs 155 (668)
+||.||+|++..++..+|+|++...... .....+.+|+++++.++|+||+++++.+......++++||+.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~-------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~ 73 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIK-------KKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGD 73 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccc-------cHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCC
Confidence 6899999999989999999998432111 114678899999999999999999999999899999999999999
Q ss_pred hhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCC
Q 005944 156 ISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP 235 (668)
Q Consensus 156 L~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~ 235 (668)
|..++.....+++..++.++.+++.+|.|||..+|+|+||+|.||+++.++.++|+|||++....... ......++.
T Consensus 74 L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 74 LFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 99999776669999999999999999999999999999999999999999999999999988654321 234567899
Q ss_pred CCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCch-h-HHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCC
Q 005944 236 YWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQ-Q-FQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEP 313 (668)
Q Consensus 236 ~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~-~-~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP 313 (668)
.|++||.+.+..++.++|||+||+++|+|++|..||.. . ............. ........++.++.+++.+||..+|
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p 229 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKP-PFPPPEWKISPEAKDLIRKLLVKDP 229 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCC-CCccccccCCHHHHHHHHHHccCCc
Confidence 99999999888889999999999999999999999965 2 2222222221111 1111111278899999999999999
Q ss_pred CCCCCHHHHHcCccc
Q 005944 314 YLRSTASELLQHPFV 328 (668)
Q Consensus 314 ~~RPSa~EIL~Hpwf 328 (668)
.+||++.++++||||
T Consensus 230 ~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 230 EKRLTAEEALQHPFF 244 (244)
T ss_pred hhccCHHHHhhCCCC
Confidence 999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=327.78 Aligned_cols=257 Identities=28% Similarity=0.397 Sum_probs=211.6
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
+.+..+..+.+.||+|-||.|.+|.. ..+..||||++.... .....+.|..|+++|.+|+|||||+|+|+|.
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a-------~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~ 605 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDA-------TKNARNDFLKEIKILSRLKHPNIVELLGVCV 605 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCccc-------chhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence 45566788999999999999999974 457999999984222 2223478999999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.++.+++|+||++.|+|.+++.++. .+.-.....|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++
T Consensus 606 ~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR 685 (807)
T KOG1094|consen 606 QDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSR 685 (807)
T ss_pred cCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCccccc
Confidence 9999999999999999999998773 33455667799999999999999999999999999999999999999999998
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh--CCCCCchhHHHHHH-----HHhhccCCCC
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT--GKPPWSQQFQEVAA-----LFHIGTTKSH 290 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT--G~~PF~~~~~~~~~-----~~~~~~~~~~ 290 (668)
-+.....+......+-..+|||+|.|..++++.++|||+||+++||+++ ...||.+..++... .+.-......
T Consensus 686 ~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 686 NLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV 765 (807)
T ss_pred ccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence 6544333332223445689999999999999999999999999999875 78899766543221 2222223334
Q ss_pred CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 291 ~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
...|..++..+.+||.+||..|-.+||+++++-.
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 4567789999999999999999999999999854
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=335.59 Aligned_cols=202 Identities=33% Similarity=0.538 Sum_probs=174.6
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....-|...+.||+||||.||+++++.+|+.||||.+.... .....+...+|+++|++|+|+|||+++++-++
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-------~~r~~e~~~~EieilkKLnh~NIVk~f~iee~ 82 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-------SLRPRERWCREIEILKKLNHPNIVKLFDIEET 82 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhc-------ccchHHHHHHHHHHHHHcCchhhhhhcccCCc
Confidence 33466888999999999999999999999999999884322 12233456789999999999999999998665
Q ss_pred CC------cceEEeeccCCCChhcccccC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC--CC--c
Q 005944 141 DD------SLNILLEFVPGGSISSLLGKF---GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN--KG--C 207 (668)
Q Consensus 141 ~~------~~~LVmEy~~gGsL~~~L~~~---~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~--~g--~ 207 (668)
.. ...+|||||.||+|+.+|.+. ..+++.+++.++.++..||.|||++|||||||||.||++-. +| .
T Consensus 83 ~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~I 162 (732)
T KOG4250|consen 83 KFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSI 162 (732)
T ss_pred cccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceE
Confidence 44 467999999999999999764 56999999999999999999999999999999999999842 23 5
Q ss_pred eEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCc
Q 005944 208 IKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWS 272 (668)
Q Consensus 208 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~ 272 (668)
-||+|||.|+-+.+.. ...+.+||+.|.+||++.. ..|+..+|.|||||++|+++||..||.
T Consensus 163 yKLtDfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 163 YKLTDFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred EeeecccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 7999999999876543 5678999999999999984 779999999999999999999999995
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=337.07 Aligned_cols=258 Identities=36% Similarity=0.650 Sum_probs=216.6
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~ 138 (668)
..+...|++.++||.|.+|.||+++++++++.+|||+.... ...-++++.|.+||+.+ .|||++.++++|
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---------~d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---------EDEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---------ccccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 45667799999999999999999999999999999988432 12234566788899888 599999999988
Q ss_pred cc-----CCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 139 RE-----DDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 139 ~~-----~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
.. ++.++||||||.||+..++++.. .++.|..+..|++.++.||.+||.+.++|||||-.|||++.+|.|||+
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEe
Confidence 53 46799999999999999998654 568899999999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-----CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhcc
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQT-----GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT 286 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-----~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~ 286 (668)
|||++..+.. +.....+.+|||.|||||++... .|+.++|+||||++..||.-|.+|+.+.. ....++.+..
T Consensus 166 DFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH-PmraLF~IpR 242 (953)
T KOG0587|consen 166 DFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPR 242 (953)
T ss_pred eeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc-hhhhhccCCC
Confidence 9999877643 33445678999999999999643 46788999999999999999999997653 3334444433
Q ss_pred CCCCC-CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 287 TKSHP-PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 287 ~~~~~-~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
..... .-|...+.++.+||..||.+|-++||+..++|+|||++
T Consensus 243 NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 243 NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT 286 (953)
T ss_pred CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence 22222 23567788999999999999999999999999999997
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=325.67 Aligned_cols=248 Identities=28% Similarity=0.466 Sum_probs=207.6
Q ss_pred eeeeeEEcccCceEEEEEEEcCC----CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDS----GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~t----g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
....++||.|-||.||.|+...- .-.||||..+.... .+..+.|..|.-+|++++|||||+|+|++.+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t-------~d~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT-------PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC-------hhhHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 34467899999999999987542 34688898754332 2334568899999999999999999999875
Q ss_pred CcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 142 DSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...+||||+++-|.|..+|+.+ ..++......++.||+.||.|||+.++|||||...||||...-+|||+|||+++.+.
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e 542 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE 542 (974)
T ss_pred cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence 5689999999999999999765 568999999999999999999999999999999999999999999999999999886
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
+...+.. ....-...|||||-+.-..++.++|||.|||++||++. |..||.+-.... .+.........+.|.++++
T Consensus 543 d~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD--VI~~iEnGeRlP~P~nCPp 619 (974)
T KOG4257|consen 543 DDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD--VIGHIENGERLPCPPNCPP 619 (974)
T ss_pred ccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc--eEEEecCCCCCCCCCCCCh
Confidence 6554433 34445678999999999999999999999999999987 999997643321 1222234556788999999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.+..|+.+||+.+|.+||.+.+|..
T Consensus 620 ~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 620 ALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HHHHHHHHHhccCcccCCcHHHHHH
Confidence 9999999999999999999998764
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=321.16 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=218.2
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
.+++....+.....+||-|-||.||.|.++.-...||||.++ .+...+.+|..|+.+|+.++|||+|+|+|
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLK---------EDtMeveEFLkEAAvMKeikHpNLVqLLG 330 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK---------EDTMEVEEFLKEAAVMKEIKHPNLVQLLG 330 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhh---------hcchhHHHHHHHHHHHHhhcCccHHHHhh
Confidence 445566667777889999999999999999999999999872 23456778999999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
+|..+..+|||+|||..|+|.++|++.. .++.-.++.++.||..|++||..+++|||||...|+||..+..|||+|||
T Consensus 331 VCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFG 410 (1157)
T KOG4278|consen 331 VCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFG 410 (1157)
T ss_pred hhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccc
Confidence 9999999999999999999999997753 46777788899999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCC
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~ 293 (668)
|++.+.. +++.......-...|.|||-|....++.++|||+|||+|||+.| |-.||.+.. ....+.+....+...-
T Consensus 411 LsRlMtg-DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid--lSqVY~LLEkgyRM~~ 487 (1157)
T KOG4278|consen 411 LSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYGLLEKGYRMDG 487 (1157)
T ss_pred hhhhhcC-CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc--HHHHHHHHhccccccC
Confidence 9997754 33333333334677999999999999999999999999999998 888887542 2233344445666778
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELL 323 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL 323 (668)
|+.+++.+..|++.||++.|.+||++.||-
T Consensus 488 PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 488 PEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 899999999999999999999999999974
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=322.79 Aligned_cols=271 Identities=20% Similarity=0.263 Sum_probs=191.2
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEc----------------CCCcEEEEEEeeecccchhhHhh------HHHHHHHH
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNL----------------DSGELLAVKQVLIAANSASKEKT------QAHIRELE 117 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~----------------~tg~~VAVK~i~~~~~~~~~~~~------~~~~~~~~ 117 (668)
.+...+|++.++||+|+||+||+|... ..++.||||.+............ ........
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 356778999999999999999999753 23568999998432211000000 00112234
Q ss_pred HHHHHHHhCCCCCe-----eeecccccc--------CCcceEEeeccCCCChhcccccC---------------------
Q 005944 118 EEVKLLKNLTHPNI-----VRYLGTARE--------DDSLNILLEFVPGGSISSLLGKF--------------------- 163 (668)
Q Consensus 118 ~Ei~iL~~L~HpNI-----V~l~g~~~~--------~~~~~LVmEy~~gGsL~~~L~~~--------------------- 163 (668)
.|+.++.+++|.++ ++++++|.. ....+|||||+.+++|.+++...
T Consensus 221 vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 221 VEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 47777777876654 667776643 35689999999999999887532
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCCh
Q 005944 164 ---GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240 (668)
Q Consensus 164 ---~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~AP 240 (668)
..+++..++.++.||+.+|.|||..+|+||||||+|||++.++.+||+|||++..+..... .......+|+.|+||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPP 379 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeCh
Confidence 1235667889999999999999999999999999999999999999999999875432111 111123458999999
Q ss_pred HHHhhcC--------------------C--CcchhHHHHHHHHHHHHhCCC-CCchhH------H----HHHHHHhhccC
Q 005944 241 EVILQTG--------------------H--SFSADIWSVGCTVIEMATGKP-PWSQQF------Q----EVAALFHIGTT 287 (668)
Q Consensus 241 Evl~~~~--------------------~--s~ksDIWSLGvILyeLLTG~~-PF~~~~------~----~~~~~~~~~~~ 287 (668)
|++.... | ..+.||||+|||+|+|++|.. ||.... . ...........
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~ 459 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ 459 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence 9986432 1 124799999999999999875 764211 0 00001111112
Q ss_pred CCCCCCCcccCHHHHHHHHHhhhhCC---CCCCCHHHHHcCccccCC
Q 005944 288 KSHPPIPEHLSMEAKDFLLKCLQKEP---YLRSTASELLQHPFVTGK 331 (668)
Q Consensus 288 ~~~~~~p~~ls~el~dLI~kcL~~dP---~~RPSa~EIL~Hpwf~~~ 331 (668)
..........+..+++||.+||..+| .+|+|+.|+|+||||...
T Consensus 460 ~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 460 KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 22233456678999999999999876 689999999999999643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=291.04 Aligned_cols=252 Identities=26% Similarity=0.473 Sum_probs=203.9
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeecccccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTARE 140 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~ 140 (668)
...+|++.+.+|+|.|+.||.|....++++++||+++. -..+.+.+|++||..|. ||||++|+++..+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP-----------VkkkKIkREikIL~nL~gg~NIi~L~DiV~D 104 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP-----------VKKKKIKREIKILQNLRGGPNIIKLLDIVKD 104 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeech-----------HHHHHHHHHHHHHHhccCCCCeeehhhhhcC
Confidence 45689999999999999999999999999999999842 22356789999999997 9999999999876
Q ss_pred C--CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-CceEEecCCchh
Q 005944 141 D--DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK-GCIKLADFGASK 217 (668)
Q Consensus 141 ~--~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~-g~vKL~DFGlA~ 217 (668)
. ....||+||+...+...+. ..++...++.++.+|+.||.|||+.||+|||+||.|+||+.. -.++|+|+|+|.
T Consensus 105 p~SktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 105 PESKTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAE 181 (338)
T ss_pred ccccCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHh
Confidence 5 4577999999887776654 457888899999999999999999999999999999999975 479999999999
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCch---hHHHHHHHHhhccC------
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQ---QFQEVAALFHIGTT------ 287 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~---~~~~~~~~~~~~~~------ 287 (668)
.+..... ....+.+..|.-||++..-. |+++.|+|||||+|..|+..+.||.. +.+....+..+...
T Consensus 182 FYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Y 258 (338)
T KOG0668|consen 182 FYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAY 258 (338)
T ss_pred hcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHH
Confidence 8755333 44567888999999997654 89999999999999999999999842 22222222111000
Q ss_pred ------CCC--------------------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 288 ------KSH--------------------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 288 ------~~~--------------------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
... ..-..-+++++.||+.++|..|..+|+|+.|++.||||..
T Consensus 259 l~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 259 LNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred HHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 000 0011234689999999999999999999999999999974
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=331.00 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=217.8
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCC---cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg---~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
++......+.++||.|.||.|++|+.+..| ..||||.++. ...+...+.|+.|+.||.+++||||++|-|
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~-------GytekqrrdFL~EAsIMGQFdHPNIIrLEG 697 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKA-------GYTEKQRRDFLSEASIMGQFDHPNIIRLEG 697 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeecc-------CccHHHHhhhhhhhhhcccCCCCcEEEEEE
Confidence 456677899999999999999999987765 5899999843 223345577999999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
+......+.||+|||+.|.|..+|+.+ +.|+..++.-+++.|+.|++||.++|+|||||...||||+.+-.+|+.||||
T Consensus 698 VVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 698 VVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred EEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccc
Confidence 999999999999999999999999776 7799999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccC--CCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH-HHHHHHHhhccCCCCC
Q 005944 216 SKKVVELATINGAKSM--KGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVAALFHIGTTKSHP 291 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~--~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~-~~~~~~~~~~~~~~~~ 291 (668)
++.+.++. ...+++. .-..+|.|||.|...+++.++||||+||++||.++ |..||.+.. +++...+.. ....
T Consensus 778 SRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~---gyRL 853 (996)
T KOG0196|consen 778 SRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQ---GYRL 853 (996)
T ss_pred eeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHh---ccCC
Confidence 99764433 2222222 23578999999999999999999999999999876 999987664 444443333 3445
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+.|-.++..+.+|+..||++|-.+||.+.+|+.+
T Consensus 854 PpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 854 PPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 5667899999999999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=316.96 Aligned_cols=261 Identities=29% Similarity=0.471 Sum_probs=209.8
Q ss_pred CCCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC------CC
Q 005944 56 IEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT------HP 129 (668)
Q Consensus 56 ~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~------Hp 129 (668)
+..++....+|.+....|+|-|++|..|.+..-|..||||+|.. .+...+.-+.|+.||+.|. --
T Consensus 424 v~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn---------NE~M~KtGl~EleiLkKL~~AD~Edk~ 494 (752)
T KOG0670|consen 424 VRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN---------NEVMHKTGLKELEILKKLNDADPEDKF 494 (752)
T ss_pred EehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec---------chHHhhhhhHHHHHHHHhhccCchhhh
Confidence 34456777899999999999999999999999999999999932 2233345678999999995 34
Q ss_pred CeeeeccccccCCcceEEeeccCCCChhcccccCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-
Q 005944 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG---SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK- 205 (668)
Q Consensus 130 NIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~---~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~- 205 (668)
|+|+|+..|...+++|||+|-+. -+|.++|.+.+ .|....++.|+.||+.||..|...||+|.||||.||||+..
T Consensus 495 Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc
Confidence 89999999999999999999884 58999998765 48889999999999999999999999999999999999865
Q ss_pred CceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH-HHHHhh
Q 005944 206 GCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV-AALFHI 284 (668)
Q Consensus 206 g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~-~~~~~~ 284 (668)
..+||||||.|..+.+ +..+.+..+.+|.|||+|+|..|++..|+||+||+||||.||+..|.+.+... ..++..
T Consensus 574 ~iLKLCDfGSA~~~~e----neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 574 NILKLCDFGSASFASE----NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred ceeeeccCcccccccc----ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 5789999999986543 33344556788999999999999999999999999999999999997543221 111111
Q ss_pred ccCCC-----------------------------------------CC------------CCCc---ccCHHHHHHHHHh
Q 005944 285 GTTKS-----------------------------------------HP------------PIPE---HLSMEAKDFLLKC 308 (668)
Q Consensus 285 ~~~~~-----------------------------------------~~------------~~p~---~ls~el~dLI~kc 308 (668)
..... .+ .++. .+-.++++|+.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 00000 00 0111 1223578999999
Q ss_pred hhhCCCCCCCHHHHHcCccccC
Q 005944 309 LQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 309 L~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
|..||.+|.|..++|.||||++
T Consensus 730 l~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 730 LILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred hccChhhcCCHHHHhcCCcccC
Confidence 9999999999999999999975
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=321.46 Aligned_cols=259 Identities=25% Similarity=0.377 Sum_probs=215.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCC---cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg---~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
+...+.++.++||+|.||.|++|.++..+ -.||||.+.... .......|.+|+.+|.+|+|+|+|+|||+
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~-------l~~~mddflrEas~M~~L~H~hliRLyGv 179 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDS-------LNAIMDDFLREASHMLKLQHPHLIRLYGV 179 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCc-------cchhHHHHHHHHHHHHhccCcceeEEeee
Confidence 55567888999999999999999987642 478999884221 11266789999999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGK--FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
..+ ..+.+|||++++|+|.+.|++ ...|....+..|+.||+.||.||..+++|||||...||||.....|||+||||
T Consensus 180 Vl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGL 258 (1039)
T KOG0199|consen 180 VLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGL 258 (1039)
T ss_pred ecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccc
Confidence 887 778899999999999999976 35688999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCC-ccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGA-KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~-~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~ 293 (668)
.+-+......... ....-...|+|||.|....++.++|||++||+||||+| |..||.+..-. .+++........+.
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--qIL~~iD~~erLpR 336 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--QILKNIDAGERLPR 336 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--HHHHhccccccCCC
Confidence 9887654433222 12334567999999999999999999999999999998 89999765321 22222235556677
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
|..++..++++++.||..+|.+|||+..|.+.-+..
T Consensus 337 Pk~csedIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 337 PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred CCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 889999999999999999999999999997655443
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=295.29 Aligned_cols=256 Identities=27% Similarity=0.449 Sum_probs=203.3
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC----
Q 005944 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD---- 142 (668)
Q Consensus 67 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~---- 142 (668)
+-.+.||.|+||.||.+++..+|+.||+|++. .....-...+.+.+|+++|.-++|.||+..+++..-..
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~p------nvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMP------NVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcc------hHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHH
Confidence 34568999999999999999999999999882 22233334566788999999999999999988765442
Q ss_pred -cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 -SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 -~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
.+|+|+|++. .+|..+|-....++.+.++-+++||++||+|||+.||+||||||.|+|++.+..+||||||+|+....
T Consensus 130 qEiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 130 QELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence 4788999995 49999999889999999999999999999999999999999999999999999999999999986543
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhc-------------
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIG------------- 285 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~------------- 285 (668)
.. ....+.-+.|.+|+|||++++.. |+.++||||+|||+.||+..+..|.... +....+....
T Consensus 209 d~-~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 209 RD-RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hh-hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 33 33344456689999999999865 8999999999999999999999885321 1111111110
Q ss_pred -------cC-CCCCCC--------CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 286 -------TT-KSHPPI--------PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 286 -------~~-~~~~~~--------p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.. ...+.+ +..-..+..+++.++|..||++|.+.++++.|+|...
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 00 001111 1233457789999999999999999999999999753
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=295.45 Aligned_cols=262 Identities=28% Similarity=0.403 Sum_probs=205.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHH-HHhCCCCCeeeecccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL-LKNLTHPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpNIV~l~g~~ 138 (668)
+....+.+-+..||.|+||+|++..++.+|+..|||.|..... +....++..|... ++.-+.||||++||..
T Consensus 60 ~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-------~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 60 TFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-------EKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred ccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-------hHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 3455567778889999999999999999999999999854322 2223456666664 4444799999999999
Q ss_pred ccCCcceEEeeccCCCChhccc-----ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEec
Q 005944 139 REDDSLNILLEFVPGGSISSLL-----GKFGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLAD 212 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L-----~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~D 212 (668)
..++..+|-||++. .+|..+. .+...++|..+-.|..-.+.||.||... +|||||+||+||||+..|.+||||
T Consensus 133 F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 133 FSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred hcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence 99999999999995 3665443 2346799999999999999999999865 899999999999999999999999
Q ss_pred CCchhhhHhhhhhcCCccCCCCCCCCChHHHh--hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCC
Q 005944 213 FGASKKVVELATINGAKSMKGTPYWMAPEVIL--QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSH 290 (668)
Q Consensus 213 FGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~--~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~ 290 (668)
||++..+.+.- ..+.-.|-..|||||.|. +.+|+.++||||||++|||+.||..|+.....-...+.++......
T Consensus 212 FGIcGqLv~Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp 288 (361)
T KOG1006|consen 212 FGICGQLVDSI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPP 288 (361)
T ss_pred ccchHhHHHHH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCC
Confidence 99998765422 223456888899999995 4468999999999999999999999987654433333333222111
Q ss_pred C----CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 291 P----PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 291 ~----~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
. .-.-+++..+..+|.-||.+|-..||...+++++||+....
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 1 11134788999999999999999999999999999997543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=305.31 Aligned_cols=265 Identities=28% Similarity=0.444 Sum_probs=205.9
Q ss_pred CCCCCCCCCC-CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-----
Q 005944 54 PPIEKTDAPP-IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT----- 127 (668)
Q Consensus 54 pp~~~~~~~~-~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~----- 127 (668)
.|...++.+. .||.+.++||.|-|+|||+|.++.+.+.||+|+++- .+...+....||++|++++
T Consensus 67 HpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS---------AqhYtEaAlDEIklL~~v~~~Dp~ 137 (590)
T KOG1290|consen 67 HPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS---------AQHYTEAALDEIKLLQQVREGDPN 137 (590)
T ss_pred ceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh---------hhHHHHHHHHHHHHHHHHHhcCCC
Confidence 4556667776 899999999999999999999999999999999842 2334556778999999983
Q ss_pred C---CCeeeecccccc----CCcceEEeeccCCCChhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCc
Q 005944 128 H---PNIVRYLGTARE----DDSLNILLEFVPGGSISSLLGK--FGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKG 197 (668)
Q Consensus 128 H---pNIV~l~g~~~~----~~~~~LVmEy~~gGsL~~~L~~--~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKP 197 (668)
| .+||+|++.|.. +.++++|+|+. |..|..+|.. ++.++...++.|++||+.||.|||.. ||||-||||
T Consensus 138 ~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKP 216 (590)
T KOG1290|consen 138 DPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKP 216 (590)
T ss_pred CCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCc
Confidence 3 359999999864 45799999999 6788888865 47799999999999999999999976 999999999
Q ss_pred ccEEeCC-------------------------------------------------------------------------
Q 005944 198 ANILVDN------------------------------------------------------------------------- 204 (668)
Q Consensus 198 eNILld~------------------------------------------------------------------------- 204 (668)
+|||+..
T Consensus 217 ENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~ 296 (590)
T KOG1290|consen 217 ENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEE 296 (590)
T ss_pred ceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 9999810
Q ss_pred -----------------------------------------C--------------------------------------
Q 005944 205 -----------------------------------------K-------------------------------------- 205 (668)
Q Consensus 205 -----------------------------------------~-------------------------------------- 205 (668)
.
T Consensus 297 ~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~ 376 (590)
T KOG1290|consen 297 EPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIAS 376 (590)
T ss_pred cccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccc
Confidence 0
Q ss_pred --------------CceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCC
Q 005944 206 --------------GCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW 271 (668)
Q Consensus 206 --------------g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF 271 (668)
-.|||+|||-|+++... .+.-+.|..|+|||+|.+..|+..+||||++||+|||+||...|
T Consensus 377 n~~v~p~~~~~~~di~vKIaDlGNACW~~kh-----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLF 451 (590)
T KOG1290|consen 377 NPLVNPDIPLPECDIRVKIADLGNACWVHKH-----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLF 451 (590)
T ss_pred ccccCCCCCCCccceeEEEeeccchhhhhhh-----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceee
Confidence 02577777777765432 23345788999999999999999999999999999999999999
Q ss_pred chh--------HHHHHHHHhh----------------------------ccCCCC---------CCCCcccCHHHHHHHH
Q 005944 272 SQQ--------FQEVAALFHI----------------------------GTTKSH---------PPIPEHLSMEAKDFLL 306 (668)
Q Consensus 272 ~~~--------~~~~~~~~~~----------------------------~~~~~~---------~~~p~~ls~el~dLI~ 306 (668)
.-. .+-+..++.. .....+ ..++.....++.+||.
T Consensus 452 ePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~ 531 (590)
T KOG1290|consen 452 EPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLS 531 (590)
T ss_pred cCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHH
Confidence 411 1111111111 000000 0122333456789999
Q ss_pred HhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 307 KCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 307 kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
-||+.+|++||||.++|+|||+.....
T Consensus 532 PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 532 PMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHhcCccccccHHHHhcCccccCCCC
Confidence 999999999999999999999986443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=326.99 Aligned_cols=248 Identities=30% Similarity=0.476 Sum_probs=200.6
Q ss_pred eeeeeEEcccCceE-EEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccCCc
Q 005944 66 WRKGELVGCGAFGR-VYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDS 143 (668)
Q Consensus 66 y~i~~~LG~G~fG~-Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~~~ 143 (668)
|.-.+++|.|+.|+ ||+|.. .|+.||||.+ -+.+.....+||.+|+.- .|||||++|+.-.+...
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrl-----------l~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF 577 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRL-----------LEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQF 577 (903)
T ss_pred eccHHHcccCCCCcEEEEEee--CCceehHHHH-----------hhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCce
Confidence 44456789999885 899976 7899999987 234556778999999998 59999999999999999
Q ss_pred ceEEeeccCCCChhcccccCC-C---CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC---C--CceEEecCC
Q 005944 144 LNILLEFVPGGSISSLLGKFG-S---FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---K--GCIKLADFG 214 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~-~---l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---~--g~vKL~DFG 214 (668)
.||..|.|.. +|.+++...+ . ......+.++.|++.||++||+.+||||||||.||||+. + ..++|.|||
T Consensus 578 ~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfg 656 (903)
T KOG1027|consen 578 LYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFG 656 (903)
T ss_pred EEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccc
Confidence 9999999975 9999997741 1 111446788999999999999999999999999999976 3 478999999
Q ss_pred chhhhHhhhhh-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhC-CCCCchhHHHHHHHHhhccCCCCCC
Q 005944 215 ASKKVVELATI-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATG-KPPWSQQFQEVAALFHIGTTKSHPP 292 (668)
Q Consensus 215 lA~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG-~~PF~~~~~~~~~~~~~~~~~~~~~ 292 (668)
+++.+...... ....+..||-+|+|||++....-+.++|||||||++|+.++| ..||.+......+++.-........
T Consensus 657 lsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~ 736 (903)
T KOG1027|consen 657 LSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLE 736 (903)
T ss_pred cccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeec
Confidence 99987544332 224567799999999999988888899999999999999995 9999988776655544322221111
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
.....++.+||.+||+++|..||+|.++|.||+|=
T Consensus 737 --~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW 771 (903)
T KOG1027|consen 737 --PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFW 771 (903)
T ss_pred --cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccC
Confidence 11122899999999999999999999999999994
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=343.51 Aligned_cols=239 Identities=20% Similarity=0.360 Sum_probs=188.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
.|...++||+|+||.||+|++..++..||||++.... . ....|++++++++|||||++++++......
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~ 758 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-----S-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGA 758 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCc-----c-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCC
Confidence 4566779999999999999999999999999873211 0 112458889999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH---KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLH---s~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
|+||||+++|+|.++++ .+++..+..++.||+.||+||| +.+|+||||||+|||++.++..++. ||.+....
T Consensus 759 ~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~- 833 (968)
T PLN00113 759 YLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC- 833 (968)
T ss_pred EEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-
Confidence 99999999999999995 3889999999999999999999 6699999999999999998888776 66554321
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH---HHHHHHhhc------------c
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ---EVAALFHIG------------T 286 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~---~~~~~~~~~------------~ 286 (668)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......... .
T Consensus 834 -----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 834 -----TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred -----cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCcc
Confidence 12234689999999999998999999999999999999999999853211 111110000 0
Q ss_pred CCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 287 ~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.......+.....++.+++.+||+.+|.+||++.|+++.
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 000011111223467789999999999999999999874
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=294.18 Aligned_cols=258 Identities=26% Similarity=0.397 Sum_probs=206.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....||..++.+|.|+- .|..|.+.-+++.||+|++... .....+.+...+|..++..+.|+||++++.+|.-
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p------f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP 86 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP------FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTP 86 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc------cccCccchhhhhhhhhhhhhcccceeeeeeccCc
Confidence 55678999999999999 8889999999999999987432 2224566778899999999999999999998865
Q ss_pred C------CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 141 D------DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 141 ~------~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
. ...|+||||+.. +|..++. -.+.-..+..|+.|++.|++|||+.||+||||||+||++..++.+||.|||
T Consensus 87 ~~~l~~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg 163 (369)
T KOG0665|consen 87 QKTLEEFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFG 163 (369)
T ss_pred cccHHHHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccch
Confidence 4 348999999964 8887776 457778899999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH------------------
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ------------------ 276 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~------------------ 276 (668)
+|+.-.. ....+.++.|..|.|||++.+-.|...+||||+||++.||++|...|.+...
T Consensus 164 ~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 164 LARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred hhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 9985422 2345668899999999999999999999999999999999999998853210
Q ss_pred -----HHHHHHhhcc-----CCCCCCCCc-----------ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 277 -----EVAALFHIGT-----TKSHPPIPE-----------HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 277 -----~~~~~~~~~~-----~~~~~~~p~-----------~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.....+-... ......+|+ .-...+++|+.+||..+|++|.+++++|+||||+-+
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW 316 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence 0000000000 000000111 113457899999999999999999999999999844
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=317.35 Aligned_cols=256 Identities=30% Similarity=0.480 Sum_probs=210.8
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcC-------CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCC
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THP 129 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~Hp 129 (668)
.++....+..+.+.||+|+||+|++|.-.. ....||||.++.... ....+.+..|+++|+.+ +|+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~-------~~~~~~~~~El~~m~~~g~H~ 362 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS-------SSEKKDLMSELNVLKELGKHP 362 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC-------cHHHHHHHHHHHHHHHhcCCc
Confidence 456666777888899999999999997431 256899998743221 13446688999999999 599
Q ss_pred CeeeeccccccCCcceEEeeccCCCChhcccccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 005944 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG----------------SFPESVIRMYTKQLLLGLEYLHKNGIMHR 193 (668)
Q Consensus 130 NIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIvHr 193 (668)
|||.++|++.....+++|+|||..|+|..+++..+ .++..+...++.||+.|++||++.++|||
T Consensus 363 niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHR 442 (609)
T KOG0200|consen 363 NIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHR 442 (609)
T ss_pred chhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccch
Confidence 99999999999999999999999999999997765 38889999999999999999999999999
Q ss_pred cCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCC--CCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCC
Q 005944 194 DIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG--TPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPP 270 (668)
Q Consensus 194 DLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~G--T~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~P 270 (668)
||-..||||..+..+||+|||+|+......... .....| ...|||||.+....|+.++||||+||+||||+| |..|
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~P 521 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTP 521 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCC
Confidence 999999999999999999999998543322221 111222 345999999999999999999999999999999 8999
Q ss_pred Cchh--HHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 271 WSQQ--FQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 271 F~~~--~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
|.+. ..++.. ..........|.+++.++.++++.||+.+|++||++.++.+
T Consensus 522 Yp~~~~~~~l~~---~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 522 YPGIPPTEELLE---FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred CCCCCcHHHHHH---HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 9762 233322 33345566778899999999999999999999999999885
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-33 Score=304.75 Aligned_cols=206 Identities=24% Similarity=0.401 Sum_probs=180.2
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC---CCCeeeeccccc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT---HPNIVRYLGTAR 139 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIV~l~g~~~ 139 (668)
..+|..++.||.|+||.|++|+++.+...|+||.|.+.+...........+-.+-.||+||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 34699999999999999999999999999999998544333222222222334567999999997 999999999999
Q ss_pred cCCcceEEeecc-CCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFV-PGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~-~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
+++++||+||-. +|-+|+++|..+..++|.+++.|++||+.|+++||+.||||||||-+||.++.+|.+||+|||.|..
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~ 719 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAY 719 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhh
Confidence 999999999976 5669999999999999999999999999999999999999999999999999999999999999875
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWS 272 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~ 272 (668)
. ...+..+++||..|.|||++.+..| +..-|||+||++||.++....||+
T Consensus 720 ~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 720 T----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred h----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 4 2345678899999999999999887 677899999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-33 Score=306.25 Aligned_cols=260 Identities=40% Similarity=0.658 Sum_probs=221.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.+..+|++.+.+|.|.||.||+|+++.+++..|+|+++.... ....-++.|+-+++..+|+|||.+++.|.-
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--------dd~~~iqqei~~~~dc~h~nivay~gsylr 83 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--------DDFSGIQQEIGMLRDCRHPNIVAYFGSYLR 83 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC--------ccccccccceeeeecCCCcChHHHHhhhhh
Confidence 556789999999999999999999999999999999965432 234456789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.+.++|.||||.||+|.+.-.--+.+++.++..+++..+++|+|||+.|=+|||||-.|||+++.|.+|++|||.+-.+.
T Consensus 84 ~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 84 RDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred hcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999987664
Q ss_pred hhhhhcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCC---C
Q 005944 221 ELATINGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI---P 294 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~---p 294 (668)
.+....+++.||++|||||+.. .+.|...+|||++|++..|+---++|..+.. ....++...+....++. +
T Consensus 164 --ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh-pmr~l~LmTkS~~qpp~lkDk 240 (829)
T KOG0576|consen 164 --ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH-PMRALFLMTKSGFQPPTLKDK 240 (829)
T ss_pred --hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc-hHHHHHHhhccCCCCCcccCC
Confidence 3455567899999999999874 5669999999999999999988888854432 22223333333333322 2
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
...++.+.+|++.+|.++|.+||+++-+|.|||+...
T Consensus 241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 3467789999999999999999999999999998753
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=305.39 Aligned_cols=249 Identities=27% Similarity=0.462 Sum_probs=211.8
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCc----EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGE----LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~----~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
..+..++||+|+||+||+|.+...|+ +||||++... .......++.+|+-+|..|+|||+++|++++..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-------t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~ 769 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-------TSPKASIELLDEALRMASLDHPNLLRLLGVCML 769 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-------CCchhhHHHHHHHHHHhcCCCchHHHHhhhccc
Confidence 35667899999999999999987764 6788877321 222334567889999999999999999999987
Q ss_pred CCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.. +-||++|+++|.|.++++.+ ..+.....+.|..||++||.|||.+++|||||-..||||..-..+||.|||+|+.+
T Consensus 770 s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll 848 (1177)
T KOG1025|consen 770 ST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLL 848 (1177)
T ss_pred ch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhcc
Confidence 66 88999999999999999765 56889999999999999999999999999999999999999999999999999988
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchh-HHHHHHHHhhccCCCCCCCCccc
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQ-FQEVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~-~~~~~~~~~~~~~~~~~~~p~~l 297 (668)
.............-.+.|||=|.+....|+.++|||||||++||++| |..|+... ..++-.++..+.. .+-|..+
T Consensus 849 ~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR---LsqPpiC 925 (1177)
T KOG1025|consen 849 APDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER---LSQPPIC 925 (1177)
T ss_pred CcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc---CCCCCCc
Confidence 66555555555555778999999999999999999999999999998 89998754 4566666665544 4456678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+-++.-++.+||..|+..||++.++..
T Consensus 926 tiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 926 TIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred cHHHHHHHHHHhccCcccCccHHHHHH
Confidence 999999999999999999999998864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=250.80 Aligned_cols=212 Identities=42% Similarity=0.693 Sum_probs=185.5
Q ss_pred EcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeecc
Q 005944 72 VGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFV 151 (668)
Q Consensus 72 LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~ 151 (668)
||+|++|.||++....++..++||++....... ....+.+|+.+++.+.|++|+++++++......+++|||+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-------~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~ 73 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-------LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC 73 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-------HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecC
Confidence 689999999999998889999999984321110 3456889999999999999999999999999999999999
Q ss_pred CCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-CCceEEecCCchhhhHhhhhhcCCc
Q 005944 152 PGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN-KGCIKLADFGASKKVVELATINGAK 229 (668)
Q Consensus 152 ~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~-~g~vKL~DFGlA~~~~~~~~~~~~~ 229 (668)
.+++|.+++... ..++...++.++.+++.+|.+||..|++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 74 ~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~ 151 (215)
T cd00180 74 EGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLK 151 (215)
T ss_pred CCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhh
Confidence 999999999765 57899999999999999999999999999999999999999 89999999999875432211 123
Q ss_pred cCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHh
Q 005944 230 SMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308 (668)
Q Consensus 230 ~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kc 308 (668)
...+...|++||.+... .++.+.|+|+||+++|+| ..+.+++.+|
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------~~~~~~l~~~ 197 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------PELKDLIRKM 197 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------HHHHHHHHHH
Confidence 35678899999999877 788999999999999999 6778999999
Q ss_pred hhhCCCCCCCHHHHHcCc
Q 005944 309 LQKEPYLRSTASELLQHP 326 (668)
Q Consensus 309 L~~dP~~RPSa~EIL~Hp 326 (668)
|+.+|.+||++.++++|+
T Consensus 198 l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 198 LQKDPEKRPSAKEILEHL 215 (215)
T ss_pred hhCCcccCcCHHHHhhCC
Confidence 999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=283.93 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=189.0
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHh--CCCCCeeeeccccccC
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN--LTHPNIVRYLGTARED 141 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIV~l~g~~~~~ 141 (668)
....+.++||+|.||.||+|.. +++.||||++. ......+++|-+|... +.|+||+++++.-...
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp-----------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~ 276 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFP-----------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRG 276 (534)
T ss_pred CchhhHHHhhcCccceeehhhc--cCceeEEEecC-----------HHHHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence 3466788999999999999976 56999999982 2333456677776665 4899999999876555
Q ss_pred C----cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccccCCcccEEeCCCCce
Q 005944 142 D----SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN---------GIMHRDIKGANILVDNKGCI 208 (668)
Q Consensus 142 ~----~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~---------gIvHrDLKPeNILld~~g~v 208 (668)
. .++||++|.+.|+|.++|..+ .+++....+++.-|++||+|||+. .|+|||||..||||..+++.
T Consensus 277 t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 277 TADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred CccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 4 789999999999999999774 789999999999999999999963 59999999999999999999
Q ss_pred EEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCC-C-----cchhHHHHHHHHHHHHhCCC------------C
Q 005944 209 KLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGH-S-----FSADIWSVGCTVIEMATGKP------------P 270 (668)
Q Consensus 209 KL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~-s-----~ksDIWSLGvILyeLLTG~~------------P 270 (668)
.|+|||||..+............+||.+|||||+|.+... . .+.||||+|.+||||++... |
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp 435 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP 435 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence 9999999998876555555556889999999999976542 2 35799999999999998432 3
Q ss_pred Cchh------HHHHHHHHhhccCCCCCCCCcc-----cCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 005944 271 WSQQ------FQEVAALFHIGTTKSHPPIPEH-----LSMEAKDFLLKCLQKEPYLRSTASELL 323 (668)
Q Consensus 271 F~~~------~~~~~~~~~~~~~~~~~~~p~~-----ls~el~dLI~kcL~~dP~~RPSa~EIL 323 (668)
|... .+++....- ..+..+.++.. -..-+++.+..||..||+.|.|+.=+.
T Consensus 436 fe~evG~hPt~e~mq~~VV--~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 436 FEAEVGNHPTLEEMQELVV--RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred hhHHhcCCCCHHHHHHHHH--hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 3311 122222221 12223333322 234578999999999999999987443
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=278.84 Aligned_cols=248 Identities=26% Similarity=0.384 Sum_probs=190.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC--CCCCeeeecccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL--THPNIVRYLGTA 138 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L--~HpNIV~l~g~~ 138 (668)
....+..+.+.||+|.||.||+|.+ -|+.||||++.. + ..+.+.+|.+|.+.+ +|+||+.+++.-
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~s------r-----dE~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSS------R-----DERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecc------c-----chhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 5566788999999999999999988 579999999831 1 113456777777764 999999999875
Q ss_pred ccC----CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCcccEEeCCCC
Q 005944 139 RED----DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN--------GIMHRDIKGANILVDNKG 206 (668)
Q Consensus 139 ~~~----~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~--------gIvHrDLKPeNILld~~g 206 (668)
..+ ..++||++|.+.|+|+++|.+ ..++.+...+++..++.||++||.. .|.|||||..||||..+|
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 444 358999999999999999988 6899999999999999999999953 499999999999999999
Q ss_pred ceEEecCCchhhhHhhhh--hcCCccCCCCCCCCChHHHhhcCC------CcchhHHHHHHHHHHHHhC----------C
Q 005944 207 CIKLADFGASKKVVELAT--INGAKSMKGTPYWMAPEVILQTGH------SFSADIWSVGCTVIEMATG----------K 268 (668)
Q Consensus 207 ~vKL~DFGlA~~~~~~~~--~~~~~~~~GT~~Y~APEvl~~~~~------s~ksDIWSLGvILyeLLTG----------~ 268 (668)
.+-|+|+|||........ .......+||-+|||||+|...-. -..+||||||.++||++.. +
T Consensus 354 ~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~ 433 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQ 433 (513)
T ss_pred cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhc
Confidence 999999999987654322 223445789999999999965432 2358999999999999862 4
Q ss_pred CCCchh------HHHHHHHHhhccCCCCCCCCccc-----CHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 269 PPWSQQ------FQEVAALFHIGTTKSHPPIPEHL-----SMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 269 ~PF~~~------~~~~~~~~~~~~~~~~~~~p~~l-----s~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+||.+. .+++.... ...+..+.+|... -..+..||+.||..+|.-|.|+--|.+
T Consensus 434 ~Pyyd~Vp~DPs~eeMrkVV--Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 434 LPYYDVVPSDPSFEEMRKVV--CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCcccCCCCCCCHHHHhcce--eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 677532 22222222 2223333343322 224668899999999999999876653
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=284.72 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=202.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcC---CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLD---SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLG 136 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~---tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g 136 (668)
.....|.+.++||.|.|++||+|++.. ..++||+|.+.... +...+.+|+++|..+ .+.||+++.+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts----------~p~ri~~El~~L~~~gG~~ni~~~~~ 102 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS----------SPSRILNELEMLYRLGGSDNIIKLNG 102 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc----------CchHHHHHHHHHHHhccchhhhcchh
Confidence 445679999999999999999999888 78999999984322 234478899999999 4999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-CceEEecCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK-GCIKLADFGA 215 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~-g~vKL~DFGl 215 (668)
.+..++...+||||.+.....+++. .++..+++.+++.++.||+++|.+|||||||||.|||.+.. +.-.|+|||+
T Consensus 103 ~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 103 CFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred hhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechh
Confidence 9999999999999999888888775 46788999999999999999999999999999999999754 6788999999
Q ss_pred hhhhHhhh-----------hhcC-------------------C------------ccCCCCCCCCChHHHhhcC-CCcch
Q 005944 216 SKKVVELA-----------TING-------------------A------------KSMKGTPYWMAPEVILQTG-HSFSA 252 (668)
Q Consensus 216 A~~~~~~~-----------~~~~-------------------~------------~~~~GT~~Y~APEvl~~~~-~s~ks 252 (668)
|....... .... . ....||++|+|||++...+ .+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 98432211 0000 0 0235999999999998655 68899
Q ss_pred hHHHHHHHHHHHHhCCCCCchhHHHHHHHHhh----------------cc------CC----------------------
Q 005944 253 DIWSVGCTVIEMATGKPPWSQQFQEVAALFHI----------------GT------TK---------------------- 288 (668)
Q Consensus 253 DIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~----------------~~------~~---------------------- 288 (668)
||||.|||+..+++++.||.....++..+.++ +. ..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 99999999999999999995322211111110 00 00
Q ss_pred -----CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 289 -----SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 289 -----~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
......+..+..+.+|+.+||..||.+|.|++++|+||||..
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 000111234557899999999999999999999999999974
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=247.88 Aligned_cols=200 Identities=39% Similarity=0.680 Sum_probs=174.3
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcce
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN 145 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~ 145 (668)
|++.+.||.|++|+||+|.+..++..+|+|.+...... .....+.+|+..++.++|+||+++++++......+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-------~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~ 73 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-------KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLY 73 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-------HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceE
Confidence 57789999999999999999988999999998432211 23567888999999999999999999999999999
Q ss_pred EEeeccCCCChhcccccCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 146 ILLEFVPGGSISSLLGKFGS-FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~~~~-l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
+++||+++++|.+++..... +++..+..++.+++.+|.+||..+++|+||+|.||+++.++.++|+|||++........
T Consensus 74 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~ 153 (225)
T smart00221 74 LVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA 153 (225)
T ss_pred EEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence 99999999999999987666 89999999999999999999999999999999999999999999999999876543220
Q ss_pred hcCCccCCCCCCCCChHHH-hhcCCCcchhHHHHHHHHHHHHhCCCCCch
Q 005944 225 INGAKSMKGTPYWMAPEVI-LQTGHSFSADIWSVGCTVIEMATGKPPWSQ 273 (668)
Q Consensus 225 ~~~~~~~~GT~~Y~APEvl-~~~~~s~ksDIWSLGvILyeLLTG~~PF~~ 273 (668)
.......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus 154 -~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 -ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122346788899999998 566678899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=254.02 Aligned_cols=203 Identities=31% Similarity=0.501 Sum_probs=166.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
........+..||+|+||.|-+.++..+|...|+|.+....+ ......+.+|+.+..+. .+|.+|++||.+.
T Consensus 43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn-------~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~ 115 (282)
T KOG0984|consen 43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN-------SQEQKRLLMDLDIIMRTVDCPFTVHFYGALF 115 (282)
T ss_pred cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC-------hHHHHHHHHhhhhhccCCCCCeEEEeehhhh
Confidence 334455556789999999999999999999999999854333 12334566777765554 7999999999999
Q ss_pred cCCcceEEeeccCCCChhcc----cccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEecCC
Q 005944 140 EDDSLNILLEFVPGGSISSL----LGKFGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~----L~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
....++|.||.+.. +|..+ +.+.+.++|..+-+|+..++.||.|||++ .|+|||+||.||||+.+|++||||||
T Consensus 116 regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFG 194 (282)
T KOG0984|consen 116 REGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFG 194 (282)
T ss_pred ccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccc
Confidence 99999999999953 77654 45668899999999999999999999987 89999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHh----hcCCCcchhHHHHHHHHHHHHhCCCCCchh
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVIL----QTGHSFSADIWSVGCTVIEMATGKPPWSQQ 274 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~----~~~~s~ksDIWSLGvILyeLLTG~~PF~~~ 274 (668)
++..+.+.-. .+.-.|--.|||||.+. ...|+.++||||||++++||.+++.||...
T Consensus 195 IsG~L~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 195 ISGYLVDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred cceeehhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 9887643221 11234667799999985 346899999999999999999999998644
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=305.57 Aligned_cols=201 Identities=20% Similarity=0.260 Sum_probs=150.7
Q ss_pred hCCC-CCeeeecccc-------ccCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 005944 125 NLTH-PNIVRYLGTA-------REDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDI 195 (668)
Q Consensus 125 ~L~H-pNIV~l~g~~-------~~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDL 195 (668)
.+.| .||+++++++ .....++++|||+ +++|.++|.. ...+++.+++.|++||+.||.|||++|||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 5788888877 2334677889987 5699999965 356999999999999999999999999999999
Q ss_pred CcccEEeCC-------------------CCceEEecCCchhhhHhhh--------hh------cCCccCCCCCCCCChHH
Q 005944 196 KGANILVDN-------------------KGCIKLADFGASKKVVELA--------TI------NGAKSMKGTPYWMAPEV 242 (668)
Q Consensus 196 KPeNILld~-------------------~g~vKL~DFGlA~~~~~~~--------~~------~~~~~~~GT~~Y~APEv 242 (668)
||+||||+. ++.+||+|||+++...... .. ......+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999954 4556777777775421100 00 00112468999999999
Q ss_pred HhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHH
Q 005944 243 ILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASEL 322 (668)
Q Consensus 243 l~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EI 322 (668)
+.+..|+.++|||||||+||||++|.+||.........+... ..++........+.+++.+||+++|.+||++.||
T Consensus 187 ~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~ei 262 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR----VLPPQILLNWPKEASFCLWLLHPEPSCRPSMSEL 262 (793)
T ss_pred hccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh----hcChhhhhcCHHHHHHHHHhCCCChhhCcChHHH
Confidence 999999999999999999999999999986433222222111 1111111224566799999999999999999999
Q ss_pred HcCccccC
Q 005944 323 LQHPFVTG 330 (668)
Q Consensus 323 L~Hpwf~~ 330 (668)
++||||..
T Consensus 263 l~h~~~~~ 270 (793)
T PLN00181 263 LQSEFINE 270 (793)
T ss_pred hhchhhhh
Confidence 99999975
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=257.60 Aligned_cols=255 Identities=24% Similarity=0.308 Sum_probs=197.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccc-c
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGT-A 138 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~-~ 138 (668)
.....|.+.+.||+|.||.+-+|.|+.+++.+++|.+. .....++.|.+|...--.| .|.|||.-|++ |
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp---------~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaF 91 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP---------RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAF 91 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccC---------cchhhHHHHHHHhccceeeccchhhhHHHHHHh
Confidence 34567999999999999999999999999999999872 1223456677887765556 58999987764 6
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC--CCCceEEecCCch
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD--NKGCIKLADFGAS 216 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld--~~g~vKL~DFGlA 216 (668)
++.+.+++++||++.|+|..-+.. ..+.|...+.++.|+++||.|||++++||||||.+||||- +...|||||||+.
T Consensus 92 qt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t 170 (378)
T KOG1345|consen 92 QTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLT 170 (378)
T ss_pred hcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccc
Confidence 777888999999999999998876 5688999999999999999999999999999999999994 3348999999998
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcC-----CCcchhHHHHHHHHHHHHhCCCCCchhH---HHHHHHHh--hcc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTG-----HSFSADIWSVGCTVIEMATGKPPWSQQF---QEVAALFH--IGT 286 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-----~s~ksDIWSLGvILyeLLTG~~PF~~~~---~~~~~~~~--~~~ 286 (668)
+...... ....-+..|.+||+..... ..+.+|||.||||+|.+|||.+||.... ....+... .+.
T Consensus 171 ~k~g~tV-----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 171 RKVGTTV-----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred cccCcee-----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence 7543211 1123456799999875432 3667899999999999999999997432 11122221 122
Q ss_pred CCCCCCCCcccCHHHHHHHHHhhhhCCCCC---CCHHHHHcCccccC
Q 005944 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLR---STASELLQHPFVTG 330 (668)
Q Consensus 287 ~~~~~~~p~~ls~el~dLI~kcL~~dP~~R---PSa~EIL~Hpwf~~ 330 (668)
....+..-..+++.+..+.++-|..+|++| .++.......|...
T Consensus 246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 222222334578899999999999999999 67777777788653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-26 Score=230.86 Aligned_cols=257 Identities=36% Similarity=0.572 Sum_probs=206.5
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCC-CeeeeccccccCCcc
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP-NIVRYLGTAREDDSL 144 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp-NIV~l~g~~~~~~~~ 144 (668)
|.+.+.||.|+||.||++.+. ..+++|.+....... ......+.+|+.++..+.|+ +|+++++.+......
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~-----~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 73 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESK-----SKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSL 73 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccc-----hhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEE
Confidence 788999999999999999986 789999884332211 12456788999999999988 799999999777778
Q ss_pred eEEeeccCCCChhcccccCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC-ceEEecCCchhhhH
Q 005944 145 NILLEFVPGGSISSLLGKFG---SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-CIKLADFGASKKVV 220 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~---~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-~vKL~DFGlA~~~~ 220 (668)
+++++|+.+++|..++.... .+++..+..++.|++.++.|+|..+++||||||+|||++..+ .++++|||+++.+.
T Consensus 74 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~ 153 (384)
T COG0515 74 YLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP 153 (384)
T ss_pred EEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence 99999999999997777664 799999999999999999999999999999999999999988 79999999988554
Q ss_pred hhhhhc----CCccCCCCCCCCChHHHhh---cCCCcchhHHHHHHHHHHHHhCCCCCchhH-----HHHHHHHhhccCC
Q 005944 221 ELATIN----GAKSMKGTPYWMAPEVILQ---TGHSFSADIWSVGCTVIEMATGKPPWSQQF-----QEVAALFHIGTTK 288 (668)
Q Consensus 221 ~~~~~~----~~~~~~GT~~Y~APEvl~~---~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-----~~~~~~~~~~~~~ 288 (668)
...... ......||..|+|||.+.+ ..+....|+|++|++++++++|..||.... ......+......
T Consensus 154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233 (384)
T ss_pred CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence 332221 2456789999999999987 568889999999999999999999986543 2333333322222
Q ss_pred -CCCCCCccc----CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 289 -SHPPIPEHL----SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 289 -~~~~~p~~l----s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
......... ...+.+++.+++..+|..|.+..+...++|...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence 112222222 257899999999999999999999999876653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.7e-28 Score=232.74 Aligned_cols=161 Identities=27% Similarity=0.331 Sum_probs=128.3
Q ss_pred CChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCC
Q 005944 154 GSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK 232 (668)
Q Consensus 154 GsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~ 232 (668)
|+|.+++... ..+++.+++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||++..... ....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence 6889999764 56999999999999999999999998 999999999999999 999875432 1236
Q ss_pred CCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH---HHHHHHhhccCCCC--CCCCcccCH--HHHHHH
Q 005944 233 GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ---EVAALFHIGTTKSH--PPIPEHLSM--EAKDFL 305 (668)
Q Consensus 233 GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~---~~~~~~~~~~~~~~--~~~p~~ls~--el~dLI 305 (668)
||+.|||||++.+..++.++|||||||++|+|+||+.||..... .............. ...+..++. ++.+||
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 89999999999999999999999999999999999999964321 11111111111100 012233444 689999
Q ss_pred HHhhhhCCCCCCCHHHHHcCcccc
Q 005944 306 LKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 306 ~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
.+||..+|.+||++.++++|+|+.
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHH
Confidence 999999999999999999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=251.57 Aligned_cols=254 Identities=25% Similarity=0.343 Sum_probs=203.6
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCC-----cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSG-----ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg-----~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
...|++...++-+|.||.||.|.+++.. +.|-+|.++ ....+..+..+..|..+|..+.|||++.+.+
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk-------~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVK-------QHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHH-------hcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3457888889999999999999877643 445566552 2334556777889999999999999999999
Q ss_pred ccccC-CcceEEeeccCCCChhcccccC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc
Q 005944 137 TARED-DSLNILLEFVPGGSISSLLGKF--------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC 207 (668)
Q Consensus 137 ~~~~~-~~~~LVmEy~~gGsL~~~L~~~--------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~ 207 (668)
+..++ ...+.++.+..-|+|..++... ..++..++..++.||+.|++|||.+||||.||...|++|++.-+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~Lq 434 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQ 434 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhee
Confidence 87655 5677788999999999998621 34667788889999999999999999999999999999999999
Q ss_pred eEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhcc
Q 005944 208 IKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGT 286 (668)
Q Consensus 208 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~ 286 (668)
+||+|=.+++.+-+.+..--...--....||+||.+.+..|+.++|||||||+||||+| |+.|+.+-.......+ ..
T Consensus 435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y--lk 512 (563)
T KOG1024|consen 435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY--LK 512 (563)
T ss_pred EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH--Hh
Confidence 99999999987654433222222234678999999999999999999999999999999 9999976443322222 22
Q ss_pred CCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 287 ~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
......-|.++++++..++.-||+..|++||+++++..
T Consensus 513 dGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 513 DGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred ccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 33444557789999999999999999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-28 Score=281.73 Aligned_cols=263 Identities=25% Similarity=0.387 Sum_probs=209.6
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceE
Q 005944 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNI 146 (668)
Q Consensus 67 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~L 146 (668)
....++|.|++|.|+.+........++.|.+... .. ..+........+..|+.+-..++|+|++..+..+.+....+-
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~-~~-~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~ 398 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVR-VK-PTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQ 398 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcc-cC-CcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchh
Confidence 4567899999999999988887777777765321 10 112222223337778888899999999998888887777777
Q ss_pred EeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhh-
Q 005944 147 LLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI- 225 (668)
Q Consensus 147 VmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~- 225 (668)
+||||++ +|+.++...+.+...++..++.||+.||+|||..||.||||||+|+|+..+|.+||+|||.+..+.-....
T Consensus 399 ~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 399 SMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred hhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 7999999 99999998889999999999999999999999999999999999999999999999999998765432222
Q ss_pred -cCCccCCCCCCCCChHHHhhcCCCc-chhHHHHHHHHHHHHhCCCCCchhHHHHHH------HHhhccCCCCCCCCccc
Q 005944 226 -NGAKSMKGTPYWMAPEVILQTGHSF-SADIWSVGCTVIEMATGKPPWSQQFQEVAA------LFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 226 -~~~~~~~GT~~Y~APEvl~~~~~s~-ksDIWSLGvILyeLLTG~~PF~~~~~~~~~------~~~~~~~~~~~~~p~~l 297 (668)
......+|+..|+|||++.+..|.. .+||||.|++++.|++|+.||......... ............+...+
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 557 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL 557 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence 3455688999999999999999865 579999999999999999999754322111 11111112223344567
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+.+.+.+|.+||+++|.+|.|+++|++.+||+...
T Consensus 558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 558 PRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred hhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 88899999999999999999999999999998643
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=6e-25 Score=238.21 Aligned_cols=172 Identities=17% Similarity=0.197 Sum_probs=132.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcC-CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeee-eccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLD-SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVR-YLGT 137 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~-tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~-l~g~ 137 (668)
.....+|.+.++||+|+||+||+|.+.. ++..||||++...... .........+.+|+++|+.++|+|||. ++++
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~---~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPW---WSKPLARHLAAREIRALKTVRGIGVVPQLLAT 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccc---cccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence 3566789999999999999999999876 6888899986311000 011223456889999999999999985 5442
Q ss_pred cccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC-CcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDI-KGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDL-KPeNILld~~g~vKL~DFGlA 216 (668)
+..|||||||+|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.+||+|||+|
T Consensus 91 ----~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA 159 (365)
T PRK09188 91 ----GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA 159 (365)
T ss_pred ----CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence 457999999999999732 11 11 2468899999999999999999999 999999999999999999999
Q ss_pred hhhHhhhhh------cCCccCCCCCCCCChHHHhh
Q 005944 217 KKVVELATI------NGAKSMKGTPYWMAPEVILQ 245 (668)
Q Consensus 217 ~~~~~~~~~------~~~~~~~GT~~Y~APEvl~~ 245 (668)
+.+...... .......+++.|+|||++.-
T Consensus 160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 865432211 11245678999999999863
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-24 Score=228.43 Aligned_cols=252 Identities=22% Similarity=0.259 Sum_probs=191.5
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCC-cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC----CCeeeecccc-
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSG-ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH----PNIVRYLGTA- 138 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg-~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H----pNIV~l~g~~- 138 (668)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+......... ..+..|+.+|..+.+ .++..+++.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--------~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~ 90 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--------SVLKIEIQVLKKLEKKNGPSHFPKLLDHGR 90 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--------ccchhHHHHHHHHhhhcCCCCCCEEEEecc
Confidence 8999999999999999999988775 6788887643211110 135567888888863 6889999888
Q ss_pred ccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-----CceEEe
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK-----GCIKLA 211 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~-----g~vKL~ 211 (668)
......||||+.+ |.+|.++.... +.|+..++..|+.|++.+|++||+.|++||||||.|+++... ..+.|.
T Consensus 91 ~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 91 STEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred CCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 5778899999998 77999987543 579999999999999999999999999999999999999765 369999
Q ss_pred cCCchhhhH--hhhhh--c---C-CccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHH
Q 005944 212 DFGASKKVV--ELATI--N---G-AKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAAL 281 (668)
Q Consensus 212 DFGlA~~~~--~~~~~--~---~-~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~ 281 (668)
|||+++.+. ..... . . .....||..|.++.+..+...+.+.|+||++.++.+|+.|..||..... .....
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998332 11110 1 1 1235599999999999999999999999999999999999999964321 12222
Q ss_pred HhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 282 FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 282 ~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
................+.++..++..+-..+...+|....+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 250 EKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22111111111333455677777777777888899998887754
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-26 Score=251.48 Aligned_cols=240 Identities=33% Similarity=0.498 Sum_probs=201.9
Q ss_pred EEcccCceEEEEEEE---cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCCcceE
Q 005944 71 LVGCGAFGRVYMGMN---LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDDSLNI 146 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~---~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~~~~L 146 (668)
++|+|+||.|+++.. .+.|.-+|+|+.+.+...... +. ....|-.++..++ ||.+|++...++.+...++
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~-~~-----~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD-RT-----HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc-cc-----ccccHHHHHhhccCCCceeeeeeeeccccchhH
Confidence 479999999998753 335788999987543322111 11 3345777888886 9999999999999999999
Q ss_pred EeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhc
Q 005944 147 LLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226 (668)
Q Consensus 147 VmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~ 226 (668)
+++|..||+|...+.+...+.+...+.+...++.+++++|..+|+|||+|++||+++.+|++|+.|||+++...+...
T Consensus 75 ~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-- 152 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-- 152 (612)
T ss_pred hhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999987655332
Q ss_pred CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHH
Q 005944 227 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLL 306 (668)
Q Consensus 227 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~ 306 (668)
.|||..|||||++. .+..++|+||||++.|+|+||..||.. +....+ ......+|..++..+++++.
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~~~~I-----l~~~~~~p~~l~~~a~~~~~ 219 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DTMKRI-----LKAELEMPRELSAEARSLFR 219 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HHHHHH-----hhhccCCchhhhHHHHHHHH
Confidence 29999999999998 678899999999999999999999977 111111 22345678889999999999
Q ss_pred HhhhhCCCCCCC-----HHHHHcCccccCC
Q 005944 307 KCLQKEPYLRST-----ASELLQHPFVTGK 331 (668)
Q Consensus 307 kcL~~dP~~RPS-----a~EIL~Hpwf~~~ 331 (668)
.++..+|..|.. +.+|++|+||+..
T Consensus 220 ~l~~r~p~nrLg~~~~~~~eik~h~f~~~i 249 (612)
T KOG0603|consen 220 QLFKRNPENRLGAGPDGVDEIKQHEFFQSI 249 (612)
T ss_pred HHHhhCHHHHhccCcchhHHHhccchheee
Confidence 999999999965 5799999999864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-24 Score=246.67 Aligned_cols=225 Identities=32% Similarity=0.483 Sum_probs=173.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|...++|..|+||.||+++|+.+.+++|+|+-+ +...+ .+ ||.....|.+|
T Consensus 80 p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk----------q~lil---Rn---ilt~a~npfvv-------- 135 (1205)
T KOG0606|consen 80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK----------QNLIL---RN---ILTFAGNPFVV-------- 135 (1205)
T ss_pred CCccccceeEeeccCCCCceeeeeccccccchhhcccc----------cchhh---hc---cccccCCccee--------
Confidence 55678999999999999999999999999999996431 00000 00 33333344444
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
|+=..+++..+.++... +.+++|||+.||+|||+||+|.||+.-|++|++|||+.+...
T Consensus 136 -------------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GL 194 (1205)
T KOG0606|consen 136 -------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGL 194 (1205)
T ss_pred -------------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhh
Confidence 55566666667777543 889999999999999999999999999999999999987532
Q ss_pred hh-------------hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccC
Q 005944 221 EL-------------ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT 287 (668)
Q Consensus 221 ~~-------------~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~ 287 (668)
.. ......+.+||||.|+|||++...+|+..+|||++|+|+|+.+.|..||.+.+.+..--.-+...
T Consensus 195 ms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 195 MSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 11 11223456799999999999999999999999999999999999999998774332222222223
Q ss_pred CCCCCCCcccCHHHHHHHHHhhhhCCCCC---CCHHHHHcCccccC
Q 005944 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLR---STASELLQHPFVTG 330 (668)
Q Consensus 288 ~~~~~~p~~ls~el~dLI~kcL~~dP~~R---PSa~EIL~Hpwf~~ 330 (668)
..++.-...+.++++++|.++|+.+|..| ..+-++.+|+||+.
T Consensus 275 i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 275 IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence 33444466788999999999999999999 67789999999985
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-23 Score=210.13 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=198.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC-CCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH-PNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIV~l~g~~~ 139 (668)
+...+|++.+.||+|+||.+|+|.+..+|..||||+=...+ .-..+..|.++.+.|+| ..|..+..+..
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a----------~hpqL~yEskvY~iL~~g~GiP~i~~y~~ 81 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA----------KHPQLLYESKVYRILQGGVGIPHIRHYGT 81 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC----------CCcchhHHHHHHHHhccCCCCchhhhhcc
Confidence 56788999999999999999999999999999999742111 11235678888888875 57777888888
Q ss_pred cCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC---CCceEEecCCc
Q 005944 140 EDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---KGCIKLADFGA 215 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---~g~vKL~DFGl 215 (668)
+...-.+||++. |.+|.++..- .+.|+..+++.++-|++.-|+|+|.+++|||||||+|+|..- ...+.|+|||+
T Consensus 82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence 889999999998 7788887743 367999999999999999999999999999999999999953 35799999999
Q ss_pred hhhhHhhhhh-----cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-----HHHHHHHhhc
Q 005944 216 SKKVVELATI-----NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-----QEVAALFHIG 285 (668)
Q Consensus 216 A~~~~~~~~~-----~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-----~~~~~~~~~~ 285 (668)
|+.+.+..+. .......||.+|.+-....+...+.+.|+=|+|.+|.++.-|..||.+.. ++...+....
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 9988665442 22345679999999988888888899999999999999999999997532 2333333333
Q ss_pred cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHH
Q 005944 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASEL 322 (668)
Q Consensus 286 ~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EI 322 (668)
.......+....+.|+.-.+.-|-..--++-|...-+
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~yl 277 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYL 277 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHH
Confidence 3333334556778888888888877766677765533
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=215.24 Aligned_cols=249 Identities=24% Similarity=0.369 Sum_probs=191.1
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~ 139 (668)
+....|+++++||+|+||.++.|++.-++++||||.=.. .....++..|.+..+.|. .++|..+|-+..
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr----------kS~APQLrdEYr~YKlL~g~~GIP~vYYFGq 94 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR----------KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQ 94 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEeccc----------cCCcchHHHHHHHHHHHcCCCCCCceeeecc
Confidence 556789999999999999999999999999999995311 112234667888888874 689999998888
Q ss_pred cCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-----CceEEecC
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK-----GCIKLADF 213 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~-----g~vKL~DF 213 (668)
++-+-.||||+. |.+|.++..-. +.|+...+..++.|++.-|+|+|++++|+|||||+|+||... ..|.|+||
T Consensus 95 eG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDF 173 (449)
T KOG1165|consen 95 EGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDF 173 (449)
T ss_pred ccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEec
Confidence 888889999998 77888877543 579999999999999999999999999999999999999654 46899999
Q ss_pred CchhhhHhhhhh-----cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhcc
Q 005944 214 GASKKVVELATI-----NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGT 286 (668)
Q Consensus 214 GlA~~~~~~~~~-----~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~ 286 (668)
|+|+.+.+..+. ...++..||.+||+-...++..-+.+.|+=|||-++++.|-|..||.+... .-....+++.
T Consensus 174 GmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 174 GMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred cchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcc
Confidence 999988655442 234567899999999999999999999999999999999999999975321 1112223333
Q ss_pred CCCCCC---CCcccCHHHHHHHHHhhhhCCCCCCCHH
Q 005944 287 TKSHPP---IPEHLSMEAKDFLLKCLQKEPYLRSTAS 320 (668)
Q Consensus 287 ~~~~~~---~p~~ls~el~dLI~kcL~~dP~~RPSa~ 320 (668)
.....+ +...++.++...+.-.-..+-.+-|..+
T Consensus 254 ~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYd 290 (449)
T KOG1165|consen 254 TKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYD 290 (449)
T ss_pred ccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHH
Confidence 333222 2345566665555544444444445443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=199.47 Aligned_cols=146 Identities=20% Similarity=0.176 Sum_probs=111.4
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhH------------------hhHHHHHHHHHHHHHHHhCCCCC
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKE------------------KTQAHIRELEEEVKLLKNLTHPN 130 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~------------------~~~~~~~~~~~Ei~iL~~L~HpN 130 (668)
...||+|+||+||+|.+. +|+.||||++.......... ...........|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999986 89999999986432111100 00011223456999999998877
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCcccEEeCCCCceE
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL-HKNGIMHRDIKGANILVDNKGCIK 209 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yL-Hs~gIvHrDLKPeNILld~~g~vK 209 (668)
|.....+.. ...+|||||++|+++...+...+.+++..+..++.||+.+|.+| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 643322221 23489999999987766544457899999999999999999999 799999999999999998 57899
Q ss_pred EecCCchhh
Q 005944 210 LADFGASKK 218 (668)
Q Consensus 210 L~DFGlA~~ 218 (668)
|+|||+|..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-22 Score=205.37 Aligned_cols=175 Identities=11% Similarity=0.145 Sum_probs=135.1
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHH------HHHHHHHHHHHhCCCCCeeee
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHI------RELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~------~~~~~Ei~iL~~L~HpNIV~l 134 (668)
....+|++.++||.|+||.||++.. ++..+|||++...... .+... ..+.+|++.+.++.|++|..+
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~-----~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~ 100 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKR-----TERFLKSFVKGDYYENLIVQTDRVRSEGLASL 100 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCc-----hHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcc
Confidence 5678999999999999999999754 4778999988422211 11222 226789999999999999998
Q ss_pred ccccccC--------CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC
Q 005944 135 LGTARED--------DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG 206 (668)
Q Consensus 135 ~g~~~~~--------~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g 206 (668)
.+++... ...+|||||++|.+|.++. .+++ ....+|+.+|..||..||+|||+||.|||++.+|
T Consensus 101 ~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g 172 (232)
T PRK10359 101 NDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG 172 (232)
T ss_pred eEeeeecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC
Confidence 8775532 3578999999999998773 2333 3466999999999999999999999999999988
Q ss_pred ceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHH
Q 005944 207 CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMA 265 (668)
Q Consensus 207 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLL 265 (668)
++|+|||......+.... ..+++...|..++|||+||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987654322111 11445666788999999999987664
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-22 Score=234.98 Aligned_cols=248 Identities=22% Similarity=0.311 Sum_probs=184.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
.|...+.||.+.|=+|.+|++.+ | .|+||++........- ..+. +...|++ ...++|||++.+..+-..+...
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL---~~~~-qrL~~ik-~~l~~~pn~lPfqk~~~t~kAA 96 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISL---RPFK-QRLEEIK-FALMKAPNCLPFQKVLVTDKAA 96 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCc---hHHH-HHHHHHH-HHhhcCCcccchHHHHHhhHHH
Confidence 78889999999999999998753 4 4999998654432221 1222 2334555 5667899999999998889999
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH--hh
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV--EL 222 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~--~~ 222 (668)
|||-+|+.. +|++.|....-+..-+.+.|+.||+.||..||..||+|||||.+||||+.-+-+.|+||..-+... ++
T Consensus 97 ylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 97 YLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 999999965 999999887778889999999999999999999999999999999999999999999998765431 11
Q ss_pred hhhc---CCccCCCCCCCCChHHHhhcC-----------CCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccC
Q 005944 223 ATIN---GAKSMKGTPYWMAPEVILQTG-----------HSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTT 287 (668)
Q Consensus 223 ~~~~---~~~~~~GT~~Y~APEvl~~~~-----------~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~ 287 (668)
+... -..+...-..|+|||.+.... .+++-||||+||+++||++ |++||.-. .++.....
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS-----QL~aYr~~ 250 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS-----QLLAYRSG 250 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH-----HHHhHhcc
Confidence 1100 011222334699999986421 4567899999999999998 79999521 11111111
Q ss_pred CCCC---CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 288 KSHP---PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 288 ~~~~---~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.... .+-..-+..++.||..|++.||.+|.+|++.|+.
T Consensus 251 ~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 251 NADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 0000 0111224467999999999999999999999975
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.86 E-value=2e-21 Score=192.14 Aligned_cols=147 Identities=20% Similarity=0.170 Sum_probs=112.7
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhh------------------HhhHHHHHHHHHHHHHHHhCCCCC
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASK------------------EKTQAHIRELEEEVKLLKNLTHPN 130 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~------------------~~~~~~~~~~~~Ei~iL~~L~HpN 130 (668)
...||+|+||+||+|.+. +|+.||||++......... .........+..|+..+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 568999999999999987 8999999998644211000 000111233467999999999998
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceE
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIK 209 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vK 209 (668)
|.....+... ..||||||++|+++...+.....+++..+..++.|++.+|.+||. .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 7443332222 248999999988654443344678889999999999999999999 9999999999999998 89999
Q ss_pred EecCCchhhh
Q 005944 210 LADFGASKKV 219 (668)
Q Consensus 210 L~DFGlA~~~ 219 (668)
|+|||++..+
T Consensus 158 liDFG~a~~~ 167 (190)
T cd05145 158 IIDVSQAVEL 167 (190)
T ss_pred EEEcccceec
Confidence 9999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.3e-21 Score=205.13 Aligned_cols=236 Identities=22% Similarity=0.326 Sum_probs=150.3
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC----------CC--
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH----------PN-- 130 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H----------pN-- 130 (668)
...+..++.||.|+|+.||.+++..||+.+|||++...... ....++.+++|.-....+.+ -.
T Consensus 11 ~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~-----~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l 85 (288)
T PF14531_consen 11 PRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADA-----SANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFL 85 (288)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTT-----HTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B-
T ss_pred ceEEEEccccccCCceEEEEEEEccCCceEEEEEEeccccc-----chHHHHHHHHHHHHhhhhccCCCHHHHHHhceEE
Confidence 34577889999999999999999999999999999665521 12234556666655544322 11
Q ss_pred ----eeeecc---ccccC---C-----cceEEeeccCCCChhcccc---cCCCC----CHHHHHHHHHHHHHHHHHHHhC
Q 005944 131 ----IVRYLG---TARED---D-----SLNILLEFVPGGSISSLLG---KFGSF----PESVIRMYTKQLLLGLEYLHKN 188 (668)
Q Consensus 131 ----IV~l~g---~~~~~---~-----~~~LVmEy~~gGsL~~~L~---~~~~l----~e~~~~~i~~QIl~aL~yLHs~ 188 (668)
++++-+ ++... . ..+++|+-+ .++|.+++. ..... .......+..|+++.+++||..
T Consensus 86 ~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~ 164 (288)
T PF14531_consen 86 VPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY 164 (288)
T ss_dssp --SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc
Confidence 222211 11111 1 246677777 458877653 22222 1222245668999999999999
Q ss_pred CcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc--------CCCcchhHHHHHHH
Q 005944 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT--------GHSFSADIWSVGCT 260 (668)
Q Consensus 189 gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~--------~~s~ksDIWSLGvI 260 (668)
||||+||+|+|||++.+|.++|+||+.......... ....+..|.+||..... .++.+.|.|+||++
T Consensus 165 GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 165 GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp TEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred ceEecccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 999999999999999999999999987765432111 12345789999988543 36889999999999
Q ss_pred HHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCC
Q 005944 261 VIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLR 316 (668)
Q Consensus 261 LyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~R 316 (668)
||.|++|..||........... ...... +++..++.||..+|+.+|.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~~~------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADPEW------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTSGG------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccccc------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999999974432211110 111223 788899999999999999987
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=189.56 Aligned_cols=189 Identities=19% Similarity=0.167 Sum_probs=140.3
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCCcce
Q 005944 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDDSLN 145 (668)
Q Consensus 67 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~~~~ 145 (668)
.+...|++|+||+||++.. .+.+++.+.+..... .........+.+|+++|++|. |++|++++++ ...+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~----~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~ 74 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPW----WLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRH 74 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchh----hhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEE
Confidence 3567899999999998865 678888776632211 111122235789999999995 5789998886 3469
Q ss_pred EEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccC-CcccEEeCCCCceEEecCCchhhhHhhhh
Q 005944 146 ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDI-KGANILVDNKGCIKLADFGASKKVVELAT 224 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDL-KPeNILld~~g~vKL~DFGlA~~~~~~~~ 224 (668)
++|||+.|.+|...+.. . ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|........
T Consensus 75 lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 75 LDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred EEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 99999999998754321 1 2457889999999999999999999 79999999999999999999974332111
Q ss_pred ------------hcCCccCCCCCCCCChHHHhhc-CCC-cchhHHHHHHHHHHHHhCCCCCch
Q 005944 225 ------------INGAKSMKGTPYWMAPEVILQT-GHS-FSADIWSVGCTVIEMATGKPPWSQ 273 (668)
Q Consensus 225 ------------~~~~~~~~GT~~Y~APEvl~~~-~~s-~ksDIWSLGvILyeLLTG~~PF~~ 273 (668)
.... -...++.|++|+...-- ..+ .+.++++.|+.+|.++|+..|+..
T Consensus 148 ~~r~L~~rDl~~llk~-~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKH-KRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHH-HHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0011 12368889999875432 223 567999999999999999988754
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-21 Score=202.03 Aligned_cols=191 Identities=24% Similarity=0.349 Sum_probs=143.1
Q ss_pred CCCCeeeecccccc---------------------------CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHH
Q 005944 127 THPNIVRYLGTARE---------------------------DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL 179 (668)
Q Consensus 127 ~HpNIV~l~g~~~~---------------------------~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl 179 (668)
+|||||++++.|.+ ...+|+||.-.+. +|..++... ..+-....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHH
Confidence 69999999887643 2357889987765 888888653 456677888999999
Q ss_pred HHHHHHHhCCcccccCCcccEEe--CCCC--ceEEecCCchhhhHhhh----hhcCCccCCCCCCCCChHHHhhcC----
Q 005944 180 LGLEYLHKNGIMHRDIKGANILV--DNKG--CIKLADFGASKKVVELA----TINGAKSMKGTPYWMAPEVILQTG---- 247 (668)
Q Consensus 180 ~aL~yLHs~gIvHrDLKPeNILl--d~~g--~vKL~DFGlA~~~~~~~----~~~~~~~~~GT~~Y~APEvl~~~~---- 247 (668)
+|+.|||.+||.|||||.+|||| ++++ .+.|+|||.+--..... ........-|.-.-||||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998 3444 68999999764211100 011112344778899999986432
Q ss_pred --CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHH
Q 005944 248 --HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTAS 320 (668)
Q Consensus 248 --~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~ 320 (668)
...++|.|+.|.+.||+++...||+...+-...... -.....+.+|+.+++.+++|+..+|+.||.+|+++.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~-Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT-YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhh-hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 245899999999999999999999863322111111 223456788999999999999999999999999865
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-20 Score=221.65 Aligned_cols=209 Identities=23% Similarity=0.317 Sum_probs=169.2
Q ss_pred CCCCCCCCCCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-
Q 005944 49 AVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT- 127 (668)
Q Consensus 49 ~~p~~pp~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~- 127 (668)
.+|.+.+....+.....|.|.+.||+|+||+||+|.+.+ |+.||||+=+...... |.--.+++.+|+
T Consensus 683 ~~~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----------fYI~~q~~~RLk~ 750 (974)
T KOG1166|consen 683 RVPKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----------FYICLQVMERLKP 750 (974)
T ss_pred cccccCccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----------eeehHHHHHhhch
Confidence 445555666667788899999999999999999999877 9999999753322211 111223444444
Q ss_pred --CCCeeeeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-
Q 005944 128 --HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN- 204 (668)
Q Consensus 128 --HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~- 204 (668)
-+-|..+...+...+.-+||+||.+.|+|.+++...+.+++..+..+..||+..|++||..+|||+||||+|+||..
T Consensus 751 ~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~ 830 (974)
T KOG1166|consen 751 QMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRRE 830 (974)
T ss_pred hhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecc
Confidence 24466666777778889999999999999999998899999999999999999999999999999999999999943
Q ss_pred ------CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCC
Q 005944 205 ------KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKP 269 (668)
Q Consensus 205 ------~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~ 269 (668)
.--++|+|||-+..+............++|-.+-.+|+..|..+++.+|.|.|.-++|.||.|+.
T Consensus 831 ~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 831 ICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 23599999998865543333334556788999999999999999999999999999999999864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-20 Score=189.94 Aligned_cols=241 Identities=21% Similarity=0.330 Sum_probs=188.6
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSL 144 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~ 144 (668)
...+.-+|.....|..|+|++. |..+++|++.+ ++......+.|..|.-.|+-+.||||+.+++.|.....+
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~v------r~~t~risrdfneefp~lrifshpnilpvlgacnsppnl 262 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNV------REVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNL 262 (448)
T ss_pred hhhhhhhhccCCCccccccccc--Ccchhhhhhhh------hhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCc
Confidence 3445556888899999999984 45677787743 333344456788899999999999999999999999999
Q ss_pred eEEeeccCCCChhcccccCCC--CCHHHHHHHHHHHHHHHHHHHhCC--cccccCCcccEEeCCCCceEEe--cCCchhh
Q 005944 145 NILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVDNKGCIKLA--DFGASKK 218 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~--l~e~~~~~i~~QIl~aL~yLHs~g--IvHrDLKPeNILld~~g~vKL~--DFGlA~~ 218 (668)
.++..|++.|+|+.+++.... ....++.+++.+|++|++|||+.. |.---|....++||++-+.+|. |--++.
T Consensus 263 v~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf- 341 (448)
T KOG0195|consen 263 VIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF- 341 (448)
T ss_pred eEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-
Confidence 999999999999999987654 567889999999999999999984 4555688899999998776664 322221
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCC---CcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGH---SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~---s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~ 295 (668)
......-.|.||+||.++...- -.++|+|||.++||||.|...||.+... ..--.++........+|.
T Consensus 342 --------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp-mecgmkialeglrv~ipp 412 (448)
T KOG0195|consen 342 --------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP-MECGMKIALEGLRVHIPP 412 (448)
T ss_pred --------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc-hhhhhhhhhccccccCCC
Confidence 1122344788999999987653 3578999999999999999999975432 112223333455667888
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHH
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELL 323 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL 323 (668)
.++..+..|+.-|+..||.+||.++.|+
T Consensus 413 gis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 413 GISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 9999999999999999999999988765
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.7e-20 Score=184.98 Aligned_cols=136 Identities=23% Similarity=0.349 Sum_probs=107.0
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-----CCCCeeeeccccccC
Q 005944 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-----THPNIVRYLGTARED 141 (668)
Q Consensus 67 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-----~HpNIV~l~g~~~~~ 141 (668)
.-.++||+|+||.||. ++.++.. +||++..... ...+.+.+|+.+++.+ .||||+++++++.++
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~--------~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~ 73 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD--------GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETD 73 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEecccc--------chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeC
Confidence 3457899999999995 7777666 6998743211 1234578999999999 579999999999887
Q ss_pred C---cce-EEeec--cCCCChhcccccCCCCCHHHHHHHHHHHHHHH-HHHHhCCcccccCCcccEEeCC----CCceEE
Q 005944 142 D---SLN-ILLEF--VPGGSISSLLGKFGSFPESVIRMYTKQLLLGL-EYLHKNGIMHRDIKGANILVDN----KGCIKL 210 (668)
Q Consensus 142 ~---~~~-LVmEy--~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL-~yLHs~gIvHrDLKPeNILld~----~g~vKL 210 (668)
. .++ +|||| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++||||||||+|||++. ++.++|
T Consensus 74 ~g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 74 CGTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred CCCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 4 333 78999 668999999976 456666 35688888888 9999999999999999999974 348999
Q ss_pred ecCCch
Q 005944 211 ADFGAS 216 (668)
Q Consensus 211 ~DFGlA 216 (668)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995443
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-21 Score=221.64 Aligned_cols=263 Identities=27% Similarity=0.409 Sum_probs=214.3
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcC-CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLD-SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAR 139 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~-tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~ 139 (668)
....|.+.+.||+|+|+.|-.+.... ....+|+|.+.... +..........|..+-..+. |.|++.+++...
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~------~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~ 91 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP------KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS 91 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCC------CccchhhhcCccccccccccccccccccCCccC
Confidence 46678899999999999999887633 45567777663322 22233444556777777777 999999999999
Q ss_pred cCCcceEEeeccCCCChhccc-ccCC-CCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCcccEEeCCCC-ceEEecCCc
Q 005944 140 EDDSLNILLEFVPGGSISSLL-GKFG-SFPESVIRMYTKQLLLGLEYLH-KNGIMHRDIKGANILVDNKG-CIKLADFGA 215 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L-~~~~-~l~e~~~~~i~~QIl~aL~yLH-s~gIvHrDLKPeNILld~~g-~vKL~DFGl 215 (668)
..+..+++++|..|++++..+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .+++.|||+
T Consensus 92 ~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~ 171 (601)
T KOG0590|consen 92 SPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGL 171 (601)
T ss_pred CCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchh
Confidence 999999999999999999999 5554 7888899999999999999999 99999999999999999999 999999999
Q ss_pred hhhhHh-hhhhcCCccCCC-CCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccC--CCC
Q 005944 216 SKKVVE-LATINGAKSMKG-TPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT--KSH 290 (668)
Q Consensus 216 A~~~~~-~~~~~~~~~~~G-T~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~--~~~ 290 (668)
|..+.. ..........+| ++.|+|||...+.. .....|+||+|+++..|++|..||................ ...
T Consensus 172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (601)
T KOG0590|consen 172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFT 251 (601)
T ss_pred hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccc
Confidence 998765 344444556788 99999999998854 5778999999999999999999997544332222222222 223
Q ss_pred CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 291 ~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
...+..++..+.+++.++|..+|..|.+.+++..+||+..
T Consensus 252 ~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 252 QLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 4567788999999999999999999999999999999986
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-20 Score=205.15 Aligned_cols=180 Identities=26% Similarity=0.358 Sum_probs=142.8
Q ss_pred CcceEEeeccCCCChhcccccCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFG---SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~---~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.++||.|++|...+|.++|.+.. ..+....+.++.|++.|++| ++.+|||+||.||+...++++||+|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 35889999999999999997543 36677889999999999999 9999999999999999999999999999876
Q ss_pred hHhhh----hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCC
Q 005944 219 VVELA----TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP 294 (668)
Q Consensus 219 ~~~~~----~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p 294 (668)
..... .....+...||..||+||.|.+..|+.++||||||+||+||++ +|......+...-.+......+.+.
T Consensus 406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~~~ 482 (516)
T KOG1033|consen 406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPEFL 482 (516)
T ss_pred cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChHHh
Confidence 65433 1223345789999999999999999999999999999999997 4544444444443333333332233
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.+. ++-..|+.+||...|.+||++.+.-.|.|.
T Consensus 483 ~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 483 QDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 333 344789999999999999988888777775
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.5e-19 Score=184.02 Aligned_cols=150 Identities=21% Similarity=0.196 Sum_probs=116.1
Q ss_pred CCeeeeeEEcccCceEEEEEE-EcCCCcEEEEEEeeecccchhh----------------HhhHHHHHHHHHHHHHHHhC
Q 005944 64 IRWRKGELVGCGAFGRVYMGM-NLDSGELLAVKQVLIAANSASK----------------EKTQAHIRELEEEVKLLKNL 126 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~-~~~tg~~VAVK~i~~~~~~~~~----------------~~~~~~~~~~~~Ei~iL~~L 126 (668)
.-|.+.+.||+|+||.||+|. +..+|+.||||++......... .........+..|+.++..+
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 358899999999999999998 7779999999998543211000 00111223467899999999
Q ss_pred CCCC--eeeeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccccCCcccEEeC
Q 005944 127 THPN--IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG-IMHRDIKGANILVD 203 (668)
Q Consensus 127 ~HpN--IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~g-IvHrDLKPeNILld 203 (668)
.+.+ +.++++. ...+|||||++|++|...+.....+....+..++.||+.+|.+||..| |+||||||+|||++
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~ 183 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH 183 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence 7533 3344432 235899999999888776645556777778899999999999999999 99999999999999
Q ss_pred CCCceEEecCCchhh
Q 005944 204 NKGCIKLADFGASKK 218 (668)
Q Consensus 204 ~~g~vKL~DFGlA~~ 218 (668)
++.++|+|||++..
T Consensus 184 -~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 -DGKVVIIDVSQSVE 197 (237)
T ss_pred -CCCEEEEEChhhhc
Confidence 88999999998864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.9e-19 Score=175.54 Aligned_cols=142 Identities=18% Similarity=0.284 Sum_probs=114.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEee
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLE 149 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmE 149 (668)
++||+|++|.||+|.+ .|..|+||+...................+.+|+.++..+.|++|+....++......++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 77889999764222111111222233457889999999999988776666666778899999
Q ss_pred ccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 150 FVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 150 y~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
|++|++|.+++..... ....++.+|+.+|.+||..|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998865322 7889999999999999999999999999999999 78999999998864
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-18 Score=172.45 Aligned_cols=138 Identities=21% Similarity=0.313 Sum_probs=107.8
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeec
Q 005944 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEF 150 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy 150 (668)
+||+|+||.||+|.. ++..|++|+...................+.+|++++..+.|+++.....++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 678999998643221111111222345678899999999988755444444456678999999
Q ss_pred cCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 151 VPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 151 ~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
++|++|.+++..... .++.||+.+|.+||+.||+|||++|.|||++ ++.++|+|||++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988754321 7899999999999999999999999999999 88999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.6e-18 Score=168.10 Aligned_cols=144 Identities=21% Similarity=0.249 Sum_probs=110.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHh--------------hHHHHHHHHHHHHHHHhCCCCC
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK--------------TQAHIRELEEEVKLLKNLTHPN 130 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~--------------~~~~~~~~~~Ei~iL~~L~HpN 130 (668)
-|.+.+.||+|+||.||+|.+. +|+.||||++........... .......+..|+.++..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3778899999999999999864 799999998753221100000 0011223677899999998874
Q ss_pred --eeeeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCce
Q 005944 131 --IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCI 208 (668)
Q Consensus 131 --IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~v 208 (668)
++..++ ....++||||++|++|..+... .....++.+|+.++.++|..||+||||||+||||+.++.+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 444443 2356899999999999776531 3467889999999999999999999999999999999999
Q ss_pred EEecCCchhhh
Q 005944 209 KLADFGASKKV 219 (668)
Q Consensus 209 KL~DFGlA~~~ 219 (668)
+|+|||++..+
T Consensus 165 ~liDfg~~~~~ 175 (198)
T cd05144 165 YIIDWPQMVST 175 (198)
T ss_pred EEEECCccccC
Confidence 99999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.75 E-value=6.8e-18 Score=192.45 Aligned_cols=145 Identities=21% Similarity=0.279 Sum_probs=114.2
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
...|...++||+|+||+||++.+. +..+++|+...................+.+|++++..++|++|+..+.++....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 445567899999999999999864 344555554221111111122233456789999999999999988776666667
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
..++||||++|++|.+++. ....++.||+.+|.+||+.||+||||||+|||+ .++.++|+|||+++.
T Consensus 410 ~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 7899999999999998875 357899999999999999999999999999999 678999999999875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.6e-17 Score=184.64 Aligned_cols=202 Identities=24% Similarity=0.417 Sum_probs=155.8
Q ss_pred HHhCCCCCeeeeccccccCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccccCCcccE
Q 005944 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGI-MHRDIKGANI 200 (668)
Q Consensus 123 L~~L~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gI-vHrDLKPeNI 200 (668)
|+.+.|.|+.+++|.+.+....++|.+||..|+|.+.+.. ...++..-...++++|+.||.|||.-.| .|+.|+..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999977 4567777888899999999999998865 9999999999
Q ss_pred EeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcC-------CCcchhHHHHHHHHHHHHhCCCCCch
Q 005944 201 LVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG-------HSFSADIWSVGCTVIEMATGKPPWSQ 273 (668)
Q Consensus 201 Lld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-------~s~ksDIWSLGvILyeLLTG~~PF~~ 273 (668)
+++..-.+||+|||+.................-...|.|||++.+.. .+.+.||||+|+++||+++..-||..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 99999999999999987653211111111122345699999997642 35678999999999999999999964
Q ss_pred hH-----HHHHHHHhh-ccCCCCCCCCc--ccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 274 QF-----QEVAALFHI-GTTKSHPPIPE--HLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 274 ~~-----~~~~~~~~~-~~~~~~~~~p~--~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.. .++...+.. +.....+.++. ...+++..++.+||..+|..||++++|-.
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 21 122222222 22223333331 34557899999999999999999999865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1e-16 Score=156.54 Aligned_cols=143 Identities=25% Similarity=0.336 Sum_probs=99.5
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhh----------------HHHHHHHHHHHHHHHhCCCCC--
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKT----------------QAHIRELEEEVKLLKNLTHPN-- 130 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~----------------~~~~~~~~~Ei~iL~~L~HpN-- 130 (668)
++.||+|+||+||+|.+. +++.||||++............ .........|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999876 7999999988532211111000 000011235666666665443
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcc-cccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCce
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSL-LGKFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCI 208 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~-L~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~v 208 (668)
+.+.++. ...++||||++++.+... +... ... ..++.++.+++.++.++|. .||+||||||+|||++ ++.+
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 3444433 236899999999654321 2111 111 6788999999999999999 9999999999999999 8999
Q ss_pred EEecCCchhhh
Q 005944 209 KLADFGASKKV 219 (668)
Q Consensus 209 KL~DFGlA~~~ 219 (668)
+|+|||.+...
T Consensus 154 ~liDfg~a~~~ 164 (187)
T cd05119 154 YIIDVPQAVEI 164 (187)
T ss_pred EEEECcccccc
Confidence 99999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=156.90 Aligned_cols=143 Identities=20% Similarity=0.262 Sum_probs=105.7
Q ss_pred eeEEc-ccCceEEEEEEEcCCCcEEEEEEeeecccchhh-----HhhHHHHHHHHHHHHHHHhCCCCCe--eeecccccc
Q 005944 69 GELVG-CGAFGRVYMGMNLDSGELLAVKQVLIAANSASK-----EKTQAHIRELEEEVKLLKNLTHPNI--VRYLGTARE 140 (668)
Q Consensus 69 ~~~LG-~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~-----~~~~~~~~~~~~Ei~iL~~L~HpNI--V~l~g~~~~ 140 (668)
..+|| .||.|+||.+.. .+..++||.+......... .........+.+|+.++..|.|++| +..+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45688 899999999976 4788999988421110000 0011233457889999999998875 566665333
Q ss_pred C-Cc---ceEEeeccCC-CChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 141 D-DS---LNILLEFVPG-GSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 141 ~-~~---~~LVmEy~~g-GsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
. .. .++||||++| .+|.+++.. ..+++.. +.||+.+|.+||++||+||||||.|||++.++.++|+|||.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~ 188 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR 188 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence 2 22 2599999997 688888765 4566543 57899999999999999999999999999989999999998
Q ss_pred hhh
Q 005944 216 SKK 218 (668)
Q Consensus 216 A~~ 218 (668)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 763
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.6e-16 Score=184.71 Aligned_cols=268 Identities=25% Similarity=0.351 Sum_probs=208.8
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.....+.+.+.+-+|.++.++.+.-..+|...++|+........ ....+....+-.++-...||-++.....+..
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~-----~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~ 875 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIR-----TNDYESIRSKSNILITPRSPAVVRSFPSFPC 875 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhc-----cccccccCCccCccccCCCCceecccCCCCC
Confidence 34556788889999999999999888888888887653221110 0111222333334444456778877766677
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
....+||++|..+++|...|+..+..+++.++.++..+.++++|||...+.|||++|.|+|+..+|..++.|||......
T Consensus 876 rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 876 RSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred CCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccc
Confidence 78899999999999999999998989999999999999999999999999999999999999999999999998543322
Q ss_pred hhhh-----------------------------hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCC
Q 005944 221 ELAT-----------------------------INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW 271 (668)
Q Consensus 221 ~~~~-----------------------------~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF 271 (668)
.... ........||+.|.+||.+.+..+...+|+|++|+++++.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 1100 00122456999999999999999999999999999999999999999
Q ss_pred chhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHH---HHHcCccccCCCC
Q 005944 272 SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTAS---ELLQHPFVTGKYQ 333 (668)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~---EIL~Hpwf~~~~~ 333 (668)
......-.-.........++.-+...+.++++++.++|..+|.+|..+. ++-.|+||+....
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 8765443333333344445556677899999999999999999998888 9999999986543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-15 Score=137.86 Aligned_cols=132 Identities=23% Similarity=0.270 Sum_probs=110.4
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC--CCeeeeccccccCCcce
Q 005944 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH--PNIVRYLGTAREDDSLN 145 (668)
Q Consensus 68 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIV~l~g~~~~~~~~~ 145 (668)
+.+.||.|.++.||++... +..++||.+..... ...+..|+.++..+.| .++++++.+....+..+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~----------~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~ 69 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK----------GADREREVAILQLLARKGLPVPKVLASGESDGWSY 69 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc----------hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccE
Confidence 4578999999999999874 37899998732111 2357789999999976 58889988888888899
Q ss_pred EEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 146 ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN---GIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~---gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
++|||+.++.+..+ +......++.+++.+|++||.. +++|+||+|.|||++..+.++++|||++..
T Consensus 70 ~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 70 LLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred EEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99999999888765 5566778899999999999985 699999999999999989999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=6.4e-15 Score=164.27 Aligned_cols=260 Identities=23% Similarity=0.230 Sum_probs=196.1
Q ss_pred CCCCCeeeeeEEcc--cCceEEEEEEE--cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeec
Q 005944 61 APPIRWRKGELVGC--GAFGRVYMGMN--LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYL 135 (668)
Q Consensus 61 ~~~~ry~i~~~LG~--G~fG~Vy~a~~--~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~ 135 (668)
.....+.+.+-+|. |.+|.||.+.. ..++..+|+|.-+......... ..-.+|+.....+ .|+|.|+.+
T Consensus 111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~------~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDS------KRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCcccc------ccccchhhcccccCccccccccC
Confidence 44556777888999 99999999988 7889999999743222111111 1113455555555 499999999
Q ss_pred cccccCCcceEEeeccCCCChhcccccCCC-CCHHHHHHHHHHHHH----HHHHHHhCCcccccCCcccEEeCCC-CceE
Q 005944 136 GTAREDDSLNILLEFVPGGSISSLLGKFGS-FPESVIRMYTKQLLL----GLEYLHKNGIMHRDIKGANILVDNK-GCIK 209 (668)
Q Consensus 136 g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~-l~e~~~~~i~~QIl~----aL~yLHs~gIvHrDLKPeNILld~~-g~vK 209 (668)
..+...+..|+-+|+|. .+|..+...... ++...++.++.++.+ ||.++|..+|+|-|+||.||++..+ ...+
T Consensus 185 ~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~ 263 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCK 263 (524)
T ss_pred cccccCCcceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceee
Confidence 99999999999999995 688887766544 899999999999999 9999999999999999999999999 8899
Q ss_pred EecCCchhhhHhhhhhcC---CccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhcc
Q 005944 210 LADFGASKKVVELATING---AKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT 286 (668)
Q Consensus 210 L~DFGlA~~~~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~ 286 (668)
++|||+...+....-... .....|...|++||.+. .-++...|||+||.++.+-.++..++....... ...+..
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~--W~~~r~ 340 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS--WSQLRQ 340 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC--cccccc
Confidence 999999887654332111 12236788999999874 458999999999999999988766543211110 011111
Q ss_pred CCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 287 ~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
......+....+.++...+..|++.+|..|++++.++.|+++..
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 11223344566778888999999999999999999999999863
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=7.5e-14 Score=158.43 Aligned_cols=149 Identities=17% Similarity=0.267 Sum_probs=97.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccch--------------------------hhHhhHHHHHHHHH
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSA--------------------------SKEKTQAHIRELEE 118 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~--------------------------~~~~~~~~~~~~~~ 118 (668)
.|.. +.||+|++|+||+|+.+.+|+.||||++....... ..+...+..+.+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 78999999999999988889999999985321100 00111122233334
Q ss_pred HHHHHHhC----------CCCCeeeecccccc-CCcceEEeeccCCCChhcc--cccCC----CCCHHHHHHHHHHHHHH
Q 005944 119 EVKLLKNL----------THPNIVRYLGTARE-DDSLNILLEFVPGGSISSL--LGKFG----SFPESVIRMYTKQLLLG 181 (668)
Q Consensus 119 Ei~iL~~L----------~HpNIV~l~g~~~~-~~~~~LVmEy~~gGsL~~~--L~~~~----~l~e~~~~~i~~QIl~a 181 (668)
|+.+++.. .+.+.|.+-.+|.+ ....+|||||+.|+.|.++ +...+ .+.+..+..++.||+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-- 277 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-- 277 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence 44433333 23333333333322 3456799999999999774 33322 244444455555554
Q ss_pred HHHHHhCCcccccCCcccEEeCCCC----ceEEecCCchhhhHh
Q 005944 182 LEYLHKNGIMHRDIKGANILVDNKG----CIKLADFGASKKVVE 221 (668)
Q Consensus 182 L~yLHs~gIvHrDLKPeNILld~~g----~vKL~DFGlA~~~~~ 221 (668)
..|++|+|+||.||||+.+| .++++|||++..+.+
T Consensus 278 -----~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 -----RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999888 999999999876543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=3e-13 Score=150.85 Aligned_cols=148 Identities=18% Similarity=0.199 Sum_probs=98.4
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhh--------------------------HhhHHHHH------HH
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASK--------------------------EKTQAHIR------EL 116 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~--------------------------~~~~~~~~------~~ 116 (668)
.+.||.|++|+||+|+. .+|+.||||+........-. ....+... .+
T Consensus 122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf 200 (437)
T TIGR01982 122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL 200 (437)
T ss_pred CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence 36799999999999985 57999999997432110000 00001111 23
Q ss_pred HHHHHHHHhC----CCCCeeeecccc-ccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 005944 117 EEEVKLLKNL----THPNIVRYLGTA-REDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLL-GLEYLHKNG 189 (668)
Q Consensus 117 ~~Ei~iL~~L----~HpNIV~l~g~~-~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~-aL~yLHs~g 189 (668)
.+|++.+.++ .|.+-|.+-.++ ......+|||||++|++|.++.... ..+ ....++.+++. .+..+|..|
T Consensus 201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 4455555554 233333333333 2234579999999999998876431 122 23456666665 478899999
Q ss_pred cccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 190 IMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 190 IvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
++|+|+||.|||++.+|.++|+|||++..+.
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.4e-14 Score=151.28 Aligned_cols=242 Identities=21% Similarity=0.315 Sum_probs=159.1
Q ss_pred EEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-----cceEEeeccCC
Q 005944 79 RVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD-----SLNILLEFVPG 153 (668)
Q Consensus 79 ~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~-----~~~LVmEy~~g 153 (668)
.||++.++..|..|....+........+... .. ...-+.-|-++-|.|||+++.++.+.. ...+++||+..
T Consensus 81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qe-ek---~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymss 156 (458)
T KOG1266|consen 81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQE-EK---RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSS 156 (458)
T ss_pred HHHHHhhhccCchhhHHHHHHHHhcChhhCH-HH---HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccc
Confidence 5677777777766665443222211111111 11 112233455567999999999886543 47789999999
Q ss_pred CChhcccccC----CCCCHHHHHHHHHHHHHHHHHHHhC--CcccccCCcccEEeCCCCceEEecCCchhhhHhhhh--h
Q 005944 154 GSISSLLGKF----GSFPESVIRMYTKQLLLGLEYLHKN--GIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT--I 225 (668)
Q Consensus 154 GsL~~~L~~~----~~l~e~~~~~i~~QIl~aL~yLHs~--gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~--~ 225 (668)
|+|..+|++. ..+....+++|+.||+.||.|||+. -|+|+++...-|++..+|-+||+--.....-..... .
T Consensus 157 gs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~ 236 (458)
T KOG1266|consen 157 GSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTRE 236 (458)
T ss_pred hhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhH
Confidence 9999999653 4588899999999999999999988 499999999999999999888853222111000000 0
Q ss_pred cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHH
Q 005944 226 NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFL 305 (668)
Q Consensus 226 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI 305 (668)
.......+-++|.|||.=.....+.++|||+||....+|..+..--............+.... ...-..--+.+|
T Consensus 237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i-----~~len~lqr~~i 311 (458)
T KOG1266|consen 237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI-----IGLENGLQRGSI 311 (458)
T ss_pred hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-----eeccCccccCcC
Confidence 111224567899999976555667789999999999999887654211111100000000000 000111235789
Q ss_pred HHhhhhCCCCCCCHHHHHcCcccc
Q 005944 306 LKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 306 ~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
.+||+..|..||++.+++.||.+-
T Consensus 312 ~kcl~~eP~~rp~ar~llfHpllf 335 (458)
T KOG1266|consen 312 TKCLEGEPNGRPDARLLLFHPLLF 335 (458)
T ss_pred cccccCCCCCCcchhhhhcCceee
Confidence 999999999999999999999763
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.3e-12 Score=128.97 Aligned_cols=145 Identities=14% Similarity=0.108 Sum_probs=103.9
Q ss_pred eeEEcccCceEEEEEEEcC------CCcEEEEEEeeecccchhh------------------HhhHHHHHHHHHHHHHHH
Q 005944 69 GELVGCGAFGRVYMGMNLD------SGELLAVKQVLIAANSASK------------------EKTQAHIRELEEEVKLLK 124 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~------tg~~VAVK~i~~~~~~~~~------------------~~~~~~~~~~~~Ei~iL~ 124 (668)
...||.|--+.||.|.... .+..+|||+.......... ...........+|++.|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3478999999999998653 3579999998654321110 001112223448999999
Q ss_pred hCCC--CCeeeeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCcccEE
Q 005944 125 NLTH--PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL-HKNGIMHRDIKGANIL 201 (668)
Q Consensus 125 ~L~H--pNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yL-Hs~gIvHrDLKPeNIL 201 (668)
++.. -++...+++ ...+|||||+.++.+....-+...+++.++..++.+++.+|..| |..||||+||++.|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL 157 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML 157 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9853 355556554 45789999997754433222223466677788899999999998 8999999999999999
Q ss_pred eCCCCceEEecCCchhh
Q 005944 202 VDNKGCIKLADFGASKK 218 (668)
Q Consensus 202 ld~~g~vKL~DFGlA~~ 218 (668)
+. ++.+.|+|||.+..
T Consensus 158 ~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 158 WH-DGKVWFIDVSQSVE 173 (197)
T ss_pred EE-CCcEEEEECCCcee
Confidence 97 47899999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=148.08 Aligned_cols=169 Identities=26% Similarity=0.403 Sum_probs=128.6
Q ss_pred EEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeeccCCCChhcccc
Q 005944 82 MGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLG 161 (668)
Q Consensus 82 ~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~ 161 (668)
.|..+.++.+|.|.+.+.... .......+.++-|+.++||||+++++.+..++.+|||+|-|. .|..++.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~--------~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk 99 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG--------EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLK 99 (690)
T ss_pred ccceeccCCceEEEEEeCCCc--------hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHH
Confidence 466677888999988743211 334456778889999999999999999999999999999984 5666776
Q ss_pred cCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCCh
Q 005944 162 KFGSFPESVIRMYTKQLLLGLEYLH-KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240 (668)
Q Consensus 162 ~~~~l~e~~~~~i~~QIl~aL~yLH-s~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~AP 240 (668)
+.+ ...+...+.||+.||.||| ..+++|++|.-.-|+|+..|..||++|.++........ ......--..|..|
T Consensus 100 ~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P 174 (690)
T KOG1243|consen 100 ELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDP 174 (690)
T ss_pred HhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccCh
Confidence 543 6778888999999999997 56899999999999999999999999998754322111 11111112235666
Q ss_pred HHHhhcCCCcchhHHHHHHHHHHHHhC
Q 005944 241 EVILQTGHSFSADIWSVGCTVIEMATG 267 (668)
Q Consensus 241 Evl~~~~~s~ksDIWSLGvILyeLLTG 267 (668)
+.+... ....|.|.|||++++++.|
T Consensus 175 ~~~~~s--~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 175 EEIDPS--EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred hhcCcc--ccchhhhhHHHHHHHHhCc
Confidence 654322 2457999999999999999
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.2e-12 Score=125.20 Aligned_cols=127 Identities=17% Similarity=0.125 Sum_probs=94.1
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCee-eeccccccCCcceEE
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV-RYLGTAREDDSLNIL 147 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV-~l~g~~~~~~~~~LV 147 (668)
.+.|+.|.++.||++.. .+..|+||+...... ....+..|+.++..+.+.+++ +++.+. ....++|
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~---------~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE---------LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLI 69 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc---------cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEE
Confidence 35789999999999986 478899998621110 112346788888888655544 444433 2345899
Q ss_pred eeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccccCCcccEEeCCCCceEEecCCchh
Q 005944 148 LEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGI-----MHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 148 mEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gI-----vHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
|||++|.++.... .....++.+++.+|..||..++ +|+|++|.|||++ ++.++|+|||.+.
T Consensus 70 ~e~i~G~~l~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 70 TEFIEGSELLTED--------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred EEecCCCcccccc--------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9999998886531 1123467899999999999985 9999999999999 6789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.35 E-value=4.2e-13 Score=149.85 Aligned_cols=252 Identities=24% Similarity=0.228 Sum_probs=183.8
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEc-CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNL-DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTA 138 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~-~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~ 138 (668)
....+|..+..||.|.|+.|+.+... .++..|++|.+........ ..+ .-..|+.+...+ .|.+++.++..|
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~-----~di-~sl~ev~l~~~l~~~~~~~g~~~~W 335 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFA-----SDI-FSLGEVILEAILGSHLPSVGKNSSW 335 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchH-----hhh-cchhhhhHhhHhhcccccCCCCCCc
Confidence 34557888999999999999998755 5788999997743222111 111 123456565555 599999988888
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-CceEEecCCchh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK-GCIKLADFGASK 217 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~-g~vKL~DFGlA~ 217 (668)
...+..||-.|||.++++...+.-...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..+++|||.++
T Consensus 336 ~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t 415 (524)
T KOG0601|consen 336 SQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT 415 (524)
T ss_pred cccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence 8888888999999999887776555668889999999999999999999999999999999999886 788999999886
Q ss_pred hhHhhhhhcCCccCCCCCCCC--ChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCc
Q 005944 218 KVVELATINGAKSMKGTPYWM--APEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~--APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~ 295 (668)
.+.- ......+.-+++ ++.......+..++|+++||..+++.+++.+.- ...... ..+ .....+..+
T Consensus 416 ~~~~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls-~~~~~~---~~i-~~~~~p~~~- 484 (524)
T KOG0601|consen 416 RLAF-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS-ESGVQS---LTI-RSGDTPNLP- 484 (524)
T ss_pred ccce-----ecccccccccccccchhhccccccccccccccccccccccccCcccC-cccccc---eee-ecccccCCC-
Confidence 4211 111222333444 455555666889999999999999999987532 111111 111 111122223
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
....++..+.+.++..++..||.+.++..|.-|-
T Consensus 485 ~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 485 GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 3347888999999999999999999999887663
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.23 E-value=4.6e-11 Score=117.37 Aligned_cols=139 Identities=19% Similarity=0.247 Sum_probs=103.3
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEEee
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLE 149 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmE 149 (668)
.++++|+-+.||.+.. -|..+++|.-.........-...-....-.+|+++|..+.--.|..-+=+..+.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 4688999999999965 34457777654433333333333344556789999999865544332333345566789999
Q ss_pred ccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 150 FVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 150 y~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
|++|..|.+++... ...+++.+-.-+.-||..||||+||.++||++...+ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999888764 256778888889999999999999999999997765 99999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.3e-10 Score=113.89 Aligned_cols=148 Identities=23% Similarity=0.252 Sum_probs=112.1
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEE
Q 005944 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNIL 147 (668)
Q Consensus 68 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LV 147 (668)
.+.+|-+|+-+.|+++.+ .|+.+.||.-............+-......+|+++|.++.--.|.--.=++.+...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567899999999999976 789999997655555555555556667788899999998654443333344555667899
Q ss_pred eeccCC-CChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC---ceEEecCCchh
Q 005944 148 LEFVPG-GSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG---CIKLADFGASK 217 (668)
Q Consensus 148 mEy~~g-GsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g---~vKL~DFGlA~ 217 (668)
|||++| -++.+++.... .........++++|-..|.-||..+|+|+||..+||+|..+| .+.|+|||++.
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence 999987 46777765432 222233378899999999999999999999999999997665 35899999975
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.15 E-value=1.9e-10 Score=114.29 Aligned_cols=139 Identities=17% Similarity=0.240 Sum_probs=105.6
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCC--CeeeeccccccC---Ccc
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP--NIVRYLGTARED---DSL 144 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp--NIV~l~g~~~~~---~~~ 144 (668)
+.||.|.++.||++... +|..++||+....... .....+..|+.++..+.+. ++.+++.+.... +..
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~-------~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~ 75 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL-------PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTP 75 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC-------cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCc
Confidence 57899999999999864 3688999986321110 1233567899999998753 356666666553 367
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK------------------------------------- 187 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs------------------------------------- 187 (668)
++||||++|.++...+.. ..+++.....++.+++.+|.+||+
T Consensus 76 ~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 76 FYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred eEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 899999999998887643 467778888888888888888884
Q ss_pred -------------------CCcccccCCcccEEeCC--CCceEEecCCchh
Q 005944 188 -------------------NGIMHRDIKGANILVDN--KGCIKLADFGASK 217 (668)
Q Consensus 188 -------------------~gIvHrDLKPeNILld~--~g~vKL~DFGlA~ 217 (668)
..++|+|++|.|||++. ++.+.|+||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999998 6778999999775
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.7e-09 Score=106.24 Aligned_cols=132 Identities=24% Similarity=0.308 Sum_probs=85.2
Q ss_pred EEEEEEEcCCCcEEEEEEeeecccch------------------hhHhhHHHHHHHHHHHHHHHhCCCC--Ceeeecccc
Q 005944 79 RVYMGMNLDSGELLAVKQVLIAANSA------------------SKEKTQAHIRELEEEVKLLKNLTHP--NIVRYLGTA 138 (668)
Q Consensus 79 ~Vy~a~~~~tg~~VAVK~i~~~~~~~------------------~~~~~~~~~~~~~~Ei~iL~~L~Hp--NIV~l~g~~ 138 (668)
.||.|.. .+|..+|||+........ .............+|++.|..+..- ++.+.+++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 4899985 467899999985432110 0112223345678899999999766 455665442
Q ss_pred ccCCcceEEeeccC--CCChhcccccCCCCCHHHHHHHHHHHHHHHHH-HHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 139 REDDSLNILLEFVP--GGSISSLLGKFGSFPESVIRMYTKQLLLGLEY-LHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 139 ~~~~~~~LVmEy~~--gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~y-LHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
..+|||||++ |..+..+... .++......++.+++..+.. +|..||+|+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 4579999998 6555544332 22245567788888885555 689999999999999999877 999999998
Q ss_pred hhh
Q 005944 216 SKK 218 (668)
Q Consensus 216 A~~ 218 (668)
+..
T Consensus 153 av~ 155 (188)
T PF01163_consen 153 AVD 155 (188)
T ss_dssp EEE
T ss_pred cee
Confidence 753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.3e-10 Score=129.94 Aligned_cols=155 Identities=23% Similarity=0.310 Sum_probs=113.9
Q ss_pred HHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEecCCchhhhHhhhh-----hcCC--ccCCCCCCCCChHHHhhcCC
Q 005944 177 QLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT-----INGA--KSMKGTPYWMAPEVILQTGH 248 (668)
Q Consensus 177 QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~-----~~~~--~~~~GT~~Y~APEvl~~~~~ 248 (668)
+++.|+.|+|.. ++||++|.|++|.++..|.+||+.|+++........ ++.. ....-...|.|||++.+...
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~ 186 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN 186 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence 344899999976 899999999999999999999999998754322111 0000 01224567999999999888
Q ss_pred CcchhHHHHHHHHHHHH-hCCCCCchhHHHHHHHHhh-ccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCc
Q 005944 249 SFSADIWSVGCTVIEMA-TGKPPWSQQFQEVAALFHI-GTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHP 326 (668)
Q Consensus 249 s~ksDIWSLGvILyeLL-TG~~PF~~~~~~~~~~~~~-~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hp 326 (668)
+.++|+|||||++|.+. .|+..+......+...+.. ........+...++.++++-|.++|..++.-||++.+++.-|
T Consensus 187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ 266 (700)
T KOG2137|consen 187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIP 266 (700)
T ss_pred cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhccc
Confidence 99999999999999998 5666654321111111111 111112234578899999999999999999999999999999
Q ss_pred cccCC
Q 005944 327 FVTGK 331 (668)
Q Consensus 327 wf~~~ 331 (668)
||++.
T Consensus 267 ff~D~ 271 (700)
T KOG2137|consen 267 FFSDP 271 (700)
T ss_pred ccCCc
Confidence 99864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.94 E-value=7.9e-09 Score=114.25 Aligned_cols=212 Identities=20% Similarity=0.223 Sum_probs=153.0
Q ss_pred CceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc----CCcceEEeecc
Q 005944 76 AFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE----DDSLNILLEFV 151 (668)
Q Consensus 76 ~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~----~~~~~LVmEy~ 151 (668)
--.+.|+|....+|..|++|.+...... .....-.-+++++++.|+|||++.+++.+ +..+++|++|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--------~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYy 359 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--------STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYY 359 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc--------CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecC
Confidence 3468999999999999999988221111 11112235778999999999999998873 35688999998
Q ss_pred CC-CChhccc---------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 152 PG-GSISSLL---------------GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 152 ~g-GsL~~~L---------------~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++ ++|.++. ......+|..+|.++.||..||.++|+.|+..+-|.|.+||++.+.+++|...|+
T Consensus 360 P~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i 439 (655)
T KOG3741|consen 360 PSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGI 439 (655)
T ss_pred CCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccc
Confidence 76 3565542 1123478999999999999999999999999999999999999998999998887
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCC-Cc-hhHHHHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPP-WS-QQFQEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~P-F~-~~~~~~~~~~~~~~~~~~~~~ 293 (668)
...+.... + |-+.+ -.+-|.=.||.++..|.||..- +. ...++. .+ ..+
T Consensus 440 ~Dvl~~d~---------~-------~~le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s-~~---------~~I 490 (655)
T KOG3741|consen 440 MDVLQEDP---------T-------EPLES---QQQNDLRDLGLLLLALATGTENSNRTDSTQSS-HL---------TRI 490 (655)
T ss_pred eeeecCCC---------C-------cchhH---HhhhhHHHHHHHHHHHhhcccccccccchHHH-HH---------HHh
Confidence 65443221 0 11111 1245888999999999999542 11 111111 00 112
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
-..++.+++++|.-+...++++ -++.+++.|
T Consensus 491 ~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 491 TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 3467889999999999999887 788999876
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.5e-08 Score=106.39 Aligned_cols=144 Identities=14% Similarity=0.067 Sum_probs=94.5
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhh----HHHHHHHHHHHHHHHhCCCCCe--eeecccccc----
Q 005944 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKT----QAHIRELEEEVKLLKNLTHPNI--VRYLGTARE---- 140 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~----~~~~~~~~~Ei~iL~~L~HpNI--V~l~g~~~~---- 140 (668)
++-......|+++.. .|+.|.||....... ....+. ..-...+.+|...+..|...+| ..++++...
T Consensus 29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~-~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGW-GEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred EEecCCCceEEEEEE--CCEEEEEEEecCCcH-HHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 333333344666543 677899997622110 000000 0001135678888877743332 233333322
Q ss_pred -CCcceEEeeccCCC-Chhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-------CCceE
Q 005944 141 -DDSLNILLEFVPGG-SISSLLGK--FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN-------KGCIK 209 (668)
Q Consensus 141 -~~~~~LVmEy~~gG-sL~~~L~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~-------~g~vK 209 (668)
....+||||++++- +|.+++.. ....+......++.+|+..+..||..||+|+||++.||||+. ++.+.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEE
Confidence 23578999999876 78888753 245567778899999999999999999999999999999975 46899
Q ss_pred EecCCchh
Q 005944 210 LADFGASK 217 (668)
Q Consensus 210 L~DFGlA~ 217 (668)
|+||+.+.
T Consensus 186 LIDl~r~~ 193 (268)
T PRK15123 186 VIDLHRAQ 193 (268)
T ss_pred EEECCccc
Confidence 99999774
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.2e-08 Score=103.87 Aligned_cols=142 Identities=20% Similarity=0.261 Sum_probs=104.4
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchh--------------hHhhHHHHHHHHHHHHHHHhCCCC--
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSAS--------------KEKTQAHIRELEEEVKLLKNLTHP-- 129 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~--------------~~~~~~~~~~~~~Ei~iL~~L~Hp-- 129 (668)
+.++..||-|.-+.||.|.+. .|.++|||.=........ ...........++|.++|..|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456789999999999999865 689999996432211110 011122344577899999999654
Q ss_pred CeeeeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceE
Q 005944 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIK 209 (668)
Q Consensus 130 NIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vK 209 (668)
.|.+.+++ +...+||||++|-.|..+- +..+.+..++..|+.-+..+-..||||+|+.+-||||+.+|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 56665554 4578999999997776543 23455666777777777777799999999999999999999999
Q ss_pred EecCCchh
Q 005944 210 LADFGASK 217 (668)
Q Consensus 210 L~DFGlA~ 217 (668)
++||--+.
T Consensus 243 vIDwPQ~v 250 (304)
T COG0478 243 VIDWPQAV 250 (304)
T ss_pred EEeCcccc
Confidence 99997553
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=6.4e-08 Score=97.38 Aligned_cols=103 Identities=23% Similarity=0.323 Sum_probs=80.2
Q ss_pred HHHHHHHHHHhCCCCC--eeeeccccccC----CcceEEeeccCCC-ChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Q 005944 115 ELEEEVKLLKNLTHPN--IVRYLGTARED----DSLNILLEFVPGG-SISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187 (668)
Q Consensus 115 ~~~~Ei~iL~~L~HpN--IV~l~g~~~~~----~~~~LVmEy~~gG-sL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs 187 (668)
...+|...+..|...+ +.+.+++.... ...+||+|++++- +|.+++.....++......++.+++..+.-||.
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~ 136 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD 136 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH
Confidence 4566777777764332 23333333321 3458999999874 799988775557788889999999999999999
Q ss_pred CCcccccCCcccEEeCCCC---ceEEecCCchh
Q 005944 188 NGIMHRDIKGANILVDNKG---CIKLADFGASK 217 (668)
Q Consensus 188 ~gIvHrDLKPeNILld~~g---~vKL~DFGlA~ 217 (668)
+||+|+|+++.||||+.++ .+.|+||+-++
T Consensus 137 ~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~ 169 (206)
T PF06293_consen 137 AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR 169 (206)
T ss_pred CcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence 9999999999999999887 89999999765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.66 E-value=2.5e-07 Score=100.39 Aligned_cols=236 Identities=17% Similarity=0.198 Sum_probs=148.1
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeee--------ecccc
Q 005944 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVR--------YLGTA 138 (668)
Q Consensus 68 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~--------l~g~~ 138 (668)
.+..||+|+-+.+|-.-.. ...+-|++......... .-+..|... .||-+-. |+|-
T Consensus 15 ~gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~a-----------qk~a~la~~p~~p~~~~rvaWPqa~L~G~- 79 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQA-----------QKVAELAATPDAPLLNYRVAWPQATLHGG- 79 (637)
T ss_pred CCccccCCccceeeecchh---hchhheeecCCCchHHH-----------HHHHHhccCCCCcchhhhhcccHHHhhCC-
Confidence 4567999999999965322 22345766322211110 112223333 4554322 1221
Q ss_pred ccCCcceEEeeccCCCC-hhccc------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 139 REDDSLNILLEFVPGGS-ISSLL------GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGs-L~~~L------~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
.....+.++|..+.|.. +..++ +....+.+.-+.++++.|+.+.+.||..|.+-+|+.++||||.+++.|.|+
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LV 159 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLV 159 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEE
Confidence 12223678888887652 22222 112346688899999999999999999999999999999999999999998
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHh-----hcCCCcchhHHHHHHHHHHHHhC-CCCCchhH---------H
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATG-KPPWSQQF---------Q 276 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGvILyeLLTG-~~PF~~~~---------~ 276 (668)
|=..-... .........+|.+.|.+||.-. +..-+...|.|.||+++++||.| +.||.+-. +
T Consensus 160 dsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E 236 (637)
T COG4248 160 DSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE 236 (637)
T ss_pred cccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence 86543221 1112233467999999999865 23346778999999999999986 89996421 1
Q ss_pred -HHHHH-Hhh----ccCCCCC---CCCcccCHHHHHHHHHhhhhC--CCCCCCHHH
Q 005944 277 -EVAAL-FHI----GTTKSHP---PIPEHLSMEAKDFLLKCLQKE--PYLRSTASE 321 (668)
Q Consensus 277 -~~~~~-~~~----~~~~~~~---~~p~~ls~el~dLI~kcL~~d--P~~RPSa~E 321 (668)
.+..- +.. ....... .-...+++.++.|..+|+..- +.-|||++.
T Consensus 237 ~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 237 TDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred hhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 11100 000 0000000 112467889999999999743 568999874
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.2e-07 Score=91.99 Aligned_cols=140 Identities=16% Similarity=0.168 Sum_probs=98.8
Q ss_pred cccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC--eeeeccccc---c--CCcce
Q 005944 73 GCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN--IVRYLGTAR---E--DDSLN 145 (668)
Q Consensus 73 G~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IV~l~g~~~---~--~~~~~ 145 (668)
|.||.+.|+.... .|..+-||.-.......-. -+.....|.+|+..|..|...+ +.+.+ ++. . ....+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r--~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~ 101 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVR--YPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRAL 101 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCccccccc--CCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEE
Confidence 6799999998764 4456888865311111111 0223456888999999885433 33333 221 1 23467
Q ss_pred EEeeccCC-CChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc--eEEecCCchh
Q 005944 146 ILLEFVPG-GSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC--IKLADFGASK 217 (668)
Q Consensus 146 LVmEy~~g-GsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~--vKL~DFGlA~ 217 (668)
||+|-+.| -+|.+++... .+.+......++.+|+.+|.-||..|+.|+|+.+.|||++.+|. ++++||.-++
T Consensus 102 LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 102 LVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 99997653 5788887553 34577777899999999999999999999999999999987777 9999998655
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.1e-06 Score=88.43 Aligned_cols=141 Identities=17% Similarity=0.223 Sum_probs=95.0
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeeecccchhh----------------HhhHHHHHHHHHHHHHHHhCCC--CCee
Q 005944 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASK----------------EKTQAHIRELEEEVKLLKNLTH--PNIV 132 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~----------------~~~~~~~~~~~~Ei~iL~~L~H--pNIV 132 (668)
.|.+|.-+.||+|.. .++..||||++......... ...+........|+.-|+++.. -.+.
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 567778889999974 56899999999654322111 0111122234567777777743 3333
Q ss_pred eeccccccCCcceEEeeccCCCChh-cccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceEE
Q 005944 133 RYLGTAREDDSLNILLEFVPGGSIS-SLLGKFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 133 ~l~g~~~~~~~~~LVmEy~~gGsL~-~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vKL 210 (668)
+-+.+. .-.|||||+....+- -.|.. -.+...++..+..++++.+.-|-. .++||+||..-|||+. ++.+.|
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 333333 247999999554221 12222 233344788899999999999877 8999999999999999 889999
Q ss_pred ecCCchhh
Q 005944 211 ADFGASKK 218 (668)
Q Consensus 211 ~DFGlA~~ 218 (668)
+|||-|..
T Consensus 208 ID~~QaV~ 215 (268)
T COG1718 208 IDVSQAVT 215 (268)
T ss_pred EECccccc
Confidence 99998753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.1e-08 Score=113.23 Aligned_cols=243 Identities=24% Similarity=0.214 Sum_probs=171.8
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC-eeeeccccccCCcc
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN-IVRYLGTAREDDSL 144 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IV~l~g~~~~~~~~ 144 (668)
|....-+++|+++.+++.+...+...+ .+.+... ....-++++|.+++||| .+..++-+..+...
T Consensus 244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~ 309 (829)
T KOG0576|consen 244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL 309 (829)
T ss_pred hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------------hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence 455566899999999999887766555 6665211 22345788999999999 88888888889999
Q ss_pred eEEeeccCCC-Chhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 145 NILLEFVPGG-SISSLL-GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 145 ~LVmEy~~gG-sL~~~L-~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.++++++.++ +-...+ ...-.+.+-+...+.+.-+.+++++|+.-=+|+| ||+... +..|..||+....+...
T Consensus 310 ~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 310 WIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred chhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc
Confidence 9999999887 222211 1112344555566777778899999988778999 887765 78999999988765433
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCc--ccCH-
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE--HLSM- 299 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~--~ls~- 299 (668)
. ...+..+|+.++|||++....+....|+|++|+--.+|.-|.+|-..... ....++.....+.+-. ..+.
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~---~~~~~g~~p~s~~L~~~~aw~~~ 458 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPA---VLPMIGNGPNSPMLTDKSAWSPV 458 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCcc---ccCCCCCCCCccccchhhhcCcc
Confidence 2 34567899999999999999999999999999988888888777543211 1111111110000000 0001
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.-.++...|+...|..|+....++.|.+|.+...
T Consensus 459 ~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl 492 (829)
T KOG0576|consen 459 FHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPL 492 (829)
T ss_pred cccCCcccccCCCCCCCcchhhHHHHHHhccCcc
Confidence 1125778899999999999999999999987543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.43 E-value=1.2e-06 Score=99.53 Aligned_cols=147 Identities=20% Similarity=0.252 Sum_probs=90.8
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccc--------------------------hhhHhhHHHHHH------HH
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANS--------------------------ASKEKTQAHIRE------LE 117 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~--------------------------~~~~~~~~~~~~------~~ 117 (668)
..|+.++-|+||+|+.. +|+.||||+....... ...+...+..+. +.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 57899999999999854 5999999998322110 001111111122 22
Q ss_pred HHHHHHHhC----C-CCCeeeecccc-ccCCcceEEeeccCCCChhccc--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005944 118 EEVKLLKNL----T-HPNIVRYLGTA-REDDSLNILLEFVPGGSISSLL--GKFGSFPESVIRMYTKQLLLGLEYLHKNG 189 (668)
Q Consensus 118 ~Ei~iL~~L----~-HpNIV~l~g~~-~~~~~~~LVmEy~~gGsL~~~L--~~~~~l~e~~~~~i~~QIl~aL~yLHs~g 189 (668)
.|..-+.++ + .++| .+-.+| +....-.|+|||++|-.+.+.. .. ..++...+...+.++. +..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 333333333 2 2322 222233 3345678999999999998874 33 4455333332222221 23333489
Q ss_pred cccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 190 IvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
++|.|.+|.||+++.+|.+.+.|||+...+.+
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999776543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.6e-06 Score=84.32 Aligned_cols=141 Identities=15% Similarity=0.205 Sum_probs=89.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHH------HHHHHHHHHhCC---CCCe
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRE------LEEEVKLLKNLT---HPNI 131 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~------~~~Ei~iL~~L~---HpNI 131 (668)
+...+|.+.+++-......|.+..- +|..+++|...... ...+..... ..+.+..+..+. -..+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~-----~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~ 100 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREEN-----RRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEP 100 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhh-----hhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccc
Confidence 4567788888888888777777643 67899999762111 111111111 122333233332 2222
Q ss_pred eeec-----cccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC
Q 005944 132 VRYL-----GTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG 206 (668)
Q Consensus 132 V~l~-----g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g 206 (668)
..++ -.+......+|||||++|..|.++.. +++ .+...|.++|..||..|++|+|.+|.|++++.+
T Consensus 101 ~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 101 ADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN- 171 (229)
T ss_pred ccceeeeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-
Confidence 2222 12233345678999999988877642 233 244567788999999999999999999999865
Q ss_pred ceEEecCCchh
Q 005944 207 CIKLADFGASK 217 (668)
Q Consensus 207 ~vKL~DFGlA~ 217 (668)
.++++||+..+
T Consensus 172 ~i~iID~~~k~ 182 (229)
T PF06176_consen 172 GIRIIDTQGKR 182 (229)
T ss_pred cEEEEECcccc
Confidence 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.1e-06 Score=84.08 Aligned_cols=137 Identities=24% Similarity=0.320 Sum_probs=78.4
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC--eeeecccc---ccCCc
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN--IVRYLGTA---REDDS 143 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IV~l~g~~---~~~~~ 143 (668)
.+.|+.|..+.||++.... ..+++|+... . .....+..|+.+++.+.... +.+++... .....
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~------~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~ 69 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRP------P----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGF 69 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESS------H----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCC------C----CCHHHHHHHHHHHHHHHhcCCCCceEEeeccccccccc
Confidence 4679999999999998644 5899998621 1 23345667888888775332 44555422 22334
Q ss_pred ceEEeeccCCCChhc----------------cc---ccC----CCCCHHH------HHHH---------------HHHHH
Q 005944 144 LNILLEFVPGGSISS----------------LL---GKF----GSFPESV------IRMY---------------TKQLL 179 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~----------------~L---~~~----~~l~e~~------~~~i---------------~~QIl 179 (668)
.+++|++++|..+.. .+ +.. ..+.... ...+ ...+.
T Consensus 70 ~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (239)
T PF01636_consen 70 PYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELE 149 (239)
T ss_dssp EEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHH
T ss_pred ceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHH
Confidence 789999999987776 11 111 0111000 0000 11122
Q ss_pred H-HHHHHHh-------CCcccccCCcccEEeC-CCCceEEecCCchh
Q 005944 180 L-GLEYLHK-------NGIMHRDIKGANILVD-NKGCIKLADFGASK 217 (668)
Q Consensus 180 ~-aL~yLHs-------~gIvHrDLKPeNILld-~~g~vKL~DFGlA~ 217 (668)
. .+..++. ..++|+|+.|.|||++ .++.+-|+||+.+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 150 ERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 2 3333332 3599999999999999 66777899999764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.35 E-value=3e-06 Score=101.57 Aligned_cols=207 Identities=27% Similarity=0.365 Sum_probs=151.9
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeccccccCCc----ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Q 005944 111 AHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS----LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186 (668)
Q Consensus 111 ~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~----~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLH 186 (668)
..+....-|...+..+.|+|++.++.|...... ..+..++|..-++...+...+.++...++.+..+++.||.|+|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 344455667888889999999999888655433 3456789999999999999999999999999999999999999
Q ss_pred hCCcccccCCcc---cEEeCCCCceEEe--cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcc--hhHHHHHH
Q 005944 187 KNGIMHRDIKGA---NILVDNKGCIKLA--DFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFS--ADIWSVGC 259 (668)
Q Consensus 187 s~gIvHrDLKPe---NILld~~g~vKL~--DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~k--sDIWSLGv 259 (668)
+....|.-|... +.-++..+.+.++ ||+..+.+.... ......-+..|.|+|......+..+ .|+|.+|.
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~---~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNE---KSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcc---cchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 997666666555 5555667777777 898877553322 1223344667888998877666554 69999999
Q ss_pred HHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 260 TVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 260 ILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
++..+..|..+-... ..... -++.....+..+++.+|+.-++++|+++.+++.|+|.....
T Consensus 381 l~~~~~~~~~i~~~~-~~~~~-----------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS-AVPVS-----------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred HHhhhhhcCcccccc-cchhh-----------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 999999876542110 00000 01111122678899999999999999999999999986543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=3.9e-06 Score=85.88 Aligned_cols=133 Identities=14% Similarity=0.174 Sum_probs=79.5
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC--eeeeccccccCCcceEE
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN--IVRYLGTAREDDSLNIL 147 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IV~l~g~~~~~~~~~LV 147 (668)
.+||+|..+.||+. .+..+++|...... ....+.+|.++++.+..-. +.+.+++....+...+|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~----------~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv 72 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF----------DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLI 72 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC----------CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeee
Confidence 57899999999984 24567888762111 1123467888888885433 35566666667778899
Q ss_pred eeccCCCC-hhccc---------------------ccC--CCCCHHHH-HHHHHH----------HHH-HHHHHHh----
Q 005944 148 LEFVPGGS-ISSLL---------------------GKF--GSFPESVI-RMYTKQ----------LLL-GLEYLHK---- 187 (668)
Q Consensus 148 mEy~~gGs-L~~~L---------------------~~~--~~l~e~~~-~~i~~Q----------Il~-aL~yLHs---- 187 (668)
||+++|.+ +...+ +.. ...+.... ..+..+ +.. ...+|..
T Consensus 73 ~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~ 152 (226)
T TIGR02172 73 YELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDT 152 (226)
T ss_pred eeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCC
Confidence 99999963 11111 110 01111100 011000 111 1222221
Q ss_pred CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 188 NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 188 ~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
..++|+|+.|.||+++.++ +.|+||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 2478999999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.05 E-value=1.8e-05 Score=80.93 Aligned_cols=134 Identities=21% Similarity=0.150 Sum_probs=79.5
Q ss_pred EEcccCc-eEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCCcceEEe
Q 005944 71 LVGCGAF-GRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDDSLNILL 148 (668)
Q Consensus 71 ~LG~G~f-G~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~~~~LVm 148 (668)
.|-.|.. +.||++.. .+..+.||+.... . ...+..|+++++.+. +--+.+++++....+..++||
T Consensus 5 ~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~------~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 71 (244)
T cd05150 5 RVTEGQSGATVYRLDG--KNPGLYLKIAPSG------P-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLT 71 (244)
T ss_pred ecCCCCCcCeEEEEcC--CCCcEEEEecCCC------c-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEE
Confidence 3445555 78999864 3467888875211 0 123556888888774 333556777766666789999
Q ss_pred eccCCCChhcccc-------------------cCC----CCCHH---HHHHH---HH----------------HHHHHHH
Q 005944 149 EFVPGGSISSLLG-------------------KFG----SFPES---VIRMY---TK----------------QLLLGLE 183 (668)
Q Consensus 149 Ey~~gGsL~~~L~-------------------~~~----~l~e~---~~~~i---~~----------------QIl~aL~ 183 (668)
|+++|..|..... ... .+... ..... +. .+...+.
T Consensus 72 e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (244)
T cd05150 72 SAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYA 151 (244)
T ss_pred EeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHH
Confidence 9999987764321 000 01100 00000 00 0111112
Q ss_pred HH-------HhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 184 YL-------HKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 184 yL-------Hs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.| ....++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 152 ~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 152 ELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred HHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 22 12348999999999999998888999999764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=2.1e-05 Score=89.52 Aligned_cols=148 Identities=21% Similarity=0.184 Sum_probs=87.9
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccch-----------------------hhHhhHHHHHH------HHHHH
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSA-----------------------SKEKTQAHIRE------LEEEV 120 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~-----------------------~~~~~~~~~~~------~~~Ei 120 (668)
+.||.-+.|+||+|+.+. |+.||||+-....... -.....+..+. |.+|.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 579999999999998654 9999999863221100 00000111111 22222
Q ss_pred H----HHHhCCCCC---eeeeccccc-cCCcceEEeeccCCCChhcc--cccCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 005944 121 K----LLKNLTHPN---IVRYLGTAR-EDDSLNILLEFVPGGSISSL--LGKFGSFPESVIRMYTKQLLLGLEYLHKNGI 190 (668)
Q Consensus 121 ~----iL~~L~HpN---IV~l~g~~~-~~~~~~LVmEy~~gGsL~~~--L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gI 190 (668)
+ +.+.+.|-+ -|.+-.+|. ......|+||||+|..+.++ |.+ ..++...+...+.++..- .|=..|+
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~~~l~~~~~~--qIf~~Gf 322 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK-RGISPHDILNKLVEAYLE--QIFKTGF 322 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH-cCCCHHHHHHHHHHHHHH--HHHhcCC
Confidence 2 333334544 122222222 23457899999999988775 333 345544444333333222 2334589
Q ss_pred ccccCCcccEEeC----CCCceEEecCCchhhhHh
Q 005944 191 MHRDIKGANILVD----NKGCIKLADFGASKKVVE 221 (668)
Q Consensus 191 vHrDLKPeNILld----~~g~vKL~DFGlA~~~~~ 221 (668)
+|+|=+|.||+|. .++.+.+-|||+...+..
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 9999999999998 367899999999875543
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.97 E-value=6.7e-05 Score=75.64 Aligned_cols=135 Identities=24% Similarity=0.275 Sum_probs=91.7
Q ss_pred CCCCeeeeeEEcccCc-eEEEEEEEcCCCcEEEEEEeee---cccchh--hH--------hhHHHHHHHHHHHHHHHhCC
Q 005944 62 PPIRWRKGELVGCGAF-GRVYMGMNLDSGELLAVKQVLI---AANSAS--KE--------KTQAHIRELEEEVKLLKNLT 127 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~f-G~Vy~a~~~~tg~~VAVK~i~~---~~~~~~--~~--------~~~~~~~~~~~Ei~iL~~L~ 127 (668)
...+++..+.||.|.- |.||++.. .|..||||++.. ...... .. .......-|..|.+...+|+
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk 112 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK 112 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence 3478999999999999 99999976 688999999421 111000 00 00123445778888777774
Q ss_pred ---CCCe--eeeccccccC------------------CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHH
Q 005944 128 ---HPNI--VRYLGTARED------------------DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184 (668)
Q Consensus 128 ---HpNI--V~l~g~~~~~------------------~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~y 184 (668)
+.++ |+.+||..-. ....||.||++... .+. ..-+.+|++-|..
T Consensus 113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHH
Confidence 4455 8888876322 11346777765533 222 2335678888999
Q ss_pred HHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 185 LHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+|..||+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc-----CCEEEecccC
Confidence 99999999999999986 2378999864
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.96 E-value=5e-06 Score=101.31 Aligned_cols=215 Identities=13% Similarity=-0.018 Sum_probs=152.5
Q ss_pred HHHHHHHHHHHHHHhCCCCCeeeeccccc--cCCcceEEeeccCCCChhcccccC----CCCCHHHHHHHHHHHHHHHHH
Q 005944 111 AHIRELEEEVKLLKNLTHPNIVRYLGTAR--EDDSLNILLEFVPGGSISSLLGKF----GSFPESVIRMYTKQLLLGLEY 184 (668)
Q Consensus 111 ~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~--~~~~~~LVmEy~~gGsL~~~L~~~----~~l~e~~~~~i~~QIl~aL~y 184 (668)
...+....|...++...|++++..+.-.. +....|++++||.+|.+++.|.+. ..+.+..+.....+.+.+..-
T Consensus 1271 Plkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~ 1350 (2724)
T KOG1826|consen 1271 PLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNV 1350 (2724)
T ss_pred HHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccch
Confidence 34455566777777789999887665443 345678999999999999988553 334555555555565888888
Q ss_pred HHhC-----CcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHH
Q 005944 185 LHKN-----GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGC 259 (668)
Q Consensus 185 LHs~-----gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGv 259 (668)
+|.. -.+|++||+-|.+|..+..+|++++|+.+...... .......+++.|++|++...-.++.++|+|..|+
T Consensus 1351 ~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~ 1428 (2724)
T KOG1826|consen 1351 ILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSL 1428 (2724)
T ss_pred hhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHH
Confidence 7765 27999999999999999999999999998332221 2233467889999999999999999999999999
Q ss_pred HHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 260 TVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 260 ILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
.+|.+.-|..+|-...+....-... ......++...+.++..+...+|-+.-..||.-..++.-+.|.
T Consensus 1429 ~ly~rs~~n~~fi~flq~~Lkgiid--n~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1429 SLYLRSDGNAYFIFFLQPALKGIID--NHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHHhcccHHHHHHHHHHHcCccc--ccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9999999988885544332221111 1122223333344445555555656666789888888887765
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.93 E-value=4.5e-05 Score=77.89 Aligned_cols=29 Identities=28% Similarity=0.408 Sum_probs=25.4
Q ss_pred CcccccCCcccEEeCCCCceEEecCCchh
Q 005944 189 GIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 189 gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
+++|+|+.|.|||++.++..-|+||+.+.
T Consensus 165 ~l~HGD~~~~Nvlv~~~~i~giIDw~~a~ 193 (235)
T cd05155 165 VWFHGDLAPGNLLVQDGRLSAVIDFGCLG 193 (235)
T ss_pred eEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence 58999999999999877666799999765
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.93 E-value=6.6e-05 Score=90.59 Aligned_cols=81 Identities=12% Similarity=0.211 Sum_probs=54.1
Q ss_pred eeEEcccCceEEEEEEEcCCC--cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCe--eeeccccccC--
Q 005944 69 GELVGCGAFGRVYMGMNLDSG--ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNI--VRYLGTARED-- 141 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg--~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNI--V~l~g~~~~~-- 141 (668)
.+.|+.|.+..+|+......+ ..+++|+..... . ......+.+|+++|+.+. |.+| .+++.++.+.
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~----~---~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v 115 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGK----L---LQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASV 115 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCc----c---CccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCc
Confidence 467899999999998764432 467777642110 0 011234678999999995 6654 6677766553
Q ss_pred -CcceEEeeccCCCCh
Q 005944 142 -DSLNILLEFVPGGSI 156 (668)
Q Consensus 142 -~~~~LVmEy~~gGsL 156 (668)
+..|+||||++|..+
T Consensus 116 ~G~~flVME~v~G~~~ 131 (822)
T PLN02876 116 IGTAFYIMEYLEGRIF 131 (822)
T ss_pred CCCceEEEEecCCccc
Confidence 467899999998654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00015 Score=72.28 Aligned_cols=100 Identities=26% Similarity=0.234 Sum_probs=81.9
Q ss_pred HHHHHHHHhCCC-CCeeeeccccccCCcceEEeeccCCCChhc---ccccCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 005944 117 EEEVKLLKNLTH-PNIVRYLGTAREDDSLNILLEFVPGGSISS---LLGKFGSFPESVIRMYTKQLLLGLEYLHK---NG 189 (668)
Q Consensus 117 ~~Ei~iL~~L~H-pNIV~l~g~~~~~~~~~LVmEy~~gGsL~~---~L~~~~~l~e~~~~~i~~QIl~aL~yLHs---~g 189 (668)
..|.-+|+.+.+ +++.+++|+|- .++|.||+..+.+.. .+......++....+|+.+++..+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 69999999984 378999998776653 22333456899999999999999999997 35
Q ss_pred cccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 190 IMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 190 IvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
+.-.|++|+||-|+.+|.+|++|...+....
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence 8889999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00015 Score=73.02 Aligned_cols=136 Identities=21% Similarity=0.342 Sum_probs=91.0
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccch--------hhHhhHHHHHHHHHHHHHHHhCC------CCCeeee
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSA--------SKEKTQAHIRELEEEVKLLKNLT------HPNIVRY 134 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~--------~~~~~~~~~~~~~~Ei~iL~~L~------HpNIV~l 134 (668)
..+||+|+.=.||.- .......||++....... .........+...+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 457999999999963 345567899885433000 00000112344555666555554 7889999
Q ss_pred ccccccCCcceEEeeccCCC------ChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC--
Q 005944 135 LGTAREDDSLNILLEFVPGG------SISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-- 206 (668)
Q Consensus 135 ~g~~~~~~~~~LVmEy~~gG------sL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-- 206 (668)
+|+.+++....+|+|.+... +|.+++.+ +.+++ .+...+-.-..||-.++|+.+||+|.||++...+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 99999999999999987432 56777744 44555 3344445566788899999999999999995432
Q ss_pred --ceEEec
Q 005944 207 --CIKLAD 212 (668)
Q Consensus 207 --~vKL~D 212 (668)
.+.|+|
T Consensus 158 ~~~lvlID 165 (199)
T PF10707_consen 158 EFRLVLID 165 (199)
T ss_pred ceEEEEEe
Confidence 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.78 E-value=6.6e-05 Score=74.00 Aligned_cols=134 Identities=21% Similarity=0.204 Sum_probs=94.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeee-eccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVR-YLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~-l~g~~~ 139 (668)
......++.+.||+|.+|.||++.+ .|..+|+|+-. .+.....+..|+++|..+.-.++-. +|.+..
T Consensus 19 ~~~~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr----------~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~ 86 (201)
T COG2112 19 EGKYELRVEKELAKGTTSVVYLGEW--RGGEVALKVRR----------RDSPRRNLEKEAKILEILAGEGVTPEVYFYGE 86 (201)
T ss_pred ccchhhhhhhhhhcccccEEEEeec--cCceEEEEEec----------CCcchhhHHHHHHHHHHhhhcCCCceEEEech
Confidence 3344556778899999999999987 56699999752 1123355788999999987766643 444432
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC-cccEEeCCCCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIK-GANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLK-PeNILld~~g~vKL~DFGlA~ 217 (668)
.++.|||+.|-.|.++-... . ++-+..++..-.-|-..||-|..|. |..++|..++.+.|+||.-|+
T Consensus 87 ----~~i~me~i~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 87 ----DFIRMEYIDGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred ----hhhhhhhhcCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 34569999998887665321 1 2334456666666788899999997 444555555699999999887
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00036 Score=70.76 Aligned_cols=75 Identities=17% Similarity=0.241 Sum_probs=45.8
Q ss_pred eeEEcccCceEEEEEEEcC-CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCe-eeeccccccCCcceE
Q 005944 69 GELVGCGAFGRVYMGMNLD-SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI-VRYLGTAREDDSLNI 146 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~-tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-V~l~g~~~~~~~~~L 146 (668)
.+.|..|-...||++.... .+..|++|+..... .......+|+.++..+...++ .++++... -.+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~---------~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~ 69 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKT---------ELIIDRERELRIHKLLSKHGLAPKLYATFQ----NGL 69 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCc---------cceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcE
Confidence 3567888888999986433 35788899762110 011122467888888754333 34444332 248
Q ss_pred EeeccCCCCh
Q 005944 147 LLEFVPGGSI 156 (668)
Q Consensus 147 VmEy~~gGsL 156 (668)
||||++|.++
T Consensus 70 l~e~i~G~~l 79 (235)
T cd05157 70 IYEFIPGRTL 79 (235)
T ss_pred EEEeeCCCcC
Confidence 9999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00021 Score=73.90 Aligned_cols=133 Identities=18% Similarity=0.202 Sum_probs=74.3
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCe-eeeccccccCCcceEEee
Q 005944 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI-VRYLGTAREDDSLNILLE 149 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-V~l~g~~~~~~~~~LVmE 149 (668)
.+..|-...+|+.. .++..+++|+..... ........+|..+++.+....+ .+++.... -++|||
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~--------~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e 68 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVC--------KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVE 68 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCccc--------ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEE
Confidence 35567778899886 356788888642110 0000123567888888754333 23333322 379999
Q ss_pred ccCCCChhcc-----------------cccCC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------CCc
Q 005944 150 FVPGGSISSL-----------------LGKFG----SFPE-SVIRMYTKQL---------LLGLEYLHK--------NGI 190 (668)
Q Consensus 150 y~~gGsL~~~-----------------L~~~~----~l~e-~~~~~i~~QI---------l~aL~yLHs--------~gI 190 (668)
|++|..+... |+... +++. ..+..+..++ ...+..+-. ..+
T Consensus 69 ~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 148 (256)
T TIGR02721 69 WLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAP 148 (256)
T ss_pred eccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCee
Confidence 9998766421 01110 1111 1112222111 111222211 258
Q ss_pred ccccCCcccEEeCCCCceEEecCCchhh
Q 005944 191 MHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 191 vHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
+|+|+.|.|||++.++ +.|+||..|..
T Consensus 149 ~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 149 LHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred ecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 9999999999999877 78999997753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00079 Score=71.78 Aligned_cols=78 Identities=14% Similarity=0.073 Sum_probs=52.4
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC---CCeeeecccccc---
Q 005944 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH---PNIVRYLGTARE--- 140 (668)
Q Consensus 67 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H---pNIV~l~g~~~~--- 140 (668)
.-.+.||.|..+.||..... ++ .+.+|..+. . .....+..|...|+.|.. -.|.++++++..
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~--------~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~ 84 (297)
T PRK10593 17 SRVECISEQPYAALWALYDS-QG-NPMPLMARS--------F--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQS 84 (297)
T ss_pred heeeecCCccceeEEEEEcC-CC-CEEEEEecc--------c--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCc
Confidence 34567999999999998642 23 567776421 0 011356788888888743 346667766543
Q ss_pred CCcceEEeeccCCCCh
Q 005944 141 DDSLNILLEFVPGGSI 156 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL 156 (668)
.+..+||||+++|+++
T Consensus 85 ~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 85 PGPDVLLLERLRGVSV 100 (297)
T ss_pred CCCeEEEEeccCCEec
Confidence 4668999999998765
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0011 Score=72.03 Aligned_cols=145 Identities=19% Similarity=0.163 Sum_probs=98.1
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccch------------------hhHhhHHHHHHHHHHHHHHHhCCCCC
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSA------------------SKEKTQAHIRELEEEVKLLKNLTHPN 130 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~------------------~~~~~~~~~~~~~~Ei~iL~~L~HpN 130 (668)
..-|..|.-+.||.|+ ..+|..+|||+++..-... .........-....|++-|.+|+...
T Consensus 149 nGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 149 NGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred ccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 3457788889999997 4578889999985432110 01111122233566888888886555
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCcccEEeCCCCceE
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH-KNGIMHRDIKGANILVDNKGCIK 209 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLH-s~gIvHrDLKPeNILld~~g~vK 209 (668)
|..---+.. ....|||+|+.+.....-.-+...++...+..+-.|++..+.-|- ..++||.||.--|+|+. +|.+.
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ly 304 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKLY 304 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEEE
Confidence 432111111 235799999965444433344457888889999999999888874 56999999999999994 68999
Q ss_pred EecCCchh
Q 005944 210 LADFGASK 217 (668)
Q Consensus 210 L~DFGlA~ 217 (668)
|+|.+-+.
T Consensus 305 iIDVSQSV 312 (520)
T KOG2270|consen 305 IIDVSQSV 312 (520)
T ss_pred EEEccccc
Confidence 99998653
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00087 Score=70.48 Aligned_cols=136 Identities=19% Similarity=0.190 Sum_probs=79.8
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC--eeeeccc------ccc
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN--IVRYLGT------ARE 140 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IV~l~g~------~~~ 140 (668)
.+.|..|....+|++.. ++..+++|+... .. ...+..|+.++..+.+.+ +.+++.. ...
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~--------~~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~ 85 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEK--------VS---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSEL 85 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCC--------CC---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeee
Confidence 45677888889999864 345788897621 01 123455777777774332 4444332 122
Q ss_pred CCcceEEeeccCCCChhcc----c----------ccC-CCCC------------HHHHH--------HHHHHHHHHHHHH
Q 005944 141 DDSLNILLEFVPGGSISSL----L----------GKF-GSFP------------ESVIR--------MYTKQLLLGLEYL 185 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~----L----------~~~-~~l~------------e~~~~--------~i~~QIl~aL~yL 185 (668)
.+..++|++|++|..+... + +.. ..+. ..... .....+..++.++
T Consensus 86 ~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l 165 (296)
T cd05153 86 AGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQ 165 (296)
T ss_pred CCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHH
Confidence 3557899999998765420 0 000 0000 00000 0111123344444
Q ss_pred Hh-------CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 186 HK-------NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 186 Hs-------~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.. .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 166 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 166 DAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 43 379999999999999988778999999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00027 Score=75.62 Aligned_cols=139 Identities=18% Similarity=0.235 Sum_probs=96.7
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhh--------------HhhHHHHHHHHHHHHHHHhCC-CCC
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASK--------------EKTQAHIRELEEEVKLLKNLT-HPN 130 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~--------------~~~~~~~~~~~~Ei~iL~~L~-HpN 130 (668)
+.+++.||-|.-+.||.+-+ ..|.+.++|.=......... .+..-..-...+|+..|+.|. |-.
T Consensus 94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 66789999999999999976 45888998853211111000 011111223456888888885 332
Q ss_pred -eeeeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceE
Q 005944 131 -IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIK 209 (668)
Q Consensus 131 -IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vK 209 (668)
|.+.++ ....++|||++.|-.|..+-+- ..+..+...+..-|.-|-.+|+||+|..--||||+.++.++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 333333 3557899999999888765422 22445666777778889999999999999999999999999
Q ss_pred EecCCc
Q 005944 210 LADFGA 215 (668)
Q Consensus 210 L~DFGl 215 (668)
++||--
T Consensus 243 vIDFPQ 248 (465)
T KOG2268|consen 243 VIDFPQ 248 (465)
T ss_pred EeechH
Confidence 999963
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0022 Score=71.20 Aligned_cols=82 Identities=16% Similarity=0.158 Sum_probs=51.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC---CCCeeeeccccccCCcceE
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT---HPNIVRYLGTAREDDSLNI 146 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIV~l~g~~~~~~~~~L 146 (668)
+.||.|.+..||++.....++.|+||.-........ ..-+........|.+.|+.+. ..++.+++.+ +.+..++
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g-~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVG-ESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCccccccc-ccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 578999999999999764446899997421100000 000112334556777777752 3456777766 3355789
Q ss_pred EeeccCCC
Q 005944 147 LLEFVPGG 154 (668)
Q Consensus 147 VmEy~~gG 154 (668)
||||+++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99999864
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0011 Score=70.44 Aligned_cols=137 Identities=20% Similarity=0.208 Sum_probs=77.1
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC--eeeecccc------cc
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN--IVRYLGTA------RE 140 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IV~l~g~~------~~ 140 (668)
.+.|+.|-...||++.. .+| .+++|+..... .. ..+..|+.++..|.... |.+++... ..
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-------~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-------KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCC-------CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 45677777789998863 334 67788762210 01 12334566666663222 33433321 22
Q ss_pred CCcceEEeeccCCCChhcc--------------cccC-CCC--------CHHHHH---------------HHHHHHHHHH
Q 005944 141 DDSLNILLEFVPGGSISSL--------------LGKF-GSF--------PESVIR---------------MYTKQLLLGL 182 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~--------------L~~~-~~l--------~e~~~~---------------~i~~QIl~aL 182 (668)
.+..++|++|++|..+... ++.. ..+ ...... .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 3567899999998654211 0100 011 000000 0111233345
Q ss_pred HHHHh-------CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 183 EYLHK-------NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 183 ~yLHs-------~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
+++.. .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 55532 589999999999999988877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0019 Score=68.91 Aligned_cols=30 Identities=23% Similarity=0.389 Sum_probs=26.1
Q ss_pred CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 188 NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 188 ~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.++||+|++|.|||++.+...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 389999999999999976666899999764
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0016 Score=68.76 Aligned_cols=29 Identities=31% Similarity=0.402 Sum_probs=26.1
Q ss_pred CcccccCCcccEEeCCC----CceEEecCCchh
Q 005944 189 GIMHRDIKGANILVDNK----GCIKLADFGASK 217 (668)
Q Consensus 189 gIvHrDLKPeNILld~~----g~vKL~DFGlA~ 217 (668)
.++|+|+.|.|||++.+ +.+.|+||..|.
T Consensus 180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 58999999999999985 889999999774
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0084 Score=63.31 Aligned_cols=30 Identities=27% Similarity=0.458 Sum_probs=25.1
Q ss_pred CcccccCCcccEEeCCCCc-eEEecCCchhh
Q 005944 189 GIMHRDIKGANILVDNKGC-IKLADFGASKK 218 (668)
Q Consensus 189 gIvHrDLKPeNILld~~g~-vKL~DFGlA~~ 218 (668)
.++|+|++|.|||++.++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999998763
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.027 Score=60.85 Aligned_cols=30 Identities=17% Similarity=0.303 Sum_probs=27.6
Q ss_pred CcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 189 GIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 189 gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.++|+|+++.||+|+..+-+=|+||+++..
T Consensus 199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 489999999999999998899999999864
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.012 Score=64.01 Aligned_cols=135 Identities=16% Similarity=0.218 Sum_probs=76.2
Q ss_pred eEEcccCceEEEEEEEcC----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCe-eeeccccccCCcc
Q 005944 70 ELVGCGAFGRVYMGMNLD----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI-VRYLGTAREDDSL 144 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-V~l~g~~~~~~~~ 144 (668)
+.|-.|-.-.+|++.... .+..|++|+.-... ...+. -.+|+.+++.+...++ .++++.+..
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--------~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~---- 108 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--------ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN---- 108 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--------Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC----
Confidence 345557788999986432 24688899762211 11111 2467888888754443 344555432
Q ss_pred eEEeeccCCCChhcc-----------------cccCC------CCCHHHHHHHHHHH-----------------HHHHHH
Q 005944 145 NILLEFVPGGSISSL-----------------LGKFG------SFPESVIRMYTKQL-----------------LLGLEY 184 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~-----------------L~~~~------~l~e~~~~~i~~QI-----------------l~aL~y 184 (668)
..|.+|+++.+|... ++... ......+..++.++ ...+..
T Consensus 109 g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~ 188 (344)
T PLN02236 109 GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINL 188 (344)
T ss_pred ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHH
Confidence 268999987665421 01100 01122233332221 111111
Q ss_pred H----H----hCCcccccCCcccEEeCC-CCceEEecCCchh
Q 005944 185 L----H----KNGIMHRDIKGANILVDN-KGCIKLADFGASK 217 (668)
Q Consensus 185 L----H----s~gIvHrDLKPeNILld~-~g~vKL~DFGlA~ 217 (668)
| . ...++|+|+++.|||++. ++.+.|+||..+.
T Consensus 189 L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 189 LEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred HHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 1 235899999999999986 4789999998775
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.064 Score=59.85 Aligned_cols=80 Identities=16% Similarity=0.110 Sum_probs=48.0
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC---CCCeeeeccccccCCcce
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT---HPNIVRYLGTAREDDSLN 145 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIV~l~g~~~~~~~~~ 145 (668)
.+.||.|.-..||++.+ .+..|+||.-......... ..+........|...|+.+. ..++.+++.++. +..+
T Consensus 37 ~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga-~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGE-SWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred EEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCc-cccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 56789999999999886 3456889975311110000 00001222233456665553 346777877766 4568
Q ss_pred EEeeccCC
Q 005944 146 ILLEFVPG 153 (668)
Q Consensus 146 LVmEy~~g 153 (668)
++|||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999977
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.067 Score=57.07 Aligned_cols=29 Identities=14% Similarity=0.206 Sum_probs=26.9
Q ss_pred CcccccCCcccEEeCCCCceEEecCCchh
Q 005944 189 GIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 189 gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
+++|+|+.+.|||++.++.+.|+||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999998765
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.02 Score=64.76 Aligned_cols=166 Identities=24% Similarity=0.334 Sum_probs=100.5
Q ss_pred HHHHHHHHHhCCCCCeeeeccccccC-CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 005944 116 LEEEVKLLKNLTHPNIVRYLGTARED-DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRD 194 (668)
Q Consensus 116 ~~~Ei~iL~~L~HpNIV~l~g~~~~~-~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrD 194 (668)
+.-...+++.+.|+|...++++-... ....+|||++ +.+|.+++..+. +-... ++ .+|+.|-
T Consensus 29 ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s-------~~-------~~~~~~~- 91 (725)
T KOG1093|consen 29 ILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDES-------LL-------AHGVLHL- 91 (725)
T ss_pred HhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhh-------hc-------cccccee-
Confidence 44567789999999999998877654 3477889999 458888876532 21111 11 1222221
Q ss_pred CCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchh
Q 005944 195 IKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ 274 (668)
Q Consensus 195 LKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~ 274 (668)
+.++++| .++. .. .+..| .++|||++|.++.++.-|...|...
T Consensus 92 -----------~~~~~td-~~~t-------~~--~~~~~----------------pKsdVwsl~~i~~el~L~~~l~~~~ 134 (725)
T KOG1093|consen 92 -----------NIIYITD-HFLT-------KY--PSPIG----------------PKSDVWSLGFIILELYLGISLEAEL 134 (725)
T ss_pred -----------hhhhccc-cccc-------cC--CCCCC----------------cchhhhhHHHHHHHHHHhhHHHHHH
Confidence 2233344 1111 00 11111 3999999999999999998776543
Q ss_pred HH--HHHHHHhhccCCCCC-------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCCCC
Q 005944 275 FQ--EVAALFHIGTTKSHP-------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335 (668)
Q Consensus 275 ~~--~~~~~~~~~~~~~~~-------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~~~ 335 (668)
.. ....+.......... .+.-.++....++..+|+-..|..||...++++++-|...+..+
T Consensus 135 ~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~~~ 204 (725)
T KOG1093|consen 135 TESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYKDL 204 (725)
T ss_pred HHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHhhh
Confidence 21 111111111110000 01123455667889999999999999999999999998765543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.036 Score=59.95 Aligned_cols=28 Identities=21% Similarity=0.516 Sum_probs=24.8
Q ss_pred cccccCCcccEEeCC-CCceEEecCCchh
Q 005944 190 IMHRDIKGANILVDN-KGCIKLADFGASK 217 (668)
Q Consensus 190 IvHrDLKPeNILld~-~g~vKL~DFGlA~ 217 (668)
++|.||.+.|||++. ++.++++||..|.
T Consensus 184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 799999999999975 5789999999764
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.049 Score=59.83 Aligned_cols=80 Identities=18% Similarity=0.141 Sum_probs=46.4
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC--CC-CeeeeccccccCCcceEE
Q 005944 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT--HP-NIVRYLGTAREDDSLNIL 147 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--Hp-NIV~l~g~~~~~~~~~LV 147 (668)
-||-|.-..||++.....++.|+||.-..-..... ...+....+..-|...|+... -| .+.++|.+ +.....+|
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g-~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVG-ESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcC-CCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 36899999999999754446899997531111000 011122233445677776653 23 45555443 34456699
Q ss_pred eeccCC
Q 005944 148 LEFVPG 153 (668)
Q Consensus 148 mEy~~g 153 (668)
||+++.
T Consensus 79 MEdL~~ 84 (370)
T TIGR01767 79 MEDLSH 84 (370)
T ss_pred HhhCcc
Confidence 999854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.58 E-value=0.049 Score=60.50 Aligned_cols=81 Identities=14% Similarity=0.081 Sum_probs=49.7
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC--CC-CeeeeccccccCCcce
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT--HP-NIVRYLGTAREDDSLN 145 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--Hp-NIV~l~g~~~~~~~~~ 145 (668)
.+.||-|.-..||++.+...+..|+||.-..-.... ..-+-...+..-|..+|+.+. -| ++.++|.+ +.....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~--~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARIS--DEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccC--CCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhh
Confidence 467899999999999874446789999753222111 111222344455777777653 23 45556544 445567
Q ss_pred EEeeccCC
Q 005944 146 ILLEFVPG 153 (668)
Q Consensus 146 LVmEy~~g 153 (668)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 89999854
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.12 E-value=0.11 Score=55.46 Aligned_cols=75 Identities=25% Similarity=0.207 Sum_probs=45.2
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC---CCCeeeeccccccCCc
Q 005944 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT---HPNIVRYLGTAREDDS 143 (668)
Q Consensus 67 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIV~l~g~~~~~~~ 143 (668)
+..+.|+.|....+|+.. .++..+.||+-.. .....+..|..-|+.|. --.+.+++++....+.
T Consensus 20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~-----------~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~ 86 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE-----------SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD 86 (288)
T ss_dssp -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG-----------GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC
T ss_pred eeeEecCCCChhheEEEE--CCCccEEEEecCh-----------hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC
Confidence 345678999999999986 6788999997621 11134566777777773 3456778888777777
Q ss_pred ceEEeeccCCC
Q 005944 144 LNILLEFVPGG 154 (668)
Q Consensus 144 ~~LVmEy~~gG 154 (668)
.+|||||++.+
T Consensus 87 ~fLlle~l~~~ 97 (288)
T PF03881_consen 87 AFLLLEFLEMG 97 (288)
T ss_dssp CEEEEE-----
T ss_pred ceEEEEeecCC
Confidence 79999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=94.80 E-value=0.26 Score=51.84 Aligned_cols=28 Identities=32% Similarity=0.483 Sum_probs=24.0
Q ss_pred cccccCCcccEEeCCC--C---ceEEecCCchh
Q 005944 190 IMHRDIKGANILVDNK--G---CIKLADFGASK 217 (668)
Q Consensus 190 IvHrDLKPeNILld~~--g---~vKL~DFGlA~ 217 (668)
++|||+++.|||+..+ | .++++||-+++
T Consensus 217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~ 249 (294)
T PF02958_consen 217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR 249 (294)
T ss_pred EEcCccCHHhEeEccccccccccceeecccccc
Confidence 8999999999999655 3 58999998765
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.65 E-value=0.061 Score=58.85 Aligned_cols=72 Identities=25% Similarity=0.259 Sum_probs=55.9
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
..+.|++|++. |+.|.- + ..-..+++..|+.+.+..+.-+..+ .+=||||.-.||||+ +|+|.|+||-+++.
T Consensus 298 ~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 34566777776 444432 2 2235678889999998888888765 789999999999999 99999999999983
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.17 E-value=0.3 Score=54.23 Aligned_cols=84 Identities=18% Similarity=0.243 Sum_probs=46.0
Q ss_pred CeeeeeEEcccCceEEEEEEEcCC-CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCe-eeeccccccCC
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDS-GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI-VRYLGTAREDD 142 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~t-g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-V~l~g~~~~~~ 142 (668)
...+. .|..|-...+|++..... +..+.+|.+....... .. ...-.-.+|+.+++.+...++ .++++.+..
T Consensus 52 ~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~---~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~-- 124 (383)
T PTZ00384 52 FIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST---YN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD-- 124 (383)
T ss_pred cEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccC---CC-ceEeccHHHHHHHHHHHhCCCCCeEEEecCC--
Confidence 34444 555588889999975432 2233333221111000 00 111122468888888865544 456666542
Q ss_pred cceEEeeccCCCChh
Q 005944 143 SLNILLEFVPGGSIS 157 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~ 157 (668)
++|.||++|..|.
T Consensus 125 --g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 --FTIQEWVEGNTMG 137 (383)
T ss_pred --EEEEEEeccccCC
Confidence 6999999987664
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.3 Score=60.77 Aligned_cols=31 Identities=39% Similarity=0.608 Sum_probs=26.0
Q ss_pred CCcccccCCcccEEeCCCC--ceE-EecCCchhh
Q 005944 188 NGIMHRDIKGANILVDNKG--CIK-LADFGASKK 218 (668)
Q Consensus 188 ~gIvHrDLKPeNILld~~g--~vK-L~DFGlA~~ 218 (668)
.++||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 555 999997653
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.53 E-value=0.15 Score=56.75 Aligned_cols=60 Identities=20% Similarity=0.278 Sum_probs=44.5
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCcccEEeCC
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH-KNGIMHRDIKGANILVDN 204 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLH-s~gIvHrDLKPeNILld~ 204 (668)
..||-+|..|-.+..++.. ...+|+..++++.-.+.||-.+- -.+++|.|++|.||++.-
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred ceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 4566678888888887755 34566677777776677766554 458999999999999953
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.17 E-value=0.22 Score=51.30 Aligned_cols=85 Identities=19% Similarity=0.228 Sum_probs=58.3
Q ss_pred HHHHHHHHHHHhCCCCCeeeeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC--Ccc
Q 005944 114 RELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN--GIM 191 (668)
Q Consensus 114 ~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~--gIv 191 (668)
..+.++.+++.+++ .|++|..- ....+.+++|+|-.... . ...++..=+.+|.-.|+. +.+
T Consensus 103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~----~~N~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------N----FSNFITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------c----hhHHHHHhHHHHHHhhccCCCee
Confidence 34567788888763 57777632 44567799999943111 1 111222224667778843 799
Q ss_pred cccCCcccEEeCCCCceEEecCCc
Q 005944 192 HRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 192 HrDLKPeNILld~~g~vKL~DFGl 215 (668)
|+|..|+|||-|..|.+||.|=+.
T Consensus 166 HGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred cCCCChhheeecCCCCEEecChhh
Confidence 999999999999999999999764
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.97 E-value=0.61 Score=50.37 Aligned_cols=28 Identities=21% Similarity=0.227 Sum_probs=23.6
Q ss_pred CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 188 NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 188 ~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.++||+|+.+.|||++ + .+.|+||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 3689999999999995 4 57899999764
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=92.41 E-value=0.2 Score=52.93 Aligned_cols=29 Identities=28% Similarity=0.447 Sum_probs=25.3
Q ss_pred CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 188 NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 188 ~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.+++|+|+++.|||++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47999999999999987 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=92.22 E-value=0.31 Score=51.04 Aligned_cols=75 Identities=27% Similarity=0.217 Sum_probs=51.4
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHH---HHHHhCCCCCeeeeccccccCCcceE
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV---KLLKNLTHPNIVRYLGTAREDDSLNI 146 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei---~iL~~L~HpNIV~l~g~~~~~~~~~L 146 (668)
..+..|..+.|+.++ ..+|..+++|+..... ....|. ..|+..+-...|++++.-. ..-.|
T Consensus 8 ~~~~~g~~s~V~pv~-~~dG~~avLKl~~p~~-------------~~~~E~~g~~~L~~w~G~GaVrll~~d~--~~~Al 71 (253)
T PF04655_consen 8 GPPAHGSSSLVVPVR-RADGTPAVLKLAPPHA-------------EAEHEARGEAALRWWNGRGAVRLLAADP--ERGAL 71 (253)
T ss_pred CCCCCCcceEEEEEE-cCCCCeEEEEecCCcc-------------cchhhhhHHhHhheeCCCCceeeecccc--ccchh
Confidence 346678899999997 5679999999873110 011232 5577777788999988753 34578
Q ss_pred Eeecc-CCCChhccc
Q 005944 147 LLEFV-PGGSISSLL 160 (668)
Q Consensus 147 VmEy~-~gGsL~~~L 160 (668)
++|.+ ++.+|.++.
T Consensus 72 LLErl~~g~~L~~~~ 86 (253)
T PF04655_consen 72 LLERLDPGRSLASLP 86 (253)
T ss_pred hhhhccCCCchhhcc
Confidence 89998 445666554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.21 E-value=0.53 Score=53.23 Aligned_cols=28 Identities=36% Similarity=0.512 Sum_probs=23.8
Q ss_pred CcccccCCcccEEeCCCCceEEecCCchh
Q 005944 189 GIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 189 gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.++|.|+-+.|||++.++ ++|+||..|.
T Consensus 285 VfCHNDl~~~NiL~~~~~-l~LIDfEYAg 312 (442)
T PTZ00296 285 VFCHNDLQENNIINTNKC-LRLIDFEYSG 312 (442)
T ss_pred eEEeCCCCccceeecCCC-EEEEeecccc
Confidence 589999999999987554 9999998764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 668 | ||||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-50 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-50 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-43 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-43 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-43 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-43 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-42 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-42 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-42 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-41 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-40 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-40 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-40 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-40 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-39 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-37 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-37 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-37 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-37 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 8e-37 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-35 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-34 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-34 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-33 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-33 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-33 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-33 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-33 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-33 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 5e-33 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-31 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-31 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-30 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-30 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-30 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-30 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-30 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-30 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-30 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-30 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-30 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-30 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-29 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-29 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-29 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-29 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-29 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-29 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-29 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-29 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-29 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-29 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 3e-29 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 3e-29 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-29 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-29 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-29 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-29 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-29 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-29 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-29 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-29 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-29 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 6e-29 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 6e-29 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-29 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-29 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 8e-29 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-29 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-29 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-29 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-28 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-28 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-28 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-28 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-28 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-28 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-28 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-28 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-28 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-28 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-28 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-28 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-28 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-28 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-28 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-28 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-28 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-28 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-28 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-28 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-28 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-28 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-28 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-28 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-28 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-28 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-28 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-28 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-28 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-28 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-28 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-28 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-28 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 5e-28 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-28 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-27 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-27 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-27 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-27 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-27 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-27 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-27 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-27 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-27 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-27 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 6e-27 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-27 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 6e-27 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-27 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-27 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 8e-27 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-27 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 9e-27 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-26 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-26 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-26 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-26 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-26 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-26 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-26 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-26 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-26 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-26 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-26 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-26 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-26 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-26 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-26 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-26 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-26 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-26 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-26 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 7e-26 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-26 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-26 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-26 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-25 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-25 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-25 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-25 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-25 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-25 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-25 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-25 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-25 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-25 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 3e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-25 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-25 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-25 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 4e-25 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-25 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-25 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-25 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-25 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-25 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-25 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-25 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 7e-25 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-25 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-25 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-25 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-25 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 8e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 9e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 9e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-24 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-24 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-24 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-24 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-24 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-24 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-24 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-24 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-24 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 3e-24 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-24 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-24 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-24 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-24 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-24 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-24 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-24 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-24 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-24 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-24 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-24 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-23 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-23 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-23 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-23 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-23 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-23 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-23 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-23 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-23 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-23 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-23 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-23 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-23 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-23 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-23 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-23 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-23 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-22 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-22 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-22 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-22 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-22 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-22 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-22 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-22 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-22 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-22 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-22 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-22 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-22 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-22 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-22 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-22 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-22 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-22 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-22 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-22 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-22 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-22 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-22 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-22 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-22 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-22 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-22 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-22 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-22 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-22 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-22 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-22 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 7e-22 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-22 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-22 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-22 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-22 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-22 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-22 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-22 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-22 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-22 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-22 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-22 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-22 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-22 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-22 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-22 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-22 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-22 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-22 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-22 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-22 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-22 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-22 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-22 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-22 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-22 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-22 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-22 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-22 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-21 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-21 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-21 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-21 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-21 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-21 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-21 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-21 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-21 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-21 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-21 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-21 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-21 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-21 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-21 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-21 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-21 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-21 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-21 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-21 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-21 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-21 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-21 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-21 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-21 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-21 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-21 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-21 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-21 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-21 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-21 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-21 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-21 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-21 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-21 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-21 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 8e-21 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-21 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-21 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 8e-21 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-21 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-21 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-21 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-21 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-21 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-21 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-20 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-20 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-20 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-20 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-20 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-20 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-20 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-20 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-20 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-20 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-20 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-20 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-20 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-20 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-20 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-20 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-20 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-20 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-20 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-20 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-20 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-20 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-20 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-20 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-20 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-20 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-20 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-20 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-20 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-20 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 5e-20 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-20 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-20 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-20 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-20 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-20 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-20 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 7e-20 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-20 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-20 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 8e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 8e-20 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-20 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 9e-20 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-20 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-20 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-20 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-19 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-19 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-19 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-19 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-19 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-19 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-19 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-19 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-19 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-19 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-19 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-19 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-19 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-19 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-19 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-19 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-19 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-19 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-19 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 6e-19 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 6e-19 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 6e-19 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-19 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-19 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 8e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-19 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-19 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 9e-19 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 9e-19 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-18 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-18 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-18 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-18 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-18 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-18 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-18 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-18 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-18 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-18 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-18 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-18 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-18 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 7e-18 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-17 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-17 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-17 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-17 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-17 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-17 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-17 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-17 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-17 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-17 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-17 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-17 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-17 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-17 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-17 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-17 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-17 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-17 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-17 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-17 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-17 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-17 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-17 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-17 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-17 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-17 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-17 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-17 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-17 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-17 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-17 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 4e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-17 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 4e-17 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-17 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 4e-17 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-17 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 4e-17 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 4e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 5e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-17 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-17 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-17 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-17 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 7e-17 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 8e-17 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 8e-17 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-17 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 8e-17 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 9e-17 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-16 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-16 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-16 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-16 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-16 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-16 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-16 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-16 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-16 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-16 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-16 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-16 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-16 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-16 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-16 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-16 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-16 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-16 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-16 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-16 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-16 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-16 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-16 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 6e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 6e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-16 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-16 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-16 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-16 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-16 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-16 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 7e-16 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 8e-16 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 8e-16 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-16 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-16 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-16 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-16 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 9e-16 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-16 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-15 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-15 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-15 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-15 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-15 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-15 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-15 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-15 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-15 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-15 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-15 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-15 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-15 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-15 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-15 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-15 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-15 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-15 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-15 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-15 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 2e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-15 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-15 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-15 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-15 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-15 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-15 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-15 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-15 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-15 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-15 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-15 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-15 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-15 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-15 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-15 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-15 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-15 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-15 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-15 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-15 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 3e-15 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-15 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-15 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-15 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-15 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-15 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-15 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-15 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-15 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-15 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-15 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-15 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-15 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-15 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-15 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-15 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-15 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-15 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-15 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-15 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-15 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-15 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 5e-15 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-15 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-15 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-15 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-15 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-15 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-15 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 6e-15 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-15 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-15 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 6e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-15 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-15 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-15 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-15 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-15 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-15 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-15 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-15 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-15 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 7e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 7e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 7e-15 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 7e-15 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-15 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 8e-15 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-15 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-15 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-15 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 9e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-15 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-15 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 9e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 9e-15 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-14 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-14 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-14 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-14 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-14 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-14 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-14 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 1e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-14 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-14 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-14 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-14 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-14 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-14 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-14 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-14 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-14 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-14 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-14 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-14 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-14 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-14 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-14 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-14 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-14 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-14 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-14 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-14 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-14 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-14 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 4e-14 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-14 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-14 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-14 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-14 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-14 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-14 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-14 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-14 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-14 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 6e-14 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-14 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 6e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-14 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-14 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-14 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 7e-14 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-14 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-14 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 7e-14 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 8e-14 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 8e-14 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 8e-14 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-14 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 8e-14 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 8e-14 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 8e-14 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-14 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 8e-14 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 8e-14 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 8e-14 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-14 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-14 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-14 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-14 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 9e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-14 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 9e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-14 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-14 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-14 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-14 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-13 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-13 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-13 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-13 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-13 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-13 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 3e-13 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 3e-13 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-13 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-13 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 3e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-13 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-13 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-13 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 4e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-13 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 4e-13 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 4e-13 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 4e-13 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-13 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-13 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 5e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 5e-13 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 6e-13 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-13 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-13 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 8e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-13 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 9e-13 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-12 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-12 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-12 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-12 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 3e-12 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-12 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-12 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-12 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 5e-12 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 5e-12 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-12 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 6e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 6e-12 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 7e-12 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-12 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 8e-12 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 9e-12 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-11 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-11 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-11 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-11 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-11 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-11 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-11 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-11 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-11 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-11 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-11 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-11 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-11 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-11 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 1e-11 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 1e-11 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-11 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-11 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-11 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-11 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 |
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 443 bits (1141), Expect = e-153
Identities = 115/280 (41%), Positives = 172/280 (61%), Gaps = 16/280 (5%)
Query: 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELE 117
+ D ++G G +G VY G +L + +A+K++ E+ + + L
Sbjct: 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI--------PERDSRYSQPLH 67
Query: 118 EEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFP--ESVIRMY 174
EE+ L K+L H NIV+YLG+ E+ + I +E VPGGS+S+LL K+G E I Y
Sbjct: 68 EEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127
Query: 175 TKQLLLGLEYLHKNGIMHRDIKGANILVDNK-GCIKLADFGASKKVVELATINGAKSMKG 233
TKQ+L GL+YLH N I+HRDIKG N+L++ G +K++DFG SK++ + ++ G
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCT--ETFTG 185
Query: 234 TPYWMAPEVILQ--TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP 291
T +MAPE+I + G+ +ADIWS+GCT+IEMATGKPP+ + + AA+F +G K HP
Sbjct: 186 TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP 245
Query: 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331
IPE +S EAK F+LKC + +P R+ A++LL F+
Sbjct: 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 420 bits (1082), Expect = e-143
Identities = 88/334 (26%), Positives = 134/334 (40%), Gaps = 32/334 (9%)
Query: 6 GSVR----RSLVFRSTSGDDGGGGISGLVEKIGSSIRKSRIGLFSKPAVPALPPIEKTDA 61
GSV SL + + G + L + + L P++
Sbjct: 3 GSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNE--------GVLLTEKLKPVDYEYR 54
Query: 62 PPIRWRKG-ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV 120
+ W VG G+FG V+ + +G AVK+V + EE+
Sbjct: 55 EEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE-------------VFRVEEL 101
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
L+ P IV G RE +NI +E + GGS+ L+ + G PE Y Q L
Sbjct: 102 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE 161
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGC-IKLADFGASKKVVEL---ATINGAKSMKGTPY 236
GLEYLH I+H D+K N+L+ + G L DFG + + ++ + GT
Sbjct: 162 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221
Query: 237 WMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT-TKSHPPIPE 295
MAPEV++ DIWS C ++ M G PW+ Q+ I + IP
Sbjct: 222 HMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT-QYFRGPLCLKIASEPPPIREIPP 280
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
+ + + L+KEP R++A EL +
Sbjct: 281 SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 363 bits (933), Expect = e-122
Identities = 76/276 (27%), Positives = 142/276 (51%), Gaps = 21/276 (7%)
Query: 62 PPIRWRK-GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV 120
R+ K +G G+F VY G++ ++ +A ++ ++ T++ + +EE
Sbjct: 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQD------RKLTKSERQRFKEEA 76
Query: 121 KLLKNLTHPNIVRYLG----TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTK 176
++LK L HPNIVR+ T + + ++ E + G++ + L +F V+R + +
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCR 136
Query: 177 QLLLGLEYLHKNG--IMHRDIKGANILVDNK-GCIKLADFGASKKVVELATINGAKSMKG 233
Q+L GL++LH I+HRD+K NI + G +K+ D G + L + AK++ G
Sbjct: 137 QILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIG 192
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP- 292
TP +MAPE+ + + S D+++ G ++EMAT + P+S + Q A ++ T+ P
Sbjct: 193 TPEFMAPEMY-EEKYDESVDVYAFGMCMLEMATSEYPYS-ECQNAAQIYRRVTSGVKPAS 250
Query: 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
+ E K+ + C+++ R + +LL H F
Sbjct: 251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 336 bits (865), Expect = e-111
Identities = 86/297 (28%), Positives = 137/297 (46%), Gaps = 13/297 (4%)
Query: 46 SKPAVPALPPIEKTDAPPI-RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSA 104
P + +R + +G G F VY L G +A+K+V I
Sbjct: 13 VPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMD 72
Query: 105 SKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG 164
+K + +E+ LLK L HPN+++Y + ED+ LNI+LE G +S ++ F
Sbjct: 73 AKARADCI-----KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK 127
Query: 165 S----FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220
PE + Y QL LE++H +MHRDIK AN+ + G +KL D G +
Sbjct: 128 KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187
Query: 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAA 280
+ A S+ GTPY+M+PE I + G++F +DIWS+GC + EMA + P+ + +
Sbjct: 188 --SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS 245
Query: 281 LFHIGTTKSHPPIP-EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPH 336
L +PP+P +H S E + + C+ +P R + +
Sbjct: 246 LCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 326 bits (837), Expect = e-106
Identities = 78/330 (23%), Positives = 143/330 (43%), Gaps = 24/330 (7%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ + +G G +V+ +N + ++ A+K V + +E + E+ L
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL------EEADNQTLDSYRNEIAYLN 62
Query: 125 NLTHPN--IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
L + I+R D + +++E ++S L K S + Y K +L +
Sbjct: 63 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAV 121
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
+H++GI+H D+K AN L+ + G +KL DFG + ++ T S GT +M PE
Sbjct: 122 HTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 180
Query: 243 ILQTG-----------HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP 291
I S +D+WS+GC + M GK P+ Q +++ L I
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 240
Query: 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIA 351
P+ + +D L CL+++P R + ELL HP+V + + + + + E +
Sbjct: 241 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 300
Query: 352 TPGMNLRNSMNSLVRRSTGLKDVCEMGSVR 381
+ NS NS+++ + L + G
Sbjct: 301 Q--LVGLNSPNSILKAAKTLYEHYSGGESH 328
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 321 bits (826), Expect = e-105
Identities = 80/299 (26%), Positives = 127/299 (42%), Gaps = 15/299 (5%)
Query: 31 EKIGSSIRKSRIGLFSKPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGE 90
++ R P P +++ +G G++G V+ + + G
Sbjct: 24 HQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGR 83
Query: 91 LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEF 150
L AVK+ + K++ + L E K HP VR E L + E
Sbjct: 84 LYAVKRSMSP-FRGPKDRARK----LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL 138
Query: 151 VPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIK 209
G S+ +G S PE+ + Y + LL L +LH G++H D+K ANI + +G K
Sbjct: 139 C-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCK 197
Query: 210 LADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKP 269
L DFG EL T + +G P +MAPE+ LQ + +AD++S+G T++E+A
Sbjct: 198 LGDFGLLV---ELGTAGAGEVQEGDPRYMAPEL-LQGSYGTAADVFSLGLTILEVACNME 253
Query: 270 PWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
+ P LS E + L+ L+ +P LR+TA LL P +
Sbjct: 254 LPHGG----EGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-105
Identities = 67/288 (23%), Positives = 117/288 (40%), Gaps = 40/288 (13%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ + E +G G FG V+ + G + A+K+ + S ++ A L E
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKP-LAGSVDEQNA----LREVYAHAV 66
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLL 180
H ++VRY EDD + I E+ GGS++ + F E+ ++ Q+
Sbjct: 67 LGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCI-------------------KLADFGASKKVVE 221
GL Y+H ++H DIK +NI + K+ D G +
Sbjct: 127 GLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR--- 183
Query: 222 LATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAA 280
I+ + +G ++A EV+ + H ADI+++ TV+ A +P
Sbjct: 184 ---ISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN-----GD 235
Query: 281 LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
+H P IP+ LS E + L + +P R +A L++H +
Sbjct: 236 QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVL 283
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 323 bits (830), Expect = e-105
Identities = 78/333 (23%), Positives = 144/333 (43%), Gaps = 24/333 (7%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ + +G G +V+ +N + ++ A+K V + +E + E+ L
Sbjct: 57 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNL------EEADNQTLDSYRNEIAYLN 109
Query: 125 NLTHPN--IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
L + I+R D + +++E ++S L K S + Y K +L +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAV 168
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
+H++GI+H D+K AN L+ + G +KL DFG + ++ T S G +M PE
Sbjct: 169 HTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEA 227
Query: 243 ILQTG-----------HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP 291
I S +D+WS+GC + M GK P+ Q +++ L I
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 287
Query: 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIA 351
P+ + +D L CL+++P R + ELL HP+V + + + + + E +
Sbjct: 288 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLG 347
Query: 352 TPGMNLRNSMNSLVRRSTGLKDVCEMGSVRCST 384
+ NS NS+++ + L + G S+
Sbjct: 348 Q--LVGLNSPNSILKAAKTLYEHYSGGESHNSS 378
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 316 bits (813), Expect = e-103
Identities = 72/295 (24%), Positives = 130/295 (44%), Gaps = 24/295 (8%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK-TQAHIRELEEEVKLL 123
+ + +G G +V+ +N + ++ A+K V + E+ + E+ L
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYV-------NLEEADNQTLDSYRNEIAYL 80
Query: 124 KNLTHPN--IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181
L + I+R D + +++E ++S L K S + Y K +L
Sbjct: 81 NKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEA 139
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
+ +H++GI+H D+K AN L+ + G +KL DFG + ++ T S GT +M PE
Sbjct: 140 VHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 242 VILQTG-----------HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSH 290
I S +D+WS+GC + M GK P+ Q +++ L I
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE 258
Query: 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVME 345
P+ + +D L CL+++P R + ELL HP+V + + + + + E
Sbjct: 259 IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEE 313
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 7e-95
Identities = 103/286 (36%), Positives = 164/286 (57%), Gaps = 15/286 (5%)
Query: 46 SKPAVPALPPIEKTDAPP-IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSA 104
P LP ++ A P + K E +G G+FG V+ G++ + +++A+K + +
Sbjct: 3 HSPVQSGLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDL----- 57
Query: 105 SKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG 164
E+ + I ++++E+ +L P + +Y G+ +D L I++E++ GGS LL + G
Sbjct: 58 --EEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPG 114
Query: 165 SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224
E+ I +++L GL+YLH +HRDIK AN+L+ G +KLADFG + ++ T
Sbjct: 115 PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT--DT 172
Query: 225 INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI 284
+ GTP+WMAPEVI Q+ + ADIWS+G T IE+A G+PP S + + LF I
Sbjct: 173 QIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS-ELHPMKVLFLI 231
Query: 285 GTTKSHPP-IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
K++PP + + S K+F+ CL KEP R TA ELL+H F+
Sbjct: 232 --PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 7e-91
Identities = 76/309 (24%), Positives = 158/309 (51%), Gaps = 15/309 (4%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ + + +G G+FG+ + + + G +K++ I+ S+ KE+ ++ EV +L
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESR-----REVAVLA 78
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL--GKFGSFPESVIRMYTKQLLLGL 182
N+ HPNIV+Y + E+ SL I++++ GG + + K F E I + Q+ L L
Sbjct: 79 NMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL 138
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
+++H I+HRDIK NI + G ++L DFG ++ + T+ A++ GTPY+++PE+
Sbjct: 139 KHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEI 196
Query: 243 ILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
++ +DIW++GC + E+ T K + + + I + S PP+ H S + +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAF-EAGSMKNLVLKI-ISGSFPPVSLHYSYDLR 254
Query: 303 DFLLKCLQKEPYLRSTASELLQHPFVTG---KYQDPHPVFRNSVMESGNQIATPGMNLRN 359
+ + ++ P R + + +L+ F+ K+ P + +++ ++ + + +
Sbjct: 255 SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKR 314
Query: 360 SMNSLVRRS 368
+ S
Sbjct: 315 PASGQNSIS 323
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 3e-90
Identities = 102/298 (34%), Positives = 169/298 (56%), Gaps = 19/298 (6%)
Query: 36 SIRKSRIGLFSKPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVK 95
S+ ++ + + L T P + E +G G++G VY ++ ++G+++A+K
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 96 QVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGS 155
QV ++ ++E+ +E+ +++ P++V+Y G+ ++ L I++E+ GS
Sbjct: 61 QV----------PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGS 110
Query: 156 ISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214
+S ++ + E I + L GLEYLH +HRDIK NIL++ +G KLADFG
Sbjct: 111 VSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG 170
Query: 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ 274
+ ++ + T+ ++ GTP+WMAPEVI + G++ ADIWS+G T IEMA GKPP++
Sbjct: 171 VAGQLTD--TMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA-D 227
Query: 275 FQEVAALFHIGTTKSHPPI---PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
+ A+F I + PP PE S DF+ +CL K P R+TA++LLQHPFV
Sbjct: 228 IHPMRAIFMI--PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 279 bits (717), Expect = 2e-89
Identities = 103/277 (37%), Positives = 154/277 (55%), Gaps = 22/277 (7%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P W +G GAFG+VY N ++G L A K + K++ + + E++
Sbjct: 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET--------KSEEELEDYIVEIE 68
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLL 180
+L HP IV+ LG D L I++EF PGG++ +++ + E I++ +Q+L
Sbjct: 69 ILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLE 128
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
L +LH I+HRD+K N+L+ +G I+LADFG S K ++ T+ S GTPYWMAP
Sbjct: 129 ALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQKRDSFIGTPYWMAP 186
Query: 241 EVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI-- 293
EV++ T + + ADIWS+G T+IEMA +PP + + L I KS PP
Sbjct: 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH-ELNPMRVLLKI--AKSDPPTLL 243
Query: 294 -PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
P S+E +DFL L K P R +A++LL+HPFV+
Sbjct: 244 TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS 280
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 278 bits (712), Expect = 2e-88
Identities = 92/303 (30%), Positives = 150/303 (49%), Gaps = 17/303 (5%)
Query: 30 VEKIGSSIRKSRIGLFSKPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSG 89
V+ ++ + + AL + P + +G G+ G V + SG
Sbjct: 11 VDLGTENLYFQSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSG 70
Query: 90 ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLE 149
+AVK + + + Q L EV ++++ H N+V + + L +L+E
Sbjct: 71 RQVAVKMMDL--------RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122
Query: 150 FVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIK 209
F+ GG+++ ++ E I + +L L YLH G++HRDIK +IL+ G +K
Sbjct: 123 FLQGGALTDIV-SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVK 181
Query: 210 LADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKP 269
L+DFG ++ + + KS+ GTPYWMAPEVI ++ ++ DIWS+G VIEM G+P
Sbjct: 182 LSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
Query: 270 PWSQQFQEVAALFHIGTTKSHPPI---PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHP 326
P+ V A+ + S PP +S +DFL + L ++P R+TA ELL HP
Sbjct: 240 PYF-SDSPVQAMKRL--RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP 296
Query: 327 FVT 329
F+
Sbjct: 297 FLL 299
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 276 bits (707), Expect = 4e-88
Identities = 93/282 (32%), Positives = 149/282 (52%), Gaps = 17/282 (6%)
Query: 51 PALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQ 110
L I P ++ + E +G GA G VY M++ +G+ +A++Q+ + + Q
Sbjct: 7 EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL--------QQQ 58
Query: 111 AHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESV 170
+ E+ +++ +PNIV YL + D L +++E++ GGS++ ++ E
Sbjct: 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQ 117
Query: 171 IRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS 230
I ++ L LE+LH N ++HRDIK NIL+ G +KL DFG ++ + +
Sbjct: 118 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRST 175
Query: 231 MKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSH 290
M GTPYWMAPEV+ + + DIWS+G IEM G+PP+ + AL+ I +
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLI--ATNG 232
Query: 291 PPI---PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
P PE LS +DFL +CL+ + R +A ELLQH F+
Sbjct: 233 TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 277 bits (710), Expect = 8e-88
Identities = 91/284 (32%), Positives = 149/284 (52%), Gaps = 19/284 (6%)
Query: 51 PALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQ 110
P + + D P + +G G+FG VY ++ + E++A+K++ + ++++
Sbjct: 41 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEK--- 97
Query: 111 AHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESV 170
+++ +EV+ L+ L HPN ++Y G + + +++E+ G + L E
Sbjct: 98 --WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE 155
Query: 171 IRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS 230
I T L GL YLH + ++HRD+K NIL+ G +KL DFG++ + + A S
Sbjct: 156 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANS 209
Query: 231 MKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT 287
GTPYWMAPEVIL + + D+WS+G T IE+A KPP ++AL+HI
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHI--A 266
Query: 288 KSHPPI--PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
++ P H S ++F+ CLQK P R T+ LL+H FV
Sbjct: 267 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 1e-86
Identities = 96/290 (33%), Positives = 145/290 (50%), Gaps = 32/290 (11%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
+ E++G GA V E +A+K++ + EK Q + EL +E++
Sbjct: 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINL-------EKCQTSMDELLKEIQ 65
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL--------GKFGSFPESVIRM 173
+ HPNIV Y + D L ++++ + GGS+ ++ K G ES I
Sbjct: 66 AMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT 125
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA---KS 230
+++L GLEYLHKNG +HRD+K NIL+ G +++ADFG S + I K+
Sbjct: 126 ILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 231 MKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS 289
GTP WMAPEV+ Q G+ F ADIWS G T IE+ATG P+ ++ + L ++
Sbjct: 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH-KYPPMKVLMLT--LQN 242
Query: 290 HPP----------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
PP + + + + CLQK+P R TA+ELL+H F
Sbjct: 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 270 bits (692), Expect = 2e-85
Identities = 94/284 (33%), Positives = 146/284 (51%), Gaps = 30/284 (10%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P + ELVG G +G+VY G ++ +G+L A+K + + T E+++E+
Sbjct: 22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV---------TGDEEEEIKQEIN 72
Query: 122 LLKNL-THPNIVRYLG------TAREDDSLNILLEFVPGGSISSLL--GKFGSFPESVIR 172
+LK H NI Y G DD L +++EF GS++ L+ K + E I
Sbjct: 73 MLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA 132
Query: 173 MYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK 232
+++L GL +LH++ ++HRDIKG N+L+ +KL DFG S ++ T+ +
Sbjct: 133 YICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFI 190
Query: 233 GTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT 287
GTPYWMAPEVI + F +D+WS+G T IEMA G PP + ALF I
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-DMHPMRALFLI--P 247
Query: 288 KSHPPI--PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
++ P + S + + F+ CL K R +L++HPF+
Sbjct: 248 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR 291
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 9e-82
Identities = 67/286 (23%), Positives = 115/286 (40%), Gaps = 40/286 (13%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++ EL+G G FG+V+ + G+ +K+V + E EVK L L
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRV-------KYNN-----EKAEREVKALAKL 61
Query: 127 THPNIVRYLG----------------TAREDDSLNILLEFVPGGSISSLLGKFGS--FPE 168
H NIV Y G + + L I +EF G++ + K +
Sbjct: 62 DHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 121
Query: 169 SVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228
+ +Q+ G++Y+H +++RD+K +NI + + +K+ DFG L
Sbjct: 122 VLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKR 178
Query: 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTK 288
KGT +M+PE I + D++++G + E+ E + F
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT----AFETSKFFTDLR-- 232
Query: 289 SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334
I + + K L K L K+P R SE+L+ V K +
Sbjct: 233 -DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 1e-78
Identities = 67/335 (20%), Positives = 118/335 (35%), Gaps = 66/335 (19%)
Query: 51 PALPPIEKTDAPPIRWRKGELVGCGA--FGRVYMGMNLDSGELLAVKQVLIAANSASKEK 108
+ + ++G G V + +GE + V+++ + +
Sbjct: 12 LYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINL------EAC 65
Query: 109 TQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL--GKFGSF 166
+ + L+ E+ + K HPNIV Y T D+ L ++ F+ GS L+
Sbjct: 66 SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGM 125
Query: 167 PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226
E I + +L L+Y+H G +HR +K ++IL+ G + L+ ++ ++
Sbjct: 126 NELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS--HGQ 183
Query: 227 GAKSMK-------GTPYWMAPEVILQ--TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE 277
+ + W++PEV+ Q G+ +DI+SVG T E+A G P+
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK-DMPA 242
Query: 278 VAALFHI--------------------------------------------GTTKSHPPI 293
L P
Sbjct: 243 TQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302
Query: 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
S F+ +CLQ+ P R +AS LL H F
Sbjct: 303 HRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 337
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 6e-78
Identities = 78/281 (27%), Positives = 133/281 (47%), Gaps = 21/281 (7%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+G G++GR G++L K++ + + EK EV LL+ L
Sbjct: 9 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLV-----SEVNLLREL 62
Query: 127 THPNIVRYLGT--AREDDSLNILLEFVPGGSISSLLGKFGS----FPESVIRMYTKQLLL 180
HPNIVRY R + +L I++E+ GG ++S++ K E + QL L
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 181 GLEYLHK-----NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP 235
L+ H+ + ++HRD+K AN+ +D K +KL DFG ++ + + AK+ GTP
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN--HDTSFAKTFVGTP 180
Query: 236 YWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295
Y+M+PE + + ++ +DIWS+GC + E+ PP+ L IP
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF--TAFSQKELAGKIREGKFRRIPY 238
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPH 336
S E + + + L + Y R + E+L++P + + H
Sbjct: 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 4e-75
Identities = 71/295 (24%), Positives = 118/295 (40%), Gaps = 37/295 (12%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
+ ++G GAFG+V N A+K++ T+ + + EV LL +L
Sbjct: 10 EIAVLGQGAFGQVVKARNALDSRYYAIKKI---------RHTEEKLSTILSEVMLLASLN 60
Query: 128 HPNIVRYLGTAREDDS-------------LNILLEFVPGGSISSLLGKFGSF-PESVIRM 173
H +VRY E + L I +E+ G++ L+
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATING------ 227
+Q+L L Y+H GI+HRD+K NI +D +K+ DFG +K V I
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 228 ------AKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAA 280
S GT ++A EV+ TGH + D++S+G EM ++ +
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK 240
Query: 281 LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
L + + P ++ K + + +P R A LL ++ K+QD
Sbjct: 241 LRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 4e-75
Identities = 79/272 (29%), Positives = 135/272 (49%), Gaps = 25/272 (9%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+G GA+G V ++ SG+++AVK+ I A S+E+ + + +L+ ++ + P
Sbjct: 13 MELGRGAYGVVEKMRHVPSGQIMAVKR--IRATVNSQEQKRL-LMDLD---ISMRTVDCP 66
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF----GSFPESVIRMYTKQLLLGLEYL 185
V + G + + I +E + S+ + + PE ++ ++ LE+L
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 186 HKNG-IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK-GTPYWMAPEVI 243
H ++HRD+K +N+L++ G +K+ DFG S +V + AK + G +MAPE I
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDV--AKDIDAGCKPYMAPERI 181
Query: 244 L----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI--PEHL 297
Q G+S +DIWS+G T+IE+A + P+ L + + P +
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV--VEEPSPQLPADKF 239
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
S E DF +CL+K R T EL+QHPF T
Sbjct: 240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFT 271
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 5e-75
Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 21/285 (7%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+G G G+V+ +G ++AVKQ + + +E + + +L+ +LK+ P
Sbjct: 31 GEMGSGTCGQVWKMRFRKTGHVIAVKQ--MRRSGNKEENKRI-LMDLD---VVLKSHDCP 84
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH-KN 188
IV+ GT + + I +E + + G PE ++ T ++ L YL K+
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVI----- 243
G++HRD+K +NIL+D +G IKL DFG S L G +MAPE I
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201
Query: 244 LQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI---PEHLSME 300
+ + AD+WS+G +++E+ATG+ P+ + L + + PP+ S +
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV--LQEEPPLLPGHMGFSGD 259
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVME 345
+ F+ CL K+ R ++LL+H F+ +Y+ + +
Sbjct: 260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIK-RYETLEVDVASWFKD 303
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 3e-74
Identities = 83/276 (30%), Positives = 134/276 (48%), Gaps = 29/276 (10%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+G GA+G V ++ SG+++AVK+ I + KE+ Q + +L+ ++++ P
Sbjct: 28 GEIGRGAYGSVNKMVHKPSGQIMAVKR--IRSTVDEKEQKQL-LMDLD---VVMRSSDCP 81
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-----GSFPESVIRMYTKQLLLGLEY 184
IV++ G + I +E + S PE ++ T + L +
Sbjct: 82 YIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140
Query: 185 LHKNG-IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK-GTPYWMAPEV 242
L +N I+HRDIK +NIL+D G IKL DFG S ++V +I AK+ G +MAPE
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSI--AKTRDAGCRPYMAPER 196
Query: 243 I----LQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI----- 293
I + G+ +D+WS+G T+ E+ATG+ P+ + L + K PP
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV--VKGDPPQLSNSE 254
Query: 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
S +F+ CL K+ R ELL+HPF+
Sbjct: 255 EREFSPSFINFVNLCLTKDESKRPKYKELLKHPFIL 290
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 4e-73
Identities = 66/279 (23%), Positives = 119/279 (42%), Gaps = 23/279 (8%)
Query: 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLL 123
I + +++G GA G + D +AVK++L + EV+LL
Sbjct: 24 ISFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRIL-----------PECFSFADREVQLL 71
Query: 124 KNLT-HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
+ HPN++RY T ++ I +E + K + +Q GL
Sbjct: 72 RESDEHPNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGL 131
Query: 183 EYLHKNGIMHRDIKGANILVDNKG-----CIKLADFGASKKVV-ELATINGAKSMKGTPY 236
+LH I+HRD+K NIL+ ++DFG KK+ + + + GT
Sbjct: 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 237 WMAPEVILQT---GHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPP 292
W+APE++ + +++ DI+S GC + + G P+ + Q A + +
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLH 251
Query: 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331
+H + A++ + K + +P R +A +L+HPF
Sbjct: 252 PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-72
Identities = 62/291 (21%), Positives = 102/291 (35%), Gaps = 36/291 (12%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+ +G G FG V+ N A+K++ + ++EK + EVK L L
Sbjct: 8 EPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREK-------VMREVKALAKL 60
Query: 127 THPNIVRYLG------------TAREDDSLNILLEFVPGGSISSLL---GKFGSFPESVI 171
HP IVRY + L I ++ ++ + SV
Sbjct: 61 EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120
Query: 172 RMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV----------VE 221
Q+ +E+LH G+MHRD+K +NI +K+ DFG +
Sbjct: 121 LHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAAL 281
+ GT +M+PE I +S DI+S+G + E+ P +Q E
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--PFSTQ--MERVRT 236
Query: 282 FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332
PP+ + L P R A ++++
Sbjct: 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 237 bits (605), Expect = 2e-72
Identities = 85/313 (27%), Positives = 140/313 (44%), Gaps = 54/313 (17%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+G G G V+ + SG ++A K + + E A ++ E+++L P
Sbjct: 39 SELGAGNGGVVFKVSHKPSGLVMARKLIHL-------EIKPAIRNQIIRELQVLHECNSP 91
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
IV + G D ++I +E + GGS+ +L K G PE ++ + ++ GL YL +
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 190 -IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGH 248
IMHRD+K +NILV+++G IKL DFG S ++++ ++ A S GT +M+PE + T +
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID--SM--ANSFVGTRSYMSPERLQGTHY 207
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT--------------------- 287
S +DIWS+G +++EMA G+ P + L
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 288 ------------------KSHPPI--PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
PP S+E +DF+ KCL K P R+ +L+ H F
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 327
Query: 328 VTGKYQDPHPVFR 340
+ + F
Sbjct: 328 IK-RSDAEEVDFA 339
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-68
Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 21/284 (7%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
G +G G FG VY+ S +LA+K ++ K + +R EV++ +L H
Sbjct: 14 GRPLGKGKFGNVYLAREKQSKFILALK--VLFKAQLEKAGVEHQLRR---EVEIQSHLRH 68
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
PNI+R G + + ++LE+ P G++ L K F E Y +L L Y H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 128
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGH 248
++HRDIK N+L+ + G +K+ADFG S + + GT ++ PE+I H
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTDLCGTLDYLPPEMIEGRMH 184
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFH-IGTTKSHPPIPEHLSMEAKDFL 305
D+WS+G E GKPP F+ + I ++ P+ ++ A+D +
Sbjct: 185 DEKVDLWSLGVLCYEFLVGKPP----FEANTYQETYKRI--SRVEFTFPDFVTEGARDLI 238
Query: 306 LKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQ 349
+ L+ P R E+L+HP++T +N ES ++
Sbjct: 239 SRLLKHNPSQRPMLREVLEHPWIT-ANSSKPSNCQNK--ESASK 279
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 5e-66
Identities = 82/290 (28%), Positives = 144/290 (49%), Gaps = 26/290 (8%)
Query: 51 PALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQ 110
+P + R+ +G +G G F + + + D+ E+ A K ++ + K +
Sbjct: 2 KEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK--IVPKSLLLKPHQR 59
Query: 111 AHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESV 170
+ E+ + ++L H ++V + G ++D + ++LE S+ L + + E
Sbjct: 60 EKMSM---EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 116
Query: 171 IRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS 230
R Y +Q++LG +YLH+N ++HRD+K N+ ++ +K+ DFG LAT
Sbjct: 117 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG-------LATKVEYDG 169
Query: 231 MK-----GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFH 283
+ GTP ++APEV+ + GHSF D+WS+GC + + GKPP F+ + +
Sbjct: 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP----FETSCLKETYL 225
Query: 284 -IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332
I K+ IP+H++ A + K LQ +P R T +ELL F T Y
Sbjct: 226 RI--KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 6e-66
Identities = 83/295 (28%), Positives = 146/295 (49%), Gaps = 26/295 (8%)
Query: 46 SKPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSAS 105
+ P +P + R+ +G +G G F + + + D+ E+ A K ++ +
Sbjct: 23 AAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGK--IVPKSLLL 80
Query: 106 KEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS 165
K + + E+ + ++L H ++V + G ++D + ++LE S+ L + +
Sbjct: 81 KPHQREKMSM---EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKA 137
Query: 166 FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI 225
E R Y +Q++LG +YLH+N ++HRD+K N+ ++ +K+ DFG LAT
Sbjct: 138 LTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFG-------LATK 190
Query: 226 NGAKSMK-----GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--V 278
+ GTP ++APEV+ + GHSF D+WS+GC + + GKPP F+ +
Sbjct: 191 VEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPP----FETSCL 246
Query: 279 AALFH-IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332
+ I K+ IP+H++ A + K LQ +P R T +ELL F T Y
Sbjct: 247 KETYLRI--KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 6e-65
Identities = 79/278 (28%), Positives = 124/278 (44%), Gaps = 18/278 (6%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
G +G G FG VY+ + ++A+K ++ + KE + +R E+++ +L H
Sbjct: 19 GRPLGKGKFGNVYLAREKQNKFIMALK--VLFKSQLEKEGVEHQLRR---EIEIQSHLRH 73
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
PNI+R + + ++LEF P G + L K G F E + ++L L Y H+
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHER 133
Query: 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGH 248
++HRDIK N+L+ KG +K+ADFG S L ++M GT ++ PE+I H
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RTMCGTLDYLPPEMIEGKTH 189
Query: 249 SFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFH-IGTTKSHPPIPEHLSMEAKDFL 305
D+W G E G PP F I P LS +KD +
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPP----FDSPSHTETHRRI--VNVDLKFPPFLSDGSKDLI 243
Query: 306 LKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSV 343
K L+ P R +++HP+V + P S
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVYQST 281
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 2e-64
Identities = 67/291 (23%), Positives = 111/291 (38%), Gaps = 29/291 (9%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ + +G G F V + L G A+K++L ++ + E + E + +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH----EQQDRE----EAQREADMHR 81
Query: 125 NLTHPNIVRYLGTAREDDS----LNILLEFVPGGS----ISSLLGKFGSFPESVIRMYTK 176
HPNI+R + + +LL F G+ I L K E I
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV-------ELATINGAK 229
+ GLE +H G HRD+K NIL+ ++G L D G+ + + T+
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201
Query: 230 SMKGTPYWMAPEVILQTGH---SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT 286
+ + T + APE+ H D+WS+GC + M G+ P+ FQ+ ++
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ 261
Query: 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHP 337
+ P S L + +P+ R LL Q P P
Sbjct: 262 NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL---QPPAP 309
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 4e-64
Identities = 79/280 (28%), Positives = 139/280 (49%), Gaps = 27/280 (9%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ G L+G G+F VY ++ +G +A+K +I + K ++ EVK+
Sbjct: 12 DFKVGNLLGKGSFAGVYRAESIHTGLEVAIK--MIDKKAMYKAGMVQRVQN---EVKIHC 66
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLE 183
L HP+I+ + + + ++LE G ++ L + F E+ R + Q++ G+
Sbjct: 67 QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 184 YLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK-----GTPYWM 238
YLH +GI+HRD+ +N+L+ IK+ADFG LAT K GTP ++
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFG-------LATQLKMPHEKHYTLCGTPNYI 179
Query: 239 APEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFH-IGTTKSHPPIPE 295
+PE+ ++ H +D+WS+GC + G+PP F V + + + +P
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPP----FDTDTVKNTLNKV--VLADYEMPS 233
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
LS+EAKD + + L++ P R + S +L HPF++
Sbjct: 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-63
Identities = 72/317 (22%), Positives = 128/317 (40%), Gaps = 57/317 (17%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
W +++G GA V+ G + +G+L A+K + + E ++LK
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-------NNISFLRPVDVQMREFEVLK 62
Query: 125 NLTHPNIVRYLGTAREDDSLNILL--EFVPGGSISSLL---GKFGSFPESVIRMYTKQLL 179
L H NIV+ E + + +L EF P GS+ ++L PES + + ++
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 180 LGLEYLHKNGIMHRDIKGANILV----DNKGCIKLADFGASKKVVELATINGAKSMKGTP 235
G+ +L +NGI+HR+IK NI+ D + KL DFGA++++ + S+ GT
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTE 179
Query: 236 YWMAPEVI--------LQTGHSFSADIWSVGCTVIEMATGKPPW-----SQQFQEVAALF 282
++ P++ Q + + D+WS+G T ATG P+ ++ +EV ++
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MY 237
Query: 283 HIGTTK-------------------SHPPIPEHLSMEAKD----FLLKCLQKEPYLRSTA 319
I T K P+ LS + L L+ +
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 320 SELLQHPFVTGKYQDPH 336
+ + H
Sbjct: 298 DQFFAETSDILHRGNSH 314
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 3e-63
Identities = 79/304 (25%), Positives = 136/304 (44%), Gaps = 39/304 (12%)
Query: 46 SKPAVPALPPIEKTDAPPIRWRKG-------ELVGCGAFGRVYMGMNLDSGELLAVK--- 95
+ P ++ PP +K +++G G+F V + L + A+K
Sbjct: 5 AAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILE 64
Query: 96 -QVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGG 154
+ +I KE ++ E ++ L HP V+ T ++D+ L L + G
Sbjct: 65 KRHII------KENKVPYVTR---ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNG 115
Query: 155 SISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214
+ + K GSF E+ R YT +++ LEYLH GI+HRD+K NIL++ I++ DFG
Sbjct: 116 ELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFG 175
Query: 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW--- 271
+K + + A S GT +++PE++ + S+D+W++GC + ++ G PP+
Sbjct: 176 TAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG 235
Query: 272 --SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLR------STASELL 323
FQ++ K PE +A+D + K L + R L
Sbjct: 236 NEYLIFQKI--------IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLK 287
Query: 324 QHPF 327
HPF
Sbjct: 288 AHPF 291
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 9e-61
Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 30/271 (11%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+G GAFG V++ SG +K + +K+++Q + ++E E+++LK+L H
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLERVIKTI-------NKDRSQVPMEQIEAEIEVLKSLDH 79
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGG----SISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
PNI++ + ++ I++E GG I S + + E + KQ++ L Y
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 185 LHKNGIMHRDIKGANILVDNK---GCIKLADFGASKKVVELATINGAKSMK---GTPYWM 238
H ++H+D+K NIL + IK+ DFG ++ + GT +M
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS------DEHSTNAAGTALYM 193
Query: 239 APEVILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPE 295
APEV + +F DIWS G V+ + TG P +EV ++
Sbjct: 194 APEV-FKRDVTFKCDIWSAG--VVMYFLLTGCLPFTGTSLEEVQQKATYKEP-NYAVECR 249
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHP 326
L+ +A D L + L K+P R +A+++L H
Sbjct: 250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHE 280
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 6e-59
Identities = 78/277 (28%), Positives = 125/277 (45%), Gaps = 13/277 (4%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVK-----QVLIAANSASKEKTQAHIRELEEEVKLL 123
+G GA+G V + + A+K Q S + + E+ E+ LL
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLE 183
K+L HPNI++ + ++ EF GG + + F E KQ+L G+
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGIC 160
Query: 184 YLHKNGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
YLHK+ I+HRDIK NIL++NK IK+ DFG S + + + GT Y++AP
Sbjct: 161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAP 217
Query: 241 EVILQTGHSFSADIWSVGCTVIEMATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
EV L+ ++ D+WS G + + G PP Q Q++ G +++S
Sbjct: 218 EV-LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISD 276
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPH 336
EAK+ + L + R TA E L ++ + +
Sbjct: 277 EAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 7e-59
Identities = 65/266 (24%), Positives = 127/266 (47%), Gaps = 22/266 (8%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+G G+FG+V + D+ ++ A+K Q + + ++ + E+++++ L
Sbjct: 22 AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCV------ERNEVRNVFK---ELQIMQGL 72
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
HP +V + ++++ + ++++ + GG + L + F E ++++ +L++ L+YL
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQ 132
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ- 245
I+HRD+K NIL+D G + + DF + + +M GT +MAPE+
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPEMFSSR 189
Query: 246 --TGHSFSADIWSVGCTVIEMATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
G+SF+ D WS+G T E+ G+ P + + H + P S E
Sbjct: 190 KGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHT-FETTVVTYPSAWSQEMV 248
Query: 303 DFLLKCLQKEPYLR-STASELLQHPF 327
L K L+ P R S S++ P+
Sbjct: 249 SLLKKLLEPNPDQRFSQLSDVQNFPY 274
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 8e-59
Identities = 71/306 (23%), Positives = 126/306 (41%), Gaps = 57/306 (18%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
W +++G GA V+ G + +G+L A+K + + E ++LK
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVF-------NNISFLRPVDVQMREFEVLK 62
Query: 125 NLTHPNIVRYLGTAREDDSLNILL--EFVPGGSISSLL---GKFGSFPESVIRMYTKQLL 179
L H NIV+ E + + +L EF P GS+ ++L PES + + ++
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 180 LGLEYLHKNGIMHRDIKGANILV----DNKGCIKLADFGASKKVVELATINGAKSMKGTP 235
G+ +L +NGI+HR+IK NI+ D + KL DFGA++++ + S+ GT
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTE 179
Query: 236 YWMAPEVI--------LQTGHSFSADIWSVGCTVIEMATGKPPW-----SQQFQEVAALF 282
++ P++ Q + + D+WS+G T ATG P+ ++ +EV ++
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV--MY 237
Query: 283 HIGTTK-------------------SHPPIPEHLSMEAKD----FLLKCLQKEPYLRSTA 319
I T K P+ LS + L L+ +
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297
Query: 320 SELLQH 325
+
Sbjct: 298 DQFFAE 303
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-58
Identities = 77/274 (28%), Positives = 127/274 (46%), Gaps = 13/274 (4%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
++G G+FG V + + +G+ AVK + S + K + L EV+LLK L H
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQECAVKVI-----SKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
PNI++ + ++ E GG + + F E +Q+L G+ Y+HKN
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 189 GIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
I+HRD+K N+L+++K I++ DFG S + K GT Y++APEV L
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYIAPEV-LH 201
Query: 246 TGHSFSADIWSVGCTVIEMATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
+ D+WS G + + +G PP ++ G P + +S AKD
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 305 LLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPV 338
+ K L P +R +A + L H ++ ++ V
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISV 295
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 3e-58
Identities = 76/271 (28%), Positives = 142/271 (52%), Gaps = 12/271 (4%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+ +G GA G V + + + +A++ + + + +E E+++LK L H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
P I++ + + I+LE + GG + + E+ ++Y Q+LL ++YLH+N
Sbjct: 200 PCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 258
Query: 189 GIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
GI+HRD+K N+L+ ++ IK+ DFG SK + E + + +++ GTP ++APEV++
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM---RTLCGTPTYLAPEVLVS 315
Query: 246 T---GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI--GTTKSHPPIPEHLSME 300
G++ + D WS+G + +G PP+S+ +V+ I G P + +S +
Sbjct: 316 VGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEK 375
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331
A D + K L +P R T E L+HP++ +
Sbjct: 376 ALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 6e-58
Identities = 71/300 (23%), Positives = 120/300 (40%), Gaps = 44/300 (14%)
Query: 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLL 123
+++G G+ G V + G +AVK++L + E+KLL
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRML-------IDFCDI----ALMEIKLL 62
Query: 124 KNLT-HPNIVRYLGTAREDDSLNILLEFVPGG------SISSLLGKFGSFPESVIRMYTK 176
HPN++RY + D L I LE S + E +
Sbjct: 63 TESDDHPNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLR 122
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGC-------------IKLADFGASKKVV--E 221
Q+ G+ +LH I+HRD+K NILV I ++DFG KK+ +
Sbjct: 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182
Query: 222 LATINGAKSMKGTPYWMAPEVILQTGH-------SFSADIWSVGCTVIEMAT-GKPPWSQ 273
+ + GT W APE++ ++ + + S DI+S+GC + + GK P+
Sbjct: 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGD 242
Query: 274 QFQEVAALF--HIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331
++ + + + L EA D + + + +P R TA ++L+HP K
Sbjct: 243 KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 7e-58
Identities = 78/283 (27%), Positives = 133/283 (46%), Gaps = 16/283 (5%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK-TQAHIRELEEEVKLLKNLT 127
+ +G GA+G V + + + A+K + K + + +L EEV +LK L
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVERAIKII-------RKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
HPNI++ + + +++E GG + + F E + KQ+L G+ YLHK
Sbjct: 95 HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHK 154
Query: 188 NGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
+ I+HRD+K N+L+++K IK+ DFG S + K GT Y++APEV L
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM---KERLGTAYYIAPEV-L 210
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
+ + D+WS+G + + G PP Q QE+ G P +++S AKD
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD 270
Query: 304 FLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMES 346
+ + LQ + R +A + L+HP++ + +
Sbjct: 271 LIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLAN 313
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 197 bits (504), Expect = 9e-58
Identities = 79/268 (29%), Positives = 140/268 (52%), Gaps = 30/268 (11%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+G G+FGRV + + +SG A+K Q ++ K K H E ++L+ +
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV------KLKQIEHTLN---EKRILQAV 98
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
P +V+ + +++ +L +++E+V GG + S L + G F E R Y Q++L EYLH
Sbjct: 99 NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
+++RD+K N+L+D +G I++ DFG +K+V ++ GTP +APE+IL
Sbjct: 159 SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-----KGRTWTLCGTPEALAPEIILSK 213
Query: 247 GHSFSADIWSVGCTVIEMATGKPP-WSQQFQEVAALFH-IGTTKSHPPIPEHLSMEAKDF 304
G++ + D W++G + EMA G PP ++ Q + ++ I P H S + KD
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKI--VSGKVRFPSHFSSDLKDL 268
Query: 305 LLKCLQKEP-----YLRSTASELLQHPF 327
L LQ + L++ +++ H +
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKW 296
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-57
Identities = 80/271 (29%), Positives = 129/271 (47%), Gaps = 16/271 (5%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK-TQAHIRELEEEVKLLKNLT 127
++G G+FG V + + + AVK + +K + EV+LLK L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVI-------NKASAKNKDTSTILREVELLKKLD 79
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
HPNI++ + S I+ E GG + + K F E KQ+ G+ Y+HK
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 188 NGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
+ I+HRD+K NIL+++K IK+ DFG S + + K GT Y++APEV L
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM---KDRIGTAYYIAPEV-L 195
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
+ + D+WS G + + +G PP + + ++ G P +S +AKD
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKD 255
Query: 304 FLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334
+ K L P LR TA++ L+HP++ +
Sbjct: 256 LIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-57
Identities = 76/268 (28%), Positives = 135/268 (50%), Gaps = 30/268 (11%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+G G+FGRV++ + +G A+K ++++ + K H + E +L +
Sbjct: 13 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVV------RLKQVEHTND---ERLMLSIV 63
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
THP I+R GT ++ + ++++++ GG + SLL K FP V + Y ++ L LEYLH
Sbjct: 64 THPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLH 123
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
I++RD+K NIL+D G IK+ DFG +K V + ++ GTP ++APEV+
Sbjct: 124 SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEVVSTK 178
Query: 247 GHSFSADIWSVGCTVIEMATGKPP-WSQQFQEVAALFH-IGTTKSHPPIPEHLSMEAKDF 304
++ S D WS G + EM G P + + + I + P + + KD
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYEKI--LNAELRFPPFFNEDVKDL 233
Query: 305 LLKCLQKEP-----YLRSTASELLQHPF 327
L + + ++ L++ ++ HP+
Sbjct: 234 LSRLITRDLSQRLGNLQNGTEDVKNHPW 261
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 2e-57
Identities = 44/305 (14%), Positives = 97/305 (31%), Gaps = 52/305 (17%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQV----LIAANSASKEKTQAHIRELE 117
P +G ++G + ++GE V +N+ + K + L
Sbjct: 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 118 EEVK----------------LLKNLTHPNIVRYLGTAREDDSLNILLEF--------VPG 153
+K L+K+ ++R R+ L+ + G
Sbjct: 131 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 190
Query: 154 GSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADF 213
+ S S T Q++ L LH G++H ++ +I++D +G + L F
Sbjct: 191 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 214 GASKKVVELATINGAKSMKGTPYWMAPEVIL-----------QTGHSFSADIWSVGCTVI 262
+ + + PE+ +T +FS D W++G +
Sbjct: 251 EHLVRDGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIY 304
Query: 263 EMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASEL 322
+ P ++ +G ++ +++ + L L+ R +
Sbjct: 305 WIWCADLPITKDAA-------LGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357
Query: 323 LQHPF 327
++ P
Sbjct: 358 METPE 362
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 3e-57
Identities = 82/293 (27%), Positives = 136/293 (46%), Gaps = 30/293 (10%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
E++G G F V +N ++G+ AVK V +A ++S + +L+ E + L H
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLS---TEDLKREASICHMLKH 85
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGG----SISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
P+IV L T D L ++ EF+ G I + E+V Y +Q+L L Y
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 185 LHKNGIMHRDIKGANILVDNKGC---IKLADFGASKKVVELATINGAKSMK---GTPYWM 238
H N I+HRD+K +L+ +K +KL FG + ++ E GTP++M
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-----SGLVAGGRVGTPHFM 200
Query: 239 APEVILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQ---FQEVAALFHIGTTKSHPP 292
APEV+ + + D+W G VI + +G P + + F+ + G K +P
Sbjct: 201 APEVVKREPYGKPVDVWGCG--VILFILLSGCLPFYGTKERLFEGIIK----GKYKMNPR 254
Query: 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVME 345
H+S AKD + + L +P R T E L HP++ + + + + +E
Sbjct: 255 QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVE 307
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 5e-57
Identities = 76/287 (26%), Positives = 138/287 (48%), Gaps = 25/287 (8%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK-TQAHIRELEEEVKLLKNLT 127
E +G GAF V ++ +G A K + + +K + ++LE E ++ + L
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEFAAKII-------NTKKLSARDFQKLEREARICRKLQ 63
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
HPNIVR + +E+ ++ + V GG + + + E+ +Q+L + Y H
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 123
Query: 188 NGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMK---GTPYWMAPE 241
NGI+HR++K N+L+ +K +KLADFG + +V + +++ GTP +++PE
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND------SEAWHGFAGTPGYLSPE 177
Query: 242 VILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLS 298
V+ + +S DIW+ G VI + G PP W + + A G P + ++
Sbjct: 178 VLKKDPYSKPVDIWACG--VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 235
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVME 345
EAK + L P R TA + L+ P++ + + + R ++
Sbjct: 236 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVD 282
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 7e-57
Identities = 86/287 (29%), Positives = 128/287 (44%), Gaps = 14/287 (4%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
GE +G G F V +G A K I + + E+E EV +L+ + H
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKF--IKKRQSRASRRGVSREEIEREVSILRQVLH 74
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
N++ + ++LE V GG + L + S E + KQ+L G+ YLH
Sbjct: 75 HNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 189 GIMHRDIKGANILVDNK----GCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
I H D+K NI++ +K IKL DFG + ++ + K++ GTP ++APE++
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVN 191
Query: 245 QTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301
AD+WS+G VI + +G P QE A + H S A
Sbjct: 192 YEPLGLEADMWSIG--VITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA 249
Query: 302 KDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGN 348
KDF+ K L KE R T E L+HP++T V R SV+ N
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLEN 296
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 8e-57
Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 22/285 (7%)
Query: 55 PIEKTDAPPIRWRK---GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQA 111
K+ P + + + +G G FG V+ G + ++A+K LI +S + +
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIK-SLILGDSEGETEMIE 65
Query: 112 HIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESV 170
+E + EV ++ NL HPNIV+ G +++EFVP G + L K SV
Sbjct: 66 KFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSV 123
Query: 171 IRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVDNKG-----CIKLADFGASKKVVELA 223
+ LG+EY+ I+HRD++ NI + + C K+ADFG S++ V
Sbjct: 124 KLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV 183
Query: 224 TINGAKSMKGTPYWMAPEVILQTGHSFS--ADIWSVGCTVIEMATGKPPWSQ-QFQEVAA 280
+ + G WMAPE I S++ AD +S + + TG+ P+ + + ++
Sbjct: 184 S-----GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKF 238
Query: 281 LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+ I P IPE ++ + C +P R S +++
Sbjct: 239 INMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-56
Identities = 84/311 (27%), Positives = 149/311 (47%), Gaps = 28/311 (9%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+ +G GA G V + + + +A+K + + + +E E+++LK L H
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
P I++ + + + I+LE + GG + + E+ ++Y Q+LL ++YLH+N
Sbjct: 75 PCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHEN 133
Query: 189 GIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMK---GTPYWMAPEV 242
GI+HRD+K N+L+ ++ IK+ DFG SK + E M+ GTP ++APEV
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE------TSLMRTLCGTPTYLAPEV 187
Query: 243 ILQT---GHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHI---GTTKSHPPI 293
++ G++ + D WS+G VI +G PP + Q +L G P +
Sbjct: 188 LVSVGTAGYNRAVDCWSLG--VILFICLSGYPPFSEHRTQV--SLKDQITSGKYNFIPEV 243
Query: 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATP 353
+S +A D + K L +P R T E L+HP++ + F++ + E A P
Sbjct: 244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRK--FQDLLSEENESTALP 301
Query: 354 GMNLRNSMNSL 364
+ + S +
Sbjct: 302 QVLAQPSTSRK 312
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 1e-56
Identities = 83/276 (30%), Positives = 130/276 (47%), Gaps = 26/276 (9%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK-TQAHIRELEEEVKLLKNLT 127
++G G+FG V + + + AVK + +K + EV+LLK L
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEYAVKVI-------NKASAKNKDTSTILREVELLKKLD 79
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
HPNI++ + S I+ E GG + + K F E KQ+ G+ Y+HK
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHK 139
Query: 188 NGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMK---GTPYWMAPE 241
+ I+HRD+K NIL+++K IK+ DFG S + MK GT Y++APE
Sbjct: 140 HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ------NTKMKDRIGTAYYIAPE 193
Query: 242 VILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLS 298
V L+ + D+WS G VI + +G PP + + ++ G P +S
Sbjct: 194 V-LRGTYDEKCDVWSAG--VILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334
+AKD + K L P LR TA++ L+HP++ +
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-56
Identities = 78/277 (28%), Positives = 133/277 (48%), Gaps = 16/277 (5%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
E++G GAF V++ +G+L A+K I + A ++ LE E+ +LK + H
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLFALKC--IKKSPAFRDS------SLENEIAVLKKIKH 65
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
NIV ++++ V GG + + + G + E + +Q+L ++YLH+N
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 189 GIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
GI+HRD+K N+L I + DFG SK + GTP ++APEV+ Q
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN----GIMSTACGTPGYVAPEVLAQ 181
Query: 246 TGHSFSADIWSVGCTVIEMATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
+S + D WS+G + G PP + + ++ G + P + +S AKDF
Sbjct: 182 KPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 305 LLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRN 341
+ L+K+P R T + L HP++ G ++ +
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPS 278
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-56
Identities = 80/273 (29%), Positives = 120/273 (43%), Gaps = 20/273 (7%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
GE +G G F V +G+ A K I S + E+E EV +L+ + H
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEYAAKF--IKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
PNI+ + ++LE V GG + L + S E + KQ+L G+ YLH
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSK 127
Query: 189 GIMHRDIKGANILVDNKGC----IKLADFGASKKVVELATINGAKSMK---GTPYWMAPE 241
I H D+K NI++ +K IKL DFG + K I K GTP ++APE
Sbjct: 128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK------IEAGNEFKNIFGTPEFVAPE 181
Query: 242 VILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLS 298
++ AD+WS+G VI + +G P + QE + S
Sbjct: 182 IVNYEPLGLEADMWSIG--VITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331
AKDF+ + L K+P R T ++ L+H ++
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 4e-56
Identities = 42/333 (12%), Positives = 89/333 (26%), Gaps = 53/333 (15%)
Query: 40 SRIGLFSKPAVPALPPIE---KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQ 96
+ + + P + + E + G V++ +++ E A+K
Sbjct: 35 AMVEAVTATVWPQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKV 94
Query: 97 VLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNI---------- 146
+ E +++ + L E L + R +
Sbjct: 95 FTM-----GAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFA 149
Query: 147 ---------------LLEFVPGGSISSLLGKF-------GSFPESVIRMYTKQLLLGLEY 184
LL + L G + + T QL+
Sbjct: 150 QLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAAN 209
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
L G++H N+ + G + L D A KV + + E +
Sbjct: 210 LQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASS-----VPVTYAPREFLN 264
Query: 245 Q--TGHSFSADIWSVGCTVIEMATGKPPW------SQQFQEVAALFHIGTTKSHPPIPEH 296
+ + + W +G ++ + P+ + + +L GT
Sbjct: 265 ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTP 324
Query: 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
L K + + L + R E ++ P
Sbjct: 325 LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 7e-56
Identities = 75/308 (24%), Positives = 117/308 (37%), Gaps = 50/308 (16%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+G G++G V + + + + A+K + + ++ + ++ EV+L+K L H
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNK---NKIRQINPKDVERIKTEVRLMKKLHH 87
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG------------------------ 164
PNI R ++ + +++E GG + L F
Sbjct: 88 PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147
Query: 165 ----------------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-- 206
E +I +Q+ L YLH GI HRDIK N L
Sbjct: 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSF 207
Query: 207 CIKLADFGASKKVVELATINGAKSMK--GTPYWMAPEVILQTGHSFS--ADIWSVGCTVI 262
IKL DFG SK+ +L GTPY++APEV+ T S+ D WS G +
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
Query: 263 EMATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASE 321
+ G P + + P LS A+D L L + R A
Sbjct: 268 LLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327
Query: 322 LLQHPFVT 329
LQHP+++
Sbjct: 328 ALQHPWIS 335
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 9e-56
Identities = 77/302 (25%), Positives = 131/302 (43%), Gaps = 57/302 (18%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ K +G G++G V+ N D+G+++A+K+ L + + +K +RE +++LK
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA--LRE----IRMLK 57
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLG----KFGSFPESVIRMYTKQLLL 180
L HPN+V L R L+++ E+ ++L PE +++ T Q L
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY---- 236
+ + HK+ +HRD+K NIL+ IKL DFG A + S
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFG-------FARLLTGPSDYYDDEVATR 166
Query: 237 WM-APEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI----GT-TKS 289
W +PE+++ T + D+W++GC E+ +G P W +V L+ I G
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW-PGKSDVDQLYLIRKTLGDLIPR 225
Query: 290 HPPIPE------------------------HLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
H + ++S A L CL +P R T +LL H
Sbjct: 226 HQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285
Query: 326 PF 327
P+
Sbjct: 286 PY 287
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-55
Identities = 67/323 (20%), Positives = 123/323 (38%), Gaps = 43/323 (13%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVK---------QVLIAANSASKEKTQAHIRE 115
+R + G F ++ + + A+K + ++ K ++ +
Sbjct: 32 DYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 116 LEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG--------SFP 167
+ E++++ ++ + + G D + I+ E++ SI F P
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 168 ESVIRMYTKQLLLGLEYLH-KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226
VI+ K +L Y+H + I HRD+K +NIL+D G +KL+DFG S+
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE----YMVDK 205
Query: 227 GAKSMKGTPYWMAPEVILQTG--HSFSADIWSVGCTVIEMATGKPPWSQQF--------- 275
K +GT +M PE + DIWS+G + M P+S +
Sbjct: 206 KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI 265
Query: 276 --------QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
+ + T K LS E DFL L+K P R T+ + L+H +
Sbjct: 266 RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325
Query: 328 VTGKYQDPHPVFRNSVMESGNQI 350
+ + F + + ++
Sbjct: 326 LADTNIEDLREFSKELYKKRKKL 348
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-55
Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 8/271 (2%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
W + +G GA+G V + +N + E +AVK V ++ +++E+ + K
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINK 60
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
L H N+V++ G RE + + LE+ GG + + PE + + QL+ G+ Y
Sbjct: 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
LH GI HRDIK N+L+D + +K++DFG + M GT ++APE++
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 245 QTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
+ H+ D+WS G + M G+ PW Q K++ + +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 304 FLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334
L K L + P R T ++ + + +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKK 271
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-55
Identities = 76/287 (26%), Positives = 138/287 (48%), Gaps = 25/287 (8%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK-TQAHIRELEEEVKLLKNLT 127
E +G GAF V ++ +G A K + + +K + ++LE E ++ + L
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEFAAKII-------NTKKLSARDFQKLEREARICRKLQ 86
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
HPNIVR + +E+ ++ + V GG + + + E+ +Q+L + Y H
Sbjct: 87 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHS 146
Query: 188 NGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMK---GTPYWMAPE 241
NGI+HR++K N+L+ +K +KLADFG + + +N +++ GTP +++PE
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE------VNDSEAWHGFAGTPGYLSPE 200
Query: 242 VILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLS 298
V+ + +S DIW+ G VI + G PP W + + A G P + ++
Sbjct: 201 VLKKDPYSKPVDIWACG--VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVT 258
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVME 345
EAK + L P R TA + L+ P++ + + + R ++
Sbjct: 259 PEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVD 305
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-55
Identities = 86/305 (28%), Positives = 129/305 (42%), Gaps = 63/305 (20%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ LVG G++G V N D+G ++A+K+ L + + +K +RE +KLLK
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA--MRE----IKLLK 79
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLG----KFGSFPESVIRMYTKQLLL 180
L H N+V L ++ ++ EFV ++L V++ Y Q++
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVD----HTILDDLELFPNGLDYQVVQKYLFQIIN 135
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY---- 236
G+ + H + I+HRDIK NILV G +KL DFG A A
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFG-------FARTLAAPGEVYDDEVATR 188
Query: 237 WM-APEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQ---EVAALFHI----GT- 286
W APE+++ + D+W++GC V EM G+P F ++ L+HI G
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP----LFPGDSDIDQLYHIMMCLGNL 244
Query: 287 TKSH---------------PPIPE---------HLSMEAKDFLLKCLQKEPYLRSTASEL 322
H P I E LS D KCL +P R +EL
Sbjct: 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAEL 304
Query: 323 LQHPF 327
L H F
Sbjct: 305 LHHDF 309
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-55
Identities = 87/287 (30%), Positives = 128/287 (44%), Gaps = 14/287 (4%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
GE +G G F V +G A K I + + E+E EV +L+ + H
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEYAAKF--IKKRQSRASRRGVCREEIEREVSILRQVLH 74
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
PNI+ + ++LE V GG + L + S E + KQ+L G+ YLH
Sbjct: 75 PNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTK 134
Query: 189 GIMHRDIKGANILVDNKGC----IKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
I H D+K NI++ +K IKL DFG + ++ + K++ GTP ++APE++
Sbjct: 135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVAPEIVN 191
Query: 245 QTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301
AD+WS+G VI + +G P QE A + S A
Sbjct: 192 YEPLGLEADMWSIG--VITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA 249
Query: 302 KDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGN 348
KDF+ K L KE R T E L+HP++T V R SV+ N
Sbjct: 250 KDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLEN 296
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-55
Identities = 66/273 (24%), Positives = 122/273 (44%), Gaps = 20/273 (7%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+G G++G V + + + A K++ K + + ++E++++K+L H
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKI-------PKYFVE-DVDRFKQEIEIMKSLDH 65
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
PNI+R T ++ + +++E GG + + F ES K +L + Y HK
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 189 GIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
+ HRD+K N L +KL DFG + + + ++ GTPY+++P+V L+
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM---RTKVGTPYYVSPQV-LE 181
Query: 246 TGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
+ D WS G V+ + G PP + EV GT ++S +A+
Sbjct: 182 GLYGPECDEWSAG--VMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE 239
Query: 303 DFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
+ + L K P R T+ + L+H + +
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 190 bits (485), Expect = 3e-55
Identities = 80/277 (28%), Positives = 121/277 (43%), Gaps = 20/277 (7%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
GE +G G F V +G A K I + ++E EV +LK + H
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVSILKEIQH 73
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
PN++ + ++LE V GG + L + S E + KQ+L G+ YLH
Sbjct: 74 PNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL 133
Query: 189 GIMHRDIKGANILVDNKGC----IKLADFGASKKVVELATINGAKSMK---GTPYWMAPE 241
I H D+K NI++ ++ IK+ DFG + K I+ K GTP ++APE
Sbjct: 134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK------IDFGNEFKNIFGTPEFVAPE 187
Query: 242 VILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLS 298
++ AD+WS+G VI + +G P QE A + + S
Sbjct: 188 IVNYEPLGLEADMWSIG--VITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS 245
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
AKDF+ + L K+P R T + LQHP++ K
Sbjct: 246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 282
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 5e-55
Identities = 75/301 (24%), Positives = 130/301 (43%), Gaps = 11/301 (3%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
W + +G GA+G V + +N + E +AVK V ++ +++E+ + K
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINK 60
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
L H N+V++ G RE + + LE+ GG + + PE + + QL+ G+ Y
Sbjct: 61 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
LH GI HRDIK N+L+D + +K++DFG + M GT ++APE++
Sbjct: 121 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 245 QTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
+ H+ D+WS G + M G+ PW Q K++ + +
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240
Query: 304 FLLKCLQKEPYLRSTASELLQHP-FVTG--KYQDPHPVFRNSVMESGNQIATPGMNLRNS 360
L K L + P R T ++ + + K V V ES + + + +
Sbjct: 241 LLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDF 300
Query: 361 M 361
Sbjct: 301 S 301
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 1e-54
Identities = 80/303 (26%), Positives = 135/303 (44%), Gaps = 22/303 (7%)
Query: 51 PALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQ 110
ALP T + E++G G V ++ + + AVK + + + +
Sbjct: 4 AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63
Query: 111 AHIRE-LEEEVKLLKNLT-HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPE 168
+RE +EV +L+ ++ HPNI++ T + ++ + + G + L + + E
Sbjct: 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 169 SVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228
R + LL + LHK I+HRD+K NIL+D+ IKL DFG S + ++
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ------LDPG 177
Query: 229 KSMK---GTPYWMAPEVI------LQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQ 276
+ ++ GTP ++APE+I G+ D+WS G VI + G PP W ++
Sbjct: 178 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTG--VIMYTLLAGSPPFWHRKQM 235
Query: 277 EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPH 336
+ + G + P + S KD + + L +P R TA E L HPF +
Sbjct: 236 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
Query: 337 PVF 339
F
Sbjct: 296 RHF 298
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-54
Identities = 73/286 (25%), Positives = 136/286 (47%), Gaps = 22/286 (7%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
E +G GAF V + + +G+ A + K+ + ++LE E ++ + L H
Sbjct: 16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINT------KKLSARDHQKLEREARICRLLKH 69
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
PNIVR + E+ ++ + V GG + + + E+ +Q+L + + H+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 189 GIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMK---GTPYWMAPEV 242
G++HR++K N+L+ +K +KLADFG + +V ++ GTP +++PEV
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-----EGEQQAWFGFAGTPGYLSPEV 184
Query: 243 ILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
+ + + D+W+ G VI + G PP W + + G P + ++
Sbjct: 185 LRKDPYGKPVDLWACG--VILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVME 345
EAKD + K L P R TA+E L+HP+++ + + R ++
Sbjct: 243 EAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVD 288
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 2e-54
Identities = 69/308 (22%), Positives = 127/308 (41%), Gaps = 38/308 (12%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
E +G G FG V+ + S + K V + +++E+ +L H
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFV---------KVKGTDQVLVKKEISILNIARH 60
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSI-SSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
NI+ + + L ++ EF+ G I + E I Y Q+ L++LH
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 188 NGIMHRDIKGANILVDNK--GCIKLADFGASKKVVELATINGAKSMK---GTPYWMAPEV 242
+ I H DI+ NI+ + IK+ +FG +++ + + + P + APEV
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ------LKPGDNFRLLFTAPEYYAPEV 174
Query: 243 ILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
S + D+WS+G + + +G P ++ Q++ + +S+
Sbjct: 175 HQHDVVSTATDMWSLG--TLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISI 232
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATPGMNLRN 359
EA DF+ + L KE R TASE LQHP++ K + + + R
Sbjct: 233 EAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV------------STKVIRTLKHRR 280
Query: 360 SMNSLVRR 367
++L+++
Sbjct: 281 YYHTLIKK 288
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 4e-54
Identities = 84/295 (28%), Positives = 138/295 (46%), Gaps = 28/295 (9%)
Query: 46 SKPAVPALPPIEKTDAPP-----IRWRK---GELVGCGAFGRVYMGMNLDSGELLAVKQV 97
S +P + A I W E +G G+FG V+ G +AVK +
Sbjct: 11 SDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKIL 68
Query: 98 LIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSIS 157
+ ++ + E EV ++K L HPNIV ++G + +L+I+ E++ GS+
Sbjct: 69 M------EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 158 SLLGKFGS---FPESVIRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVDNKGCIKLAD 212
LL K G+ E + G+ YLH I+HR++K N+LVD K +K+ D
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182
Query: 213 FGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVI--EMATGKPP 270
FG S+ ++ +T +KS GTP WMAPEV+ + +D++S G VI E+AT + P
Sbjct: 183 FGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFG--VILWELATLQQP 238
Query: 271 WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
W + +G IP +L+ + + C EP+ R + + ++
Sbjct: 239 WG-NLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDL 292
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-54
Identities = 50/325 (15%), Positives = 102/325 (31%), Gaps = 67/325 (20%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK----------------- 108
+ + +G G FG V+ N A+K++ + ++EK
Sbjct: 8 FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 109 ---------------------------------TQAHIRELEEEVKLLKNLTHPNIVRYL 135
+ + + +++ + + N V L
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 136 GTAREDDSLNILLEFVPGGSISSLLGK---FGSFPESVIRMYTKQLLLGLEYLHKNGIMH 192
+ L I ++ ++ + + V Q+ +E+LH G+MH
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187
Query: 193 RDIKGANILVDNKGCIKLADFG----------ASKKVVELATINGAKSMKGTPYWMAPEV 242
RD+K +NI +K+ DFG + + GT +M+PE
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247
Query: 243 ILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
I +S DI+S+G + E+ E + P + +
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLYSFST----QMERVRIITDVRNLKFPLLFTQKYPQEH 303
Query: 303 DFLLKCLQKEPYLRSTASELLQHPF 327
+ L P R A++++++
Sbjct: 304 MMVQDMLSPSPTERPEATDIIENAI 328
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 5e-54
Identities = 79/266 (29%), Positives = 139/266 (52%), Gaps = 19/266 (7%)
Query: 71 LVGCGAFGRVYM---GMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
++G G +G+V+ ++G++ A+K VL A K AH + E +L+ +
Sbjct: 24 VLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTAHTKA---ERNILEEVK 79
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
HP IV + + L ++LE++ GG + L + G F E Y ++ + L +LH+
Sbjct: 80 HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
GI++RD+K NI+++++G +KL DFG K+ + + GT +MAPE+++++G
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSG 197
Query: 248 HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH-IGTTKSHPPIPEHLSMEAKDFLL 306
H+ + D WS+G + +M TG PP++ + I K +P +L+ EA+D L
Sbjct: 198 HNRAVDWWSLGALMYDMLTGAPPFTG--ENRKKTIDKI--LKCKLNLPPYLTQEARDLLK 253
Query: 307 KCLQKEPYLR-----STASELLQHPF 327
K L++ R A E+ HPF
Sbjct: 254 KLLKRNAASRLGAGPGDAGEVQAHPF 279
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 6e-54
Identities = 69/286 (24%), Positives = 128/286 (44%), Gaps = 25/286 (8%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
E +G GAFG V+ + +G + K + ++ E+ ++ L H
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVFVAKFI--------NTPYPLDKYTVKNEISIMNQLHH 107
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSI-SSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
P ++ + + ++LEF+ GG + + + E+ + Y +Q GL+++H+
Sbjct: 108 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 167
Query: 188 NGIMHRDIKGANILVDNKG--CIKLADFGASKKVVELATINGAKSMK---GTPYWMAPEV 242
+ I+H DIK NI+ + K +K+ DFG + K +N + +K T + APE+
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATK------LNPDEIVKVTTATAEFAAPEI 221
Query: 243 ILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
+ + F D+W++G V+ + +G P + E + +S
Sbjct: 222 VDREPVGFYTDMWAIG--VLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 279
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVME 345
EAKDF+ LQKEP R T + L+HP++ G + + +S
Sbjct: 280 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYN 325
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 8e-54
Identities = 74/326 (22%), Positives = 136/326 (41%), Gaps = 37/326 (11%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
K + +G G+F ++ S + AVK + SK ++E+ LK
Sbjct: 15 KDKPLGEGSFSICRKCVHKKSNQAFAVKII-------SKRM----EANTQKEITALKLCE 63
Query: 128 -HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
HPNIV+ + +++E + GG + + K F E+ ++L+ + ++H
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMH 123
Query: 187 KNGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMK---GTPYWMAP 240
G++HRD+K N+L ++ IK+ DFG ++ + +K T ++ AP
Sbjct: 124 DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-----DNQPLKTPCFTLHYAAP 178
Query: 241 EVILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAA----LFH-IGTTKSHPP 292
E++ Q G+ S D+WS+G VI M +G+ P S + I
Sbjct: 179 ELLNQNGYDESCDLWSLG--VILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE 236
Query: 293 IPE--HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP-HPVFRNSVMESGNQ 349
++S EAKD + L +P R S L + ++ Q +P+ ++ S
Sbjct: 237 GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGA 296
Query: 350 IATPGMNLR-NSMNSLVRRSTGLKDV 374
+ ++ N R L++V
Sbjct: 297 AVHTCVKATFHAFNKYKREGFCLQNV 322
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-53
Identities = 78/274 (28%), Positives = 129/274 (47%), Gaps = 30/274 (10%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+G GA VY + + A+K + K + + E+ +L L+H
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVL----------KKTVDKKIVRTEIGVLLRLSH 107
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN 188
PNI++ ++++LE V GG + + + G + E KQ+L + YLH+N
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 189 GIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
GI+HRD+K N+L +K+ADFG SK V + K++ GTP + APE++
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM---KTVCGTPGYCAPEILRG 224
Query: 246 TGHSFSADIWSVGCTVIE--MATGKPP-WSQQ-----FQEVAALFHIGTTKSHPPIPEHL 297
+ D+WSVG +I + G P + ++ F+ + P + +
Sbjct: 225 CAYGPEVDMWSVG--IITYILLCGFEPFYDERGDQFMFRRILN----CEYYFISPWWDEV 278
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331
S+ AKD + K + +P R T + LQHP+VTGK
Sbjct: 279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 4e-53
Identities = 70/296 (23%), Positives = 115/296 (38%), Gaps = 25/296 (8%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
W E +G G FG V ++ D+GE +A+KQ +E + + E++++K
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQC-------RQELSPKNRERWCLEIQIMK 67
Query: 125 NLTHPNIVR------YLGTAREDDSLNILLEFVPGGSISSLL---GKFGSFPESVIRMYT 175
L HPN+V L +D + +E+ GG + L E IR
Sbjct: 68 KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLL 127
Query: 176 KQLLLGLEYLHKNGIMHRDIKGANILVD---NKGCIKLADFGASKKVVELATINGAKSMK 232
+ L YLH+N I+HRD+K NI++ + K+ D G +K EL
Sbjct: 128 SDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCTEFV 184
Query: 233 GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP 292
GT ++APE++ Q ++ + D WS G E TG P+ +Q V +H +
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV--QWHGKVREKSNE 242
Query: 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGN 348
+ P S ++ H R + ++ N
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMW-HQRQRGTDPQNPN 297
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-53
Identities = 91/270 (33%), Positives = 147/270 (54%), Gaps = 19/270 (7%)
Query: 71 LVGCGAFGRVYM---GMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
++G GA+G+V++ D+G+L A+K VL A K KT H R E +V L
Sbjct: 61 VLGTGAYGKVFLVRKISGHDTGKLYAMK-VLKKATIVQKAKTTEHTR-TERQV-LEHIRQ 117
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
P +V + + L+++L+++ GG + + L + F E +++Y +++L LE+LHK
Sbjct: 118 SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHK 177
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL--Q 245
GI++RDIK NIL+D+ G + L DFG SK+ V T A GT +MAP+++
Sbjct: 178 LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGD 236
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFH-IGTTKSHPPIPEHLSMEAK 302
+GH + D WS+G + E+ TG P++ ++ A + I KS PP P+ +S AK
Sbjct: 237 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI--LKSEPPYPQEMSALAK 294
Query: 303 DFLLKCLQKEPYLR-----STASELLQHPF 327
D + + L K+P R A E+ +H F
Sbjct: 295 DLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 5e-53
Identities = 87/266 (32%), Positives = 139/266 (52%), Gaps = 21/266 (7%)
Query: 71 LVGCGAFGRVYM---GMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
++G G+FG+V++ D+ +L A+K VL A K + + + E +L +
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMK-VLKKATL--KVRDRVRTKM---ERDILVEVN 84
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
HP IV+ + + L ++L+F+ GG + + L K F E ++ Y +L L L++LH
Sbjct: 85 HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS 144
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
GI++RD+K NIL+D +G IKL DFG SK+ ++ A S GT +MAPEV+ + G
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRG 202
Query: 248 HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH-IGTTKSHPPIPEHLSMEAKDFLL 306
H+ SAD WS G + EM TG P+ ++ I K+ +P+ LS EA+ L
Sbjct: 203 HTQSADWWSFGVLMFEMLTGTLPFQG--KDRKETMTMI--LKAKLGMPQFLSPEAQSLLR 258
Query: 307 KCLQKEPYLR-----STASELLQHPF 327
++ P R E+ +H F
Sbjct: 259 MLFKRNPANRLGAGPDGVEEIKRHSF 284
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-53
Identities = 75/277 (27%), Positives = 132/277 (47%), Gaps = 25/277 (9%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
K E++G G FG+V+ +G LA K + K + E++ E+ ++ L
Sbjct: 93 KTEILGGGRFGQVHKCEETATGLKLAAKII--------KTRGMKDKEEVKNEISVMNQLD 144
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSI-SSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
H N+++ + + +++E+V GG + ++ + + E ++ KQ+ G+ ++H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204
Query: 187 KNGIMHRDIKGANILVDNKG--CIKLADFGASKKVVELATINGAKSMK---GTPYWMAPE 241
+ I+H D+K NIL N+ IK+ DFG +++ + +K GTP ++APE
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLARR------YKPREKLKVNFGTPEFLAPE 258
Query: 242 VILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLS 298
V+ SF D+WSVG VI + +G P E + +S
Sbjct: 259 VVNYDFVSFPTDMWSVG--VIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDIS 316
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
EAK+F+ K L KE R +ASE L+HP+++
Sbjct: 317 EEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHS 353
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 1e-52
Identities = 79/294 (26%), Positives = 131/294 (44%), Gaps = 39/294 (13%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVK------------------QVLIAANSASK 106
++ + +G G++G V + N + A+K
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 107 EKTQAHIRELEEEVKLLKNLTHPNIVR-Y--LGTAREDDSLNILLEFVPGGSISSLLGKF 163
+ + I ++ +E+ +LK L HPN+V+ L +D L ++ E V G + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDP-NEDHLYMVFELVNQGPVMEVPTL- 131
Query: 164 GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223
E R Y + L+ G+EYLH I+HRDIK +N+LV G IK+ADFG S
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS------N 185
Query: 224 TINGAKSMK----GTPYWMAPEVILQTGHSFS---ADIWSVGCTVIEMATGKPPWSQQFQ 276
G+ ++ GTP +MAPE + +T FS D+W++G T+ G+ P+ +
Sbjct: 186 EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER- 244
Query: 277 EVAALFH-IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
+ L I + P ++ + KD + + L K P R E+ HP+VT
Sbjct: 245 -IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 3e-52
Identities = 80/346 (23%), Positives = 143/346 (41%), Gaps = 39/346 (11%)
Query: 47 KPAVPALPPIEKTDAPPIR--WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSA 104
V ++ ++ + E +G G++ ++ + AVK +
Sbjct: 3 TVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII------- 55
Query: 105 SKEKTQAHIRELEEEVK-LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF 163
K K R+ EE++ LL+ HPNI+ + + ++ E + GG + + +
Sbjct: 56 DKSK-----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ 110
Query: 164 GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV----DNKGCIKLADFGASKKV 219
F E + +EYLH G++HRD+K +NIL N I++ DFG +K++
Sbjct: 111 KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170
Query: 220 VELATINGAKSMK---GTPYWMAPEVILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQ 273
+ T ++APEV+ + G+ + DIWS+G V+ M TG P +
Sbjct: 171 RA-----ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLG--VLLYTMLTGYTPFANG 223
Query: 274 QFQEVAALFH-IGTTKSHPPIPE--HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330
+ IG+ K +S AKD + K L +P+ R TA+ +L+HP++
Sbjct: 224 PDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283
Query: 331 KYQDPHPVFRNSVMESGNQIATPGMNLRNSMNSLVRRSTGLKDVCE 376
Q P + A +++N +S L+ V
Sbjct: 284 WDQLPQYQLNRQDAPHLVKGAMAATY--SALNRN--QSPVLEPVGR 325
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 3e-52
Identities = 68/283 (24%), Positives = 117/283 (41%), Gaps = 30/283 (10%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
+ +G G F V ++ +G+ A K + + + Q E+ E+ +L+
Sbjct: 33 TSKELGRGKFAVVRQCISKSTGQEYAAKFL------KKRRRGQDCRAEILHEIAVLELAK 86
Query: 128 H-PNIVRYLGTAREDDSLNILLEFVPGG----SISSLLGKFGSFPESVIRMYTKQLLLGL 182
P ++ + ++LE+ GG E+ + KQ+L G+
Sbjct: 87 SCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGV 144
Query: 183 EYLHKNGIMHRDIKGANILVDNK---GCIKLADFGASKKVVELATINGAKSMK---GTPY 236
YLH+N I+H D+K NIL+ + G IK+ DFG S+K I A ++ GTP
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRK------IGHACELREIMGTPE 198
Query: 237 WMAPEVILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPI 293
++APE++ + + D+W++G +I + T P + QE
Sbjct: 199 YLAPEILNYDPITTATDMWNIG--IIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256
Query: 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPH 336
+S A DF+ L K P R TA L H ++ +
Sbjct: 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 3e-52
Identities = 71/274 (25%), Positives = 127/274 (46%), Gaps = 21/274 (7%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT- 127
+++G G V ++ +G AVK + + A S E+ + E +L+ +
Sbjct: 99 KDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAG 158
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
HP+I+ + + + ++ + + G + L + + E R + LL + +LH
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK---GTPYWMAPEVI- 243
N I+HRD+K NIL+D+ I+L+DFG S + + ++ GTP ++APE++
Sbjct: 219 NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP------GEKLRELCGTPGYLAPEILK 272
Query: 244 -----LQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPE 295
G+ D+W+ G VI + G PP W ++ + + G + P +
Sbjct: 273 CSMDETHPGYGKEVDLWACG--VILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
S KD + + LQ +P R TA + LQHPF
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 182 bits (465), Expect = 4e-52
Identities = 78/304 (25%), Positives = 131/304 (43%), Gaps = 61/304 (20%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKE--KTQAHIRELEEEVKL 122
R+ K + +G G F VY + ++ +++A+K++ + S +K+ A +RE +KL
Sbjct: 11 RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA-LRE----IKL 65
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLG 181
L+ L+HPNI+ L +++++ +F+ + ++ S I+ Y L G
Sbjct: 66 LQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQG 124
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY----- 236
LEYLH++ I+HRD+K N+L+D G +KLADFG LA + Y
Sbjct: 125 LEYLHQHWILHRDLKPNNLLLDENGVLKLADFG-------LAK---SFGSPNRAYTHQVV 174
Query: 237 --WM-APEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQ---EVAALFHI----G 285
W APE++ D+W+VGC + E+ P ++ L I G
Sbjct: 175 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP----FLPGDSDLDQLTRIFETLG 230
Query: 286 T-----------------TKSHPPIP-----EHLSMEAKDFLLKCLQKEPYLRSTASELL 323
T KS P IP + D + P R TA++ L
Sbjct: 231 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 290
Query: 324 QHPF 327
+ +
Sbjct: 291 KMKY 294
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 5e-52
Identities = 69/272 (25%), Positives = 118/272 (43%), Gaps = 25/272 (9%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
E +G GAFG V+ +G A K V ++ + +E++ + L H
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNFAAKFV--------MTPHESDKETVRKEIQTMSVLRH 213
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSI-SSLLGKFGSFPESVIRMYTKQLLLGLEYLHK 187
P +V +D+ + ++ EF+ GG + + + E Y +Q+ GL ++H+
Sbjct: 214 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273
Query: 188 NGIMHRDIKGANILVDNKG--CIKLADFGASKKVVELATINGAKSMK---GTPYWMAPEV 242
N +H D+K NI+ K +KL DFG + ++ +S+K GT + APEV
Sbjct: 274 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH------LDPKQSVKVTTGTAEFAAPEV 327
Query: 243 ILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
+ D+WSVG V+ + +G P + E +S
Sbjct: 328 AEGKPVGYYTDMWSVG--VLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE 385
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331
+ KDF+ K L +P R T + L+HP++T
Sbjct: 386 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 8e-52
Identities = 65/279 (23%), Positives = 120/279 (43%), Gaps = 28/279 (10%)
Query: 64 IRWRK---GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV 120
R GE++G G FG+ + ++GE++ +K++ + R +EV
Sbjct: 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKEL--------IRFDEETQRTFLKEV 58
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLL 179
K+++ L HPN+++++G +D LN + E++ GG++ ++ +P S + K +
Sbjct: 59 KVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIA 118
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA----------- 228
G+ YLH I+HRD+ N LV + +ADFG ++ +V+ T
Sbjct: 119 SGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178
Query: 229 -KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWS--QQFQEVAALFHIG 285
++ G PYWMAPE+I + D++S G + E+ L G
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238
Query: 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
P + ++C +P R + +L
Sbjct: 239 --FLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-51
Identities = 65/264 (24%), Positives = 122/264 (46%), Gaps = 26/264 (9%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
E+VG GAFG V + +A+KQ+ ++++ + E++ L + H
Sbjct: 13 EEVVGRGAFGVVCKAKW--RAKDVAIKQI----------ESESERKAFIVELRQLSRVNH 60
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL---LGLEYL 185
PNIV+ G + + +++E+ GGS+ ++L P L G+ YL
Sbjct: 61 PNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 186 HK---NGIMHRDIKGANILVDNKG-CIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
H ++HRD+K N+L+ G +K+ DFG + + T + KG+ WMAPE
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT-----NNKGSAAWMAPE 173
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301
V + +S D++S G + E+ T + P+ + + + PP+ ++L
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI 233
Query: 302 KDFLLKCLQKEPYLRSTASELLQH 325
+ + +C K+P R + E+++
Sbjct: 234 ESLMTRCWSKDPSQRPSMEEIVKI 257
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-51
Identities = 82/312 (26%), Positives = 131/312 (41%), Gaps = 79/312 (25%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEE------ 118
+ K + +G G + VY G + + L+A+K++ + E EE
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRL---------------EHEEGAPCTA 47
Query: 119 --EVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-----GSFPESVI 171
EV LLK+L H NIV + SL ++ E++ L ++ +
Sbjct: 48 IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-----DKDLKQYLDDCGNIINMHNV 102
Query: 172 RMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSM 231
+++ QLL GL Y H+ ++HRD+K N+L++ +G +KLADFG LA AKS+
Sbjct: 103 KLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFG-------LAR---AKSI 152
Query: 232 KGTPY-------WM-APEVIL-QTGHSFSADIWSVGCTVIEMATGKP------------- 269
Y W P+++L T +S D+W VGC EMATG+P
Sbjct: 153 PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF 212
Query: 270 -------PWSQQFQEVAAL--FHIGTTKSHPPIP-----EHLSMEAKDFLLKCLQKEPYL 315
P + + + + F + L + D L K LQ E
Sbjct: 213 IFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRN 272
Query: 316 RSTASELLQHPF 327
R +A + ++HPF
Sbjct: 273 RISAEDAMKHPF 284
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-51
Identities = 82/267 (30%), Positives = 127/267 (47%), Gaps = 25/267 (9%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
L+G G FG+V + +G A+K +V+I + AH E ++L+N
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVII------AKDEVAHTVT---ESRVLQNT 62
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
HP + + D L ++E+ GG + L + F E R Y +++ LEYLH
Sbjct: 63 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
+++RDIK N+++D G IK+ DFG K+ + K+ GTP ++APEV+
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDN 180
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH-IGTTKSHPPIPEHLSMEAKDFL 305
+ + D W +G + EM G+ P+ Q E LF I P LS EAK L
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELI--LMEEIRFPRTLSPEAKSLL 236
Query: 306 LKCLQKEPYLR-----STASELLQHPF 327
L+K+P R S A E+++H F
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRF 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-51
Identities = 77/266 (28%), Positives = 129/266 (48%), Gaps = 23/266 (8%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++G G+FG+V + + AVK + ++ K+K + HI E V LLKN+
Sbjct: 45 VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL------KKKEEKHIM-SERNV-LLKNV 96
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
HP +V + + D L +L+++ GG + L + F E R Y ++ L YLH
Sbjct: 97 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
I++RD+K NIL+D++G I L DFG K+ +E + + GTP ++APEV+ +
Sbjct: 157 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQ 214
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH-IGTTKSHPPIPEHLSMEAKDFL 305
+ + D W +G + EM G PP+ + A ++ I + +++ A+ L
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYS--RNTAEMYDNI--LNKPLQLKPNITNSARHLL 270
Query: 306 LKCLQKEPYLR----STASELLQHPF 327
LQK+ R E+ H F
Sbjct: 271 EGLLQKDRTKRLGAKDDFMEIKSHVF 296
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 4e-51
Identities = 83/306 (27%), Positives = 127/306 (41%), Gaps = 66/306 (21%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK----TQAHIRELEEEV 120
++ K E +G G +G V+ N ++ E++A+K+V + + + A +RE +
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL-----DDDDEGVPSSA-LRE----I 52
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-----GSFPESVIRMYT 175
LLK L H NIVR D L ++ EF L K+ G +++ +
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-----DQDLKKYFDSCNGDLDPEIVKSFL 107
Query: 176 KQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP 235
QLL GL + H ++HRD+K N+L++ G +KLA+FG LA G +
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFG-------LARAFGIPVRCYSA 160
Query: 236 ------YWMAPEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI---- 284
Y P+V+ +S S D+WS GC E+A P L I
Sbjct: 161 EVVTLWYR-PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 219
Query: 285 GT--------------TKSHPPIPE---------HLSMEAKDFLLKCLQKEPYLRSTASE 321
GT K +P P L+ +D L L+ P R +A E
Sbjct: 220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEE 279
Query: 322 LLQHPF 327
LQHP+
Sbjct: 280 ALQHPY 285
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-51
Identities = 78/278 (28%), Positives = 129/278 (46%), Gaps = 30/278 (10%)
Query: 64 IRWRK---GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV 120
I + + E++G G FG+VY + G+ +AVK AA E I + +E
Sbjct: 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVK----AARHDPDEDISQTIENVRQEA 57
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
KL L HPNI+ G ++ +L +++EF GG ++ +L P+ ++ Q+
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW-AVQIAR 116
Query: 181 GLEYLHKNG---IMHRDIKGANILVDNKG--------CIKLADFGASKKVVELATINGAK 229
G+ YLH I+HRD+K +NIL+ K +K+ DFG +++
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR----TTKM 172
Query: 230 SMKGTPYWMAPEVILQTGHSFSADIWSVGCTVI--EMATGKPPWSQQFQEVAALFHIGTT 287
S G WMAPEVI + S +D+WS G V+ E+ TG+ P+ + +A + +
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYG--VLLWELLTGEVPF-RGIDGLAVAYGVAMN 229
Query: 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
K PIP + C +P+ R + + +L
Sbjct: 230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-51
Identities = 76/300 (25%), Positives = 132/300 (44%), Gaps = 44/300 (14%)
Query: 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRE-LEEEVKLLKNL 126
+ +++G GA RV +NL + + AVK + EK HIR + EV++L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKII---------EKQPGHIRSRVFREVEMLYQC 67
Query: 127 T-HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
H N++ + E+D ++ E + GGSI S + K F E + + + L++L
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFL 127
Query: 186 HKNGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMK-----GTPYW 237
H GI HRD+K NIL ++ +K+ DF + + + + G+ +
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 238 MAPEVI-----LQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVAALFHIGTTKS 289
MAPEV+ + + D+WS+G VI + +G PP + +
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLG--VILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245
Query: 290 HPPI-------------PE--HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334
+ + H+S AKD + K L ++ R +A+++LQHP+V G +
Sbjct: 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 7e-51
Identities = 87/320 (27%), Positives = 135/320 (42%), Gaps = 86/320 (26%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEE------ 118
++++ E +G G + VY G+N +G +A+K+V + + EE
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKL---------------DSEEGTPSTA 50
Query: 119 --EVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVP---GGSISSLLGKF--GSFPESVI 171
E+ L+K L H NIVR ++ L ++ EF+ + S +++
Sbjct: 51 IREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV 110
Query: 172 RMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSM 231
+ + QLL GL + H+N I+HRD+K N+L++ +G +KL DFG LA A +
Sbjct: 111 KYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFG-------LA---RAFGI 160
Query: 232 KGTPY-------WM-APEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ---EVA 279
+ W AP+V++ +S S DIWS GC + EM TGKP F +
Sbjct: 161 PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPL----FPGTNDEE 216
Query: 280 ALFHI----GT------------------TKSHPPIP----------EHLSMEAKDFLLK 307
L I GT + PP E L DFL
Sbjct: 217 QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHG 276
Query: 308 CLQKEPYLRSTASELLQHPF 327
LQ P +R +A + L HP+
Sbjct: 277 LLQLNPDMRLSAKQALHHPW 296
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 1e-50
Identities = 70/268 (26%), Positives = 125/268 (46%), Gaps = 22/268 (8%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEV-KLLKN 125
++G G FG VY D+G++ A+K + + ++ + E + L+
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK------MKQGETLAL-NERIMLSLVST 248
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
P IV D L+ +L+ + GG + L + G F E+ +R Y +++LGLE++
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL- 244
H +++RD+K ANIL+D G ++++D G + + + GT +MAPEV+
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQK 364
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
+ SAD +S+GC + ++ G P+ Q + T +P+ S E +
Sbjct: 365 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSL 424
Query: 305 LLKCLQKEPYLR-----STASELLQHPF 327
L LQ++ R A E+ + PF
Sbjct: 425 LEGLLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 1e-50
Identities = 73/267 (27%), Positives = 132/267 (49%), Gaps = 20/267 (7%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
++G GAFG V + + + ++ A+K +L + + A E E ++ P
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMK-LLSKFEMIKRSDS-AFFWE---ERDIMAFANSPW 130
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGI 190
+V+ ++D L +++E++PGG + +L+ + PE R YT +++L L+ +H G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGF 189
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG--- 247
+HRD+K N+L+D G +KLADFG K+ + + + GTP +++PEV+ G
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDG 248
Query: 248 -HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH-IGTTKSHPPIPEH--LSMEAKD 303
+ D WSVG + EM G P+ + + I K+ P+ +S EAK+
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPFYA--DSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306
Query: 304 FLLKCLQKEPYLR---STASELLQHPF 327
L+ + +R + E+ +H F
Sbjct: 307 -LICAFLTDREVRLGRNGVEEIKRHLF 332
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 2e-50
Identities = 74/272 (27%), Positives = 123/272 (45%), Gaps = 27/272 (9%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++G G FG V+ +G+L A K + L K K E K+L +
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKKRLK------KRKGYQGAMV---EKKILAKV 242
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGS----ISSLLGKFGSFPESVIRMYTKQLLLGL 182
IV L +++ + GG I ++ F E YT Q++ GL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
E+LH+ I++RD+K N+L+D+ G ++++D G + ++ T K GTP +MAPE+
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPEL 360
Query: 243 ILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAA--LFHIGTTKSHPPIPEHLSME 300
+L + FS D +++G T+ EM + P+ + ++V L + P+ S
Sbjct: 361 LLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR-VLEQAVTYPDKFSPA 419
Query: 301 AKDFLLKCLQKEPYLR-----STASELLQHPF 327
+KDF LQK+P R + L HP
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 4e-50
Identities = 76/312 (24%), Positives = 121/312 (38%), Gaps = 74/312 (23%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK----TQAHIRELEEEV 120
R+R+ +G G +G VY ++ + E +A+K++ + E+ A IRE V
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL-----EHEEEGVPGTA-IRE----V 84
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
LLK L H NI+ + L+++ E+ + + K VI+ + QL+
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 181 GLEYLHKNGIMHRDIKGANILVD-----NKGCIKLADFGASKKVVELATINGAKSMKGTP 235
G+ + H +HRD+K N+L+ +K+ DFG LA A +
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFG-------LAR---AFGIPIRQ 193
Query: 236 Y-------WM-APEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ---EVAALFH 283
+ W PE++L +S S DIWS+ C EM P F E+ LF
Sbjct: 194 FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPL----FPGDSEIDQLFK 249
Query: 284 I----GT------------------TKSHPP------IPEHLSMEAKDFLLKCLQKEPYL 315
I G + L E D L L+ +P
Sbjct: 250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVK 309
Query: 316 RSTASELLQHPF 327
R +A L+HP+
Sbjct: 310 RISAKNALEHPY 321
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 7e-50
Identities = 66/265 (24%), Positives = 123/265 (46%), Gaps = 19/265 (7%)
Query: 69 GELVGCGAFGRVYMGM-NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT 127
G+ +G G+FG VY G + G++ AVK + + T ++ + EV +L+
Sbjct: 29 GQRIGSGSFGTVYKGKWH---GDV-AVKMLNV------TAPTPQQLQAFKNEVGVLRKTR 78
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLEYLH 186
H NI+ ++G + L I+ ++ G S+ L F + +Q G++YLH
Sbjct: 79 HVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH 137
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
I+HRD+K NI + +K+ DFG + + + + + + G+ WMAPEVI
Sbjct: 138 AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 247 GH---SFSADIWSVGCTVIEMATGKPPWS--QQFQEVAALFHIGTTK-SHPPIPEHLSME 300
SF +D+++ G + E+ TG+ P+S ++ + G+ + +
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKR 257
Query: 301 AKDFLLKCLQKEPYLRSTASELLQH 325
K + +CL+K+ R + +L
Sbjct: 258 MKRLMAECLKKKRDERPSFPRILAE 282
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-49
Identities = 74/276 (26%), Positives = 131/276 (47%), Gaps = 32/276 (11%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKE-----KTQAHIRELEEEVKLLKN 125
++G G++ +V + + + A+K V+ KE + ++ E+ V +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMK-VV------KKELVNDDEDIDWVQ-TEKHV-FEQA 66
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
HP +V + + L ++E+V GG + + + PE R Y+ ++ L L YL
Sbjct: 67 SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYL 126
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
H+ GI++RD+K N+L+D++G IKL D+G K+ L + + GTP ++APE++
Sbjct: 127 HERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRG 184
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAA-------LFH-IGTTKSHPPIPEHL 297
+ FS D W++G + EM G+ P+ LF I + IP L
Sbjct: 185 EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSL 242
Query: 298 SMEAKDFLLKCLQKEPYLR------STASELLQHPF 327
S++A L L K+P R + +++ HPF
Sbjct: 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-49
Identities = 74/270 (27%), Positives = 128/270 (47%), Gaps = 26/270 (9%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++G G FG V +G++ A K + + K K +A E ++L+ +
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIK------KRKGEAMALN---EKQILEKV 241
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEY 184
+V D+L ++L + GG + + G FPE+ Y ++ GLE
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
LH+ I++RD+K NIL+D+ G I+++D G + V E TI GT +MAPEV+
Sbjct: 302 LHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK---GRVGTVGYMAPEVVK 358
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAA--LFHIGTTKSHPPIPEHLSMEAK 302
++FS D W++GC + EM G+ P+ Q+ +++ + + E S +A+
Sbjct: 359 NERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER-LVKEVPEEYSERFSPQAR 417
Query: 303 DFLLKCLQKEPYLR-----STASELLQHPF 327
+ L K+P R +A E+ +HP
Sbjct: 418 SLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 85/311 (27%), Positives = 127/311 (40%), Gaps = 78/311 (25%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK----TQAHIRELEEEV 120
++ E +G G +G VY N + GE A+K++ + KE + IRE +
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRL-----EKEDEGIPSTT-IRE----I 51
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-----GSFPESVIRMYT 175
+LK L H NIV+ L ++ E + L K G + +
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHL-----DQDLKKLLDVCEGGLESVTAKSFL 106
Query: 176 KQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP 235
QLL G+ Y H ++HRD+K N+L++ +G +K+ADFG LA A +
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFG-------LAR---AFGIPVRK 156
Query: 236 Y-------WM-APEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ---EVAALFH 283
Y W AP+V++ +S + DIWSVGC EM G P F E L
Sbjct: 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL----FPGVSEADQLMR 212
Query: 284 I----GT------------------TKSHPPIP-----EHLSMEAKDFLLKCLQKEPYLR 316
I GT + P+P + L D L K L+ +P R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 317 STASELLQHPF 327
TA + L+H +
Sbjct: 273 ITAKQALEHAY 283
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 2e-49
Identities = 73/269 (27%), Positives = 136/269 (50%), Gaps = 20/269 (7%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
++G GAFG V + ++ ++ A+K +L + +T A RE E +L N
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMK-ILNKWEMLKRAET-ACFRE---ERDVLVNGDSKW 135
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNG 189
I ++D++L +++++ GG + +LL KF PE + R Y ++++ ++ +H+
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL----- 244
+HRDIK NIL+D G I+LADFG+ K++E T+ + GTP +++PE++
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGG 254
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH-IGTTKSHPPIPEH---LSME 300
+ + D WS+G + EM G+ P+ + + + I K P +S
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGKIMNHKERFQFPTQVTDVSEN 312
Query: 301 AKDFLLKCLQKEPY-L-RSTASELLQHPF 327
AKD + + + + L ++ + +HPF
Sbjct: 313 AKDLIRRLICSREHRLGQNGIEDFKKHPF 341
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-49
Identities = 69/299 (23%), Positives = 118/299 (39%), Gaps = 39/299 (13%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R R ++ G F VY ++ SG A+K++L + R + +EV +K
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLS--------NEEEKNRAIIQEVCFMK 80
Query: 125 NLT-HPNIVRYLGTAREDDSLN--------ILLEFVPGGSISSLL--GKFGSFPESVIRM 173
L+ HPNIV++ A + +L E G + L G +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 174 YTKQLLLGLEYLHKNG--IMHRDIKGANILVDNKGCIKLADFG----------ASKKVVE 221
Q ++++H+ I+HRD+K N+L+ N+G IKL DFG S
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 222 LATINGAKSMKGTPYWMAPEVILQTGH---SFSADIWSVGCTVIEMATGKPPWSQQFQEV 278
A + + TP + PE+I + DIW++GC + + + P F++
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP----FEDG 256
Query: 279 AALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHP 337
A L I K P + + LQ P R + +E++ ++ +P
Sbjct: 257 AKL-RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNP 314
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 2e-49
Identities = 89/312 (28%), Positives = 123/312 (39%), Gaps = 71/312 (22%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAH----IRELEEEV 120
R+ +G GA+G VY + SG +A+K V + +RE V
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV---PNGGGGGGGLPISTVRE----V 62
Query: 121 KLLKNL---THPNIVRYL-----GTAREDDSLNILLEFVP---GGSISSLLGKFGSFPES 169
LL+ L HPN+VR + + + ++ E V + P
Sbjct: 63 ALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG--LPAE 120
Query: 170 VIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAK 229
I+ +Q L GL++LH N I+HRD+K NILV + G +KLADFG LA I
Sbjct: 121 TIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG-------LARIYS-Y 172
Query: 230 SMKGTP------YWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ---EVAA 280
M TP Y APEV+LQ+ ++ D+WSVGC EM KP F E
Sbjct: 173 QMALTPVVVTLWYR-APEVLLQSTYATPVDMWSVGCIFAEMFRRKP----LFCGNSEADQ 227
Query: 281 LFHI----GT----------------TKSHPPIP-----EHLSMEAKDFLLKCLQKEPYL 315
L I G P P + LL+ L P+
Sbjct: 228 LGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHK 287
Query: 316 RSTASELLQHPF 327
R +A LQH +
Sbjct: 288 RISAFRALQHSY 299
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-49
Identities = 74/284 (26%), Positives = 132/284 (46%), Gaps = 28/284 (9%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAH---IRELEEEVK 121
++ G+L+G G++G+V ++ ++ AVK + K+K + +++E++
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKIL-------KKKKLRRIPNGEANVKKEIQ 58
Query: 122 LLKNLTHPNIVR-Y--LGTAREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTK 176
LL+ L H N+++ L + + +++E+ G +L FP Y
Sbjct: 59 LLRRLRHKNVIQLVDVLYNEEKQK-MYMVMEYCVCGM-QEMLDSVPEKRFPVCQAHGYFC 116
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY 236
QL+ GLEYLH GI+H+DIK N+L+ G +K++ G ++ + A + ++ +G+P
Sbjct: 117 QLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 237 WMAPEVILQTG--HSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFH-IGTTKSHP 291
+ PE+ F DIWS G T+ + TG P F+ + LF IG
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP----FEGDNIYKLFENIGKGSYA- 231
Query: 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
IP D L L+ EP R + ++ QH + K+
Sbjct: 232 -IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPA 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 66/281 (23%), Positives = 129/281 (45%), Gaps = 27/281 (9%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK-TQAHIRELEEEVKLL 123
+R + +G G F +V + ++ +G +A+K + K + +++L EV+++
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKII-------DKTQLNPTSLQKLFREVRIM 68
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLE 183
K L HPNIV+ + +L +++E+ GG + L G E R +Q++ ++
Sbjct: 69 KILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ 128
Query: 184 YLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK---GTPYWMAP 240
Y H+ I+HRD+K N+L+D IK+ADFG S + G P + AP
Sbjct: 129 YCHQKRIVHRDLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDAFCGAPPYAAP 182
Query: 241 EVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALF-HIGTTKSHPPIPEH 296
E+ D+WS+G + + +G P F + L + + IP +
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLP----FDGQNLKELRERV--LRGKYRIPFY 236
Query: 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHP 337
+S + ++ L + L P R T ++++ ++ +++
Sbjct: 237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL 277
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-49
Identities = 80/263 (30%), Positives = 132/263 (50%), Gaps = 20/263 (7%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++G G+FG+V++ + + A+K V++ + +E+ V L
Sbjct: 24 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL------MDDDVECTM-VEKRV-LSLAW 75
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
HP + T + ++L ++E++ GG + + F S Y +++LGL++LH
Sbjct: 76 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
GI++RD+K NIL+D G IK+ADFG K+ + + GTP ++APE++L
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQ 193
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH-IGTTKSHPPIPEHLSMEAKDFL 305
++ S D WS G + EM G+ P+ Q +E LFH I +P P L EAKD L
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFHSI--RMDNPFYPRWLEKEAKDLL 249
Query: 306 LKCLQKEPYLR-STASELLQHPF 327
+K +EP R ++ QHP
Sbjct: 250 VKLFVREPEKRLGVRGDIRQHPL 272
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-49
Identities = 73/268 (27%), Positives = 128/268 (47%), Gaps = 25/268 (9%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++G G+FG+V + ++G+L AVK V++ ++ E+ + L
Sbjct: 30 VLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL------QDDDVECTM-TEKRI-LSLAR 81
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
HP + + + D L ++EFV GG + + K F E+ R Y +++ L +LH
Sbjct: 82 NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLH 141
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
GI++RD+K N+L+D++G KLADFG K+ + + GTP ++APE++ +
Sbjct: 142 DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE--GICNGVTTATFCGTPDYIAPEILQEM 199
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH-IGTTKSHPPIPEHLSMEAKDFL 305
+ + D W++G + EM G P+ + ++ LF I P L +A L
Sbjct: 200 LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD--LFEAI--LNDEVVYPTWLHEDATGIL 255
Query: 306 LKCLQKEPYLR------STASELLQHPF 327
+ K P +R +L+HPF
Sbjct: 256 KSFMTKNPTMRLGSLTQGGEHAILRHPF 283
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 6e-49
Identities = 88/305 (28%), Positives = 132/305 (43%), Gaps = 65/305 (21%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK----TQAHIRELEEEV 120
+++K E VG G +G VY + G ++A+K++ + E + A IRE +
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRL-----DAEDEGIPSTA-IRE----I 70
Query: 121 KLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
LLK L HPNIV + + L ++ EF+ L +S I++Y QLL
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP----- 235
G+ + H++ I+HRD+K N+L+++ G +KLADFG LA G T
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFG-------LARAFGIPVRSYTHEVVTL 183
Query: 236 -YWMAPEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ---EVAALFHI----GT 286
Y AP+V++ +S S DIWS+GC EM TGKP F + L I GT
Sbjct: 184 WYR-APDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL----FPGVTDDDQLPKIFSILGT 238
Query: 287 -------------------TKSHPPIP-----EHLSMEAKDFLLKCLQKEPYLRSTASEL 322
+ P E D L L +P R +A +
Sbjct: 239 PNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298
Query: 323 LQHPF 327
+ HP+
Sbjct: 299 MNHPY 303
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 6e-49
Identities = 72/267 (26%), Positives = 127/267 (47%), Gaps = 24/267 (8%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++G G+FG+V + + EL AVK V+I ++ +E+ V L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVI------QDDDVECTM-VEKRV-LALPG 78
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
P + + + D L ++E+V GG + + + G F E Y ++ +GL +L
Sbjct: 79 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 138
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
GI++RD+K N+++D++G IK+ADFG K+ + K+ GTP ++APE+I
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAPEIIAYQ 196
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH-IGTTKSHPPIPEHLSMEAKDFL 305
+ S D W+ G + EM G+ P+ + ++ LF I + + P+ +S EA
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSI--MEHNVAYPKSMSKEAVAIC 252
Query: 306 LKCLQKEPYLR-----STASELLQHPF 327
+ K P R ++ +H F
Sbjct: 253 KGLMTKHPGKRLGCGPEGERDIKEHAF 279
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 1e-48
Identities = 74/270 (27%), Positives = 133/270 (49%), Gaps = 20/270 (7%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
++G GAF V + +G++ A+K ++ + + + + RE E +L N
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMK-IMNKWDMLKRGEV-SCFRE---ERDVLVNGDRRW 122
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS-FPESVIRMYTKQLLLGLEYLHKNG 189
I + ++++ L +++E+ GG + +LL KFG P + R Y ++++ ++ +H+ G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG-- 247
+HRDIK NIL+D G I+LADFG+ K+ T+ + GTP +++PE++ G
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSPEILQAVGGG 241
Query: 248 -----HSFSADIWSVGCTVIEMATGKPPW-SQQFQEV-AALFHIGTTKSHPPIPEHLSME 300
+ D W++G EM G+ P+ + E + H S P + E + E
Sbjct: 242 PGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEE 301
Query: 301 AKDFLLKCLQKEPYLR---STASELLQHPF 327
A+D ++ L P R A + HPF
Sbjct: 302 ARD-FIQRLLCPPETRLGRGGAGDFRTHPF 330
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 2e-48
Identities = 46/268 (17%), Positives = 101/268 (37%), Gaps = 29/268 (10%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+ G ++ G G + VK + + ++ + R+ EE L+ +H
Sbjct: 15 LTKLNENHSGELWKGRW--QGNDIVVKVLKV------RDWSTRKSRDFNEECPRLRIFSH 66
Query: 129 PNIVRYLG--TAREDDSLNILLEFVPGGSISSLL--GKFGSFPESVIRMYTKQLLLGLEY 184
PN++ LG + ++ ++P GS+ ++L G +S + + G+ +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 185 LH--KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
LH + I + ++++D +++ P W+APE
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPEA 179
Query: 243 ILQ---TGHSFSADIWSVGCTVI--EMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297
+ + + SAD+WS V+ E+ T + P++ + + P IP +
Sbjct: 180 LQKKPEDTNRRSADMWSFA--VLLWELVTREVPFA-DLSNMEIGMKVALEGLRPTIPPGI 236
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQH 325
S + C+ ++P R ++
Sbjct: 237 SPHVSKLMKICMNEDPAKRPKFDMIVPI 264
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-48
Identities = 70/275 (25%), Positives = 131/275 (47%), Gaps = 30/275 (10%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++G G++ +V + + + A++ +++ ++ ++ E+ V +
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVN------DDEDIDWVQ-TEKHV-FEQAS 110
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
HP +V + + L ++E+V GG + + + PE R Y+ ++ L L YLH
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
+ GI++RD+K N+L+D++G IKL D+G K+ L + + GTP ++APE++
Sbjct: 171 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGE 228
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAA-------LFH-IGTTKSHPPIPEHLS 298
+ FS D W++G + EM G+ P+ LF I + IP LS
Sbjct: 229 DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--LEKQIRIPRSLS 286
Query: 299 MEAKDFLLKCLQKEPYLR------STASELLQHPF 327
++A L L K+P R + +++ HPF
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 3e-48
Identities = 75/284 (26%), Positives = 136/284 (47%), Gaps = 30/284 (10%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAH--IRELEEEVKL 122
+ G+ +G G FG+V +G + +G +AVK + +++K ++ + +++ E++
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKIL-------NRQKIRSLDVVGKIKREIQN 64
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
LK HP+I++ +++E+V GG + + K G E R +Q+L +
Sbjct: 65 LKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK---GTPYWMA 239
+Y H++ ++HRD+K N+L+D K+ADFG S ++ + ++ G+P + A
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDGEFLRTSCGSPNYAA 178
Query: 240 PEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFH-IGTTKSHPPIPE 295
PEVI DIWS G + + G P F + V LF I IPE
Sbjct: 179 PEVISGRLYAGPEVDIWSCGVILYALLCGTLP----FDDEHVPTLFKKI--RGGVFYIPE 232
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVF 339
+L+ L+ LQ +P R+T ++ +H + P +F
Sbjct: 233 YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL--PSYLF 274
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 3e-48
Identities = 78/268 (29%), Positives = 128/268 (47%), Gaps = 26/268 (9%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVK----QVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
L+G G FG+V + +G A+K +V++ + AH E ++L+N
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIV------AKDEVAHTLT---ENRVLQNS 205
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
HP + + + D L ++E+ GG + L + F E R Y +++ L+YLH
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 187 -KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
+ +++RD+K N+++D G IK+ DFG K+ ++ K+ GTP ++APEV+
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLED 323
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH-IGTTKSHPPIPEHLSMEAKDF 304
+ + D W +G + EM G+ P+ Q E LF I P L EAK
Sbjct: 324 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELI--LMEEIRFPRTLGPEAKSL 379
Query: 305 LLKCLQKEPYLR-----STASELLQHPF 327
L L+K+P R A E++QH F
Sbjct: 380 LSGLLKKDPKQRLGGGSEDAKEIMQHRF 407
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-48
Identities = 95/365 (26%), Positives = 153/365 (41%), Gaps = 66/365 (18%)
Query: 15 RSTSGDDGGGGISGLVEKIGSSIRKSRIGLFSKPAVPALPPIEKTDAPPIRWRKGELVGC 74
R+TS + + + + + G V A P + + +++G
Sbjct: 6 RTTSFAESCKPVQQPSAFGSMKVSRDKDG-SKVTTVVATPGQGPDRPQEVSYTDTKVIGN 64
Query: 75 GAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134
G+FG VY DSGEL+A+K+VL + K REL ++++ L H NIVR
Sbjct: 65 GSFGVVYQAKLCDSGELVAIKKVLQDK----RFKN----REL----QIMRKLDHCNIVRL 112
Query: 135 L------GTAREDDSLNILLEFVPG---GSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
G +++ LN++L++VP + P +++Y QL L Y+
Sbjct: 113 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172
Query: 186 HKNGIMHRDIKGANILVD-NKGCIKLADFGASKKVVELATINGAKSMKG---TPYWMAPE 241
H GI HRDIK N+L+D + +KL DFG++K++V + + Y+ APE
Sbjct: 173 HSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR------GEPNVSYICSRYYRAPE 226
Query: 242 VILQ-TGHSFSADIWSVGCTVIEMATGKP--------------------PWSQQFQEVAA 280
+I T ++ S D+WS GC + E+ G+P P +Q +E+
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP 286
Query: 281 LFHIGTTKSHPPIPEH---------LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331
+ T P I H EA + L+ P R T E H F
Sbjct: 287 NY---TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDE- 342
Query: 332 YQDPH 336
+DP+
Sbjct: 343 LRDPN 347
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 172 bits (436), Expect = 6e-48
Identities = 49/322 (15%), Positives = 107/322 (33%), Gaps = 34/322 (10%)
Query: 26 ISGLVEKIGSSIRKSRIGLFSKPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMN 85
I L+ + + + +PA+ P + L+G GAF +VY
Sbjct: 27 IFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQ 86
Query: 86 LDSGELLAVKQVLIAANSASKEKTQAHIRE---LEEEVKLLKNLTHPNIVRYLGTAREDD 142
D + ++ ++ K + A+ E + ++ LK +++ +
Sbjct: 87 GDLNDAKNKQKFVL------KVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQN 140
Query: 143 SLNILLEFVPGGSISSLLGKFGS-----FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKG 197
++ E G++ + + + + P+ ++ + ++L +E +H I+H DIK
Sbjct: 141 GSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKP 200
Query: 198 ANILV-----------DNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
N ++ D + L D G S + + T + E++
Sbjct: 201 DNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK 260
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA-KDFL 305
++ D + V TV M G + G K ++ +F
Sbjct: 261 PWNYQIDYFGVAATVYCMLFGTYMKVKNEG--------GECKPEGLFRRLPHLDMWNEFF 312
Query: 306 LKCLQKEPYLRSTASELLQHPF 327
L + +LL+
Sbjct: 313 HVMLNIPDCHHLPSLDLLRQKL 334
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 6e-48
Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 24/270 (8%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
GEL+G G FG+VY G GE+ A++ + I + + ++ + EV + H
Sbjct: 38 GELIGKGRFGQVYHGRW--HGEV-AIRLIDI------ERDNEDQLKAFKREVMAYRQTRH 88
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLEYLHK 187
N+V ++G L I+ G ++ S++ + R ++++ G+ YLH
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK---GTPYWMAPEVI- 243
GI+H+D+K N+ DN G + + DFG L ++ G +APE+I
Sbjct: 149 KGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 244 ------LQTGHSFS--ADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295
+ FS +D++++G E+ + P+ Q A ++ +GT
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-PAEAIIWQMGTGMKPNLSQI 266
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+ E D LL C E R T ++L+
Sbjct: 267 GMGKEISDILLFCWAFEQEERPTFTKLMDM 296
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 7e-48
Identities = 71/287 (24%), Positives = 126/287 (43%), Gaps = 42/287 (14%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-H 128
+++G G G+V + +G+ A+K + + +EV +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLL-------YDSP------KARQEVDHHWQASGG 81
Query: 129 PNIVR----YLGTAREDDSLNILLEFVPGGSISSLLGK-----FGSFPESVIRMYTKQLL 179
P+IV Y L I++E + GG L + +F E + +
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGE---LFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMKGTPY 236
+++LH + I HRD+K N+L +K +KL DFG +K+ + N ++ TPY
Sbjct: 139 TAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQTPCYTPY 194
Query: 237 WMAPEVILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEVA-ALFH-IGTTKSHP 291
++APEV+ + S D+WS+G VI + G PP +S Q ++ + I +
Sbjct: 195 YVAPEVLGPEKYDKSCDMWSLG--VIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252
Query: 292 PIPE--HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPH 336
P PE +S +AK + L+ +P R T ++ + HP++ P
Sbjct: 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQ 299
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-47
Identities = 76/310 (24%), Positives = 128/310 (41%), Gaps = 47/310 (15%)
Query: 46 SKPAVPALPPIEKTDAPPI-RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSA 104
+ P P PP K +R G L+G G FG V+ G L +A+K +
Sbjct: 12 APPGTPTPPPGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI------- 64
Query: 105 SKEKTQAHIRE-----LEEEVKLLKNL----THPNIVRYLGTAREDDSLNILLEF-VPGG 154
+ + EV LL + HP ++R L + ++LE +P
Sbjct: 65 PRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ 124
Query: 155 SISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD-NKGCIKLADF 213
+ + + G E R + Q++ +++ H G++HRDIK NIL+D +GC KL DF
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184
Query: 214 GASKKVVELATINGAKSMK-----GTPYWMAPEVILQTG-HSFSADIWSVGCTVI--EMA 265
G+ GT + PE I + H+ A +WS+G ++ +M
Sbjct: 185 GSG---------ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLG--ILLYDMV 233
Query: 266 TGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
G P+ + + + A H P H+S + + +CL +P R + E+L
Sbjct: 234 CGDIPFERDQEILEAELH---------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284
Query: 326 PFVTGKYQDP 335
P++ +D
Sbjct: 285 PWMQTPAEDV 294
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-47
Identities = 91/320 (28%), Positives = 132/320 (41%), Gaps = 89/320 (27%)
Query: 65 RWRKGELVGCGAFGRVYMGMNL-DSGELLAVKQVLIAAN------SASKEKTQAHIRELE 117
++ +G GA+G+V+ +L + G +A+K+V + S IRE
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST--------IRE-- 61
Query: 118 EEVKLLKNL---THPNIVR-----YLGTAREDDSLNILLEFVP---GGSISSLLGKFGSF 166
V +L++L HPN+VR + + L ++ E V + +
Sbjct: 62 --VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--V 117
Query: 167 PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG-A---------S 216
P I+ QLL GL++LH + ++HRD+K NILV + G IKLADFG A +
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT 177
Query: 217 KKVVELATINGAKSMKGTPYWM-APEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF 275
VV L W APEV+LQ+ ++ D+WSVGC EM KP F
Sbjct: 178 SVVVTL--------------WYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP----LF 219
Query: 276 Q---EVAALFHI----GT----------------TKSHPPIP-----EHLSMEAKDFLLK 307
+ +V L I G S P + KD LLK
Sbjct: 220 RGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLK 279
Query: 308 CLQKEPYLRSTASELLQHPF 327
CL P R +A L HP+
Sbjct: 280 CLTFNPAKRISAYSALSHPY 299
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 90/345 (26%), Positives = 138/345 (40%), Gaps = 91/345 (26%)
Query: 56 IEKTDAPPIR----WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEK--- 108
+ + P + K +G G FG V+ + +G+ +A+K+VL+ EK
Sbjct: 5 YDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM-----ENEKEGF 59
Query: 109 --TQAHIRELEEEVKLLKNLTHPNIVR--------YLGTAREDDSLNILLEFVP---GGS 155
T +RE +K+L+ L H N+V R S+ ++ +F G
Sbjct: 60 PITA--LRE----IKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL 113
Query: 156 ISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215
+S++L KF S I+ + LL GL Y+H+N I+HRD+K AN+L+ G +KLADFG
Sbjct: 114 LSNVLVKF---TLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG- 169
Query: 216 SKKVVELA-TINGAKSMKGTPY-------WM-APEVIL-QTGHSFSADIWSVGCTVIEMA 265
LA + AK+ + Y W PE++L + + D+W GC + EM
Sbjct: 170 ------LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW 223
Query: 266 TGKPPWSQQFQ---EVAALFHI----GT---------------TKSHPPIPE-------- 295
T P Q E L I G+ K +
Sbjct: 224 TRSP----IMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL 279
Query: 296 ---HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHP 337
A D + K L +P R + + L H F DP P
Sbjct: 280 KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW---SDPMP 321
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 3e-47
Identities = 84/305 (27%), Positives = 139/305 (45%), Gaps = 59/305 (19%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
I + +++G G+FG V+ ++S E+ A+K+VL + K REL ++
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDK----RFKN----REL----QI 85
Query: 123 LKNLTHPNIVRYL------GTAREDDSLNILLEFVPG---GSISSLLGKFGSFPESVIRM 173
++ + HPN+V G +++ LN++LE+VP + + P +I++
Sbjct: 86 MRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKL 145
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVD-NKGCIKLADFGASKKVVELATINGAKSMK 232
Y QLL L Y+H GI HRDIK N+L+D G +KL DFG++K ++ +
Sbjct: 146 YMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG------EPNV 199
Query: 233 G---TPYWMAPEVIL-QTGHSFSADIWSVGCTVIEMATGKP------------------- 269
+ Y+ APE+I T ++ + DIWS GC + E+ G+P
Sbjct: 200 SYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG 259
Query: 270 -PWSQQFQEVAALFHIGTTKSHPPIP------EHLSMEAKDFLLKCLQKEPYLRSTASEL 322
P +Q + + + P P +A D + + L+ P R TA E
Sbjct: 260 TPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEA 319
Query: 323 LQHPF 327
L HPF
Sbjct: 320 LCHPF 324
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-47
Identities = 80/316 (25%), Positives = 131/316 (41%), Gaps = 41/316 (12%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT- 127
+++G G G+V N + E A+K + + EV+L +
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCP------KARREVELHWRASQ 113
Query: 128 HPNIVR----YLGTAREDDSLNILLEFVPGG----SISSLLGKFGSFPESVIRMYTKQLL 179
P+IVR Y L I++E + GG I + F E K +
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIG 171
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMKGTPY 236
++YLH I HRD+K N+L +K +KL DFG +K+ N + TPY
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYTPY 228
Query: 237 WMAPEVILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEV-AALFH-IGTTKSHP 291
++APEV+ + S D+WS+G VI + G PP +S + + I +
Sbjct: 229 YVAPEVLGPEKYDKSCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286
Query: 292 PIPE--HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQ 349
P PE +S E K + L+ EP R T +E + HP++ + P S + ++
Sbjct: 287 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK 346
Query: 350 IATPGMNLRNSMNSLV 365
+++ M S +
Sbjct: 347 ERW--EDVKEEMTSAL 360
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 1e-46
Identities = 69/278 (24%), Positives = 127/278 (45%), Gaps = 25/278 (8%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ E +G G+FG+V + + + + +A+K I+ K + E E+ LK
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALK--FISRQLLKKSDMHMRV---EREISYLK 64
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
L HP+I++ + +++E+ GG + + + E R + +Q++ +EY
Sbjct: 65 LLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEY 123
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK---GTPYWMAPE 241
H++ I+HRD+K N+L+D+ +K+ADFG S + +K G+P + APE
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGLS------NIMTDGNFLKTSCGSPNYAAPE 177
Query: 242 VILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFH-IGTTKSHPPIPEHL 297
VI D+WS G + M G+ P F + + LF + +P+ L
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLP----FDDEFIPNLFKKV--NSCVYVMPDFL 231
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
S A+ + + + +P R T E+ + P+ D
Sbjct: 232 SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDY 269
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-46
Identities = 66/305 (21%), Positives = 126/305 (41%), Gaps = 31/305 (10%)
Query: 46 SKPAVPALPPIEKTDAPPI-RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVL---IAA 101
P L + + ++ +G GAFG V+ ++ + + + VK + +
Sbjct: 5 EPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLE 64
Query: 102 NSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEF-VPGGSISSLL 160
+ ++ + E+ +L + H NI++ L +++E G + + +
Sbjct: 65 DCWIEDPKLGKVTL---EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFI 121
Query: 161 GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220
+ E + +QL+ + YL I+HRDIK NI++ IKL DFG++
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSA---- 177
Query: 221 ELATINGAKSMK---GTPYWMAPEVILQTGHSFS---ADIWSVGCTVIEMATGKPPWSQQ 274
A + K GT + APEV++ G+ + ++WS+G T+ + + P+ +
Sbjct: 178 --AYLERGKLFYTFCGTIEYCAPEVLM--GNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233
Query: 275 FQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334
+ V A H P +S E + LQ P R+T +L+ P+VT
Sbjct: 234 EETVEAAIH---------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNL 284
Query: 335 PHPVF 339
+
Sbjct: 285 ADYTW 289
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 3e-46
Identities = 70/267 (26%), Positives = 124/267 (46%), Gaps = 24/267 (8%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAV----KQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
++G G+FG+V + + EL AV K V+I + + + L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV--------LALPG 399
Query: 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH 186
P + + + D L ++E+V GG + + + G F E Y ++ +GL +L
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT 246
GI++RD+K N+++D++G IK+ADFG K+ + K+ GTP ++APE+I
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NIWDGVTTKTFCGTPDYIAPEIIAYQ 517
Query: 247 GHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH-IGTTKSHPPIPEHLSMEAKDFL 305
+ S D W+ G + EM G+ P+ + ++ LF I + + P+ +S EA
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LFQSI--MEHNVAYPKSMSKEAVAIC 573
Query: 306 LKCLQKEPYLR-----STASELLQHPF 327
+ K P R ++ +H F
Sbjct: 574 KGLMTKHPGKRLGCGPEGERDIKEHAF 600
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-46
Identities = 78/326 (23%), Positives = 130/326 (39%), Gaps = 42/326 (12%)
Query: 33 IGSSIRKSRIGLFSKPAVPALPPIEKTDAPPI-----------RWRKGELVGCGAFGRVY 81
+GSS P + P A + +++ G L+G G FG VY
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVY 60
Query: 82 MGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH--PNIVRYLGTAR 139
G+ + +A+K + + S + + EV LLK ++ ++R L
Sbjct: 61 SGIRVSDNLPVAIK--HVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118
Query: 140 EDDSLNILLEFV-PGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGA 198
DS ++LE P + + + G+ E + R + Q+L + + H G++HRDIK
Sbjct: 119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDE 178
Query: 199 NILVD-NKGCIKLADFGASKKVVELATINGAKSMK---GTPYWMAPEVILQTG-HSFSAD 253
NIL+D N+G +KL DFG + GT + PE I H SA
Sbjct: 179 NILIDLNRGELKLIDFG-------SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAA 231
Query: 254 IWSVGCTVI--EMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQK 311
+WS+G ++ +M G P+ + + + +S E + + CL
Sbjct: 232 VWSLG--ILLYDMVCGDIPFEHDEEIIRGQVF---------FRQRVSSECQHLIRWCLAL 280
Query: 312 EPYLRSTASELLQHPFVTGKYQDPHP 337
P R T E+ HP++ P
Sbjct: 281 RPSDRPTFEEIQNHPWMQ-DVLLPQE 305
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-45
Identities = 41/299 (13%), Positives = 90/299 (30%), Gaps = 41/299 (13%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSAS---------------- 105
P +G ++G + ++GE V S
Sbjct: 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 135
Query: 106 -KEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVP-----------G 153
K Q + + + P + + ++ + +L F G
Sbjct: 136 RGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFG 195
Query: 154 GSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADF 213
+ S S T Q++ L LH G++H ++ +I++D +G + L F
Sbjct: 196 EVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 214 GASKKVVELATINGAKSMKGTPYWMAPEVILQTGH-----SFSADIWSVGCTVIEMATGK 268
+ A + P A ++ H +F+ D W++G + +
Sbjct: 256 EHLVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
Query: 269 PPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
P + +G ++ +++ + L L+ R + ++ P
Sbjct: 315 LPNTDDAA-------LGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 2e-45
Identities = 76/295 (25%), Positives = 137/295 (46%), Gaps = 30/295 (10%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAH--IRELEEEVKL 122
+ G+ +G G FG+V +G + +G +AVK + +++K ++ + ++ E++
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKIL-------NRQKIRSLDVVGKIRREIQN 69
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
LK HP+I++ + +++E+V GG + + K G E R +Q+L G+
Sbjct: 70 LKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK---GTPYWMA 239
+Y H++ ++HRD+K N+L+D K+ADFG S ++ + ++ G+P + A
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------NMMSDGEFLRTSCGSPNYAA 183
Query: 240 PEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFH-IGTTKSHPPIPE 295
PEVI DIWS G + + G P F + V LF I P+
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCGTLP----FDDDHVPTLFKKI--CDGIFYTPQ 237
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQI 350
+L+ L LQ +P R+T ++ +H + P +F S I
Sbjct: 238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL--PKYLFPEDPSYSSTMI 290
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 4e-45
Identities = 93/372 (25%), Positives = 155/372 (41%), Gaps = 49/372 (13%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R+ + +G G FG + + + EL+AVK + E+ A ++ E+ +
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYI---------ERGAAIDENVQREIINHR 71
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
+L HPNIVR+ L I++E+ GG + + G F E R + +QLL G+ Y
Sbjct: 72 SLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSY 131
Query: 185 LHKNGIMHRDIKGANILVDNKGC--IKLADFGASKKVVELATINGA-KSMKGTPYWMAPE 241
H I HRD+K N L+D +K+ DFG SK + ++ KS GTP ++APE
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPKSTVGTPAYIAPE 187
Query: 242 VILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFH-----IGTTKSHPPI 293
V+L+ AD+WS G T+ M G P F++ + I + K P
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYP----FEDPEEPRDYRKTIQRILSVKYSIPD 243
Query: 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATP 353
+S E + + +P R + E+ H + P + +G+Q P
Sbjct: 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNL----PADLMNESNTGSQFQEP 299
Query: 354 GMNLRNSMNSLVRRSTGLKDVCEMGSVRCSTVYPENLSSGSYWKAGNCDDDMCLIDDKDD 413
+++ M + +T+ + + D++ L DD DD
Sbjct: 300 EQPMQSLDTI-------------MQIISEATI--PAVRNRCLDDF--MTDNLDLDDDMDD 342
Query: 414 FGISESVKFNSS 425
F + +SS
Sbjct: 343 FDSESEIDIDSS 354
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-44
Identities = 83/327 (25%), Positives = 134/327 (40%), Gaps = 66/327 (20%)
Query: 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIREL 116
E++ R++ + G G FG V +G +G +A+K+V+ + + REL
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI--------QDPRFRNREL 67
Query: 117 EEEVKLLKNLTHPNIVR----YLGTAREDDS---LNILLEFVPG---GSISSLLGKFGSF 166
+ ++ L L HPNIV+ + D LN+++E+VP + + +
Sbjct: 68 -QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAP 126
Query: 167 PESVIRMYTKQLLLGLEYLHKN--GIMHRDIKGANILVDNKGC-IKLADFGASKKVVELA 223
P +I+++ QL+ + LH + HRDIK N+LV+ +KL DFG++KK+
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS--- 183
Query: 224 TINGAKSMKGTPYWM-----APEVIL-QTGHSFSADIWSVGCTVIEMATGKP-------- 269
S Y APE+I ++ + DIWSVGC EM G+P
Sbjct: 184 -----PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238
Query: 270 ------------PWSQQFQEVA---ALFHIGTTKSHP------PIPEHLSMEAKDFLLKC 308
P + +++ + +K P + EA D L
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298
Query: 309 LQKEPYLRSTASELLQHPFVTGKYQDP 335
LQ P R E L HP+ DP
Sbjct: 299 LQYLPEERMKPYEALCHPYFDE-LHDP 324
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-43
Identities = 71/309 (22%), Positives = 123/309 (39%), Gaps = 65/309 (21%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
++ +G G + V+ +N+ + E + VK + K+K RE +K+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKI---KRE----IKI 83
Query: 123 LKNLT-HPNIVRYLGTAREDDSLNILL--EFVPGGSISSLLGKFGSFPESVIRMYTKQLL 179
L+NL PNI+ ++ S L E V L + + + IR Y ++L
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEIL 140
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGC-IKLADFGASKKVVELA-TINGAKSMKG---T 234
L+Y H GIMHRD+K N+++D++ ++L D+G LA + + +
Sbjct: 141 KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWG-------LAEFYHPGQEYNVRVAS 193
Query: 235 PYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPP----------------------- 270
Y+ PE+++ +S D+WS+GC + M K P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDL 253
Query: 271 --WSQQFQEVAALFHIGTTKSHPPIP----------EHLSMEAKDFLLKCLQKEPYLRST 318
+ ++ H +S EA DFL K L+ + R T
Sbjct: 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313
Query: 319 ASELLQHPF 327
A E ++HP+
Sbjct: 314 AREAMEHPY 322
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-42
Identities = 89/365 (24%), Positives = 147/365 (40%), Gaps = 93/365 (25%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
++ G+ +G G+FG V +++SG+ A+K+VL REL +
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK--------NREL----DI 53
Query: 123 LKNLTHPNIVR--------------------------------------YLGTAREDDSL 144
+K L H NI++ + ++ L
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 145 NILLEFVPG---GSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANIL 201
N+++E+VP + S + S P ++I +Y QL + ++H GI HRDIK N+L
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLL 173
Query: 202 VDNKGCI-KLADFGASKKVVELATINGAKSMKG---TPYWMAPEVIL-QTGHSFSADIWS 256
V++K KL DFG++KK++ ++ + ++ APE++L T ++ S D+WS
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIP------SEPSVAYICSRFYRAPELMLGATEYTPSIDLWS 227
Query: 257 VGCTVIEMATGKP--------------------PWSQQFQEV---AALFHIGTTKSHP-- 291
+GC E+ GKP P +Q + T K+
Sbjct: 228 IGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWR 287
Query: 292 -PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP--HPVFRNSVMESGN 348
+PE A D L + L+ EP LR E + HPF ++ V NS G
Sbjct: 288 KILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH-LRNSYESEVKNNSNFPHGV 346
Query: 349 QIATP 353
P
Sbjct: 347 NQNIP 351
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 76/340 (22%), Positives = 121/340 (35%), Gaps = 89/340 (26%)
Query: 67 RKGELVGCGAFGRVYMGMNLD--SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+G VG G +G VY D + A+KQ+ S S RE + LL+
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA------CRE----IALLR 73
Query: 125 NLTHPNIVRYLG--TAREDDSLNILLEFVP--------GGSISSLLGKFGSFPESVIRMY 174
L HPN++ + D + +L ++ S K P +++
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL 133
Query: 175 TKQLLLGLEYLHKNGIMHRDIKGANILV----DNKGCIKLADFGASKKVVELATINGAKS 230
Q+L G+ YLH N ++HRD+K ANILV +G +K+AD G A + +
Sbjct: 134 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG-------FARLFNSPL 186
Query: 231 MKGTPYWM--------APEVILQTGH-SFSADIWSVGCTVIEMATGKP--------PWSQ 273
APE++L H + + DIW++GC E+ T +P +
Sbjct: 187 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 246
Query: 274 QFQEVAALFHI----GT---------------TKSHPPIPEH-----------------L 297
L I G + +
Sbjct: 247 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKP 306
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHP 337
+A L K L +P R T+ + +Q P+ +DP P
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL---EDPLP 343
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 67/295 (22%), Positives = 110/295 (37%), Gaps = 51/295 (17%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
E VG G +G V+ G GE +AVK + + + S + E E+ L H
Sbjct: 13 LECVGKGRYGEVWRGSW--QGENVAVK-IFSSRDEKSWFR--------ETELYNTVMLRH 61
Query: 129 PNIVRYLGTAREDDSLN----ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
NI+ ++ + + ++ + GS+ L S +R+ + GL +
Sbjct: 62 ENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRI-VLSIASGLAH 120
Query: 185 LH--------KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSM--KGT 234
LH K I HRD+K NILV G +AD G + + + GT
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 180
Query: 235 PYWMAPEVI-----LQTGHSFS-ADIWSVGCTVIEMATG----------KPPWSQQFQEV 278
+MAPEV+ + S+ DIW+ G + E+A KPP+
Sbjct: 181 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240
Query: 279 AALFHI----GTTKSHPPIPEHLSMEA-----KDFLLKCLQKEPYLRSTASELLQ 324
+ + + P IP + + +C + P R TA + +
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 66/309 (21%), Positives = 115/309 (37%), Gaps = 56/309 (18%)
Query: 59 TDAPPIRWRK---GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRE 115
T+ + E+ G FG V+ E +AVK + + S +
Sbjct: 16 TENLYFQSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVK-IFPIQDKQSWQN------- 65
Query: 116 LEEEVKLLKNLTHPNIVRYLGTAREDDSLN----ILLEFVPGGSISSLLGKFGSFPESVI 171
E EV L + H NI++++G + S++ ++ F GS+S L +
Sbjct: 66 -EYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELC 124
Query: 172 RMYTKQLLLGLEYLH----------KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221
+ + + GL YLH K I HRDIK N+L+ N +ADFG + K
Sbjct: 125 HIA-ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 222 LATINGAKSMKGTPYWMAPEVILQTGHSFS------ADIWSVGCTVIEMATGKPPWSQQF 275
+ GT +MAPEV L+ +F D++++G + E+A+
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEV-LEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242
Query: 276 QEVAALFH---------------IGTTKSHPPIPEHLSMEA-----KDFLLKCLQKEPYL 315
E F + K P + ++ A + + +C +
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302
Query: 316 RSTASELLQ 324
R +A + +
Sbjct: 303 RLSAGCVGE 311
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 7e-40
Identities = 69/318 (21%), Positives = 119/318 (37%), Gaps = 55/318 (17%)
Query: 46 SKPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSAS 105
S +P L ++T A I+ + +G G +G V+MG GE +AVK V AS
Sbjct: 23 SGSGLPLLV--QRTIAKQIQ--MVKQIGKGRYGEVWMGKW--RGEKVAVK-VFFTTEEAS 75
Query: 106 KEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN----ILLEFVPGGSISSLLG 161
+ E E+ + H NI+ ++ + ++ ++ GS+ L
Sbjct: 76 WFR--------ETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLK 127
Query: 162 KFGSFPESVIRMYTKQLLLGLEYLH--------KNGIMHRDIKGANILVDNKGCIKLADF 213
+S++++ + GL +LH K I HRD+K NILV G +AD
Sbjct: 128 STTLDAKSMLKL-AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADL 186
Query: 214 GASKKVVELATI--NGAKSMKGTPYWMAPEVILQTGHSFS------ADIWSVGCTVIEMA 265
G + K + + GT +M PEV+ ++ + AD++S G + E+A
Sbjct: 187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246
Query: 266 TG----------KPPWSQQFQEVAALFHIGTTKSH----PPIPEHLSMEAKDFLLK---- 307
+ P+ + + P P S + +
Sbjct: 247 RRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMT 306
Query: 308 -CLQKEPYLRSTASELLQ 324
C P R TA + +
Sbjct: 307 ECWAHNPASRLTALRVKK 324
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-39
Identities = 71/300 (23%), Positives = 112/300 (37%), Gaps = 60/300 (20%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT- 127
+++G G G+V N + E A+K + + EV+L +
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKFALKML-------QDCP------KARREVELHWRASQ 69
Query: 128 HPNIVR----YLGTAREDDSLNILLEFVPGG----SISSLLGKFGSFPESVIRMYTKQLL 179
P+IVR Y L I++E + GG I + F E K +
Sbjct: 70 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIG 127
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELATINGAKSMKGTPY 236
++YLH I HRD+K N+L +K +KL DFG
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------- 165
Query: 237 WMAPEVILQTGHSFSADIWSVGCTVIE--MATGKPP-WSQQFQEV-AALFH-IGTTKSHP 291
A E + S D+WS+G VI + G PP +S + + I +
Sbjct: 166 -FAKET-TGEKYDKSCDMWSLG--VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 221
Query: 292 PIPE--HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQ 349
P PE +S E K + L+ EP R T +E + HP++ + P S + ++
Sbjct: 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDK 281
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-38
Identities = 67/263 (25%), Positives = 122/263 (46%), Gaps = 9/263 (3%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R++ + +G G VY+ + +A+K I KE+T EV
Sbjct: 12 RYKIVDKLGGGGMSTVYLAEDTILNIKVAIK--AIFIPPREKEETLKRFER---EVHNSS 66
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
L+H NIV + EDD +++E++ G ++S + G +T Q+L G+++
Sbjct: 67 QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
H I+HRDIK NIL+D+ +K+ DFG +K + E ++ + GT + +PE
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE-TSLTQTNHVLGTVQYFSPEQAK 185
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP--IPEHLSMEAK 302
DI+S+G + EM G+PP++ + A+ HI + + + + +
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS 245
Query: 303 DFLLKCLQKEPYLR-STASELLQ 324
+ +L+ +K+ R T E+
Sbjct: 246 NVILRATEKDKANRYKTIQEMKD 268
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 76/313 (24%), Positives = 122/313 (38%), Gaps = 54/313 (17%)
Query: 52 ALPPIEK-TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQ 110
LP + + T A I E +G G FG V+ G GE +AVK + + S +
Sbjct: 31 GLPLLVQRTIARTIV--LQESIGKGRFGEVWRGKW--RGEEVAVK-IFSSREERSWFR-- 83
Query: 111 AHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN----ILLEFVPGGSISSLLGKFGSF 166
E E+ L H NI+ ++ +D+ ++ ++ GS+ L ++
Sbjct: 84 ------EAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT 137
Query: 167 PESVIRMYTKQLLLGLEYLH--------KNGIMHRDIKGANILVDNKGCIKLADFG-ASK 217
E +I++ GL +LH K I HRD+K NILV G +AD G A +
Sbjct: 138 VEGMIKL-ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 218 KVVELATINGA-KSMKGTPYWMAPEVI-----LQTGHSF-SADIWSVGCTVIEMATG--- 267
TI+ A GT +MAPEV+ ++ SF ADI+++G E+A
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256
Query: 268 -------KPPWSQQFQEVAAL----FHIGTTKSHPPIPEHLSMEAKDFLLK-----CLQK 311
+ P+ ++ + K P IP ++ C
Sbjct: 257 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 316
Query: 312 EPYLRSTASELLQ 324
R TA + +
Sbjct: 317 NGAARLTALRIKK 329
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 69/294 (23%), Positives = 121/294 (41%), Gaps = 32/294 (10%)
Query: 67 RKGELVGCGAFGRVYMG----MNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
+ +G G FG V + + ++G L+AVKQ+ + R+ + E+++
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQL--------QHSGPDQQRDFQREIQI 77
Query: 123 LKNLTHPNIVRYLG--TAREDDSLNILLEFVPGGSISS-LLGKFGSFPESVIRMYTKQLL 179
LK L IV+Y G SL +++E++P G + L S + +Y+ Q+
Sbjct: 78 LKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WM 238
G+EYL +HRD+ NILV+++ +K+ADFG +K + + +P W
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 239 APEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHP------ 291
APE + S +D+WS G + E+ T S + + + +
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257
Query: 292 ------PIPEHLSMEAKDFLLKCLQKEPYLRSTASEL---LQHPFVTGKYQDPH 336
P P E + + C P R + S L L + + + H
Sbjct: 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH 311
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 6e-37
Identities = 76/305 (24%), Positives = 132/305 (43%), Gaps = 36/305 (11%)
Query: 45 FSKPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMG----MNLDSGELLAVKQVLIA 100
F A + T + + +G G FG V M + ++GE++AVK++
Sbjct: 22 FQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--- 78
Query: 101 ANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG--TAREDDSLNILLEFVPGGSISS 158
+ T+ H+R+ E E+++LK+L H NIV+Y G + +L +++E++P GS+
Sbjct: 79 -----QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133
Query: 159 -LLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217
L + YT Q+ G+EYL +HRD+ NILV+N+ +K+ DFG +K
Sbjct: 134 YLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193
Query: 218 KVVELATINGAKSMKGTP-YWMAPEVILQTGHSFSADIWSVGCTVIEMAT---------- 266
+ + K +P +W APE + ++ S ++D+WS G + E+ T
Sbjct: 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA 253
Query: 267 ------GKPPWSQ-QFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTA 319
G Q + L P P+ E + +C R +
Sbjct: 254 EFMRMIGNDKQGQMIVFHLIELLKNN---GRLPRPDGCPDEIYMIMTECWNNNVNQRPSF 310
Query: 320 SELLQ 324
+L
Sbjct: 311 RDLAL 315
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-36
Identities = 61/268 (22%), Positives = 115/268 (42%), Gaps = 35/268 (13%)
Query: 65 RWRKGELVGCGAFGRVYMG--MNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
++ + G G +Y+ N++ G + +K L+ + A +A E +
Sbjct: 81 QYEVKGCIAHGGLGWIYLALDRNVN-GRPVVLK-GLVHSGDA-----EAQAM-AMAERQF 132
Query: 123 LKNLTHPNIVRYLGTAREDDSLN-----ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ 177
L + HP+IV+ D I++E+V G S+ G+ E++ Y +
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA--YLLE 190
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 237
+L L YLH G+++ D+K NI++ + +KL D GA IN + GTP +
Sbjct: 191 ILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS------RINSFGYLYGTPGF 243
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297
APE++ +TG + + DI++VG T+ + P + + + + +
Sbjct: 244 QAPEIV-RTGPTVATDIYTVGRTLAALTLDLPTRNGR-----YVDGLPEDDPVLKTYDSY 297
Query: 298 SMEAKDFLLKCLQKEPYLR-STASELLQ 324
L + + +P R +TA E+
Sbjct: 298 G----RLLRRAIDPDPRQRFTTAEEMSA 321
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 79/350 (22%), Positives = 136/350 (38%), Gaps = 83/350 (23%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-- 127
+G G F V++ ++ + +A+K V A E+E+KLL+ +
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAA-----EDEIKLLQRVNDA 75
Query: 128 ---------HPNIVRYLG--TAREDDSLNILLEF-VPGGSISSLLGK--FGSFPESVIRM 173
+I++ L + + +++++ F V G ++ +L+ K P ++
Sbjct: 76 DNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 174 YTKQLLLGLEYLHKN-GIMHRDIKGANILVD------NKGCIKLADFGASKKVVELATIN 226
+KQLLLGL+Y+H+ GI+H DIK N+L++ N IK+AD G + E T
Sbjct: 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT-- 193
Query: 227 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKP----------------- 269
+ T + +PEV+L ADIWS C + E+ TG
Sbjct: 194 ---NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 250
Query: 270 ------------------PWSQQ-FQEVAALFHI---GTTKSHPPIPEHLSMEAK----- 302
+++ F L +I + E
Sbjct: 251 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 310
Query: 303 -DFLLKCLQKEPYLRSTASELLQHPFVTGKY-QDPHPVFRNSVMESGNQI 350
DFL LQ +P R+ A L+ HP++ + V + SG+ I
Sbjct: 311 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDI 360
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-36
Identities = 73/284 (25%), Positives = 128/284 (45%), Gaps = 36/284 (12%)
Query: 67 RKGELVGCGAFGRVYMG----MNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
+ + +G G FG V M + ++GE++AVK++ + T+ H+R+ E E+++
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKL--------QHSTEEHLRDFEREIEI 64
Query: 123 LKNLTHPNIVRYLG--TAREDDSLNILLEFVPGGSISS-LLGKFGSFPESVIRMYTKQLL 179
LK+L H NIV+Y G + +L +++E++P GS+ L + YT Q+
Sbjct: 65 LKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTP-YWM 238
G+EYL +HRD+ NILV+N+ +K+ DFG +K + + K +P +W
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY 184
Query: 239 APEVILQTGHSFSADIWSVGCTVIEMAT----------------GKPPWSQ-QFQEVAAL 281
APE + ++ S ++D+WS G + E+ T G Q + L
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL 244
Query: 282 FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
P P+ E + +C R + +L
Sbjct: 245 LKNN---GRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 3e-36
Identities = 74/294 (25%), Positives = 117/294 (39%), Gaps = 19/294 (6%)
Query: 38 RKSRIGLFSKPAVPALPPIEKTD--APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVK 95
++ L K V + K GE +G G FG V+ G L+AVK
Sbjct: 86 LSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVK 145
Query: 96 QVLIAANSASKE-KTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGG 154
+E + +E ++LK +HPNIVR +G + + I++E V GG
Sbjct: 146 SC--------RETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197
Query: 155 SISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADF 213
+ L G + G+EYL +HRD+ N LV K +K++DF
Sbjct: 198 DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257
Query: 214 GASKKVVELATINGAKSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPP- 270
G S++ + + ++ P W APE + +S +D+WS G + E + G P
Sbjct: 258 GMSREEAD-GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316
Query: 271 WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+ Q+ G P PE + +C EP R + S + Q
Sbjct: 317 PNLSNQQTREFVEKG---GRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 4e-36
Identities = 65/267 (24%), Positives = 112/267 (41%), Gaps = 19/267 (7%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+R LVG G G VY + ++A+K L++ +S + ++ E +
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALK--LMSETLSSDPVFRTRMQR---EARTAG 89
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSF-PESVIRMYTKQLLLGLE 183
L P++V D L + + + G ++++L + G P + + +Q+ L+
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAI-VRQIGSALD 148
Query: 184 YLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVI 243
H G HRD+K NILV L DFG + + + + GT Y+MAPE
Sbjct: 149 AAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYMAPERF 207
Query: 244 LQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT-----TKSHPPIPEHLS 298
++ ++ ADI+++ C + E TG PP+ V HI + P IP
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-MGAHINQAIPRPSTVRPGIPVAFD 266
Query: 299 MEAKDFLLKCLQKEPYLR-STASELLQ 324
+ + + K P R T +L
Sbjct: 267 ----AVIARGMAKNPEDRYVTCGDLSA 289
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 71/290 (24%), Positives = 128/290 (44%), Gaps = 28/290 (9%)
Query: 55 PIEKTDAPPIRWRKGELVGCGAFGRVYMGM----NLDSGELLAVKQVLIAANSASKEKTQ 110
P + T +K +G G FG+V + N +GE++AVK + +
Sbjct: 22 PGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKAL-------KADAGP 74
Query: 111 AHIRELEEEVKLLKNLTHPNIVRYLG--TAREDDSLNILLEFVPGGSISSLLGKFGSFPE 168
H ++E+ +L+ L H +I++Y G SL +++E+VP GS+ L + S
Sbjct: 75 QHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR-HSIGL 133
Query: 169 SVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228
+ + ++ +Q+ G+ YLH +HRD+ N+L+DN +K+ DFG +K V E
Sbjct: 134 AQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 193
Query: 229 KSMKGTP-YWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGT 286
+ +P +W APE + + +++D+WS G T+ E+ T S + + +
Sbjct: 194 REDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQG 253
Query: 287 TKSHP------------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+ P P+ E + C + E R T L+
Sbjct: 254 QMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-34
Identities = 77/337 (22%), Positives = 139/337 (41%), Gaps = 87/337 (25%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
R+ + +GCG G V+ ++ D + +A+K++++ + K L E +K+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK-------HALRE-IKI 61
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPE-------------S 169
++ L H NIV+ IL G ++ +G +
Sbjct: 62 IRRLDHDNIVKVF---------EILGP--SGSQLTDDVGSLTELNSVYIVQEYMETDLAN 110
Query: 170 VIR------------MYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC-IKLADFGAS 216
V+ MY QLL GL+Y+H ++HRD+K AN+ ++ + +K+ DFG +
Sbjct: 111 VLEQGPLLEEHARLFMY--QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
Query: 217 KKVVELATINGAKSMKG---TPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWS 272
+ + + G + T ++ +P ++L + + + D+W+ GC EM TGK ++
Sbjct: 169 RIMDPHYSHKGH--LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226
Query: 273 -----QQFQEVAALFHIGT----------------TKSHPPIPE--------HLSMEAKD 303
+Q Q + I ++ P +S EA D
Sbjct: 227 GAHELEQMQLILES--IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVD 284
Query: 304 FLLKCLQKEPYLRSTASELLQHPFVTGKYQDPH--PV 338
FL + L P R TA E L HP+++ Y P P+
Sbjct: 285 FLEQILTFSPMDRLTAEEALSHPYMS-IYSFPMDEPI 320
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 73/279 (26%), Positives = 123/279 (44%), Gaps = 36/279 (12%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R+ GE++G G V++ +L +AVK VL A+ A R E +
Sbjct: 13 RYELGEILGFGGMSEVHLARDLRDHRDVAVK-VL-RADLARDPSFYLRFRR---EAQNAA 67
Query: 125 NLTHPNIVRYLGTAREDDSLN----ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
L HP IV T + I++E+V G ++ ++ G
Sbjct: 68 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE-LATINGAKSMKGTPYWMA 239
L + H+NGI+HRD+K ANI++ +K+ DFG ++ + + ++ ++ GT +++
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 240 PEVILQ-TGHSFSA--DIWSVGCTVIEMATGKPPWS---------QQFQE-VAALFHIGT 286
PE Q G S A D++S+GC + E+ TG+PP++ Q +E
Sbjct: 188 PE---QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP----- 239
Query: 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLR-STASELLQ 324
+ H + L +LK L K P R TA+E+
Sbjct: 240 SARHEGLSADL----DAVVLKALAKNPENRYQTAAEMRA 274
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 6e-34
Identities = 71/293 (24%), Positives = 132/293 (45%), Gaps = 28/293 (9%)
Query: 54 PPIEKTDAPPIRWRKGELVGCGAFGRVYMGM----NLDSGELLAVKQVLIAANSASKEKT 109
++ T ++ +G G FG+V + ++GE +AVK + E
Sbjct: 11 TEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-------KPESG 63
Query: 110 QAHIRELEEEVKLLKNLTHPNIVRYLG--TAREDDSLNILLEFVPGGSISS-LLGKFGSF 166
HI +L++E+++L+NL H NIV+Y G T + + +++EF+P GS+ L
Sbjct: 64 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKI 123
Query: 167 PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226
Y Q+ G++YL +HRD+ N+LV+++ +K+ DFG +K +
Sbjct: 124 NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYY 183
Query: 227 GAKSMKGTP-YWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHI 284
K + +P +W APE ++Q+ ++D+WS G T+ E+ T S + +
Sbjct: 184 TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPT 243
Query: 285 GTTKSHP------------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+ P P + E + KC + +P R++ L++
Sbjct: 244 HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEG 296
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-34
Identities = 72/308 (23%), Positives = 117/308 (37%), Gaps = 66/308 (21%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
EL+G G +G VY G LD +AVK V AN + E+ + + + H
Sbjct: 18 LELIGRGRYGAVYKGS-LD-ERPVAVK-VFSFANRQNFIN--------EKNIYRVPLMEH 66
Query: 129 PNIVRYLGTAREDDSLN-----ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLE 183
NI R++ + +++E+ P GS+ L S S R+ + GL
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL-AHSVTRGLA 125
Query: 184 YLH---------KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI------NGA 228
YLH K I HRD+ N+LV N G ++DFG S ++ + N A
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 229 KSMKGTPYWMAPEVI-------LQTGHSFSADIWSVGCTVIEMATG-------------K 268
S GT +MAPEV+ D++++G E+ +
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245
Query: 269 PPWSQQ------FQEVAALFHIGTTKSHPPIPEHLSMEA------KDFLLKCLQKEPYLR 316
+ + F+++ L + K P PE + K+ + C ++ R
Sbjct: 246 MAFQTEVGNHPTFEDMQVL--VSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 317 STASELLQ 324
TA +
Sbjct: 304 LTAQXAEE 311
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-33
Identities = 75/347 (21%), Positives = 124/347 (35%), Gaps = 107/347 (30%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL--- 126
+++G G+FG+V + + +A+K ++ QA E+++L++L
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALK--MVRNEKRFHR--QAAE-----EIRILEHLRKQ 153
Query: 127 ----THPNIVRYLGT---------AREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRM 173
T N++ L E S+N L E + KF F ++R
Sbjct: 154 DKDNTM-NVIHMLENFTFRNHICMTFELLSMN-LYELIKKN-------KFQGFSLPLVRK 204
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILV--DNKGCIKLADFGASKKVVELATINGAKSM 231
+ +L L+ LHKN I+H D+K NIL+ + IK+ DFG+S +
Sbjct: 205 FAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---------- 254
Query: 232 KGTPY-----WMAPEVILQTGHSFSADIWSVGCTVIEMATG------------------- 267
+ Y + APEVIL + D+WS+GC + E+ TG
Sbjct: 255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIEL 314
Query: 268 --KPP---------WSQQFQEVAALFHIGTTKS------------------HPPIPEHLS 298
P + T PP
Sbjct: 315 LGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWG 374
Query: 299 MEAK--------DFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHP 337
K DFL +CL+ +P +R T + L+HP++ + P
Sbjct: 375 NALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPT 421
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-33
Identities = 76/328 (23%), Positives = 137/328 (41%), Gaps = 77/328 (23%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
++ L+G GA+G V + +GE++A+K++ +T +RE+ K+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT---LREI----KI 62
Query: 123 LKNLTHPNIVRYL-----GTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIR----- 172
LK+ H NI+ + + + I+ E + + L VI
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ----TDL--------HRVISTQMLS 110
Query: 173 -------MYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI 225
+Y Q L ++ LH + ++HRD+K +N+L+++ +K+ DFG ++ + E A
Sbjct: 111 DDHIQYFIY--QTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 226 NGAKSMKG---TPY----WM-APEVILQTGH-SFSADIWSVGCTVIEMATGKP------- 269
N + + + W APEV+L + S + D+WS GC + E+ +P
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY 228
Query: 270 -------------PWSQQFQEV----AALFHIGTTKSHPPIP-----EHLSMEAKDFLLK 307
P S A +I + +P P ++ + D L +
Sbjct: 229 RHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288
Query: 308 CLQKEPYLRSTASELLQHPFVTGKYQDP 335
L +P R TA E L+HP++ Y DP
Sbjct: 289 MLVFDPAKRITAKEALEHPYLQT-YHDP 315
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 7e-33
Identities = 88/317 (27%), Positives = 135/317 (42%), Gaps = 66/317 (20%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P + VG GA+G V ++ SGE +A+K++ S K R E + L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK-----RAYRE-LLL 76
Query: 123 LKNLTHPNIVRYL------GTAREDDSLNILLEFVP---GGSISSLLGKFGSFPESVIRM 173
LK++ H N++ L + R +++ F+ + E I+
Sbjct: 77 LKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFS------EEKIQY 130
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
Q+L GL+Y+H G++HRD+K N+ V+ +K+ DFG LA A M G
Sbjct: 131 LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG-------LARHADA-EMTG 182
Query: 234 ---TPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKP--P---WSQQFQEVAALFHI 284
T ++ APEVIL H + + DIWSVGC + EM TGK + Q ++ +
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV--T 240
Query: 285 GT-----------------TKSHPPIPE--------HLSMEAKDFLLKCLQKEPYLRSTA 319
G +S P P S +A D L K L+ + R TA
Sbjct: 241 GVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 300
Query: 320 SELLQHPFVTGKYQDPH 336
++ L HPF ++DP
Sbjct: 301 AQALTHPFFEP-FRDPE 316
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-32
Identities = 81/334 (24%), Positives = 133/334 (39%), Gaps = 90/334 (26%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
R++ + +G GA G V + +A+K++ + + K R E + L
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK-----RAYRE-LVL 77
Query: 123 LKNLTHPNIVRYLGTAREDDSLN------ILLEFVPGGSISSLLGKFGSFPESVIRM--- 173
+K + H NI+ L SL I++E + ++L VI+M
Sbjct: 78 MKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD----ANL--------CQVIQMELD 125
Query: 174 --------YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI 225
Y Q+L G+++LH GI+HRD+K +NI+V + +K+ DFG ++
Sbjct: 126 HERMSYLLY--QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---- 179
Query: 226 NGAKSMKGTPYWM-----APEVILQTGHSFSADIWSVGCTVIEMATGKP----------- 269
S TPY + APEVIL G+ + DIWSVGC + EM G
Sbjct: 180 ----SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 235
Query: 270 ---------PWSQQFQEV-------------------AALFHIGTTKSHPPIPEHLSMEA 301
P + +++ LF + + + +A
Sbjct: 236 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 295
Query: 302 KDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
+D L K L + R + E LQHP++ + DP
Sbjct: 296 RDLLSKMLVIDASKRISVDEALQHPYINV-WYDP 328
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 71/289 (24%), Positives = 127/289 (43%), Gaps = 32/289 (11%)
Query: 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELL----AVKQVLIAANSASKEKT-QAHIRE 115
++K +++G GAFG VY G+ + GE + A+K L +E T +E
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIK-EL-------REATSPKANKE 63
Query: 116 LEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISS-LLGKFGSFPESVIRMY 174
+ +E ++ ++ +P++ R LG ++ ++ + +P G + + + + +
Sbjct: 64 ILDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW 122
Query: 175 TKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE---LATINGAKSM 231
Q+ G+ YL ++HRD+ N+LV +K+ DFG +K + G K
Sbjct: 123 CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK-- 180
Query: 232 KGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTK 288
P WMA E IL ++ +D+WS G TV E+ T G P E++++ G
Sbjct: 181 --VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 238
Query: 289 SHPPI-PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPH 336
PPI + M + KC + R EL+ + +DP
Sbjct: 239 PQPPICTIDVYM----IMRKCWMIDADSRPKFRELII--EFSKMARDPQ 281
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 80/327 (24%), Positives = 132/327 (40%), Gaps = 76/327 (23%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
R++ + +G GA G V + +A+K++ + + K R E + L
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-----RAYRE-LVL 114
Query: 123 LKNLTHPNIVRYL------GTAREDDSLNILLEFVP---GGSISSLLGKFGSFPESVIRM 173
+K + H NI+ L T E + +++E + I L +
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSY 168
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA-TINGAKSMK 232
Q+L G+++LH GI+HRD+K +NI+V + +K+ DFG LA T + M
Sbjct: 169 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG-------LARTAGTSFMM- 220
Query: 233 GTPYWM-----APEVILQTGHSFSADIWSVGCTVIEMATGKP------------------ 269
TPY + APEVIL G+ + DIWSVGC + EM K
Sbjct: 221 -TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 279
Query: 270 --PWSQQFQEV-------------------AALFHIGTTKSHPPIPEHLSMEAKDFLLKC 308
P + +++ LF + + + +A+D L K
Sbjct: 280 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 339
Query: 309 LQKEPYLRSTASELLQHPFVTGKYQDP 335
L +P R + + LQHP++ + DP
Sbjct: 340 LVIDPAKRISVDDALQHPYINV-WYDP 365
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 70/267 (26%), Positives = 118/267 (44%), Gaps = 18/267 (6%)
Query: 64 IRWRKGELVGCGAFGRVYMGM-NLDSGELL-AVKQVLIAANSASKEKTQAHIRELEEEVK 121
+ EL GCG FG V G+ + ++ A+K + + + E+ E +
Sbjct: 11 LLIADIEL-GCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKADT-----EEMMREAQ 62
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISS-LLGKFGSFPESVIRMYTKQLLL 180
++ L +P IVR +G + ++L +++E GG + L+GK P S + Q+ +
Sbjct: 63 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 121
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMA 239
G++YL + +HRD+ N+L+ N+ K++DFG SK + + A+S P W A
Sbjct: 122 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 181
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHL 297
PE I S +D+WS G T+ E + G+ P + EV A G P
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG---KRMECPPEC 238
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQ 324
E + C + R + Q
Sbjct: 239 PPELYALMSDCWIYKWEDRPDFLTVEQ 265
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 64/281 (22%), Positives = 110/281 (39%), Gaps = 22/281 (7%)
Query: 68 KGELVGCGAFGRVYMGM-NLDSGELL-AVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+ + +G G FG V G + AVK + + EL E +++
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKI--LKNEANDPALKD----ELLAEANVMQQ 74
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
L +P IVR +G E +S +++E G ++ L + + I Q+ +G++YL
Sbjct: 75 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAPEVIL 244
++ +HRD+ N+L+ + K++DFG SK + A++ P W APE I
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 245 QTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
S +D+WS G + E + G+ P + EV A+ G P E
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPAGCPREMY 250
Query: 303 DFLLKCLQKEP-------YLRSTASELLQHPFVTGKYQDPH 336
D + C + + G + H
Sbjct: 251 DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHHHHHH 291
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 65/265 (24%), Positives = 114/265 (43%), Gaps = 21/265 (7%)
Query: 69 GELVGCGAFGRVYMGM--NLDSGELL-AVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+++G G G V G ++ A+K + A +++ R+ E ++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA--LKAGYTERQR-----RDFLSEASIMGQ 106
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLEY 184
HPNI+R G I+ E++ GS+ + L G F + + + G+ Y
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY 166
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGT--PY-WMAPE 241
L G +HRD+ N+LVD+ K++DFG S+ + + + A + G P W APE
Sbjct: 167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGKIPIRWTAPE 224
Query: 242 VILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
I S ++D+WS G + E+ G+ P W+ ++V + G P P
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RLPAPMGCPH 281
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQ 324
+L C K+ R S+++
Sbjct: 282 ALHQLMLDCWHKDRAQRPRFSQIVS 306
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-31
Identities = 70/322 (21%), Positives = 132/322 (40%), Gaps = 73/322 (22%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
R+ +G GA+G V + + +A+K++ + ++T +RE+ K+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LREI----KI 78
Query: 123 LKNLTHPNIVRYL-----GTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIR----- 172
L H NI+ T + + I+ + + + L K +++
Sbjct: 79 LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-----TDLYK-------LLKTQHLS 126
Query: 173 -------MYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI 225
+Y Q+L GL+Y+H ++HRD+K +N+L++ +K+ DFG ++
Sbjct: 127 NDHICYFLY--QILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 184
Query: 226 NGAKSMKG---TPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKP------------ 269
G + T ++ APE++L + + S DIWSVGC + EM + +P
Sbjct: 185 TGF--LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN 242
Query: 270 --------PWSQQFQEVA---ALFHIGTTKSHPPIP-----EHLSMEAKDFLLKCLQKEP 313
P + + A ++ + +P + +A D L K L P
Sbjct: 243 HILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNP 302
Query: 314 YLRSTASELLQHPFVTGKYQDP 335
+ R + L HP++ Y DP
Sbjct: 303 HKRIEVEQALAHPYLEQ-YYDP 323
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 77/320 (24%), Positives = 140/320 (43%), Gaps = 73/320 (22%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P R++ VG GA+G V + +G +AVK++ S K R E ++L
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-----RTYRE-LRL 81
Query: 123 LKNLTHPNIVRYL------GTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIR---- 172
LK++ H N++ L + E + + ++ + + L ++++
Sbjct: 82 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG----ADL--------NNIVKCQKL 129
Query: 173 --------MYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224
+Y Q+L GL+Y+H I+HRD+K +N+ V+ +K+ DFG ++ + T
Sbjct: 130 TDDHVQFLIY--QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
Query: 225 INGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKP-------------- 269
A T ++ APE++L H + + DIWSVGC + E+ TG+
Sbjct: 188 GYVA-----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 242
Query: 270 ------PWSQQFQEVA---ALFHIGTTKSHPPIP-----EHLSMEAKDFLLKCLQKEPYL 315
P ++ ++++ A +I + P + + A D L K L +
Sbjct: 243 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 302
Query: 316 RSTASELLQHPFVTGKYQDP 335
R TA++ L H + +Y DP
Sbjct: 303 RITAAQALAHAYFA-QYHDP 321
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-31
Identities = 85/310 (27%), Positives = 136/310 (43%), Gaps = 53/310 (17%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
+R + VG GA+G V ++ +G +A+K++ S K R E ++L
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-----RAYRE-LRL 77
Query: 123 LKNLTHPNIVRYLGTAREDDSLN------ILLEFVPGGSISSLLGKFGSFPESVIRMYTK 176
LK++ H N++ L D++L+ +++ F+ G + L+ K E I+
Sbjct: 78 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVY 135
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY 236
Q+L GL Y+H GI+HRD+K N+ V+ +K+ DFG +++ T T +
Sbjct: 136 QMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVV-----TRW 190
Query: 237 WMAPEVILQTGH-SFSADIWSVGCTVIEMATGKP--P---WSQQFQEVAALFHIGT---- 286
+ APEVIL + + DIWSVGC + EM TGK Q +E+ + GT
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV--TGTPPAE 248
Query: 287 -------------TKSHPPIPE--------HLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
K P + + + S A + L K L + R TA E L H
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308
Query: 326 PFVTGKYQDP 335
P+ D
Sbjct: 309 PYFE-SLHDT 317
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 5e-31
Identities = 66/262 (25%), Positives = 107/262 (40%), Gaps = 19/262 (7%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+G G +G VY G+ +AVK L +E +E ++K + H
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVK-TLKEDTMEVEE--------FLKEAAVMKEIKH 275
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLH 186
PN+V+ LG + I+ EF+ G++ L + V+ Q+ +EYL
Sbjct: 276 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 335
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAPEVILQ 245
K +HR++ N LV +K+ADFG S+ + A + P W APE +
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTAPESLAY 393
Query: 246 TGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
S +D+W+ G + E+AT G P +V L PE + +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCPEKVYE 450
Query: 304 FLLKCLQKEPYLRSTASELLQH 325
+ C Q P R + +E+ Q
Sbjct: 451 LMRACWQWNPSDRPSFAEIHQA 472
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 68/270 (25%), Positives = 116/270 (42%), Gaps = 15/270 (5%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGM-NLDSGELL--AVKQVLIAANSASKEKTQAHIRELEE 118
R E +G G+FG V G + SG+ + AVK + + S+ + + +
Sbjct: 16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKC--LKPDVLSQPEA---MDDFIR 70
Query: 119 EVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISS-LLGKFGSFPESVIRMYTKQ 177
EV + +L H N++R G + ++ E P GS+ L G F + Y Q
Sbjct: 71 EVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY- 236
+ G+ YL +HRD+ N+L+ + +K+ DFG + + + + + P+
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 189
Query: 237 WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPW-SQQFQEVAALFHIGTTKSHPPIP 294
W APE + S ++D W G T+ EM T G+ PW ++ L I P P
Sbjct: 190 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI--LHKIDKEGERLPRP 247
Query: 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
E + + +++C +P R T L
Sbjct: 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 71/332 (21%), Positives = 122/332 (36%), Gaps = 85/332 (25%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHI----RELEE 118
+ + G++G V G++ G +A+K+V + + R L E
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE 79
Query: 119 EVKLLKNLTHPNIVRYLG--TAREDDSLN---ILLEFVPGGSISSLLGKFGSFPESVIR- 172
++LL + HPNI+ E+ +++ ++ E + + L VI
Sbjct: 80 -IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR----TDL--------AQVIHD 126
Query: 173 -------------MYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219
MY +LLGL LH+ G++HRD+ NIL+ + I + DF
Sbjct: 127 QRIVISPQHIQYFMY--HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN----- 179
Query: 220 VELA-TINGAKSMKG---TPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKP--PWS 272
LA + ++ APE+++Q + D+WS GC + EM K S
Sbjct: 180 --LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGS 237
Query: 273 ---QQFQEVAALFHIGT------------------TKSHPPIPE--------HLSMEAKD 303
Q ++ + +GT S +P A D
Sbjct: 238 TFYNQLNKIVEV--VGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALD 295
Query: 304 FLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
+ K L+ P R + + L+HP+ DP
Sbjct: 296 LIAKMLEFNPQRRISTEQALRHPYFE-SLFDP 326
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 65/276 (23%), Positives = 125/276 (45%), Gaps = 26/276 (9%)
Query: 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELL----AVKQVLIAANSASKEKTQAHIREL 116
++K +++G GAFG VY G+ + GE + A+K++ A + + + E+
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-------EI 64
Query: 117 EEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISS-LLGKFGSFPESVIRMYT 175
+E ++ ++ +P++ R LG ++ ++ + +P G + + + + +
Sbjct: 65 LDEAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 123
Query: 176 KQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE---LATINGAKSMK 232
Q+ G+ YL ++HRD+ N+LV +K+ DFG +K + G K
Sbjct: 124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK--- 180
Query: 233 GTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKS 289
P WMA E IL ++ +D+WS G TV E+ T G P E++++ G
Sbjct: 181 -VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG---E 236
Query: 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
P P +++ ++KC + R EL+
Sbjct: 237 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 68/341 (19%), Positives = 116/341 (34%), Gaps = 96/341 (28%)
Query: 70 ELVGCGAFGRVYMGM-NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-- 126
+G G FG+V + + +A+K +I +E A + E+ +LK +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALK--IIRNVGKYRE--AARL-----EINVLKKIKE 75
Query: 127 -----THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL--GKFGSFPESVIRMYTKQLL 179
V + I E + G + L F +P +R QL
Sbjct: 76 KDKENKF-LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLC 133
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGC-------------------IKLADFGASKKVV 220
L +LH+N + H D+K NIL N I++ADFG+
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGS----- 188
Query: 221 ELATINGAKSMKGTPY-----WMAPEVILQTGHSFSADIWSVGCTVIEMATGKP------ 269
AT + T + PEVIL+ G + D+WS+GC + E G
Sbjct: 189 --ATFDHEHH---TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243
Query: 270 -----------------------PWSQQFQEVAALFHIGTTKSH------PPIPEHLSME 300
+ F + ++ ++ P+ ++ +
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303
Query: 301 AK------DFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
+ D + + L+ +P R T +E L HPF G +
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEE 344
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 68/267 (25%), Positives = 116/267 (43%), Gaps = 25/267 (9%)
Query: 69 GELVGCGAFGRVYMGM-NLDSGELL--AVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
++VG G FG V G L S + + A+K + K++ R+ E ++
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKT--LKVGYTEKQR-----RDFLGEASIMGQ 102
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEY 184
HPNI+R G + + I+ E++ GS+ S L K F + + + G++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA----TINGAKSMKGTPY-WMA 239
L G +HRD+ NIL+++ K++DFG + + + T G K P W +
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKI----PIRWTS 218
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHL 297
PE I + ++D+WS G + E+ + G+ P W Q+V G P P
Sbjct: 219 PEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPPPMDC 275
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQ 324
+L C QK+ R +++
Sbjct: 276 PAALYQLMLDCWQKDRNNRPKFEQIVS 302
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-30
Identities = 72/356 (20%), Positives = 124/356 (34%), Gaps = 114/356 (32%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R+ L+G G+FG+V + E +A+K +I A QA I EV+LL+
Sbjct: 55 RYEIDSLIGKGSFGQVVKAYDRVEQEWVAIK--IIKNKKAFLN--QAQI-----EVRLLE 105
Query: 125 NLTHP------NIVRYLGTAREDDSLNILLEFVPGGSISSLLG----------KFGSFPE 168
+ IV + L ++ E +L F
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE---------MLSYNLYDLLRNTNFRGVSL 156
Query: 169 SVIRMYTKQLLLGLEYLH--KNGIMHRDIKGANILVDN--KGCIKLADFGASKKVVELAT 224
++ R + +Q+ L +L + I+H D+K NIL+ N + IK+ DFG+S ++ +
Sbjct: 157 NLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--- 213
Query: 225 INGAKSMKGTPY-----WMAPEVILQTGHSFSADIWSVGCTVIEMAT------------- 266
+ Y + +PEV+L + + D+WS+GC ++EM T
Sbjct: 214 -------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 267 --------GKPP---------WSQQFQEVAA----------------------LFHIGTT 287
G PP + F+++ L +I
Sbjct: 267 MNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGV 326
Query: 288 KSHPPIPEHLSMEAK---------DFLLKCLQKEPYLRSTASELLQHPFVTGKYQD 334
++ P D +L+ L +P R LQH F +
Sbjct: 327 ETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 382
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 7e-30
Identities = 69/270 (25%), Positives = 121/270 (44%), Gaps = 26/270 (9%)
Query: 67 RKGELVGCGAFGRVYMGM-NLDSGELL---AVKQVLIAANSASKEKTQAHIRELEEEVKL 122
+ +++G G FG VY GM SG+ A+K + A K++ + E +
Sbjct: 47 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT--LKAGYTEKQR-----VDFLGEAGI 99
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLG 181
+ +H NI+R G + + I+ E++ G++ L K G F + + + G
Sbjct: 100 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA----TINGAKSMKGTPY- 236
++YL +HRD+ NILV++ K++DFG S+ + + T +G K P
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI----PIR 215
Query: 237 WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIP 294
W APE I + ++D+WS G + E+ T G+ P W EV + G P P
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTP 272
Query: 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+++C Q+E R ++++
Sbjct: 273 MDCPSAIYQLMMQCWQQERARRPKFADIVS 302
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 63/223 (28%), Positives = 111/223 (49%), Gaps = 32/223 (14%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
G +G G FG VY G ++ +AVK++ + ++ + ++ ++E+K
Sbjct: 29 ERPISVGGNKMGEGGFGVVYKGY-VN-NTTVAVKKLAAMVDITTE---ELK-QQFDQEIK 82
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILL--EFVPGGSISS-LLGKFGSFPES-VIRMYTKQ 177
++ H N+V LG + + D L L ++P GS+ L G+ P S +R +
Sbjct: 83 VMAKCQHENLVELLGFSSDGDDL--CLVYVYMPNGSLLDRLSCLDGTPPLSWHMRC---K 137
Query: 178 LLL----GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSM-- 231
+ G+ +LH+N +HRDIK ANIL+D K++DFG ++ + A+++
Sbjct: 138 IAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEK-----FAQTVMT 192
Query: 232 ---KGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPP 270
GT +MAPE + G + +DI+S G ++E+ TG P
Sbjct: 193 SRIVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPA 233
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 62/263 (23%), Positives = 106/263 (40%), Gaps = 27/263 (10%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+ +G G FG V +G G +AVK + K A + E ++ L H
Sbjct: 26 LQTIGKGEFGDVMLGD--YRGNKVAVKCI----------KNDATAQAFLAEASVMTQLRH 73
Query: 129 PNIVRYLGT-AREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRM--YTKQLLLGLEYL 185
N+V+ LG E L I+ E++ GS+ L G + ++ + +EYL
Sbjct: 74 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 133
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAPEVIL 244
N +HRD+ N+LV K++DFG +K+ K P W APE +
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGK----LPVKWTAPEALR 187
Query: 245 QTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
+ S +D+WS G + E+ + G+ P ++V G P+
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY---KMDAPDGCPPAVY 244
Query: 303 DFLLKCLQKEPYLRSTASELLQH 325
+ + C + +R + +L +
Sbjct: 245 EVMKNCWHLDAAMRPSFLQLREQ 267
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 8e-30
Identities = 69/263 (26%), Positives = 113/263 (42%), Gaps = 25/263 (9%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+G G FG V+MG + + A+K L + + +E +++K L H
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRV-AIK-TLKPGTMSPEA--------FLQEAQVMKKLRH 238
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLEY 184
+V+ E+ + I+ E++ GS+ L GK+ P+ V Q+ G+ Y
Sbjct: 239 EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV--DMAAQIASGMAY 295
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAPEVI 243
+ + +HRD++ ANILV K+ADFG ++ + + A+ P W APE
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLARLIED--NEYTARQGAKFPIKWTAPEAA 353
Query: 244 LQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301
L + +D+WS G + E+ T G+ P +EV G P P
Sbjct: 354 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG---YRMPCPPECPESL 410
Query: 302 KDFLLKCLQKEPYLRSTASELLQ 324
D + +C +KEP R T L
Sbjct: 411 HDLMCQCWRKEPEERPTFEYLQA 433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 68/262 (25%), Positives = 119/262 (45%), Gaps = 23/262 (8%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+ +G G FG V++G L+ ++ A+K + +E + + EE +++ L+H
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKV-AIKTI--------REGAMSE-EDFIEEAEVMMKLSH 62
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHK 187
P +V+ G E + ++ EF+ G +S L G F + + G+ YL +
Sbjct: 63 PKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGT--PY-WMAPEVIL 244
++HRD+ N LV IK++DFG ++ V++ + S GT P W +PEV
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKFPVKWASPEVFS 178
Query: 245 QTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
+ +S +D+WS G + E+ + GK P ++ EV G P S
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG---FRLYKPRLASTHVY 235
Query: 303 DFLLKCLQKEPYLRSTASELLQ 324
+ C ++ P R S LL+
Sbjct: 236 QIMNHCWRERPEDRPAFSRLLR 257
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 74/347 (21%), Positives = 118/347 (34%), Gaps = 112/347 (32%)
Query: 70 ELVGCGAFGRVYMGMNLDSG-ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-- 126
+ +G GAFG+V ++ +G +AVK ++ E A E+++L++L
Sbjct: 20 DTLGEGAFGKVVECIDHKAGGRHVAVK--IVKNVDRYCE--AARS-----EIQVLEHLNT 70
Query: 127 -----THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLG----------KFGSFPESVI 171
T V+ L + I+ E LLG F F I
Sbjct: 71 TDPNSTF-RCVQMLEWFEHHGHICIVFE---------LLGLSTYDFIKENGFLPFRLDHI 120
Query: 172 RMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC-------------------IKLAD 212
R Q+ + +LH N + H D+K NIL IK+ D
Sbjct: 121 RKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVD 180
Query: 213 FGASKKVVELATINGAKSMKGTPY-----WMAPEVILQTGHSFSADIWSVGCTVIEMATG 267
FG+ AT + + + APEVIL G S D+WS+GC +IE G
Sbjct: 181 FGS-------ATYDDEHH---STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLG 230
Query: 268 KP-----------------------------PWSQQFQEVAALFHIGTT------KSHPP 292
+ F + ++ ++ P
Sbjct: 231 FTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP 290
Query: 293 IPEHLSMEAK------DFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333
+ E + + D + K L+ +P R T E L+HPF +
Sbjct: 291 LKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 78/291 (26%), Positives = 120/291 (41%), Gaps = 58/291 (19%)
Query: 69 GELVGCGAFGRVYMGM--NLDSGE---LLAVKQVLIAANSASKEKTQAHIRELEEEVKLL 123
+G GAFG+V++ NL + L+AVK + K+ T A ++ + E +LL
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL--------KDPTLAARKDFQREAELL 71
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL---------GKFGSFPESVIRMY 174
NL H +IV++ G + D L ++ E++ G ++ L G ++ +
Sbjct: 72 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 175 TKQLL-------LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATING 227
Q+L G+ YL +HRD+ N LV +K+ DFG S+ V
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS------ 185
Query: 228 AKSMKGTPY------------WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQ 274
T Y WM PE I+ + +D+WS G + E+ T GK PW Q
Sbjct: 186 ------TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL 239
Query: 275 -FQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
EV G P E D +L C Q+EP R E+ +
Sbjct: 240 SNTEVIECITQG---RVLERPRVCPKEVYDVMLGCWQREPQQRLNIKEIYK 287
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 41/311 (13%), Positives = 83/311 (26%), Gaps = 52/311 (16%)
Query: 45 FSKPAVPALPPIEKTDAPPI---------RWRKGELVGCGAFGRVYMGMNLDSGELLAVK 95
F P D + R+R G + + ++ +A+
Sbjct: 3 FDALREPDRESSAPPDDVQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALT 62
Query: 96 QVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGS 155
V +E L + P + R L ++ E++ GGS
Sbjct: 63 FVDPQGVLPDDVL-----QETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117
Query: 156 ISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215
+ + P IR + L + H+ G+ + + V G + LA
Sbjct: 118 LQEVADT-SPSPVGAIRA-MQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT 175
Query: 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF 275
M + DI +G ++ + + P +
Sbjct: 176 ----------------------MPDA-------NPQDDIRGIGASLYALLVNRWPLPEAG 206
Query: 276 QEVAALFHIGTTKSHPPIPEHL----SMEAKDFLLKCLQKEPYLRS---TASELLQHPFV 328
T P P + + + +Q + +RS + + Q V
Sbjct: 207 VRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLLNLMQQATAV 266
Query: 329 TGKYQDPHPVF 339
+ + P+
Sbjct: 267 ADRTEVLGPID 277
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-29
Identities = 69/281 (24%), Positives = 120/281 (42%), Gaps = 18/281 (6%)
Query: 51 PALPPIEKTDAPPIRWRKGELV-GCGAFGRVYMGM-NLDSGELL-AVKQVLIAANSASKE 107
P +K ++ GCG FG V G+ + ++ A+K + + +
Sbjct: 322 PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKV--LKQGTEKAD 379
Query: 108 KTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISS-LLGKFGSF 166
E+ E +++ L +P IVR +G + ++L +++E GG + L+GK
Sbjct: 380 T-----EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEI 433
Query: 167 PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226
P S + Q+ +G++YL + +HR++ N+L+ N+ K++DFG SK + +
Sbjct: 434 PVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY 493
Query: 227 GAKSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFH 283
A+S P W APE I S +D+WS G T+ E + G+ P + EV A
Sbjct: 494 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553
Query: 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
G P E + C + R + Q
Sbjct: 554 QGK---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-29
Identities = 68/291 (23%), Positives = 112/291 (38%), Gaps = 34/291 (11%)
Query: 47 KPAVPALPPIEKTDAPPIRW-------RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLI 99
KP V + + W + + +G G FG V +G G +AVK +
Sbjct: 169 KPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI-- 224
Query: 100 AANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA-REDDSLNILLEFVPGGSISS 158
K A + E ++ L H N+V+ LG E L I+ E++ GS+
Sbjct: 225 --------KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVD 276
Query: 159 LLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216
L G + ++ + +EYL N +HRD+ N+LV K++DFG +
Sbjct: 277 YLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
Query: 217 KKVVELATINGAKSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQ 273
K+ K P W APE + + S +D+WS G + E+ + G+ P
Sbjct: 337 KEASSTQD--TGK----LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390
Query: 274 QFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
++V G P+ D + C + R T +L +
Sbjct: 391 PLKDVVPRVEKGY---KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 2e-29
Identities = 80/347 (23%), Positives = 121/347 (34%), Gaps = 116/347 (33%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH- 128
+G G FGRV + ++D+ + AVK ++ A I E +LK + +
Sbjct: 41 RKMGDGTFGRVLLCQHIDNKKYYAVK--VVRNIKKYTR--SAKI-----EADILKKIQND 91
Query: 129 ----PNIVRYLGTAREDDSLNILLEFVPGGSISSLLG----------KFGSFPESVIRMY 174
NIV+Y G D + ++ E LG + F I++Y
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFE---------PLGPSLYEIITRNNYNGFHIEDIKLY 142
Query: 175 TKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC-------------------------IK 209
++L L YL K + H D+K NIL+D+ IK
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 210 LADFGASKKVVELATINGAKSMKGTPY-----WMAPEVILQTGHSFSADIWSVGCTVIEM 264
L DFG AT + APEVIL G S+D+WS GC + E+
Sbjct: 203 LIDFGC-------ATFKSDYH---GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252
Query: 265 ATGKP------------------------------------------PWSQQFQEVAALF 282
TG + +++
Sbjct: 253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSIN 312
Query: 283 HIGTTKSHPPIPEHLSMEA-KDFLLKCLQKEPYLRSTASELLQHPFV 328
I K P+ + + E DFL LQ +P LR + +ELL+H F+
Sbjct: 313 SIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 27/211 (12%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
L+G G FG+VY G+ L G +A+K+ + E +Q E E E++ L HP+
Sbjct: 46 LIGHGVFGKVYKGV-LRDGAKVALKR-------RTPESSQGI-EEFETEIETLSFCRHPH 96
Query: 131 IVRYLGTAREDDSLNILL-EFVPGGSISSLLGKFGSFPESV-----IRMYTKQLLL---- 180
+V +G E + + IL+ +++ G++ L +GS ++ R+ ++ +
Sbjct: 97 LVSLIGFCDERNEM-ILIYKYMENGNLKRHL--YGSDLPTMSMSWEQRL---EICIGAAR 150
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
GL YLH I+HRD+K NIL+D K+ DFG SKK EL + + +KGT ++ P
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDP 210
Query: 241 EVILQTGH-SFSADIWSVGCTVIEMATGKPP 270
E + G + +D++S G + E+ +
Sbjct: 211 EYFI-KGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 68/279 (24%), Positives = 118/279 (42%), Gaps = 28/279 (10%)
Query: 69 GELVGCGAFGRVYMGM--NLDSGELL-AVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
G +G G FG V+ G+ + ++ L A+K ++ + + +E ++
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKT--CKNCTSDSVR-----EKFLQEALTMRQ 72
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISS-LLGKFGSFPESVIRMYTKQLLLGLEY 184
HP+IV+ +G ++ + I++E G + S L + S + + +Y QL L Y
Sbjct: 73 FDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSM---KGTPYWMAPE 241
L +HRDI N+LV + C+KL DFG S+ + + +K K WMAPE
Sbjct: 132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPE 187
Query: 242 VILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPI-PEHLS 298
I + ++D+W G + E+ G P + +V G PP P L
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLY 247
Query: 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHP 337
+ KC +P R +EL ++ ++
Sbjct: 248 ----SLMTKCWAYDPSRRPRFTEL--KAQLSTILEEEKA 280
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 68/262 (25%), Positives = 114/262 (43%), Gaps = 23/262 (8%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+ +G G FG V +G +AVK I S S++ E +E + + L+H
Sbjct: 13 LKELGSGQFGVVKLGK-WKGQYDVAVKM--IKEGSMSED-------EFFQEAQTMMKLSH 62
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHK 187
P +V++ G ++ + I+ E++ G + + L G S + + G+ +L
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGT--PY-WMAPEVIL 244
+ +HRD+ N LVD C+K++DFG ++ V++ + S GT P W APEV
Sbjct: 123 HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD----DQYVSSVGTKFPVKWSAPEVFH 178
Query: 245 QTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
+S +D+W+ G + E+ + GK P EV G P S
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG---HRLYRPHLASDTIY 235
Query: 303 DFLLKCLQKEPYLRSTASELLQ 324
+ C + P R T +LL
Sbjct: 236 QIMYSCWHELPEKRPTFQQLLS 257
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 68/270 (25%), Positives = 128/270 (47%), Gaps = 26/270 (9%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELL----AVKQVLIAANSASKEKTQAHIRELEEEVKL 122
RK +++G G FG V+ G+ + GE + +K + + S + + + +
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ-------AVTDHMLA 68
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISS-LLGKFGSFPESVIRMYTKQLLLG 181
+ +L H +IVR LG SL ++ +++P GS+ + G+ ++ + Q+ G
Sbjct: 69 IGSLDHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKG 127
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV---ELATINGAKSMKGTPY-W 237
+ YL ++G++HR++ N+L+ + +++ADFG + + + + AK TP W
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAK----TPIKW 183
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPE 295
MA E I ++ +D+WS G TV E+ T G P + EV L G P+
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG---ERLAQPQ 240
Query: 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+++ ++KC + +R T EL
Sbjct: 241 ICTIDVYMVMVKCWMIDENIRPTFKELANE 270
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-29
Identities = 78/363 (21%), Positives = 123/363 (33%), Gaps = 98/363 (26%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P R+ L+G G++G V + ++A+K++L K +RE+ +
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI--LREI----AI 105
Query: 123 LKNLTHPNIVRYL-----GTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ 177
L L H ++V+ L + D L ++LE L E I+
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYN 164
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 237
LL+G++Y+H GI+HRD+K AN LV+ +K+ DFG ++ V N +
Sbjct: 165 LLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 238 M-------------------------APEVIL-QTGHSFSADIWSVGCTVIEM------- 264
M APE+IL Q ++ + D+WS+GC E+
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284
Query: 265 ----ATGKP-------------------PWSQQFQEVAALFHI----GT----------- 286
A P L I GT
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344
Query: 287 ------TKSHPPIPE--------HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332
+ P S +A L + L P R T +E L HPF +
Sbjct: 345 EDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFK-EV 403
Query: 333 QDP 335
+
Sbjct: 404 RIA 406
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 6e-29
Identities = 55/278 (19%), Positives = 102/278 (36%), Gaps = 44/278 (15%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELL-------AVKQVLIAANSASKEKTQAHIRELEEEVK 121
E +G G F +++ G+ + G+ +K + + + + E
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVL--------DKAHRNYSESFFEAAS 64
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISS-LLGKFGSFPESVIRMYTKQLLL 180
++ L+H ++V G D ++ EFV GS+ + L KQL
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKG--------CIKLADFGASKKVVELATINGAKSMK 232
+ +L +N ++H ++ NIL+ + IKL+D G S V+ K +
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP-------KDIL 177
Query: 233 GTPY-WMAPEVILQTGHSFS--ADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTT 287
W+ PE I + + D WS G T+ E+ + G P + Q +
Sbjct: 178 QERIPWVPPECIEN-PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQ 236
Query: 288 KSHPPIPE-HLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
P E + C+ EP R + +++
Sbjct: 237 LPAPKAAELANLI------NNCMDYEPDHRPSFRAIIR 268
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 74/282 (26%), Positives = 117/282 (41%), Gaps = 39/282 (13%)
Query: 69 GELVGCGAFGRVYMGM--NLDSGE---LLAVKQVLIAANSASKEKTQAHIRELEEEVKLL 123
+G GAFG+V++ NL + L+AVK + KE +++ ++ + E +LL
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL--------KEASESARQDFQREAELL 97
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL--------GKFGSFPESVIRMYT 175
L H +IVR+ G E L ++ E++ G ++ L G + +
Sbjct: 98 TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157
Query: 176 KQLL-------LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA--TIN 226
QLL G+ YL +HRD+ N LV +K+ DFG S+ + +
Sbjct: 158 GQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVG 217
Query: 227 GAKSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQ-FQEVAALFH 283
G + P WM PE IL + +D+WS G + E+ T GK PW Q E
Sbjct: 218 GRTML---PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT 274
Query: 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
G P E + C Q+EP R + ++
Sbjct: 275 QG---RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 63/276 (22%), Positives = 119/276 (43%), Gaps = 17/276 (6%)
Query: 60 DAPPIRWRK----GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRE 115
E++G G FG VY G LD+ K++ A S ++ + +
Sbjct: 17 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQ 72
Query: 116 LEEEVKLLKNLTHPNIVRYLGT-AREDDSLNILLEFVPGGSISS-LLGKFGSFPESVIRM 173
E ++K+ +HPN++ LG R + S ++L ++ G + + + + + +
Sbjct: 73 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 132
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
+ Q+ G++YL +HRD+ N ++D K +K+ADFG ++ + + +
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 234 T-PY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKS 289
P WMA E + + +D+WS G + E+ T G PP ++ G
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---R 249
Query: 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
PE+ + +LKC + +R + SEL+
Sbjct: 250 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 285
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 67/264 (25%), Positives = 108/264 (40%), Gaps = 23/264 (8%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+G G +G VY G+ +AVK + ++ E E +E ++K + H
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKT--LKEDTMEVE-------EFLKEAAVMKEIKH 68
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLL--GKFGSFPESVIRMYTKQLLLGLEYLH 186
PN+V+ LG + I+ EF+ G++ L V+ Q+ +EYL
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE---LATINGAKSMKGTPYWMAPEVI 243
K +HRD+ N LV +K+ADFG S+ + A +K W APE +
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK----WTAPESL 184
Query: 244 LQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301
S +D+W+ G + E+AT G P +V L PE +
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCPEKV 241
Query: 302 KDFLLKCLQKEPYLRSTASELLQH 325
+ + C Q P R + +E+ Q
Sbjct: 242 YELMRACWQWNPSDRPSFAEIHQA 265
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 9e-29
Identities = 70/289 (24%), Positives = 115/289 (39%), Gaps = 37/289 (12%)
Query: 55 PIEKTDAPPIRWRK------------GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAAN 102
+ K +G G FG V+MG + + A+K L
Sbjct: 246 VCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIK-TLKPGT 303
Query: 103 SASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-- 160
+ + +E +++K L H +V+ E+ + I+ E++ GS+ L
Sbjct: 304 MSPEA--------FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKG 354
Query: 161 --GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218
GK+ P+ V Q+ G+ Y+ + +HRD++ ANILV K+ADFG ++
Sbjct: 355 ETGKYLRLPQLV--DMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 219 VVELATINGAKSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQF 275
+ + A+ P W APE L + +D+WS G + E+ T G+ P
Sbjct: 413 IED--NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470
Query: 276 QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+EV G P P D + +C +KEP R T L
Sbjct: 471 REVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 61/282 (21%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 69 GELVGCGAFGRVYMG----MNLDSGELL-AVKQVLIAANSASKEK-TQAHIRELEEEVKL 122
+G G+FG VY G + D E A+K V E + E E +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV--------NEAASMRERIEFLNEASV 81
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL---GKFGSFPESVIRMYTKQLL 179
+K ++VR LG + +++E + G + S L + + +++
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 180 L-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE----LATINGA 228
G+ YL+ N +HRD+ N +V +K+ DFG ++ + E G
Sbjct: 142 QMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 201
Query: 229 KSMKGTPYWMAPEVILQ---TGHSFSADIWSVGCTVIEMAT-GKPPWSQ-QFQEVAALFH 283
++ WM+PE + T +S D+WS G + E+AT + P+ ++V
Sbjct: 202 LPVR----WMSPESLKDGVFTTYS---DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254
Query: 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
G P++ + + C Q P +R + E++
Sbjct: 255 EG---GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-28
Identities = 85/353 (24%), Positives = 150/353 (42%), Gaps = 100/353 (28%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
++ + +G GA+G V+ ++ +GE++AVK++ A +++ + R E + +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ-----RTFRE-IMI 61
Query: 123 LKNL-THPNIVRYLG--TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIR------- 172
L L H NIV L A D + ++ +++ + L VIR
Sbjct: 62 LTELSGHENIVNLLNVLRADNDRDVYLVFDYME-----TDLHA-------VIRANILEPV 109
Query: 173 -----MYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATING 227
+Y QL+ ++YLH G++HRD+K +NIL++ + +K+ADFG S+ V + +
Sbjct: 110 HKQYVVY--QLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 228 AKSMKG--------------TPY----WM-APEVIL-QTGHSFSADIWSVGCTVIEMATG 267
+ T Y W APE++L T ++ D+WS+GC + E+ G
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227
Query: 268 KP--------------------PWSQQFQEVA---ALFHIGTTKSHPPIP---------- 294
KP P ++ + + A I + K I
Sbjct: 228 KPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK 287
Query: 295 -----------EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPH 336
+ EA D L K LQ P R +A++ L+HPFV+ + +P+
Sbjct: 288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVS-IFHNPN 339
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 68/293 (23%), Positives = 114/293 (38%), Gaps = 55/293 (18%)
Query: 69 GELVGCGAFGRVYMG--MNLDSGE---LLAVKQVLIAANSASKEK-TQAHIRELEEEVKL 122
G+ +G GAFG+V L + +AVK + K L E+K+
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML--------KPSAHLTEREALMSELKV 79
Query: 123 LKNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-----------GKFGSFPESV 170
L L H NIV LG ++ E+ G + + L +
Sbjct: 80 LSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139
Query: 171 IRMYTKQLLL-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE-- 221
+ + + LL G+ +L +HRD+ NIL+ + K+ DFG ++ +
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 222 --LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-------GKPPWS 272
+ N +K WMAPE I ++F +D+WS G + E+ + G P S
Sbjct: 200 NYVVKGNARLPVK----WMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255
Query: 273 QQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+ ++ + F + PEH E D + C +P R T +++Q
Sbjct: 256 KFYKMIKEGFRM-------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-28
Identities = 65/265 (24%), Positives = 114/265 (43%), Gaps = 20/265 (7%)
Query: 67 RKGELVGCGAFGRVYMGM--NLDSGELL-AVKQVLIAANSASKEKTQAHIRELEEEVKLL 123
G +G G FG V+ G+ + ++ + A+K ++ + + +E +
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC--KNCTSDSVR-----EKFLQEALTM 445
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISS-LLGKFGSFPESVIRMYTKQLLLGL 182
+ HP+IV+ +G ++ + I++E G + S L + S + + +Y QL L
Sbjct: 446 RQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPY-WMAPE 241
YL +HRDI N+LV + C+KL DFG S+ + + +K P WMAPE
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK--LPIKWMAPE 562
Query: 242 VILQTGHSFSADIWSVGCTVIEMAT--GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
I + ++D+W G + E+ KP + +V G P+P +
Sbjct: 563 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG---ERLPMPPNCPP 619
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQ 324
+ KC +P R +EL
Sbjct: 620 TLYSLMTKCWAYDPSRRPRFTELKA 644
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 58/271 (21%), Positives = 111/271 (40%), Gaps = 25/271 (9%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANSASKEK-TQAHIRELEEEVKL 122
++G G FG VY G +D + A+K + + E L
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--------SRITEMQQVEAFLREGLL 75
Query: 123 LKNLTHPNIVRYLGT-AREDDSLNILLEFVPGGSISS-LLGKFGSFPESVIRMYTKQLLL 180
++ L HPN++ +G + ++LL ++ G + + + + + Q+
Sbjct: 76 MRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGT-PY-WM 238
G+EYL + +HRD+ N ++D +K+ADFG ++ +++ + + P W
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 239 APEVILQTGHSFSA--DIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIP 294
A E + + F+ D+WS G + E+ T G PP ++ G P P
Sbjct: 196 ALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG---RRLPQP 250
Query: 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
E+ + +C + +P +R T L+
Sbjct: 251 EYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 69 GELVGCGAFGRVYMGM-NLDSGELL--AVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
++G G FG VY G+ GE + AVK +KE + E ++KN
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE-------KFMSEAVIMKN 69
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEY 184
L HP+IV+ +G E++ I++E P G + L + S + +Y+ Q+ + Y
Sbjct: 70 LDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAY 128
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSM---KGTPYWMAPE 241
L +HRDI NILV + C+KL DFG S+ + + + + K WM+PE
Sbjct: 129 LESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK----WMSPE 184
Query: 242 VILQTGHSFSADIWSVGCTVIEMAT-GKPPW 271
I + ++D+W + E+ + GK P+
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPF 215
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 3e-28
Identities = 78/316 (24%), Positives = 132/316 (41%), Gaps = 57/316 (18%)
Query: 50 VPALPPIEKTDAPPIRW-------RKGELVGCGAFGRVYMG--MNLDSGELL---AVKQV 97
+P E+ +W + G+ +G GAFG+V +D AVK +
Sbjct: 6 LPLDEHCERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML 65
Query: 98 LIAANSASKEK-TQAHIRELEEEVKLLKNL-THPNIVRYLGT-AREDDSLNILLEFVPGG 154
KE T + R L E+K+L ++ H N+V LG + L +++EF G
Sbjct: 66 --------KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 155 SISSLL---------GKFGSFPESVIRMYTKQLLL-------GLEYLHKNGIMHRDIKGA 198
++S+ L K + + L+ G+E+L +HRD+
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 177
Query: 199 NILVDNKGCIKLADFGASKKVVE----LATINGAKSMKGTPYWMAPEVILQTGHSFSA-- 252
NIL+ K +K+ DFG ++ + + + + +K WMAPE I ++
Sbjct: 178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK----WMAPETIFD--RVYTIQS 231
Query: 253 DIWSVGCTVIEMAT-GKPPWS--QQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCL 309
D+WS G + E+ + G P+ + +E GT P++ + E +L C
Sbjct: 232 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT---RMRAPDYTTPEMYQTMLDCW 288
Query: 310 QKEPYLRSTASELLQH 325
EP R T SEL++H
Sbjct: 289 HGEPSQRPTFSELVEH 304
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 65/298 (21%), Positives = 125/298 (41%), Gaps = 23/298 (7%)
Query: 60 DAPPIRWRK----GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRE 115
E++G G FG VY G LD+ K++ A S ++ + +
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDG----KKIHCAVKSLNRITDIGEVSQ 136
Query: 116 LEEEVKLLKNLTHPNIVRYLGT-AREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRM 173
E ++K+ +HPN++ LG R + S ++L ++ G + + + + + +
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 196
Query: 174 YTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKG 233
+ Q+ G+++L +HRD+ N ++D K +K+ADFG ++ + + +
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 234 T-PY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKS 289
P WMA E + + +D+WS G + E+ T G PP ++ G
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG---R 313
Query: 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ------HPFVTGKYQDPHPVFRN 341
PE+ + +LKC + +R + SEL+ F+ Y + + N
Sbjct: 314 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVN 371
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 77/368 (20%), Positives = 126/368 (34%), Gaps = 116/368 (31%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P + L+G G++G VY+ + ++ + +A+K+V K R L E + +
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK-----RILRE-ITI 78
Query: 123 LKNLTHPNIVRYL-----GTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIR----- 172
L L I+R + D L I+LE S L + + +
Sbjct: 79 LNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD----SDL--------KKLFKTPIFL 126
Query: 173 --------MYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224
+Y LLLG ++H++GI+HRD+K AN L++ +K+ DFG ++ +
Sbjct: 127 TEEHIKTILY--NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184
Query: 225 INGAKSMKG---------------TPY----WM-APEVIL-QTGHSFSADIWSVGCTVIE 263
N ++ T + W APE+IL Q ++ S DIWS GC E
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAE 244
Query: 264 MATGKPPWSQQFQEVAALF-------------------------------HIGT------ 286
+ LF IGT
Sbjct: 245 LLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDL 304
Query: 287 -----------TKSHPPIPE--------HLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
K P +S + + L L+ P R T + L HP+
Sbjct: 305 KNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPY 364
Query: 328 VTGKYQDP 335
+ +
Sbjct: 365 LK-DVRKK 371
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 7e-28
Identities = 67/263 (25%), Positives = 115/263 (43%), Gaps = 23/263 (8%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+ +G G FG V G +A+K + KE + + E EE K++ NL+H
Sbjct: 29 LKELGTGQFGVVKYGK-WRGQYDVAIKMI--------KEGSMSE-DEFIEEAKVMMNLSH 78
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLEYLHK 187
+V+ G + + I+ E++ G + + L F + K + +EYL
Sbjct: 79 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA--TINGAKSMKGTPY-WMAPEVIL 244
+HRD+ N LV+++G +K++DFG S+ V++ + G+K P W PEV++
Sbjct: 139 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK----FPVRWSPPEVLM 194
Query: 245 QTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
+ S +DIW+ G + E+ + GK P E A G P S +
Sbjct: 195 YSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG---LRLYRPHLASEKVY 251
Query: 303 DFLLKCLQKEPYLRSTASELLQH 325
+ C ++ R T LL +
Sbjct: 252 TIMYSCWHEKADERPTFKILLSN 274
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 63/219 (28%), Positives = 102/219 (46%), Gaps = 40/219 (18%)
Query: 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
++G G FG+VY G L G L+AVK++ +E+TQ + + EV+++ H N
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRL-------KEERTQGGELQFQTEVEMISMAVHRN 88
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESV-----IRMYTKQLLLG---- 181
++R G ++ ++ GS++S L R ++ LG
Sbjct: 89 LLRLRGFCMTPTERLLVYPYMANGSVASCL--RERPESQPPLDWPKRQ---RIALGSARG 143
Query: 182 LEYLHKNG---IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS------MK 232
L YLH + I+HRD+K ANIL+D + + DFG LA + K ++
Sbjct: 144 LAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG-------LAKLMDYKDTHVTTAVR 196
Query: 233 GTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPP 270
GT +APE L TG S D++ G ++E+ TG+
Sbjct: 197 GTIGHIAPEY-LSTGKSSEKTDVFGYGVMLLELITGQRA 234
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 73/282 (25%), Positives = 113/282 (40%), Gaps = 43/282 (15%)
Query: 69 GELVGCGAFGRVYMG----MNLDSGELL-AVKQVLIAANSASKEK-TQAHIRELEEEVKL 122
+G GAFG VY G M D L AVK + E ++ + E +
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--------PEVCSEQDELDFLMEALI 86
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL-- 180
+ H NIVR +G + + IL+E + GG + S L + P + LL
Sbjct: 87 ISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 146
Query: 181 -----GLEYLHKNGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELA-TINGAKSM 231
G +YL +N +HRDI N L+ G K+ DFG ++ + + G +M
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 232 ---KGTPYWMAPEVILQ---TGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFH 283
K WM PE ++ T + D WS G + E+ + G P S+ QEV
Sbjct: 207 LPVK----WMPPEAFMEGIFTSKT---DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 259
Query: 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
G P++ + +C Q +P R + +L+
Sbjct: 260 SG---GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 9e-28
Identities = 59/281 (20%), Positives = 106/281 (37%), Gaps = 40/281 (14%)
Query: 69 GELVGCGAFGRVYMGM--NLDSGELL-AVKQVLIAANSASKEK--TQAHIRELEEEVKLL 123
G ++G G FG V D + AVK + K + I E E +
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKML--------KADIIASSDIEEFLREAACM 79
Query: 124 KNLTHPNIVRYLG------TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ 177
K HP++ + +G ++L F+ G + + L E+ + +
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQT 138
Query: 178 LLL-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE----LATIN 226
L+ G+EYL +HRD+ N ++ + +ADFG S+K+
Sbjct: 139 LVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCA 198
Query: 227 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPW-SQQFQEVAALFHI 284
+K W+A E + ++ +D+W+ G T+ E+ T G+ P+ + E+
Sbjct: 199 SKLPVK----WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
Query: 285 GTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
G P E D + +C +P R + + L
Sbjct: 255 GN---RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 73/313 (23%), Positives = 118/313 (37%), Gaps = 43/313 (13%)
Query: 38 RKSRIGLFSKPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELL---AV 94
GL + + +E G+++G G FG V G AV
Sbjct: 8 HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAV 67
Query: 95 KQVLIAANSASKEK--TQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN-----IL 147
K + K +Q I E E +K+ +HPN++R LG E S ++
Sbjct: 68 KTM--------KLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVI 119
Query: 148 LEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL-------GLEYLHKNGIMHRDIKGANI 200
L F+ G + + L + + + LL G+EYL +HRD+ N
Sbjct: 120 LPFMKYGDLHTYL-LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNC 178
Query: 201 LVDNKGCIKLADFGASKKVVE----LATINGAKSMKGTPYWMAPEVILQTGHSFSA--DI 254
++ + + +ADFG SKK+ +K W+A E + +++ D+
Sbjct: 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK----WIAIESLAD--RVYTSKSDV 232
Query: 255 WSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKE 312
W+ G T+ E+AT G P Q E+ G PE E + + C + +
Sbjct: 233 WAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG---HRLKQPEDCLDELYEIMYSCWRTD 289
Query: 313 PYLRSTASELLQH 325
P R T S L
Sbjct: 290 PLDRPTFSVLRLQ 302
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 74/282 (26%), Positives = 112/282 (39%), Gaps = 43/282 (15%)
Query: 69 GELVGCGAFGRVYMG----MNLDSGELL-AVKQVLIAANSASKEK-TQAHIRELEEEVKL 122
+G GAFG VY G M D L AVK + E ++ + E +
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTL--------PEVCSEQDELDFLMEALI 127
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL--- 179
+ H NIVR +G + + ILLE + GG + S L + P + LL
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187
Query: 180 ----LGLEYLHKNGIMHRDIKGANILVDNKG---CIKLADFGASKKVVELA-TINGAKSM 231
G +YL +N +HRDI N L+ G K+ DFG ++ + G +M
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 232 ---KGTPYWMAPEVILQ---TGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFH 283
K WM PE ++ T + D WS G + E+ + G P S+ QEV
Sbjct: 248 LPVK----WMPPEAFMEGIFTSKT---DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT 300
Query: 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
G P++ + +C Q +P R + +L+
Sbjct: 301 SGGR---MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 339
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 4e-27
Identities = 72/303 (23%), Positives = 126/303 (41%), Gaps = 36/303 (11%)
Query: 38 RKSRIGLFSKPAVPALPPIEKTDAPPIRW-------RKGELVGCGAFGRVYMGMNLDSGE 90
+K GL K +VP + + W + + +G G FG V+M +
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTK 214
Query: 91 LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEF 150
+ AVK + + + E ++K L H +V+ ++ + I+ EF
Sbjct: 215 V-AVK-TMKPGSMSV--------EAFLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEF 263
Query: 151 VPGGSISSLL----GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG 206
+ GS+ L G P+ + ++ Q+ G+ ++ + +HRD++ ANILV
Sbjct: 264 MAKGSLLDFLKSDEGSKQPLPKLI--DFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL 321
Query: 207 CIKLADFGASKKVVELA--TINGAKSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIE 263
K+ADFG ++ + + GAK P W APE I + +D+WS G ++E
Sbjct: 322 VCKIADFGLARVIEDNEYTAREGAK----FPIKWTAPEAINFGSFTIKSDVWSFGILLME 377
Query: 264 MAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASE 321
+ T G+ P EV G P PE+ E + +++C + P R T
Sbjct: 378 IVTYGRIPYPGMSNPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERPTFEY 434
Query: 322 LLQ 324
+
Sbjct: 435 IQS 437
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 67/287 (23%), Positives = 112/287 (39%), Gaps = 47/287 (16%)
Query: 69 GELVGCGAFGRVYMG----MNLDSGELL-AVKQVLIAANSASKEKTQAHIRELEE---EV 120
G+ +G GAFG+V + + L AVK + K+ AH E E E+
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKML----------KSTAHADEKEALMSEL 100
Query: 121 KLLKNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-------GKFGSFPESVIR 172
K++ +L H NIV LG + ++ E+ G + + L +F +
Sbjct: 101 KIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANST 160
Query: 173 MYTKQLLL-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE---- 221
T+ LL G+ +L +HRD+ N+L+ N K+ DFG ++ ++
Sbjct: 161 ASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPW--SQQFQEV 278
+ N +K WMAPE I ++ +D+WS G + E+ + G P+ +
Sbjct: 221 IVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF 276
Query: 279 AALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
L G P + C EP R T ++
Sbjct: 277 YKLVKDGY---QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 67/264 (25%), Positives = 111/264 (42%), Gaps = 25/264 (9%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
E +G G FG V+MG ++ AVK + S S + E L+K L H
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTKV-AVKS--LKQGSMSPD-------AFLAEANLMKQLQH 67
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRM--YTKQLLLGLEYLH 186
+VR ++ + I+ E++ GS+ L ++ ++ Q+ G+ ++
Sbjct: 68 QRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA--TINGAKSMKGTPY-WMAPEVI 243
+ +HRD++ ANILV + K+ADFG ++ + + GAK P W APE I
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK----FPIKWTAPEAI 182
Query: 244 LQTGHSFSADIWSVGCTVIEMAT-GKPP-WSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301
+ +D+WS G + E+ T G+ P EV G P++ E
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG---YRMVRPDNCPEEL 239
Query: 302 KDFLLKCLQKEPYLRSTASELLQH 325
+ C ++ P R T L
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSV 263
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-27
Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 51/293 (17%)
Query: 69 GELVGCGAFGRVYMGM--NLDSGE---LLAVKQVLIAANSASKEK-TQAHIRELEEEVKL 122
+G GAFGRV+ L E ++AVK + KE+ + + + E L
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML--------KEEASADMQADFQREAAL 103
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-----------------GKFGS 165
+ +PNIV+ LG + +L E++ G ++ L +
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 166 FPESVIRMYTKQLL-------LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218
+ + L G+ YL + +HRD+ N LV +K+ADFG S+
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN 223
Query: 219 VVE----LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ 273
+ A N A ++ WM PE I ++ +D+W+ G + E+ + G P+
Sbjct: 224 IYSADYYKADGNDAIPIR----WMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 274 -QFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+EV G PE+ +E + + C K P R + + +
Sbjct: 280 MAHEEVIYYVRDGN---ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 65/287 (22%), Positives = 109/287 (37%), Gaps = 47/287 (16%)
Query: 69 GELVGCGAFGRVYMGM--NLDSGE---LLAVKQVLIAANSASKEK-TQAHIRELEEEVKL 122
E +G FG+VY G GE +A+K + K+K E E L
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTL--------KDKAEGPLREEFRHEAML 65
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL---------GKFGSFPESVIRM 173
L HPN+V LG +D L+++ + G + L G +
Sbjct: 66 RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 174 YTKQLLL-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT-I 225
+ G+EYL + ++H+D+ N+LV +K +K++D G ++V
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYK 185
Query: 226 NGAKSM---KGTPYWMAPEVILQTGHSFSA--DIWSVGCTVIEMAT--GKPPWSQQFQEV 278
S+ + WMAPE I+ FS DIWS G + E+ + +P Q+V
Sbjct: 186 LLGNSLLPIR----WMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV 239
Query: 279 AALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+ P P+ +++C + P R ++
Sbjct: 240 VEMIRNR---QVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 283
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 63/292 (21%), Positives = 115/292 (39%), Gaps = 48/292 (16%)
Query: 69 GELVGCGAFGRVYMGM--NLDSGE---LLAVKQVLIAANSASKEK-TQAHIRELEEEVKL 122
G+++G GAFG+V + +AVK + KEK + L E+K+
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML--------KEKADSSEREALMSELKM 101
Query: 123 LKNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL----------------GKFGS 165
+ L +H NIV LG + ++ E+ G + + L K
Sbjct: 102 MTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 161
Query: 166 FPESVIRMYTKQLLL-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218
E + + + LL G+E+L +HRD+ N+LV + +K+ DFG ++
Sbjct: 162 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 219 VVE----LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQ 273
++ + N +K WMAPE + + ++ +D+WS G + E+ + G P+
Sbjct: 222 IMSDSNYVVRGNARLPVK----WMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY-P 276
Query: 274 QFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
A + + P + + E + C + R + L
Sbjct: 277 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 68/293 (23%), Positives = 124/293 (42%), Gaps = 51/293 (17%)
Query: 69 GELVGCGAFGRVYMG--MNLDSGE---LLAVKQVLIAANSASKEK-TQAHIRELEEEVKL 122
G+ +G G FG+V +L +AVK + KE + + +R+L E +
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKML--------KENASPSELRDLLSEFNV 79
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-----------------GKFGS 165
LK + HP++++ G +D L +++E+ GS+ L
Sbjct: 80 LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 166 FPESVIRMYTKQLLL-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218
+ L+ G++YL + ++HRD+ NILV +K++DFG S+
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 219 VVE----LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPW-S 272
V E + G +K WMA E + ++ +D+WS G + E+ T G P+
Sbjct: 200 VYEEDSYVKRSQGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPG 255
Query: 273 QQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+ + L G P++ S E +L+C ++EP R +++ +
Sbjct: 256 IPPERLFNLLKTGH---RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 72/290 (24%), Positives = 123/290 (42%), Gaps = 50/290 (17%)
Query: 69 GELVGCGAFGRVYMGM--NLDSGELL-----AVKQVLIAANSASKEK-TQAHIRELEEEV 120
G+ +G GAFG+V M +D + AVK + K+ T+ + +L E+
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML--------KDDATEKDLSDLVSEM 91
Query: 121 KLLKNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL---------GKFGSFPESV 170
+++K + H NI+ LG +D L +++E+ G++ L +
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 171 IRMYTKQLLL-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE-- 221
+M K L+ G+EYL +HRD+ N+LV +K+ADFG ++ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 222 --LATINGAKSMKGTPYWMAPEVILQTGHSFSA--DIWSVGCTVIEMAT-GKPPW-SQQF 275
T NG +K WMAPE + ++ D+WS G + E+ T G P+
Sbjct: 212 YYKKTTNGRLPVK----WMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265
Query: 276 QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+E+ L G P + + E + C P R T +L++
Sbjct: 266 EELFKLLKEG---HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 71/290 (24%), Positives = 122/290 (42%), Gaps = 50/290 (17%)
Query: 69 GELVGCGAFGRVYMGM--NLDSGELL-----AVKQVLIAANSASKEK-TQAHIRELEEEV 120
G+ +G G FG+V M +D + AVK + K+ T+ + +L E+
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML--------KDDATEKDLSDLVSEM 137
Query: 121 KLLKNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL---------GKFGSFPESV 170
+++K + H NI+ LG +D L +++E+ G++ L +
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 171 IRMYTKQLLL-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE-- 221
+M K L+ G+EYL +HRD+ N+LV +K+ADFG ++ +
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 222 --LATINGAKSMKGTPYWMAPEVILQTGHSFSA--DIWSVGCTVIEMAT-GKPPW-SQQF 275
T NG +K WMAPE + ++ D+WS G + E+ T G P+
Sbjct: 258 YYKKTTNGRLPVK----WMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311
Query: 276 QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+E+ L G P + + E + C P R T +L++
Sbjct: 312 EELFKLLKEGH---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 81/377 (21%), Positives = 134/377 (35%), Gaps = 134/377 (35%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R+ +G G F V++ ++ + +A+K V+ +A + +E++LLK
Sbjct: 38 RYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEH--------YTETALDEIRLLK 88
Query: 125 NL-----THPN---IVRYLGTAREDDSLNIL--------LEFVP-GGSISSLLGKF--GS 165
++ PN +V+ L D I + F G + + K
Sbjct: 89 SVRNSDPNDPNREMVVQLL------DDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQG 142
Query: 166 FPESVIRMYTKQLLLGLEYLH-KNGIMHRDIKGANILV---------------------- 202
P ++ +Q+L GL+YLH K I+H DIK NIL+
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 203 ---------------------------DNKGCIKLADFGASKKVVELATINGAKSMKGTP 235
K +K+AD G + V + T T
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFT-----EDIQTR 257
Query: 236 YWMAPEVILQTGHSFSADIWSVGCTVIEMAT---------------------------GK 268
+ + EV++ +G++ ADIWS C E+AT GK
Sbjct: 258 QYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGK 317
Query: 269 PP--------WSQQ-FQEVAALFHIGTTKSHP---PIPEHLSMEAKD------FLLKCLQ 310
P +S++ F + L HI K + E ++ FLL L+
Sbjct: 318 VPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLE 377
Query: 311 KEPYLRSTASELLQHPF 327
P R+TA+E L+HP+
Sbjct: 378 LIPEKRATAAECLRHPW 394
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-25
Identities = 71/288 (24%), Positives = 126/288 (43%), Gaps = 46/288 (15%)
Query: 69 GELVGCGAFGRVYMG--MNLDSGE-----LLAVKQVLIAANSASKEK-TQAHIRELEEEV 120
G+ +G GAFG+V + + LD + +AVK + K T+ + +L E+
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML--------KSDATEKDLSDLISEM 125
Query: 121 KLLKNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLL---------GKFGSFPESV 170
+++K + H NI+ LG +D L +++E+ G++ L +
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 171 IRMYTKQLLL-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE-- 221
++ +K L+ G+EYL +HRD+ N+LV +K+ADFG ++ +
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 222 --LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPW-SQQFQE 277
T NG +K WMAPE + ++ +D+WS G + E+ T G P+ +E
Sbjct: 246 YYKKTTNGRLPVK----WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
Query: 278 VAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+ L G P + + E + C P R T +L++
Sbjct: 302 LFKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 70/295 (23%), Positives = 125/295 (42%), Gaps = 41/295 (13%)
Query: 57 EKTDAPPIRWRK---GELVGCGAFGRVYMGM-NLDSGELL-AVKQVLIAANSASKEK-TQ 110
+ T P + W +++G G FG+V D + A+K++ KE ++
Sbjct: 15 DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRM--------KEYASK 66
Query: 111 AHIRELEEEVKLLKNLT-HPNIVRYLGTAREDDSLNILLEFVPGGSISSLL--------- 160
R+ E+++L L HPNI+ LG L + +E+ P G++ L
Sbjct: 67 DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETD 126
Query: 161 GKFGSFPESVIRMYTKQLLL-------GLEYLHKNGIMHRDIKGANILVDNKGCIKLADF 213
F + + ++QLL G++YL + +HRD+ NILV K+ADF
Sbjct: 127 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 186
Query: 214 GASKKVVELATINGAKSMKGTPY-WMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPP- 270
G S+ + P WMA E + + ++ ++D+WS G + E+ + G P
Sbjct: 187 GLSRGQEVYVKKTMGR----LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY 242
Query: 271 WSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
E+ G P + E D + +C +++PY R + +++L
Sbjct: 243 CGMTCAELYEKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 53/217 (24%), Positives = 93/217 (42%), Gaps = 21/217 (9%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R+R G +G G+FG +Y+G ++ +GE +A+K E + +L E K+ K
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL----------ECVKTKHPQLHIESKIYK 59
Query: 125 NLTH-PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGL 182
+ I E D N+++ + G S+ L F + + Q++ +
Sbjct: 60 MMQGGVGIPTIRWCGAEGDY-NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 118
Query: 183 EYLHKNGIMHRDIKGANILV---DNKGCIKLADFGASKKVVELAT-----INGAKSMKGT 234
EY+H +HRD+K N L+ + + DFG +KK + T K++ GT
Sbjct: 119 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 235 PYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW 271
+ + L S D+ S+G ++ G PW
Sbjct: 179 ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPW 215
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 54/238 (22%), Positives = 94/238 (39%), Gaps = 42/238 (17%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+W G+ +G G FG +Y+ + E A K + Q + L E+K +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARH--------VVKVEYQEN-GPLFSELKFYQ 88
Query: 125 NLTHPNIVRYLGTAREDDSLNI----------------------LLEFVPGGSISSLLGK 162
+ + ++ ++ D L I L G + + G+
Sbjct: 89 RVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL----GIDLQKISGQ 144
Query: 163 FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC--IKLADFGASKKVV 220
G+F +S + ++L LEY+H+N +H DIK AN+L+ K + LAD+G S +
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYC 204
Query: 221 ELAT-----INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQ 273
N K GT + + + S +D+ +G ++ GK PW Q
Sbjct: 205 PNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 23/219 (10%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ G +G G+FG ++ G NL + + +A+K E ++ +L +E + K
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF----------EPRRSDAPQLRDEYRTYK 60
Query: 125 NLTH-PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGL 182
L I +E N+L+ + G S+ LL G F + M KQ+L +
Sbjct: 61 LLAGCTGIPNVYYFGQEGLH-NVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 119
Query: 183 EYLHKNGIMHRDIKGANILVDNKGC-----IKLADFGASKKVVELAT-----INGAKSMK 232
+ +H+ +++RDIK N L+ I + DFG K + T K++
Sbjct: 120 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179
Query: 233 GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW 271
GT +M+ L S D+ ++G + G PW
Sbjct: 180 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPW 218
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 99.3 bits (247), Expect = 4e-22
Identities = 53/217 (24%), Positives = 92/217 (42%), Gaps = 21/217 (9%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++R G +G G+FG +Y+G N+ + E +A+K E + +L E K+ +
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL----------ENVKTKHPQLLYESKIYR 57
Query: 125 NLT-HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGL 182
L I E D N+L+ + G S+ L + M Q++ +
Sbjct: 58 ILQGGTGIPNVRWFGVEGDY-NVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRV 116
Query: 183 EYLHKNGIMHRDIKGANILV---DNKGCIKLADFGASKKVVELATIN-----GAKSMKGT 234
E++H +HRDIK N L+ + + DFG +KK + +T K++ GT
Sbjct: 117 EFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 235 PYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW 271
+ + L S D+ S+G ++ G PW
Sbjct: 177 ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 1e-21
Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 23/219 (10%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+R G+ +GCG FG + +G NL + E +A+K E ++ +L E + K
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKL----------EPMKSRAPQLHLEYRFYK 59
Query: 125 NLTH-PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGL 182
L I + N ++ + G S+ L +F + M QL+ +
Sbjct: 60 QLGSGDGIPQVYYFGPCGKY-NAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRM 118
Query: 183 EYLHKNGIMHRDIKGANILV-----DNKGCIKLADFGASKKVVELAT---ING--AKSMK 232
EY+H +++RD+K N L+ + I + DF +K+ ++ T I KS+
Sbjct: 119 EYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178
Query: 233 GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW 271
GT +M+ L S D+ ++G + G PW
Sbjct: 179 GTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPW 217
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 45/242 (18%), Positives = 86/242 (35%), Gaps = 24/242 (9%)
Query: 52 ALPPIEK-TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQ 110
ALP TD +W+ G +Y + + Q + + +
Sbjct: 29 ALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGR 88
Query: 111 -----------AHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNIL-LEFVPGGSISS 158
A ++ + KL + I +G D L L + G S+ S
Sbjct: 89 LFNEQNFFQRAAKPLQVNKWKKL-YSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS 146
Query: 159 LLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV--DNKGCIKLADFG 214
L E + +LL LE+LH+N +H ++ NI V +++ + LA +G
Sbjct: 147 ALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYG 206
Query: 215 ASKKVVELAT-----INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKP 269
+ + +G +++ ++ G S +D+ S+G +++ G
Sbjct: 207 FAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266
Query: 270 PW 271
PW
Sbjct: 267 PW 268
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 6e-20
Identities = 48/271 (17%), Positives = 93/271 (34%), Gaps = 43/271 (15%)
Query: 31 EKIGSSIRKSRIGLFSKPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGE 90
K + R+S TD W+ G +G G FG +Y+ +++S E
Sbjct: 4 VKAAQAGRQSSAKRHLAEQFA--VGEIITDMAAAAWKVGLPIGQGGFGCIYLA-DMNSSE 60
Query: 91 LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNI---- 146
+ K + + L E+K + P ++ R+ L +
Sbjct: 61 SVGSDA-----PCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114
Query: 147 ------------------LLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHK 187
G + + F + + ++L LEY+H+
Sbjct: 115 GSGLHDKNGKSYRFMIMDRF----GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE 170
Query: 188 NGIMHRDIKGANILVDNKGC--IKLADFGASKKVVELAT-----INGAKSMKGTPYWMAP 240
+ +H DIK +N+L++ K + L D+G + + + + GT + +
Sbjct: 171 HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSI 230
Query: 241 EVILQTGHSFSADIWSVGCTVIEMATGKPPW 271
+ S D+ +G +I+ TG PW
Sbjct: 231 DAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 76.5 bits (187), Expect = 3e-15
Identities = 53/324 (16%), Positives = 97/324 (29%), Gaps = 64/324 (19%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P + ++ E +G G FG V+ + +A+K + I Q E+ E+
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75
Query: 122 LLKNLT---------HPNIVRYLG------------------------------TAREDD 142
+ K L+ + +DD
Sbjct: 76 ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135
Query: 143 SLNILLEFVPGG-SISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANI 200
L I+LEF GG + + K S + QL L + HRD+ N+
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLAT--AKSILHQLTASLAVAEASLRFEHRDLHWGNV 193
Query: 201 LVDNKGCIKLADFGASKKV--------VELATINGAK-SMKGTPYWM---APEVILQTGH 248
L+ KL K V + ++ G + E +
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG 253
Query: 249 SFSADIWSVGCTVIEMATGKP-PWSQQF---QEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
+ DI+ + G+ P+S + T K+ P ++ K
Sbjct: 254 DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRK-- 311
Query: 305 LLKCLQKEPYLRSTASELLQHPFV 328
++ + S+A++LL +
Sbjct: 312 -IQEFHRTMLNFSSATDLLCQHSL 334
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 72.7 bits (178), Expect = 6e-14
Identities = 45/160 (28%), Positives = 77/160 (48%), Gaps = 14/160 (8%)
Query: 173 MYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE----LATINGA 228
Y+ Q+ G+E+L +HRD+ NIL+ K +K+ DFG ++ + + + +
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWS--QQFQEVAALFHIG 285
+K WMAPE I ++ +D+WS G + E+ + G P+ + +E G
Sbjct: 257 LPLK----WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 312
Query: 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
T P++ + E +L C EP R T SEL++H
Sbjct: 313 T---RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 5e-07
Identities = 26/96 (27%), Positives = 45/96 (46%), Gaps = 8/96 (8%)
Query: 69 GELVGCGAFGRVYMGM--NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
G+ +G GAFG+V +D +A + T + R L E+K+L ++
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTA----TCRTVAVKMLKEGATHSEHRALMSELKILIHI 82
Query: 127 -THPNIVRYLGT-AREDDSLNILLEFVPGGSISSLL 160
H N+V LG + L +++EF G++S+ L
Sbjct: 83 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 1e-10
Identities = 48/399 (12%), Positives = 99/399 (24%), Gaps = 158/399 (39%)
Query: 301 AKDFLLKCLQKE-PYLRST-ASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATPG---- 354
+ F+ + L+ +L S +E Q +T Y + + + NQ+
Sbjct: 79 VQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR-----DRLYNDNQVFAKYNVSR 133
Query: 355 ----MNLRNSMNSLVRRSTGL---------K-----DVCEMGSVRCSTVYPENLSSGSYW 396
+ LR ++ L R + + K DVC V+C + +W
Sbjct: 134 LQPYLKLRQALLEL-RPAKNVLIDGVLGSGKTWVALDVCLSYKVQC------KMDFKIFW 186
Query: 397 -KAGNCDDDMCLIDDKDDFGISESVKFNSSFASADLDKSFNPMCEPTDDWPCKFDESPEV 455
NC+ +++ +D ++ + + + +
Sbjct: 187 LNLKNCNSPETVLEMLQKL-------------LYQIDPNWTSRSDHSSNIKLRIHSIQAE 233
Query: 456 ERNRM-------------NISSSQAINEAAGSIGVSKAENEFTFPC-------GSSAAED 495
R + N+ +++A N F C +
Sbjct: 234 LRRLLKSKPYENCLLVLLNVQNAKAWNA-------------FNLSCKILLTTRFKQVTDF 280
Query: 496 DDEVTESKI------KAFLDEKALDL--KKLETPLYEEFYNTLNATGHPRGVGITNGENL 547
T + I ++ L K L+ +
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQD----------------------- 317
Query: 548 MNLPP--KSRSPKRLPSRRLSAAVLGAANSASPGHQKDRVSNVNSIQDQALQEIQPPQLN 605
LP + +P +++ SI+D +
Sbjct: 318 --LPREVLTTNP-------RRLSIIAE-----------------SIRDG------LATWD 345
Query: 606 EWKELLLSAQKETISPRMSISERLRKWEEELDEEIERKR 644
WK + I S+ L+ RK
Sbjct: 346 NWKHVNCDKLTTIIE--SSL--------NVLEPAEYRKM 374
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 53.3 bits (127), Expect = 2e-07
Identities = 62/382 (16%), Positives = 112/382 (29%), Gaps = 130/382 (34%)
Query: 44 LFSKPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANS 103
+F+K V L P K + R + V + G+ L SG K + A +
Sbjct: 125 VFAKYNVSRLQPYLKLRQALLELRPAKNVL------ID-GV-LGSG-----KTWV-ALDV 170
Query: 104 ASKEKTQ------------AHIRELEEEVKLLKNLTH---PNIVRYLGTAREDDSLNILL 148
K Q + E +++L+ L + PN T+R D S NI L
Sbjct: 171 CLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPN-----WTSRSDHSSNIKL 225
Query: 149 EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANIL--VDNKG 206
SI + L + + Y LL ++ +++ A +
Sbjct: 226 RI---HSIQAELRRL--LKS---KPYENCLL----------VL-LNVQNAKAWNAFNL-S 265
Query: 207 C--------IKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWS-- 256
C ++ DF ++ ++ + + ++ TP E +
Sbjct: 266 CKILLTTRFKQVTDFLSAATTTHISLDHHSMTL--TP----DE---------VKSLLLKY 310
Query: 257 VGCTV----IEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQK- 311
+ C E+ T P ++ +A + ++ D L ++
Sbjct: 311 LDCRPQDLPREVLTTNP---RRLSIIAESI-----RDGLATWDNWKHVNCDKLTTIIESS 362
Query: 312 ----EPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATPGMNL---------- 357
EP E + + VF S I P + L
Sbjct: 363 LNVLEPA------EYRKM------FDR-LSVFPPSA-----HI--PTILLSLIWFDVIKS 402
Query: 358 --RNSMNSLVRRSTGLKDVCEM 377
+N L + S K E
Sbjct: 403 DVMVVVNKLHKYSLVEKQPKES 424
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.7 bits (115), Expect = 6e-06
Identities = 83/544 (15%), Positives = 160/544 (29%), Gaps = 163/544 (29%)
Query: 84 MNLDSGEL-LAVKQVLIAANSASKEKTQA-HIRELE------EEVKLLKNLTHP-NIVRY 134
M+ ++GE K +L A + ++++ EE+ + +
Sbjct: 7 MDFETGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLR 66
Query: 135 LGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQ-LLLGLEYLHKNGIMHR 193
L ++ +FV +L F S I+ +Q ++ Y+ + ++
Sbjct: 67 LFWTLLSKQEEMVQKFV-----EEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYN 121
Query: 194 D---IKGANI----LVDN--KGCIKLADFGASKKVVELATINGAKSMKG---TPYWMAPE 241
D N+ + ++L +K V+ I+G + G T W+A +
Sbjct: 122 DNQVFAKYNVSRLQPYLKLRQALLELRP---AKNVL----IDG---VLGSGKT--WVALD 169
Query: 242 VILQTG--HSFSADI-W-SVGC-----TVIEM-----ATGKPPWSQQFQEVAALFHIGTT 287
V L I W ++ TV+EM P W+ +
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR------------- 216
Query: 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELL-----QHP-----F-------VTG 330
H + + L + L+ +PY LL Q+ F +T
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENC----LLVLLNVQNAKAWNAFNLSCKILLTT 272
Query: 331 KYQDPHPVFRNSVMESGNQIAT---------PGMNLRNSMNSLVRRSTGLK------DVC 375
+++ V + + T + SL+ + + +V
Sbjct: 273 RFK--------QVTDFLSAATTTHISLDHHSMTLTPDEVK-SLLLKYLDCRPQDLPREVL 323
Query: 376 EMGSVRCSTVYPENLSSG----SYWKAGNCDD-----DMCL--IDDKD------DFGI-S 417
R S + E++ G WK NCD + L ++ + +
Sbjct: 324 TTNPRRLSII-AESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFP 382
Query: 418 ESVKFNSSFASADLDKSFNPMCEPTDD----WPCKFDESPEVERNRMNISSSQAINEAAG 473
S PT W V N+++ S
Sbjct: 383 PSAHI------------------PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES 424
Query: 474 SIGVSKAENEFTFPCGSSAAEDDDEVTESKIKAFLDEKALDLKKLETPLYEE--FYNTLN 531
+I + E E++ + S + + K D L P Y + FY+ +
Sbjct: 425 TISIPSIYLELKVKL-----ENEYALHRSIVDHYNIPKTFDSDDL-IPPYLDQYFYSHI- 477
Query: 532 ATGH 535
GH
Sbjct: 478 --GH 479
|
| >3lvg_D LCB, clathrin light chain B; SELF assembly, coated PIT, cytoplasmic vesicle, membrane, Ca structural protein; 7.94A {Bos taurus} Length = 190 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 1e-04
Identities = 14/70 (20%), Positives = 29/70 (41%), Gaps = 18/70 (25%)
Query: 593 DQALQEIQPPQLNEWKELLLSAQKETISPRMSISER------------LRKWEEELDEEI 640
D+ QE P + +W+E Q++ + + S+ L +W + E++
Sbjct: 78 DRLTQE--PESIRKWRE----EQRKRLQELDAASKVMEQEWREKAKKDLEEWNQRQSEQV 131
Query: 641 ERKREMRRQA 650
E+ + R A
Sbjct: 132 EKNKINNRIA 141
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 668 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.83 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.71 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.12 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.8 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.56 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.31 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.25 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.12 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.11 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.97 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.65 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.58 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.5 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.38 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.36 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.27 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.08 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.08 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.07 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.02 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.94 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.64 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.34 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.03 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.1 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 92.75 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 86.44 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-61 Score=507.99 Aligned_cols=262 Identities=28% Similarity=0.491 Sum_probs=228.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|+++++||+|+||+||+|+++.+|+.||||++.... .......+.+.+|+++|+.++|||||+++++|.+
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~-----~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 103 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH-----IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 103 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHH-----CCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 34467999999999999999999999999999999984321 1122334668899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
++.+|||||||+||+|.++|.+.+.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 104 ~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 104 DEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp SSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 99999999999999999999998999999999999999999999999999999999999999999999999999998765
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.........+.+||+.|||||++.+..|+.++|||||||+||+|+||++||..... .+...+.. ....+|..+++
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~----~~~~~p~~~s~ 259 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK----LEYDFPEKFFP 259 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----TCCCCCTTCCH
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCCCCcccCH
Confidence 44444455678999999999999999999999999999999999999999975432 22222221 22456778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHH------HHcCccccCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASE------LLQHPFVTGK 331 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~E------IL~Hpwf~~~ 331 (668)
++++||.+||++||.+|||++| |++||||++.
T Consensus 260 ~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 260 KARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp HHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 9999999999999999999987 6899999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-59 Score=505.38 Aligned_cols=257 Identities=32% Similarity=0.519 Sum_probs=222.1
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
...|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--------~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 144 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--------RRELLFNEVVIMRDYQHENVVEMYNSYLVGD 144 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--------SGGGGHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--------HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45699999999999999999999999999999998543211 1234678999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.+|||||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 145 ~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 223 (346)
T 4fih_A 145 ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 223 (346)
T ss_dssp EEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence 99999999999999999875 67999999999999999999999999999999999999999999999999999865332
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
.....+.+||+.|||||++.+..|+.++||||||||||||++|++||..... +....+. .........+..+++++
T Consensus 224 --~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-~~~~~~~~~~~~~s~~~ 300 (346)
T 4fih_A 224 --VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPPRLKNLHKVSPSL 300 (346)
T ss_dssp --SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSSCCCCSCGGGSCHHH
T ss_pred --CCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-cCCCCCCCccccCCHHH
Confidence 2234578999999999999999999999999999999999999999976432 2222222 22222334556899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++||.+||++||.+|||+.|||+||||+..
T Consensus 301 ~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 301 KGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 999999999999999999999999999854
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-59 Score=503.30 Aligned_cols=258 Identities=26% Similarity=0.505 Sum_probs=217.8
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++++.||+|+||+||+|+++.+|+.||||++..... .....+.+.+|+++|+.|+|||||++++++.+++.
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~ 97 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM------SSKEREESRREVAVLANMKHPNIVQYRESFEENGS 97 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC------CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence 589999999999999999999999999999999854321 22345678899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 144 LNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
+|||||||+||+|.++|... ..+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999999999643 4579999999999999999999999999999999999999999999999999987643
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
... ...+.+||+.|||||++.+..|+.++||||||||||||+||++||...... +...+. ....++++..++.+
T Consensus 178 ~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~---~~~~~~~~~~~s~~ 252 (350)
T 4b9d_A 178 TVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII---SGSFPPVSLHYSYD 252 (350)
T ss_dssp HHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HTCCCCCCTTSCHH
T ss_pred Ccc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH---cCCCCCCCccCCHH
Confidence 322 123578999999999999999999999999999999999999999764332 221111 12334667789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+++||.+||++||.+|||+.|||+||||+...
T Consensus 253 ~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 253 LRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 99999999999999999999999999998643
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-58 Score=486.99 Aligned_cols=257 Identities=27% Similarity=0.466 Sum_probs=216.0
Q ss_pred CCCe-eeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc-
Q 005944 63 PIRW-RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE- 140 (668)
Q Consensus 63 ~~ry-~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~- 140 (668)
..+| ++.+.||+|+||+||+|+++.++..||||++.... ........+.+|+.+|++|+|||||+++++|..
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~ 97 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST 97 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG------SCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh------CCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence 3455 78889999999999999999999999999984322 122345678899999999999999999999864
Q ss_pred ---CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCcccEEeCC-CCceEEecCC
Q 005944 141 ---DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVDN-KGCIKLADFG 214 (668)
Q Consensus 141 ---~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~g--IvHrDLKPeNILld~-~g~vKL~DFG 214 (668)
...+|||||||+||+|.+++.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||+. +|.+||+|||
T Consensus 98 ~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFG 177 (290)
T 3fpq_A 98 VKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp ETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTT
T ss_pred cCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCc
Confidence 3568999999999999999999899999999999999999999999998 999999999999985 7999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCC
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP 294 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p 294 (668)
+|+... .....+.+||+.|||||++.+ .|+.++|||||||+||||+||++||............+........++
T Consensus 178 la~~~~----~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~ 252 (290)
T 3fpq_A 178 LATLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp GGGGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred CCEeCC----CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC
Confidence 997532 223456899999999999865 699999999999999999999999965332221222222222333456
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
..+++++++||.+||++||.+|||+.|+|+||||++
T Consensus 253 ~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 678899999999999999999999999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-59 Score=483.88 Aligned_cols=254 Identities=24% Similarity=0.410 Sum_probs=207.5
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|+++.+|+.||||++..... ........+.+|+.+|+.++|||||++++++.+.+.
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~ 87 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVL-----AKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDE 87 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC-----------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHc-----CCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 589999999999999999999999999999999853221 112234568899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+||||||| +|+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+|+.....
T Consensus 88 ~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 88 IIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp EEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred EEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence 99999999 6799999998899999999999999999999999999999999999999999999999999999875432
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
....+.+||+.|||||++.+..| +.++|||||||+||+|+||++||...... ....+.. ....+|..+++++
T Consensus 166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~----~~~~~p~~~s~~~ 239 (275)
T 3hyh_A 166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN----GVYTLPKFLSPGA 239 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----TCCCCCTTSCHHH
T ss_pred --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc----CCCCCCCCCCHHH
Confidence 23456799999999999998876 58999999999999999999999764332 2222221 2345677899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
++||.+||++||.+|||++|+++||||+.
T Consensus 240 ~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 240 AGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred HHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 99999999999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-58 Score=507.07 Aligned_cols=257 Identities=32% Similarity=0.519 Sum_probs=222.1
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
...|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--------~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~ 221 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--------RRELLFNEVVIMRDYQHENVVEMYNSYLVGD 221 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--------SGGGHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--------HHHHHHHHHHHHHhCCCCCCCceEEEEEECC
Confidence 35699999999999999999999999999999998543211 1234678999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.+|||||||+||+|.+++.. +.+++.+++.|++||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 222 ~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~ 300 (423)
T 4fie_A 222 ELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE 300 (423)
T ss_dssp EEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred EEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence 99999999999999999865 67999999999999999999999999999999999999999999999999999865332
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
.....+.+||+.|||||++.+..|+.++||||||||||||++|++||..... +....+. .........+..+++++
T Consensus 301 --~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-~~~~~~~~~~~~~s~~~ 377 (423)
T 4fie_A 301 --VPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPPRLKNLHKVSPSL 377 (423)
T ss_dssp --CCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCCCCSCTTSSCHHH
T ss_pred --CccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-cCCCCCCcccccCCHHH
Confidence 2234578999999999999999999999999999999999999999975432 2222222 22222334556899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++||.+||++||.+|||+.|||+||||+..
T Consensus 378 ~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 378 KGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 999999999999999999999999999864
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-58 Score=485.06 Aligned_cols=258 Identities=32% Similarity=0.513 Sum_probs=215.9
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEc---CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
.+.+|++.+.||+|+||+||+|++. .+++.||||++......... ...+.+|+.+|++++|||||++++++
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~------~~~~~~E~~il~~l~HpnIv~l~~~~ 95 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD------RVRTKMERDILVEVNHPFIVKLHYAF 95 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE------CC------CCCCCCCCTTEECEEEEE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH------HHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence 3468999999999999999999984 46889999998543221111 12467899999999999999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.+++.+|||||||+||+|.++|.+.+.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.
T Consensus 96 ~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 96 QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 99999999999999999999999989999999999999999999999999999999999999999999999999999986
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~l 297 (668)
.... .....+.+||+.|||||++.+..|+.++|||||||+||||+||++||...... ....+.. ....+|..+
T Consensus 176 ~~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~----~~~~~p~~~ 249 (304)
T 3ubd_A 176 SIDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK----AKLGMPQFL 249 (304)
T ss_dssp -------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCTTS
T ss_pred ccCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc----CCCCCCCcC
Confidence 5332 23345689999999999999999999999999999999999999999764332 2222211 234567889
Q ss_pred CHHHHHHHHHhhhhCCCCCCC-----HHHHHcCccccCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRST-----ASELLQHPFVTGK 331 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~~ 331 (668)
|+++++||.+||++||.+||| ++||++||||++.
T Consensus 250 s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 999999999999999999998 5899999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-58 Score=488.61 Aligned_cols=255 Identities=31% Similarity=0.467 Sum_probs=214.9
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
...|++.+.||+|+||+||+|+++.+|+.||||++.... ...+|+.+|+.++|||||++++++.+++
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-------------~~~~E~~il~~l~HpnIV~l~~~~~~~~ 123 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-------------FRVEELVACAGLSSPRIVPLYGAVREGP 123 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-------------CCTHHHHTTTTCCCTTBCCEEEEEEETT
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-------------hHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 456899999999999999999999999999999984321 1236999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC-ceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-CIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-~vKL~DFGlA~~~~~ 221 (668)
.+|||||||+||+|.++|.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||+|+.+..
T Consensus 124 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~ 203 (336)
T 4g3f_A 124 WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQP 203 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC--
T ss_pred EEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccC
Confidence 9999999999999999999889999999999999999999999999999999999999999988 699999999987644
Q ss_pred hhhh---cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCccc
Q 005944 222 LATI---NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 222 ~~~~---~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~l 297 (668)
.... ......+||+.|||||++.+..|+.++||||||||||||+||++||...... +...+. ........++..+
T Consensus 204 ~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~~ 282 (336)
T 4g3f_A 204 DGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA-SEPPPIREIPPSC 282 (336)
T ss_dssp ----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH-HSCCGGGGSCTTS
T ss_pred CCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-cCCCCchhcCccC
Confidence 3221 1233568999999999999999999999999999999999999999754321 111111 1111123467789
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHH-------------HcCccccCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASEL-------------LQHPFVTGK 331 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EI-------------L~Hpwf~~~ 331 (668)
++++.+||.+||++||.+|||+.|+ |+|||+...
T Consensus 283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 9999999999999999999999998 579998754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-56 Score=469.07 Aligned_cols=256 Identities=25% Similarity=0.369 Sum_probs=204.2
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC--
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD-- 142 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~-- 142 (668)
+|++.+.||+|+||+||+|+++.+|+.||||++.... .+...+.+.+|+++|+.|+|||||+++++|.+.+
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 78 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-------RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-------SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence 5999999999999999999999999999999985432 1233456889999999999999999999987544
Q ss_pred ----------cceEEeeccCCCChhcccccCCCC---CHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceE
Q 005944 143 ----------SLNILLEFVPGGSISSLLGKFGSF---PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIK 209 (668)
Q Consensus 143 ----------~~~LVmEy~~gGsL~~~L~~~~~l---~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vK 209 (668)
.+|||||||+||+|.+++...+.+ .+..++.|+.||+.||+|||++|||||||||+||||+.+|.+|
T Consensus 79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEE
Confidence 379999999999999999876554 4566889999999999999999999999999999999999999
Q ss_pred EecCCchhhhHhhhhh----------cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHH
Q 005944 210 LADFGASKKVVELATI----------NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVA 279 (668)
Q Consensus 210 L~DFGlA~~~~~~~~~----------~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~ 279 (668)
|+|||+|+.+...... ....+.+||+.|||||++.+..|+.++|||||||+||||++ ||........
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~ 235 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVR 235 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHH
Confidence 9999999876543221 12235689999999999999999999999999999999997 8876544433
Q ss_pred HHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 280 ALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 280 ~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.+..... ...++.+...++.+.+||.+||++||.+|||+.|||+||||++.
T Consensus 236 ~~~~~~~-~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 236 TLTDVRN-LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHHT-TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHHhc-CCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 3333322 22233344567788999999999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-55 Score=477.97 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=215.8
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc-
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE- 140 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~- 140 (668)
...+|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+.+|+++|+.|+|||||++++++..
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~------~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~ 125 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF------DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPT 125 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc------cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecc
Confidence 3468999999999999999999999999999999984221 222334567899999999999999999998653
Q ss_pred -----CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 141 -----DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 141 -----~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
...+|||||||. |+|.+++.+.+.+++..++.|++||+.||.|||++|||||||||+||||+.+|.+||+|||+
T Consensus 126 ~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 126 VPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecce
Confidence 467899999996 68999999989999999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhh--hhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCC--
Q 005944 216 SKKVVELA--TINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTK-- 288 (668)
Q Consensus 216 A~~~~~~~--~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~-- 288 (668)
|+.+.... ......+.+||+.|||||++.+.. |+.++||||||||+|||++|++||.+... ....+.......
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~ 284 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSP 284 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCG
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 98654322 223345789999999999998764 69999999999999999999999975422 222222111000
Q ss_pred -------------------CCCC-----CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 289 -------------------SHPP-----IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 289 -------------------~~~~-----~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
...+ +...+++++.+||.+||++||.+|||+.|+|+||||+...
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 285 AVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp GGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred HHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 0001 1135789999999999999999999999999999998653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-55 Score=459.79 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=216.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
+...+|.+.+.||+|+||+||+|++. .++..||||++... .....+.|.+|+++|++++|||||+++
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--------~~~~~~~f~~E~~il~~l~HpnIV~l~ 81 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--------SDNARKDFHREAELLTNLQHEHIVKFY 81 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--------CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--------ChHHHHHHHHHHHHHHhCCCCCCccEE
Confidence 55678999999999999999999875 35889999998421 223456789999999999999999999
Q ss_pred cccccCCcceEEeeccCCCChhcccccC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe
Q 005944 136 GTAREDDSLNILLEFVPGGSISSLLGKF-------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV 202 (668)
Q Consensus 136 g~~~~~~~~~LVmEy~~gGsL~~~L~~~-------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl 202 (668)
+++.+.+.+|||||||++|+|.++|.+. ..+++.++..|+.||+.||.|||+++||||||||+||||
T Consensus 82 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl 161 (299)
T 4asz_A 82 GVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 161 (299)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE
Confidence 9999999999999999999999999654 369999999999999999999999999999999999999
Q ss_pred CCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHH
Q 005944 203 DNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAA 280 (668)
Q Consensus 203 d~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~ 280 (668)
+.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ++..
T Consensus 162 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 241 (299)
T 4asz_A 162 GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE 241 (299)
T ss_dssp CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999987654443333445679999999999999999999999999999999999 9999976432 2222
Q ss_pred HHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 281 LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 281 ~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
.+.. ....+.|..++.++.+||.+||+.||.+|||+.+| |+|++
T Consensus 242 ~i~~---~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 242 CITQ---GRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HHHH---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred HHHc---CCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 2222 23456778899999999999999999999999999 45765
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=458.16 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=207.7
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
.+++...++++.+.||+|+||+||+|++. ..||||+++... ......+.|.+|+.+|++++|||||+++++
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~------~~~~~~~~f~~E~~il~~l~HpNIV~l~g~ 100 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVD------PTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSS------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecC------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 35677889999999999999999999853 369999985322 123345678999999999999999999998
Q ss_pred cccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+.. +.+|||||||++|+|.++|... +.+++.++..|+.||+.||.|||+++||||||||+||||+.++.+||+|||+|
T Consensus 101 ~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 179 (307)
T 3omv_A 101 MTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLA 179 (307)
T ss_dssp ECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSC
T ss_pred EEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCc
Confidence 754 5689999999999999999654 67999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhc---CCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhcc-CCCC
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQT---GHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGT-TKSH 290 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~---~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~-~~~~ 290 (668)
+..............+||+.|||||++.+. .|+.++|||||||+||||+||+.||.... ..+........ ....
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~ 259 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDL 259 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCS
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCc
Confidence 876544444445667999999999999743 58999999999999999999999997533 22222222211 1122
Q ss_pred CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 291 ~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
...+..++.++.+||.+||+.||.+|||+.||+++
T Consensus 260 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 34567889999999999999999999999988654
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-54 Score=459.82 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=208.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
+...+|.+.+.||+|+||+||+|++. .++..||||++.. ......+.|.+|+++|++++|||||+++
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~--------~~~~~~~~f~~E~~il~~l~HpnIV~l~ 109 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE--------ASESARQDFQREAELLTMLQHQHIVRFF 109 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC--------CSHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc--------CCHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 45578999999999999999999865 3688999999842 1223456789999999999999999999
Q ss_pred cccccCCcceEEeeccCCCChhcccccC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccE
Q 005944 136 GTAREDDSLNILLEFVPGGSISSLLGKF---------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANI 200 (668)
Q Consensus 136 g~~~~~~~~~LVmEy~~gGsL~~~L~~~---------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNI 200 (668)
+++.+.+.+|||||||++|+|.++|.+. +.+++.++..|+.||+.||.|||+++||||||||+||
T Consensus 110 g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NI 189 (329)
T 4aoj_A 110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNC 189 (329)
T ss_dssp EEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred EEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhE
Confidence 9999999999999999999999998653 3589999999999999999999999999999999999
Q ss_pred EeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HH
Q 005944 201 LVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EV 278 (668)
Q Consensus 201 Lld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~ 278 (668)
||+.++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||+||||+| |+.||..... ++
T Consensus 190 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~ 269 (329)
T 4aoj_A 190 LVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269 (329)
T ss_dssp EEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH
T ss_pred EECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH
Confidence 999999999999999987654444444456789999999999999999999999999999999999 9999976432 22
Q ss_pred HHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 279 AALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 279 ~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
...+.. ....+.|..+++++.+||.+||+.||.+|||+.||+++
T Consensus 270 ~~~i~~---g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 270 IDCITQ---GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHH---TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHc---CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 222222 23456778899999999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-54 Score=456.36 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=218.0
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l 134 (668)
++...++++.+.||+|+||+||+|+.. .+++.||||++.... .....+.|.+|+.+|++++|||||++
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-------~~~~~~~f~~E~~il~~l~HpNIV~l 94 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-------EGPLREEFRHEAMLRARLQHPNVVCL 94 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-------CC-CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-------ChHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 456678999999999999999999863 467899999984321 11223568899999999999999999
Q ss_pred ccccccCCcceEEeeccCCCChhcccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcc
Q 005944 135 LGTAREDDSLNILLEFVPGGSISSLLGKF----------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGA 198 (668)
Q Consensus 135 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPe 198 (668)
+|++.+.+.++||||||++|+|.++|... ..+++.++..|+.||+.||.|||+++||||||||+
T Consensus 95 ~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~ 174 (308)
T 4gt4_A 95 LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATR 174 (308)
T ss_dssp EEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 99999999999999999999999998542 35899999999999999999999999999999999
Q ss_pred cEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-
Q 005944 199 NILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ- 276 (668)
Q Consensus 199 NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~- 276 (668)
||||+.++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||+||||+| |..||.+...
T Consensus 175 NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 175 NVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp GEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred ceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999987755444444556789999999999999999999999999999999998 8999976543
Q ss_pred HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 277 EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 277 ~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
++...+. .....+.|..++.++.+||.+||+.||.+|||+.||+++
T Consensus 255 ~~~~~i~---~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 255 DVVEMIR---NRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHH---cCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2222222 234456788999999999999999999999999999875
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=496.69 Aligned_cols=263 Identities=26% Similarity=0.421 Sum_probs=222.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
..-.+|+++++||+|+||+||+|+++.+|+.||||++...... .............++.+++.++|||||+++++|.+
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~--~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHH--HTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcc--hhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 4456899999999999999999999999999999998533211 11222333444556778888899999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.+.+|||||||+||+|.++|.+.+.|++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccC
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls 298 (668)
. ....+.|||+.|||||++.+ ..|+.++||||||||||||++|.+||..... ....+.. ........+|..+|
T Consensus 344 ~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~-~i~~~~~~~p~~~S 418 (689)
T 3v5w_A 344 K----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-MTLTMAVELPDSFS 418 (689)
T ss_dssp S----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH-HHHHCCCCCCTTSC
T ss_pred C----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-hhcCCCCCCCccCC
Confidence 2 23456899999999999974 5799999999999999999999999975321 1111111 11123345678899
Q ss_pred HHHHHHHHHhhhhCCCCCCC-----HHHHHcCccccC
Q 005944 299 MEAKDFLLKCLQKEPYLRST-----ASELLQHPFVTG 330 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~ 330 (668)
+++++||.+||++||.+|++ ++||++||||++
T Consensus 419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 99999999999999999998 899999999986
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-54 Score=464.36 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=205.4
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEc---CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGT 137 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~ 137 (668)
...+|++.+.||+|+||+||+|+++ .+++.||||++.... ....+.+|+++|+.+ +|||||+++++
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----------~~~~~~~E~~~l~~~~~h~nIv~l~~~ 88 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----------HPIRIAAELQCLTVAGGQDNVMGVKYC 88 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----------CHHHHHHHHHHHHHTCSBTTBCCCSEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----------CHHHHHHHHHHHHHhcCCCCCceEEEE
Confidence 3467999999999999999999875 467899999883211 123467899999998 69999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-CceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK-GCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~-g~vKL~DFGlA 216 (668)
+.+.+.+|||||||+||+|.+++. .+++.+++.|++||+.||+|||++|||||||||+||||+.+ +.+||+|||+|
T Consensus 89 ~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 89 FRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999999999984 59999999999999999999999999999999999999876 89999999999
Q ss_pred hhhHhhh--------------------------hhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCC
Q 005944 217 KKVVELA--------------------------TINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKP 269 (668)
Q Consensus 217 ~~~~~~~--------------------------~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~ 269 (668)
+...... ......+.+||+.|||||++.+. .|+.++||||+|||+|+|+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 7542211 01123456899999999999876 48999999999999999999999
Q ss_pred CCchhHHH---HHHHHhhc-------------------------------------------------cCCCCCCCCccc
Q 005944 270 PWSQQFQE---VAALFHIG-------------------------------------------------TTKSHPPIPEHL 297 (668)
Q Consensus 270 PF~~~~~~---~~~~~~~~-------------------------------------------------~~~~~~~~p~~l 297 (668)
||.....+ ...+.... ........+..+
T Consensus 246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i 325 (361)
T 4f9c_A 246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV 325 (361)
T ss_dssp SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence 99532211 11111100 000011224568
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+++++|||.+||++||.+|+|++|+|+||||++
T Consensus 326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 899999999999999999999999999999985
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-53 Score=482.55 Aligned_cols=260 Identities=26% Similarity=0.398 Sum_probs=223.5
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++++.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+|+.|+|||||+++++|.+..
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--------~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~ 227 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 227 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSS
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--------hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 358999999999999999999999999999999984321 122356788999999999999999999999999
Q ss_pred cceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC--CceEEecCCchhhh
Q 005944 143 SLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK--GCIKLADFGASKKV 219 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~--g~vKL~DFGlA~~~ 219 (668)
.+|||||||+||+|.++|.. .+.+++.+++.|++||+.||.|||++||+||||||+||||+.+ |.+||+|||+|+.+
T Consensus 228 ~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~ 307 (573)
T 3uto_A 228 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307 (573)
T ss_dssp EEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred EEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence 99999999999999998854 4689999999999999999999999999999999999999854 89999999999876
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls 298 (668)
... ....+.+||+.|||||++.+..|+.++||||||||||+|++|.+||..... +....+...........+..++
T Consensus 308 ~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 384 (573)
T 3uto_A 308 DPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 384 (573)
T ss_dssp CTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSC
T ss_pred cCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCC
Confidence 432 224467899999999999999999999999999999999999999976543 2222222233333344556789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.++++||.+||++||.+|||+.|+|+||||+....
T Consensus 385 ~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 385 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 99999999999999999999999999999986543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=456.48 Aligned_cols=257 Identities=28% Similarity=0.447 Sum_probs=216.6
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCC-----CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC-CCee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH-PNIV 132 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIV 132 (668)
+++...+|++++.||+|+||+||+|++..+ ++.||||++... ......+.+.+|+++|.++.| ||||
T Consensus 59 wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-------~~~~~~~~~~~E~~il~~l~hhpnIV 131 (353)
T 4ase_A 59 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-------ATHSEHRALMSELKILIHIGHHLNVV 131 (353)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred cEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-------cChHHHHHHHHHHHHHHHcCCCCcEE
Confidence 457778999999999999999999998654 468999988421 122334678899999999965 8999
Q ss_pred eecccccc-CCcceEEeeccCCCChhcccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 005944 133 RYLGTARE-DDSLNILLEFVPGGSISSLLGKF----------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDI 195 (668)
Q Consensus 133 ~l~g~~~~-~~~~~LVmEy~~gGsL~~~L~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDL 195 (668)
+++++|.. ...+|||||||++|+|.++|++. ..+++..+..|+.||+.||+|||+++||||||
T Consensus 132 ~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDL 211 (353)
T 4ase_A 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 211 (353)
T ss_dssp CEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCcc
Confidence 99999865 45789999999999999999643 34899999999999999999999999999999
Q ss_pred CcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchh
Q 005944 196 KGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQ 274 (668)
Q Consensus 196 KPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~ 274 (668)
||+||||+.++.+||+|||+|+.+............+||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999987654333333445789999999999999999999999999999999998 99999753
Q ss_pred H--HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 275 F--QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 275 ~--~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
. ..+...+.. ....+.|..+++++.+||.+||+.||.+|||+.||++|
T Consensus 292 ~~~~~~~~~i~~---g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 292 KIDEEFCRRLKE---GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CCSHHHHHHHHH---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHc---CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 2 333333322 33456778899999999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=423.15 Aligned_cols=259 Identities=25% Similarity=0.445 Sum_probs=224.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+|+.||||++.... ........+.+|+++|+.++||||+++++++..
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 85 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ------LNPTSLQKLFREVRIMKILNHPNIVKLFEVIET 85 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhc------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence 44568999999999999999999999999999999984322 123345668899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...+|+||||+++|+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 86 EKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp SSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred CCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 99999999999999999999888899999999999999999999999999999999999999999999999999997653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCC-cchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccC
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHS-FSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s-~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls 298 (668)
.. ......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||..... ......... ...+|..++
T Consensus 166 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~----~~~~p~~~s 238 (328)
T 3fe3_A 166 VG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG----KYRIPFYMS 238 (328)
T ss_dssp SS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTSC
T ss_pred CC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC----CCCCCCCCC
Confidence 32 223467899999999999988875 799999999999999999999976532 222222222 234566789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.++.+||.+||+.||.+|||++|+++||||+...
T Consensus 239 ~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 239 TDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999999999999999999998644
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=413.86 Aligned_cols=259 Identities=34% Similarity=0.589 Sum_probs=221.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|.+..+++.||||++...... ....+.+|+.+++.++|||||++++++..
T Consensus 17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (297)
T 3fxz_A 17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLV 88 (297)
T ss_dssp CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc--------HHHHHHHHHHHHhcCCCCCCCeEeEEEEE
Confidence 3456899999999999999999999999999999998533211 12457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.+.+|+|||||++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 89 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 89 GDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp TTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCEEEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 9999999999999999999976 479999999999999999999999999999999999999999999999999987653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......................+..++..
T Consensus 168 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (297)
T 3fxz_A 168 PEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245 (297)
T ss_dssp STT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHH
T ss_pred Ccc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHH
Confidence 322 223456899999999999999999999999999999999999999975433222222222223334456789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+.+||.+||+.||.+|||+.|+++||||+.
T Consensus 246 ~~~li~~~l~~dp~~Rps~~ell~h~~~~~ 275 (297)
T 3fxz_A 246 FRDFLNRCLEMDVEKRGSAKELLQHQFLKI 275 (297)
T ss_dssp HHHHHHHHSCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhhChhhcc
Confidence 999999999999999999999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=419.42 Aligned_cols=265 Identities=26% Similarity=0.400 Sum_probs=222.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+++.||||++..... ......+.+|+.+++.++|||||++++++..
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 76 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-------VDCPENIKKEICINKMLNHENVVKFYGHRRE 76 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-------cchHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 345789999999999999999999999999999999843221 1223457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.+..|+|||||++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 77 GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp SSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred CCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999998654
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
...........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......................+..++.
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDS 236 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCH
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCH
Confidence 3333333456789999999999988775 778999999999999999999997543221122222222233334567899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 237 ~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 237 APLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 999999999999999999999999999998644
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=424.01 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=217.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|++.++||+|+||+||+|++..+|+.||||++... ..........+.+|..+|..+ +|||||++++++.
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~-----~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 94 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKD-----VILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQ 94 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHH-----HHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHH-----HhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEE
Confidence 4557899999999999999999999999999999998432 111223445677899999988 7999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
+.+.+|||||||+||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 95 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 95 TPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999998753
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls 298 (668)
.. ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||...... ....+.. ....++..++
T Consensus 175 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----~~~~~p~~~~ 248 (353)
T 3txo_A 175 IC--NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN----DEVVYPTWLH 248 (353)
T ss_dssp CC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCTTSC
T ss_pred cc--CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCCCCCCCC
Confidence 21 122344678999999999999999999999999999999999999999765432 2222221 2234567799
Q ss_pred HHHHHHHHHhhhhCCCCCCCH------HHHHcCccccCC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTA------SELLQHPFVTGK 331 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa------~EIL~Hpwf~~~ 331 (668)
.++.+||.+||++||.+||++ .+|++||||++.
T Consensus 249 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 999999999999999999999 999999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=419.90 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=222.2
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.++||+|+||+||+|++..+|+.||||++.... .........+.+|+.+|+.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~ 77 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV-----IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH 77 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC
Confidence 3468999999999999999999999999999999984321 11122345678899999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
+.+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 78 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 78 DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999875321
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
........+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+.. ....++..++.+
T Consensus 158 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~ 231 (337)
T 1o6l_A 158 --DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPRTLSPE 231 (337)
T ss_dssp --TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCTTSCHH
T ss_pred --CCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc----CCCCCCCCCCHH
Confidence 122345678999999999999999999999999999999999999999754322 2222221 123466789999
Q ss_pred HHHHHHHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 301 AKDFLLKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
+.+||.+||+.||.+|| ++.+|++||||.+
T Consensus 232 ~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 232 AKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp HHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 99999999999999999 9999999999975
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=425.23 Aligned_cols=265 Identities=30% Similarity=0.429 Sum_probs=224.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++++.||+|+||+||+|++..+|..||||++......... .......+.+|+.+|+.++|||||++++++.+
T Consensus 9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASR--RGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEcccccccc--chhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 4567899999999999999999999999999999998643322111 00123457889999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC----ceEEecCCch
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG----CIKLADFGAS 216 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g----~vKL~DFGlA 216 (668)
...+|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 999999999999999999998888999999999999999999999999999999999999998877 7999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~ 295 (668)
+.+.. .......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... +....+...........+.
T Consensus 167 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (361)
T 2yab_A 167 HEIED---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFS 243 (361)
T ss_dssp EECCT---TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred eEcCC---CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhcc
Confidence 86543 2234567899999999999998999999999999999999999999975432 2222222222222223345
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.++.++++||.+||..||.+|||+.|+|+||||+.
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 78999999999999999999999999999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=420.75 Aligned_cols=248 Identities=25% Similarity=0.315 Sum_probs=193.7
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD- 142 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~- 142 (668)
.+|.+.+.||+|+||+||+|++ +|+.||||++... . .. ....+.|+.++..++|||||++++++..++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~------~-~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~ 71 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------E-ER--SWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGG------G-HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------c-hh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCC
Confidence 4689999999999999999987 6899999998321 1 11 122346777788899999999999987654
Q ss_pred ---cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCcccEEeCCCCceEEe
Q 005944 143 ---SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN--------GIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 143 ---~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~--------gIvHrDLKPeNILld~~g~vKL~ 211 (668)
.+|||||||++|+|.++|.. ..+++..+..++.|++.||+|||++ +||||||||+||||+.++.+||+
T Consensus 72 ~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~ 150 (303)
T 3hmm_A 72 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEE
Confidence 47999999999999999976 5799999999999999999999987 99999999999999999999999
Q ss_pred cCCchhhhHhhhhh--cCCccCCCCCCCCChHHHhhc------CCCcchhHHHHHHHHHHHHhCCCCCchh---------
Q 005944 212 DFGASKKVVELATI--NGAKSMKGTPYWMAPEVILQT------GHSFSADIWSVGCTVIEMATGKPPWSQQ--------- 274 (668)
Q Consensus 212 DFGlA~~~~~~~~~--~~~~~~~GT~~Y~APEvl~~~------~~s~ksDIWSLGvILyeLLTG~~PF~~~--------- 274 (668)
|||+|+........ ......+||+.|||||++.+. .|+.++|||||||+||||+||.+||...
T Consensus 151 DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~ 230 (303)
T 3hmm_A 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred eCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchh
Confidence 99999865433221 122346899999999999764 3577999999999999999998765311
Q ss_pred -------HHHHHHHHhhccCCCCCCCCcc-----cCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 275 -------FQEVAALFHIGTTKSHPPIPEH-----LSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 275 -------~~~~~~~~~~~~~~~~~~~p~~-----ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
....... .......+.+|.. .+..+.+||.+||+.||.+|||+.||++.
T Consensus 231 ~~~~~~~~~~~~~~--~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 231 LVPSDPSVEEMRKV--VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TSCSSCCHHHHHHH--HTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccccchHHHHHHH--HhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1122111 1222333444433 33578899999999999999999999863
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=424.74 Aligned_cols=265 Identities=30% Similarity=0.420 Sum_probs=220.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+|+.||||++......... ......+.+|+.+|+.++|||||++++++..
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 97 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSP---GLSTEDLKREASICHMLKHPHIVELLETYSS 97 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSS---SCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccc---cchHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 3456899999999999999999999999999999998432111000 0123567899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc---eEEecC
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF----GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC---IKLADF 213 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~----~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~---vKL~DF 213 (668)
.+.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+||
T Consensus 98 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Df 177 (351)
T 3c0i_A 98 DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGF 177 (351)
T ss_dssp TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecC
Confidence 99999999999999998877543 35899999999999999999999999999999999999987654 999999
Q ss_pred CchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCC
Q 005944 214 GASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 214 GlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~ 293 (668)
|++..+... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||..........+...........
T Consensus 178 g~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~i~~~~~~~~~~~ 255 (351)
T 3c0i_A 178 GVAIQLGES--GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKERLFEGIIKGKYKMNPRQ 255 (351)
T ss_dssp TTCEECCTT--SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHHHHHHHHHTCCCCCHHH
T ss_pred cceeEecCC--CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHHHHHHHHcCCCCCCccc
Confidence 999765432 122345689999999999999999999999999999999999999998765544444333332222223
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+..++.++++||.+||+.||.+|||+.++|+||||+.
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence 3568999999999999999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=419.22 Aligned_cols=260 Identities=27% Similarity=0.432 Sum_probs=223.2
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||.||+|.+..+|..||||++..... .......+.+|+.+|+.++|||||++++++.+.
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~ 100 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL------SARDFQKLEREARICRKLQHPNIVRLHDSIQEE 100 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC------CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC
Confidence 34679999999999999999999999999999999853221 223446688999999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC---ceEEecCCchhh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG---CIKLADFGASKK 218 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g---~vKL~DFGlA~~ 218 (668)
...|+|||||.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 101 SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999999999998888899999999999999999999999999999999999998654 599999999976
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-HHHHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-QEVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-~~~~~~~~~~~~~~~~~~p~~l 297 (668)
+.. .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||.... ......+.........+.+..+
T Consensus 181 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 257 (362)
T 2bdw_A 181 VND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTV 257 (362)
T ss_dssp CTT---CCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGS
T ss_pred ecC---CcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCC
Confidence 542 222345789999999999999899999999999999999999999997543 2333333333333333445678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+.++++||.+||+.||.+||++.++|+||||+.
T Consensus 258 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 258 TPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 999999999999999999999999999999975
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=411.69 Aligned_cols=255 Identities=29% Similarity=0.485 Sum_probs=221.0
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|++..+|+.||||++.... .........+.+|+.+|+.++|||||++++++.+.
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 78 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI-----VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA 78 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----hhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC
Confidence 4468999999999999999999999999999999984321 11112345677899999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++....
T Consensus 79 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 79 QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999999999999888999999999999999999999999999999999999999999999999999975422
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
.....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+.. ....++..++.+
T Consensus 159 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~----~~~~~p~~~~~~ 229 (318)
T 1fot_A 159 -----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----AELRFPPFFNED 229 (318)
T ss_dssp -----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----CCCCCCTTSCHH
T ss_pred -----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh----CCCCCCCCCCHH
Confidence 234578999999999999999999999999999999999999999754322 1111111 123456788999
Q ss_pred HHHHHHHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 301 AKDFLLKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
+.+||.+||+.||.+|| ++++|++||||++
T Consensus 230 ~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 230 VKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp HHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 99999999999999999 9999999999975
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=422.79 Aligned_cols=262 Identities=29% Similarity=0.431 Sum_probs=210.0
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||+||+|++..+++.||||++..... ....+.+|+.+++.++|||||++++++.
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~~~~~~~ 86 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---------IDENVQREIINHRSLRHPNIVRFKEVIL 86 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---------SCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---------ccHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3556799999999999999999999999999999999843211 1134678999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc--eEEecCCchh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC--IKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~--vKL~DFGlA~ 217 (668)
....+|+|||||.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+++
T Consensus 87 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~ 166 (361)
T 3uc3_A 87 TPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSK 166 (361)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-
T ss_pred eCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccc
Confidence 99999999999999999999988889999999999999999999999999999999999999987765 9999999997
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcc-hhHHHHHHHHHHHHhCCCCCchhHH--H-HHHHHhhccCCCCCCC
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFS-ADIWSVGCTVIEMATGKPPWSQQFQ--E-VAALFHIGTTKSHPPI 293 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~k-sDIWSLGvILyeLLTG~~PF~~~~~--~-~~~~~~~~~~~~~~~~ 293 (668)
..... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... . ...+..+.......+.
T Consensus 167 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (361)
T 3uc3_A 167 SSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD 243 (361)
T ss_dssp -----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT
T ss_pred ccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC
Confidence 53322 22345679999999999998887655 8999999999999999999975321 0 1111112222223333
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
...++.++.+||.+||+.||.+|||+.||++||||.....
T Consensus 244 ~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 244 DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 4468999999999999999999999999999999976543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=421.02 Aligned_cols=261 Identities=28% Similarity=0.482 Sum_probs=221.3
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~ 138 (668)
.....+|++.++||+|+||+||+|+++.+|+.||||++..... ........+..|..+|..+ +||||+++++++
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~ 87 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-----LMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 87 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHH-----HHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHh-----hhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE
Confidence 3566789999999999999999999999999999999843211 1112234567788888876 899999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.+...+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.
T Consensus 88 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~ 167 (345)
T 1xjd_A 88 QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167 (345)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999999975
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~l 297 (668)
... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+.. ....++..+
T Consensus 168 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~----~~~~~p~~~ 241 (345)
T 1xjd_A 168 NML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----DNPFYPRWL 241 (345)
T ss_dssp CCC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCTTS
T ss_pred ccc--CCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh----CCCCCCccc
Confidence 321 122345678999999999999999999999999999999999999999754332 2222222 123456779
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHH-HHHcCccccCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTAS-ELLQHPFVTGK 331 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~-EIL~Hpwf~~~ 331 (668)
+.++++||.+||+.||.+||++. +|++||||++.
T Consensus 242 s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 242 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred CHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 99999999999999999999998 99999999753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=404.07 Aligned_cols=260 Identities=28% Similarity=0.461 Sum_probs=211.8
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|.+..+++.||||++..... .......+.+|+.+|+.++|||||++++++.....
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 75 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC------cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence 479999999999999999999999999999999854322 12233557789999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+++||||+.++.+..+....+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....
T Consensus 76 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~-- 153 (292)
T 3o0g_A 76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-- 153 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--
T ss_pred EEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--
Confidence 999999998755555555567899999999999999999999999999999999999999999999999999976532
Q ss_pred hhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCc-hhH--HHHHHHHhhccCC-----------
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWS-QQF--QEVAALFHIGTTK----------- 288 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~-~~~--~~~~~~~~~~~~~----------- 288 (668)
.........||+.|+|||++.+.. ++.++|||||||++|+|++|..||. ... .....+.......
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (292)
T 3o0g_A 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred ccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccc
Confidence 122234567899999999998766 8999999999999999999888753 221 1122222111000
Q ss_pred -------------CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 289 -------------SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 289 -------------~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
........++.++++||.+||+.||.+|||+.|+|+||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 0111223578999999999999999999999999999999864
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=416.64 Aligned_cols=259 Identities=26% Similarity=0.471 Sum_probs=221.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|++.+.||+|+||+||+|++..+++.||||++..... ........+.+|+.+|..+ +|||||++++++.
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 80 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-----NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 80 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGS-----CSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHh-----cchHHHHHHHHHHHHHHhcCCCCccCeEEEEEE
Confidence 445689999999999999999999999999999999853321 1233456678899999988 8999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
+...+|+||||++||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 81 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 81 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred eCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999999753
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchh----------HHHHHHHHhhccCCC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ----------FQEVAALFHIGTTKS 289 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~----------~~~~~~~~~~~~~~~ 289 (668)
.. ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||... .......+. ..
T Consensus 161 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~----~~ 234 (345)
T 3a8x_A 161 LR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----EK 234 (345)
T ss_dssp CC--TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHH----HC
T ss_pred cC--CCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHH----cC
Confidence 21 122345678999999999999999999999999999999999999999631 111111111 12
Q ss_pred CCCCCcccCHHHHHHHHHhhhhCCCCCCCH------HHHHcCccccC
Q 005944 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTA------SELLQHPFVTG 330 (668)
Q Consensus 290 ~~~~p~~ls~el~dLI~kcL~~dP~~RPSa------~EIL~Hpwf~~ 330 (668)
...++..++.++++||.+||+.||.+||++ .+|++||||.+
T Consensus 235 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 235 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 334677899999999999999999999995 89999999975
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=428.57 Aligned_cols=259 Identities=26% Similarity=0.468 Sum_probs=220.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|++.++||+|+||+||+|++..+++.||||++..... ........+..|..+|.++ +|||||++++++.
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~-----~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~ 123 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV-----NDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ 123 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGT-----C----CCHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhc-----cCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEE
Confidence 455789999999999999999999999999999999854321 1223344577899999887 8999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
+...+|||||||+||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 124 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 124 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999999752
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH----------HHHHHHHhhccCCC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF----------QEVAALFHIGTTKS 289 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~----------~~~~~~~~~~~~~~ 289 (668)
.. ........+||+.|+|||++.+..|+.++|||||||++|+|++|++||.... ......+. ..
T Consensus 204 ~~--~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~----~~ 277 (396)
T 4dc2_A 204 LR--PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL----EK 277 (396)
T ss_dssp CC--TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH----HC
T ss_pred cc--CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh----cc
Confidence 21 2233456889999999999999999999999999999999999999995211 11111111 22
Q ss_pred CCCCCcccCHHHHHHHHHhhhhCCCCCCCH------HHHHcCccccC
Q 005944 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTA------SELLQHPFVTG 330 (668)
Q Consensus 290 ~~~~p~~ls~el~dLI~kcL~~dP~~RPSa------~EIL~Hpwf~~ 330 (668)
...+|..++.++++||.+||+.||.+||++ .||++||||++
T Consensus 278 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 278 QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 345677899999999999999999999984 89999999975
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=394.13 Aligned_cols=263 Identities=27% Similarity=0.426 Sum_probs=225.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|.+..++..||+|++.... ........+.+|+.+++.++||||+++++++..
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 76 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK------LSARDFQKLEREARICRKLQHPNIVRLHDSIQE 76 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeeccc------CCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc
Confidence 45688999999999999999999999999999999984322 123345668899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc---eEEecCCchh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC---IKLADFGASK 217 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~---vKL~DFGlA~ 217 (668)
....++||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++.
T Consensus 77 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 77 ESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 9999999999999999999988888999999999999999999999999999999999999986655 9999999997
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ 296 (668)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...............+....
T Consensus 157 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T 3kk8_A 157 EVND---SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 233 (284)
T ss_dssp ECCS---SCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTT
T ss_pred Eccc---CccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcc
Confidence 5432 2223456799999999999999999999999999999999999999975432 33333333333444444567
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 234 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 899999999999999999999999999999998643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=428.56 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=223.5
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.+|+.++|||||++++++.+.
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~ 82 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL------SARDHQKLEREARICRLLKHPNIVRLHDSISEE 82 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC------HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC------CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC
Confidence 45679999999999999999999999999999999853321 223345688999999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC---CCCceEEecCCchhh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD---NKGCIKLADFGASKK 218 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld---~~g~vKL~DFGlA~~ 218 (668)
+..|+|||||.||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++..
T Consensus 83 ~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 83 GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 99999999999999999998888999999999999999999999999999999999999998 467899999999976
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-HHHHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-QEVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-~~~~~~~~~~~~~~~~~~p~~l 297 (668)
+... .......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.... ......+.........+.+..+
T Consensus 163 ~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (444)
T 3soa_A 163 VEGE--QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTV 240 (444)
T ss_dssp CCTT--CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTS
T ss_pred ecCC--CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccC
Confidence 5332 222345789999999999999899999999999999999999999997543 3333334444444444555688
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 241 s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 241 TPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 999999999999999999999999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-48 Score=410.31 Aligned_cols=265 Identities=29% Similarity=0.424 Sum_probs=222.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+|..||||++......... .......+.+|+.+|+.++|||||++++++..
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--RGVSREDIEREVSILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEcccccccc--chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 4456799999999999999999999999999999998543321111 00123457889999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC----ceEEecCCch
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG----CIKLADFGAS 216 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g----~vKL~DFGlA 216 (668)
...+++||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999999998888999999999999999999999999999999999999999887 8999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~ 295 (668)
+.+... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .................+.
T Consensus 166 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (326)
T 2y0a_A 166 HKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 242 (326)
T ss_dssp EECCTT---SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHT
T ss_pred eECCCC---CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccc
Confidence 865322 233457899999999999989999999999999999999999999975432 2222222222222222335
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.++.++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 243 ~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence 67899999999999999999999999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=412.69 Aligned_cols=258 Identities=26% Similarity=0.352 Sum_probs=219.0
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|++..++..||+|++.... .....+.+|+.+|+.++|||||++++++...
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---------~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 73 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---------TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---------ccHHHHHHHHHHHHhCCCCCCCeEeEEEecC
Confidence 4578999999999999999999999999999999984321 1234578899999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC--CCceEEecCCchhh
Q 005944 142 DSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN--KGCIKLADFGASKK 218 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~--~g~vKL~DFGlA~~ 218 (668)
+.+++|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++.
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~ 153 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeE
Confidence 9999999999999999999765 47999999999999999999999999999999999999987 78999999999986
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~l 297 (668)
+.... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+...........+..+
T Consensus 154 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (321)
T 1tki_A 154 LKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230 (321)
T ss_dssp CCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred CCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccC
Confidence 53321 23346799999999999988899999999999999999999999975432 222222222222222223468
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
+.++.+||.+||..||.+|||+.|+|+||||+..
T Consensus 231 s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 9999999999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=424.33 Aligned_cols=259 Identities=25% Similarity=0.481 Sum_probs=222.9
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.++||+|+||+||+|.+..+++.||||++.... .........+.+|+.+|+.++|||||++++++.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 85 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQK-----CVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ 85 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhh-----cccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 456688999999999999999999999999999999984321 112223456788999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
+...+|+||||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+
T Consensus 86 ~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 165 (384)
T 4fr4_A 86 DEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165 (384)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999999865
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhh---cCCCcchhHHHHHHHHHHHHhCCCCCchh----HHHHHHHHhhccCCCCCC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQ---TGHSFSADIWSVGCTVIEMATGKPPWSQQ----FQEVAALFHIGTTKSHPP 292 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDIWSLGvILyeLLTG~~PF~~~----~~~~~~~~~~~~~~~~~~ 292 (668)
.. .......+||+.|+|||++.+ ..|+.++|||||||++|+|++|..||... .......+. .....
T Consensus 166 ~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~~~~ 238 (384)
T 4fr4_A 166 PR---ETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TTVVT 238 (384)
T ss_dssp CT---TCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HCCCC
T ss_pred cC---CCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hcccC
Confidence 32 233456789999999999974 45899999999999999999999999632 122222222 22345
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCC-HHHHHcCccccC
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRST-ASELLQHPFVTG 330 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPS-a~EIL~Hpwf~~ 330 (668)
++..++.++.+||.+||+.||.+||+ ++++++||||.+
T Consensus 239 ~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 239 YPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred CCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 66788999999999999999999998 999999999975
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=414.73 Aligned_cols=256 Identities=30% Similarity=0.511 Sum_probs=222.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+|+.||||++.... .........+.+|+.+|+.++||||+++++++.+
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 112 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-----VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD 112 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHH-----hccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 44578999999999999999999999999999999984321 1111234567889999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+.
T Consensus 113 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 113 NSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceecc
Confidence 99999999999999999999988899999999999999999999999999999999999999999999999999998643
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccCH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
. .....+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+... ...++..++.
T Consensus 193 ~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----~~~~p~~~~~ 263 (350)
T 1rdq_E 193 G-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG----KVRFPSHFSS 263 (350)
T ss_dssp S-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTCCH
T ss_pred C-----CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC----CCCCCCCCCH
Confidence 2 23457899999999999999999999999999999999999999975432 222222221 2345678999
Q ss_pred HHHHHHHHhhhhCCCCCCC-----HHHHHcCccccC
Q 005944 300 EAKDFLLKCLQKEPYLRST-----ASELLQHPFVTG 330 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~ 330 (668)
++.+||.+||+.||.+||+ +++|++||||.+
T Consensus 264 ~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 9999999999999999998 999999999975
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=414.70 Aligned_cols=259 Identities=25% Similarity=0.396 Sum_probs=220.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|++.++||+|+||+||+|++..+++.||||++.... .........+..|..+|..+ +||||+++++++.
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~-----~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~ 91 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV-----VIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 91 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHH-----hhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEE
Confidence 45678999999999999999999999999999999984321 11112345577899999988 7999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
..+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++..
T Consensus 92 ~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 92 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999999753
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls 298 (668)
.. ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....+.. ....++..++
T Consensus 172 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s 245 (353)
T 2i0e_A 172 IW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME----HNVAYPKSMS 245 (353)
T ss_dssp CC--TTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCTTSC
T ss_pred cc--CCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh----CCCCCCCCCC
Confidence 21 122345678999999999999999999999999999999999999999754332 2222221 2234567899
Q ss_pred HHHHHHHHHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 299 MEAKDFLLKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
.++.+||.+||+.||.+|| ++.+|++||||++
T Consensus 246 ~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 246 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999999999999 5799999999975
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=403.42 Aligned_cols=263 Identities=30% Similarity=0.510 Sum_probs=210.9
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
.+....+|++.+.||+|+||+||+|++. +|+.||||++.... ........+.+|+.+|+.++|||||++++++
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 88 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA------EDEGIPSTAIREISLLKELHHPNIVSLIDVI 88 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------------CHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc------ccchhhHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence 3567789999999999999999999985 58999999984321 1222345678899999999999999999999
Q ss_pred ccCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.....+++||||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 89 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 167 (311)
T 3niz_A 89 HSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLAR 167 (311)
T ss_dssp CCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCce
Confidence 999999999999986 67766654 4569999999999999999999999999999999999999999999999999997
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCCCCC---
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTKSHP--- 291 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~~~~--- 291 (668)
.... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... .....+..........
T Consensus 168 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 245 (311)
T 3niz_A 168 AFGI--PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245 (311)
T ss_dssp ETTS--CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSG
T ss_pred ecCC--CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhh
Confidence 6532 1222345678999999999987 458999999999999999999999996432 1112222111110000
Q ss_pred ----------------------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 292 ----------------------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 292 ----------------------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.+...++.++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp GGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 0123467899999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-48 Score=408.33 Aligned_cols=262 Identities=27% Similarity=0.435 Sum_probs=216.8
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC--CCeeeecccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH--PNIVRYLGTA 138 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIV~l~g~~ 138 (668)
....+|++.+.||+|+||+||+|.+ .+++.||||++.... ........+.+|+.+|..+.| +||+++++++
T Consensus 6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~ 78 (343)
T 3dbq_A 6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78 (343)
T ss_dssp SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc------cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeE
Confidence 5677899999999999999999987 568999999985332 223445678899999999976 9999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.....+||||| +.+++|.+++...+.+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.
T Consensus 79 ~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~ 156 (343)
T 3dbq_A 79 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQ 156 (343)
T ss_dssp ECSSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred eeCCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence 99999999999 55789999999888999999999999999999999999999999999999997 68899999999987
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhh-----------cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccC
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQ-----------TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT 287 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~ 287 (668)
+............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||................
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 236 (343)
T 3dbq_A 157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP 236 (343)
T ss_dssp C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC
Confidence 654433333446789999999999976 668899999999999999999999997654443334444344
Q ss_pred CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 288 ~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.....++...+.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 44556677788999999999999999999999999999999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=398.92 Aligned_cols=266 Identities=29% Similarity=0.480 Sum_probs=206.3
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC---CCCCeeeecc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL---THPNIVRYLG 136 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIV~l~g 136 (668)
.....+|++.+.||+|+||+||+|++..+++.||||++............ ...+.+|+.+++.+ .||||+++++
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~---~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGL---PISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCC---CHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEeccccccccccc---chhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 46678999999999999999999999999999999998643321111111 11234566665555 5999999999
Q ss_pred ccccCC-----cceEEeeccCCCChhcccccCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceE
Q 005944 137 TAREDD-----SLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIK 209 (668)
Q Consensus 137 ~~~~~~-----~~~LVmEy~~gGsL~~~L~~~~~--l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vK 209 (668)
++.... .+++||||+. |+|.+++..... +++..++.++.||+.||+|||++||+||||||+||||+.++.+|
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~k 160 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVK 160 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEE
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEE
Confidence 987655 4799999997 599999877644 99999999999999999999999999999999999999999999
Q ss_pred EecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccC
Q 005944 210 LADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTT 287 (668)
Q Consensus 210 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~ 287 (668)
|+|||+++.... .......+||+.|+|||++.+..++.++|||||||++|+|++|++||...... ...+......
T Consensus 161 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 237 (308)
T 3g33_A 161 LADFGLARIYSY---QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGL 237 (308)
T ss_dssp ECSCSCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EeeCccccccCC---CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999986532 22334568999999999999999999999999999999999999999654322 2222221111
Q ss_pred CCCCC----------------------CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 288 KSHPP----------------------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 288 ~~~~~----------------------~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
..... ....++.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 10000 1135788999999999999999999999999999998643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-48 Score=392.57 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=220.3
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||+++++++.....
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-------VDCPENIKKEICINKMLNHENVVKFYGHRREGNI 79 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-------TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-------hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCE
Confidence 579999999999999999999999999999999853221 1233567889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 159 (276)
T 2yex_A 80 QYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (276)
T ss_dssp EEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred EEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999987654322
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......................+..++.++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (276)
T 2yex_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239 (276)
T ss_dssp EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHH
T ss_pred chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHH
Confidence 2233445789999999999987765 778999999999999999999997543211111111112222233457899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 303 DFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 303 dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+||.+||+.||.+|||+.++++||||+...
T Consensus 240 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 240 ALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp HHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred HHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 999999999999999999999999998643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=404.50 Aligned_cols=261 Identities=28% Similarity=0.512 Sum_probs=212.9
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEc---CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
.....+|++.++||+|+||+||+|++. .+++.||||++...... ........+.+|+.+|+.++|||||++++
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 88 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV----RNAKDTAHTKAERNILEEVKHPFIVDLIY 88 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC------------------HHHHHHHCCCTTBCCEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhh----hhhhHHHHHHHHHHHHHhCCCCCccceeE
Confidence 356678999999999999999999985 68999999998532111 11223455778999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
++...+.+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 89 AFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999999999988889999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~ 295 (668)
+...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+.. ....++.
T Consensus 169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~----~~~~~p~ 242 (327)
T 3a62_A 169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK----CKLNLPP 242 (327)
T ss_dssp ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH----TCCCCCT
T ss_pred cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh----CCCCCCC
Confidence 7543222 2234568999999999999999999999999999999999999999754322 2111111 1234567
Q ss_pred ccCHHHHHHHHHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
.++.++.+||.+||+.||.+|| ++.++++||||++
T Consensus 243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence 7899999999999999999999 8999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=424.00 Aligned_cols=265 Identities=27% Similarity=0.428 Sum_probs=200.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||+||+|++..+++.||||++... .......+.+.+|+.+|+.++|||||++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~------~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 123 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV------FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIP 123 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECST------TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh------hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEec
Confidence 4567899999999999999999999999999999998422 1223345678899999999999999999999843
Q ss_pred -----CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 141 -----DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 141 -----~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
...+|+||||+ +|+|..++.....+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+
T Consensus 124 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 124 KDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp SCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeeccccc
Confidence 35689999998 469999998888899999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhh-------------------------hcCCccCCCCCCCCChHHHh-hcCCCcchhHHHHHHHHHHHHh---
Q 005944 216 SKKVVELAT-------------------------INGAKSMKGTPYWMAPEVIL-QTGHSFSADIWSVGCTVIEMAT--- 266 (668)
Q Consensus 216 A~~~~~~~~-------------------------~~~~~~~~GT~~Y~APEvl~-~~~~s~ksDIWSLGvILyeLLT--- 266 (668)
++.+..... .......+||+.|+|||++. +..|+.++||||||||||||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~ 282 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK 282 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence 986532111 01234568999999999875 5569999999999999999999
Q ss_pred --------CCCCCchhH----------------------HHHHHHHhhccC-----------------------C---CC
Q 005944 267 --------GKPPWSQQF----------------------QEVAALFHIGTT-----------------------K---SH 290 (668)
Q Consensus 267 --------G~~PF~~~~----------------------~~~~~~~~~~~~-----------------------~---~~ 290 (668)
|+++|.+.. ..+..++..... . ..
T Consensus 283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (458)
T 3rp9_A 283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL 362 (458)
T ss_dssp TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence 677774321 111111111000 0 00
Q ss_pred CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 291 ~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
......++.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 111235689999999999999999999999999999998654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=396.97 Aligned_cols=264 Identities=28% Similarity=0.464 Sum_probs=210.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhh------------------HhhHHHHHHHHHHHHH
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASK------------------EKTQAHIRELEEEVKL 122 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~------------------~~~~~~~~~~~~Ei~i 122 (668)
....+|++.+.||+|+||+||+|++..+++.||||++......... .........+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3346899999999999999999999999999999998543211100 0111234568899999
Q ss_pred HHhCCCCCeeeecccccc--CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccE
Q 005944 123 LKNLTHPNIVRYLGTARE--DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANI 200 (668)
Q Consensus 123 L~~L~HpNIV~l~g~~~~--~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNI 200 (668)
|+.++||||+++++++.. ...+|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999876 5678999999999999987654 6899999999999999999999999999999999999
Q ss_pred EeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcC---CCcchhHHHHHHHHHHHHhCCCCCchhHHH
Q 005944 201 LVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG---HSFSADIWSVGCTVIEMATGKPPWSQQFQE 277 (668)
Q Consensus 201 Lld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~---~s~ksDIWSLGvILyeLLTG~~PF~~~~~~ 277 (668)
||+.++.+||+|||+++.+.... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~ 246 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIM 246 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHH
Confidence 99999999999999997653221 1123467999999999997765 377899999999999999999999754322
Q ss_pred -HHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 278 -VAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 278 -~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
....... .....+....++.++.+||.+||+.||.+|||+.|+++||||+
T Consensus 247 ~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 247 CLHSKIKS--QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHH--CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HHHHHHhc--ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 1111111 1222233457899999999999999999999999999999996
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=414.83 Aligned_cols=266 Identities=26% Similarity=0.395 Sum_probs=215.5
Q ss_pred CCCCCeeeeeEEccc--CceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 61 APPIRWRKGELVGCG--AFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G--~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
....+|++.++||+| +||+||+|++..+|+.||||++.... ........+.+|+.+|+.++|||||++++++
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 95 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEA------CSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGG------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccc------cChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence 556789999999999 99999999999999999999985322 1234556788999999999999999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
...+.+|+|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~ 175 (389)
T 3gni_B 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175 (389)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccc
Confidence 9999999999999999999999765 67999999999999999999999999999999999999999999999999987
Q ss_pred hhhHhhhh-----hcCCccCCCCCCCCChHHHhh--cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhc--
Q 005944 217 KKVVELAT-----INGAKSMKGTPYWMAPEVILQ--TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIG-- 285 (668)
Q Consensus 217 ~~~~~~~~-----~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~-- 285 (668)
........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... .........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP 255 (389)
T ss_dssp EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence 64422111 111223579999999999987 5789999999999999999999999964211 000000000
Q ss_pred ---------------------------------------cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCc
Q 005944 286 ---------------------------------------TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHP 326 (668)
Q Consensus 286 ---------------------------------------~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hp 326 (668)
......+.+..+++++.+||.+||+.||.+|||+.|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 00001124556889999999999999999999999999999
Q ss_pred cccCCC
Q 005944 327 FVTGKY 332 (668)
Q Consensus 327 wf~~~~ 332 (668)
||+...
T Consensus 336 ~f~~~~ 341 (389)
T 3gni_B 336 FFKQIK 341 (389)
T ss_dssp GGGGC-
T ss_pred HHHHHh
Confidence 998644
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=414.70 Aligned_cols=260 Identities=25% Similarity=0.419 Sum_probs=220.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|.+..+++.||||++.... .........+.+|+.+|+.++|||||++++++..
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 80 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQL-----LKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT 80 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHH-----ccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 34468999999999999999999999999999999984211 1111223467899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...+++||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 81 ~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 81 PTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp SSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred CCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 99999999999 78999999888899999999999999999999999999999999999999999999999999998654
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... ...........++..+++
T Consensus 160 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i~~~~~~~p~~~s~ 233 (336)
T 3h4j_B 160 DG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---LFKKVNSCVYVMPDFLSP 233 (336)
T ss_dssp TS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---CBCCCCSSCCCCCTTSCH
T ss_pred CC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---HHHHHHcCCCCCcccCCH
Confidence 32 23456789999999999988776 789999999999999999999997532110 011112223456778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
++.+||.+||+.||.+|||+.||++||||+...
T Consensus 234 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 266 (336)
T 3h4j_B 234 GAQSLIRRMIVADPMQRITIQEIRRDPWFNVNL 266 (336)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhChhhccCC
Confidence 999999999999999999999999999998643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=425.25 Aligned_cols=264 Identities=26% Similarity=0.429 Sum_probs=219.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||+||+|++..+++.||||++..... ........+.+|+.+|..++|||||++++++.+
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEM-----IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHH-----HHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhh-----hhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 556789999999999999999999999999999999842111 111112346789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...+|||||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.+.
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~ 219 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 219 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeec
Confidence 9999999999999999999875 579999999999999999999999999999999999999999999999999997653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcC----CCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCc
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTG----HSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~----~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~ 295 (668)
... .....+.+||+.|+|||++.+.. |+.++|||||||+||+|++|+.||...... ....+.........+.+.
T Consensus 220 ~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 298 (410)
T 3v8s_A 220 KEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDN 298 (410)
T ss_dssp TTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTC
T ss_pred cCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcc
Confidence 321 12234678999999999998765 788999999999999999999999754322 212111111112233345
Q ss_pred ccCHHHHHHHHHhhhhCCCC--CCCHHHHHcCccccCC
Q 005944 296 HLSMEAKDFLLKCLQKEPYL--RSTASELLQHPFVTGK 331 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~--RPSa~EIL~Hpwf~~~ 331 (668)
.++.++++||.+||+.+|.+ |++++||++||||++.
T Consensus 299 ~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 299 DISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp CCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred cccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 78999999999999999988 9999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=393.56 Aligned_cols=257 Identities=28% Similarity=0.484 Sum_probs=207.4
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|.+ .+|+.||||++...... ......+.+|+.+|+.++||||+++++++...+.
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKED------EGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGG------GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccc------cccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence 5799999999999999999998 67999999998543211 1122456789999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
+++||||+.+ +|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 75 LVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp EEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred EEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 9999999986 888888654 67999999999999999999999999999999999999999999999999999865321
Q ss_pred hhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCCC----------
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTKS---------- 289 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~~---------- 289 (668)
........||+.|+|||++.+. .++.++|||||||++|+|++|..||..... ....+........
T Consensus 154 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 154 --VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcc
Confidence 1223346789999999999764 489999999999999999999999975432 2222222110000
Q ss_pred --------------CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 290 --------------HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 290 --------------~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.......++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 00122457899999999999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=423.52 Aligned_cols=259 Identities=29% Similarity=0.468 Sum_probs=214.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||.||+|.+..+|+.||||++.... .........+.+|+.+|+.++||||+++++++..
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 219 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEV-----IVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT 219 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HC-------------CCCCCSCTTSCCEEEEEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhh-----hhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee
Confidence 45578999999999999999999999999999999984221 1122334567789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.+.+||||||+++|+|..++...+.+++..++.++.||+.||+|||+ +||+||||||+||||+.++.+||+|||+++..
T Consensus 220 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 220 HDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp TTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred CCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 99999999999999999999888899999999999999999999998 99999999999999999999999999999753
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls 298 (668)
... .......+||+.|+|||++.+..|+.++|||||||+||+|++|+.||...... ....+... ...++..++
T Consensus 300 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~----~~~~p~~~~ 373 (446)
T 4ejn_A 300 IKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME----EIRFPRTLG 373 (446)
T ss_dssp CC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC----CCCCCTTSC
T ss_pred cCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC----CCCCCccCC
Confidence 221 22244678999999999999999999999999999999999999999754332 22222221 234567889
Q ss_pred HHHHHHHHHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 299 MEAKDFLLKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
+++.+||.+||+.||.+|| ++.|+++||||++
T Consensus 374 ~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence 9999999999999999999 9999999999985
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=408.83 Aligned_cols=261 Identities=30% Similarity=0.401 Sum_probs=209.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
+....+|++.+.||+|+||+||+|++..+++.||||++.... ..+.+.+|+.+|+.++||||+++++++.
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~~ 118 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----------DKKIVRTEIGVLLRLSHPNIIKLKEIFE 118 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------------CHHHHHCCCTTBCCEEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----------hHHHHHHHHHHHHhCCCCCCcceeeeEe
Confidence 345678999999999999999999999999999999984211 2245778999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC---CCceEEecCCch
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---KGCIKLADFGAS 216 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---~g~vKL~DFGlA 216 (668)
....+++||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++
T Consensus 119 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 119 TPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp CSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred cCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 99999999999999999999988888999999999999999999999999999999999999975 889999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccCCCCCCCC
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTTKSHPPIP 294 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~~~~~~~p 294 (668)
+..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+.........+.+
T Consensus 199 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 275 (349)
T 2w4o_A 199 KIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW 275 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTT
T ss_pred cccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchh
Confidence 865432 1234568999999999999989999999999999999999999999654322 22222222233333455
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
..++.++.+||.+||+.||.+|||+.++|+||||++...
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 314 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA 314 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence 678999999999999999999999999999999986543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=426.03 Aligned_cols=266 Identities=25% Similarity=0.403 Sum_probs=220.1
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.++||+|+||+||+|++..+++.||||++.... .........+.+|+.+|..++|||||++++++.
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWE-----MLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-----HHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHH-----hhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 355678999999999999999999999999999999984211 111112234778999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
+...+|||||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999999999987 47899999999999999999999999999999999999999999999999999976
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHh-----hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccCCCCC
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTTKSHP 291 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~~~~~ 291 (668)
+..... ......+||+.|+|||++. ...|+.++|||||||++|||++|++||...... ...+.........+
T Consensus 225 ~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p 303 (437)
T 4aw2_A 225 LMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP 303 (437)
T ss_dssp CCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC
T ss_pred cccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCC
Confidence 533221 2234578999999999997 455899999999999999999999999754321 22222211112233
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCC--CCCHHHHHcCccccCC
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYL--RSTASELLQHPFVTGK 331 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~--RPSa~EIL~Hpwf~~~ 331 (668)
.....++.++++||.+||..+|++ |++++||++||||++.
T Consensus 304 ~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 334568999999999999988888 9999999999999864
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=397.77 Aligned_cols=260 Identities=27% Similarity=0.467 Sum_probs=210.9
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.....
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE------DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRR 76 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC------C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc------cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCe
Confidence 57999999999999999999999999999999884322 223344667889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.++||||+++++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 77 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 156 (311)
T 4agu_A 77 LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS 156 (311)
T ss_dssp EEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999997653221
Q ss_pred hhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH--HHHHhh--------------cc
Q 005944 224 TINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV--AALFHI--------------GT 286 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~--~~~~~~--------------~~ 286 (668)
......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ..+... ..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (311)
T 4agu_A 157 --DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ 234 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCG
T ss_pred --cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccc
Confidence 12335679999999999986 568999999999999999999999996543211 111110 00
Q ss_pred C--CCCCCC----------CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 287 T--KSHPPI----------PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 287 ~--~~~~~~----------p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
. ....+. ...++.++.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 0 000000 13578899999999999999999999999999999864
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=391.22 Aligned_cols=261 Identities=29% Similarity=0.488 Sum_probs=220.8
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||+||+|.+..++..||||++.... .........+.+|+.+++.++||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccc-----cchhhHHHHHHHHHHHHHcCCCCCCcchhheEe
Confidence 355678999999999999999999999999999999984211 111223456788999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.....++||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 80 DATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred cCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999998654
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls 298 (668)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....... ....++..++
T Consensus 160 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~ 231 (279)
T 3fdn_A 160 PSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR----VEFTFPDFVT 231 (279)
T ss_dssp ------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----TCCCCCTTSC
T ss_pred Ccc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHh----CCCCCCCcCC
Confidence 322 223567999999999999999999999999999999999999999754322 2222111 2234567789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 232 ~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 232 EGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence 99999999999999999999999999999986543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=413.42 Aligned_cols=260 Identities=28% Similarity=0.431 Sum_probs=214.1
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHH-HHhCCCCCeeeecccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL-LKNLTHPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~i-L~~L~HpNIV~l~g~~ 138 (668)
.....+|++.++||+|+||+||+|++..++..||||++...... .......+..|..+ ++.++|||||++++++
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~-----~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~ 108 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAIL-----KKKEEKHIMSERNVLLKNVKHPFLVGLHFSF 108 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC------------------CCBCCCCCTTBCCEEEEE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhh-----hhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE
Confidence 35567899999999999999999999999999999998543221 11223345566665 5778999999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.+.+.+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.
T Consensus 109 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 109 QTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp ECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999999975
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~l 297 (668)
... ........+||+.|+|||++.+..|+.++|||||||++|+|++|..||..... +....+... ...++..+
T Consensus 189 ~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~----~~~~~~~~ 262 (373)
T 2r5t_A 189 NIE--HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK----PLQLKPNI 262 (373)
T ss_dssp GBC--CCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS----CCCCCSSS
T ss_pred ccc--CCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc----ccCCCCCC
Confidence 322 12234567899999999999999999999999999999999999999975432 222222111 23456679
Q ss_pred CHHHHHHHHHhhhhCCCCCCCH----HHHHcCccccC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTA----SELLQHPFVTG 330 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa----~EIL~Hpwf~~ 330 (668)
+.++++||.+||+.||.+||++ .+|++||||++
T Consensus 263 ~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 263 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp CHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred CHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 9999999999999999999986 69999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=404.03 Aligned_cols=264 Identities=25% Similarity=0.424 Sum_probs=207.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+++.||||++.... ........+.+|+.+|+.++|||||++++++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 104 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEH------EEEGVPGTAIREVSLLKELQHRNIIELKSVIHH 104 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccc------cccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence 45568999999999999999999999999999999984321 122334556789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe-----CCCCceEEecCCc
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV-----DNKGCIKLADFGA 215 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl-----d~~g~vKL~DFGl 215 (668)
...+||||||+.+ +|.+++.....+++..++.++.||+.||.|||++||+||||||+|||| +..+.+||+|||+
T Consensus 105 ~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~ 183 (329)
T 3gbz_A 105 NHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183 (329)
T ss_dssp TTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTH
T ss_pred CCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCC
Confidence 9999999999985 999999888899999999999999999999999999999999999999 4555699999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCCCCC-
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTKSHP- 291 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~~~~- 291 (668)
++.+... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... ....+..........
T Consensus 184 a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 184 ARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred ccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 9865322 22234567899999999998754 89999999999999999999999975432 222222211110000
Q ss_pred ------------C------------CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 292 ------------P------------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 292 ------------~------------~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
. ++..++.++.+||.+||+.||.+|||+.|+|+||||++...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 0 01227889999999999999999999999999999987543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=415.76 Aligned_cols=262 Identities=26% Similarity=0.422 Sum_probs=215.1
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC--CCCeeeeccccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT--HPNIVRYLGTAR 139 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIV~l~g~~~ 139 (668)
...+|++.+.||+|+||+||+|.+.. +..||||++.... ........+.+|+.+|..+. |||||++++++.
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~------~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~ 126 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEE------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 126 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTT------CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccc------ccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe
Confidence 34569999999999999999999765 8999999985422 12344567889999999996 599999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
..+.+||||| +.+++|.+++.....+++.+++.++.||+.||.|||++||+||||||+||||+ ++.+||+|||+++.+
T Consensus 127 ~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 127 TDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp CSSEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred cCCEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 9999999999 56889999998888999999999999999999999999999999999999995 589999999999876
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhh-----------cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQ-----------TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTK 288 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~ 288 (668)
............+||+.|+|||++.+ ..++.++||||||||||+|++|+.||.........+..+....
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~ 284 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPN 284 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTT
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcc
Confidence 54333333456789999999999975 3688999999999999999999999976433322333333333
Q ss_pred CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 289 SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 289 ~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
....++...+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 285 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 285 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 34456667789999999999999999999999999999998543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=408.32 Aligned_cols=257 Identities=26% Similarity=0.366 Sum_probs=218.6
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|++.+.||+|+||+||+|.+..+|+.||||++..... ...+|+.+|.++ +|||||++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------------~~~~E~~~l~~~~~hp~iv~~~~~~~ 86 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------------DPTEEIEILLRYGQHPNIITLKDVYD 86 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------------CCHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------------ChHHHHHHHHHhcCCCCcCeEEEEEE
Confidence 345679999999999999999999999999999999843211 124577788777 7999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC----CceEEecCCc
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK----GCIKLADFGA 215 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~----g~vKL~DFGl 215 (668)
+...+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+... +.+||+|||+
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~ 166 (342)
T 2qr7_A 87 DGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGF 166 (342)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTT
T ss_pred cCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCC
Confidence 999999999999999999999888899999999999999999999999999999999999998543 3599999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCch----hHHHHHHHHhhccCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQ----QFQEVAALFHIGTTKSHP 291 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~----~~~~~~~~~~~~~~~~~~ 291 (668)
++.+... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.. ...++...+.........
T Consensus 167 a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~ 244 (342)
T 2qr7_A 167 AKQLRAE--NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSG 244 (342)
T ss_dssp CEECBCT--TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCS
T ss_pred cccCcCC--CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCc
Confidence 9865322 1223467899999999999988899999999999999999999999974 223344444444444444
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
..+..++.++++||.+||..||.+|||+.++++||||...
T Consensus 245 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 245 GYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 4567899999999999999999999999999999999764
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=400.80 Aligned_cols=256 Identities=22% Similarity=0.331 Sum_probs=208.6
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD- 142 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~- 142 (668)
.+|++.+.||+|+||+||+|++..+|+.||||++.... .....+.+.+|+.+|+.++|||||++++++.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 78 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-------RELAREKVMREVKALAKLEHPGIVRYFNAWLETPP 78 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-------TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCS
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-------chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEecc
Confidence 47999999999999999999999999999999985432 1123356789999999999999999999875443
Q ss_pred --------------------------------------------------------cceEEeeccCCCChhcccccCCC-
Q 005944 143 --------------------------------------------------------SLNILLEFVPGGSISSLLGKFGS- 165 (668)
Q Consensus 143 --------------------------------------------------------~~~LVmEy~~gGsL~~~L~~~~~- 165 (668)
.+++|||||++|+|.+++.....
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 158 (332)
T 3qd2_B 79 EKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158 (332)
T ss_dssp CHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG
T ss_pred chhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc
Confidence 37999999999999999977543
Q ss_pred --CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh----------hcCCccCCC
Q 005944 166 --FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT----------INGAKSMKG 233 (668)
Q Consensus 166 --l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~----------~~~~~~~~G 233 (668)
.++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++....... .......+|
T Consensus 159 ~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~g 238 (332)
T 3qd2_B 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVG 238 (332)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-
T ss_pred cchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCC
Confidence 45667899999999999999999999999999999999999999999999986543211 112344679
Q ss_pred CCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCC
Q 005944 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEP 313 (668)
Q Consensus 234 T~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP 313 (668)
|+.|+|||++.+..++.++|||||||++|+|++|..|+........... ....+..+...++++.+||.+||+.||
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~~p 314 (332)
T 3qd2_B 239 TKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVR----NLKFPLLFTQKYPQEHMMVQDMLSPSP 314 (332)
T ss_dssp CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHHHHHHHH----TTCCCHHHHHHCHHHHHHHHHHHCSSG
T ss_pred CcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHHHHHHhh----ccCCCcccccCChhHHHHHHHHccCCC
Confidence 9999999999999999999999999999999999888644332222111 122222334567889999999999999
Q ss_pred CCCCCHHHHHcCccccC
Q 005944 314 YLRSTASELLQHPFVTG 330 (668)
Q Consensus 314 ~~RPSa~EIL~Hpwf~~ 330 (668)
.+|||+.|+|+||||++
T Consensus 315 ~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 315 TERPEATDIIENAIFEN 331 (332)
T ss_dssp GGSCCHHHHHHSTTCCC
T ss_pred CcCCCHHHHhhchhhhc
Confidence 99999999999999975
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=411.85 Aligned_cols=262 Identities=25% Similarity=0.390 Sum_probs=221.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+|+.||+|++.... ......+.+|+.+|+.++|||||++++++..
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--------~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~ 119 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--------PLDKYTVKNEISIMNQLHHPKLINLHDAFED 119 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC
T ss_pred ccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--------hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe
Confidence 34568999999999999999999999999999999984321 1123467899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC--CCceEEecCCchh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN--KGCIKLADFGASK 217 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~--~g~vKL~DFGlA~ 217 (668)
...+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++. .+.+||+|||+++
T Consensus 120 ~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~ 199 (387)
T 1kob_A 120 KYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT 199 (387)
T ss_dssp SSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccce
Confidence 99999999999999999998765 47999999999999999999999999999999999999974 4789999999998
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ 296 (668)
.+... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+...........+..
T Consensus 200 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 276 (387)
T 1kob_A 200 KLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276 (387)
T ss_dssp ECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTT
T ss_pred ecCCC---cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccc
Confidence 65322 122345799999999999999999999999999999999999999975432 22222223333334445567
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
++.++.+||.+||+.||.+|||+.++|+||||++...
T Consensus 277 ~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 8999999999999999999999999999999986543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=421.02 Aligned_cols=265 Identities=27% Similarity=0.439 Sum_probs=217.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.++||+|+||+||+|+++.+|+.||||++.... .........+.+|..+|..++|||||++++++.
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~-----~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD-----MLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHH-----hhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 356678999999999999999999999999999999984211 111222345778999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
+.+.+|||||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+++.
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~ 211 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLK 211 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhee
Confidence 999999999999999999999775 4799999999999999999999999999999999999999999999999999976
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhh-------cCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-H-HHHHhhccCCC
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQ-------TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-V-AALFHIGTTKS 289 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~-------~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~-~~~~~~~~~~~ 289 (668)
+..... ......+||+.|+|||++.. ..|+.++|||||||++|||++|+.||...... . ..+........
T Consensus 212 ~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~ 290 (412)
T 2vd5_A 212 LRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS 290 (412)
T ss_dssp CCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC
T ss_pred ccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC
Confidence 533221 12335689999999999983 45899999999999999999999999754322 1 22222111122
Q ss_pred CCCCCcccCHHHHHHHHHhhhhCCCCC---CCHHHHHcCccccCC
Q 005944 290 HPPIPEHLSMEAKDFLLKCLQKEPYLR---STASELLQHPFVTGK 331 (668)
Q Consensus 290 ~~~~p~~ls~el~dLI~kcL~~dP~~R---PSa~EIL~Hpwf~~~ 331 (668)
.+..+..++.++++||.+||. +|.+| ++++||++||||++.
T Consensus 291 ~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 291 LPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp CC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred CCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 233456799999999999999 99998 599999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=393.50 Aligned_cols=260 Identities=26% Similarity=0.391 Sum_probs=211.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||+||+|.+..++..||+|++..... ......+.+|+++|+.++||||+++++++.
T Consensus 18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 90 (285)
T 3is5_A 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS-------QVPMEQIEAEIEVLKSLDHPNIIKIFEVFE 90 (285)
T ss_dssp SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC-------CSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc-------chhHHHHHHHHHHHHhCCCchHHhHHHhee
Confidence 3556789999999999999999999999999999999853321 112355788999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe---CCCCceEEec
Q 005944 140 EDDSLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV---DNKGCIKLAD 212 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl---d~~g~vKL~D 212 (668)
.....++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~D 170 (285)
T 3is5_A 91 DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIID 170 (285)
T ss_dssp CSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECC
T ss_pred cCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEe
Confidence 99999999999999999998854 3679999999999999999999999999999999999999 4567899999
Q ss_pred CCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCC
Q 005944 213 FGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP 292 (668)
Q Consensus 213 FGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~ 292 (668)
||++..+.... ......||+.|+|||++. ..++.++|||||||++|+|++|..||.....................
T Consensus 171 fg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 171 FGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV 246 (285)
T ss_dssp CCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC
T ss_pred eecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc
Confidence 99997654322 234567999999999985 56899999999999999999999999765432222222212222222
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
....+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 247 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 33457899999999999999999999999999999974
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-48 Score=427.69 Aligned_cols=264 Identities=30% Similarity=0.446 Sum_probs=222.3
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.++||+|+||+||+|++..+++.||||++..... .......+.+|+.+|+.++|||||++++++.
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 91 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA------KNKDTSTILREVELLKKLDHPNIMKLFEILE 91 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH------BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc------cchHHHHHHHHHHHHHhCCCCCcCeEEEEEE
Confidence 3556789999999999999999999999999999999843211 1112356789999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC---CCCceEEecCCch
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD---NKGCIKLADFGAS 216 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld---~~g~vKL~DFGlA 216 (668)
....+|+|||||.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||++
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 92 DSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred cCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999999999999998888999999999999999999999999999999999999995 4567999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~ 295 (668)
+.+... ......+||+.|+|||++.+ .|+.++||||||||+|+|++|.+||..... +....+.........+.+.
T Consensus 172 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 247 (486)
T 3mwu_A 172 TCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247 (486)
T ss_dssp TTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGG
T ss_pred eECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccC
Confidence 865332 22345689999999999875 599999999999999999999999975432 3333333333333444556
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.++.++++||.+||+.||.+|||+.++|+||||+....
T Consensus 248 ~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 78999999999999999999999999999999986543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=390.11 Aligned_cols=259 Identities=26% Similarity=0.447 Sum_probs=217.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
.....|++.+.||+|+||+||+|.+..++..||+|++.... ........+.+|+.+|+.++||||+++++++..
T Consensus 23 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 23 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWES 96 (290)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG------SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred cCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchh------hCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence 45567999999999999999999999999999999984322 123345678899999999999999999998764
Q ss_pred ----CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCcccEEeC-CCCceEEecC
Q 005944 141 ----DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVD-NKGCIKLADF 213 (668)
Q Consensus 141 ----~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~g--IvHrDLKPeNILld-~~g~vKL~DF 213 (668)
...+++||||+++|+|.+++...+.+++..++.++.||+.||.|||++| |+||||||+||||+ .++.+||+||
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Df 176 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDL 176 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence 4568999999999999999988889999999999999999999999999 99999999999998 7899999999
Q ss_pred CchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCC
Q 005944 214 GASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 214 GlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~ 293 (668)
|++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......................
T Consensus 177 g~~~~~~~----~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 251 (290)
T 1t4h_A 177 GLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 251 (290)
T ss_dssp TGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGG
T ss_pred CCcccccc----cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCcccc
Confidence 99864322 22345679999999998864 58999999999999999999999997533222222222222333345
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+...++++.+||.+||+.||.+|||+.++++||||++
T Consensus 252 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 252 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 5667889999999999999999999999999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=414.04 Aligned_cols=263 Identities=27% Similarity=0.452 Sum_probs=202.6
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeecccccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTARE 140 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~ 140 (668)
...+|++.+.||+|+||+||+|.+..+|+.||||++... .........+.+|+.+|+.+. |||||++++++..
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~------~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~ 80 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA------FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA 80 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--------CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc------ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec
Confidence 346899999999999999999999999999999988422 122234456778999999997 9999999999865
Q ss_pred CC--cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 DD--SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 ~~--~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.+ .+|+|||||. |+|..++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.
T Consensus 81 ~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 81 DNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp TTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred CCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 43 6899999997 589888876 5799999999999999999999999999999999999999999999999999975
Q ss_pred hHhh-------------------hhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--
Q 005944 219 VVEL-------------------ATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-- 276 (668)
Q Consensus 219 ~~~~-------------------~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-- 276 (668)
+... .........+||+.|+|||++.+ ..|+.++||||||||+|+|++|++||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 4220 01112345689999999999987 5689999999999999999999999964321
Q ss_pred HHHHHHhhccCCC-----------------------------CC-------------CCCcccCHHHHHHHHHhhhhCCC
Q 005944 277 EVAALFHIGTTKS-----------------------------HP-------------PIPEHLSMEAKDFLLKCLQKEPY 314 (668)
Q Consensus 277 ~~~~~~~~~~~~~-----------------------------~~-------------~~p~~ls~el~dLI~kcL~~dP~ 314 (668)
....+........ .. ..+..+++++.+||.+||+.||.
T Consensus 239 ~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~ 318 (388)
T 3oz6_A 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPN 318 (388)
T ss_dssp HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGG
T ss_pred HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcc
Confidence 1111111110000 00 01226788999999999999999
Q ss_pred CCCCHHHHHcCccccCCC
Q 005944 315 LRSTASELLQHPFVTGKY 332 (668)
Q Consensus 315 ~RPSa~EIL~Hpwf~~~~ 332 (668)
+|||+.|+|+||||+...
T Consensus 319 ~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 319 KRISANDALKHPFVSIFH 336 (388)
T ss_dssp GSCCHHHHTTSTTTTTTC
T ss_pred cCCCHHHHhCCHHHHHhc
Confidence 999999999999998644
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=400.31 Aligned_cols=263 Identities=27% Similarity=0.379 Sum_probs=209.5
Q ss_pred CCCCCeeee-eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccc
Q 005944 61 APPIRWRKG-ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTA 138 (668)
Q Consensus 61 ~~~~ry~i~-~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~ 138 (668)
....+|++. ++||+|+||+||+|.+..+++.||||++..... .....+.+|+.+|.++ +||||+++++++
T Consensus 9 ~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~~~~h~~i~~~~~~~ 80 (316)
T 2ac3_A 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--------HIRSRVFREVEMLYQCQGHRNVLELIEFF 80 (316)
T ss_dssp CTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--------CCHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred ccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--------hhHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence 456789985 789999999999999999999999999853211 1224577899999885 799999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc---eEEecCCc
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC---IKLADFGA 215 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~---vKL~DFGl 215 (668)
...+.+|+||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||+
T Consensus 81 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 81 EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred eeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 999999999999999999999988889999999999999999999999999999999999999998776 99999999
Q ss_pred hhhhHhhhh-----hcCCccCCCCCCCCChHHHhh-----cCCCcchhHHHHHHHHHHHHhCCCCCchhH----------
Q 005944 216 SKKVVELAT-----INGAKSMKGTPYWMAPEVILQ-----TGHSFSADIWSVGCTVIEMATGKPPWSQQF---------- 275 (668)
Q Consensus 216 A~~~~~~~~-----~~~~~~~~GT~~Y~APEvl~~-----~~~s~ksDIWSLGvILyeLLTG~~PF~~~~---------- 275 (668)
+..+..... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 876532211 112234579999999999975 558899999999999999999999996431
Q ss_pred ------HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 276 ------QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 276 ------~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
......+..............++.++++||.+||+.||.+|||+.|+|+||||++.
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 302 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC 302 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred cchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence 11222222221111111123578999999999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=406.51 Aligned_cols=257 Identities=25% Similarity=0.339 Sum_probs=196.5
Q ss_pred CCeeee---eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccc
Q 005944 64 IRWRKG---ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAR 139 (668)
Q Consensus 64 ~ry~i~---~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~ 139 (668)
.+|++. ++||+|+||+||+|.+..+++.||||++... ....+.+|+.+|+.+. |||||++++++.
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~e~~~l~~l~~h~niv~~~~~~~ 76 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----------MEANTQKEITALKLCEGHPNIVKLHEVFH 76 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----------GHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----------hhhhHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 356664 7899999999999999999999999998321 1234568999999997 999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC---ceEEecCCch
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG---CIKLADFGAS 216 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g---~vKL~DFGlA 216 (668)
+....|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 77 DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred cCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 9999999999999999999999888999999999999999999999999999999999999998766 8999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--------HHHHHHhhccCC
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--------EVAALFHIGTTK 288 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--------~~~~~~~~~~~~ 288 (668)
+..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... +....+......
T Consensus 157 ~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~ 234 (325)
T 3kn6_A 157 RLKPPD--NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS 234 (325)
T ss_dssp EECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC
T ss_pred eecCCC--CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC
Confidence 754322 2223456789999999999999999999999999999999999999975322 222222222222
Q ss_pred CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 289 SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 289 ~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.....+..++.++++||.+||+.||.+|||+.++++||||++...
T Consensus 235 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 222223468999999999999999999999999999999986543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=399.11 Aligned_cols=257 Identities=32% Similarity=0.513 Sum_probs=215.9
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
..|...+.||+|+||+||+|++..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++...+.
T Consensus 45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (321)
T 2c30_A 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ--------QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEE 116 (321)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch--------hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCE
Confidence 358889999999999999999999999999999843211 123457789999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 117 ~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 194 (321)
T 2c30_A 117 LWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD- 194 (321)
T ss_dssp EEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-
T ss_pred EEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC-
Confidence 9999999999999999865 57999999999999999999999999999999999999999999999999998765322
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~d 303 (668)
.......+||+.|+|||++.+..++.++|||||||++|+|++|+.||......................+..++.++.+
T Consensus 195 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 273 (321)
T 2c30_A 195 -VPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRD 273 (321)
T ss_dssp -SCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHH
T ss_pred -ccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHH
Confidence 1123456899999999999998999999999999999999999999975432211111111111122234568899999
Q ss_pred HHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 304 FLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 304 LI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
||.+||+.||.+|||+.++++||||...
T Consensus 274 li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 274 FLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred HHHHHccCChhhCcCHHHHhcChhhccC
Confidence 9999999999999999999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=400.86 Aligned_cols=268 Identities=28% Similarity=0.420 Sum_probs=214.2
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|.+..++..||||++..... ..........+.+|+.+|+.++|||||++++++.+.
T Consensus 24 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 24 LQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKI---RQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH---HC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhh---cccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 34679999999999999999999999999999999843211 011223456788999999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccC----------------------------------------CCCCHHHHHHHHHHHHHH
Q 005944 142 DSLNILLEFVPGGSISSLLGKF----------------------------------------GSFPESVIRMYTKQLLLG 181 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~----------------------------------------~~l~e~~~~~i~~QIl~a 181 (668)
...++|||||++|+|.+++... ..+++..++.++.||+.|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 9999999999999999988521 124678889999999999
Q ss_pred HHHHHhCCcccccCCcccEEeCCCC--ceEEecCCchhhhHhhhh--hcCCccCCCCCCCCChHHHhh--cCCCcchhHH
Q 005944 182 LEYLHKNGIMHRDIKGANILVDNKG--CIKLADFGASKKVVELAT--INGAKSMKGTPYWMAPEVILQ--TGHSFSADIW 255 (668)
Q Consensus 182 L~yLHs~gIvHrDLKPeNILld~~g--~vKL~DFGlA~~~~~~~~--~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDIW 255 (668)
|.|||++||+||||||+||||+.++ .+||+|||+++.+..... ........||+.|+|||++.+ ..++.++|||
T Consensus 181 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diw 260 (345)
T 3hko_A 181 LHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260 (345)
T ss_dssp HHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHH
T ss_pred HHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHH
Confidence 9999999999999999999998776 899999999986543221 112345679999999999975 6689999999
Q ss_pred HHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 256 SVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 256 SLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
||||++|+|++|+.||...... ..............+....++.++.+||.+||+.||.+||++.++|+||||+...
T Consensus 261 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 261 SAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 9999999999999999754332 2222222222222233345899999999999999999999999999999998643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=398.72 Aligned_cols=264 Identities=30% Similarity=0.524 Sum_probs=226.0
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
......+|.+.+.||+|+||.||+|.+..+++.||+|++..... ......+.+.+|+.+++.++|+||+++++++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 110 (335)
T 2owb_A 36 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-----LKPHQREKMSMEISIHRSLAHQHVVGFHGFF 110 (335)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-----CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhh-----cCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34567789999999999999999999999999999999843221 1223456678899999999999999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
...+.+|+||||+.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 190 (335)
T 2owb_A 111 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 190 (335)
T ss_dssp ECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCcee
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999999976
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~l 297 (668)
+... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ....... ....++..+
T Consensus 191 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~ 264 (335)
T 2owb_A 191 VEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----NEYSIPKHI 264 (335)
T ss_dssp CCST--TCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----TCCCCCTTS
T ss_pred cccC--cccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc----CCCCCCccC
Confidence 5321 12234567999999999999999999999999999999999999999754322 2111111 123456678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
+.++.+||.+||+.||.+||++.++++||||+..+.
T Consensus 265 ~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 265 NPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 999999999999999999999999999999987554
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=388.80 Aligned_cols=261 Identities=28% Similarity=0.465 Sum_probs=222.6
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||+||+|.+..++..||||++.... .........+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 84 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQ-----LEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccc-----cchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE
Confidence 456678999999999999999999999999999999984211 111122356788999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.....++||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 85 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~ 164 (284)
T 2vgo_A 85 DRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHA 164 (284)
T ss_dssp CSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999998654
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|..||............. .....++..++.
T Consensus 165 ~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~ 237 (284)
T 2vgo_A 165 PS----LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV---NVDLKFPPFLSD 237 (284)
T ss_dssp SS----SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH---TTCCCCCTTSCH
T ss_pred cc----cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh---ccccCCCCcCCH
Confidence 22 22345679999999999999889999999999999999999999997543222111111 122345677899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
++++||.+||+.||.+||++.++++||||+...
T Consensus 238 ~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS 270 (284)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred HHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence 999999999999999999999999999998543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=388.62 Aligned_cols=259 Identities=24% Similarity=0.381 Sum_probs=217.8
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|.+..++..||+|++..... .....+.+|+.+|+.++||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--------~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 78 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--------EDVDRFKQEIEIMKSLDHPNIIRLYETFEDN 78 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC--------SCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc--------chHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 34679999999999999999999999999999999843221 1234578899999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe---CCCCceEEecCCchhh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV---DNKGCIKLADFGASKK 218 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl---d~~g~vKL~DFGlA~~ 218 (668)
...++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~ 158 (277)
T 3f3z_A 79 TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR 158 (277)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence 9999999999999999999888889999999999999999999999999999999999999 7889999999999876
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~l 297 (668)
+.. ........||+.|+|||++.+. ++.++|||||||++|+|++|..||...... ...................+
T Consensus 159 ~~~---~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (277)
T 3f3z_A 159 FKP---GKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNV 234 (277)
T ss_dssp CCT---TSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTS
T ss_pred ccC---ccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcC
Confidence 532 2233456799999999998654 899999999999999999999999764432 22222222211111112267
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 235 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 235 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 89999999999999999999999999999997543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=418.09 Aligned_cols=264 Identities=28% Similarity=0.483 Sum_probs=207.8
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|.+.+.||+|+||+||+|.+..+++.||||++..................+.+|+.+|+.++|||||++++++.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 568999999999999999999999999999999985433221122222333457889999999999999999999754 4
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC---ceEEecCCchhhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG---CIKLADFGASKKV 219 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g---~vKL~DFGlA~~~ 219 (668)
.+|+||||+++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++.+
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5899999999999999999889999999999999999999999999999999999999997544 5999999999865
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhh---cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCCCCCCCC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQ---TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTKSHPPIP 294 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~~~~~~p 294 (668)
... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ..............+..+
T Consensus 293 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 369 (419)
T 3i6u_A 293 GET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 369 (419)
T ss_dssp C--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred CCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence 432 22345789999999999864 5678899999999999999999999964321 122222222222222233
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
..++.++.+||.+||+.||.+|||+.++|+||||++
T Consensus 370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence 568999999999999999999999999999999975
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=399.04 Aligned_cols=261 Identities=31% Similarity=0.553 Sum_probs=200.0
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||+|+||+||+|.+..+|+.||||++...... .....+.+|+.+|+.++|||||++++++...+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 76 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-------GTPSTAIREISLMKELKHENIVRLYDVIHTEN 76 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT-------CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTT
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-------ccHHHHHHHHHHHHhcCCCCcceEEEEEEECC
Confidence 45799999999999999999999999999999998543211 11234678999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 143 SLNILLEFVPGGSISSLLGKF------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
.+|+||||++ |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++
T Consensus 77 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~ 155 (317)
T 2pmi_A 77 KLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155 (317)
T ss_dssp EEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccc
Confidence 9999999998 5898887543 45899999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccCCC----
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTTKS---- 289 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~~~---- 289 (668)
+.+.. ........+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ...+........
T Consensus 156 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 156 RAFGI--PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp EETTS--CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTC
T ss_pred eecCC--CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHh
Confidence 76532 12223456799999999999874 5899999999999999999999999754322 112211110000
Q ss_pred -------------------------CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 290 -------------------------HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 290 -------------------------~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
....+..++.++.+||.+||+.||.+|||+.|+|+||||+..+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH 302 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence 00112357889999999999999999999999999999987554
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=387.55 Aligned_cols=265 Identities=31% Similarity=0.539 Sum_probs=226.3
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
......+|++.+.||+|+||+||+|.+..+++.||+|++..... ........+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-----~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 84 (294)
T 2rku_A 10 DPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLL-----LKPHQREKMSMEISIHRSLAHQHVVGFHGFF 84 (294)
T ss_dssp ETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-----CSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred CCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhc-----cCHHHHHHHHHHHHHHHhCCCCCEeeeeeee
Confidence 34667889999999999999999999999999999999843221 1223446688899999999999999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
...+..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 164 (294)
T 2rku_A 85 EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK 164 (294)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred ccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCcee
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999999876
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccC
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls 298 (668)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... .+. .....++..++
T Consensus 165 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~--~~~~~~~~~~~ 239 (294)
T 2rku_A 165 VEYD--GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-RIK--KNEYSIPKHIN 239 (294)
T ss_dssp CCST--TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-HHH--TTCCCCCTTSC
T ss_pred cccC--ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHh--hccCCCccccC
Confidence 5321 122345679999999999999889999999999999999999999997643222111 111 12234567889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.++.+||.+||+.||.+|||+.++++||||+....
T Consensus 240 ~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 240 PVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp HHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 99999999999999999999999999999986554
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=386.20 Aligned_cols=270 Identities=27% Similarity=0.390 Sum_probs=224.8
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccch-hhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSA-SKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGT 137 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~-~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~ 137 (668)
.....+|++.+.||+|+||.||+|.+..+|+.||||++....... .........+.+.+|+.+|+.+. ||||++++++
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~ 92 (298)
T 1phk_A 13 HGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 92 (298)
T ss_dssp --CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred cchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeee
Confidence 456789999999999999999999999999999999985432111 11223345567889999999995 9999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
+......++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 93 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 172 (298)
T 1phk_A 93 YETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC 172 (298)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred eccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchh
Confidence 99999999999999999999999888899999999999999999999999999999999999999999999999999987
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHh------hcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCC
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVIL------QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSH 290 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~------~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~ 290 (668)
.+.. ........||+.|+|||++. ...++.++|||||||++|+|++|..||..... ..............
T Consensus 173 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1phk_A 173 QLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG 249 (298)
T ss_dssp ECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred hcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccC
Confidence 6532 22234567999999999986 34578899999999999999999999975432 22222222333333
Q ss_pred CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 291 ~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.+.+..++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 250 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 250 SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 334467899999999999999999999999999999998643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=398.01 Aligned_cols=266 Identities=29% Similarity=0.418 Sum_probs=222.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||.||+|++..+|..||||++.......... ......+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 86 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRR--GVSREEIEREVSILRQVLHHNVITLHDVYEN 86 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSS--SBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEeccccccccc--chhHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 44567999999999999999999999999999999985433221110 0123457889999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC----ceEEecCCch
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG----CIKLADFGAS 216 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g----~vKL~DFGlA 216 (668)
...+++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~ 166 (321)
T 2a2a_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (321)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence 999999999999999999998888899999999999999999999999999999999999999888 7999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~ 295 (668)
..+... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+...........+.
T Consensus 167 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 167 HEIEDG---VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp EECCTT---CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred eecCcc---ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 765332 2234567999999999999999999999999999999999999999754322 222222221111122235
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.++..+.+||.+||+.||.+|||+.++++||||+..
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 678999999999999999999999999999999753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=411.21 Aligned_cols=266 Identities=26% Similarity=0.417 Sum_probs=210.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||+||+|++..+++.||||++... .........+.+|+.+|+.++|+|||++++++..
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~------~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~ 96 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIP 96 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST------TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCC
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch------hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEec
Confidence 4567899999999999999999999999999999998422 1223345678899999999999999999999876
Q ss_pred C-----CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 141 D-----DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 141 ~-----~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
. ..+|+||||+. |+|.+++.....+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 97 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 97 DDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp SCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 6 56899999996 59999998888899999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhh--------------------cCCccCCCCCCCCChHHHh-hcCCCcchhHHHHHHHHHHHHhCCC-----
Q 005944 216 SKKVVELATI--------------------NGAKSMKGTPYWMAPEVIL-QTGHSFSADIWSVGCTVIEMATGKP----- 269 (668)
Q Consensus 216 A~~~~~~~~~--------------------~~~~~~~GT~~Y~APEvl~-~~~~s~ksDIWSLGvILyeLLTG~~----- 269 (668)
++........ ......+||+.|+|||++. +..|+.++||||||||||+|++|..
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 255 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND 255 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence 9866432211 1235678999999999974 5569999999999999999998544
Q ss_pred ------CCchh-------------------HHHHHHHHhhcc---------------------CCCCCC-----CCcccC
Q 005944 270 ------PWSQQ-------------------FQEVAALFHIGT---------------------TKSHPP-----IPEHLS 298 (668)
Q Consensus 270 ------PF~~~-------------------~~~~~~~~~~~~---------------------~~~~~~-----~p~~ls 298 (668)
+|.+. ...+..++.... .....+ ....++
T Consensus 256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 335 (432)
T 3n9x_A 256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS 335 (432)
T ss_dssp GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence 33221 111111111100 000111 113578
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
+++.+||.+||+.||.+|||++|+|+||||+....
T Consensus 336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 336 DDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred HHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 99999999999999999999999999999987543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=387.67 Aligned_cols=261 Identities=29% Similarity=0.423 Sum_probs=203.2
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
++...+|++.+.||+|+||+||+|.+..+|+.||||++.... ......+.+.++..+++.++||||+++++++.
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~ 76 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV------NSQEQKRLLMDLDISMRTVDCPFTVTFYGALF 76 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---------CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc------CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeee
Confidence 456789999999999999999999999999999999984321 12233344556666788899999999999999
Q ss_pred cCCcceEEeeccCCCChhcccc----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEecCC
Q 005944 140 EDDSLNILLEFVPGGSISSLLG----KFGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~----~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
..+..++||||+++ +|.+++. ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T 3fme_A 77 REGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFG 155 (290)
T ss_dssp CSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-
T ss_pred ccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecC
Confidence 99999999999975 7766654 356899999999999999999999998 99999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHH----hhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCC
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVI----LQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSH 290 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl----~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~ 290 (668)
+++...... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||...................
T Consensus 156 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 232 (290)
T 3fme_A 156 ISGYLVDDV---AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSP 232 (290)
T ss_dssp -----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCC
T ss_pred Ccccccccc---cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCC
Confidence 998664322 22345799999999997 45568999999999999999999999996422221222222222222
Q ss_pred CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 291 ~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
...+..++.++.+||.+||+.||.+|||+.++++||||+.
T Consensus 233 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~ 272 (290)
T 3fme_A 233 QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272 (290)
T ss_dssp CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence 3334578999999999999999999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=408.24 Aligned_cols=253 Identities=28% Similarity=0.413 Sum_probs=207.7
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceE
Q 005944 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNI 146 (668)
Q Consensus 67 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~L 146 (668)
...++||+|+||+||+|.+..+|..||||++.... ......+.+|+.+|+.++|||||++++++...+.++|
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 163 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--------MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL 163 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--------cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence 33678999999999999999999999999984321 1233567899999999999999999999999999999
Q ss_pred EeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe--CCCCceEEecCCchhhhHhhh
Q 005944 147 LLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV--DNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 147 VmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl--d~~g~vKL~DFGlA~~~~~~~ 223 (668)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+++.+...
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~- 242 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR- 242 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT-
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCc-
Confidence 99999999999888554 469999999999999999999999999999999999999 56789999999999865332
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+..............++.++.
T Consensus 243 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 320 (373)
T 2x4f_A 243 --EKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320 (373)
T ss_dssp --CBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHH
T ss_pred --cccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHH
Confidence 2234567999999999999888999999999999999999999999754322 2222222222222223356899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 303 DFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 303 dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+||.+||+.||.+|||+.|+|+||||+.
T Consensus 321 ~li~~~L~~dp~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 321 EFISKLLIKEKSWRISASEALKHPWLSD 348 (373)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHHSHHHHC
T ss_pred HHHHHHcCCChhhCCCHHHHhcCcCcCC
Confidence 9999999999999999999999999975
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=405.03 Aligned_cols=263 Identities=26% Similarity=0.443 Sum_probs=221.5
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccCC
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDD 142 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~~ 142 (668)
.+|++.+.||+|+||+||+|++..+|+.||||++................+.+.+|+.+++.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 479999999999999999999999999999999865433223333445567788999999999 7999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
..|+||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+||||+.+|.+||+|||++..+...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998765432
Q ss_pred hhhcCCccCCCCCCCCChHHHhhc------CCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCc
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQT------GHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~------~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~ 295 (668)
......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ....+.........+.+.
T Consensus 254 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 330 (365)
T 2y7j_A 254 ---EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330 (365)
T ss_dssp ---CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred ---cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence 223457899999999999743 5788999999999999999999999754322 222222222222222234
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
.++.++.+||.+||+.||.+|||+.++|+||||+
T Consensus 331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 6788999999999999999999999999999996
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=424.10 Aligned_cols=264 Identities=28% Similarity=0.428 Sum_probs=223.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.++||+|+||+||+|++..+|+.||||++....... ......+.+|+.+|+.++|||||++++++.
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 96 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQ-----KTDKESLLREVQLLKQLDHPNIMKLYEFFE 96 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCB-----SSCHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhccc-----chHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 355678999999999999999999999999999999984332111 112356788999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe---CCCCceEEecCCch
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV---DNKGCIKLADFGAS 216 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl---d~~g~vKL~DFGlA 216 (668)
....+|+|||||.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 97 DKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred eCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999999999999888899999999999999999999999999999999999999 56789999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~ 295 (668)
+.+... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||..... .....+.........+.+.
T Consensus 177 ~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 252 (484)
T 3nyv_A 177 THFEAS---KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWK 252 (484)
T ss_dssp HHBCCC---CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGG
T ss_pred EEcccc---cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccc
Confidence 765321 12234679999999999876 699999999999999999999999975432 3333333333333344456
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.++.++++||.+||+.||.+|||+.++|+||||+...
T Consensus 253 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 253 KVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp GSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 7899999999999999999999999999999998643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=421.04 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=223.2
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|.+++.||+|+||+||+|++..+|+.||||++.... .........+.+|+.+|+.++||||+++++++.
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~-----~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~ 86 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQK-----IRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHH-----HHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhh-----ccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 355678999999999999999999999999999999984211 111123456889999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
....+|+|||||++|+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++...
T Consensus 87 ~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~ 166 (476)
T 2y94_A 87 TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166 (476)
T ss_dssp CSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred ECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999999865
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCccc
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~l 297 (668)
... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... .....+.. .....+..+
T Consensus 167 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~----~~~~~p~~~ 239 (476)
T 2y94_A 167 SDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICD----GIFYTPQYL 239 (476)
T ss_dssp CTT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHT----TCCCCCTTC
T ss_pred ccc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc----CCcCCCccC
Confidence 332 22346789999999999998775 7899999999999999999999975432 22222211 123456678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++++.+||.+||+.||.+|||+.+|++||||+..
T Consensus 240 s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 9999999999999999999999999999999854
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=400.12 Aligned_cols=261 Identities=32% Similarity=0.506 Sum_probs=219.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
+....+|++.+.||+|+||+||+|.+..++..||+|++.... .......+.+|+.+|+.++||||+++++++.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 101 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-------KPAIRNQIIRELQVLHECNSPYIVGFYGAFY 101 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-------CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-------CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEE
Confidence 466789999999999999999999999999999999985321 2334566889999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
..+.+++||||+++++|.+++...+.+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||+|||++..
T Consensus 102 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 102 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp ETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred ECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999999999999998888999999999999999999999996 999999999999999999999999999986
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHh---------------
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH--------------- 283 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~--------------- 283 (668)
+... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............
T Consensus 182 ~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (360)
T 3eqc_A 182 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 257 (360)
T ss_dssp HHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred cccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence 6432 234568999999999999999999999999999999999999999643221111100
Q ss_pred --------------------------hccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 284 --------------------------IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 284 --------------------------~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.............++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 000111111223578899999999999999999999999999999854
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-47 Score=400.77 Aligned_cols=259 Identities=31% Similarity=0.422 Sum_probs=212.5
Q ss_pred CCCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-----CCC
Q 005944 56 IEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-----HPN 130 (668)
Q Consensus 56 ~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----HpN 130 (668)
+..+.....+|++.+.||+|+||+||+|++..+++.||||++.. .......+..|+.+|+.+. |||
T Consensus 27 ~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~h~~ 97 (360)
T 3llt_A 27 WKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN---------IKKYTRSAKIEADILKKIQNDDINNNN 97 (360)
T ss_dssp CCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---------CHHHHHHHHHHHHHHHHTCCCSTTGGG
T ss_pred eecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc---------chhhhhhhHHHHHHHHHhcccCCCCCC
Confidence 34456778899999999999999999999999999999999831 1223345677999999996 999
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC----
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---- 204 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---- 204 (668)
||++++++...+.+++||||+ +++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 98 iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 98 IVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp BCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred eecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence 999999999999999999999 899999997653 5999999999999999999999999999999999999975
Q ss_pred ---------------------CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHH
Q 005944 205 ---------------------KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIE 263 (668)
Q Consensus 205 ---------------------~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILye 263 (668)
++.+||+|||+++... ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS-----DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT-----SCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecC-----CCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 7899999999997532 22345789999999999999999999999999999999
Q ss_pred HHhCCCCCchhHHH--HHHHHhhccCC---------------------CCCCC--------------------CcccCHH
Q 005944 264 MATGKPPWSQQFQE--VAALFHIGTTK---------------------SHPPI--------------------PEHLSME 300 (668)
Q Consensus 264 LLTG~~PF~~~~~~--~~~~~~~~~~~---------------------~~~~~--------------------p~~ls~e 300 (668)
|++|+.||...... ...+....... ....+ ....+..
T Consensus 252 ll~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHEL 331 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHH
T ss_pred HHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHH
Confidence 99999999643221 11111110000 00000 1122477
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
+.+||.+||+.||.+|||+.|+|+||||+
T Consensus 332 l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 332 FCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 88999999999999999999999999995
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=418.75 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=203.8
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++++.||+|+||+||+|.+..+++.||||++... .........+.+|+.+|+.++|||||++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~------~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 134 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK 134 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG------GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc------ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCC
Confidence 57899999999999999999999999999999998432 123344567889999999999999999999986554
Q ss_pred ------cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 143 ------SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 143 ------~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
.+||||||+.++ |...+.. .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 135 ~~~~~~~~~lv~E~~~~~-l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 135 TLEEFQDVYLVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp STTTCCEEEEEEECCSEE-HHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred ccccCCeEEEEEeCCCCC-HHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence 469999999864 6555543 5999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCC------
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTK------ 288 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~------ 288 (668)
+.... .......+||+.|+|||++.+..|+.++||||||||||+|++|++||.+.. .....+.......
T Consensus 212 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~ 288 (464)
T 3ttj_A 212 RTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 288 (464)
T ss_dssp --------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHT
T ss_pred eecCC---CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 86533 223456789999999999999999999999999999999999999997532 1111111110000
Q ss_pred ----------------CCCC----CCc-----------ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 289 ----------------SHPP----IPE-----------HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 289 ----------------~~~~----~p~-----------~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.... ++. ..+.++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 0000 011 115679999999999999999999999999999854
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=399.00 Aligned_cols=266 Identities=24% Similarity=0.406 Sum_probs=214.9
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||+||+|++..+++.||||++.... .........+.+|+.+++.++|||||++++++.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 82 (311)
T 3ork_A 8 SHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADL-----ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 82 (311)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTT-----TTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEE
T ss_pred ceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccc-----cCCHHHHHHHHHHHHHHHcCCCCCcceEEEeee
Confidence 456789999999999999999999999999999999984321 123345567889999999999999999999987
Q ss_pred cCCcc----eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 140 EDDSL----NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 140 ~~~~~----~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
..... |+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 83 AETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 76554 99999999999999998888999999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhh-hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhcc-CCCCCCC
Q 005944 216 SKKVVELAT-INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT-TKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~-~~~~~~~ 293 (668)
++.+..... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||............... .......
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence 986643222 12233467999999999999999999999999999999999999999765433222211111 1111112
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
...++.++.+||.+||+.||.+||++.+++.|+|++.
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 3468999999999999999999999999999999974
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=395.90 Aligned_cols=258 Identities=27% Similarity=0.375 Sum_probs=205.8
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHh-CCCCCeeeecc
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN-LTHPNIVRYLG 136 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIV~l~g 136 (668)
..+....+|++.++||+|+||+||+|++..+|+.||||++...... .........|+..+.. ..|+|||++++
T Consensus 51 ~~~~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~~~~~~~h~~iv~l~~ 124 (311)
T 3p1a_A 51 PESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRG------PKDRARKLAEVGSHEKVGQHPCCVRLEQ 124 (311)
T ss_dssp SSCHHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCS------HHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccC------hHHHHHHHHHHHHHHHhcCCCcEEEEEE
Confidence 3344557899999999999999999999999999999987432111 1122233445544444 49999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++.....+|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~ 203 (311)
T 3p1a_A 125 AWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL 203 (311)
T ss_dssp EEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTT
T ss_pred EEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEcccee
Confidence 999999999999999 66888877654 4699999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCc
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~ 295 (668)
+...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||..... .. .+........++.
T Consensus 204 a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-~~---~~~~~~~~~~~~~ 275 (311)
T 3p1a_A 204 LVELGTA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-WQ---QLRQGYLPPEFTA 275 (311)
T ss_dssp CEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-HH---HHTTTCCCHHHHT
T ss_pred eeecccC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-HH---HHhccCCCccccc
Confidence 8765332 22345679999999999876 799999999999999999999766644321 11 1111222223445
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.++.++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 276 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 276 GLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 78999999999999999999999999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=421.13 Aligned_cols=260 Identities=29% Similarity=0.446 Sum_probs=217.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..++..||||++...... ......+.+|+.+|+.++|||||++++++..
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~------~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 107 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS------TSSNSKLLEEVAVLKLLDHPNIMKLYDFFED 107 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----------CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC------chHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence 3445799999999999999999999999999999998533211 1123457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC---CceEEecCCchh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK---GCIKLADFGASK 217 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~---g~vKL~DFGlA~ 217 (668)
...+|+|||||.+|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.. +.+||+|||++.
T Consensus 108 ~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 108 KRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 99999999999999999999888899999999999999999999999999999999999999764 559999999997
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ 296 (668)
.+.. .......+||+.|+|||++. ..|+.++|||||||++|+|++|.+||..... +....+.........+.+..
T Consensus 188 ~~~~---~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 263 (494)
T 3lij_A 188 VFEN---QKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN 263 (494)
T ss_dssp ECBT---TBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTT
T ss_pred ECCC---CccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhccc
Confidence 6533 22344678999999999986 4699999999999999999999999975433 33333333333333444567
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
++.++++||.+||+.||.+|||+.++|+||||+.
T Consensus 264 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred CCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 8999999999999999999999999999999975
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=386.57 Aligned_cols=262 Identities=37% Similarity=0.615 Sum_probs=214.9
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||+||+|.+..++..||+|++... .......+.+|+.+|+.++||||+++++++.
T Consensus 15 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 86 (302)
T 2j7t_A 15 LDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--------SEEELEDYIVEIEILATCDHPYIVKLLGAYY 86 (302)
T ss_dssp SCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------------CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--------CHHHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence 35667899999999999999999999999999999998432 1122456788999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
..+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred eCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 99999999999999999998865 46799999999999999999999999999999999999999999999999999875
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHh-----hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCC
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~ 293 (668)
..... .......||+.|+|||++. +..++.++|||||||++|+|++|..||......................
T Consensus 167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T 2j7t_A 167 NLKTL--QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT 244 (302)
T ss_dssp HHHHH--HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS
T ss_pred ccccc--cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCC
Confidence 43322 2234567999999999984 5568899999999999999999999997543222111111112222234
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
+..++.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 282 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence 56789999999999999999999999999999999753
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=406.24 Aligned_cols=258 Identities=23% Similarity=0.350 Sum_probs=218.1
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|++..+++.||||++..................+.+|+.+|+.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 34689999999999999999999999999999999854322111000001123456799999999999999999999999
Q ss_pred CcceEEeeccCCC-ChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 142 DSLNILLEFVPGG-SISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 142 ~~~~LVmEy~~gG-sL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
..+++||||+.+| +|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 9999999999776 999999988899999999999999999999999999999999999999999999999999997653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||..... ........+..++.
T Consensus 182 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------~~~~~~~~~~~~~~ 249 (335)
T 3dls_A 182 RG---KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------TVEAAIHPPYLVSK 249 (335)
T ss_dssp TT---CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG---------GTTTCCCCSSCCCH
T ss_pred CC---CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH---------HHhhccCCCcccCH
Confidence 32 22345679999999999998876 7899999999999999999999975321 11222344566899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++.+||.+||+.||.+|||+.++++||||+..
T Consensus 250 ~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred HHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 99999999999999999999999999999753
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=381.89 Aligned_cols=252 Identities=26% Similarity=0.389 Sum_probs=211.3
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTARE 140 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~ 140 (668)
...+|++.+.||+|+||+||+|.+..+++.||||++...... ......+.+|+.++..+ +||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG------SVDEQNALREVYAHAVLGQHSHVVRYFSAWAE 82 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT------SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc------cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 346799999999999999999999999999999998533211 12234567899999999 99999999999999
Q ss_pred CCcceEEeeccCCCChhcccccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-----------
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF----GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK----------- 205 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~----~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~----------- 205 (668)
.+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 99999999999999999999765 679999999999999999999999999999999999999844
Q ss_pred --------CceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH
Q 005944 206 --------GCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ 276 (668)
Q Consensus 206 --------g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~ 276 (668)
..+||+|||++..... .....||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.....
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp -------CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred cccccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 4799999999876432 2345699999999999876 466899999999999999999988754322
Q ss_pred HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 277 EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 277 ~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
...+ . ......++..++.++.+||.+||+.||.+|||+.++++||||+.
T Consensus 237 -~~~~-~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 285 (289)
T 1x8b_A 237 -WHEI-R---QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285 (289)
T ss_dssp -HHHH-H---TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred -HHHH-H---cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence 1111 1 22334567789999999999999999999999999999999975
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=390.61 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=220.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+|+.||||++.... ......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 77 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--------AFRDSSLENEIAVLKKIKHENIVTLEDIYES 77 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------------HHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--------ccchHHHHHHHHHHHhCCCCCeeehhhhccc
Confidence 34568999999999999999999999999999999985321 1122457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe---CCCCceEEecCCchh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV---DNKGCIKLADFGASK 217 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl---d~~g~vKL~DFGlA~ 217 (668)
...+|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~ 157 (304)
T 2jam_A 78 TTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK 157 (304)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTC
T ss_pred CCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcce
Confidence 99999999999999999999888889999999999999999999999999999999999999 778999999999987
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ 296 (668)
.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+.........+.+..
T Consensus 158 ~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (304)
T 2jam_A 158 MEQN----GIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDD 233 (304)
T ss_dssp CCCC----BTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTT
T ss_pred ecCC----CccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccccc
Confidence 5321 112345699999999999988899999999999999999999999975432 22233333333334455678
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++.++.+||.+||+.||.+|||+.++++||||++.
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 234 ISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 89999999999999999999999999999999864
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=412.06 Aligned_cols=254 Identities=28% Similarity=0.423 Sum_probs=205.1
Q ss_pred CCCeeee-eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHH-HhCCCCCeeeecccccc
Q 005944 63 PIRWRKG-ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLL-KNLTHPNIVRYLGTARE 140 (668)
Q Consensus 63 ~~ry~i~-~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpNIV~l~g~~~~ 140 (668)
..+|.+. ++||+|+||+||+|.+..+|+.||||++... ..+.+|+.++ +..+|||||++++++..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------------~~~~~E~~~~~~~~~hp~iv~l~~~~~~ 126 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYEN 126 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------------hhHHHHHHHHHHhcCCCCcceEeEEEee
Confidence 3467776 7999999999999999999999999998311 1345677776 45589999999998865
Q ss_pred ----CCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC---CCceEEe
Q 005944 141 ----DDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---KGCIKLA 211 (668)
Q Consensus 141 ----~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---~g~vKL~ 211 (668)
...+|||||||+||+|.+++...+ .+++..++.|+.||+.||.|||++||+||||||+||||+. ++.+||+
T Consensus 127 ~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 127 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred cccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEE
Confidence 567899999999999999997753 5999999999999999999999999999999999999997 7899999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-----HHHHHHhhcc
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-----EVAALFHIGT 286 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-----~~~~~~~~~~ 286 (668)
|||+++..... ......+||+.|+|||++.+..|+.++||||||||||+|++|..||..... .....+....
T Consensus 207 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~ 283 (400)
T 1nxk_A 207 DFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 283 (400)
T ss_dssp CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred ecccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence 99999864322 223467899999999999988999999999999999999999999964321 1222223333
Q ss_pred CCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 287 ~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.....+.+..++.++.+||.+||+.||.+|||+.+|++||||....
T Consensus 284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 3333344567899999999999999999999999999999997543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=395.82 Aligned_cols=264 Identities=29% Similarity=0.491 Sum_probs=210.5
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||+|+||.||+|++..+++.||||++..................+.+|+.+|+.++||||+++++++....
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 45799999999999999999999999999999998533211111122233445788999999999999999999987655
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc---eEEecCCchhhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC---IKLADFGASKKV 219 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~---vKL~DFGlA~~~ 219 (668)
+|+||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++...
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 167 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEEC
T ss_pred -eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceec
Confidence 8999999999999999988889999999999999999999999999999999999999987664 999999998765
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCCCCCCCC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTKSHPPIP 294 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~~~~~~p 294 (668)
..... .....||+.|+|||++. ...++.++|||||||++|+|++|..||..... .....+........+..+
T Consensus 168 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T 2ycf_A 168 GETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244 (322)
T ss_dssp CCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred ccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence 32211 12356899999999985 45688999999999999999999999964321 122222222222222233
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
..++.++.+||.+||+.||.+||++.++|+||||+.
T Consensus 245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 567899999999999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=401.86 Aligned_cols=259 Identities=29% Similarity=0.481 Sum_probs=209.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++..
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 95 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF------QSELFAKRAYRELRLLKHMRHENVIGLLDVFTP 95 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECS
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc------cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEec
Confidence 34578999999999999999999999999999999884321 223345668899999999999999999999876
Q ss_pred CC------cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 141 DD------SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 141 ~~------~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
.. .+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 96 DETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred CCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeee
Confidence 53 469999999 7899999876 679999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhcc-----
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGT----- 286 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~----- 286 (668)
+++... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||..... ....+.....
T Consensus 174 ~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~ 248 (367)
T 1cm8_A 174 LARQAD-----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248 (367)
T ss_dssp TCEECC-----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cccccc-----cccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 998642 22445789999999999987 6799999999999999999999999974321 1111111100
Q ss_pred ---------------------CCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 287 ---------------------TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 287 ---------------------~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
......+...+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0011123346789999999999999999999999999999998643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=420.06 Aligned_cols=270 Identities=28% Similarity=0.394 Sum_probs=221.1
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchh-----hHhhHHHHHHHHHHHHHHHhCCCCCeeee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSAS-----KEKTQAHIRELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~-----~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l 134 (668)
.....+|++.+.||+|+||+||+|.+..++..||||++........ ........+.+.+|+.+|+.++|||||++
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~ 111 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKL 111 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCE
T ss_pred CCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeE
Confidence 3556789999999999999999999999999999999854321110 00111234568899999999999999999
Q ss_pred ccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC---ceEEe
Q 005944 135 LGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG---CIKLA 211 (668)
Q Consensus 135 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g---~vKL~ 211 (668)
++++.....+|+|||||++|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+
T Consensus 112 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~ 191 (504)
T 3q5i_A 112 FDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIV 191 (504)
T ss_dssp EEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEEC
T ss_pred EEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEE
Confidence 999999999999999999999999998888999999999999999999999999999999999999998876 69999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCC
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSH 290 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~ 290 (668)
|||+++.+... ......+||+.|+|||++. ..++.++|||||||++|+|++|.+||..... .....+........
T Consensus 192 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 267 (504)
T 3q5i_A 192 DFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267 (504)
T ss_dssp CCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred ECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99999865332 2344578999999999987 4689999999999999999999999976432 33333333322222
Q ss_pred CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 291 ~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.+.+..++.++++||.+||+.||.+|||+.|+|+||||+....
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred ccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 2333578999999999999999999999999999999986543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=396.04 Aligned_cols=260 Identities=29% Similarity=0.472 Sum_probs=205.3
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|++..+++.||||++..... ......+.+|+.+|+.++||||+++++++.....
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 74 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-------EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKS 74 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-------cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCE
Confidence 479999999999999999999999999999999843211 1111234569999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
+++||||+.+ +|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.....
T Consensus 75 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 153 (324)
T 3mtl_A 75 LTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP 153 (324)
T ss_dssp EEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred EEEEeccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence 9999999975 888887654 45999999999999999999999999999999999999999999999999998754322
Q ss_pred hhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccCCCCCC-------
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTTKSHPP------- 292 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~~~~~~------- 292 (668)
.......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...+...........
T Consensus 154 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (324)
T 3mtl_A 154 --TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred --ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence 122334678999999999987 56899999999999999999999999754322 112222111111000
Q ss_pred ------------------CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 293 ------------------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 293 ------------------~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
....++.++.+||.+||+.||.+|||+.|+|+||||.....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 11346889999999999999999999999999999986543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=385.11 Aligned_cols=259 Identities=28% Similarity=0.551 Sum_probs=196.2
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||+|+||+||+|++..+|+.||||++.... .........+.+|+.+++.++||||+++++++...+
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKA-----MYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSN 84 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSS
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhh-----hhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCC
Confidence 357999999999999999999999999999999984211 111123456889999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 85 YVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 999999999999999998765 6799999999999999999999999999999999999999999999999999876532
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
.. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .... .......+..++.++
T Consensus 165 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~ 239 (278)
T 3cok_A 165 PH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-LNKV--VLADYEMPSFLSIEA 239 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------C--CSSCCCCCTTSCHHH
T ss_pred CC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-HHHH--hhcccCCccccCHHH
Confidence 11 122346799999999999988899999999999999999999999964321100 0011 112234567789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.+||.+||+.||.+|||+.++++||||...
T Consensus 240 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 240 KDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 999999999999999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=402.93 Aligned_cols=259 Identities=25% Similarity=0.439 Sum_probs=217.3
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEc-------CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CC
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNL-------DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-TH 128 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~-------~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~H 128 (668)
........+|++++.||+|+||+||+|.+. .++..||||++... ........+.+|+.+|+.+ +|
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h 146 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-------ATEKDLSDLVSEMEMMKMIGKH 146 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-------CBHHHHHHHHHHHHHHHHSCCC
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-------cCHHHHHHHHHHHHHHHHhcCC
Confidence 334566789999999999999999999875 34568999998422 1234456788999999999 89
Q ss_pred CCeeeeccccccCCcceEEeeccCCCChhcccccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 005944 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG----------------SFPESVIRMYTKQLLLGLEYLHKNGIMH 192 (668)
Q Consensus 129 pNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIvH 192 (668)
||||++++++...+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+|
T Consensus 147 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 226 (370)
T 2psq_A 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 226 (370)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 999999999999999999999999999999987643 4789999999999999999999999999
Q ss_pred ccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCC
Q 005944 193 RDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPW 271 (668)
Q Consensus 193 rDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF 271 (668)
|||||+||||+.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|+|+| |..||
T Consensus 227 rDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~ 306 (370)
T 2psq_A 227 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 306 (370)
T ss_dssp SCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCC
Confidence 99999999999999999999999986544333333445667899999999999999999999999999999999 99999
Q ss_pred chhH-HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 272 SQQF-QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 272 ~~~~-~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.... .+...... .......+..++.++.+||.+||+.||.+||++.|++++
T Consensus 307 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 307 PGIPVEELFKLLK---EGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TTCCGGGHHHHHH---TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHh---cCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7542 22222222 223445677899999999999999999999999999974
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=381.22 Aligned_cols=260 Identities=26% Similarity=0.431 Sum_probs=213.4
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||.||+|.+..+|+.||||++... ..........+.+|+.+++.++||||+++++++.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 81 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQ-----KIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHH-----HHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccc-----cccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe
Confidence 35567899999999999999999999999999999998421 1111223456789999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.....|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 82 TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 99999999999999999999988888999999999999999999999999999999999999999999999999998765
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCccc
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~l 297 (668)
.... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||...... ....... .....+..+
T Consensus 162 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~ 234 (276)
T 2h6d_A 162 SDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG----GVFYIPEYL 234 (276)
T ss_dssp CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCTTS
T ss_pred CCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc----CcccCchhc
Confidence 3321 1234578999999999988765 68999999999999999999999754322 2222221 123456678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
+.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 235 ~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 9999999999999999999999999999999854
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=388.41 Aligned_cols=264 Identities=24% Similarity=0.428 Sum_probs=216.2
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||+||+|.+..++..||||++..... ........+.+|+.++..++||||+++++++.
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~ 81 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPR-----EKEETLKRFEREVHNSSQLSHQNIVSMIDVDE 81 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSS-----CCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCcc-----ccHHHHHHHHHHHHHHhcCCCCCCceEEEeee
Confidence 4667899999999999999999999999999999999854322 22344567889999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
..+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus 82 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 82 EDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred eCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999999865
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCC--CCCCCccc
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS--HPPIPEHL 297 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~--~~~~p~~l 297 (668)
.... .......+||+.|+|||++.+..++.++|||||||++|+|+||+.||.................. ....+..+
T Consensus 162 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T 4eqm_A 162 SETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI 240 (294)
T ss_dssp --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred cccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCC
Confidence 4322 22234567999999999999999999999999999999999999999765433222222211111 11234568
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
+..+.++|.+||+.||.+||+..+.+.+.|..
T Consensus 241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 89999999999999999999666666666643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=389.23 Aligned_cols=260 Identities=36% Similarity=0.639 Sum_probs=213.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.+|+.++||||+++++++.
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----------~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 94 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----------DLQEIIKEISIMQQCDSPHVVKYYGSYF 94 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----------CCHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----------HHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence 456788999999999999999999999999999999984321 1245778999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~-~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
....+|+||||+++++|.+++. ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 95 KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp ETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 9999999999999999999986 456799999999999999999999999999999999999999999999999999976
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccC
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls 298 (668)
+... ........||+.|+|||++.+..++.++|||||||++|+|++|..||......................+..++
T Consensus 175 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (314)
T 3com_A 175 LTDT--MAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWS 252 (314)
T ss_dssp CBTT--BSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSC
T ss_pred hhhh--ccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCC
Confidence 5322 12234567999999999999988999999999999999999999999754332222211122222233456789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.++.+||.+||..||.+|||+.++++||||+..
T Consensus 253 ~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~ 285 (314)
T 3com_A 253 DNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA 285 (314)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence 999999999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=429.38 Aligned_cols=258 Identities=29% Similarity=0.461 Sum_probs=221.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||.||+|++..+|+.||||++.... .........+.+|+.+|..++|||||++++++.+
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~-----~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR-----IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHh-----hhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 56678999999999999999999999999999999984321 1111223457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.+.+||||||++||+|.+++...+ .+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999999999987654 499999999999999999999999999999999999999999999999999986
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-----HHHHHHHhhccCCCCCCC
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-----QEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-----~~~~~~~~~~~~~~~~~~ 293 (668)
+.... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.... ..+...... ....+
T Consensus 336 ~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----~~~~~ 408 (576)
T 2acx_A 336 VPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----VPEEY 408 (576)
T ss_dssp CCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----CCCCC
T ss_pred cccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----ccccC
Confidence 53321 2345689999999999999889999999999999999999999997532 222222221 23345
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
+..++.++++||.+||+.||.+|| ++.||++||||++
T Consensus 409 p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 409 SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 678999999999999999999999 8999999999975
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=392.55 Aligned_cols=263 Identities=25% Similarity=0.335 Sum_probs=218.2
Q ss_pred CCCCCeeee-eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccc
Q 005944 61 APPIRWRKG-ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTA 138 (668)
Q Consensus 61 ~~~~ry~i~-~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~ 138 (668)
....+|.+. +.||+|+||+||+|++..+++.||||++....... .....+.+|+.++..+ +||||+++++++
T Consensus 25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~~~~~iv~~~~~~ 98 (327)
T 3lm5_A 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ------DCRAEILHEIAVLELAKSCPRVINLHEVY 98 (327)
T ss_dssp HHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE------ECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred hhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch------HHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 455678887 89999999999999999999999999985432211 1234577899999999 469999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC---CCceEEecC
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---KGCIKLADF 213 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---~g~vKL~DF 213 (668)
.....+++||||+.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+||
T Consensus 99 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Df 178 (327)
T 3lm5_A 99 ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDF 178 (327)
T ss_dssp ECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCG
T ss_pred EeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeC
Confidence 9999999999999999999998553 67999999999999999999999999999999999999988 789999999
Q ss_pred CchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCC
Q 005944 214 GASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPP 292 (668)
Q Consensus 214 GlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~ 292 (668)
|+++.+.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...............
T Consensus 179 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 255 (327)
T 3lm5_A 179 GMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEE 255 (327)
T ss_dssp GGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred ccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCch
Confidence 9998654322 233567999999999999999999999999999999999999999754322 222223333334445
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.+..++..+.+||.+||+.||.+|||+.++|+||||+...
T Consensus 256 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~ 295 (327)
T 3lm5_A 256 TFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD 295 (327)
T ss_dssp TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred hhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence 5567899999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=397.85 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=208.7
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc-
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE- 140 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~- 140 (668)
...+|++.+.||+|+||+||+|++..+|+.||||++....... .....+.+|+.+|+.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 88 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE------GFPITALREIKILQLLKHENVVNLIEICRTK 88 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS------SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc------cchHHHHHHHHHHHhccCCCcccHhheeecc
Confidence 3468999999999999999999999999999999885432211 112345689999999999999999998876
Q ss_pred -------CCcceEEeeccCCCChhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEec
Q 005944 141 -------DDSLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLAD 212 (668)
Q Consensus 141 -------~~~~~LVmEy~~gGsL~~~L~-~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~D 212 (668)
.+.+|+||||+.+ +|...+. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 89 ~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~D 167 (351)
T 3mi9_A 89 ASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLAD 167 (351)
T ss_dssp --------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECC
T ss_pred ccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence 3468999999986 5655554 446799999999999999999999999999999999999999999999999
Q ss_pred CCchhhhHhhh--hhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHHH--HHHHhhccC
Q 005944 213 FGASKKVVELA--TINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQEV--AALFHIGTT 287 (668)
Q Consensus 213 FGlA~~~~~~~--~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~--~~~~~~~~~ 287 (668)
||+++.+.... ........+||+.|+|||++.+. .++.++|||||||++|+|++|.+||....... ..+......
T Consensus 168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 247 (351)
T 3mi9_A 168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS 247 (351)
T ss_dssp CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99997653211 12223456789999999999864 58999999999999999999999997543221 111111111
Q ss_pred CCCCCCCc---------------------------ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 288 KSHPPIPE---------------------------HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 288 ~~~~~~p~---------------------------~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
......+. ..++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 248 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp CCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred CChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence 11110110 1267899999999999999999999999999998644
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=383.95 Aligned_cols=263 Identities=29% Similarity=0.437 Sum_probs=216.6
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||+|+||+||+|++..+++.||||++......... .......+.+|+.+|+.++||||+++++++....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSR--RGVSREEIEREVNILREIRHPNIITLHDIFENKT 81 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccc--cchHHHHHHHHHHHHHhCCCCCeeehhheecCCC
Confidence 35799999999999999999999999999999998543322111 0112346788999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC----ceEEecCCchhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG----CIKLADFGASKK 218 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g----~vKL~DFGlA~~ 218 (668)
..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~ 161 (283)
T 3bhy_A 82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK 161 (283)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence 9999999999999999998888899999999999999999999999999999999999998877 899999999976
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~l 297 (668)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+...........+..+
T Consensus 162 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 162 IEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp CC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred ccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 53322 233467999999999999889999999999999999999999999754332 22222222211122223467
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+..+.+||.+||..||.+||++.++++||||+.
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~ 271 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA 271 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence 889999999999999999999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=396.42 Aligned_cols=262 Identities=28% Similarity=0.443 Sum_probs=212.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 95 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD------DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK 95 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS------SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC------CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec
Confidence 34568999999999999999999999999999999884322 222344567889999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
....++||||+++++|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 96 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 96 KKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp TTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred CCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99999999999999999988877889999999999999999999999999999999999999999999999999997654
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhcc-----------
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGT----------- 286 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~----------- 286 (668)
... .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... ...+.....
T Consensus 176 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 176 APG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHH
T ss_pred CCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhh
Confidence 322 223456799999999999875 6899999999999999999999999754321 111111000
Q ss_pred ------CCCCCC---------CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 287 ------TKSHPP---------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 287 ------~~~~~~---------~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
....+. ....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 000000 11257899999999999999999999999999999974
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=432.19 Aligned_cols=261 Identities=25% Similarity=0.388 Sum_probs=222.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|++.++||+|+||+||+|++..+++.||||++.... .........+..|..+|..+ +||||+.+++++.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~-----~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~ 412 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDV-----VIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ 412 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHH-----HHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccc-----cccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE
Confidence 34568999999999999999999999999999999985321 11122345567899999987 7999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
+.+.+||||||++||+|..++...+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+++..
T Consensus 413 ~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 413 TMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred eCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999999753
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.. ........+||+.|+|||++.+..|+.++||||||||||||++|.+||............. .....++..++.
T Consensus 493 ~~--~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~---~~~~~~p~~~s~ 567 (674)
T 3pfq_A 493 IW--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM---EHNVAYPKSMSK 567 (674)
T ss_dssp CC--TTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---SSCCCCCTTSCH
T ss_pred cc--CCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH---hCCCCCCccCCH
Confidence 21 1223456889999999999999999999999999999999999999997654322111111 223456778999
Q ss_pred HHHHHHHHhhhhCCCCCCCH-----HHHHcCccccCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTA-----SELLQHPFVTGK 331 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa-----~EIL~Hpwf~~~ 331 (668)
++.+||.+||+.||.+||++ +||++||||++.
T Consensus 568 ~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 99999999999999999997 999999999863
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=389.33 Aligned_cols=269 Identities=22% Similarity=0.388 Sum_probs=196.9
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCc---EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~---~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
......+|++.+.||+|+||+||+|++..++. .||||++.... ......+.+.+|+.+++.++||||++++
T Consensus 18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 91 (323)
T 3qup_A 18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI------IASSDIEEFLREAACMKEFDHPHVAKLV 91 (323)
T ss_dssp TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------------CHHHHHHHHHHHHHTTCCCTTBCCCC
T ss_pred cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccc------cCHHHHHHHHHHHHHHHHCCCCceehhh
Confidence 34677899999999999999999999877765 89999884321 1223356788999999999999999999
Q ss_pred cccccCCcc------eEEeeccCCCChhcccccCC------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC
Q 005944 136 GTAREDDSL------NILLEFVPGGSISSLLGKFG------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD 203 (668)
Q Consensus 136 g~~~~~~~~------~LVmEy~~gGsL~~~L~~~~------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld 203 (668)
+++...... ++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+
T Consensus 92 ~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~ 171 (323)
T 3qup_A 92 GVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA 171 (323)
T ss_dssp EEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEc
Confidence 998877655 99999999999999985432 599999999999999999999999999999999999999
Q ss_pred CCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHH
Q 005944 204 NKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAAL 281 (668)
Q Consensus 204 ~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~ 281 (668)
.++.+||+|||+++.+.............+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... ....
T Consensus 172 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~ 251 (323)
T 3qup_A 172 EDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251 (323)
T ss_dssp TTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH
T ss_pred CCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHH
Confidence 999999999999987654433333344567889999999999999999999999999999999 99999754322 1111
Q ss_pred HhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCC-------HHHHHcCccccCCCCCCC
Q 005944 282 FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRST-------ASELLQHPFVTGKYQDPH 336 (668)
Q Consensus 282 ~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPS-------a~EIL~Hpwf~~~~~~~~ 336 (668)
.. .......+..++.++.+||.+||+.||.+||| +++++.|||+....++|.
T Consensus 252 ~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl 310 (323)
T 3qup_A 252 LI---GGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPL 310 (323)
T ss_dssp HH---TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----------
T ss_pred Hh---cCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCC
Confidence 11 12234456678999999999999999999999 888899999987655543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=386.86 Aligned_cols=266 Identities=33% Similarity=0.547 Sum_probs=195.8
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
..+...+|++.+.||+|+||+||+|.+..++..||||++.... .......+.+|+.+++.++||||+++++++
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 82 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-------CQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------------CCCCCCCTTBCCEEEEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-------cchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence 3567789999999999999999999998899999999874221 123345678899999999999999999999
Q ss_pred ccCCcceEEeeccCCCChhccccc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEE
Q 005944 139 REDDSLNILLEFVPGGSISSLLGK--------FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~--------~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL 210 (668)
...+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl 162 (303)
T 2vwi_A 83 VVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQI 162 (303)
T ss_dssp ESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEE
Confidence 999999999999999999999863 456999999999999999999999999999999999999999999999
Q ss_pred ecCCchhhhHhhhh---hcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhh
Q 005944 211 ADFGASKKVVELAT---INGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHI 284 (668)
Q Consensus 211 ~DFGlA~~~~~~~~---~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~ 284 (668)
+|||++..+..... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .......
T Consensus 163 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 242 (303)
T 2vwi_A 163 ADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQN 242 (303)
T ss_dssp CCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTS
T ss_pred EeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhcc
Confidence 99999876533211 111234679999999999976 56899999999999999999999999653211 1111111
Q ss_pred ccCC-----CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 285 GTTK-----SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 285 ~~~~-----~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.... ........++.++.+||.+||+.||.+||++.++++||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 294 (303)
T 2vwi_A 243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA 294 (303)
T ss_dssp SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence 1100 1122345678999999999999999999999999999999754
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=388.97 Aligned_cols=254 Identities=25% Similarity=0.445 Sum_probs=209.2
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeecccccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTARE 140 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~ 140 (668)
...+|++.+.||+|+||+||+|++..+++.||||++... ....+.+|+.+|+.+. ||||+++++++..
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~ 102 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----------KKKKIKREIKILENLRGGPNIITLADIVKD 102 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----------CHHHHHHHHHHHHHHTTSTTBCCEEEEEEC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----------chHHHHHHHHHHHHcCCCCCEEEeeeeecc
Confidence 346899999999999999999999999999999998421 1235778999999997 9999999999987
Q ss_pred --CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC-ceEEecCCchh
Q 005944 141 --DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-CIKLADFGASK 217 (668)
Q Consensus 141 --~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-~vKL~DFGlA~ 217 (668)
....++||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+++
T Consensus 103 ~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 103 PVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp TTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred CCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 667899999999999999885 489999999999999999999999999999999999999777 89999999997
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhH---HHHHHH------------
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQF---QEVAAL------------ 281 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~---~~~~~~------------ 281 (668)
.+... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .....+
T Consensus 180 ~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 180 FYHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp ECCTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred EcCCC---CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH
Confidence 65332 23445689999999999987 568999999999999999999999994211 111110
Q ss_pred HhhccCC--------------------CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 282 FHIGTTK--------------------SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 282 ~~~~~~~--------------------~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
....... .....+..++.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 0000000 01112234799999999999999999999999999999998643
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=393.00 Aligned_cols=266 Identities=26% Similarity=0.456 Sum_probs=208.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+|+.||||++...... .......+.+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 83 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcc---hhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee
Confidence 3457899999999999999999999999999999998432211 1111223457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
....++||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 84 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (346)
T 1ua2_A 84 KSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF 162 (346)
T ss_dssp TTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred CCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceec
Confidence 9999999999986 787777654 46999999999999999999999999999999999999999999999999999865
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCCC---CC--
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTKS---HP-- 291 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~~---~~-- 291 (668)
... .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||..... ....++....... ++
T Consensus 163 ~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 240 (346)
T 1ua2_A 163 GSP--NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDM 240 (346)
T ss_dssp TSC--CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSST
T ss_pred cCC--cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhh
Confidence 321 2233456899999999999764 489999999999999999999999975432 2222222111100 00
Q ss_pred -------------C-----CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 292 -------------P-----IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 292 -------------~-----~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
. +...++.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred ccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 0 1145678999999999999999999999999999998654
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=423.09 Aligned_cols=259 Identities=27% Similarity=0.405 Sum_probs=220.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||+||+|+++.+|+.||||++.... .........+.+|+.+|+.++|||||++++++..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~-----~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKR-----LKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHH-----hhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee
Confidence 55678999999999999999999999999999999984321 1111234567889999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF----GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~----~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
...+|+||||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++
T Consensus 257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla 336 (543)
T 3c4z_A 257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336 (543)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeeccee
Confidence 99999999999999999988653 46999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-----HHHHHHHhhccCCCCC
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-----QEVAALFHIGTTKSHP 291 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-----~~~~~~~~~~~~~~~~ 291 (668)
+.+.... ......+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.... ..+...... ...
T Consensus 337 ~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~----~~~ 410 (543)
T 3c4z_A 337 VELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE----QAV 410 (543)
T ss_dssp EECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH----CCC
T ss_pred eeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh----ccc
Confidence 8653321 12334689999999999999999999999999999999999999997531 222222221 223
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCCCCC-----HHHHHcCccccC
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYLRST-----ASELLQHPFVTG 330 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~ 330 (668)
.++..++.++++||.+||+.||.+||+ +++|++||||++
T Consensus 411 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 411 TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 456789999999999999999999995 589999999975
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=387.34 Aligned_cols=262 Identities=30% Similarity=0.513 Sum_probs=211.4
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
..++...+|++.+.||+|+||+||+|.+ +|..||||++.... ........+.+|+.+|++++|||||+++++
T Consensus 31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 102 (309)
T 3p86_A 31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQD------FHAERVNEFLREVAIMKRLRHPNIVLFMGA 102 (309)
T ss_dssp -CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCC------CSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCC------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3457778999999999999999999986 68899999984322 123345668899999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccCCC---CCHHHHHHHHHHHHHHHHHHHhCC--cccccCCcccEEeCCCCceEEec
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKFGS---FPESVIRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVDNKGCIKLAD 212 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~~~---l~e~~~~~i~~QIl~aL~yLHs~g--IvHrDLKPeNILld~~g~vKL~D 212 (668)
+.....+++||||+++|+|.+++...+. +++..++.++.||+.||+|||++| |+||||||+||||+.++.+||+|
T Consensus 103 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~D 182 (309)
T 3p86_A 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182 (309)
T ss_dssp ECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECC
T ss_pred EEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECC
Confidence 9999999999999999999999987654 999999999999999999999999 99999999999999999999999
Q ss_pred CCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCC
Q 005944 213 FGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP 292 (668)
Q Consensus 213 FGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~ 292 (668)
||+++..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||......... ...........
T Consensus 183 fg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~-~~~~~~~~~~~ 259 (309)
T 3p86_A 183 FGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV-AAVGFKCKRLE 259 (309)
T ss_dssp CC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-HHHHHSCCCCC
T ss_pred CCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHhcCCCCC
Confidence 9999754322 22234568999999999999999999999999999999999999999764332211 11222233456
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc--CccccC
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ--HPFVTG 330 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~--Hpwf~~ 330 (668)
++..+++++.+||.+||+.||.+|||+.++++ +++++.
T Consensus 260 ~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 67889999999999999999999999999998 466553
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=399.27 Aligned_cols=255 Identities=31% Similarity=0.547 Sum_probs=205.1
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
+....+|++.+.||+|+||+||+|++..+|+.||||++..... ...+|+.+|+.++|||||++++++.
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------------~~~~E~~il~~l~hpnIv~l~~~~~ 70 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------------YKNRELDIMKVLDHVNIIKLVDYFY 70 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------------SCCHHHHHHTTCCCTTBCCEEEEEE
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------------hHHHHHHHHHHcCCCCccchhheee
Confidence 3566789999999999999999999999999999998843211 1236999999999999999999884
Q ss_pred c--------------------------------------CCcceEEeeccCCCChhccc----ccCCCCCHHHHHHHHHH
Q 005944 140 E--------------------------------------DDSLNILLEFVPGGSISSLL----GKFGSFPESVIRMYTKQ 177 (668)
Q Consensus 140 ~--------------------------------------~~~~~LVmEy~~gGsL~~~L----~~~~~l~e~~~~~i~~Q 177 (668)
. ...+++||||+++ +|.+.+ .....+++..++.++.|
T Consensus 71 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~q 149 (383)
T 3eb0_A 71 TTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQ 149 (383)
T ss_dssp EC-------------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHH
T ss_pred ecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHH
Confidence 3 3448899999985 766655 34578999999999999
Q ss_pred HHHHHHHHHhCCcccccCCcccEEeC-CCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHH
Q 005944 178 LLLGLEYLHKNGIMHRDIKGANILVD-NKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG-HSFSADIW 255 (668)
Q Consensus 178 Il~aL~yLHs~gIvHrDLKPeNILld-~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIW 255 (668)
|+.||.|||++||+||||||+||||+ .++.+||+|||+++.+.. ........||+.|+|||++.+.. ++.++|||
T Consensus 150 i~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 226 (383)
T 3eb0_A 150 LFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLW 226 (383)
T ss_dssp HHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred HHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence 99999999999999999999999997 688999999999986532 22344568999999999998754 89999999
Q ss_pred HHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCC---------------CC---------CCCCcccCHHHHHHHHHhh
Q 005944 256 SVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTK---------------SH---------PPIPEHLSMEAKDFLLKCL 309 (668)
Q Consensus 256 SLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~---------------~~---------~~~p~~ls~el~dLI~kcL 309 (668)
||||++|+|++|++||.... .....+....... .. ..++..++.++.+||.+||
T Consensus 227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999999997542 2222222111000 00 0134568899999999999
Q ss_pred hhCCCCCCCHHHHHcCccccC
Q 005944 310 QKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 310 ~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+.||.+|||+.|+|+||||+.
T Consensus 307 ~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp CSSGGGSCCHHHHHTSGGGHH
T ss_pred cCChhhCCCHHHHhcCHHHHH
Confidence 999999999999999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=382.51 Aligned_cols=256 Identities=43% Similarity=0.715 Sum_probs=211.6
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcce
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN 145 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~ 145 (668)
|....+||+|+||+||+|.+..++..||||++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 95 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--------SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK 95 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--------C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--------hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence 344459999999999999999999999999884321 123456788999999999999999999999999999
Q ss_pred EEeeccCCCChhcccccC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-CCceEEecCCchhhhHh
Q 005944 146 ILLEFVPGGSISSLLGKF---GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN-KGCIKLADFGASKKVVE 221 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~~---~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~-~g~vKL~DFGlA~~~~~ 221 (668)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.....
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999999999998764 24678999999999999999999999999999999999987 89999999999876532
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcC--CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTG--HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~--~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.. .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.....................++..++.
T Consensus 176 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (295)
T 2clq_A 176 IN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA 253 (295)
T ss_dssp -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred CC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence 21 1223567999999999998754 8899999999999999999999996543222222222223344566788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++.+||.+||+.||.+||++.++++||||+..
T Consensus 254 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVS 285 (295)
T ss_dssp HHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence 99999999999999999999999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=397.40 Aligned_cols=260 Identities=26% Similarity=0.402 Sum_probs=209.9
Q ss_pred CCCCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-------
Q 005944 55 PIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT------- 127 (668)
Q Consensus 55 p~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~------- 127 (668)
++..++....+|++.+.||+|+||+||+|++..+++.||||++.. .......+.+|+.+|+.+.
T Consensus 28 ~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---------~~~~~~~~~~E~~~l~~l~~~~~~~~ 98 (397)
T 1wak_A 28 LVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---------AEHYTETALDEIRLLKSVRNSDPNDP 98 (397)
T ss_dssp SSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---------CHHHHHHHHHHHHHHHHHHHSCTTCG
T ss_pred EEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec---------CCcchHHHHHHHHHHHHHhhcCCCCC
Confidence 344456677899999999999999999999999999999999842 1233456778999999985
Q ss_pred -CCCeeeeccccc----cCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCccc
Q 005944 128 -HPNIVRYLGTAR----EDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGAN 199 (668)
Q Consensus 128 -HpNIV~l~g~~~----~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeN 199 (668)
|+||+++++++. ....+|+||||+ +++|.+++... ..+++..++.|+.||+.||.|||++ ||+||||||+|
T Consensus 99 ~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~N 177 (397)
T 1wak_A 99 NREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPEN 177 (397)
T ss_dssp GGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGG
T ss_pred CcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHH
Confidence 788999999987 566899999999 55665555433 5699999999999999999999998 99999999999
Q ss_pred EEeCCCC-------------------------------------------------ceEEecCCchhhhHhhhhhcCCcc
Q 005944 200 ILVDNKG-------------------------------------------------CIKLADFGASKKVVELATINGAKS 230 (668)
Q Consensus 200 ILld~~g-------------------------------------------------~vKL~DFGlA~~~~~~~~~~~~~~ 230 (668)
|||+.++ .+||+|||+++.... ....
T Consensus 178 Ill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~ 252 (397)
T 1wak_A 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTE 252 (397)
T ss_dssp EEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCS
T ss_pred eeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCcc
Confidence 9999775 799999999976532 2445
Q ss_pred CCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchh--------HHHHHHHHhhccCC--------------
Q 005944 231 MKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ--------FQEVAALFHIGTTK-------------- 288 (668)
Q Consensus 231 ~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~--------~~~~~~~~~~~~~~-------------- 288 (668)
.+||+.|+|||++.+..++.++|||||||+||+|+||+.||... ......+.......
T Consensus 253 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 332 (397)
T 1wak_A 253 DIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332 (397)
T ss_dssp CCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGT
T ss_pred CCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccc
Confidence 68999999999999999999999999999999999999999631 11111111110000
Q ss_pred -----------------------CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 289 -----------------------SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 289 -----------------------~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
.....+...+.++.+||.+||+.||.+|||+.|||+||||+
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp BCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 00122345567889999999999999999999999999996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=405.35 Aligned_cols=259 Identities=27% Similarity=0.464 Sum_probs=209.6
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC------CCCCeee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL------THPNIVR 133 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L------~HpNIV~ 133 (668)
+....+|++.++||+|+||+||+|.+..+++.||||++... ......+.+|+.+++.+ .|+||++
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---------~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~ 163 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---------KRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---------cchHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence 45677899999999999999999999999999999998421 12334566788888777 5779999
Q ss_pred eccccccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc--eE
Q 005944 134 YLGTAREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC--IK 209 (668)
Q Consensus 134 l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~--vK 209 (668)
+++++.....+++||||+. ++|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++. +|
T Consensus 164 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vk 242 (429)
T 3kvw_A 164 MLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIK 242 (429)
T ss_dssp EEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEE
T ss_pred EEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceE
Confidence 9999999999999999996 5898888665 35999999999999999999999999999999999999999887 99
Q ss_pred EecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccC
Q 005944 210 LADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTT 287 (668)
Q Consensus 210 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~ 287 (668)
|+|||+++... ......+||+.|+|||++.+..++.++|||||||+||+|+||.+||...... ...+......
T Consensus 243 L~DFG~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~ 317 (429)
T 3kvw_A 243 VIDFGSSCYEH-----QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM 317 (429)
T ss_dssp ECCCTTCEETT-----CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred EeecccceecC-----CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999996532 2344678999999999999999999999999999999999999999654321 1111111000
Q ss_pred ------------------CCCC------------------------------------CCCcccCHHHHHHHHHhhhhCC
Q 005944 288 ------------------KSHP------------------------------------PIPEHLSMEAKDFLLKCLQKEP 313 (668)
Q Consensus 288 ------------------~~~~------------------------------------~~p~~ls~el~dLI~kcL~~dP 313 (668)
...+ .++...++++.+||.+||+.||
T Consensus 318 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP 397 (429)
T 3kvw_A 318 PSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDP 397 (429)
T ss_dssp CCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSST
T ss_pred CCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCCh
Confidence 0000 0112347889999999999999
Q ss_pred CCCCCHHHHHcCccccCCCC
Q 005944 314 YLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 314 ~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.+|||+.|+|+||||+....
T Consensus 398 ~~Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 398 AVRMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp TTSCCHHHHHTSTTTC----
T ss_pred hhCCCHHHHhCChhhccCCC
Confidence 99999999999999986543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=394.43 Aligned_cols=257 Identities=36% Similarity=0.607 Sum_probs=215.1
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|++..+++.||||++..... ........+.+|+.+|+.++|||||++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 126 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 126 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSS-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccc-----cchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34569999999999999999999999999999999853221 1233456788999999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 142 DSLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~-~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
+..++||||+. |+|.+++. ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 127 ~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 127 HTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp TEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred CeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99999999997 57777764 45679999999999999999999999999999999999999999999999999997542
Q ss_pred hhhhhcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCccc
Q 005944 221 ELATINGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~l 297 (668)
.....+||+.|+|||++. ...++.++|||||||++|+|++|+.||....... ....+.........+..+
T Consensus 206 ------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~ 278 (348)
T 1u5q_A 206 ------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPALQSGHW 278 (348)
T ss_dssp ------SBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCCCCTTS
T ss_pred ------CCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhcCCCCCCCCCC
Confidence 234568999999999996 4568999999999999999999999997543221 111222222223335578
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
+..+.+||.+||+.||.+|||+.++++||||...
T Consensus 279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 312 (348)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence 9999999999999999999999999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=398.77 Aligned_cols=258 Identities=25% Similarity=0.453 Sum_probs=195.2
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 100 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF------QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 100 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc------cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence 4578999999999999999999999999999999984321 1223456678999999999999999999988654
Q ss_pred ------CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 142 ------DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 142 ------~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 101 RSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp SSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred CccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5689999999 6899998876 6799999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccC-----
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTT----- 287 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~----- 287 (668)
++.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||..... ....+......
T Consensus 179 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~ 253 (367)
T 2fst_X 179 ARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 986532 2345689999999999987 6789999999999999999999999965321 11111111000
Q ss_pred ----------------CCCC-----CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 288 ----------------KSHP-----PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 288 ----------------~~~~-----~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.... .....+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 254 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0000 01134688999999999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=394.05 Aligned_cols=262 Identities=24% Similarity=0.392 Sum_probs=212.6
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|.+..++..||||++... ........+.+|+++|+.++||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 97 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF-------EHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 97 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT-------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc-------cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecC
Confidence 347899999999999999999999999999999998421 1233446678999999999999999999988654
Q ss_pred -----CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 142 -----DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 142 -----~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
...|+||||+.+ +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 98 ~~~~~~~~~iv~e~~~~-~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 175 (364)
T 3qyz_A 98 TIEQMKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175 (364)
T ss_dssp STTTCCCEEEEEECCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CccccceEEEEEcccCc-CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence 468999999974 89988865 57999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhc-CCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhcc------
Q 005944 217 KKVVELATIN-GAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGT------ 286 (668)
Q Consensus 217 ~~~~~~~~~~-~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~------ 286 (668)
+......... .....+||+.|+|||++.+.. ++.++|||||||++|+|++|++||.... .....+.....
T Consensus 176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 255 (364)
T 3qyz_A 176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 255 (364)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH
T ss_pred EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 8654332221 134568999999999987554 8999999999999999999999996432 11111111000
Q ss_pred ---------------CCCCC-----CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 287 ---------------TKSHP-----PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 287 ---------------~~~~~-----~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
..... .....++.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00000 11245788999999999999999999999999999998754
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=399.69 Aligned_cols=261 Identities=31% Similarity=0.531 Sum_probs=215.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEc---CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLG 136 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g 136 (668)
....+|++.+.||+|+||+||+|++. .+++.||||++......... .....+.+|+.+|..+ +||||+++++
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~----~~~~~~~~E~~~l~~l~~h~~iv~~~~ 126 (355)
T 1vzo_A 51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHIRQSPFLVTLHY 126 (355)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE----SSGGGCCCHHHHHHHHHTCTTBCCEEE
T ss_pred ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhh----hHHHHHHHHHHHHHHccCCCceeEEEE
Confidence 44578999999999999999999985 58999999998533211100 1112355789999999 6999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
++.....++|||||+++|+|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 127 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 127 AFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999999999988889999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhc--CCCcchhHHHHHHHHHHHHhCCCCCchh-----HHHHHHHHhhccCCC
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQT--GHSFSADIWSVGCTVIEMATGKPPWSQQ-----FQEVAALFHIGTTKS 289 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~--~~s~ksDIWSLGvILyeLLTG~~PF~~~-----~~~~~~~~~~~~~~~ 289 (668)
+.+..... ......+||+.|+|||++.+. .++.++|||||||+||+|++|..||... ...+..... ..
T Consensus 207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----~~ 281 (355)
T 1vzo_A 207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL----KS 281 (355)
T ss_dssp EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH----HC
T ss_pred eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh----cc
Confidence 76533222 223356899999999999863 4789999999999999999999999632 122221111 12
Q ss_pred CCCCCcccCHHHHHHHHHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 290 ~~~~p~~ls~el~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
...++..++..+.+||.+||..||.+|| ++.++++||||+.
T Consensus 282 ~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 282 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 3456778899999999999999999999 9999999999985
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=388.08 Aligned_cols=264 Identities=26% Similarity=0.433 Sum_probs=212.1
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||+||+|++..+|+.||||++... ........+.+|+.+|+.++||||+++++++.
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 79 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-------DKPLFALRTLREIKILKHFKHENIITIFNIQR 79 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-------ccchHHHHHHHHHHHHHhCcCCCcCCeeeeec
Confidence 35678999999999999999999999999999999998421 12234456778999999999999999999876
Q ss_pred cC-----CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 140 ED-----DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 140 ~~-----~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
.. ...|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 80 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 80 PDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred ccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 54 67899999997 589888865 579999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhh--------cCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHh
Q 005944 215 ASKKVVELATI--------NGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFH 283 (668)
Q Consensus 215 lA~~~~~~~~~--------~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~ 283 (668)
++..+...... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ...+..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 237 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFG 237 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 99765322111 11234679999999999875 66899999999999999999999999754321 111111
Q ss_pred hccCC----------------------CCC-----CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 284 IGTTK----------------------SHP-----PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 284 ~~~~~----------------------~~~-----~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
..... ... .....++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 10000 000 01236789999999999999999999999999999998644
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=386.23 Aligned_cols=257 Identities=26% Similarity=0.412 Sum_probs=210.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||+||+|.+..+++.||||++..... ......+.+|+.+|+.++||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 78 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-------cchHHHHHHHHHHHHhcCCCCcceEEEEeec
Confidence 566789999999999999999999999999999999842211 1123456789999999999999999998876
Q ss_pred CC--cceEEeeccCCCChhcccccCCC---CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe----CCCCceEEe
Q 005944 141 DD--SLNILLEFVPGGSISSLLGKFGS---FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV----DNKGCIKLA 211 (668)
Q Consensus 141 ~~--~~~LVmEy~~gGsL~~~L~~~~~---l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl----d~~g~vKL~ 211 (668)
.. ..++||||+++|+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (319)
T 4euu_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (319)
T ss_dssp TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEEC
T ss_pred CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEc
Confidence 55 77999999999999999976533 9999999999999999999999999999999999999 788899999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHh--------hcCCCcchhHHHHHHHHHHHHhCCCCCch-----hHHHH
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVIL--------QTGHSFSADIWSVGCTVIEMATGKPPWSQ-----QFQEV 278 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~--------~~~~s~ksDIWSLGvILyeLLTG~~PF~~-----~~~~~ 278 (668)
|||+++.+... ......+||+.|+|||++. +..++.++|||||||++|+|+||..||.. .....
T Consensus 159 Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 235 (319)
T 4euu_A 159 DFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (319)
T ss_dssp CCTTCEECCTT---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHH
T ss_pred cCCCceecCCC---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHH
Confidence 99999865332 2234567999999999997 46789999999999999999999999952 11222
Q ss_pred HHHHhhccC---------------------CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcc
Q 005944 279 AALFHIGTT---------------------KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327 (668)
Q Consensus 279 ~~~~~~~~~---------------------~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpw 327 (668)
......... .....+...++..+.+||.+||+.||.+|||+.|+|+||-
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp HHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred HHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 211111110 1111334566778999999999999999999999999985
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=391.55 Aligned_cols=249 Identities=26% Similarity=0.479 Sum_probs=210.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|+++++||+|+||+||+|.+..++..||+|++.. ......+.+.+|+.+|+.++||||+++++++..
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--------~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 78 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--------FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK 78 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--------CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec
Confidence 456789999999999999999999999999999998732 123445678899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
....++||||+++|+|.+++.. ...+++.+++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 158 (310)
T 3s95_A 79 DKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLM 158 (310)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEEC
T ss_pred CCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceec
Confidence 9999999999999999999976 467999999999999999999999999999999999999999999999999999765
Q ss_pred Hhhhhhc------------CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-------HHH
Q 005944 220 VELATIN------------GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-------VAA 280 (668)
Q Consensus 220 ~~~~~~~------------~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-------~~~ 280 (668)
....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 238 (310)
T 3s95_A 159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238 (310)
T ss_dssp C--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHH
T ss_pred ccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhc
Confidence 3322111 112567999999999999999999999999999999999999998542110 000
Q ss_pred HHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 281 LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 281 ~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
... ...+..++.++.+||.+||+.||.+|||+.++++
T Consensus 239 ~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 239 FLD-------RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHH-------HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccc-------ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000 1234567888999999999999999999999987
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=395.27 Aligned_cols=259 Identities=27% Similarity=0.407 Sum_probs=201.5
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|.+..+++.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 96 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ 96 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT------SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSC
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc------CChHHHHHHHHHHHHHHhcCCCCccceEEeeccc
Confidence 3468999999999999999999999999999999984321 1233456678999999999999999999998765
Q ss_pred C------cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 142 D------SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 142 ~------~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
. .+|+||||+.+ +|.+++. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 97 ~~~~~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 97 KSLEEFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp CSTTTCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred cccccccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeec
Confidence 5 67999999975 7777775 4699999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccCC-----
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTTK----- 288 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~~----- 288 (668)
++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...... ...+.......
T Consensus 174 a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 250 (371)
T 2xrw_A 174 ARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM 250 (371)
T ss_dssp -------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred ccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9865432 1234568999999999999999999999999999999999999999754321 11111100000
Q ss_pred ------------CCCC--------------CC------cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 289 ------------SHPP--------------IP------EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 289 ------------~~~~--------------~p------~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
..+. .+ ...+.++++||.+||+.||.+|||+.|+|+||||+...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 0000 00 11267899999999999999999999999999998644
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-46 Score=397.92 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=217.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEE-----EcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGM-----NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~-----~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l 134 (668)
+....+|++.+.||+|+||+||+|+ +..++..||||++... ........+.+|+.+|+.++|||||++
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~hpnIv~~ 139 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-------CSEQDELDFLMEALIISKFNHQNIVRC 139 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-------CCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-------cChhhHHHHHHHHHHHHhCCCCCCCeE
Confidence 4667889999999999999999999 4457889999988321 112233457789999999999999999
Q ss_pred ccccccCCcceEEeeccCCCChhcccccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC-
Q 005944 135 LGTAREDDSLNILLEFVPGGSISSLLGKF-------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG- 206 (668)
Q Consensus 135 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~-------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g- 206 (668)
++++......++|||||++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|
T Consensus 140 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 219 (367)
T 3l9p_A 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 219 (367)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred EEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCC
Confidence 99999999999999999999999998654 3589999999999999999999999999999999999999555
Q ss_pred --ceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHH
Q 005944 207 --CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALF 282 (668)
Q Consensus 207 --~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~ 282 (668)
.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 220 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i 299 (367)
T 3l9p_A 220 GRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 299 (367)
T ss_dssp TCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred CceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 599999999987755444444455678999999999999999999999999999999998 99999765432 22222
Q ss_pred hhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 283 HIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 283 ~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
. .......+..++.++.+||.+||+.||.+||++.+|++|.++.
T Consensus 300 ~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 300 T---SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp H---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred H---cCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 2 2223455678899999999999999999999999999998864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=380.43 Aligned_cols=262 Identities=26% Similarity=0.444 Sum_probs=212.5
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc--cc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA--RE 140 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~--~~ 140 (668)
..+|++.+.||+|+||.||+|.+..++..||||++..... .........+.+|+.+++.++||||+++++++ ..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKL----RRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEE 79 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHH----HHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC-
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccc----cccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCC
Confidence 4689999999999999999999999999999999843211 11122346688999999999999999999988 45
Q ss_pred CCcceEEeeccCCCChhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGK--FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
....|+||||+.++ |.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 80 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 80 KQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp --CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccc
Confidence 56899999999887 6666644 35799999999999999999999999999999999999999999999999999976
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcC--CCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTG--HSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~--~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~ 295 (668)
..............||+.|+|||++.+.. ++.++|||||||++|+|++|..||..... .....+... ...++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~----~~~~~~ 234 (305)
T 2wtk_C 159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG----SYAIPG 234 (305)
T ss_dssp CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC----CCCCCS
T ss_pred cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC----CCCCCC
Confidence 54322222234567999999999998654 37799999999999999999999975432 222222221 234567
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.++.++.+||.+||+.||.+|||+.++++||||+....
T Consensus 235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 78999999999999999999999999999999987543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=385.44 Aligned_cols=265 Identities=26% Similarity=0.419 Sum_probs=214.5
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC--CCCeeeecc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT--HPNIVRYLG 136 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIV~l~g 136 (668)
......+|++.+.||+|+||.||+|.+. +++.||||++.... ........+.+|+.+|..+. |+||+++++
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~------~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE------ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSS------CCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEecccc------ccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 3466778999999999999999999875 58999999985322 12334567889999999997 599999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
++......|+||| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~ 173 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIA 173 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccc
Confidence 9999999999999 56789999998888999999999999999999999999999999999999996 489999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhh-----------cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQ-----------TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIG 285 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-----------~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~ 285 (668)
..+............+||+.|+|||++.+ ..++.++|||||||++|+|++|..||..............
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~ 253 (313)
T 3cek_A 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 253 (313)
T ss_dssp CC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred ccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH
Confidence 87654333333345679999999999976 4688899999999999999999999976433333333333
Q ss_pred cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 286 ~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.......++...+.++.+||.+||+.||.+||++.++++||||+...
T Consensus 254 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 254 DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 33344456677789999999999999999999999999999998643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=383.51 Aligned_cols=258 Identities=28% Similarity=0.377 Sum_probs=210.8
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEE-cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCC------C
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMN-LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP------N 130 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~-~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp------N 130 (668)
.++....+|++.+.||+|+||+||+|.+ ..+++.||||++.. .......+.+|+.+++.++|+ +
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~~~~~ 78 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN---------VDRYCEAARSEIQVLEHLNTTDPNSTFR 78 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---------SHHHHHHHHHHHHHHHHHHHHCTTCTTC
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec---------CCchhHHHHHHHHHHHHhhhcCCCCcee
Confidence 3456778999999999999999999998 56889999999832 122345677899999888665 4
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC----
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---- 204 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---- 204 (668)
|+++++++...+.+++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 79 i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~ 157 (339)
T 1z57_A 79 CVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYT 157 (339)
T ss_dssp BCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEE
T ss_pred eEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccc
Confidence 999999999999999999999 889999987664 6899999999999999999999999999999999999987
Q ss_pred ---------------CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCC
Q 005944 205 ---------------KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKP 269 (668)
Q Consensus 205 ---------------~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~ 269 (668)
++.+||+|||+++... ......+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 232 (339)
T 1z57_A 158 EAYNPKIKRDERTLINPDIKVVDFGSATYDD-----EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232 (339)
T ss_dssp EEEC----CEEEEESCCCEEECCCSSCEETT-----SCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCccccccccccCCCceEeeCcccccCc-----cccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCC
Confidence 6689999999997532 22345689999999999999999999999999999999999999
Q ss_pred CCchhHHHH-H-HHHhhccC---------------------------------------CCCCCCCcccCHHHHHHHHHh
Q 005944 270 PWSQQFQEV-A-ALFHIGTT---------------------------------------KSHPPIPEHLSMEAKDFLLKC 308 (668)
Q Consensus 270 PF~~~~~~~-~-~~~~~~~~---------------------------------------~~~~~~p~~ls~el~dLI~kc 308 (668)
||....... . .+...... ..........+.++.+||.+|
T Consensus 233 pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 233 VFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp SCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 996432211 1 11110000 000111233467889999999
Q ss_pred hhhCCCCCCCHHHHHcCccccC
Q 005944 309 LQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 309 L~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
|+.||.+|||+.|+++||||+.
T Consensus 313 L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 313 LEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp TCSSTTTSCCHHHHTTSGGGGG
T ss_pred hCcCcccccCHHHHhcCHHHHH
Confidence 9999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=385.06 Aligned_cols=260 Identities=35% Similarity=0.632 Sum_probs=209.8
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~ 138 (668)
.....+|++.+.||+|+||+||+|++..+++.||||++..... ....+.+|+.+++.+ +||||+++++++
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---------~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 90 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---------EEEEIKQEINMLKKYSHHRNIATYYGAF 90 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS---------TTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc---------cHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence 4567899999999999999999999999999999999853221 123567899999999 799999999998
Q ss_pred cc------CCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEE
Q 005944 139 RE------DDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 139 ~~------~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL 210 (668)
.. ...+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEE
T ss_pred eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEE
Confidence 76 46789999999999999999764 57999999999999999999999999999999999999999999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHh-----hcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhc
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIG 285 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~ 285 (668)
+|||++..+.... .......||+.|+|||++. +..++.++|||||||++|+|++|..||........ ...+.
T Consensus 171 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~ 247 (326)
T 2x7f_A 171 VDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-LFLIP 247 (326)
T ss_dssp CCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH-HHHHH
T ss_pred eeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-HHHhh
Confidence 9999988654321 1233467999999999997 55689999999999999999999999975432211 11121
Q ss_pred cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 286 ~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
........+..++.++.+||.+||..||.+||++.++++||||+..
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 248 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred cCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 2222223356789999999999999999999999999999999853
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=378.03 Aligned_cols=259 Identities=31% Similarity=0.524 Sum_probs=215.4
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc--c
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA--R 139 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~--~ 139 (668)
...+|++.+.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++ .
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 77 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM------TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR 77 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC------CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC------CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC
Confidence 34689999999999999999999999999999999853321 223456788999999999999999999977 4
Q ss_pred cCCcceEEeeccCCCChhcccccC----CCCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCCcccEEeCCCCceEE
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF----GSFPESVIRMYTKQLLLGLEYLHKNG-----IMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~----~~l~e~~~~~i~~QIl~aL~yLHs~g-----IvHrDLKPeNILld~~g~vKL 210 (668)
....+|+||||+++++|.+++... ..+++..++.++.||+.||.|||+.| |+||||||+|||++.++.+||
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl 157 (279)
T 2w5a_A 78 TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKL 157 (279)
T ss_dssp GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEE
T ss_pred CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEE
Confidence 467899999999999999998653 34999999999999999999999999 999999999999999999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCC
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKS 289 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~ 289 (668)
+|||+++........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+.. ..
T Consensus 158 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~---~~ 232 (279)
T 2w5a_A 158 GDFGLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---GK 232 (279)
T ss_dssp CCCCHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---TC
T ss_pred ecCchheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhh---cc
Confidence 999999765432111 12356899999999999988999999999999999999999999754322 2222222 22
Q ss_pred CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 290 ~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
...++..++.++.+||.+||+.||.+||++.+|++|+|+...
T Consensus 233 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 233 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 335667889999999999999999999999999999999753
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=395.16 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=214.1
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEE-----EcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGM-----NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIV 132 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~-----~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV 132 (668)
++....+|++.+.||+|+||.||+|. +..+++.||||++... ......+.+.+|+.+|..+ +|||||
T Consensus 17 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 17 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-------ATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp HBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-------CCHHHHHHHHHHHHHHHhhcCCccee
Confidence 45678899999999999999999998 4557799999998421 1223346688999999999 799999
Q ss_pred eeccccccCC-cceEEeeccCCCChhcccccCCC----------------------------------------------
Q 005944 133 RYLGTAREDD-SLNILLEFVPGGSISSLLGKFGS---------------------------------------------- 165 (668)
Q Consensus 133 ~l~g~~~~~~-~~~LVmEy~~gGsL~~~L~~~~~---------------------------------------------- 165 (668)
++++++...+ .+++|||||++|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 9999987754 48999999999999999876533
Q ss_pred --------------------CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhh
Q 005944 166 --------------------FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATI 225 (668)
Q Consensus 166 --------------------l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~ 225 (668)
+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+......
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 899999999999999999999999999999999999999999999999999865433333
Q ss_pred cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH--HHHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 226 NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF--QEVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 226 ~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~--~~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
.......||+.|+|||++.+..++.++|||||||++|+|+| |..||.... ......... ......+..+++++.
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~ 326 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE---GTRMRAPDYTTPEMY 326 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH---TCCCCCCTTCCHHHH
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc---CCCCCCCCCCCHHHH
Confidence 33445678999999999999999999999999999999998 999997532 222222222 233456677899999
Q ss_pred HHHHHhhhhCCCCCCCHHHHHcC
Q 005944 303 DFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 303 dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+||.+||+.||.+|||+.++++|
T Consensus 327 ~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 327 QTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHccCChhhCCCHHHHHHH
Confidence 99999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=383.45 Aligned_cols=258 Identities=25% Similarity=0.430 Sum_probs=217.9
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCee
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV 132 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV 132 (668)
..+....+|++.+.||+|+||.||+|.+. .++..||||++... ......+.+.+|+.+|+.++||||+
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv 89 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-------ASPSELRDLLSEFNVLKQVNHPHVI 89 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-------CCHHHHHHHHHHHHHHTTCCCTTBC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-------CCHHHHHHHHHHHHHHhhCCCCcee
Confidence 44577889999999999999999999984 45689999998421 1233456788999999999999999
Q ss_pred eeccccccCCcceEEeeccCCCChhcccccCCC------------------------CCHHHHHHHHHHHHHHHHHHHhC
Q 005944 133 RYLGTAREDDSLNILLEFVPGGSISSLLGKFGS------------------------FPESVIRMYTKQLLLGLEYLHKN 188 (668)
Q Consensus 133 ~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~------------------------l~e~~~~~i~~QIl~aL~yLHs~ 188 (668)
++++++...+..++||||+++|+|.+++..... +++..++.++.||+.||.|||++
T Consensus 90 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 169 (314)
T 2ivs_A 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM 169 (314)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT
T ss_pred eEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC
Confidence 999999999999999999999999999976543 89999999999999999999999
Q ss_pred CcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-C
Q 005944 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-G 267 (668)
Q Consensus 189 gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G 267 (668)
||+||||||+||||+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |
T Consensus 170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g 249 (314)
T 2ivs_A 170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLG 249 (314)
T ss_dssp TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTS
T ss_pred CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999986644333333445668899999999999889999999999999999999 9
Q ss_pred CCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 268 KPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 268 ~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
..||..... ....... .......+..++.++.+||.+||+.||.+||++.+++++
T Consensus 250 ~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 250 GNPYPGIPPERLFNLLK---TGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp CCSSTTCCGGGHHHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHhh---cCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999975432 2222222 223345667889999999999999999999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=385.73 Aligned_cols=257 Identities=23% Similarity=0.387 Sum_probs=216.8
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVR 133 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~ 133 (668)
......+|++.+.||+|+||.||+|++. .++..||||++... ........+.+|+.+|+.++||||++
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~ 114 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-------ASADMQADFQREAALMAEFDNPNIVK 114 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-------CCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-------cCHHHHHHHHHHHHHHHhCCCCCEEE
Confidence 4567789999999999999999999987 45689999998421 12334567889999999999999999
Q ss_pred eccccccCCcceEEeeccCCCChhcccccC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005944 134 YLGTAREDDSLNILLEFVPGGSISSLLGKF------------------------GSFPESVIRMYTKQLLLGLEYLHKNG 189 (668)
Q Consensus 134 l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~------------------------~~l~e~~~~~i~~QIl~aL~yLHs~g 189 (668)
+++++...+..|+||||+++|+|.+++... ..+++.+++.++.||+.||.|||++|
T Consensus 115 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ 194 (343)
T 1luf_A 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194 (343)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999998763 56899999999999999999999999
Q ss_pred cccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CC
Q 005944 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GK 268 (668)
Q Consensus 190 IvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~ 268 (668)
|+||||||+||||+.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|+|+| |.
T Consensus 195 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 274 (343)
T 1luf_A 195 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274 (343)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCC
Confidence 99999999999999999999999999987654333333445678999999999999999999999999999999999 99
Q ss_pred CCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 269 PPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 269 ~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.||...... ...... .......+..++.++.+||.+||+.||.+||++.+++++
T Consensus 275 ~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 275 QPYYGMAHEEVIYYVR---DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CTTTTSCHHHHHHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCCCChHHHHHHHh---CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 999764432 222222 223345667889999999999999999999999999864
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=375.36 Aligned_cols=256 Identities=26% Similarity=0.397 Sum_probs=205.5
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc---
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE--- 140 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~--- 140 (668)
.+|++.+.||+|+||+||+|++..+++.||||++.. .......+.+|+.+++.++||||+++++++..
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 76 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH---------TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE---------EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec---------cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence 479999999999999999999999999999999842 12344668899999999999999999988754
Q ss_pred ----------CCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceE
Q 005944 141 ----------DDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIK 209 (668)
Q Consensus 141 ----------~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vK 209 (668)
...+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+|
T Consensus 77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp CCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEE
T ss_pred hhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEE
Confidence 45689999999999999999754 4688999999999999999999999999999999999999999999
Q ss_pred EecCCchhhhHhhh------------hhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH
Q 005944 210 LADFGASKKVVELA------------TINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ 276 (668)
Q Consensus 210 L~DFGlA~~~~~~~------------~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~ 276 (668)
|+|||++....... .........||+.|+|||++.+. .++.++|||||||++|+|++ ||.....
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~ 233 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME 233 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence 99999987653211 01123356799999999999865 68999999999999999998 5643322
Q ss_pred --HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 277 --EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 277 --~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
................++...+..+.+||.+||+.||.+|||+.++++||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 234 RVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred HHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 2222222222333444566778899999999999999999999999999999753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=391.52 Aligned_cols=256 Identities=29% Similarity=0.487 Sum_probs=208.3
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc------cchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 4578999999999999999999999999999999984321 2233456788999999999999999999999877
Q ss_pred Ccc------eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 142 DSL------NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 142 ~~~------~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
... |+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 114 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQ-TDLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp SSSTTCCCCEEEEECCC-EEHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred CCcccceeEEEEEcccc-ccHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCc
Confidence 655 99999997 588887753 599999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccC-----
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTT----- 287 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~----- 287 (668)
++.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ....+......
T Consensus 191 a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 265 (371)
T 4exu_A 191 ARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 265 (371)
T ss_dssp C-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred cccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHH
Confidence 986532 2345689999999999987 6789999999999999999999999975321 11111111000
Q ss_pred ------------------CC---CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 288 ------------------KS---HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 288 ------------------~~---~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.. ....+..+++++.+||.+||+.||.+|||+.|+|+||||+..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 266 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp HTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 00 001123578999999999999999999999999999999854
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=379.90 Aligned_cols=258 Identities=36% Similarity=0.653 Sum_probs=220.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+++.||||++..... ......+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 91 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-------EDEIEDIQQEITVLSQCDSPYVTKYYGSYLK 91 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC-------STTHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc-------HHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 445679999999999999999999999999999999853321 1224567899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
...+++||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 92 ~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 92 DTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp TTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred CCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 9999999999999999999865 679999999999999999999999999999999999999999999999999997653
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
... .......||+.|+|||++.+..++.++|||||||++|+|++|..||............. ......++..++.+
T Consensus 171 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 246 (303)
T 3a7i_A 171 DTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP--KNNPPTLEGNYSKP 246 (303)
T ss_dssp TTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HSCCCCCCSSCCHH
T ss_pred ccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhh--cCCCCCCccccCHH
Confidence 221 22345679999999999999999999999999999999999999997543222111111 12234566788999
Q ss_pred HHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+.+||.+||+.||.+|||+.++++||||..
T Consensus 247 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~ 276 (303)
T 3a7i_A 247 LKEFVEACLNKEPSFRPTAKELLKHKFILR 276 (303)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTCHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhChhhhc
Confidence 999999999999999999999999999975
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=404.83 Aligned_cols=251 Identities=16% Similarity=0.190 Sum_probs=201.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHH---HHHHhCCCCCeeeec--
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEV---KLLKNLTHPNIVRYL-- 135 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei---~iL~~L~HpNIV~l~-- 135 (668)
....+|++.+.||+|+||+||+|++..+|+.||||++...... .....+.+.+|+ ++|+.++|||||+++
T Consensus 70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~ 144 (377)
T 3byv_A 70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERP-----PSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 144 (377)
T ss_dssp CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-C-----CTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHC
T ss_pred CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeecccc-----chHHHHHHHHHHHHHHhccccCCHHHHHHHhh
Confidence 3457899999999999999999999999999999998533211 112345678899 555566899999998
Q ss_pred -----cccccCC-----------------cceEEeeccCCCChhcccccCCCCCH-------HHHHHHHHHHHHHHHHHH
Q 005944 136 -----GTAREDD-----------------SLNILLEFVPGGSISSLLGKFGSFPE-------SVIRMYTKQLLLGLEYLH 186 (668)
Q Consensus 136 -----g~~~~~~-----------------~~~LVmEy~~gGsL~~~L~~~~~l~e-------~~~~~i~~QIl~aL~yLH 186 (668)
+++...+ ..||||||+ +|+|.+++...+.+++ ..++.|+.||+.||+|||
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 145 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp BCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 4444332 378999999 6799999987655665 778889999999999999
Q ss_pred hCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-----------CCCcchhHH
Q 005944 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT-----------GHSFSADIW 255 (668)
Q Consensus 187 s~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-----------~~s~ksDIW 255 (668)
++||+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .++.++|||
T Consensus 224 ~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dvw 297 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAW 297 (377)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHH
T ss_pred hCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHH
Confidence 99999999999999999999999999999985322 2345678 999999999988 899999999
Q ss_pred HHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 256 SVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 256 SLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
||||+||+|++|+.||....... ........+..++.++.+||.+||+.||.+|||+.++++||||+.
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALG-------GSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp HHHHHHHHHHHSSCCC------C-------CSGGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred HHHHHHHHHHHCCCCCccccccc-------chhhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 99999999999999996532211 001111223578899999999999999999999999999999974
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=380.45 Aligned_cols=261 Identities=27% Similarity=0.481 Sum_probs=204.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc-
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR- 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~- 139 (668)
....+|++.+.||+|+||+||+|.+..+++.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 79 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--------DPQSVKHALREIKIIRRLDHDNIVKVFEILGP 79 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--------SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECT
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--------ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccc
Confidence 4567899999999999999999999999999999988432 2234566789999999999999999998763
Q ss_pred -------------cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC-CC
Q 005944 140 -------------EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD-NK 205 (668)
Q Consensus 140 -------------~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld-~~ 205 (668)
.....|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 80 SGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED 157 (320)
T ss_dssp TSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT
T ss_pred cccccccccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC
Confidence 4467899999997 599998865 6799999999999999999999999999999999999997 56
Q ss_pred CceEEecCCchhhhHhhhh-hcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHH
Q 005944 206 GCIKLADFGASKKVVELAT-INGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAAL 281 (668)
Q Consensus 206 g~vKL~DFGlA~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~ 281 (668)
+.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...... ...+
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 237 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7999999999986543211 122334568999999999876 66899999999999999999999999754321 1111
Q ss_pred Hhhcc----------------------CCCC---CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 282 FHIGT----------------------TKSH---PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 282 ~~~~~----------------------~~~~---~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
..... .... ...+..++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 312 (320)
T 2i6l_A 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312 (320)
T ss_dssp HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccc
Confidence 11000 0000 01224578999999999999999999999999999999854
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=383.75 Aligned_cols=256 Identities=29% Similarity=0.486 Sum_probs=209.0
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|.+.+.||+|+||+||+|++..+|+.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 95 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF------QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 95 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCCcccHhheEecc
Confidence 3568999999999999999999999999999999984321 2233456688999999999999999999998876
Q ss_pred Cc------ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 142 DS------LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 142 ~~------~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
.. +|+||||+. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 96 ~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 96 SSLRNFYDFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp SSGGGCCCCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred cccccceeEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeeccc
Confidence 54 499999997 588888754 599999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhc-------
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIG------- 285 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~------- 285 (668)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+....
T Consensus 173 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 247 (353)
T 3coi_A 173 ARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247 (353)
T ss_dssp TTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHH
T ss_pred ccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 9865321 234678999999999987 6789999999999999999999999975321 111111100
Q ss_pred -------------------cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 286 -------------------TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 286 -------------------~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
...........++.++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 312 (353)
T ss_dssp HTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred HHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0111123345679999999999999999999999999999999854
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=377.43 Aligned_cols=257 Identities=28% Similarity=0.463 Sum_probs=210.4
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEE----EcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGM----NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~----~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
.....+|++.+.||+|+||+||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||++++
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 77 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------TEEHLRDFEREIEILKSLQHDNIVKYK 77 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--------CHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 4677899999999999999999998 5678999999998421 233456788999999999999999999
Q ss_pred ccccc--CCcceEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEec
Q 005944 136 GTARE--DDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLAD 212 (668)
Q Consensus 136 g~~~~--~~~~~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~D 212 (668)
+++.. ...+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 78 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~D 157 (295)
T 3ugc_A 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD 157 (295)
T ss_dssp EEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC
T ss_pred EEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEcc
Confidence 98754 356899999999999999997654 599999999999999999999999999999999999999999999999
Q ss_pred CCchhhhHhhhhh-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHH-----------
Q 005944 213 FGASKKVVELATI-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAA----------- 280 (668)
Q Consensus 213 FGlA~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~----------- 280 (668)
||+++.+...... .......+|+.|+|||++.+..++.++|||||||++|+|+||..||.........
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 158 FGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237 (295)
T ss_dssp CCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred CcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence 9999876433221 1223355788899999999999999999999999999999999998754433211
Q ss_pred ---HHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 281 ---LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 281 ---~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
...........+.+..++.++.+||.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 11112223345567789999999999999999999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-45 Score=386.56 Aligned_cols=267 Identities=22% Similarity=0.403 Sum_probs=204.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchh---hHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSAS---KEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~---~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
....+|++.+.||+|+||.||+|.+.. |..||||++........ ........+.+.+|+.+|+.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 456789999999999999999999755 99999999854322211 12234455778999999999999999999999
Q ss_pred cc-----cCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 138 AR-----EDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 138 ~~-----~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
+. ....+|+||||+.+ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 83 34468999999984 77766654 3579999999999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccC-
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTT- 287 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~- 287 (668)
|||++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ....+......
T Consensus 177 Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 177 DFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp CTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99999754332 22345679999999999987 6689999999999999999999999975321 11111111000
Q ss_pred ------------------CCCC--------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 288 ------------------KSHP--------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 288 ------------------~~~~--------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.... .....+++.+.+||.+||+.||.+|||+.|+|+||||+..+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 0000 11235688899999999999999999999999999998754
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=377.56 Aligned_cols=261 Identities=31% Similarity=0.461 Sum_probs=216.8
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+++.||||++...... ......+.+|+.+++.++||||+++++++..
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK------NKDTSTILREVELLKKLDHPNIMKLFEILED 92 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS------SSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc------hHHHHHHHHHHHHHHhccCCCccEEEEEEeC
Confidence 3446899999999999999999999999999999998533211 1123457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC---CceEEecCCchh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK---GCIKLADFGASK 217 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~---g~vKL~DFGlA~ 217 (668)
....++||||+++++|.+++.....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++.
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 93 SSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred CCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 99999999999999999998877889999999999999999999999999999999999999764 479999999987
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ 296 (668)
..... .......||+.|+|||++.+. ++.++|||||||++|+|++|..||..... .....+.........+.+..
T Consensus 173 ~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (287)
T 2wei_A 173 CFQQN---TKMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRT 248 (287)
T ss_dssp TBCCC---SSCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTT
T ss_pred eecCC---CccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhh
Confidence 64321 122344689999999998764 89999999999999999999999975432 22222222222222233356
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 249 ~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred cCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 89999999999999999999999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=390.92 Aligned_cols=262 Identities=25% Similarity=0.431 Sum_probs=220.2
Q ss_pred CCCCCCCCCCCCeeeeeEEcccCceEEEEEEEcCC-------CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC
Q 005944 54 PPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDS-------GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126 (668)
Q Consensus 54 pp~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t-------g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 126 (668)
++...++....+|++++.||+|+||+||+|++..+ +..||||++... ........+.+|+.+++.+
T Consensus 59 ~~~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l 131 (382)
T 3tt0_A 59 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-------ATEKDLSDLISEMEMMKMI 131 (382)
T ss_dssp CCCTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHH
T ss_pred ccCcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-------cCHHHHHHHHHHHHHHHHh
Confidence 44445567788999999999999999999997543 468999998422 1233456788999999999
Q ss_pred -CCCCeeeeccccccCCcceEEeeccCCCChhcccccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 005944 127 -THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG----------------SFPESVIRMYTKQLLLGLEYLHKNG 189 (668)
Q Consensus 127 -~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~g 189 (668)
+|||||++++++...+..++||||+++|+|.+++.... .+++..++.|+.||+.||.|||++|
T Consensus 132 ~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 211 (382)
T 3tt0_A 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 211 (382)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 89999999999999999999999999999999997643 4999999999999999999999999
Q ss_pred cccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CC
Q 005944 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GK 268 (668)
Q Consensus 190 IvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~ 268 (668)
|+||||||+||||+.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 212 ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~ 291 (382)
T 3tt0_A 212 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 291 (382)
T ss_dssp CCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred EecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999986543333333445668899999999999999999999999999999999 99
Q ss_pred CCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 269 PPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 269 ~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.||..... +....+. .......+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 292 ~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 292 SPYPGVPVEELFKLLK---EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CSSTTCCHHHHHHHHH---TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHH---cCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99975432 2222222 233445567889999999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=385.68 Aligned_cols=266 Identities=25% Similarity=0.394 Sum_probs=215.1
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhH---------hhHHHHHHHHHHHHHHHhCCCCC
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKE---------KTQAHIRELEEEVKLLKNLTHPN 130 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~---------~~~~~~~~~~~Ei~iL~~L~HpN 130 (668)
.....+|++.+.||+|+||.||+|.+ +++.||||++.......... ........+.+|+.+++.++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 35567999999999999999999998 89999999984322111000 00011156789999999999999
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcc------ccc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEE
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSL------LGK--FGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANIL 201 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~------L~~--~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNIL 201 (668)
|+++++++...+.+|+||||+++|+|.++ +.. ...+++..++.++.||+.||.|||+ +||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999999 766 5779999999999999999999999 99999999999999
Q ss_pred eCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-CCCc-chhHHHHHHHHHHHHhCCCCCchhHH--H
Q 005944 202 VDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT-GHSF-SADIWSVGCTVIEMATGKPPWSQQFQ--E 277 (668)
Q Consensus 202 ld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~-ksDIWSLGvILyeLLTG~~PF~~~~~--~ 277 (668)
|+.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|..||..... .
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 999999999999999765322 23456799999999999877 5665 99999999999999999999975432 2
Q ss_pred HHHHHhhccCCCCCC---------------CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 278 VAALFHIGTTKSHPP---------------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 278 ~~~~~~~~~~~~~~~---------------~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
............... ....++.++.+||.+||+.||.+|||+.++++||||+..
T Consensus 261 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 222222111111100 015689999999999999999999999999999999753
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=399.51 Aligned_cols=258 Identities=15% Similarity=0.144 Sum_probs=191.7
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC--CCCCeeeeccc--
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL--THPNIVRYLGT-- 137 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L--~HpNIV~l~g~-- 137 (668)
....|++.+.||+|+||+||+|++..+|+.||||++..... ........+.+|+.++..| +|||||+++..
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~ 134 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAE-----NSRSELERLHEATFAAARLLGESPEEARDRRRLL 134 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCST-----THHHHHHHHHHHHHHHHHHHC----------CBC
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEeccc-----ccccHHHHHHHHHHHHHHhcccChhhhhhceeEE
Confidence 34569999999999999999999999999999999854321 1223345567775444444 69998885533
Q ss_pred -----cccC-----------------CcceEEeeccCCCChhcccccC-CCCCHHHH------HHHHHHHHHHHHHHHhC
Q 005944 138 -----ARED-----------------DSLNILLEFVPGGSISSLLGKF-GSFPESVI------RMYTKQLLLGLEYLHKN 188 (668)
Q Consensus 138 -----~~~~-----------------~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~------~~i~~QIl~aL~yLHs~ 188 (668)
+... ..+|||||||+ |+|.+++... ..+.+... ..++.||+.||+|||++
T Consensus 135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~ 213 (371)
T 3q60_A 135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK 213 (371)
T ss_dssp CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHC
Confidence 2222 33799999998 8999999764 33444444 57779999999999999
Q ss_pred CcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhh--cCCCcchhHHHHHHHHHHHHh
Q 005944 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ--TGHSFSADIWSVGCTVIEMAT 266 (668)
Q Consensus 189 gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGvILyeLLT 266 (668)
||+||||||+||||+.+|.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||+||+|+|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt 288 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC 288 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC-----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence 9999999999999999999999999999865321 113457799999999987 679999999999999999999
Q ss_pred CCCCCchhHHHHHHHHh------hccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 267 GKPPWSQQFQEVAALFH------IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 267 G~~PF~~~~~~~~~~~~------~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
|+.||..........+. ........+.+..++.++.+||.+||+.||.+|||+.++|+||||+.
T Consensus 289 g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 289 LFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp SSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred CCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 99999754221111000 01111222333578999999999999999999999999999999974
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=398.53 Aligned_cols=256 Identities=30% Similarity=0.500 Sum_probs=204.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||+||+|++..+|+.||||++.... ....+|+++|+.++|||||++++++..
T Consensus 51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------------~~~~~E~~il~~l~hpniv~l~~~~~~ 118 (420)
T 1j1b_A 51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------------RFKNRELQIMRKLDHCNIVRLRYFFYS 118 (420)
T ss_dssp CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------------TSCCHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------------hhHHHHHHHHHHcCCCCccceeeEEec
Confidence 34557999999999999999999999999999999884321 112369999999999999999998743
Q ss_pred ------CCcceEEeeccCCCChhcccc----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-CceE
Q 005944 141 ------DDSLNILLEFVPGGSISSLLG----KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK-GCIK 209 (668)
Q Consensus 141 ------~~~~~LVmEy~~gGsL~~~L~----~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~-g~vK 209 (668)
...+++||||+++ +|..++. ....+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+|
T Consensus 119 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~k 197 (420)
T 1j1b_A 119 SGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 197 (420)
T ss_dssp EETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEE
T ss_pred cCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEE
Confidence 2236799999986 5555543 34679999999999999999999999999999999999999965 6789
Q ss_pred EecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhcc
Q 005944 210 LADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGT 286 (668)
Q Consensus 210 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~ 286 (668)
|+|||+++.+... ......+||+.|+|||++.+. .|+.++||||||||||||++|++||.... ..+..++....
T Consensus 198 l~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg 274 (420)
T 1j1b_A 198 LCDFGSAKQLVRG---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG 274 (420)
T ss_dssp ECCCTTCEECCTT---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eccchhhhhcccC---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 9999999865322 223457899999999999775 68999999999999999999999997542 22222222100
Q ss_pred ------------CC---CCCC---------CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 287 ------------TK---SHPP---------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 287 ------------~~---~~~~---------~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.. ..+. ++..++.++.+||.+||+.||.+||++.|+++||||+...
T Consensus 275 ~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 275 TPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 344 (420)
T ss_dssp SCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccc
Confidence 00 0000 2345689999999999999999999999999999997643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=398.84 Aligned_cols=258 Identities=25% Similarity=0.412 Sum_probs=190.2
Q ss_pred CCeee-eeEEcccCceEEEEEEEc--CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc--
Q 005944 64 IRWRK-GELVGCGAFGRVYMGMNL--DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA-- 138 (668)
Q Consensus 64 ~ry~i-~~~LG~G~fG~Vy~a~~~--~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~-- 138 (668)
..|++ +++||+|+||+||+|++. .++..||||++..... ...+.+|+.+|+.++|||||++++++
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----------~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----------SMSACREIALLRELKHPNVISLQKVFLS 89 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----------CHHHHHHHHHHHHCCCTTBCCCCEEEEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----------CHHHHHHHHHHHhcCCCCeeeEeeEEec
Confidence 45776 568999999999999976 4689999999842211 12466899999999999999999998
Q ss_pred ccCCcceEEeeccCCCChhcccccC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe----CCC
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKF---------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV----DNK 205 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~---------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl----d~~ 205 (668)
.....+||||||+.+ +|.+++... ..+++..++.|+.||+.||.|||++||+||||||+|||| +.+
T Consensus 90 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~ 168 (405)
T 3rgf_A 90 HADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 168 (405)
T ss_dssp TTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTT
T ss_pred CCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCC
Confidence 457789999999975 777776422 249999999999999999999999999999999999999 677
Q ss_pred CceEEecCCchhhhHhhhh-hcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhH--------
Q 005944 206 GCIKLADFGASKKVVELAT-INGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQF-------- 275 (668)
Q Consensus 206 g~vKL~DFGlA~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~-------- 275 (668)
+.+||+|||+++.+..... .......+||+.|+|||++.+. .++.++||||||||||+|++|.+||....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~ 248 (405)
T 3rgf_A 169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP 248 (405)
T ss_dssp TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence 8999999999987643211 1223457899999999999875 48999999999999999999999995322
Q ss_pred ---HHHHHHHhhccCCCCCC---------------------------------CCcccCHHHHHHHHHhhhhCCCCCCCH
Q 005944 276 ---QEVAALFHIGTTKSHPP---------------------------------IPEHLSMEAKDFLLKCLQKEPYLRSTA 319 (668)
Q Consensus 276 ---~~~~~~~~~~~~~~~~~---------------------------------~p~~ls~el~dLI~kcL~~dP~~RPSa 319 (668)
..+..++.......... .....+.++.+||.+||+.||.+|||+
T Consensus 249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta 328 (405)
T 3rgf_A 249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328 (405)
T ss_dssp CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 11222222111110000 001126788999999999999999999
Q ss_pred HHHHcCccccCCC
Q 005944 320 SELLQHPFVTGKY 332 (668)
Q Consensus 320 ~EIL~Hpwf~~~~ 332 (668)
.|+|+||||+...
T Consensus 329 ~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 329 EQAMQDPYFLEDP 341 (405)
T ss_dssp HHHHTSGGGTSSS
T ss_pred HHHhcChhhccCC
Confidence 9999999998654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-45 Score=383.11 Aligned_cols=255 Identities=24% Similarity=0.400 Sum_probs=212.2
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCc---EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~---~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
+....+|++.+.||+|+||+||+|.+..++. .||||++... ......+.+.+|+.+|+.++||||+++++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 117 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-------YTERQRRDFLSEASIMGQFDHPNIIRLEG 117 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-------CCHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-------CCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence 4667899999999999999999999986554 5999998421 12233466889999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++......|+||||+++|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 197 (325)
T 3kul_A 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGL 197 (325)
T ss_dssp EECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSS
T ss_pred EEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCc
Confidence 999999999999999999999999654 6799999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhh-hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHH-HHHHhhccCCCCCC
Q 005944 216 SKKVVELAT-INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEV-AALFHIGTTKSHPP 292 (668)
Q Consensus 216 A~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~-~~~~~~~~~~~~~~ 292 (668)
++.+..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||....... ..... .....+
T Consensus 198 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---~~~~~~ 274 (325)
T 3kul_A 198 SRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE---EGYRLP 274 (325)
T ss_dssp CEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH---TTCCCC
T ss_pred ccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---cCCCCC
Confidence 986543221 112223456888999999999999999999999999999999 999997544322 22221 223445
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.+..++.++.+||.+||..||.+|||+.+|++
T Consensus 275 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 275 APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 66789999999999999999999999999986
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=369.14 Aligned_cols=253 Identities=25% Similarity=0.405 Sum_probs=213.3
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.+...+|++.+.||+|+||+||+|.+. ++..||||++..... ..+.+.+|+.++++++||||+++++++.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 75 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---------SEEDFIEEAEVMMKLSHPKLVQLYGVCL 75 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB---------CHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc---------CHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 356678999999999999999999986 577899999843211 1134788999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
+....++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 76 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 155 (269)
T 4hcu_A 76 EQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 155 (269)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGG
T ss_pred cCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccc
Confidence 999999999999999999999654 5699999999999999999999999999999999999999999999999999986
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~~l 297 (668)
..... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||............ ........+..+
T Consensus 156 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~ 232 (269)
T 4hcu_A 156 VLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI--STGFRLYKPRLA 232 (269)
T ss_dssp BCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH--HTTCCCCCCTTS
T ss_pred ccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--hcCccCCCCCcC
Confidence 54332 223345567889999999999999999999999999999999 99999764432211111 122334456678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+.++.+||.+||+.||.+||++.++++|
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999999999999999999976
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=377.79 Aligned_cols=263 Identities=26% Similarity=0.401 Sum_probs=218.3
Q ss_pred CCCCCCCCCCCCCeeeeeEEcccCceEEEEEEE-----cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-
Q 005944 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMN-----LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL- 126 (668)
Q Consensus 53 ~pp~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L- 126 (668)
.+.....+....+|++.+.||+|+||+||+|++ ..++..||||++.... .....+.+.+|+.+|..+
T Consensus 12 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~ 84 (313)
T 1t46_A 12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-------HLTEREALMSELKVLSYLG 84 (313)
T ss_dssp SCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHC
T ss_pred CCCccccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-------hHHHHHHHHHHHHHHhhcc
Confidence 334444567788999999999999999999985 4578899999984221 122346688999999999
Q ss_pred CCCCeeeeccccccCCcceEEeeccCCCChhcccccCC------------------CCCHHHHHHHHHHHHHHHHHHHhC
Q 005944 127 THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG------------------SFPESVIRMYTKQLLLGLEYLHKN 188 (668)
Q Consensus 127 ~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~------------------~l~e~~~~~i~~QIl~aL~yLHs~ 188 (668)
+||||+++++++...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++
T Consensus 85 ~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 164 (313)
T 1t46_A 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK 164 (313)
T ss_dssp CCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999999999999999999999999999987653 489999999999999999999999
Q ss_pred CcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-C
Q 005944 189 GIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-G 267 (668)
Q Consensus 189 gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G 267 (668)
||+||||||+||||+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |
T Consensus 165 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 244 (313)
T 1t46_A 165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244 (313)
T ss_dssp TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999986644332222334567889999999999999999999999999999999 9
Q ss_pred CCCCchhH--HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 268 KPPWSQQF--QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 268 ~~PF~~~~--~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
..||.... ......... ......+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 245 ~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 245 SSPYPGMPVDSKFYKMIKE---GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CCSSTTCCSSHHHHHHHHH---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccchhHHHHHhcc---CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 99996532 222222221 22334456789999999999999999999999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=380.67 Aligned_cols=258 Identities=25% Similarity=0.347 Sum_probs=207.7
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCC-cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC------e
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSG-ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN------I 131 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg-~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN------I 131 (668)
++....+|++.+.||+|+||+||+|.+..++ ..||||++.. .......+.+|+.+|+.+.|++ |
T Consensus 14 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~---------~~~~~~~~~~E~~~l~~l~~~~~~~~~~~ 84 (355)
T 2eu9_A 14 GDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN---------VGKYREAARLEINVLKKIKEKDKENKFLC 84 (355)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS---------CHHHHHHHHHHHHHHHHHHHHCTTSCSCB
T ss_pred CceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc---------cccchhHHHHHHHHHHHHhhcCCCCceeE
Confidence 4567789999999999999999999998877 7999999832 1123355778999999987665 8
Q ss_pred eeeccccccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe-------
Q 005944 132 VRYLGTAREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV------- 202 (668)
Q Consensus 132 V~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl------- 202 (668)
+.+++++.....+++||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~ 163 (355)
T 2eu9_A 85 VLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET 163 (355)
T ss_dssp CCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEE
T ss_pred EEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccc
Confidence 99999999999999999999 55666666544 469999999999999999999999999999999999999
Q ss_pred ------------CCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCC
Q 005944 203 ------------DNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPP 270 (668)
Q Consensus 203 ------------d~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~P 270 (668)
+.++.+||+|||+++... ......+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 164 ~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p 238 (355)
T 2eu9_A 164 LYNEHKSCEEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTL 238 (355)
T ss_dssp EECCC-CCCEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCC
Confidence 567899999999997532 223456899999999999999999999999999999999999999
Q ss_pred CchhHHH--HHHHHhhccCC---------------------------------------CCCCCCcccCHHHHHHHHHhh
Q 005944 271 WSQQFQE--VAALFHIGTTK---------------------------------------SHPPIPEHLSMEAKDFLLKCL 309 (668)
Q Consensus 271 F~~~~~~--~~~~~~~~~~~---------------------------------------~~~~~p~~ls~el~dLI~kcL 309 (668)
|...... ...+....... .........+.++.+||.+||
T Consensus 239 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 318 (355)
T 2eu9_A 239 FQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRML 318 (355)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHT
T ss_pred CCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHh
Confidence 9754321 11111110000 000111223568899999999
Q ss_pred hhCCCCCCCHHHHHcCccccCC
Q 005944 310 QKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 310 ~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
+.||.+|||+.|+|+||||++.
T Consensus 319 ~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 319 EFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp CSSTTTSCCHHHHTTSGGGGGC
T ss_pred cCChhhCcCHHHHhcChhhcCC
Confidence 9999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=387.20 Aligned_cols=261 Identities=28% Similarity=0.409 Sum_probs=195.8
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+|..||||++...... .....++++.+..++|||||++++++..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~~l~~l~h~niv~~~~~~~~ 90 (360)
T 3e3p_A 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---------RNRELQIMQDLAVLHHPNIVQLQSYFYT 90 (360)
T ss_dssp HHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---------CCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred hhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---------cHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence 3346899999999999999999999999999999988432211 1234567888888999999999999865
Q ss_pred CCc-------ceEEeeccCCCChh---cccccCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCCcccEEeCC-CCc
Q 005944 141 DDS-------LNILLEFVPGGSIS---SLLGKFGSFPESVIRMYTKQLLLGLEYLH--KNGIMHRDIKGANILVDN-KGC 207 (668)
Q Consensus 141 ~~~-------~~LVmEy~~gGsL~---~~L~~~~~l~e~~~~~i~~QIl~aL~yLH--s~gIvHrDLKPeNILld~-~g~ 207 (668)
... +++||||+.++.+. .++.....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.
T Consensus 91 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 91 LGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp ECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTE
T ss_pred cccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCc
Confidence 433 78999999875332 33345678999999999999999999999 999999999999999996 899
Q ss_pred eEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhh
Q 005944 208 IKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHI 284 (668)
Q Consensus 208 vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~ 284 (668)
+||+|||+++.+... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...... ...+...
T Consensus 171 ~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 247 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPS---EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRV 247 (360)
T ss_dssp EEECCCTTCBCCCTT---SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEeeCCCceecCCC---CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHH
Confidence 999999999865432 2234567999999999997655 899999999999999999999999754321 1111111
Q ss_pred ccCC---------------------------CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 285 GTTK---------------------------SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 285 ~~~~---------------------------~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.... .........+.++.+||.+||+.||.+|||+.|+|+||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCC
Confidence 0000 001122236789999999999999999999999999999987544
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=384.70 Aligned_cols=259 Identities=22% Similarity=0.339 Sum_probs=214.9
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIV 132 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV 132 (668)
++....+|++.+.||+|+||+||+|++. .++..||||++.... .......+.+|+.+|..+ .||||+
T Consensus 40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~hp~iv 112 (344)
T 1rjb_A 40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-------DSSEREALMSELKMMTQLGSHENIV 112 (344)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-------CHHHHHHHHHHHHHHHhhcCCCCee
Confidence 4567789999999999999999999973 467789999984221 123345688999999999 899999
Q ss_pred eeccccccCCcceEEeeccCCCChhcccccCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 005944 133 RYLGTAREDDSLNILLEFVPGGSISSLLGKFG-----------------------SFPESVIRMYTKQLLLGLEYLHKNG 189 (668)
Q Consensus 133 ~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~-----------------------~l~e~~~~~i~~QIl~aL~yLHs~g 189 (668)
++++++...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++|
T Consensus 113 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 192 (344)
T 1rjb_A 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 192 (344)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999997643 3789999999999999999999999
Q ss_pred cccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CC
Q 005944 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GK 268 (668)
Q Consensus 190 IvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~ 268 (668)
|+||||||+||||+.++.+||+|||++..+.............||+.|+|||++.+..++.++|||||||++|+|+| |.
T Consensus 193 ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred cccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999986644332222334567889999999999999999999999999999998 99
Q ss_pred CCCchhH--HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcc
Q 005944 269 PPWSQQF--QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327 (668)
Q Consensus 269 ~PF~~~~--~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpw 327 (668)
.||.... ........ .......+..++.++.+||.+||+.||.+|||+.++++|-.
T Consensus 273 ~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 273 NPYPGIPVDANFYKLIQ---NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp CSSTTCCCSHHHHHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCcccCCcHHHHHHHHh---cCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence 9997542 22222222 22334556778999999999999999999999999998754
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=373.80 Aligned_cols=261 Identities=31% Similarity=0.510 Sum_probs=209.2
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEc-CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC---CCCCeeeeccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNL-DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL---THPNIVRYLGT 137 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~-~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIV~l~g~ 137 (668)
...+|++.+.||+|+||+||+|.+. .+|+.||||++......... ...+.+|+.+++.+ .||||++++++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~------~~~~~~e~~~l~~l~~~~h~~i~~~~~~ 82 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM------PLSTIREVAVLRHLETFEHPNVVRLFDV 82 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSC------BCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccC------CchhhHHHHHHHhhhccCCCCeEeeeee
Confidence 4478999999999999999999995 67899999998643321111 11234566666555 89999999999
Q ss_pred cc-----cCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEE
Q 005944 138 AR-----EDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 138 ~~-----~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL 210 (668)
+. ....+++||||+. |+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp EEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEE
Confidence 86 5677899999998 5999998764 34999999999999999999999999999999999999999999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhccC-
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIGTT- 287 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~~~- 287 (668)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+......
T Consensus 162 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 238 (326)
T 1blx_A 162 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 238 (326)
T ss_dssp CSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 9999997654322 234567999999999999999999999999999999999999999754321 1222211000
Q ss_pred ---------------------CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 288 ---------------------KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 288 ---------------------~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.....+...++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 000123356889999999999999999999999999999998643
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=370.17 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=211.7
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
.+.+...+|++.+.||+|+||+||+|.+. ++..||||++..... . ...+.+|+.+|+.++||||++++++
T Consensus 18 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~------~---~~~~~~E~~~l~~l~h~~i~~~~~~ 87 (283)
T 3gen_A 18 SWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM------S---EDEFIEEAKVMMNLSHEKLVQLYGV 87 (283)
T ss_dssp TTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB------C---HHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC------C---HHHHHHHHHHHhcCCCCCEeeEEEE
Confidence 34577789999999999999999999875 677899999843211 1 1347789999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+.....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 167 (283)
T 3gen_A 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167 (283)
T ss_dssp ECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGG
T ss_pred EecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccc
Confidence 9999999999999999999999976 467999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHH-HHHHhhccCCCCCCCC
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEV-AALFHIGTTKSHPPIP 294 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~-~~~~~~~~~~~~~~~p 294 (668)
+....... .......+|+.|+|||++.+..++.++|||||||++|+|+| |+.||....... ..... .......+
T Consensus 168 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~---~~~~~~~~ 243 (283)
T 3gen_A 168 RYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---QGLRLYRP 243 (283)
T ss_dssp GGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH---TTCCCCCC
T ss_pred cccccccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh---cccCCCCC
Confidence 86543322 22344567889999999999999999999999999999998 999997543322 22221 12234456
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
..++..+.+||.+||+.+|.+|||+.++++|
T Consensus 244 ~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 244 HLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 6788999999999999999999999999986
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=394.37 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=215.5
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
.+.....+|++.+.||+|+||.||+|++..+++.||||++... ........+.+|+++|+.++|||||+++++
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 180 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-------LPPDLKAKFLQEARILKQYSHPNIVRLIGV 180 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-------SCHHHHTTTTHHHHHHTTCCCTTBCCEEEE
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-------CCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3456677999999999999999999999999999999987421 122334567889999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+...+.+|+||||+++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 181 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s 260 (377)
T 3cbl_A 181 CTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260 (377)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCc
Confidence 99999999999999999999999765 35999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~ 295 (668)
+...............+++.|+|||++.+..++.++|||||||++|||+| |..||............ ......+.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~--~~~~~~~~~~ 338 (377)
T 3cbl_A 261 REEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV--EKGGRLPCPE 338 (377)
T ss_dssp EECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH--HTTCCCCCCT
T ss_pred eecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH--HcCCCCCCCC
Confidence 75432211111122335778999999998889999999999999999998 99999765432222111 1233455677
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.++.++.+||.+||+.||.+|||+.+|++
T Consensus 339 ~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 339 LCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 88999999999999999999999999985
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-45 Score=378.73 Aligned_cols=261 Identities=26% Similarity=0.471 Sum_probs=207.3
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC----CCCCee
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL----THPNIV 132 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L----~HpNIV 132 (668)
...+....+|++.+.||+|+||.||+|.+..+++.||||++....... .........+.+|+.++..+ +|+||+
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~ 101 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLG--WSPLSDSVTCPLEVALLWKVGAGGGHPGVI 101 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC----------CCCCHHHHHHHHHHSSCCCSSBC
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccc--cccchhhHHHHHHHHHHHhhcccCCCCCee
Confidence 334567789999999999999999999999999999999984322111 11112233456789999988 899999
Q ss_pred eeccccccCCcceEEeec-cCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC-CCCceEE
Q 005944 133 RYLGTAREDDSLNILLEF-VPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD-NKGCIKL 210 (668)
Q Consensus 133 ~l~g~~~~~~~~~LVmEy-~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld-~~g~vKL 210 (668)
++++++...+..++|||| +.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||
T Consensus 102 ~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 102 RLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp CEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEE
T ss_pred eEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEE
Confidence 999999999999999999 78999999998888899999999999999999999999999999999999999 8899999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCC-cchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCC
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHS-FSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS 289 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s-~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~ 289 (668)
+|||++..... .......||+.|+|||++.+..+. .++|||||||++|+|++|+.||....... . .
T Consensus 182 ~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~----~-----~ 248 (312)
T 2iwi_A 182 IDFGSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEIL----E-----A 248 (312)
T ss_dssp CCCSSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----H-----T
T ss_pred EEcchhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHHh----h-----h
Confidence 99999876532 223456799999999999877764 58999999999999999999997643211 1 1
Q ss_pred CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 290 ~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
...++..++.++.+||.+||+.||.+|||+.++++||||+...
T Consensus 249 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 249 ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 2335667899999999999999999999999999999998643
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=380.77 Aligned_cols=259 Identities=26% Similarity=0.434 Sum_probs=216.4
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEc-------CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CC
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNL-------DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-TH 128 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~-------~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~H 128 (668)
+.+.....+|++.+.||+|+||+||+|.+. .++..||||++... ........+.+|+.+|+.+ +|
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~h 100 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-------ATEKDLSDLVSEMEMMKMIGKH 100 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-------CCHHHHHHHHHHHHHHHHHCCC
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-------CcHHHHHHHHHHHHHHHHhhcC
Confidence 344577889999999999999999999986 46788999998421 1233456788999999999 89
Q ss_pred CCeeeeccccccCCcceEEeeccCCCChhcccccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 005944 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG----------------SFPESVIRMYTKQLLLGLEYLHKNGIMH 192 (668)
Q Consensus 129 pNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIvH 192 (668)
|||+++++++...+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+|
T Consensus 101 p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 180 (334)
T 2pvf_A 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIH 180 (334)
T ss_dssp TTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 999999999999999999999999999999997653 3899999999999999999999999999
Q ss_pred ccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCC
Q 005944 193 RDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPW 271 (668)
Q Consensus 193 rDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF 271 (668)
|||||+||||+.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus 181 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 181 RDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY 260 (334)
T ss_dssp SCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999986544333333445567899999999999889999999999999999999 99999
Q ss_pred chhHH-HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 272 SQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 272 ~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
..... +....... ......+..++.++.+||.+||+.||.+||++.+++++
T Consensus 261 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 261 PGIPVEELFKLLKE---GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TTCCHHHHHHHHHH---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCHHHHHHHHhc---CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 75432 22222222 22344567889999999999999999999999999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=385.59 Aligned_cols=258 Identities=28% Similarity=0.451 Sum_probs=209.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-----------CC
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-----------HP 129 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-----------Hp 129 (668)
....+|++.+.||+|+||+||+|++..+++.||||++.. .......+.+|+.+++.+. |+
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 86 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG---------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---------CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC---------CccchhhhhHHHHHHHHhhcccccchhccccc
Confidence 456789999999999999999999999999999999842 1123345678899888886 89
Q ss_pred CeeeeccccccCC----cceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEe
Q 005944 130 NIVRYLGTAREDD----SLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILV 202 (668)
Q Consensus 130 NIV~l~g~~~~~~----~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILl 202 (668)
||+++++++.... .+++||||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+||||
T Consensus 87 ~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll 165 (373)
T 1q8y_A 87 HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165 (373)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred hHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEE
Confidence 9999999987654 789999999 88999998763 4599999999999999999999998 99999999999999
Q ss_pred C------CCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-
Q 005944 203 D------NKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF- 275 (668)
Q Consensus 203 d------~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~- 275 (668)
+ ..+.+||+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|+|+||..||....
T Consensus 166 ~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 240 (373)
T 1q8y_A 166 EIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEG 240 (373)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred eccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcc
Confidence 4 445899999999976532 2345689999999999999999999999999999999999999996432
Q ss_pred -------HHHHHHHhhccC-------------------------------------CCCCCCCcccCHHHHHHHHHhhhh
Q 005944 276 -------QEVAALFHIGTT-------------------------------------KSHPPIPEHLSMEAKDFLLKCLQK 311 (668)
Q Consensus 276 -------~~~~~~~~~~~~-------------------------------------~~~~~~p~~ls~el~dLI~kcL~~ 311 (668)
.....+...... .....++..++.++.+||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 320 (373)
T 1q8y_A 241 HSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320 (373)
T ss_dssp ----CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCS
T ss_pred cccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhcc
Confidence 111111111000 001123456678899999999999
Q ss_pred CCCCCCCHHHHHcCccccCCCC
Q 005944 312 EPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 312 dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
||.+|||+.|+|+||||++...
T Consensus 321 dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 321 DPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp STTTCBCHHHHHTCGGGTTCTT
T ss_pred CccccCCHHHHhhChhhhcccC
Confidence 9999999999999999987543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=392.89 Aligned_cols=256 Identities=30% Similarity=0.514 Sum_probs=203.1
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||+||+|++..++. ||+|++..... ...+|+.+|+.++|||||++++++..
T Consensus 37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------------~~~~E~~il~~l~h~niv~l~~~~~~ 103 (394)
T 4e7w_A 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------------FKNRELQIMRIVKHPNVVDLKAFFYS 103 (394)
T ss_dssp EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------------SCCHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------------hHHHHHHHHHhCCCCCcceEEEEEEe
Confidence 445689999999999999999999887665 88888743211 12368999999999999999999854
Q ss_pred CC------cceEEeeccCCCChhccc---ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC-CCCceEE
Q 005944 141 DD------SLNILLEFVPGGSISSLL---GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD-NKGCIKL 210 (668)
Q Consensus 141 ~~------~~~LVmEy~~gGsL~~~L---~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld-~~g~vKL 210 (668)
.. .+++||||++++.+..+. .....+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||
T Consensus 104 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL 183 (394)
T 4e7w_A 104 NGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKL 183 (394)
T ss_dssp ESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEE
T ss_pred cCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEE
Confidence 33 388999999875444332 2356799999999999999999999999999999999999999 7999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccC
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTT 287 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~ 287 (668)
+|||+++.+... ......+||+.|+|||++.+. .|+.++|||||||++|+|++|++||.... .....+......
T Consensus 184 ~DFG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~ 260 (394)
T 4e7w_A 184 IDFGSAKILIAG---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGT 260 (394)
T ss_dssp CCCTTCEECCTT---CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeCCCcccccCC---CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999999865322 233457899999999999775 48999999999999999999999997542 122222211000
Q ss_pred ---------------CCCC---------CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 288 ---------------KSHP---------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 288 ---------------~~~~---------~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
...+ .++..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 261 PSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELR 329 (394)
T ss_dssp CCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred CCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhc
Confidence 0000 12335789999999999999999999999999999998654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=382.99 Aligned_cols=264 Identities=25% Similarity=0.375 Sum_probs=213.8
Q ss_pred CCCCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeee
Q 005944 55 PIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 55 p~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l 134 (668)
+.........+|++.+.||+|+||+||+|++ .++..||||++.... ......+.+|+.+|+.++||||+++
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~~iv~~ 100 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES--------SQGIEEFETEIETLSFCRHPHLVSL 100 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC--------SSHHHHHHHHHHGGGSCCCTTBCCE
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC--------hHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 3444556778999999999999999999985 468999999874321 1234567899999999999999999
Q ss_pred ccccccCCcceEEeeccCCCChhcccccCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEE
Q 005944 135 LGTAREDDSLNILLEFVPGGSISSLLGKFG----SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 135 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~----~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL 210 (668)
++++...+..++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||
T Consensus 101 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl 180 (321)
T 2qkw_B 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKI 180 (321)
T ss_dssp EEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEE
T ss_pred EEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEE
Confidence 999999999999999999999999996643 5899999999999999999999999999999999999999999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-------HH-HHHH
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-------EV-AALF 282 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-------~~-~~~~ 282 (668)
+|||+++...............||+.|+|||++.+..++.++|||||||++|+|+||+.||..... .. ....
T Consensus 181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 999998754322222223345689999999999999999999999999999999999999964211 00 0000
Q ss_pred hhc------cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcc
Q 005944 283 HIG------TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327 (668)
Q Consensus 283 ~~~------~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpw 327 (668)
... .......++..++.++.+||.+||+.||.+|||+.++++|-.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 000 011112234456778999999999999999999999998754
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=364.13 Aligned_cols=254 Identities=28% Similarity=0.517 Sum_probs=203.6
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
+....+|++.+.||+|+||+||+|.+ ++..||||++..... .......+.+.+|+.+++.++||||+++++++.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 76 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPD----EDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC--------------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCc----ccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 35567899999999999999999987 489999998843221 111233456889999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCCcccEEeCC--------CCce
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG---IMHRDIKGANILVDN--------KGCI 208 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~g---IvHrDLKPeNILld~--------~g~v 208 (668)
.....++||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.+
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 77 KEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp CC--CEEEEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred cCCceEEEEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence 99999999999999999999864 58999999999999999999999999 899999999999986 7789
Q ss_pred EEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCC
Q 005944 209 KLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTK 288 (668)
Q Consensus 209 KL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~ 288 (668)
||+|||++....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||........ ........
T Consensus 156 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~ 230 (271)
T 3dtc_A 156 KITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV-AYGVAMNK 230 (271)
T ss_dssp EECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH-HHHHHTSC
T ss_pred EEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHhhhcCC
Confidence 999999998654322 2245799999999999999999999999999999999999999976543322 22222334
Q ss_pred CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 289 SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 289 ~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
...+.+..++.++.+||.+||+.||.+|||+.++++|
T Consensus 231 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 231 LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 4456677899999999999999999999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=376.33 Aligned_cols=259 Identities=22% Similarity=0.366 Sum_probs=216.9
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCee
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV 132 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV 132 (668)
.+.....+|++.+.||+|+||+||+|++. .++..||||++... ........+.+|+.+|+.++||||+
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~ 91 (322)
T 1p4o_A 19 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-------ASMRERIEFLNEASVMKEFNCHHVV 91 (322)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-------SCHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred hhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-------cCHHHHHHHHHHHHHHHhcCCCCEe
Confidence 34567789999999999999999999876 36789999988421 1223345678999999999999999
Q ss_pred eeccccccCCcceEEeeccCCCChhcccccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe
Q 005944 133 RYLGTAREDDSLNILLEFVPGGSISSLLGKF----------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV 202 (668)
Q Consensus 133 ~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~----------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl 202 (668)
++++++......++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||
T Consensus 92 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli 171 (322)
T 1p4o_A 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 171 (322)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred eeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE
Confidence 9999999999999999999999999998653 457999999999999999999999999999999999999
Q ss_pred CCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHH
Q 005944 203 DNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAAL 281 (668)
Q Consensus 203 d~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~ 281 (668)
+.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||..........
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 251 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH
Confidence 9999999999999987654433333344567899999999999999999999999999999999 899997543322111
Q ss_pred HhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 282 FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 282 ~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
... .......+..++.++.+||.+||+.||.+|||+.++++|
T Consensus 252 ~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 252 FVM--EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHH--TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHH--cCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 111 122344567889999999999999999999999999986
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=372.19 Aligned_cols=259 Identities=27% Similarity=0.462 Sum_probs=212.6
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEE----EcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGM----NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~----~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l 134 (668)
......+|++.+.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+|+.++||||+++
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~i~~~ 88 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-------GGNHIADLKKEIEILRNLYHENIVKY 88 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------------CCHHHHHHHHHHHHTCCCTTBCCE
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-------cchhHHHHHHHHHHHHhCCCCCeeee
Confidence 34666789999999999999999998 56789999999984321 12234567899999999999999999
Q ss_pred ccccccC--CcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 135 LGTARED--DSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 135 ~g~~~~~--~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
++++... ..+++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 89 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~ 168 (302)
T 4e5w_A 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 168 (302)
T ss_dssp EEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred eeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEEC
Confidence 9998876 668999999999999999944 4679999999999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhhhhh-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH------------
Q 005944 212 DFGASKKVVELATI-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV------------ 278 (668)
Q Consensus 212 DFGlA~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~------------ 278 (668)
|||++..+...... .......||+.|+|||++.+..++.++|||||||++|+|+||..||.......
T Consensus 169 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 248 (302)
T 4e5w_A 169 DFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248 (302)
T ss_dssp CCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGH
T ss_pred cccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccC
Confidence 99999765432211 22345678999999999999999999999999999999999999875432211
Q ss_pred -HHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 279 -AALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 279 -~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.............+.+..++.++.+||.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 249 VTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 1112222233345567789999999999999999999999999986
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=381.57 Aligned_cols=254 Identities=24% Similarity=0.442 Sum_probs=204.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEE----EEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELL----AVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~V----AVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
....+|++.++||+|+||+||+|++..++..+ |+|.+.. .........+.+|+.+|+.++|||||++++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 84 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE-------ATSPKANKEILDEAYVMASVDNPHVCRLLG 84 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------------CHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccc-------ccCHHHHHHHHHHHHHHHhCCCCCEeEEEE
Confidence 45678999999999999999999998888765 5565421 112233456889999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++.... .++|+||+.+|+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 85 ~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~ 163 (327)
T 3poz_A 85 ICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGL 163 (327)
T ss_dssp EEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTH
T ss_pred EEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcc
Confidence 998754 7899999999999999876 46799999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~ 293 (668)
++.+.............||+.|+|||++.+..++.++|||||||++|+|+| |..||..... ....... .....+.
T Consensus 164 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~~~~~ 240 (327)
T 3poz_A 164 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGERLPQ 240 (327)
T ss_dssp HHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCCCCC
T ss_pred eeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH---cCCCCCC
Confidence 987654433333344567889999999999999999999999999999999 9999975432 2222222 2223455
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+..++.++.+||.+||+.||.+||++.+++++
T Consensus 241 ~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 241 PPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 67789999999999999999999999999976
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=370.56 Aligned_cols=254 Identities=26% Similarity=0.436 Sum_probs=201.0
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCC---CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDS---GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
+....+|++.+.||+|+||+||+|.+..+ +..||||++... ......+.+.+|+.+|+.++||||+++++
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 83 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-------TSDSVREKFLQEALTMRQFDHPHIVKLIG 83 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-------TSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-------CCHHHHHHHHHHHHHHHhCCCCccceEEE
Confidence 56778999999999999999999998654 457999987321 12334567889999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++. ++..|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 84 ~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 162 (281)
T 1mp8_A 84 VIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGL 162 (281)
T ss_dssp EEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---
T ss_pred EEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccc
Confidence 984 567899999999999999997653 699999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~ 293 (668)
++....... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... +....+. .....+.
T Consensus 163 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~---~~~~~~~ 238 (281)
T 1mp8_A 163 SRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---NGERLPM 238 (281)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCCCCC
T ss_pred ccccCcccc-cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH---cCCCCCC
Confidence 987643221 22234567889999999999999999999999999999997 9999975322 1111111 1223456
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 239 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 239 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 77899999999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=382.35 Aligned_cols=267 Identities=27% Similarity=0.440 Sum_probs=217.2
Q ss_pred CCCCCCCCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC--C
Q 005944 51 PALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT--H 128 (668)
Q Consensus 51 p~~pp~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--H 128 (668)
....+....+....+|++.+.||+|+||+||+|++..+++.||||++........... .....+.+|+.+++.+. |
T Consensus 30 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~--~~~~~~~~E~~~l~~l~~~~ 107 (320)
T 3a99_A 30 TKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGEL--PNGTRVPMEVVLLKKVSSGF 107 (320)
T ss_dssp ----------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEEC--TTCCEEEHHHHHHHHHCSSS
T ss_pred hccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhh--hhhhHHHHHHHHHHhhccCC
Confidence 3445555667888999999999999999999999999999999999854322110000 01123557899999996 5
Q ss_pred CCeeeeccccccCCcceEEeeccCC-CChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC-CCC
Q 005944 129 PNIVRYLGTAREDDSLNILLEFVPG-GSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD-NKG 206 (668)
Q Consensus 129 pNIV~l~g~~~~~~~~~LVmEy~~g-GsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld-~~g 206 (668)
+||+++++++...+..++||||+.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+ .++
T Consensus 108 ~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 187 (320)
T 3a99_A 108 SGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG 187 (320)
T ss_dssp CSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT
T ss_pred CCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC
Confidence 9999999999999999999999976 89999998888999999999999999999999999999999999999999 789
Q ss_pred ceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhc
Q 005944 207 CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIG 285 (668)
Q Consensus 207 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~ 285 (668)
.+||+|||+++.+.. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... .
T Consensus 188 ~~kL~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~----~-- 257 (320)
T 3a99_A 188 ELKLIDFGSGALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII----R-- 257 (320)
T ss_dssp EEEECCCTTCEECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHH----H--
T ss_pred CEEEeeCcccccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhhh----c--
Confidence 999999999876532 22345679999999999988776 688999999999999999999997643211 1
Q ss_pred cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 286 ~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.....+..++.++.+||.+||+.||.+|||+.+|++||||+...
T Consensus 258 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 258 ---GQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp ---CCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ---ccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 12234567899999999999999999999999999999998643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=374.62 Aligned_cols=258 Identities=22% Similarity=0.348 Sum_probs=206.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|.+..+++.||||++... ..........+.+|+.+++.++||||+++++++..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 105 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSET-----LSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI 105 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGG-----GGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcc-----cccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence 4457899999999999999999999999999999998422 12233445678899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
.+..|+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 106 DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 99999999999999999999888889999999999999999999999999999999999999999999999999997654
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHH
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......................+..++.+
T Consensus 186 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (309)
T 2h34_A 186 DEK-LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVA 264 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTH
T ss_pred ccc-cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHH
Confidence 322 1223356799999999999988899999999999999999999999986554432222222222223455678899
Q ss_pred HHHHHHHhhhhCCCCCC-CHHHHHc
Q 005944 301 AKDFLLKCLQKEPYLRS-TASELLQ 324 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RP-Sa~EIL~ 324 (668)
+.+||.+||+.||.+|| +++++++
T Consensus 265 l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 265 FDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp HHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred HHHHHHHhccCCHHHHHHhHHHHHH
Confidence 99999999999999999 8888875
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=388.19 Aligned_cols=260 Identities=25% Similarity=0.408 Sum_probs=207.9
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CC-----C
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HP-----N 130 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-Hp-----N 130 (668)
...+....+|++.+.||+|+||+||+|++..+++.||||++.. .......+..|+.++..+. |+ +
T Consensus 47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~---------~~~~~~~~~~e~~~l~~l~~~~~~~~~~ 117 (382)
T 2vx3_A 47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN---------KKAFLNQAQIEVRLLELMNKHDTEMKYY 117 (382)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS---------SHHHHHHHHHHHHHHHHHHHCSSGGGGG
T ss_pred ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec---------cHHHHHHHHHHHHHHHHHHhccccccee
Confidence 3345667899999999999999999999999999999999842 1223455677888888885 55 4
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHH--hCCcccccCCcccEEeC--C
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLH--KNGIMHRDIKGANILVD--N 204 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLH--s~gIvHrDLKPeNILld--~ 204 (668)
|+++++++...+.+||||||+. |+|.+++... ..+++..++.++.||+.||.||| ..||+||||||+||||+ .
T Consensus 118 iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~ 196 (382)
T 2vx3_A 118 IVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPK 196 (382)
T ss_dssp BCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTT
T ss_pred EEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCC
Confidence 9999999999999999999996 5999988664 46999999999999999999999 57999999999999995 4
Q ss_pred CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHH
Q 005944 205 KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALF 282 (668)
Q Consensus 205 ~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~ 282 (668)
++.+||+|||+++... ......+||+.|+|||++.+..++.++|||||||++|+|+||++||..... ....+.
T Consensus 197 ~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~ 271 (382)
T 2vx3_A 197 RSAIKIVDFGSSCQLG-----QRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIV 271 (382)
T ss_dssp SCCEEECCCTTCEETT-----CCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcEEEEeccCceecc-----cccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 7889999999997653 223457899999999999999999999999999999999999999975322 111111
Q ss_pred hhccCC----------------------------------CCCCCC-------------------------cccCHHHHH
Q 005944 283 HIGTTK----------------------------------SHPPIP-------------------------EHLSMEAKD 303 (668)
Q Consensus 283 ~~~~~~----------------------------------~~~~~p-------------------------~~ls~el~d 303 (668)
...... ...+.. .....++.+
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 351 (382)
T 2vx3_A 272 EVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351 (382)
T ss_dssp HHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHH
T ss_pred HHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHH
Confidence 110000 000000 001147899
Q ss_pred HHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 304 FLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 304 LI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
||.+||+.||.+|||+.|+|+||||+..
T Consensus 352 li~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 352 LILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 9999999999999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=370.72 Aligned_cols=259 Identities=26% Similarity=0.466 Sum_probs=199.2
Q ss_pred CCCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 56 IEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 56 ~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
...+++...+|++.+.||+|+||+||+|++. ..||||++..... .....+.+.+|+.+|+.++||||++++
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP------TPQQLQAFKNEVGVLRKTRHVNILLFM 86 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC------CHHHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC------CHHHHHHHHHHHHHHHhCCCCcEEEEE
Confidence 3445788999999999999999999999753 3599999854321 233456788999999999999999999
Q ss_pred cccccCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 136 GTAREDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 136 g~~~~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
++. .....++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 87 ~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg 165 (289)
T 3og7_A 87 GYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFG 165 (289)
T ss_dssp EEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC
T ss_pred eec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccce
Confidence 965 55678999999999999999854 4569999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccC-C
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTT-K 288 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~-~ 288 (668)
++................||+.|+|||++. +..++.++|||||||++|+|++|+.||.... ............ .
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (289)
T 3og7_A 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSP 245 (289)
T ss_dssp ------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCC
T ss_pred eccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCc
Confidence 998654433333344567999999999996 5668889999999999999999999997532 222222222221 1
Q ss_pred CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 289 SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 289 ~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
........++.++.+||.+||+.||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 222345578899999999999999999999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=366.99 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=211.8
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
+....+|++.+.||+|+||+||+|.+. ++..||||++..... ....+.+|+.+++.++||||+++++++.
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 73 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM---------SEDEFFQEAQTMMKLSHPKLVKFYGVCS 73 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB---------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC---------cHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 456788999999999999999999765 577899999843221 1134778999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.....++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~ 153 (268)
T 3sxs_A 74 KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY 153 (268)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEE
T ss_pred cCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCcccee
Confidence 9999999999999999999997654 599999999999999999999999999999999999999999999999999976
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~~l 297 (668)
...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||............. .......+..+
T Consensus 154 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~ 230 (268)
T 3sxs_A 154 VLDDQY-VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS--QGHRLYRPHLA 230 (268)
T ss_dssp CCTTCE-EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH--TTCCCCCCTTS
T ss_pred cchhhh-hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH--cCCCCCCCCcC
Confidence 543221 22234557788999999999889999999999999999999 999997544332211111 22234455678
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+.++.+||.+||+.||.+|||+.++++|
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999999986
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=371.05 Aligned_cols=259 Identities=30% Similarity=0.454 Sum_probs=195.0
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|.+..+|+.||||++.... ......+.+.++..+++.++||||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG------NKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS------CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc------cchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 45578999999999999999999999999999999984321 112233445556667888999999999999999
Q ss_pred CCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.+.+++||||+ ++.+..++.. ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++..
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 99999999999 5555555543 46799999999999999999999995 999999999999999999999999999976
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHh-----hcCCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhccCCCCC
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGTTKSHP 291 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~~~~~~ 291 (668)
+.... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.... .......... .....
T Consensus 175 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~ 250 (318)
T 2dyl_A 175 LVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLL 250 (318)
T ss_dssp ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-CCCCC
T ss_pred ccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhcc-CCCCC
Confidence 54322 223457999999999994 4568899999999999999999999997522 1221111111 11222
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+....++.++.+||.+||+.||.+||++.+|++||||+.
T Consensus 251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence 233468999999999999999999999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-45 Score=385.39 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=187.7
Q ss_pred CCCCCCeeee-eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 60 DAPPIRWRKG-ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~-~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
.....+|++. ++||+|+||+||+|++..+|+.||||++... ... ..+....++.+.||||+++++++
T Consensus 24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---------~~~---~~e~~~~~~~~~h~~i~~~~~~~ 91 (336)
T 3fhr_A 24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---------PKA---RQEVDHHWQASGGPHIVCILDVY 91 (336)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---------HHH---HHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---------HHH---HHHHHHHHHhcCCCChHHHHHHH
Confidence 4667889995 4799999999999999999999999998421 111 12233446677999999999998
Q ss_pred cc----CCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC---CCceE
Q 005944 139 RE----DDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---KGCIK 209 (668)
Q Consensus 139 ~~----~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---~g~vK 209 (668)
.. ...+++|||||++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+|
T Consensus 92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~k 171 (336)
T 3fhr_A 92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLK 171 (336)
T ss_dssp EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEE
T ss_pred hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEE
Confidence 76 455899999999999999997653 6999999999999999999999999999999999999976 45699
Q ss_pred EecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHH-----HHHhh
Q 005944 210 LADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVA-----ALFHI 284 (668)
Q Consensus 210 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~-----~~~~~ 284 (668)
|+|||+++.... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||........ .....
T Consensus 172 l~Dfg~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 247 (336)
T 3fhr_A 172 LTDFGFAKETTQ----NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247 (336)
T ss_dssp ECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------
T ss_pred Eeccccceeccc----cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhc
Confidence 999999975432 223456789999999999888899999999999999999999999965432211 11112
Q ss_pred ccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 285 GTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 285 ~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.......+.+..++.++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 222223334467899999999999999999999999999999998644
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=378.15 Aligned_cols=260 Identities=23% Similarity=0.361 Sum_probs=211.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEE-----EcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGM-----NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~-----~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l 134 (668)
+....+|++.+.||+|+||+||+|+ +..++..||||++... ........+.+|+.+++.++||||+++
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~ 98 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-------CSEQDELDFLMEALIISKFNHQNIVRC 98 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-------CCHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-------cchhhHHHHHHHHHHHhhCCCCCCCeE
Confidence 4677899999999999999999998 5567889999998421 112234467889999999999999999
Q ss_pred ccccccCCcceEEeeccCCCChhcccccC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC---
Q 005944 135 LGTAREDDSLNILLEFVPGGSISSLLGKF-------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN--- 204 (668)
Q Consensus 135 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~-------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~--- 204 (668)
++++......|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 99 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~ 178 (327)
T 2yfx_A 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGP 178 (327)
T ss_dssp EEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSST
T ss_pred EEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCC
Confidence 99999999999999999999999999765 34899999999999999999999999999999999999984
Q ss_pred CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHH
Q 005944 205 KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALF 282 (668)
Q Consensus 205 ~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~ 282 (668)
+..+||+|||++................||+.|+|||++.+..++.++|||||||++|+|+| |..||...... .....
T Consensus 179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 258 (327)
T 2yfx_A 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFV 258 (327)
T ss_dssp TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHH
Confidence 44699999999986654333333445678999999999999999999999999999999998 99999754332 22222
Q ss_pred hhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 283 HIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 283 ~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
. .......+..++.++.+||.+||+.||.+||++.++++|.|+.
T Consensus 259 ~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 259 T---SGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp H---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred h---cCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 2 2223445678899999999999999999999999999998864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=378.36 Aligned_cols=259 Identities=24% Similarity=0.400 Sum_probs=216.0
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCc-----EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCC
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGE-----LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPN 130 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~-----~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpN 130 (668)
...+....+|++.+.||+|+||+||+|.+..++. .||||++.... .......+.+|+.+|+.+ +|||
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~~h~~ 111 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-------HADEKEALMSELKIMSHLGQHEN 111 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-------CHHHHHHHHHHHHHHHHHCCCTT
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-------ChHHHHHHHHHHHHHHhhcCCCC
Confidence 3456778899999999999999999999977664 79999884221 223346688999999999 8999
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcccccC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCC
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKF--------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIK 196 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~--------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLK 196 (668)
|+++++++...+.+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 112 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlk 191 (333)
T 2i1m_A 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA 191 (333)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred eeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcc
Confidence 999999999999999999999999999998642 458999999999999999999999999999999
Q ss_pred cccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH
Q 005944 197 GANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF 275 (668)
Q Consensus 197 PeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~ 275 (668)
|+||||+.++.+||+|||++..+.............||+.|+|||++.+..++.++|||||||++|+|+| |..||....
T Consensus 192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 9999999999999999999986644333222334567889999999999999999999999999999998 999997532
Q ss_pred --HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 276 --QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 276 --~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
......... ......+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 272 ~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 272 VNSKFYKLVKD---GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp SSHHHHHHHHH---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHhc---CCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 222222221 22334566788999999999999999999999999873
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=371.57 Aligned_cols=255 Identities=20% Similarity=0.286 Sum_probs=209.7
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeecccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~ 138 (668)
.....+|++.+.||+|+||+||+|.+..+++.||||++..... ...+.+|+.++..+ +|+||+++++++
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~~~~l~~~~~i~~~~~~~ 75 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----------APQLRDEYRTYKLLAGCTGIPNVYYFG 75 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----------SCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----------cHHHHHHHHHHHHHhcCCCCCeEEeec
Confidence 4567889999999999999999999999999999998842211 12366799999999 799999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc-----eEEec
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC-----IKLAD 212 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~-----vKL~D 212 (668)
......++||||+ +++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|
T Consensus 76 ~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~D 154 (298)
T 1csn_A 76 QEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 154 (298)
T ss_dssp EETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred CCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEE
Confidence 9999999999999 999999997654 5999999999999999999999999999999999999987775 99999
Q ss_pred CCchhhhHhhhhh-----cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchh----HHH-HHHHH
Q 005944 213 FGASKKVVELATI-----NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ----FQE-VAALF 282 (668)
Q Consensus 213 FGlA~~~~~~~~~-----~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~----~~~-~~~~~ 282 (668)
||+++.+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||... ... ...+.
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 234 (298)
T 1csn_A 155 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234 (298)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred CccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHH
Confidence 9999865432221 1234567999999999999999999999999999999999999999652 111 11111
Q ss_pred hhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 283 HIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 283 ~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
..............++.++.+||.+||+.||.+||++.+|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 235 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred hhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 1111111122234678999999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=371.30 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=217.8
Q ss_pred CCCCCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeee
Q 005944 54 PPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVR 133 (668)
Q Consensus 54 pp~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~ 133 (668)
|.+..++....+|++.+.||+|+||+||+|.+..++..||||++... ....+.+.+|+.+++.++||||++
T Consensus 3 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~~~~E~~~l~~l~h~~i~~ 73 (288)
T 3kfa_A 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---------TMEVEEFLKEAAVMKEIKHPNLVQ 73 (288)
T ss_dssp TTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---------STHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---------HHHHHHHHHHHHHHHhCCCCCEee
Confidence 34455678889999999999999999999999999999999998421 112356788999999999999999
Q ss_pred eccccccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 134 YLGTAREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 134 l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
+++++.....+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 74 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~ 153 (288)
T 3kfa_A 74 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 153 (288)
T ss_dssp EEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEc
Confidence 999999999999999999999999999764 459999999999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCC
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKS 289 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~ 289 (668)
|||++....... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... ....... ...
T Consensus 154 Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---~~~ 229 (288)
T 3kfa_A 154 DFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KDY 229 (288)
T ss_dssp CCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TTC
T ss_pred cCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---ccC
Confidence 999997653221 112233457889999999999999999999999999999999 9999965322 2222221 223
Q ss_pred CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 290 ~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
....+..++.++.+||.+||..||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 34556788999999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=367.64 Aligned_cols=257 Identities=26% Similarity=0.434 Sum_probs=210.2
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||+||+|++..+++.||||++........ .......+.+.+|+.+++.++||||+++++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE-TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCC-HHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccc-hhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 3667899999999999999999999999999999999854322111 111112256889999999999999999999987
Q ss_pred cCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCcccEEeCCCCc-----eEEe
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVDNKGC-----IKLA 211 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~g--IvHrDLKPeNILld~~g~-----vKL~ 211 (668)
... ++||||+++|+|.+++... ..+++..++.++.||+.||.|||++| |+||||||+||||+.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 654 7999999999998877544 57999999999999999999999999 999999999999988776 9999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHh--hcCCCcchhHHHHHHHHHHHHhCCCCCchhH-HHHHHHHhhccCC
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVIL--QTGHSFSADIWSVGCTVIEMATGKPPWSQQF-QEVAALFHIGTTK 288 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~--~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-~~~~~~~~~~~~~ 288 (668)
|||+++... .......||+.|+|||++. ...++.++|||||||++|+|++|+.||.... .............
T Consensus 172 Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 246 (287)
T 4f0f_A 172 DFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEG 246 (287)
T ss_dssp CCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSC
T ss_pred CCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccC
Confidence 999987432 2234567999999999984 4457889999999999999999999996432 1111122222334
Q ss_pred CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 289 SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 289 ~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
....++..+++++.+||.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 247 LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 455677889999999999999999999999999986
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=376.19 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=212.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEE-----cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMN-----LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVR 133 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~-----~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~ 133 (668)
.....+|++.+.||+|+||+||+|.+ ..+++.||||++... ......+.+.+|+.+|..+ +||||++
T Consensus 23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-------ATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-------CCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 46678999999999999999999985 356789999998422 1223345688999999999 7999999
Q ss_pred eccccccCC-cceEEeeccCCCChhcccccCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCcccccCC
Q 005944 134 YLGTAREDD-SLNILLEFVPGGSISSLLGKFGS----------------FPESVIRMYTKQLLLGLEYLHKNGIMHRDIK 196 (668)
Q Consensus 134 l~g~~~~~~-~~~LVmEy~~gGsL~~~L~~~~~----------------l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLK 196 (668)
+++++...+ .+++||||+++|+|.+++..... +++..++.++.||+.||.|||++||+|||||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dik 175 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 175 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCc
Confidence 999987654 59999999999999999976544 8999999999999999999999999999999
Q ss_pred cccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH
Q 005944 197 GANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF 275 (668)
Q Consensus 197 PeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~ 275 (668)
|+||||+.++.+||+|||+++.+.............||+.|+|||++.+..++.++|||||||++|+|+| |..||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999986543322222334567899999999999999999999999999999998 999996532
Q ss_pred --HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 276 --QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 276 --~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
......... ......+..+++++.+||.+||+.||.+|||+.++++|
T Consensus 256 ~~~~~~~~~~~---~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 256 IDEEFCRRLKE---GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CSHHHHHHHHH---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHhcc---CccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222222222 22344566789999999999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=376.65 Aligned_cols=262 Identities=29% Similarity=0.445 Sum_probs=192.2
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHH-HHHhCCCCCeeeecc
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK-LLKNLTHPNIVRYLG 136 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~-iL~~L~HpNIV~l~g 136 (668)
.......+|++.+.||+|+||.||+|.+..+|+.||||++..... ......+..|+. +++.++||||+++++
T Consensus 16 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~e~~~~~~~~~h~niv~~~~ 88 (327)
T 3aln_A 16 HWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD-------EKEQKQLLMDLDVVMRSSDCPYIVQFYG 88 (327)
T ss_dssp EECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC-------HHHHHHHHHHHHHHHSSCCCTTBCCEEE
T ss_pred hcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC-------chHHHHHHHHHHHHHHcCCCCcEeeeee
Confidence 345677899999999999999999999999999999999853211 112233444554 778889999999999
Q ss_pred ccccCCcceEEeeccCCCChhccccc-----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCCcccEEeCCCCceEE
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGK-----FGSFPESVIRMYTKQLLLGLEYLHKN-GIMHRDIKGANILVDNKGCIKL 210 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~-----~~~l~e~~~~~i~~QIl~aL~yLHs~-gIvHrDLKPeNILld~~g~vKL 210 (668)
++...+..++||||+.+ +|.+++.. ...+++..++.++.||+.||.|||+. ||+||||||+||||+.++.+||
T Consensus 89 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl 167 (327)
T 3aln_A 89 ALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKL 167 (327)
T ss_dssp EEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEE
T ss_pred EEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEE
Confidence 99999999999999986 77777653 56799999999999999999999999 9999999999999999999999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHH----hhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhcc
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVI----LQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT 286 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl----~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~ 286 (668)
+|||+++.+.... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||..............
T Consensus 168 ~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~- 243 (327)
T 3aln_A 168 CDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVV- 243 (327)
T ss_dssp CCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCC-
T ss_pred ccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHh-
Confidence 9999998654322 12334799999999999 456689999999999999999999999975432221111111
Q ss_pred CCCCC----CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 287 TKSHP----PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 287 ~~~~~----~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
..... .....++.++.+||.+||+.||.+||++.+|++||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence 11111 1224688999999999999999999999999999999753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=379.19 Aligned_cols=254 Identities=25% Similarity=0.425 Sum_probs=207.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcE----EEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGEL----LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~----VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
....+|++.++||+|+||+||+|++..++.. ||+|++..... ......+.+|+.+++.++|||||++++
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~ 82 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG-------RQSFQAVTDHMLAIGSLDHAHIVRLLG 82 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS-------CSCBCSCCHHHHHHHTCCCTTBCCEEE
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc-------HHHHHHHHHHHHHHhcCCCCCcCeEEE
Confidence 5567899999999999999999999988876 56665522111 111234567999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++. +...++||||+.+|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 83 ~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~ 161 (325)
T 3kex_A 83 LCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGV 161 (325)
T ss_dssp EEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSG
T ss_pred EEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCc
Confidence 886 56789999999999999998764 5799999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH-HHHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~-~~~~~~~~~~~~~~~~~~ 293 (668)
++.+.............||+.|+|||++.+..++.++|||||||++|+|+| |..||.... ......... ......
T Consensus 162 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~---~~~~~~ 238 (325)
T 3kex_A 162 ADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK---GERLAQ 238 (325)
T ss_dssp GGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT---TCBCCC
T ss_pred ccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc---CCCCCC
Confidence 987644333333445678889999999999999999999999999999999 999997543 222222222 223445
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+..++.++.+||.+||+.||.+||++.++++|
T Consensus 239 ~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 239 PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 56688889999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=360.12 Aligned_cols=249 Identities=18% Similarity=0.316 Sum_probs=209.3
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.+...+|++.+.||+|+||+||+|++ ++..||||++.... ......+.+.+|+.+|+.++||||+++++++.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~------~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 77 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRD------WSTRKSRDFNEECPRLRIFSHPNVLPVLGACQ 77 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTT------CCHHHHHHHHHHGGGGCCCSCTTEECEEEEEC
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccc------cCHHHHHHHHHHHHHHHhcCCCchhheEEEEc
Confidence 46667899999999999999999998 48999999985422 12234466889999999999999999999988
Q ss_pred cC--CcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCcccEEeCCCCceEEecC
Q 005944 140 ED--DSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVDNKGCIKLADF 213 (668)
Q Consensus 140 ~~--~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~g--IvHrDLKPeNILld~~g~vKL~DF 213 (668)
.. ...++||||+++|+|.+++.... .+++..++.++.||+.||.|||++| |+||||||+|||++.++.++|+||
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~ 157 (271)
T 3kmu_A 78 SPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMA 157 (271)
T ss_dssp TTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGG
T ss_pred cCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEec
Confidence 77 78899999999999999998765 4899999999999999999999999 999999999999999999999988
Q ss_pred CchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCc---chhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCC
Q 005944 214 GASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSF---SADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSH 290 (668)
Q Consensus 214 GlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~---ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~ 290 (668)
|++... ......||+.|+|||++.+..++. ++|||||||++|+|++|+.||......... .........
T Consensus 158 ~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~~~ 229 (271)
T 3kmu_A 158 DVKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG-MKVALEGLR 229 (271)
T ss_dssp GSCCTT-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH-HHHHHSCCC
T ss_pred cceeee-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH-HHHHhcCCC
Confidence 876532 223467899999999998765544 799999999999999999999754332221 122223344
Q ss_pred CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 291 ~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
...+..++.++.+||.+||+.||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 5667789999999999999999999999999986
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=367.16 Aligned_cols=248 Identities=23% Similarity=0.340 Sum_probs=205.8
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCC-------cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSG-------ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV 132 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg-------~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV 132 (668)
.+...+|++.+.||+|+||+||+|++..++ ..||+|++... .....+.+.+|+.+|+.++||||+
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv 75 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--------HRNYSESFFEAASMMSKLSHKHLV 75 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--------GGGGHHHHHHHHHHHHTSCCTTBC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--------cHHHHHHHHHHHHHHHhCCCCCEe
Confidence 356678999999999999999999998877 47999988321 112335678999999999999999
Q ss_pred eeccccccCCcceEEeeccCCCChhcccccCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc----
Q 005944 133 RYLGTAREDDSLNILLEFVPGGSISSLLGKFGS-FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC---- 207 (668)
Q Consensus 133 ~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~-l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~---- 207 (668)
++++++...+..++||||+++|+|.+++..... +++..++.++.||+.||.|||++||+||||||+||||+.++.
T Consensus 76 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~ 155 (289)
T 4fvq_A 76 LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG 155 (289)
T ss_dssp CEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGT
T ss_pred EEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccc
Confidence 999999999999999999999999999977654 999999999999999999999999999999999999998886
Q ss_pred ----eEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhC-CCCCchhHHHHHHH
Q 005944 208 ----IKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATG-KPPWSQQFQEVAAL 281 (668)
Q Consensus 208 ----vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG-~~PF~~~~~~~~~~ 281 (668)
+||+|||++....... ...||+.|+|||++.+ ..++.++|||||||++|+|++| .+||..........
T Consensus 156 ~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~ 229 (289)
T 4fvq_A 156 NPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ 229 (289)
T ss_dssp BCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred ccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH
Confidence 9999999987553222 2457889999999987 6689999999999999999995 45554332222111
Q ss_pred HhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 282 FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 282 ~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
... ....++...+.++.+||.+||+.||.+|||+.++++|
T Consensus 230 ~~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 230 FYE----DRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHH----TTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred Hhh----ccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 111 1233455667889999999999999999999999986
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=370.28 Aligned_cols=258 Identities=25% Similarity=0.389 Sum_probs=202.7
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcC---CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLD---SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~---tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
......+|.+.+.||+|+||+||+|.+.. ++..||||++.... ........+.+|+.+++.++||||++++
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 102 (313)
T 3brb_A 29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN------SSQREIEEFLSEAACMKDFSHPNVIRLL 102 (313)
T ss_dssp TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C------CCHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc------cchhHHHHHHHHHHHHhcCCCCCeeeee
Confidence 34667889999999999999999998765 45689999984321 1233456788999999999999999999
Q ss_pred cccccCC-----cceEEeeccCCCChhcccc------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC
Q 005944 136 GTAREDD-----SLNILLEFVPGGSISSLLG------KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN 204 (668)
Q Consensus 136 g~~~~~~-----~~~LVmEy~~gGsL~~~L~------~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~ 204 (668)
+++.... ..++||||+++|+|.+++. ....+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 103 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 103 GVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRD 182 (313)
T ss_dssp EEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECT
T ss_pred EEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcC
Confidence 9987655 3599999999999999883 3457999999999999999999999999999999999999999
Q ss_pred CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHH
Q 005944 205 KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALF 282 (668)
Q Consensus 205 ~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~ 282 (668)
++.+||+|||+++.+.............+++.|+|||++.+..++.++|||||||++|+|++ |..||...... .....
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 262 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH
Confidence 99999999999987654333333344567889999999999999999999999999999999 99999653321 11111
Q ss_pred hhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 283 HIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 283 ~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
. .......+..++.++.+||.+||..||.+|||+.+++++
T Consensus 263 ~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 263 L---HGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp H---TTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred H---cCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1 122345567889999999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=359.78 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=212.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.+...+|++.+.||+|+||.||+|.+. ++..||||++..... . .+.+.+|+.+++.++||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~---~~~~~~e~~~l~~l~h~~i~~~~~~~~ 73 (267)
T 3t9t_A 4 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM------S---EEDFIEEAEVMMKLSHPKLVQLYGVCL 73 (267)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB------C---HHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC------C---HHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence 355678999999999999999999986 678999999843211 1 135788999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 74 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~ 153 (267)
T 3t9t_A 74 EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF 153 (267)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGG
T ss_pred cCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccc
Confidence 999999999999999999999765 5689999999999999999999999999999999999999999999999999986
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCCCcc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ 296 (668)
..... ........||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ...... .......+..
T Consensus 154 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~---~~~~~~~~~~ 229 (267)
T 3t9t_A 154 VLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---TGFRLYKPRL 229 (267)
T ss_dssp BCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TTCCCCCCTT
T ss_pred ccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh---cCCcCCCCcc
Confidence 53322 223344567889999999999999999999999999999999 89999754322 222211 1223345667
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
++.++.+||.+||+.||.+||++.+++++
T Consensus 230 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 230 ASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999999999999999974
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=379.44 Aligned_cols=252 Identities=23% Similarity=0.353 Sum_probs=205.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|+.+|+.+ +||||+++++++.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 75 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----------APQLHLEYRFYKQLGSGDGIPQVYYFGP 75 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----------SCCHHHHHHHHHHHCSCTTSCCEEEEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----------hHHHHHHHHHHHHhhCCCCCCEEEEEEe
Confidence 456789999999999999999999999999999998843211 12467899999999 9999999999999
Q ss_pred cCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc-----eEEecC
Q 005944 140 EDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC-----IKLADF 213 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~-----vKL~DF 213 (668)
.....++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+||
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DF 154 (330)
T 2izr_A 76 CGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDF 154 (330)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCC
T ss_pred cCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEc
Confidence 999999999999 9999999976 368999999999999999999999999999999999999998887 999999
Q ss_pred CchhhhHhhhhhc-----CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH----HHHHHHH-h
Q 005944 214 GASKKVVELATIN-----GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF----QEVAALF-H 283 (668)
Q Consensus 214 GlA~~~~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~----~~~~~~~-~ 283 (668)
|+++.+....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ......+ .
T Consensus 155 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~ 234 (330)
T 2izr_A 155 ALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234 (330)
T ss_dssp TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHH
T ss_pred ccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHh
Confidence 9998653322211 1246789999999999999999999999999999999999999997421 1111111 1
Q ss_pred hccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 284 ~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.............++ ++.+||.+||+.||.+||++.+|++
T Consensus 235 ~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 235 TKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 100000001112244 8999999999999999999999886
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=367.71 Aligned_cols=258 Identities=32% Similarity=0.536 Sum_probs=201.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||.||+|.+..+|..||||++..... ........+.+|+.+|+.++||||+++++++..
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 103 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDL-----MDAKARADCIKEIDLLKQLNHPNVIKYYASFIE 103 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSS-----CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhc-----cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 345689999999999999999999999999999999843211 123345667899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 141 DDSLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~ 183 (310)
T 2wqm_A 104 DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183 (310)
T ss_dssp TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---
T ss_pred CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccce
Confidence 9999999999999999998864 466999999999999999999999999999999999999999999999999998
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHH-hhccCCCCCCCCc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALF-HIGTTKSHPPIPE 295 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~-~~~~~~~~~~~p~ 295 (668)
....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........... .+.........+.
T Consensus 184 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (310)
T 2wqm_A 184 RFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSD 261 (310)
T ss_dssp -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTT
T ss_pred eeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCccc
Confidence 8654322 123346799999999999999999999999999999999999999965321111111 1111122222336
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.++.++.+||.+||..||.+|||+.+++++
T Consensus 262 ~~~~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 262 HYSEELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 789999999999999999999999999973
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=377.49 Aligned_cols=250 Identities=24% Similarity=0.347 Sum_probs=201.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||+||+|++. ++.||||++.... ........|+.+|+.++|||||++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 89 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---------KQSWQNEYEVYSLPGMKHENILQFIGAEKR 89 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---------hHHHHHHHHHHHHhcCCCCCchhhcceecc
Confidence 45678999999999999999999874 7999999984211 122344569999999999999999999887
Q ss_pred CCc----ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccccCCcccEEeCCCC
Q 005944 141 DDS----LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN----------GIMHRDIKGANILVDNKG 206 (668)
Q Consensus 141 ~~~----~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~----------gIvHrDLKPeNILld~~g 206 (668)
... +++|||||++|+|.+++.. ..+++..++.++.||+.||.|||+. ||+||||||+||||+.++
T Consensus 90 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 90 GTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp ECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 544 6999999999999999976 4699999999999999999999999 999999999999999999
Q ss_pred ceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-----CCCcchhHHHHHHHHHHHHhCCCCCchh-------
Q 005944 207 CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQT-----GHSFSADIWSVGCTVIEMATGKPPWSQQ------- 274 (668)
Q Consensus 207 ~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-----~~s~ksDIWSLGvILyeLLTG~~PF~~~------- 274 (668)
.+||+|||+++.+............+||+.|+|||++.+. .++.++|||||||++|+|+||+.||...
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~ 248 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCT
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccc
Confidence 9999999999866543333334457899999999999873 4567889999999999999999998532
Q ss_pred ----------HHHHHHHHhhccCCCCCCCCc-----ccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 275 ----------FQEVAALFHIGTTKSHPPIPE-----HLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 275 ----------~~~~~~~~~~~~~~~~~~~p~-----~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
......... .....+.++. ..+.++.+||.+||+.||.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 249 FEEEIGQHPSLEDMQEVVV--HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp THHHHCSSCCHHHHHHHHT--TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhhccCCchhhhhhhhh--cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 111111111 1122222222 23456999999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=375.70 Aligned_cols=258 Identities=24% Similarity=0.427 Sum_probs=203.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||+||+|.+..++..||+|+......... .......+.+|+.+|+.++||||+++++++..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 88 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT---SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS---SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEES
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEec
Confidence 556789999999999999999999998888765544322111111 11123457889999999999999999999886
Q ss_pred CCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhh
Q 005944 141 DDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV 219 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~ 219 (668)
.. .++|++|+.+|+|.+++.. ...+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+++.+
T Consensus 89 ~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred CC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 54 8899999999999999876 467999999999999999999999999999999999999999999999999999876
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCccc
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~l 297 (668)
.............||+.|+|||++.+..++.++|||||||++|+|++ |..||..... ....... .....+.+..+
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~ 244 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGERLPQPPIC 244 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCCCCCCTTB
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cCCCCCCCccC
Confidence 54444333445567889999999999999999999999999999999 9999975432 2222222 22344556778
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+.++.+||.+||+.||.+||++.++++.
T Consensus 245 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 245 TIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999999973
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=363.20 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=210.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||.||+|.+..+++.||||++.... ..+.+|+.+++.++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------------~~~~~e~~~l~~l~h~~i~~~~~~~~~ 75 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------------EKAEREVKALAKLDHVNIVHYNGCWDG 75 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------------GGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------------HHHHHHHHHHHhCCCCCEEEEeeeEec
Confidence 34467999999999999999999999999999999985321 135679999999999999999998754
Q ss_pred ----------------CCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe
Q 005944 141 ----------------DDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV 202 (668)
Q Consensus 141 ----------------~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl 202 (668)
...+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 76 FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL 155 (284)
T ss_dssp EEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred cccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE
Confidence 44589999999999999999654 679999999999999999999999999999999999999
Q ss_pred CCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHH
Q 005944 203 DNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALF 282 (668)
Q Consensus 203 d~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~ 282 (668)
+.++.+||+|||++..+... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......... .
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~-~ 231 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKND---GKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTD-L 231 (284)
T ss_dssp EETTEEEECCCTTCEESSCC---SCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHHHHHH-H
T ss_pred cCCCCEEECcchhheecccc---ccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHHHHHH-h
Confidence 99999999999998765322 1234567999999999999999999999999999999999999998643322211 1
Q ss_pred hhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 283 HIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 283 ~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.. ..++..++.++.+||.+||+.||.+|||+.++++|.+.-.
T Consensus 232 ~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 232 RD------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp HT------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred hc------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 11 2245678899999999999999999999999999988643
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=365.76 Aligned_cols=246 Identities=26% Similarity=0.448 Sum_probs=199.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
+...+|++.+.||+|+||+||+|.+ .++.||||++.. ....+.+.+|+.+|+.++||||+++++++.+
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~----------~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 72 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIES----------ESERKAFIVELRQLSRVNHPNIVKLYGACLN 72 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSS----------TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT
T ss_pred CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecC----------hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence 4557899999999999999999987 478999998731 1123567889999999999999999998874
Q ss_pred CCcceEEeeccCCCChhcccccCC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccccCCcccEEeCCCCc-eEEecC
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFG---SFPESVIRMYTKQLLLGLEYLHK---NGIMHRDIKGANILVDNKGC-IKLADF 213 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~---~l~e~~~~~i~~QIl~aL~yLHs---~gIvHrDLKPeNILld~~g~-vKL~DF 213 (668)
..++||||+++|+|.+++.... .+++..+..++.||+.||.|||+ +||+||||||+||||+.++. +||+||
T Consensus 73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Df 150 (307)
T 2eva_A 73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDF 150 (307)
T ss_dssp --TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCC
T ss_pred --CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccc
Confidence 5899999999999999997654 37899999999999999999999 89999999999999998886 799999
Q ss_pred CchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCC
Q 005944 214 GASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 214 GlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~ 293 (668)
|++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......................
T Consensus 151 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 225 (307)
T 2eva_A 151 GTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL 225 (307)
T ss_dssp CC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCC
T ss_pred ccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCc
Confidence 999765321 234569999999999999899999999999999999999999997432111111111122334456
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 226 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 67889999999999999999999999999984
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=383.08 Aligned_cols=255 Identities=24% Similarity=0.416 Sum_probs=201.2
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEc---CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~---~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
+....+|++.++||+|+||+||+|++. .++..||||++.... .....+.+.+|+.+|++++|||||++++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~~~~ 113 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-------TEKQRRDFLGEASIMGQFDHPNIIRLEG 113 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-------CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-------CHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 455678999999999999999999876 467789999984321 2234467889999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++.....+++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 114 ~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 193 (373)
T 2qol_A 114 VVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGL 193 (373)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--
T ss_pred EEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcc
Confidence 999999999999999999999999765 4699999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhh-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCC
Q 005944 216 SKKVVELATI-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPP 292 (668)
Q Consensus 216 A~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~ 292 (668)
++.+...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||...... ...... .....+
T Consensus 194 a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~---~~~~~~ 270 (373)
T 2qol_A 194 GRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD---EGYRLP 270 (373)
T ss_dssp --------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHH---TTEECC
T ss_pred ccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCC
Confidence 9876432211 11222346788999999999999999999999999999998 99999754322 222222 122334
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.+..++.++.+||.+||+.||.+||++.+|++
T Consensus 271 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 45678999999999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=373.30 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=205.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc-
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR- 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~- 139 (668)
+...+|++.+.||+|+||.||+|.+..+++.||||++... .......+.+|+.+++.++||||+++++++.
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 97 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--------EQQDREEAQREADMHRLFNHPNILRLVAYCLR 97 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--------SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--------CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEe
Confidence 4567899999999999999999999999999999988431 1234456789999999999999999999986
Q ss_pred ---cCCcceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEec
Q 005944 140 ---EDDSLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLAD 212 (668)
Q Consensus 140 ---~~~~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~D 212 (668)
.....++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 98 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~d 177 (317)
T 2buj_A 98 ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMD 177 (317)
T ss_dssp EETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECC
T ss_pred ccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEe
Confidence 34578999999999999998865 46799999999999999999999999999999999999999999999999
Q ss_pred CCchhhhHhh-------hhhcCCccCCCCCCCCChHHHhhcC---CCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHH
Q 005944 213 FGASKKVVEL-------ATINGAKSMKGTPYWMAPEVILQTG---HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALF 282 (668)
Q Consensus 213 FGlA~~~~~~-------~~~~~~~~~~GT~~Y~APEvl~~~~---~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~ 282 (668)
||++...... ..........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........
T Consensus 178 fg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 257 (317)
T 2buj_A 178 LGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257 (317)
T ss_dssp CSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHH
T ss_pred cCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhh
Confidence 9987643110 0001112345799999999987554 68899999999999999999999964322100011
Q ss_pred hhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCc
Q 005944 283 HIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHP 326 (668)
Q Consensus 283 ~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hp 326 (668)
.........+.+..++.++.+||.+||+.||.+||++.+++++-
T Consensus 258 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 258 LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 11111222344567899999999999999999999999999863
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-44 Score=374.06 Aligned_cols=257 Identities=26% Similarity=0.418 Sum_probs=213.9
Q ss_pred CCCCCeeeeeEEcccCceEEEEEE----EcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGM----NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~----~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
....+|++.+.||+|+||+||+|+ +..++..||||++... .....+.+.+|+.+|+.++||||+++++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 91 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--------GPDQQRDFQREIQILKALHSDFIVKYRG 91 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--------CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--------CHHHHHHHHHHHHHHHhcCCCceeEEEE
Confidence 456789999999999999999998 4678999999998421 2233456889999999999999999999
Q ss_pred ccc--cCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecC
Q 005944 137 TAR--EDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADF 213 (668)
Q Consensus 137 ~~~--~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DF 213 (668)
++. ....+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+||
T Consensus 92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Df 171 (327)
T 3lxl_A 92 VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADF 171 (327)
T ss_dssp EEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCG
T ss_pred EEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccc
Confidence 875 45668999999999999999976 356999999999999999999999999999999999999999999999999
Q ss_pred CchhhhHhhhh-hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH-------------H
Q 005944 214 GASKKVVELAT-INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV-------------A 279 (668)
Q Consensus 214 GlA~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~-------------~ 279 (668)
|++..+..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||....... .
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence 99986533221 112334568899999999999889999999999999999999999996544321 1
Q ss_pred HHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 280 ALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 280 ~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
............+.+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 252 RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 1222222333455677899999999999999999999999999765
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=365.77 Aligned_cols=255 Identities=24% Similarity=0.340 Sum_probs=210.4
Q ss_pred CCCCCCeeeee-EEcccCceEEEEEEE--cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 60 DAPPIRWRKGE-LVGCGAFGRVYMGMN--LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 60 ~~~~~ry~i~~-~LG~G~fG~Vy~a~~--~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
.....+|++.+ .||+|+||+||+|.+ ..++..||||++.... ......+.+.+|+.+++.++||||+++++
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~~~e~~~l~~l~h~~i~~~~~ 85 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------NDPALKDELLAEANVMQQLDNPYIVRMIG 85 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc------cCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 35567899998 999999999999954 5678999999984321 12234567889999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
++ ..+..++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 86 ~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 164 (291)
T 1xbb_A 86 IC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLS 164 (291)
T ss_dssp EE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred EE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcc
Confidence 98 56778999999999999999988888999999999999999999999999999999999999999999999999998
Q ss_pred hhhHhhhhh-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCC
Q 005944 217 KKVVELATI-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPI 293 (668)
Q Consensus 217 ~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~ 293 (668)
..+...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... ...... .......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~---~~~~~~~ 241 (291)
T 1xbb_A 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERMGC 241 (291)
T ss_dssp EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCCCC
T ss_pred eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH---cCCCCCC
Confidence 765332211 12223457789999999998889999999999999999999 99999764332 222222 2233456
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+..++.++.+||.+||+.||.+||++.++++
T Consensus 242 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 242 PAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6788999999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=377.81 Aligned_cols=265 Identities=21% Similarity=0.264 Sum_probs=204.0
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcC---CCcEEEEEEeeecccchhhHh---hHHHHHHHHHHHHHHHhCCCCCeee
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLD---SGELLAVKQVLIAANSASKEK---TQAHIRELEEEVKLLKNLTHPNIVR 133 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~---tg~~VAVK~i~~~~~~~~~~~---~~~~~~~~~~Ei~iL~~L~HpNIV~ 133 (668)
+....+|++.+.||+|+||+||+|.+.. ++..||||++.........+. .......+.+|+.++..+.||||++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~ 112 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence 4566799999999999999999999987 789999999854322111111 0111233667899999999999999
Q ss_pred ecccccc----CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC--c
Q 005944 134 YLGTARE----DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG--C 207 (668)
Q Consensus 134 l~g~~~~----~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g--~ 207 (668)
+++++.. ....|+||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++ .
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~ 191 (345)
T 2v62_A 113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQ 191 (345)
T ss_dssp EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTS
T ss_pred eecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCc
Confidence 9999877 67899999999 999999998888999999999999999999999999999999999999998877 9
Q ss_pred eEEecCCchhhhHhhhhhc-----CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH---HHHH
Q 005944 208 IKLADFGASKKVVELATIN-----GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF---QEVA 279 (668)
Q Consensus 208 vKL~DFGlA~~~~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~---~~~~ 279 (668)
+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ....
T Consensus 192 ~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~ 271 (345)
T 2v62_A 192 VYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ 271 (345)
T ss_dssp EEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred EEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence 9999999998664332211 1135679999999999999999999999999999999999999995421 1111
Q ss_pred HHHhhccCCCCC-----CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 280 ALFHIGTTKSHP-----PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 280 ~~~~~~~~~~~~-----~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
............ .....++.++.+||.+||..||.+||++.+|++.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 111100000000 0112688899999999999999999999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=360.83 Aligned_cols=254 Identities=21% Similarity=0.397 Sum_probs=207.4
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCc---EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~---~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
....|++.++||+|+||+||+|.+..++. .||+|++.. .......+.+.+|+.+|+.++||||+++++++
T Consensus 19 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 91 (298)
T 3pls_A 19 ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR-------ITEMQQVEAFLREGLLMRGLNHPNVLALIGIM 91 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETT-------CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred cceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccc-------cccHHHHHHHHHHHHHHHhCCCCCeeeEEEEE
Confidence 34568888999999999999999766554 799998732 12233456788999999999999999999999
Q ss_pred ccCCcc-eEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 139 REDDSL-NILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 139 ~~~~~~-~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
...+.. ++||||+.+|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 92 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 171 (298)
T 3pls_A 92 LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171 (298)
T ss_dssp CCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSS
T ss_pred ecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCc
Confidence 876655 999999999999999976 466899999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhh--hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCC-CchhHH-HHHHHHhhccCCCCCC
Q 005944 217 KKVVELAT--INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPP-WSQQFQ-EVAALFHIGTTKSHPP 292 (668)
Q Consensus 217 ~~~~~~~~--~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~P-F~~~~~-~~~~~~~~~~~~~~~~ 292 (668)
+.+..... ........+|+.|+|||++.+..++.++|||||||++|+|++|..| |..... ....... ......
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~---~~~~~~ 248 (298)
T 3pls_A 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA---QGRRLP 248 (298)
T ss_dssp CTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH---TTCCCC
T ss_pred ccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh---cCCCCC
Confidence 86543322 2233446788999999999999999999999999999999995554 443221 1222222 222345
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.+..++.++.+||.+||+.||.+|||+.++++.
T Consensus 249 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 249 QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 567789999999999999999999999999863
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=379.88 Aligned_cols=264 Identities=18% Similarity=0.245 Sum_probs=203.2
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCC-----CcEEEEEEeeecccchhhHhh---HHHHHHHHHHHHHHHhCCCCCe
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDS-----GELLAVKQVLIAANSASKEKT---QAHIRELEEEVKLLKNLTHPNI 131 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t-----g~~VAVK~i~~~~~~~~~~~~---~~~~~~~~~Ei~iL~~L~HpNI 131 (668)
+....+|++.+.||+|+||+||+|.+..+ ++.||||++.........+.. ......+..|+..+..++|+||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 35567999999999999999999998765 589999998433211111000 0011223456777888999999
Q ss_pred eeeccccccC----CcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC--C
Q 005944 132 VRYLGTARED----DSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD--N 204 (668)
Q Consensus 132 V~l~g~~~~~----~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld--~ 204 (668)
+++++++... ...||||||+ +++|.+++... +.+++..++.|+.||+.||.|||++||+||||||+||||+ .
T Consensus 111 v~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~ 189 (364)
T 3op5_A 111 PKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKN 189 (364)
T ss_dssp CCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSC
T ss_pred CeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCC
Confidence 9999998765 4589999999 99999999765 6799999999999999999999999999999999999999 8
Q ss_pred CCceEEecCCchhhhHhhhhhc-----CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--H
Q 005944 205 KGCIKLADFGASKKVVELATIN-----GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--E 277 (668)
Q Consensus 205 ~g~vKL~DFGlA~~~~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~ 277 (668)
++.+||+|||+++.+....... .....+||+.|+|||++.+..++.++|||||||+||+|+||+.||..... .
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~ 269 (364)
T 3op5_A 190 PDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK 269 (364)
T ss_dssp TTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred CCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence 8999999999998664432211 12345699999999999999999999999999999999999999975321 1
Q ss_pred HHHHHhhccCCCC------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 278 VAALFHIGTTKSH------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 278 ~~~~~~~~~~~~~------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
............. ......++.++.+||..||..+|.+||++.+|++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1110100000000 0012467899999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=371.79 Aligned_cols=253 Identities=23% Similarity=0.393 Sum_probs=209.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEE--EEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELL--AVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~V--AVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~ 137 (668)
....+|++.+.||+|+||.||+|++..++..+ |||++... ......+.+.+|+.+|+.+ +||||++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~-------~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 94 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-------ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 94 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc-------cchHHHHHHHHHHHHHHhccCCCchhhhcee
Confidence 45578999999999999999999999888866 88987421 1123345678899999999 89999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEE
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKFG----------------SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANIL 201 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~~----------------~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNIL 201 (668)
+...+.+|+||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl 174 (327)
T 1fvr_A 95 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 174 (327)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred eeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEE
Confidence 999999999999999999999997654 6999999999999999999999999999999999999
Q ss_pred eCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHH
Q 005944 202 VDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAA 280 (668)
Q Consensus 202 ld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~ 280 (668)
|+.++.+||+|||+++.... ........+|+.|+|||++.+..++.++|||||||++|+|+| |..||........
T Consensus 175 ~~~~~~~kL~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~- 250 (327)
T 1fvr_A 175 VGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL- 250 (327)
T ss_dssp ECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-
T ss_pred EcCCCeEEEcccCcCccccc---cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-
Confidence 99999999999999874321 122234567899999999998889999999999999999998 9999976543221
Q ss_pred HHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 281 LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 281 ~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
............+..++.++.+||.+||+.||.+|||+.+++++
T Consensus 251 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 251 -YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp -HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11111223345567889999999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=369.42 Aligned_cols=256 Identities=24% Similarity=0.413 Sum_probs=206.6
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCC----cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSG----ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg----~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
++...+|++.++||+|+||+||+|.+..++ ..||||++.... .......+.+|+.+++.++||||++++
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~h~~iv~~~ 112 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIRLE 112 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-------CHHHHHHHHHHHHHHHhCCCCCCCcEE
Confidence 567789999999999999999999987653 459999984211 223345688999999999999999999
Q ss_pred cccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 136 GTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 136 g~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
+++......++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 113 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg 192 (333)
T 1mqb_A 113 GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 192 (333)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCC
Confidence 9999999999999999999999999764 679999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhh-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCC
Q 005944 215 ASKKVVELATI-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHP 291 (668)
Q Consensus 215 lA~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~ 291 (668)
+++.+...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... .....+. .....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~---~~~~~ 269 (333)
T 1mqb_A 193 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---DGFRL 269 (333)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TTCCC
T ss_pred cchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH---CCCcC
Confidence 99876432211 11223456889999999999999999999999999999999 9999975432 2222222 22234
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+.+..++.++.+||.+||+.||.+||++.+++++
T Consensus 270 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5567889999999999999999999999999874
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=360.82 Aligned_cols=254 Identities=26% Similarity=0.412 Sum_probs=207.2
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcC---CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLD---SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~---tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
.....+|++.+.||+|+||+||+|++.. ++..||||++... ......+.+.+|+.+++.++||||+++++
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 80 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-------CTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-------SCHHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-------cCchHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 4667899999999999999999998754 3456999987422 12234467889999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++.. +..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 159 (281)
T 3cc6_A 81 IIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGL 159 (281)
T ss_dssp EECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCG
T ss_pred EEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCC
Confidence 9865 4578999999999999999765 4599999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH-HHHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~-~~~~~~~~~~~~~~~~~~ 293 (668)
+........ .......+|+.|+|||++.+..++.++|||||||++|+|+| |+.||.... ......... ....+.
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~---~~~~~~ 235 (281)
T 3cc6_A 160 SRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GDRLPK 235 (281)
T ss_dssp GGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH---TCCCCC
T ss_pred Ccccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc---CCCCCC
Confidence 986543221 12334567889999999999999999999999999999998 999996322 122222222 223445
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+..+++.+.+||.+||..||.+||++.+++++
T Consensus 236 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 236 PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 66789999999999999999999999999975
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=362.02 Aligned_cols=256 Identities=25% Similarity=0.380 Sum_probs=211.9
Q ss_pred CCCCCeeeee-EEcccCceEEEEEEEc--CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 61 APPIRWRKGE-LVGCGAFGRVYMGMNL--DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~-~LG~G~fG~Vy~a~~~--~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
....+|.+.+ .||+|+||+||+|++. .++..||||++... ......+.+.+|+.+|+.++||||++++++
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 78 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------TEKADTEEMMREAQIMHQLDNPYIVRLIGV 78 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc-------cchhHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 4567788887 9999999999999864 46889999998432 123345678899999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+ ..+..++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 79 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~ 157 (287)
T 1u59_A 79 C-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157 (287)
T ss_dssp E-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred e-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccce
Confidence 8 556799999999999999998654 56999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhh-hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCC
Q 005944 217 KKVVELAT-INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPI 293 (668)
Q Consensus 217 ~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~ 293 (668)
........ ........||+.|+|||++.+..++.++|||||||++|+|++ |..||..... +....... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~---~~~~~~ 234 (287)
T 1u59_A 158 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ---GKRMEC 234 (287)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHT---TCCCCC
T ss_pred eeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhc---CCcCCC
Confidence 86533221 112234567899999999998889999999999999999998 9999975432 22222221 233456
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpw 327 (668)
+..++.++.+||.+||+.||.+||++.++++|.+
T Consensus 235 ~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 235 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 6789999999999999999999999999998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=383.89 Aligned_cols=255 Identities=25% Similarity=0.411 Sum_probs=206.8
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||+||+|++..+|+.||||++..... ......+.+|+.+|+.++|||||++++++..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 78 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-------LRPVDVQMREFEVLKKLNHKNIVKLFAIEEE 78 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-------GSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-------cchHHHHHHHHHHHHhcCCCCCCeEEEeecc
Confidence 567789999999999999999999999999999999842211 1123456789999999999999999999876
Q ss_pred CC--cceEEeeccCCCChhcccccCCC---CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe----CCCCceEEe
Q 005944 141 DD--SLNILLEFVPGGSISSLLGKFGS---FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV----DNKGCIKLA 211 (668)
Q Consensus 141 ~~--~~~LVmEy~~gGsL~~~L~~~~~---l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl----d~~g~vKL~ 211 (668)
.. ..++|||||++|+|.+++..... +++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+
T Consensus 79 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~ 158 (396)
T 4eut_A 79 TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLT 158 (396)
T ss_dssp TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEEC
T ss_pred CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEe
Confidence 55 67999999999999999976533 9999999999999999999999999999999999999 778889999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhh--------cCCCcchhHHHHHHHHHHHHhCCCCCchh-----HHHH
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQ--------TGHSFSADIWSVGCTVIEMATGKPPWSQQ-----FQEV 278 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~--------~~~s~ksDIWSLGvILyeLLTG~~PF~~~-----~~~~ 278 (668)
|||+++.+.... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... ..+.
T Consensus 159 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~ 235 (396)
T 4eut_A 159 DFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEV 235 (396)
T ss_dssp CGGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHH
T ss_pred cCCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHH
Confidence 999998654322 2345679999999999975 55788999999999999999999999521 1222
Q ss_pred HHHHhhccC---------------------CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 279 AALFHIGTT---------------------KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 279 ~~~~~~~~~---------------------~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
......... .....++..++..+.+||.+||+.||.+||++.+++++
T Consensus 236 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 236 MYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 222111110 11112334567788999999999999999999998654
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=358.33 Aligned_cols=251 Identities=24% Similarity=0.396 Sum_probs=209.3
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
++....+|++.+.||+|+||+||+|.+. ++..||||++..... ....+.+|+.+|+.++||||+++++++
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~h~~i~~~~~~~ 77 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM---------SPDAFLAEANLMKQLQHQRLVRLYAVV 77 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc---------cHHHHHHHHHHHHhCCCcCcceEEEEE
Confidence 4566789999999999999999999864 577899998843211 124578899999999999999999988
Q ss_pred ccCCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
. .+..++||||+++++|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 78 ~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~ 156 (279)
T 1qpc_A 78 T-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLA 156 (279)
T ss_dssp C-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred c-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccc
Confidence 6 456899999999999999997653 6999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCCC
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPIP 294 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~p 294 (668)
....... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... ...... .......+
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~ 232 (279)
T 1qpc_A 157 RLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE---RGYRMVRP 232 (279)
T ss_dssp EECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCCCCC
T ss_pred ccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHh---cccCCCCc
Confidence 7653321 122334567889999999998889999999999999999999 99999754332 222221 22334456
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..++.++.+||.+||..||.+|||+.++++
T Consensus 233 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 788999999999999999999999999986
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=385.34 Aligned_cols=252 Identities=24% Similarity=0.430 Sum_probs=212.0
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
.+++...+|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.+|+.++|||||+++++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~h~~iv~l~~~ 251 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---------MSVEAFLAEANVMKTLQHDKLVKLHAV 251 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS---------BCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC---------ccHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence 34567789999999999999999999875 47889999984321 123567899999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
+. ...+||||||+.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 252 ~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~ 330 (454)
T 1qcf_A 252 VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGL 330 (454)
T ss_dssp EC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred Ee-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCC
Confidence 86 66799999999999999999764 3689999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~ 293 (668)
++.+.... ........+|+.|+|||++....++.++|||||||+||||+| |+.||..... ++...+. .....+.
T Consensus 331 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~~~~~~~ 406 (454)
T 1qcf_A 331 ARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE---RGYRMPR 406 (454)
T ss_dssp GGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH---HTCCCCC
T ss_pred ceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCCC
Confidence 98654322 222334557889999999999999999999999999999999 9999975432 2222222 1234456
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+..++.++.+||.+||+.||.+|||+.+|++
T Consensus 407 ~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 407 PENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 7789999999999999999999999999985
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=377.32 Aligned_cols=256 Identities=17% Similarity=0.179 Sum_probs=204.2
Q ss_pred CCCCCCCCCCCCCCeeeeeEEcccCceEEEEE-----EEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC
Q 005944 52 ALPPIEKTDAPPIRWRKGELVGCGAFGRVYMG-----MNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126 (668)
Q Consensus 52 ~~pp~~~~~~~~~ry~i~~~LG~G~fG~Vy~a-----~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 126 (668)
...+.........+|++.++||+|+||+||+| .+..+++.||||++... ....+..|+.++..+
T Consensus 53 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----------~~~~~~~e~~~~~~l 121 (365)
T 3e7e_A 53 AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----------NPWEFYIGTQLMERL 121 (365)
T ss_dssp CCCSSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----------CHHHHHHHHHHHHHS
T ss_pred ccccceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----------ChhHHHHHHHHHHHh
Confidence 33344445567788999999999999999999 46778999999998321 122456777888888
Q ss_pred C---CCCeeeeccccccCCcceEEeeccCCCChhccccc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcc
Q 005944 127 T---HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGK-----FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGA 198 (668)
Q Consensus 127 ~---HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~-----~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPe 198 (668)
+ |+||+.+++++...+..|||||||++|+|.+++.. ...+++..++.|+.||+.||+|||++|||||||||+
T Consensus 122 ~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~ 201 (365)
T 3e7e_A 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPD 201 (365)
T ss_dssp CGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGG
T ss_pred hhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHH
Confidence 6 99999999999999999999999999999999963 467999999999999999999999999999999999
Q ss_pred cEEeCC-----------CCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhC
Q 005944 199 NILVDN-----------KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATG 267 (668)
Q Consensus 199 NILld~-----------~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG 267 (668)
||||+. ++.+||+|||+|+.+............+||+.|+|||++.+..++.++|||||||++|+|+||
T Consensus 202 NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg 281 (365)
T 3e7e_A 202 NFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281 (365)
T ss_dssp GEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHS
T ss_pred HEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 999998 899999999999765433333344567899999999999999999999999999999999999
Q ss_pred CCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 268 KPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 268 ~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+.||....... .......... ..+..+.+++.+||+.+|.+|++..+.+.+
T Consensus 282 ~~pf~~~~~~~-----~~~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 282 TYMKVKNEGGE-----CKPEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp SCCCEEEETTE-----EEECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred CCccccCCCCc-----eeechhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 99996432210 0001111111 246778999999999999999655444443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=360.14 Aligned_cols=254 Identities=24% Similarity=0.424 Sum_probs=203.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCC---cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg---~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
....+|++.++||+|+||+||+|++..++ ..||+|++.. .........+.+|+.+++.++||||++++++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~-------~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 94 (298)
T 3f66_A 22 PSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR-------ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGI 94 (298)
T ss_dssp GGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETT-------CCSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred ccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEeccc-------CCCHHHHHHHHHHHHHHHhCCCCCEeeeeeE
Confidence 34567999999999999999999976543 4689998732 1223345678899999999999999999998
Q ss_pred c-ccCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 138 A-REDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 138 ~-~~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
+ ..+...++||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 174 (298)
T 3f66_A 95 CLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 174 (298)
T ss_dssp ECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGG
T ss_pred EEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccc
Confidence 4 556788999999999999999975 35689999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhh--hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCC
Q 005944 216 SKKVVELAT--INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHP 291 (668)
Q Consensus 216 A~~~~~~~~--~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~ 291 (668)
++.+..... ........||+.|+|||++.+..++.++|||||||++|+|++ |.+||..... ....... .....
T Consensus 175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~ 251 (298)
T 3f66_A 175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---QGRRL 251 (298)
T ss_dssp GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH---TTCCC
T ss_pred cccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh---cCCCC
Confidence 976543221 112334567889999999999999999999999999999999 6667654321 1111111 12233
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..+..++.++.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 252 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 446678999999999999999999999999986
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=376.71 Aligned_cols=260 Identities=23% Similarity=0.318 Sum_probs=209.1
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||+||+|.+ .+++.||||++..... ......+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERT-------QGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC------------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccC-------chHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 46678999999999999999999974 4689999999843211 111224788999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccccCCcccEEeCCCCceEEec
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFG----SFPESVIRMYTKQLLLGLEYLHKN---GIMHRDIKGANILVDNKGCIKLAD 212 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~----~l~e~~~~~i~~QIl~aL~yLHs~---gIvHrDLKPeNILld~~g~vKL~D 212 (668)
.....++||||+.+|+|.+++.... .+++..++.++.||+.||.|||++ ||+||||||+||||+.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999987643 499999999999999999999999 999999999999999999999999
Q ss_pred CCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH------HHHHHhh--
Q 005944 213 FGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE------VAALFHI-- 284 (668)
Q Consensus 213 FGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~------~~~~~~~-- 284 (668)
||+++...... ........||+.|+|||++.+..++.++|||||||++|+|++|..||...... .......
T Consensus 178 fg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 256 (326)
T 3uim_A 178 FGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256 (326)
T ss_dssp CSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTT
T ss_pred CccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHh
Confidence 99997653221 11233456999999999999988999999999999999999999999632110 0000000
Q ss_pred --------ccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 285 --------GTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 285 --------~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.........+...+.++.+||.+||+.||.+|||+.++++|-.-
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp SSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred hchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 00011122334456789999999999999999999999998653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=362.98 Aligned_cols=249 Identities=27% Similarity=0.398 Sum_probs=197.4
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHh--CCCCCeeeeccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN--LTHPNIVRYLGT 137 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIV~l~g~ 137 (668)
.....+|++.+.||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++||||++++++
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----------~~~~~~~e~~~~~~~~l~h~niv~~~~~ 70 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR-----------DEKSWFRETELYNTVMLRHENILGFIAS 70 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG-----------GHHHHHHHHHHHHHTCCCCTTBCCEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc-----------cchhhHHHHHHHHHhhccCcCeeeEEEe
Confidence 35677899999999999999999987 6899999998321 11223445666665 799999999998
Q ss_pred ccc----CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccccCCcccEEeCCC
Q 005944 138 ARE----DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH--------KNGIMHRDIKGANILVDNK 205 (668)
Q Consensus 138 ~~~----~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLH--------s~gIvHrDLKPeNILld~~ 205 (668)
+.. ...+++||||+++|+|.+++.. ..+++..++.++.||+.||.||| ++||+||||||+||||+.+
T Consensus 71 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~ 149 (301)
T 3q4u_A 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKN 149 (301)
T ss_dssp EEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTT
T ss_pred eccccCCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCC
Confidence 543 3568999999999999999964 57999999999999999999999 9999999999999999999
Q ss_pred CceEEecCCchhhhHhhhhh--cCCccCCCCCCCCChHHHhhc------CCCcchhHHHHHHHHHHHHhC----------
Q 005944 206 GCIKLADFGASKKVVELATI--NGAKSMKGTPYWMAPEVILQT------GHSFSADIWSVGCTVIEMATG---------- 267 (668)
Q Consensus 206 g~vKL~DFGlA~~~~~~~~~--~~~~~~~GT~~Y~APEvl~~~------~~s~ksDIWSLGvILyeLLTG---------- 267 (668)
+.+||+|||+++........ ......+||+.|+|||++.+. .++.++|||||||++|+|+||
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 99999999999755332221 112345899999999999876 345789999999999999999
Q ss_pred CCCCchh------HHHHHHHHhhccCCCCCCCC-----cccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 268 KPPWSQQ------FQEVAALFHIGTTKSHPPIP-----EHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 268 ~~PF~~~------~~~~~~~~~~~~~~~~~~~p-----~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..||... .......... ....+.++ ..++.++.+||.+||+.||.+|||+.+|++
T Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDMRKVVCV--DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTT--SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccccCCCCcchhhhhHHHhc--cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 8898542 1222222221 12222233 235678999999999999999999999986
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=368.32 Aligned_cols=256 Identities=27% Similarity=0.468 Sum_probs=209.4
Q ss_pred CCCCCe-eeeeEEcccCceEEEEEEE----cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 61 APPIRW-RKGELVGCGAFGRVYMGMN----LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 61 ~~~~ry-~i~~~LG~G~fG~Vy~a~~----~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
....+| ++.+.||+|+||+||+|.. ..+++.||||++... ........+.+|+.+|+.++||||++++
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 99 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-------AGPQHRSGWKQEIDILRTLYHEHIIKYK 99 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-------CCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-------cChHHHHHHHHHHHHHHhCCCcchhhEE
Confidence 344555 9999999999999988754 447899999998422 1233456688999999999999999999
Q ss_pred cccccC--CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecC
Q 005944 136 GTARED--DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADF 213 (668)
Q Consensus 136 g~~~~~--~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DF 213 (668)
+++... ..+++||||+++|+|.+++... .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Df 178 (318)
T 3lxp_A 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDF 178 (318)
T ss_dssp EEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCG
T ss_pred EEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCc
Confidence 999774 5689999999999999999764 5999999999999999999999999999999999999999999999999
Q ss_pred CchhhhHhhhhh-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH-------------H
Q 005944 214 GASKKVVELATI-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV-------------A 279 (668)
Q Consensus 214 GlA~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~-------------~ 279 (668)
|++..+...... .......||+.|+|||++.+..++.++|||||||++|+|+||..||....... .
T Consensus 179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 258 (318)
T 3lxp_A 179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL 258 (318)
T ss_dssp GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHH
T ss_pred cccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHH
Confidence 999865432211 12334568899999999999889999999999999999999999997543221 1
Q ss_pred HHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 280 ALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 280 ~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
............+.+..++.++.+||.+||+.||.+|||+.++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 122222233445667789999999999999999999999999985
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=396.02 Aligned_cols=255 Identities=26% Similarity=0.416 Sum_probs=216.2
Q ss_pred CCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecc
Q 005944 57 EKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLG 136 (668)
Q Consensus 57 ~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g 136 (668)
..+++...+|++.+.||+|+||.||+|++..++..||||++.... .....+.+|+.+|+.++|||||++++
T Consensus 213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~E~~~l~~l~hpniv~l~~ 283 (495)
T 1opk_A 213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPNLVQLLG 283 (495)
T ss_dssp SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---------SCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---------cchHHHHHHHHHHHhcCCCCEeeEEE
Confidence 445567788999999999999999999999999999999984321 11345789999999999999999999
Q ss_pred ccccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 137 TAREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
++.....+||||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 284 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG 363 (495)
T 1opk_A 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFG 363 (495)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTT
T ss_pred EEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecc
Confidence 999999999999999999999999753 458999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCC
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPP 292 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~ 292 (668)
+++.+... .........+|+.|+|||++.+..++.++|||||||+||+|+| |..||..... .+...+. ......
T Consensus 364 ~a~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~---~~~~~~ 439 (495)
T 1opk_A 364 LSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KDYRME 439 (495)
T ss_dssp CEECCTTC-CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TTCCCC
T ss_pred cceeccCC-ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCC
Confidence 99865322 2222334557789999999999999999999999999999999 9999975322 2222221 233445
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.+..++.++.+||.+||+.||.+|||+.+|++
T Consensus 440 ~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 67789999999999999999999999999986
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=361.22 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=200.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc-c
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA-R 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~-~ 139 (668)
....+|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.+.|++++..+..+ .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------HPQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------------CCCHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----------chHHHHHHHHHHHhcCCCCCCeeeeecC
Confidence 456789999999999999999999999999999998643211 12367799999999988877666555 6
Q ss_pred cCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe---CCCCceEEecCCc
Q 005944 140 EDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV---DNKGCIKLADFGA 215 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl---d~~g~vKL~DFGl 215 (668)
.....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTT
T ss_pred CCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcc
Confidence 667789999999 9999999874 4679999999999999999999999999999999999999 7889999999999
Q ss_pred hhhhHhhhhh-----cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-----HHHHHHHhhc
Q 005944 216 SKKVVELATI-----NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-----QEVAALFHIG 285 (668)
Q Consensus 216 A~~~~~~~~~-----~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-----~~~~~~~~~~ 285 (668)
++.+...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ..........
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 9865432221 12335689999999999999999999999999999999999999996421 1111111111
Q ss_pred cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 286 ~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
...........++.++.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 111111122467899999999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=366.93 Aligned_cols=254 Identities=25% Similarity=0.412 Sum_probs=190.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeecccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTA 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~ 138 (668)
+....+|++.++||+|+||+||+|.+..+++.||||++... .......+.+|+.+|..+. ||||+++++++
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~ 95 (337)
T 3ll6_A 24 ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--------EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95 (337)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--------SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred eccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--------chHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence 35567899999999999999999999999999999988422 2233456788999999996 99999999987
Q ss_pred --------ccCCcceEEeeccCCCChhccccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCcccEEeCCC
Q 005944 139 --------REDDSLNILLEFVPGGSISSLLGK---FGSFPESVIRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVDNK 205 (668)
Q Consensus 139 --------~~~~~~~LVmEy~~gGsL~~~L~~---~~~l~e~~~~~i~~QIl~aL~yLHs~g--IvHrDLKPeNILld~~ 205 (668)
.....+++||||+. |+|.+++.. .+.+++..++.++.||+.||.|||++| |+||||||+||||+.+
T Consensus 96 ~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~ 174 (337)
T 3ll6_A 96 SIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQ 174 (337)
T ss_dssp EECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTT
T ss_pred cccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCC
Confidence 34455899999996 688888754 467999999999999999999999999 9999999999999999
Q ss_pred CceEEecCCchhhhHhhhhh----------cCCccCCCCCCCCChHHH---hhcCCCcchhHHHHHHHHHHHHhCCCCCc
Q 005944 206 GCIKLADFGASKKVVELATI----------NGAKSMKGTPYWMAPEVI---LQTGHSFSADIWSVGCTVIEMATGKPPWS 272 (668)
Q Consensus 206 g~vKL~DFGlA~~~~~~~~~----------~~~~~~~GT~~Y~APEvl---~~~~~s~ksDIWSLGvILyeLLTG~~PF~ 272 (668)
+.+||+|||+++.+...... ......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~ 254 (337)
T 3ll6_A 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE 254 (337)
T ss_dssp SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999765321110 111245699999999999 56678899999999999999999999996
Q ss_pred hhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcc
Q 005944 273 QQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327 (668)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpw 327 (668)
..... .........+.+...+..+.+||.+||+.||.+|||+.++++|-+
T Consensus 255 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 255 DGAKL-----RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred chhHH-----HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 53221 111112223344566778999999999999999999999999854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=366.62 Aligned_cols=258 Identities=28% Similarity=0.463 Sum_probs=211.5
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEE----EcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGM----NLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~----~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l 134 (668)
......+|++.+.||+|+||.||+|+ +..+++.||||++... .....+.+.+|+.+|+.++||||+++
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~~iv~~ 107 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--------TEEHLRDFEREIEILKSLQHDNIVKY 107 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--------CSHHHHHHHHHHHHHHTCCCTTBCCE
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--------CHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence 34667789999999999999999998 4568999999998421 22344668899999999999999999
Q ss_pred ccccccCC--cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 135 LGTAREDD--SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 135 ~g~~~~~~--~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
++++...+ .+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 108 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~ 187 (326)
T 2w1i_A 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIG 187 (326)
T ss_dssp EEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEEC
T ss_pred EEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEe
Confidence 99876544 789999999999999999765 469999999999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhhhhh-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHH----------
Q 005944 212 DFGASKKVVELATI-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAA---------- 280 (668)
Q Consensus 212 DFGlA~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~---------- 280 (668)
|||++......... .......+++.|+|||++.+..++.++|||||||++|+|+||..||.........
T Consensus 188 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~ 267 (326)
T 2w1i_A 188 DFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267 (326)
T ss_dssp CCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred cCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence 99999765332211 1123356788899999999988999999999999999999999998654322211
Q ss_pred ----HHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 281 ----LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 281 ----~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+..........+.+..++.++.+||.+||+.||.+|||+.++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11111222334567789999999999999999999999999985
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=356.83 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=203.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc-c
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA-R 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~-~ 139 (668)
....+|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|+.+++.+.|++++..+..+ .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----------~~~~~~e~~~l~~l~~~~~i~~~~~~~~ 75 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------HPQLHIESKIYKMMQGGVGIPTIRWCGA 75 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----------CCHHHHHHHHHHHHTTSTTCCCEEEEEE
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----------hhHHHHHHHHHHHhhcCCCCCccccccC
Confidence 346789999999999999999999999999999998743221 12367899999999988876665554 5
Q ss_pred cCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe---CCCCceEEecCCc
Q 005944 140 EDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV---DNKGCIKLADFGA 215 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl---d~~g~vKL~DFGl 215 (668)
.....++||||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||+
T Consensus 76 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 76 EGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred CCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 667789999999 8999999973 4679999999999999999999999999999999999999 4788999999999
Q ss_pred hhhhHhhhhh-----cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-----HHHHHHHhhc
Q 005944 216 SKKVVELATI-----NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-----QEVAALFHIG 285 (668)
Q Consensus 216 A~~~~~~~~~-----~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-----~~~~~~~~~~ 285 (668)
+......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .....+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 9865432221 12345689999999999999999999999999999999999999996421 1111111111
Q ss_pred cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 286 ~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
........+..++.++.+||.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 011111123567899999999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=385.20 Aligned_cols=257 Identities=28% Similarity=0.379 Sum_probs=196.4
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
.....|.+.++||+|+||+||.+ ...+|+.||||++... ....+.+|+.+|..+ +|||||++++++.
T Consensus 12 ~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~-----------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~ 79 (434)
T 2rio_A 12 SLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID-----------FCDIALMEIKLLTESDDHPNVIRYYCSET 79 (434)
T ss_dssp SCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG-----------GHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred hhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH-----------HHHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 55667888999999999999876 4567999999988421 113456899999876 8999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCC-------CHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC-------
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSF-------PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK------- 205 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l-------~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~------- 205 (668)
....+|||||||. |+|.+++...... ++..++.++.||+.||.|||++||+||||||+||||+.+
T Consensus 80 ~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~ 158 (434)
T 2rio_A 80 TDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQ 158 (434)
T ss_dssp CSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCC
T ss_pred cCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCccccccc
Confidence 9999999999996 5999999765433 233467899999999999999999999999999999754
Q ss_pred ------CceEEecCCchhhhHhhhhh--cCCccCCCCCCCCChHHHhh-------cCCCcchhHHHHHHHHHHHHh-CCC
Q 005944 206 ------GCIKLADFGASKKVVELATI--NGAKSMKGTPYWMAPEVILQ-------TGHSFSADIWSVGCTVIEMAT-GKP 269 (668)
Q Consensus 206 ------g~vKL~DFGlA~~~~~~~~~--~~~~~~~GT~~Y~APEvl~~-------~~~s~ksDIWSLGvILyeLLT-G~~ 269 (668)
+.+||+|||+++.+...... ......+||+.|+|||++.+ ..++.++|||||||++|+|+| |..
T Consensus 159 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~ 238 (434)
T 2rio_A 159 QTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238 (434)
T ss_dssp TTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCC
T ss_pred ccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCC
Confidence 48999999999865432211 11234679999999999976 568999999999999999999 999
Q ss_pred CCchhHHHHHHHHhhccCC-C-CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 270 PWSQQFQEVAALFHIGTTK-S-HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 270 PF~~~~~~~~~~~~~~~~~-~-~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
||.........+....... . ....+..++.++.+||.+||+.||.+|||+.++++||||..
T Consensus 239 Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 239 PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp TTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 9976543332222211111 1 11112356789999999999999999999999999999963
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-43 Score=384.56 Aligned_cols=246 Identities=25% Similarity=0.410 Sum_probs=206.6
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
+.+...+|++.+.||+|+||+||+|.+ .++.||||++.... ..+.+.+|+.+|++++|||||++++++
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~----------~~~~~~~E~~~l~~l~h~niv~~~~~~ 255 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA----------TAQAFLAEASVMTQLRHSNLVQLLGVI 255 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT----------TSHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch----------HHHHHHHHHHHHHhccCCCEEEEEEEE
Confidence 346677899999999999999999987 47899999984211 234578899999999999999999997
Q ss_pred ccCC-cceEEeeccCCCChhcccccCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 139 REDD-SLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 139 ~~~~-~~~LVmEy~~gGsL~~~L~~~~~--l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
.... .+||||||+++|+|.+++...+. +++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 256 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 335 (450)
T 1k9a_A 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335 (450)
T ss_dssp ECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCC
Confidence 6654 79999999999999999976543 79999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH-HHHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~-~~~~~~~~~~~~~~~~~~ 293 (668)
++.... ......+++.|+|||++.+..++.++|||||||+||||+| |..||.... .+....+. .......
T Consensus 336 a~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~~~~~~~ 407 (450)
T 1k9a_A 336 TKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE---KGYKMDA 407 (450)
T ss_dssp CEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH---TTCCCCC
T ss_pred cccccc-----cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCCC
Confidence 874321 1223467899999999999999999999999999999998 999997532 22222222 2234556
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+..+++++.+||.+||+.||.+|||+.+|++
T Consensus 408 p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 408 PDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7789999999999999999999999999985
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=356.50 Aligned_cols=245 Identities=24% Similarity=0.410 Sum_probs=199.6
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.....+|++.+.||+|+||+||+|.+ +|..||||++... ...+.+.+|+.+++.++||||+++++++.
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~----------~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 84 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----------ATAQAFLAEASVMTQLRHSNLVQLLGVIV 84 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----------C--HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecch----------hHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence 35567899999999999999999987 5899999988421 12346788999999999999999999865
Q ss_pred c-CCcceEEeeccCCCChhcccccCCC--CCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 140 E-DDSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 140 ~-~~~~~LVmEy~~gGsL~~~L~~~~~--l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
. .+..++||||+++++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~ 164 (278)
T 1byg_A 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164 (278)
T ss_dssp CC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred cCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeecccc
Confidence 4 4579999999999999999976543 899999999999999999999999999999999999999999999999998
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCC
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIP 294 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p 294 (668)
...... .....+++.|+|||++.+..++.++|||||||++|+|+| |..||..... ...... ........+
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~---~~~~~~~~~ 236 (278)
T 1byg_A 165 KEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---EKGYKMDAP 236 (278)
T ss_dssp ----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH---TTTCCCCCC
T ss_pred cccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---hcCCCCCCc
Confidence 754322 223467899999999999999999999999999999998 9999975422 211111 122334566
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..+++++.+||.+||+.||.+||++.++++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 237 DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 788999999999999999999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=370.47 Aligned_cols=250 Identities=18% Similarity=0.211 Sum_probs=201.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCC--------CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCee
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDS--------GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV 132 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~t--------g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV 132 (668)
....+|++.+.||+|+||+||+|++..+ ++.||||++... ..+.+|+.+++.++|||||
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------------~~~~~E~~~l~~l~h~niv 105 (352)
T 2jii_A 39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------------GRLFNEQNFFQRAAKPLQV 105 (352)
T ss_dssp TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------------STHHHHHHHHHHHCCHHHH
T ss_pred ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------------chHHHHHHHHHHhcccchh
Confidence 4468999999999999999999999874 889999998421 2467899999999999999
Q ss_pred ee---------------cccccc-CCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Q 005944 133 RY---------------LGTARE-DDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRD 194 (668)
Q Consensus 133 ~l---------------~g~~~~-~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrD 194 (668)
++ ++++.. ....|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 106 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~D 184 (352)
T 2jii_A 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGN 184 (352)
T ss_dssp HHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSC
T ss_pred hhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 84 444444 67789999999 99999999876 7899999999999999999999999999999
Q ss_pred CCcccEEeCCCC--ceEEecCCchhhhHhhhhhc-----CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhC
Q 005944 195 IKGANILVDNKG--CIKLADFGASKKVVELATIN-----GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATG 267 (668)
Q Consensus 195 LKPeNILld~~g--~vKL~DFGlA~~~~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG 267 (668)
|||+||||+.++ .+||+|||+++.+....... ......||+.|+|||++.+..++.++|||||||+||+|++|
T Consensus 185 ikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 264 (352)
T 2jii_A 185 VTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYG 264 (352)
T ss_dssp CCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999998 99999999998664332211 12345799999999999998999999999999999999999
Q ss_pred CCCCchhH---HHHHHHHhhccCCC-----CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 268 KPPWSQQF---QEVAALFHIGTTKS-----HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 268 ~~PF~~~~---~~~~~~~~~~~~~~-----~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+.||.... ..+........... ....+..++.++.+||.+||+.||.+||++.+|++
T Consensus 265 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 265 FLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 99997542 12211111100000 11112357899999999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=386.70 Aligned_cols=257 Identities=25% Similarity=0.398 Sum_probs=199.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~ 139 (668)
....+|.+.++||+|+||+||. ....+++.||||++..... ..+.+|+.+|+.+ +|||||++++++.
T Consensus 21 i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----------~~~~~E~~~l~~l~~HpnIv~l~~~~~ 88 (432)
T 3p23_A 21 VGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----------SFADREVQLLRESDEHPNVIRYFCTEK 88 (432)
T ss_dssp ETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----------EECHHHHHHHHHSCCCTTBCCEEEEEE
T ss_pred EccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----------HHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence 4556799999999999999764 3456899999998842111 1245799999999 7999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC---C--CceEEecC
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---K--GCIKLADF 213 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---~--g~vKL~DF 213 (668)
.....|||||||. |+|.+++... ..+.+..++.++.||+.||.|||++||+||||||+||||+. + ..+||+||
T Consensus 89 ~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DF 167 (432)
T 3p23_A 89 DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167 (432)
T ss_dssp ETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCT
T ss_pred cCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecc
Confidence 9999999999996 5999988665 34666678899999999999999999999999999999953 2 35789999
Q ss_pred CchhhhHhhhh-hcCCccCCCCCCCCChHHHh---hcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCC
Q 005944 214 GASKKVVELAT-INGAKSMKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTK 288 (668)
Q Consensus 214 GlA~~~~~~~~-~~~~~~~~GT~~Y~APEvl~---~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~ 288 (668)
|+++.+..... .......+||+.|+|||++. ...++.++|||||||++|+|+| |..||.................
T Consensus 168 G~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~ 247 (432)
T 3p23_A 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSL 247 (432)
T ss_dssp TEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCC
T ss_pred cceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCc
Confidence 99986643221 12234578999999999997 4567889999999999999999 9999976544433333222222
Q ss_pred CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 289 SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 289 ~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.........+..+.+||.+||+.||.+|||+.++++||||..
T Consensus 248 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 248 DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 222223455677899999999999999999999999999964
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=381.85 Aligned_cols=252 Identities=25% Similarity=0.409 Sum_probs=206.1
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
.+++...+|++.+.||+|+||+||+|.+.. +..||||++..... ..+.+.+|+.+|+.++|||||+++++
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hp~iv~~~~~ 247 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAV 247 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC---------CHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 345677889999999999999999999864 56799999843211 12457889999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
+.. ...||||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 248 ~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~ 326 (452)
T 1fmk_A 248 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 326 (452)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred EcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCcc
Confidence 876 6789999999999999999753 5699999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~ 293 (668)
++.+.... ........+|+.|+|||++.+..++.++|||||||+||+|+| |..||..... +...... .....+.
T Consensus 327 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~---~~~~~~~ 402 (452)
T 1fmk_A 327 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGYRMPC 402 (452)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCCCC
T ss_pred ceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCCC
Confidence 98764322 122234457889999999999999999999999999999999 9999975432 2222222 2234556
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+..++.++.+||.+||+.||.+|||+.+|++
T Consensus 403 ~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 403 PPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 7789999999999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=356.88 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=201.5
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcC-CCc--EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLD-SGE--LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~-tg~--~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
....+|++.+.||+|+||+||+|++.. ++. .||||++.... .......+.+.+|+.+++.++||||++++++
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~ 89 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV-----LSQPEAMDDFIREVNAMHSLDHRNLIRLYGV 89 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCc-----cCCHHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence 556789999999999999999998644 333 68999874221 1122345678899999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+.... .++||||+++++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 90 VLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp ECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred EccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccc
Confidence 88765 89999999999999998764 56999999999999999999999999999999999999999999999999998
Q ss_pred hhhHhhhhh-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCC
Q 005944 217 KKVVELATI-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIP 294 (668)
Q Consensus 217 ~~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p 294 (668)
..+...... .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||........ ...+.......+.+
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~ 247 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-LHKIDKEGERLPRP 247 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTSCCCCCCC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-HHHHHccCCCCCCC
Confidence 765332211 12234567889999999998889999999999999999999 9999975433221 11222223344556
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..++.++.+||.+||..||.+|||+.++++
T Consensus 248 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 248 EDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 788999999999999999999999999997
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=364.51 Aligned_cols=260 Identities=25% Similarity=0.327 Sum_probs=194.1
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc-
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA- 138 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~- 138 (668)
.....+|++.+.||+|+||+||+|++ +++.||||++.... .. ......|+..+..++|+||+++++.+
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-------~~--~~~~e~~~~~~~~~~h~~i~~~~~~~~ 77 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN-------RQ--NFINEKNIYRVPLMEHDNIARFIVGDE 77 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG-------HH--HHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc-------hh--hHHHHHHHHHHHhccCcchhhheeccc
Confidence 45678999999999999999999976 78999999984211 11 11123445555568999999998743
Q ss_pred ----ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccccCCcccEEeCCC
Q 005944 139 ----REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN---------GIMHRDIKGANILVDNK 205 (668)
Q Consensus 139 ----~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~---------gIvHrDLKPeNILld~~ 205 (668)
.....+++|||||++|+|.+++... .+++..++.++.||+.||.|||+. ||+||||||+||||+.+
T Consensus 78 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 78 RVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred ccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCC
Confidence 3344678999999999999999664 558999999999999999999999 99999999999999999
Q ss_pred CceEEecCCchhhhHhh------hhhcCCccCCCCCCCCChHHHhh-------cCCCcchhHHHHHHHHHHHHhCCCCCc
Q 005944 206 GCIKLADFGASKKVVEL------ATINGAKSMKGTPYWMAPEVILQ-------TGHSFSADIWSVGCTVIEMATGKPPWS 272 (668)
Q Consensus 206 g~vKL~DFGlA~~~~~~------~~~~~~~~~~GT~~Y~APEvl~~-------~~~s~ksDIWSLGvILyeLLTG~~PF~ 272 (668)
+.+||+|||+++.+... .........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 99999999999765321 11122335679999999999986 346678999999999999999977663
Q ss_pred hh-------------------HHHHHHHHhhccCCCCCCCCc------ccCHHHHHHHHHhhhhCCCCCCCHHHHH----
Q 005944 273 QQ-------------------FQEVAALFHIGTTKSHPPIPE------HLSMEAKDFLLKCLQKEPYLRSTASELL---- 323 (668)
Q Consensus 273 ~~-------------------~~~~~~~~~~~~~~~~~~~p~------~ls~el~dLI~kcL~~dP~~RPSa~EIL---- 323 (668)
.. ........ ......+.++. .++.++.+||.+||+.||.+|||+.|++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~ 314 (336)
T 3g2f_A 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLV--SREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMA 314 (336)
T ss_dssp TTSCCCCCCCTTHHHHCSSCCHHHHHHHH--TTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred CccchhHHHHhhhcccCCCchHHHHHhhh--cccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHH
Confidence 21 01111111 11222223332 2556899999999999999999999994
Q ss_pred --cCccccCCCC
Q 005944 324 --QHPFVTGKYQ 333 (668)
Q Consensus 324 --~Hpwf~~~~~ 333 (668)
.++|-++...
T Consensus 315 ~ll~~~~~~~~~ 326 (336)
T 3g2f_A 315 ELMMIWERNKSV 326 (336)
T ss_dssp HHHHCCCC----
T ss_pred HHHHHHHhcccC
Confidence 4677665443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=374.51 Aligned_cols=253 Identities=20% Similarity=0.272 Sum_probs=195.8
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-------------
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT------------- 127 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~------------- 127 (668)
....+|++.+.||+|+||+||+|++ +|+.||||++................+.+.+|+.+|+.++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999988 7899999999654321111111122345678888888886
Q ss_pred -------------CCCeeeecccccc-------------CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHH
Q 005944 128 -------------HPNIVRYLGTARE-------------DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181 (668)
Q Consensus 128 -------------HpNIV~l~g~~~~-------------~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~a 181 (668)
|||||++++++.. ...+|||||||++|++.+.+.+ +.+++..++.|+.||+.|
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence 5555566666554 7889999999999987777654 678999999999999999
Q ss_pred HHHHH-hCCcccccCCcccEEeCCCC--------------------ceEEecCCchhhhHhhhhhcCCccCCCCCCCCCh
Q 005944 182 LEYLH-KNGIMHRDIKGANILVDNKG--------------------CIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240 (668)
Q Consensus 182 L~yLH-s~gIvHrDLKPeNILld~~g--------------------~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~AP 240 (668)
|.||| ++||+||||||+||||+.++ .+||+|||+|+.... ...+||+.|+||
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP 246 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE 246 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence 99999 99999999999999999887 899999999986532 245899999999
Q ss_pred HHHhhcCCCcchhHHHHHHH-HHHHHhCCCCCchhHH--HHH-HHHhhccCC--CCCCCCcccCHHHHHHHHHhhhhCCC
Q 005944 241 EVILQTGHSFSADIWSVGCT-VIEMATGKPPWSQQFQ--EVA-ALFHIGTTK--SHPPIPEHLSMEAKDFLLKCLQKEPY 314 (668)
Q Consensus 241 Evl~~~~~s~ksDIWSLGvI-LyeLLTG~~PF~~~~~--~~~-~~~~~~~~~--~~~~~p~~ls~el~dLI~kcL~~dP~ 314 (668)
|++.+.. +.++||||||++ .+++++|..||..... ... .+....... .....+..+++++++||.+||+.|
T Consensus 247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 9998766 889999998777 7889999999965321 111 111111111 112223468899999999999977
Q ss_pred CCCCHHHHH-cCcccc
Q 005944 315 LRSTASELL-QHPFVT 329 (668)
Q Consensus 315 ~RPSa~EIL-~Hpwf~ 329 (668)
|+.|+| +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=360.39 Aligned_cols=250 Identities=24% Similarity=0.398 Sum_probs=196.5
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHh--CCCCCeeeeccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN--LTHPNIVRYLGT 137 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIV~l~g~ 137 (668)
.....+|++.+.||+|+||+||+|++. ++.||||++... .. ..+..|..++.. ++||||++++++
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~-----~~~~~e~~~~~~~~~~h~~i~~~~~~ 99 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EE-----ASWFRETEIYQTVLMRHENILGFIAA 99 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GH-----HHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------cc-----chhhhHHHHHHHHhhcCCCeeeEEEE
Confidence 355678999999999999999999874 899999998321 11 122334444444 489999999999
Q ss_pred cccC----CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccccCCcccEEeCCC
Q 005944 138 ARED----DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN--------GIMHRDIKGANILVDNK 205 (668)
Q Consensus 138 ~~~~----~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~--------gIvHrDLKPeNILld~~ 205 (668)
+... ..+|+||||+++|+|.+++.. ..+++..++.++.||+.||.|||++ ||+||||||+||||+.+
T Consensus 100 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 100 DIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178 (337)
T ss_dssp EEESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred EccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence 8776 678999999999999999965 4799999999999999999999998 99999999999999999
Q ss_pred CceEEecCCchhhhHhhhhh--cCCccCCCCCCCCChHHHhhcCCCcc------hhHHHHHHHHHHHHhC----------
Q 005944 206 GCIKLADFGASKKVVELATI--NGAKSMKGTPYWMAPEVILQTGHSFS------ADIWSVGCTVIEMATG---------- 267 (668)
Q Consensus 206 g~vKL~DFGlA~~~~~~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~k------sDIWSLGvILyeLLTG---------- 267 (668)
+.+||+|||+++.+...... ......+||+.|+|||++.+..+... +|||||||++|+|+||
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 99999999999755332221 11235689999999999988776655 9999999999999999
Q ss_pred CCCCchh------HHHHHHHHhhccCCCCCCCCc-----ccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 268 KPPWSQQ------FQEVAALFHIGTTKSHPPIPE-----HLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 268 ~~PF~~~------~~~~~~~~~~~~~~~~~~~p~-----~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
..||... .......... ....+..+. .++.++.+||.+||+.||.+|||+.++++|
T Consensus 259 ~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 259 QLPYHDLVPSDPSYEDMREIVCI--KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTT--SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cccHhhhcCCCCchhhhHHHHhh--hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 7777532 1222222222 222233332 567789999999999999999999999975
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=356.73 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=202.8
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcce
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLN 145 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~ 145 (668)
|..++.||+|+||+||+|.+ ++..||||++...... ........+.+|+.+++.++||||+++++++...+..+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 106 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDI----TTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLC 106 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTS----CTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCc----chHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceE
Confidence 55568999999999999975 6889999998432211 11233456889999999999999999999999999999
Q ss_pred EEeeccCCCChhccccc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 146 ILLEFVPGGSISSLLGK---FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 146 LVmEy~~gGsL~~~L~~---~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
+||||+++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 186 (307)
T 2nru_A 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKF 186 (307)
T ss_dssp EEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred EEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccc
Confidence 99999999999998863 356999999999999999999999999999999999999999999999999998765332
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-----HHHHHHHhhc-------cCCCC
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-----QEVAALFHIG-------TTKSH 290 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-----~~~~~~~~~~-------~~~~~ 290 (668)
..........||+.|+|||++.+ .++.++|||||||++|+|++|..||.... ..+....... .....
T Consensus 187 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (307)
T 2nru_A 187 AQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM 265 (307)
T ss_dssp SSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSC
T ss_pred cccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccc
Confidence 22222334679999999999865 48899999999999999999999996431 1111111110 01112
Q ss_pred CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 291 ~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
...+...+..+.+||.+||+.||.+|||+.+++++
T Consensus 266 ~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 266 NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 23445567789999999999999999999999864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=372.91 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=197.0
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCC---cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg---~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
....|++.++||+|+||+||+|++..++ ..||||.+... ........+.+|+.+|+.++|||||++++++
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~ 159 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC 159 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-------SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEE
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-------CCHHHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence 3446899999999999999999876443 46899987321 1123456688999999999999999999986
Q ss_pred c-cCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 139 R-EDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 139 ~-~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
. .++..++||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 160 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a 239 (373)
T 3c1x_A 160 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239 (373)
T ss_dssp CCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccc
Confidence 4 456889999999999999999765 45899999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhh--cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCC
Q 005944 217 KKVVELATI--NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPP 292 (668)
Q Consensus 217 ~~~~~~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~ 292 (668)
+.+...... .......+|+.|+|||++.+..++.++|||||||++|+|+| |.+||..... +....... .....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~---~~~~~ 316 (373)
T 3c1x_A 240 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---GRRLL 316 (373)
T ss_dssp ------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT---TCCCC
T ss_pred ccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc---CCCCC
Confidence 865432211 11233567889999999999999999999999999999999 7888864321 11111111 22334
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.+..++.++.+||.+||+.||.+||++.+++++
T Consensus 317 ~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 317 QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 566789999999999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=356.71 Aligned_cols=236 Identities=26% Similarity=0.404 Sum_probs=190.3
Q ss_pred CCCCCeeee-eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHH-HhCCCCCeeeecccc
Q 005944 61 APPIRWRKG-ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLL-KNLTHPNIVRYLGTA 138 (668)
Q Consensus 61 ~~~~ry~i~-~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL-~~L~HpNIV~l~g~~ 138 (668)
....+|.+. ++||+|+||.||+|.+..+++.||||++... ..+.+|+.++ +.++||||+++++++
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------------~~~~~e~~~~~~~~~h~~i~~~~~~~ 80 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVY 80 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------------HHHHHHHHHHHHhccCCCchhHHhhh
Confidence 344567776 8899999999999999999999999998311 2345678777 666999999999998
Q ss_pred cc----CCcceEEeeccCCCChhcccccCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC---CCceE
Q 005944 139 RE----DDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---KGCIK 209 (668)
Q Consensus 139 ~~----~~~~~LVmEy~~gGsL~~~L~~~~--~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---~g~vK 209 (668)
.. ...+++||||+++|+|.+++.... .+++..++.++.||+.||.|||++||+||||||+||||+. ++.+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~k 160 (299)
T 3m2w_A 81 ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160 (299)
T ss_dssp EEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEE
T ss_pred hhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEE
Confidence 76 677999999999999999997654 6999999999999999999999999999999999999998 78999
Q ss_pred EecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHH-HhhccCC
Q 005944 210 LADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAAL-FHIGTTK 288 (668)
Q Consensus 210 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~-~~~~~~~ 288 (668)
|+|||++.... +..++.++|||||||++|+|++|..||.......... .......
T Consensus 161 l~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 216 (299)
T 3m2w_A 161 LTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216 (299)
T ss_dssp ECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCT
T ss_pred Eeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhh
Confidence 99999986421 2346789999999999999999999997543221100 0001111
Q ss_pred CCCCCC----cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 289 SHPPIP----EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 289 ~~~~~p----~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
.....+ ..++.++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 111222 468999999999999999999999999999999986543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=393.61 Aligned_cols=245 Identities=25% Similarity=0.366 Sum_probs=201.6
Q ss_pred eEEcccCceEEEEEEE--cCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEE
Q 005944 70 ELVGCGAFGRVYMGMN--LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNIL 147 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~--~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LV 147 (668)
+.||+|+||+||+|.+ ..+++.||||++.... ......+.+.+|+.+|+.++|||||++++++.. +.++||
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv 447 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 447 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG------GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEecccc------CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence 4899999999999955 4567899999984321 112234568899999999999999999999864 568999
Q ss_pred eeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh-hc
Q 005944 148 LEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT-IN 226 (668)
Q Consensus 148 mEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~-~~ 226 (668)
||||++|+|.+++...+.+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999987643222 12
Q ss_pred CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHHHH
Q 005944 227 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAKDF 304 (668)
Q Consensus 227 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~dL 304 (668)
......||+.|+|||++.+..++.++|||||||+||||++ |+.||...... +...+. .......+..++.++.+|
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---~~~~~~~p~~~~~~l~~l 604 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERMGCPAGCPREMYDL 604 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCCCCCTTCCHHHHHH
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCCCCCCCCHHHHHH
Confidence 2233457889999999999999999999999999999998 99999765432 222222 233455677899999999
Q ss_pred HHHhhhhCCCCCCCHHHHHc
Q 005944 305 LLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 305 I~kcL~~dP~~RPSa~EIL~ 324 (668)
|.+||+.||.+||++.+|++
T Consensus 605 i~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 605 MNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp HHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHH
Confidence 99999999999999999985
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=385.96 Aligned_cols=253 Identities=25% Similarity=0.408 Sum_probs=212.1
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
.+++...+|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++|+|||+++++
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---------~~~~~~~E~~~l~~l~hpniv~~~~~ 330 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAV 330 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC---------CHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 355677889999999999999999999864 56799999843211 12457889999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
+.. ..+||||||+.+|+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 331 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~ 409 (535)
T 2h8h_A 331 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 409 (535)
T ss_dssp ECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTS
T ss_pred Eee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEccccc
Confidence 876 6789999999999999999753 5699999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~ 293 (668)
++.+.... ........+++.|+|||++.+..++.++|||||||+||||++ |+.||..... ++...+. .....+.
T Consensus 410 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~---~~~~~~~ 485 (535)
T 2h8h_A 410 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGYRMPC 485 (535)
T ss_dssp TTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH---TTCCCCC
T ss_pred ceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCCC
Confidence 98654322 222334567889999999999999999999999999999999 9999975432 2222222 2234456
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+..++.++.+||.+||+.||.+|||+.+|++.
T Consensus 486 ~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 486 PPECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 67899999999999999999999999999873
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=356.71 Aligned_cols=259 Identities=25% Similarity=0.399 Sum_probs=205.5
Q ss_pred CCCCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeee
Q 005944 55 PIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRY 134 (668)
Q Consensus 55 p~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l 134 (668)
.....++...+|++.+.||+|+||+||+|.+.. .||||++....... ...+.+.+|+.+++.++||||+++
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~~ 94 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE------DQLKAFKREVMAYRQTRHENVVLF 94 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC------CCCCCCCTTGGGGTTCCCTTBCCC
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH------HHHHHHHHHHHHHhcCCCCCEeEE
Confidence 345566888999999999999999999998754 59999985432211 112345679999999999999999
Q ss_pred ccccccCCcceEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecC
Q 005944 135 LGTAREDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADF 213 (668)
Q Consensus 135 ~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DF 213 (668)
++++.....+++||||+++++|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 95 ~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Df 173 (319)
T 2y4i_B 95 MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDF 173 (319)
T ss_dssp CEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCC
T ss_pred EEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeec
Confidence 999999999999999999999999998754 699999999999999999999999999999999999998 689999999
Q ss_pred CchhhhHhhh---hhcCCccCCCCCCCCChHHHhh---------cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHH
Q 005944 214 GASKKVVELA---TINGAKSMKGTPYWMAPEVILQ---------TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAAL 281 (668)
Q Consensus 214 GlA~~~~~~~---~~~~~~~~~GT~~Y~APEvl~~---------~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~ 281 (668)
|+++...... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||..........
T Consensus 174 g~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 253 (319)
T 2y4i_B 174 GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW 253 (319)
T ss_dssp SCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH
T ss_pred CCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9987553221 1222334568999999999975 347889999999999999999999997654332211
Q ss_pred HhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 282 FHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 282 ~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
...........+..++.++.+||.+||..||.+|||+.++++
T Consensus 254 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 254 -QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp -HHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred -HhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111122222233467889999999999999999999999997
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=388.10 Aligned_cols=252 Identities=25% Similarity=0.392 Sum_probs=202.5
Q ss_pred CCCCeeeee-EEcccCceEEEEEEEcC--CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 62 PPIRWRKGE-LVGCGAFGRVYMGMNLD--SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 62 ~~~ry~i~~-~LG~G~fG~Vy~a~~~~--tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
...++.+.+ .||+|+||+||+|.+.. ++..||||++..... ....+.+.+|+++|+.++|||||++++++
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-------~~~~~~~~~E~~il~~l~hpniv~l~~~~ 405 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-------KADTEEMMREAQIMHQLDNPYIVRLIGVC 405 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-------STTHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-------hHHHHHHHHHHHHHHhCCCCCEeeEEEEe
Confidence 344566666 89999999999998763 567899999853211 12235678999999999999999999998
Q ss_pred ccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.. +.+|||||||.+|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 406 ~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~ 484 (613)
T 2ozo_A 406 QA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSK 484 (613)
T ss_dssp ES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred cc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence 76 5699999999999999998654 569999999999999999999999999999999999999999999999999998
Q ss_pred hhHhhhh-hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH-HHHHHHHhhccCCCCCCCC
Q 005944 218 KVVELAT-INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVAALFHIGTTKSHPPIP 294 (668)
Q Consensus 218 ~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~-~~~~~~~~~~~~~~~~~~p 294 (668)
.+..... ........+|+.|+|||++.+..++.++|||||||+||||++ |+.||.... .++...+. .......+
T Consensus 485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---~~~~~~~p 561 (613)
T 2ozo_A 485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---QGKRMECP 561 (613)
T ss_dssp TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH---TTCCCCCC
T ss_pred cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---cCCCCCCC
Confidence 6543221 111223456789999999999999999999999999999998 999997543 22222222 22345567
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
..++.++.+||.+||+.+|.+||++.+|++
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 789999999999999999999999999854
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=356.31 Aligned_cols=249 Identities=26% Similarity=0.345 Sum_probs=200.8
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHh--CCCCCeeeecccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN--LTHPNIVRYLGTA 138 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~--L~HpNIV~l~g~~ 138 (668)
....+|++.+.||+|+||+||+|++ +|+.||||++... ....+.+|++++.. ++||||+++++++
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-----------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~ 105 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR-----------EERSWFREAEIYQTVMLRHENILGFIAAD 105 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG-----------GHHHHHHHHHHHHHSCCCCTTBCCEEEEE
T ss_pred cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch-----------hHHHHHHHHHHHHHhhcCCCcEEEEEeee
Confidence 4456899999999999999999987 5899999998311 11345678888887 7899999999998
Q ss_pred ccCC----cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccccCCcccEEeCCCC
Q 005944 139 REDD----SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH--------KNGIMHRDIKGANILVDNKG 206 (668)
Q Consensus 139 ~~~~----~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLH--------s~gIvHrDLKPeNILld~~g 206 (668)
.... .+++||||+++|+|.+++.+ ..+++..++.++.||+.||.||| +.||+||||||+||||+.++
T Consensus 106 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~ 184 (342)
T 1b6c_B 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 184 (342)
T ss_dssp ECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS
T ss_pred cccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC
Confidence 8776 78999999999999999976 47999999999999999999999 89999999999999999999
Q ss_pred ceEEecCCchhhhHhhhhh--cCCccCCCCCCCCChHHHhhcC------CCcchhHHHHHHHHHHHHhC----------C
Q 005944 207 CIKLADFGASKKVVELATI--NGAKSMKGTPYWMAPEVILQTG------HSFSADIWSVGCTVIEMATG----------K 268 (668)
Q Consensus 207 ~vKL~DFGlA~~~~~~~~~--~~~~~~~GT~~Y~APEvl~~~~------~s~ksDIWSLGvILyeLLTG----------~ 268 (668)
.+||+|||++......... .......||+.|+|||++.+.. ++.++|||||||++|+|+|| .
T Consensus 185 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~ 264 (342)
T 1b6c_B 185 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 264 (342)
T ss_dssp CEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccc
Confidence 9999999999765432211 1234567999999999998653 23689999999999999999 7
Q ss_pred CCCchh------HHHHHHHHhhccCCCCCCCCc-----ccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 269 PPWSQQ------FQEVAALFHIGTTKSHPPIPE-----HLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 269 ~PF~~~------~~~~~~~~~~~~~~~~~~~p~-----~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.||... ......... .....+.++. .++..+.+||.+||+.||.+|||+.++++|
T Consensus 265 ~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 265 LPYYDLVPSDPSVEEMRKVVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp CTTTTTSCSSCCHHHHHHHHT--TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCccccCcCcccHHHHHHHHH--HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 888643 122222221 1222233332 345688999999999999999999999976
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-41 Score=374.27 Aligned_cols=253 Identities=22% Similarity=0.331 Sum_probs=204.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC-CCeeeeccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH-PNIVRYLGTAR 139 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIV~l~g~~~ 139 (668)
....+|++.++||+|+||.||+|++..+++.||||++...... ..+..|+.+++.+.| ++|+.+..++.
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----------~~~~~E~~il~~L~~~~~i~~i~~~~~ 73 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----------PQLLYESKIYRILQGGTGIPNVRWFGV 73 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----------CCHHHHHHHHHHTTTSTTCCCEEEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----------HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 4467899999999999999999999999999999987432211 235679999999987 55556666667
Q ss_pred cCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe---CCCCceEEecCCc
Q 005944 140 EDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV---DNKGCIKLADFGA 215 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl---d~~g~vKL~DFGl 215 (668)
.....+|||||+ +++|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+|||| +.++.+||+|||+
T Consensus 74 ~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 74 EGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred eCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 778889999999 9999999975 4679999999999999999999999999999999999999 5889999999999
Q ss_pred hhhhHhhhhh-----cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhH-----HHHHHHHhhc
Q 005944 216 SKKVVELATI-----NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQF-----QEVAALFHIG 285 (668)
Q Consensus 216 A~~~~~~~~~-----~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~-----~~~~~~~~~~ 285 (668)
++.+...... ......+||+.|+|||++.+..++.++||||||||||+|++|+.||.... .....+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 9866433221 12236789999999999999999999999999999999999999996421 1111111111
Q ss_pred cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 286 ~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.......+...++.++.+||.+||+.+|.+||++.+|++
T Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 111111223467899999999999999999999998875
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=384.97 Aligned_cols=258 Identities=25% Similarity=0.421 Sum_probs=209.6
Q ss_pred CCCCCCCCCCeeeeeEEcccCceEEEEEEEcCC---CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCee
Q 005944 56 IEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDS---GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV 132 (668)
Q Consensus 56 ~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV 132 (668)
....+....+|++.+.||+|+||+||+|++..+ +..||||++... ......+.+.+|+.+|+.++|||||
T Consensus 382 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~HpnIv 454 (656)
T 2j0j_A 382 TRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-------TSDSVREKFLQEALTMRQFDHPHIV 454 (656)
T ss_dssp GGGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-------TCHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-------CCHHHHHHHHHHHHHHHhCCCCCCC
Confidence 334456678899999999999999999998654 467999987321 1233446788999999999999999
Q ss_pred eeccccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEe
Q 005944 133 RYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 133 ~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
++++++. ++..|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+
T Consensus 455 ~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~ 533 (656)
T 2j0j_A 455 KLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLG 533 (656)
T ss_dssp CEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEEC
T ss_pred eEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEE
Confidence 9999985 46689999999999999999754 369999999999999999999999999999999999999999999999
Q ss_pred cCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCC
Q 005944 212 DFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKS 289 (668)
Q Consensus 212 DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~ 289 (668)
|||+++.+.... ........+|+.|+|||++.+..++.++|||||||++|+|++ |..||..... +....+.. ..
T Consensus 534 DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~---~~ 609 (656)
T 2j0j_A 534 DFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN---GE 609 (656)
T ss_dssp CCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHH---TC
T ss_pred ecCCCeecCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHc---CC
Confidence 999998653322 122234567889999999999999999999999999999997 9999975432 22222221 23
Q ss_pred CCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 290 ~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
..+.+..++.++.+||.+||..||.+|||+.+|+++
T Consensus 610 ~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 610 RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 345677899999999999999999999999999863
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=369.54 Aligned_cols=251 Identities=17% Similarity=0.160 Sum_probs=192.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC-CCeeeec----
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH-PNIVRYL---- 135 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIV~l~---- 135 (668)
.....|+++++||+|+||+||+|++..+|+.||||++..... ......+.+.+|+.+++.+.| +|+..+.
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~-----~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~ 149 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTER-----PPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLR 149 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC---------CCHHHHHHHHGGGGSTTCCSHHHHHHHTC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCC-----ccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcc
Confidence 344568999999999999999999999999999998852221 111234568899999999987 3322111
Q ss_pred -----------------ccccc-----CCcceEEeeccCCCChhccccc-------CCCCCHHHHHHHHHHHHHHHHHHH
Q 005944 136 -----------------GTARE-----DDSLNILLEFVPGGSISSLLGK-------FGSFPESVIRMYTKQLLLGLEYLH 186 (668)
Q Consensus 136 -----------------g~~~~-----~~~~~LVmEy~~gGsL~~~L~~-------~~~l~e~~~~~i~~QIl~aL~yLH 186 (668)
.++.. ...++++|+++ +++|.+++.. ...+++..+..++.||+.||.|||
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 228 (413)
T 3dzo_A 150 FIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH 228 (413)
T ss_dssp BCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 11111 12356777766 5799988841 234778889999999999999999
Q ss_pred hCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHH----------hhcCCCcchhHHH
Q 005944 187 KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVI----------LQTGHSFSADIWS 256 (668)
Q Consensus 187 s~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl----------~~~~~s~ksDIWS 256 (668)
++||+||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++||||
T Consensus 229 ~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS 302 (413)
T 3dzo_A 229 HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302 (413)
T ss_dssp HTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred hCCcccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence 999999999999999999999999999998764322 345678 999999999 4445788999999
Q ss_pred HHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 257 VGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 257 LGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
|||++|+|+||+.||........ ..........++.++.+||.+||+.||.+||++.++++||||+.
T Consensus 303 lGvil~elltg~~Pf~~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 303 LGLAIYWIWCADLPNTDDAALGG-------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp HHHHHHHHHHSSCCCCTTGGGSC-------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred HHHHHHHHHHCCCCCCCcchhhh-------HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 99999999999999975432110 00011122367899999999999999999999999999999974
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=393.19 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=207.4
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc-
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE- 140 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~- 140 (668)
...+|++.+.||+|+||+||+|.+..+|..||||++... ........+.+|+.+|+.++|||||++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-------~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~ 84 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-------LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGL 84 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-------CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTT
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-------CCHHHHHHHHHHHHHHHhCCCCCCCceeeeeccc
Confidence 347899999999999999999999999999999987422 122344668899999999999999999998765
Q ss_pred -----CCcceEEeeccCCCChhcccccCC---CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCc---eE
Q 005944 141 -----DDSLNILLEFVPGGSISSLLGKFG---SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGC---IK 209 (668)
Q Consensus 141 -----~~~~~LVmEy~~gGsL~~~L~~~~---~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~---vK 209 (668)
.+..|+|||||+||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+||||+.++. +|
T Consensus 85 ~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vK 164 (676)
T 3qa8_A 85 QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHK 164 (676)
T ss_dssp CCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEE
T ss_pred ccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEE
Confidence 677899999999999999997654 6999999999999999999999999999999999999997764 99
Q ss_pred EecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHH----------
Q 005944 210 LADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVA---------- 279 (668)
Q Consensus 210 L~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~---------- 279 (668)
|+|||++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........
T Consensus 165 L~DFG~a~~~~~~---~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~ 241 (676)
T 3qa8_A 165 IIDLGYAKELDQG---ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241 (676)
T ss_dssp ECSCCCCCBTTSC---CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred Ecccccccccccc---cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence 9999999865332 223456899999999999999999999999999999999999999964322110
Q ss_pred H-HHhhcc----C------CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 280 A-LFHIGT----T------KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 280 ~-~~~~~~----~------~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
. ...... . .....+...++..+.+||.+||..||.+|||+.++++||||+.
T Consensus 242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 0 000000 0 0011233457789999999999999999999999999999975
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=385.78 Aligned_cols=249 Identities=21% Similarity=0.370 Sum_probs=204.5
Q ss_pred CCCCCCCCCCCeeeeeEEcccCceEEEEEEEcC-CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeee
Q 005944 55 PIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLD-SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVR 133 (668)
Q Consensus 55 p~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~-tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~ 133 (668)
.+..++....+|++.+.||+|+||+||+|.+.. +|+.||||++... ........+.+|+.+|..++|||||+
T Consensus 71 ~~~~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~hp~iv~ 143 (681)
T 2pzi_A 71 QLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-------GDAEAQAMAMAERQFLAEVVHPSIVQ 143 (681)
T ss_dssp SSCTTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS-------CCHHHHHHHHHHHGGGGGCCCTTBCC
T ss_pred CCCCCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc-------CCHHHHHHHHHHHHHHHhcCCCCcCe
Confidence 344556677899999999999999999999976 7899999987421 12234456789999999999999999
Q ss_pred eccccccCCc-----ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCce
Q 005944 134 YLGTAREDDS-----LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCI 208 (668)
Q Consensus 134 l~g~~~~~~~-----~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~v 208 (668)
+++++...+. .||||||++|++|.+++.. .+++.+++.|+.||+.||.|||++|||||||||+||||+.+ .+
T Consensus 144 ~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~ 220 (681)
T 2pzi_A 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QL 220 (681)
T ss_dssp EEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CE
T ss_pred EeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cE
Confidence 9999987665 6999999999999998765 79999999999999999999999999999999999999875 99
Q ss_pred EEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCC
Q 005944 209 KLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTK 288 (668)
Q Consensus 209 KL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~ 288 (668)
||+|||+++.+.. ....+||+.|+|||++.+. ++.++|||||||+||+|++|.+||...... ..
T Consensus 221 kl~DFG~a~~~~~------~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~ 284 (681)
T 2pzi_A 221 KLIDLGAVSRINS------FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GL 284 (681)
T ss_dssp EECCCTTCEETTC------CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SC
T ss_pred EEEecccchhccc------CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc---------cc
Confidence 9999999976532 2456799999999998765 488999999999999999999998642110 00
Q ss_pred CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 289 SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 289 ~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
.........+..+.+||.+||+.||.+||+..+++.|+|+.
T Consensus 285 ~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 00011123467899999999999999999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=341.53 Aligned_cols=235 Identities=15% Similarity=0.135 Sum_probs=189.5
Q ss_pred CCCCCCC-CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCee
Q 005944 54 PPIEKTD-APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV 132 (668)
Q Consensus 54 pp~~~~~-~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV 132 (668)
+.+..+. ....+|++.+.||+|+||+||+|++..+++.||||++..... ........+.+|+.++..++||||+
T Consensus 20 ~~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~e~~~l~~l~hp~iv 94 (286)
T 3uqc_A 20 VQLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGV-----LPDDVLQETLSRTLRLSRIDKPGVA 94 (286)
T ss_dssp CCCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCC-----SCHHHHHHHHHHHHHHHTCCCTTBC
T ss_pred CcCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccc-----cCHHHHHHHHHHHHHHhcCCCCCcc
Confidence 3344445 667899999999999999999999999999999999843221 1234456788999999999999999
Q ss_pred eeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEec
Q 005944 133 RYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLAD 212 (668)
Q Consensus 133 ~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~D 212 (668)
++++++...+..|+||||++|++|.+++.. + ....++..|+.||+.||.|||++||+||||||+||||+.+|.+||++
T Consensus 95 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~ 172 (286)
T 3uqc_A 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAY 172 (286)
T ss_dssp CEEEEEEETTEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECS
T ss_pred eeeEEEEECCcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEe
Confidence 999999999999999999999999999965 2 46667899999999999999999999999999999999999999985
Q ss_pred CCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCC-
Q 005944 213 FGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP- 291 (668)
Q Consensus 213 FGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~- 291 (668)
+| |++ .++.++|||||||++|+|+||+.||....................
T Consensus 173 ~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 223 (286)
T 3uqc_A 173 PA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI 223 (286)
T ss_dssp CC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBC
T ss_pred cc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCC
Confidence 54 333 378899999999999999999999975321100000000000001
Q ss_pred ---CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 292 ---PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 292 ---~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.....++.++.+||.+||+.||.+| |+.++++.
T Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 224 EPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp CHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 1235688999999999999999999 99999973
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-33 Score=317.32 Aligned_cols=236 Identities=17% Similarity=0.157 Sum_probs=160.3
Q ss_pred EEcccCceEEEEEEEcCCCcEEEEEEeeeccc--chhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccccccCCcceEE
Q 005944 71 LVGCGAFGRVYMGMNLDSGELLAVKQVLIAAN--SASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGTAREDDSLNIL 147 (668)
Q Consensus 71 ~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~--~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~~~~~~~~~LV 147 (668)
.++.|++|.+..++....|+.||||++..... .......+...+.+.+|+++|+++ .|+||++++++++++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 36788888888888888899999999864422 123344556677899999999999 799999999999999999999
Q ss_pred eeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcC
Q 005944 148 LEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATING 227 (668)
Q Consensus 148 mEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~ 227 (668)
||||+|++|.++|.+.+.+++. .|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+... ...
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~--~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD--CSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--Ccc
Confidence 9999999999999998888865 58899999999999999999999999999999999999999999865432 223
Q ss_pred CccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHH
Q 005944 228 AKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307 (668)
Q Consensus 228 ~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~k 307 (668)
..+.+||+.|||||++.+. +..++|+|++|+++|+|.++..+|... ..... +.. ..+..++..
T Consensus 396 ~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~~~~------l~~~~--------~~~--~~~~~l~~~ 458 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNWLYA------VWQEP--------VER--WNFVLLLAL 458 (569)
T ss_dssp SHHHHHHHHHHHHHHC------------------CCCCTTHHHHHHH------HHTSC--------GGG--CSHHHHHHH
T ss_pred ccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchhHHH------hhcCC--------CCC--CcHHHHHHH
Confidence 4567899999999998754 677899999999999887765544211 11000 000 013455555
Q ss_pred hhhhCCCCCCCHHHHHcCccc
Q 005944 308 CLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 308 cL~~dP~~RPSa~EIL~Hpwf 328 (668)
++..+|..|+.......|+|.
T Consensus 459 l~~~~~~~~~~~~~~~~~~~~ 479 (569)
T 4azs_A 459 FEKKAKLPSAEQQRGATEQWI 479 (569)
T ss_dssp HHTGGGSCCGGGSSCCHHHHH
T ss_pred HhCCCCCCCCChhhhccchhH
Confidence 666666666665555555554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7.1e-29 Score=280.88 Aligned_cols=193 Identities=15% Similarity=0.128 Sum_probs=149.8
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceE
Q 005944 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNI 146 (668)
Q Consensus 67 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~L 146 (668)
...++||+|+||+||+|. ..+..+|+|++................+.+.+|+++|++++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 446789999999999994 467899999875433222223333445678999999999999999965555557778899
Q ss_pred EeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhc
Q 005944 147 LLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226 (668)
Q Consensus 147 VmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~ 226 (668)
|||||+|++|.+++.. +..++.||+.||.|||++||+||||||+|||++. .+||+|||+++.........
T Consensus 417 VmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~ 486 (540)
T 3en9_A 417 MMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA 486 (540)
T ss_dssp EEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred EEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence 9999999999999976 6789999999999999999999999999999998 99999999998764322111
Q ss_pred -----CCccCCCCCCCCChHHHhh--cCCCcchhHHHHHHHHHHHHhCCCCC
Q 005944 227 -----GAKSMKGTPYWMAPEVILQ--TGHSFSADIWSVGCTVIEMATGKPPW 271 (668)
Q Consensus 227 -----~~~~~~GT~~Y~APEvl~~--~~~s~ksDIWSLGvILyeLLTG~~PF 271 (668)
.....+||+.|||||++.. ..|+..+|+|+..+-..+.+.++.+|
T Consensus 487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 1235689999999999987 56788899999999888888777665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=229.48 Aligned_cols=152 Identities=19% Similarity=0.162 Sum_probs=119.1
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhH----------hhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKE----------KTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~----------~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
|.+++.||+|+||.||+|.+ .+|+.||||++.......... ........+.+|+.+|+.++ | ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 44559999999999999999 889999999984322111000 00123456889999999998 5 6666
Q ss_pred cccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 136 GTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 136 g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
+++. .+..|+||||++||+|.+ +.. .....++.||+.||.|||++||+||||||+||||+ +|.+||+|||+
T Consensus 168 ~~~~-~~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 168 KVYA-WEGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CEEE-EETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred eEEe-ccceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 6554 356799999999999998 422 23567999999999999999999999999999999 99999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhh
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQ 245 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~ 245 (668)
|+. +..|+|||++..
T Consensus 239 a~~---------------~~~~~a~e~l~r 253 (282)
T 1zar_A 239 SVE---------------VGEEGWREILER 253 (282)
T ss_dssp CEE---------------TTSTTHHHHHHH
T ss_pred CeE---------------CCCCCHHHHHHH
Confidence 862 445899999853
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=9.7e-21 Score=193.86 Aligned_cols=145 Identities=17% Similarity=0.189 Sum_probs=109.5
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcE--EEEEEeeecccchhhH----------------hhHHHHHHHHHHHHHHHhC
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGEL--LAVKQVLIAANSASKE----------------KTQAHIRELEEEVKLLKNL 126 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~--VAVK~i~~~~~~~~~~----------------~~~~~~~~~~~Ei~iL~~L 126 (668)
-|++.+.||+|+||.||+|.+..+|.. ||||++.......... ........+.+|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 488999999999999999998788999 9999874331110000 0112234578899999999
Q ss_pred CCCCe--eeeccccccCCcceEEeeccCC-C----ChhcccccCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccccCCcc
Q 005944 127 THPNI--VRYLGTAREDDSLNILLEFVPG-G----SISSLLGKFGSFPESVIRMYTKQLLLGLEYLH-KNGIMHRDIKGA 198 (668)
Q Consensus 127 ~HpNI--V~l~g~~~~~~~~~LVmEy~~g-G----sL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLH-s~gIvHrDLKPe 198 (668)
.|++| ..+++. ...+|||||+.+ | .|.+++.. +++..+..++.||+.+|.||| ..||+||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88764 333332 367899999942 4 55554432 345678899999999999999 999999999999
Q ss_pred cEEeCCCCceEEecCCchhh
Q 005944 199 NILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 199 NILld~~g~vKL~DFGlA~~ 218 (668)
|||++. .++|+|||+|..
T Consensus 201 NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp SEEESS--SEEECCCTTCEE
T ss_pred HEEEcC--cEEEEECccccc
Confidence 999988 999999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.71 E-value=1.4e-17 Score=181.03 Aligned_cols=144 Identities=15% Similarity=0.142 Sum_probs=101.7
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchh--------------hHhhHHHHHHHHHHHHHHHhCCCCC
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSAS--------------KEKTQAHIRELEEEVKLLKNLTHPN 130 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~--------------~~~~~~~~~~~~~Ei~iL~~L~HpN 130 (668)
-|+++..||+|+||.||+|.+ .+|+.||||++........ .............|...|.++.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 389999999999999999987 4699999998753211100 0000111112345677777775444
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC----
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG---- 206 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g---- 206 (668)
+... ..+. ....+|||||++|+.|..+... ..+..++.||+.+|.+||.+|||||||||.||||+.+|
T Consensus 175 v~vp-~p~~-~~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d 246 (397)
T 4gyi_A 175 FPVP-EPIA-QSRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAED 246 (397)
T ss_dssp CSCC-CEEE-EETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSC
T ss_pred CCCC-eeee-ccCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccc
Confidence 3211 1111 1234799999999998776532 24567899999999999999999999999999998776
Q ss_pred ------ceEEecCCchh
Q 005944 207 ------CIKLADFGASK 217 (668)
Q Consensus 207 ------~vKL~DFGlA~ 217 (668)
.+.|+||+-+.
T Consensus 247 ~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 247 PSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TTSEEEEEEECCCTTCE
T ss_pred ccccccceEEEEeCCcc
Confidence 38999999654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.29 E-value=2.7e-12 Score=129.89 Aligned_cols=138 Identities=19% Similarity=0.150 Sum_probs=108.1
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCCc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDDS 143 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~~ 143 (668)
.|++...+|.|+++.||++.. .+..++||+...... . ....+.+|+.+|+.+. +..+.++++++...+.
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~---~-----~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~ 84 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYK---G-----TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGT---T-----STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccC---C-----CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCc
Confidence 588888899999999999964 368999998732110 0 0123678999999884 6677888888888888
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK------------------------------------ 187 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs------------------------------------ 187 (668)
.|+||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 85 ~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 85 SNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred eEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 999999999999987642 122345788999999999998
Q ss_pred -----------------------CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 188 -----------------------NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 188 -----------------------~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
..++|+|++|.|||++.++.+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 448999999999999876666799999764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=1e-11 Score=124.05 Aligned_cols=134 Identities=20% Similarity=0.166 Sum_probs=98.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC--eeeeccccccC
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN--IVRYLGTARED 141 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IV~l~g~~~~~ 141 (668)
..|.+..+.+.|..+.||++. ..+|..++||+.... ....+..|+.+|+.+.+.+ +.+++++....
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~-----------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~ 87 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSG-----------ALNELQDEAARLSWLATTGVPCAAVLDVVTEA 87 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSC-----------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS
T ss_pred CCCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcc-----------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCC
Confidence 345554444466679999996 456788999986321 0123567888888886544 45588887777
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG-------------------------------- 189 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~g-------------------------------- 189 (668)
+..++||||++|.+|. ... .. ...++.+++..|..||...
T Consensus 88 ~~~~~v~e~i~G~~l~--~~~---~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (264)
T 1nd4_A 88 GRDWLLLGEVPGQDLL--SSH---LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLD 159 (264)
T ss_dssp SCEEEEEECCSSEETT--TSC---CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCC
T ss_pred CCCEEEEEecCCcccC--cCc---CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhh
Confidence 7889999999998884 211 12 2367778888888888753
Q ss_pred --------------------------cccccCCcccEEeCCCCceEEecCCchh
Q 005944 190 --------------------------IMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 190 --------------------------IvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
++|+|++|.|||++.++.+.|+|||.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 160 EEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 9999999999999877667799999865
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.12 E-value=2e-10 Score=121.99 Aligned_cols=142 Identities=13% Similarity=0.185 Sum_probs=104.0
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC--CCeeeeccccccC---C
Q 005944 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH--PNIVRYLGTARED---D 142 (668)
Q Consensus 68 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIV~l~g~~~~~---~ 142 (668)
..+.|+.|.++.||++.. .+..+++|+..... .........+.+|+.+|+.|.+ ..+.+++.++.+. +
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~-----~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g 114 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPK-----SKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIG 114 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC---------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTS
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCC-----CCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccC
Confidence 356789999999999875 34678888652000 0000112356789999999873 4577788777665 4
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK----------------------------------- 187 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs----------------------------------- 187 (668)
..|+||||++|..+.+.. ...++..+...++.+++..|..||.
T Consensus 115 ~~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 115 RAFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SCEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CeEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 589999999998885422 2347888889999999999999997
Q ss_pred -----------------------CCcccccCCcccEEeCCCCc--eEEecCCchhh
Q 005944 188 -----------------------NGIMHRDIKGANILVDNKGC--IKLADFGASKK 218 (668)
Q Consensus 188 -----------------------~gIvHrDLKPeNILld~~g~--vKL~DFGlA~~ 218 (668)
..++|+|++|.|||++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 35899999999999987753 69999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=8.2e-11 Score=122.22 Aligned_cols=181 Identities=19% Similarity=0.172 Sum_probs=121.9
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCC--eeeeccccccCC---c
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPN--IVRYLGTAREDD---S 143 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpN--IV~l~g~~~~~~---~ 143 (668)
+.|+.|....||++. ..+++|+... ......+.+|+.+|+.+. +.. +.+++....... .
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~----------~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~ 90 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKH----------SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQM 90 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESS----------HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSC
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCC----------cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCc
Confidence 458999999999863 4688997521 123356788999998873 332 334444433332 3
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK------------------------------------ 187 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs------------------------------------ 187 (668)
.|+||++++|..|..... ..++..+...++.|++..|..||.
T Consensus 91 ~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGP 168 (304)
T ss_dssp SCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHH
T ss_pred ceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcc
Confidence 589999999988865332 357788888899999999999986
Q ss_pred ----------------------CCcccccCCcccEEeCC--CCceEEecCCchhhhHhhhhhcCCccCCCCCCC---CCh
Q 005944 188 ----------------------NGIMHRDIKGANILVDN--KGCIKLADFGASKKVVELATINGAKSMKGTPYW---MAP 240 (668)
Q Consensus 188 ----------------------~gIvHrDLKPeNILld~--~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y---~AP 240 (668)
..++|+|++|.|||++. .+.+.|+||+.+..-....... ....+ ..|
T Consensus 169 ~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~------~~~~~~~~~~~ 242 (304)
T 3sg8_A 169 QMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFI------SLMEDDEEYGM 242 (304)
T ss_dssp HHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHH------TTCCTTTSCCH
T ss_pred cHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHH------HHHhhccccCH
Confidence 13799999999999998 5568999999876432111110 01111 344
Q ss_pred HHHhh----cCC----------CcchhHHHHHHHHHHHHhCCCCCch
Q 005944 241 EVILQ----TGH----------SFSADIWSVGCTVIEMATGKPPWSQ 273 (668)
Q Consensus 241 Evl~~----~~~----------s~ksDIWSLGvILyeLLTG~~PF~~ 273 (668)
+.+.. ... ....+.|++|.++|.+.+|..+|..
T Consensus 243 ~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 243 EFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 43321 111 1225899999999999999988744
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=5.1e-07 Score=94.18 Aligned_cols=133 Identities=20% Similarity=0.171 Sum_probs=93.2
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCC---Ceeeeccccc-cCCcc
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP---NIVRYLGTAR-EDDSL 144 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp---NIV~l~g~~~-~~~~~ 144 (668)
.+.++.|....||+. |..++||+.. .......+..|+.+|+.|.+. .|.+++.+.. ..+..
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~----------~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~ 88 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPK----------SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNP 88 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEES----------SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecC----------CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCce
Confidence 456889999999988 5678888741 112335678899999999753 2444555442 44567
Q ss_pred eEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 005944 145 NILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKN------------------------------------ 188 (668)
Q Consensus 145 ~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~------------------------------------ 188 (668)
++||||++|..|....- ..++..+...++.++...|..||+.
T Consensus 89 ~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~ 166 (306)
T 3tdw_A 89 FVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE 166 (306)
T ss_dssp EEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred EEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence 89999999988865321 2345566666666666666666643
Q ss_pred ------------------------CcccccCCcccEEeCC---CCc-eEEecCCchhh
Q 005944 189 ------------------------GIMHRDIKGANILVDN---KGC-IKLADFGASKK 218 (668)
Q Consensus 189 ------------------------gIvHrDLKPeNILld~---~g~-vKL~DFGlA~~ 218 (668)
.++|+|++|.|||++. ++. +.|+||+.+..
T Consensus 167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 3589999999999987 355 58999997753
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=5.4e-07 Score=91.04 Aligned_cols=131 Identities=20% Similarity=0.193 Sum_probs=93.6
Q ss_pred EcccCce-EEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCCcceEEee
Q 005944 72 VGCGAFG-RVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDDSLNILLE 149 (668)
Q Consensus 72 LG~G~fG-~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~~~~LVmE 149 (668)
+..|..+ .||+......+..+.||+-.. .....+.+|..+|+.+. +--|.+++.++...+..++|||
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~-----------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme 100 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKG-----------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTT 100 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEET-----------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCC-----------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEE
Confidence 4445444 799988777788899997521 12234677899888884 3235667777888888999999
Q ss_pred ccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 005944 150 FVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK------------------------------------------ 187 (668)
Q Consensus 150 y~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs------------------------------------------ 187 (668)
+++|.++.+..... ......+..++...|..||.
T Consensus 101 ~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 101 AIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred eeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 99998877654321 22334556666666666663
Q ss_pred ----------------CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 188 ----------------NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 188 ----------------~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
..++|+|+.+.|||++.++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 027999999999999987777899999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.12 E-value=3.1e-06 Score=90.90 Aligned_cols=83 Identities=17% Similarity=0.156 Sum_probs=47.4
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC--CC-eeeeccccccCCcce
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH--PN-IVRYLGTAREDDSLN 145 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pN-IV~l~g~~~~~~~~~ 145 (668)
.+.||.|.++.||++....++..|+||........ ...........+..|+++|+.+.. +. +.+++.+ +....+
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~-~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKV-VGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC--------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcc-cCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46799999999999976556789999976321100 000000012234567888877632 33 3345543 344578
Q ss_pred EEeeccCCC
Q 005944 146 ILLEFVPGG 154 (668)
Q Consensus 146 LVmEy~~gG 154 (668)
+||||+++.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.11 E-value=2.5e-06 Score=89.97 Aligned_cols=88 Identities=10% Similarity=0.050 Sum_probs=53.2
Q ss_pred eeeeeEE-cccCceEEEEEEEc--C----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-C--CCeeeec
Q 005944 66 WRKGELV-GCGAFGRVYMGMNL--D----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-H--PNIVRYL 135 (668)
Q Consensus 66 y~i~~~L-G~G~fG~Vy~a~~~--~----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H--pNIV~l~ 135 (668)
....+.| +.|....+|++... . ++..+++|+........ ... ...+..|+.+|+.|. + -.+.+++
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~--~~~---~~~~~~E~~~l~~L~~~~~vpvP~v~ 96 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVP--VFP---TYRLDHQFEVIRLVGELTDVPVPRVR 96 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCC--SSS---CCCHHHHHHHHHHHHHHCCSCCCCEE
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccc--cCc---hhHHHHHHHHHHHHhhcCCCCCCcEE
Confidence 3445778 88989999988643 1 25678898752211000 000 012456777777763 2 2455666
Q ss_pred cccccC---CcceEEeeccCCCChhc
Q 005944 136 GTARED---DSLNILLEFVPGGSISS 158 (668)
Q Consensus 136 g~~~~~---~~~~LVmEy~~gGsL~~ 158 (668)
.+.... +..++||||++|..+.+
T Consensus 97 ~~~~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 97 WIETTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp EEECSSTTTSSCEEEEECCCCBCCCB
T ss_pred EEccCCCccCCceEEEEecCCCChhh
Confidence 665544 35689999999877654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.97 E-value=2.7e-05 Score=80.64 Aligned_cols=30 Identities=20% Similarity=0.299 Sum_probs=27.1
Q ss_pred CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 188 NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 188 ~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
..++|+|+++.|||++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888899999999764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.65 E-value=0.0001 Score=80.01 Aligned_cols=32 Identities=16% Similarity=0.288 Sum_probs=27.7
Q ss_pred HhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 186 Hs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
+...++|+|++|.|||++.++ ++|+||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence 356799999999999998876 99999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00027 Score=74.34 Aligned_cols=76 Identities=16% Similarity=0.100 Sum_probs=56.6
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC---CCCeeeeccccccCCcc
Q 005944 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT---HPNIVRYLGTAREDDSL 144 (668)
Q Consensus 68 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~---HpNIV~l~g~~~~~~~~ 144 (668)
-.+.|+.|....+|+... ++..++||+... . ....+..|+..|+.|. ...|.+++.+....+..
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~-------~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~ 106 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINER-------S----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHS 106 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEG-------G----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCc-------c----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCce
Confidence 356789999999999864 567888997621 0 1244677888888873 34577777777777889
Q ss_pred eEEeeccCCCCh
Q 005944 145 NILLEFVPGGSI 156 (668)
Q Consensus 145 ~LVmEy~~gGsL 156 (668)
++||||++|..+
T Consensus 107 ~lvme~l~G~~~ 118 (312)
T 3jr1_A 107 FLLLEALNKSKN 118 (312)
T ss_dssp EEEEECCCCCCC
T ss_pred EEEEEeccCCCC
Confidence 999999998765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00018 Score=74.24 Aligned_cols=71 Identities=7% Similarity=0.003 Sum_probs=42.2
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCe-eeeccccccCCcceEE
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI-VRYLGTAREDDSLNIL 147 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-V~l~g~~~~~~~~~LV 147 (668)
.+.|+.|....+|++ ..+++|+...... .......|+.+++.+...++ .++++.. .+.-++|
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---------~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v 85 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE---------EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMV 85 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC-------------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEE
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc---------ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEE
Confidence 678999999999998 4688897632100 00112346666666642222 3444433 3345789
Q ss_pred eecc-CCCCh
Q 005944 148 LEFV-PGGSI 156 (668)
Q Consensus 148 mEy~-~gGsL 156 (668)
+||+ +|.+|
T Consensus 86 ~e~i~~g~~l 95 (301)
T 3dxq_A 86 TRYIAGAQTM 95 (301)
T ss_dssp EECCTTCEEC
T ss_pred EeecCCCccC
Confidence 9999 66554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.00039 Score=71.83 Aligned_cols=139 Identities=14% Similarity=0.132 Sum_probs=75.6
Q ss_pred eeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC--eeeecccc------
Q 005944 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN--IVRYLGTA------ 138 (668)
Q Consensus 67 ~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IV~l~g~~------ 138 (668)
.-.+.|+.|....||++... +| .+++|+.... . ....+..|+.++..|...+ +.+++...
T Consensus 25 ~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~-------~---~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~ 92 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKR-------V---EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 92 (322)
T ss_dssp EEEEEECC---EEEEEEEES-SC-CEEEEEECC-------------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred eEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCC-------C---CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEE
Confidence 34567888988999999753 34 6889987321 0 0122345666666663222 23333221
Q ss_pred ccCCcceEEeeccCCCChhcc--------------cc----cCC-C----CCHHHHHHH---------------HHHHHH
Q 005944 139 REDDSLNILLEFVPGGSISSL--------------LG----KFG-S----FPESVIRMY---------------TKQLLL 180 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~--------------L~----~~~-~----l~e~~~~~i---------------~~QIl~ 180 (668)
...+..++||+|++|..+... ++ ... . ......... ...+..
T Consensus 93 ~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~ 172 (322)
T 2ppq_A 93 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 172 (322)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred EECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHH
Confidence 123456899999998654210 11 000 0 111100000 011334
Q ss_pred HHHHHHh-------CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 181 GLEYLHK-------NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 181 aL~yLHs-------~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.+.+++. .+++|+|+++.|||++.++.+.|+||+.+.
T Consensus 173 ~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 173 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 4555542 369999999999999887666899999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00051 Score=70.31 Aligned_cols=80 Identities=20% Similarity=0.062 Sum_probs=53.0
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCC---Ceeeecccccc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP---NIVRYLGTARE 140 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~Hp---NIV~l~g~~~~ 140 (668)
....-.+.+|.|..+.||+++ ..+|+.|.||+...... .....+..|+..|+.|.-. -+.+++++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~--------~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--- 82 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAP--------ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--- 82 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCC--------CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE---
T ss_pred CCeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCc--------chhhHHHHHHHHHHHHHhhCCCCcceEEec---
Confidence 345667889999999999997 46789999997521110 0112366788888888422 23444443
Q ss_pred CCcceEEeeccCCCCh
Q 005944 141 DDSLNILLEFVPGGSI 156 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL 156 (668)
+..++||||++++..
T Consensus 83 -~~~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 83 -DDRTLAMEWVDERPP 97 (288)
T ss_dssp -ETTEEEEECCCCCCC
T ss_pred -cCceEEEEeecccCC
Confidence 235899999987643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.27 E-value=0.0012 Score=66.11 Aligned_cols=121 Identities=18% Similarity=0.104 Sum_probs=81.3
Q ss_pred ChhcccccC-CCCCHHHHHHHHHHHHHHHHHH-HhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCC
Q 005944 155 SISSLLGKF-GSFPESVIRMYTKQLLLGLEYL-HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK 232 (668)
Q Consensus 155 sL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yL-Hs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~ 232 (668)
+|.++|... .+++|+++|.++.|.+.+|.-+ +...-..+=+.|..|+|..+|.|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 677877654 6899999999999999998887 222222444567999999999988774 2211 1
Q ss_pred CCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhh
Q 005944 233 GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQK 311 (668)
Q Consensus 233 GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~ 311 (668)
....+.|||... ...+.+.=|||||++||.-+-=.. .......+|+.+..||..|..-
T Consensus 99 ~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL--------------------~e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL--------------------KENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC--------------------CTTEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC--------------------CcccchhhCHHHHHHHHHHHhc
Confidence 122366787753 345678899999999999875222 2233457899999999999765
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0011 Score=68.49 Aligned_cols=135 Identities=15% Similarity=0.100 Sum_probs=74.2
Q ss_pred eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC--eeeeccc-----cccCC
Q 005944 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN--IVRYLGT-----AREDD 142 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN--IV~l~g~-----~~~~~ 142 (668)
..|+ |....||++.. .+|..+++|+..... .. ...+..|+.++..|.... +++++.. ....+
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~------~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g 100 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER------WT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQG 100 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT------SC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETT
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC------CC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECC
Confidence 4566 88889998753 456689999873110 01 123445677776663222 3444433 11234
Q ss_pred cceEEeeccCCCChhc-----------c---cc----cC-----CCCCHHHH----------------------HHHHHH
Q 005944 143 SLNILLEFVPGGSISS-----------L---LG----KF-----GSFPESVI----------------------RMYTKQ 177 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~-----------~---L~----~~-----~~l~e~~~----------------------~~i~~Q 177 (668)
..++||+|++|..+.. . ++ .. ..+..... ...+.+
T Consensus 101 ~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 180 (328)
T 1zyl_A 101 FYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDE 180 (328)
T ss_dssp EEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHH
T ss_pred EEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHH
Confidence 5678999998855421 0 00 00 01111110 111122
Q ss_pred HHHHHHHH----HhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 178 LLLGLEYL----HKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 178 Il~aL~yL----Hs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
++..+.-+ +...++|+|+++.|||++ + .+.|+||+.+.
T Consensus 181 ~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 181 LIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 22222222 234589999999999998 4 89999998764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.001 Score=71.79 Aligned_cols=135 Identities=19% Similarity=0.160 Sum_probs=78.6
Q ss_pred eEEcccCceEEEEEEEcC-------CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC-eeeeccccccC
Q 005944 70 ELVGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN-IVRYLGTARED 141 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IV~l~g~~~~~ 141 (668)
+.|..|-...+|++.... ++..|.+|+.-. .. .....+.+|.++++.|...+ ..++++.+..
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~------~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~- 125 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA------IL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE- 125 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC------cc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-
Confidence 467778888899987532 357899997511 00 01123447888888774222 3456665543
Q ss_pred CcceEEeeccCCCChhcc-c----------------ccC----C-CC--CHHHHHHHHHHHHH-----------------
Q 005944 142 DSLNILLEFVPGGSISSL-L----------------GKF----G-SF--PESVIRMYTKQLLL----------------- 180 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~-L----------------~~~----~-~l--~e~~~~~i~~QIl~----------------- 180 (668)
.+||||++|..|..- + +.. + .. -..++..++.++..
T Consensus 126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 202 (379)
T 3feg_A 126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL 202 (379)
T ss_dssp ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence 399999998665421 0 110 1 11 13455555554422
Q ss_pred --HHHHHH----h----CCcccccCCcccEEeCCC----CceEEecCCchh
Q 005944 181 --GLEYLH----K----NGIMHRDIKGANILVDNK----GCIKLADFGASK 217 (668)
Q Consensus 181 --aL~yLH----s----~gIvHrDLKPeNILld~~----g~vKL~DFGlA~ 217 (668)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 233332 2 258999999999999876 789999999875
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.0011 Score=72.45 Aligned_cols=75 Identities=12% Similarity=0.203 Sum_probs=47.8
Q ss_pred eeeEEcccCceEEEEEEEcC-------CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCe-eeeccccc
Q 005944 68 KGELVGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI-VRYLGTAR 139 (668)
Q Consensus 68 i~~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-V~l~g~~~ 139 (668)
..+.|+.|....||++.... ++..+++|+.... ... ..+..|..+++.|...++ .++++.+.
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-------~~~---~~li~E~~~l~~L~~~g~~P~l~~~~~ 146 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-------ETE---SHLVAESVIFTLLSERHLGPKLYGIFS 146 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-------CCH---HHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-------CcH---HHHHHHHHHHHHHHhCCCCCcEEEEeC
Confidence 34678888899999998643 2578999986210 010 123357888877743333 55666554
Q ss_pred cCCcceEEeeccCCCCh
Q 005944 140 EDDSLNILLEFVPGGSI 156 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL 156 (668)
. .+|+||++|..|
T Consensus 147 ~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 147 G----GRLEEYIPSRPL 159 (429)
T ss_dssp T----EEEECCCCEEEC
T ss_pred C----CEEEEEeCCccc
Confidence 2 389999987554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0009 Score=70.96 Aligned_cols=75 Identities=9% Similarity=0.057 Sum_probs=41.6
Q ss_pred eeEEcccCceEEEEEEEcC--------CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC-eeeeccccc
Q 005944 69 GELVGCGAFGRVYMGMNLD--------SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN-IVRYLGTAR 139 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~--------tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN-IV~l~g~~~ 139 (668)
.+.|+.|....||++.... .+..+++|+..... .. ......|..+++.+...+ +.++++...
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-----~~----~~~~~~E~~~l~~L~~~g~~P~~~~~~~ 108 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-----DE----LYNTISEFEVYKTMSKYKIAPQLLNTFN 108 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-----GG----TSCHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-----cc----eecHHHHHHHHHHHHhcCCCCceEEecC
Confidence 4567888888999997643 13688888762110 00 001245777777764333 335554432
Q ss_pred cCCcceEEeeccCCCCh
Q 005944 140 EDDSLNILLEFVPGGSI 156 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL 156 (668)
-++||||++|..+
T Consensus 109 ----~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 ----GGRIEEWLYGDPL 121 (369)
T ss_dssp ----TEEEEECCCSEEC
T ss_pred ----CcEEEEEecCCcC
Confidence 3789999988644
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.94 E-value=0.0012 Score=68.90 Aligned_cols=31 Identities=26% Similarity=0.352 Sum_probs=26.8
Q ss_pred CCcccccCCcccEEeCCC----CceEEecCCchhh
Q 005944 188 NGIMHRDIKGANILVDNK----GCIKLADFGASKK 218 (668)
Q Consensus 188 ~gIvHrDLKPeNILld~~----g~vKL~DFGlA~~ 218 (668)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999874 6899999998753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.64 E-value=0.014 Score=64.54 Aligned_cols=75 Identities=13% Similarity=0.074 Sum_probs=47.1
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCe-eeeccccccCCcceEE
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI-VRYLGTAREDDSLNIL 147 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-V~l~g~~~~~~~~~LV 147 (668)
.+.|+.|-...+|++.....+..+++|+.-.... ... ....|..+|..|...++ .++++++.. .+|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~i------dR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v 179 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EII------NREREKKISCILYNKNIAKKIYVFFTN----GRI 179 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCS------CHHHHHHHHHHHTTSSSBCCEEEEETT----EEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhc------CHHHHHHHHHHHHhcCCCCCEEEEeCC----eEE
Confidence 4578888899999998754457899997621110 000 01468888888865444 456666532 369
Q ss_pred eeccCCCCh
Q 005944 148 LEFVPGGSI 156 (668)
Q Consensus 148 mEy~~gGsL 156 (668)
|||++|..|
T Consensus 180 ~e~I~G~~l 188 (458)
T 2qg7_A 180 EEFMDGYAL 188 (458)
T ss_dssp EECCCSEEC
T ss_pred EEeeCCccC
Confidence 999988554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.34 E-value=0.026 Score=59.28 Aligned_cols=31 Identities=29% Similarity=0.444 Sum_probs=27.5
Q ss_pred CCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 188 NGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 188 ~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3699999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.10 E-value=0.031 Score=61.13 Aligned_cols=28 Identities=25% Similarity=0.484 Sum_probs=25.5
Q ss_pred CcccccCCcccEEeCCCCceEEecCCchh
Q 005944 189 GIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 189 gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.++|+|+.+.||| +.++.+.|+||..|.
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCC
Confidence 4899999999999 778899999999875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=92.75 E-value=0.42 Score=51.24 Aligned_cols=28 Identities=36% Similarity=0.491 Sum_probs=24.5
Q ss_pred cccccCCcccEEe------CCCCceEEecCCchh
Q 005944 190 IMHRDIKGANILV------DNKGCIKLADFGASK 217 (668)
Q Consensus 190 IvHrDLKPeNILl------d~~g~vKL~DFGlA~ 217 (668)
++|+|+.+.|||+ +.++.+.|+||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 6899999999999 456789999999875
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=86.44 E-value=1.6 Score=43.18 Aligned_cols=124 Identities=14% Similarity=0.072 Sum_probs=81.4
Q ss_pred HHHHHHhCCCCCeeeeccccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcc
Q 005944 119 EVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGA 198 (668)
Q Consensus 119 Ei~iL~~L~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPe 198 (668)
|+.+|.. .||+++.. .+-..++.+.+.++.-+.+.=+..+ ..++....++++.+|+....+++. =+|--|+|+
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~ 108 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPD 108 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGG
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecc
Confidence 3344333 68888865 4555666555555544322222223 357888899999999888855543 377789999
Q ss_pred cEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCch
Q 005944 199 NILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQ 273 (668)
Q Consensus 199 NILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~ 273 (668)
||+++.++.++|.=.|+-..+ .|.=+.+|-+ +-.+=|++..+++++..|..
T Consensus 109 NL~f~~~~~p~i~~RGik~~l--------------~P~~~~ee~f----------L~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV--------------DPLPVSEAEF----------LTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB--------------SCCCCCHHHH----------HHHHHHHHHHHHCTTCCHHH
T ss_pred eEEEcCCCCEEEEEccCccCC--------------CCCCCCHHHH----------HHHHHHHHHHHHcCCCCHHH
Confidence 999999999999988864322 1111233333 23577899999999998854
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 668 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-82 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-81 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-81 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-79 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-76 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-76 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-76 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-75 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 9e-75 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-73 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-73 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-73 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-72 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-70 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-69 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-68 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 7e-68 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-68 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-66 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-66 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 7e-66 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-64 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-64 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-63 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-62 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-61 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-61 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-60 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-60 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 5e-60 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-59 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-59 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-59 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-59 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-59 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-59 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-58 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 9e-58 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-57 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-57 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-57 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-57 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-57 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-56 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-55 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-55 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-55 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-54 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-52 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-52 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-47 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-43 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-21 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (662), Expect = 2e-82
Identities = 75/266 (28%), Positives = 126/266 (47%), Gaps = 12/266 (4%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ G +G G FG VY+ S +LA+K + ++ + +L EV++
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVL-----FKAQLEKAGVEHQLRREVEIQS 61
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
+L HPNI+R G + + ++LE+ P G++ L K F E Y +L L Y
Sbjct: 62 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSY 121
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
H ++HRDIK N+L+ + G +K+ADFG S + ++ GT ++ PE+I
Sbjct: 122 CHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----SRRTTLCGTLDYLPPEMIE 177
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
H D+WS+G E GKPP+ I ++ P+ ++ A+D
Sbjct: 178 GRMHDEKVDLWSLGVLCYEFLVGKPPFEAN-TYQETYKRI--SRVEFTFPDFVTEGARDL 234
Query: 305 LLKCLQKEPYLRSTASELLQHPFVTG 330
+ + L+ P R E+L+HP++T
Sbjct: 235 ISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (657), Expect = 3e-81
Identities = 108/297 (36%), Positives = 151/297 (50%), Gaps = 19/297 (6%)
Query: 56 IEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRE 115
+ + P W +G GAFG+VY N ++ L A K + K++ + +
Sbjct: 4 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVI--------DTKSEEELED 55
Query: 116 LEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMY 174
E+ +L + HPNIV+ L +++L IL+EF GG++ +++ + ES I++
Sbjct: 56 YMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVV 115
Query: 175 TKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGT 234
KQ L L YLH N I+HRD+K NIL G IKLADFG S K TI S GT
Sbjct: 116 CKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRDSFIGT 173
Query: 235 PYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKS 289
PYWMAPEV++ + + AD+WS+G T+IEMA +PP + L +
Sbjct: 174 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP 233
Query: 290 HPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMES 346
P S KDFL KCL+K R T S+LLQHPFVT P R + E+
Sbjct: 234 TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKP---IRELIAEA 287
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 255 bits (653), Expect = 5e-81
Identities = 70/266 (26%), Positives = 121/266 (45%), Gaps = 8/266 (3%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
W + +G GA+G V + +N + E +AVK V ++ +++E+ + K
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIV-------DMKRAVDCPENIKKEICINK 58
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
L H N+V++ G RE + + LE+ GG + + PE + + QL+ G+ Y
Sbjct: 59 MLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
LH GI HRDIK N+L+D + +K++DFG + M GT ++APE++
Sbjct: 119 LHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 245 -QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
+ H+ D+WS G + M G+ PW Q K++ + +
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 238
Query: 304 FLLKCLQKEPYLRSTASELLQHPFVT 329
L K L + P R T ++ + +
Sbjct: 239 LLHKILVENPSARITIPDIKKDRWYN 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 251 bits (642), Expect = 6e-79
Identities = 93/285 (32%), Positives = 148/285 (51%), Gaps = 15/285 (5%)
Query: 51 PALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQ 110
P + + D P + +G G+FG VY ++ + E++A+K++ S S +++
Sbjct: 2 PDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKM-----SYSGKQSN 56
Query: 111 AHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESV 170
+++ +EV+ L+ L HPN ++Y G + + +++E+ G + L E
Sbjct: 57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE 116
Query: 171 IRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKS 230
I T L GL YLH + ++HRD+K NIL+ G +KL DFG++ + A S
Sbjct: 117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANS 170
Query: 231 MKGTPYWMAPEVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTT 287
GTPYWMAPEVIL + + D+WS+G T IE+A KPP ++AL+HI
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQN 229
Query: 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332
+S H S ++F+ CLQK P R T+ LL+H FV +
Sbjct: 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (627), Expect = 1e-76
Identities = 87/308 (28%), Positives = 144/308 (46%), Gaps = 53/308 (17%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ K +G G G V+ + SG ++A K + E A ++ E+++L
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLI-------HLEIKPAIRNQIIRELQVLH 59
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
P IV + G D ++I +E + GGS+ +L K G PE ++ + ++ GL Y
Sbjct: 60 ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119
Query: 185 LH-KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVI 243
L K+ IMHRD+K +NILV+++G IKL DFG S ++++ + A S GT +M+PE +
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYMSPERL 175
Query: 244 LQTGHSFSADIWSVGCTVIEMATGKPPW----SQQFQEVAALFHIGTTKSHPPIPEH--- 296
T +S +DIWS+G +++EMA G+ P +++ + + G PP P
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235
Query: 297 ----------------------------------LSMEAKDFLLKCLQKEPYLRSTASEL 322
S+E +DF+ KCL K P R+ +L
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
Query: 323 LQHPFVTG 330
+ H F+
Sbjct: 296 MVHAFIKR 303
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 244 bits (623), Expect = 3e-76
Identities = 74/279 (26%), Positives = 132/279 (47%), Gaps = 13/279 (4%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P ++ G+++G G+F V + L + A+K + + + + E +
Sbjct: 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKIL-----EKRHIIKENKVPYVTRERDV 61
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
+ L HP V+ T ++D+ L L + G + + K GSF E+ R YT +++ L
Sbjct: 62 MSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
EYLH GI+HRD+K NIL++ I++ DFG +K + + A S GT +++PE+
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 243 ILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302
+ + S+D+W++GC + ++ G PP+ + E I K PE +A+
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQKI--IKLEYDFPEKFFPKAR 238
Query: 303 DFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRN 341
D + K L + R E+ + + HP F +
Sbjct: 239 DLVEKLLVLDATKRLGCEEMEGYGPLK-----AHPFFES 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 5e-76
Identities = 90/276 (32%), Positives = 143/276 (51%), Gaps = 11/276 (3%)
Query: 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAH 112
L I P ++ + E +G GA G VY M++ +G+ +A++Q+ + Q
Sbjct: 9 LRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--------NLQQQPK 60
Query: 113 IRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIR 172
+ E+ +++ +PNIV YL + D L +++E++ GGS++ ++ + E I
Sbjct: 61 KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIA 119
Query: 173 MYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMK 232
++ L LE+LH N ++HRDIK NIL+ G +KL DFG ++ + +M
Sbjct: 120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMV 177
Query: 233 GTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP 292
GTPYWMAPEV+ + + DIWS+G IEM G+PP+ + A
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ 237
Query: 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
PE LS +DFL +CL + R +A ELLQH F+
Sbjct: 238 NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 239 bits (611), Expect = 8e-75
Identities = 70/268 (26%), Positives = 135/268 (50%), Gaps = 18/268 (6%)
Query: 67 RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126
+ +G G+F VY G++ ++ +A ++ ++ T++ + +EE ++LK L
Sbjct: 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCEL------QDRKLTKSERQRFKEEAEMLKGL 65
Query: 127 THPNIVRYLG----TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
HPNIVR+ T + + ++ E + G++ + L +F V+R + +Q+L GL
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGL 125
Query: 183 EYLHKNG--IMHRDIKGANILVDNK-GCIKLADFGASKKVVELATINGAKSMKGTPYWMA 239
++LH I+HRD+K NI + G +K+ D G + L + AK++ GTP +MA
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMA 181
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
PE+ + + S D+++ G ++EMAT + P+S+ + + +
Sbjct: 182 PEM-YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPF 327
E K+ + C+++ R + +LL H F
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAF 268
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 242 bits (618), Expect = 9e-75
Identities = 69/307 (22%), Positives = 129/307 (42%), Gaps = 15/307 (4%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ E +G GAFG V+ + +G + K + ++ E+ ++
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFI--------NTPYPLDKYTVKNEISIMN 81
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLE 183
L HP ++ + + ++LEF+ GG + + + E+ + Y +Q GL+
Sbjct: 82 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141
Query: 184 YLHKNGIMHRDIKGANILVDNK--GCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
++H++ I+H DIK NI+ + K +K+ DFG + K+ K T + APE
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPE 198
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPW-SQQFQEVAALFHIGTTKSHPPIPEHLSME 300
++ + F D+W++G + +G P+ + E + +S E
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNSVMESGNQIATPGMNLRNS 360
AKDF+ LQKEP R T + L+HP++ G + + +S Q +
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPA 318
Query: 361 MNSLVRR 367
+ R
Sbjct: 319 PQPAIGR 325
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 239 bits (610), Expect = 1e-73
Identities = 68/277 (24%), Positives = 114/277 (41%), Gaps = 15/277 (5%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ E +G GAFG V+ +G A K V ++ + +E++ +
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFV--------MTPHESDKETVRKEIQTMS 78
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGLE 183
L HP +V +D+ + ++ EF+ GG + + + E Y +Q+ GL
Sbjct: 79 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138
Query: 184 YLHKNGIMHRDIKGANILVDNK--GCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
++H+N +H D+K NI+ K +KL DFG + L K GT + APE
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH---LDPKQSVKVTTGTAEFAAPE 195
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPW-SQQFQEVAALFHIGTTKSHPPIPEHLSME 300
V + D+WSVG + +G P+ + E +S +
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHP 337
KDF+ K L +P R T + L+HP++T
Sbjct: 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 292
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 1e-73
Identities = 80/274 (29%), Positives = 136/274 (49%), Gaps = 21/274 (7%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+ +G G++GR G++L K++ T+A + L EV LL+
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDY------GSMTEAEKQMLVSEVNLLRE 59
Query: 126 LTHPNIVRYL--GTAREDDSLNILLEFVPGGSISSLLGKF----GSFPESVIRMYTKQLL 179
L HPNIVRY R + +L I++E+ GG ++S++ K E + QL
Sbjct: 60 LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119
Query: 180 LGLEYLHK-----NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGT 234
L L+ H+ + ++HRD+K AN+ +D K +KL DFG ++ + + AK+ GT
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGT 177
Query: 235 PYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP 294
PY+M+PE + + ++ +DIWS+GC + E+ PP+ F + I K IP
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELAGKIREGK-FRRIP 235
Query: 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328
S E + + + L + Y R + E+L++P +
Sbjct: 236 YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 234 bits (599), Expect = 6e-73
Identities = 77/273 (28%), Positives = 126/273 (46%), Gaps = 14/273 (5%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQV-LIAANSASKEKTQAHIRELEEEVKLL 123
+ E++G G V ++ + + AVK + + S S E+ Q +EV +L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 124 KNL-THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGL 182
+ + HPNI++ T + ++ + + G + L + + E R + LL +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEV 242
LHK I+HRD+K NIL+D+ IKL DFG S + L + + GTP ++APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ---LDPGEKLREVCGTPSYLAPEI 180
Query: 243 IL------QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE- 295
I G+ D+WS G + + G PP+ + +++ L I + PE
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR-KQMLMLRMIMSGNYQFGSPEW 239
Query: 296 -HLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
S KD + + L +P R TA E L HPF
Sbjct: 240 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 234 bits (599), Expect = 1e-72
Identities = 75/279 (26%), Positives = 134/279 (48%), Gaps = 16/279 (5%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ +++G GAF V + + + +L+A+K + +K+ + +E E+ +L
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-------AKKALEGKEGSMENEIAVLH 62
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
+ HPNIV L ++++ V GG + + + G + E Q+L ++Y
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKY 122
Query: 185 LHKNGIMHRDIKGANILV---DNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
LH GI+HRD+K N+L D I ++DFG SK + ++ + GTP ++APE
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS---TACGTPGYVAPE 179
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI--GTTKSHPPIPEHLSM 299
V+ Q +S + D WS+G + G PP+ + + I + P + +S
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE-NDAKLFEQILKAEYEFDSPYWDDISD 238
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPV 338
AKDF+ ++K+P R T + LQHP++ G +
Sbjct: 239 SAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNI 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 4e-70
Identities = 75/267 (28%), Positives = 127/267 (47%), Gaps = 10/267 (3%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ +++G G+FG+V++ + + A+K + + + E+ L
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVE----CTMVEKRVLSL 58
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
HP + T + ++L ++E++ GG + + F S Y +++LGL++
Sbjct: 59 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQF 118
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
LH GI++RD+K NIL+D G IK+ADFG K+ + + GTP ++APE++L
Sbjct: 119 LHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN--TFCGTPDYIAPEILL 176
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
++ S D WS G + EM G+ P+ Q E I +P P L EAKD
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ-DEEELFHSI--RMDNPFYPRWLEKEAKDL 233
Query: 305 LLKCLQKEPYLR-STASELLQHPFVTG 330
L+K +EP R ++ QHP
Sbjct: 234 LVKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (575), Expect = 2e-69
Identities = 68/271 (25%), Positives = 123/271 (45%), Gaps = 17/271 (6%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P + G+ +G G+FG VY G +AVK + + A + ++ + EV
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ------QLQAFKNEVG 56
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLL 180
+L+ H NI+ ++G L I+ ++ G S+ L F + +Q
Sbjct: 57 VLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQ 115
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
G++YLH I+HRD+K NI + +K+ DFG + + + + + G+ WMAP
Sbjct: 116 GMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 241 EVIL---QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP---IP 294
EVI + +SF +D+++ G + E+ TG+ P+S +F +G P +
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVR 235
Query: 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+ K + +CL+K+ R ++L
Sbjct: 236 SNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 7e-68
Identities = 71/271 (26%), Positives = 119/271 (43%), Gaps = 20/271 (7%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+++ G L+G G FG VY G+ + +A+K + + S + + EV LLK
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKH--VEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 125 NLT--HPNIVRYLGTAREDDSLNILLEFVPGGS-ISSLLGKFGSFPESVIRMYTKQLLLG 181
++ ++R L DS ++LE + + + G+ E + R + Q+L
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 182 LEYLHKNGIMHRDIKGANILVD-NKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
+ + H G++HRDIK NIL+D N+G +KL DFG+ L GT + P
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDGTRVYSPP 178
Query: 241 EVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
E I H SA +WS+G + +M G P+ + + + +S
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------IIRGQVFFRQRVSS 229
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330
E + + CL P R T E+ HP++
Sbjct: 230 ECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 260
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 224 bits (572), Expect = 7e-68
Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 12/272 (4%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ ++G G FG VY D+G++ A+K + ++ + + L+
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKC--LDKKRIKMKQGETLALNERIMLSLVS 62
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
P IV D L+ +L+ + GG + L + G F E+ +R Y +++LGLE+
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
+H +++RD+K ANIL+D G ++++D G + + + GT +MAPEV+
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASVGTHGYMAPEVLQ 178
Query: 245 -QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303
+ SAD +S+GC + ++ G P+ Q + T +P+ S E +
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238
Query: 304 FLLKCLQKEPYLRST-----ASELLQHPFVTG 330
L LQ++ R A E+ + PF
Sbjct: 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (568), Expect = 7e-68
Identities = 69/273 (25%), Positives = 122/273 (44%), Gaps = 16/273 (5%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ E +G G FG V+ + S + K V + +++E+ +L
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV---------KVKGTDQVLVKKEISILN 56
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLE 183
H NI+ + + L ++ EF+ G I + E I Y Q+ L+
Sbjct: 57 IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 184 YLHKNGIMHRDIKGANILVDNKGC--IKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
+LH + I H DI+ NI+ + IK+ +FG ++ +L + + + P + APE
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPE 173
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPW-SQQFQEVAALFHIGTTKSHPPIPEHLSME 300
V S + D+WS+G V + +G P+ ++ Q++ + +S+E
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 301 AKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333
A DF+ + L KE R TASE LQHP++ K +
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 2e-66
Identities = 81/287 (28%), Positives = 126/287 (43%), Gaps = 17/287 (5%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ GE +G G F V +G A K I + ++E EV +LK
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKF--IKKRRTKSSRRGVSREDIEREVSILK 68
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
+ HPN++ + ++LE V GG + L + S E + KQ+L G+ Y
Sbjct: 69 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYY 128
Query: 185 LHKNGIMHRDIKGANILVDNKGC----IKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
LH I H D+K NI++ ++ IK+ DFG + K + N K++ GTP ++AP
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNIFGTPEFVAP 185
Query: 241 EVILQTGHSFSADIWSVGCTVIEMATGKPPW-SQQFQEVAALFHIGTTKSHPPIPEHLSM 299
E++ AD+WS+G + +G P+ QE A + + S
Sbjct: 186 EIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSA 245
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQD-------PHPVF 339
AKDF+ + L K+P R T + LQHP++ K HP F
Sbjct: 246 LAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWSHPQF 292
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 4e-66
Identities = 71/288 (24%), Positives = 121/288 (42%), Gaps = 29/288 (10%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+++G G G+V N + E A+K + + RE+E + +
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKML---------QDCPKARREVELHWRASQ---C 64
Query: 129 PNIVRYLGT----AREDDSLNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLGL 182
P+IVR + L I++E + GG + S + G +F E K + +
Sbjct: 65 PHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 124
Query: 183 EYLHKNGIMHRDIKGANILVD---NKGCIKLADFGASKKVVELATINGAKSMKGTPYWMA 239
+YLH I HRD+K N+L +KL DFG +K+ ++ + TPY++A
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVA 181
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWS-----QQFQEVAALFHIGTTKSHPPIP 294
PEV+ + S D+WS+G + + G PP+ + +G + P
Sbjct: 182 PEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHPVFRNS 342
+S E K + L+ EP R T +E + HP++ + P S
Sbjct: 242 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 289
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 217 bits (554), Expect = 7e-66
Identities = 74/267 (27%), Positives = 132/267 (49%), Gaps = 18/267 (6%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
++ +G G+FGRV++ + +G A+K + + +E +L
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVL-----KKEIVVRLKQVEHTNDERLMLSI 60
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
+THP I+R GT ++ + ++++++ GG + SLL K FP V + Y ++ L LEYL
Sbjct: 61 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
H I++RD+K NIL+D G IK+ DFG +K V ++ ++ GTP ++APEV+
Sbjct: 121 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVVST 175
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFL 305
++ S D WS G + EM G P+ + I + P + + KD L
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTPFYDS-NTMKTYEKI--LNAELRFPPFFNEDVKDLL 232
Query: 306 LKCLQKEP-----YLRSTASELLQHPF 327
+ + ++ L++ ++ HP+
Sbjct: 233 SRLITRDLSQRLGNLQNGTEDVKNHPW 259
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 3e-64
Identities = 73/294 (24%), Positives = 130/294 (44%), Gaps = 31/294 (10%)
Query: 70 ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHP 129
+ +G G F VY + ++ +++A+K++ + S +K+ R E+KLL+ L+HP
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN---RTALREIKLLQELSHP 60
Query: 130 NIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
NI+ L +++++ +F+ + S I+ Y L GLEYLH++
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ-TGH 248
I+HRD+K N+L+D G +KLADFG +K T ++ APE++ +
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 249 SFSADIWSVGCTVIEMATGKPPW--------------------SQQFQEVAALFHIGTTK 288
D+W+VGC + E+ P +Q+ ++ +L T K
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 289 SHPPIPEH-----LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDPHP 337
S P IP H + D + P R TA++ L+ + + +
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 6e-64
Identities = 76/270 (28%), Positives = 125/270 (46%), Gaps = 15/270 (5%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
+ +L+G G FG+V + +G A+K + + + E ++L+N
Sbjct: 7 FDYLKLLGKGTFGKVILVREKATGRYYAMKIL-----RKEVIIAKDEVAHTVTESRVLQN 61
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
HP + + D L ++E+ GG + L + F E R Y +++ LEYL
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYL 121
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
H +++RDIK N+++D G IK+ DFG K+ + K+ GTP ++APEV+
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLED 179
Query: 246 TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFL 305
+ + D W +G + EM G+ P+ Q+ LF + P LS EAK L
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYN--QDHERLFEL-ILMEEIRFPRTLSPEAKSLL 236
Query: 306 LKCLQKEPYLR-----STASELLQHPFVTG 330
L+K+P R S A E+++H F
Sbjct: 237 AGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 209 bits (533), Expect = 2e-63
Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 14/268 (5%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R+ GE++G G V++ +L +AVK + A + + E +
Sbjct: 8 RYELGEILGFGGMSEVHLARDLRLHRDVAVKVL-----RADLARDPSFYLRFRREAQNAA 62
Query: 125 NLTHPNIVRYLGTAREDDSLN----ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
L HP IV T + I++E+V G ++ ++ G
Sbjct: 63 ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT-INGAKSMKGTPYWMA 239
L + H+NGI+HRD+K ANI++ +K+ DFG ++ + + + ++ GT +++
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP--IPEHL 297
PE +D++S+GC + E+ TG+PP++ V+ + PP E L
Sbjct: 183 PEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD-SPVSVAYQHVREDPIPPSARHEGL 241
Query: 298 SMEAKDFLLKCLQKEPYLR-STASELLQ 324
S + +LK L K P R TA+E+
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRA 269
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 4e-63
Identities = 57/264 (21%), Positives = 104/264 (39%), Gaps = 21/264 (7%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+ + +G G FG V +G G +AVK + K A + E ++
Sbjct: 8 ELKLLQTIGKGEFGDVMLGD--YRGNKVAVKCI----------KNDATAQAFLAEASVMT 55
Query: 125 NLTHPNIVRYLGTAREDDS-LNILLEFVPGGSISSLLGKFG--SFPESVIRMYTKQLLLG 181
L H N+V+ LG E+ L I+ E++ GS+ L G + ++ +
Sbjct: 56 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
+EYL N +HRD+ N+LV K++DFG +K+ + K W APE
Sbjct: 116 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPE 170
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301
+ + S +D+WS G + E+ + + + + P+
Sbjct: 171 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-EKGYKMDAPDGCPPAV 229
Query: 302 KDFLLKCLQKEPYLRSTASELLQH 325
+ + C + +R + +L +
Sbjct: 230 YEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 6e-63
Identities = 57/298 (19%), Positives = 110/298 (36%), Gaps = 28/298 (9%)
Query: 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAH 112
K + P G+++G GAFG+V + QV A ++ +
Sbjct: 26 YEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV--AVKMLKEKADSSE 83
Query: 113 IRELEEEVKLLKNLT-HPNIVRYLGTAREDDSLNILLEFVPGGSISSLL----------- 160
L E+K++ L H NIV LG + ++ E+ G + + L
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 143
Query: 161 ------------GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCI 208
+ + Q+ G+E+L +HRD+ N+LV + +
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 203
Query: 209 KLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-G 267
K+ DFG ++ ++ + + + WMAPE + + ++ +D+WS G + E+ + G
Sbjct: 204 KICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG 263
Query: 268 KPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
P+ A + + P + + E + C + R + L
Sbjct: 264 VNPY-PGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 2e-62
Identities = 68/279 (24%), Positives = 119/279 (42%), Gaps = 26/279 (9%)
Query: 73 GCGAFGRVYMGMN--LDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
GCG FG V G+ +A+K + + +A E+ E +++ L +P
Sbjct: 18 GCGNFGSVRQGVYRMRKKQIDVAIKVL-------KQGTEKADTEEMMREAQIMHQLDNPY 70
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLEYLHKNG 189
IVR +G + ++L +++E GG + L GK P S + Q+ +G++YL +
Sbjct: 71 IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 129
Query: 190 IMHRDIKGANILVDNKGCIKLADFGASKKV-VELATINGAKSMKGTPYWMAPEVILQTGH 248
+HRD+ N+L+ N+ K++DFG SK + + + + K W APE I
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 249 SFSADIWSVGCTVIEMAT-GKPPWSQQ-FQEVAALFHIGTTKSHPPIPEHLSMEAKDFLL 306
S +D+WS G T+ E + G+ P+ + EV A G P E +
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPPECPPELYALMS 246
Query: 307 KCLQKEPYLRSTASEL---LQHPFVT------GKYQDPH 336
C + R + ++ + + G + H
Sbjct: 247 DCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGHHHHHH 285
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 4e-62
Identities = 66/263 (25%), Positives = 112/263 (42%), Gaps = 18/263 (6%)
Query: 73 GCGAFGRVYMGMNLD--SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130
G G FG V G + +AVK + AN A EL E +++ L +P
Sbjct: 16 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND------PALKDELLAEANVMQQLDNPY 69
Query: 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGI 190
IVR +G E +S +++E G ++ L + + I Q+ +G++YL ++
Sbjct: 70 IVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 191 MHRDIKGANILVDNKGCIKLADFGASKKV-VELATINGAKSMKGTPYWMAPEVILQTGHS 249
+HRD+ N+L+ + K++DFG SK + + K W APE I S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 250 FSADIWSVGCTVIEMAT-GKPPW-SQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLK 307
+D+WS G + E + G+ P+ + EV A+ G P E D +
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG---ERMGCPAGCPREMYDLMNL 245
Query: 308 CLQKEPYLRSTASEL---LQHPF 327
C + R + + L++ +
Sbjct: 246 CWTYDVENRPGFAAVELRLRNYY 268
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 4e-61
Identities = 63/259 (24%), Positives = 113/259 (43%), Gaps = 15/259 (5%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
+ +G G FG V G +A+K + ++ E EE K++ NL+H
Sbjct: 9 LKELGTGQFGVVKYGK-WRGQYDVAIKMI---------KEGSMSEDEFIEEAKVMMNLSH 58
Query: 129 PNIVRYLGTAREDDSLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGLEYLHK 187
+V+ G + + I+ E++ G + + L F + K + +EYL
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTG 247
+HRD+ N LV+++G +K++DFG S+ V++ + K W PEV++ +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 248 HSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLL 306
S +DIW+ G + E+ + GK P+ ++F HI P S + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQGL-RLYRPHLASEKVYTIMY 235
Query: 307 KCLQKEPYLRSTASELLQH 325
C ++ R T LL +
Sbjct: 236 SCWHEKADERPTFKILLSN 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (519), Expect = 4e-61
Identities = 55/290 (18%), Positives = 108/290 (37%), Gaps = 27/290 (9%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R+R G +G G+FG +Y+G ++ +GE +A+K E + +L E K+ K
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIK----------LECVKTKHPQLHIESKIYK 57
Query: 125 NLTHPNIVRYLGTAREDDSLNILL-EFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLE 183
+ + + + N+++ E + F + + Q++ +E
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117
Query: 184 YLHKNGIMHRDIKGANILVDNKGC---IKLADFGASKKVVELAT-----INGAKSMKGTP 235
Y+H +HRD+K N L+ + + DFG +KK + T K++ GT
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 236 YWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIP- 294
+ + L S D+ S+G ++ G PW + ++ P
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 295 ----EHLSMEAKDFLLKCLQKEPYLRSTAS---ELLQHPFVTGKYQDPHP 337
+ E +L C + S +L ++ F + +
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYV 287
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 8e-61
Identities = 61/261 (23%), Positives = 114/261 (43%), Gaps = 6/261 (2%)
Query: 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
++K +++G GAFG VY G+ + GE + + +A + + +E+ +E ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVMAS 67
Query: 126 LTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYL 185
+ +P++ R LG I G + + + + + Q+ G+ YL
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 186 HKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQ 245
++HRD+ N+LV +K+ DFG +K + A+ K WMA E IL
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 187
Query: 246 TGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
++ +D+WS G TV E+ T G P+ + + I P P +++
Sbjct: 188 RIYTHQSDVWSYGVTVWELMTFGSKPYDG--IPASEISSILEKGERLPQPPICTIDVYMI 245
Query: 305 LLKCLQKEPYLRSTASELLQH 325
++KC + R EL+
Sbjct: 246 MVKCWMIDADSRPKFRELIIE 266
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (515), Expect = 1e-60
Identities = 65/276 (23%), Positives = 114/276 (41%), Gaps = 13/276 (4%)
Query: 51 PALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQ 110
P+ P +K + +G G +G VY G+ +AVK + ++
Sbjct: 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---------KEDT 54
Query: 111 AHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL--GKFGSFPE 168
+ E +E ++K + HPN+V+ LG + I+ EF+ G++ L
Sbjct: 55 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 114
Query: 169 SVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGA 228
V+ Q+ +EYL K +HRD+ N LV +K+ADFG S+ + T
Sbjct: 115 VVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAH 173
Query: 229 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTK 288
K W APE + S +D+W+ G + E+AT +++ ++ +
Sbjct: 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI-DLSQVYELLEKD 232
Query: 289 SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
PE + + + C Q P R + +E+ Q
Sbjct: 233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 1e-60
Identities = 60/264 (22%), Positives = 111/264 (42%), Gaps = 13/264 (4%)
Query: 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKL 122
P + +G G FG V++G L+ + +A+K + + + EE ++
Sbjct: 4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI---------REGAMSEEDFIEEAEV 53
Query: 123 LKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSL-LGKFGSFPESVIRMYTKQLLLG 181
+ L+HP +V+ G E + ++ EF+ G +S + G F + + G
Sbjct: 54 MMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEG 113
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPE 241
+ YL + ++HRD+ N LV IK++DFG ++ V++ + K W +PE
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPE 172
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301
V + +S +D+WS G + E+ + + + I T P S
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHV 231
Query: 302 KDFLLKCLQKEPYLRSTASELLQH 325
+ C ++ P R S LL+
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (516), Expect = 1e-60
Identities = 65/296 (21%), Positives = 113/296 (38%), Gaps = 31/296 (10%)
Query: 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVYMG-----MNLDSGELLAVKQVLIAANSASKE 107
LP K + P R G+ +G GAFG+V + D+ +AVK +
Sbjct: 12 LPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKML-------KPS 64
Query: 108 KTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS- 165
L E+K+L L H NIV LG ++ E+ G + + L +
Sbjct: 65 AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 166 -----------------FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCI 208
+ ++ Q+ G+ +L +HRD+ NIL+ +
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184
Query: 209 KLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGK 268
K+ DFG ++ + + + + WMAPE I ++F +D+WS G + E+ +
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 269 PPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+ + + PEH E D + C +P R T +++Q
Sbjct: 245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 2e-60
Identities = 60/272 (22%), Positives = 106/272 (38%), Gaps = 17/272 (6%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P + E +G G FG V+MG + +AVK + ++ E
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSL---------KQGSMSPDAFLAEAN 60
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS--FPESVIRMYTKQLL 179
L+K L H +VR + + I+ E++ GS+ L + + Q+
Sbjct: 61 LMKQLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIA 119
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMA 239
G+ ++ + +HRD++ ANILV + K+ADFG ++ + + + K W A
Sbjct: 120 EGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTA 178
Query: 240 PEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299
PE I + +D+WS G + E+ T + ++ P++
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRMVRPDNCPE 237
Query: 300 EAKDFLLKCLQKEPYLRSTASELLQ--HPFVT 329
E + C ++ P R T L F T
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 5e-60
Identities = 65/265 (24%), Positives = 110/265 (41%), Gaps = 9/265 (3%)
Query: 65 RWRKGELVGCGAFGRVYMG-MNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLL 123
R E +G G+FG V G + SG+ ++V + + S+ + + + EV +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPE---AMDDFIREVNAM 65
Query: 124 KNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSL-LGKFGSFPESVIRMYTKQLLLGL 182
+L H N++R G + ++ E P GS+ G F + Y Q+ G+
Sbjct: 66 HSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 183 EYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE-LATINGAKSMKGTPYWMAPE 241
YL +HRD+ N+L+ + +K+ DFG + + + + K W APE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184
Query: 242 VILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSME 300
+ S ++D W G T+ EM T G+ PW L I P PE +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKIDKEGERLPRPEDCPQD 243
Query: 301 AKDFLLKCLQKEPYLRSTASELLQH 325
+ +++C +P R T L
Sbjct: 244 IYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 201 bits (511), Expect = 2e-59
Identities = 76/271 (28%), Positives = 137/271 (50%), Gaps = 18/271 (6%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ + + +G G+FGRV + + +SG A+K + K I E ++L+
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKIL-----DKQKVVKLKQIEHTLNEKRILQ 96
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
+ P +V+ + +++ +L +++E+V GG + S L + G F E R Y Q++L EY
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
LH +++RD+K N+L+D +G I++ DFG +K+ ++ GTP +APE+IL
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAPEIIL 211
Query: 245 QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDF 304
G++ + D W++G + EMA G PP+ Q + I P H S + KD
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYPPFFAD-QPIQIYEKI--VSGKVRFPSHFSSDLKDL 268
Query: 305 LLKCLQKEP-----YLRSTASELLQHPFVTG 330
L LQ + L++ +++ H +
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (507), Expect = 2e-59
Identities = 57/300 (19%), Positives = 111/300 (37%), Gaps = 37/300 (12%)
Query: 54 PPIEKTDAPPIRWRKGELVGCGAFGRVYMG-----MNLDSGELLAVKQVLIAANSASKEK 108
P + + P +G GAFGRV+ + + ++AVK + +E
Sbjct: 3 PKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML-------KEEA 55
Query: 109 TQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGS--- 165
+ + + E L+ +PNIV+ LG + +L E++ G ++ L
Sbjct: 56 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 115
Query: 166 ---------------------FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN 204
+ +Q+ G+ YL + +HRD+ N LV
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE 175
Query: 205 KGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEM 264
+K+ADFG S+ + + WM PE I ++ +D+W+ G + E+
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 235
Query: 265 ATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+ ++++ + PE+ +E + + C K P R + + +
Sbjct: 236 FSYGLQPYYGMAHEEVIYYV-RDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 3e-59
Identities = 76/313 (24%), Positives = 130/313 (41%), Gaps = 49/313 (15%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ K +G G FG V+ + +G+ +A+K+VL+ + + + E+K+L+
Sbjct: 11 KYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLM------ENEKEGFPITALREIKILQ 64
Query: 125 NLTHPNIVRYLGTAREDDS--------LNILLEFVPGGSISSLLGKFGSFPESVIRMYTK 176
L H N+V + R S + ++ +F L F S I+ +
Sbjct: 65 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ 124
Query: 177 QLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKV--VELATINGAKSMKGT 234
LL GL Y+H+N I+HRD+K AN+L+ G +KLADFG ++ + + N + T
Sbjct: 125 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 235 PYWMAPEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWS-----QQFQEVAALFHIGTTK 288
++ PE++L + + D+W GC + EM T P Q ++ L T +
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE 244
Query: 289 SHPPIPEH------------------------LSMEAKDFLLKCLQKEPYLRSTASELLQ 324
P + + A D + K L +P R + + L
Sbjct: 245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
Query: 325 HPFVTGKYQDPHP 337
H F DP P
Sbjct: 305 HDFFW---SDPMP 314
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 7e-59
Identities = 73/306 (23%), Positives = 127/306 (41%), Gaps = 45/306 (14%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R+ +G GA+G V + + +A+K++ S + Q + + E+K+L
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI-------SPFEHQTYCQRTLREIKILL 61
Query: 125 NLTHPNIVRYLGTAREDDSLN----ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
H NI+ R L+ + G + LL K I + Q+L
Sbjct: 62 RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILR 120
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV-ELATINGAKSMKGTPYWMA 239
GL+Y+H ++HRD+K +N+L++ +K+ DFG ++ + T ++ A
Sbjct: 121 GLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 240 PEVIL-QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP------ 292
PE++L G++ S DIWSVGC + EM + +P + + + L HI P
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGK-HYLDQLNHILGILGSPSQEDLNC 239
Query: 293 -----------------------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329
+ + +A D L K L P+ R + L HP++
Sbjct: 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLE 299
Query: 330 GKYQDP 335
+Y DP
Sbjct: 300 -QYYDP 304
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 7e-59
Identities = 66/268 (24%), Positives = 111/268 (41%), Gaps = 14/268 (5%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEE 118
R G +G G FG V+ G+ + + +A+K + + + +
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-------KNCTSDSVREKFLQ 57
Query: 119 EVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQ 177
E ++ HP+IV+ +G ++ + I++E G + S L S + + +Y Q
Sbjct: 58 EALTMRQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 237
L L YL +HRDI N+LV + C+KL DFG S + +E +T A K W
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS-RYMEDSTYYKASKGKLPIKW 175
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHL 297
MAPE I + ++D+W G + E+ Q + + I P+P +
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPMPPNC 234
Query: 298 SMEAKDFLLKCLQKEPYLRSTASELLQH 325
+ KC +P R +EL
Sbjct: 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 7e-59
Identities = 65/295 (22%), Positives = 111/295 (37%), Gaps = 18/295 (6%)
Query: 47 KPAVPALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASK 106
KP L + + P R +G G FG V+MG + +A+K +
Sbjct: 1 KPQTQGLAK-DAWEIPRESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTL--------- 49
Query: 107 EKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSL--LGKFG 164
+ +E +++K L H +V+ ++ + I+ E++ GS+
Sbjct: 50 KPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGK 108
Query: 165 SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT 224
+ Q+ G+ Y+ + +HRD++ ANILV K+ADFG + +++E
Sbjct: 109 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA-RLIEDNE 167
Query: 225 INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI 284
+ K W APE L + +D+WS G + E+ T L +
Sbjct: 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 227
Query: 285 GTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ--HPFVTGKYQDPHP 337
P P D + +C +KEP R T L + T P
Sbjct: 228 ERGY-RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (503), Expect = 7e-59
Identities = 60/269 (22%), Positives = 112/269 (41%), Gaps = 11/269 (4%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
+ +++G G FG V G G+ +++ +A + T+ R+ E
Sbjct: 24 DISCVKIEQVIGAGEFGEVCSGHLKLPGK----REIFVAIKTLKSGYTEKQRRDFLSEAS 79
Query: 122 LLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSL-LGKFGSFPESVIRMYTKQLLL 180
++ HPN++ G + + I+ EF+ GS+ S G F + + +
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE---LATINGAKSMKGTPYW 237
G++YL +HRD+ NILV++ K++DFG S+ + + T A K W
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPEH 296
APE I + ++D+WS G + E+ + G+ P+ + + + P P
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDYRLPPPMD 257
Query: 297 LSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+L C QK+ R +++
Sbjct: 258 CPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 7e-59
Identities = 81/294 (27%), Positives = 130/294 (44%), Gaps = 37/294 (12%)
Query: 65 RWRKGELVGCGAFGRVYMGMNL-DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLL 123
++ +G GA+G+V+ +L + G +A+K+ + + + + IRE+ ++ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKR--VRVQTGEEGMPLSTIREVAV-LRHL 64
Query: 124 KNLTHPNIVRYLG-----TAREDDSLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQ 177
+ HPN+VR + L ++ E V + L P I+ Q
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYW 237
LL GL++LH + ++HRD+K NILV + G IKLADFG ++ + S+ T ++
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR---IYSFQMALTSVVVTLWY 181
Query: 238 MAPEVILQTGHSFSADIWSVGCTVIEMATGKPP------------------------WSQ 273
APEV+LQ+ ++ D+WSVGC EM KP W +
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 241
Query: 274 QFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
FH + + + KD LLKCL P R +A L HP+
Sbjct: 242 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 2e-58
Identities = 89/278 (32%), Positives = 150/278 (53%), Gaps = 17/278 (6%)
Query: 65 RWRKGELVGCGAFGRVYMGMNL---DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
+ +++G GA+G+V++ + D+G+L A+K VL A K KT H R E +
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMK-VLKKATIVQKAKTTEHTRT---ERQ 80
Query: 122 LLKNLTH-PNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLL 180
+L+++ P +V + + L+++L+++ GG + + L + F E +++Y +++L
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL 140
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
LE+LHK GI++RDIK NIL+D+ G + L DFG SK+ V T A GT +MAP
Sbjct: 141 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAP 199
Query: 241 EVIL--QTGHSFSADIWSVGCTVIEMATGKPPWS-QQFQEVAALFHIGTTKSHPPIPEHL 297
+++ +GH + D WS+G + E+ TG P++ + A KS PP P+ +
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEM 259
Query: 298 SMEAKDFLLKCLQKEPYLR-----STASELLQHPFVTG 330
S AKD + + L K+P R A E+ +H F
Sbjct: 260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 4e-58
Identities = 61/268 (22%), Positives = 112/268 (41%), Gaps = 6/268 (2%)
Query: 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEE 118
T+ P + +++G G FG VY GM S K+V +A + T+ +
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGK---KEVPVAIKTLKAGYTEKQRVDFLG 58
Query: 119 EVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSL-LGKFGSFPESVIRMYTKQ 177
E ++ +H NI+R G + + I+ E++ G++ K G F + +
Sbjct: 59 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118
Query: 178 LLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE-LATINGAKSMKGTPY 236
+ G++YL +HRD+ NILV++ K++DFG S+ + + K
Sbjct: 119 IAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 237 WMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEH 296
W APE I + ++D+WS G + E+ T + + I P P
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLPTPMD 237
Query: 297 LSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+++C Q+E R ++++
Sbjct: 238 CPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 9e-58
Identities = 60/264 (22%), Positives = 116/264 (43%), Gaps = 15/264 (5%)
Query: 69 GELVGCGAFGRVYMGMNLDS---GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN 125
E++G G FG VY G LD+ AVK + ++ + + E ++K+
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL-------NRITDIGEVSQFLTEGIIMKD 84
Query: 126 LTHPNIVRYLGTAREDD-SLNILLEFVPGGSISSLLGKFGSFPESVIRM-YTKQLLLGLE 183
+HPN++ LG + S ++L ++ G + + + P + + Q+ G++
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 144
Query: 184 YLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV--ELATINGAKSMKGTPYWMAPE 241
+L +HRD+ N ++D K +K+ADFG ++ + E +++ K WMA E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204
Query: 242 VILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301
+ + +D+WS G + E+ T P ++ + PE+
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPL 263
Query: 302 KDFLLKCLQKEPYLRSTASELLQH 325
+ +LKC + +R + SEL+
Sbjct: 264 YEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 1e-57
Identities = 65/291 (22%), Positives = 121/291 (41%), Gaps = 20/291 (6%)
Query: 53 LPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAH 112
LP + + P R G+ +G GAFG+V + + + + +A + T+
Sbjct: 2 LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD 61
Query: 113 IRELEEEVKLLKNLT-HPNIVRYLGTAREDDSLNILLEFVPGGSISSLL----------- 160
+ +L E++++K + H NI+ LG +D L +++E+ G++ L
Sbjct: 62 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121
Query: 161 -----GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215
+ Q+ G+EYL +HRD+ N+LV +K+ADFG
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 181
Query: 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQ 274
++ + + + + WMAPE + ++ +D+WS G + E+ T G P+
Sbjct: 182 ARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG- 240
Query: 275 FQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
V LF + P + + E + C P R T +L++
Sbjct: 241 -VPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (494), Expect = 1e-57
Identities = 83/302 (27%), Positives = 134/302 (44%), Gaps = 39/302 (12%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++K E +G G +G VY N +GE++A+K++ + +T+ E+ LLK
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL------DTETEGVPSTAIREISLLK 56
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLE 183
L HPNIV+ L ++ L ++ EF+ + P +I+ Y QLL GL
Sbjct: 57 ELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 184 YLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVI 243
+ H + ++HRD+K N+L++ +G IKLADFG ++ + T ++ APE++
Sbjct: 117 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVRTYTHEVVTLWYRAPEIL 174
Query: 244 LQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP---------- 292
L + S + DIWS+GC EM T + + E+ LF I T P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD-SEIDQLFRIFRTLGTPDEVVWPGVTSM 233
Query: 293 -----------------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
+ L + + L + L +P R +A L HPF P
Sbjct: 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD-VTKP 292
Query: 336 HP 337
P
Sbjct: 293 VP 294
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-57
Identities = 73/299 (24%), Positives = 122/299 (40%), Gaps = 37/299 (12%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ K E +G G +G V+ N ++ E++A+K+V + + + E+ LLK
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD------EGVPSSALREICLLK 56
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
L H NIVR D L ++ EF G +++ + QLL GL +
Sbjct: 57 ELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
H ++HRD+K N+L++ G +KLA+FG ++ + + T ++ P+V+
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLF 174
Query: 245 QTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPP----------- 292
+S S D+WS GC E+A P L I P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 293 ----------------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQDP 335
+ L+ +D L L+ P R +A E LQHP+ + + P
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS-DFCPP 292
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 192 bits (489), Expect = 6e-57
Identities = 72/290 (24%), Positives = 122/290 (42%), Gaps = 36/290 (12%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ E +G G +G VY N + GE A+K++ + E+ +LK
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPS------TTIREISILK 55
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
L H NIV+ L ++ E + L G + + QLL G+ Y
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 185 LHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVIL 244
H ++HRD+K N+L++ +G +K+ADFG ++ + T ++ AP+V++
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLM 173
Query: 245 QTG-HSFSADIWSVGCTVIEMATGKPPW-----SQQFQEVAALFHIGTTKSHPPIPE--- 295
+ +S + DIWSVGC EM G P + + Q + + +K+ P + E
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 296 ------------------HLSMEAKDFLLKCLQKEPYLRSTASELLQHPF 327
L D L K L+ +P R TA + L+H +
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 9e-57
Identities = 87/329 (26%), Positives = 140/329 (42%), Gaps = 52/329 (15%)
Query: 46 SKPAVPALPPIEKTDAP-PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSA 104
SK P + D P + + +++G G+FG VY DSGEL+A+K+VL
Sbjct: 1 SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL------ 54
Query: 105 SKEKTQAHIRELEEEVKLLKNLTHPNIVRYL------GTAREDDSLNILLEFVPGGSISS 158
++K R E+++++ L H NIVR G +++ LN++L++VP
Sbjct: 55 -QDK-----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 159 LL---GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-CIKLADFG 214
+ P +++Y QL L Y+H GI HRDIK N+L+D +KL DFG
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFG 168
Query: 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWS-- 272
++K++V + Y + T ++ S D+WS GC + E+ G+P +
Sbjct: 169 SAKQLVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 273 ---QQFQEVAAL------------------FHIGTTKSHP---PIPEHLSMEAKDFLLKC 308
Q E+ + F K+HP EA +
Sbjct: 227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 286
Query: 309 LQKEPYLRSTASELLQHPFVTGKYQDPHP 337
L+ P R T E H F + +DP+
Sbjct: 287 LEYTPTARLTPLEACAHSFFD-ELRDPNV 314
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 9e-56
Identities = 59/275 (21%), Positives = 112/275 (40%), Gaps = 28/275 (10%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT- 127
+++G G FG+V G + + + ++ R+ E+++L L
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRM-----KEYASKDDHRDFAGELEVLCKLGH 69
Query: 128 HPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF----------------GSFPESVI 171
HPNI+ LG L + +E+ P G++ L K + +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 172 RMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSM 231
+ + G++YL + +HRD+ NILV K+ADFG S+
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK---KTMG 186
Query: 232 KGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSH 290
+ WMA E + + ++ ++D+WS G + E+ + G P+ A L+
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG--MTCAELYEKLPQGYR 244
Query: 291 PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
P + E D + +C +++PY R + +++L
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-55
Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 20/282 (7%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVK 121
P R + G+ +G GAFG+V + + V A + T + R L E+K
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV--AVKMLKEGATHSEHRALMSELK 68
Query: 122 -LLKNLTHPNIVRYLGTAREDDS-LNILLEFVPGGSISSLLGKFGS-------------- 165
L+ H N+V LG + L +++EF G++S+ L +
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYK 128
Query: 166 --FPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223
+ Y+ Q+ G+E+L +HRD+ NIL+ K +K+ DFG ++ + +
Sbjct: 129 DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH 283
+ WMAPE I ++ +D+WS G + E+ + +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248
Query: 284 IGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
+ P++ + E +L C EP R T SEL++H
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 188 bits (479), Expect = 2e-55
Identities = 58/292 (19%), Positives = 106/292 (36%), Gaps = 29/292 (9%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ G +G G+FG ++ G NL + + +A+K E ++ +L +E + K
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIK----------FEPRRSDAPQLRDEYRTYK 55
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLE 183
L + + ++ N+L+ + G S+ LL G F + M KQ+L ++
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115
Query: 184 YLHKNGIMHRDIKGANILVDNK-----GCIKLADFGASKKVVELAT-----INGAKSMKG 233
+H+ +++RDIK N L+ I + DFG K + T K++ G
Sbjct: 116 SIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 234 TPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW--SQQFQEVAALFHIGTTKSHP 291
T +M+ L S D+ ++G + G PW + IG K
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235
Query: 292 PIPE---HLSMEAKDFLLKCLQKEPYLR---STASELLQHPFVTGKYQDPHP 337
P+ E E ++ L +
Sbjct: 236 PLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDEN 287
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 189 bits (480), Expect = 3e-55
Identities = 67/303 (22%), Positives = 121/303 (39%), Gaps = 57/303 (18%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
++ +G G + V+ +N+ + E + VK + ++++ E+K+L+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----------KPVKKKKIKREIKILE 84
Query: 125 NL-THPNIVRYLGTAREDDS--LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLG 181
NL PNI+ ++ S ++ E V L + IR Y ++L
Sbjct: 85 NLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL---TDYDIRFYMYEILKA 141
Query: 182 LEYLHKNGIMHRDIKGANILVDNKGC-IKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
L+Y H GIMHRD+K N+++D++ ++L D+G ++ N + Y+ P
Sbjct: 142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYN---VRVASRYFKGP 198
Query: 241 EVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHP-------- 291
E+++ + +S D+WS+GC + M K P+ L I
Sbjct: 199 ELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258
Query: 292 ---------------------------PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324
+S EA DFL K L+ + R TA E ++
Sbjct: 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
Query: 325 HPF 327
HP+
Sbjct: 319 HPY 321
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-54
Identities = 81/299 (27%), Positives = 128/299 (42%), Gaps = 44/299 (14%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
+R + VG GA+G V ++ +G +A+K++ S + + E++LLK
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS------ELFAKRAYRELRLLK 72
Query: 125 NLTHPNIVRYLGTAREDDSLNILLEFV----PGGSISSLLGKFGSFPESVIRMYTKQLLL 180
++ H N++ L D++L+ +F G+ L K E I+ Q+L
Sbjct: 73 HMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLK 132
Query: 181 GLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAP 240
GL Y+H GI+HRD+K N+ V+ +K+ DFG +++ T T ++ AP
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-----GYVVTRWYRAP 187
Query: 241 EVILQTG-HSFSADIWSVGCTVIEMATGKPPW---SQQFQEVAALFHIGT---------- 286
EVIL ++ + DIWSVGC + EM TGK + Q + GT
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 287 ---------------TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330
K I + S A + L K L + R TA E L HP+
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 2e-52
Identities = 55/279 (19%), Positives = 104/279 (37%), Gaps = 23/279 (8%)
Query: 62 PPIRWRKGELVGCGAFGRVYMGMN-----LDSGELLAVKQVLIAANSASKEKTQAHIREL 116
+ +G G+FG VY G+ + +A+K V ++ + E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-------NEAASMRERIEF 70
Query: 117 EEEVKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLL----------GKFGSF 166
E ++K ++VR LG + +++E + G + S L
Sbjct: 71 LNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPP 130
Query: 167 PESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATIN 226
S + ++ G+ YL+ N +HRD+ N +V +K+ DFG ++ + E
Sbjct: 131 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 227 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGT 286
WM+PE + + +D+WS G + E+AT Q L +
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV-M 249
Query: 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325
P++ + + C Q P +R + E++
Sbjct: 250 EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-52
Identities = 73/305 (23%), Positives = 139/305 (45%), Gaps = 47/305 (15%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R++ VG GA+G V + +G +AVK++ + ++ H + E++LLK
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL------SRPFQSIIHAKRTYRELRLLK 72
Query: 125 NLTHPNIVRYLGTAREDDSLN-----ILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLL 179
++ H N++ L SL L+ + G ++++ K + ++ Q+L
Sbjct: 73 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQIL 131
Query: 180 LGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMA 239
GL+Y+H I+HRD+K +N+ V+ +K+ DFG ++ T + T ++ A
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH-----TDDEMTGYVATRWYRA 186
Query: 240 PEVILQTGH-SFSADIWSVGCTVIEMATGKPPW--------------------SQQFQEV 278
PE++L H + + DIWSVGC + E+ TG+ + ++ +++
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 279 AALFHIGTTKSHPPIPE--------HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330
++ +S +P+ + A D L K L + R TA++ L H +
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA- 305
Query: 331 KYQDP 335
+Y DP
Sbjct: 306 QYHDP 310
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 2e-49
Identities = 75/319 (23%), Positives = 131/319 (41%), Gaps = 58/319 (18%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R++ + +G GA G V + +A+K++ + + Q H + E+ L+K
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKL------SRPFQNQTHAKRAYRELVLMK 71
Query: 125 NLTHPNIVRYLG------TAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQL 178
+ H NI+ L T E + +++E + + + + Q+
Sbjct: 72 CVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQM 128
Query: 179 LLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWM 238
L G+++LH GI+HRD+K +NI+V + +K+ DFG ++ + T Y+
Sbjct: 129 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMT---PYVVTRYYR 185
Query: 239 APEVILQTGHSFSADIWSVGCTVIEMATGKPPW-----SQQFQEVAA------------- 280
APEVIL G+ + DIWSVGC + EM K + Q+ +V
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 281 ---------------------LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTA 319
LF + + + +A+D L K L +P R +
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 320 SELLQHPFVTGKYQDPHPV 338
+ LQHP++ + DP V
Sbjct: 306 DDALQHPYIN-VWYDPAEV 323
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-47
Identities = 66/295 (22%), Positives = 107/295 (36%), Gaps = 51/295 (17%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH 128
E +G G FG V+ G GE +AVK S + ++ RE E + L H
Sbjct: 8 QESIGKGRFGEVWRGK--WRGEEVAVKIF-------SSREERSWFREAE--IYQTVMLRH 56
Query: 129 PNIVRYLGTAREDDS----LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEY 184
NI+ ++ +D+ L ++ ++ GS+ L ++ E +I++ GL +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLA-LSTASGLAH 115
Query: 185 LH--------KNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA--TINGAKSMKGT 234
LH K I HRD+K NILV G +AD G + + GT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175
Query: 235 PYWMAPEVILQTGH------SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFH----- 283
+MAPEV+ + + ADI+++G E+A +
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 284 ---------IGTTKSHPPIPEHLSM-----EAKDFLLKCLQKEPYLRSTASELLQ 324
+ K P IP + +C R TA + +
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (395), Expect = 6e-43
Identities = 70/350 (20%), Positives = 123/350 (35%), Gaps = 73/350 (20%)
Query: 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK 124
R+ +G G F V++ ++ + +A+K V + + E+E+KLL+
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---------RGDKVYTEAAEDEIKLLQ 64
Query: 125 NLTHPNIVRYLGTARE-------------DDSLNILLEFVPGGSISSLL---GKFGSFPE 168
+ + + + +++++ F G L + P
Sbjct: 65 RVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPL 124
Query: 169 SVIRMYTKQLLLGLEYLH-KNGIMHRDIKGANILVDNKGCI-KLADFGASKKVVELATIN 226
++ +KQLLLGL+Y+H + GI+H DIK N+L++ L +
Sbjct: 125 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184
Query: 227 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWS-------------- 272
+ T + +PEV+L ADIWS C + E+ TG +
Sbjct: 185 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244
Query: 273 ----------------------QQFQEVAALFHIGTTKSHP---------PIPEHLSMEA 301
F L +I K P + + E
Sbjct: 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304
Query: 302 KDFLLKCLQKEPYLRSTASELLQHPFVTGKY-QDPHPVFRNSVMESGNQI 350
DFL LQ +P R+ A L+ HP++ + V + SG+ I
Sbjct: 305 SDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDI 354
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 91.0 bits (225), Expect = 1e-21
Identities = 34/208 (16%), Positives = 65/208 (31%), Gaps = 34/208 (16%)
Query: 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEE--------- 119
G+L+G G V+ + VK + S K K + +L
Sbjct: 5 GKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 120 -VKLLKNLTHPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQL 178
+ L+ L + + +L+E + + +
Sbjct: 64 EFRALQKLQGLAVPKVYAWEGNA----VLMELIDAKELYR-------VRVENPDEVLDMI 112
Query: 179 LLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWM 238
L + + GI+H D+ N+LV +G I + DF S VE+ + +
Sbjct: 113 LEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS---VEVGEEG-WREI----LER 163
Query: 239 APEVIL---QTGHSFSADIWSVGCTVIE 263
I+ + DI S +++
Sbjct: 164 DVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 668 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.91 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.31 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.03 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.8 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.95 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.6 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.36 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=486.49 Aligned_cols=261 Identities=26% Similarity=0.413 Sum_probs=223.2
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||+|+||+||+|+++.+|+.||||++.... .....+.+.+|+.+|++++|||||++++++.+++
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~ 76 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKR-------AVDCPENIKKEICINKMLNHENVVKFYGHRREGN 76 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------------CHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhh-------cchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCc
Confidence 457999999999999999999999999999999985321 1123346789999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.+|||||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+|+.+...
T Consensus 77 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 77 IQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp EEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred eeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999876544
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
.........+||+.|||||++.+..+ +.++|||||||+||+|+||++||......................+..+++++
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 236 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAP 236 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHH
T ss_pred CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHH
Confidence 33344556789999999999998876 67899999999999999999999654332222222223333344456789999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
.+||.+||+.||.+|||++|+|+||||+.
T Consensus 237 ~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 237 LALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp HHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 99999999999999999999999999975
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-58 Score=470.17 Aligned_cols=255 Identities=29% Similarity=0.516 Sum_probs=223.1
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
-.+|++++.||+|+||+||+|+++.+++.||||++.... .........+.+|+++|+.++|||||++++++.+++
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~ 79 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQ-----LEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT 79 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHH-----ccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence 357999999999999999999999999999999984321 112223456789999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.+|||||||++|+|.+++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 80 ~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~- 158 (263)
T d2j4za1 80 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 158 (263)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC-
T ss_pred EEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC-
Confidence 9999999999999999999888999999999999999999999999999999999999999999999999999976432
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
......+||+.|||||++.+..|+.++|||||||+||+|++|+.||...... ...... .....+|..+++++
T Consensus 159 ---~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~ 231 (263)
T d2j4za1 159 ---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS----RVEFTFPDFVTEGA 231 (263)
T ss_dssp ---CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH----TTCCCCCTTSCHHH
T ss_pred ---CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH----cCCCCCCccCCHHH
Confidence 2344578999999999999999999999999999999999999999764322 222211 22345677899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
++||.+||+.||.+|||+.|+|+||||+.
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=476.92 Aligned_cols=258 Identities=34% Similarity=0.588 Sum_probs=222.1
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
+..+|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+.
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~--------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 89 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--------KKELIINEILVMRENKNPNIVNYLDSYLVG 89 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS--------CHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh--------HHHHHHHHHHHHHhCCCCCEeeEeEEEEEC
Confidence 356899999999999999999999999999999998543211 124578999999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
+.+|||||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 999999999999999998765 5799999999999999999999999999999999999999999999999999986533
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
. .......+||+.|+|||++.+..|+.++|||||||++|+|+||++||......................+..++.++
T Consensus 169 ~--~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 246 (293)
T d1yhwa1 169 E--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (293)
T ss_dssp T--TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHH
T ss_pred c--cccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHH
Confidence 2 22345678999999999999999999999999999999999999999754332222222222233345667899999
Q ss_pred HHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 302 KDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
++||.+||+.||.+|||+.|+|+||||+.
T Consensus 247 ~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 99999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-57 Score=472.52 Aligned_cols=261 Identities=28% Similarity=0.497 Sum_probs=221.2
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
.+.+|+++++||+|+||+||+|+++.+|+.||||++.... .......+.+.+|+++|++++|||||++++++.++
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-----~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~ 80 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRH-----IIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD 80 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHH-----ccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC
Confidence 3467999999999999999999999999999999984221 11223345688999999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
+.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 81 ~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 81 EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999999987654
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSME 300 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~e 300 (668)
........+.+||+.|||||++.+..|+.++|||||||+||+|+||+.||...... +...+. .....+|..++++
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~ 236 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII----KLEYDFPEKFFPK 236 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH----TTCCCCCTTCCHH
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH----cCCCCCCccCCHH
Confidence 33333445678999999999999999999999999999999999999999754322 221111 1234567789999
Q ss_pred HHHHHHHhhhhCCCCCCCHHH------HHcCccccCC
Q 005944 301 AKDFLLKCLQKEPYLRSTASE------LLQHPFVTGK 331 (668)
Q Consensus 301 l~dLI~kcL~~dP~~RPSa~E------IL~Hpwf~~~ 331 (668)
+++||.+||+.||.+|||++| |++||||++.
T Consensus 237 ~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 237 ARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp HHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred HHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 999999999999999999987 6889999764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-57 Score=474.50 Aligned_cols=261 Identities=28% Similarity=0.431 Sum_probs=211.2
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.++||+|+||+||+|+++.+|+.||||++..... ......+.+|+.+|+.++|||||++++++.+
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~ 78 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL-------EGKEGSMENEIAVLHKIKHPNIVALDDIYES 78 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------------CHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHh-------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 445679999999999999999999999999999999853221 1223457789999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC---CCCceEEecCCchh
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD---NKGCIKLADFGASK 217 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld---~~g~vKL~DFGlA~ 217 (668)
++.+|||||||+||+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+|||+. .++.+||+|||+|+
T Consensus 79 ~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 79 GGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp SSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred CCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeE
Confidence 999999999999999999999888999999999999999999999999999999999999995 57899999999998
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ 296 (668)
...... ...+.+||+.|||||++.+..|+.++|||||||+||+|++|++||..... .....+.........+.+..
T Consensus 159 ~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (307)
T d1a06a_ 159 MEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDD 235 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTT
T ss_pred EccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccC
Confidence 654322 23457899999999999999999999999999999999999999976432 33333333334444556678
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
+++++++||.+||++||.+|||+.|+|+||||++.
T Consensus 236 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-56 Score=463.00 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=214.1
Q ss_pred CCe-eeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc--
Q 005944 64 IRW-RKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE-- 140 (668)
Q Consensus 64 ~ry-~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~-- 140 (668)
.+| ++.+.||+|+||+||+|++..++..||||++.... ......+.+.+|+++|++++|||||++++++..
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 81 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK------LTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGG------SCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhh------CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc
Confidence 345 77889999999999999999999999999984322 122335678899999999999999999998854
Q ss_pred --CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCCcccEEeC-CCCceEEecCCc
Q 005944 141 --DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNG--IMHRDIKGANILVD-NKGCIKLADFGA 215 (668)
Q Consensus 141 --~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~g--IvHrDLKPeNILld-~~g~vKL~DFGl 215 (668)
...+|||||||++|+|.+++.+...+++..++.|+.||+.||+|||+++ |+||||||+||||+ .++.+||+|||+
T Consensus 82 ~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGl 161 (270)
T d1t4ha_ 82 KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161 (270)
T ss_dssp SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCc
Confidence 3568999999999999999998889999999999999999999999998 99999999999997 478999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCc
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~ 295 (668)
|+... .......+||+.|||||++.+ .|+.++|||||||+||+|++|+.||............+........++.
T Consensus 162 a~~~~----~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 236 (270)
T d1t4ha_ 162 ATLKR----ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236 (270)
T ss_dssp GGGCC----TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred ceecc----CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCc
Confidence 97532 223446789999999999865 5999999999999999999999999754322212222222223334566
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
.+++++++||.+||+.||++|||++|||+||||+
T Consensus 237 ~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 7899999999999999999999999999999995
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-57 Score=469.13 Aligned_cols=256 Identities=39% Similarity=0.600 Sum_probs=217.1
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
..|++++.||+|+||+||+|+++.+|..||||++..... ...+.+.+|+++|++++|||||++++++.+.+.
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--------~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 83 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--------EELEDYMVEIDILASCDHPNIVKLLDAFYYENN 83 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--------GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCH--------HHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCe
Confidence 469999999999999999999999999999999853211 123457789999999999999999999999999
Q ss_pred ceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
+|||||||++|+|.+++.+ .+.+++.+++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.....
T Consensus 84 ~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~ 163 (288)
T d2jfla1 84 LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence 9999999999999998765 467999999999999999999999999999999999999999999999999999765433
Q ss_pred hhhcCCccCCCCCCCCChHHHh-----hcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcc
Q 005944 223 ATINGAKSMKGTPYWMAPEVIL-----QTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~-----~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ 296 (668)
.. ...+.+||+.|+|||++. +..|+.++|||||||+||+|+||++||..... +...... .........+..
T Consensus 164 ~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~-~~~~~~~~~~~~ 240 (288)
T d2jfla1 164 IQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPTLAQPSR 240 (288)
T ss_dssp HH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-HSCCCCCSSGGG
T ss_pred cc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCCCCCCcccc
Confidence 22 233578999999999994 45588999999999999999999999975432 1111111 112223345678
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
+++++++||.+||+.||.+|||+.|+|+||||+.
T Consensus 241 ~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999999999974
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-57 Score=474.48 Aligned_cols=260 Identities=32% Similarity=0.533 Sum_probs=218.2
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
++...+|++.+.||+|+||+||+|+++.+|+.||||++..... ......+.+|+.+|+.++|||||+++++|.
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-------~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~ 74 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-------PAIRNQIIRELQVLHECNSPYIVGFYGAFY 74 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-------TTHHHHHHHHGGGGGGCCCTTBCCEEEEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-------HHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 3556789999999999999999999999999999999854321 122356789999999999999999999999
Q ss_pred cCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
+...+|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|+.
T Consensus 75 ~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~ 154 (322)
T d1s9ja_ 75 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 154 (322)
T ss_dssp CSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred ECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccc
Confidence 999999999999999999999988899999999999999999999997 5999999999999999999999999999997
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHH----------------
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALF---------------- 282 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~---------------- 282 (668)
+... ...+.+||+.|||||++.+..|+.++|||||||++|||++|+.||...........
T Consensus 155 ~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (322)
T d1s9ja_ 155 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP 230 (322)
T ss_dssp HHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred cCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence 6542 23467999999999999999999999999999999999999999954221100000
Q ss_pred ------------------------hhccCCCCCCCC-cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 283 ------------------------HIGTTKSHPPIP-EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 283 ------------------------~~~~~~~~~~~p-~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
........+..+ ..++.++++||.+||+.||.+|||++|+|+||||+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 000001111122 246889999999999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=461.01 Aligned_cols=254 Identities=31% Similarity=0.526 Sum_probs=207.0
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc--C
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE--D 141 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~--~ 141 (668)
.+|++.+.||+|+||+||+|+++.+|+.||||++.... ..+...+.+.+|+++|++++|||||++++++.+ +
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~------~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 77 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS------MTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTT------SCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhh------CCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence 57999999999999999999999999999999985432 122345678899999999999999999998854 4
Q ss_pred CcceEEeeccCCCChhccccc----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccccCCcccEEeCCCCceEEec
Q 005944 142 DSLNILLEFVPGGSISSLLGK----FGSFPESVIRMYTKQLLLGLEYLHKNG-----IMHRDIKGANILVDNKGCIKLAD 212 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~----~~~l~e~~~~~i~~QIl~aL~yLHs~g-----IvHrDLKPeNILld~~g~vKL~D 212 (668)
..+|||||||++|+|.+++.+ ...+++..++.++.||+.||.|||++| ||||||||+||||+.+|.+||+|
T Consensus 78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D 157 (269)
T d2java1 78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD 157 (269)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence 668999999999999999854 367999999999999999999999876 99999999999999999999999
Q ss_pred CCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCC
Q 005944 213 FGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHP 291 (668)
Q Consensus 213 FGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~ 291 (668)
||+|+.+.... ......+||+.|||||++.+..|+.++|||||||++|+|+||+.||...... +...+.. ....
T Consensus 158 FG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~---~~~~ 232 (269)
T d2java1 158 FGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE---GKFR 232 (269)
T ss_dssp HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH---TCCC
T ss_pred ccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHc---CCCC
Confidence 99998764322 2234678999999999999999999999999999999999999999764332 2222221 2334
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccc
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFV 328 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf 328 (668)
.++..+++++++||.+||+.||.+|||+.|||+|||+
T Consensus 233 ~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 233 RIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 5677899999999999999999999999999999995
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-56 Score=470.70 Aligned_cols=258 Identities=29% Similarity=0.461 Sum_probs=225.0
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
-.+|+++++||+|+||+||+|+++.+|+.||||++.... .........+.+|+.+|+.++|||||++++++.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 78 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEV-----IIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD 78 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhh-----ccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence 357999999999999999999999999999999984321 112223566789999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+....
T Consensus 79 ~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~- 157 (337)
T d1o6la_ 79 RLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS- 157 (337)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred ccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999986532
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
........+||+.|+|||++.+..|+.++|||||||+||+|++|++||...... +...... ....+|..+++++
T Consensus 158 -~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~ 232 (337)
T d1o6la_ 158 -DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM----EEIRFPRTLSPEA 232 (337)
T ss_dssp -TTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCTTSCHHH
T ss_pred -CCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc----CCCCCCccCCHHH
Confidence 122345678999999999999999999999999999999999999999765433 2222222 2345678899999
Q ss_pred HHHHHHhhhhCCCCCCC-----HHHHHcCccccCC
Q 005944 302 KDFLLKCLQKEPYLRST-----ASELLQHPFVTGK 331 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~~ 331 (668)
++||.+||++||.+|++ ++||++||||.+.
T Consensus 233 ~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 233 KSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp HHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 99999999999999994 9999999999753
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-56 Score=462.04 Aligned_cols=266 Identities=29% Similarity=0.427 Sum_probs=224.7
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++++.||+|+||+||+|+++.+|+.||||++......... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSR--RGVSREDIEREVSILKEIQHPNVITLHEVYEN 84 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCS--SSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhh--hhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 3456899999999999999999999999999999998543322111 11224568899999999999999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC----ceEEecCCch
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG----CIKLADFGAS 216 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g----~vKL~DFGlA 216 (668)
.+.+|||||||+||+|.+++...+.+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 999999999999999999998888999999999999999999999999999999999999998776 5999999999
Q ss_pred hhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCc
Q 005944 217 KKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 217 ~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~ 295 (668)
+.+.. .......+||+.|+|||++.+..++.++|||||||+||+|+||+.||..... +....+...........+.
T Consensus 165 ~~~~~---~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~ 241 (293)
T d1jksa_ 165 HKIDF---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFS 241 (293)
T ss_dssp EECTT---SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred hhcCC---CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcC
Confidence 86533 2234567899999999999999999999999999999999999999975432 2222222222222233446
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.++.++++||.+||+.||.+|||++|||+||||++.
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 789999999999999999999999999999999753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-55 Score=470.55 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=221.8
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
-.+|++++.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.+|+.++|||||++++++.+++
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~ 96 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--------ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDN 96 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--------HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETT
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--------hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 358999999999999999999999999999999984321 122356789999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC--CCceEEecCCchhhh
Q 005944 143 SLNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN--KGCIKLADFGASKKV 219 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~-~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~--~g~vKL~DFGlA~~~ 219 (668)
.+|||||||+||+|.+++. ..+.+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||+|+.+
T Consensus 97 ~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~ 176 (350)
T d1koaa2 97 EMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 176 (350)
T ss_dssp EEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence 9999999999999999885 4567999999999999999999999999999999999999964 578999999999865
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls 298 (668)
.. .....+.+||+.|||||++.+..|+.++|||||||++|+|+||+.||..... +....+..............++
T Consensus 177 ~~---~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 253 (350)
T d1koaa2 177 DP---KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGIS 253 (350)
T ss_dssp CT---TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCC
T ss_pred cc---ccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 33 2334467899999999999999999999999999999999999999975432 2222223333333334456789
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+++++||.+||+.||.+|||+.|||+||||+...
T Consensus 254 ~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 254 EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp HHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 9999999999999999999999999999998643
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-55 Score=464.52 Aligned_cols=257 Identities=34% Similarity=0.575 Sum_probs=220.5
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||+|+||+||+|++..+|+.||||++..... ......+.+.+|+.+|++++|||||++++++.+.+
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-----~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 88 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGK-----QSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH 88 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSS-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhc-----cCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence 3469999999999999999999999999999999853221 22344567889999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.+|||||||.+|+|..++...+.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+...
T Consensus 89 ~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~-- 166 (309)
T d1u5ra_ 89 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-- 166 (309)
T ss_dssp EEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS--
T ss_pred EEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC--
Confidence 999999999999998888777899999999999999999999999999999999999999999999999999997542
Q ss_pred hhhcCCccCCCCCCCCChHHHhh---cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQ---TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~---~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.....+||+.|||||++.+ ..|+.++|||||||++|+|++|..||....... .+..+.........+..+++
T Consensus 167 ----~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~s~ 241 (309)
T d1u5ra_ 167 ----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNESPALQSGHWSE 241 (309)
T ss_dssp ----SBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCCCCCSCTTSCH
T ss_pred ----CCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHhCCCCCCCCCCCCH
Confidence 2345789999999999964 358899999999999999999999997543321 12222222333344567899
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++++||.+||+.||.+|||++|+|+||||...
T Consensus 242 ~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 242 YFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 99999999999999999999999999999753
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-55 Score=470.12 Aligned_cols=260 Identities=25% Similarity=0.394 Sum_probs=223.4
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
..+|++.+.||+|+||+||+|+++.+|+.||||++.... ......+.+|+.+|++++|||||++++++.+++
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--------~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~ 99 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--------PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKY 99 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--------HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSS
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--------hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357999999999999999999999999999999984321 112345788999999999999999999999999
Q ss_pred cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeC--CCCceEEecCCchhhh
Q 005944 143 SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVD--NKGCIKLADFGASKKV 219 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld--~~g~vKL~DFGlA~~~ 219 (668)
.+|||||||+||+|.+++... ..+++.+++.|+.||+.||+|||++|||||||||+||||+ .++.+||+|||+|+.+
T Consensus 100 ~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~ 179 (352)
T d1koba_ 100 EMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179 (352)
T ss_dssp EEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred EEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceec
Confidence 999999999999999877654 4699999999999999999999999999999999999998 5789999999999876
Q ss_pred HhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCcccC
Q 005944 220 VELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 220 ~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls 298 (668)
... ......+||+.|+|||++.+..|+.++|||||||+||+|+||++||.+... .....+...........+..++
T Consensus 180 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 256 (352)
T d1koba_ 180 NPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 256 (352)
T ss_dssp CTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred CCC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence 432 234457899999999999999999999999999999999999999976432 2222333333344445567899
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
+++++||.+||++||.+|||+.|||+||||++...
T Consensus 257 ~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 99999999999999999999999999999987543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=6.1e-55 Score=460.26 Aligned_cols=254 Identities=29% Similarity=0.488 Sum_probs=222.0
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++++.||+|+||+||+|+++.+|+.||||++.... .......+.+.+|+.+|+.++|||||++++++.+.+.
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~-----~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 78 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEI-----VVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQ 78 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHH-----ccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCe
Confidence 47999999999999999999999999999999984221 1112234668899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|+|||||.||+|..++.....+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 79 ~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 79 IFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp EEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999999986532
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
...+.+||+.|||||++.+..|+.++|||||||+||+|+||+.||...... ....+.. ....++..++++++
T Consensus 157 ---~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~~ 229 (316)
T d1fota_ 157 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----AELRFPPFFNEDVK 229 (316)
T ss_dssp ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH----CCCCCCTTSCHHHH
T ss_pred ---ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc----CCCCCCCCCCHHHH
Confidence 344678999999999999999999999999999999999999999764322 2222211 12356678999999
Q ss_pred HHHHHhhhhCCCCCC-----CHHHHHcCccccCC
Q 005944 303 DFLLKCLQKEPYLRS-----TASELLQHPFVTGK 331 (668)
Q Consensus 303 dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~~ 331 (668)
+||.+||.+||.+|+ |+++|++||||++.
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 999999999999996 99999999999763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.6e-55 Score=468.64 Aligned_cols=261 Identities=26% Similarity=0.421 Sum_probs=220.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.++||+|+||+||+|+++.+|+.||||++..... ..............|+.+++.++|||||++++++.+.+.
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~--~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRI--KMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHH--HHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHc--chhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 579999999999999999999999999999999843211 111122223334456788888899999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+|||||||+||+|.++|.+...+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+..
T Consensus 82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-- 159 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 159 (364)
T ss_dssp EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS--
T ss_pred EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC--
Confidence 999999999999999999889999999999999999999999999999999999999999999999999999986532
Q ss_pred hhcCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAK 302 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~ 302 (668)
......+||+.|+|||++.. ..|+.++|||||||+||+|+||+.||..........+..........++..++++++
T Consensus 160 --~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 237 (364)
T d1omwa3 160 --KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 237 (364)
T ss_dssp --SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHH
T ss_pred --CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHH
Confidence 23446789999999999975 568999999999999999999999997532211111222233445567788999999
Q ss_pred HHHHHhhhhCCCCCCC-----HHHHHcCccccC
Q 005944 303 DFLLKCLQKEPYLRST-----ASELLQHPFVTG 330 (668)
Q Consensus 303 dLI~kcL~~dP~~RPS-----a~EIL~Hpwf~~ 330 (668)
+||.+||++||.+||| ++||++||||++
T Consensus 238 ~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 238 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp HHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred HHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence 9999999999999999 799999999975
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2e-54 Score=448.26 Aligned_cols=265 Identities=28% Similarity=0.396 Sum_probs=226.8
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchh-hHhhHHHHHHHHHHHHHHHhCC-CCCeeeecccccc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSAS-KEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTARE 140 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~-~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~ 140 (668)
..+|++.+.||+|+||+||+|+++.+|+.||||++........ ....+.....+.+|+.+|++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 4689999999999999999999999999999999865433221 2233445567889999999997 9999999999999
Q ss_pred CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 141 DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
++.+|||||||++|+|.++|...+.+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999999998764
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhh------cCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH-HHHHhhccCCCCCCC
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQ------TGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV-AALFHIGTTKSHPPI 293 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~------~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~-~~~~~~~~~~~~~~~ 293 (668)
. .......+||+.|+|||++.+ ..++.++||||+||+||+|+||+.||....... ...+.........+.
T Consensus 162 ~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (277)
T d1phka_ 162 P---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238 (277)
T ss_dssp T---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred C---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence 3 223455789999999999974 346889999999999999999999998654332 222222333334445
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
..++|+++++||.+||+.||.+|||++|||+||||+.
T Consensus 239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 5689999999999999999999999999999999975
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-54 Score=462.85 Aligned_cols=255 Identities=29% Similarity=0.497 Sum_probs=222.0
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++++.||+|+||+||+|+++.+|+.||||++.... .........+.+|+++|+.++|||||++++++.....
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~-----~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 115 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQK-----VVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHH-----ccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccc
Confidence 58999999999999999999999999999999984221 1122334567899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
+++||||+.+|+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 116 ~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~--- 192 (350)
T d1rdqe_ 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK--- 192 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS---
T ss_pred cccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc---
Confidence 99999999999999999988999999999999999999999999999999999999999999999999999998653
Q ss_pred hhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHH
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKD 303 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~d 303 (668)
....+.+||+.|||||++.+..|+.++|||||||+||+|+||+.||......... ..+. ......+..+++++.+
T Consensus 193 --~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~-~~i~--~~~~~~p~~~s~~~~~ 267 (350)
T d1rdqe_ 193 --GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY-EKIV--SGKVRFPSHFSSDLKD 267 (350)
T ss_dssp --SCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHH--HCCCCCCTTCCHHHHH
T ss_pred --cccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHH-HHHh--cCCCCCCccCCHHHHH
Confidence 2234678999999999999999999999999999999999999999765322111 1111 1234556789999999
Q ss_pred HHHHhhhhCCCCCC-----CHHHHHcCccccCC
Q 005944 304 FLLKCLQKEPYLRS-----TASELLQHPFVTGK 331 (668)
Q Consensus 304 LI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~~ 331 (668)
||.+||++||.+|+ |+++|++||||++.
T Consensus 268 li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 268 LLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 99999999999994 99999999999753
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-54 Score=445.16 Aligned_cols=260 Identities=27% Similarity=0.442 Sum_probs=210.9
Q ss_pred eeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEE
Q 005944 68 KGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNIL 147 (668)
Q Consensus 68 i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LV 147 (668)
.+++||+|+||+||+|+++.+|+.||||++...... .......+.+.+|+.+|++++|||||++++++..++.+|||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~iv 78 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRS---EAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLV 78 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC---------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhh---hhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeeh
Confidence 568999999999999999999999999998432211 11122335688999999999999999999999999999999
Q ss_pred eeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcC
Q 005944 148 LEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATING 227 (668)
Q Consensus 148 mEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~ 227 (668)
||||.++++..++.....+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~--~~~ 156 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRA 156 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC--CCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC--ccc
Confidence 999999998888887888999999999999999999999999999999999999999999999999999865432 223
Q ss_pred CccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCC----------------
Q 005944 228 AKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTK---------------- 288 (668)
Q Consensus 228 ~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~---------------- 288 (668)
....+||+.|+|||++.+. .|+.++|||||||++|+|+||.+||..... ....+.......
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCC
T ss_pred ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhh
Confidence 4457899999999999755 579999999999999999999999975432 222222211000
Q ss_pred --CCCC-----CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 289 --SHPP-----IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 289 --~~~~-----~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
..+. ....+++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred hccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0000 1135688999999999999999999999999999998643
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-54 Score=453.56 Aligned_cols=256 Identities=29% Similarity=0.503 Sum_probs=219.3
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHH-hCCCCCeeeeccccccCC
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLK-NLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~-~L~HpNIV~l~g~~~~~~ 142 (668)
.+|++++.||+|+||+||+|+++.+|+.||||++.... .........+..|+.++. .++|||||++++++.+++
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~-----~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~ 76 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV-----VLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 76 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHH-----HHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhh-----ccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCC
Confidence 47999999999999999999999999999999984321 111122344556666654 689999999999999999
Q ss_pred cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 143 SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
.+|||||||++|+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 77 ~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~- 155 (320)
T d1xjda_ 77 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 155 (320)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred ceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc-
Confidence 9999999999999999999989999999999999999999999999999999999999999999999999999986432
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCcccCHHH
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSMEA 301 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~el 301 (668)
........+||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+.... +...+.. ..+.+|..+++++
T Consensus 156 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~----~~~~~p~~~s~~~ 230 (320)
T d1xjda_ 156 -GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM----DNPFYPRWLEKEA 230 (320)
T ss_dssp -TTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH----CCCCCCTTSCHHH
T ss_pred -ccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHc----CCCCCCccCCHHH
Confidence 223344578999999999999999999999999999999999999999765432 2222222 2345677899999
Q ss_pred HHHHHHhhhhCCCCCCCHH-HHHcCccccC
Q 005944 302 KDFLLKCLQKEPYLRSTAS-ELLQHPFVTG 330 (668)
Q Consensus 302 ~dLI~kcL~~dP~~RPSa~-EIL~Hpwf~~ 330 (668)
++||.+||++||.+||++. ++++||||++
T Consensus 231 ~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 231 KDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp HHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred HHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 9999999999999999995 8999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-54 Score=455.77 Aligned_cols=258 Identities=26% Similarity=0.366 Sum_probs=218.8
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++++.||+|+||+||+|+++.+|+.||||++.... .....+.+|+++|+.++|||||++++++.+.
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---------~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~ 73 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---------TDQVLVKKEISILNIARHRNILHLHESFESM 73 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---------HHHHHHHHHHHHHHHSCCTTBCCEEEEEEET
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---------ccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 4578999999999999999999999999999999984321 1123477899999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCC--CceEEecCCchhh
Q 005944 142 DSLNILLEFVPGGSISSLLGKFG-SFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNK--GCIKLADFGASKK 218 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~~-~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~--g~vKL~DFGlA~~ 218 (668)
+.+|||||||+||+|.++|...+ .+++.+++.|+.||+.||+|||++||+||||||+||||+.+ +.+||+|||+++.
T Consensus 74 ~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~ 153 (321)
T d1tkia_ 74 EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ 153 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhc
Confidence 99999999999999999997765 79999999999999999999999999999999999999854 4899999999986
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-HHHHHhhccCCCCCCCCccc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-VAALFHIGTTKSHPPIPEHL 297 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~l 297 (668)
... .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||...... ....+...........+..+
T Consensus 154 ~~~---~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (321)
T d1tkia_ 154 LKP---GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEI 230 (321)
T ss_dssp CCT---TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred ccc---CCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCC
Confidence 532 22234567999999999999999999999999999999999999999765432 22222222222222233468
Q ss_pred CHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 298 SMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 298 s~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
++++++||.+||+.||.+|||+.|+|+||||+..
T Consensus 231 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 9999999999999999999999999999999753
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-54 Score=442.77 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=215.5
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC--CCCeeeeccccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT--HPNIVRYLGTAR 139 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~--HpNIV~l~g~~~ 139 (668)
...+|+++++||+|+||+||+|+++.+|+.||||++.......... ......+.+|+.+|++++ |||||++++++.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~--~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~ 79 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGE--LPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 79 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEE--CTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhh--hhHHHHHHHHHHHHHHhccCCCCccEEEEEEe
Confidence 4578999999999999999999999999999999985432211110 011123557999999996 899999999999
Q ss_pred cCCcceEEeeccCC-CChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-CCceEEecCCchh
Q 005944 140 EDDSLNILLEFVPG-GSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN-KGCIKLADFGASK 217 (668)
Q Consensus 140 ~~~~~~LVmEy~~g-GsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~-~g~vKL~DFGlA~ 217 (668)
+.+.+|+||||+.+ +++.+++.+...+++.+++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||+|+
T Consensus 80 ~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 80 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 99999999999976 678888888889999999999999999999999999999999999999985 4799999999997
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCC-CcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcc
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGH-SFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~-s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ 296 (668)
... .....+.+||+.|+|||++.+..+ +.++|||||||+||+|+||+.||..... +.. ....++..
T Consensus 160 ~~~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i~~-----~~~~~~~~ 226 (273)
T d1xwsa_ 160 LLK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----IIR-----GQVFFRQR 226 (273)
T ss_dssp ECC----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HHH-----CCCCCSSC
T ss_pred ecc----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH----Hhh-----cccCCCCC
Confidence 542 223456789999999999988775 6779999999999999999999976432 111 12345678
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+|+++++||.+||+.||.+|||++|||+||||++..
T Consensus 227 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 227 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 999999999999999999999999999999998643
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-53 Score=442.52 Aligned_cols=261 Identities=25% Similarity=0.387 Sum_probs=220.4
Q ss_pred CCCCCCCCCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCC
Q 005944 51 PALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPN 130 (668)
Q Consensus 51 p~~pp~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpN 130 (668)
|..|....+++...+|++.+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+++|+.++|||
T Consensus 4 p~~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---------~~~~~~~~E~~il~~l~Hpn 74 (287)
T d1opja_ 4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---------MEVEEFLKEAAVMKEIKHPN 74 (287)
T ss_dssp TTSTTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---------SCHHHHHHHHHHHHHCCCTT
T ss_pred CCCCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---------chHHHHHHHHHHHHhCCCCC
Confidence 444555667788889999999999999999999999999999999884211 11245789999999999999
Q ss_pred eeeeccccccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCce
Q 005944 131 IVRYLGTAREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCI 208 (668)
Q Consensus 131 IV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~v 208 (668)
||++++++.+.+.+|||||||++|+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+
T Consensus 75 Iv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~ 154 (287)
T d1opja_ 75 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLV 154 (287)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcE
Confidence 999999999999999999999999999998643 678999999999999999999999999999999999999999999
Q ss_pred EEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchh-H-HHHHHHHhhcc
Q 005944 209 KLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ-F-QEVAALFHIGT 286 (668)
Q Consensus 209 KL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~-~-~~~~~~~~~~~ 286 (668)
||+|||+|+...... ........||+.|+|||++.+..|+.++|||||||++|||++|..||... . ..+.... .
T Consensus 155 Kl~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i---~ 230 (287)
T d1opja_ 155 KVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---E 230 (287)
T ss_dssp EECCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---H
T ss_pred EEccccceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHH---h
Confidence 999999998654321 12223345899999999999999999999999999999999976665432 2 2222222 2
Q ss_pred CCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 287 TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 287 ~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.....+.+..+++++.+||.+||+.||.+|||+.+|++
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 33456678889999999999999999999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=438.68 Aligned_cols=257 Identities=26% Similarity=0.449 Sum_probs=206.6
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
+++...+|++++.||+|+||+||+|++. ..||||++...... ....+.+.+|+.+|++++|||||++++++
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~------~~~~~~~~~E~~~l~~l~HpnIv~~~~~~ 73 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPT------PQQLQAFKNEVGVLRKTRHVNILLFMGYS 73 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCC------TTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCC------HHHHHHHHHHHHHHHhCCCCCEeeeeEEE
Confidence 4577889999999999999999999743 36999998543221 22356788999999999999999999987
Q ss_pred ccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
. ...++||||||++|+|.+++... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|+
T Consensus 74 ~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~ 152 (276)
T d1uwha_ 74 T-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLAT 152 (276)
T ss_dssp C-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSC
T ss_pred e-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEcccccee
Confidence 5 45689999999999999998654 669999999999999999999999999999999999999999999999999998
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhc---CCCcchhHHHHHHHHHHHHhCCCCCchhH--HHHHHHHhhcc-CCCCC
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQT---GHSFSADIWSVGCTVIEMATGKPPWSQQF--QEVAALFHIGT-TKSHP 291 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~---~~s~ksDIWSLGvILyeLLTG~~PF~~~~--~~~~~~~~~~~-~~~~~ 291 (668)
...............||+.|||||++.+. .|+.++|||||||+||||+||+.||.... ..+........ .....
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 232 (276)
T d1uwha_ 153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLS 232 (276)
T ss_dssp C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGG
T ss_pred eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcch
Confidence 76554444445667899999999999753 47899999999999999999999997533 22222222211 11222
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.++..+++++.+||.+||+.||.+|||+.||++|
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 4566789999999999999999999999999987
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-52 Score=432.37 Aligned_cols=261 Identities=30% Similarity=0.511 Sum_probs=210.7
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|+++.+|+.||||++.... ..+.....+.+|+++|++++|||||++++++.+.+.
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~------~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~ 75 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT------ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK 75 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh------cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence 47999999999999999999999999999999984321 112234567889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhh
Q 005944 144 LNILLEFVPGGSISSLLG-KFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVEL 222 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~-~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~ 222 (668)
+|+|||||.++.+..+.. ....+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+....
T Consensus 76 ~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~- 154 (298)
T d1gz8a_ 76 LYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV- 154 (298)
T ss_dssp EEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC-
T ss_pred eeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC-
Confidence 999999997755544433 346799999999999999999999999999999999999999999999999999986532
Q ss_pred hhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCCC----------
Q 005944 223 ATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTKS---------- 289 (668)
Q Consensus 223 ~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~~---------- 289 (668)
........+||+.|+|||++.... ++.++|||||||++|+|++|+.||..... ....+........
T Consensus 155 -~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 155 -PVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp -CSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred -CcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccc
Confidence 223344568999999999988766 47899999999999999999999975432 1122211100000
Q ss_pred ---CCC-----------CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 290 ---HPP-----------IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 290 ---~~~-----------~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
... ....++.++++||.+||+.||.+|||+.|||+||||++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 000 0125678999999999999999999999999999998653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=452.35 Aligned_cols=256 Identities=27% Similarity=0.407 Sum_probs=209.2
Q ss_pred CCCCeeee-eEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHh-CCCCCeeeeccccc
Q 005944 62 PPIRWRKG-ELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKN-LTHPNIVRYLGTAR 139 (668)
Q Consensus 62 ~~~ry~i~-~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~-L~HpNIV~l~g~~~ 139 (668)
...+|++. ++||+|+||+||+|++..+++.||||++... ..+.+|+.++.+ ++|||||+++++|.
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------------~~~~~E~~~~~~~~~hpnIv~l~~~~~ 75 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------------PKARREVELHWRASQCPHIVRIVDVYE 75 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------------HHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------------HHHHHHHHHHHHhcCCCCCCeEEEEEe
Confidence 34579886 5699999999999999999999999998311 235678888655 58999999999986
Q ss_pred c----CCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC---CCceEE
Q 005944 140 E----DDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---KGCIKL 210 (668)
Q Consensus 140 ~----~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---~g~vKL 210 (668)
+ +..+|||||||+||+|.++|.+. ..+++.+++.|+.||+.||+|||++||+||||||+|||++. .+.+||
T Consensus 76 ~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl 155 (335)
T d2ozaa1 76 NLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKL 155 (335)
T ss_dssp EEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEE
T ss_pred ecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccc
Confidence 5 46789999999999999999764 46999999999999999999999999999999999999985 567999
Q ss_pred ecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH-HHH-HHHh-h--c
Q 005944 211 ADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVA-ALFH-I--G 285 (668)
Q Consensus 211 ~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~-~~~~-~--~ 285 (668)
+|||+|+.... .......+||+.|||||++.+..|+.++|||||||+||+|+||++||.+... ... .+.. + .
T Consensus 156 ~DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~ 232 (335)
T d2ozaa1 156 TDFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 232 (335)
T ss_dssp CCCTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC
T ss_pred cccceeeeccC---CCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC
Confidence 99999986543 2334567899999999999999999999999999999999999999975421 111 1111 1 1
Q ss_pred cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 286 TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 286 ~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
......+.+..+++++++||.+||+.||.+|||+.|||+||||+....
T Consensus 233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 111111223468999999999999999999999999999999976443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-53 Score=445.70 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=215.5
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCc-----EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGE-----LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIV 132 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~-----~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV 132 (668)
+++...+|+++++||+|+||+||+|++..+++ .||||++... ........+.+|+.+|.++ +|||||
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~~HpnIv 104 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-------ADSSEREALMSELKMMTQLGSHENIV 104 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------------CHHHHHHHHHHHHHCCCTTBC
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc-------cCHHHHHHHHHHHHHHHHhcCCCcEe
Confidence 45667899999999999999999999876543 6999987422 1223345678899999998 899999
Q ss_pred eeccccccCCcceEEeeccCCCChhcccccC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005944 133 RYLGTAREDDSLNILLEFVPGGSISSLLGKF-----------------------GSFPESVIRMYTKQLLLGLEYLHKNG 189 (668)
Q Consensus 133 ~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~-----------------------~~l~e~~~~~i~~QIl~aL~yLHs~g 189 (668)
++++++.+.+.+|||||||++|+|.++|... ..+++..++.|+.||+.||+|||++|
T Consensus 105 ~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~ 184 (325)
T d1rjba_ 105 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS 184 (325)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 9999999999999999999999999998654 24889999999999999999999999
Q ss_pred cccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CC
Q 005944 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GK 268 (668)
Q Consensus 190 IvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~ 268 (668)
||||||||+|||++.++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |.
T Consensus 185 IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCC
Confidence 99999999999999999999999999987655443333345678999999999999999999999999999999998 89
Q ss_pred CCCchhH--HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 269 PPWSQQF--QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 269 ~PF~~~~--~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+||.+.. .....+.. .....+.|..+++++++||.+||+.||.+|||++||++|
T Consensus 265 ~Pf~~~~~~~~~~~~~~---~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 265 NPYPGIPVDANFYKLIQ---NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CSSTTCCCSHHHHHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHh---cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9997532 22222222 234556778899999999999999999999999999976
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-52 Score=430.65 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=213.5
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
.+++...+|++.+.||+|+||+||+|++. ++..||||++.... ...+.+.+|+.+|++++|||||+++++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~---------~~~~~~~~E~~~l~~l~HpnIv~~~g~ 76 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS---------MSPDAFLAEANLMKQLQHQRLVRLYAV 76 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS---------SCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc---------CCHHHHHHHHHHHHhCCCCCEeEEEee
Confidence 34567789999999999999999999975 67899999984221 112457899999999999999999998
Q ss_pred cccCCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
+.. +.+|||||||++|+|.+++... ..+++..+..|+.||+.||.|||++||+||||||+||||+.++.+||+|||+
T Consensus 77 ~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGl 155 (272)
T d1qpca_ 77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGL 155 (272)
T ss_dssp ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred ecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccc
Confidence 754 5679999999999999977554 3599999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCC-CCchhHH-HHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKP-PWSQQFQ-EVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~-PF~~~~~-~~~~~~~~~~~~~~~~~ 293 (668)
|+.+... .........||+.|||||++.+..++.++|||||||+||||+||.. ||..... +....+ ........
T Consensus 156 a~~~~~~-~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i---~~~~~~~~ 231 (272)
T d1qpca_ 156 ARLIEDN-EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL---ERGYRMVR 231 (272)
T ss_dssp CEECSSS-CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HTTCCCCC
T ss_pred eEEccCC-ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHH---HhcCCCCC
Confidence 9876432 2223345679999999999999999999999999999999999654 4543322 222222 22344566
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHc--Ccccc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQ--HPFVT 329 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~--Hpwf~ 329 (668)
+..++.++.+||.+||+.||.+|||+.+|++ |+||+
T Consensus 232 p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 7889999999999999999999999999998 78885
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=6.7e-52 Score=433.32 Aligned_cols=255 Identities=24% Similarity=0.415 Sum_probs=203.1
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCc---EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGE---LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~---~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
+...+|++.++||+|+||+||+|++..++. .||||++... ......+.+.+|+.+|++++|||||+++++
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~ 95 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-------YTEKQRRDFLSEASIMGQFDHPNVIHLEGV 95 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-------CCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-------cCHHHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence 456789999999999999999999987664 5888876321 122344668899999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+...+.+|+|||||++|+|.+++... +.+++.++..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+|
T Consensus 96 ~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla 175 (299)
T d1jpaa_ 96 VTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175 (299)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---
T ss_pred EeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccc
Confidence 99999999999999999999988764 57999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhhhc---CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCC
Q 005944 217 KKVVELATIN---GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHP 291 (668)
Q Consensus 217 ~~~~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~ 291 (668)
+.+....... ......||+.|||||++.+..|+.++|||||||+||||+| |++||..... ++...+. .....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~---~~~~~ 252 (299)
T d1jpaa_ 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE---QDYRL 252 (299)
T ss_dssp --------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH---TTCCC
T ss_pred eEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCC
Confidence 8765433221 1223568999999999999999999999999999999998 8999976443 2222222 23445
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+.+..++.++.+||.+||+.||.+|||+.||+++
T Consensus 253 ~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 253 PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 6677899999999999999999999999999875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=427.96 Aligned_cols=260 Identities=30% Similarity=0.487 Sum_probs=207.1
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCC-CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC---CCCCeeeecccc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDS-GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL---THPNIVRYLGTA 138 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~t-g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L---~HpNIV~l~g~~ 138 (668)
..+|++++.||+|+||+||+|++..+ ++.||||++.......... ..+.+|+.+|+.| +|||||++++++
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~------~~~~~E~~~l~~l~~~~HpnIv~~~~~~ 79 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP------LSTIREVAVLRHLETFEHPNVVRLFDVC 79 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCB------CTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHH------HHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence 36899999999999999999999765 6789999986543221111 1234566665554 899999999988
Q ss_pred c-----cCCcceEEeeccCCCChhccc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEec
Q 005944 139 R-----EDDSLNILLEFVPGGSISSLL-GKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLAD 212 (668)
Q Consensus 139 ~-----~~~~~~LVmEy~~gGsL~~~L-~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~D 212 (668)
. ....++++||||.++.+.... .....+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|
T Consensus 80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 80 TVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp EEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECS
T ss_pred cccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecc
Confidence 4 335689999999988775443 3446799999999999999999999999999999999999999999999999
Q ss_pred CCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccC---
Q 005944 213 FGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTT--- 287 (668)
Q Consensus 213 FGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~--- 287 (668)
||+++..... ......+||+.|+|||++.+..|+.++|||||||++|||+||++||..... ....+......
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred hhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCch
Confidence 9998765332 234567899999999999999999999999999999999999999975432 12222211000
Q ss_pred -------------------CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 288 -------------------KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 288 -------------------~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.....++..+++++++||.+||++||.+|||+.|+|+||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 00112345688999999999999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.2e-51 Score=426.34 Aligned_cols=258 Identities=28% Similarity=0.442 Sum_probs=210.8
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|+++ +|+.||||++..... .+.....+.+|+.+|+.++|||||++++++...+.
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 74 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE------DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR 74 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG------GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc------ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence 58999999999999999999985 789999999854321 11223567889999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.+++|||+.++.+..+....+.+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 75 ~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~- 153 (286)
T d1ob3a_ 75 LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153 (286)
T ss_dssp EEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred eeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC-
Confidence 9999999999888888888889999999999999999999999999999999999999999999999999999865332
Q ss_pred hhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhccCC------------
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIGTTK------------ 288 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~~~~------------ 288 (668)
........|++.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ....+.......
T Consensus 154 -~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 154 -VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred -ccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhh
Confidence 22234457999999999997654 68999999999999999999999975422 112211110000
Q ss_pred ------------CCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccC
Q 005944 289 ------------SHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTG 330 (668)
Q Consensus 289 ------------~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~ 330 (668)
........+++++.+||.+||++||++|||+.|+|+||||+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 001123467899999999999999999999999999999973
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.5e-52 Score=427.19 Aligned_cols=264 Identities=24% Similarity=0.409 Sum_probs=209.6
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE 140 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~ 140 (668)
....+|++.+.||+|+||+||+|++..+|+.||||++.... .........+.+|+++|+.++|||||++++++..
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~ 78 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADL-----ARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 78 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-----TTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhh-----ccCHHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence 34678999999999999999999999999999999984321 2233455678999999999999999999999876
Q ss_pred CCc----ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 141 DDS----LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 141 ~~~----~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
.+. +|||||||+||+|..++...+.+++.+++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||++
T Consensus 79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 79 ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp ECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred ccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhh
Confidence 543 7899999999999999988899999999999999999999999999999999999999999999999999988
Q ss_pred hhhHhh-hhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhh-ccCCCCCCCC
Q 005944 217 KKVVEL-ATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHI-GTTKSHPPIP 294 (668)
Q Consensus 217 ~~~~~~-~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~-~~~~~~~~~p 294 (668)
...... .........+||+.|+|||++.+..|+.++|||||||++|+|+||++||............. .........+
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 238 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTS
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhc
Confidence 654322 12223456789999999999999999999999999999999999999997654322211111 1112222345
Q ss_pred cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCcccc
Q 005944 295 EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVT 329 (668)
Q Consensus 295 ~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~ 329 (668)
..+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus 239 ~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp SSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred cCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 67899999999999999999999444444577753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-52 Score=431.19 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=206.2
Q ss_pred eEEcccCceEEEEEEEcC--CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCcceEE
Q 005944 70 ELVGCGAFGRVYMGMNLD--SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDSLNIL 147 (668)
Q Consensus 70 ~~LG~G~fG~Vy~a~~~~--tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~~~LV 147 (668)
+.||+|+||+||+|.+.. +++.||||++.... ......+.+.+|+++|++++|||||++++++.. +..+||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~------~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lv 85 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA------NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV 85 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh------CCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEE
Confidence 479999999999998643 56789999984221 122344678899999999999999999999865 567899
Q ss_pred eeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhhh-hc
Q 005944 148 LEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELAT-IN 226 (668)
Q Consensus 148 mEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~-~~ 226 (668)
||||++|+|.+++.+...+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||+++.+..... ..
T Consensus 86 mE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred EEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999999999999889999999999999999999999999999999999999999999999999999986543222 22
Q ss_pred CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHHHH
Q 005944 227 GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDF 304 (668)
Q Consensus 227 ~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dL 304 (668)
......||+.|||||++.+..++.++|||||||++|||+| |++||..... ++...+. .....+.|..++.++.+|
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~---~~~~~~~p~~~~~~~~~l 242 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---KGERMGCPAGCPREMYDL 242 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCCCCCTTCCHHHHHH
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH---cCCCCCCCcccCHHHHHH
Confidence 2334679999999999999999999999999999999998 8999976433 2222222 234556778899999999
Q ss_pred HHHhhhhCCCCCCCHHHH---HcCccc
Q 005944 305 LLKCLQKEPYLRSTASEL---LQHPFV 328 (668)
Q Consensus 305 I~kcL~~dP~~RPSa~EI---L~Hpwf 328 (668)
|.+||+.||.+|||+.+| |+|+|+
T Consensus 243 i~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 243 MNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 999999999999999998 466665
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-51 Score=422.74 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=200.9
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
.+.+|++.+.||+|+||+||+|++. ++..||||++..... ..+.+.+|+++|+.++|||||++++++...
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~---------~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~ 72 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM---------SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS---------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC---------cHHHHHHHHHHHHhcCCCCcccccceeccC
Confidence 3568999999999999999999975 577899999843211 113578899999999999999999999999
Q ss_pred CcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhH
Q 005944 142 DSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVV 220 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~ 220 (668)
+.++||||||++|+|.+++... ..+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||+++.+.
T Consensus 73 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 152 (263)
T d1sm2a_ 73 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL 152 (263)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------
T ss_pred CceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheecc
Confidence 9999999999999999988654 568999999999999999999999999999999999999999999999999998765
Q ss_pred hhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCCCcccC
Q 005944 221 ELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPIPEHLS 298 (668)
Q Consensus 221 ~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls 298 (668)
.... .......||+.|+|||++.+..|+.++|||||||+||||+| |.+||..... ++...+.. ......|..++
T Consensus 153 ~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~---~~~~~~p~~~~ 228 (263)
T d1sm2a_ 153 DDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST---GFRLYKPRLAS 228 (263)
T ss_dssp -------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHH---TCCCCCCTTSC
T ss_pred CCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHh---cCCCCCccccC
Confidence 4322 22334679999999999999999999999999999999999 5666654322 22222222 23445677889
Q ss_pred HHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 299 MEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 299 ~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+++.+||.+||+.||.+|||++||++|
T Consensus 229 ~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 229 THVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 999999999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-51 Score=428.89 Aligned_cols=263 Identities=27% Similarity=0.411 Sum_probs=209.8
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc--
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE-- 140 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~-- 140 (668)
-.+|++.+.||+|+||+||+|++..+|+.||||++..... .+.....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~ 82 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE------KEGFPITALREIKILQLLKHENVVNLIEICRTKA 82 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C------TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc------chHHHHHHHHHHHHHHHhcCCCccceEeeeeccc
Confidence 4789999999999999999999999999999999843321 12233457789999999999999999998754
Q ss_pred ------CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 141 ------DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 141 ------~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
...+|+|||||.++.+..+......+++..++.+++||+.||.|||++||+||||||+||||+.++.+||+|||
T Consensus 83 ~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 83 SPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCT
T ss_pred ccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecc
Confidence 34689999999988888777777889999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhh--hhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHHH--HHHHhhccCCC
Q 005944 215 ASKKVVELA--TINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQEV--AALFHIGTTKS 289 (668)
Q Consensus 215 lA~~~~~~~--~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~--~~~~~~~~~~~ 289 (668)
+++.+.... ........+||+.|+|||++.+. .|+.++|||||||++|+|++|++||....... ..+........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 997654322 22334456899999999999865 58999999999999999999999997543221 11111111000
Q ss_pred CC---CC---------------C---------cccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 290 HP---PI---------------P---------EHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 290 ~~---~~---------------p---------~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.. .. . ...++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 00 00 0 1136788999999999999999999999999999854
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=427.42 Aligned_cols=258 Identities=24% Similarity=0.398 Sum_probs=214.4
Q ss_pred CCCCCeeeeeE-EcccCceEEEEEEEcC--CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 61 APPIRWRKGEL-VGCGAFGRVYMGMNLD--SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~~-LG~G~fG~Vy~a~~~~--tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
+...+|.+.++ ||+|+||+||+|+++. ++..||||++... ......+.+.+|+++|++++|||||+++++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~-------~~~~~~~~~~~E~~il~~l~HpnIv~l~g~ 77 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-------TEKADTEEMMREAQIMHQLDNPYIVRLIGV 77 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS-------CCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh-------cCHHHHHHHHHHHHHHHhCCCCCEeeEeee
Confidence 34467888886 9999999999998754 4568999998432 122345678899999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCch
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGAS 216 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA 216 (668)
+.. +.+|||||||++|+|.+++.. ...+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+|
T Consensus 78 ~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla 156 (285)
T d1u59a_ 78 CQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 156 (285)
T ss_dssp EES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTC
T ss_pred ecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhh
Confidence 865 568999999999999998754 467999999999999999999999999999999999999999999999999999
Q ss_pred hhhHhhhh-hcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH-HHHHHHHhhccCCCCCCC
Q 005944 217 KKVVELAT-INGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 217 ~~~~~~~~-~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~-~~~~~~~~~~~~~~~~~~ 293 (668)
+.+..... .......+||+.|+|||++.+..++.++|||||||++|||+| |+.||.... .++...+. ....++.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~---~~~~~~~ 233 (285)
T d1u59a_ 157 KALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE---QGKRMEC 233 (285)
T ss_dssp EECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH---TTCCCCC
T ss_pred hcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---cCCCCCC
Confidence 87644322 222345679999999999999999999999999999999998 999997543 22222222 2334567
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHH---HcCcccc
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASEL---LQHPFVT 329 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EI---L~Hpwf~ 329 (668)
|..+++++.+||.+||+.||++|||+.+| |+|+|+.
T Consensus 234 p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 234 PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 78899999999999999999999999988 6678764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-51 Score=419.18 Aligned_cols=260 Identities=28% Similarity=0.459 Sum_probs=217.3
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCCc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDDS 143 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~~ 143 (668)
.+|++.+.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+|+.++|||||++++++.....
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~------~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 75 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD------DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK 75 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS------STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC------ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence 489999999999999999999999999999999854321 12345678899999999999999999999999999
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHhhh
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVELA 223 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~ 223 (668)
.++|++++.+++|..++...+.+++..++.++.|++.||+|||++|||||||||+||||+.++.+||+|||+++.....
T Consensus 76 ~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~- 154 (292)
T d1unla_ 76 LTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154 (292)
T ss_dssp EEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSC-
T ss_pred eeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCC-
Confidence 9999999999999999988899999999999999999999999999999999999999999999999999999865332
Q ss_pred hhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhH---HHHHHHHhhcc-------------
Q 005944 224 TINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQF---QEVAALFHIGT------------- 286 (668)
Q Consensus 224 ~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~---~~~~~~~~~~~------------- 286 (668)
........+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.... .....+.....
T Consensus 155 -~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 155 -VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp -CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred -CccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhc
Confidence 22233456889999999998765 6899999999999999999999974221 11111111100
Q ss_pred -----------CCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 287 -----------TKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 287 -----------~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
..........+++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 011112334678899999999999999999999999999999853
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=418.11 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=205.2
Q ss_pred CCCCCCeeeeeEEcccCceEEEEEEEcCCC----cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 60 DAPPIRWRKGELVGCGAFGRVYMGMNLDSG----ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 60 ~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg----~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
++.+..|++.++||+|+||+||+|.+..++ ..||||++.... .......+.+|+.+|+.++|||||+++
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-------~~~~~~~~~~E~~il~~l~H~nIv~~~ 75 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-------TEKQRVDFLGEAGIMGQFSHHNIIRLE 75 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-------ChHHHHHHHHHHHHHHhcCCCCEeeee
Confidence 566788999999999999999999987654 479999884221 223345688999999999999999999
Q ss_pred cccccCCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 136 GTAREDDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 136 g~~~~~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
+++.+....++|||||.+|+|.+++... ..+++.++..++.||+.||+|||+++|+||||||+||||+.++.+||+|||
T Consensus 76 g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFG 155 (283)
T d1mqba_ 76 GVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFG 155 (283)
T ss_dssp EEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred EEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccc
Confidence 9999999999999999999999877654 679999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhc-CCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCch-hH-HHHHHHHhhccCCCCC
Q 005944 215 ASKKVVELATIN-GAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQ-QF-QEVAALFHIGTTKSHP 291 (668)
Q Consensus 215 lA~~~~~~~~~~-~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~-~~-~~~~~~~~~~~~~~~~ 291 (668)
+++.+....... ......||+.|||||++.+..++.++|||||||+||||++|..||.. .. .++...+ ......
T Consensus 156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i---~~~~~~ 232 (283)
T d1mqba_ 156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI---NDGFRL 232 (283)
T ss_dssp C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HTTCCC
T ss_pred hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHH---hccCCC
Confidence 998765432221 22345689999999999999999999999999999999996555533 22 2222222 233455
Q ss_pred CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 292 PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 292 ~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+.+..++.++.+||.+||+.||.+|||+.||++
T Consensus 233 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 233 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 677889999999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=429.30 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=207.0
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++.+.||+|+||+||+|+++.+|+.||||++... .......+.+.+|+++|+.++|||||+++++|...
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~------~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~ 89 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD 89 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSST------TSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchh------hcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence 567999999999999999999999999999999998422 12234456788999999999999999999998765
Q ss_pred C------cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 142 D------SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 142 ~------~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
+ .+||||||| +.+|..++. .+.+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 90 ETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp SSTTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence 4 479999999 557776664 46899999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHHHH--HHHHhhc-------
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQEV--AALFHIG------- 285 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~--~~~~~~~------- 285 (668)
|+... ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||....... .......
T Consensus 168 a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 168 ARQAD-----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242 (346)
T ss_dssp CEECC-----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred eeccC-----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence 98643 234567899999999999875 46899999999999999999999996532111 1111000
Q ss_pred -------------------cCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 286 -------------------TTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 286 -------------------~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
...........+++++.+||.+||..||.+|||+.|||+||||+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00111123456789999999999999999999999999999998644
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-51 Score=416.87 Aligned_cols=249 Identities=25% Similarity=0.388 Sum_probs=213.7
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD 142 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~ 142 (668)
+.+|++.+.||+|+||+||+|+++ ++..||||++..... ..+.+.+|+.+++.++|||||++++++.+++
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~---------~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~ 72 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM---------SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQR 72 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS---------CHHHHHHHHHHHHTCCCTTBCCEEEEECCSS
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC---------CHHHHHHHHHHHHhcCCCceeeEEEEEeeCC
Confidence 468999999999999999999974 788999999853211 1235789999999999999999999999999
Q ss_pred cceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
.+++||||+++|+|..++.. ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+..
T Consensus 73 ~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~ 152 (258)
T d1k2pa_ 73 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 152 (258)
T ss_dssp SEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred ceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccC
Confidence 99999999999999998644 46799999999999999999999999999999999999999999999999999986543
Q ss_pred hhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHH-HHHHHhhccCCCCCCCCcccCH
Q 005944 222 LATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQE-VAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 222 ~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~-~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.. ........||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +...+. .......|..++.
T Consensus 153 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~---~~~~~~~p~~~~~ 228 (258)
T d1k2pa_ 153 DE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---QGLRLYRPHLASE 228 (258)
T ss_dssp SS-CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH---TTCCCCCCTTCCH
T ss_pred CC-ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH---hCCCCCCcccccH
Confidence 22 223345679999999999999999999999999999999998 89999865433 222222 2334567788999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
++.+||.+||+.||.+|||+++|++|
T Consensus 229 ~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 229 KVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999999999999999999999987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-51 Score=418.18 Aligned_cols=255 Identities=25% Similarity=0.425 Sum_probs=202.8
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCC---CcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDS---GELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~t---g~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
+++...+|++++.||+|+||+||+|++..+ +..||||++.. .........+.+|+.+|++++|||||+++
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~-------~~~~~~~~~~~~E~~~l~~l~HpnIv~l~ 74 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKN-------CTSDSVREKFLQEALTMRQFDHPHIVKLI 74 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTT-------TTSHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecc-------ccCHHHHHHHHHHHHHHHhCCCCCEeeEE
Confidence 356678999999999999999999998764 35688887632 12234456788999999999999999999
Q ss_pred cccccCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCC
Q 005944 136 GTAREDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFG 214 (668)
Q Consensus 136 g~~~~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFG 214 (668)
+++. ++.+|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 75 ~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 75 GVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp EEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--
T ss_pred EEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccch
Confidence 9986 5678999999999999998654 4579999999999999999999999999999999999999999999999999
Q ss_pred chhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCC
Q 005944 215 ASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPP 292 (668)
Q Consensus 215 lA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~ 292 (668)
+|+.+.... ........||+.|+|||++.+..|+.++|||||||+||||+| |.+||..... ++...+. .....+
T Consensus 154 ~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~---~~~~~~ 229 (273)
T d1mp8a_ 154 LSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE---NGERLP 229 (273)
T ss_dssp ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTCCCC
T ss_pred hheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH---cCCCCC
Confidence 998764322 223345678999999999999999999999999999999998 8999975432 2222222 233456
Q ss_pred CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 293 IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 293 ~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
++..+++++.+||.+||+.||.+|||+.||++|
T Consensus 230 ~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 230 MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 788999999999999999999999999999976
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-50 Score=428.50 Aligned_cols=255 Identities=29% Similarity=0.465 Sum_probs=204.8
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc--
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE-- 140 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~-- 140 (668)
..+|+..++||+|+||+||+|++..+|+.||||++..... ...+|+.+|++++|||||+++++|..
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------------~~~~Ei~il~~l~h~niv~~~~~~~~~~ 86 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------------FKNRELQIMRKLDHCNIVRLRYFFYSSG 86 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------------SCCHHHHHHHHCCCTTBCCEEEEEEEC-
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------------HHHHHHHHHHhcCCCCCCcEEEEEEecC
Confidence 4579999999999999999999999999999999853211 12369999999999999999998743
Q ss_pred ----CCcceEEeeccCCCChhcc---cccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC-ceEEec
Q 005944 141 ----DDSLNILLEFVPGGSISSL---LGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-CIKLAD 212 (668)
Q Consensus 141 ----~~~~~LVmEy~~gGsL~~~---L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-~vKL~D 212 (668)
...+|||||||+++.+..+ ......+++..++.|++||+.||+|||++||+||||||+||||+.++ .+||+|
T Consensus 87 ~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~D 166 (350)
T d1q5ka_ 87 EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCD 166 (350)
T ss_dssp -CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECC
T ss_pred ccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEec
Confidence 3347899999987654433 23456799999999999999999999999999999999999999775 899999
Q ss_pred CCchhhhHhhhhhcCCccCCCCCCCCChHHHhhc-CCCcchhHHHHHHHHHHHHhCCCCCchhHH--HHHHHHhhc----
Q 005944 213 FGASKKVVELATINGAKSMKGTPYWMAPEVILQT-GHSFSADIWSVGCTVIEMATGKPPWSQQFQ--EVAALFHIG---- 285 (668)
Q Consensus 213 FGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~s~ksDIWSLGvILyeLLTG~~PF~~~~~--~~~~~~~~~---- 285 (668)
||+++.+.. .....+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||..... ....+....
T Consensus 167 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~ 243 (350)
T d1q5ka_ 167 FGSAKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243 (350)
T ss_dssp CTTCEECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ccchhhccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCCh
Confidence 999986533 2334567899999999998764 689999999999999999999999964322 111111100
Q ss_pred --------cC---CCC---------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 286 --------TT---KSH---------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 286 --------~~---~~~---------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
.. ... ......+++++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp HHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 00 000 011235789999999999999999999999999999998643
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=419.56 Aligned_cols=259 Identities=24% Similarity=0.371 Sum_probs=208.7
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccc
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGT 137 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~ 137 (668)
.+++...+|++++.||+|+||+||+|++..+ ..||||++..... ..+.+.+|+.+|++++|||||+++++
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~---------~~~~~~~E~~~l~~l~h~nIv~~~g~ 80 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM---------SPEAFLQEAQVMKKLRHEKLVQLYAV 80 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS---------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC---------CHHHHHHHHHHHHhcccCCEeEEEEE
Confidence 3567778999999999999999999998654 6799999842211 12457899999999999999999999
Q ss_pred cccCCcceEEeeccCCCChhccccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGK--FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~--~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
+.+ +.+++|||||++|+|..++.. ...+++.+++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 81 ~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGl 159 (285)
T d1fmka3 81 VSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGL 159 (285)
T ss_dssp ECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred Eec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccch
Confidence 854 568999999999999988764 35799999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCc-hhH-HHHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWS-QQF-QEVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~-~~~-~~~~~~~~~~~~~~~~~~ 293 (668)
|+.+.... ........||+.|+|||++.+..++.++|||||||+||||+||..||. ... .+....+. .....+.
T Consensus 160 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~---~~~~~~~ 235 (285)
T d1fmka3 160 ARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE---RGYRMPC 235 (285)
T ss_dssp TC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---TTCCCCC
T ss_pred hhhccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH---hcCCCCC
Confidence 98764322 222344679999999999999999999999999999999999655553 322 22222222 2334567
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHc--CccccCC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQ--HPFVTGK 331 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~--Hpwf~~~ 331 (668)
+..++.++++||.+||+.||++||++++|++ |+||+..
T Consensus 236 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 236 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 8889999999999999999999999999988 7888653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-51 Score=423.18 Aligned_cols=257 Identities=27% Similarity=0.441 Sum_probs=204.4
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcC-----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIV 132 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV 132 (668)
+++...+|++++.||+|+||+||+|++.. +++.||||++... ......+.+.+|+.++.++ +|+|||
T Consensus 8 wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-------~~~~~~~~~~~e~~~l~~~~~h~~iv 80 (299)
T d1ywna1 8 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-------ATHSEHRALMSELKILIHIGHHLNVV 80 (299)
T ss_dssp HBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----------CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred ccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-------cCcHHHHHHHHHHHHHHhhcCCCeEE
Confidence 34667889999999999999999999754 4578999988421 1222345566777777776 689999
Q ss_pred eecccccc-CCcceEEeeccCCCChhcccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccC
Q 005944 133 RYLGTARE-DDSLNILLEFVPGGSISSLLGKF----------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDI 195 (668)
Q Consensus 133 ~l~g~~~~-~~~~~LVmEy~~gGsL~~~L~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDL 195 (668)
.+++++.. +..+++|||||++|+|.+++... ..+++..++.++.||+.||+|||++|||||||
T Consensus 81 ~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDl 160 (299)
T d1ywna1 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDL 160 (299)
T ss_dssp CEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcC
Confidence 99998765 45689999999999999998543 34889999999999999999999999999999
Q ss_pred CcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhC-CCCCchh
Q 005944 196 KGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATG-KPPWSQQ 274 (668)
Q Consensus 196 KPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG-~~PF~~~ 274 (668)
||+||||+.++.+||+|||+|+..............+||+.|+|||++.+..++.++|||||||++|||+|| .+||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544444444567899999999999999999999999999999999986 5677543
Q ss_pred H--HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 275 F--QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 275 ~--~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
. ........ .......+..+++++.+||.+||+.||.+|||+.||++|
T Consensus 241 ~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 241 KIDEEFCRRLK---EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp CCSHHHHHHHH---HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHh---cCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2 22222222 233456778899999999999999999999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=426.77 Aligned_cols=264 Identities=25% Similarity=0.388 Sum_probs=208.3
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED 141 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~ 141 (668)
...+|++++.||+|+||+||+|+++.+|+.||||++... ......+.+.+|+.+|+.++|||||++++++...
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-------~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~ 78 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF-------EHQTYCQRTLREIKILLRFRHENIIGINDIIRAP 78 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT-------TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCS
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh-------cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeec
Confidence 346899999999999999999999999999999998421 1233445678999999999999999999998655
Q ss_pred C----cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 142 D----SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 142 ~----~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
. ..+++++|+.+|+|.+++.. ..+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||+|+
T Consensus 79 ~~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 79 TIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp STTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred cccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 3 23455566779999999965 579999999999999999999999999999999999999999999999999998
Q ss_pred hhHhhhhh-cCCccCCCCCCCCChHHHhh-cCCCcchhHHHHHHHHHHHHhCCCCCchhHHH--HHHHHhhc--------
Q 005944 218 KVVELATI-NGAKSMKGTPYWMAPEVILQ-TGHSFSADIWSVGCTVIEMATGKPPWSQQFQE--VAALFHIG-------- 285 (668)
Q Consensus 218 ~~~~~~~~-~~~~~~~GT~~Y~APEvl~~-~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~--~~~~~~~~-------- 285 (668)
........ ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||...... ........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence 65443222 22345789999999999855 45789999999999999999999999643211 11110000
Q ss_pred -------------cCCCCC-----CCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 286 -------------TTKSHP-----PIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 286 -------------~~~~~~-----~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
...... .....+++++++||.+||+.||.+|||+.|+|+||||+....
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 000000 123467889999999999999999999999999999986543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=5.5e-50 Score=421.69 Aligned_cols=252 Identities=25% Similarity=0.449 Sum_probs=206.5
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeecccccc-
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTARE- 140 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~- 140 (668)
..+|+++++||+|+||+||+|+++.+|+.||||++... ..+.+.+|+.+|+.+. ||||+++++++..
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~ 102 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----------KKKKIKREIKILENLRGGPNIITLADIVKDP 102 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECT
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----------HHHHHHHHHHHHHhccCCCCCcEEEEEEEec
Confidence 45799999999999999999999999999999998421 1235678999999995 9999999999864
Q ss_pred -CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCC-ceEEecCCchhh
Q 005944 141 -DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKG-CIKLADFGASKK 218 (668)
Q Consensus 141 -~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g-~vKL~DFGlA~~ 218 (668)
...+++|||||.+++|..+. +.+++..++.+++||+.||+|||++|||||||||+||||+.++ .+||+|||+|+.
T Consensus 103 ~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 103 VSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp TTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred CCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeeccccccee
Confidence 45699999999999998775 4699999999999999999999999999999999999998655 699999999986
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHH---HHHHHHhh----------
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQ---EVAALFHI---------- 284 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~---~~~~~~~~---------- 284 (668)
+... ......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ....+...
T Consensus 180 ~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 180 YHPG---QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CCTT---CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred ccCC---CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 5432 2345678999999999998764 79999999999999999999999953211 11111000
Q ss_pred --ccC--------------------CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 285 --GTT--------------------KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 285 --~~~--------------------~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
... .........+++++.+||.+||++||.+|||++|||+||||+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 000 01111234578999999999999999999999999999999853
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-50 Score=423.74 Aligned_cols=252 Identities=25% Similarity=0.446 Sum_probs=204.9
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCc----EEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccc
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGE----LLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAR 139 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~----~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~ 139 (668)
.+|++.++||+|+||+||+|++..+|+ +||||++... ......+.+.+|+.+|++++|||||++++++.
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~-------~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~ 81 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-------TSPKANKEILDEAYVMASVDNPHVCRLLGICL 81 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----------CTHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc-------cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 579999999999999999999988876 4777766321 11223456889999999999999999999997
Q ss_pred cCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 140 EDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 140 ~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
++ ..+++|||+.+|+|.+++.. ...+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||+|+.
T Consensus 82 ~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~ 160 (317)
T d1xkka_ 82 TS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160 (317)
T ss_dssp SS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred cC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeecccccee
Confidence 64 57888999999999887755 46799999999999999999999999999999999999999999999999999987
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhH-HHHHHHHhhccCCCCCCCCcc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQF-QEVAALFHIGTTKSHPPIPEH 296 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~-~~~~~~~~~~~~~~~~~~p~~ 296 (668)
+.............||+.|+|||++.+..|+.++|||||||+||||+| |.+||.... .++...+.. ....+.+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~---~~~~~~p~~ 237 (317)
T d1xkka_ 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPI 237 (317)
T ss_dssp TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH---TCCCCCCTT
T ss_pred cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc---CCCCCCCcc
Confidence 654433333445679999999999999999999999999999999998 899997543 223233322 334567788
Q ss_pred cCHHHHHHHHHhhhhCCCCCCCHHHHHcCc
Q 005944 297 LSMEAKDFLLKCLQKEPYLRSTASELLQHP 326 (668)
Q Consensus 297 ls~el~dLI~kcL~~dP~~RPSa~EIL~Hp 326 (668)
++.++.+||.+||+.||.+|||+.||++|.
T Consensus 238 ~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 238 CTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp BCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 999999999999999999999999999883
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-49 Score=415.98 Aligned_cols=262 Identities=25% Similarity=0.432 Sum_probs=217.1
Q ss_pred CCCCCCCCCCCCeeeeeEEcccCceEEEEEEEcCCC-------cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC
Q 005944 54 PPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNLDSG-------ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126 (668)
Q Consensus 54 pp~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg-------~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 126 (668)
|..+.+++...+|++++.||+|+||.||+|++..++ ..||||++... ........+.+|+.++.++
T Consensus 3 ~~~~~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-------~~~~~~~~~~~e~~~l~~~ 75 (299)
T d1fgka_ 3 PEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-------ATEKDLSDLISEMEMMKMI 75 (299)
T ss_dssp CCCTTTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-------CCHHHHHHHHHHHHHHHHH
T ss_pred CcCCcCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-------cChHHHHHHHHHHHHHHHh
Confidence 444556788899999999999999999999976554 47999988422 1223345678888888888
Q ss_pred -CCCCeeeeccccccCCcceEEeeccCCCChhcccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 005944 127 -THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKF----------------GSFPESVIRMYTKQLLLGLEYLHKNG 189 (668)
Q Consensus 127 -~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~g 189 (668)
+|||||++++++.+++.+++|||||++|+|.++|... ..+++.+++.++.||+.||+|||++|
T Consensus 76 ~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ 155 (299)
T d1fgka_ 76 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 155 (299)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC
Confidence 7999999999999999999999999999999999654 34899999999999999999999999
Q ss_pred cccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CC
Q 005944 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GK 268 (668)
Q Consensus 190 IvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~ 268 (668)
||||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++ |.
T Consensus 156 ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~ 235 (299)
T d1fgka_ 156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235 (299)
T ss_dssp CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred EEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCC
Confidence 99999999999999999999999999998766555555566789999999999999999999999999999999998 79
Q ss_pred CCCchhHHHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 269 PPWSQQFQEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 269 ~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+||........ .........+..+..+++++.+||.+||+.||.+|||+.||++
T Consensus 236 ~p~~~~~~~~~--~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 236 SPYPGVPVEEL--FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CSSTTCCHHHH--HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHH--HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 99975443321 1222234456678889999999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-49 Score=414.55 Aligned_cols=256 Identities=23% Similarity=0.381 Sum_probs=215.2
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeee
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVR 133 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~ 133 (668)
.+.+..+|++.+.||+|+||+||+|+++ .+++.||||++... ........+.+|+.+|+.++||||++
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-------~~~~~~~~~~~E~~il~~l~h~niv~ 80 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-------ASADMQADFQREAALMAEFDNPNIVK 80 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-------CCHHHHHHHHHHHHHHHTCCCTTBCC
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-------cChHHHHHHHHHHHHHHhcCCCCccc
Confidence 3566778999999999999999999975 35689999988421 12234567889999999999999999
Q ss_pred eccccccCCcceEEeeccCCCChhcccccCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 005944 134 YLGTAREDDSLNILLEFVPGGSISSLLGKFG------------------------SFPESVIRMYTKQLLLGLEYLHKNG 189 (668)
Q Consensus 134 l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~------------------------~l~e~~~~~i~~QIl~aL~yLHs~g 189 (668)
+++++......++||||+.+|+|.+++.... .+++..+..|+.||+.||+|||+++
T Consensus 81 ~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 160 (301)
T d1lufa_ 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 160 (301)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC
Confidence 9999999999999999999999999885432 3889999999999999999999999
Q ss_pred cccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCC-
Q 005944 190 IMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGK- 268 (668)
Q Consensus 190 IvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~- 268 (668)
||||||||+||||+.++.+||+|||+|+.+..........+.+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCC
Confidence 9999999999999999999999999998776554444455678999999999999999999999999999999999985
Q ss_pred CCCchhHH-HHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 269 PPWSQQFQ-EVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 269 ~PF~~~~~-~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
+||..... ++...+. ....++.+..+++++.+||.+||+.+|.+|||+.||++
T Consensus 241 ~p~~~~~~~e~~~~v~---~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 241 QPYYGMAHEEVIYYVR---DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CTTTTSCHHHHHHHHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHH---cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 67765433 2222222 23345678889999999999999999999999999965
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=421.29 Aligned_cols=259 Identities=25% Similarity=0.405 Sum_probs=207.3
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccC-
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARED- 141 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~- 141 (668)
+.||++.+.||+|+||+||+|+++.+|+.||||++... .......+.+.+|+.+|+.++|||||++++++...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~ 90 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 90 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCT------TSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECch------hcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecc
Confidence 56899999999999999999999999999999998432 12233445678999999999999999999988533
Q ss_pred ----CcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 142 ----DSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 142 ----~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
...++||+|+.+|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.
T Consensus 91 ~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 91 SLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp STTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----
T ss_pred ccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhc
Confidence 345677788889999999865 579999999999999999999999999999999999999999999999999987
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcC-CCcchhHHHHHHHHHHHHhCCCCCchhHHHH--HHHHhhcc--------
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTG-HSFSADIWSVGCTVIEMATGKPPWSQQFQEV--AALFHIGT-------- 286 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~--~~~~~~~~-------- 286 (668)
.... ...+..||+.|+|||++.+.. ++.++|||||||++|+|++|++||....... ..+.....
T Consensus 170 ~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 170 HTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred ccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 5432 234578999999999987765 6889999999999999999999996432111 11111000
Q ss_pred -------------CCCCCC-----CCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCCCC
Q 005944 287 -------------TKSHPP-----IPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGKYQ 333 (668)
Q Consensus 287 -------------~~~~~~-----~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~~~ 333 (668)
...... ....+++++++||.+||+.||.+|||+.|||+||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 309 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence 000000 12357899999999999999999999999999999986543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-50 Score=423.40 Aligned_cols=263 Identities=30% Similarity=0.504 Sum_probs=217.1
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcC---CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC-CCeeeecccc
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLD---SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH-PNIVRYLGTA 138 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~---tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIV~l~g~~ 138 (668)
-.+|++++.||+|+||+||+|++.. +|+.||||++......... .....+.+|+++|++++| |||+++++++
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~----~~~~~~~~E~~il~~l~h~pnIv~~~~~~ 98 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKA----KTTEHTRTERQVLEHIRQSPFLVTLHYAF 98 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEE----SSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccch----HHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence 3679999999999999999999744 6899999998543221111 112346789999999976 8999999999
Q ss_pred ccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKK 218 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~ 218 (668)
.+...+++||||+.+|+|.+++...+.+++..++.++.||+.||.|||++|||||||||+||||+.+|.+||+|||+++.
T Consensus 99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999986
Q ss_pred hHhhhhhcCCccCCCCCCCCChHHHhhcC--CCcchhHHHHHHHHHHHHhCCCCCchhHH-HHHHHHhhccCCCCCCCCc
Q 005944 219 VVELATINGAKSMKGTPYWMAPEVILQTG--HSFSADIWSVGCTVIEMATGKPPWSQQFQ-EVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 219 ~~~~~~~~~~~~~~GT~~Y~APEvl~~~~--~s~ksDIWSLGvILyeLLTG~~PF~~~~~-~~~~~~~~~~~~~~~~~p~ 295 (668)
+..... ....+..|++.|+|||.+.+.. ++.++|||||||+||+|+||+.||..... .....+.........+++.
T Consensus 179 ~~~~~~-~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~ 257 (322)
T d1vzoa_ 179 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257 (322)
T ss_dssp CCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred hccccc-ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence 543322 2244578999999999997654 67899999999999999999999964321 1111111112233456677
Q ss_pred ccCHHHHHHHHHhhhhCCCCCC-----CHHHHHcCccccC
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRS-----TASELLQHPFVTG 330 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RP-----Sa~EIL~Hpwf~~ 330 (668)
.+++++.+||.+||++||.+|| |++|+++||||++
T Consensus 258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 8999999999999999999999 5899999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-49 Score=421.27 Aligned_cols=256 Identities=26% Similarity=0.358 Sum_probs=198.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc---
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE--- 140 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~--- 140 (668)
.+|+++++||+|+||+||+|+++.+|+.||||++.... ........+.+|+.+|+.++|||||+++++|..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~------~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~ 90 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF------QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT------SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCS
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh------cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccc
Confidence 68999999999999999999999999999999984322 223445668899999999999999999999864
Q ss_pred ---CCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 141 ---DDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 141 ---~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
...+|+|||||.++.+..+ . ..+++..++.+++||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~~~~~~~iv~Ey~~~~l~~~~-~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 91 LEEFQDVYLVMELMDANLCQVI-Q--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp TTTCCEEEEEEECCSEEHHHHH-T--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred cccCceeEEEEeccchHHHHhh-h--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhh
Confidence 3678999999987655544 2 468999999999999999999999999999999999999999999999999988
Q ss_pred hhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHH--HHHHhhcc---------
Q 005944 218 KVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEV--AALFHIGT--------- 286 (668)
Q Consensus 218 ~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~--~~~~~~~~--------- 286 (668)
..... ......+||+.|+|||++.+..++.++||||+||++|+|++|++||....... ..+.....
T Consensus 168 ~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccccc---cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHH
Confidence 65432 23456789999999999999999999999999999999999999996432111 11110000
Q ss_pred -----------CCCC-----------------CCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcCccccCC
Q 005944 287 -----------TKSH-----------------PPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQHPFVTGK 331 (668)
Q Consensus 287 -----------~~~~-----------------~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~Hpwf~~~ 331 (668)
.... ...+...+.++.+||.+||..||.+|||++|||+||||+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0000 00012356789999999999999999999999999999864
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-49 Score=415.59 Aligned_cols=263 Identities=26% Similarity=0.406 Sum_probs=220.4
Q ss_pred CCCCCCCCCCCCCCeeeeeEEcccCceEEEEEEEc-----CCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC
Q 005944 52 ALPPIEKTDAPPIRWRKGELVGCGAFGRVYMGMNL-----DSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL 126 (668)
Q Consensus 52 ~~pp~~~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~-----~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L 126 (668)
.+|+...+++...+|+++++||+|+||.||+|++. .+++.||||++.... .......+.+|+.++..+
T Consensus 11 ~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-------~~~~~~~~~~E~~~~~~l 83 (311)
T d1t46a_ 11 QLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-------HLTEREALMSELKVLSYL 83 (311)
T ss_dssp TSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-------CHHHHHHHHHHHHHHHHH
T ss_pred cCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-------CHHHHHHHHHHHHHHHhc
Confidence 34445566788899999999999999999999863 467899999984321 223345688999999999
Q ss_pred -CCCCeeeeccccccCCcceEEeeccCCCChhcccccCC------------------CCCHHHHHHHHHHHHHHHHHHHh
Q 005944 127 -THPNIVRYLGTAREDDSLNILLEFVPGGSISSLLGKFG------------------SFPESVIRMYTKQLLLGLEYLHK 187 (668)
Q Consensus 127 -~HpNIV~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~~------------------~l~e~~~~~i~~QIl~aL~yLHs 187 (668)
+|||||++++++.+.+.+|||||||++|+|.+++.+.. .+++..++.|+.||+.||+|||+
T Consensus 84 ~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~ 163 (311)
T d1t46a_ 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS 163 (311)
T ss_dssp CCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 69999999999999999999999999999999986543 58999999999999999999999
Q ss_pred CCcccccCCcccEEeCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-
Q 005944 188 NGIMHRDIKGANILVDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT- 266 (668)
Q Consensus 188 ~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT- 266 (668)
+|||||||||+|||++.++.+||+|||+++.+............+||+.|+|||++.+..++.++|||||||++|||+|
T Consensus 164 ~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~ 243 (311)
T d1t46a_ 164 KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243 (311)
T ss_dssp TTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhC
Confidence 9999999999999999999999999999987755444344455789999999999999999999999999999999999
Q ss_pred CCCCCchhH--HHHHHHHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 267 GKPPWSQQF--QEVAALFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 267 G~~PF~~~~--~~~~~~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
|.+||.... ..+..+... ...+..+..++.++.+||.+||+.||.+|||+.+|++
T Consensus 244 g~p~~~~~~~~~~~~~~i~~---~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 244 GSSPYPGMPVDSKFYKMIKE---GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TCCSSTTCCSSHHHHHHHHH---TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhc---CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 566664332 222233322 3445567788999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-49 Score=405.54 Aligned_cols=247 Identities=23% Similarity=0.394 Sum_probs=202.8
Q ss_pred CCCCCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 59 TDAPPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 59 ~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
+++...+|++++.||+|+||.||+|++ .|..||||++... ...+.+.+|+++|++++|||||++++++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~----------~~~~~~~~E~~~l~~l~HpnIv~~~g~~ 69 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND----------ATAQAFLAEASVMTQLRHSNLVQLLGVI 69 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCC----------C--HHHHHTHHHHTTCCCTTBCCEEEEE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcH----------HHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence 356677899999999999999999987 5789999998421 1224578999999999999999999988
Q ss_pred cc-CCcceEEeeccCCCChhcccccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 139 RE-DDSLNILLEFVPGGSISSLLGKF--GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 139 ~~-~~~~~LVmEy~~gGsL~~~L~~~--~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
.+ .+.+|+||||+++|+|.++|.+. ..+++..++.|+.||+.||.|||+.+|+||||||+|||++.+|.+||+|||+
T Consensus 70 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~ 149 (262)
T d1byga_ 70 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 149 (262)
T ss_dssp CCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC
T ss_pred EecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeeccccc
Confidence 54 56789999999999999999654 3589999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHH-HHHHHHhhccCCCCCCC
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQ-EVAALFHIGTTKSHPPI 293 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~-~~~~~~~~~~~~~~~~~ 293 (668)
++.... ......+|+.|+|||++.+..++.++|||||||++|||+| |++||..... ++...+ .....+++
T Consensus 150 s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i---~~~~~~~~ 221 (262)
T d1byga_ 150 TKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---EKGYKMDA 221 (262)
T ss_dssp -----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH---TTTCCCCC
T ss_pred ceecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---HcCCCCCC
Confidence 986432 2234578999999999999999999999999999999998 7888865432 222222 23355677
Q ss_pred CcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 294 PEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 294 p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
+..+++++++||.+||..||.+|||+.+|+++
T Consensus 222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 88899999999999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-48 Score=408.69 Aligned_cols=257 Identities=22% Similarity=0.359 Sum_probs=217.4
Q ss_pred CCCCCCCCeeeeeEEcccCceEEEEEEEcC-----CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCee
Q 005944 58 KTDAPPIRWRKGELVGCGAFGRVYMGMNLD-----SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIV 132 (668)
Q Consensus 58 ~~~~~~~ry~i~~~LG~G~fG~Vy~a~~~~-----tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV 132 (668)
.+++...+|++++.||+|+||+||+|++.. +++.||||++... ........+.+|+.+|++++|||||
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-------~~~~~~~~~~~E~~il~~l~h~nIv 86 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-------ASMRERIEFLNEASVMKEFNCHHVV 86 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-------SCHHHHHHHHHHHHHGGGCCCTTBC
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-------cChHHHHHHHHHHHHHHHcCCCCEe
Confidence 356778899999999999999999998753 4679999988421 1222345688999999999999999
Q ss_pred eeccccccCCcceEEeeccCCCChhcccccC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEe
Q 005944 133 RYLGTAREDDSLNILLEFVPGGSISSLLGKF----------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILV 202 (668)
Q Consensus 133 ~l~g~~~~~~~~~LVmEy~~gGsL~~~L~~~----------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILl 202 (668)
++++++..+...++|||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+||||
T Consensus 87 ~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl 166 (308)
T d1p4oa_ 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV 166 (308)
T ss_dssp CEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE
T ss_pred eeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee
Confidence 9999999999999999999999999987542 347889999999999999999999999999999999999
Q ss_pred CCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhC-CCCCchhHHH-HHH
Q 005944 203 DNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATG-KPPWSQQFQE-VAA 280 (668)
Q Consensus 203 d~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG-~~PF~~~~~~-~~~ 280 (668)
+.++++||+|||+|+.+............+||+.|+|||.+.+..++.++|||||||+||||+|| .+||...... ...
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~ 246 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 99999999999999877655444444556799999999999999999999999999999999998 5777654322 222
Q ss_pred HHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 281 LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 281 ~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.+. .....+.+..++..+.+||.+||+.+|.+|||+.+|++
T Consensus 247 ~i~---~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 247 FVM---EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHH---TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHH---hCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 221 23345677889999999999999999999999999998
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=409.92 Aligned_cols=253 Identities=23% Similarity=0.375 Sum_probs=208.3
Q ss_pred CCCCCeeeeeEEcccCceEEEEEEEcCCCcE--EEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhC-CCCCeeeeccc
Q 005944 61 APPIRWRKGELVGCGAFGRVYMGMNLDSGEL--LAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNL-THPNIVRYLGT 137 (668)
Q Consensus 61 ~~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~--VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L-~HpNIV~l~g~ 137 (668)
+...+|++.++||+|+||+||+|+++.+|.. ||||++... ......+.+.+|+++|.++ +|||||+++++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~-------~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~ 79 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-------ASKDDHRDFAGELEVLCKLGHHPNIINLLGA 79 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------------CHHHHHHHHHTTCCCCTTBCCEEEE
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc-------cChHHHHHHHHHHHHHHhccCCCCEeeEEEE
Confidence 3457899999999999999999999988875 566665211 1122345688999999999 79999999999
Q ss_pred cccCCcceEEeeccCCCChhcccccC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEE
Q 005944 138 AREDDSLNILLEFVPGGSISSLLGKF----------------GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANIL 201 (668)
Q Consensus 138 ~~~~~~~~LVmEy~~gGsL~~~L~~~----------------~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNIL 201 (668)
+.+.+.+|+|||||++|+|.++|.+. ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 80 ~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL 159 (309)
T d1fvra_ 80 CEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 159 (309)
T ss_dssp EEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEE
Confidence 99999999999999999999998654 56999999999999999999999999999999999999
Q ss_pred eCCCCceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCC-CCCchhHHHHHH
Q 005944 202 VDNKGCIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGK-PPWSQQFQEVAA 280 (668)
Q Consensus 202 ld~~g~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~-~PF~~~~~~~~~ 280 (668)
++.++.+||+|||+++.... ........||+.|+|||.+.+..|+.++|||||||++|||++|. +||........
T Consensus 160 ~~~~~~~kl~DfG~a~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~- 235 (309)
T d1fvra_ 160 VGENYVAKIADFGLSRGQEV---YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL- 235 (309)
T ss_dssp ECGGGCEEECCTTCEESSCE---ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-
T ss_pred EcCCCceEEccccccccccc---cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH-
Confidence 99999999999999975432 22233567999999999999999999999999999999999965 56765432221
Q ss_pred HHhhccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 281 LFHIGTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 281 ~~~~~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.........++.+..+++++++||.+||+.||++|||+.+|++|
T Consensus 236 -~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 236 -YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -HHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11112234566778899999999999999999999999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-49 Score=404.68 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=202.1
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCC-C--cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDS-G--ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTA 138 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~t-g--~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~ 138 (668)
...+|++.+.||+|+||+||+|++..+ + ..||||++.... .......+.+.+|+.+|++++|||||++++++
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~-----~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~ 80 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDV-----LSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 80 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-------------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhh-----cCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 356799999999999999999986533 3 478999874321 12233456789999999999999999999999
Q ss_pred ccCCcceEEeeccCCCChhccccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 139 REDDSLNILLEFVPGGSISSLLGK-FGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 139 ~~~~~~~LVmEy~~gGsL~~~L~~-~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.+ ..+++|||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++
T Consensus 81 ~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 81 LT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp CS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred ee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhh
Confidence 65 568999999999999987754 3579999999999999999999999999999999999999999999999999998
Q ss_pred hhHhhhhh-cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHh-CCCCCchhHHHHHHHHhhccCCCCCCCCc
Q 005944 218 KVVELATI-NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMAT-GKPPWSQQFQEVAALFHIGTTKSHPPIPE 295 (668)
Q Consensus 218 ~~~~~~~~-~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLT-G~~PF~~~~~~~~~~~~~~~~~~~~~~p~ 295 (668)
.+...... .......||+.|+|||++.+..++.++|||||||++|||+| |..||........ ...+.......+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~-~~~i~~~~~~~~~~~ 238 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-LHKIDKEGERLPRPE 238 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-HHHHHTSCCCCCCCT
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH-HHHHHhCCCCCCCcc
Confidence 76433222 22334568889999999999999999999999999999998 8999976543321 222333344556778
Q ss_pred ccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 296 HLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 296 ~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
.++.++.+||.+||+.||++|||+.+|++
T Consensus 239 ~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 239 DCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 89999999999999999999999999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-47 Score=398.47 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=203.6
Q ss_pred eeeeEEcccCceEEEEEEEcCCC---cEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeecccccc-CC
Q 005944 67 RKGELVGCGAFGRVYMGMNLDSG---ELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTARE-DD 142 (668)
Q Consensus 67 ~i~~~LG~G~fG~Vy~a~~~~tg---~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~-~~ 142 (668)
...++||+|+||+||+|++..++ ..||||++... ........+.+|+++|++++|||||++++++.. +.
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-------~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 102 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-------TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 102 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-------CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-------cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC
Confidence 34689999999999999987653 36899988421 123445678999999999999999999998764 56
Q ss_pred cceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCchhhhHh
Q 005944 143 SLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGASKKVVE 221 (668)
Q Consensus 143 ~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGlA~~~~~ 221 (668)
.+++|||||++|+|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+||||+.++.+||+|||+++.+..
T Consensus 103 ~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~ 182 (311)
T d1r0pa_ 103 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182 (311)
T ss_dssp EEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTT
T ss_pred ceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccc
Confidence 789999999999999988754 4578889999999999999999999999999999999999999999999999987644
Q ss_pred hhhh--cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHHHHHHHhhccCCCCCCCCcccCH
Q 005944 222 LATI--NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQEVAALFHIGTTKSHPPIPEHLSM 299 (668)
Q Consensus 222 ~~~~--~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~~~~~~~~~~~~~~~~~p~~ls~ 299 (668)
.... .......||+.|+|||++.+..++.++|||||||+||||+||..||............+ .....+..|..+++
T Consensus 183 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i-~~g~~~~~p~~~~~ 261 (311)
T d1r0pa_ 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRLLQPEYCPD 261 (311)
T ss_dssp TTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH-HTTCCCCCCTTCCH
T ss_pred cccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCCCCcccCcH
Confidence 3221 12234578999999999999999999999999999999999888876433221111111 12234556778999
Q ss_pred HHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 300 EAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 300 el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
++.+||.+||+.||++||++.||++|
T Consensus 262 ~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 262 PLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999999988
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-46 Score=390.90 Aligned_cols=258 Identities=22% Similarity=0.301 Sum_probs=201.4
Q ss_pred CCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCe-eeeccccccC
Q 005944 63 PIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI-VRYLGTARED 141 (668)
Q Consensus 63 ~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-V~l~g~~~~~ 141 (668)
+.+|++++.||+|+||+||+|++..+|+.||||++..... ...+..|+++++.++|+|+ +.+..++...
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~ 75 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----------HPQLHIESKIYKMMQGGVGIPTIRWCGAEG 75 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----------SCCHHHHHHHHHHSTTSTTCCCEEEEEEET
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----------CHHHHHHHHHHHHccCCCcccEEEEEEecC
Confidence 4579999999999999999999999999999998753211 1235679999999987765 4555666777
Q ss_pred CcceEEeeccCCCChhcc-cccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC---CCceEEecCCchh
Q 005944 142 DSLNILLEFVPGGSISSL-LGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN---KGCIKLADFGASK 217 (668)
Q Consensus 142 ~~~~LVmEy~~gGsL~~~-L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~---~g~vKL~DFGlA~ 217 (668)
+..++||||+.+ +|... ....+.+++..+..++.||+.||+|||++|||||||||+|||++. +..+||+|||+|+
T Consensus 76 ~~~~ivme~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~ 154 (299)
T d1ckia_ 76 DYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154 (299)
T ss_dssp TEEEEEEECCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCE
T ss_pred CEEEEEEEEcCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcce
Confidence 889999999955 55444 445578999999999999999999999999999999999999864 4579999999998
Q ss_pred hhHhhhhh-----cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchhHHH-----HHHHHhhccC
Q 005944 218 KVVELATI-----NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQFQE-----VAALFHIGTT 287 (668)
Q Consensus 218 ~~~~~~~~-----~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~~~~-----~~~~~~~~~~ 287 (668)
.+...... ......+||+.|||||++.+..++.++|||||||++|||+||+.||...... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ckia_ 155 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 234 (299)
T ss_dssp ECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH
T ss_pred eccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC
Confidence 76443221 1234568999999999999999999999999999999999999999643211 1111111001
Q ss_pred CCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHH---HHcCccccCC
Q 005944 288 KSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASE---LLQHPFVTGK 331 (668)
Q Consensus 288 ~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~E---IL~Hpwf~~~ 331 (668)
.........+++++.+||.+||+.+|.+||++.+ +|+|+|.+..
T Consensus 235 ~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~ 281 (299)
T d1ckia_ 235 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG 281 (299)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred CChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence 1112234578899999999999999999999874 5778876543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=7.1e-46 Score=385.70 Aligned_cols=252 Identities=21% Similarity=0.280 Sum_probs=204.4
Q ss_pred CCCCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC-CCeeeecccccc
Q 005944 62 PPIRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH-PNIVRYLGTARE 140 (668)
Q Consensus 62 ~~~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H-pNIV~l~g~~~~ 140 (668)
...+|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|++++..+.| +||+.+++++..
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----------~~~~~~e~~~~~~l~~~~~i~~~~~~~~~ 72 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----------APQLRDEYRTYKLLAGCTGIPNVYYFGQE 72 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----------SCCHHHHHHHHHHTTTCTTCCCEEEEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC----------cHHHHHHHHHHHHhcCCCCCCEEEEEeec
Confidence 46789999999999999999999999999999998743211 1235678889999975 899999999999
Q ss_pred CCcceEEeeccCCCChhcccccC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCC-----CCceEEecCC
Q 005944 141 DDSLNILLEFVPGGSISSLLGKF-GSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDN-----KGCIKLADFG 214 (668)
Q Consensus 141 ~~~~~LVmEy~~gGsL~~~L~~~-~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~-----~g~vKL~DFG 214 (668)
....++||||+ +++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||||+. .+.+||+|||
T Consensus 73 ~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 73 GLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred CCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccc
Confidence 99999999999 68998888665 46999999999999999999999999999999999999964 5789999999
Q ss_pred chhhhHhhhhh-----cCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCCchh-----HHHHHHHHhh
Q 005944 215 ASKKVVELATI-----NGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSQQ-----FQEVAALFHI 284 (668)
Q Consensus 215 lA~~~~~~~~~-----~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF~~~-----~~~~~~~~~~ 284 (668)
+|+.+...... ......+||+.|||||++.+..++.++|||||||++|+|+||..||... ......+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 99876432221 2234568999999999999999999999999999999999999999632 1111111111
Q ss_pred ccCCCCCCCCcccCHHHHHHHHHhhhhCCCCCCCHHHHHc
Q 005944 285 GTTKSHPPIPEHLSMEAKDFLLKCLQKEPYLRSTASELLQ 324 (668)
Q Consensus 285 ~~~~~~~~~p~~ls~el~dLI~kcL~~dP~~RPSa~EIL~ 324 (668)
........+...+++++.+|+..|+..+|++||+++.+.+
T Consensus 232 ~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 232 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1111112234567899999999999999999999887654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-45 Score=385.85 Aligned_cols=248 Identities=25% Similarity=0.303 Sum_probs=193.2
Q ss_pred CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCeeeeccccccCC-
Q 005944 64 IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNIVRYLGTAREDD- 142 (668)
Q Consensus 64 ~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~g~~~~~~- 142 (668)
.+|.+.+.||+|+||+||+|++ +|+.||||++... . .. ....+.|+..+..++|||||++++++...+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~-~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~ 71 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------E-ER--SWFREAEIYQTVMLRHENILGFIAADNKDNG 71 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------G-HH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------c-hh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCC
Confidence 4689999999999999999986 6899999988321 1 11 122335677777889999999999987654
Q ss_pred ---cceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccccCCcccEEeCCCCceEEe
Q 005944 143 ---SLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK--------NGIMHRDIKGANILVDNKGCIKLA 211 (668)
Q Consensus 143 ---~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs--------~gIvHrDLKPeNILld~~g~vKL~ 211 (668)
.+|+|||||++|+|.++|++ ..+++..+..++.|++.||.|||. +|||||||||+||||+.++.+||+
T Consensus 72 ~~~~~~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~ 150 (303)
T d1vjya_ 72 TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 150 (303)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred cceEEEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEE
Confidence 57899999999999999976 479999999999999999999996 599999999999999999999999
Q ss_pred cCCchhhhHhhhhh--cCCccCCCCCCCCChHHHhhcC------CCcchhHHHHHHHHHHHHhCCCCCch----------
Q 005944 212 DFGASKKVVELATI--NGAKSMKGTPYWMAPEVILQTG------HSFSADIWSVGCTVIEMATGKPPWSQ---------- 273 (668)
Q Consensus 212 DFGlA~~~~~~~~~--~~~~~~~GT~~Y~APEvl~~~~------~s~ksDIWSLGvILyeLLTG~~PF~~---------- 273 (668)
|||+++.+...... ......+||+.|+|||++.+.. ++.++|||||||+||||+||..||..
T Consensus 151 DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~ 230 (303)
T d1vjya_ 151 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230 (303)
T ss_dssp CCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTT
T ss_pred ecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhh
Confidence 99999876433221 1234578999999999987643 56789999999999999999887732
Q ss_pred ------hHHHHHHHHhhccCCCCCCCCcc-----cCHHHHHHHHHhhhhCCCCCCCHHHHHcC
Q 005944 274 ------QFQEVAALFHIGTTKSHPPIPEH-----LSMEAKDFLLKCLQKEPYLRSTASELLQH 325 (668)
Q Consensus 274 ------~~~~~~~~~~~~~~~~~~~~p~~-----ls~el~dLI~kcL~~dP~~RPSa~EIL~H 325 (668)
.......... .....+.++.. ....+.+|+.+||+.||.+|||+.||+++
T Consensus 231 ~~~~~~~~~~~~~~~~--~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 231 LVPSDPSVEEMRKVVC--EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TSCSSCCHHHHHHHHT--TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cccccchHHHHHHHHh--ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1122222221 12223333332 23468899999999999999999999863
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-43 Score=375.91 Aligned_cols=263 Identities=26% Similarity=0.413 Sum_probs=199.9
Q ss_pred CCCCCCCC-CCeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-------
Q 005944 56 IEKTDAPP-IRWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT------- 127 (668)
Q Consensus 56 ~~~~~~~~-~ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~------- 127 (668)
+..++... .||+++++||+|+||+||+|+++.+|+.||||++... ......+.+|+++|+.++
T Consensus 4 ~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---------~~~~~~~~~Ei~~l~~l~~~~~~~~ 74 (362)
T d1q8ya_ 4 AFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---------KVYTEAAEDEIKLLQRVNDADNTKE 74 (362)
T ss_dssp CCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---------HHHHHHHHHHHHHHHHHHHTCCSHH
T ss_pred CCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---------ccchHHHHHHHHHHHHhcchhhhhh
Confidence 33445443 5799999999999999999999999999999998421 122345667888888775
Q ss_pred ----CCCeeeeccccccC--CcceEEeeccCCCChhcc---cccCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccccCCc
Q 005944 128 ----HPNIVRYLGTARED--DSLNILLEFVPGGSISSL---LGKFGSFPESVIRMYTKQLLLGLEYLHK-NGIMHRDIKG 197 (668)
Q Consensus 128 ----HpNIV~l~g~~~~~--~~~~LVmEy~~gGsL~~~---L~~~~~l~e~~~~~i~~QIl~aL~yLHs-~gIvHrDLKP 197 (668)
|+|||++++++... ...+++|+++..+..... ......+++..++.++.||+.||.|||+ .||+||||||
T Consensus 75 ~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp 154 (362)
T d1q8ya_ 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 154 (362)
T ss_dssp HHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSG
T ss_pred hhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCCh
Confidence 57899999887543 456667777655543222 2344678999999999999999999998 8999999999
Q ss_pred ccEEeCCCC------ceEEecCCchhhhHhhhhhcCCccCCCCCCCCChHHHhhcCCCcchhHHHHHHHHHHHHhCCCCC
Q 005944 198 ANILVDNKG------CIKLADFGASKKVVELATINGAKSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPW 271 (668)
Q Consensus 198 eNILld~~g------~vKL~DFGlA~~~~~~~~~~~~~~~~GT~~Y~APEvl~~~~~s~ksDIWSLGvILyeLLTG~~PF 271 (668)
+||||+.++ .+||+|||.+.... ......+||+.|+|||++.+..|+.++|||||||++++|++|+.||
T Consensus 155 ~NIll~~~~~~~~~~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF 229 (362)
T d1q8ya_ 155 ENVLMEIVDSPENLIQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLF 229 (362)
T ss_dssp GGEEEEEEETTTTEEEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC
T ss_pred hHeeeeccCcccccceeeEeecccccccc-----cccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCC
Confidence 999998665 49999999987542 2335678999999999999999999999999999999999999999
Q ss_pred chhHH--------HHHHHHhh-cc---------------------CCC---------------CCCCCcccCHHHHHHHH
Q 005944 272 SQQFQ--------EVAALFHI-GT---------------------TKS---------------HPPIPEHLSMEAKDFLL 306 (668)
Q Consensus 272 ~~~~~--------~~~~~~~~-~~---------------------~~~---------------~~~~p~~ls~el~dLI~ 306 (668)
..... ........ +. ... ....+...++++.+||.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~ 309 (362)
T d1q8ya_ 230 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309 (362)
T ss_dssp ---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHG
T ss_pred CCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHH
Confidence 63211 11111100 00 000 11123456788999999
Q ss_pred HhhhhCCCCCCCHHHHHcCccccCCC
Q 005944 307 KCLQKEPYLRSTASELLQHPFVTGKY 332 (668)
Q Consensus 307 kcL~~dP~~RPSa~EIL~Hpwf~~~~ 332 (668)
+||+.||.+|||+.|||+||||++..
T Consensus 310 ~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 310 PMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp GGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHCCCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999999999999998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.91 E-value=6e-25 Score=212.73 Aligned_cols=173 Identities=18% Similarity=0.133 Sum_probs=123.1
Q ss_pred eeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccch----------hhHhhHHHHHHHHHHHHHHHhCCCCCeeeec
Q 005944 66 WRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSA----------SKEKTQAHIRELEEEVKLLKNLTHPNIVRYL 135 (668)
Q Consensus 66 y~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~----------~~~~~~~~~~~~~~Ei~iL~~L~HpNIV~l~ 135 (668)
+.++++||+|+||+||+|++. +|+.||||++....... ..............|+..|.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 468999999999999999874 68999999874321110 0011122234456789999999999999887
Q ss_pred cccccCCcceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCCcccEEeCCCCceEEecCCc
Q 005944 136 GTAREDDSLNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHKNGIMHRDIKGANILVDNKGCIKLADFGA 215 (668)
Q Consensus 136 g~~~~~~~~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs~gIvHrDLKPeNILld~~g~vKL~DFGl 215 (668)
++. ..++||||++++.+.. +++..+..++.||+.+|.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred Eec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 653 2479999998866543 3445578899999999999999999999999999999865 589999999
Q ss_pred hhhhHhhhhhcCCccCCCCCCCCCh--HH---HhhcCCCcchhHHHHHHHH
Q 005944 216 SKKVVELATINGAKSMKGTPYWMAP--EV---ILQTGHSFSADIWSVGCTV 261 (668)
Q Consensus 216 A~~~~~~~~~~~~~~~~GT~~Y~AP--Ev---l~~~~~s~ksDIWSLGvIL 261 (668)
|+....... ..|... +. +....|+.++||||+.--+
T Consensus 149 a~~~~~~~~----------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 149 SVEVGEEGW----------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CEETTSTTH----------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred cccCCCCCc----------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 865321110 011111 00 1235678899999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.31 E-value=2.7e-07 Score=90.40 Aligned_cols=138 Identities=18% Similarity=0.138 Sum_probs=89.2
Q ss_pred CeeeeeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-CCCeeeeccccccCCc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-HPNIVRYLGTAREDDS 143 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-HpNIV~l~g~~~~~~~ 143 (668)
.|+..+..+-++.+.||+.. .++..+.||+...... .....+.+|+.+|..+. +--+.+++.+...++.
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~--------~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK--------GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT--------TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred ceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc--------cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 45666655445567899885 3566778887632110 01123556788877764 3335566777777788
Q ss_pred ceEEeeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 005944 144 LNILLEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLHK------------------------------------ 187 (668)
Q Consensus 144 ~~LVmEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLHs------------------------------------ 187 (668)
.++||++++|..+....... .....++.++...|..||+
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGS
T ss_pred eEEEEEeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccc
Confidence 99999999998876543221 1122334445555555552
Q ss_pred -----------------------CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 188 -----------------------NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 188 -----------------------~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 160 ~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 137999999999999977666799999765
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.03 E-value=4.4e-06 Score=81.05 Aligned_cols=127 Identities=24% Similarity=0.194 Sum_probs=80.3
Q ss_pred EEcccC-ceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCC--CCeeeeccccccCCcceEE
Q 005944 71 LVGCGA-FGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTH--PNIVRYLGTAREDDSLNIL 147 (668)
Q Consensus 71 ~LG~G~-fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~H--pNIV~l~g~~~~~~~~~LV 147 (668)
.+..|. .+.||++. ..++..+.+|...... ...+..|+..|+.+.. -.+.+++.+....+..++|
T Consensus 17 ~~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~-----------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v 84 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGA-----------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLL 84 (255)
T ss_dssp ECSCTTSSCEEEEEE-CTTSCCEEEEEECSCT-----------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEE
T ss_pred EcCCcccCCeEEEEE-eCCCCEEEEEeCCccC-----------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEE
Confidence 345554 46899886 4567778899752111 1124567777776643 2355677777777889999
Q ss_pred eeccCCCChhcccccCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 005944 148 LEFVPGGSISSLLGKFGSFPESVIRMYTKQLLLGLEYLH----------------------------------------- 186 (668)
Q Consensus 148 mEy~~gGsL~~~L~~~~~l~e~~~~~i~~QIl~aL~yLH----------------------------------------- 186 (668)
|++++|.++.... .... .++.++...|..||
T Consensus 85 ~~~i~G~~~~~~~-----~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (255)
T d1nd4a_ 85 LGEVPGQDLLSSH-----LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 156 (255)
T ss_dssp EECCSSEETTTSC-----CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred EEeeecccccccc-----ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhh
Confidence 9999987765421 1111 11122223333333
Q ss_pred ----------h-------CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 187 ----------K-------NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 187 ----------s-------~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
. ..++|+|+.|.|||++.++.+-|+||+.+.
T Consensus 157 ~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 157 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1 137999999999999987677899999764
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.80 E-value=1.4e-05 Score=83.97 Aligned_cols=84 Identities=15% Similarity=0.127 Sum_probs=46.7
Q ss_pred eeEEcccCceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCC-C--CCeeeeccccccCCcce
Q 005944 69 GELVGCGAFGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLT-H--PNIVRYLGTAREDDSLN 145 (668)
Q Consensus 69 ~~~LG~G~fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~-H--pNIV~l~g~~~~~~~~~ 145 (668)
.+.||.|....||++.+..+++.|+||.-......... ..+........|+..|+.+. + ..+.+++.+ +....+
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~-~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~ 107 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGE-SWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 107 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--C-CCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCC-CCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCE
Confidence 34689999999999988777889999975321110000 00001122345677776652 2 335555544 345678
Q ss_pred EEeeccCCCC
Q 005944 146 ILLEFVPGGS 155 (668)
Q Consensus 146 LVmEy~~gGs 155 (668)
+|||++.+..
T Consensus 108 lvmE~L~~~~ 117 (392)
T d2pula1 108 TVMEDLSHLK 117 (392)
T ss_dssp EEECCCTTSE
T ss_pred EEEeccCCcc
Confidence 9999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.95 E-value=0.00043 Score=70.11 Aligned_cols=69 Identities=17% Similarity=0.103 Sum_probs=41.2
Q ss_pred ceEEEEEEEcCCCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCe-----eeec--cccccCCcceEEee
Q 005944 77 FGRVYMGMNLDSGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI-----VRYL--GTAREDDSLNILLE 149 (668)
Q Consensus 77 fG~Vy~a~~~~tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-----V~l~--g~~~~~~~~~LVmE 149 (668)
--.||++. ..+|..|++|+.... ... ...+..|...|..|...+| +..- ..+...+..+.|++
T Consensus 35 EN~vy~v~-~~dg~~~VlK~~rp~------~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~ 104 (325)
T d1zyla1 35 ENRVYQFQ-DEDRRRFVVKFYRPE------RWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFP 104 (325)
T ss_dssp SSEEEEEC-CTTCCCEEEEEECTT------TSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEE
T ss_pred cceeEEEE-cCCCCEEEEEEeCCC------CCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEe
Confidence 36899997 467889999986211 111 2335567777777743322 1111 12234556788999
Q ss_pred ccCCCC
Q 005944 150 FVPGGS 155 (668)
Q Consensus 150 y~~gGs 155 (668)
+++|..
T Consensus 105 ~~~G~~ 110 (325)
T d1zyla1 105 SVGGRQ 110 (325)
T ss_dssp CCCCEE
T ss_pred ecCCcC
Confidence 998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.60 E-value=0.0025 Score=65.87 Aligned_cols=78 Identities=14% Similarity=0.227 Sum_probs=48.9
Q ss_pred CeeeeeEEcccCceEEEEEEEcC-------CCcEEEEEEeeecccchhhHhhHHHHHHHHHHHHHHHhCCCCCe-eeecc
Q 005944 65 RWRKGELVGCGAFGRVYMGMNLD-------SGELLAVKQVLIAANSASKEKTQAHIRELEEEVKLLKNLTHPNI-VRYLG 136 (668)
Q Consensus 65 ry~i~~~LG~G~fG~Vy~a~~~~-------tg~~VAVK~i~~~~~~~~~~~~~~~~~~~~~Ei~iL~~L~HpNI-V~l~g 136 (668)
.+++ +.|+.|-.-.+|++.... ....|.+++.- .. ... ....+|..+++.+.-.++ .++++
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~---~~~------idr~~E~~i~~~ls~~gl~Pkll~ 112 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP---ETE------SHLVAESVIFTLLSERHLGPKLYG 112 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC---CCH------HHHHHHHHHHHHHHHTTSSSCEEE
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc---chh------hHHHHHHHHHHHHHhCCCCCeEEE
Confidence 3444 578888889999998653 24567777652 11 011 123467888887753343 46777
Q ss_pred ccccCCcceEEeeccCCCChh
Q 005944 137 TAREDDSLNILLEFVPGGSIS 157 (668)
Q Consensus 137 ~~~~~~~~~LVmEy~~gGsL~ 157 (668)
++.. .+|+||++|..|.
T Consensus 113 ~~~~----g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 113 IFSG----GRLEEYIPSRPLS 129 (395)
T ss_dssp EETT----EEEECCCCEEECC
T ss_pred EcCC----ceEEEEeccccCC
Confidence 6643 6899999886543
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.36 E-value=0.0033 Score=62.41 Aligned_cols=30 Identities=23% Similarity=0.310 Sum_probs=27.0
Q ss_pred CCcccccCCcccEEeCCCCceEEecCCchh
Q 005944 188 NGIMHRDIKGANILVDNKGCIKLADFGASK 217 (668)
Q Consensus 188 ~gIvHrDLKPeNILld~~g~vKL~DFGlA~ 217 (668)
.|+||+|+.+.||+++.+...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhcccccceeEecccccc
Confidence 479999999999999988877899999875
|